PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Guo, JB; Xu, C; Li, XC; Chen, S				Guo, Jiubiao; Xu, Ci; Li, Xuechen; Chen, Sheng			A Simple, Rapid and Sensitive FRET Assay for Botulinum Neurotoxin Serotype B Detection	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; LASER-DESORPTION IONIZATION; CLOSTRIDIUM-BOTULINUM; SUBSTRATE RECOGNITION; ENDOPEP-MS; TOXINS; IDENTIFICATION; TETANUS; TRANSCYTOSIS; SPECIFICITY	Botulinum neurotoxins (BoNTs), the most potent naturally-occurring neurotoxins known to humans, comprise seven distinct serotypes (BoNT/A-G), each of which exhibits unique substrate specificity. Many methods have been developed for BoNT detection, in particular for BoNT/A, with various complexity and sensitivity, while substrate based FRET assay is considered as the most widely used approach due to its simplicity and sensitivity. In this study, we designed a vesicle-associated membrane protein 2 (VAMP2) based FRET assay based on the understanding of the VAMP2 and light chain/B (LC/B) interactions in our previous studies. The current design constituted the shortest peptide, VAMP2 (63-85), with FRET dyes (EDAN and Dabcyl) labelled at position 76 and 85, respectively, which showed minimal effect on VAMP2 substrate catalysis by LC/B and therefore enhanced the sensitivity of the assay. The FRET peptide, designated as FVP-B, was specific to LC/B, with a detection sensitivity as low as similar to 20 pM in 2 h. Importantly, FVP-B showed the potential to be scaled up and used in high throughput screening of LC/B inhibitor. The currently developed FRET assay is one of the most economic and rapid FRET assays for LC/B detection.	[Guo, Jiubiao; Chen, Sheng] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Xu, Ci; Li, Xuechen] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong	Li, XC (corresponding author), Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China.	xuechenl@hku.hk; sheng.chen@polyu.edu.hk		Guo, Jiubiao/0000-0003-2716-1712; Chen, Sheng/0000-0003-3526-7808	Hong Kong Research Grant Council [560211]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was sponsored by the grant from Hong Kong Research Grant Council, 560211 for SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne C, 2001, ANAL BIOCHEM, V291, P253, DOI 10.1006/abio.2001.5028; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P2081; Barr JR, 2011, ACS SYM SER, V1065, P83; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Bossi Philippe, 2004, Euro Surveill, V9, pE13; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Chen S, 2011, BIOCHEM J, V433, P277, DOI 10.1042/BJ20101310; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dunning FM, 2012, APPL ENVIRON MICROB, V78, P7687, DOI 10.1128/AEM.01664-12; FACH P, 1993, J APPL BACTERIOL, V75, P234, DOI 10.1111/j.1365-2672.1993.tb02771.x; Fach P, 2009, J APPL MICROBIOL, V107, P465, DOI 10.1111/j.1365-2672.2009.04215.x; Feltrup TM, 2012, ANAL CHEM, V84, P10549, DOI 10.1021/ac302997n; Ferreira JL, 2003, J AOAC INT, V86, P314; Fujinaga Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/974943; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Joshi SG, 2012, J PHARMACOL TOX MET, V65, P8, DOI 10.1016/j.vascn.2011.11.002; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2012, ANAL BIOANAL CHEM, V403, P215, DOI 10.1007/s00216-012-5767-3; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; Kirchner S, 2010, APPL ENVIRON MICROB, V76, P4387, DOI 10.1128/AEM.02490-09; Kohler G, 2005, J IMMUNOL, V174, P2453; KOZAKI S, 1979, JPN J MED SCI BIOL, V32, P199, DOI 10.7883/yoken1952.32.199; LANGE DJ, 1991, MUSCLE NERVE, V14, P672, DOI 10.1002/mus.880140711; Liu W, 2003, P NATL ACAD SCI USA, V100, P13621, DOI 10.1073/pnas.2233819100; Maksymowych AB, 1998, J BIOL CHEM, V273, P21950, DOI 10.1074/jbc.273.34.21950; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; NOTERMANS S, 1979, APPL ENVIRON MICROB, V37, P1173, DOI 10.1128/AEM.37.6.1173-1175.1979; OHISHI I, 1980, INFECT IMMUN, V28, P303; Pickett Andy, 2011, Int J Neurosci, V121 Suppl 1, P22, DOI 10.3109/00207454.2010.539306; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salzameda NT, 2009, BIOORG MED CHEM LETT, V19, P5848, DOI 10.1016/j.bmcl.2009.08.079; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Scotcher MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011047; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; van Baar BLM, 2004, J CHROMATOGR A, V1035, P97, DOI 10.1016/j.chroma.2004.02.047; van Baar BLM, 2002, J CHROMATOGR A, V970, P95, DOI 10.1016/S0021-9673(02)00508-3; WANG GT, 1990, TETRAHEDRON LETT, V31, P6493, DOI 10.1016/S0040-4039(00)97099-0; Wictome M, 1999, APPL ENVIRON MICROB, V65, P3787	45	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114124	10.1371/journal.pone.0114124	http://dx.doi.org/10.1371/journal.pone.0114124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437190	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900122
J	Llufriu, S; Sepulveda, M; Blanco, Y; Marin, P; Moreno, B; Berenguer, J; Gabilondo, I; Martinez-Heras, E; Sola-Valls, N; Arnaiz, JA; Andreu, EJ; Fernandez, B; Bullich, S; Sanchez-Dalmau, B; Graus, F; Villoslada, P; Saiz, A				Llufriu, Sara; Sepulveda, Maria; Blanco, Yolanda; Marin, Pedro; Moreno, Beatriz; Berenguer, Joan; Gabilondo, Inigo; Martinez-Heras, Eloy; Sola-Valls, Nuria; Arnaiz, Joan-Albert; Andreu, Enrique J.; Fernandez, Begona; Bullich, Santi; Sanchez-Dalmau, Bernardo; Graus, Francesc; Villoslada, Pablo; Saiz, Albert			Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis	PLOS ONE			English	Article							OPEN-LABEL; THERAPY; TH1; TRANSPLANTATION; DISEASES; OUTCOMES; SAFETY	Objective: Uncontrolled studies of mesenchymal stem cells (MSCs) in multiple sclerosis suggested some beneficial effect. In this randomized, double-blind, placebo-controlled, crossover phase II study we investigated their safety and efficacy in relapsing-remitting multiple sclerosis patients. Efficacy was evaluated in terms of cumulative number of gadolinium-enhancing lesions (GEL) on magnetic resonance imaging (MRI) at 6 months and at the end of the study. Methods: Patients unresponsive to conventional therapy, defined by at least 1 relapse and/or GEL on MRI scan in past 12 months, disease duration 2 to 10 years and Expanded Disability Status Scale (EDSS) 3.0-6.5 were randomized to receive IV 1-2 x 10(6) bone-marrow-derived-MSCs/Kg or placebo. After 6 months, the treatment was reversed and patients were followed-up for another 6 months. Secondary endpoints were clinical outcomes (relapses and disability by EDSS and MS Functional Composite), and several brain MRI and optical coherence tomography measures. Immunological tests were explored to assess the immunomodulatory effects. Results: At baseline 9 patients were randomized to receive MSCs (n=5) or placebo (n=4). One patient on placebo withdrew after having 3 relapses in the first 5 months. We did not identify any serious adverse events. At 6 months, patients treated with MSCs had a trend to lower mean cumulative number of GEL (3.1, 95% CI=1.1-8.8 vs 12.3, 95% CI=4.4-34.5, p=0.064), and at the end of study to reduced mean GEL (-2.8 +/- 5.9 vs 3 +/- 5.4, p=0.075). No significant treatment differences were detected in the secondary endpoints. We observed a non-significant decrease of the frequency of Th1 (CD4(+) IFN-gamma(+)) cells in blood of MSCs treated patients. Conclusion: Bone-marrow-MSCs are safe and may reduce inflammatory MRI parameters supporting their immunomodulatory properties.	[Llufriu, Sara; Sepulveda, Maria; Blanco, Yolanda; Moreno, Beatriz; Gabilondo, Inigo; Martinez-Heras, Eloy; Sola-Valls, Nuria; Fernandez, Begona; Bullich, Santi; Sanchez-Dalmau, Bernardo; Graus, Francesc; Villoslada, Pablo; Saiz, Albert] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Llufriu, Sara; Sepulveda, Maria; Blanco, Yolanda; Moreno, Beatriz; Berenguer, Joan; Gabilondo, Inigo; Martinez-Heras, Eloy; Sola-Valls, Nuria; Fernandez, Begona; Bullich, Santi; Sanchez-Dalmau, Bernardo; Graus, Francesc; Villoslada, Pablo; Saiz, Albert] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Marin, Pedro] Hosp Clin Barcelona, CDB, Hemotherapy Serv, Barcelona, Spain; [Berenguer, Joan] Hosp Clin Barcelona, Serv Neurorradiol, Barcelona, Spain; [Arnaiz, Joan-Albert] Hosp Clin Barcelona, Dept Clin Pharmacol, Barcelona, Spain; [Andreu, Enrique J.] Univ Navarra Clin, Cell Therapy Area, Pamplona, Spain; [Sanchez-Dalmau, Bernardo] Hosp Clin Barcelona, Serv Ophtalmol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona	Saiz, A (corresponding author), Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain.	asaiz@clinic.ub.es	Andreu, Enrique J/F-9813-2016; Llufriu, Sara/T-6761-2019; Martinez-Heras, Eloy/AAN-1849-2020; Llufriu, Sara/K-2987-2014; Villoslada, Pablo/AAF-9547-2019; Graus, Francesc/K-9904-2018; Gabilondo, Iñigo/I-8274-2012	Andreu, Enrique J/0000-0001-5317-9989; Martinez-Heras, Eloy/0000-0001-9937-3162; Llufriu, Sara/0000-0003-4273-9121; Gabilondo, Iñigo/0000-0001-6045-2840; Graus, Francesc/0000-0002-8924-8322; Sola-Valls, Nuria/0000-0002-6396-219X; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759	Ministerio de Sanidad y Politica Social, Spain [TRA-066]	Ministerio de Sanidad y Politica Social, Spain	This work was supported by Ministerio de Sanidad y Politica Social [grant number TRA-066], Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bonab MM, 2012, CURR STEM CELL RES T, V7, P407; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Darlington PJ, 2010, ANN NEUROL, V68, P540, DOI 10.1002/ana.22065; de Mendizabal NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073361; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Rice CM, 2010, CLIN PHARMACOL THER, V87, P679, DOI 10.1038/clpt.2010.44; Rice CM, 2013, LANCET, V382, P1204, DOI 10.1016/S0140-6736(13)61810-3; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013	18	98	100	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113936	10.1371/journal.pone.0113936	http://dx.doi.org/10.1371/journal.pone.0113936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436769	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900099
J	Vanegas, JM; Arroyo, M				Vanegas, Juan M.; Arroyo, Marino			Force Transduction and Lipid Binding in MscL: A Continuum-Molecular Approach	PLOS ONE			English	Article							ION-CHANNEL MSCL; MECHANOSENSITIVE CHANNEL; HYDROPHOBIC MISMATCH; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; LARGE-CONDUCTANCE; CRYSTAL-STRUCTURE; GATING MECHANISM; SIMULATION; RHODOPSIN	The bacterial mechanosensitive channel MscL, a small protein mainly activated by membrane tension, is a central model system to study the transduction of mechanical stimuli into chemical signals. Mutagenic studies suggest that MscL gating strongly depends on both intra-protein and interfacial lipid-protein interactions. However, there is a gap between this detailed chemical information and current mechanical models of MscL gating. Here, we investigate the MscL bilayer-protein interface through molecular dynamics simulations, and take a combined continuum-molecular approach to connect chemistry and mechanics. We quantify the effect of membrane tension on the forces acting on the surface of the channel, and identify interactions that may be critical in the force transduction between the membrane and MscL. We find that the local stress distribution on the protein surface is largely asymmetric, particularly under tension, with the cytoplasmic side showing significantly larger and more localized forces, which pull the protein radially outward. The molecular interactions that mediate this behavior arise from hydrogen bonds between the electronegative oxygens in the lipid headgroup and a cluster of positively charged lysine residues on the amphipathic S1 domain and the C-terminal end of the second trans-membrane helix. We take advantage of this strong interaction (estimated to be 10-13 kT per lipid) to actuate the channel (by applying forces on protein-bound lipids) and explore its sensitivity to the pulling magnitude and direction. We conclude by highlighting the simple motif that confers MscL with strong anchoring to the bilayer, and its presence in various integral membrane proteins including the human mechanosensitive channel K2P1 and bovine rhodopsin.	[Vanegas, Juan M.; Arroyo, Marino] Univ Politecn Cataluna, BarcelonaTech, LaCaN, Barcelona, Spain	Universitat Politecnica de Catalunya	Vanegas, JM (corresponding author), Sandia Natl Labs, Ctr Biol & Mat Sci, POB 5800, Albuquerque, NM 87185 USA.	jmvaneg@sandia.gov	Arroyo, Marino/B-5696-2008	Arroyo, Marino/0000-0003-1647-940X	European Research Council [240487]; "ICREA Academia" for excellence in research - Generalitat de Catalunya	European Research Council(European Research Council (ERC)European Commission); "ICREA Academia" for excellence in research - Generalitat de Catalunya(ICREA)	JMV and MA acknowledge the support of the European Research Council (http://erc.europa.eu/ grant agreement nr 240487 (FP7/2007-2013). MA acknowledges the support received through the prize "ICREA Academia" for excellence in research, funded by the Generalitat de Catalunya (http://www.gencat.cat/generalitat/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chiu SW, 2009, J PHYS CHEM B, V113, P2748, DOI 10.1021/jp807056c; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Maurer JA, 2003, J BIOL CHEM, V278, P21076, DOI 10.1074/jbc.M302892200; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Powl AM, 2007, BIOPHYS J, V93, P113, DOI 10.1529/biophysj.107.105130; Reeves D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041901; Rycroft CH, 2009, CHAOS, V19, DOI 10.1063/1.3215722; Sawada Y, 2012, CHANNELS, V6, P317, DOI 10.4161/chan.21895; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Strandberg E, 2012, BBA-BIOMEMBRANES, V1818, P1242, DOI 10.1016/j.bbamem.2012.01.023; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tadmor E. B., 2011, MODELING MAT CONTINU; Vanegas JM, 2014, J CHEM THEORY COMPUT, V10, P691, DOI 10.1021/ct4008926; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wiggins P, 2005, BIOPHYS J, V88, P880, DOI 10.1529/biophysj.104.047431; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yang LM, 2013, CELL REP, V3, P520, DOI 10.1016/j.celrep.2013.01.018; Yang LM, 2012, ACS NANO, V6, P1134, DOI 10.1021/nn203703j; Yoo J, 2013, BIOPHYS J, V104, P117, DOI 10.1016/j.bpj.2012.11.3812; Yoshimura K, 2004, BIOPHYS J, V86, P2113, DOI 10.1016/S0006-3495(04)74270-8; Zhong DL, 2014, BIOPHYS J, V106, P375, DOI 10.1016/j.bpj.2013.12.006	61	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113947	10.1371/journal.pone.0113947	http://dx.doi.org/10.1371/journal.pone.0113947			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437007	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900101
J	Yeka, A; Lameyre, V; Afizi, K; Fredrick, M; Lukwago, R; Kamya, MR; Talisuna, AO				Yeka, Adoke; Lameyre, Valerie; Afizi, Kibuuka; Fredrick, Mudangha; Lukwago, Robinson; Kamya, Moses R.; Talisuna, Ambrose O.			Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children	PLOS ONE			English	Article							ARTEMISININ COMBINATION THERAPY; PLASMODIUM-FALCIPARUM MALARIA; ANTIMALARIAL; SITES	The safety and efficacy of the two most widely used fixed-dose artemisinin-based combination therapies (ACT), artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) are well established for single episodes of uncomplicated Plasmodium falciparum malaria, but the effects of repeated, long-term use are not well documented. We conducted a 2-year randomized, open-label, longitudinal, phase IV clinical trial comparing the efficacy and safety of fixed-dose ASAQ and AL for repeated treatment of uncomplicated malaria in children under 5 years at Nagongera Health Centre, Uganda. Participants were randomized to ASAQ or AL and all subsequent malaria episodes were treated with the same regimen. 413 children were enrolled and experienced a total of 6027 malaria episodes (mean 15; range, 1-26). For the first malaria episode, the PCR-corrected-cure rate for ASAQ (97.5%) was non-inferior to that for AL (97.0%; 95% CI [-0.028; 0.037]). PCR-corrected cure rates for subsequent malaria episodes that had over 100 cases (episodes 2-18), ranged from 88.1% to 98.9% per episode, with no clear difference between the treatment arms. Parasites were completely cleared by day 3 for all malaria episodes and gametocyte carriage was less than 1% by day 21. Fever clearance was faster in the ASAQ group for the first episode. Treatment compliance for subsequent episodes (only first dose administration observed) was close to 100%. Adverse events though common were similar between treatment arms and mostly related to the disease. Serious adverse events were uncommon, comparable between treatment arms and resolved spontaneously. Anemia and neutropenia occurred in <0.5% of cases per episode, abnormal liver function tests occurred in 0.3% to 1.4% of cases. Both regimens were safe and effective for repeated treatment of malaria.	[Yeka, Adoke] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Lameyre, Valerie] Sanofi Access Med, Gentilly, France; [Afizi, Kibuuka; Kamya, Moses R.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Yeka, Adoke; Fredrick, Mudangha; Lukwago, Robinson; Kamya, Moses R.; Talisuna, Ambrose O.] Uganda Malaria Surveillance Program, Kampala, Uganda; [Talisuna, Ambrose O.] Univ Oxford KEMRI Wellcome Trust Programme, Malaria Publ Hlth Dept, Nairobi, Kenya	Makerere University; Sanofi-Aventis; Sanofi France; Makerere University	Yeka, A (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda.	yadoke@yahoo.com			Sanofi [ARAMF _ L_ 02661]	Sanofi	Funding: Financial support was provided by Sanofi Access to Medicines for the study number ARAMF _ L_ 02661, SMART-CURIE. One of the authors, Valerie Lameyre, works with Sanofi Access to Medicines, Gentilly, France, who are the funders of this study. The funders gave advice on the design of the study and were responsible for monitoring the conduct of the trial. The study monitoring was done by monitors from the funders. The investigators worked in consultation with the funders in analysis of data, decision to publish, and in preparation of the manuscript.	Adjei GO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-127; [Anonymous], ASS MON ANT DRUG EFF; [Anonymous], UG DEM HLTH SURV 200; [Anonymous], J TROP MED HYG; [Anonymous], 2007, METHODS TECHNIQUES C; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], UG MAL IND SURV 2009; [Anonymous], WHO MODEL LIST OF ES; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Ayede IA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-378; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duffy PE, 2005, LANCET, V366, P1908, DOI 10.1016/S0140-6736(05)67768-9; Espie E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-174; Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378; Faye B, 2010, TROP MED INT HEALTH, V15, P608, DOI 10.1111/j.1365-3156.2010.02487.x; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Gbotosho GO, 2012, AM J THER, V19, pE122, DOI 10.1097/MJT.0b013e318209e031; Greenwood B, 2012, LANCET INFECT DIS, V12, P512, DOI 10.1016/S1473-3099(12)70105-6; Griffin A, 2007, BRIT MED J, V334, P443, DOI 10.1136/bmj.39139.346782.DB; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Meyer CG, 2012, LANCET INFECT DIS, V12, P513, DOI 10.1016/S1473-3099(12)70106-8; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Ndiaye JL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-125; Ndiaye JLA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-16; Ndiaye JLA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-237; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250; Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48; Staedke SG, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-114; Taylor WRJ, 2006, B WORLD HEALTH ORGAN, V84, P956, DOI 10.2471/BLT.06.031492; Thiam S, 2012, LANCET INFECT DIS, V12, P512, DOI 10.1016/S1473-3099(12)70107-X; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Wanzira H, 2014, CLIN INFECT DIS, V59, P509, DOI 10.1093/cid/ciu353; WHO, 2012, WORLD MALARIA REPORT 2012, P1	40	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113311	10.1371/journal.pone.0113311	http://dx.doi.org/10.1371/journal.pone.0113311			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436614	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900038
J	Ortiz, JR; Neuzil, KM; Cooke, CR; Neradilek, MB; Goss, CH; Shay, DK				Ortiz, Justin R.; Neuzil, Kathleen M.; Cooke, Colin R.; Neradilek, Moni B.; Goss, Christopher H.; Shay, David K.			Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; RESPIRATORY VIRUSES; ADVISORY-COMMITTEE; UNITED-STATES; SEVERE SEPSIS; MORTALITY; ILLNESS; RECOMMENDATIONS; EPIDEMIOLOGY; AFRICA	Background: Studies seeking to estimate the burden of influenza among hospitalized adults often use case definitions that require presence of pneumonia. The goal of this study was to assess the extent to which restricting influenza testing to adults hospitalized with pneumonia could underestimate the total burden of hospitalized influenza disease. Methods: We conducted a modelling study using the complete State Inpatient Databases from Arizona, California, and Washington and regional influenza surveillance data acquired from CDC from January 2003 through March 2009. The exposures of interest were positive laboratory tests for influenza A (H1N1), influenza A (H3N2), and influenza B from two contiguous US Federal Regions encompassing the study area. We identified the two outcomes of interest by ICD-9-CM code: respiratory and circulatory hospitalizations, as well as critical illness hospitalizations (acute respiratory failure, severe sepsis, and in-hospital death). We linked the hospitalization datasets with the virus surveillance datasets by geographic region and month of hospitalization. We used negative binomial regression models to estimate the number of influenza-associated events for the outcomes of interest. We sub-categorized these events to include all outcomes with or without pneumonia diagnosis codes. Results: We estimated that there were 80,834 (95% CI 29,214-174,033) influenza-associated respiratory and circulatory hospitalizations and 26,760 (95% CI 14,541-47,464) influenza-associated critical illness hospitalizations. When a pneumonia diagnosis was excluded, the estimated number of influenza-associated respiratory and circulatory hospitalizations was 24,816 (95% CI 6,342-92,624). The estimated number of influenza-associated critical illness hospitalizations was 8,213 (95% CI 3,764-20,799). Around 30% of both influenza-associated respiratory and circulatory hospitalizations, as well as influenza-associated critical illness hospitalizations did not have pneumonia diagnosis codes. Conclusions: Surveillance studies which only consider hospitalizations that include a diagnosis of pneumonia may underestimate the total burden of influenza hospitalizations.	[Ortiz, Justin R.; Neuzil, Kathleen M.; Goss, Christopher H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] PATH, Vaccine Access & Delivery Global Program, Seattle, WA USA; [Cooke, Colin R.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Neradilek, Moni B.] Mt Whisper Light Stat, Seattle, WA USA; [Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA	Ortiz, JR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jrortiz@uw.edu		Ortiz, Justin/0000-0002-3138-5965; Goss, Christopher/0000-0001-8602-0309; Cooke, Colin/0000-0001-9713-5371; Shay, David/0000-0001-9619-4820	Robert Wood Johnson Harold Amos Medical Faculty Development Program [67423]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020672] Funding Source: NIH RePORTER	Robert Wood Johnson Harold Amos Medical Faculty Development Program(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the Robert Wood Johnson Harold Amos Medical Faculty Development Program, grant 67423 (JRO), http://www.amfdp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed JA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-7; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], WEEKL SURV REP; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Barakat A, 2012, J INFECT DIS, V206, pS94, DOI 10.1093/infdis/jis547; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Cardoso Y, 2012, J INFECT DIS, V206, pS136, DOI 10.1093/infdis/jis534; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Dalhatu IT, 2012, J INFECT DIS, V206, pS121, DOI 10.1093/infdis/jis584; Davison AC, 1997, BOOTSTRAP METHODS TH; DeForest L.B., 2008, GROWERS AGRICULURAL; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fuller JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056882; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Healthcare Cost and Utilization Project (HCUP), DIET DIET HOSP; Healthcare Cost and Utilization Project (HCUP), 2003, HCUP STAT INP DAT, P2003; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jacks A, 2012, EURO SURVEILL, V17; Joint Committee on Vaccination and Immunisation, 2012, JCVI STAT ANN INFL V; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Mmbaga VM, 2012, J INFECT DIS, V206, pS80, DOI 10.1093/infdis/jis540; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; Ortiz JR, 2013, AM J RESP CRIT CARE, V188, P710, DOI 10.1164/rccm.201212-2341OC; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Seymour CW, 2012, AM J RESP CRIT CARE, V186, P1264, DOI 10.1164/rccm.201204-0713OC; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; World Health Organization, 2012, WHO GLOB EP SURV STA; Yang L, 2012, EUROSURVEILLANCE, V17, P8; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113903	10.1371/journal.pone.0113903	http://dx.doi.org/10.1371/journal.pone.0113903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423025	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700076
J	Pokorny, T; Lunau, K; Eltz, T				Pokorny, Tamara; Lunau, Klaus; Eltz, Thomas			Raising the Sugar Content - Orchid Bees Overcome the Constraints of Suction Feeding through Manipulation of Nectar and Pollen Provisions	PLOS ONE			English	Article							EUGLOSSINE BEES; HYMENOPTERA; ENERGY; EFFICIENCY; EVOLUTION; BIOLOGY; APIDAE; FLIGHT; DEPTH	Unlike most other bees, the long-tongued orchid bees ingest nectar using suction feeding. Although long tongues allow exploitation of flowers with deep spurs, the energy intake rate is optimal at 10-20% lower nectar sugar concentrations compared to that of lapping bees. This constraint might be compensated by a higher digestive throughput. Additionally, orchid bees might evaporate water from regurgitated droplets of crop contents. We found male Euglossa championi (n=10) and Euglossa dodsoni (n=12) to regularly regurgitate droplets of crop content to the base of their proboscis, generating a fluid film between the proximal parts of the galeae, glossa and labial palps. Rhythmic movements of the proboscis may help to increase convection. There was a significant change in sugar concentration between the initially imbibed solution and the resulting crop content (P<0.05) and the time individual bees had engaged in this liquid exposure behavior was positively correlated with the resulting crop sugar concentration. Female Euglossa townsendi and Euglossa viridissima showed the same behavior. Additionally, they manipulated their nectar-enriched pollen provisions for extensive periods of time before deposition in brood cells. The deposited pollen loads (n=14) showed a significantly higher sugar concentration than the sugar-water available to the bees (P<0.001). Thus, both male and female euglossines show behaviors that promote evaporative water loss from nectar. We suggest that the behaviors have evolved in concert with suction feeding on dilute nectar from deep floral tubes.	[Pokorny, Tamara; Eltz, Thomas] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Pokorny, Tamara; Lunau, Klaus] Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany	Ruhr University Bochum; Heinrich Heine University Dusseldorf	Pokorny, T (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, Bochum, Germany.	tamara.pokorny@ruhr-uni-bochum.de	Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201; Eltz, Thomas/0000-0002-8465-7944	German Science Foundation [EL 249/6]; Deutscher Akademischer Austausch Dienst	German Science Foundation(German Research Foundation (DFG)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financially supported by the German Science Foundation (www.dfg.de), grant EL 249/6 to TE, and by a short-term fellowship of the Deutscher Akademischer Austausch Dienst (www.daad.de) to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H G, 1975, Biotropica, V7, P37, DOI 10.2307/2989798; Banschbach VS, 1992, THESIS; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Blatt J, 2002, J INSECT PHYSIOL, V48, P643, DOI 10.1016/S0022-1910(02)00090-2; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Borrell BJ, 2004, P ROY SOC LOND B BIO, V271, P164; Borrell BJ, 2007, AM NAT, V169, P569, DOI 10.1086/512689; Burkle L, 2009, ENVIRON ENTOMOL, V38, P1293, DOI 10.1603/022.038.0441; Cane JH, 2011, APIDOLOGIE, V42, P401, DOI 10.1007/s13592-011-0005-0; Corbet S. A., 1979, Plant Cell and Environment, V2, P293, DOI 10.1111/j.1365-3040.1979.tb00084.x; CORBET SA, 1980, J AGR SCI, V95, P655, DOI 10.1017/S0021859600088055; CORBET SA, 1981, OECOLOGIA, V51, P412, DOI 10.1007/BF00540915; Cortopassi-Laurino Marilda, 2007, Bioscience Journal, V23, P153; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Elliott SE, 2008, ECOL ENTOMOL, V33, P298, DOI 10.1111/j.1365-2311.2007.00974.x; Eltz T, 2005, J COMP PHYSIOL A, V191, P575, DOI 10.1007/s00359-005-0603-2; GMEINBAUER R, 1993, J INSECT PHYSIOL, V39, P959, DOI 10.1016/0022-1910(93)90005-C; Harano K, 2013, BEHAV ECOL SOCIOBIOL, V67, P1169, DOI 10.1007/s00265-013-1542-5; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; HEYNEMAN AJ, 1983, OECOLOGIA, V60, P198, DOI 10.1007/BF00379522; INOUYE DW, 1980, ECOLOGY, V61, P992, DOI 10.2307/1936767; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; Kato Makoto, 1992, Tropics, V1, P259; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; KIMSEY LS, 1980, ANIM BEHAV, V28, P996, DOI 10.1016/S0003-3472(80)80088-1; Konzmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091900; MARSHALL LD, 1981, J ZOOL, V193, P315, DOI 10.1111/j.1469-7998.1981.tb03447.x; MICHENER C D, 1974, P404; NEFF JL, 1992, J KANSAS ENTOMOL SOC, V65, P377; Nicolson SW, 2008, BIOL LETTERS, V4, P299, DOI 10.1098/rsbl.2008.0034; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; Nicolson SW, 1998, AM ZOOL, V38, P418; Pacini E, 1996, SEX PLANT REPROD, V9, P362, DOI 10.1007/BF02441957; Pasedach-Poeverlein K., 1940, Zeitschrift fuer Vergleichende Physiologie Berlin, V28, P197, DOI 10.1007/BF00342435; PLOWRIGHT RC, 1987, CAN J BOT, V65, P1011, DOI 10.1139/b87-139; Pokorny T, 2015, APIDOLOGIE, V46, P224, DOI 10.1007/s13592-014-0317-y; R Core Team, 2021, R LANGUAGE ENV STAT; Rocha-Filho L.C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/934951; Roubik D.W., 1992, P327; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Roubik D. W., 2004, ORCHID BEES TROPICAL; ROUBIK DW, 1995, APIDOLOGIE, V26, P197, DOI 10.1051/apido:19950303; ROUBIK DW, 1984, OECOLOGIA, V61, P1, DOI 10.1007/BF00379082; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Rozen J. G. Jr., 1984, American Museum Novitates, P1; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Todd FE, 1942, J ECON ENTOMOL, V35, P312, DOI 10.1093/jee/35.3.312; VELTHUIS H H W, 1984, Israel Journal of Entomology, V18, P39; VOGEL STEFAN, 1966, OSTERREICH BOT ZEITSCHR, V113, P302, DOI 10.1007/BF01373435; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Weiner CN, 2010, APIDOLOGIE, V41, P476, DOI 10.1051/apido/2009083; WITTMANN D, 1989, BEHAV ECOL SOCIOBIOL, V25, P387, DOI 10.1007/BF00300184; Zimmermann Y, 2006, BEHAV ECOL SOCIOBIOL, V60, P833, DOI 10.1007/s00265-006-0227-8	54	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113823	10.1371/journal.pone.0113823	http://dx.doi.org/10.1371/journal.pone.0113823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422945	gold, Green Published			2022-12-27	WOS:000345899700068
J	Harris, JBC; Rasmussen, PC; Yong, DL; Prawiradilaga, DM; Putra, DD; Round, PD; Rheindt, FE				Harris, J. Berton C.; Rasmussen, Pamela C.; Yong, Ding Li; Prawiradilaga, Dewi M.; Putra, Dadang Dwi; Round, Philip D.; Rheindt, Frank E.			A New Species of Muscicapa Flycatcher from Sulawesi, Indonesia	PLOS ONE			English	Article							BIOGEOGRAPHIC RECORDS; HAWK-OWL; BIRDS; DEFORESTATION; BIODIVERSITY; AVIFAUNA; ISLANDS; FORESTS; NINOX; MODEL	The Indonesian island of Sulawesi, a globally important hotspot of avian endemism, has been relatively poorly studied ornithologically, to the extent that several new bird species from the region have been described to science only recently, and others have been observed and photographed, but never before collected or named to science. One of these is a new species of Muscicapa flycatcher that has been observed on several occasions since 1997. We collected two specimens in Central Sulawesi in 2012, and based on a combination of morphological, vocal and genetic characters, we describe the new species herein, more than 15 years after the first observations. The new species is superficially similar to the highly migratory, boreal-breeding Gray-streaked Flycatcher Muscicapa griseisticta, which winters in Sulawesi; however, the new species differs strongly from M. griseisticta in several morphological characters, song, and mtDNA. Based on mtDNA, the new species is only distantly related to M. griseisticta, instead being a member of the M. dauurica clade. The new species is evidently widely distributed in lowland and submontane forest throughout Sulawesi. This wide distribution coupled with the species' apparent tolerance of disturbed habitats suggests it is not currently threatened with extinction.	[Harris, J. Berton C.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Harris, J. Berton C.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Harris, J. Berton C.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Rasmussen, Pamela C.] Michigan State Univ, Museum & Dept Integrat Biol, E Lansing, MI 48824 USA; [Rasmussen, Pamela C.] Nat Hist Museum Tring, Dept Life Sci, Bird Grp, Tring, Herts, England; [Yong, Ding Li] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Yong, Ding Li] South East Asian Biodivers Soc, Singapore, Singapore; [Prawiradilaga, Dewi M.] Lembaga Ilmu Pengetahuan Indonesia, Biol Res Ctr, Div Zool, Cibinong Bogor, West Java, Indonesia; [Putra, Dadang Dwi] Celebes Bird Club, Palu, Central Sulawes, Indonesia; [Round, Philip D.] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Rheindt, Frank E.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Adelaide; University of Adelaide; Princeton University; Michigan State University; Natural History Museum London; Australian National University; Indonesian Institute of Sciences; Mahidol University; National University of Singapore	Rheindt, FE (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsrfe@nus.edu.sg		Yong, Ding Li/0000-0003-3115-6916	National Geographic Society [NGS CRE 8919-11]; Loke Wan Tho Memorial Foundation; EIPR scholarship at the University of Adelaide; National University of Singapore Faculty of Science start-up grant [WBS R-154-000-570-133]; Research Centre for Biology-LIPI	National Geographic Society(National Geographic Society); Loke Wan Tho Memorial Foundation; EIPR scholarship at the University of Adelaide; National University of Singapore Faculty of Science start-up grant(National University of Singapore); Research Centre for Biology-LIPI	This project was funded by the National Geographic Society (NGS CRE 8919-11; granted to PCR), the Loke Wan Tho Memorial Foundation (granted to DLY), and an EIPR scholarship at the University of Adelaide (granted to JBCH). Labwork for this project was co-funded by a National University of Singapore Faculty of Science start-up grant to FER (WBS R-154-000-570-133). We thank RISTEK for issuing the national research permits (for 2011, 0215/SIP/FRP/VI/2011; for 2012, 183/SIP/FRP/SM/VI/2012) and Lore Lindu National Park for permit letters. The Research Centre for Biology-LIPI supported DMP and DDP in their field research and provided facilities for laboratory analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BirdLife International, 2014, BIRDLIFE INT DAT ZON; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Catterall M, 1997, RESULTS 1996 B UNPUB; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Coates B.J., 1997, GUIDE BIRDS WALLACEA; de Boer M, 2004, BIRDWATCHING TRIP RE; Dickinson EC, 2014, ZOOTAXA, V3869, P343, DOI 10.11646/zootaxa.3869.3.8; Farrow D, 2009, SULAWESI HALMAHERA B; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gregory P, 2000, SULAWESI BIRDING TRI; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; Hendriks H, 2012, REPORT BIRDS SEEN TR; Indrawan M., 2004, Bulletin of the British Ornithologists' Club, V124, P160; Indrawan M, 2008, WILSON J ORNITHOL, V120, P1, DOI 10.1676/06-051.1; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; King Ben, 1999, Forktail, V15, P104; Lambert FR, 1998, NEW SPECIES GYMNOCRE, V13, P1; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P67; Luijendijk TJC, 1997, BIRD OBSERVATIONS SU; Madika Buttu, 2011, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V131, P94; Martin T, 2010, CONSERV SOC, V8, P127, DOI DOI 10.4103/0972-4923.68914; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; *MUNS COL, 2000, MUNS SOIL COL CHARTS; Owen J, 2004, NATL GEOGRAPHIC NEWS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proctor NS, 1993, MANUAL ORNITHOLOGY; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen PC, 1999, WILSON BULL, V111, P457; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; Rheindt FE, 2008, MOL PHYLOGENET EVOL, V46, P88, DOI 10.1016/j.ympev.2007.09.011; Rheindt Frank E., 2010, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V130, P181; Rheindt Frank E., 2010, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V130, P33; Sangster G, 2010, MOL PHYLOGENET EVOL, V57, P380, DOI 10.1016/j.ympev.2010.07.008; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2006, AUK, V123, P275, DOI 10.1642/0004-8038(2006)123[0275:SABIP]2.0.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sodhi NS, 2005, BIOL CONSERV, V122, P547, DOI 10.1016/j.biocon.2004.07.023; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebb Graham, 2008, BirdingASIA, V10, P67; Ueda H, 1999, 283 WILD BIRD SONGS; Whitten T, 2002, ECOLOGY INDONESIA SE, V4	47	6	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112657	10.1371/journal.pone.0112657	http://dx.doi.org/10.1371/journal.pone.0112657			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419968	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900011
J	Islam, MZ; Hu, XM; Jin, LF; Liu, YZ; Peng, SA				Islam, Mohammad Zahidul; Hu, Xiao-Mei; Jin, Long-Fei; Liu, Yong-Zhong; Peng, Shu-Ang			Genome-Wide Identification and Expression Profile Analysis of Citrus Sucrose Synthase Genes: Investigation of Possible Roles in the Regulation of Sugar Accumulation	PLOS ONE			English	Article							DEFICIT IRRIGATION; FRUIT-QUALITY; FAMILY; DROUGHT; METABOLISM; CELLULOSE; ENZYMES; TISSUES; YIELD	Sucrose synthase (Sus) (EC 2.4.1.13) is a key enzyme for the sugar accumulation that is critical to form fruit quality. In this study, extensive data-mining and PCR amplification confirmed that there are at least six Sus genes (CitSus1-6) in the citrus genome. Gene structure and phylogeny analysis showed an evolutionary consistency with other plant species. The six Sus genes contain 12-15 exons and 11-14 introns and were evenly distributed into the three plant Sus groups (CitSus1 and CitSus2 in the Sus I group, CitSus3 and CitSus6 in the Sus II group, and CitSus4 and CitSus5 in the Sus III group). Transcripts of these six CitSus genes were subsequently examined. For tissues and organs, CitSus1 and 2 were predominantly expressed in fruit juice sacs (JS) whereas CitSus3 and 4 were predominantly expressed in early leaves (immature leaves), and CitSus5 and 6 were predominantly expressed in fruit JS and in mature leaves. During fruit development, CitSus5 transcript increased significantly and CitSus6 transcript decreased significantly in fruit JS. In the fruit segment membrane (SM), the transcript levels of CitSus2 and 5 were markedly higher and the abundant levels of CitSus3 and 6 gradually decreased. Moreover, transcript levels of CitSus1-4 examined were higher and the CitSus5 transcript level was lower in the fruit SM than in fruit JS, while CitSus6 had a similar transcript level in fruit JS and SM. In addition, transcripts of CitSus1-6 responded differently to dehydration in mature leaves or to mild drought stress in fruit JS and SM. Finally, the possible roles of Sus genes in the regulation of sugar accumulation are discussed; however, further study is required.	[Islam, Mohammad Zahidul; Hu, Xiao-Mei; Jin, Long-Fei; Liu, Yong-Zhong; Peng, Shu-Ang] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Liu, YZ (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	liuyongzhong@mail.hzau.edu.cn	Peng, shuang/GPX-0999-2022; 金, 龙飞/GWZ-6946-2022		Fundamental Research Funds for the Central Universities in China [2013PY082]	Fundamental Research Funds for the Central Universities in China	This work was supported by Fundamental Research Funds for the Central Universities in China (Grant No. 2013PY082) YZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XM, 2014, GENE, V539, P58, DOI 10.1016/j.gene.2014.01.062; Baier MC, 2010, PLANT PHYSIOL, V152, P1000, DOI 10.1104/pp.109.149898; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Barrero-Sicilia C, 2011, PLANTA, V234, P391, DOI 10.1007/s00425-011-1408-x; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen AQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-85; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; Garcia-Tejero I, 2010, AGR WATER MANAGE, V97, P614, DOI 10.1016/j.agwat.2009.12.005; GONZALEZ EM, 1995, J EXP BOT, V46, P1515, DOI 10.1093/jxb/46.10.1515; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hirose T, 2008, PLANT SCI, V174, P534, DOI 10.1016/j.plantsci.2008.02.009; Hockema BR, 2001, J AM SOC HORTIC SCI, V126, P599, DOI 10.21273/JASHS.126.5.599; Iglesias DJ, 2002, PHYSIOL PLANTARUM, V116, P563, DOI 10.1034/j.1399-3054.2002.1160416.x; Jiang N, 2014, SCI HORTIC-AMSTERDAM, V168, P73, DOI 10.1016/j.scienta.2014.01.021; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOCH KE, 1984, PLANT CELL ENVIRON, V7, P647, DOI 10.1111/1365-3040.ep11571540; Komatsu A, 2002, J EXP BOT, V53, P61, DOI 10.1093/jexbot/53.366.61; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; [LIU Yongzhong 刘永忠], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P300; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWELL CA, 1989, PLANT PHYSIOL, V90, P1394, DOI 10.1104/pp.90.4.1394; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Pelah D, 1997, PHYSIOL PLANTARUM, V99, P153, DOI 10.1034/j.1399-3054.1997.990121.x; Romero P, 2006, TREE PHYSIOL, V26, P1537, DOI 10.1093/treephys/26.12.1537; SCHAFFER AA, 1987, PHYSIOL PLANTARUM, V69, P151, DOI 10.1111/j.1399-3054.1987.tb01959.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiao XH, 2014, FEBS J, V281, P291, DOI 10.1111/febs.12595; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yakushiji H, 1996, J AM SOC HORTIC SCI, V121, P466, DOI 10.21273/JASHS.121.3.466; Yakushiji H, 1998, J AM SOC HORTIC SCI, V123, P719, DOI 10.21273/JASHS.123.4.719; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zou CS, 2013, J INTEGR PLANT BIOL, V55, P643, DOI 10.1111/jipb.12068	39	25	38	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113623	10.1371/journal.pone.0113623	http://dx.doi.org/10.1371/journal.pone.0113623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420091	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900062
J	Carrim, N; Walsh, TG; Consonni, A; Torti, M; Berndt, MC; Metharom, P				Carrim, Naadiya; Walsh, Tony G.; Consonni, Alessandra; Torti, Mauro; Berndt, Michael C.; Metharom, Pat			Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation	PLOS ONE			English	Article							SRC FAMILY KINASES; GLYCOPROTEIN-VI; PHOSPHOLIPASE C-GAMMA-2; INTEGRIN; PHOSPHORYLATION; PYK2; COLLAGEN; FAK; INHIBITOR; GENERATION	Background: We have previously shown the presence of a TRAF4/p47(phox)/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation. In other cell systems, NOX-dependent ROS formation is facilitated by Pyk2, which along with its closely related homologue FAK are known to be activated and phosphorylated downstream of ligand binding to GPVI. Aims: To evaluate the relative roles of Pyk2 and FAK in GPVI-dependent ROS formation and to determine their location within the GPVI signaling pathway. Methods and Results: Human and mouse washed platelets (from WT or Pyk2 KO mice) were pre-treated with pharmacological inhibitors targeting FAK or Pyk2 (PF-228 and Tyrphostin A9, respectively) and stimulated with the GPVI-specific agonist, CRP. FAK, but not Pyk2, was found to be essential for GPVI-dependent ROS production and aggregation. Subsequent human platelet studies with PF-228 confirmed FAK is essential for GPVI-mediated phosphatidylserine exposure, alpha-granule secretion (P-selectin (CD62P) surface expression) and integrin alpha(IIb)beta(3) activation. To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLC gamma 2, Ca2+ release, PKC, Hic-5, NOX1 and alpha(IIb)beta(3) activation. Conclusion: Overall, these data suggest a novel role for FAK in GPVI-dependent ROS formation and platelet activation and elucidate a proximal signaling role for FAK within the GPVI pathway.	[Carrim, Naadiya; Walsh, Tony G.; Berndt, Michael C.; Metharom, Pat] Royal Coll Surgeons Ireland, Dept Expt Med, Dublin 2, Ireland; [Berndt, Michael C.; Metharom, Pat] Curtin Univ, Fac Hlth Sci, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia; [Consonni, Alessandra; Torti, Mauro] Univ Pavia, Dept Biol & Biotechnol, Labs Biochem, I-27100 Pavia, Italy	Royal College of Surgeons - Ireland; Curtin University; University of Pavia	Metharom, P (corresponding author), Royal Coll Surgeons Ireland, Dept Expt Med, Dublin 2, Ireland.	pat.metharom@curtin.edu.au			Science Foundation Ireland [09/IN.1/B2601]; Fondazione Cariplo [2011-0436]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fondazione Cariplo(Fondazione Cariplo)	The work was supported by Science Foundation Ireland 09/IN.1/B2601 and Fondazione Cariplo, grant number 2011-0436, to Mauro Torti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achison M, 2001, J BIOL CHEM, V276, P3167, DOI 10.1074/jbc.M007186200; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Arthur JF, 2011, J THROMB HAEMOST, V9, P163, DOI 10.1111/j.1538-7836.2010.04091.x; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canobbio I, 2002, THROMB HAEMOSTASIS, V87, P509, DOI 10.1055/s-0037-1613032; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Choi JH, 2007, CELL SIGNAL, V19, P1784, DOI 10.1016/j.cellsig.2007.04.002; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Cipolla L, 2013, J THROMB HAEMOST, V11, P345, DOI 10.1111/jth.12099; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Evangelista V, 2007, BLOOD, V109, P2461, DOI 10.1182/blood-2006-06-029082; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hagmann J, 1998, J CELL SCI, V111, P2181; Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Ichinohe T, 1997, J BIOL CHEM, V272, P63; Jones ML, 2009, BIOCHEM BIOPH RES CO, V389, P198, DOI 10.1016/j.bbrc.2009.08.132; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V294, P1001, DOI 10.1016/S0006-291X(02)00568-5; Kim S, 2013, J BIOL CHEM, V288, P18194, DOI 10.1074/jbc.M113.461087; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lakkakorpi PT, 2001, J CELL SCI, V114, P149; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MARCUS AJ, 1977, J CLIN INVEST, V59, P149, DOI 10.1172/JCI108613; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Messina S, 2003, J NEUROCHEM, V84, P253, DOI 10.1046/j.1471-4159.2003.01519.x; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Olas B, 2007, PLATELETS, V18, P555, DOI 10.1080/09537100701504087; Park SJ, 2011, BIOCHEM BIOPH RES CO, V408, P465, DOI 10.1016/j.bbrc.2011.04.053; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Pasquet JM, 1999, MOL CELL BIOL, V19, P8326; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Raja S, 1997, J BIOL CHEM, V272, P10941; Roh ME, 2013, J THROMB HAEMOST, V11, P1776, DOI 10.1111/jth.12343; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; Wachowicz B, 2002, PLATELETS, V13, P175, DOI 10.1080/09533710022149395; Walsh TG, 2014, REDOX BIOL, V2, P178, DOI 10.1016/j.redox.2013.12.023; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Zhang X, 1999, P NATL ACAD SCI USA, V96, P9021, DOI 10.1073/pnas.96.16.9021	55	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113679	10.1371/journal.pone.0113679	http://dx.doi.org/10.1371/journal.pone.0113679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415317	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600070
J	Sleddering, MA; Markvoort, AJ; Dharuri, HK; Jeyakar, S; Snel, M; Juhasz, P; Lynch, M; Hines, W; Li, XH; Jazet, IM; Adourian, A; Hilbers, PAJ; Smit, JWA; Van Dijk, KW				Sleddering, Maria A.; Markvoort, Albert J.; Dharuri, Harish K.; Jeyakar, Skhandhan; Snel, Marieke; Juhasz, Peter; Lynch, Moira; Hines, Wade; Li, Xiaohong; Jazet, Ingrid M.; Adourian, Aram; Hilbers, Peter A. J.; Smit, Johannes W. A.; Van Dijk, Ko Willems			Proteomic Analysis in Type 2 Diabetes Patients before and after a Very Low Calorie Diet Reveals Potential Disease State and Intervention Specific Biomarkers	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; HORMONE-BINDING GLOBULIN; OBESE-PATIENTS; COMPLEMENT C3; PLASMA-CONCENTRATIONS; GLYCEMIC CONTROL; MELLITUS; INSULIN; PROTEIN; FIBRINOGEN	Very low calorie diets (VLCD) with and without exercise programs lead to major metabolic improvements in obese type 2 diabetes patients. The mechanisms underlying these improvements have so far not been elucidated fully. To further investigate the mechanisms of a VLCD with or without exercise and to uncover possible biomarkers associated with these interventions, blood samples were collected from 27 obese type 2 diabetes patients before and after a 16-week VLCD (Modifast,450 kcal/day). Thirteen of these patients followed an exercise program in addition to the VCLD. Plasma was obtained from 27 lean and 27 obese controls as well. Proteomic analysis was performed using mass spectrometry (MS) and targeted multiple reaction monitoring (MRM) and a large scale isobaric tags for relative and absolute quantitation (iTRAQ) approach. After the 16-week VLCD, there was a significant decrease in body weight and HbA1c in all patients, without differences between the two intervention groups. Targeted MRM analysis revealed differences in several proteins, which could be divided in diabetes-associated (fibrinogen, transthyretin), obesity-associated (complement C3), and diet-associated markers (apolipoproteins, especially apolipoprotein A-IV). To further investigate the effects of exercise, large scale iTRAQ analysis was performed. However, no proteins were found showing an exercise effect. Thus, in this study, specific proteins were found to be differentially expressed in type 2 diabetes patients versus controls and before and after a VLCD. These proteins are potential disease state and intervention specific biomarkers.	[Sleddering, Maria A.; Snel, Marieke; Jazet, Ingrid M.; Smit, Johannes W. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [Sleddering, Maria A.; Snel, Marieke; Jazet, Ingrid M.; Smit, Johannes W. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands; [Dharuri, Harish K.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Leiden, Netherlands; [Markvoort, Albert J.; Hilbers, Peter A. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Juhasz, Peter; Lynch, Moira; Hines, Wade; Li, Xiaohong; Adourian, Aram] BG Med Inc, Waltham, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eindhoven University of Technology	Sleddering, MA (corresponding author), Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands.	m.a.sleddering@lumc.nl	van Dijk, Ko Willems/A-1798-2008; Markvoort, Albert J/A-9833-2013; Markvoort, Albert/AAI-4535-2021; van Dijk, Ko Willems/AAT-4681-2021	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394	Roba Metals BV (IJsselstein, The Netherlands); Center for Translational Molecular Medicine (CTMM), project PREDICCt [01C-104]; Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)	Roba Metals BV (IJsselstein, The Netherlands)(Netherlands Government); Center for Translational Molecular Medicine (CTMM), project PREDICCt; Center of Medical Systems Biology (CMSB); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO))	Funding: This study was funded by an unrestricted grant of Roba Metals BV (IJsselstein, The Netherlands). Nutrition & Sante (Antwerp, Belgium) freely supplied the Modifast. This research was furthermore supported by the Center for Translational Molecular Medicine (CTMM), project PREDICCt (grant 01C-104), and by grants from the Center of Medical Systems Biology (CMSB), the Netherlands Consortium for Systems Biology (NCSB) established by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi PR, 2007, AM J PHYSIOL-ENDOC M, V293, pE1580, DOI 10.1152/ajpendo.00169.2007; Barazzoni R, 2003, DIABETES, V52, P1851, DOI 10.2337/diabetes.52.7.1851; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Becker A, 2003, NETH J MED, V61, P129; Bertile F, 2009, PROTEOMICS, V9, P148, DOI 10.1002/pmic.200701001; CABALLERO MJ, 1992, EUR J APPL PHYSIOL O, V64, P9, DOI 10.1007/BF00376432; Caballero MJ, 1996, ENDOCR RES, V22, P131, DOI 10.1080/07435809609030502; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Ceriello A, 1998, DIABETOLOGIA, V41, P1270, DOI 10.1007/s001250051064; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Culnan DM, 2009, OBESITY, V17, P46, DOI 10.1038/oby.2008.428; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dandona P, 2002, AM J CARDIOL, V90, p27G; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; EHNHOLM C, 1994, ATHEROSCLEROSIS, V107, P229, DOI 10.1016/0021-9150(94)90024-8; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; ERNST E, 1993, BRIT HEART J, V70, P116; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hammer S, 2008, J AM COLL CARDIOL, V52, P1006, DOI 10.1016/j.jacc.2008.04.068; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Hernandez-Mijares A, 2007, INT J OBESITY, V31, P927, DOI 10.1038/sj.ijo.0803543; Hess K, 2012, DIABETOLOGIA, V55, P1103, DOI 10.1007/s00125-011-2301-7; HOFFER LJ, 1984, METABOLISM, V33, P820, DOI 10.1016/0026-0495(84)90108-2; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JACOBSSON B, 1989, J HISTOCHEM CYTOCHEM, V37, P31, DOI 10.1177/37.1.2642294; Jae SY, 2008, AM J CARDIOL, V102, P700, DOI 10.1016/j.amjcard.2008.05.012; Jazet IM, 2007, DIABETES RES CLIN PR, V77, P70, DOI 10.1016/j.diabres.2006.10.019; Juhasz P, 2011, J PROTEOME RES, V10, P34, DOI 10.1021/pr100659e; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; KELLEHER PC, 1983, METABOLISM, V32, P95, DOI 10.1016/0026-0495(83)90163-4; Kim HJ, 2007, J PROTEOME RES, V6, P735, DOI 10.1021/pr060489g; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kriegel TM, 2009, REPROD BIOMED ONLINE, V19, P660, DOI 10.1016/j.rbmo.2009.07.001; Kronenberg F, 2000, J AM COLL CARDIOL, V36, P751, DOI 10.1016/S0735-1097(00)00775-0; Lyons TJ, 2012, TRANSL RES, V159, P303, DOI 10.1016/j.trsl.2012.01.009; Maris M, 2008, PROTEOM CLIN APPL, V2, P312, DOI 10.1002/prca.200780093; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Missov RM, 1996, DIABETES CARE, V19, P157, DOI 10.2337/diacare.19.2.157; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; PASQUALI R, 1987, METABOLISM, V36, P1141, DOI 10.1016/0026-0495(87)90240-X; Quilliot D, 2001, METABOLISM, V50, P1019, DOI 10.1053/meta.2001.25656; R Core Team, 2018, R LANG ENV STAT COMP; Ramalho R, 2009, OBES SURG, V19, P915, DOI 10.1007/s11695-009-9848-0; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; Riaz S, 2010, DIABETES TECHNOL THE, V12, P979, DOI 10.1089/dia.2010.0078; Riaz S, 2010, J PHARMACEUT BIOMED, V51, P1103, DOI 10.1016/j.jpba.2009.11.016; Ritz P, 2009, OBES SURG, V19, P840, DOI 10.1007/s11695-008-9627-3; SCALFI L, 1987, ANN NUTR METAB, V31, P154, DOI 10.1159/000177262; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Snel M, 2012, OBESITY, V20, P1572, DOI 10.1038/oby.2011.390; Snel M, 2012, J CLIN ENDOCR METAB, V97, P2512, DOI 10.1210/jc.2011-3178; Snel M, 2012, EUR J INTERN MED, V23, P143, DOI 10.1016/j.ejim.2011.07.004; Snel M, 2011, FOOD CHEM TOXICOL, V49, P3104, DOI 10.1016/j.fct.2011.09.032; Sun ZY, 2000, ATHEROSCLEROSIS, V151, P381, DOI 10.1016/S0021-9150(99)00395-0; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tymchuk CN, 1998, NUTR CANCER, V31, P127, DOI 10.1080/01635589809514691; Tymchuk CN, 2000, NUTR CANCER, V38, P158, DOI 10.1207/S15327914NC382_3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verges B, 2001, J LIPID RES, V42, P2021; VERGES BL, 1994, DIABETES CARE, V17, P810, DOI 10.2337/diacare.17.8.810; Wang YA, 2011, DIABETES CARE, V34, P2576, DOI 10.2337/dc11-0685; WEINBERG RB, 1990, GASTROENTEROLOGY, V98, P17, DOI 10.1016/0016-5085(90)91285-E; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016470	71	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112835	10.1371/journal.pone.0112835	http://dx.doi.org/10.1371/journal.pone.0112835			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415563	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600019
J	Amaya, MJ; Oliveira, AG; Schroeder, LK; Allgeyer, ES; Bewersdorf, J; Nathanson, MH				Amaya, Maria Jimena; Oliveira, Andre G.; Schroeder, Lena K.; Allgeyer, Edward S.; Bewersdorf, Joerg; Nathanson, Michael H.			Apical Localization of Inositol 1,4,5-Trisphosphate Receptors Is Independent of Extended Synaptotagmins in Hepatocytes	PLOS ONE			English	Article							BILE-DUCT EPITHELIA; PANCREATIC ACINAR-CELLS; RAT HEPATOCYTES; SANDWICH CONFIGURATION; BILIARY EPITHELIA; LIPID-TRANSFER; CONTACT SITES; CA2+; PROTEINS; LIVER	Extended synaptotagmins (E-Syts) are a recently identified family of proteins that tether the endoplasmic reticulum (ER) to the plasma membrane (PM) in part by conferring regulation of cytosolic calcium (Ca2+) at these contact sites (Cell, 2013). However, the mechanism by which E-Syts link this tethering to Ca2+ signaling is unknown. Ca2+ waves in polarized epithelia are initiated by inositol 1,4,5-trisphosphate receptors (InsP3Rs), and these waves begin in the apical region because InsP3Rs are targeted to the ER adjacent to the apical membrane. In this study we investigated whether E-Syts are responsible for this targeting. Primary rat hepatocytes were used as a model system, because a single InsP3R isoform (InsP3R-II) is tethered to the peri-apical ER in these cells. Additionally, it has been established in hepatocytes that the apical localization of InsP3Rs is responsible for Ca2+ waves and secretion and is disrupted in disease states in which secretion is impaired. We found that rat hepatocytes express two of the three identified E-Syts (E-Syt1 and E-Syt2). Individual or simultaneous siRNA knockdown of these proteins did not alter InsP3R-II expression levels, apical localization or average InsP3R-II cluster size. Moreover, apical secretion of the organic anion 5-chloromethylfluorescein diacetate (CMFDA) was not changed in cells lacking E-Syts but was reduced in cells in which cytosolic Ca2+ was buffered. These data provide evidence that E-Syts do not participate in the targeting of InsP3Rs to the apical region. Identifying tethers that bring InsP3Rs to the apical region remains an important question, since mis-targeting of InsP3Rs leads to impaired secretory activity.	[Amaya, Maria Jimena; Oliveira, Andre G.; Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Schroeder, Lena K.; Allgeyer, Edward S.; Bewersdorf, Joerg] Yale Univ, Dept Cell Biol, New Haven, CT USA; [Bewersdorf, Joerg] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Bewersdorf, Joerg] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Nathanson, MH (corresponding author), Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA.	michael.nathanson@yale.edu		Oliveira, Andre/0000-0002-1744-8229; Bewersdorf, Joerg/0000-0002-4085-7020	National Institutes of Health [DK57751, DK45710, DK34989, DK61747, P30KD034989]; Connecticut Department of Public Health; CAPES (Coordination for the Improvement of Higher Education Personnel); Lemann Foundation; FAPEMIG (Foundation of Support for Research of Minas Gerais); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK061747, P30DK034989, R29DK045710, R01DK045710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Public Health; CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Lemann Foundation; FAPEMIG (Foundation of Support for Research of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (www.nih.gov/) Grants DK57751, DK45710, DK34989, DK61747, P30KD034989, a Biomedical Research Grant from the Connecticut Department of Public Health (www.ct.gov/dph), and grants from CAPES (Coordination for the Improvement of Higher Education Personnel; www.capes.gov.br), Lemann Foundation (www.fundacaolemann.org.br) and FAPEMIG (Foundation of Support for Research of Minas Gerais; www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MJ, 2014, CELL CALCIUM, V55, P317, DOI 10.1016/j.ceca.2014.02.003; Amaya MJ, 2013, COMPR PHYSIOL, V3, P515, DOI 10.1002/cphy.c120013; Amaya MJ, 2013, HEPATOLOGY; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; BRUCK R, 1994, HEPATOLOGY, V20, P1032, DOI 10.1002/hep.1840200436; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Gould TJ, 2012, ANNU REV BIOMED ENG, V14, P231, DOI [10.1146/annurev-bioeng-071811-150025, 10.1146/annurev.bioeng-071811-150025]; GRAF J, 1990, J HEPATOL, V10, P387, DOI 10.1016/0168-8278(90)90152-H; Haj FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036633; Hirata K, 2002, HEPATOLOGY, V36, P284, DOI 10.1053/jhep.2002.34432; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Nagata J, 2007, GASTROENTEROLOGY, V133, P256, DOI 10.1053/j.gastro.2007.03.115; Nathanson MH, 1996, AM J PHYSIOL-GASTR L, V271, pG86, DOI 10.1152/ajpgi.1996.271.1.G86; Nathanson MH, 1998, J CLIN INVEST, V101, P2665, DOI 10.1172/JCI2835; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; NATHANSON MH, 1994, AM J PHYSIOL, V267, pG338, DOI 10.1152/ajpgi.1994.267.3.G338; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orabi AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048465; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roberts SK, 1997, GASTROENTEROLOGY, V112, P269, DOI 10.1016/S0016-5085(97)70244-0; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Yule DI, 1997, J BIOL CHEM, V272, P9093; Zhang D, 2012, CURR BIOL, V22, P2048, DOI 10.1016/j.cub.2012.08.047; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	47	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114043	10.1371/journal.pone.0114043	http://dx.doi.org/10.1371/journal.pone.0114043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437447	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900113
J	Wang, YY; Huang, S; Zhong, JH; Ke, Y; Guo, Z; Liu, JQ; Ma, L; Li, H; Ou, BN; Li, LQ				Wang, Yan-Yan; Huang, Shan; Zhong, Jian-Hong; Ke, Yang; Guo, Zhe; Liu, Jia-Qi; Ma, Liang; Li, Hang; Ou, Bing-Ning; Li, Le-Qun			Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; HEPATIC RESECTION; THERAPY OPTIONS; RISK; CANCER; CIRRHOSIS; OUTCOMES; PREVALENCE; RECURRENCE; MORTALITY	Background: The influence of diabetes mellitus (DM) on the prognosis of patients with hepatocellular carcinoma (HCC) remains controversial. Here we investigated the impact of DM on the prognosis of such patients after curative hepatectomy. Methods: A consecutive cohort of 505 patients with HCC (134 with DM, 371 without) underwent curative hepatectomy were retrospectively evaluated. Postoperative morbidity and mortality, overall survival (OS) and disease-free survival (DFS) were compared between patients with or without DM. Independent prognostic predictors were identified using the Cox proportional hazards model. Results: Patients with or without DM showed similar morbidity and 30- and 90-day mortality after curative hepatectomy (all P> 0.05), as well as similar DFS at 1, 3, 5 years (P=0.781). However, the group of patients with DM showed significantly lower OS at 1, 3, 5 years than the group without DM (P=0.038). Similar results were obtained in the propensity-matched cohort. Cox multivariate analysis identified DM as an independent predictor of poor OS, but not of poor DFS. We repeat compared OS and DFS for DM and non-DM subgroups defined according to the presence or absence of hepatitis B virus infection and cirrhosis. Similar results were obtained in all subgroups except the non-cirrhotic subgroup which showed patients with and without DM had similar OS. Conclusions: DM does not significantly affect the postoperative morbidity or mortality or the DFS of patients with HCC after curative hepatectomy. It is, however, associated with significantly lower OS, especially in patients with cirrhosis.	[Wang, Yan-Yan; Huang, Shan; Zhong, Jian-Hong; Ke, Yang; Guo, Zhe; Liu, Jia-Qi; Ma, Liang; Li, Le-Qun] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Li, Hang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound, Nanning, Peoples R China; [Ou, Bing-Ning] Guangxi Med Univ, Pharmaceut Coll, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.	xitongpingjia@163.com	LI, LI/GVS-5344-2022; Zhong, Jian-Hong/D-6641-2018; LI, LI QING/GRR-8855-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Hepatocellular Carcinoma Bridge Study [CA182023]; Scientific Research and Technical Development Project of Guangxi Province [0632007-1E, 10124001A-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hepatocellular Carcinoma Bridge Study; Scientific Research and Technical Development Project of Guangxi Province	This work was supported by funding from the National Natural Science Foundation of China (no. 81160262/H1602), Hepatocellular Carcinoma Bridge Study (no. CA182023), and Scientific Research and Technical Development Project of Guangxi Province (nos. 0632007-1E and 10124001A-4) to LQL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abougalambou SSI, 2013, DIABETES METAB SYND, V7, P64, DOI 10.1016/j.dsx.2013.02.034; Adachi E, 2002, SURGERY, V131, pS148, DOI 10.1067/msy.2002.119496; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Aggarwal G, 2013, PANCREAS, V42, P198, DOI 10.1097/MPA.0b013e3182592c96; Aloia TA, 2009, HPB, V11, P510, DOI 10.1111/j.1477-2574.2009.00095.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chiang CH, 2014, HEPATOLOGY, V59, P2207, DOI 10.1002/hep.27014; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Ledinghen V, 2006, J HEPATOL, V45, P592, DOI 10.1016/j.jhep.2006.05.008; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Guo Z, 2014, ANN SURG ONCOL, V21, P3069, DOI 10.1245/s10434-014-3704-8; Holstein A, 2002, J GASTROEN HEPATOL, V17, P677, DOI 10.1046/j.1440-1746.2002.02755.x; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Ke Yang, 2014, Zhonghua Yi Xue Za Zhi, V94, P747; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nielsen MF, 2005, AM J PHYSIOL-GASTR L, V288, pG1135, DOI 10.1152/ajpgi.00278.2004; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Pol B, 1999, EUR J SURG, V165, P446; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Sasazuki S, 2013, CANCER SCI, V104, P1499, DOI 10.1111/cas.12241; Shau WY, 2012, ONCOLOGIST, V17, P856, DOI 10.1634/theoncologist.2012-0065; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Ting CT, 2012, TOHOKU J EXP MED, V227, P73, DOI 10.1620/tjem.227.73; Toyoda H, 2001, CANCER-AM CANCER SOC, V91, P957; Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251; Wlazlo N, 2010, DIABETIC MED, V27, P1308, DOI 10.1111/j.1464-5491.2010.03093.x; YANAGA K, 1993, ARCH SURG-CHICAGO, V128, P445; Yang WS, 2013, ANN ONCOL, V24, P1679, DOI 10.1093/annonc/mdt017; Yoon JM, 2013, WORLD J GASTROENTERO, V19, P936, DOI 10.3748/wjg.v19.i6.936; Zheng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084776; Zhong JH, 2012, EJSO-EUR J SURG ONC, V38, P286, DOI 10.1016/j.ejso.2012.01.006; Zhong JH, 2012, INT J CLIN PRACT, V66, P21, DOI 10.1111/j.1742-1241.2011.02814.x; Zhong JH, 2014, GUT; Zhong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108755; Zhong JH, 2014, SCAND J GASTROENTERO, V49, P649, DOI 10.3109/00365521.2014.905626; Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	46	21	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113858	10.1371/journal.pone.0113858	http://dx.doi.org/10.1371/journal.pone.0113858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436613	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900088
J	Bridge, TCL; Ferrari, R; Bryson, M; Hovey, R; Figueira, WF; Williams, SB; Pizarro, O; Harborne, AR; Byrne, M				Bridge, Tom C. L.; Ferrari, Renata; Bryson, Mitch; Hovey, Renae; Figueira, Will F.; Williams, Stefan B.; Pizarro, Oscar; Harborne, Alastair R.; Byrne, Maria			Variable Responses of Benthic Communities to Anomalously Warm Sea Temperatures on a High-Latitude Coral Reef	PLOS ONE			English	Article							CLIMATE-CHANGE; PHASE-SHIFTS; RECOVERY; RESILIENCE; MORTALITY; DEGRADATION; RECRUITMENT; DISTURBANCE; ASSEMBLAGE; SURVIVAL	High-latitude reefs support unique ecological communities occurring at the biogeographic boundaries between tropical and temperate marine ecosystems. Due to their lower ambient temperatures, they are regarded as potential refugia for tropical species shifting poleward due to rising sea temperatures. However, acute warming events can cause rapid shifts in the composition of high-latitude reef communities, including range contractions of temperate macroalgae and bleaching-induced mortality in corals. While bleaching has been reported on numerous high-latitude reefs, post-bleaching trajectories of benthic communities are poorly described. Consequently, the longer-term effects of thermal anomalies on high-latitude reefs are difficult to predict. Here, we use an autonomous underwater vehicle to conduct repeated surveys of three 625 m(2) plots on a coral-dominated high-latitude reef in the Houtman Abrolhos Islands, Western Australia, over a four-year period spanning a large-magnitude thermal anomaly. Quantification of benthic communities revealed high coral cover (>70%, comprising three main morphospecies) prior to the bleaching event. Plating Montipora was most susceptible to bleaching, but in the plot where it was most abundant, coral cover did not change significantly because of post-bleaching increases in branching Acropora. In the other two plots, coral cover decreased while macroalgal cover increased markedly. Overall, coral cover declined from 73% to 59% over the course of the study, while macroalgal cover increased from 11% to 24%. The significant differences in impacts and post-bleaching trajectories among plots underline the importance of understanding the underlying causes of such variation to improve predictions of how climate change will affect reefs, especially at high-latitudes.	[Bridge, Tom C. L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bridge, Tom C. L.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Ferrari, Renata; Figueira, Will F.; Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ferrari, Renata; Bryson, Mitch; Williams, Stefan B.; Pizarro, Oscar] Univ Sydney, Sch Engn, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Hovey, Renae] Univ Western Australia, Sch Earth & Environm, Crawley, WA, Australia; [Hovey, Renae] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, Brisbane, Qld, Australia; [Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Byrne, Maria] Univ Sydney, Sch Anat, Sydney, NSW 2006, Australia	James Cook University; Australian Institute of Marine Science; University of Sydney; University of Sydney; University of Western Australia; University of Western Australia; University of Queensland; University of Queensland; University of Sydney	Bridge, TCL (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	thomas.bridge@jcu.edu.au	Bridge, Tom/J-2693-2014; Figueira, Will/A-5163-2009; Ferrari, Renata/E-3109-2016; Williams, Stefan/AAE-4376-2020; Harborne, Alastair R/F-6155-2013; Byrne, Maria/K-6355-2016	Bridge, Tom/0000-0003-3951-284X; Figueira, Will/0000-0001-9472-8710; Ferrari, Renata/0000-0002-5056-1178; Williams, Stefan/0000-0001-9416-5639; Harborne, Alastair R/0000-0002-6818-8615; hovey, renae/0000-0003-0308-3609; Pizarro, Oscar/0000-0001-6612-2738; Byrne, Maria/0000-0002-8902-9808	Great Barrier Reef Foundation; Australian Government; Australian Research Council (ARC); Australia's Integrated Marine Observing System (IMOS) - Department of Innovation, Industry, Science and Research through National Collaborative Research Infrastructure Scheme; Education Investment Fund; Marine Biodiversity Hub from Australian Government's National Environmental Research Program (NERP)	Great Barrier Reef Foundation; Australian Government(Australian GovernmentCGIAR); Australian Research Council (ARC)(Australian Research Council); Australia's Integrated Marine Observing System (IMOS) - Department of Innovation, Industry, Science and Research through National Collaborative Research Infrastructure Scheme(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund; Marine Biodiversity Hub from Australian Government's National Environmental Research Program (NERP)	Funding: This project was funded by the Great Barrier Reef Foundation's Resilient Coral Reefs Successfully Adapting to Climate Change research and development program in collaboration with the Australian Government. Additional support was provided by The Australian Research Council (ARC) and Australia's Integrated Marine Observing System (IMOS), funded by the Department of Innovation, Industry, Science and Research through the National Collaborative Research Infrastructure Scheme and the Education Investment Fund, and the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ateweberhan M, 2005, MAR ECOL PROG SER, V292, P159, DOI 10.3354/meps292159; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beger M, 2014, DIVERS DISTRIB, V20, P245, DOI 10.1111/ddi.12140; Beijbom O., 2012, IEEE C COMP VIS PATT; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bridge TCL, 2014, F1000 RES, DOI 10.12688/f1000research.2-187.v3; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bryson M., 2013, IEEE RSJ INT C INT R; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Dalton Steven J., 2011, Diversity, V3, P592, DOI 10.3390/d3040592; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FAIRBRIDGE RW, 1950, J GEOL, V58, P330, DOI 10.1086/625751; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Foster T, 2014, J EXP MAR BIOL ECOL, V461, P133, DOI 10.1016/j.jembe.2014.07.014; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gorley C.K., 2006, GETTING STARTED PRIM; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Harris A, 2014, AQUAT CONSERV, V24, P667, DOI 10.1002/aqc.2464; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Hatcher BG, 1985, P 5 INT COR REEF C T, P191; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; Kincaid T., 2012, PACKAGE SPSURVEY; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Mahon I, 2008, IEEE T ROBOT, V24, P1002, DOI 10.1109/TRO.2008.2004888; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2005, CORAL REEFS, V24, P230, DOI 10.1007/s00338-004-0471-1; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Core Team, 2018, R LANG ENV STAT COMP; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Smale DA, 2012, CORAL REEFS, V31, P441, DOI 10.1007/s00338-012-0873-4; Smale DA, 2010, ESTUAR COAST SHELF S, V86, P83, DOI 10.1016/j.ecss.2009.10.016; Smale DA, 2012, ICES J MAR SCI, V69, P1108, DOI 10.1093/icesjms/fss082; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1988, HERMATYPIC CORALS W; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; West J, 2003, COMMENTARY, V115, P17; Western Australian Herbarium, 1998, FLOR THE W AUSTR FLO; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772; Wilson BR, 1979, P INT S MAR BIOG EV; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	87	28	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113079	10.1371/journal.pone.0113079	http://dx.doi.org/10.1371/journal.pone.0113079			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426718	Green Published, Green Accepted, gold			2022-12-27	WOS:000349145400032
J	Chen, LS; Lin, L; Cai, GZ; Sun, YY; Huang, T; Wang, K; Deng, JS				Chen, Lisu; Lin, Lin; Cai, Guangzhe; Sun, Yuanyuan; Huang, Tao; Wang, Ke; Deng, Jinsong			Identification of Nitrogen, Phosphorus, and Potassium Deficiencies in Rice Based on Static Scanning Technology and Hierarchical Identification Method	PLOS ONE			English	Article							REFLECTANCE MEASUREMENTS; DIAGNOSIS; SELECTION; CANOPIES	Establishing an accurate, fast, and operable method for diagnosing crop nutrition is very important for crop nutrient management. In this study, static scanning technology was used to collect images of a rice sample's fully expanded top three leaves and corresponding sheathes. From these images, 32 spectral and shape characteristic parameters were extracted using an RGB mean value function and using the Regionprops function in MATLAB. Hierarchical identification was used to identify NPK deficiencies. First, the normal samples and non-normal (NPK deficiencies) samples were identified. Then, N deficiency and PK deficiencies were identified. Finally, P deficiency and K deficiency were identified. In the identification of every hierarchy, SVFS was used to select the optimal characteristic set for different deficiencies in a targeted manner, and Fisher discriminant analysis was used to build the diagnosis model. In the first hierarchy, the selected characteristics were the leaf sheath R, leaf sheath G, leaf sheath B, leaf sheath length, leaf tip R, leaf tip G, leaf area and leaf G. In the second hierarchy, the selected characteristics were the leaf sheath G, leaf sheath B, white region of the leaf sheath, leaf B, and leaf G. In the third hierarchy the selected characteristics were the leaf G, leaf sheath length, leaf area/leaf length, leaf tip G, difference between the 2nd and 3rd leaf lengths, leaf sheath G, and leaf lightness. The results showed that the overall identification accuracies of NPK deficiencies were 86.15, 87.69, 90.00 and 89.23% for the four growth stages. Data from multiple years were used for validation, and the identification accuracies were 83.08, 83.08, 89.23 and 90.77%.	[Chen, Lisu; Lin, Lin; Cai, Guangzhe; Sun, Yuanyuan; Huang, Tao; Wang, Ke; Deng, Jinsong] Zhejiang Univ, Inst Appl Remote Sensing & Informat Technol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, K (corresponding author), Zhejiang Univ, Inst Appl Remote Sensing & Informat Technol, Hangzhou 310003, Zhejiang, Peoples R China.	kwang@zju.edu.cn			National Natural Science Foundation of China [31172023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Natural Science Foundation of China (Grant No. 31172023).	Chen L.S, 2014, J. Soil Sci. Plant Nutr., P0; Chen L.S., 2013, LIFE SCI J, V10, P2655; Chen LS, 2014, SENSOR LETT, V12, P824, DOI DOI 10.1166/sl.2014.3148; EVERITT JH, 1987, WEED SCI, V35, P295; Fung GM, 2004, COMPUT OPTIM APPL, V28, P185, DOI 10.1023/B:COAP.0000026884.66338.df; Glenn MF, 2004, COMPUT OPTIM APPL, V2, P185; Jia LL, 2009, SPECTROSC SPECT ANAL, V29, P2176, DOI 10.3964/j.issn.1000-0593(2009)08-2176-04; Li G, 2004, INTRO SUPPORT VECTOR; Li WM, 2012, QINGHAI AGROTECHNOLO, V2, P44; Lin FF, 2009, SPECTROSC SPECT ANAL, V29, P2467, DOI 10.3964/j.issn.1000-0593(2009)09-2467-04; Liu QS, 2004, IEEE T CIRC SYST VID, V14, P42, DOI 10.1109/TCSVT.2003.818352; MILTON NM, 1991, REMOTE SENS ENVIRON, V36, P121, DOI 10.1016/0034-4257(91)90034-4; Shi YY, 2009, SPECTROSC SPECT ANAL, V29, P1745; SHIBAYAMA M, 1991, REMOTE SENS ENVIRON, V36, P45, DOI 10.1016/0034-4257(91)90029-6; SHIBAYAMA M, 1989, REMOTE SENS ENVIRON, V27, P119, DOI 10.1016/0034-4257(89)90011-4; SHIBAYAMA M, 1993, REMOTE SENS ENVIRON, V45, P117, DOI 10.1016/0034-4257(93)90036-W; THOMAS JR, 1972, AGRON J, V64, P11, DOI 10.2134/agronj1972.00021962006400010004x; Tiwari K.N., 2002, BETTER CROPS INT, V16, P23; Tkalcic M., 2003, COLOUR SPACES PERCEP; Weston J, 2000, NIPS, V12, P68; Zhao F, 2007, J ELECT INFORM TECHN, V7, P1731	21	40	42	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113200	10.1371/journal.pone.0113200	http://dx.doi.org/10.1371/journal.pone.0113200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426712	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400039
J	Festing, MFW				Festing, Michael F. W.			The Extended Statistical Analysis of Toxicity Tests Using Standardised Effect Sizes (SESs): A Comparison of Nine Published Papers	PLOS ONE			English	Article							ORAL TOXICITY; SAFETY	The safety of chemicals, drugs, novel foods and genetically modified crops is often tested using repeat-dose sub-acute toxicity tests in rats or mice. It is important to avoid misinterpretations of the results as these tests are used to help determine safe exposure levels in humans. Treated and control groups are compared for a range of haematological, biochemical and other biomarkers which may indicate tissue damage or other adverse effects. However, the statistical analysis and presentation of such data poses problems due to the large number of statistical tests which are involved. Often, it is not clear whether a "statistically significant" effect is real or a false positive (type I error) due to sampling variation. The author"s conclusions appear to be reached somewhat subjectively by the pattern of statistical significances, discounting those which they judge to be type I errors and ignoring any biomarker where the p-value is greater than p=0.05. However, by using standardised effect sizes (SESs) a range of graphical methods and an overall assessment of the mean absolute response can be made. The approach is an extension, not a replacement of existing methods. It is intended to assist toxicologists and regulators in the interpretation of the results. Here, the SES analysis has been applied to data from nine published sub-acute toxicity tests in order to compare the findings with those of the author"s. Line plots, box plots and bar plots show the pattern of response. Dose-response relationships are easily seen. A "bootstrap" test compares the mean absolute differences across dose groups. In four out of seven papers where the no observed adverse effect level (NOAEL) was estimated by the authors, it was set too high according to the bootstrap test, suggesting that possible toxicity is under-estimated.	Med Res Council Toxicol Unit, Lancaster, England		Festing, MFW (corresponding author), Med Res Council Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Lancaster, England.	michaelfesting@aol.com						Budin SB, 2012, J ZHEJIANG UNIV-SC B, V13, P783, DOI 10.1631/jzus.B1100021; Caldwell Gary W., 2001, Current Topics in Medicinal Chemistry, V1, P353, DOI 10.2174/1568026013394949; Chihara L, 2013, MATH STAT RESAMPLING; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; FESTING MFW, 1984, FOOD CHEM TOXICOL, V22, P559, DOI 10.1016/0278-6915(84)90227-8; Festing MFW, 2014, TOXICOL PATHOL, V42, P1238, DOI 10.1177/0192623313517771; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kim JK, 2012, SAF HEALTH WORK, V3, P224, DOI 10.5491/SHAW.2012.3.3.224; Lakmichi H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/317090; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Matulka RA, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-1; NIH, NAT LIB MED OP ACC S; OECD, 2018, TEST NO 408 REP DOS; Pucaj K, 2011, TOXICOL MECH METHOD, V21, P520, DOI 10.3109/15376516.2011.568983; R Development Core Team, 2011, LANG ENV STAT COMP V; Seo Dong Seok, 2011, Environ Health Toxicol, V26, pe2011014, DOI 10.5620/eht.2011.26.e2011014; Sireeratawong S, 2013, AFR J TRADIT COMPLEM, V10, P128, DOI 10.4314/ajtcam.v10i1.17; Sung JH, 2010, SAF HEALTH WORK, V1, P192, DOI 10.5491/SHAW.2010.1.2.192	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112955	10.1371/journal.pone.0112955	http://dx.doi.org/10.1371/journal.pone.0112955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426843	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400026
J	He, MJ; Gong, YT; Shi, J; Pan, ZW; Zou, H; Sun, DH; Tu, X; Tan, XY; Li, JQ; Li, WM; Liu, B; Xue, JY; Sheng, L; Xiu, CH; Yang, N; Xue, HJ; Ding, X; Yu, CY; Li, Y				He, Meijiao; Gong, Yongtai; Shi, Jing; Pan, Zhenwei; Zou, Hui; Sun, Danghui; Tu, Xin; Tan, Xiangyang; Li, Jianqiang; Li, Weimin; Liu, Bin; Xue, Jingyi; Sheng, Li; Xiu, Chunhong; Yang, Ning; Xue, Hongjie; Ding, Xue; Yu, Chengyuan; Li, Yue			Plasma MicroRNAs as Potential Noninvasive Biomarkers for In-Stent Restenosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; INFLAMMATION; EXPRESSION; PROTEINS; MARKER; RNAS	Objective: To investigate whether microRNAs (miRs) can serve as novel biomarkers for in-stent restenosis (ISR). Methods: This retrospective, observational single-centre study was conducted at the cardiovascular department of a tertiary hospital centre in the north of China. Follow-up coronary angiography at 6 to 12 months was performed in 181 consecutive patients implanted with drug-eluting stents. Fifty-two healthy volunteers served as the control group. The plasma miRs levels were analyzed by quantitative real-time PCR. Receiver-operating characteristic curve (ROC) analysis was performed to investigate the characters of these miRs as potential biomarkers of ISR. Results: MiR-21 levels in ISR patients were significantly higher than those in nonISR patients and healthy controls (P<0.05), while miR-100 (P<0.05), miR-143 (P<0.001) and miR-145 (P< 0.0001) levels were significantly decreased in ISR patients. Further analysis showed that miR-21 levels were remarkably increased (P=0.045), while miR-100 (P=0.041), miR-143 (P=0.029) and miR-145 (P< 0.01) levels were dramatically decreased in patients with diffuse ISR compared to those with focal ISR. ROC analysis demonstrated that the area under curve of miR-145, miR-143, miR-100 and miR-21 were 0.880 (95% confidence interval; CI=0.791-0.987, P <0.001), 0.818 (95% confidence interval; CI=0.755-0.963, P< 0.001), 0.608 (95% confidence interval; CI=0.372-0.757, P, 0.05) and 0.568 (95% confidence interval; CI=0.372-0.757, P, 0.05), with specificity of 83.1%, 80.1%, 68.9% and 68.6%, and sensitivity of 88.7%, 82.1%, 60.2% and 50.1%, respectively. Conclusions: Circulating miR-143 and miR-145 levels are associated with the occurrence of ISR and can serve as novel noninvasive biomarkers for ISR.	[He, Meijiao; Gong, Yongtai; Shi, Jing; Sun, Danghui; Li, Jianqiang; Li, Weimin; Liu, Bin; Xue, Jingyi; Sheng, Li; Xiu, Chunhong; Yang, Ning; Xue, Hongjie; Ding, Xue; Yu, Chengyuan; Li, Yue] Harbin Med Univ, Affiliated Hosp 1, Cardiovasc Dept, Harbin, Heilongjiang, Peoples R China; [Pan, Zhenwei] Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China; [Zou, Hui] Hosp Heilongjiang Prov, Cardiovasc Dept, Harbin, Heilongjiang, Peoples R China; [Tu, Xin] Huazhong Univ Sci & Technol, Life Sci & Technol Coll, Wuhan 430074, Hubei Province, Peoples R China; [Tan, Xiangyang] Wyeth Res, Cambridge, MA USA	Harbin Medical University; Harbin Medical University; Huazhong University of Science & Technology; Pfizer	Li, Y (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Cardiovasc Dept, Harbin, Heilongjiang, Peoples R China.	ly99ly@vip.163.com			National Basic Research Program of China (973 program) [2014CB542401]; Natural Science Foundation of China [30971251, 81070160, 81470462, 81100121, 81100071]; Heilongjiang Province Outstanding Youth Foundation [JC201208]; Collegiate Changjiang Scholar Reserve Support Plan of Heilongjiang Province [2013CJHB001]; Heilongjiang Provincial Science and Technology agency [LC08C36]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Outstanding Youth Foundation; Collegiate Changjiang Scholar Reserve Support Plan of Heilongjiang Province; Heilongjiang Provincial Science and Technology agency	Funding: This work was supported by a grant of National Basic Research Program of China (973 program, 2014CB542401 to YL), Natural Science Foundation of China (No. 30971251, 81070160, 81470462, 81100121, 81100071), the Heilongjiang Province Outstanding Youth Foundation (No. JC201208), the Collegiate Changjiang Scholar Reserve Support Plan of Heilongjiang Province (No. 2013CJHB001), the grants for study abroad from the Heilongjiang Provincial Science and Technology agency (No. LC08C36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Devaux Y, 2013, CIRC-CARDIOVASC GENE, V6, P290, DOI 10.1161/CIRCGENETICS.113.000077; Eitel I, 2012, AM HEART J, V164, P706, DOI 10.1016/j.ahj.2012.08.004; Gaspardone A, 2005, AM J CARDIOL, V96, p65L, DOI 10.1016/j.amjcard.2005.09.064; Gerber RT, 2011, CARDIOVASC REVASCULA, V12, P220, DOI 10.1016/j.carrev.2010.10.002; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jensen LO, 2007, CIRCULATION, V116, P2802, DOI 10.1161/CIRCULATIONAHA.107.704064; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kaudewitz D, 2013, THROMB HAEMOSTASIS, V110, P609, DOI 10.1160/TH13-05-0368; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; LIU MW, 1989, CIRCULATION, V79, P1374, DOI 10.1161/01.CIR.79.6.1374; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Matsumoto S, 2012, BIOCHEM BIOPH RES CO, V427, P280, DOI 10.1016/j.bbrc.2012.09.039; McMillan DH, 2013, AM J PHYSIOL-LUNG C, V304, pL774, DOI 10.1152/ajplung.00352.2012; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; O'Sullivan JF, 2011, J AM COLL CARDIOL, V57, P383, DOI 10.1016/j.jacc.2010.09.029; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Ren JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080738; Rippe C, 2012, EXP GERONTOL, V47, P45, DOI 10.1016/j.exger.2011.10.004; Roy S, 2012, MICROCIRCULATION, V19, P224, DOI 10.1111/j.1549-8719.2011.00156.x; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; SHIFENG H, 2013, PLOS ONE, V0008; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Yamakuchi M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/794898; Yang IP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066842	44	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112043	10.1371/journal.pone.0112043	http://dx.doi.org/10.1371/journal.pone.0112043			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427155	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400008
J	Heritage, S				Heritage, Steven			Modeling Olfactory Bulb Evolution through Primate Phylogeny	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE TIMES; BRAIN; SENSITIVITY; VOLUME; ENDOCASTS; INSIGHTS; MAMMALIA; ANATOMY; CRANIUM	Adaptive characterizations of primates have usually included a reduction in olfactory sensitivity. However, this inference of derivation and directionality assumes an ancestral state of olfaction, usually by comparison to a group of extant non-primate mammals. Thus, the accuracy of the inference depends on the assumed ancestral state. Here I present a phylogenetic model of continuous trait evolution that reconstructs olfactory bulb volumes for ancestral nodes of primates and mammal outgroups. Parent-daughter comparisons suggest that, relative to the ancestral euarchontan, the crown-primate node is plesiomorphic and that derived reduction in olfactory sensitivity is an attribute of the haplorhine lineage. The model also suggests a derived increase in olfactory sensitivity at the strepsirrhine node. This oppositional diversification of the strepsirrhine and haplorhine lineages from an intermediate and non-derived ancestor is inconsistent with a characterization of graded reduction through primate evolution.	SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Heritage, S (corresponding author), SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA.	steven.heritage@stonybrook.edu		Zucker-Scharff, Thomas/0000-0002-1790-7405	Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University; Turkana Basin Institute	Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University; Turkana Basin Institute	SH is supported by a scholarship from the Interdepartmental Doctoral Program in Anthropological Sciences at Stony Brook University and by a fellowship from the Turkana Basin Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; Boyer DM, 2013, AM J PHYS ANTHROPOL, V151, P420, DOI 10.1002/ajpa.22283; Bush EC, 2004, ANAT REC PART A, V281A, P1083, DOI 10.1002/ar.a.20113; Cartmill M, 1970, THESIS U CHICAGO; CAVE AJE, 1967, AM J PHYS ANTHROPOL, V26, P277, DOI 10.1002/ajpa.1330260302; Colangelo P, 2010, MOL PHYLOGENET EVOL, V55, P372, DOI 10.1016/j.ympev.2010.01.038; Dubey S, 2007, MOL PHYLOGENET EVOL, V44, P126, DOI 10.1016/j.ympev.2006.12.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gurche J.A., 1982, P227; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; JERISON HJ, 1979, J HUM EVOL, V8, P615, DOI 10.1016/0047-2484(79)90115-5; Kay RF, 2004, ANAT REC PART A, V281A, P1157, DOI 10.1002/ar.a.20121; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kirk EC, 2014, J HUM EVOL, V74, P82, DOI 10.1016/j.jhevol.2014.03.007; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; MARTIN RD, 1968, MAN, V3, P377, DOI 10.2307/2798876; MEISAMI E, 1989, DEV BRAIN RES, V46, P9, DOI 10.1016/0165-3806(89)90139-9; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Negas V, 1958, COMP ANATOMY PHYSL N; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Pagel M, 2011, BAYESTRAITS; Pagel M, 2007, BAYESTRAITS V1 1B; PIRLOT P, 1982, CAN J ZOOL, V60, P565, DOI 10.1139/z82-084; Poux C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-102; RADINSKY L, 1973, AM J PHYS ANTHROPOL, V39, P239, DOI 10.1002/ajpa.1330390214; Rambaut A, 2009, TRACER V 1 5; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanderson MJ, 2012, R8S V1 8; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Silcox MT, 2010, J HUM EVOL, V58, P505, DOI 10.1016/j.jhevol.2010.03.008; Silcox MT, 2009, P NATL ACAD SCI USA, V106, P10987, DOI 10.1073/pnas.0812140106; Simons EL, 2007, P NATL ACAD SCI USA, V104, P8731, DOI 10.1073/pnas.0703129104; Smith TD, 2001, ANAT RECORD, V265, P176, DOI 10.1002/ar.1152; Smith T, 2006, OLFACTION AND THE BRAIN, P135, DOI 10.1017/CBO9780511543623.010; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; STEPHAN H, 1970, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V8, P200; Stephan H, 1970, THE PRIMATE BRAIN, P289; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wilson D. E., 2005, MAMMAL SPECIES WORLD	47	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113904	10.1371/journal.pone.0113904	http://dx.doi.org/10.1371/journal.pone.0113904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426851	gold, Green Submitted, Green Published			2022-12-27	WOS:000349145400099
J	Huang, X; Guo, Y; Huang, WH; Zhang, W; Tan, ZR; Peng, JB; Wang, YC; Hu, DL; Ouyang, DS; Xiao, J; Wang, Y; Luo, M; Chen, Y				Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Xiao, Jian; Wang, Yang; Luo, Min; Chen, Yao			Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; SEROTONIN REUPTAKE INHIBITORS; DEPRESSION; POLYMORPHISM; AGOMELATINE; POPULATION; VOLUNTEERS; EXTRACT; CYP2C19; CYP1A2	Meranzin hydrate (MH), an absorbed bioactive compound from the Traditional Chinese Medicine (TCM) Chaihu-Shugan-San (CSS), was first isolated in our laboratory and was found to possess anti-depression activity. However, the role of cytochrome P450s (CYPs) in the metabolism of MH was unclear. In this study, we screened the CYPs for the metabolism of MH in vitro by human liver microsomes (HLMs) or human recombinant CYPs. MH inhibited the enzyme activities of CYP1A2 and CYP2C19 in a concentration-dependent manner in the HLMs. The K-m and V-max values of MH were 10.3 +/- 1.3 mu M and 99.1 +/- 3.3 nmol/mg protein/min, respectively, for the HLMs; 8.0 +/- 1.6 mu M and 112.4 +/- 5.7 nmol/nmol P450/min, respectively, for CYP1A2; and 25.9 +/- 6.6 mu M and 134.3 +/- 12.4 nmol/nmol P450/min, respectively, for CYP2C19. Other human CYP isoforms including CYP2A6, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 showed minimal or no effect on MH metabolism. The results suggested that MH was simultaneously a substrate and an inhibitor of CYP1A2 and CYP2C9, and MH had the potential to perpetrate drug-drug interactions with other CYP1A2 and CYP2C19 substrates.	[Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Chen, Yao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Hunan, Peoples R China; [Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Chen, Yao] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China; [Huang, Xi; Xiao, Jian; Wang, Yang; Luo, Min; Chen, Yao] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Hunan, Peoples R China.	cbohua@163.com	Chen, Yao/AAJ-5658-2020	Chen, Yao/0000-0001-7231-9860; Huang, Wei-Hua/0000-0003-4167-8304	National Scientific Foundation of China [81302850]; China Postdoctoral Science Foundation [2013M531817, 2014T70793, 2013M542146]; Science and Technology Plan Projects of Hunan Province [2014RS4011]; 863 Project [2012AA02A518]; Key Laboratory Funds of Hunan Province [13K003]; Fundamental Research Funds for the Central South University [1681-7608040003]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Plan Projects of Hunan Province; 863 Project(National High Technology Research and Development Program of China); Key Laboratory Funds of Hunan Province; Fundamental Research Funds for the Central South University	National Scientific Foundation of China (No. 81302850), General Financial Grant from the China Postdoctoral Science Foundation (No. 2013M531817 and 2014T70793), Science and Technology Plan Projects of Hunan Province (2014RS4011) to YC, General Financial Grant from the China Postdoctoral Science Foundation (No. 2013M542146) to JBP, 863 Project (No. 2012AA02A518) to WZ, Key Laboratory Funds of Hunan Province (13K003) and the Fundamental Research Funds for the Central South University (No. 1681-7608040003) to WHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321; Chancellor D, 2011, NAT REV DRUG DISCOV, V10, P809, DOI 10.1038/nrd3585; Chen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072428; Chen Y, 2009, XENOBIOTICA, V39, P508, DOI 10.1080/00498250902951763; CHING MS, 1995, BIOCHEM PHARMACOL, V50, P833, DOI 10.1016/0006-2952(95)00207-G; De Crescenzo F, 2014, J AFFECT DISORDERS, V152, P39, DOI 10.1016/j.jad.2013.09.019; Gebhardt AC, 1997, HEPATOLOGY, V26, P957, DOI 10.1053/jhep.1997.v26.pm0009328319; Graf H., 2013, PHARM BIOCH BEHAV; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P419; Huang W, 2011, J GASTROINTEST SURG, V15, P87, DOI 10.1007/s11605-010-1374-9; Johnson TN, 2009, PHARM STAT, V8, P186, DOI 10.1002/pst.373; Keers R, 2011, EXPERT REV NEUROTHER, V11, P101, DOI [10.1586/ern.10.186, 10.1586/ERN.10.186]; Kim SH, 2005, LIFE SCI, V76, P1297, DOI 10.1016/j.lfs.2004.10.022; Kocsis JH, 2013, EVID-BASED MENT HEAL, V16, P82, DOI 10.1136/eb-2013-101268; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Lee YC, 2013, J CLIN PSYCHOPHARM, V33, P782, DOI 10.1097/JCP.0b013e31829c970e; Li X, 2013, CHEM-BIOL INTERACT, V204, P140, DOI 10.1016/j.cbi.2013.05.007; McInerney M, 2013, J HEALTH ECON, V32, P1090, DOI 10.1016/j.jhealeco.2013.09.002; Plesnicar BK, 2014, PATIENT PREFER ADHER, V8, P603, DOI 10.2147/PPA.S.12789; Qin CZ, 2014, BIOMED CHROMATOGR, V28, P197, DOI 10.1002/bmc.3003; Ring BJ, 1996, BRIT J CLIN PHARMACO, V41, P181, DOI 10.1111/j.1365-2125.1996.tb00180.x; Schurink B, 2014, J CLIN PSYCHOPHARM, V34, P66, DOI 10.1097/JCP.0000000000000055; Song L, 2014, J CLIN PHARM THER, V39, P204, DOI 10.1111/jcpt.12118; Taavitsainen P, 2001, DRUG METAB DISPOS, V29, P217; Tan E, 2013, CAN FAM PHYSICIAN, V59, P263; Tang C, 2005, DRUG METAB DISPOS, V33, P603, DOI 10.1124/dmd.104.003236; Tombal B, 2010, EUR UROL, V57, P396, DOI 10.1016/j.eururo.2009.11.039; Walker J, 2011, PSYCHOSOMATICS, V52, P424, DOI 10.1016/j.psym.2011.02.003; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Xie Y, 2013, NEUROPHARMACOLOGY, V67, P318, DOI 10.1016/j.neuropharm.2012.10.003; Xie Y, 2013, AMINO ACIDS, V44, P413, DOI 10.1007/s00726-012-1347-2; Xu C, 2013, DRUG METAB PHARMACOK, V28, P362, DOI 10.2133/dmpk.DMPK-12-RG-124; Yamamoto Y, 2013, THER DRUG MONIT, V35, P305, DOI 10.1097/FTD.0b013e318283b49a	33	9	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113819	10.1371/journal.pone.0113819	http://dx.doi.org/10.1371/journal.pone.0113819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427198	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400089
J	Pereira, T; Ivanova, G; Caseiro, AR; Barbosa, P; Bartolo, PJ; Santos, JD; Luis, AL; Mauricio, AC				Pereira, Tiago; Ivanova, Galya; Caseiro, Ana Rita; Barbosa, Paula; Bartolo, Paulo Jorge; Santos, Jose Domingos; Luis, Ana Lucia; Mauricio, Ana Colette			MSCs Conditioned Media and Umbilical Cord Blood Plasma Metabolomics and Composition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NMR-SPECTROSCOPY; STROMAL CELLS; BONE-MARROW; IN-VITRO; SERUM; CULTURE; DIFFERENTIATE; THERAPY; TRANSPLANTATION	Human mesenchymal stem cells (hMSCs) from umbilical cord (UC) blood (UCB) and matrix are tested clinically for a variety of pathologies but in vitro expansion using culture media containing fetal bovine serum (FBS) is essential to achieve appropriate cell numbers for clinical use. Human UCB plasma (hUCBP) can be used as a supplement for hMSCs culture, since UCB is rich in soluble growth factors and due to worldwide increased number of cryopreserved UCB units in public and private banks, without the disadvantages listed for FBS. On the other hand, the culture media enriched in growth factors produced by these hMSCs in expansion (Conditioned medium - CM) can be an alternative to hMSCs application. The CM of the hMSCs from the UC might be a better therapeutic option compared to cell transplantation, as it can benefit from the local tissue response to the secreted molecules without the difficulties and complications associated to the engraftment of the allo-or xeno-transplanted cells. These facts drove us to know the detailed composition of the hUCBP and CM, by H-1-NMR and Multiplexing LASER Bead Technology. hUCBP is an adequate alternative for the FBS and the CM and hUCBP are important sources of growth factors, which can be used in MSCs-based therapies. Some of the major proliferative, chemotactic and immunomodulatory soluble factors (TGF-beta, G-CSF, GM-CSF, MCP-1, IL-6, IL-8) were detected in high concentrations in CM and even higher in hUCBP. The results from H-1-NMR spectroscopic analysis of CM endorsed a better understanding of hMSCs metabolism during in vitro culture, and the relative composition of several metabolites present in CM and hUCBP was obtained. The data reinforces the potential use of hUCBP and CM in tissue regeneration and focus the possible use of hUCBP as a substitute for the FBS used in hMSCs in vitro culture.	[Pereira, Tiago; Caseiro, Ana Rita; Luis, Ana Lucia; Mauricio, Ana Colette] Univ Porto, ICBAS, Dept Clin Vet, P-4100 Oporto, Portugal; [Pereira, Tiago; Caseiro, Ana Rita; Luis, Ana Lucia; Mauricio, Ana Colette] CECA, Inst Ciencias & Tecnol Agrarias & Agroalimentares, Oporto, Portugal; [Ivanova, Galya] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE, P-4100 Oporto, Portugal; [Barbosa, Paula] TecMaia, Biosckin Mol & Cell Therapies SA, Maia, Portugal; [Caseiro, Ana Rita; Bartolo, Paulo Jorge] Inst Politecn Leiria, CDRsp Ctr Desenvolvimento Rapido Sustentado Prod, Marinha Grande, Portugal; [Santos, Jose Domingos] Univ Porto, CEMUC, Fac Engn, Dept Engn Met & Mat, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Polytechnic Institute of Leiria; Universidade de Coimbra; Universidade do Porto	Mauricio, AC (corresponding author), Univ Porto, ICBAS, Dept Clin Vet, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ana.colette@hotmail.com	Maurício, Ana Colette/AAD-3601-2021; Maurício, Ana Colette/AIC-5064-2022; Ivanova, Galya I/G-5805-2011; Pereira, Tiago/AAJ-6738-2021; da Silva Bartolo, Paulo Jorge/ABF-9466-2020; Santos, Jose Domingos/Q-9462-2018; Bartolo, Paulo/F-2421-2013; Caseiro Santos, Ana Rita/D-1845-2018	Maurício, Ana Colette/0000-0002-0018-9363; Ivanova, Galya I/0000-0003-3195-634X; Pereira, Tiago/0000-0003-1050-9268; Santos, Jose Domingos/0000-0002-6871-9850; Bartolo, Paulo/0000-0003-3683-726X; Caseiro Santos, Ana Rita/0000-0002-1143-2461	QREN IDT [2008/1372]; European Community; QREN [38853/2013, NORTE-07-0162-FEDER-000048]; project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone" [ENMED/0002/2010]; program COMPETE - Programa Operacional Factores de Competitividade [Pest-OE/AGR/UI0211/2011]; FCT [PTDC/CVT/103081/2008, SFRH/BPD/79539/2011]	QREN IDT; European Community(European Commission); QREN; project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone"; program COMPETE - Programa Operacional Factores de Competitividade; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by QREN I&DT Cluster in Development of Products for Regenerative Medicine and Cell Therapies - Projects Biomat & Cell QREN 2008/1372, co-financed by the European Community FEDER fund through ON2 - O Novo Norte - North Portugal Regional Operational Program 2007-2013, by QREN no 38853/2013 - "Solucoes avancadas de regeneracao ossea com base em hidrogeis de dextrin - DEXGELERATION", by project "Hybrid Nanostructured Hydrogels: Bone regeneration using Multifunctional injectable Hydrogels - Rebone" - ENMED/0002/2010, and by the program COMPETE - Programa Operacional Factores de Competitividade, Project Pest-OE/AGR/UI0211/2011, and from FCT project PTDC/CVT/103081/2008. The co-author A Almeida is supported by a Post-Doc grant from FCT under the reference SFRH/BPD/79539/2011. The Bruker Avance III HD 600 MHz NMR spectrometer was purchased under the framework of QREN, through project NORTE-07-0162-FEDER-000048, and is part of the Portuguese National NMR Network. The authors would like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Ding Y, 2013, IN VITRO CELL DEV-AN, V49, P771, DOI 10.1007/s11626-013-9663-8; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Duarte IF, 2005, ANAL CHEM, V77, P5570, DOI 10.1021/ac050455c; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Fraga JS, 2013, BIOCHIMIE; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Friedman R, 2007, BIOL BLOOD MARROW TR, V13, P1477, DOI 10.1016/j.bbmt.2007.08.048; Gartner A, 2012, DIFFERENTIATION, V84, P355, DOI 10.1016/j.diff.2012.10.001; Gartner A., 2013, ADV BIOMATERIALS SCI; Gartner A, 2012, NEURAL REGENERATION, V07; Gartner A, 2014, J STEM CELLS REGENER, VX; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Jung J, 2009, STEM CELLS DEV, V18, P559, DOI 10.1089/scd.2008.0105; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Knowles P, 1996, BIOCHEM EDUC, V24, p[444, 67], DOI DOI 10.1016/S0307-4412(96)80024-0; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Li LL, 2009, MOL BIOL REP, V36, P725, DOI 10.1007/s11033-008-9235-2; Lin HD, 2013, STEM CELL REV REP, V9, P172, DOI 10.1007/s12015-013-9426-7; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; MacIntyre DA, 2011, PLOS ONE, V6; Malz F, 2005, J PHARMACEUT BIOMED, V38, P813, DOI 10.1016/j.jpba.2005.01.043; Muraglia A, 2000, J CELL SCI, V113, P1161; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Musteata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081192; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pereira T, 2014, STEM CELLS IN PRESS; Pereira T., 2013, ADV BIOMATERIALS SCI; Phadnis SM, 2006, IN VITRO CELL DEV-AN, V42, P283; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Russell WMS., 1959, MED J AUSTRALIA; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Seagle C, 2008, TISSUE ENG PART C-ME, V14, P107, DOI 10.1089/ten.tec.2007.0401; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Shetty P, 2007, CELL BIOL INT, V31, P293, DOI 10.1016/j.cellbi.2006.11.010; Shi CM, 2008, J TISSUE ENG REGEN M, V2, P482, DOI 10.1002/term.120; Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041; Simoes IN, 2013, BIOTECHNOL J, V8, P448, DOI 10.1002/biot.201200340; Simonetti AB, 2007, BRAZ J MICROBIOL, V38, P153, DOI 10.1590/S1517-83822007000100032; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Vasaghi Attiyeh, 2013, Hematol Oncol Stem Cell Ther, V6, P1, DOI 10.1016/j.hemonc.2013.02.002; Viant Mark R., 2008, P44; Wang YL, 2005, J PROTEOME RES, V4, P1324, DOI 10.1021/pr050032r; Wen SH, 2012, TRANSFUS APHER SCI, V46, P39, DOI 10.1016/j.transci.2011.10.031; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang SC, 2010, ANALYST, V135, P1490, DOI 10.1039/c000091d; Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058	74	48	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113769	10.1371/journal.pone.0113769	http://dx.doi.org/10.1371/journal.pone.0113769			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423186	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700064
J	By, S; Rispoli, JV; Cheshkov, S; Dimitrov, I; Cui, JM; Seiler, S; Goudreau, S; Malloy, C; Wright, SM; McDougall, MP				By, Samantha; Rispoli, Joseph V.; Cheshkov, Sergey; Dimitrov, Ivan; Cui, Jiaming; Seiler, Stephen; Goudreau, Sally; Malloy, Craig; Wright, Steven M.; McDougall, Mary Preston			A 16-Channel Receive, Forced Current Excitation Dual-Transmit Coil for Breast Imaging at 7T	PLOS ONE			English	Article							MRI; TESLA; SPECTROSCOPY; FEASIBILITY; MAMMOGRAPHY; WOMEN	Purpose: To enable high spatial and temporal breast imaging resolution via combined use of high field MRI, array coils, and forced current excitation (FCE) multi channel transmit. Materials and Methods: A unilateral 16-channel receive array insert was designed for use in a transmit volume coil optimized for quadrature operation with dual-transmit RF shimming at 7T. Signal-to-noise ratio (SNR) maps, g-factor maps, and high spatial and temporal resolution in vivo images were acquired to demonstrate the utility of the coil architecture. Results: The dual-transmit FCE coil provided homogeneous excitation and the array provided an increase in average SNR of 3.3 times (max 10.8, min 1.5) compared to the volume coil in transmit/receive mode. High resolution accelerated in vivo breast imaging demonstrated the ability to achieve isotropic spatial resolution of 0.5 mm within clinically relevant 90 s scan times, as well as the ability to perform 1.0 mm isotropic resolution imaging, 7 s per dynamics, with the use of bidirectional SENSE acceleration of up to R=9. Conclusion: The FCE design of the transmit coil easily accommodates the addition of a sixteen channel array coil. The improved spatial and temporal resolution provided by the high-field array coil with FCE dual-channel transmit will ultimately be beneficial in lesion detection and characterization.	[By, Samantha; Rispoli, Joseph V.; Wright, Steven M.; McDougall, Mary Preston] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Cheshkov, Sergey; Dimitrov, Ivan; Malloy, Craig] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Cheshkov, Sergey; Seiler, Stephen; Goudreau, Sally; Malloy, Craig] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Dimitrov, Ivan] Philips Med Syst, Cleveland, OH USA; [Cui, Jiaming; Wright, Steven M.; McDougall, Mary Preston] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Malloy, Craig] VA North Texas Hlth Care Syst, Dallas, TX USA	Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Philips; Philips Healthcare; Texas A&M University System; Texas A&M University College Station; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	McDougall, MP (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	mpmcdougall@tamu.edu	Rispoli, Joseph Vincent/AAB-1655-2019	Rispoli, Joseph Vincent/0000-0003-4514-3390; Seiler, Stephen/0000-0002-7501-9844; Malloy, Craig/0000-0001-5077-0642	Cancer Prevention and Research Institute of Texas (CPRIT) [RP100625]; National Institutes of Health [EB015908, EB016394]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016394, P41EB015908] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Cancer Prevention and Research Institute of Texas (CPRIT), grant number RP100625 (CM) (http://www.cprit.state.tx.us); and the National Institutes of Health grant numbers EB015908 (CM) and EB016394 (MM) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Bolan PJ, 2008, P INT SOC MAG RESON, P1588; BOTTOMLEY PA, 1978, PHYS MED BIOL, V23, P630, DOI 10.1088/0031-9155/23/4/006; Brown R, 2011, P 17 ANN M ISMRM MON, P3092; Brown R, 2013, EUR RADIOL, V23, P2969, DOI 10.1007/s00330-013-2972-1; Cheshkov S, 2013, P INT SOC MAG RESON, P407; Cheshkov S, 2012, P INT SOC MAG RESON, P1783; Cui J., 2013, P INT SOC MAG RESON, P2727; Dimitrov I, 2013, P INT SOC MAG RESON, P3370; Dimitrov IE, 2012, MAGN RESON MED, V67, P20, DOI 10.1002/mrm.22993; Huang W, 2008, P NATL ACAD SCI USA, V105, P17943, DOI 10.1073/pnas.0711226105; Italiaander M, 2013, P INT SOC MAG RESON, P2729; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Kim J, 2013, P INT SOC MAG RESON, P4396; Klomp DWJ, 2013, NMR BIOMED, V26, P1271, DOI 10.1002/nbm.2947; Korteweg MA, 2011, INVEST RADIOL, V46, P370, DOI 10.1097/RLI.0b013e31820df706; Kraff O, 2015, J MAGN RESON IMAGING, V41, P13, DOI 10.1002/jmri.24573; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, J MAGN RESON IMAGING, V12, P965, DOI 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Marshall H, 2010, J MAGN RESON IMAGING, V31, P328, DOI 10.1002/jmri.22023; McDougall MP, 2014, J MAGN RESON IMAGING, V40, P1165, DOI 10.1002/jmri.24473; McGhee DE, 2011, INT J CLOTH SCI TECH, V23, P351, DOI 10.1108/09556221111166284; Nnewihe AN, 2011, MAGN RESON MED, V66, P281, DOI 10.1002/mrm.22771; Orzada S., 2012, P INT SOC MAG RESON, V20, P0430; Pinker K, 2014, EUR RADIOL, V24, P913, DOI 10.1007/s00330-013-3075-8; Sodickson D, 2007, COIL ARRAY DESIGN PA; Stehouwer BL, 2013, MAGN RESON IMAGING, V31, P613, DOI 10.1016/j.mri.2012.09.005; Umutlu L, 2010, ACAD RADIOL, V17, P1050, DOI 10.1016/j.acra.2010.03.017; van de Bank BL, 2013, NMR BIOMED, V26, P367, DOI 10.1002/nbm.2868; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Versluis MJ, 2010, MAGN RESON MED, V63, P207, DOI 10.1002/mrm.22195; Wald LL, 2009, MAGNETOM FLASH, V40, P2009; Webb AG, 2010, INT J IMAG SYST TECH, V20, P2, DOI 10.1002/ima.20219; Wiesinger F, 2004, MAGN RESON MED, V52, P953, DOI 10.1002/mrm.20281; Wiesinger F, 2006, NMR BIOMED, V19, P368, DOI 10.1002/nbm.1050; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Wright SM, 2011, P INT SOC MAG RESON, P3847; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Zheng T, 2011, P INT SOC MAG RESON, P3819	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113969	10.1371/journal.pone.0113969	http://dx.doi.org/10.1371/journal.pone.0113969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420018	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900082
J	Marti-Soler, H; Gonseth, S; Gubelmann, C; Stringhini, S; Bovet, P; Chen, PC; Wojtyniak, B; Paccaud, F; Tsai, DH; Zdrojewski, T; Marques-Vidal, P				Marti-Soler, Helena; Gonseth, Semira; Gubelmann, Cedric; Stringhini, Silvia; Bovet, Pascal; Chen, Pau-Chung; Wojtyniak, Bogdan; Paccaud, Fred; Tsai, Dai-Hua; Zdrojewski, Tomasz; Marques-Vidal, Pedro			Seasonal Variation of Overall and Cardiovascular Mortality: A Study in 19 Countries from Different Geographic Locations	PLOS ONE			English	Article							EXCESS WINTER MORTALITY; MYOCARDIAL-INFARCTION; INFLUENZA EPIDEMICS; COLD WEATHER; RISK-FACTORS; DISEASE; HOSPITALIZATIONS; PARTICIPANTS; EUROPE; STROKE	Background: Cardiovascular diseases (CVD) mortality has been shown to follow a seasonal pattern. Several studies suggested several possible determinants of this pattern, including misclassification of causes of deaths. We aimed at assessing seasonality in overall, CVD, cancer and non-CVD/non-cancer mortality using data from 19 countries from different latitudes. Methods and Findings: Monthly mortality data were compiled from 19 countries, amounting to over 54 million deaths. We calculated ratios of the observed to the expected numbers of deaths in the absence of a seasonal pattern. Seasonal variation (peak to nadir difference) for overall and cause-specific (CVD, cancer or non-CVD/non-cancer) mortality was analyzed using the cosinor function model. Mortality from overall, CVD and non-CVD/non-cancer showed a consistent seasonal pattern. In both hemispheres, the number of deaths was higher than expected in winter. In countries close to the Equator the seasonal pattern was considerably lower for mortality from any cause. For CVD mortality, the peak to nadir differences ranged from 0.185 to 0.466 in the Northern Hemisphere, from 0.087 to 0.108 near the Equator, and from 0.219 to 0.409 in the Southern Hemisphere. For cancer mortality, the seasonal variation was nonexistent in most countries. Conclusions: In countries with seasonal variation, mortality from overall, CVD and non-CVD/non-cancer show a seasonal pattern with mortality being higher in winter than in summer. Conversely, cancer mortality shows no substantial seasonality.	[Marti-Soler, Helena; Gonseth, Semira; Gubelmann, Cedric; Stringhini, Silvia; Bovet, Pascal; Paccaud, Fred; Tsai, Dai-Hua; Marques-Vidal, Pedro] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Gonseth, Semira] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Wojtyniak, Bogdan] Natl Inst Hyg, Natl Inst Publ Hlth, PL-00791 Warsaw, Poland; [Zdrojewski, Tomasz] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; National Taiwan University; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Fahrenheit Universities; Medical University Gdansk; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	paccaud, fred/M-7516-2019; Marques-Vidal, Pedro M/C-9449-2009; Bovet, Pascal/F-4477-2011; Gubelmann, Cédric/J-1513-2016; Marti-Soler, Helena/AAA-7659-2019; Zdrojewski, Tomasz/AAA-8875-2020; Chen, Pau-Chung/H-5686-2011	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bovet, Pascal/0000-0002-0242-4259; Gubelmann, Cédric/0000-0002-4358-4769; Marti-Soler, Helena/0000-0002-7127-205X; Zdrojewski, Tomasz/0000-0001-6015-8561; Chen, Pau-Chung/0000-0002-6242-5974; Wojtyniak, Bogdan/0000-0002-2135-8226; Gonseth Nussle, Semira/0000-0001-5484-9016	Swiss Cancer League [BIL KLS-3124-02-2013]; SICPA Foundation; Swiss National Science Foundation [PZ00P3_147998]	Swiss Cancer League; SICPA Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	SG is supported by grants from the Swiss Cancer League (BIL KLS-3124-02-2013) and from the SICPA Foundation and thanks those entities. SS is supported by an Ambizione Grant (no PZ00P3_147998) from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; [Anonymous], 2008, R LANG ENV STAT COMP; Boulay F, 2001, AM J GASTROENTEROL, V96, P1881, DOI 10.1016/S0002-9270(01)02452-2; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Central Intelligence Agency, 2013, WORLD FACTBOOK; Chadwick J., 2005, HIPPOCRATIC WRITINGS; Clinch JP, 2000, J EPIDEMIOL COMMUN H, V54, P719, DOI 10.1136/jech.54.9.719; CROMBIE DL, 1995, J EPIDEMIOL COMMUN H, V49, P373, DOI 10.1136/jech.49.4.373; Douglas S, 1999, CHRONOBIOL INT, V16, P199, DOI 10.3109/07420529909019086; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Faure H, 2006, EUR J CLIN NUTR, V60, P706, DOI 10.1038/sj.ejcn.1602372; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Gomez-Acebo I, 2013, PUBLIC HEALTH, V127, P252, DOI 10.1016/j.puhe.2012.12.014; Gouveia N, 2003, INT J EPIDEMIOL, V32, P390, DOI 10.1093/ije/dyg077; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; IZZO JL, 1990, AM J HYPERTENS, V3, P405, DOI 10.1093/ajh/3.5.405; Kamezaki F, 2010, J ATHEROSCLER THROMB, V17, P638, DOI 10.5551/jat.3566; Kysely J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-19; Madjid M, 2003, CIRCULATION, V108, P2730, DOI 10.1161/01.CIR.0000102380.47012.92; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; Marti-Soler H, 2014, HEART, V100, P1517, DOI 10.1136/heartjnl-2014-305623; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Reavey M, 2013, INT J CARDIOL, V168, P2195, DOI 10.1016/j.ijcard.2013.01.224; Rudez G, 2009, J THROMB HAEMOST, V7, P1247, DOI 10.1111/j.1538-7836.2009.03488.x; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Su D, 2014, INT J EPIDEMIOL; von Klot S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-74; Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544	31	72	75	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113500	10.1371/journal.pone.0113500	http://dx.doi.org/10.1371/journal.pone.0113500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419711	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900044
J	To, C; Farnsworth, RH; Vail, ME; Chheang, C; Gargett, CE; Murone, C; Llerena, C; Major, AT; Scott, AM; Janes, PW; Lackmann, M				To, Catherine; Farnsworth, Rae H.; Vail, Mary E.; Chheang, Chanly; Gargett, Caroline E.; Murone, Carmel; Llerena, Carmen; Major, Andrew T.; Scott, Andrew M.; Janes, Peter W.; Lackmann, Martin			Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth	PLOS ONE			English	Article							EMBRYONIC MOTOR-NEURONS; DONOR STEM-CELLS; INDUCIBLE FACTOR-1-ALPHA; REGULATES EXPRESSION; REGENERATIVE CELLS; ENDOTHELIAL-CELLS; TYROSINE KINASE; ANGIOGENESIS; RECEPTORS; ADHESION	Eph and ephrin proteins are essential cell guidance cues that orchestrate cell navigation and control cell-cell interactions during developmental tissue patterning, organogenesis and vasculogenesis. They have been extensively studied in animal models of embryogenesis and adult tissue regeneration, but less is known about their expression and function during human tissue and organ regeneration. We discovered the hypoxia inducible factor (HIF)-1 alpha-controlled expression of EphA3, an Eph family member with critical functions during human tumour progression, in the vascularised tissue of regenerating human endometrium and on isolated human endometrial multipotent mesenchymal stromal cells (eMSCs), but not in other highly vascularised human organs. EphA3 affinity-isolation from human biopsy tissue yielded multipotent CD29(+)/CD73(+)/CD90(+)/CD146(+) eMSCs that can be clonally propagated and respond to EphA3 agonists with EphA3 phosphorylation, cell contraction, cell-cell segregation and directed cell migration. EphA3 silencing significantly inhibited the ability of transplanted eMSCs to support neovascularisation in immunocompromised mice. In accord with established roles of Eph receptors in mediating interactions between endothelial and perivascular stromal cells during mouse development, our findings suggest that HIF-1 alpha-controlled expression of EphA3 on human MSCs functions during the hypoxiainitiated early stages of adult blood vessel formation.	[To, Catherine; Farnsworth, Rae H.; Vail, Mary E.; Chheang, Chanly; Llerena, Carmen; Janes, Peter W.; Lackmann, Martin] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Major, Andrew T.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Gargett, Caroline E.] MIMR PHI Inst Med Res, Clayton, Vic, Australia; [Murone, Carmel; Scott, Andrew M.] Olivia Newton John Canc & Wellness Ctr, Ludwig Inst Canc Res, Melbourne, Vic, Australia	Monash University; Monash University; Prince Henry's Institute of Medical Research; La Trobe University; Olivia Newton-John Cancer Research Institute; Ludwig Institute for Cancer Research	Farnsworth, RH (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	rae.farnsworth@monash.edu	Gargett, Caroline E/Q-7911-2019; Major, Andrew T./B-8469-2016; Gargett, Caroline Eve/I-4895-2019	Gargett, Caroline E/0000-0002-3590-2077; Major, Andrew T./0000-0001-9036-6652; Janes, Peter/0000-0002-9039-1097; Farnsworth, Rae/0000-0002-7930-1206; Scott, Andrew/0000-0002-6656-295X	KaloBios Pharmaceuticals; National Health and Medical Research Council Australia [384241, 487922]; Human Frontiers Science Program [RGP0039/2009-C]; Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Scholarship	KaloBios Pharmaceuticals; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Human Frontiers Science Program(Human Frontier Science Program); Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Scholarship	This work was supported in part by research funding from KaloBios Pharmaceuticals to ML and AMS and by National Health and Medical Research Council Australia Grants #384241, 487922, Human Frontiers Science Program Grant #RGP0039/2009-C, a Victorian Government's Operational Infrastructure Support Program (CEG) and a Monash Postgraduate Scholarship to CT. ML and CEG are NH&MRC Senior Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adini A, 2009, J IMMUNOL METHODS, V342, P78, DOI 10.1016/j.jim.2008.11.016; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Arthur A, 2011, BONE, V48, P533, DOI 10.1016/j.bone.2010.10.180; Ball SG, 2014, STEM CELLS, V32, P694, DOI 10.1002/stem.1538; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bieche I, 2000, CLIN CANCER RES, V6, P452; Bockeria L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-56; Bosco MC, 2011, BLOOD, V117, P2625, DOI 10.1182/blood-2010-06-292136; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; BOYD AW, 1992, J BIOL CHEM, V267, P3262; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Critchley HOD, 2006, ENDOCRINOLOGY, V147, P744, DOI 10.1210/en.2005-1153; Cui CH, 2007, MOL BIOL CELL, V18, P1586, DOI 10.1091/mbc.E06-09-0872; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dottori M, 1999, BLOOD, V94, P2477, DOI 10.1182/blood.V94.7.2477.419k13_2477_2486; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Gargett CE, 2001, REPRODUCTION, V121, P181, DOI 10.1530/rep.0.1210181; Hagey A, 2011, BLOOD, V118, P4893; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kilpatrick TJ, 1996, MOL CELL NEUROSCI, V7, P62, DOI 10.1006/mcne.1996.0005; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lancet J, 2013, ASH ANN M, V122, P3838; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lin CS, 2013, STEM CELLS DEV, V22, P1018, DOI 10.1089/scd.2012.0504; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Maybin JA, 2011, ENDOCRINOLOGY, V152, P2845, DOI 10.1210/en.2010-1256; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Melero-Martin JM, 2011, STEM CELLS, V29, P163, DOI 10.1002/stem.583; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Murphy MP, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-45; Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Oates AC, 1999, MECH DEVELOP, V83, P77, DOI 10.1016/S0925-4773(99)00036-2; Okada H, 2014, J OBSTET GYNAECOL RE, V40, P1180, DOI 10.1111/jog.12392; Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Palath V, 2009, ASH ANN M, V114, P1728; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajaraman G, 2013, TISSUE ENG PART C-ME, V19, DOI 10.1089/ten.tec.2011.0718; Robb AO, 2009, HUM REPROD, V24, P619, DOI 10.1093/humrep/den411; Roura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049447; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Shoae-Hassani A, 2013, BJU INT, V112, P854, DOI 10.1111/bju.12195; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; Sugrue T, 2014, STEM CELLS, V32, P2188, DOI 10.1002/stem.1683; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Tsuzuki T, 2012, HUM REPROD, V27, P523, DOI 10.1093/humrep/der405; Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170; Ulrich D, 2013, EXPERT OPIN BIOL TH, V13, P1387, DOI 10.1517/14712598.2013.826187; Vail ME, 2014, CANCER RES, V74, P4470, DOI 10.1158/0008-5472.CAN-14-0218; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Verdi J, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-20; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Yano H, 2000, P NATL ACAD SCI USA, V97, P9076, DOI 10.1073/pnas.97.16.9076; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab; Yu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062703; Zhang J, 2002, HUM REPROD, V17, P265, DOI 10.1093/humrep/17.2.265; Zhou B, 2012, BRIT J HAEMATOL, V157, P299, DOI 10.1111/j.1365-2141.2012.09050.x	88	9	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112106	10.1371/journal.pone.0112106	http://dx.doi.org/10.1371/journal.pone.0112106			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420155	Green Published, gold			2022-12-27	WOS:000346766900006
J	Wang, L; Sadayappan, S; Kawai, M				Wang, Li; Sadayappan, Sakthivel; Kawai, Masakata			Cardiac Myosin Binding Protein C Phosphorylation Affects Cross-Bridge Cycle's Elementary Steps in a Site-Specific Manner	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; SHORTENING VELOCITY; PAPILLARY-MUSCLES; THICK FILAMENTS; N-TERMINUS; MYBP-C; FORCE; SKELETAL; RELEASE; ISOFORMS	Based on our recent finding that cardiac myosin binding protein C (cMyBP-C) phosphorylation affects muscle contractility in a site-specific manner, we further studied the force per cross-bridge and the kinetic constants of the elementary steps in the six-state cross-bridge model in cMyBP-C mutated transgenic mice for better understanding of the influence of cMyBP-C phosphorylation on contractile functions. Papillary muscle fibres were dissected from cMyBP-C mutated mice of ADA (Ala273-Asp282-Ala302), DAD (Asp273-Ala282-Asp302), SAS (Ser273-Ala282-Ser302), and t/t (cMyBP-C null) genotypes, and the results were compared to transgenic mice expressing wide-type (WT) cMyBP-C. Sinusoidal analyses were performed with serial concentrations of ATP, phosphate (Pi), and ADP. Both t/t and DAD mutants significantly reduced active tension, force per cross-bridge, apparent rate constant (2pc), and the rate constant of cross-bridge detachment. In contrast to the weakened ATP binding and enhanced Pi and ADP release steps in t/t mice, DAD mice showed a decreased ADP release without affecting the ATP binding and the Pi release. ADA showed decreased ADP release, and slightly increased ATP binding and cross-bridge detachment steps, whereas SAS diminished the ATP binding step and accelerated the ADP release step. t/t has the broadest effects with changes in most elementary steps of the cross-bridge cycle, DAD mimics t/t to a large extent, and ADA and SAS predominantly affect the nucleotide binding steps. We conclude that the reduced tension production in DAD and t/t is the result of reduced force per cross-bridge, instead of the less number of strongly attached cross-bridges. We further conclude that cMyBP-C is an allosteric activator of myosin to increase cross-bridge force, and its phosphorylation status modulates the force, which is regulated by variety of protein kinases.	[Wang, Li; Kawai, Masakata] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Wang, Li] Soochow Univ, Sch Nursing, Suzhou, Jiangsu, Peoples R China; [Sadayappan, Sakthivel] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, Maywood, IL USA	University of Iowa; Soochow University - China; Loyola University Chicago	Wang, L (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	li-wang-1@suda.edu.cn		Kawai, Masataka/0000-0002-3219-3527; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [HL070041, R01HL105826, K02HL114749]; American Heart Association Scientist Development Grant [0830311N, 14GRNT20490025, 13GRNT16810043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105826, K02HL114749, R01HL070041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health HL070041 (MK), R01HL105826 and K02HL114749 (SS) (http://www.nih.gov/), The American Heart Association Scientist Development Grant (0830311N), Grant-in-Aid (14GRNT20490025) (SS) and Grant-in-Aid (13GRNT16810043) (MK) (http://www.heart.org/HEARTORG/). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2013, J MUSCLE RES CELL M, V34, P295, DOI 10.1007/s10974-013-9343-z; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Colson BA, 2012, P NATL ACAD SCI USA, V109, P20437, DOI 10.1073/pnas.1213027109; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; Desjardins CL, 2012, CIRC-CARDIOVASC IMAG, V5, P127, DOI 10.1161/CIRCIMAGING.111.965772; FORTUNE NS, 1991, P NATL ACAD SCI USA, V88, P7323, DOI 10.1073/pnas.88.16.7323; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2014, FASEB J, V28; Granzier HL, 2006, CIRC RES, V99, P795, DOI 10.1161/01.RES.0000247031.56868.10; Greenberg MJ, 2009, AM J PHYSIOL-REG I, V297, pR265, DOI 10.1152/ajpregu.00171.2009; Gupta MK, 2013, J MOL CELL CARDIOL, V64, P39, DOI 10.1016/j.yjmcc.2013.08.006; KAWAI M, 1993, BIOPHYS J, V65, P638, DOI 10.1016/S0006-3495(93)81109-3; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; KAWAI M, 1993, CIRC RES, V73, P35, DOI 10.1161/01.RES.73.1.35; Kawai M, 2007, J MUSCLE RES CELL M, V28, P371, DOI 10.1007/s10974-008-9131-3; Kulikovskaya I, 2003, AM J PHYSIOL-HEART C, V285, pH857, DOI 10.1152/ajpheart.00841.2002; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Levine RJC, 1998, J STRUCT BIOL, V122, P149, DOI 10.1006/jsbi.1998.3980; LIM MS, 1986, BIOCHEM CELL BIOL, V64, P622, DOI 10.1139/o86-086; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Mamidi R, 2013, J GEN PHYSIOL, V142, P413, DOI 10.1085/jgp.201310971; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; Michalek AJ, 2013, BIOPHYS J, V104, P442, DOI [10.1016/j.bpj.2012.10.021, 10.1016/j.bpj.2012.12.021]; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Palmer BM, 2011, BIOPHYS J, V101, P1661, DOI 10.1016/j.bpj.2011.08.047; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan Sakthivel, 2012, Biophys Rev, V4, P93, DOI 10.1007/s12551-012-0067-x; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Wang L, 2013, J MUSCLE RES CELL MO; Wang L, 2014, BIOPHYS J, V106, P1112, DOI 10.1016/j.bpj.2014.01.029; Wang L, 2013, J MOL CELL CARDIOL, V62, P153, DOI 10.1016/j.yjmcc.2013.05.012; Wang L, 2013, J MUSCLE RES CELL M, V34, P93, DOI 10.1007/s10974-013-9337-x; Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; ZHAO Y, 1994, BIOPHYS J, V67, P1655, DOI 10.1016/S0006-3495(94)80638-1	49	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113417	10.1371/journal.pone.0113417	http://dx.doi.org/10.1371/journal.pone.0113417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420047	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900033
J	Wuolikainen, A; Acimovic, J; Lovgren-Sandblom, A; Parini, P; Andersen, PM; Bjorkhem, I				Wuolikainen, Anna; Acimovic, Jure; Loevgren-Sandblom, Anita; Parini, Paolo; Andersen, Peter M.; Bjoerkhem, Ingemar			Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DILUTION MASS-SPECTROMETRY; SERUM-LEVELS; HUMAN PLASMA; IN-VIVO; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; MECHANISM; STATINS; BENEFIT; SYSTEM	High plasma levels of cholesterol have been suggested to be neuroprotective for the degenerative disease amyotrophic lateral sclerosis (ALS) and to be associated with increased survival time. The gene encoding cholesterol 27-hydroxylase, CYP27A1, was recently identified as a susceptibility gene for sporadic ALS. A product of this enzyme is 27-hydroxycholesterol. We investigated plasma samples from 52 ALS patients and 40 control subjects (spouses) regarding cholesterol homeostasis, lipid profiles, and coenzyme Q. Eleven of the patients carried mutations in C9orf72 and seven in SOD1. Plasma levels of 27-hydroxycholesterol were significantly lower in male patients with ALS than in controls. It was not possible to link the reduced levels to any specific mutation, and there was no significant correlation between 27-hydroxycholesterol and survival. With normalization for diet using the spouses, a correlation was found between survival and total cholesterol, very low density lipoprotein cholesterol, low density lipoprotein cholesterol, and coenzyme Q. We conclude that cholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 27-hydroxycholesterol and lipid profiles in plasma are of limited prognostic value in individual ALS patients.	[Wuolikainen, Anna] Umea Univ, Computat Lifesci Cluster CLiC, Umea, Sweden; [Wuolikainen, Anna] Umea Univ, Dept Chem, Umea, Sweden; [Acimovic, Jure; Loevgren-Sandblom, Anita; Parini, Paolo; Bjoerkhem, Ingemar] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden	Umea University; Umea University; Karolinska Institutet; Umea University	Wuolikainen, A (corresponding author), Umea Univ, Computat Lifesci Cluster CLiC, Umea, Sweden.	anna.wuolikainen@chem.umu.se		Wuolikainen, Anna/0000-0003-0838-5526; Bjorkhem, Ingemar/0000-0002-0575-9425; Bjorkhem, Ingemar/0000-0001-6087-9190	Swedish Brain Power; Swedish Science Council; Bertil Hallsten Brain Research Foundation; Ulla-Carin Lindquist ALS Foundation; Erling Persson Family Foundation	Swedish Brain Power; Swedish Science Council; Bertil Hallsten Brain Research Foundation; Ulla-Carin Lindquist ALS Foundation; Erling Persson Family Foundation	This work was supported by grants from Swedish Brain Power, the Swedish Science Council, the Bertil Hallsten Brain Research Foundation, the Ulla-Carin Lindquist ALS Foundation, and the Erling Persson Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2012, BIOCHEM BIOPH RES CO, V425, P348, DOI 10.1016/j.bbrc.2012.07.094; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; AXELSON M, 1991, FEBS LETT, V284, P216, DOI 10.1016/0014-5793(91)80688-Y; Babiker A, 2005, SCAND J CLIN LAB INV, V65, P365, DOI 10.1080/00365510510025746; Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Dedic SIK, 2012, NEUROL RES, V34, P576, DOI 10.1179/1743132812Y.0000000049; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Diekstra FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035333; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Hansen G, 2004, ANALYST, V129, P45, DOI 10.1039/b308690a; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Lovgren-Sandblom A, 2007, J CHROMATOGR B, V856, P15, DOI 10.1016/j.jchromb.2007.05.019; LUND E, 1989, SCAND J CLIN LAB INV, V49, P165, DOI 10.3109/00365518909105417; Mateos L, 2009, BRAIN PATHOL, V19, P69, DOI 10.1111/j.1750-3639.2008.00174.x; Mateos L, 2011, J BIOL CHEM, V286, P25574, DOI 10.1074/jbc.M111.236877; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Molina JA, 2000, J NEURAL TRANSM, V107, P1021, DOI 10.1007/s007020070050; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Sutedja NA, 2011, J NEUROL NEUROSUR PS, V82, P638, DOI 10.1136/jnnp.2010.236752; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zheng ZZ, 2013, AMYOTROPH LAT SCL FR, V14, P241, DOI 10.3109/21678421.2012.732078	30	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113619	10.1371/journal.pone.0113619	http://dx.doi.org/10.1371/journal.pone.0113619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415378	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600065
J	De Backer, O; Arnous, S; Lonborg, J; Brooks, M; Biasco, L; Joensson, A; Franzen, OW; Sondergaard, L				De Backer, Ole; Arnous, Samer; Lonborg, Jacob; Brooks, Matthew; Biasco, Luigi; Joensson, Anders; Franzen, Olaf W.; Sondergaard, Lars			Recovery from Anemia in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation - Prevalence, Predictors and Clinical Outcome	PLOS ONE			English	Article							VON-WILLEBRAND-SYNDROME; HIGH-RISK PATIENTS; PREOPERATIVE ANEMIA; PARAVALVULAR LEAKS; HEYDES SYNDROME; REPLACEMENT; TRANSFUSION; MORTALITY; ANGIODYSPLASIA; SURGERY	Introduction: Preoperative anemia is common in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and has been linked to a poorer outcome - including a higher 1-year mortality. The aim of this study was to investigate the impact of successful TAVI on baseline anemia. Methods: A total of 253 patients who survived at least 1 year following TAVI were included in this study. The prevalence, predictors and clinical outcome of hemoglobin (Hb)-recovery were assessed. Results: The prevalence of baseline anemia was 49% (n=124) -recovery from anemia occurred in 40% of the anemic patients (n=49) at 1 year after TAVI with an increase in mean Hb-level of 1.35 g/dL from baseline. This increase was not related to an improvement in renal function. At multivariate analysis, a high peak gradient (OR 4.82, P=0.003) was shown to be an independent predictor for Hb-recovery, while blood transfusion (OR 0.31, P=0.038) and chronic kidney disease (CKD, OR 0.33, P=0.043) were identified as negative predictors at, respectively, one and two years after TAVI. When compared to patients without baseline anemia, those anemic patients with Hb-recovery had a similar functional improvement (OR 0.98, P=0.975), whereas those without Hb-recovery had a significantly lower likelihood of functional improvement with >= 2 NYHA classes (OR 0.49, P=0.034) and a higher likelihood of re-hospitalization within the first year after TAVI (OR 1.91, P=0.024). Conclusion: Recovery from anemia occurs in 40% of anemic patients at 1 year after TAVI - mainly in those with a high gradient and without CKD. Blood transfusion was found to have a transient adverse effect on this Hb-recovery. Finally, anemic patients without Hb-recovery experience less functional improvement and have a higher re-hospitalization rate within the first year after TAVI.	[De Backer, Ole; Arnous, Samer; Lonborg, Jacob; Brooks, Matthew; Biasco, Luigi; Joensson, Anders; Franzen, Olaf W.; Sondergaard, Lars] Rigshosp Univ Hosp, Dept Cardiol, Sjaelland, Denmark	Rigshospitalet	De Backer, O (corresponding author), Rigshosp Univ Hosp, Dept Cardiol, Sjaelland, Denmark.	ole.debacker@gmail.com	De Backer, Ole/AAQ-2369-2020; Biasco, Luigi/X-1217-2019	De Backer, Ole/0000-0002-9674-0278; 	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Anders Jonsson and Lars Sondergaard: proctoring for Medtronic. Olaf W. Franzen: proctoring for and research grant from Abbott Vascular. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no conflicts of interest.	D'Ascenzo F, 2013, INT J CARDIOL, V167, P1514, DOI 10.1016/j.ijcard.2012.04.161; Elmariah S, 2013, CIRC-CARDIOVASC INTE, V6, P604, DOI 10.1161/CIRCINTERVENTIONS.113.000650; Elmistekawy E, 2013, EUR J CARDIO-THORAC, V44, P1051, DOI 10.1093/ejcts/ezt143; Godino C, 2013, J AM COLL CARDIOL, V61, P687, DOI 10.1016/j.jacc.2012.10.041; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Keles T, 2013, J GERIATR CARDIOL, V10, P317, DOI 10.3969/j.issn.1671-5411.2013.04.010; Kliger C, 2013, EUR HEART J, V34, P638, DOI 10.1093/eurheartj/ehs347; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Loscalzo J, 2012, NEW ENGL J MED, V367, P1954, DOI 10.1056/NEJMcibr1205363; Marggraf O, 2012, AM HEAR ASS SCI SESS; Nuis RJ, 2013, CIRC-CARDIOVASC INTE, V6, P625, DOI 10.1161/CIRCINTERVENTIONS.113.000409; Nuis RJ, 2012, CIRC-CARDIOVASC INTE, V5, P680, DOI 10.1161/CIRCINTERVENTIONS.112.971291; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; Pasricha SR, 2013, BLOOD, V122, P124, DOI 10.1182/blood-2012-12-471441; Ruiz CE, 2011, J AM COLL CARDIOL, V58, P2210, DOI 10.1016/j.jacc.2011.03.074; Shander A, 2011, BRIT J ANAESTH, V107, P41, DOI 10.1093/bja/aer350; Shapira Y, 2009, CARDIOL REV, V17, P121, DOI 10.1097/CRD.0b013e31819f1a83; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Tchetche D, 2012, AM HEART J, V164, P402, DOI 10.1016/j.ahj.2012.07.003; Van Mieghem NM, 2012, CATHETER CARDIO INTE, V79, P726, DOI 10.1002/ccd.23275; van Straten AHM, 2013, J CARDIOTHOR VASC AN, V27, P716, DOI 10.1053/j.jvca.2012.12.021; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; Warkentin TE, 2003, TRANSFUS MED REV, V17, P272, DOI 10.1016/S0887-7963(03)00037-3; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114038	10.1371/journal.pone.0114038	http://dx.doi.org/10.1371/journal.pone.0114038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437191	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900112
J	Jitraruch, S; Dhawan, A; Hughes, RD; Filippi, C; Soong, D; Philippeos, C; Lehec, SC; Heaton, ND; Longhi, MS; Mitry, RR				Jitraruch, Suttiruk; Dhawan, Anil; Hughes, Robin D.; Filippi, Celine; Soong, Daniel; Philippeos, Christina; Lehec, Sharon C.; Heaton, Nigel D.; Longhi, Maria S.; Mitry, Ragai R.			Alginate Microencapsulated Hepatocytes Optimised for Transplantation in Acute Liver Failure	PLOS ONE			English	Article							IMMORTALIZED XENOGENEIC HEPATOCYTES; CELL TRANSPLANTATION; IMPROVED SURVIVAL; HEPATIC-FAILURE; IN-VITRO; MICROCAPSULES; RAT; BIOCOMPATIBILITY; CRYOPRESERVATION; ENCAPSULATION	Background and Aim: Intraperitoneal transplantation of alginate-microencapsulated human hepatocytes is an attractive option for the management of acute liver failure (ALF) providing short-term support to allow native liver regeneration. The main aim of this study was to establish an optimised protocol for production of alginate-encapsulated human hepatocytes and evaluate their suitability for clinical use. Methods: Human hepatocyte microbeads (HMBs) were prepared using sterile GMP grade materials. We determined physical stability, cell viability, and hepatocyte metabolic function of HMBs using different polymerisation times and cell densities. The immune activation of peripheral blood mononuclear cells (PBMCs) after co-culture with HMBs was studied. Rats with ALF induced by galactosamine were transplanted intraperitoneally with rat hepatocyte microbeads (RMBs) produced using a similar optimised protocol. Survival rate and biochemical profiles were determined. Retrieved microbeads were evaluated for morphology and functionality. Results: The optimised HMBs were of uniform size (583.5 +/- 3.3 mm) and mechanically stable using 15 min polymerisation time compared to 10 min and 20 min (p< 0.001). 3D confocal microscopy images demonstrated that hepatocytes with similar cell viability were evenly distributed within HMBs. Cell density of 3.56106 cells/ml provided the highest viability. HMBs incubated in human ascitic fluid showed better cell viability and function than controls. There was no significant activation of PBMCs co-cultured with empty or hepatocyte microbeads, compared to PBMCs alone. Intraperitoneal transplantation of RMBs was safe and significantly improved the severity of liver damage compared to control groups (empty microbeads and medium alone; p < 0.01). Retrieved RMBs were intact and free of immune cell adherence and contained viable hepatocytes with preserved function. Conclusion: An optimised protocol to produce GMP grade alginate-encapsulated human hepatocytes has been established. Transplantation of microbeads provided effective metabolic function in ALF. These high quality HMBs should be suitable for use in clinical transplantation.	[Jitraruch, Suttiruk; Dhawan, Anil; Hughes, Robin D.; Filippi, Celine; Philippeos, Christina; Lehec, Sharon C.; Heaton, Nigel D.; Longhi, Maria S.; Mitry, Ragai R.] Kings Coll London, Sch Med, Inst Liver Studies, London WC2R 2LS, England; [Soong, Daniel] Kings Coll London, Sch Med, British Heart Fdn Ctr, Excellence Cardiovasc Div, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Dhawan, A (corresponding author), Kings Coll London, Sch Med, Inst Liver Studies, London WC2R 2LS, England.	anil.dhawan@kcl.ac.uk; ragai.mitry@kcl.ac.uk	Philippeos, Christina/S-3780-2019; Heaton, Nigel/AAK-8363-2020; Filippi, Celine/H-3140-2019	Philippeos, Christina/0000-0001-8654-0291; Filippi, Celine/0000-0002-4679-3275; Dhawan, Anil/0000-0002-4942-0845	National Institute for Health Research; WellChild; Medical Research Council [MR/J006742/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); WellChild; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institute for Health Research (AD and RDH), funds for consumables; and WellChild (RRM and AD), funds were given to purchase the encapsulator used in the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2005, CELL TRANSPLANT, V14, P609, DOI 10.3727/000000005783982710; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; BURCH RE, 1979, ARCH INTERN MED, V139, P680, DOI 10.1001/archinte.139.6.680; Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Durkut S, 2013, ARTIF CELLS IN PRESS; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fitzpatrick E, 2013, CELL TRANSP IN PRESS, V18; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; Haque T, 2005, BIOTECHNOL LETT, V27, P317, DOI 10.1007/s10529-005-0687-3; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Kim AR, 2013, J BIOMAT SCI-POLYM E, V24, P1084, DOI 10.1080/09205063.2012.735100; Kusano T, 2008, HEPATOL RES, V38, P593, DOI 10.1111/j.1872-034X.2007.00311.x; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Mai G, 2005, TRANSPL P, V37, P527, DOI 10.1016/j.transproceed.2005.01.017; Mai G, 2005, XENOTRANSPLANTATION, V12, P457, DOI 10.1111/j.1399-3089.2005.00248.x; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Mitry Ragai R., 2009, V481, P17, DOI 10.1007/978-1-59745-201-4_2; Mitry RR, 2005, TRANSPLANT P, V37, P2391, DOI 10.1016/j.transproceed.2005.03.019; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7; Puppi J, 2014, CELL TRANSPLANT, V23, P329, DOI 10.3727/096368913X663596; Reebye V, 2014, HEPATOLOGY IN PRESS, V59; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Sgroi A, 2011, CELL TRANSPLANT, V20, P1791, DOI 10.3727/096368911X564976; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F; Umehara Y, 2001, SURGERY, V130, P513, DOI 10.1067/msy.2001.116929; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; Wang LS, 2000, ARTIF CELL BLOOD SUB, V28, P215, DOI 10.3109/10731190009119353; Wu Yao-Ming, 2009, V481, P107, DOI 10.1007/978-1-59745-201-4_10; Zhang FT, 2011, WORLD J GASTROENTERO, V17, P938, DOI 10.3748/wjg.v17.i7.938; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2	36	86	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113609	10.1371/journal.pone.0113609	http://dx.doi.org/10.1371/journal.pone.0113609			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438038	gold, Green Published			2022-12-27	WOS:000347114900055
J	Wagner, BG; Behrend, MR; Klein, DJ; Upfill-Brown, AM; Eckhoff, PA; Hu, H				Wagner, Bradley G.; Behrend, Matthew R.; Klein, Daniel J.; Upfill-Brown, Alexander M.; Eckhoff, Philip A.; Hu, Hao			Quantifying the Impact of Expanded Age Group Campaigns for Polio Eradication	PLOS ONE			English	Article							LONG-TERM IMMUNITY; ACQUIRED-IMMUNITY; FOLLOW-UP; VACCINE; POLIOMYELITIS; CHILDREN; TRANSMISSION; IMMUNIZATION; ANTIBODIES; EXCRETION	A priority of the Global Polio Eradication Initiative (GPEI) 2013-2018 strategic plan is to evaluate the potential impact on polio eradication resulting from expanding one or more Supplementary Immunization Activities (SIAs) to children beyond age five-years in polio endemic countries. It has been hypothesized that such expanded age group (EAG) campaigns could accelerate polio eradication by eliminating immunity gaps in older children that may have resulted from past periods of low vaccination coverage. Using an individual-based mathematical model, we quantified the impact of EAG campaigns in terms of probability of elimination, reduction in polio transmission and age stratified immunity levels. The model was specifically calibrated to seroprevalence data from a polio-endemic region: Zaria, Nigeria. We compared the impact of EAG campaigns, which depend only on age, to more targeted interventions which focus on reaching missed populations. We found that EAG campaigns would not significantly improve prospects for polio eradication; the probability of elimination increased by 8% (from 24% at baseline to 32%) when expanding three annual SIAs to 5-14 year old children and by 18% when expanding all six annual SIAs. In contrast, expanding only two of the annual SIAs to target hard-to-reach populations at modest vaccination coverage-representing less than one tenth of additional vaccinations required for the six SIA EAG scenario-increased the probability of elimination by 55%. Implementation of EAG campaigns in polio endemic regions would not improve prospects for eradication. In endemic areas, vaccination campaigns which do not target missed populations will not benefit polio eradication efforts.	[Wagner, Bradley G.; Behrend, Matthew R.; Klein, Daniel J.; Upfill-Brown, Alexander M.; Eckhoff, Philip A.; Hu, Hao] Inst Dis Modeling, Bellevue, WA 98009 USA		Wagner, BG (corresponding author), Inst Dis Modeling, Bellevue, WA 98009 USA.	bwagner@intven.com			Global Good Fund	Global Good Fund	The authors gratefully acknowledge financial support from the Global Good Fund (BGW, MRB, DJK, AUB, PAE, and HH; http://www.intellectualventures.com/globalgood/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; [Anonymous], 2013, POL ER ENDG STRAT PL; Behrend MR, 2014, INT J INFECT DIS, V18, P4, DOI 10.1016/j.ijid.2013.09.005; Blake IM, 2014, P NATL ACAD SCI USA, V111, P10604, DOI 10.1073/pnas.1323688111; BOTTIGER M, 1984, REV INFECT DIS, V6, pS548; BOTTIGER M, 1990, VACCINE, V8, P443, DOI 10.1016/0264-410X(90)90244-G; Callaway E, 2013, NATURE, V496, P290, DOI 10.1038/496290a; DAVIS DC, 1958, PEDIATRICS, V22, P33; DICK GW, 1961, BRIT MED J, V2, P266, DOI 10.1136/bmj.2.5247.266; FADEN H, 1993, J INFECT DIS, V168, P452, DOI 10.1093/infdis/168.2.452; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; FOX JP, 1984, REV INFECT DIS, V6, pS352; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Giwa FJ, 2012, VACCINE, V30, P6759, DOI 10.1016/j.vaccine.2012.09.023; GREEN MS, 1993, VACCINE, V11, P75, DOI 10.1016/0264-410X(93)90342-U; Grotto I, 2001, VACCINE, V19, P4162, DOI 10.1016/S0264-410X(01)00165-7; Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030; Mayer BT, 2013, AM J EPIDEMIOL, V177, P1236, DOI 10.1093/aje/kws378; Nates SV, 2007, VIRAL IMMUNOL, V20, P3, DOI 10.1089/vim.2006.0071; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; NISHIO O, 1984, J BIOL STAND, V12, P1, DOI 10.1016/S0092-1157(84)80015-3; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; World Health Assembly, 2012, WORLD HLTH ASS RES C; Wringe A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003433; Zhang J, 1997, J INFECT DIS, V175, pS210, DOI 10.1093/infdis/175.Supplement_1.S210	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113538	10.1371/journal.pone.0113538	http://dx.doi.org/10.1371/journal.pone.0113538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437014	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900051
J	Wen, C; Chen, YP; Wu, P; Wang, T; Zhou, YM				Wen, Chao; Chen, Yueping; Wu, Ping; Wang, Tian; Zhou, Yanmin			MSTN, mTOR and FoxO4 Are Involved in the Enhancement of Breast Muscle Growth by Methionine in Broilers with Lower Hatching Weight	PLOS ONE			English	Article							SKELETAL-MUSCLE; DIETARY METHIONINE; PROTEIN-METABOLISM; BODY-WEIGHT; EXPRESSION; PERFORMANCE; IMPROVES; DNA; METHYLATION; MECHANISMS	Broilers with lower hatching weight (HW) present poorer performance than those with high HW, but there is limited research on the growth regulation of broilers with lower HW. The objective of this study was to investigate the effect of dietary methionine (Met) levels on the growth performance and breast muscle yield of broilers with different HW and underlying mechanisms. A total of 192 one-day-old Arbor Acres broiler chicks with different HW (heavy: 48.3 +/- 0.1 g, and light: 41.7 +/- 0.1 g) were allocated to a 262 factorial arrangement with 6 replicates of 8 chicks per replicate cage. Control starter (1-21 d) and finisher (22-42 d) diets were formulated to contain 0.50% and 0.43% Met, respectively. Corresponding values for a high Met treatment were 0.60% and 0.53%. Light chicks had lower body weight gain (BWG) and breast muscle yield than heavy chicks when the broilers were fed the control diets. High Met diets improved BWG, gain to feed ratio and breast muscle yield in light but not heavy chicks. Decreased DNA content and increased RNA/DNA and protein/DNA ratios in breast muscle were induced by high Met diets only in light chicks. MSTN mRNA level was decreased by high Met diets only in light chicks, and this decrease was accompanied by a significant increase in MSTN gene exon 1 methylation. In addition, high Met diets increased mTOR phosphorylation, but decreased FoxO4 phosphorylation in breast muscle of light chicks. In conclusion, the BWG and breast muscle yield of light chicks were improved by increasing dietary Met levels probably through alterations of MSTN transcription and phosphorylation of mTOR and FoxO4.	[Wen, Chao; Chen, Yueping; Wu, Ping; Wang, Tian; Zhou, Yanmin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, YM (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhouym6308@163.com						Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Blattler A, 2013, J BIOL CHEM, V288, P34287, DOI 10.1074/jbc.R113.512517; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen J, 2011, ANIMAL, V5, P1082, DOI 10.1017/S1751731111000085; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; HICKLING D, 1990, CAN J ANIM SCI, V70, P673, DOI 10.4141/cjas90-079; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; JOHNSON LR, 1973, AM J PHYSIOL, V224, P937, DOI 10.1152/ajplegacy.1973.224.4.937; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kim JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048455; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liu GQ, 2010, AGR SCI CHINA, V9, P1338, DOI 10.1016/S1671-2927(09)60224-8; Mendes AS, 2011, BRAZ J POULTRY SCI, V13, P165, DOI 10.1590/S1516-635X2011000300001; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Mogyca Leandro NS, 2006, REV BRAS ZOOTECN, V35, P2314, DOI 10.1590/S1516-35982006000800017; Singh PM, 2006, INDIAN J ANIM SCI, V76, P1043; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; SHANAWANY MM, 1987, WORLD POULTRY SCI J, V43, P107, DOI 10.1079/WPS19870008; Sklan D, 2003, POULTRY SCI, V82, P1778, DOI 10.1093/ps/82.11.1778; Tesseraud S, 2011, WORLD POULTRY SCI J, V67, P243, DOI 10.1017/S0043933911000274; Uni Z, 1996, BRIT POULTRY SCI, V37, P63, DOI 10.1080/00071669608417837; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XQ, 2013, J ANIM PHYSIOL AN N, V97, P797, DOI 10.1111/j.1439-0396.2012.01320.x; Wang YX, 2012, BRIT J NUTR, V108, P1371, DOI 10.1017/S0007114511006763; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Wen C, 2012, ANIM FEED SCI TECH, V172, P180, DOI 10.1016/j.anifeedsci.2011.11.012; Wen C, 2014, BRIT J NUTR, V111, P201, DOI 10.1017/S0007114513002419; Willemsen H, 2008, POULTRY SCI, V87, P2358, DOI 10.3382/ps.2008-00095; Zhai W, 2012, POULTRY SCI, V91, P2548, DOI 10.3382/ps.2012-02213	33	13	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114236	10.1371/journal.pone.0114236	http://dx.doi.org/10.1371/journal.pone.0114236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437444	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900133
J	Zhang, XS; Bian, XW; Kong, J				Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming			The Proapoptotic Protein BNIP3 Interacts with VDAC to Induce Mitochondrial Release of Endonuclease G	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; NEURONAL DEATH; UP-REGULATION; CYTOCHROME-C; APOPTOSIS; EXPRESSION; HYPOXIA; TRANSLOCATION; CASPASE-3	BNIP3 is a proapoptotic protein that induces cell death through a mitochondria-mediated pathway. We reported previously that mitochondrial localization of BNIP3 and translocation of EndoG from mitochondria to the nucleus are critical steps of the BNIP3 pathway. It is not clear, however, that how BNIP3 interacts with mitochondria. Here we show that expression of BNIP3 resulted in mitochondrial release and nuclear translocation of EndoG. Incubation of a recombinant GST-BNIP3 protein with freshly isolated mitochondria led to the integration of BNIP3 into mitochondria, reduction in the levels of EndoG in mitochondria and the presence of EndoG in the supernatant that was able to cleave chromatin DNA. Co-immunoprecipitation and mass spectrometry analysis reveals that BNIP3 interacted with the voltage-dependent anion channel (VDAC) to increase opening probabilities of mitochondrial permeability transition (PT) pores and induce mitochondrial release of EndoG. Blocking VDAC with a VDAC antibody largely abolished mitochondrial localization of BNIP3 and prevented EndoG release. Together, the data identify VDAC as an interacting partner of BNIP3 and support endonuclease G as a mediator of the BNIP3 pathway.	[Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming] Third Mil Med Univ, Southwest Canc Ctr, Chongqing, Peoples R China; [Zhang, Xiaosha; Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada	Army Medical University; Army Medical University; University of Manitoba	Bian, XW (corresponding author), Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China.	bianxiuwu@263.net; Jiming.Kong@med.umanitoba.ca	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; Kong, Jiming/0000-0002-2859-9831	Canadian Stroke Network; Manitoba Health Research Council; Canadian Institutes of Health Research; China Scholarship Council	Canadian Stroke Network; Manitoba Health Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council)	The project was supported by Canadian Stroke Network, Manitoba Health Research Council and Canadian Institutes of Health Research. X. Zhang received a studentship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Li CR, 2013, J NEUROCHEM, V127, P426, DOI 10.1111/jnc.12314; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Tomicic MT, 2001, BIOCHEM BIOPH RES CO, V281, P404, DOI 10.1006/bbrc.2001.4367; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017998; Zhang SR, 2007, BRAIN RES, V1138, P221, DOI 10.1016/j.brainres.2006.12.086; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhao ST, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-113	29	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113642	10.1371/journal.pone.0113642	http://dx.doi.org/10.1371/journal.pone.0113642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436615	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900058
J	Aguirre, M; Jonkers, DMAE; Troost, FJ; Roeselers, G; Venema, K				Aguirre, Marisol; Jonkers, Daisy M. A. E.; Troost, Freddy J.; Roeselers, Guus; Venema, Koen			In Vitro Characterization of the Impact of Different Substrates on Metabolite Production, Energy Extraction and Composition of Gut Microbiota from Lean and Obese Subjects	PLOS ONE			English	Article							FATTY-ACID PRODUCTION; HUMAN COLONIC MICROBIOTA; LARGE-INTESTINE; FECAL MICROBIOTA; EPITHELIAL-CELLS; DIETARY FIBER; HUMAN FECES; WEIGHT-LOSS; FERMENTATION; BACTERIA	The aim of this study was to investigate the effect of galacto-oligosaccharides, lactulose, apple fiber and sugar beet pectin on the composition and activity of human colonic microbiota of lean and obese healthy subjects using an in vitro model of the proximal colon: TIM-2. Substrate fermentation was assessed by measuring the production of short-chain and branched-chain fatty acids, lactate and ammonia and by studying the composition of the bacterial communities over time. The results suggest that energy harvest (in terms of metabolites) of lean and obese microbiotas is different and may depend on the fermentable substrate. For galacto-oligosaccharides and lactulose, the cumulative amount of short-chain fatty acids plus lactate produced in TIM-2 was lower in the fermentation experiments with the lean microbiota (123 and 155 mmol, respectively) compared to the obese (162 and 173 mmol, respectively). This was reversed for the pectin and the fiber. The absolute amount produced of short-chain fatty acids including lactate was higher after 72 h in the fermentation experiments with apple fiber-L (108 mmol) than with apple fiber-O (92 mmol). Sugar beet-L was also higher (130 mmol) compared to sugar beet-O (103 mmol). Galacto-oligosaccharides and lactulose boosted the balance of health-promoting over toxic metabolites produced by the microbiota from obese subjects. Firmicutes were more predominant in the inoculum prepared from feces of obese subjects compared to lean subjects. The average abundance at time zero was 92% and 74%, respectively. On the other hand, Bacteroidetes were more dominant in the microbiota prepared with homogenates from lean subjects with an average abundance of 22% compared with the microbiota prepared with homogenates from obese subjects (3.6%). This study brings evidence that different fermentable carbohydrates are fermented differently by lean and obese microbiotas, which contributes to the understanding of the role of diet and the microbiota in tackling obesity.	[Aguirre, Marisol; Venema, Koen] Top Inst Food & Nutr, Wageningen, Gelderland, Netherlands; [Aguirre, Marisol; Jonkers, Daisy M. A. E.; Troost, Freddy J.] Maastricht Univ, Dept Human Biol, NL-6200 MD Maastricht, Limburg, Netherlands; [Aguirre, Marisol; Roeselers, Guus; Venema, Koen] Netherlands Org Appl Sci Res, Dept Microbiol & Syst Biol, Utrecht, Netherlands	Top Institute Food & Nutrition; Maastricht University	Venema, K (corresponding author), Top Inst Food & Nutr, Wageningen, Gelderland, Netherlands.	koen.venema@outlook.com	Troost, Freddy/B-2782-2015; Roeselers, Guus/J-2971-2012	Roeselers, Guus/0000-0002-4725-6105	Netherlands Organisation for Applied Scientific Research (TNO), Zeist, The Netherlands	Netherlands Organisation for Applied Scientific Research (TNO), Zeist, The Netherlands	Funding was provided by the Netherlands Organisation for Applied Scientific Research (TNO; no grant number; www.tno.nl; Utrechtseweg 48, 3700 AJ, Zeist, The Netherlands). TNO was involved in study design, but had no role in data collection and analysis, decision to publish or preparation of the manuscript. None of the people deciding on funding are authors on the manuscript.	Aguirre M, 2014, J MICROBIOL METH, V107, P1, DOI 10.1016/j.mimet.2014.08.022; Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Beards E, 2010, ANAEROBE, V16, P420, DOI 10.1016/j.anaerobe.2010.05.006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bernalier-Donadille A, 2010, GASTROEN CLIN BIOL, V34, pS16, DOI 10.1016/S0399-8320(10)70016-6; Bouhnik Y, 1997, J NUTR, V127, P444, DOI 10.1093/jn/127.3.444; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brook I, 2008, DIGEST DIS SCI, V53, P2585, DOI 10.1007/s10620-007-0194-6; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; de Graaf AA, 2010, NMR BIOMED, V23, P2, DOI 10.1002/nbm.1418; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferchaud-Roucher V, 2005, AM J PHYSIOL-ENDOC M, V289, pE716, DOI 10.1152/ajpendo.00430.2004; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; FLOURIE B, 1985, AM J CLIN NUTR, V42, P495, DOI 10.1093/ajcn/42.3.495; FREDSTROM SB, 1994, JPEN-PARENTER ENTER, V18, P14, DOI 10.1177/014860719401800114; Fukunaga T, 2003, DIGESTION, V67, P42, DOI 10.1159/000069705; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GIBSON GR, 1988, APPL ENVIRON MICROB, V54, P2750, DOI 10.1128/AEM.54.11.2750-2755.1988; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; GIBSON PR, 1992, J GASTROEN HEPATOL, V7, P165, DOI 10.1111/j.1440-1746.1992.tb00956.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kageyama A, 2000, INT J SYST EVOL MICR, V50, P1595, DOI 10.1099/00207713-50-4-1595; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lawson DJ, 2011, BIOMETRICAL J, V53, P543, DOI 10.1002/bimj.201000250; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Libby DB, 2009, INT J INFECT DIS, V13, pE305, DOI 10.1016/j.ijid.2009.01.014; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Maathuis AJH, 2012, J NUTR, V142, P1205, DOI 10.3945/jn.111.157420; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Marino PL, 2012, ICU BOOK; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; Morrison DJ, 2006, BRIT J NUTR, V96, P570, DOI 10.1079/BJN20061853; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Parkar SG, 2010, J FUNCT FOODS, V2, P210, DOI 10.1016/j.jff.2010.04.009; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Petersen Craig, 2005, Nutr Clin Pract, V20, P634, DOI 10.1177/0115426505020006634; Playne MJ, 2009, ADV DAIRY CHEM, V3, P121, DOI DOI 10.1007/978-0-387-84865-5; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; ROWLAND IR, 1993, J APPL BACTERIOL, V74, P667, DOI 10.1111/j.1365-2672.1993.tb05201.x; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; SALVADOR V, 1993, BRIT J NUTR, V70, P189, DOI 10.1079/BJN19930116; Sarbini SR, 2013, BRIT J NUTR, V109, P1980, DOI 10.1017/S0007114512004205; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHWARTZ SE, 1982, GASTROENTEROLOGY, V83, P812; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Shinohara K, 2010, ANAEROBE, V16, P510, DOI 10.1016/j.anaerobe.2010.03.005; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Van den Abbeele P, 2013, J AGR FOOD CHEM, V61, P9819, DOI 10.1021/jf4021784; van den Heuvel EGHM, 1999, J BONE MINER RES, V14, P1211, DOI 10.1359/jbmr.1999.14.7.1211; Van der Kamp J. W., 2010, DIETARY FIBRE NEW FR; Van Nuenen M., 2003, MICROB ECOL HEALTH D, V15, P137, DOI DOI 10.1080/08910600310018959; Venema K., 2000, Ernahrung, V24, P558; Venema K, 2012, INT DAIRY J, V22, P123, DOI 10.1016/j.idairyj.2011.10.011; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; World Health Organization, 2014, 311 WHO	70	64	67	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113864	10.1371/journal.pone.0113864	http://dx.doi.org/10.1371/journal.pone.0113864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426858	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400092
J	Hamilton, SG; de la Guardia, LC; Derocher, AE; Sahanatien, V; Tremblay, B; Huard, D				Hamilton, Stephen G.; de la Guardia, Laura Castro; Derocher, Andrew E.; Sahanatien, Vicki; Tremblay, Bruno; Huard, David			Projected Polar Bear Sea Ice Habitat in the Canadian Arctic Archipelago	PLOS ONE			English	Article							WESTERN HUDSON-BAY; FOOD AVAILABILITY; MARINE MAMMALS; CONSEQUENCES; REPRODUCTION; ABUNDANCE; SELECTION; SURVIVAL; ECOLOGY; LAND	Background: Sea ice across the Arctic is declining and altering physical characteristics of marine ecosystems. Polar bears (Ursus maritimus) have been identified as vulnerable to changes in sea ice conditions. We use sea ice projections for the Canadian Arctic Archipelago from 2006 - 2100 to gain insight into the conservation challenges for polar bears with respect to habitat loss using metrics developed from polar bear energetics modeling. Principal Findings: Shifts away from multiyear ice to annual ice cover throughout the region, as well as lengthening ice-free periods, may become critical for polar bears before the end of the 21 st century with projected warming. Each polar bear population in the Archipelago may undergo 2-5 months of ice-free conditions, where no such conditions exist presently. We identify spatially and temporally explicit ice-free periods that extend beyond what polar bears require for nutritional and reproductive demands. Conclusions/Significance: Under business-as-usual climate projections, polar bears may face starvation and reproductive failure across the entire Archipelago by the year 2100.	[Hamilton, Stephen G.; de la Guardia, Laura Castro; Derocher, Andrew E.; Sahanatien, Vicki] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [de la Guardia, Laura Castro] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E9, Canada; [Sahanatien, Vicki] World Wildlife Fund Canada, Iqaluit, NU X0A 0H0, Canada; [Tremblay, Bruno] McGill Univ, Montreal, PQ H3A 0B9, Canada; [Huard, David] David Huard Solut, Quebec City, PQ G1W 4G8, Canada	University of Alberta; University of Alberta; McGill University	Hamilton, SG (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	stephen.hamilton@ualberta.ca	Derocher, Andrew/J-4469-2012	Derocher, Andrew/0000-0002-1104-7774; Huard, David/0000-0003-0311-5498	WWF (Canada); ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Environment Canada; Hauser Bears; Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant [N000141110977]; Pittsburgh Zoo, Polar Continental Shelf Project; Polar Bears International; Quark Expeditions	WWF (Canada); ArcticNet; Canadian Association of Zoos and Aquariums; Canadian Wildlife Federation; Environment Canada(CGIAR); Hauser Bears; Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant; Pittsburgh Zoo, Polar Continental Shelf Project; Polar Bears International; Quark Expeditions	Funding was provided by WWF (Canada), ArcticNet, the Canadian Association of Zoos and Aquariums, Canadian Wildlife Federation, Environment Canada, Hauser Bears, Natural Sciences and Engineering Research Council of Canada, Office of Naval Research grant (N000141110977), Pittsburgh Zoo, Polar Continental Shelf Project, Polar Bears International, and Quark Expeditions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author David Huard is employed by David Huard Solutions. David Huard Solutions provided support in the form of salary for author David Huard, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amstrup SC, 2000, CAN J ZOOL, V78, P948, DOI 10.1139/cjz-78-6-948; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Arrigo K.R., 2008, GEOPHYS RES LETT, V35; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Christensen O.B., 2011, EUROPEAN GLOBAL CLIM; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; de la Guardia LC, 2013, GLOBAL CHANGE BIOL, V19, P2675, DOI 10.1111/gcb.12272; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; DEROCHER AE, 1995, CAN J ZOOL, V73, P1657, DOI 10.1139/z95-197; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Ferguson SH, 2000, ECOLOGY, V81, P761, DOI 10.1890/0012-9658(2000)081[0761:IOSIDO]2.0.CO;2; Hezel PJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052794; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; IUCN/PBSG, 2013, STAT TABL WORLDS POL; KINGSLEY MCS, 1985, CAN J FISH AQUAT SCI, V42, P1189, DOI 10.1139/f85-147; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Menemenlis D., 2008, AGU FALL M ABSTRACTS, V31, pOS31C; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Nguyen AT, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006573; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Pilfold NW, 2014, GLOBAL ECOL BIOGEOGR, V23, P425, DOI 10.1111/geb.12112; Polischuk SC, 2002, ENVIRON POLLUT, V118, P29, DOI 10.1016/S0269-7491(01)00278-0; RAMSAY MA, 1986, CAN J ZOOL, V64, P2142, DOI 10.1139/z86-329; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Tilmes S, 2014, GEOPHYS RES LETT, V41, P880, DOI 10.1002/2013GL058731; Watts P.D., 1987, Symposia of the Zoological Society of London, P305	45	23	26	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113746	10.1371/journal.pone.0113746	http://dx.doi.org/10.1371/journal.pone.0113746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426720	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400083
J	Navale, R; Atul; Allanki, AD; Sijwali, PS				Navale, Rahul; Atul; Allanki, Aparna Devi; Sijwali, Puran Singh			Characterization of the Autophagy Marker Protein Atg8 Reveals Atypical Features of Autophagy in Plasmodium falciparum	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; MALARIA PARASITE; AMINOPEPTIDASE-I; HEMOGLOBIN CATABOLISM; CYSTEINE PROTEASES; CYTOPLASM; CVT; DIFFERENTIATION; DEGRADATION; ROLES	Conventional autophagy is a lysosome-dependent degradation process that has crucial homeostatic and regulatory functions in eukaryotic organisms. As malaria parasites must dispose a number of self and host cellular contents, we investigated if autophagy in malaria parasites is similar to the conventional autophagy. Genome wide analysis revealed a partial autophagy repertoire in Plasmodium, as homologs for only 15 of the 33 yeast autophagy proteins could be identified, including the autophagy marker Atg8. To gain insights into autophagy in malaria parasites, we investigated Plasmodium falciparum Atg8 (PfAtg8) employing techniques and conditions that are routinely used to study autophagy. Atg8 was similarly expressed and showed punctate localization throughout the parasite in both asexual and sexual stages; it was exclusively found in the pellet fraction as an integral membrane protein, which is in contrast to the yeast or mammalian Atg8 that is distributed among cytosolic and membrane fractions, and suggests for a constitutive autophagy. Starvation, the best known autophagy inducer, decreased PfAtg8 level by almost 3-fold compared to the normally growing parasites. Neither the Atg8-associated puncta nor the Atg8 expression level was significantly altered by treatment of parasites with routinely used autophagy inhibitors (cysteine (E64) and aspartic (pepstatin) protease inhibitors, the kinase inhibitor 3-methyladenine, and the lysosomotropic agent chloroquine), indicating an atypical feature of autophagy. Furthermore, prolonged inhibition of the major food vacuole protease activity by E64 and pepstatin did not cause accumulation of the Atg8-associated puncta in the food vacuole, suggesting that autophagy is primarily not meant for degradative function in malaria parasites. Atg8 showed partial colocalization with the apicoplast; doxycycline treatment, which disrupts apicoplast, did not affect Atg8 localization, suggesting a role, but not exclusive, in apicoplast biogenesis. Collectively, our results reveal several atypical features of autophagy in malaria parasites, which may be largely associated with non-degradative processes.	[Navale, Rahul; Atul; Allanki, Aparna Devi; Sijwali, Puran Singh] CSIR, Ctr Cellular & Mol Biol, Hyderabad, AP, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sijwali, PS (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, AP, India.	psijwali@ccmb.res.in			Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR); CSIR	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Funding: The authors wish to acknowledge the Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR) for funding the study. RN is financially supported by a fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Aminake MN, 2012, INT J PARASITOL-DRUG, V2, P1, DOI 10.1016/j.ijpddr.2011.12.001; Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Cervantes S, 2014, AUTOPHAGY, V10, P80, DOI 10.4161/auto.26743; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Eickel N, 2013, AUTOPHAGY, V9, P568, DOI 10.4161/auto.23689; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hutchins MU, 1999, J CELL SCI, V112, P4079; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2014, AUTOPHAGY, V10, P269, DOI 10.4161/auto.27166; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2010, AUTOPHAGY, V6; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Leber R, 2001, J BIOL CHEM, V276, P29210, DOI 10.1074/jbc.M101438200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Rigden DJ, 2009, AUTOPHAGY, V5, P784, DOI 10.4161/auto.8838; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rosenthal PJ, 2005, MOLECULAR APPROACHES TO MALARIA, P311; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Sijwali PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010227; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Suriapranata I, 2000, J CELL SCI, V113, P4025; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Walker J.M., 2002, PROTEIN PROTOCOLS HD, P11, DOI [DOI 10.1385/1-59259-169-8:11, 10.1385/1-59259-169-8:11]; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	82	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113220	10.1371/journal.pone.0113220	http://dx.doi.org/10.1371/journal.pone.0113220			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426852	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400040
J	Sato, T; Hamada, N				Sato, Tatsuhiko; Hamada, Nobuyuki			Model Assembly for Estimating Cell Surviving Fraction for Both Targeted and Nontargeted Effects Based on Microdosimetric Probability Densities	PLOS ONE			English	Article							RADIORESISTANT TUMOR-CELLS; NORMAL HUMAN FIBROBLASTS; KINETIC-MODEL; IONIZING-RADIATION; ION RADIOTHERAPY; DNA-DAMAGE; BCL-2; IRRADIATION; COMMUNICATION; DEPENDENCE	We here propose a new model assembly for estimating the surviving fraction of cells irradiated with various types of ionizing radiation, considering both targeted and nontargeted effects in the same framework. The probability densities of specific energies in two scales, which are the cell nucleus and its substructure called a domain, were employed as the physical index for characterizing the radiation fields. In the model assembly, our previously established double stochastic microdosimetric kinetic (DSMK) model was used to express the targeted effect, whereas a newly developed model was used to express the nontargeted effect. The radioresistance caused by overexpression of anti-apoptotic protein Bcl-2 known to frequently occur in human cancer was also considered by introducing the concept of the adaptive response in the DSMK model. The accuracy of the model assembly was examined by comparing the computationally and experimentally determined surviving fraction of Bcl-2 cells (Bcl-2 overexpressing HeLa cells) and Neo cells (neomycin resistant gene-expressing HeLa cells) irradiated with microbeam or broadbeam of energetic heavy ions, as well as the WI-38 normal human fibroblasts irradiated with X-ray microbeam. The model assembly reproduced very well the experimentally determined surviving fraction over a wide range of dose and linear energy transfer (LET) values. Our newly established model assembly will be worth being incorporated into treatment planning systems for heavy-ion therapy, brachytherapy, and boron neutron capture therapy, given critical roles of the frequent Bcl-2 overexpression and the nontargeted effect in estimating therapeutic outcomes and harmful effects of such advanced therapeutic modalities.	[Sato, Tatsuhiko] Japan Atom Energy Agcy, Res Grp Radiat Protect, Nucl Sci & Engn Ctr, Tokai, Ibaraki, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Tokyo 201, Japan	Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Sato, T (corresponding author), Japan Atom Energy Agcy, Res Grp Radiat Protect, Nucl Sci & Engn Ctr, Tokai, Ibaraki, Japan.	sato.tatsuhiko@jaea.go.jp	Sato, Tatsuhiko/G-5964-2012	Sato, Tatsuhiko/0000-0001-9902-7083; Hamada, Nobuyuki/0000-0003-2518-6131	Japan Society for the Promotion of Science (JSPS) [26461900]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (C), Grant Number 26461900, TS (http://www.jsps.go.jp/j-grantsinaid/index.html). The funder supported preparation of the manuscript but had no role in study design, data collection and analysis, or decision to publish.	Antonovic L, 2013, J RADIAT RES, V54, P18, DOI 10.1093/jrr/rrs070; Autsavapromporn N, 2013, MUTAT RES-GEN TOX EN, V756, P78, DOI 10.1016/j.mrgentox.2013.07.001; Belka C, 2002, INT J RADIAT BIOL, V78, P643, DOI 10.1080/09553000210137680; Chandna S, 2002, RADIAT RES, V157, P516, DOI 10.1667/0033-7587(2002)157[0516:LDRHIH]2.0.CO;2; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Fakir H, 2009, RADIAT RES, V171, P320, DOI 10.1667/RR1293.1; Friedrich T, 2013, J RADIAT RES, V54, P494, DOI 10.1093/jrr/rrs114; Furusawa Y, 2000, RADIAT RES, V154, P485, DOI 10.1667/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Hamada N, 2008, BIOL SCI SPACE, V22, P46, DOI DOI 10.2187/BSS.22.46; Hamada N, 2008, CANCER LETT, V268, P76, DOI 10.1016/j.canlet.2008.03.029; Hamada N, 2008, MUTAT RES-FUND MOL M, V639, P35, DOI 10.1016/j.mrfmmm.2007.11.001; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Hamada N, 2008, RADIOTHER ONCOL, V89, P231, DOI 10.1016/j.radonc.2008.02.013; Hara T, 2005, INT J RADIAT ONCOL, V61, P517, DOI 10.1016/j.ijrobp.2004.10.008; Harada K, 2009, CANCER SCI, V100, P684, DOI 10.1111/j.1349-7006.2009.01093.x; Hawkins RB, 1996, INT J RADIAT BIOL, V69, P739, DOI 10.1080/095530096145481; Hawkins RB, 2013, RADIAT RES, V180, P584, DOI 10.1667/RR13257.1; Inaniwa T, 2013, RADIAT RES, V180, P44, DOI 10.1667/RR3178.1; Inaniwa T, 2010, PHYS MED BIOL, V55, P6721, DOI 10.1088/0031-9155/55/22/008; International Commission on Radiation Units and Measurements, 1983, 36 ICRU, V36; Kanai T, 2006, INT J RADIAT ONCOL, V64, P650, DOI 10.1016/j.ijrobp.2005.09.043; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Kundrat P, 2012, INT J RADIAT BIOL, V88, P743, DOI 10.3109/09553002.2012.698029; Kundrat P, 2009, APPL RADIAT ISOTOPES, V67, P399, DOI 10.1016/j.apradiso.2008.06.014; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Mariotti L, 2010, RADIAT RES, V174, P280, DOI 10.1667/RR1889.1; Matsumoto Hideki, 2011, Curr Mol Pharmacol, V4, P126; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Mothersill C, 2002, RADIAT RES, V157, P526, DOI 10.1667/0033-7587(2002)157[0526:RBRILD]2.0.CO;2; Nakashima T, 2000, CANCER RES, V60, P1229; Nikjoo H, 2003, INT J RADIAT BIOL, V79, P43, DOI 10.1080/0955300021000034701; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sato T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099831; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Sato T, 2012, RADIAT RES, V178, P341, DOI 10.1667/RR2842.1; Sato T, 2012, INT J RADIAT BIOL, V88, P143, DOI 10.3109/09553002.2011.611216; Sato T, 2009, RADIAT RES, V171, P107, DOI 10.1667/RR1510.1; Shiraiwa N, 1997, BIOMED RES-TOKYO, V18, P405, DOI 10.2220/biomedres.18.405; Shuryak I, 2007, RADIAT RES, V168, P741, DOI 10.1667/RR1117.1; Stewart RD, 2006, RADIAT RES, V165, P460, DOI 10.1667/RR3520.1; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Wedenberg M, 2010, RADIAT RES, V174, P517, DOI 10.1667/RR2045.1	45	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114056	10.1371/journal.pone.0114056	http://dx.doi.org/10.1371/journal.pone.0114056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426641	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400111
J	Hernandez, A; Banos, JE; Llop, C; Farre, M				Hernandez, Astrid; Banos, Josep-E.; Llop, Cristina; Farre, Magi			The Definition of Placebo in the Informed Consent Forms of Clinical Trials	PLOS ONE			English	Article							QUALITY; PARTICIPANTS; RECRUITMENT; ATTITUDES	Aim: Lack of knowledge concerning the nature of placebo and why it is necessary may influence the participation of patients in clinical trials. The objective of the present study is to review how placebo is described in written information for participants in clinical trials to be evaluated by a Human Research Ethics Committee. Methods: All research protocols submitted for evaluation in a Spanish hospital during 2007-2013 were reviewed. The main characteristics of the studies using a placebo were collected. Three authors read each of them to determine how the term "placebo'' was explained and if there was any comment on its efficacy and safety. Results: Two thousand seven-hundred and forty research protocols were evaluated, of which three hundred and fifty-nine used a placebo. Pharmaceutical companies sponsored most placebo-controlled clinical trials (91.9%), and phase III studies were the commonest (59.9%). Oncology (15.0%), cardiology (14.2%), and neurology (13.1%) made the greatest contributions. A review of the informed consent forms showed that placebo was described in a similar manner in most studies: the explanation was limited to between four and eight words. Very few gave information about the risks of its use or adverse reactions from its administration. None of the studies provided details about the placebo effect. And 23 lacked any information about placebo at all. Conclusions: Explanations about placebo in informed consent forms is often scarce, and information about the placebo effect and associated risks are absent. This situation may influence a full understanding of placebo by participants in clinical trials and might reduce their informed decision to participate.	[Hernandez, Astrid; Llop, Cristina; Farre, Magi] Hosp Mar Med Res Inst IMIM, Human Pharmacol Unit, Barcelona, Spain; [Hernandez, Astrid; Farre, Magi] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Bellaterra, Spain; [Banos, Josep-E.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Pompeu Fabra University	Banos, JE (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.	josepeladi.banos@upf.edu	Banos, Josep-E/D-8118-2014	banos, josep-e/0000-0001-8202-6893	Victor Grifols i Lucas Foundation; Spanish Agency for International Development Cooperation	Victor Grifols i Lucas Foundation; Spanish Agency for International Development Cooperation(Spanish Government)	The study was supported in part by a grant from Victor Grifols i Lucas Foundation (2010-2011). Astrid Hernandez is the recipient of a predoctoral fellowship from the Spanish Agency for International Development Cooperation. No external funding source had any role in the design or interpretation of the data of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1948, Br Med J, V2, P769; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435, DOI 10.1038/clpt.1980.60; Bertoli AM, 2007, CONTEMP CLIN TRIALS, V28, P730, DOI 10.1016/j.cct.2007.04.005; Bhansali S, 2009, CONTEMP CLIN TRIALS, V30, P427, DOI 10.1016/j.cct.2009.03.005; Bishop FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039661; Bishop FL, 2012, SOC SCI MED, V74, P767, DOI 10.1016/j.socscimed.2011.11.020; Chen GF, 2009, NEW ZEAL MED J, V122, P35; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Day S, 1999, DICT CLIN TRIALS, P140; Dunn LB, 2006, SCHIZOPHRENIA BULL, V32, P137; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; GROSSMAN L, 1980, HOSP COMMUNITY PSYCH, V31, P205; Halpern SD, 2003, AM HEART J, V146, P985, DOI 10.1016/S0002-8703(03)00507-6; Hereu P, 2010, CONTEMP CLIN TRIALS, V31, P443, DOI 10.1016/j.cct.2010.05.004; Hou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076799; IRWIN M, 1985, AM J PSYCHIAT, V142, P1351; Jefford M, 2011, SUPPORT CARE CANCER, V19, P371, DOI 10.1007/s00520-010-0829-6; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; Lynoe N, 1996, ACTA ONCOL, V35, P749, DOI 10.3109/02841869609084010; Macedo A, 2003, EUR J CLIN PHARMACOL, V59, P337, DOI 10.1007/s00228-003-0612-4; Macedo A, 2008, EUR J PAIN, V12, P68, DOI 10.1016/j.ejpain.2007.03.002; MILLER C, 1994, J CLIN RES DRUG DEV, V8, P237; Miller Franklin G., 2002, American Journal of Bioethics, V2, P3, DOI 10.1162/152651602317533523; Millum J, 2013, JAMA-J AM MED ASSOC, V310, P2143, DOI 10.1001/jama.2013.281632; Naudet F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-230; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Paris A, 2010, BRIT J CLIN PHARMACO, V69, P231, DOI 10.1111/j.1365-2125.2009.03565.x; Preziosi MP, 1997, NEW ENGL J MED, V336, P370, DOI 10.1056/NEJM199701303360511; Resnik DB, 2009, CONTEMP CLIN TRIALS, V30, P114, DOI 10.1016/j.cct.2008.10.004; Ryan RE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003717.pub2; Streiner DL, 1991, HLTH MEASUREMENT SCA, P79; van Stuijvenberg M, 1998, ARCH DIS CHILD, V79, P120, DOI 10.1136/adc.79.2.120; Welton AJ, 1999, BRIT MED J, V318, P1114, DOI 10.1136/bmj.318.7191.1114; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; Yazici Y, 2010, BULL HOSP JT DIS, V68, P127; Yuwal R, 2000, ARCH INTERN MED, V160, P1142	45	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113654	10.1371/journal.pone.0113654	http://dx.doi.org/10.1371/journal.pone.0113654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423149	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700047
J	Wirth, J; Buijsse, B; di Giuseppe, R; Fritsche, A; Hense, HW; Westphal, S; Isermann, B; Boeing, H; Weikert, C				Wirth, Janine; Buijsse, Brian; di Giuseppe, Romina; Fritsche, Andreas; Hense, Hans W.; Westphal, Sabine; Isermann, Berend; Boeing, Heiner; Weikert, Cornelia			Relationship between N-Terminal Pro-Brain Natriuretic Peptide, Obesity and the Risk of Heart Failure in Middle-Aged German Adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; EPIC-GERMANY; DIAGNOSIS; PREDICTION; GUIDELINES; ECHOCARDIOGRAPHY; ESC	Background: Both high concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP) and obesity are related to higher heart failure risk. However, inverse relationships between NT-proBNP and obesity have been reported. Therefore, it was investigated whether the association between NT-proBNP and the risk of heart failure differed according to obesity status. Methods: A case-cohort study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam, comprising a random sub-cohort (non-cases=1,150, cases=13, mean age: 50.5 +/- 9.0 years) and heart failure cases outside the sub-cohort (n=197). Weighted Cox proportional hazards regression was used to examine the association between NT-proBNP and heart failure risk during a mean follow-up time of 8 years. Stratified analyses were performed according to obesity status as defined by body mass index (<30 kg/m(2) versus >= 30 kg/m(2)). Results: Overall, NT-proBNP was associated with higher risk of heart failure after multivariable adjustment (hazard ratio (HR) and 95% confidence interval (CI): 2.56 (1.49-4.41) for the top versus bottom tertile of NT-proBNP, p(trend):, 0.01). In stratified analyses, the shape of association was linear in non-obese and U-shaped in obese participants: HRs (95% CI) from the first to the third tertile of NT-proBNP for non-obese: reference, 1.72 (0.85-3.49), 2.72 (1.42-5.22), and for obese: 3.29 (1.04-10.40), reference, 3.74 (1.52-9.21). Conclusions: Although high circulating concentrations of NT-proBNP were positively associated with incident heart failure in the entire sample, the association differed according to obesity status. In obese, an increased risk of heart failure was also observed in those with low NT-proBNP concentrations. If confirmed, this observation warrants further investigation to understand underlying pathophysiological mechanisms.	[Wirth, Janine; di Giuseppe, Romina; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Buijsse, Brian; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fritsche, Andreas] Univ Tubingen, Div Endocrinol Diabetol Nephrol Vasc Dis & Clin C, Dept Internal Med, Tubingen, Germany; [Hense, Hans W.] Univ Hosp, Clin Epidemiol Unit, Inst Epidemiol & Social Med, Munster, Germany; [Westphal, Sabine; Isermann, Berend] Otto Von Guericke Univ, Dept Clin Chem & Pathobiochem, Magdeburg, Germany; [Weikert, Cornelia] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; University of Munster; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wirth, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany.	Janine.Wirth@dife.de		di Giuseppe, Romina/0000-0002-5214-8897; Wirth, Janine/0000-0001-7075-9686	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Heart failure Network - Federal Ministry of Education and Research (BMBF)	Federal Ministry of Science, Germany; European Union(European Commission); German Heart failure Network - Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401), and the European Union (SOC 95201408 05F02). Identification of HF cases was supported by German Heart failure Network funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baessler A, 2012, EUR J HEART FAIL, V14, P1240, DOI 10.1093/eurjhf/hfs116; Bayes-Genis A, 2007, ARCH INTERN MED, V167, P400, DOI 10.1001/archinte.167.4.400; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Carlsson AC, 2013, INT J OBESITY, V37, P1579, DOI 10.1038/ijo.2013.46; Cheng S, 2011, AM J CARDIOL, V108, P979, DOI 10.1016/j.amjcard.2011.05.033; Choi HS, 2012, J CARDIOL, V60, P508, DOI 10.1016/j.jjcc.2012.07.006; Choi Seon Gyu, 2010, Korean Circ J, V40, P558, DOI 10.4070/kcj.2010.40.11.558; Christenson RH, 2010, CLIN CHEM, V56, P633, DOI 10.1373/clinchem.2009.129742; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; di Giuseppe R, 2014, J CLIN ENDOCR METAB, V99, P947, DOI 10.1210/jc.2013-2963; di Giuseppe R, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-19; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frankenstein L, 2008, EUR HEART J, V29, P2634, DOI 10.1093/eurheartj/ehn388; Habbu A, 2006, AM J CARDIOL, V98, P944, DOI 10.1016/j.amjcard.2006.04.039; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Kalogeropoulos AP, 2012, JACC-CARDIOVASC IMAG, V5, P131, DOI [10.1016/j.jcmg.2011.11.011, 10.1016/J.Jcmg.2011.11.011]; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Khan AM, 2011, J CLIN ENDOCR METAB, V96, P3242, DOI 10.1210/jc.2011-1182; Lorgis L, 2011, HEART, V97, P551, DOI 10.1136/hrt.2010.213041; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Pivovarova O, 2012, J CLIN ENDOCR METAB, V97, pE731, DOI 10.1210/jc.2011-2839; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Rutten JHW, 2010, HYPERTENSION, V55, P785, DOI 10.1161/HYPERTENSIONAHA.109.143313; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Shimabukuro M, 2011, DIABETES CARE, V34, P686, DOI 10.2337/dc10-1141; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Swedberg K, 2005, REV ESP CARDIOL, V58, P1062, DOI 10.1157/13078554	35	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113710	10.1371/journal.pone.0113710	http://dx.doi.org/10.1371/journal.pone.0113710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423197	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700056
J	Jovcevska, I; Zupanec, N; Kocevar, N; Cesselli, D; Podergais, N; Stokin, CL; Myers, MP; Muyldermans, S; Ghassabeh, GH; Motaln, H; Ruaro, ME; Bourkoula, E; Turnsek, TL; Komel, R				Jovcevska, Ivana; Zupanec, Neja; Kocevar, Nina; Cesselli, Daniela; Podergajs, Neza; Stokin, Clara Limbaeck; Myers, Michael P.; Muyldermans, Serge; Ghassabeh, Gholamreza Hassanzadeh; Motaln, Helena; Ruaro, Maria Elisabetta; Bourkoula, Evgenia; Turnsek, Tamara Lah; Komel, Radovan			TRIM28 and beta-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; TRIPARTITE MOTIF; BRAIN-TUMORS; EXPRESSION; PROTEIN; PHAGE; SURVIVAL; VECTORS; FINGER; MARKER	Malignant gliomas are among the rarest brain tumours, and they have the worst prognosis. Grade IV astrocytoma, known as glioblastoma multiforme (GBM), is a highly lethal disease where the standard therapies of surgery, followed by radiation and chemotherapy, cannot significantly prolong the life expectancy of the patients. Tumour recurrence shows more aggressive form compared to the primary tumour, and results in patient survival from 12 to 15 months only. Although still controversial, the cancer stem cell hypothesis postulates that cancer stem cells are responsible for early relapse of the disease after surgical intervention due to their high resistance to therapy. Alternative strategies for GBM therapy are thus urgently needed. Nanobodies are single-domain antigen-binding fragments of heavy-chain antibodies, and together with classical antibodies, they are part of the camelid immune system. Nanobodies are small and stable, and they share a high degree of sequence identity to the human heavy chain variable domain, and these characteristics offer them advantages over classical antibodies or antibody fragments. We first immunised an alpaca with a human GBM stem-like cell line prepared from primary GBM cultures. Next, a nanobody library was constructed in a phage-display vector. Using nanobody phage-display technology, we selected specific GBM stem-like cell binders through a number of affinity selections, using whole cell protein extracts and membrane protein-enriched extracts from eight different GBM patients, and membrane protein-enriched extracts from two established GBM stem-like cell lines (NCH644 and NCH421K cells). After the enrichment, periplasmic extract ELISA was used to screen for specific clones. These nanobody clones were recloned into the pHEN6 vector, expressed in Escherichia coli WK6, and purified using immobilised metal affinity chromatography and size-exclusion chromatography. Specific nanobody: antigen pairs were obtained and mass spectrometry analysis revealed two proteins, TRIM28 and beta-actin, that were up-regulated in the GBM stem-like cells compared to the controls.	[Jovcevska, Ivana; Zupanec, Neja; Kocevar, Nina; Komel, Radovan] Univ Ljubljana, Fac Med, Inst Biochem, Med Ctr Mol Biol, Ljubljana 61000, Slovenia; [Cesselli, Daniela; Ruaro, Maria Elisabetta; Bourkoula, Evgenia] Univ Udine, Dept Med & Biol Sci DSMB, I-33100 Udine, Italy; [Podergajs, Neza; Motaln, Helena; Turnsek, Tamara Lah] NIB, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Stokin, Clara Limbaeck] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia; [Myers, Michael P.] ICGEB, Trieste, Italy; [Muyldermans, Serge; Ghassabeh, Gholamreza Hassanzadeh] Vrije Univ Brussel, Brussels, Belgium; [Muyldermans, Serge] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Ghassabeh, Gholamreza Hassanzadeh] VIB, Nanobody Serv Facil, Brussels, Belgium	University of Ljubljana; University of Udine; University of Ljubljana; International Center for Genetic Engineering & Biotechnology (ICGEB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB)	Komel, R (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Med Ctr Mol Biol, Ljubljana 61000, Slovenia.	radovan.komel@mf.uni-lj.si	Motaln, Helena/AAD-1507-2022; Muyldermans, Serge V/C-6418-2016; Muyldermans, Serge/AAC-7374-2019; Motaln, Helena/AAF-3489-2019	Motaln, Helena/0000-0002-0646-7934; Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; Jovcevska, Ivana/0000-0002-0418-2986; Cesselli, Daniela/0000-0002-0562-7852; Kocevar Britovsek, Nina/0000-0002-0985-2707; Komel, Radovan/0000-0002-8463-2181	Slovenian Scientific Agency [P1-0104]; INTERREG EC Project; European Molecular Biology Organisation (EMBO) [113]; Slovene Human Resources Development and Scholarship Fund; Vrije Universiteit Brussel	Slovenian Scientific Agency; INTERREG EC Project; European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Slovene Human Resources Development and Scholarship Fund; Vrije Universiteit Brussel	This work was supported by P1-0104: Research Programme Grant from the Slovenian Scientific Agency (ARRS: https://www.arrs.gov.si) research grant to RK; INTERREG EC Project 2011, Ref. No. 42: Identification of novel biomarkers to brain tumors - glioma, for diagnosis and as new therapeutic targets, Acronym: GLIOMA (http://www.ita-slo.eu/projects/projects_2007_2013/2012051514451367); ASTF 26-2013: European Molecular Biology Organisation (EMBO: www.embo.org), as short-term fellowship to IJ; 113. JR: Slovene Human Resources Development and Scholarship Fund (http://www.sklad-kadri.si/), as a scholarship for doctorate studies of foreign citizens in Slovenia in the year 2011; three-year scholarship to IJ. SM thanks the Strategic Research Program financing from the Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q; Anderson MD, 2014, NEUROONCOL; Association ABT, 2010, FACTS STAT BRAIN TUM; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Bourkoula E, 2013, STEM CELLS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Caljon G, 2012, BRIT J PHARMACOL, V165, P2341, DOI 10.1111/j.1476-5381.2011.01723.x; Cammas F, 2012, ADV EXP MED BIOL, V770, P59; Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chames P., 2012, ANTIBODY ENG; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Chi Alexander, 2010, Cancers (Basel), V2, P2100, DOI 10.3390/cancers2042100; Com E, 2012, J PROTEOMICS, V75, P3898, DOI 10.1016/j.jprot.2012.04.034; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Daga A, 2011, CURR PHARM DESIGN, V17, P2439, DOI 10.2174/138161211797249206; De Genest E, 2005, J BIOL CHEM, V280, P14114, DOI 10.1074/jbc.M413011200; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Ebrahimizadeh W, 2013, APPL MICROBIOL BIOT, V97, P4457, DOI 10.1007/s00253-012-4518-x; Fages C, 1998, J CELL SCI, V111, P3073; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Ghassabeh GH, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P251, DOI 10.1007/978-3-642-01147-4_20; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gruber ML, 2004, AM J CLIN ONCOL-CANC, V27, P33, DOI 10.1097/01.coc.0000045852.88461.80; Guo CM, 2013, CLIN CHIM ACTA, V417, P39, DOI 10.1016/j.cca.2012.12.012; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hernandez-Pedro NY, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/716813; Kaufmann JK, 2014, NEURO-ONCOLOGY, V16, P334, DOI 10.1093/neuonc/not310; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Le PU, 1998, CANCER RES, V58, P1631; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Liu L, 2013, CANCER EPIDEMIOL, V37, P71, DOI 10.1016/j.canep.2012.08.005; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micale L, 2012, ADV EXP MED BIOL, V770, P11; Mitelman F, 1993, HUMAN GENE MAPPING, P773; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nowak D, 2005, ACTA BIOCHIM POL, V52, P461; Nowak D, 2002, ACTA BIOCHIM POL, V49, P823; Panopoulos A, 2011, MOL BIOL CELL, V22, P2212, DOI 10.1091/mbc.E10-10-0849; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Podergajs N, 2013, RADIOL ONCOL, V47, P330, DOI 10.2478/raon-2013-0063; Popow A, 2006, J PHYSIOL PHARMACOL, V57, P111; Qi H, 2012, J MOL BIOL, V417, P129, DOI 10.1016/j.jmb.2012.01.038; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SKERRA A, 1993, CURR OPIN IMMUNOL, V5, P256, DOI 10.1016/0952-7915(93)90014-J; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8	61	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113688	10.1371/journal.pone.0113688	http://dx.doi.org/10.1371/journal.pone.0113688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419715	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900065
J	Aznar, F; Pujol, FA; Pujol, M; Rizo, R; Pujol, MJ				Aznar, Fidel; Pujol, Francisco A.; Pujol, Mar; Rizo, Ramon; Pujol, Maria-Jose			Learning Probabilistic Features for Robotic Navigation Using Laser Sensors	PLOS ONE			English	Article							SIMULTANEOUS LOCALIZATION; SLAM; RANSAC	SLAM is a popular task used by robots and autonomous vehicles to build a map of an unknown environment and, at the same time, to determine their location within the map. This paper describes a SLAM-based, probabilistic robotic system able to learn the essential features of different parts of its environment. Some previous SLAM implementations had computational complexities ranging from O(Nlog(N)) to O(N-2), where N is the number of map features. Unlike these methods, our approach reduces the computational complexity to O(N) by using a model to fuse the information from the sensors after applying the Bayesian paradigm. Once the training process is completed, the robot identifies and locates those areas that potentially match the sections that have been previously learned. After the training, the robot navigates and extracts a three-dimensional map of the environment using a single laser sensor. Thus, it perceives different sections of its world. In addition, in order to make our system able to be used in a low-cost robot, low-complexity algorithms that can be easily implemented on embedded processors or microcontrollers are used.	[Aznar, Fidel; Pujol, Mar; Rizo, Ramon] Univ Alicante, Dept Ciencia Computac & Inteligencia Artificial, E-03080 Alicante, Spain; [Pujol, Francisco A.] Univ Alicante, Dept Tecnol Inform & Computac, E-03080 Alicante, Spain; [Pujol, Maria-Jose] Univ Alicante, Dept Matemat Aplicada, E-03080 Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Pujol, FA (corresponding author), Univ Alicante, Dept Tecnol Inform & Computac, E-03080 Alicante, Spain.	fpujol@dtic.ua.es	Rizo, Ramón/D-3774-2018	Rizo, Ramón/0000-0001-7250-2067; PUJOL, MAR/0000-0002-8575-0067	Spanish Ministerio de Ciencia e Innovacion [TIN2009-10581]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding: This work has been supported by the Spanish Ministerio de Ciencia e Innovacion (www.micinn.es), project TIN2009-10581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aznar F, 2005, LECT NOTES ARTIF INT, V3673, P518; Borenstein J., 1996, NAVIGATING MOBILE RO; Castellanos JA, 2000, MOBILE ROBOT LOCALIZ; Censi A, 2008, IEEE INT CONF ROBOT, P19, DOI 10.1109/ROBOT.2008.4543181; Ceriani S, 2009, AUTON ROBOT, V27, P353, DOI 10.1007/s10514-009-9156-5; Chow KM, 2010, ADV ROBOTICS, V24, P1577, DOI 10.1163/016918610X512604; Csorba M, 1997, THESIS OXFORD U; De la Cruz C, 2010, PROC IEEE INT SYMP, P2331, DOI 10.1109/ISIE.2010.5637760; Di Marco M, 2001, INT J ROBUST NONLIN, V11, P709, DOI 10.1002/rnc.619; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; Druon S, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON INFORMATION ACQUISITION, VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P249, DOI 10.1109/ICIA.2006.306004; Durrant-Whyte H, 1996, P 7 INT S ISRR 95, P613; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Elfes Alberto, 1991, OCCUPANCY GRIDS PROB; Elinas P, 2007, P IEEE RSJ INT C INT, P4108; Fulgenzi C, 2009, MECHATRONICS, V19, P609, DOI 10.1016/j.mechatronics.2009.01.007; Ganganath N., 2012, 2012 IEEE International Conference on Emerging Signal Processing Applications, P91, DOI 10.1109/ESPA.2012.6152453; Guivant JE, 2001, IEEE T ROBOTIC AUTOM, V17, P242, DOI 10.1109/70.938382; Kjer H, 2010, THESIS TU DENMARK; Matas J, 2004, IMAGE VISION COMPUT, V22, P837, DOI 10.1016/j.imavis.2004.02.009; Nguyen V, 2007, AUTON ROBOT, V23, P97, DOI 10.1007/s10514-007-9034-y; Nieto J, 2005, P INT C FIELD SERV R, P129; Nieto J, 2007, ROBOT AUTON SYST, V55, P39, DOI 10.1016/j.robot.2006.06.008; O'Callaghan Simon, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P1054, DOI 10.1109/ROBOT.2009.5152754; Pakki K, 2010, IEEE INT SYMP INTELL, P818, DOI 10.1109/ISIC.2010.5612907; Paz LM, 2008, IEEE T ROBOT, V24, P1107, DOI 10.1109/TRO.2008.2004639; Pears N, 2012, 3D IMAGING ANAL APPL; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; Romero V. A., 2010, Proceedings 2010 Latin American Robotics Symposium and Intelligent Robotic Meeting (LARS 2010), P61, DOI 10.1109/LARS.2010.20; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Smith R., 1987, CAMBRIDGE, P467; Thrun S, 2003, IEEE INT CONF ROBOT, P4270; Thrun S., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P321, DOI 10.1109/ROBOT.2000.844077; Tordoff B, 2002, LECT NOTES COMPUT SC, V2350, P82; Weeb A, 1999, STAT PATTERN RECOGNI; Weingarten JD, 2004, IEEE INT CONF ROBOT, P2153, DOI 10.1109/ROBOT.2004.1307381; West ME, 2006, IEEE INT CONF ROBOT, P436, DOI 10.1109/ROBOT.2006.1641750	37	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112507	10.1371/journal.pone.0112507	http://dx.doi.org/10.1371/journal.pone.0112507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415377	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600011
J	Dunbar, MS; Dufour, MSK; Lambdin, B; Mudekunye-Mahaka, I; Nhamo, D; Padian, NS				Dunbar, Megan S.; Dufour, Mi-Suk Kang; Lambdin, Barrot; Mudekunye-Mahaka, Imelda; Nhamo, Definate; Padian, Nancy S.			The SHAZ! Project: Results from a Pilot Randomized Trial of a Structural Intervention to Prevent HIV among Adolescent Women in Zimbabwe	PLOS ONE			English	Article							INTIMATE-PARTNER VIOLENCE; SOUTH-AFRICA; RISK; AIDS; TRANSMISSION; MICROFINANCE; REFLECTIONS; PREVALENCE; EDUCATION; MARRIAGE	Adolescent females in Zimbabwe are at high risk for HIV acquisition. Shaping the Health of Adolescents in Zimbabwe (SHAZ!) was a randomized controlled trial of a combined intervention package including life-skills and health education, vocational training, micro-grants and social supports compared to life-skills and health education alone. SHAZ! was originally envisioned as a larger effectiveness trial, however, the intervention was scaled back due to contextual and economic conditions in the country at the time. SHAZ! enrolled 315 participants randomly assigned to study arm within blocks of 50 participants (158 intervention and 157 control). The intervention arm participants showed statistically significant differences from the control arm participants for several outcomes during the two years of follow up including; reduced food insecurity [IOR=0.83 vs. COR=0.68, p-0.02], and having their own income [IOR=2.05 vs. COR=1.67, p=0.02]. Additionally, within the Intervention arm there was a lower risk of transactional sex [IOR=0.64, 95% CI (0.50, 0.83)], and a higher likelihood of using a condom with their current partner [IOR=1.79, 95% CI (1.23, 2.62)] over time compared to baseline. There was also evidence of fewer unintended pregnancies among intervention participants [HR=0.61, 95% CI (0.37, 1.01)], although this relationship achieved only marginal statistical significance. Several important challenges in this study included the coordination with vocational training programs, the political and economic instability of the area at the time of the study, and the difficulty in creating a true standard of care control arm. Overall the results of the SHAZ! study suggest important potential for HIV prevention intervention packages that include vocational training and micro-grants, and lessons for further economic livelihoods interventions with adolescent females. Further work is needed to refine the intervention model, and test the impact of the intervention at scale on biological outcomes.	[Dunbar, Megan S.; Lambdin, Barrot] Pangaea Global AIDS Fdn, Oakland, CA USA; [Dufour, Mi-Suk Kang] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Padian, Nancy S.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Mudekunye-Mahaka, Imelda; Nhamo, Definate] Zimbabwe AIDS Prevent Program, Harare, Zimbabwe	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Dufour, MSK (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	Mi-Suk.KangDufour@ucsf.edu		Lambdin, Barrot/0000-0001-8546-0126	National Institutes of Health [5 R01 HD04513-05]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health (www.nichd.nih.gov, Grant# 5 R01 HD04513-05) awarded to Megan S. Dunbar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Bureau PR, 1998, WOMEN OUR WORLD; Calves AE, 1996, AD9604 PENNS STAT U; CDC, 2003, TALK TIM 1 HIV AIDS; Central Statistical Office, 2007, ZIMB DEM HLTH SURV 2; Chinake H, 2002, INT SEX ADOLESCENTS; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cremin I, 2009, SEX TRANSM INFECT, V85, pI34, DOI 10.1136/sti.2008.033431; Dunbar MS, 2010, J PREV INTERV COMMUN, V38, P147, DOI 10.1080/10852351003640849; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Fuglesang M, 1997, SOC SCI MED, V44, P1245, DOI 10.1016/S0277-9536(96)00314-0; GAGE AJ, 1994, SOC BIOL, V41, P44; Gibbs A, 2013, STEPPING STONES CREA; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Gregson S, 2005, AIDS CARE, V17, P785, DOI 10.1080/09540120500258029; Gupta G R, 2000, Can HIV AIDS Policy Law Rev, V5, P86; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; Hanke S, 2009, CATO J, V29; Haram L., 1995, YOUNG PEOPLE RISK FI, P31; Howard BH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-27; Irvin A, 2000, TAKING STEPS COURAGE; Jewkes R, 2008, BMJ-BRIT MED J, P337; Kabeer N, 1996, IDS BULL-I DEV STUD, V27, P11, DOI 10.1111/j.1759-5436.1996.mp27001002.x; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kang M, 2008, AIDS CARE, V20, P221, DOI 10.1080/09540120701534715; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Komba-Malekela B, 1994, CHELEWA CHELEWA DILE; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Laga M, 2001, AIDS, V15, P931, DOI 10.1097/00002030-200105040-00014; Mlambo A., 2010, EL PROC LIB MOV DEM; Nyamukapa C, 2005, SOC SCI MED, V60, P2155, DOI 10.1016/j.socscimed.2004.10.005; Nzyuko S, 1997, AIDS S1, V09, P21; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; PRONYK PM, 2005, SMALL ENTERPRISE DEV, V16, P26, DOI [DOI 10.1016/S0140-6736(06)69744-4, DOI 10.3362/0957-1329.2005.030]; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Schrieber, 1999, HE MUST GIVE ME MONE; Seeley J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17397; Shelan Daniel., 1996, VULNERABILITY OPPORT; Sherman SG, 2006, AIDS CARE, V18, P1, DOI 10.1080/09540120500101625; Strickland R. S., 2004, HAVE HOLD WOMENS PRO; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Sumartojo E, 2000, AIDS S1, V06, P1; Tibaijuka, 2005, REPORT FACT FINDING; Webb D., 1997, HIV AIDS AFRICA; Wilson F, 2013, PROJECT COORDINATOR; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; Zimbabwe National Statistics Agency, 2011, ZIM DEM HLTH SURV 20	55	62	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113621	10.1371/journal.pone.0113621	http://dx.doi.org/10.1371/journal.pone.0113621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415455	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600066
J	Kim, YI; DeVincenzo, JP; Jones, BG; Rudraraju, R; Harrison, L; Meyers, R; Cehelsky, J; Alvarez, R; Hurwitz, JL				Kim, Young-In; DeVincenzo, John P.; Jones, Bart G.; Rudraraju, Rajeev; Harrison, Lisa; Meyers, Rachel; Cehelsky, Jeff; Alvarez, Rene; Hurwitz, Julia L.			Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus	PLOS ONE			English	Article							RSV G-PROTEIN; SUBGROUP-B; MOLECULAR EPIDEMIOLOGY; GENETIC-VARIABILITY; DISEASE SEVERITY; FUSION PROTEIN; VIRAL LOAD; IDENTIFICATION; GLYCOPROTEIN; REPLICATION	Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children and is responsible for as many as 199,000 childhood deaths annually worldwide. To support the development of viral therapeutics and vaccines for RSV, a human adult experimental infection model has been established. In this report, we describe the provenance and sequence of RSV Memphis-37, the low-passage clinical isolate used for the model's reproducible, safe, experimental infections of healthy, adult volunteers. The predicted amino acid sequences for major proteins of Memphis-37 are compared to nine other RSV A and B amino acid sequences to examine sites of vaccine, therapeutic, and pathophysiologic interest. Human T-cell epitope sequences previously defined by in vitro studies were observed to be closely matched between Memphis-37 and the laboratory strain RSV A2. Memphis-37 sequences provide baseline data with which to assess: (i) virus heterogeneity that may be evident following virus infection/ transmission, (ii) the efficacy of candidate RSV vaccines and therapeutics in the experimental infection model, and (iii) the potential emergence of escape mutants as a consequence of experimental drug treatments. Memphis-37 is a valuable tool for pre-clinical research, and to expedite the clinical development of vaccines, therapeutic immunomodulatory agents, and other antiviral drug strategies for the protection of vulnerable populations against RSV disease.	[Kim, Young-In; DeVincenzo, John P.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [DeVincenzo, John P.; Hurwitz, Julia L.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Kim, Young-In; DeVincenzo, John P.; Harrison, Lisa] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Jones, Bart G.; Rudraraju, Rajeev; Hurwitz, Julia L.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Meyers, Rachel; Cehelsky, Jeff; Alvarez, Rene] Alnylam Pharmaceut, Cambridge, MA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Hurwitz, JL (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	julia.hurwitz@stjude.org	Hurwitz, Julia/N-2301-2018	Rudraraju, Rajeev/0000-0003-0080-6728	National Institutes of Health (NIH) NIAID [R01 AI088729]; NIH [P01 P30 CA21765, RR 16187-01]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088729] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was supported by the National Institutes of Health (NIH) NIAID R01 AI088729, NIH P01 P30 CA21765 and the American Lebanese Syrian Associated Charities to JLH, NIH RR 16187-01 to JPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MR, 2014, ILAR J, V55, P4, DOI 10.1093/ilar/ilu003; Bates JT, 2014, VIROLOGY, V454, P139, DOI 10.1016/j.virol.2014.02.010; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Brandenburg AH, 2000, J VIROL, V74, P10240, DOI 10.1128/JVI.74.21.10240-10244.2000; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; de Graaff PMA, 2004, VIROLOGY, V326, P220, DOI 10.1016/j.virol.2004.06.008; Derscheid RJ, 2014, BIORESEARCH OPEN ACC, V3, P60, DOI 10.1089/biores.2013.0044; Derscheid RJ, 2013, VIRUSES-BASEL, V5, P2881, DOI 10.3390/v5112881; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; DeVincenzo JP, 2007, INT C ANT AG CHEM IC; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Eyles JE, 2013, J INFECT DIS, V208, P319, DOI 10.1093/infdis/jit169; Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103; Frabasile S, 2003, J MED VIROL, V71, P305, DOI 10.1002/jmv.10484; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; Grad YH, 2014, J VIROL, V88, P7286, DOI 10.1128/JVI.00038-14; Grosz Drew D, 2014, BMC Res Notes, V7, P158, DOI 10.1186/1756-0500-7-158; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Heidema J, 2004, J GEN VIROL, V85, P2365, DOI 10.1099/vir.0.80131-0; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kumaria R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-372; LEVELY ME, 1991, J VIROL, V65, P3789, DOI 10.1128/JVI.65.7.3789-3796.1991; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Rock MT, 2003, IMMUNOLOGY, V108, P474, DOI 10.1046/j.1365-2567.2003.01619.x; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; STEC DS, 1991, VIROLOGY, V183, P273, DOI 10.1016/0042-6822(91)90140-7; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van Bleek GM, 2003, J VIROL, V77, P980, DOI 10.1128/JVI.77.2.980-988.2003; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zimmer G, 2002, J VIROL, V76, P9218, DOI 10.1128/JVI.76.18.9218-9224.2002	44	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113100	10.1371/journal.pone.0113100	http://dx.doi.org/10.1371/journal.pone.0113100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415360	gold, Green Published			2022-12-27	WOS:000346906600029
J	Durmaz, R; Kalaycioglu, AT; Acar, S; Bakkaloglu, Z; Karagoz, A; Korukluoglu, G; Ertek, M; Torunoglu, MA				Durmaz, Riza; Kalaycioglu, Atila Taner; Acar, Sumeyra; Bakkaloglu, Zekiye; Karagoz, Alper; Korukluoglu, Gulay; Ertek, Mustafa; Torunoglu, Mehmet Ali		Turkish Rotavirus Surveillance Net	Prevalence of Rotavirus Genotypes in Children Younger than 5 Years of Age before the Introduction of a Universal Rotavirus Vaccination Program: Report of Rotavirus Surveillance in Turkey	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; CHANGING PATTERNS; STRAINS; DIVERSITY; POPULATION; DIARRHEA; HUNGARY; EPIDEMIOLOGY; EMERGENCE; MORTALITY	Background: Group A rotaviruses are the most common causative agent of acute gastroenteritis among children less than 5 years of age throughout the world. This sentinel surveillance study was aimed to obtain baseline data on the rotavirus G and P genotypes across Turkey before the introduction of a universal rotavirus vaccination program. Methods: Rotavirus antigen-positive samples were collected from 2102 children less than 5 years of age who attended hospitals participating in the Turkish Rotavirus Surveillance Network. Rotavirus antigen was detected in the laboratories of participating hospitals by commercial serological tests such as latex agglutination, immunochromatographic test or enzyme immunoassay. Rotavirus G and P genotypes were determined by reverse transcription polymerase chain reaction (RT-PCR) using consensus primers detecting the VP7 and VP4 genes, followed by semi-nested type-specific multiplex PCR. Results: RT-PCR found rotavirus RNA in 1644 (78.2%) of the samples tested. The highest rate of rotavirus positivity (38.7%) was observed among children in the 13 to 24 month age group, followed by children in the age group of 25 to 36 months (28.3%). A total of eight different G types, six different P types, and 42 different G-P combinations were obtained. Four common G types (G1, G2, G3, and G9) and two common P types (P[8] and P[4]) accounted for 95.1% and 98.8% of the strains, respectively. G9P[8] was the most common G/P combination found in 40.5% of the strains followed by G1P[8] (21.6%), G2P[8] (9.3%), G2P[4] (6.5%), G3P[8] (3.5%), and finally, G4P[8] (3.4%). These six common genotypes included 83.7% of the strains tested in this study. The rate of uncommon genotypes was 14%. Conclusion: The majority of the strains analyzed belonged to the G1-G4 and G9 genotypes, suggesting high coverage of current rotavirus vaccines. This study also demonstrates a dramatic increase in G9 genotype across the country.	[Durmaz, Riza; Kalaycioglu, Atila Taner; Acar, Sumeyra; Bakkaloglu, Zekiye; Karagoz, Alper; Ertek, Mustafa; Torunoglu, Mehmet Ali] Publ Hlth Agcy Turkey, Mol Microbiol Res & Appl Lab, Ankara, Turkey; [Durmaz, Riza] Yildirim Beyazit Univ, Fac Med, Dept Med Microbiol, Ankara, Turkey; [Korukluoglu, Gulay] Publ Hlth Agcy Turkey, Virol Reference Cent Lab, Ankara, Turkey	Ankara Yildirim Beyazit University	Durmaz, R (corresponding author), Publ Hlth Agcy Turkey, Mol Microbiol Res & Appl Lab, Ankara, Turkey.	rdurmaz@ybu.edu.tr	Ozgur Gundeslioglu, Ozlem/T-1959-2018; Bakkaloğlu, Zekiye/K-9150-2019; Emiroğlu, Melike/AAH-3566-2019; NUHOĞLU, ÇAĞATAY/A-3223-2019; Korukluoglu, Gulay/AAB-5176-2022; ALDEMİR KOCABAŞ, Bilge/J-7145-2018; Feyzioğlu, Bahadır/W-4440-2017; Temel, Fehminaz/V-7066-2018	NUHOĞLU, ÇAĞATAY/0000-0003-2187-4121; ALDEMİR KOCABAŞ, Bilge/0000-0002-6396-5243; Feyzioğlu, Bahadır/0000-0002-0991-2132; Emiroglu, Melike/0000-0003-1307-0246; Temel, Fehminaz/0000-0003-3470-3823; Bayram, Nuri/0000-0003-1802-2518; TOPAL, SELMUR/0000-0002-6325-9760; saz, eylem ulas/0000-0002-2555-2712; Bakkaloglu, Zekiye/0000-0001-9137-016X; saz, eylem ulas/0000-0002-0012-544X; aksaray, sebahat/0000-0002-0552-1337	Turkish Ministry of Health, National Public Health Agency of Turkey [B.10.1.HSK.O.16.00.00/94/6386]	Turkish Ministry of Health, National Public Health Agency of Turkey(Ministry of Health - Turkey)	This sentinel surveillance study was supported by the Turkish Ministry of Health, National Public Health Agency of Turkey (B.10.1.HSK.O.16.00.00/94/6386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; Altindis M, 2010, CENT EUR J MED, V5, P640, DOI 10.2478/s11536-009-0130-6; Anca Ioana Alina, 2014, Germs, V4, P30, DOI 10.11599/germs.2014.1053; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Banyai K, 2005, J MED VIROL, V76, P414, DOI 10.1002/jmv.20372; Banyai K, 2009, J MED VIROL, V81, P362, DOI 10.1002/jmv.21375; Benhafid M, 2013, J MED VIROL, V85, P354, DOI 10.1002/jmv.23445; Bernstein DI, 2006, PEDIATR ANN, V35, P38, DOI 10.3928/0090-4481-20060101-12; Bozdayi G, 2008, J MED VIROL, V80, P733, DOI 10.1002/jmv.21120; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Cataloluk O, 2005, EPIDEMIOL INFECT, V133, P673, DOI 10.1017/S0950268805003882; Ceyhan M, 2009, J INFECT DIS, V200, pS234, DOI 10.1086/605056; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Hacimustafaoglu M, 2011, TURKISH J PEDIATR, V53, P604; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Ianiro G, 2014, J MED VIROL, V86, P1073, DOI 10.1002/jmv.23871; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iturriza-gomara M, 2011, ROTAVIRUS STRAIN SUR; Jin Y, 2008, WORLD J PEDIATR, V4, P197, DOI 10.1007/s12519-008-0036-4; Kirkwood CD, 2011, COMMUN DIS INTELL, V35, P281; Kirkwood CD, 2010, COMMUN DIS INTELL, V34, P427; Konstantopoulos A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003570; Kurugol Z, 2003, TURKISH J PEDIATR, V45, P290; Laszlo B, 2012, J CLIN VIROL, V55, P140, DOI 10.1016/j.jcv.2012.06.016; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084699; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Meral M, 2011, MIKROBIYOL BUL, V45, P104; Midgley S, 2014, INFECT GENET EVOL, V27, P114, DOI 10.1016/j.meegid.2014.07.008; Mladenova Z, 2010, EUR J CLIN MICROBIOL, V29, P555, DOI 10.1007/s10096-010-0895-1; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Ndze VN, 2013, J MED VIROL, V85, P1485, DOI 10.1002/jmv.23603; Offit PA, 2006, PEDIATR ANN, V35, P29, DOI 10.3928/0090-4481-20060101-11; Ogilvie I, 2011, HUM VACCINES, V7, P523, DOI 10.4161/hv.7.5.14819; Oh Ho-Kyung, 2012, Osong Public Health Res Perspect, V3, P36, DOI 10.1016/j.phrp.2012.01.006; Ozdemir S, 2010, MIKROBIYOL BUL, V44, P571; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Ramig RF, 1997, ANNU REV MICROBIOL, V51, P225, DOI 10.1146/annurev.micro.51.1.225; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simmonds MK, 2008, J CLIN VIROL, V42, P368, DOI 10.1016/j.jcv.2008.02.011; Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tapisiz A, 2011, CURR MICROBIOL, V63, P517, DOI 10.1007/s00284-011-0014-2; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; World Health Organization, GEN PROT MON IMP POT; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	48	39	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113674	10.1371/journal.pone.0113674	http://dx.doi.org/10.1371/journal.pone.0113674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437502	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900063
J	LaPlante, RA; Douw, L; Tang, W; Stufflebeam, SM				LaPlante, Roan A.; Douw, Linda; Tang, Wei; Stufflebeam, Steven M.			The Connectome Visualization Utility: Software for Visualization of Human Brain Networks	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; ANATOMICAL NETWORKS; COMMUNITY STRUCTURE; DIFFUSION MRI; MEG; PARCELLATION; ORGANIZATION; DYNAMICS	In analysis of the human connectome, the connectivity of the human brain is collected from multiple imaging modalities and analyzed using graph theoretical techniques. The dimensionality of human connectivity data is high, and making sense of the complex networks in connectomics requires sophisticated visualization and analysis software. The current availability of software packages to analyze the human connectome is limited. The Connectome Visualization Utility (CVU) is a new software package designed for the visualization and network analysis of human brain networks. CVU complements existing software packages by offering expanded interactive analysis and advanced visualization features, including the automated visualization of networks in three different complementary styles and features the special visualization of scalar graph theoretical properties and modular structure. By decoupling the process of network creation from network visualization and analysis, we ensure that CVU can visualize networks from any imaging modality. CVU offers a graphical user interface, interactive scripting, and represents data uses transparent neuroimaging and matrix-based file types rather than opaque application-specific file formats.	[LaPlante, Roan A.; Douw, Linda; Tang, Wei; Stufflebeam, Steven M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Douw, Linda] Vrije Univ Amsterdam Med Ctr, Dept Anat & Clin Neurosci, Amsterdam, Netherlands; [Stufflebeam, Steven M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stufflebeam, Steven M.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard Medical School; Harvard University	LaPlante, RA (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	rlaplant@nmr.mgh.harvard.edu		Tang, Wei/0000-0003-3550-4076; Douw, Linda/0000-0001-7058-4062	National Institute of Health [R01-NS069696, U01-MH093765, P41-RR14075]; Defense Advanced Research Projects Agency; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069696] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (http://www.nih.gov/) grants R01-NS069696, U01-MH093765, and P41-RR14075 provided to SMS, and by the Defense Advanced Research Projects Agency (http://www.darpa.mil/) provided to SMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cook P.A., 2006, 14 SCI M INT SOC MAG; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis FC, 2013, CEREB CORTEX, V23, P1444, DOI 10.1093/cercor/bhs126; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; DeSalvo MN, 2014, RADIOLOGY, V270, P842, DOI 10.1148/radiol.13131044; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gerhard S, 2011, FRONT NEUROINFORM, V5; Ghoniem M., 2005, Information Visualization, V4, P114, DOI 10.1057/palgrave.ivs.9500092; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gray WR, 2012, IEEE PULSE, V3, P42, DOI 10.1109/MPUL.2011.2181023; Greenblatt RE, 2012, J NEUROSCI METH, V207, P1, DOI 10.1016/j.jneumeth.2012.02.025; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Holten D, 2006, IEEE T VIS COMPUT GR, V12, P741, DOI 10.1109/TVCG.2006.147; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35; Roca P, 2009, LECT NOTES COMPUT SC, V5761, P935, DOI 10.1007/978-3-642-04268-3_115; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Dixhoorn A, 2010, EUR WORKSH VIS COMP, V2010; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062789; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yeh F-C, 2010, IEEE T MED IMAGING, V27, P1415; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	88	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113838	10.1371/journal.pone.0113838	http://dx.doi.org/10.1371/journal.pone.0113838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437873	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900084
J	Talla, C; Diallo, D; Dia, I; Ba, Y; Ndione, JA; Sall, AA; Morse, A; Diop, A; Diallo, M				Talla, Cheikh; Diallo, Diawo; Dia, Ibrahima; Ba, Yamar; Ndione, Jacques-Andre; Sall, Amadou Alpha; Morse, Andy; Diop, Aliou; Diallo, Mawlouth			Statistical Modeling of the Abundance of Vectors of West African Rift Valley Fever in Barkedji, Senegal	PLOS ONE			English	Article							CULEX-POICILIPES DIPTERA; AEDES-VEXANS; POPULATION-DYNAMICS; VIRUS TRANSMISSION; MOSQUITO VECTORS; TEMPERATURE; RAINFALL; RISK; PATTERNS; CLIMATE	Rift Valley fever is an emerging mosquito-borne disease that represents a threat to human and animal health. The exophilic and exophagic behavior of the two main vector in West Africa (Aedes vexans and Culex poicilipes), adverse events post-vaccination, and lack of treatment, render ineffective the disease control. Therefore it is essential to develop an information system that facilitates decision-making and the implementation of adaptation strategies. In East Africa, RVF outbreaks are linked with abnormally high rainfall, and can be predicted up to 5 months in advance by modeling approaches using climatic and environmental parameters. However, the application of these models in West Africa remains unsatisfactory due to a lack of data for animal and human cases and differences in the dynamics of the disease emergence and the vector species involved in transmission. Models have been proposed for West Africa but they were restricted to rainfall impact analysis without a spatial dimension. In this study, we developed a mixed Bayesian statistical model to evaluate the effects of climatic and ecological determinants on the spatiotemporal dynamics of the two main vectors. Adult mosquito abundance data were generated from July to December every fortnight in 2005-2006 at 79 sites, including temporary ponds, bare soils, shrubby savannah, wooded savannah, steppes, and villages in the Barkedji area. The results demonstrate the importance of environmental factors and weather conditions for predicting mosquito abundance. The rainfall and minimum temperature were positively correlated with the abundance of Cx. poicilipes, whereas the maximum temperature had negative effects. The rainfall was negatively correlated with the abundance of Ae. vexans. After combining land cover classes, weather conditions, and vector abundance, our model was used to predict the areas and periods with the highest risks of vector pressure. This information could support decision-making to improve RVF surveillance activities and to implement better intervention strategies.	[Talla, Cheikh; Diallo, Diawo; Dia, Ibrahima; Ba, Yamar; Diallo, Mawlouth] Inst Pasteur, Unite Entomol Med, Dakar, Senegal; [Talla, Cheikh; Diop, Aliou] Univ Gaston Berger, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Ndione, Jacques-Andre] Ctr Suivi Ecol, Dakar, Senegal; [Sall, Amadou Alpha] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal; [Morse, Andy] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University of Liverpool	Diallo, M (corresponding author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.	diallo@pasteur.sn	Talla, Cheikh/AAZ-5134-2020	Talla, Cheikh/0000-0003-0678-1226; DIOP, Aliou/0000-0002-0808-5622; DIALLO, Diawo/0000-0002-7478-5248; Morse, Andrew/0000-0002-0413-2065	EU - European Commission [243964]; Institut Pasteur de Dakar	EU - European Commission(European CommissionEuropean Commission Joint Research Centre); Institut Pasteur de Dakar	This study was partially supported by the EU project QWeCI (Quantifying Weather and Climate Impacts on Health in Developing Countries; funded by the European Commission's Seventh Framework Research Programme under the grant agreement 243964) and The Institut Pasteur de Dakar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; [Anonymous], 1956, REUN SPEC CSE MAT PH, P22; Anyamba A, 2006, EMERG INFECT DIS, V12, P518, DOI 10.3201/eid1203.050973; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Ba Y., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P283; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1; BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123; Bicout DJ, 2004, VECTOR-BORNE ZOONOT, V4, P33, DOI 10.1089/153036604773082979; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Botros B, 2006, J MED VIROL, V78, P787, DOI 10.1002/jmv.20624; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; BREELAND S. G., 1967, MOSQUITO NEWS, V27, P343; Chuang TW, 2012, J MED ENTOMOL, V49, P851, DOI 10.1603/ME11150; Clements AN, 1999, BIOL MOSQUITOES SENS, V2, P752; Clements ACA, 2007, VECTOR-BORNE ZOONOT, V7, P203, DOI 10.1089/vbz.2006.0600; Cressie N., 2011, STAT SPATIO TEMPORAL; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267; Diallo D, 2008, Bull Soc Pathol Exot, V101, P410; Diallo D, 2011, J VECTOR ECOL, V36, P426, DOI 10.1111/j.1948-7134.2011.00184.x; Diallo M, 2005, MED VET ENTOMOL, V19, P119, DOI 10.1111/j.0269-283X.2005.00564.x; Diallo M, 2000, AM J TROP MED HYG, V62, P702, DOI 10.4269/ajtmh.2000.62.702; Easterday B C, 1965, Adv Vet Sci, V10, P65; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Fao, 1997, AFRICOVER CLASS OCC, P80; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Ganser C, 2013, J VECTOR ECOL, V38, P229, DOI 10.1111/j.1948-7134.2013.12035.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilks WR, 1996, MARKOV CHAIN MONTE C, P512; Hunter P, 2002, ONDERSTEPOORT J VET, V69, P95; Janousek TE, 1999, J AM MOSQUITO CONTR, V15, P253; JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7; Kamal SA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-94; Katz MH., 2011, MULTIVARIABLE ANAL A; Kendall M.G., 1975, RANK CORRELATION MEA; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Linthicum Kenneth J, 2007, Vet Ital, V43, P663; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McCulloch CE, 2001, GEN LINEAR MIXED MOD, P99; Meegan J, 1988, RIFT VALLEY FEVER AR; Mellor PS, 2000, REV SCI TECH OIE, V19, P41, DOI 10.20506/rst.19.1.1211; Mondet B, 2005, J VECTOR ECOL, V30, P102; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Muturi EJ, 2007, AM J TROP MED HYG, V76, P95, DOI 10.4269/ajtmh.2007.76.95; Ndiaye PI, 2006, J THEOR BIOL, V243, P222, DOI 10.1016/j.jtbi.2006.06.005; Ndione J-A, 2008, CLIMATOLOGIE, V5, P83, DOI [10.4267/climatologie.794, DOI 10.4267/CLIMATOLOGIE.794]; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Plummer M., 2005, OUTPUT ANAL DIAGNOST; Porphyre T, 2005, ECOL MODEL, V183, P173, DOI 10.1016/j.ecolmodel.2004.06.044; R Development Core Team, 2013, R LANG ENV STAT COMP, P409, DOI DOI 10.1007/978-3-540-74686-7; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; SMITHBURN KC, 1949, BRIT J EXP PATHOL, V30, P1; Soti V, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-10; Soti V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001795; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; TRPIS M, 1970, CAN ENTOMOL, V102, P1048, DOI 10.4039/Ent1021048-8; Vignolles C, 2009, GEOSPATIAL HEALTH, V3, P211, DOI 10.4081/gh.2009.221; Wilberg MJ, 2008, FISH RES, V93, P212, DOI 10.1016/j.fishres.2008.04.010; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235	75	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114047	10.1371/journal.pone.0114047	http://dx.doi.org/10.1371/journal.pone.0114047			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437856	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900114
J	Toledo, M; Penna, F; Busquets, S; Lopez-Soriano, FJ; Argiles, JM				Toledo, Miriam; Penna, Fabio; Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.			Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; LEWIS LUNG-CARCINOMA; CANCER CACHEXIA; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; ACTRIIB ANTAGONISM; CACHECTIC PATIENTS; PANCREATIC-CANCER; PHYSICAL-ACTIVITY; LEAN TISSUE	The presence of a tumour is very often associated with wasting in the host, affecting both skeletal muscle and adipose tissue. In the present study we used sorafenib, a multi-kinase inhibitor with anti-tumour activity, in order to investigate the effects of chemotherapy on wasting. Three different experimental mouse tumour models were included: C26 colon carcinoma, B16 melanoma and Lewis lung carcinoma (LLC). The results obtained clearly show that sorafenib was effective in reducing tumour growth in LLC and B16 models, while it had no effect on C26. Interestingly, sorafenib treatment reduced the signs of muscle wasting and improved the physical activity in the LLC model and also in the C26, despite the absence of antineoplastic action in the latter. Our results discard a role for IL-6 in the action of sorafenib since the drug did not affect the levels of this cytokine. Conversely, sorafenib seems to act by influencing both STAT3 and ERK activity at muscle level, leading to reduced accumulation of Pax7 and atrogin-1. Sorafenib may interfere with muscle wasting by decreasing the activation of these signal transduction pathways.	[Toledo, Miriam; Penna, Fabio; Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Canc Res Grp, Barcelona, Spain; [Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Penna, Fabio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Barcelona; University of Barcelona; University of Turin	Busquets, S (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Canc Res Grp, Barcelona, Spain.	silviabusquets@ub.edu	Toledo, Miriam/B-1229-2019; Argiles, Josep M/L-5741-2014; Penna, Fabio/K-5090-2016; Busquets, Silvia/C-5544-2017; Lopez-Soriano, Francisco J./W-4947-2018	Toledo, Miriam/0000-0002-1332-7454; Penna, Fabio/0000-0002-2774-6027; Busquets, Silvia/0000-0002-9319-3555; Lopez-Soriano, Francisco J./0000-0003-1493-3023; Argiles, Josep M./0000-0003-4683-5428	grant for the Ministerio de Ciencia y Tecnologia [SAF-26091-2011]	grant for the Ministerio de Ciencia y Tecnologia	This work was supported by a grant for the Ministerio de Ciencia y Tecnologia (SAF-26091-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Argiles JM, 1997, MED RES REV, V17, P477, DOI 10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-R; Argiles JM, 2012, NUTR METAB CARDIOVAS, P1; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; DONATI MB, 1978, EUR J CANCER, V14, P343, DOI 10.1016/0014-2964(78)90203-7; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Greig CA, 2014, SUPPORT CARE CANCER, V22, P1269, DOI 10.1007/s00520-013-2081-3; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE171, DOI 10.1152/ajpendo.00065.2013; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Loberg RD, 2007, CA-CANCER J CLIN, V57, P225, DOI 10.3322/canjclin.57.4.225; Maccio A, 2012, GYNECOL ONCOL, V124, P417, DOI 10.1016/j.ygyno.2011.12.435; Moses AGW, 2009, ONCOL REP, V21, P1091, DOI 10.3892/or_00000328; Moses AWG, 2004, BRIT J CANCER, V90, P996, DOI 10.1038/sj.bjc.6601620; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; NG EH, 1991, HEMATOL ONCOL CLIN N, V5, P161, DOI 10.1016/S0889-8588(18)30460-X; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; Prado CMM, 2011, CURR OPIN CLIN NUTR, V14, P250, DOI 10.1097/MCO.0b013e3283455d45; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Scott HR, 1996, BRIT J CANCER, V73, P1560, DOI 10.1038/bjc.1996.294; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; YANG F, 2012, SORAFENIB INHIBITS E, V13, P534; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	40	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113931	10.1371/journal.pone.0113931	http://dx.doi.org/10.1371/journal.pone.0113931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436606	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900098
J	Yang, MY; Stowe, DF; Udoh, KB; Heisner, JS; Camara, AKS				Yang, Meiying; Stowe, David F.; Udoh, Kenechukwu B.; Heisner, James S.; Camara, Amadou K. S.			Reversible Blockade of Complex I or Inhibition of PKC beta Reduces Activation and Mitochondria Translocation of p66(Shc) to Preserve Cardiac Function after Ischemia	PLOS ONE			English	Article							KINASE-C-BETA; REACTIVE OXYGEN; REPERFUSION INJURY; RESPIRATORY-CHAIN; OXIDATIVE STRESS; CYTOCHROME-C; LIFE-SPAN; ELECTRON; HEART; ROS	Aim: Excess mitochondrial reactive oxygen species (mROS) play a vital role in cardiac ischemia reperfusion (IR) injury. P66(Shc), a splice variant of the ShcA adaptor protein family, enhances mROS production by oxidizing reduced cytochrome c to yield H2O2. Ablation of p66(Shc) protects against IR injury, but it is unknown if and when p66(Shc) is activated during cardiac ischemia and/or reperfusion and if attenuating complex I electron transfer or deactivating PKC beta alters p66(Shc) activation during IR is associated with cardioprotection. Methods: Isolated guinea pig hearts were perfused and subjected to increasing periods of ischemia and reperfusion with or without amobarbital, a complex I blocker, or hispidin, a PKC beta inhibitor. Phosphorylation of p66(Shc) at serine 36 and levels of p66(Shc) in mitochondria and cytosol were measured. Cardiac functional variables and redox states were monitored online before, during and after ischemia. Infarct size was assessed in some hearts after 120 min reperfusion. Results: Phosphorylation of p66(Shc) and its translocation into mitochondria increased during reperfusion after 20 and 30 min ischemia, but not during ischemia only, or during 5 or 10 min ischemia followed by 20 min reperfusion. Correspondingly, cytosolic p66(Shc) levels decreased during these ischemia and reperfusion periods. Amobarbital or hispidin reduced phosphorylation of p66(Shc) and its mitochondrial translocation induced by 30 min ischemia and 20 min reperfusion. Decreased phosphorylation of p66(Shc) by amobarbital or hispidin led to better functional recovery and less infarction during reperfusion. Conclusion: Our results show that IR activates p66(Shc) and that reversible blockade of electron transfer from complex I, or inhibition of PKC beta activation, decreases p66(Shc) activation and translocation and reduces IR damage. These observations support a novel potential therapeutic intervention against cardiac IR injury.	[Yang, Meiying; Stowe, David F.; Udoh, Kenechukwu B.; Heisner, James S.; Camara, Amadou K. S.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Stowe, David F.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Stowe, David F.; Camara, Amadou K. S.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Stowe, David F.] Zablocki VA Med Ctr, Res Serv, Milwaukee, WI USA; [Stowe, David F.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	Camara, AKS (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	aksc@mcw.edu		STOWE, DAVID/0000-0003-2180-4844	National Heart Lung and Blood Institute of the National Institutes of Health [R01 HL 095122 NIH, R01 HL 089514 NIH]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095122, R01HL089514] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Heart Lung and Blood Institute of the National Institutes of Health R01 HL 095122 NIH (awarded to Dr. Camara) and R01 HL 089514 NIH (awarded to Dr. Stowe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2012, J CARDIOVASC PHARM T, V17, P93, DOI 10.1177/1074248410389815; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aldakkak M, 2009, J CARDIOVASC PHARM, V54, P298, DOI 10.1097/FJC.0b013e3181b2b842; Camara AK, 2014, SYSTEM BIOL FREE RAD, P1; Camara AKS, 2004, AM J PHYSIOL-HEART C, V286, pH1289, DOI 10.1152/ajpheart.00811.2003; Camara AKS, 2007, AM J PHYSIOL-CELL PH, V292, pC2021, DOI 10.1152/ajpcell.00231.2006; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Gadicherla AK, 2012, BBA-BIOENERGETICS, V1817, P419, DOI 10.1016/j.bbabio.2011.11.021; Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gorenkova N, 2013, ANTIOXID REDOX SIGNA; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Haumann J, 2010, BIOPHYS J, V99, P997, DOI 10.1016/j.bpj.2010.04.069; Heinen A, 2007, AM J PHYSIOL-HEART C, V293, pH1400, DOI 10.1152/ajpheart.00198.2007; Hiona A, 2011, J THORAC CARDIOV SUR, V142, P396, DOI 10.1016/j.jtcvs.2010.07.097; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kong L, 2008, AM J PHYSIOL-HEART C, V294, pH1862, DOI 10.1152/ajpheart.01346.2007; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Liu B, 2009, BBA-PROTEINS PROTEOM, V1794, P476, DOI 10.1016/j.bbapap.2008.12.008; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Novalija E, 2002, AM J PHYSIOL-HEART C, V283, pH44, DOI 10.1152/ajpheart.01056.2001; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; SPIEGEL HE, 1969, J PHARMACOL EXP THER, V165, P23; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Stowe DF, 2013, BBA-BIOMEMBRANES, V1828, P427, DOI 10.1016/j.bbamem.2012.08.031; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; VEITCH K, 1992, BIOCHEM J, V281, P709, DOI 10.1042/bj2810709; Yang CPH, 2002, BBA-MOL CELL RES, V1590, P76, DOI 10.1016/S0167-4889(02)00200-8; Yang MY, 2012, BBA-BIOENERGETICS, V1817, P2049, DOI 10.1016/j.bbabio.2012.06.004; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	48	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113534	10.1371/journal.pone.0113534	http://dx.doi.org/10.1371/journal.pone.0113534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436907	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900050
J	Augner, K; Eichler, J; Utz, W; Pischetsrieder, M				Augner, Kerstin; Eichler, Jutta; Utz, Wolfgang; Pischetsrieder, Monika			Influence of Nonenzymatic Posttranslational Modifications on Constitution, Oligomerization and Receptor Binding of S100A12	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BETA-LACTOGLOBULIN MODIFICATIONS; CELL-SURFACE RECEPTOR; HUMAN SERUM-ALBUMIN; CALGRANULIN-C; PROTEINS; RAGE; SITE; IDENTIFICATION; METHYLGLYOXAL	This study examined the effect of methylglyoxal (MGO)-derived nonenzymatic posttranslational modifications (nePTMs) on the binding affinity of S100A12 to its natural receptor for advanced glycation end-products (RAGE). Binding of MGO-modified S100A12 to RAGE decreased significantly with increasing MGO concentration and incubation time. Ca2+-induced S100A12 hexamerization was impaired only at higher MGO concentrations indicating that the loss of affinity is not predominantly caused by disturbance of ligand oligomerization. nePTM mapping showed carboxyethylation of lysine (CEL) and the N-terminus without preferential modification sites. Besides, hydroimidazolone, hemiaminals, argpyrimidine, and tetrahydropyrimidine rapidly formed at R21. Even at the highest modification rate, hexamerization of synthesized CEL-S100A12 was unaffected and RAGE-binding only slightly impaired. Thus, nePTMs at R21 seem to be the major cause of MGO-induced impairment of S100A12 oligomerization and RAGE binding.	[Augner, Kerstin; Utz, Wolfgang; Pischetsrieder, Monika] Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, D-91054 Erlangen, Germany; [Eichler, Jutta] Univ Erlangen Nurnberg, Dept Chem & Pharm, Div Med Chem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Pischetsrieder, M (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, D-91054 Erlangen, Germany.	monika.pischetsrieder@fau.de	Eichler, Jutta/H-7847-2018	Eichler, Jutta/0000-0001-6683-9456				Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; Brock JWC, 2003, J PROTEOME RES, V2, P506, DOI 10.1021/pr0340173; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929; Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847; Fogliano V, 1998, BBA-PROTEIN STRUCT M, V1388, P295, DOI 10.1016/S0167-4838(98)00177-0; Fritz G, 2004, HDB METALLOPROTEINS, V3, P529, DOI [10.1002/0470028637.met046, DOI 10.1002/0470028637.MET046]; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Gao Y, 2006, BIOCHEMISTRY-US, V45, P15654, DOI 10.1021/bi061410o; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Klopfer A, 2011, J AGR FOOD CHEM, V59, P394, DOI 10.1021/jf103116c; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Meltretter J, 2008, J AGR FOOD CHEM, V56, P5165, DOI 10.1021/jf800571j; Meltretter J, 2007, J AGR FOOD CHEM, V55, P6096, DOI 10.1021/jf0705567; Meltretter J, 2013, J AGR FOOD CHEM, V61, P6971, DOI 10.1021/jf401549j; Mittelmaier S, 2011, ANAL CHEM, V83, P9660, DOI 10.1021/ac2025706; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Nagaraj RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030257; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tae HJ, 2013, J MOL MED, V91, P1369, DOI 10.1007/s00109-013-1091-4; TAKAHASHI M, 1995, BIOCHEMISTRY-US, V34, P1433, DOI 10.1021/bi00004a038; Thornalley PJ, 2006, J RENAL NUTR, V16, P178, DOI 10.1053/j.jrn.2006.04.012; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; WESTWOOD ME, 1995, J PROTEIN CHEM, V14, P359, DOI 10.1007/BF01886793; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yagmur E, 2006, CLIN BIOCHEM, V39, P39, DOI 10.1016/j.clinbiochem.2005.07.016	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113418	10.1371/journal.pone.0113418	http://dx.doi.org/10.1371/journal.pone.0113418			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426955	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400049
J	Cunillera, T; Fuentemilla, L; Brignani, D; Cucurell, D; Miniussi, C				Cunillera, Toni; Fuentemilla, Lluis; Brignani, Debora; Cucurell, David; Miniussi, Carlo			A Simultaneous Modulation of Reactive and Proactive Inhibition Processes by Anodal tDCS on the Right Inferior Frontal Cortex	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; STOP-SIGNAL; RESPONSE-INHIBITION; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; PERFORMANCE; ATTENTION; MODEL; DISSOCIATION; MECHANISMS	Proactive and reactive inhibitory processes are a fundamental part of executive functions, allowing a person to stop inappropriate responses when necessary and to adjust performance in in a long term in accordance to the goals of a task. In the current study, we manipulate, in a single task, both reactive and proactive inhibition mechanisms, and we investigate the within-subjects effect of increasing, by means of anodal transcranial direct current stimulation (tDCS), the involvement of the right inferior frontal cortex (rIFC). Our results show a simultaneous enhancement of these two cognitive mechanisms when modulating the neural activity of rIFC. Thus, the application of anodal tDCS increased reaction times on Go trials, indicating a possible increase in proactive inhibition. Concurrently, the stop-signal reaction time, as a covert index of the inhibitory process, was reduced, demonstrating an improvement in reactive inhibition. In summary, the current pattern of results validates the engagement of the rIFC in these two forms of inhibitory processes, proactive and reactive inhibition and it provides evidence that both processes can operate concurrently in the brain.	[Cunillera, Toni; Fuentemilla, Lluis; Cucurell, David] Univ Barcelona, Dept Basic Psychol, Barcelona, Spain; [Fuentemilla, Lluis] Inst Biomed Res Bellvitge IDIBELL, Cognit & Brain Plast Unit, Lhospitalet De Llobregat, Spain; [Brignani, Debora; Miniussi, Carlo] IRCCS Ctr San Giovanni Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy; [Miniussi, Carlo] Univ Brescia, Neurosci Sect, Dept Clin & Expt Sci, Brescia, Italy	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); IRCCS Fatebenefratelli; University of Brescia	Cunillera, T (corresponding author), Univ Barcelona, Dept Basic Psychol, Barcelona, Spain.	tcunillera@ub.edu	Miniussi, Carlo/P-5610-2019; Cunillera, Toni/I-4212-2015; Miniussi, Carlo/E-7602-2010; Brignani, Debora/K-4495-2016; Fuentemilla, Lluís/E-3926-2012	Miniussi, Carlo/0000-0002-5436-4745; Cunillera, Toni/0000-0002-1768-5910; Miniussi, Carlo/0000-0002-5436-4745; Brignani, Debora/0000-0003-0848-5164; Fuentemilla, Lluís/0000-0002-5482-7615	Spanish Government [PSI2011-23624, PSI2010-15024]; Italian Ministry of Health	Spanish Government(Spanish GovernmentEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by: TC: Spanish Government PSI2011-23624; LF: Spanish Government PSI2010-15024; CM and DB: Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2008, PSYCHOL SCI, V19, P1146, DOI 10.1111/j.1467-9280.2008.02216.x; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Band GPH, 1999, ACTA PSYCHOL, V101, P179, DOI 10.1016/S0001-6918(99)00005-0; Barch DM, 2009, SCHIZOPHRENIA BULL, V35, P115, DOI 10.1093/schbul/sbn154; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Cai WD, 2011, J NEUROSCI, V31, P5965, DOI 10.1523/JNEUROSCI.6292-10.2011; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Claffey MP, 2010, NEUROPSYCHOLOGIA, V48, P541, DOI 10.1016/j.neuropsychologia.2009.10.015; CREUTZFELDT O, 1962, EXP NEUROL, V5, P436, DOI 10.1016/0014-4886(62)90056-0; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Greenhouse I, 2012, J NEUROPHYSIOL, V107, P384, DOI 10.1152/jn.00704.2011; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Kemmotsu N, 2005, COGNITIVE BRAIN RES, V24, P335, DOI 10.1016/j.cogbrainres.2005.02.015; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSMAN A, 1992, J EXP PSYCHOL HUMAN, V18, P217, DOI 10.1037/0096-1523.18.1.217; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rieger M, 1999, BRIT J PSYCHOL, V90, P509, DOI 10.1348/000712699161585; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Verbruggen F, 2014, J EXP PSYCHOL HUM PE; Verbruggen F, 2008, J EXP PSYCHOL HUMAN, V34, P413, DOI 10.1037/0096-1523.34.2.413; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726	52	47	48	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113537	10.1371/journal.pone.0113537	http://dx.doi.org/10.1371/journal.pone.0113537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426713	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400060
J	Gaffney, PM; Imai, DM; Clifford, DL; Ghassemian, M; Sasik, R; Chang, AN; O'Brien, TD; Coppinger, J; Trejo, M; Masliah, E; Munson, L; Sigurdson, C				Gaffney, Patricia M.; Imai, Denise M.; Clifford, Deana L.; Ghassemian, Majid; Sasik, Roman; Chang, Aaron N.; O'Brien, Timothy D.; Coppinger, Judith; Trejo, Margarita; Masliah, Eliezer; Munson, Linda; Sigurdson, Christina			Proteomic Analysis of Highly Prevalent Amyloid A Amyloidosis Endemic to Endangered Island Foxes	PLOS ONE			English	Article							HUMAN SECONDARY AMYLOIDOSIS; HIGH-DENSITY-LIPOPROTEIN; AMINO-ACID-SEQUENCE; E-DEFICIENT MICE; SHAR-PEI DOGS; APOLIPOPROTEIN-E; PROTEIN-AA; UROCYON-CINEREOARGENTEUS; RHEUMATOID-ARTHRITIS; HEPARAN-SULFATE	Amyloid A (AA) amyloidosis is a debilitating, often fatal, systemic amyloid disease associated with chronic inflammation and persistently elevated serum amyloid A (SAA). Elevated SAA is necessary but not sufficient to cause disease and the risk factors for AA amyloidosis remain poorly understood. Here we identify an extraordinarily high prevalence of AA amyloidosis (34%) in a genetically isolated population of island foxes (Urocyon littoralis) with concurrent chronic inflammatory diseases. Amyloid deposits were most common in kidney (76%), spleen (58%), oral cavity (45%), and vasculature (44%) and were composed of unbranching, 10 nm in diameter fibrils. Peptide sequencing by mass spectrometry revealed that SAA peptides were dominant in amyloid-laden kidney, together with high levels of apolipoprotein E, apolipoprotein A-IV, fibrinogen-alpha chain, and complement C3 and C4 (false discovery rate <= 0.05). Reassembled peptide sequences showed island fox SAA as an 111 amino acid protein, most similar to dog and artic fox, with 5 unique amino acid variants among carnivores. SAA peptides extended to the last two C-terminal amino acids in 5 of 9 samples, indicating that near full length SAA was often present in amyloid aggregates. These studies define a remarkably prevalent AA amyloidosis in island foxes with widespread systemic amyloiddeposition, a unique SAA sequence, and the co-occurrence of AA with apolipoproteins.	[Gaffney, Patricia M.; Coppinger, Judith; Trejo, Margarita; Masliah, Eliezer; Sigurdson, Christina] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gaffney, Patricia M.; Coppinger, Judith; Sigurdson, Christina] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gaffney, Patricia M.; Imai, Denise M.; Munson, Linda; Sigurdson, Christina] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Clifford, Deana L.] Univ Calif Davis, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sasik, Roman; Chang, Aaron N.] Univ Calif San Diego, Ctr Computat Biol, Inst Genom Med, La Jolla, CA 92093 USA; [O'Brien, Timothy D.] Univ Minnesota, Vet Populat Med Dept, Vet Diagnost Lab, St Paul, MN 55108 USA; [Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Sigurdson, C (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu		Lipton, Stuart/0000-0002-3490-1259; O'Brien, Timothy/0000-0001-9742-0930; coppinger, judith/0000-0001-6813-9840	University of California San Diego Academic Senate Award; ARCS Foundation; Dr. Linda Munson Fellowship for Wildlife Pathology Research; Dr. Peter C. Kennedy Endowed Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440] Funding Source: NIH RePORTER	University of California San Diego Academic Senate Award; ARCS Foundation; Dr. Linda Munson Fellowship for Wildlife Pathology Research; Dr. Peter C. Kennedy Endowed Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a University of California San Diego Academic Senate Award and the ARCS Foundation (https://www.arcsfoundation.org/). PMG was supported by the Dr. Linda Munson Fellowship for Wildlife Pathology Research organized by the ACVP/STP Coalition (http://www.vetpathcoalition.org/) and the Dr. Peter C. Kennedy Endowed Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDSON TE, 1981, J WILDLIFE DIS, V17, P17, DOI 10.7589/0090-3558-17.1.17; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; [Anonymous], 2014, STAT FED LIST END TH, P12; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Cangul IT, 2002, J VET MED A, V49, P307, DOI 10.1046/j.1439-0442.2002.00456.x; Caughey B, 2008, P NATL ACAD SCI USA, V105, P7113, DOI 10.1073/pnas.0803438105; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; DAVIDSON WR, 1992, J WILDLIFE DIS, V28, P28, DOI 10.7589/0090-3558-28.1.28; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; GILBERT DA, 1990, NATURE, V344, P764, DOI 10.1038/344764a0; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gouvea AF, 2012, J ORAL PATHOL MED, V41, P178, DOI 10.1111/j.1600-0714.2011.01073.x; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hoshii Y, 1997, AM J PATHOL, V151, P911; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; JOHNSON KH, 1995, AMYLOID, V2, P92, DOI 10.3109/13506129509031893; Kelly TR, 2003, J WILDLIFE DIS, V39, P467, DOI 10.7589/0090-3558-39.2.467; Kindy MS, 1998, AM J PATHOL, V152, P1387; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Kobayashi H, 1996, BRIT J RHEUMATOL, V35, P44; Koivuniemi R, 2008, AMYLOID, V15, P262, DOI 10.1080/13506120802524676; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Li LL, 2011, EMERG INFECT DIS, V17, P1876, DOI 10.3201/eid1710.110233; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; Lindsay DS, 2001, VET PARASITOL, V97, P159, DOI 10.1016/S0304-4017(01)00390-9; LINKE RP, 1991, BIOL CHEM H-S, V372, P835, DOI 10.1515/bchm3.1991.372.2.835; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Moriguchi M, 1999, HUM GENET, V105, P360, DOI 10.1007/s004390051115; Moriguchi M, 2005, AMYLOID, V12, P26, DOI 10.1080/13506120500032394; Murakami T, 2013, AMYLOID, V20, P80, DOI 10.3109/13506129.2013.783474; Niewold TA, 1999, AMYLOID, V6, P205, DOI 10.3109/13506129909007328; Noborn F, 2012, J BIOL CHEM, V287, P25669, DOI 10.1074/jbc.M112.363895; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Papendick RE, 1997, VET PATHOL, V34, P549, DOI 10.1177/030098589703400602; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Penner CR, 2006, ORAL ONCOL, V42, P421, DOI 10.1016/j.oraloncology.2005.09.010; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; ROWLAND PH, 1991, VET PATHOL, V28, P125, DOI 10.1177/030098589102800204; Sethi S, 2012, KIDNEY INT, V82, P226, DOI 10.1038/ki.2012.108; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; SIPE JD, 1976, J IMMUNOL, V116, P1151; SOTO C, 1995, FEBS LETT, V371, P110, DOI 10.1016/0014-5793(95)00863-5; SUZUKI A, 1994, J RHEUMATOL, V21, P33; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Theis JD, 2013, J MASS SPECTROM, V48, P1067, DOI 10.1002/jms.3264; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; WESTERMARK P, 1985, COMP BIOCHEM PHYS B, V82, P211, DOI 10.1016/0305-0491(85)90228-7; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; Zhang B, 2008, J HERED, V99, P355, DOI 10.1093/jhered/esn015; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458	72	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113765	10.1371/journal.pone.0113765	http://dx.doi.org/10.1371/journal.pone.0113765			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25429466	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400085
J	Loe, H; Steinshamn, S; Wisloff, U				Loe, Henrik; Steinshamn, Sigurd; Wisloff, Ulrik			Cardio-Respiratory Reference Data in 4631 Healthy Men and Women 20-90 Years: The HUNT 3 Fitness Study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; AEROBICALLY TRAINED MEN; PEAK OXYGEN-UPTAKE; ANAEROBIC THRESHOLD; VENTILATORY THRESHOLD; REFERENCE VALUES; GAS-EXCHANGE; CARDIOPULMONARY RESPONSES; EXERCISE CAPACITY	Purpose: To provide a large reference material on key cardio-respiratory variables in a healthy population of Norwegian men and women aged 20-90 years. Methods: Sub maximal and peak levels of cardio-respiratory variables were measured using cardiopulmonary exercise testing during treadmill running. Results: The highest peak ventilation among men (141.9 +/- 24.5 L.min(-1)) and women (92.0 +/- 16.5 L.min(-1)) was observed in the youngest age group (20-29 years, sex differences p<0.001) with an average 7% reduction per decade. The highest tidal volumes were observed in the 30-39 and 40-49 year age groups among men (2.94 +/- 0.46 L) and women (2.06 +/- 0.32 L) (sex differences p<0.001), with a subsequent average 6% reduction per decade. Ventilatory threshold and respiratory compensation point were observed at approximately 77% and 87% of peak oxygen uptake (VO2peak) among men and women, respectively. The best ventilatory efficiency (EqVCO(2Than)) was observed in the youngest age group (2029 years) in both men (26.2 +/- 2.8) and woman (27.5 +/- 2.7) (sex differences p<0.001) with an average 3% deterioration in ventilatory efficiency per decade. Conclusion: This is the largest European reference material of cardio-respiratory variables in healthy men and women aged 20-90 years, establishing normal values for, and associations between key cardio-respiratory parameters. This will be useful in clinical decision making when evaluating cardiopulmonary health in similar populations.	[Loe, Henrik; Steinshamn, Sigurd; Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Loe, Henrik] Valnesfjord Rehabil Ctr, Valnesfjord, Norway; [Steinshamn, Sigurd] Univ Trondheim Hosp, St Olavs Hosp, Dept Thorac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway(Research Council of Norway); Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	This study was funded by K.G. Jebsen Foundation, The Norwegian Council on Cardiovascular Disease, The Research Council of Norway, Foundation for Cardiovascular Research at St. Olav's Hospital, Norwegian State Railways, Roche Norway Incorporated and Valnesfjord Rehabilitation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghobain MO, 2013, CLIN RESP J; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Baur X, 2013, Pneumologie, V67, P401, DOI 10.1055/s-0033-1344331; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BLACKIE SP, 1991, CHEST, V100, P136, DOI 10.1378/chest.100.1.136; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Cao ZB, 2009, EUR J APPL PHYSIOL, V105, P289, DOI 10.1007/s00421-008-0902-8; CUNNINGHAM DA, 1985, J GERONTOL, V40, P703, DOI 10.1093/geronj/40.6.703; DAVIS JA, 1979, J APPL PHYSIOL, V46, P1039, DOI 10.1152/jappl.1979.46.6.1039; Davis JA, 1997, EUR J APPL PHYSIOL O, V76, P157, DOI 10.1007/s004210050228; Dejsomritrutai W, 2000, J Med Assoc Thai, V83, P457; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Dempsey JA, 2012, J PHYSIOL-LONDON, V590, P4129, DOI 10.1113/jphysiol.2012.233908; Deruelle F, 2004, CAN J APPL PHYSIOL, V29, P564, DOI 10.1139/h04-036; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Fabre N, 2008, J STRENGTH COND RES, V22, P1977, DOI 10.1519/JSC.0b013e3181874ae9; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Gonzales JU, 2012, INT J SPORTS MED, V33, P537, DOI 10.1055/s-0032-1304659; Guazzi M, 2012, CIRCULATION, V126, P2261, DOI 10.1161/CIR.0b013e31826fb946; Habedank D, 1998, EUR J APPL PHYSIOL O, V77, P421, DOI 10.1007/s004210050354; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; HELGERUD J, 1990, EUR J APPL PHYSIOL O, V61, P433, DOI 10.1007/BF00236064; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Hopker JG, 2011, ANAESTHESIA, V66, P111, DOI 10.1111/j.1365-2044.2010.06604.x; INBAR O, 1994, MED SCI SPORT EXER, V26, P538; Itoh H, 2013, J CARDIOL, V61, P71, DOI 10.1016/j.jjcc.2012.09.010; Jakovljevic DG, 2012, CLIN PHYSIOL FUNCT I, V32, P388, DOI 10.1111/j.1475-097X.2012.01143.x; JOHNSON BD, 1991, AM REV RESPIR DIS, V143, P960, DOI 10.1164/ajrccm/143.5_Pt_1.960; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kamen G, 2004, J GERONTOL A-BIOL, V59, P1334, DOI 10.1093/gerona/59.12.1334; Kift J, 2008, LUNG, V186, P345, DOI 10.1007/s00408-008-9101-y; Kilbride E, 2003, EUR J APPL PHYSIOL, V89, P595, DOI 10.1007/s00421-003-0853-z; Kjelkenes I, 2010, CLIN PHYSIOL FUNCT I, V30, P333, DOI 10.1111/j.1475-097X.2010.00948.x; Kleber FX, 2000, CIRCULATION, V101, P2803, DOI 10.1161/01.CIR.101.24.2803; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; Lenti M, 2011, J STRENGTH COND RES, V25, P1326, DOI 10.1519/JSC.0b013e3181d99061; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Loth DW, 2013, EUR J EPIDEMIOL, V28, P329, DOI 10.1007/s10654-013-9800-4; Ma YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063875; Malek MH, 2005, J STRENGTH COND RES, V19, P559; Malek MH, 2009, CLIN PHYSIOL FUNCT I, V29, P143, DOI 10.1111/j.1475-097X.2008.00850.x; Markovic G, 2007, ANN HUM BIOL, V34, P315, DOI 10.1080/03014460701219358; Marques-Neto SR, 2012, J STRENGTH COND RES, V26, P1967, DOI 10.1519/JSC.0b013e318234eb5d; McArdle W, 2010, EXERCISE PHYS NUTR E; MEYER K, 1994, CARDIOLOGY, V85, P341, DOI 10.1159/000176733; Meyer T, 2004, BRIT J SPORT MED, V38, P622, DOI 10.1136/bjsm.2003.007815; Mikulski MA, 2013, J OCCUP ENVIRON MED, V55, P802, DOI 10.1097/JOM.0b013e31828b22cc; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Nelson MD, 2010, MED SCI SPORT EXER, V42, P255, DOI 10.1249/MSS.0b013e3181b0e534; Nes BM, 2011, MED SCI SPORT EXER, V43, P2024, DOI 10.1249/MSS.0b013e31821d3f6f; Nikooie R, 2009, J STRENGTH COND RES, V23, P2107, DOI 10.1519/JSC.0b013e3181b73bc2; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Pessoa DM, 2012, INT J SPORTS MED, V33, P744, DOI 10.1055/s-0031-1299753; Piepoli MF, 2006, EUR J CARDIOV PREV R, V13, P300; Piepoli MF, 2006, EUR J CARDIOV PREV R, V13, P150; POSNER JD, 1987, J APPL PHYSIOL, V63, P1519, DOI 10.1152/jappl.1987.63.4.1519; Rissanen APE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00265; Roca J, 1997, EUR RESPIR J, V10, P2662; Sanada K, 2007, EUR J APPL PHYSIOL, V99, P475, DOI 10.1007/s00421-006-0375-6; Stathokostas L, 2004, J APPL PHYSIOL, V97, P781, DOI 10.1152/japplphysiol.00447.2003; SULLIVAN MJ, 1988, CIRCULATION, V77, P552, DOI 10.1161/01.CIR.77.3.552; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Venturelli M, 2012, MATURITAS, V73, P115, DOI 10.1016/j.maturitas.2012.07.009; Vogel T, 2011, J NUTR HEALTH AGING, V15, P905, DOI 10.1007/s12603-011-0087-4; Wasserman K, 2012, EXERCISE TESTING INT, V167, P200; Yu F, 2007, ACTA PHYSIOL, V190, P229, DOI 10.1111/j.1748-1716.2007.01699.x	73	37	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113884	10.1371/journal.pone.0113884	http://dx.doi.org/10.1371/journal.pone.0113884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426954	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400094
J	Parente, DB; Rodrigues, RS; Paiva, FF; Neto, JAO; Machado-Silva, L; Lanzoni, V; Campos, CFF; Eiras-Araujo, AL; do Brasil, PEAA; Garteiser, P; Gomes, MD; Perez, RD				Parente, Daniella Braz; Rodrigues, Rosana Souza; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Machado-Silva, Lilian; Lanzoni, Valeria; Ferreira Campos, Carlos Frederico; Eiras-Araujo, Antonio Luis; Alvarenga Americano do Brasil, Pedro Emmanuel; Garteiser, Philippe; Gomes, Marilia de Brito; Perez, Renata de Mello			Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice?	PLOS ONE			English	Article							HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE ASSESSMENT; COMPUTED-TOMOGRAPHY; SCORING SYSTEM; DISEASE; QUANTIFICATION; PREVALENCE; ACCURACY; FRACTION	Objective: To investigate if magnetic resonance spectroscopy (MRS) is the best Magnetic Resonance (MR)-based method when compared to gradient-echo magnetic resonance imaging (MRI) for the detection and quantification of liver steatosis in diabetic patients in the clinical practice using liver biopsy as the reference standard, and to assess the influence of steatohepatitis and fibrosis on liver fat quantification. Methods: Institutional approval and patient consent were obtained for this prospective study. Seventy-three patients with type 2 diabetes (60 women and 13 men; mean age, 5469 years) underwent MRI and MRS at 3.0 T. The liver fat fraction was calculated from triple-and multi-echo gradient-echo sequences, and MRS data. Liver specimens were obtained in all patients. The accuracy for liver fat detection was estimated by receiver operator characteristic (ROC) analysis, and the correlation between fat quantification by imaging and histolopathology was analyzed by Spearman's correlation coefficients. Results: The prevalence of hepatic steatosis was 92%. All gradient-echo MRI and MRS findings strongly correlated with biopsy findings (triple-echo, rho = 0.819; multi-echo, rho = 0.773; MRS, rho = 0.767). Areas under the ROC curves to detect mild, moderate, and severe steatosis were: triple-echo sequences, 0.961, 0.975, and 0.962; multi-echo sequences, 0.878, 0.979, and 0.961; and MRS, 0.981, 0.980, and 0.954. The thresholds for mild, moderate, and severe steatosis were: triple-echo sequences, 4.09, 9.34, and 12.34, multi-echo sequences, 7.53, 11.75, and 15.08, and MRS, 1.71, 11.69, and 14.91. Quantification was not significantly influenced by steatohepatitis or fibrosis. Conclusions: Liver fat quantification by MR methods strongly correlates with histopathology. Due to the wide availability and easier post-processing, gradient-echo sequences may represent the best imaging method for the detection and quantification of liver fat fraction in diabetic patients in the clinical practice.	[Parente, Daniella Braz; Rodrigues, Rosana Souza; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Eiras-Araujo, Antonio Luis; Alvarenga Americano do Brasil, Pedro Emmanuel; Perez, Renata de Mello] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Parente, Daniella Braz; Rodrigues, Rosana Souza; Eiras-Araujo, Antonio Luis; Perez, Renata de Mello] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Machado-Silva, Lilian; Ferreira Campos, Carlos Frederico; Gomes, Marilia de Brito; Perez, Renata de Mello] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Paiva, Fernando Fernandes] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil; [Lanzoni, Valeria] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Garteiser, Philippe] Univ Paris Diderot Sorbonne, Paris, France	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); UDICE-French Research Universities; Universite Paris Cite	Parente, DB (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.	daniella.parente@gmail.com	Rodrigues, Rosana Souza/N-9866-2013; Garteiser, Philippe/P-5719-2017; Brasil, Pedro E A A/B-4357-2008; Paiva, Fernando F/C-1429-2012; Parente, Daniella/AAP-7677-2020	Rodrigues, Rosana Souza/0000-0002-9952-3834; Garteiser, Philippe/0000-0003-0157-8851; Brasil, Pedro E A A/0000-0002-6700-2268; Paiva, Fernando F/0000-0002-8989-9707; Parente, Daniella/0000-0003-0031-5785; GOMES, MARILIA/0000-0003-4458-4741	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by the D'Or Institute for Research and Education and by FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2010, AM J GASTROENTEROL, V105, P1567, DOI 10.1038/ajg.2010.18; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Kim H, 2008, MAGN RESON MED, V59, P521, DOI 10.1002/mrm.21561; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Loomba R, 2012, HEPATOLOGY; Ma XZ, 2009, RADIOGRAPHICS, V29, P1253, DOI 10.1148/rg.295085186; Mashhood A, 2012, J MAGN RESON IMAGING; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Noworolski SM, 2012, RADIOLOGY, V264, P88, DOI 10.1148/radiol.12110673; O'Regan DP, 2008, RADIOLOGY, V247, P550, DOI 10.1148/radiol.2472070880; Obuchowski NA, 2006, STAT MED, V25, P481, DOI 10.1002/sim.2228; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Qayyum A, 2009, CLIN IMAG, V33, P110, DOI 10.1016/j.clinimag.2008.06.036; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Reeder SB, 2009, J MAGN RESON IMAGING, V29, P1332, DOI 10.1002/jmri.21751; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Strauss S, 2007, AM J ROENTGENOL, V189, pW320, DOI 10.2214/AJR.07.2123; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tang A, 2013, RADIOLOGY, V267, P422, DOI 10.1148/radiol.12120896; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; van Werven JR, 2010, RADIOLOGY, V256, P159, DOI 10.1148/radiol.10091790; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666	47	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112574	10.1371/journal.pone.0112574	http://dx.doi.org/10.1371/journal.pone.0112574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426708	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400018
J	Belter, A; Gudanis, D; Rolle, K; Piwecka, M; Gdaniec, Z; Naskret-Barciszewska, MZ; Barciszewski, J				Belter, Agnieszka; Gudanis, Dorota; Rolle, Katarzyna; Piwecka, Monika; Gdaniec, Zofia; Naskret-Barciszewska, Miroslawa Z.; Barciszewski, Jan			Mature MiRNAs Form Secondary Structure, which Suggests Their Function beyond RISC	PLOS ONE			English	Article							MICRORNA BIOGENESIS; TARGET RECOGNITION; NUCLEAR EXPORT; EXPRESSION; BINDING; RNAS; INACTIVATION; SIGNATURE; TURNOVER; APTAMERS	The generally accepted model of the miRNA-guided RNA down-regulation suggests that mature miRNA targets mRNA in a nucleotide sequence-specific manner. However, we have shown that the nucleotide sequence of miRNA is not the only determinant of miRNA specificity. Using specific nucleases, T1, V1 and S1 as well as NMR, UV/Vis and CD spectroscopies, we found that miR-21, miR-93 and miR-296 can adopt hairpin and/or homoduplex structures. The secondary structure of those miRNAs in solution is a function of RNA concentration and ionic conditions. Additionally, we have shown that a formation of miRNA hairpin is facilitated by cellular environment. Looking for functional consequences of this observation, we have perceived that structure of these miRNAs resemble RNA aptamers, short oligonucleotides forming a stable 3D structures with a high affinity and specificity for their targets. We compared structures of anti-tenascin C (anti-Tn-C) aptamers, which inhibit brain tumor glioblastoma multiforme (GBM, WHO IV) and selected miRNA. A strong overexpression of miR-21, miR-93 as well Tn-C in GBM may imply some connections between them. The structural similarity of these miRNA hairpins and anti-Tn-C aptamers indicates that miRNAs may function also beyond RISC and are even more sophisticated regulators, that it was previously expected. We think that the knowledge of the miRNA structure may give a new insight into miRNA-dependent gene regulation mechanism and be a step forward in the understanding their function and involvement in cancerogenesis. This may improve design process of anti-miRNA therapeutics.	[Belter, Agnieszka; Gudanis, Dorota; Rolle, Katarzyna; Piwecka, Monika; Gdaniec, Zofia; Naskret-Barciszewska, Miroslawa Z.; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Barciszewski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Ul Noskowskiego 12-14, PL-61704 Poznan, Poland.	Jan.Barciszewski@ibch.poznan.pl	Gdaniec, Zofia/D-2649-2015; Belter, Agnieszka/W-6074-2018; Barciszewski, Jan/N-9283-2019	Gdaniec, Zofia/0000-0003-2955-1829; Belter, Agnieszka/0000-0001-7082-4986; Barciszewski, Jan/0000-0001-7766-5594; Rolle, Katarzyna/0000-0002-4175-2490; Gudanis, Dorota/0000-0001-5046-9761; Piwecka, Monika/0000-0003-4104-6577	National Science Centre [UMO-2012/05/N/NZ1/01919, NN401595538]; Innovative Economy Operational Programme [UDA-POIG.01.03.01-30-050/09-05]	National Science Centre(National Science Centre, Poland); Innovative Economy Operational Programme	Researchers were supported by: grant number: UMO-2012/05/N/NZ1/01919, funder: National Science Centre (https://www.ncn.gov.pl/?language=en), author who received the funding: AB; grant number: UDA-POIG.01.03.01-30-050/09-05, funder: Innovative Economy Operational Programme (https://www.poig.gov.pl/english/Strony/Introduction.aspx), author who received the funding: MB; grant number: NN401595538, funder: National Science Centre (https://www.ncn.gov.pl/?language=en), author who received the funding: KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary M, 2011, INT J COMP BIOL, V2, P35; Adilakshmi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039674; Aqil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074472; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARCISZEWSKA MZ, 1985, FEBS LETT, V192, P289, DOI 10.1016/0014-5793(85)80127-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cevec M, 2008, NUCLEIC ACIDS RES, V36, P2330, DOI 10.1093/nar/gkn088; Chen AK, 2014, P NATL ACAD SCI USA, V111, pE2676, DOI 10.1073/pnas.1408037111; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Das A.K., 2011, INT J AGR SCI, V3, P62; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; Gan HH, 2013, RNA, V19, P539, DOI 10.1261/rna.035691.112; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Godlewski J, 2012, CANCER RES, V68, P9125; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Held DM, 2006, FRONT BIOSCI-LANDMRK, V11, P89, DOI 10.2741/1782; Hicke BJ, 2001, J BIOL CHEM, V276, P48644, DOI 10.1074/jbc.M104651200; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Janas MM, 2012, RNA, V18, P2041, DOI 10.1261/rna.035675.112; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; King IN, 2014, J BIOL CHEM, V289, P14263, DOI 10.1074/jbc.M114.561902; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lambert NJ, 2011, NUCLEIC ACIDS RES, V39, P4827, DOI 10.1093/nar/gkr077; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maiti M, 2010, BIOCHEM BIOPH RES CO, V392, P572, DOI 10.1016/j.bbrc.2010.01.072; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nowakowski J, 1997, SEMIN VIROL, V8, P153, DOI 10.1006/smvy.1997.0118; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Piwecka M, 2011, CURR PHARM BIOTECHNO, V12, P1805, DOI 10.2174/138920111798377067; Ragan C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001090; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Schwarz DS, 2002, GENE DEV, V16, P1025, DOI 10.1101/gad.992502; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594738; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zardo G, 2012, BLOOD, V119, P4034, DOI 10.1182/blood-2011-08-371344; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	63	31	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113848	10.1371/journal.pone.0113848	http://dx.doi.org/10.1371/journal.pone.0113848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423301	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700073
J	Surma, MA; Szczepaniak, A; Kroliczewski, J				Surma, Michal A.; Szczepaniak, Andrzej; Kroliczewski, Jaroslaw			Comparative Studies on Detergent-Assisted Apocytochrome b(6) Reconstitution into Liposomal Bilayers Monitored by Zetasizer Instruments	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; CYTOCHROME B(6); TRANSBILAYER MOVEMENT; CYTOPLASMIC MEMBRANE; 2-DIMENSIONAL CRYSTALLIZATION; LIPID-MEMBRANES; SOLUBILIZATION; TRANSPORTER	The present paper is a systematic, comparative study on the reconstitution of an apocytochrome b(6) purified from a heterologous system using a detergent-free method and reconstitution into liposomes performed using three different detergents: SDS, Triton X-100 and DM, and two methods of detergent removal by dialysis and using Bio-Beads. The product size, its distribution and zeta potential, and other parameters were monitored throughout the process. We found that zeta potential of proteoliposomes is correlated with reconstitution efficiency and, as such, can serve as a quick and convenient quality control for reconstitution experiments. We also advocate using detergent-free protein purification methods as they allow for an unfettered choice of detergent for reconstitution, which is the most crucial factor influencing the final product parameters.	[Surma, Michal A.; Szczepaniak, Andrzej; Kroliczewski, Jaroslaw] Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Wroclaw	Kroliczewski, J (corresponding author), Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland.	jarekk@ibmb.uni.wroc.pl	Króliczewski, Jarosław/H-5930-2019; Surma, Michal/B-1955-2016	Króliczewski, Jarosław/0000-0002-5895-5104; Surma, Michal/0000-0001-7833-2214	University of Wroclaw, Poland; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	University of Wroclaw, Poland; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	This research was supported by the University of Wroclaw, Poland to AS. Publication fee was partially paid by the Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center) 2014-2018.	AMALOU Z, 1994, PLANT PHYSIOL, V106, P79, DOI 10.1104/pp.106.1.79; Arnold T., 2001, CURRENT PROTOCOLS PR; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Benes M, 2002, BIOL CHEM, V383, P337, DOI 10.1515/BC.2002.037; Boulter JM, 2001, PROTEIN EXPRES PURIF, V22, P337, DOI 10.1006/prep.2001.1440; CRAMER WA, 1994, CURR OPIN STRUC BIOL, V4, P536, DOI 10.1016/S0959-440X(94)90216-X; Dreher C, 2007, FEBS LETT, V581, P2647, DOI 10.1016/j.febslet.2007.05.007; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; EYTAN GD, 1982, BIOCHIM BIOPHYS ACTA, V694, P185, DOI 10.1016/0304-4157(82)90024-7; Freisleben HJ, 1995, CHEM PHYS LIPIDS, V78, P137, DOI 10.1016/0009-3084(95)02491-Z; Goni FM, 2000, BBA-BIOMEMBRANES, V1508, P51, DOI 10.1016/S0304-4157(00)00011-3; Hanke G, 1999, J EXP BOT, V50, P1715, DOI 10.1093/jexbot/50.341.1715; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HELENIUS A, 1981, EUR J BIOCHEM, V116, P27, DOI 10.1111/j.1432-1033.1981.tb05296.x; Hochstadt J, 1975, TRANSPORT, P117; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Ishijima S, 2012, BBA-BIOMEMBRANES, V1818, P2202, DOI 10.1016/j.bbamem.2012.04.015; John K, 2002, BIOPHYS J, V83, P1525, DOI 10.1016/S0006-3495(02)73922-2; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; JONAS A, 1971, BIOCHEMISTRY-US, V10, P4492, DOI 10.1021/bi00800a022; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; KRAGHHANSEN U, 1993, BIOCHEMISTRY-US, V32, P1648, DOI 10.1021/bi00057a032; Kroliczewski J, 2005, BIOCHEMISTRY-US, V44, P7570, DOI 10.1021/bi047422w; Kroliczewski J, 2002, BBA-PROTEINS PROTEOM, V1598, P177, DOI 10.1016/S0167-4838(02)00369-2; Kroliczewski J, 1999, THESIS U WROCLAW; Kroliczewski J, 2011, ACTA BIOCHIM POL, V58, P335; Kubelt J, 2002, BIOCHEMISTRY-US, V41, P5605, DOI 10.1021/bi0118714; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Perez JL, 2009, VACCINE, V27, P205, DOI 10.1016/j.vaccine.2008.10.052; Miller C., 1986, P257; MILSMANN MHW, 1978, BIOCHIM BIOPHYS ACTA, V512, P147, DOI 10.1016/0005-2736(78)90225-0; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Ollivon M, 2000, BBA-BIOMEMBRANES, V1508, P34, DOI 10.1016/S0304-4157(00)00006-X; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Pochini L, 2011, BIOCHEM J, V439, P227, DOI 10.1042/BJ20110544; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2; Scherphof GL, 1997, ADV DRUG DELIVER REV, V24, P179, DOI 10.1016/S0169-409X(96)00457-7; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; TORCHILIN V, 1990, LIPOSOMES PRACTICAL; Tunuguntla R, 2013, BIOPHYS J, V105, P1388, DOI 10.1016/j.bpj.2013.07.043; UENO M, 1984, BIOCHEMISTRY-US, V23, P3070, DOI 10.1021/bi00308a034; Wallgren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061452; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WEISER HB, 1950, J PHYS COLLOID CHEM, V54, P990, DOI 10.1021/j150481a003; Zak E, 1997, PLANTA, V201, P334, DOI 10.1007/s004250050075; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	55	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111341	10.1371/journal.pone.0111341	http://dx.doi.org/10.1371/journal.pone.0111341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423011	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700005
J	Vanhatalo, J; Vetemaa, M; Herrero, A; Aho, T; Tiilikainen, R				Vanhatalo, Jarno; Vetemaa, Markus; Herrero, Annika; Aho, Teija; Tiilikainen, Raisa			By-Catch of Grey Seals (Halichoerus grypus) in Baltic Fisheries-A Bayesian Analysis of Interview Survey	PLOS ONE			English	Article							SAFE TRAP-NET; GRAY	Baltic seals are recovering after a population decline. The increasing seal stocks cause notable damage to fisheries in the Baltic Sea, with an unknown number of seals drowning in fishing gear every year. Thus, sustainable seal management requires updated knowledge of the by-catch of seals-the number of specimens that die in fishing gear. We analyse the by-catch of grey seals (Halichoerus grypus) in Finland, Sweden, and Estonia in 2012. We collect data with interviews (35 in Finland, 54 in Sweden, and 72 in Estonia) and analyse them with a hierarchical Bayesian model. The model accounts for variability in seal abundance, seal mortality and fishing effort in different sub-areas of the Baltic Sea and allows us to predict the by-catch in areas where interview data was not available. We provide a detailed description of the survey design and interview methods, and discuss different factors affecting fishermen's motivation to report by-catch and how this may affect the results. Our analysis shows that the total yearly by-catch by trap and gill nets in Finland, Sweden and Estonia is, with 90% probability, more than 1240 but less than 2860; and the posterior median and mean of the total by-catch are 1550 and 1880 seals, respectively. Trap nets make about 88% of the total by-catch. However, results also indicate that in one of the sub-areas of this study, fishermen may have underreported their by-catch. Taking the possible underreporting into account the posterior mean of the total by-catch is between 2180 and 2380. The by-catch in our study area is likely to represent at least 90% of the total yearly grey seal by-catch in the Baltic Sea.	[Vanhatalo, Jarno] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Vetemaa, Markus] Univ Tartu, Estonian Marine Inst, EE-50090 Tartu, Estonia; [Herrero, Annika] Finnish Game & Fisheries Res Inst, Helsinki, Finland; [Aho, Teija] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden; [Tiilikainen, Raisa] Metsahallitus, Savonlinna, Finland	University of Helsinki; University of Tartu; Estonian Marine Institute; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences	Vanhatalo, J (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	jarno.vanhatalo@helsinki.fi	Vanhatalo, Jarno/H-4435-2012	Vanhatalo, Jarno/0000-0002-6831-0211	Academy of Finland [266349]; Estonian state [SF0180005s10]; INTERREG project ECOSEAL	Academy of Finland(Academy of Finland); Estonian state; INTERREG project ECOSEAL	This work was supported by the Academy of Finland (grant 266349, http://www.aka.fi, to JV), Estonian state financed project SF0180005s10 to MV, and INTERREG project ECOSEAL, (http://www.ecosealproject.eu/, to JV, MV, AH, TA, and RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2012, MONITORING GAME ABUN; [Anonymous], 2013, TEXTS STAT SCI SERIE; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Dmitrieva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067074; Gilks E.B.W.R, 1996, MARKOV CHAIN MONTE C; Harding KC, 1999, AMBIO, V28, P619; HELCOM, 2006, HELCOM REC; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Hiby L., 2007, NAMMCO SCI PUBL, V6, P163, DOI [10.7557/3.2731, DOI 10.7557/3.2731]; Karamanlidis Alexandros A., 2008, Endangered Species Research, V5, P205, DOI 10.3354/esr00092; Konigson S., 2010, J NW ATLANTIC FISHER, V42, P41, DOI DOI 10.2960/J.V42.M654; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Lunneryd SG, 2005, ICES CM X 04; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Ojaveer E, 2008, J MARINE SYST, V74, P672, DOI 10.1016/j.jmarsys.2008.07.001; Sipil? T., 2003, THESIS U HELSINKI; Suuronen P, 2006, FISH RES, V79, P129, DOI 10.1016/j.fishres.2006.02.014; Varjopuro R, 2011, MAR POLICY, V35, P450, DOI 10.1016/j.marpol.2010.10.023	18	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113836	10.1371/journal.pone.0113836	http://dx.doi.org/10.1371/journal.pone.0113836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423168	gold, Green Published			2022-12-27	WOS:000345899700071
J	Hou, PF; Kuo, CY; Cheng, CT; Liou, JP; Ann, DK; Chen, Q				Hou, Peifeng; Kuo, Ching-Ying; Cheng, Chun-Ting; Liou, Jing-Ping; Ann, David K.; Chen, Qiang			Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1 alpha by Inhibiting Prolyl-4-Hydroxylase PHD2	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE; FACTOR-I; PROLYL HYDROXYLASES; HIF-ALPHA; LIFE-SPAN; HIF-1-ALPHA; CANCER; DEGRADATION; PROTEIN; DESTABILIZATION	Hypoxia-inducible factor 1 alpha (HIF-1 alpha), a major mediator of tumor physiology, is activated during tumor progression, and its abundance is correlated with therapeutic resistance in a broad range of solid tumors. The accumulation of HIF-1 alpha is mainly caused by hypoxia or through the mutated succinate dehydrogenase A (SDHA) or fumarate hydratase (FH) expression to inhibit its degradation. However, its activation under normoxic conditions, termed pseudohypoxia, in cells without mutated SDHA or FH is not well documented. Here, we show that dimethyl-2-ketoglutarate (DKG), a cell membrane-permeable precursor of a key metabolic intermediate, alpha-ketoglutarate (alpha-KG), known for its ability to rescue glutamine deficiency, transiently stabilized HIF-1 alpha by inhibiting activity of the HIF prolyl hydroxylase domain-containing protein, PHD2. Consequently, prolonged DKG-treatment under normoxia elevated HIF-1 alpha abundance and up-regulated the expression of its downstream target genes, thereby inducing a pseudohypoxic condition. This HIF-1 alpha stabilization phenotype is similar to that from treatment of cells with desferrioxamine (DFO), an iron chelator, or dimethyloxalyglycine (DMOG), an established PHD inhibitor, but was not recapitulated with other alpha-KG analogues, such as Octyl-2KG, MPTOM001 and MPTOM002. Our study is the first example of an alpha-KG precursor to increase HIF-1 alpha abundance and activity. We propose that DKG acts as a potent HIF-1 alpha activator, highlighting the potential use of DKG to investigate the contribution of PHD2-HIF-1 alpha pathway to tumor biology.	[Hou, Peifeng; Kuo, Ching-Ying; Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA; [Hou, Peifeng; Chen, Qiang] Fujian Med Univ, Union Hosp, Dept Oncol, Fuzhou, Fujian, Peoples R China; [Kuo, Ching-Ying; Cheng, Chun-Ting; Ann, David K.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Beckman Res Inst, Duarte, CA USA; [Hou, Peifeng; Chen, Qiang] Fujian Key Lab Translat Canc Med, Fuzhou, Fujian, Peoples R China; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan	City of Hope; Beckman Research Institute of City of Hope; Fujian Medical University; City of Hope; Beckman Research Institute of City of Hope; Taipei Medical University	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA.	dann@coh.org; cqiang8@189.cn	chen, qiang/HGU-5418-2022; chen, qiang/GWZ-7308-2022	KUO, CHING-YING/0000-0003-1555-3057	National Institutes of Health Research [R01DE10742, R01DE14183]; The Mary Kay Foundation [005-13]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Mary Kay Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health Research Grants R01DE10742 and R01DE14183 and The Mary Kay Foundation Research Grant number 005-13 (to D.K.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Clavijo C, 2007, AM J PHYSIOL-CELL PH, V292, pC2150, DOI 10.1152/ajpcell.00425.2006; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang X, 2010, ONCOGENE, V29, P5568, DOI 10.1038/onc.2010.297; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kwon SJ, 2005, CLIN CANCER RES, V11, P4694, DOI 10.1158/1078-0432.CCR-04-2530; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Lin TC, 2012, AUTOPHAGY, V8, P1477, DOI 10.4161/auto.21228; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rzeski W, 2012, SCAND J GASTROENTERO, V47, P565, DOI 10.3109/00365521.2012.660539; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; TAIT L, 1990, CANCER RES, V50, P6087; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; WANG GL, 1993, BLOOD, V82, P3610; Warfel NA, 2013, CELL CYCLE, V12, P3689, DOI 10.4161/cc.26930; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Zhang N, CELL METABOLISM, V11, P364; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113865	10.1371/journal.pone.0113865	http://dx.doi.org/10.1371/journal.pone.0113865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420025	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900075
J	Porfirio, LL; Harris, RMB; Lefroy, EC; Hugh, S; Gould, SF; Lee, G; Bindoff, NL; Mackey, B				Porfirio, Luciana L.; Harris, Rebecca M. B.; Lefroy, Edward C.; Hugh, Sonia; Gould, Susan F.; Lee, Greg; Bindoff, Nathaniel L.; Mackey, Brendan			Improving the Use of Species Distribution Models in Conservation Planning and Management under Climate Change	PLOS ONE			English	Article							EXTINCTION RISK; IMPACTS; UNCERTAINTIES; PROJECTIONS; PREDICTION; ENSEMBLE; SELECTION; RESERVE; AREAS; QUANTIFICATION	Choice of variables, climate models and emissions scenarios all influence the results of species distribution models under future climatic conditions. However, an overview of applied studies suggests that the uncertainty associated with these factors is not always appropriately incorporated or even considered. We examine the effects of choice of variables, climate models and emissions scenarios can have on future species distribution models using two endangered species: one a short-lived invertebrate species (Ptunarra Brown Butterfly), and the other a long-lived paleo-endemic tree species (King Billy Pine). We show the range in projected distributions that result from different variable selection, climate models and emissions scenarios. The extent to which results are affected by these choices depends on the characteristics of the species modelled, but they all have the potential to substantially alter conclusions about the impacts of climate change. We discuss implications for conservation planning and management, and provide recommendations to conservation practitioners on variable selection and accommodating uncertainty when using future climate projections in species distribution models.	[Porfirio, Luciana L.; Hugh, Sonia] Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia; [Harris, Rebecca M. B.; Lee, Greg; Bindoff, Nathaniel L.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Lefroy, Edward C.] Univ Tasmania, Ctr Environm, Hobart, Tas, Australia; [Gould, Susan F.; Mackey, Brendan] Griffith Univ, Griffith Climate Change Response Program, Gold Coast, Qld, Australia; [Bindoff, Nathaniel L.] Australia Res Council, Ctr Excellence Climate Syst Sci, Hobart, Tas, Australia; [Bindoff, Nathaniel L.] Commonwealth Sci & Ind Res Org, Oceans & Atmosphere Flagship, Hobart, Tas, Australia	Australian National University; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Porfirio, LL (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Coll Med Biol & Environm, Canberra, ACT, Australia.	Luciana.Porfirio@anu.edu.au	Bindoff, Nathaniel L/C-8050-2011; Lefroy, Ted/J-7144-2014; Mackey, Brendan/ABE-3805-2020; Gould, Sue/AAY-6889-2021; Gould, Sue/T-6979-2019; Harris, Rebecca/N-2790-2013	Bindoff, Nathaniel L/0000-0001-5662-9519; Lefroy, Ted/0000-0002-3164-8948; Mackey, Brendan/0000-0003-1996-4064; Harris, Rebecca/0000-0002-6426-2179	Australian Government's National Environmental Research Programme	Australian Government's National Environmental Research Programme(Australian Government)	This research is an output from the Landscapes and Policy Research Hub. The hub is supported through funding from the Australian Government's National Environmental Research Programme and involves researchers from the University of Tasmania (UTAS), The Australian National University (ANU), Murdoch University, the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC), Griffith University and Charles Sturt University (CSU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WORLDCLIM INTERPOLAT; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barrows CW, 2010, BIOL CONSERV, V143, P731, DOI 10.1016/j.biocon.2009.12.013; Bateman BL, 2012, DIVERS DISTRIB, V18, P861, DOI 10.1111/j.1472-4642.2012.00922.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Bradley BA, 2010, ECOGRAPHY, V33, P198, DOI 10.1111/j.1600-0587.2009.05684.x; Bradley BA, 2009, RESTOR ECOL, V17, P715, DOI 10.1111/j.1526-100X.2009.00586.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P196, DOI 10.1111/j.1365-2486.2008.01709.x; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Corney S., 2010, CLIMATE FUTURES TASM; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Flower A, 2013, ENVIRON SCI POLICY, V26, P63, DOI 10.1016/j.envsci.2012.07.024; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Harris RMB, 2013, ECOLOGICAL MANAGEMEN, V14; Harris RMB, 2014, CLIMATE PROJECTIONS; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, CONTRIBUTION WORKING; Januchowski SR, 2010, INT J GEOGR INF SCI, V24, P1327, DOI 10.1080/13658811003591680; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Kriticos DJ, 1999, PEOPLE AND RANGELANDS BUILDING THE FUTURE, VOLS 1 AND 2, P870; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Li YP, 2009, CLIM RES, V39, P31, DOI 10.3354/cr00797; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Meehl GA, 2007, B AM METEOROLOGICAL, V88; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004; Pyke CR, 2005, BIOL CONSERV, V121, P429, DOI 10.1016/j.biocon.2004.05.019; R Development Core Team, 2005, R LANG ENV STAT COMP; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Rosentrater LD, 2010, WIRES CLIM CHANGE, V1, P253, DOI 10.1002/wcc.32; Shabani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094867; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Shoo L. P., 2011, SDMTOOLS SPECIES DIS; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tellez-Valdes O, 2003, CONSERV BIOL, V17, P846, DOI 10.1046/j.1523-1739.2003.01622.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weaver CP, 2013, WIRES CLIM CHANGE, V4, P39, DOI 10.1002/wcc.202; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Xu T., 2011, ANUCLIM VERSION 6 1; Yang GJ, 2006, AM J TROP MED HYG, V75, P549, DOI 10.4269/ajtmh.2006.75.549	64	192	203	10	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113749	10.1371/journal.pone.0113749	http://dx.doi.org/10.1371/journal.pone.0113749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420020	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900068
J	Jin, X; Ouyang, ZB; Wang, Q; Lin, M; Wen, GH; Wang, JJ				Jin, Xin; Ouyang, Zhengbiao; Wang, Qiong; Lin, Mi; Wen, Guohua; Wang, Jingjing			Highly Compact Circulators in Square-Lattice Photonic Crystal Waveguides	PLOS ONE			English	Article							MICROWAVE DIELECTRIC-PROPERTIES; CAVITY	We propose, demonstrate and investigate highly compact circulators with ultra-low insertion loss in square-lattice-square-rod-photonic-crystal waveguides. Only a single magneto-optical square rod is required to be inserted into the cross center of waveguides, making the structure very compact and ultra efficient. The square rods around the center defect rod are replaced by several right-angled-triangle rods, reducing the insertion loss further and promoting the isolations as well. By choosing a linear-dispersion region and considering the mode patterns in the square magneto-optical rod, the operating mechanism of the circulator is analyzed. By applying the finite-element method together with the Nelder-Mead optimization method, an extremely low insertion loss of 0.02 dB for the transmitted wave and ultra high isolation of 46 dB similar to 48 dB for the isolated port are obtained. The idea presented can be applied to build circulators in different wavebands, e. g., microwave or Tera-Hertz.	[Jin, Xin; Ouyang, Zhengbiao; Wang, Qiong; Lin, Mi; Wen, Guohua; Wang, Jingjing] Shenzhen Univ, Coll Elect Sci & Technol, THz Tech Res Ctr, Shenzhen Key Lab Micronano Photon Informat Techno, Shenzhen 518060, Peoples R China	Shenzhen University	Ouyang, ZB (corresponding author), Shenzhen Univ, Coll Elect Sci & Technol, THz Tech Res Ctr, Shenzhen Key Lab Micronano Photon Informat Techno, Shenzhen 518060, Peoples R China.	zbouyang@szu.edu.cn	Ouyang, Zhengbiao/G-8630-2012; WANG, JINGYI/GSJ-1241-2022; Jin, Xin/ABA-3547-2021; wang, jing/GRS-7509-2022	Ouyang, Zhengbiao/0000-0002-1466-7813; Jin, Xin/0000-0001-5858-6217; 	NSFC [61275043, 60877034, 61307048, 61171006]; Guangdong Province NSF [82518060-01000004]; Shenzhen Science Bureau [200805, CXB201105050064A, JCYJ20120613115000529]	NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Province NSF; Shenzhen Science Bureau	This work is supported by the NSFC (Grant No.: 61275043, 60877034, 61307048, 61171006), the Guangdong Province NSF (Key project, Grant No.: 82518060-01000004), the Shenzhen Science Bureau (Grant No. 200805, CXB201105050064A, JCYJ20120613115000529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270; Dmitriev V, 2013, OPT LETT, V38, P4040, DOI 10.1364/OL.38.004040; Dmitriev V, 2013, OPT LETT, V38, P1016, DOI 10.1364/OL.38.001016; Dmitriev V, 2012, OPT LETT, V37, P3192, DOI 10.1364/OL.37.003192; Fan F, 2012, OPT COMMUN, V285, P3763, DOI 10.1016/j.optcom.2012.05.044; Gao FC, 2012, COMPUT OPTIM APPL, V51, P259, DOI 10.1007/s10589-010-9329-3; Ha JY, 2003, J EUR CERAM SOC, V23, P2413, DOI 10.1016/S0955-2219(03)00162-6; Jalas D, 2014, OPT LETT, V39, P1425, DOI 10.1364/OL.39.001425; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Jin X, 2013, OPT EXPRESS, V21, P25592, DOI 10.1364/OE.21.025592; Joannopoulos JD, 2011, PHOTONIC CRYSTALS MO, P193; Liu TL, 2014, OPT EXPRESS, V22, P8219, DOI 10.1364/OE.22.008219; Park HG, 2008, NAT PHOTONICS, V2, P622, DOI 10.1038/nphoton.2008.180; Pozar D. M., 2009, MICROWAVE ENG; Rashidi Arash, 2010, Journal of Electromagnetic Analysis and Applications, V2, P529, DOI 10.4236/jemaa.2010.29069; Sigalov M, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/016003; Sigalov M, 2008, PHYS LETT A, V372, P91, DOI 10.1016/j.physleta.2007.07.046; Wang Q, 2012, PHYS LETT A, V376, P646, DOI 10.1016/j.physleta.2011.11.032; Wang QO, 2011, J OPT SOC AM B, V28, P703, DOI 10.1364/JOSAB.28.000703; Wang Z, 2005, OPT LETT, V30, P1989, DOI 10.1364/OL.30.001989; Wang Z, 2005, APPL PHYS B-LASERS O, V81, P369, DOI 10.1007/s00340-005-1846-x; Yang QH, 2003, MATER CHEM PHYS, V79, P236, DOI 10.1016/S0254-0584(02)00284-5; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273	23	9	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113508	10.1371/journal.pone.0113508	http://dx.doi.org/10.1371/journal.pone.0113508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415417	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600053
J	Lee, MR; Shim, D; Yoon, J; Jang, HS; Oh, SW; Suh, SH; Choi, JH; Oh, GT				Lee, Mi-Ran; Shim, Dahee; Yoon, Jihye; Jang, Hyung Seok; Oh, Se-Woong; Suh, Suk Hyo; Choi, Jae-Hoon; Oh, Goo Taeg			Retnla Overexpression Attenuates Allergic Inflammation of the Airway	PLOS ONE			English	Article							RESISTIN-LIKE MOLECULE; INDUCED MITOGENIC FACTOR; TYPE-2 INFLAMMATION; LUNG INFLAMMATION; ACTIVATION; CELLS; EXPRESSION; ASTHMA; FIZZ1; MACROPHAGES	Resistin-like molecule alpha (Retnla), also known as ` Found in inflammatory zone 1', is a secreted protein that has been found in bronchoalveolar lavage (BAL) fluid of ovalbumin (OVA)-induced asthmatic mice and plays a role as a regulator of T helper (Th) 2-driven inflammation. However, the role of Retnla in the progress of Th2-driven airway inflammation is not yet clear. To better understand the function of Retnla in Th2driven airway inflammation, we generated Retnla-overexpressing (Retnla-Tg) mice. Retnla-Tg mice showed increased expression of Retnla protein in BAL fluid and airway epithelial cells. Retnla overexpression itself did not induce any alteration in lung histology or lung function compared to non-Tg controls. However, OVA-sensitized/ challenged Retnla-Tg mice had decreased numbers of cells in BAL and inflammatory cells accumulating in the lung. They also showed a reduction in mucus production in the airway epithelium, concomitant with a decreased Muc5ac level. These results were accompanied by reduced levels of Th2 cytokines, including interleukin (IL)-4, IL5, and IL-13, with no effect on levels of OVA-specific immunoglobulin isotypes. Furthermore, phosphorylation of ERK was markedly reduced in the lungs of OVAchallenged Retnla-Tg mice. Taken together, these results indicates that Retnla protects against Th2-mediated inflammation in an experimental mouse model of asthma, suggesting that therapeutic approaches to enhance the production of Retnla or Retnla-like molecules could be valuable for preventing allergic lung inflammation.	[Lee, Mi-Ran; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Shim, Dahee; Yoon, Jihye; Jang, Hyung Seok; Choi, Jae-Hoon] Hanyang Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Oh, Se-Woong] Yuhan Corp, Yuhan Res Inst, Yongin, Gyeonggi Do, South Korea; [Suh, Suk Hyo] Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea	Ewha Womans University; Hanyang University; Ewha Womans University	Choi, JH (corresponding author), Hanyang Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea.	jchoi75@hanyang.ac.kr; gootaeg@ewha.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Choi, Jae-Hoon/R-6224-2016	Choi, Jae-Hoon/0000-0002-5265-3463	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A3A2026454, 2010-0019866, 2013R1A1A1063441, 2013S1A2A2035348]; Hanyang University [HY-2012-N]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Hanyang University	Funding: This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (No. 2012R1A3A2026454 (GTO), No. 2010-0019866 (GTO), No. 2013R1A1A1063441 (JHC), No. 2013S1A2A2035348 (JHC), and the research fund of Hanyang University (HY-2012-N)(JHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen H, 2010, EUR RESPIR J, V36, P1165, DOI 10.1183/09031936.00097609; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Jackson AD, 2001, TRENDS PHARMACOL SCI, V22, P39, DOI 10.1016/S0165-6147(00)01600-X; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; Kumar A, 2003, FASEB J, V17, P1800, DOI 10.1096/fj.02-1148com; Kushiyama A, 2013, ARTERIOSCL THROM VAS, V33, P1986, DOI 10.1161/ATVBAHA.113.301546; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Madala SK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-51; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Munitz A, 2012, AM J RESP CELL MOL, V46, P703, DOI 10.1165/rcmb.2011-0391OC; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nava S, 1999, THORAX, V54, P390, DOI 10.1136/thx.54.5.390; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Wert SE, 2002, DEV BIOL, V242, P75, DOI 10.1006/dbio.2001.0540; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006; Yamaji-Kegan K, 2010, J IMMUNOL, V185, P5539, DOI 10.4049/jimmunol.0904021	42	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112666	10.1371/journal.pone.0112666	http://dx.doi.org/10.1371/journal.pone.0112666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415454	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600012
J	Ramos, L; del Rey, J; Daina, G; Garcia-Aragones, M; Armengol, L; Fernandez-Encinas, A; Parriego, M; Boada, M; Martinez-Passarell, O; Martorell, MR; Casagran, O; Benet, J; Navarro, J				Ramos, Laia; del Rey, Javier; Daina, Gemma; Garcia-Aragones, Manel; Armengol, Lluis; Fernandez-Encinas, Alba; Parriego, Monica; Boada, Montserrat; Martinez-Passarell, Olga; Rosa Martorell, Maria; Casagran, Oriol; Benet, Jordi; Navarro, Joaquima			Oligonucleotide Arrays vs. Metaphase-Comparative Genomic Hybridisation and BAC Arrays for Single-Cell Analysis: First Applications to Preimplantation Genetic Diagnosis for Robertsonian Translocation Carriers	PLOS ONE			English	Article							HUMAN EMBRYOS; CHROMOSOME-ABNORMALITIES; MICROARRAY ANALYSIS; PCR AMPLIFICATION; DNA-REPLICATION; S-PHASE; ANEUPLOIDY; PROFILES; REVEALS; BLASTOMERES	Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CGH) and array-CGH are available for single-cell analysis. However, while metaphase-CGH and BAC array-CGH have been widely used for Preimplantation Genetic Diagnosis, oligonucleotide array-CGH has not been used in an extensive way. A comparison between oligonucleotide array-CGH and metaphase-CGH has been performed analysing 15 single fibroblasts from aneuploid cell-lines and 18 single blastomeres from human cleavage-stage embryos. Afterwards, oligonucleotide array-CGH and BAC array-CGH were also compared analysing 16 single blastomeres from human cleavage-stage embryos. All three comprehensive analysis techniques provided broadly similar cytogenetic profiles; however, non-identical profiles appeared when extensive aneuploidies were present in a cell. Both array techniques provided an optimised analysis procedure and a higher resolution than metaphase-CGH. Moreover, oligonucleotide array-CGH was able to define extra segmental imbalances in 14.7% of the blastomeres and it better determined the specific unbalanced chromosome regions due to a higher resolution of the technique (approximate to 20 kb). Applicability of oligonucleotide array-CGH for Preimplantation Genetic Diagnosis has been demonstrated in two cases of Robertsonian translocation carriers 45, XY, der(13; 14)(q10;q10). Transfer of euploid embryos was performed in both cases and pregnancy was achieved by one of the couples. This is the first time that an oligonucleotide array-CGH approach has been successfully applied to Preimplantation Genetic Diagnosis for balanced chromosome rearrangement carriers.	[Ramos, Laia; del Rey, Javier; Daina, Gemma; Fernandez-Encinas, Alba; Benet, Jordi; Navarro, Joaquima] Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra 08193, Spain; [Garcia-Aragones, Manel; Armengol, Lluis] Qgen Lab, Barcelona 08003, Spain; [Parriego, Monica; Boada, Montserrat] Inst Univ Dexeus, Barcelona 08028, Spain; [Martinez-Passarell, Olga] Hosp Sant Pau & Santa Creu, Fundacio Puigvert, Barcelona 08025, Spain; [Rosa Martorell, Maria] Clin Girona, Unitat Reprod Humana & Diagnost Genet, Girona 17002, Spain; [Casagran, Oriol] CRAG, Genom Serv, Bellaterra 08193, Spain	Autonomous University of Barcelona; Fundacio Puigvert; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Navarro, J (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular & Genet Med, Bellaterra 08193, Spain.	Joaquima.Navarro@uab.cat	Benet, Jordi/I-1690-2017	Benet, Jordi/0000-0001-6185-2555; Ramos Masdeu, Laia/0000-0003-0869-8063; FERNANDEZ ENCINAS, ALBA/0000-0003-2701-4739; Daina Noves, Gemma/0000-0002-5285-6914; DEL REY AZPIRI, JAVIER/0000-0001-7887-7871; Navarro, Joaquima/0000-0002-9245-2260	Fondo de Investigaciones Sanitarias; Instituto Carlos III [PI 08/0012, PI 11/00625]; Grup de Suport a la Recerca of the Generalitat de Catalunya [2009SGR1107]; Universitat Autonoma de Barcelona; Qgenomics Laboratory	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto Carlos III(Instituto de Salud Carlos III); Grup de Suport a la Recerca of the Generalitat de Catalunya; Universitat Autonoma de Barcelona; Qgenomics Laboratory	Funding: This work was funded by the Fondo de Investigaciones Sanitarias, Instituto Carlos III (PI 08/0012, PI 11/00625) and Grup de Suport a la Recerca of the Generalitat de Catalunya (2009SGR1107). The first author had a pre-doctoral grant from the Universitat Autonoma de Barcelona. Qgenomics Laboratory provided support in the form of salaries for authors MG & LA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Alfarawati S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003025; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Barbash-Hazan S, 2009, FERTIL STERIL, V92, P890, DOI 10.1016/j.fertnstert.2008.07.1761; Bi WM, 2012, PRENATAL DIAG, V32, P10, DOI 10.1002/pd.2855; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Capalbo A, 2013, HUM REPROD, V28, P509, DOI 10.1093/humrep/des394; Cheng JQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r80; Daphnis DD, 2008, MOL HUM REPROD, V14, P117, DOI 10.1093/molehr/gam087; Dekel-Naftali M, 2013, J ASSIST REPROD GENE; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fiorentino F, 2011, HUM REPROD, V26, P1925, DOI 10.1093/humrep/der082; Fragouli E, 2010, FERTIL STERIL, V94, P875, DOI 10.1016/j.fertnstert.2009.04.053; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; Gianaroli L, 2002, HUM REPROD, V17, P3201, DOI 10.1093/humrep/17.12.3201; Gutierrez-Mateo C, 2004, HUM REPROD, V19, P2859, DOI 10.1093/humrep/deh515; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hellani A, 2008, REPROD BIOMED ONLINE, V17, P841, DOI 10.1016/S1472-6483(10)60413-0; Liang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061838; Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362; Moore DH, 1997, CYTOMETRY, V28, P183, DOI 10.1002/(SICI)1097-0320(19970701)28:3<183::AID-CYTO1>3.0.CO;2-F; Northrop LE, 2010, MOL HUM REPROD, V16, P590, DOI 10.1093/molehr/gaq037; Ramos L, 2014, FERTIL STERIL, V101, P488, DOI 10.1016/j.fertnstert.2013.10.031; Ribas-Maynou J, 2012, HUM REPROD, V27, P652, DOI 10.1093/humrep/der461; Ribas-Maynou J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044679; Rius M, 2010, HUM REPROD, V25, P1824, DOI 10.1093/humrep/deq118; Rius M, 2011, FERTIL STERIL, V96, P134, DOI 10.1016/j.fertnstert.2011.04.052; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; Traversa MV, 2011, REPROD BIOL, V11, P51; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Van der Aa N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1352; van Echten-Arends J, 2011, HUM REPROD UPDATE, V17, P620, DOI 10.1093/humupd/dmr014; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wells D, 1999, NUCLEIC ACIDS RES, V27, P1214, DOI 10.1093/nar/27.4.1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113223	10.1371/journal.pone.0113223	http://dx.doi.org/10.1371/journal.pone.0113223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415307	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600033
J	Usami, M; Iwadare, Y; Watanabe, K; Kodaira, M; Ushijima, H; Tanaka, T; Harada, M; Tanaka, H; Sasaki, Y; Okamoto, S; Sekine, K; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Kodaira, Masaki; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Okamoto, Seiko; Sekine, Keisuke; Saito, Kazuhiko			Prosocial Behaviors during School Activities among Child Survivors after the 2011 Earthquake and Tsunami in Japan: A Retrospective Observational Study	PLOS ONE			English	Article							POSTTRAUMATIC SYMPTOMS; QUESTIONNAIRE	Background: The 2011 Japan massive tsunami traumatized many children. The aim of this study was to assess changes in strengths and difficulties experienced in home and school by among surviving children after the 2011 tsunami, in comparison with published normal Japanese data. Methods: In November 2012 (20 months after the disaster) and September 2013 (30 months after the disaster), the Strengths and Difficulties Questionnaire (SDQ), a questionnaire on children's strengths and difficulties in home and school activities, were distributed to 12,193 and 11,819 children, respectively. An effective response of children 20 months and 30 month after the disaster was obtained in 10,597 children (86.9%), and 10,812 children (91.4%), respectively. The SDQ scores evaluated by parents and teachers were compared with published normal Japanese SDQ scores. Results: The SDQ scores (emotional problems, conduct problems, hyperactivity/inattention, peer relationship problems, and total difficulty score) evaluated by parents of children in the 4th to 9th grade who were evaluated after 30 and 20 months were significantly high compared with the published normal data of children without traumatic experiences (all P<0.001). The SDQ scores (prosocial behavior) evaluated by teachers of children in the 4th to 9th grade who were evaluated after 30 and 20 months were significantly low compared with the published normal data of children without traumatic experiences (all P<0.001). Conclusions: This study showed that the experience of the disaster affected those children with prosocial behaviors towards teachers and friends at school. However, no significant changes (in their prosocial attitude) had been seen at home, where they continued to keep their respect and caring feelings for parents. These results indicate that for accurate diagnosis, clinicians should not only evaluate these children's daily activities at home but also try to objectively assess their daily activities at school.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya; Okamoto, Seiko; Sekine, Keisuke] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Imperial Gift Fdn, Dept Child Mental Hlth, Tokyo, Japan; [Harada, Maiko] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Yamaguchi, Japan; [Tanaka, Hiromi] Tokyo Womens Med Univ, Inst Womens Hlth, Tokyo, Japan; [Sasaki, Yoshinori] Tokyo Metropolitan Tama Med Ctr, Dept Psychiat, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Saiseikai Imperial Gift Foundation, Inc.; Yamaguchi University; Tokyo Women's Medical University	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan.	usami.masahide@hospk.ncgm.go.jp	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971	National Center for Global Health and Medicine [24-108]; Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki Rotary Club; Yaohigashi Rotary Club; Tokuyama Rotary Club	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki Rotary Club; Yaohigashi Rotary Club; Tokuyama Rotary Club	This work was supported by grants from the National Center for Global Health and Medicine (24-108); Soroptimist International of the Americas Japan Shimomatsu Region; and Ishinomaki, Yaohigashi, and Tokuyama Rotary Clubs. The funders were not involved in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Coghill David, 2008, Child Adolesc Psychiatry Ment Health, V2, P31, DOI 10.1186/1753-2000-2-31; Dyb Grete, 2011, Clin Child Psychol Psychiatry, V16, P621, DOI 10.1177/1359104510391048; Endo T, 2009, PSYCHIAT CLIN NEUROS, V63, P253, DOI 10.1111/j.1440-1819.2008.01914.x; Hafstad GS, 2011, PSYCHOL TRAUMA-US, V3, P130, DOI 10.1037/a0023236; Iwadare Y, 2014, J PEDIATR-US, V164, P917, DOI 10.1016/j.jpeds.2013.11.061; Iwadare Y, 2014, SLEEP BIOL RHYTHMS, V12, P53, DOI 10.1111/sbr.12047; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Kadak MT, 2013, EUR PSYCHIAT, V28; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; Kato Yutaka, 2012, Keio Journal of Medicine, V61, P15, DOI 10.2302/kjm.61.15; Kim BN, 2009, J CLIN PSYCHIAT, V70, P1148, DOI 10.4088/JCP.08m04896; Kuwabara H, 2014, BRAIN DEV, V53, P157, DOI [10.1016/j.jpsychires.2014.01.015, DOI 10.1016/J.JPSYCHIRES.2014.01.015]; Kuwabara H, 2015, BRAIN DEV-JPN, V37, P130, DOI 10.1016/j.braindev.2014.02.003; Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Ministry of Health L Welfare, STRENGTHS DIFF QUEST; Moriwaki A, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-1; Mullett-Hume E, 2008, AM J ORTHOPSYCHIAT, V78, P103, DOI 10.1037/0002-9432.78.1.103; Osawa M, 2013, BRAIN DEV-JPN, V35, P188, DOI 10.1016/j.braindev.2012.07.006; Piyasil V, 2008, ASEAN J PSYCHIAT, V9, P1; Piyasil V, 2008, ASEAN J PSYCHIATR, V9, P99; Tominaga Y, 2002, HATTATSU SHINRI RINS, V8, p29.36; Uemoto M, 2012, INT J BEHAV MED, V19, P243, DOI 10.1007/s12529-011-9184-3; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096459; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088885; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; Usami M, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-11; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; Weisz J.R., 2001, EUROPEAN CHILD ADOLE, V10, P12, DOI DOI 10.1007/S007870170003; Wiguna T, 2010, ASIA-PAC PSYCHIAT, V2, P151, DOI 10.1111/j.1758-5872.2010.00079.x	33	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113709	10.1371/journal.pone.0113709	http://dx.doi.org/10.1371/journal.pone.0113709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415450	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600073
J	Bonner, K; Siemieniuk, RA; Boozary, A; Roberts, T; Fajardo, E; Cohn, J				Bonner, Kimberly; Siemieniuk, Reed A.; Boozary, Andrew; Roberts, Teri; Fajardo, Emmanuel; Cohn, Jennifer			Expanding Access to HIV Viral Load Testing: A Systematic Review of RNA Stability in EDTA Tubes and PPT beyond Current Time and Temperature Thresholds	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS RNA; PLASMA; STORAGE; QUALITY; BLOOD; GRADE	Background: HIV viral load (VL) testing is the gold standard for antiretroviral treatment monitoring, but many barriers exist to VL testing in resource-limited settings, including storage and transport limitations for whole blood and plasma. Data from various studies indicate that HIV RNA is stable beyond current recommendations. We conducted a systematic review to assess stability data of HIV RNA in whole blood and plasma across times and temperatures. Methods and Findings: Using a pre-defined protocol, five databases were searched for studies where blood samples from HIV patients were stored at time and temperature points that exceeded manufacturer recommendations. RNA stability, the primary outcome, was measured by the difference in means compared to samples stored within established thresholds. RNA stability was defined as <= 0.5 log degradation. The search identified 10,716 titles, of which nine full-text articles were included for review. HIV RNA maintained stability in EDTA whole blood and plasma at all measured time points up to 168 hours when stored at 4 degrees C, while stability was detected at 72 hours (95% confidence) in whole blood at 25 degrees C, with data points before and beyond 72 hours suggesting stability but not reaching statistical significance. For EDTA plasma stored at 30 degrees C, stability was maintained up to 48 hours (95% confidence), with OLS linear regression estimates up to 127 hours, suggesting stability. Overall, quality of studies was moderate. Limitations included small sample sizes, few studies meeting inclusion criteria, and no studies examining RNA stability in low viremia (<3,000 copies/mL) environments. Conclusions: Whole blood and plasma samples in EDTA may remain stable under conditions exceeding current manufacturer recommendations for HIV VL testing. However, given the limited number of studies addressing this question, especially at low levels of viremia, additional evaluations on HIV RNA stability in EDTA tubes and PPT in field conditions are needed.	[Bonner, Kimberly; Roberts, Teri; Cohn, Jennifer] Medecins Sans Frontieres, Access Campaign, Geneva, Switzerland; [Siemieniuk, Reed A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Boozary, Andrew] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Fajardo, Emmanuel] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Cohn, Jennifer] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	Doctors Without Borders; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Bonner, K (corresponding author), Medecins Sans Frontieres, Access Campaign, Geneva, Switzerland.	Kimberly.Bonner@msf.org		Bonner, Kimberly/0000-0002-6942-4050	UNITAID	UNITAID	UNITAID provided a grant to Doctors without Borders to demonstrate the feasibility and cost-effectiveness of viral load monitoring and CD4 testing in decentralized areas, including research and implementation establishing best practices. (More information on the grant can be accessed here: http://www.unitaid.eu/en/cd4.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action P., 2013, POOR PEOPLES ENERGY; *AFR SOC LAB MED, 2013, EXP CONS VIR LOAD MO; Amellal B, 2008, HIV MED, V9, P790, DOI 10.1111/j.1468-1293.2008.00632.x; Amellal B, 2007, HIV MED, V8, P396, DOI 10.1111/j.1468-1293.2007.00484.x; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; *BECT DICK CO, 2011, UPD PROD INF BD VAC; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bruisten SM, 1997, J VIROL METHODS, V67, P199, DOI 10.1016/S0166-0934(97)00097-9; Dickover RE, 1998, J CLIN MICROBIOL, V36, P1070, DOI 10.1128/JCM.36.4.1070-1073.1998; Gessoni G, 2004, TRANSFUS APHER SCI, V30, P197, DOI 10.1016/j.transci.2003.11.010; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Halpern S.H., 2005, APPENDIX JADAD SCALE, P237; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Holguin A, 1997, Antivir Ther, V2, P265; HOLODNIY M, 1995, J CLIN MICROBIOL, V33, P1562, DOI 10.1128/JCM.33.6.1562-1566.1995; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Kim SH, 2014, AIDS, V28, P1945, DOI 10.1097/QAD.0000000000000316; Kirstein LM, 1999, J CLIN MICROBIOL, V37, P2428, DOI 10.1128/JCM.37.8.2428-2433.1999; METCALF C, 2014, 1 HIV VIRAL LOAD IMP; Mtapuri-Zinyowera S., 2013, 7 IAS C HIV PATH TRE; Portman MD, 2012, HIV MED, V13, P578, DOI 10.1111/j.1468-1293.2012.01016.x; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; Vandamme AM, 1999, EUR J CLIN INVEST, V29, P445; *WHO, TEXTB 7 3 MON RESP A	29	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113813	10.1371/journal.pone.0113813	http://dx.doi.org/10.1371/journal.pone.0113813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437009	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900081
J	He, S; Feng, M; Liu, M; Yang, SB; Yan, S; Zhang, W; Wang, ZZ; Hu, CF; Xu, Q; Chen, LC; Zhu, HX; Xu, NZ				He, Shun; Feng, Min; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi			P21-Activated Kinase 7 Mediates Cisplatin-Resistance of Esophageal Squamous Carcinoma Cells with Aurora-A Overexpression	PLOS ONE			English	Article							DOWN-REGULATION; GASTRIC-CANCER; OVARIAN-CANCER; C-MYC; PAK5; PROGRESSION; MIGRATION; BRAIN	Aurora-A overexpression is common in various types of cancers and has been shown to be involved in tumorigenesis through different signaling pathways, yet how the deregulation affects cancer therapeutics remains elusive. Here we showed that overexpression of Aurora-A rendered esophageal cancer cells resistance to cisplatin (CDDP) by inhibiting apoptosis. By using an apoptosis array, we identified a downstream gene, p21-activated kinase 7 (PAK7). PAK7 was upregulated by Aurora-A overexpression at both mRNA and protein levels. Importantly, the expression levels of Aurora-A and PAK7 were correlated in ESCC primary samples. Chromatin immunoprecipitation (ChIP) assay revealed that binding of E2F1 to the promoter of PAK7 was significantly enhanced upon Aurora-A activation, and knockdown of transcription factor E2F1 decreased PAK7 expression, suggesting that Aurora-A regulated PAK7 through E2F1. Furthermore, we demonstrated that PAK7 knockdown led to increased apoptosis, and Aurora-A-induced resistance to CDDP was reversed by downregulation of PAK7, suggesting PAK7 was a downstream player of Aurora-A that mediated chemoresistance of ESCC cells to CDDP. Our data suggest that PAK7 may serve as an attractive candidate for therapeutics in ESCC patients with Aurora-A abnormality.	[He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Feng, Min] Sichuan Univ, West China Womens & Childrens Hosp, West China Univ Hosp 2, Dept Pathol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Zhu, HX (corresponding author), Chinese Acad Med Sci, Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	drhxzhu@cicams.ac.cn; xningzhi@public.bta.net.cn	Liu, Mei/GWN-1774-2022; He, Shun/K-7448-2014; Chen, Lechuang/AAF-8351-2020		Beijing Natural Science Foundation [5102038]; National Natural Science Foundation [81321091, 81021061, 31171322]; Chinese Hi-Tech RD Program [2012AA02A503]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Hi-Tech RD Program	This work was supported by the Beijing Natural Science Foundation (5102038), National Natural Science Foundation (81321091, 81021061, 31171322), Chinese Hi-Tech R&D Program (2012AA02A503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Gong W, 2009, INT J CANCER, V125, P548, DOI 10.1002/ijc.24428; Gu J, 2013, FEBS J, V280, P46, DOI 10.1111/febs.12048; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; He S, 2010, CELL MOL LIFE SCI, V67, P2069, DOI 10.1007/s00018-010-0340-8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li DY, 2013, MOL CELL BIOCHEM, V383, P191, DOI 10.1007/s11010-013-1767-7; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Strochlic TI, 2012, P NATL ACAD SCI USA, V109, P4116, DOI 10.1073/pnas.1116560109; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Wang XX, 2013, TUMOR BIOL, V34, P2721, DOI 10.1007/s13277-013-0824-x; Wang YH, 2005, CANCER BIOL THER, V4, P974, DOI 10.4161/cbt.4.9.1914; Xu YP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-173; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907; Yang SB, 2010, EXP MOL MED, V42, P759, DOI 10.3858/emm.2010.42.11.077	27	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113989	10.1371/journal.pone.0113989	http://dx.doi.org/10.1371/journal.pone.0113989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436453	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900107
J	Iizuka, S; Oridate, N; Nashimoto, M; Fukuda, S; Tamura, M				Iizuka, Satoshi; Oridate, Nobuhiko; Nashimoto, Masayuki; Fukuda, Satoshi; Tamura, Masato			Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing	PLOS ONE			English	Article							HEPTAMER-TYPE SGRNA; PROGNOSTIC-SIGNIFICANCE; ANTISENSE; CANCER; EXPRESSION; PROLIFERATION; APOPTOSIS; TRNASE; OLIGODEOXYNUCLEOTIDES; TUMORIGENICITY	Head and neck squamous cell carcinoma (HNSCC) exhibits increased expression of cyclin D1 (CCND1). Previous studies have shown a correlation between poor prognosis of HNSCC and cyclin D1 overexpression. tRNase ZL-utilizing efficacious gene silencing (TRUE gene silencing) is one of the RNA-mediated gene expression control technologies that have therapeutic potential. This technology is based on a unique enzymatic property of mammalian tRNase ZL, which is that it can cleave any target RNA at any desired site by recognizing a pre-tRNA-like complex formed between the target RNA and an artificial small guide RNA (sgRNA). In this study, we designed several sgRNAs targeting human cyclin D1 mRNA to examine growth inhibition of HNSCC cells. Transfection of certain sgRNAs decreased levels of cyclin D1 mRNA and protein in HSC-2 and HSC-3 cells, and also inhibited their proliferation. The combination of these sgRNAs and cisplatin showed more than additive inhibition of cancer cell growth. These findings demonstrate that TRUE gene silencing of cyclin D1 leads to inhibition of the growth of HNSCC cells and suggest that these sgRNAs alone or combined with cisplatin may be a useful new therapy for HNSCCs.	[Iizuka, Satoshi; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Healthy Living, Niigata, Japan; [Tamura, Masato] Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Hokkaido University; Yokohama City University; Niigata University; Hokkaido University	Tamura, M (corresponding author), Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan.	mtamura@den.hokudai.ac.jp	Oridate, Nobuhiko/ABC-4116-2020; tamura, masato/B-7304-2009	Oridate, Nobuhiko/0000-0002-6968-3028; tamura, masato/0000-0003-3700-5203	JSPS [24592588]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the JSPS Grants-in-Aid for scientific research #24592588 (NO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 1997, CANCER RES, V57, P1569; Bali A, 2004, CLIN CANCER RES, V10, P5168, DOI 10.1158/1078-0432.CCR-03-0751; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Cagnoli M, 1998, GYNECOL ONCOL, V70, P372, DOI 10.1006/gyno.1998.5062; Driscoll B, 1997, AM J PHYSIOL-LUNG C, V273, pL941, DOI 10.1152/ajplung.1997.273.5.L941; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Higuchl E, 2007, HEAD NECK-J SCI SPEC, V29, P940, DOI 10.1002/hed.20632; Hung WC, 1996, BIOCHEM BIOPH RES CO, V220, P719, DOI 10.1006/bbrc.1996.0470; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; Oridate N, 2005, CANCER BIOL THER, V4, P318, DOI 10.4161/cbt.4.3.1504; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; Sauter ER, 1999, CANCER RES, V59, P4876; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schrump DS, 1996, CANCER GENE THER, V3, P131; Scott EN, 2009, CANCER CHEMOTH PHARM, V64, P425, DOI 10.1007/s00280-009-0968-y; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Takahashi M, 2014, LEUKEMIA RES, V38, P808, DOI 10.1016/j.leukres.2014.03.021; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Thomas GR, 2005, INT J EXP PATHOL, V86, P347, DOI 10.1111/j.0959-9673.2005.00447.x; TONKINSON JL, 1994, NUCLEIC ACIDS RES, V22, P4268, DOI 10.1093/nar/22.20.4268; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Volavsek M, 2003, J LARYNGOL OTOL, V117, P286, DOI 10.1258/00222150360600896; Wang MB, 1998, OTOLARYNG HEAD NECK, V119, P593, DOI 10.1016/S0194-5998(98)70017-8; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; ZHOU P, 1995, ONCOGENE, V11, P571	53	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114121	10.1371/journal.pone.0114121	http://dx.doi.org/10.1371/journal.pone.0114121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437003	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900121
J	Liu, HF; Chang, QL; Feng, WJ; Zhang, BG; Wu, T; Li, N; Yao, FY; Ding, XH; Chu, ZH				Liu, Haifeng; Chang, Qingle; Feng, Wenjie; Zhang, Baogang; Wu, Tao; Li, Ning; Yao, Fangyin; Ding, Xinhua; Chu, Zhaohui			Domain Dissection of AvrRxo1 for Suppressor, Avirulence and Cytotoxicity Functions	PLOS ONE			English	Article							ORYZAE-PV. ORYZAE; DISEASE-SUSCEPTIBILITY GENE; PAMP-TRIGGERED IMMUNITY; PROGRAMMED CELL-DEATH; XANTHOMONAS-ORYZAE; BACTERIAL-BLIGHT; III EFFECTORS; PROTEIN; PLANT; HOST	AvrRxo1, a type III effector from Xanthomonas oryzae pv. oryzicola (Xoc) which causes bacterial leaf streak (BLS) in rice, can be recognised by non-host resistance protein Rxo1. It triggers a hypersensitive response (HR) in maize. Little is known regarding the virulence function of AvrRxo1. In this study, we determined that AvrRxo1 is able to suppress the HR caused by the non-host resistance recognition of Xanthomonas oryzae pv. oryzae (Xoo) by Nicotiana benthamiana. It is toxic, inducing cell death from transient expression in N. benthamiana, as well as in yeast. Among the four AvrRxo1 alleles from different Xoc strains, we concluded that the toxicity is abolished by a single amino acid substitution at residue 344 in two AvrRxo1 alleles. A series of truncations from the carboxyl terminus (C-terminus) indicate that the complete C-terminus of AvrRxo1 plays an essential role as a suppressor or cytotoxic protein. The C-terminus was also required for the avirulence function, but the last two residues were not necessary. The first 52 amino acids of N-terminus are unessential for toxicity. Point mutagenesis experiments indicate that the ATP/GTP binding site motif A is required for all three functions of AvrRxo1, and NLS is required for both the avirulence and the suppression of non-host resistance. The putative thiol protease site is only required for the cytotoxicity function. These results determine that AvrRxo1 plays a role in the complex interaction with host proteins after delivery into plant cells.	[Liu, Haifeng; Chang, Qingle; Feng, Wenjie; Zhang, Baogang; Wu, Tao; Li, Ning; Ding, Xinhua; Chu, Zhaohui] Shandong Agr Univ, Shandong Prov Key Lab Agr Microbiol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Yao, Fangyin] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China	Shandong Agricultural University; Shandong Academy of Agricultural Sciences	Ding, XH (corresponding author), Shandong Agr Univ, Shandong Prov Key Lab Agr Microbiol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	xhding@sdau.edu.cn; zchu@sdau.edu.cn	ding, xinhua/AAV-2612-2020; Chu, Zhaohui/AAX-9925-2021	ding, xinhua/0000-0002-6510-5992; Zhang, Baogang/0000-0002-5448-0092	National Natural Science Foundation of China [3 0900050]; Ph.D. Programs Foundation of Ministry of Education of China [20093702120013]; Shandong Province Science Foundation for Youths [BS2010NY017]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201132]; Taishan Scholar of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shandong Province Science Foundation for Youths; Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Taishan Scholar of Shandong Province	This work was supported by National Natural Science Foundation of China (Grant No. 3 0900050) and Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20093702120013). XD was granted from Shandong Province Science Foundation for Youths (BS2010NY017) and Foundation for the Author of National Excellent Doctoral Dissertation of PR China (Grant No. 201132). ZC was granted from Taishan Scholar of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Ali GS, 2008, PLANT SIGNAL BEHAV, V3, P423, DOI 10.4161/psb.3.6.5472; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bahadur RP, 2014, J BIOMOL STRUCT DYN, V32, P669, DOI 10.1080/07391102.2013.787370; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; CHOI SH, 1994, MOL GEN GENET, V244, P383, DOI 10.1007/BF00286690; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cui YP, 2013, MOL PLANT PATHOL, V14, P678, DOI 10.1111/mpp.12039; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; [冯雯杰 Feng Wenjie], 2013, [植物病理学报, Acta Phytopathologica Sinica], V43, P581; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Guo Xiaoxia, 2010, Wei Sheng Wu Xue Bao, V50, P1155; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang L, 2004, MOL PLANT MICROBE IN, V17, P1328, DOI 10.1094/MPMI.2004.17.12.1328; Kang MJ, 2008, J MICROBIOL BIOTECHN, V18, P1492; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042796; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Makino S, 2006, MOL PLANT MICROBE IN, V19, P240, DOI 10.1094/MPMI-19-0240; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Sinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075867; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhao S, 2013, WORLD J MICROB BIOT, V29, P733, DOI 10.1007/s11274-012-1229-5; Zhu WG, 2000, J BACTERIOL, V182, P1844, DOI 10.1128/JB.182.7.1844-1853.2000	51	9	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113875	10.1371/journal.pone.0113875	http://dx.doi.org/10.1371/journal.pone.0113875			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437277	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900092
J	Stevens, AJ; Stuffrein-Roberts, S; Cree, SL; Gibb, A; Miller, AL; Doudney, K; Aitchison, A; Eccles, MR; Joyce, PR; Filichev, VV; Kennedy, MA				Stevens, Aaron J.; Stuffrein-Roberts, Selma; Cree, Simone L.; Gibb, Andrew; Miller, Allison L.; Doudney, Kit; Aitchison, Alan; Eccles, Michael R.; Joyce, Peter R.; Filichev, Vyacheslav V.; Kennedy, Martin A.			G-Quadruplex Structures and CpG Methylation Cause Drop-Out of the Maternal Allele in Polymerase Chain Reaction Amplification of the Imprinted MEST Gene Promoter	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCES; HUMAN PEG1/MEST; HUMAN GENOME; DNA METHYLATION; PCR ASSAY; IDENTIFICATION; MOTIFS; SERVER; CHROMOSOME-7; CYTOSINE	We observed apparent non-Mendelian behaviour of alleles when genotyping a region in a CpG island at the 59 end of the maternally imprinted human MEST isoform. This region contains three single nucleotide polymorphisms (SNPs) in total linkage disequilibrium, such that only two haplotypes occur in the human population. Only one haplotype was detectable in each subject, never both, despite the use of multiple primers and several genotyping methods. We observed that this region contains motifs capable of forming several G-quadruplex structures. Circular dichroism spectroscopy and native polyacrylamide gel electrophoresis confirmed that at least three G-quadruplexes form in vitro in the presence of potassium ions, and one of these structures has a Tm of greater than 99 degrees C in polymerase chain reaction (PCR) buffer. We demonstrate that it is the methylated maternal allele that is always lost during PCR amplification, and that formation of G-quadruplexes and presence of methylated cytosines both contributed to this phenomenon. This observed parent-of-origin specific allelic drop-out has important implications for analysis of imprinted genes in research and diagnostic settings.	[Stevens, Aaron J.; Stuffrein-Roberts, Selma; Cree, Simone L.; Gibb, Andrew; Miller, Allison L.; Doudney, Kit; Aitchison, Alan; Kennedy, Martin A.] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand; [Eccles, Michael R.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Joyce, Peter R.] Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand; [Filichev, Vyacheslav V.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	University of Otago; University of Otago; University of Otago; Massey University	Kennedy, MA (corresponding author), Univ Otago, Dept Pathol, Christchurch 8140, New Zealand.	martin.kennedy@otago.ac.nz	Doudney, Kit/Q-9728-2019; Stevens, Aaron J./Y-2145-2019; Kennedy, Martin/O-4540-2019; Kennedy, Martin A/A-4942-2008	Doudney, Kit/0000-0002-0089-1152; Stevens, Aaron J./0000-0001-9148-8045; Kennedy, Martin/0000-0002-6445-8526; Kennedy, Martin A/0000-0002-6445-8526; Miller, Allison/0000-0003-3816-2251; Filichev, Vyacheslav/0000-0002-7383-3025; Cree, Simone/0000-0002-7349-422X; Aitchison, Alan/0000-0002-0857-1815	Marsden Fund Council from New Zealand Government; Marsden Fund [11-UOO-175 BMS]	Marsden Fund Council from New Zealand Government(Royal Society of New ZealandMarsden Fund (NZ)); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Marsden Fund Council from New Zealand Government funding, administered by the Royal Society of New Zealand. Funding for open access charge was provided by Marsden Fund (11-UOO-175 BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boan F, 2004, FEBS LETT, V571, P112, DOI 10.1016/j.febslet.2004.06.062; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Bunyan DJ, 2011, OPEN J GENET, V1, P234; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; EHRLICH M, 1975, BIOCHIM BIOPHYS ACTA, V395, P109, DOI 10.1016/0005-2787(75)90149-5; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gill GE, 1974, BIOCHIM BIOPHYS ACTA, V335, P330; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joyce PR, 2009, BIOL PSYCHIAT, V66, P717, DOI 10.1016/j.biopsych.2009.03.005; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; McMinn J, 2006, PLACENTA, V27, P119, DOI 10.1016/j.placenta.2004.12.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422; Moore MW, 2003, HUM MUTAT, V21, P645, DOI 10.1002/humu.10222; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; Saunders CJ, 2010, GENET TEST MOL BIOMA, V14, P241, DOI 10.1089/gtmb.2009.0178; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; Stuffrein-Roberts S, 2008, THESIS U OTAGO CHRIS; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; SZER W, 1966, J MOL BIOL, V17, P174, DOI 10.1016/S0022-2836(66)80102-X; Tomaz RA, 2010, GENET TEST MOL BIOMA, V14, P455, DOI 10.1089/gtmb.2010.0029; Wenzel JJ, 2009, CLIN CHEM, V55, P1361, DOI 10.1373/clinchem.2008.118661; WOODFORD K, 1995, NUCLEIC ACIDS RES, V23, P539, DOI 10.1093/nar/23.3.539; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	42	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113955	10.1371/journal.pone.0113955	http://dx.doi.org/10.1371/journal.pone.0113955			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437198	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900102
J	Graham, S; Ye, SQ; Qian, M; Sanford, AR; Di Tullio, MR; Sacco, RL; Mann, DL; Levin, B; Pullicino, PM; Freudenberger, RS; Teerlink, JR; Mohr, JP; Labovitz, AJ; Lip, GYH; Estol, CJ; Lok, DJ; Ponikowski, P; Anker, SD; Thompson, JLP; Homma, S				Graham, Susan; Ye, Siqin; Qian, Min; Sanford, Alexandra R.; Di Tullio, Marco R.; Sacco, Ralph L.; Mann, Douglas L.; Levin, Bruce; Pullicino, Patrick M.; Freudenberger, Ronald S.; Teerlink, John R.; Mohr, J. P.; Labovitz, Arthur J.; Lip, Gregory Y. H.; Estol, Conrado J.; Lok, Dirk J.; Ponikowski, Piotr; Anker, Stefan D.; Thompson, John L. P.; Homma, Shunichi		WARCEF Investigators	Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial	PLOS ONE			English	Article							MINI-MENTAL-STATE; OLDER-ADULTS; 6-MINUTE WALK; IMPAIRMENT; ASSOCIATION; OUTPATIENTS; PREVALENCE; ANEMIA	We sought to determine whether cognitive function in stable outpatients with heart failure (HF) is affected by HF severity. A retrospective, cross-sectional analysis was performed using data from 2, 043 outpatients with systolic HF and without prior stroke enrolled in the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. Multivariable regression analysis was used to assess the relationship between cognitive function measured using the Mini-Mental Status Exam (MMSE) and markers of HF severity (left ventricular ejection fraction [LVEF], New York Heart Association [NYHA] functional class, and 6-minute walk distance). The mean (SD) for the MMSE was 28.6 (2.0), with 64 (3.1%) of the 2,043 patients meeting the cut-off of MMSE,24 that indicates need for further evaluation of cognitive impairment. After adjustment for demographic and clinical covariates, 6-minute walk distance (beta-coefficient 0.002, p<0.0001), but not LVEF or NYHA functional class, was independently associated with the MMSE as a continuous measure. Age, education, smoking status, body mass index, and hemoglobin level were also independently associated with the MMSE. In conclusion, six-minute walk distance, but not LVEF or NYHA functional class, was an important predictor of cognitive function in ambulatory patients with systolic heart failure.	[Graham, Susan] SUNY Upstate Med Univ, Dept Med, Div Cardiol, Buffalo, NY USA; [Ye, Siqin; Di Tullio, Marco R.] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY USA; [Qian, Min; Sanford, Alexandra R.; Levin, Bruce; Thompson, John L. P.; Homma, Shunichi] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10027 USA; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Mann, Douglas L.] Washington Univ, Dept Med, St Louis, MO USA; [Pullicino, Patrick M.] Univ Kent, Kent Inst Med & Hlth Sci, Canterbury, Kent, England; [Freudenberger, Ronald S.] Lehigh Valley Hosp, Div Cardiol, Dept Med, Allentown, PA USA; [Teerlink, John R.] Univ Calif San Francisco, Dept Med, Cardiol Sect, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Mohr, J. P.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Labovitz, Arthur J.] Univ S Florida, Dept Cardiovasc Med, Tampa, FL USA; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Estol, Conrado J.] Ctr Neurol Tratamiento & Rehabil, Buenos Aires, DF, Argentina; [Lok, Dirk J.] Deventer Hosp, Dept Cardiol, Deventer, Overijssel, Netherlands; [Ponikowski, Piotr] Wroclaw Med Univ, Mil Hosp, Dept Heart Dis, Wroclaw, Lower Silesia, Poland; [Anker, Stefan D.] Univ Med Ctr Gottingen, Dept Innovat Clin Trials, Gottingen, Lower Saxony, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Columbia University; Columbia University; University of Miami; Washington University (WUSTL); University of Kent; Lehigh Valley Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Columbia University; State University System of Florida; University of South Florida; University of Birmingham; Deventer Hospital; Wroclaw Medical University	Homma, S (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10027 USA.	sh23@columbia.edu	Kolomiets, Sergiy M/P-8059-2017; Ponikowski, Piotr/O-6454-2015; Teerlink, John R/D-2986-2012; Mohr, J/AAO-9694-2020; Sacco, Ralph/Y-9278-2019; Mann, Douglas Lowell/AAQ-3524-2021; pullicino, Patrick/AAO-9018-2021; Kozhukhov, Sergey/E-6498-2018	Ponikowski, Piotr/0000-0002-3391-7064; Kozhukhov, Sergey/0000-0002-7973-7894; Kolomiets, Sergiy/0000-0002-3095-7386; Gutmann, Laurie/0000-0003-3926-4209; Kovalenko, Volodymyr/0000-0003-3802-9207; Mann, Douglas/0000-0002-2516-0145	National Institute of Neurological Diseases and Stroke [U01-NS-043975, U01-NS-039143]; Division Of Mathematical Sciences [1307838] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL121144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS043975, U01NS039143] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The WARCEF trial was supported by grant #s U01-NS-043975 to S Homma, and U01-NS-039143 to JLP Thompson from the National Institute of Neurological Diseases and Stroke. Warfarin and warfarin placebo were provided by Taro Pharmaceuticals USA, and aspirin and aspirin placebo by Bayer HealthCare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athilingam P, 2011, HEART LUNG, V40, P521, DOI 10.1016/j.hrtlng.2010.11.002; Baldasseroni S, 2010, AGING CLIN EXP RES, V22, P308, DOI 10.1007/BF03324936; Cacciatore F, 1998, J AM GERIATR SOC, V46, P1343, DOI 10.1111/j.1532-5415.1998.tb05999.x; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cronk BB, 2010, ALZ DIS ASSOC DIS, V24, P126, DOI 10.1097/WAD.0b013e3181a6bf3f; Dodson JA, 2013, AM J MED, V126, P120, DOI 10.1016/j.amjmed.2012.05.029; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forman DE, 2012, J AM COLL CARDIOL, V60, P2653, DOI 10.1016/j.jacc.2012.08.1010; Garcia S, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-29; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hajduk AM, 2013, CIRC-CARDIOVASC QUAL, V6, P451, DOI 10.1161/CIRCOUTCOMES.113.000121; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Homma S, 2012, NEW ENGL J MED, V366, P1859, DOI 10.1056/NEJMoa1202299; Hoth KF, 2008, COGN BEHAV NEUROL, V21, P65, DOI 10.1097/WNN.0b013e3181799dc8; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Kindermann I, 2012, EUR J HEART FAIL, V14, P404, DOI 10.1093/eurjhf/hfs015; Lopez M, 2005, ASSESSMENT, V12, P137, DOI 10.1177/1073191105275412; Pullicino P, 2006, J CARD FAIL, V12, P39, DOI 10.1016/j.cardfail.2005.07.007; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rubin DB, 2004, MULTIPLE IMPUTATION; Sabia S, 2008, ARCH INTERN MED, V168, P1165, DOI 10.1001/archinte.168.11.1165; Sauve MJ, 2009, J CARD FAIL, V15, P1, DOI 10.1016/j.cardfail.2008.08.007; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Terekeci HM, 2010, EUR J INTERN MED, V21, P87, DOI 10.1016/j.ejim.2009.12.005; Trojano L, 2003, J NEUROL, V250, P1456, DOI 10.1007/s00415-003-0249-3; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Woo MA, 2009, J CARD FAIL, V15, P214, DOI 10.1016/j.cardfail.2008.10.020; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; Zuccala G, 2005, AM J MED, V118, P496, DOI 10.1016/j.amjmed.2005.01.030; Zuccala G, 2001, NEUROLOGY, V57, P1986, DOI 10.1212/WNL.57.11.1986	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113447	10.1371/journal.pone.0113447	http://dx.doi.org/10.1371/journal.pone.0113447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426862	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400054
J	So, WC; Ching, THW; Lim, PE; Cheng, XQ; Ip, KY				So, Wing Chee; Ching, Terence Han-Wei; Lim, Phoebe Elizabeth; Cheng, Xiaoqin; Ip, Kit Yee			Producing Gestures Facilitates Route Learning	PLOS ONE			English	Article							MENTAL REPRESENTATION; HANDS; SPEECH; SPEAKING; MEMORY; MATH	The present study investigates whether producing gestures would facilitate route learning in a navigation task and whether its facilitation effect is comparable to that of hand movements that leave physical visible traces. In two experiments, we focused on gestures produced without accompanying speech, i. e., co-thought gestures (e. g., an index finger traces the spatial sequence of a route in the air). Adult participants were asked to study routes shown in four diagrams, one at a time. Participants reproduced the routes (verbally in Experiment 1 and non-verbally in Experiment 2) without rehearsal or after rehearsal by mentally simulating the route, by drawing it, or by gesturing (either in the air or on paper). Participants who moved their hands (either in the form of gestures or drawing) recalled better than those who mentally simulated the routes and those who did not rehearse, suggesting that hand movements produced during rehearsal facilitate route learning. Interestingly, participants who gestured the routes in the air or on paper recalled better than those who drew them on paper in both experiments, suggesting that the facilitation effect of co-thought gesture holds for both verbal and nonverbal recall modalities. It is possibly because, co-thought gesture, as a kind of representational action, consolidates spatial sequence better than drawing and thus exerting more powerful influence on spatial representation.	[So, Wing Chee; Ip, Kit Yee] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China; [Ching, Terence Han-Wei; Lim, Phoebe Elizabeth; Cheng, Xiaoqin] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	Chinese University of Hong Kong; National University of Singapore	So, WC (corresponding author), Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China.	wingchee@cuhk.edu.hk	Ching, Terence/HHN-5683-2022	Cheng, Xiaoqin/0000-0002-4560-1403; So, Wing Chee/0000-0002-6538-1663	Research Grants Council of the Hong Kong Special Administrative Region, China [449813]; Chinese University of Hong Kong [CUHK4930017]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	Funding: This research has been fully supported by the Research Grants Council of the Hong Kong Special Administrative Region, China (Project no. 449813), and a grant from the Chinese University of Hong Kong (Project no. CUHK4930017). There was no further funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW., 2005, SPAT COGN COMPUT, V5, P307, DOI [10.1207/s15427633scc0504_2, DOI 10.1207/S15427633SCC0504_2]; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Broaders SC, 2007, J EXP PSYCHOL GEN, V136, P539, DOI 10.1037/0096-3445.136.4.539; Brunye TT, 2008, COGNITION, V108, P418, DOI 10.1016/j.cognition.2008.03.005; Cartmill EA, 2012, PHILOS T R SOC B, V367, P129, DOI 10.1098/rstb.2011.0162; Chu MY, 2008, J EXP PSYCHOL GEN, V137, P706, DOI 10.1037/a0013157; Chu MY, 2011, J EXP PSYCHOL GEN, V140, P102, DOI 10.1037/a0021790; Cook SW, 2008, COGNITION, V106, P1047, DOI 10.1016/j.cognition.2007.04.010; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; de Ruiter JP, 1998, THESIS CATHOLIC U NI; EdrawSoft, 2012, EDR MAX V6 3 2; Ehrlich SB, 2006, DEV PSYCHOL, V42, P1259, DOI 10.1037/0012-1649.42.6.1259; Forbus K, 2011, TOP COGN SCI, V3, P648, DOI 10.1111/j.1756-8765.2011.01149.x; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; Goldin-Meadow S, 2010, PERSPECT PSYCHOL SCI, V5, P664, DOI 10.1177/1745691610388764; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Hegarty M, 2005, SPAT COGN COMPUT, V5, P333, DOI DOI 10.1207/S15427633SCC0504_3; Hostetter AB, 2008, PSYCHON B REV, V15, P495, DOI 10.3758/PBR.15.3.495; Hostetter AB, 2007, LANG COGNITIVE PROC, V22, P313, DOI 10.1080/01690960600632812; HUMPHREYS LG, 1993, J APPL PSYCHOL, V78, P250, DOI 10.1037/0021-9010.78.2.250; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; LAVERGNE J, 1987, NEUROPSYCHOLOGIA, V25, P689, DOI 10.1016/0028-3932(87)90060-1; McFarlane KA, 2012, J EXP PSYCHOL LEARN, V38, P1001, DOI 10.1037/a0026783; McNeill D., 1992, HAND MIND WHAT GESTU; McNeill D., 2005, GESTURE THOUGHT, DOI 10.7208/chicago/9780226514642.001.0001; Melinger A, 2007, LANG COGNITIVE PROC, V22, P473, DOI 10.1080/01690960600696916; N??ez R., 1998, MATH COGNITION, V4, P85, DOI DOI 10.1080/135467998387343; Novack MA, 2014, PSYCHOL SCI, V25, P903, DOI 10.1177/0956797613518351; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Sauter M, 2012, J EXP CHILD PSYCHOL, V111, P587, DOI 10.1016/j.jecp.2011.11.009; SCHOOLER JW, 1990, COGNITIVE PSYCHOL, V22, P36, DOI 10.1016/0010-0285(90)90003-M; SCHOOLER JW, 1993, J EXP PSYCHOL GEN, V122, P166, DOI 10.1037/0096-3445.122.2.166; Schooler JW, 1997, HDB LEARNING MOTIVAT, P293; So WC, 2005, COGNITIVE SCI, V29, P1029, DOI 10.1207/s15516709cog0000_38; So WC, 2009, COGNITIVE SCI, V33, P115, DOI 10.1111/j.1551-6709.2008.01006.x; Uttal DH, 2008, MODEL MODEL SCI EDUC, V3, P53; Wagner SM, 2004, J MEM LANG, V50, P395, DOI 10.1016/j.jml.2004.01.002; Wesp R, 2001, AM J PSYCHOL, V114, P591, DOI 10.2307/1423612; [No title captured], DOI DOI 10.1023/A:1013118114571	40	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112543	10.1371/journal.pone.0112543	http://dx.doi.org/10.1371/journal.pone.0112543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426624	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400017
J	Bibault, JE; Nickers, P; Tresch, E; Cordoba, A; Leblanc, E; Comte, P; Lacornerie, T; Lartigau, E				Bibault, Jean-Emmanuel; Nickers, Philippe; Tresch, Emmanuelle; Cordoba, Abel; Leblanc, Eric; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric			Feasibility Study of Pelvic Helical IMRT for Elderly Patients with Endometrial Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; POSTOPERATIVE RADIOTHERAPY; ADJUVANT TREATMENT; CARCINOMA; SURGERY; TRIAL; SURVIVAL; IMPACT	Purpose: Standard treatment for early-stage endometrial cancer involves surgery (when possible) followed by brachytherapy or external-beam radiotherapy (EBRT) for high-risk tumors. EBRT is not without toxicity, meaning that it could be difficult to complete for elderly patients, who typically have decreased reserve and resistance to stressors. Patients and methods: Patients aged 70 and over treated between April 2009 and May 2013 for endometrial cancer and received IMRT (Intensity-Modulated Radiation Therapy) were included in this observational study. IMRT could be performed as adjuvant treatment or as an exclusive treatment for patients not amenable to surgery. The primary endpoints of this study were to assess the feasibility and toxicity of pelvic IMRT in this population. Secondary endpoints were to assess disease-specific survival, overall survival, and local control. Predictors of toxicity were also explored. Results: Forty seven consecutive patients were included in the analysis. Median age at diagnosis was 75 years (range, 70-89 years). Eleven patients were aged 80 years and older. Toxicities were found in thirty four patients (72%) during treatment. Among these, toxicity did not exceed grade 2 for 32 patients (68%). Two patients had a grade 3 toxicity (4%). Overall survival rates were 87% and 83% at 1 and 2 years, respectively. Six patients (12.8%) had a local relapse and nine others (19.1%) had distant relapse. Conclusions: Pelvic helical IMRT for patients aged 70 and older is feasible with full standard radiation doses, showing that age greater than 70 should not be considered as a reason not to perform optimal treatment.	[Bibault, Jean-Emmanuel; Nickers, Philippe; Cordoba, Abel; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric] Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, Lille, France; [Tresch, Emmanuelle] Oscar Lambret Comprehens Canc Ctr, Dept Biostat, Lille, France; [Leblanc, Eric] Oscar Lambret Comprehens Canc Ctr, Gynaecol Oncol Dept, Lille, France; [Bibault, Jean-Emmanuel; Lartigau, Eric] Univ Lille 2, Fac Med, Lille, France; [Bibault, Jean-Emmanuel; Nickers, Philippe; Tresch, Emmanuelle; Cordoba, Abel; Leblanc, Eric; Comte, Pauline; Lacornerie, Thomas; Lartigau, Eric] ONCOLille, Maison Reg Rech Clin, Lille, France	UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Lartigau, E (corresponding author), Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, 3 Rue Frederic Combemale, Lille, France.	e-lartigau@o-lambret.fr	lartigau, eric/GSI-5327-2022	leblanc, eric/0000-0001-7299-0339; Bibault, Jean-Emmanuel/0000-0002-1728-6776; Lacornerie, Thomas/0000-0001-8994-5999	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. Dr. Lartigau has been acting Chief Medical Officer at Accuray from April 2014 until September 2014 and has participated in coordination of the study, provided mentorship and edited the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Ahmed A, 2008, GYNECOL ONCOL, V111, P35, DOI 10.1016/j.ygyno.2008.06.026; Alektiar KM, 2003, CANCER-AM CANCER SOC, V98, P2368, DOI 10.1002/cncr.11830; Barillot I, 2014, RADIOTHER ONCOL, V111, P138, DOI 10.1016/j.radonc.2014.01.018; Baumann M, 1998, RADIOTHER ONCOL, V46, P225; Beriwal S, 2006, GYNECOL ONCOL, V102, P195, DOI 10.1016/j.ygyno.2006.01.062; Blake P, 2009, LANCET, V373, P137, DOI 10.1016/S0140-6736(08)61767-5; Boyer AL, 2001, INT J RADIAT ONCOL, V51, P880, DOI 10.1016/S0360-3016(01)01749-7; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fleming ND, 2011, GYNECOL ONCOL, V120, P189, DOI 10.1016/j.ygyno.2010.10.038; FRICK HC, 1973, AM J OBSTET GYNECOL, V115, P663, DOI 10.1016/0002-9378(73)90615-7; Heron DE, 2003, GYNECOL ONCOL, V91, P39, DOI 10.1016/S0090-8258(03)00461-X; Hsieh CH, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-62; Igdem S, 2009, EUR J GYNAECOL ONCOL, V30, P547; Jolly S, 2006, GYNECOL ONCOL, V103, P87, DOI 10.1016/j.ygyno.2006.01.038; Jutzi L, 2013, GYNECOL ONCOL, V131, P581, DOI 10.1016/j.ygyno.2013.09.012; Keys HM, 2004, GYNECOL ONCOL, V92, P744, DOI 10.1016/j.ygyno.2003.11.048; Klopp AH, 2013, INT J RADIAT ONCOL, V86, P83, DOI 10.1016/j.ijrobp.2013.01.017; Lim K, 2009, INT J RADIAT ONCOL, V74, P304, DOI 10.1016/j.ijrobp.2008.12.043; Nelson NJ, 2000, J NATL CANCER I, V92, P1968, DOI 10.1093/jnci/92.24.1968; Njolstad TS, 2013, GYNECOL ONCOL, V131, P410, DOI 10.1016/j.ygyno.2013.08.032; NOER MC, 2014, ACTA OBSTET GYNECOL, DOI DOI 10.1111/A0GS.12338; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Nout RA, 2011, J CLIN ONCOL, V29, P1692, DOI 10.1200/JCO.2010.32.4590; Okuma K, 2010, J OBSTET GYNAECOL RE, V36, P757, DOI 10.1111/j.1447-0756.2010.01202.x; Quaglia A, 2009, EUR J CANCER, V45, P1006, DOI 10.1016/j.ejca.2008.11.028; Roeske JC, 2000, INT J RADIAT ONCOL, V48, P1613, DOI 10.1016/S0360-3016(00)00771-9; Small W, 2008, INT J RADIAT ONCOL, V71, P428, DOI 10.1016/j.ijrobp.2007.09.042; Suh DH, 2012, INT J GYNECOL CANCER, V22, P161, DOI 10.1097/IGC.0b013e318234f8d5; Vaknin Z, 2009, INT J GYNECOL CANCER, V19, P879, DOI 10.1111/IGC.0b013e3181a73a12; Wagner A, 2013, GYNECOL ONCOL, V130, P229, DOI 10.1016/j.ygyno.2013.04.052; Wright JD, 2009, CANCER-AM CANCER SOC, V115, P1276, DOI 10.1002/cncr.24160	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113279	10.1371/journal.pone.0113279	http://dx.doi.org/10.1371/journal.pone.0113279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423024	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700029
J	Chu, C; Zhang, J; Wu, YF				Chu, Chong; Zhang, Jin; Wu, Yufeng			GINDEL: Accurate Genotype Calling of Insertions and Deletions from Low Coverage Population Sequence Reads	PLOS ONE			English	Article							COPY NUMBER VARIATION; DISCOVERY; MODELS	Insertions and deletions (indels) are important types of structural variations. Obtaining accurate genotypes of indels may facilitate further genetic study. There are a few existing methods for calling indel genotypes from sequence reads. However, none of these tools can accurately call indel genotypes for indels of all lengths, especially for low coverage sequence data. In this paper, we present GINDEL, an approach for calling genotypes of both insertions and deletions from sequence reads. GINDEL uses a machine learning approach which combines multiple features extracted from next generation sequencing data. We test our approach on both simulated and real data and compare with existing tools, including Genome STRiP, Pindel and Clever-sv. Results show that GINDEL works well for deletions larger than 50 bp on both high and low coverage data. Also, GINDEL performs well for insertion genotyping on both simulated and real data. For comparison, Genome STRiP performs less well for shorter deletions (50-200 bp) on both simulated and real sequence data from the 1000 Genomes Project. Clever-sv performs well for intermediate deletions (200-1500 bp) but is less accurate when coverage is low. Pindel only works well for high coverage data, but does not perform well at low coverage. To summarize, we show that GINDEL not only can call genotypes of insertions and deletions (both short and long) for high and low coverage population sequence data, but also is more accurate and efficient than other approaches. The program GINDEL can be downloaded at: http://sourceforge.net/p/gindel	[Chu, Chong; Wu, Yufeng] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Zhang, Jin] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	University of Connecticut; Washington University (WUSTL)	Wu, YF (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	ywu@engr.uconn.edu	Chu, Chong/AAA-4613-2022	Chu, Chong/0000-0002-0796-2339; Zhang, Jin/0000-0002-9117-2793	National Science Foundation [IIS0953563]; Div Of Information & Intelligent Systems [0953563] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	National Science Foundation grant IIS0953563 (http://www.nsf.gov/) supporting CC, JZ and YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bellos E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r120; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Duitama J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S53; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Marschall T, 2013, BIOINFORMATICS, V29, P3143, DOI 10.1093/bioinformatics/btt556; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S6; Zhang J, 2011, BIOINFORMATICS, V27, P3228, DOI 10.1093/bioinformatics/btr563	20	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113324	10.1371/journal.pone.0113324	http://dx.doi.org/10.1371/journal.pone.0113324			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423315	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700031
J	Falanga, A; Tarallo, R; Carberry, T; Galdiero, M; Weck, M; Galdiero, S				Falanga, Annarita; Tarallo, Rossella; Carberry, Thomas; Galdiero, Massimiliano; Weck, Marcus; Galdiero, Stefania			Elucidation of the Interaction Mechanism with Liposomes of gH625-Peptide Functionalized Dendrimers	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; CELL-PENETRATING PEPTIDES; SUPPORTED LIPID-BILAYERS; POLY(AMIDOAMINE) DENDRIMERS; PAMAM DENDRIMERS; PORE FORMATION; INTRACELLULAR DELIVERY; POLYCATIONIC POLYMERS; MOLECULAR-DYNAMICS; HOLE FORMATION	We have demonstrated that amide-based dendrimers functionalized with the membrane-interacting peptide gH625 derived from the herpes simplex virus type 1 (HSV-1) envelope glycoprotein H enter cells mainly through a non-active translocation mechanism. Herein, we investigate the interaction between the peptide-functionalized dendrimer and liposomes composed of PC/Chol using fluorescence spectroscopy, isothermal titration calorimetry, and surface plasmon resonance to get insights into the mechanism of internalization. The affinity for the membrane bilayer is very high and the interaction between the peptide-dendrimer and liposomes took place without evidence of pore formation. These results suggest that the presented peptidodendrimeric scaffold may be a promising material for efficient drug delivery.	[Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, CIRPEB, Naples, Italy; [Falanga, Annarita; Galdiero, Stefania] Univ Naples Federico II, DFM Scarl, Naples, Italy; [Tarallo, Rossella; Carberry, Thomas; Weck, Marcus] NYU, Inst Mol Design, New York, NY USA; [Tarallo, Rossella; Carberry, Thomas; Weck, Marcus] NYU, Dept Chem, New York, NY 10003 USA; [Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; New York University; New York University; Universita della Campania Vanvitelli	Galdiero, S (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	stefania.galdiero@unina.it	Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Galdiero, Massimiliano/0000-0002-1576-6290; FALANGA, Annarita/0000-0001-6538-8585; Weck, Marcus/0000-0002-6486-4268	MIUR [PON01_02388]	MIUR(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by MIUR - PON01_02388 "Verso la medicina personalizzata: nuovi sistemi molecolari per la diagnosi e la terapia di patologie oncologiche ad alto impatto sociale'' SALUTE DELL'UOMO E BIOTECNOLOGIE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardo A, 2013, POLYM J, V45, P481, DOI 10.1038/pj.2012.215; Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022; Cantor C.R., 1980, BIOPHYS CHEM; Carberry TP, 2012, CHEM-EUR J, V18, P13678, DOI 10.1002/chem.201202358; Castile JD, 1999, INT J PHARM, V182, P101, DOI 10.1016/S0378-5173(99)00069-1; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Falanga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032186; Falanga A, 2011, NANOMED-NANOTECHNOL, V7, P925, DOI 10.1016/j.nano.2011.04.009; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2012, BIOCHEMISTRY-US, V51, P3121, DOI 10.1021/bi201589m; Galdiero S, 2012, CURR DRUG METAB, V13, P93, DOI 10.2174/138920012798356961; Galdiero S, 2010, J BIOL CHEM, V285, P17123, DOI 10.1074/jbc.M110.114819; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Gardikis K, 2006, INT J PHARM, V318, P118, DOI 10.1016/j.ijpharm.2006.03.023; Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3; Guarnieri D, 2013, SMALL, V9, P853, DOI 10.1002/smll.201201870; Hong SP, 2006, BIOCONJUGATE CHEM, V17, P728, DOI 10.1021/bc060077y; Hong S, 2009, BIOCONJUGATE CHEM, V20, P1503, DOI 10.1021/bc900029k; Hong SP, 2004, BIOCONJUGATE CHEM, V15, P774, DOI 10.1021/bc049962b; Ionov M., 2011, ACTA PHYS U COMENIAN, V52, P33; Jain K, 2010, INT J PHARMACEUT, V394, P122, DOI 10.1016/j.ijpharm.2010.04.027; Kelly CV, 2008, J PHYS CHEM B, V112, P9346, DOI 10.1021/jp8013783; Kelly CV, 2009, ACS NANO, V3, P1886, DOI 10.1021/nn900173e; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Klajnert B, 2004, BIOELECTROCHEMISTRY, V65, P23, DOI 10.1016/j.bioelechem.2004.06.004; Klajnert B, 2005, INT J PHARMACEUT, V305, P154, DOI 10.1016/j.ijpharm.2005.08.015; Klajnert B, 2006, INT J PHARMACEUT, V327, P145, DOI 10.1016/j.ijpharm.2006.07.018; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lee H, 2008, J PHYS CHEM B, V112, P7778, DOI 10.1021/jp802606y; Lee H, 2006, J PHYS CHEM B, V110, P18204, DOI 10.1021/jp0630830; Leroueil PR, 2007, ACCOUNTS CHEM RES, V40, P335, DOI 10.1021/ar600012y; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Mecke A, 2005, LANGMUIR, V21, P10348, DOI 10.1021/la050629l; Mecke A, 2005, LANGMUIR, V21, P8588, DOI 10.1021/la051800w; Mecke A, 2004, CHEM PHYS LIPIDS, V132, P3, DOI 10.1016/j.chemphyslip.2004.09.001; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Newkome GR, 2001, DENDRIMERS DENDRONS; Ornelas C, 2011, ORG LETT, V13, P976, DOI 10.1021/ol103019z; Ottaviani MF, 1999, LANGMUIR, V15, P1973, DOI 10.1021/la9803068; Ottaviani MF, 1998, J PHYS CHEM B, V102, P6029, DOI 10.1021/jp980715c; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; Pearson RM, 2012, THER DELIV, V3, P941, DOI 10.4155/TDE.12.76; Purohit G, 2001, INT J PHARMACEUT, V214, P71, DOI 10.1016/S0378-5173(00)00635-9; Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q; Ruzza P, 2010, PHARMACEUTICALS, V3, P1045, DOI 10.3390/ph3041045; Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654; Saovapakhiran A, 2009, BIOCONJUGATE CHEM, V20, P693, DOI 10.1021/bc8002343; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Seib FP, 2007, J CONTROL RELEASE, V117, P291, DOI 10.1016/j.jconrel.2006.10.020; SHAI Y, 1990, J BIOL CHEM, V265, P20202; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shcharbin D, 2006, CELL MOL BIOL LETT, V11, P242, DOI 10.2478/s11658-006-0018-2; Smaldone G, 2013, INT J NANOMED, V8, P2555, DOI 10.2147/IJN.S44186; Smith DK, 2008, CURR TOP MED CHEM, V8, P1187, DOI 10.2174/156802608785849030; Smith PES, 2010, J AM CHEM SOC, V132, P8087, DOI 10.1021/ja101524z; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018; Tarallo R, 2013, INT J NANOMED, V8, P521, DOI 10.2147/IJN.S37739; Tarallo R, 2011, CHEM-EUR J, V17, P12659, DOI 10.1002/chem.201101425; Tiriveedhi V, 2011, BBA-BIOMEMBRANES, V1808, P209, DOI 10.1016/j.bbamem.2010.08.017; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wrobel D, 2012, CHEM PHYS LIPIDS, V165, P401, DOI 10.1016/j.chemphyslip.2012.01.008; Wrobel D, 2011, BBA-MOL CELL BIOL L, V1811, P221, DOI 10.1016/j.bbalip.2010.11.007; Yan LT, 2009, ACS NANO, V3, P2171, DOI 10.1021/nn9004236; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	71	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112128	10.1371/journal.pone.0112128	http://dx.doi.org/10.1371/journal.pone.0112128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423477	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700009
J	Bruckel, JT; Gurm, HS; Seth, M; Prager, RL; Jensen, A; Nallamothu, BK				Bruckel, Jeffrey T.; Gurm, Hitinder S.; Seth, Milan; Prager, Richard L.; Jensen, Andrea; Nallamothu, Brahmajee K.			Use of a Heart Team in Decision-Making for Patients with Complex Coronary Disease at Hospitals in Michigan Prior to Guideline Endorsement	PLOS ONE			English	Article							INTERVENTION; ASSOCIATION	Background: Revascularization decisions can profoundly impact patient survival, quality of life, and procedural risk. Although use of Heart Teams to make revascularization decisions is growing, data on their implementation in the real-world are limited. Our objective was to assess the prevalence of Heart Teams and their association with collaboration in routine practice. Methods: A survey of cardiologists and cardiac surgeons at 31 hospitals in Michigan was performed in May, 2011 - prior to the recommendation for using Heart Teams in national guidelines. This survey included all percutaneous coronary intervention-performing hospitals in Michigan participating in the Blue Cross/Blue Shield of Michigan Cardiovascular Consortium and Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative. It targeted both the use of Heart Teams and multidisciplinary Case Conferences. Results: There were 53 physician survey respondents from 27 hospitals with 4 hospitals not responding. Among respondents, 11 (40.7%) hospitals reported no Heart Teams or Case Conferences while 7 (25.9%) hospitals reported either a Heart Team or Case Conference. However, there was disagreement about the presence of a Heart Team at seven hospitals, and about Case Conferences at nine hospitals. Hospitals with definite Heart Teams reported significantly greater levels of collaboration between cardiologists and cardiac surgeons. Conclusion: The overall presence of Heart Teams prior to their recommendation in national guidelines was limited. Even among hospitals with a potential Heart Team, there was substantial disagreement between respondents about their presence. Further refinement of the definition of a Heart Team and measures of successful implementation are needed.	[Bruckel, Jeffrey T.] Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA; [Bruckel, Jeffrey T.; Nallamothu, Brahmajee K.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Gurm, Hitinder S.; Seth, Milan; Jensen, Andrea] Blue Cross Blue Shield Michigan Cardiovasc Consor, Ann Arbor, MI USA; [Gurm, Hitinder S.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA; [Prager, Richard L.] Univ Michigan Hlth Syst, Dept Cardiac Surg, Ann Arbor, MI USA; [Prager, Richard L.] Michigan Soc Thorac & Cardiovasc Surg Qual Collab, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Ann Arbor VA Ctr Clin Management & Res, Ann Arbor, MI USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nallamothu, BK (corresponding author), Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	bnallamo@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan	Blue Cross Blue Shield of Michigan	Funding: The BMC2 registry is funded by Blue Cross Blue Shield of Michigan. The sponsor had no role in study design, review or the decision to submit the work for publication. There are no current funding sources for this specific study and no internal or external funding was used to support the work presented in this manuscript.	Holmes DR, 2013, J AM COLL CARDIOL, V61, P903, DOI 10.1016/j.jacc.2012.08.1034; Khambatta S, 2013, AM HEART J, V165, P893, DOI 10.1016/j.ahj.2013.02.030; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Sanchez CE, 2013, CIRC-CARDIOVASC QUAL, V6, P598, DOI 10.1161/CIRCOUTCOMES.113.000269; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	6	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113241	10.1371/journal.pone.0113241	http://dx.doi.org/10.1371/journal.pone.0113241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415332	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600034
J	Chen, R; Tao, F; Ma, Y; Zhong, LQ; Qin, X; Hu, Z				Chen, Ren; Tao, Feng; Ma, Ying; Zhong, Liqin; Qin, Xia; Hu, Zhi			Associations between Social Support and Condom Use among Commercial Sex Workers in China: A Cross-Sectional Study	PLOS ONE			English	Article							YUNNAN PROVINCE; HIV-INFECTION; MENTAL-HEALTH; RISK BEHAVIORS; KAIYUAN CITY; GAY; FAMILY; IMPACT; DISCRIMINATION; PREVALENCE	Objective: The aim of this study was to investigate the association between social support and AIDS high-risk behaviors in commercial sex workers (CSWs) in China. Methods: A cross-sectional study was performed based on a convenience sample. Data were collected through questionnaire interviews including information about social demographic characteristics, the Social Support Rating Scale (SSRS) and AIDS knowledge. Multiple logistic regression was performed to evaluate the association between social support and AIDS high-risk behaviors, specifically condom use during commercial sex. Results: A total of 581 commercial sex workers from 4 counties in East China participated in the study. The majority of the participants were 15 to 30 years old (79.7%). Sources of individual and family support were mainly provided by their parents (50.3%), relatives and friends (46.3%), spouses (18.4%), respectively. Univariate analysis revealed that marital status, hobbies, smoking habit, individual monthly income and family monthly income were all significantly correlated with current levels of social support being received (P=0.04, P=0.00, P=0.01, P=0.01, P=0.01, respectively). Furthermore, Multiple logistic regression analysis indicated that after adjusting for confounding factors, high levels of social support were significantly correlated with increased condom use at the last sexual encounter (P=0.02, OR=1.86, 95% CI: 1.10-3.16); and consistently in the past month with clients (P=0.03, OR=2.10, 95% CI: 1.09-4.04). Conclusion: CSWs with high levels of social support are more likely to use condoms during commercial sex. This suggests that increasing social support can potentially reduce AIDS-related high-risk behaviors and accordingly play an important role in AIDS prevention.	[Chen, Ren; Hu, Zhi] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hefei, Anhui, Peoples R China; [Chen, Ren; Tao, Feng; Ma, Ying; Zhong, Liqin; Qin, Xia; Hu, Zhi] Anhui Med Univ, Sch Hlth Serv Management, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Hu, Z (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hefei, Anhui, Peoples R China.	aywghz@126.com	Chen, Ren/AAV-5572-2021		National Natural Science Foundation of China [70973001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Grant No. 70973001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2013, INT J STD AIDS, V24, P813, DOI 10.1177/0956462413486452; Angadi M M, 2013, J Indian Med Assoc, V111, P30; Bai Y, 2003, MED PHILOS, V24, P27; Baum A, 1984, HDB PSYCHOL HLTH; Benoit C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-76; Cao H, 2003, CHINESE J AIDS STD, V9, P185; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; Cullen F. T., 1994, JUSTICE Q, V11, P527, DOI [10.1080/07418829400092421, DOI 10.1080/07418829400092421]; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; GALAVOTTI C, 1995, HEALTH PSYCHOL, V14, P570, DOI 10.1037/0278-6133.14.6.570; Hall V P, 1999, J Assoc Nurses AIDS Care, V10, P74, DOI 10.1016/S1055-3290(05)60121-5; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062290; House JS, 1981, WORK STRESS SOCIAL S; Ingram KM, 1999, AIDS CARE, V11, P313, DOI 10.1080/09540129947947; JACKSON L, 1992, SOC SCI MED, V35, P281, DOI 10.1016/0277-9536(92)90024-K; Kalinka J, 2005, AM J PERINAT, V22, P41, DOI 10.1055/s-2004-837266; Kimberly JA, 1999, AIDS EDUC PREV, V11, P465; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; Li L, 2006, AIDS BEHAV, V10, P509, DOI 10.1007/s10461-006-9071-0; Li X, 2007, MED PHILOS HUMANISTI, V28, P28, DOI DOI 10.1016/J.M0LCEL.2007.07.032; Liu L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-324; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048888; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; MORRIS M, 1995, AIDS, V9, P507, DOI 10.1097/00002030-199509050-00014; Nyamathi A, 2000, NURS RES, V49, P318, DOI 10.1097/00006199-200011000-00004; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Robinson NJ, 1996, 11 INT C AIDS; Sarason I. G., 1985, SOCIAL SUPPORT THEOR; Satcher D, 1996, PUBLIC HEALTH REP, V111, P1; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Takahashi LM, 2008, HEALTH PLACE, V14, P182, DOI 10.1016/j.healthplace.2007.06.002; The National Health and Family Planning Commission, 2012, CHIN AIDS PREV CONTR; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; Turner-Cobb JM, 2002, J BEHAV MED, V25, P337, DOI 10.1023/A:1015814431481; Wang HB, 2008, INT J STD AIDS, V19, P635, DOI 10.1258/ijsa.2008.008013; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang Y., 2002, CHINESE J AIDS STD, V8, P166; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Wu QB, 2010, AM J COMMUN PSYCHOL, V45, P1, DOI 10.1007/s10464-009-9284-2; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yoshikawa H, 2004, AIDS EDUC PREV, V16, P84, DOI 10.1521/aeap.16.1.84.27719; Zhang S, 2000, J CHINA AIDS STD, V6, P344; Zhong L, 2011, THESIS ANHUI MED U	53	9	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113794	10.1371/journal.pone.0113794	http://dx.doi.org/10.1371/journal.pone.0113794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25436910	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900080
J	Garcia, JC; Posada-Suarez, H; Laderach, P				Garcia L, Juan Carlos; Posada-Suarez, Huver; Laederach, Peter			Recommendations for the Regionalizing of Coffee Cultivation in Colombia: A Methodological Proposal Based on Agro-Climatic Indices	PLOS ONE			English	Article							MODELS; RADIATION; CANADA	The Colombian National Federation of Coffee Growers (FNC) conducted an agro-ecological zoning study based on climate, soil, and terrain of the Colombian coffee-growing regions (CCGR) located in the tropics, between 1 degrees and 11.5 degrees N, in areas of complex topography. To support this study, a climate baseline was constructed at a spatial resolution of 5 km. Twenty-one bioclimatic indicators were drawn from this baseline data and from yield data for different coffee genotypes evaluated under conditions at eight experimental stations (ESs) belonging to the National Center for Coffee Research (CENICAFE). Three topographic indicators were obtained from a digital elevation model (DEM). Zoning at a national level resulted in the differentiation of 12 agro-climatic zones. Altitude notably influenced zone differentiation, however other factors such as large air currents, low-pressure atmospheric systems, valleys of the great rivers, and physiography also played an important role. The strategy of zoning according to coffee-growing conditions will enable areas with the greatest potential for the development of coffee cultivation to be identified, criteria for future research to be generated, and the level of technology implementation to be assessed.	[Garcia L, Juan Carlos] Natl Ctr Coffee Res CENICAFE, Prod & Prod Program, Manizales, Colombia; [Garcia L, Juan Carlos] Univ Caldas, Agr Sci Fac, Manizales, Colombia; [Posada-Suarez, Huver] Natl Federat Coffee Growers Colombia FNC, Tech Div, Bogota, Colombia; [Laederach, Peter] Int Ctr Trop Agr CIAT, Decis & Policy Anal DAPA, Cali, Colombia	Universidad de Caldas; Alliance; International Center for Tropical Agriculture - CIAT	Garcia, JC (corresponding author), Natl Ctr Coffee Res CENICAFE, Prod & Prod Program, Manizales, Colombia.	juan.garcia@cafedecolombia.com.co		Laderach, Peter/0000-0001-8708-6318	Colombian National Federation of Coffee Growers (FNC)	Colombian National Federation of Coffee Growers (FNC)	The Colombian National Federation of Coffee Growers (FNC, its Spanish acronym) funded Juan Carlos Garcia L.'s doctoral program. The FNC provided the information used in the development of the thesis, as research outcome data, the coffee weather information network, and the coffee information system (SICA (R), its Spanish acronym), which is related to the characterization of coffee farms. The base information used by Juan Carlos Garcia L. as part of his doctoral thesis was restricted to the scope thereof and the results generated from this will be public, with priority use for the Colombian coffee growers. The salary of researchers Huver Posada and Juan Carlos Garcia L. is in charge of the FNC. The salary of Peter Laderach and the logistics of the seven months internship conducted by Juan Carlos Garcia L. was assumed by CIAT (Centro Internacional de Agricultura Tropical). The donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila J, 2001, APLICACION ESCALA BB, P32; Arcila J, 1993, AVANCE TECNICOS CENI, V193, P1; Arcila-Pulgarin J., 2007, SISTEMAS PRODUCCION, P61; Arcila-Pulgarin J., 2003, AVANCES TECNICOS CEN, V311, P1; Baldion J, 1992, ESTUDIO AGROCLIMATIC; CAMARGO M. B. P., 2007, INFORM AGROPECUARIO, V28, P58; Camayo-Velez GC, 2003, REV CENICAFE, V54, P35; Cano C.G., 2012, BORRADORES EC, V7, P1; Caramori P. H., 2007, Informe Agropecuario, V28, P66; Carbonell J, 2011, ZONIFICACION AGROECO, P119; Carvalho HD, 2011, REV BRAS ENG AGR AMB, V15, P601, DOI 10.1590/S1415-43662011000600010; Chessel D., 2012, ANAL ECOLOGICAL DATA; Cock J, 2011, AGR SYST, V104, P755, DOI 10.1016/j.agsy.2011.07.001; Diaz L, 2007, ESTADISTICA MUTIVARI; Dimitriadou E, 2012, CONVEX CLUSTERING ME; Farfan F, 2013, ESTABLECIMIENTO SIST, P44; Federacion Nacional de Cafeteros de Colombia (FNC), 2012, 77 C NAC CAF 2012; Florez C, 2013, ESTRUCTURA FUNCIONAM, P123; Gomez L, 1995, REV CENICAFE, V46, P205; Gomez L, 1991, ECOTOPOS CAFETEROS C, P131; Guzman M.O., 1984, CENICAFE COLOMBIA, V35, P57; Hijmans R, 2010, INRO RASTER PACKAGE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hurtado G, 1988, CARACTERIZACION AGRO; Hutchinson M, 2006, ANUSPLIN VERSION 4 3, P54; Hutchinson M.F., 1998, J GEOGR INF DECIS AN, V2, P139; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; Jaramillo, 2009, AVANCES TECNICOS CE, V379, P1; Jaramillo A, 2011, AVANCE TECNICOS CENI, V411, P1; Jaramillo A, 2009, AVANCES TECNICOS CEN, V390, P1; Jaramillo A, 2005, CLIMA ANDINO CAFE CO; Jaramillo A, 1982, REV CENICAFE, V33, P15; Jaramillo A, 2002, DESARROLLO APLICACIO; Jaramillo A, 1996, AVANCE TECNICOS CENI, V229; Jaramillo-Robledo A., 2009, AVANCES TECNICOS CEN, V389, P1; Laderach P., 2012, ESCENARIOS IMPACTO C; Leibovich J, 2008, ENSAYOS EC CAFETERA, V21, P67; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; Pezzopane JRM, 2008, CIENC AGROTEC, V32, P1781, DOI 10.1590/S1413-70542008000600016; Malagon D, 1995, FACTORES BIOCLIMATIC, P221; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; Meireles E. J. L., 2007, Informe Agropecuario, V28, P50; Meza F, 2000, AGR FOREST METEOROL, V100, P231, DOI 10.1016/S0168-1923(99)00090-8; Niekerk A, 2011, WATER SA, V37; Nunes Fabiana Lataro, 2010, Bragantia, V69, P1011, DOI 10.1590/S0006-87052010000400029; Oberthur T, 2011, FOOD POLICY, V36, P783, DOI 10.1016/j.foodpol.2011.07.005; OVALLE O., 2011, CAFE MESOAMERICANO D; Palmer W.C., 1965, METEOROLOGICAL DROUG; Pena Daniel, 2002, ANAL DATOS MULTIVARI; Ramirez J., 2010, DOWNSCALING GLOBAL C; Ramirez V, 2013, ESTABLECIMIENTO CAFE, P28; Ramirez V, 2013, GESTION RIESGO AGROC, P91; Ramirez V, 2010, REV CENICAFE, V61, P132; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Reymondin L, 2011, NEAR REAL TIME PAN T; Rivington M, 2005, AGR FOREST METEOROL, V132, P228, DOI 10.1016/j.agrformet.2005.07.013; Rivington M, 2002, P INT ENV MOD SOFTW, V3, P193; Sadeghian S, 2013, NUTR CAFETALES MANUA, P85; Salazar L, 2013, MANEJO INTEGRADO ARV, P117; Salazar L, 2013, CONSERVACION SUELOS, P287; Santos Marco Antonio dos, 2006, Bragantia, V65, P173; Silva F, 2000, DELIMITACAO AREAS AP, P123; Suarez S, 2000, CARACTERISTICAS FISI; Team RDC, 2019, R LANG ENV STAT COMP; Trojer H, 1959, REV CENICAFE, V10, P287; Trojer H, 1954, REV CENICAFE, V5, P22; Trojer H., 1968, P READ S UNESCO PAR, P107; UPME I. D. E. A. M, 2005, ATL RAD SOL COL	68	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113510	10.1371/journal.pone.0113510	http://dx.doi.org/10.1371/journal.pone.0113510			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436456	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900047
J	Beutner, G; Eliseev, RA; Porter, GA				Beutner, Gisela; Eliseev, Roman A.; Porter, George A., Jr.			Initiation of Electron Transport Chain Activity in the Embryonic Heart Coincides with the Activation of Mitochondrial Complex 1 and the Formation of Supercomplexes	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C-OXIDASE; IN-VIVO; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; FUNCTIONAL ASSAYS; CELL-DEATH; PROTEIN; DIFFERENTIATION; METABOLISM	Mitochondria provide energy in form of ATP in eukaryotic cells. However, it is not known when, during embryonic cardiac development, mitochondria become able to fulfill this function. To assess this, we measured mitochondrial oxygen consumption and the activity of the complexes (Cx) 1 and 2 of the electron transport chain (ETC) and used immunoprecipitation to follow the generation of mitochondrial supercomplexes. We show that in the heart of mouse embryos at embryonic day (E) 9.5, mitochondrial ETC activity and oxidative phosphorylation (OXPHOS) are not coupled, even though the complexes are present. We show that Cx-1 of the ETC is able to accept electrons from the Krebs cycle, but enzyme assays that specifically measure electron flow to ubiquinone or Cx-3 show no activity at this early embryonic stage. At E11.5, mitochondria appear functionally more mature; ETC activity and OXPHOS are coupled and respond to ETC inhibitors. In addition, the assembly of highly efficient respiratory supercomplexes containing Cx-1, -3, and -4, ubiquinone, and cytochrome c begins at E11.5, the exact time when Cx-1 becomes functional activated. At E13.5, ETC activity and OXPHOS of embryonic heart mitochondria are indistinguishable from adult mitochondria. In summary, our data suggest that between E9.5 and E11.5 dramatic changes occur in the mitochondria of the embryonic heart, which result in an increase in OXPHOS due to the activation of complex 1 and the formation of supercomplexes.	[Beutner, Gisela; Porter, George A., Jr.] Univ Rochester, Med Ctr, Dept Pediat, Div Cardiol, Rochester, NY 14642 USA; [Eliseev, Roman A.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Porter, GA (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, Div Cardiol, 601 Elmwood Ave,Box 631, Rochester, NY 14642 USA.	george_porter@urmc.rochester.edu	George A, Porter/E-7315-2013	George A, Porter/0000-0003-0726-9988	American Heart Association [12GRNT12060233]; National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [5K01 AR064610]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042, KL2TR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR064610] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	GP is supported by American Heart Association Founder's Affiliate (12GRNT12060233). RE is supported by a National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases) award number 5K01 AR064610.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alavian KN, 2014, P NATL ACAD IN PRESS; Ascuitto RJ, 1996, SEMIN PERINATOL, V20, P542, DOI 10.1016/S0146-0005(96)80068-1; Babot M, 2014, BIOCH BIOPHYS ACTA; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker CN, 2013, OA BIOTECHNOLOGY, V2; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; COX SJ, 1972, J EMBRYOL EXP MORPH, V28, P235; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Devlin TM, 1997, TXB BIOCH CLIN CORRE; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nicholls DG, 2013, BIONENERGETIS, V4, P60; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Sokolova N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083214; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006	51	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113330	10.1371/journal.pone.0113330	http://dx.doi.org/10.1371/journal.pone.0113330			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427064	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400043
J	Goekoop, R; Goekoop, JG				Goekoop, Rutger; Goekoop, Jaap G.			A Network View on Psychiatric Disorders: Network Clusters of Symptoms as Elementary Syndromes of Psychopathology	PLOS ONE			English	Article							NORMAL PLASMA VASOPRESSIN; NEGATIVE-SYNDROME-SCALE; PERSONALITY-ASSESSMENT; UNIPOLAR DEPRESSION; DIMENSIONAL MODELS; FAMILY-HISTORY; RATING-SCALE; DSM-III; ANXIETY; VALIDATION	Introduction: The vast number of psychopathological syndromes that can be observed in clinical practice can be described in terms of a limited number of elementary syndromes that are differentially expressed. Previous attempts to identify elementary syndromes have shown limitations that have slowed progress in the taxonomy of psychiatric disorders. Aim: To examine the ability of network community detection (NCD) to identify elementary syndromes of psychopathology and move beyond the limitations of current classification methods in psychiatry. Methods: 192 patients with unselected mental disorders were tested on the Comprehensive Psychopathological Rating Scale (CPRS). Principal component analysis (PCA) was performed on the bootstrapped correlation matrix of symptom scores to extract the principal component structure (PCS). An undirected and weighted network graph was constructed from the same matrix. Network community structure (NCS) was optimized using a previously published technique. Results: In the optimal network structure, network clusters showed a 89% match with principal components of psychopathology. Some 6 network clusters were found, including "DEPRESSION", "MANIA", "ANXIETY'', "PSYCHOSIS", "RETARDATION", and "BEHAVIORAL DISORGANIZATION". Network metrics were used to quantify the continuities between the elementary syndromes. Conclusion: We present the first comprehensive network graph of psychopathology that is free from the biases of previous classifications: a 'Psychopathology Web'. Clusters within this network represent elementary syndromes that are connected via a limited number of bridge symptoms. Many problems of previous classifications can be overcome by using a network approach to psychopathology.	[Goekoop, Rutger] PsyQ Psychomed Programs, Dept Mood Disorders, The Hague, Netherlands; [Goekoop, Rutger] Parnassia Grp, The Hague, Netherlands; [Goekoop, Jaap G.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Parnassia Psychiatric Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goekoop, R (corresponding author), PsyQ Psychomed Programs, Dept Mood Disorders, The Hague, Netherlands.	R.Goekoop@PsyQ.nl			Parnassia Academy	Parnassia Academy	Funding: RG received funding of Parnassia Academy (http://www.parnassia-academie.nl/) that allowed him to devote some of his time (0.2fte) to doing research instead of providing healthcare as a clinical psychiatrist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2003, J AFFECT DISORDERS, V73, P7, DOI 10.1016/S0165-0327(02)00318-X; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P245, DOI 10.1016/j.jad.2004.12.004; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; ANGST J, 1993, INT CLIN PSYCHOPHARM, V8, P21, DOI 10.1097/00004850-199309001-00003; Asami T, 2013, SCHIZOPHR RES, V143, P253, DOI 10.1016/j.schres.2012.11.030; ASBERG M, 1979, PROG NEURO-PSYCHOPHA, V3, P405, DOI 10.1016/0364-7722(79)90055-9; Association AP, 1980, DIAGN STAT MAN MENT; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; BarabuYSi A., 2003, LINKED EVERYTHING IS; Bertschy G, 2008, PSYCHOPATHOLOGY, V41, P187, DOI 10.1159/000120987; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; BROPHY CJ, 1988, J PERS ASSESS, V52, P334, DOI 10.1207/s15327752jpa5202_14; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cassidy F, 1998, J AFFECT DISORDERS, V50, P187, DOI 10.1016/S0165-0327(98)00016-0; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; de Winter RFP, 2004, PSYCHIAT RES, V127, P111, DOI 10.1016/j.psychres.2004.03.010; Docx L, 2012, ACTA PSYCHIAT SCAND, V126, P256, DOI 10.1111/j.1600-0447.2012.01846.x; Emsley R, 2003, SCHIZOPHR RES, V61, P47, DOI 10.1016/S0920-9964(02)00302-X; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; EVERITT BS, 1971, BRIT J PSYCHIAT, V119, P399, DOI 10.1192/bjp.119.551.399; Goekoop JG, 2009, J PSYCHOPHARMACOL, V23, P891, DOI 10.1177/0269881108093584; Goekoop Jaap G, 2011, Depress Res Treat, V2011, P730295, DOI 10.1155/2011/730295; Goekoop JG, 2006, PSYCHIAT RES, V141, P201, DOI 10.1016/j.psychres.2005.09.003; GOEKOOP JG, 1994, ACTA PSYCHIAT SCAND, V90, P399, DOI 10.1111/j.1600-0447.1994.tb01614.x; GOEKOOP JG, 1991, ACTA PSYCHIAT SCAND, V83, P202, DOI 10.1111/j.1600-0447.1991.tb05525.x; GOEKOOP JG, 1992, ACTA PSYCHIAT SCAND, V86, P306, DOI 10.1111/j.1600-0447.1992.tb03271.x; Goekoop JG, 2011, DEPRESS RES TREAT, V2011; Goekoop R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051558; Griesinger Wilhelm, 1871, PATHOLOGIE THERAPIE, V3; Grunze H, 2013, WORLD J BIOL PSYCHIA, V14, P154, DOI 10.3109/15622975.2013.770551; Hantouche EG, 2003, J AFFECT DISORDERS, V73, P39, DOI 10.1016/S0165-0327(02)00319-1; Haslam N, 2012, PSYCHOL MED, V42, P903, DOI 10.1017/S0033291711001966; Hempel C, 1961, FIELD STUDIES MENTAL; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; Hirano S, 2002, J AFFECT DISORDERS, V69, P31, DOI 10.1016/S0165-0327(00)00329-3; Hoff P, 1999, EINFUHRUNG, pviii; HOFFMANN NG, 1978, J CONSULT CLIN PSYCH, V46, P1187, DOI 10.1037/0022-006X.46.6.1187; Huprich SK, 2007, J PERS ASSESS, V89, P3, DOI 10.1080/00223890701356904; Insel T, 2011, NIMH RES DOMAIN CRIT; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Jaspers K, 1997, SYMPTOM COMPLEXES SY; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; KF S, 2002, CLIN ETIOLOGICAL PSY; Kraepelin E, 1919, Z GESAMTE NEUROL PSY, V51, P224, DOI 10.1007/BF02899798; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Kruger S, 2003, COMPR PSYCHIAT, V44, P472, DOI 10.1016/S0010-440X(03)00108-1; Landsheer J. A., 2010, Structural Equation Modeling, V17, P703, DOI 10.1080/10705511.2010.510074; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Levine SZ, 2007, J CLIN PSYCHOPHARM, V27, P431, DOI 10.1097/jcp/.0b013e31814cfabd; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lowe JR, 2009, J PERS DISORD, V23, P211, DOI 10.1521/pedi.2009.23.3.211; Mayes R, 2005, J HIST BEHAV SCI, V41, P249, DOI 10.1002/jhbs.20103; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Pacchiarotti I, 2013, J AFFECT DISORDERS, V149, P56, DOI 10.1016/j.jad.2013.01.003; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Patrick CJ, 2013, J ABNORM PSYCHOL, V122, P902, DOI 10.1037/a0032807; Peralta V, 1999, SCHIZOPHR RES, V38, P13, DOI 10.1016/S0920-9964(99)00003-1; Peralta V, 1997, BIOL PSYCHIAT, V42, P806, DOI 10.1016/S0006-3223(96)00496-9; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Regier DA, 2009, AM J PSYCHIAT, V166, P645, DOI 10.1176/appi.ajp.2009.09020279; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Ross D, 2010, BEHAV BRAIN SCI, V33, P166, DOI 10.1017/S0140525X10000671; Roy AK, 2013, J AM ACAD CHILD PSY, V52, P290, DOI 10.1016/j.jaac.2012.12.010; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Schmittmann VDC A.O.J., 2011, NEW IDEAS PSYCHOL; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; STEER RA, 1994, J PERS ASSESS, V62, P525, DOI 10.1207/s15327752jpa6203_12; Strakowski SM, 2005, MOL PSYCHIATR, V10, P105, DOI 10.1038/sj.mp.4001585; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Troisfontaines B, 1987, Acta Psychiatr Belg, V87, P23; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; van der Gaag M, 2006, SCHIZOPHR RES, V85, P273, DOI 10.1016/j.schres.2006.04.001; van Os J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086652; van Praag H M, 2008, Tijdschr Psychiatr, V50, P171; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	90	54	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112734	10.1371/journal.pone.0112734	http://dx.doi.org/10.1371/journal.pone.0112734			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25427156	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400023
J	Rodrigues, ASL; Brooks, TM; Butchart, SHM; Chanson, J; Cox, N; Hoffmann, M; Stuart, SN				Rodrigues, Ana S. L.; Brooks, Thomas M.; Butchart, Stuart H. M.; Chanson, Janice; Cox, Neil; Hoffmann, Michael; Stuart, Simon N.			Spatially Explicit Trends in the Global Conservation Status of Vertebrates	PLOS ONE			English	Article							RED-LIST INDEX; BREEDING BIRDS; BIODIVERSITY; WORLDS; EXTINCTIONS; ECOREGIONS; ALLOCATION; IMPACT; LAND; MAP	The world's governments have committed to preventing the extinction of threatened species and improving their conservation status by 2020. However, biodiversity is not evenly distributed across space, and neither are the drivers of its decline, and so different regions face very different challenges. Here, we quantify the contribution of regions and countries towards recent global trends in vertebrate conservation status (as measured by the Red List Index), to guide action towards the 2020 target. We found that. 50% of the global deterioration in the conservation status of birds, mammals and amphibians is concentrated in,1% of the surface area, 39/1098 ecoregions (4%) and eight/195 countries (4%) - Australia, China, Colombia, Ecuador, Indonesia, Malaysia, Mexico, and the United States. These countries hold a third of global diversity in these vertebrate groups, partially explaining why they concentrate most of the losses. Yet, other megadiverse countries - most notably Brazil (responsible for 10% of species but just 1% of deterioration), plus India and Madagascar - performed better in conserving their share of global vertebrate diversity. Very few countries, mostly island nations (e.g. Cook Islands, Fiji, Mauritius, Seychelles, and Tonga), have achieved net improvements. Per capita wealth does not explain these patterns, with two of the richest countries - United States and Australia - fairing conspicuously poorly. Different countries were affected by different combinations of threats. Reducing global rates of biodiversity loss will require investment in the regions and countries with the highest responsibility for the world's biodiversity, focusing on conserving those species and areas most in peril and on reducing the drivers with the highest impacts.	[Rodrigues, Ana S. L.] CNRS, Ctr Ecol Fonct & Evolut, UMR5175, F-34293 Montpellier, France; [Brooks, Thomas M.; Chanson, Janice; Cox, Neil; Hoffmann, Michael; Stuart, Simon N.] IUCN, CH-1196 Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Cox, Neil; Stuart, Simon N.] Conservat Int, Arlington, VA 22202 USA; [Hoffmann, Michael; Stuart, Simon N.] United Nations, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Al Ain Zoo, Abu Dhabi, U Arab Emirates	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; Conservation International; University of Bath	Rodrigues, ASL (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR5175, 1919 Route Mende, F-34293 Montpellier, France.	ana.rodrigues@cefe.cnrs.fr	Rodrigues, Ana/GYQ-6273-2022; Butchart, Stuart/AAJ-1852-2021; Butchart, Stuart HM/Y-2711-2018; Rodrigues, Ana S.L./A-5914-2009; Hoffmann, Michael/E-6419-2010	Butchart, Stuart/0000-0002-1140-4049; Rodrigues, Ana S.L./0000-0003-4775-0127; Hoffmann, Michael/0000-0003-4785-2254; Brooks, Thomas/0000-0001-8159-3116	Gordon and Betty Moore Foundation; Critical Ecosystem Partnership Fund; Conservation International; BirdLife's Founder Patrons; Aage V. Jensen Charity Foundation; French National Research Agency [MORSE: ANR 11 CEPL 006 01]; NatureServe	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Critical Ecosystem Partnership Fund; Conservation International; BirdLife's Founder Patrons; Aage V. Jensen Charity Foundation; French National Research Agency(French National Research Agency (ANR)); NatureServe	This analysis is based on data compiled under the IUCN Red List of Threatened Species for bird, mammals and amphibians, an effort involving thousands of individuals over decades. This compilation was funded by a diversity of donors (full list in reference 7), and in particular by: Gordon and Betty Moore Foundation (http://www.moore.org/); Critical Ecosystem Partnership Fund (http://www.cepf.net); Conservation International (http://www.conservation.org); NatureServe (www.natureserve.org); BirdLife's Founder Patrons (http://www.birdlife.org/worldwide/partnership/major-donors-and-supporters); Aage V. Jensen Charity Foundation (www.avjf.dk). A.S.L.R. was funded by the French National Research Agency (project MORSE: ANR 11 CEPL 006 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Convention on Biological Diversity, 2010, BIOD TARG; GEF (Global Environment Facility), 2009, GEF 5 IN STAR ALL; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Herrando Sergi, 2013, Revista Catalana d'Ornitologia, V29, P20; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; International Monetary Fund, 2010, WORLD EC OUTL DAT; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Juslen A, 2013, CONSERV BIOL, V27, P398, DOI 10.1111/cobi.12016; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Miller DC, 2013, CONSERV LETT, V6, P12, DOI 10.1111/j.1755-263X.2012.00270.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pihl Stefan, 2011, Dansk Ornitologisk Forenings Tidsskrift, V105, P211; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Quayle JF, 2005, CONSERV BIOL, V19, P1306, DOI 10.1111/j.1523-1739.2005.00083.x; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Safford RJ, 1998, CONSERV BIOL, V12, P169, DOI 10.1046/j.1523-1739.1998.96177.x; Sahr K., 2003, CARTOGR GEOGR INF SC, V30, P121, DOI [10.1559/152304003100011090, DOI 10.1559/152304003100011090]; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Secretariat of the Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Sodhi NS, 2005, SE ASIAN BIODIVERSIT; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Szabo JK, 2012, BIOL CONSERV, V148, P61, DOI 10.1016/j.biocon.2012.01.062; *VLIZ, 2010, MAR BOUND GEOD VERS; Xu HG, 2009, BIOSCIENCE, V59, P843, DOI 10.1525/bio.2009.59.10.6	38	42	46	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113934	10.1371/journal.pone.0113934	http://dx.doi.org/10.1371/journal.pone.0113934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426636	Green Published, gold			2022-12-27	WOS:000349145400104
J	Claes, AK; Steck, N; Schultz, D; Zahringer, U; Lipinski, S; Rosenstiel, P; Geddes, K; Philpott, DJ; Heine, H; Grassl, GA				Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Zaehringer, Ulrich; Lipinski, Simone; Rosenstiel, Philip; Geddes, Kaoru; Philpott, Dana J.; Heine, Holger; Grassl, Guntram A.			Salmonella enterica serovar Typhimurium Delta msbB Triggers Exacerbated Inflammation in Nod2 Deficient Mice	PLOS ONE			English	Article							INSERTION/DELETION POLYMORPHISM; ADAPTIVE IMMUNITY; DENDRITIC CELLS; CROHNS-DISEASE; BOWEL-DISEASE; COLITIS MODEL; INNATE; BACTERIAL; ASSOCIATION; INDUCTION	The intracellular pathogen Salmonella enterica serovar Typhimurium causes intestinal inflammation characterized by edema, neutrophil influx and increased pro-inflammatory cytokine expression. A major bacterial factor inducing pro-inflammatory host responses is lipopolysaccharide (LPS). S. Typhimurium Delta msbB possesses a modified lipid A, has reduced virulence in mice, and is being considered as a potential anti-cancer vaccine strain. The lack of a late myristoyl transferase, encoded by MsbB leads to attenuated TLR4 stimulation. However, whether other host receptor pathways are also altered remains unclear. Nod1 and Nod2 are cytosolic pattern recognition receptors recognizing bacterial peptidoglycan. They play important roles in the host's immune response to enteric pathogens and in immune homeostasis. Here, we investigated how deletion of msbB affects Salmonella's interaction with Nod1 and Nod2. S. Typhimurium Delta msbB-induced inflammation was significantly exacerbated in Nod2(-/-) mice compared to C57Bl/6 mice. In addition, S. Typhimurium Delta msbB maintained robust intestinal colonization in Nod2(-/-) mice from day 2 to day 7 p. i., whereas colonization levels significantly decreased in C57Bl/6 mice during this time. Similarly, infection of Nod2(-/-) and Nod1/Nod2 double-knockout mice revealed that both Nod1 and Nod2 play a protective role in S. Typhimurium DmsbB-induced an exacerbated inflammatory response in Nod2(-/-) mice, we used HEK293 cells which were transiently transfected with pathogen recognition receptors.Stimulation of TLR2-transfected cells with S. Typhimurium Delta msbB resulted in increased IL-8 production compared to wild-type S. Typhimurium. Our results indicate that S. Typhimurium DmsbB triggers exacerbated colitis in the absence of Nod1 and/or Nod2, which is likely due to increased TLR2 stimulation. How bacteria with "genetically detoxified'' LPS stimulate various innate responses has important implications for the development of safe and effective bacterial vaccines and adjuvants.	[Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Grassl, Guntram A.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Claes, Anne-Kathrin; Steck, Natalie; Schultz, Dorothee; Grassl, Guntram A.] Res Ctr Borstel, Div Models Inflammat, Borstel, Germany; [Zaehringer, Ulrich] Res Ctr Borstel, Div Immunochem, Borstel, Germany; [Lipinski, Simone; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Geddes, Kaoru; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Heine, Holger] Res Ctr Borstel, Div Innate Immun, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel; University of Toronto; Forschungszentrum Borstel	Grassl, GA (corresponding author), Univ Kiel, Inst Expt Med, Kiel, Germany.	g.grassl@iem.uni-kiel.de	Lipinski, Simone/HHY-9238-2022; Lipinski, Simone/L-9818-2017; Rosenstiel, Philip/A-5137-2009; Heine, Holger/H-4552-2012	Lipinski, Simone/0000-0002-9322-7372; Rosenstiel, Philip/0000-0002-9692-8828; Heine, Holger/0000-0001-8128-5068	German Research Foundation (DFG) Excellence Cluster "Inflammation at Interfaces" [EXC306GTP4]	German Research Foundation (DFG) Excellence Cluster "Inflammation at Interfaces"	This work was supported by the German Research Foundation (DFG) (www.dfg.de) Excellence Cluster "Inflammation at Interfaces" (grant# EXC306GTP4) to GAG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Borm MEA, 2008, GENES IMMUN, V9, P274, DOI 10.1038/gene.2008.9; Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Franke A, 2006, GUT, V55, P1679, DOI 10.1136/gut.2006.104646; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; Hedl M, 2013, MUCOSAL IMMUNOL, V6, P205, DOI 10.1038/mi.2012.139; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; Hiemstra IH, 2012, MOL IMMUNOL, V52, P264, DOI 10.1016/j.molimm.2012.06.007; HORMAECHE CE, 1979, IMMUNOLOGY, V37, P311; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kong QK, 2011, INFECT IMMUN, V79, P5027, DOI 10.1128/IAI.05524-11; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; Le Bourhis L, 2009, INFECT IMMUN, V77, P4480, DOI 10.1128/IAI.00519-09; Liu T, 2010, CANCER GENE THER, V17, P97, DOI 10.1038/cgt.2009.58; Loetscher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034812; Matsuura M, 2012, INNATE IMMUN-LONDON, V18, P764, DOI 10.1177/1753425912440599; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rubino SJ, 2012, CURR OPIN IMMUNOL, V24, P398, DOI 10.1016/j.coi.2012.04.010; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Selvanantham T, 2013, J IMMUNOL, V191, P5646, DOI 10.4049/jimmunol.1301412; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Wang YF, 2007, J DIGEST DIS, V8, P121, DOI 10.1111/j.1443-9573.2007.00296.x; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113645	10.1371/journal.pone.0113645	http://dx.doi.org/10.1371/journal.pone.0113645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423082	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700046
J	Park, CH; Skarra, DV; Rivera, AJ; Arriola, DJ; Thackray, VG				Park, Chung Hyun; Skarra, Danalea V.; Rivera, Alissa J.; Arriola, David J.; Thackray, Varykina G.			Constitutively Active FOXO1 Diminishes Activin Induction of Fshb Transcription in Immortalized Gonadotropes	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; BETA-GENE-EXPRESSION; GROWTH-FACTOR-I; LUTEINIZING-HORMONE; FORKHEAD TRANSCRIPTION; PITUITARY-CELLS; SUBUNIT GENE; DNA-BINDING; SIGNAL-TRANSDUCTION; PROMOTER ELEMENT	In the present study, we investigate whether the FOXO1 transcription factor modulates activin signaling in pituitary gonadotropes. Our studies show that overexpression of constitutively active FOXO1 decreases activin induction of murine Fshb gene expression in immortalized L beta T2 cells. We demonstrate that FOXO1 suppression of activin induction maps to the -304/-95 region of the Fshb promoter containing multiple activin response elements and that the suppression requires the FOXO1 DNA-binding domain (DBD). FOXO1 binds weakly to the -125/-91 region of the Fshb promoter in a gel-shift assay. Since this region of the promoter contains a composite SMAD/FOXL2 binding element necessary for activin induction of Fshb transcription, it is possible that FOXO1 DNA binding interferes with SMAD and/or FOXL2 function. In addition, our studies demonstrate that FOXO1 directly interacts with SMAD3/4 but not SMAD2 in a FOXO1 DBD-dependent manner. Moreover, we show that SMAD3/4 induction of Fshb-luc and activin induction of a multimerized SMAD-binding element-luc are suppressed by FOXO1 in a DBD-dependent manner. These results suggest that FOXO1 binding to the proximal Fshb promoter as well as FOXO1 interaction with SMAD3/4 proteins may result in decreased activin induction of Fshb in gonadotropes.	[Thackray, Varykina G.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Thackray, VG (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	vthackray@ucsd.edu		Park, Chung Hyun/0000-0001-9579-7566	National Institutes of Health [K01 DK080467, R01 HD067448, T32 HD007203, F32 HD074414]; University of California, San Diego/University of California, Los Angeles Diabetes Research Center [P30 DK063491]; National Institute of Child Health and Human Development through Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; University of California, San Diego Academic Senate Health Sciences Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, F32HD074414, R01HD067448, P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080467, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego/University of California, Los Angeles Diabetes Research Center; National Institute of Child Health and Human Development through Specialized Cooperative Centers Program in Reproduction and Infertility Research; University of California, San Diego Academic Senate Health Sciences Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants K01 DK080467 and R01 HD067448 to V.G.T. as well as T32 HD007203 and F32 HD074414 to D.V.S. This work was also supported by a pilot and feasibility grant from the University of California, San Diego/University of California, Los Angeles Diabetes Research Center (P30 DK063491), by the National Institute of Child Health and Human Development through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and by a University of California, San Diego Academic Senate Health Sciences Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; Apter D, 1997, ANN NY ACAD SCI, V816, P9, DOI 10.1111/j.1749-6632.1997.tb52125.x; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Buggs C, 2006, MOL CELL ENDOCRINOL, V249, P99, DOI 10.1016/j.mce.2006.02.001; Burns KH, 2002, ENDOCRINOLOGY, V143, P2823, DOI 10.1210/en.143.8.2823; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Choi YS, 2014, ENDOCRINOLOGY, V155, P2277, DOI 10.1210/en.2013-1177; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Coss D, 2007, MOL ENDOCRINOL, V21, P3071, DOI 10.1210/me.2007-0247; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Dorn C, 2004, AM J OBSTET GYNECOL, V191, P132, DOI 10.1016/j.ajog.2004.01.054; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Fortin J, 2014, FASEB J; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregory SJ, 2005, MOL ENDOCRINOL, V19, P237, DOI 10.1210/me.2003-0473; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ho CC, 2010, ENDOCRINOLOGY, V151, P3445, DOI 10.1210/en.2010-0071; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Leblanc P, 1997, ENDOCRINOLOGY, V138, P574, DOI 10.1210/en.138.2.574; Liu ZL, 2013, MOL ENDOCRINOL, V27, P238, DOI 10.1210/me.2012-1296; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Mazhawidza W, 2006, HISTOL HISTOPATHOL, V21, P167, DOI 10.14670/HH-21.167; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Norwitz ER, 2002, ENDOCRINOLOGY, V143, P985, DOI 10.1210/en.143.3.985; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Rosenberg SB, 2002, MOL ENDOCRINOL, V16, P1280, DOI 10.1210/me.16.6.1280; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Skarra DV, 2013, MOL ENDOCRINOL, V27, P1825, DOI 10.1210/me.2013-1185; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; SOLDANI R, 1994, EUR J ENDOCRINOL, V131, P641, DOI 10.1530/eje.0.1310641; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thackray VG, 2006, MOL ENDOCRINOL, V20, P2062, DOI 10.1210/me.2005-0316; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Xia YX, 2001, EUR J ENDOCRINOL, V144, P73, DOI 10.1530/eje.0.1440073; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732; Zhang H, 2006, MOL ENDOCRINOL, V20, P2909, DOI 10.1210/me.2006-0109; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	64	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113839	10.1371/journal.pone.0113839	http://dx.doi.org/10.1371/journal.pone.0113839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423188	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700072
J	Yang, CX; Pan, HP; Liu, Y; Zhou, XG				Yang, Chunxiao; Pan, Huipeng; Liu, Yong; Zhou, Xuguo			Selection of Reference Genes for Expression Analysis Using Quantitative Real-Time PCR in the Pea Aphid, Acyrthosiphon pisum (Harris) (Hemiptera, Aphidiae)	PLOS ONE			English	Article								To facilitate gene expression study and obtain accurate qRT-PCR analysis, normalization relative to stable expressed housekeeping genes is required. In this study, expression profiles of 11 candidate reference genes, including actin (Actin), elongation factor 1 alpha (EF1A), TATA-box-binding protein (TATA), ribosomal protein L12 (RPL12), beta-tubulin (Tubulin), NADH dehydrogenase (NADH), vacuolar-type H+-ATPase (v-ATPase), succinate dehydrogenase B (SDHB), 28S ribosomal RNA (28S), 16S ribosomal RNA (16S), and 18S ribosomal RNA (18S) from the pea aphid Acyrthosiphon pisum, under different developmental stages and temperature conditions, were investigated. A total of four analytical tools, geNorm, Normfinder, BestKeeper, and the Delta C-t method, were used to evaluate the suitability of these genes as endogenous controls. According to RefFinder, a web-based software tool which integrates all four above-mentioned algorithms to compare and rank the reference genes, SDHB, 16S, and NADH were the three most stable house-keeping genes under different developmental stages and temperatures. This work is intended to establish a standardized qRT-PCR protocol in pea aphid and serves as a starting point for the genomics and functional genomics research in this emerging insect model.	[Yang, Chunxiao; Liu, Yong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China; [Yang, Chunxiao; Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Academy of Agricultural Sciences; University of Kentucky	Liu, Y (corresponding author), Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China.	haoasliu@163.com; xuguozhou@uky.edu			University of Kentucky; USDA BRAG [3048108827]; Special Fund for Agroscience Research in the Public Interest [201303028]	University of Kentucky; USDA BRAG; Special Fund for Agroscience Research in the Public Interest	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ, and a Special Fund for Agroscience Research in the Public Interest (Award Agreement No.: 201303028) to YL. The granting agencies have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Walsh TK, 2010, INSECT MOL BIOL, V19, P215, DOI 10.1111/j.1365-2583.2009.00974.x; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	20	60	64	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e110454	10.1371/journal.pone.0110454	http://dx.doi.org/10.1371/journal.pone.0110454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423476	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700002
J	Bolognesi, C; Bruzzi, P; Gismondi, V; Volpi, S; Viassolo, V; Pedemonte, S; Varesco, L				Bolognesi, Claudia; Bruzzi, Paolo; Gismondi, Viviana; Volpi, Samantha; Viassolo, Valeria; Pedemonte, Simona; Varesco, Liliana			Clinical Application of Micronucleus Test: A Case-Control Study on the Prediction of Breast Cancer Risk/Susceptibility	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; BRCA2 MUTATION CARRIERS; CHROMOSOMAL RADIOSENSITIVITY; DNA-DAMAGE; IN-VITRO; FREQUENCY; ASSAY; RISK; PREDISPOSITION; SUSCEPTIBILITY	The micronucleus test is a well-established DNA damage assay in human monitoring. The test was proposed as a promising marker of cancer risk/susceptibility mainly on the basis of studies on breast cancer. Our recent meta-analysis showed that the association between micronuclei frequency, either at baseline or after irradiation, and breast cancer risk or susceptibility, has been evaluated in few studies of small size, with inconsistent results. The aim of the present study is to investigate the role of micronucleus assay in evaluating individual breast cancer susceptibility. Two-hundred and twenty untreated breast cancer patients and 295 female controls were enrolled in the study. All women were characterized for cancer family history and 155 subjects were evaluated for the presence of BRCA mutations. Micronuclei frequency was evaluated at baseline and after irradiation with 1-Gy gamma rays from a 137Cs source. The results show a non significant increase of frequency of micronucleated binucleated lymphocytes in cancer patients compared with the controls at baseline (Mean (S.E.): 16.8 (0.7) vs 15.7 (0.5), but not after irradiation (Mean (S.E.): 145.8 (3.0) vs 154.0 (2.6)). Neither a family history of breast cancer nor the presence of a pathogenic mutation in BRCA1/2 genes were associated with an increased micronuclei frequency. Our results do not support a significant role of micronucleus frequency as a biomarker of breast cancer risk/susceptibility.	[Bolognesi, Claudia; Volpi, Samantha; Pedemonte, Simona] IRCCS San Martino, IST Ist Nazl Ric Cancro, Unit Environm Carcinogenesis, Genoa, Italy; [Bruzzi, Paolo] IRCCS San Martino, IST Ist Nazl Ric Cancro, Clin Epidemiol Unit, Genoa, Italy; [Gismondi, Viviana; Viassolo, Valeria; Varesco, Liliana] IRCCS San Martino, IST Ist Nazl Ric Cancro, Unit Hereditary Canc, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Bruzzi, P (corresponding author), IRCCS San Martino, IST Ist Nazl Ric Cancro, Clin Epidemiol Unit, Genoa, Italy.	paolo.bruzzi@hsanmartino.it	Varesco, Liliana/AAF-6521-2019; Bruzzi, Paolo/AAU-3363-2021	Varesco, Liliana/0000-0003-4871-6668; Bruzzi, Paolo/0000-0002-7874-2077; Viassolo, Valeria/0000-0002-8738-7492; Gismondi, Viviana/0000-0002-1115-0325	Italian Association for Research on Cancer (AIRC) [IG 5706 2008]	Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Funding: This work was funded by the Italian Association for Research on Cancer (AIRC), (Project IG 5706 2008 to PB CB LV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi MG, 2011, MUTAGENESIS, V26, P77, DOI 10.1093/mutage/geq077; Baeyens A, 2004, INT J RADIAT BIOL, V80, P745, DOI 10.1080/09553000400017937; Baeyens A, 2002, BRIT J CANCER, V87, P1379, DOI 10.1038/sj.bjc.6600628; Baria K, 2001, BRIT J CANCER, V84, P892, DOI 10.1054/bjoc.2000.1701; Barwell J, 2007, INT J CANCER, V121, P1631, DOI 10.1002/ijc.22915; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Burrill W, 2000, INT J RADIAT BIOL, V76, P1617, DOI 10.1080/09553000050201109; Cardinale F, 2012, BRIT J CANCER, V106, P780, DOI 10.1038/bjc.2011.567; Depuydt J, 2013, INT J RADIAT BIOL, V89, P532, DOI 10.3109/09553002.2013.782447; El-Zein R, 2011, MUTAGENESIS, V26, P101, DOI 10.1093/mutage/geq071; El-Zein RA, 2006, CANCER RES, V66, P6449, DOI 10.1158/0008-5472.CAN-06-0326; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P45, DOI 10.1016/S1383-5718(02)00248-6; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050; Finnon P, 2012, RADIOTHER ONCOL, V105, P329, DOI 10.1016/j.radonc.2012.10.007; HEDDLE JA, 1978, CANCER RES, V38, P2983; IAEA, 2011, EPR BIOD CYT DOS APP; Maffei F, 2014, MUTAGENESIS, V29, P221, DOI 10.1093/mutage/geu007; Maluf SW, 2001, CANCER GENET CYTOGEN, V124, P71, DOI 10.1016/S0165-4608(00)00322-8; McHugh MK, 2013, CANCER EPIDEM BIOMAR, V22, P135, DOI 10.1158/1055-9965.EPI-12-0435; Migliore L, 2011, MUTAGENESIS, V26, P85, DOI 10.1093/mutage/geq067; Murgia E, 2008, MUTAT RES-FUND MOL M, V639, P27, DOI 10.1016/j.mrfmmm.2007.10.010; OECD Library, 2010, OECD GUID TEST CHEM; Patel RK, 1997, INT J CANCER, V73, P20, DOI 10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Rothfuss A, 2000, CANCER RES, V60, P390; Scott D, 1998, BRIT J CANCER, V77, P614, DOI 10.1038/bjc.1998.98; Scott D, 1996, INT J RADIAT BIOL, V70, P521, DOI 10.1080/095530096144725; Scott D, 1999, INT J RADIAT BIOL, V75, P1, DOI 10.1080/095530099140744; Terzoudi GI, 2000, INT J RADIAT BIOL, V76, P607, DOI 10.1080/095530000138268; Trenz K, 2003, MUTAT RES-REV MUTAT, V544, P279, DOI 10.1016/j.mrrev.2003.06.011; Trenz K, 2002, MUTAT RES-FUND MOL M, V500, P89, DOI 10.1016/S0027-5107(01)00300-1; Varga D, 2006, MUTAGENESIS, V21, P313, DOI 10.1093/mutage/gel035; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang LE, 2012, BREAST CANCER RES TR, V132, P1147, DOI 10.1007/s10549-011-1940-1; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112354	10.1371/journal.pone.0112354	http://dx.doi.org/10.1371/journal.pone.0112354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415331	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600010
J	Li, D; Wei, LX; Xu, BH; Yu, DK; Chang, J; Yuan, P; Du, ZL; Tan, W; Shen, HB; Wu, TC; Wu, C; Lin, DX				Li, Dong; Wei, Lixuan; Xu, Binghe; Yu, Dianke; Chang, Jiang; Yuan, Peng; Du, Zhongli; Tan, Wen; Shen, Hongbing; Wu, Tangchun; Wu, Chen; Lin, Dongxin			Association of GWAS-Identified Lung Cancer Susceptibility Loci with Survival Length in Patients with Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; RISK; ADENOCARCINOMA; POPULATION; PROGNOSIS; CARCINOMA; JAPANESE; SMOKING; MATTERS	Genetic variants have been shown to affect length of survival in cancer patients. This study explored the association between lung cancer susceptibility loci tagged by single-nucleotide polymorphisms (SNPs) identified in the genome-wide association studies and length of survival in small-cell lung cancer (SCLC). Eighteen SNPs were genotyped among 874 SCLC patients and Cox proportional hazards regression was used to examine the effects of genotype on survival length under an additive model with age, sex, smoking status and clinical stage as covariates. We identified 3 loci, 20q13.2 (rs4809957G >A), 22q12.2 (rs36600C >T) and 5p15.33 (rs401681C >T), significantly associated with the survival time of SCLC patients. The adjusted hazard ratio (HR) for patients with the rs4809957 GA or AA genotype was 0.80 (95% CI, 0.66-0.96; P=0.0187) and 0.73 (95% CI, 0.55-0.96; P=0.0263) compared with the GG genotype. Using the dominant model, the adjusted HR for patients carrying at least one T allele at rs36600 or rs401681 was 0.78 (95% CI, 0.63-0.96; P=0.0199) and 1.29 (95% CI, 1.08-1.55; P=0.0047), respectively, compared with the CC genotype. Stratification analyses showed that the significant associations of these 3 loci were only seen in smokers and male patients. The rs4809957 SNP was only significantly associated with length of survival of patients with extensive-stage but not limited-stage tumor. These results suggest that some of the lung cancer susceptibility loci might also affect the prognosis of SCLC.	[Li, Dong; Wei, Lixuan; Wu, Chen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Li, Dong; Wei, Lixuan; Xu, Binghe; Yu, Dianke; Chang, Jiang; Du, Zhongli; Tan, Wen; Wu, Chen; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Dong; Yu, Dianke; Chang, Jiang; Du, Zhongli; Tan, Wen; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Xu, Binghe] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Nanjing Medical University; Huazhong University of Science & Technology	Wu, C (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	chenwu@cicams.ac.cn; lindx72@cicams.ac.cn		Lin, Dongxin/0000-0002-8723-8868; wei, lixuan/0000-0001-7465-7513; Wu, Chen/0000-0003-4954-1011	National High-Tech Research and Development Program of China [B02126-2]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work is funded by National High-Tech Research and Development Program of China (B02126-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Chen GA, 2011, CLIN CANCER RES, V17, P817, DOI 10.1158/1078-0432.CCR-10-1789; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Gallagher DJ, 2010, CLIN CANCER RES, V16, P2819, DOI 10.1158/1078-0432.CCR-10-0028; Haiman CA, 2011, NAT GENET; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu LM, 2012, CLIN CANCER RES, V18, P5507, DOI 10.1158/1078-0432.CCR-12-1202; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Kuo YZ, 2013, ORAL DIS; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mimori K, 2004, ANN ONCOL, V15, P236, DOI 10.1093/annonc/mdh056; Ni ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052598; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pollitzer E, 2013, NATURE, V500, P23, DOI 10.1038/500023a; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Shiraishi K, 2012, NAT GENET, V44, P900, DOI 10.1038/ng.2353; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Wu C, 2010, CANCER RES, V70, P9721, DOI 10.1158/0008-5472.CAN-10-1493; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Yin J, 2012, PLOS ONE, V7, P30; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612	33	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113574	10.1371/journal.pone.0113574	http://dx.doi.org/10.1371/journal.pone.0113574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415319	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600058
J	Dao, X; Wang, Z; Lv, YB; Teng, EJ; Zhang, LL; Wang, C				Dao, Xu; Wang, Zhen; Lv, Yibing; Teng, Enjiang; Zhang, Linlin; Wang, Chao			Chemical Characteristics of Water-Soluble Ions in Particulate Matter in Three Metropolitan Areas in the North China Plain	PLOS ONE			English	Article							SOURCE APPORTIONMENT; SEASONAL-VARIATIONS; ATMOSPHERIC PARTICLES; SIZE DISTRIBUTIONS; FINE PARTICLES; AIR-POLLUTION; MASS CLOSURE; PM2.5; AEROSOL; PM10	PM2.5 and PM10 samples were collected simultaneously in each season in Beijing, Tianjin and Shijiazhuang to identify the characteristics of water-soluble ion compositions in the North China Plain. The water-soluble ions displayed significant seasonal variation. The dominant ions were NO3-, SO42-, NH4+ and Cl-, accounting for more than 90% and 86% to the mass of total water- soluble ions in PM2.5 and PM10, respectively. The anion/cation ratio indicated that the ion acidity of each city varied both between sites and seasonally. Over 50% of the ion species were enriched in small particles <= 1 mu m in diameter. The [NO3-]/[SO42-] ratio indicated that vehicles accounted for the majority of the particulate pollution in Beijing. Shijiazhuang, a city highly reliant on coal combustion, had a higher SO42- concentration.	[Dao, Xu; Lv, Yibing; Teng, Enjiang; Zhang, Linlin; Wang, Chao] China Natl Environm Monitoring Ctr, Beijing, Peoples R China; [Wang, Zhen] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Hubei, Peoples R China; [Wang, Zhen] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Wuhan University; University of California System; University of California Santa Barbara	Wang, Z (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Hubei, Peoples R China.	sinoo.whu@gmail.com	Wang, Zhen/V-2047-2019; Wang, Zhen/V-2219-2019	Wang, Zhen/0000-0002-7902-4093	National Natural Science Foundation of China [41101567]; State Scholarship Fund of China Scholarship Council [201308420277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (Grant No. 41101567) to ZW. The authors also thank the financial award from State Scholarship Fund of China Scholarship Council (File No. 201308420277) to support the research at UCSB (to ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian R, 2013, ATMOS ENVIRON, V78, P268, DOI 10.1016/j.atmosenv.2011.10.066; Beijing Municipal Bureau of Statistics, 2013, BEIJ STAT YB 2013; Bellouin N, 2005, NATURE, V438, P1138, DOI 10.1038/nature04348; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671; Chen J, 2014, AEROSOL AIR QUAL RES, V14, P260, DOI 10.4209/aaqr.2012.12.0360; Contini D, 2014, SCI TOTAL ENVIRON, V472, P248, DOI 10.1016/j.scitotenv.2013.10.127; Fan J, 2014, J ENVIRON SCI, V26, P353, DOI 10.1016/S1001-0742(13)60431-3; Gao J, 2014, J ENVIRON SCI, V26, P44, DOI 10.1016/S1001-0742(13)60379-4; Gao QingXian, 2002, China Environmental Science, V22, P468; GRAY HA, 1986, ENVIRON SCI TECHNOL, V20, P580, DOI 10.1021/es00148a006; Gu JX, 2010, AEROSOL AIR QUAL RES, V10, P167, DOI 10.4209/aaqr.2009.12.0080; Guo YT, 2011, J ATMOS CHEM, V68, P299, DOI 10.1007/s10874-012-9223-8; Han TT, 2014, ATMOS RES, V137, P25, DOI 10.1016/j.atmosres.2013.10.004; He KB, 2001, ATMOS ENVIRON, V35, P4959, DOI 10.1016/S1352-2310(01)00301-6; Heo JB, 2009, ATMOS CHEM PHYS, V9, P4957, DOI 10.5194/acp-9-4957-2009; Ho KF, 2006, SCI TOTAL ENVIRON, V355, P276, DOI 10.1016/j.scitotenv.2005.03.013; Huang Z, 2004, ATMOS RES, V71, P215, DOI 10.1016/j.atmosres.2004.05.002; Hughes LS, 1999, ENVIRON SCI TECHNOL, V33, P3506, DOI 10.1021/es980884a; Karthikeyan S, 2006, MICROCHEM J, V82, P49, DOI 10.1016/j.microc.2005.07.003; Kawashima H, 2011, ATMOS ENVIRON, V45, P6309, DOI 10.1016/j.atmosenv.2011.08.057; Khan MF, 2010, ATMOS ENVIRON, V44, P2646, DOI 10.1016/j.atmosenv.2010.03.040; Kong LD, 2014, J GEOPHYS RES-ATMOS, V119, P341, DOI 10.1002/2013JD020222; Lai SC, 2007, J ENVIRON SCI, V19, P939, DOI 10.1016/S1001-0742(07)60155-7; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Li XR, 2012, ATMOS ENVIRON, V50, P278, DOI 10.1016/j.atmosenv.2011.12.021; Liu J, 2011, ENV SCI, V29, P1059; Lopez-Villarrubia E, 2012, ENVIRON RES, V112, P129, DOI 10.1016/j.envres.2011.10.005; Martins LD, 2012, ENVIRON MONIT ASSESS, V184, P2663, DOI 10.1007/s10661-011-2142-3; Mkoma SL, 2014, FUEL, V115, P109, DOI 10.1016/j.fuel.2013.06.044; Ni TR, 2013, AEROSOL AIR QUAL RES, V13, P1832, DOI 10.4209/aaqr.2012.10.0283; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Rogula-Kozlowska W, 2014, AIR QUAL ATMOS HLTH, V7, P41, DOI 10.1007/s11869-013-0222-y; Satsangi A, 2013, AEROSOL AIR QUAL RES, V13, P1877, DOI 10.4209/aaqr.2012.08.0227; Shen JL, 2011, ATMOS ENVIRON, V45, P5033, DOI 10.1016/j.atmosenv.2011.02.031; Shen Z, 2013, ENVIRON SCI POLLUT R, V21, P3697; Shi Y, 2014, INT J INF TECH DECIS, V13, P1, DOI 10.1142/S0219622014010019; Shijiazhuang Municipal Bureau of Statistics Survey Office of the National Bureau of Statistics in Shijiazhuang, 2013, SHIJ STAT YB 2013; Shon ZH, 2013, ATMOS RES, V132, P309, DOI 10.1016/j.atmosres.2013.06.003; Song Y, 2006, SCI TOTAL ENVIRON, V372, P278, DOI 10.1016/j.scitotenv.2006.08.041; Sun Ying, 2011, Huanjing Kexue, V32, P2732; TANG IN, 1993, ATMOS ENVIRON A-GEN, V27, P467, DOI 10.1016/0960-1686(93)90204-C; Tao J, 2014, ATMOS RES, V135, P48, DOI 10.1016/j.atmosres.2013.08.015; Tianjin Municipal Bureau of Statistics & Survey office of National Bureau of Statistics in Tianjin, 2013, TIANJ STAT YB 2013; United States Environmental Protection Agency, 2004, AIR QUAL CRIT PART M, VI, P1; Wang HL, 2008, J ENVIRON SCI, V20, P1323, DOI 10.1016/S1001-0742(08)62228-7; Wang L, 2013, ATMOS RES, V127, P22, DOI 10.1016/j.atmosres.2013.02.011; Wang SX, 2011, ENVIRON SCI TECHNOL, V45, P9293, DOI 10.1021/es2022347; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Wang ZS, 2012, AEROSOL AIR QUAL RES, V12, P39, DOI 10.4209/aaqr.2011.04.0045; World Health Organization, 2006, AIR QUAL GUID GLOB U; Xu GJ, 2013, J GEOPHYS RES-ATMOS, V118, P13303, DOI 10.1002/2013JD019496; Yao XH, 2003, ATMOS ENVIRON, V37, P2991, DOI 10.1016/S1352-2310(03)00255-3; Yao XH, 2002, ATMOS ENVIRON, V36, P4223, DOI 10.1016/S1352-2310(02)00342-4; Yin LQ, 2014, ENVIRON SCI POLLUT R, V21, P5141, DOI 10.1007/s11356-013-2134-7; Zhang F, 2014, ATMOS ENVIRON, V86, P193, DOI 10.1016/j.atmosenv.2013.12.008; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461; Zhang YM, 2013, SCI CHINA EARTH SCI, V56, P890, DOI 10.1007/s11430-012-4515-z; Zhou JM, 2012, AEROSOL AIR QUAL RES, V12, P492, DOI 10.4209/aaqr.2011.11.0218	60	31	32	11	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113831	10.1371/journal.pone.0113831	http://dx.doi.org/10.1371/journal.pone.0113831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437210	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900082
J	Matz, J; Herate, C; Bouchet, J; Dusetti, N; Gayet, O; Baty, D; Benichou, S; Chames, P				Matz, Julie; Herate, Cecile; Bouchet, Jerome; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Benichou, Serge; Chames, Patrick			Selection of Intracellular Single-Domain Antibodies Targeting the HIV-1 Vpr Protein by Cytoplasmic Yeast Two-Hybrid System	PLOS ONE			English	Article							IN-VITRO; PHAGE DISPLAY; LIFE-CYCLE; INTRABODIES; REPLICATION; FRAGMENT; INHIBITORS; ANTIGEN; BINDING; MATRIX	The targeting of HIV-1 using antibodies is of high interest as molecular tools to better understand the biology of the virus or as a first step toward the design of new inhibitors targeting critical viral intracellular proteins. Small and highly stable llama-derived single-domain antibodies can often be functionally expressed as intracellular antibodies in the cytoplasm of eukaryotic cells. Using a selection method based on the Sos Recruitment System, a cytoplasmic yeast two-hybrid approach, we have isolated single-domain antibodies able to bind HIV-1 Vpr and Capside proteins in the yeast cytoplasm. One anti-Vpr single domain antibody was able to bind the HIV-1 regulatory Vpr protein in the cytoplasm of eukaryotic cells, leading to its delocalization from the nucleus to the cytoplasm. To our knowledge, this is the first description of a functional single-domain intrabody targeting HIV-1 Vpr, isolated using an in vivo cytoplasmic selection method that alleviates some limitations of the conventional yeast two-hybrid system.	[Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Inserm U1068, CRCM, Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Aix Marseille Univ UM105, Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] CNRS, UMR7258, CRCM, Marseille, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] CNRS UMR8104, Inst Cochin, Paris, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Paris, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] Inserm U1016, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chames, P (corresponding author), Inserm U1068, CRCM, Marseille, France.	patrick.chames@inserm.fr	bouchet, jerome/I-7716-2019; Dusetti, Nelson/O-7919-2017; Chames, Patrick/R-1800-2016	bouchet, jerome/0000-0002-6611-4380; Dusetti, Nelson/0000-0002-6161-8483; Chames, Patrick/0000-0002-6104-6286; Benichou, Serge/0000-0003-3602-3530; Baty, Daniel/0000-0001-8443-4444	Inserm; CNRS; Universite Paris-Descartes; "Agence Nationale de Recherche sur le SIDA (ANRS)"; ANRS	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; "Agence Nationale de Recherche sur le SIDA (ANRS)"(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by Inserm, CNRS, Universite Paris-Descartes, and grants from the "Agence Nationale de Recherche sur le SIDA (ANRS)" (SB, DB). JM was supported by a fellowship from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1995, TRENDS BIOCHEM SCI, V20, P511, DOI 10.1016/S0968-0004(00)89119-7; Alzogaray V, 2011, FASEB J, V25, P526, DOI 10.1096/fj.10-162958; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Behar G, 2009, FEBS J, V276, P4305, DOI 10.1111/j.1742-4658.2009.07101.x; Bouchet J, 2012, J VIROL; Bouchet J, 2011, BLOOD, V117, P3559, DOI 10.1182/blood-2010-07-296749; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Fu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056222; Ghosh RK, 2011, EXPERT OPIN PHARMACO, V12, P31, DOI 10.1517/14656566.2010.509345; Guenzel CA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00127; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacquot G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007514; Jarviluoma A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040331; Krichevsky A, 2003, VIROLOGY, V305, P77, DOI 10.1006/viro.2002.1765; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Levin R, 1997, MOL MED, V3, P96, DOI 10.1007/BF03401802; Matz J, 2013, J VIROL, V87, P1137, DOI 10.1128/JVI.00461-12; Mhashilkar AM, 1999, HUM GENE THER, V10, P1453, DOI 10.1089/10430349950017798; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Muyldermans S, 2001, J Biotechnol, V74, P277; Pellis M, 2012, ARCH BIOCHEM BIOPHYS, V526, P114, DOI 10.1016/j.abb.2012.04.023; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seillier M, 2012, CELL DEATH DIFFER; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Vercruysse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060259; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Vielemeyer O, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-59; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	42	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113729	10.1371/journal.pone.0113729	http://dx.doi.org/10.1371/journal.pone.0113729			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436999	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900070
J	Tom, M; Fletcher, TD; McCarthy, DT				Tom, Minna; Fletcher, Tim D.; McCarthy, David T.			Heavy Metal Contamination of Vegetables Irrigated by Urban Stormwater: A Matter of Time?	PLOS ONE			English	Article							PLANT-GROWTH; GENOTYPIC VARIATIONS; OXIDATIVE STRESS; HEALTH-RISKS; WASTE-WATER; ACCUMULATION; RUNOFF; CADMIUM; SOILS; LEAD	Urban stormwater is a crucial resource at a time when climate change and population growth threaten freshwater supplies; but there are health risks from contaminants, such as toxic metals. It is vitally important to understand how to use this resource safely and responsibly. Our study investigated the extent of metal contamination in vegetable crops irrigated with stormwater under short-and longterm conditions. We created artificially aged gardens by adding metal-contaminated sediment to soil, simulating accumulation of metals in the soil from irrigation with raw stormwater over zero, five and ten years. Our crops - French bean (Phaseolus vulgaris), kale (Brassica oleracea var. acephala), and beetroot (Beta vulgaris) were irrigated twice a week for 11 weeks, with either synthetic stormwater or potable water. They were then tested for concentrations of Cd, Cr, Pb, Cu and Zn. An accumulation of Pb was the most marked sign of contamination, with six of nine French bean and seven of nine beetroot leaf samples breaching Australia's existing guidelines. Metal concentration in a crop tended to increase with the effective age of the garden; but importantly, its rate of increase did not match the rate of increase in the soil. Our study also highlighted differences in sensitivity between different crop types. French bean demonstrated the highest levels of uptake, while kale displayed restrictive behaviour. Our study makes it clear: irrigation with stormwater is indeed feasible, as long as appropriate crops are selected and media are frequently turned over. We have also shown that an understanding of such risks yields meaningful information on appropriate safeguards. A holistic approach is needed - to account for all routes to toxic metal exposure, including especially Pb. A major outcome of our study is critical information for minimising health risks from stormwater irrigation of crops.	[Tom, Minna; McCarthy, David T.] Monash Univ, Dept Civil Engn, Environm & Publ Hlth Microbiol Lab, Melbourne, Vic 3004, Australia; [Fletcher, Tim D.] Monash Univ, Fac Sci, Sch Ecosyst & Forest Sci, Waterway Ecosyst Res Grp, Melbourne, Vic 3004, Australia	Monash University; Monash University	McCarthy, DT (corresponding author), Monash Univ, Dept Civil Engn, Environm & Publ Hlth Microbiol Lab, Melbourne, Vic 3004, Australia.	david.mccarthy@monash.edu	Fletcher, Tim/AAB-8356-2019	Fletcher, Tim/0000-0001-8819-5567; McCarthy, David/0000-0001-8845-6501	Melbourne Water (MWC) [11/13]	Melbourne Water (MWC)	Funding: This research was supported by funding from Melbourne Water (MWC 11/13), http://www.melbournewater.com.au/Pages/home.aspx. This funding was received by MT, DM, and TF. The funders assisted with establishing overall study aims and objectives but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdu N, 2011, NUTR CYCL AGROECOSYS, V89, P387, DOI 10.1007/s10705-010-9403-3; ABS, 2011, WAT US AUSTR FARMS 2; Ahmed W, 2011, J ENVIRON QUAL, V40, P13, DOI 10.2134/jeq2010.0345; Alexander PD, 2006, ENVIRON POLLUT, V144, P736, DOI 10.1016/j.envpol.2006.03.001; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Alloway B. J., 2004, Land Contamination & Reclamation, V12, P179, DOI 10.2462/09670513.658; ALTMANN L, 1993, TOXICOL LETT, V66, P105, DOI 10.1016/0378-4274(93)90085-C; Angelova V, 2008, COMMUN SOIL SCI PLAN, V39, P344, DOI 10.1080/00103620701826480; Arora M, 2008, FOOD CHEM, V111, P811, DOI 10.1016/j.foodchem.2008.04.049; Bahemuka TE, 1999, FOOD CHEM, V66, P63, DOI 10.1016/S0308-8146(98)00213-1; BANNERMAN RT, 1993, WATER SCI TECHNOL, V28, P241, DOI 10.2166/wst.1993.0426; Barraud S, 1999, WATER SCI TECHNOL, V39, P185, DOI 10.1016/S0273-1223(99)00022-0; Bedan ES, 2009, J AM WATER RESOUR AS, V45, P998, DOI 10.1111/j.1752-1688.2009.00342.x; Berti WR, 1996, J ENVIRON QUAL, V25, P1025, DOI 10.2134/jeq1996.00472425002500050014x; Bester PK, 2013, ECOTOX ENVIRON SAFE, V96, P182, DOI 10.1016/j.ecoenv.2013.06.011; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Brattebo BO, 2003, WATER RES, V37, P4369, DOI 10.1016/S0043-1354(03)00410-X; Choe JS, 2002, WATER SCI TECHNOL, V45, P249, DOI 10.2166/wst.2002.0251; Cobb GP, 2000, ENVIRON TOXICOL CHEM, V19, P600, DOI [10.1002/etc.5620190311, 10.1897/1551-5028(2000)019&lt;0600:AOHMBV&gt;2.3.CO;2]; Cui YJ, 2004, ENVIRON INT, V30, P785, DOI 10.1016/j.envint.2004.01.003; Datta S. P., 2000, Journal of the Indian Society of Soil Science, V48, P836; de Meeus C, 2002, SCI TOTAL ENVIRON, V291, P167, DOI 10.1016/S0048-9697(01)01098-1; De Wolf H, 2008, ENVIRON POLLUT, V152, P636, DOI 10.1016/j.envpol.2007.06.064; Dierkes C, 2006, WATER SCI TECHNOL, V54, P291, DOI 10.2166/wst.2006.597; Dimkpa CO, 2009, SOIL BIOL BIOCHEM, V41, P154, DOI 10.1016/j.soilbio.2008.10.010; Duncan H.P., 1999, DATABASE URBAN STORM; Eastmond DA, 2008, CRIT REV TOXICOL, V38, P173, DOI 10.1080/10408440701845401; Eick MJ, 1999, SOIL SCI, V164, P28, DOI 10.1097/00010694-199901000-00005; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; Fang YY, 2012, ENVIRON SCI POLLUT R, V19, P1659, DOI 10.1007/s11356-011-0674-2; Fletcher TD, 2004, 048 COOP RES CTR CAT; Food Standards Australia New Zealand, 2013, 141 FOOD STAND AUSTR; Ford RG, 1999, ENVIRON SCI TECHNOL, V33, P3140, DOI 10.1021/es990271d; Fuerhacker M, 2011, DESALINATION, V275, P118, DOI 10.1016/j.desal.2011.02.041; Fytianos K, 2001, B ENVIRON CONTAM TOX, V67, P423; Gardening Australia, 2011, FACT SHEET MAN NUTR; Gardner T, 2010, ARCHIT SCI REV, V53, P107, DOI 10.3763/asre.2009.0074; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; Gnecco I, 2005, ATMOS RES, V77, P60, DOI 10.1016/j.atmosres.2004.10.017; Goyer, 2004, ISSUE PAPER HUMAN HL; Gromaire-Mertz MC, 1999, WATER SCI TECHNOL, V39, P1, DOI 10.1016/S0273-1223(99)00002-5; Hatt B, 2006, QUANTIFYING STROMWAT; Hatt BE, 2007, WATER SCI TECHNOL, V55, P201, DOI 10.2166/wst.2007.110; Hatt BE, 2004, INT C WAT SENS URB D; HE QB, 1993, J SOIL SCI, V44, P641, DOI 10.1111/j.1365-2389.1993.tb02329.x; HELSEL DR, 1979, J WATER POLLUT CON F, V51, P709; Hooda PS, 1997, J SCI FOOD AGR, V73, P446, DOI [10.1002/(SICI)1097-0010(199704)73:4<446::AID-JSFA749>3.3.CO;2-U, 10.1002/(SICI)1097-0010(199704)73:4&lt;446::AID-JSFA749&gt;3.0.CO;2-2]; Ikeda M, 2000, SCI TOTAL ENVIRON, V249, P373, DOI 10.1016/S0048-9697(99)00527-6; ISHAQ AM, 1988, WATER RESOUR BULL, V24, P1227; Joint FAO/WHO Food Standards Program Codex Committee on Contaminants in Foods, 2011, WORK DOC INF US DISC, P17; Khan FH, 2012, SCI TOTAL ENVIRON, V430, P68, DOI 10.1016/j.scitotenv.2012.04.063; Khan MU, 2013, CHEMOSPHERE, V93, P2230, DOI 10.1016/j.chemosphere.2013.07.067; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; KINNERSLEY AM, 1993, PLANT GROWTH REGUL, V12, P207, DOI 10.1007/BF00027200; KLEIN LA, 1974, J WATER POLLUT CON F, V46, P2653; KUBOI T, 1986, PLANT SOIL, V92, P405, DOI 10.1007/BF02372488; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042944; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; Luo CL, 2011, J HAZARD MATER, V186, P481, DOI 10.1016/j.jhazmat.2010.11.024; McBride M.B., 1994, ENV CHEM SOILS; McCarthy D, 2011, 4 MON U; McCarthy DT, 2010, EFFECTIVE MONITORING; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Melbourne Water, 2012, BUILD PLANT BOX RAIN; Melbourne Water, 2013, DRINK WAT QUAL DAT; Nabulo G, 2010, SCI TOTAL ENVIRON, V408, P5338, DOI 10.1016/j.scitotenv.2010.06.034; Nigg JT, 2008, BIOL PSYCHIAT, V63, P325, DOI 10.1016/j.biopsych.2007.07.013; Occupational Health and Safety Administration (OHSA), 2009, TOX MET; Orsini F, 2013, AGRON SUSTAIN DEV, V33, P695, DOI 10.1007/s13593-013-0143-z; OWE M, 1982, WATER RESOUR BULL, V18, P863; Park JH, 2011, J HAZARD MATER, V185, P829, DOI 10.1016/j.jhazmat.2010.09.095; Philp M, 2008, TECHNICAL REPORT; Piechalak A, 2002, PHYTOCHEMISTRY, V60, P153, DOI 10.1016/S0031-9422(02)00067-5; Rattan R. K., 2002, Fertiliser News, V47, P21; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; REINELT LE, 1995, ECOL ENG, V4, P77, DOI 10.1016/0925-8574(94)00002-M; Rushton BT, 2001, J WATER RES PL-ASCE, V127, P172, DOI 10.1061/(ASCE)0733-9496(2001)127:3(172); Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Saravanan VS, 2007, CHEMOSPHERE, V66, P1794, DOI 10.1016/j.chemosphere.2006.07.067; Smit CE, 1996, APPL SOIL ECOL, V3, P127, DOI 10.1016/0929-1393(95)00078-X; SMITH SR, 1994, ENVIRON POLLUT, V86, P5, DOI 10.1016/0269-7491(94)90003-5; Steuer S, 1997, 974242 USGS WAT RES; Tiller K. G., 1986, Transactions. XIII. Congress of the International Society of Soil Science. Plenary Papers. Volume I., P29; Tuccillo ME, 2006, SCI TOTAL ENVIRON, V355, P288, DOI 10.1016/j.scitotenv.2005.03.003; UN-Water, 2006, COP WAT SCARC STRAT; United State Environmental Protection Agency (US-EPA), 2013, LEAD COMP IN CASRN 7; United States Environmental Protection Agency (US-EPA), 2013, CHROM 6 CASRN 18540; United States Environmental Protection Agency (USEPA), 1996, 6010B USEPA; USEPA, 2007, 6020A USEPA; Wang QR, 2002, J ENVIRON SCI HEAL A, V37, P611, DOI 10.1081/ESE-120003241; Wium-Andersen T, 2011, WATER SCI TECHNOL, V64, P503, DOI 10.2166/wst.2011.075; Yadav RK, 2002, ENVIRON INT, V28, P481, DOI 10.1016/S0160-4120(02)00070-3; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Zhao LYL, 2007, ENVIRON SCI TECHNOL, V41, P2770, DOI 10.1021/es062032d; Zheng N, 2007, SCI TOTAL ENVIRON, V383, P81, DOI 10.1016/j.scitotenv.2007.05.002	95	27	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112441	10.1371/journal.pone.0112441	http://dx.doi.org/10.1371/journal.pone.0112441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426946	Green Published, gold			2022-12-27	WOS:000349145400014
J	Yoo, JJ; Lee, JH; Lee, SH; Lee, M; Lee, DH; Cho, Y; Lee, YB; Yu, SJ; Kim, HC; Kim, YJ; Yoon, JH; Kim, CY; Lee, HS				Yoo, Jeong-Ju; Lee, Jeong-Hoon; Lee, Sang Hwan; Lee, Minjong; Lee, Dong Hyeon; Cho, Yuri; Lee, Yun Bin; Yu, Su Jong; Kim, Hyo-Cheol; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk			Comparison of the Effects of Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma between Patients with and without Extrahepatic Metastases	PLOS ONE			English	Article							PROMOTES; MANAGEMENT; SORAFENIB; DIAGNOSIS; SURVIVAL; IMPROVE; VEIN	Background/Aims: Sorafenib is a standard treatment for advanced hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] stage C). However, transarterial chemoembolization (TACE) has also been widely used as a treatment for patients with advanced HCC, even if they have extrahepatic metastases (EHM). The aim of this study was to determine the efficacy of TACE for advanced HCC patients with EHM upon initial diagnosis, as compared with those patients without EHM. Methods: This cohort study involved consecutive patients who underwent TACE as an initial treatment for advanced HCC. One hundred seventy-seven patients with EHM (the EHM group) and 205 with portal vein invasion without EHM (the non-EHM group) were included. A survival analysis was performed to compare overall survival between the two groups. Results: The mean age was 54.5 +/- 9.9 years, and median follow-up duration was 13.1 months (range, 0.5-111.0). Overall survival was significantly shorter in the EHM group than the non-EHM group (median, 8.3 vs. 19.1 months; P<0.001). A multivariate analysis showed that the presence of EHM was an independent poor prognostic factor for shorter overall survival (adjusted hazard ratio, 1.74; 95% confidence interval, 1.39-2.17; P<0.001) after adjustment for Child-Pugh classification, intrahepatic tumor T classification, tumor response to TACE, and serum alpha-fetoprotein level. Patients administered TACE and systemic therapy demonstrated a better survival rate than those administered TACE alone in both the EHM (median, 13.5 vs. 7.2 months) and non-EHM groups (median, 27.9 vs. 18.2 months) (both, P<0.05). Conclusions: The prognosis of advanced HCC patients with EHM is significantly worse than those without EHM administered repeated TACE treatments, even if their tumor stage was similar to BCLC stage C. These results suggest that EHM presence means aggressive tumor biology and that BCLC stage C might be subclassified according to EHM presence.	[Yoo, Jeong-Ju; Lee, Jeong-Hoon; Lee, Minjong; Lee, Dong Hyeon; Cho, Yuri; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Yoo, Jeong-Ju; Lee, Jeong-Hoon; Lee, Minjong; Lee, Dong Hyeon; Cho, Yuri; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Liver Res Inst, Seoul, South Korea; [Lee, Sang Hwan; Kim, Hyo-Cheol] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Sang Hwan; Kim, Hyo-Cheol] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea.	pindra@empal.com	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; , minjong/0000-0002-3159-5444; Yoo, Jeong-Ju/0000-0002-7802-0381; Kim, Hyo-Cheol/0000-0002-6016-247X; Yu, Su Jong/0000-0001-8888-7977; Lee, Yun Bin/0000-0002-3193-9745; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610				Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Kanda M, 2008, LIVER INT, V28, P1256, DOI 10.1111/j.1478-3231.2008.01864.x; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kim HC, 2013, J VASC INTERV RADIOL, V24, P274, DOI 10.1016/j.jvir.2012.11.002; Lee HS, 2011, DIGEST DIS, V29, P333, DOI 10.1159/000327572; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Xia L, 2014, ONCOGENE, V33, P1395, DOI 10.1038/onc.2013.90; Xia LM, 2014, HEPATOLOGY, V59, P958, DOI 10.1002/hep.26735; Yoo DJ, 2011, J GASTROEN HEPATOL, V26, P145, DOI 10.1111/j.1440-1746.2010.06341.x; Zhao FT, 2013, ASIAN PAC J CANCER P, V14, P3831, DOI 10.7314/APJCP.2013.14.6.3831	21	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113926	10.1371/journal.pone.0113926	http://dx.doi.org/10.1371/journal.pone.0113926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427152	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400103
J	Anhoj, J; Olesen, AV				Anhoj, Jacob; Olesen, Anne Vingaard			Run Charts Revisited: A Simulation Study of Run Chart Rules for Detection of Non-Random Variation in Health Care Processes	PLOS ONE			English	Article								Background: A run chart is a line graph of a measure plotted over time with the median as a horizontal line. The main purpose of the run chart is to identify process improvement or degradation, which may be detected by statistical tests for non-random patterns in the data sequence. Methods: We studied the sensitivity to shifts and linear drifts in simulated processes using the shift, crossings and trend rules for detecting non-random variation in run charts. Results: The shift and crossings rules are effective in detecting shifts and drifts in process centre over time while keeping the false signal rate constant around 5% and independent of the number of data points in the chart. The trend rule is virtually useless for detection of linear drift over time, the purpose it was intended for.	[Anhoj, Jacob] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Olesen, Anne Vingaard] Aalborg Univ, Dept Business & Management, Danish Ctr Healthcare Improvements, Aalborg, Denmark	Rigshospitalet; University of Copenhagen; Aalborg University	Anhoj, J (corresponding author), Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark.	jacob.anhoej@regionh.dk	Olesen, Anne Vingaard/AAL-7716-2021; Olesen, Anne Vingaard/C-8130-2018	Olesen, Anne Vingaard/0000-0002-1503-8269; Anhoj, Jacob/0000-0002-7701-1774				[Anonymous], 2014, R LANG ENV STAT COMP; Carey Raymond G, 2002, J Ambul Care Manage, V25, P78; Carey RG, 2002, J AMBULATORY CARE MA, V25, P80, DOI DOI 10.1097/00004479-200201000-00011; Chen Z., 2010, MODEL ASSIST STAT AP, V5, P73, DOI [10.3233/MAS-2010-0142, DOI 10.3233/MAS-2010-0142]; DAVIS RB, 1988, J QUAL TECHNOL, V20, P260, DOI 10.1080/00224065.1988.11979118; Jones-Farmer LA, 2014, J QUAL TECHNOL, V46, P265, DOI 10.1080/00224065.2014.11917969; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; OLMSTEAD PS, 1946, ANN MATH STAT, V17, P24, DOI 10.1214/aoms/1177731019; Perla RJ, 2013, QUAL MANAG HEALTH CA, V22, P36, DOI 10.1097/QMH.0b013e31827deadb; Perla RJ, 2011, BMJ QUAL SAF, V20, P46, DOI 10.1136/bmjqs.2009.037895; Provost LP, 2011, HLTH CARE DATA GUIDE; Schilling MF, 2012, MATH MAG, V85, P141, DOI DOI 10.4169/MATH.MAG.85.2.141; Swed FS, 1943, ANN MATH STAT, V14, P66, DOI 10.1214/aoms/1177731494; WILLEMAIN TR, 1994, J STAT COMPUT SIM, V51, P7, DOI 10.1080/00949659408811617	14	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113825	10.1371/journal.pone.0113825	http://dx.doi.org/10.1371/journal.pone.0113825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423037	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700069
J	Ivanovska, T; Laqua, R; Wang, L; Liebscher, V; Volzke, H; Hegenscheid, K				Ivanovska, Tatyana; Laqua, Rene; Wang, Lei; Liebscher, Volkmar; Voelzke, Henry; Hegenscheid, Katrin			A Level Set Based Framework for Quantitative Evaluation of Breast Tissue Density from MRI Data	PLOS ONE			English	Article							CANCER RISK; MAMMOGRAPHIC DENSITIES; SEGMENTATION; CLASSIFICATION; INHOMOGENEITY; PATTERNS; FEATURES; VOLUME	Breast density is a risk factor associated with the development of breast cancer. Usually, breast density is assessed on two dimensional (2D) mammograms using the American College of Radiology (ACR) classification. Magnetic resonance imaging (MRI) is a non-radiation based examination method, which offers a three dimensional (3D) alternative to classical 2D mammograms. We propose a new framework for automated breast density calculation on MRI data. Our framework consists of three steps. First, a recently developed method for simultaneous intensity inhomogeneity correction and breast tissue and parenchyma segmentation is applied. Second, the obtained breast component is extracted, and the breast-air and breast-body boundaries are refined. Finally, the fibroglandular/parenchymal tissue volume is extracted from the breast volume. The framework was tested on 37 randomly selected MR mammographies. All images were acquired on a 1.5T MR scanner using an axial, T1-weighted time-resolved angiography with stochastic trajectories sequence. The results were compared to manually obtained groundtruth. Dice's Similarity Coefficient (DSC) as well as Bland-Altman plots were used as the main tools for evaluation of similarity between automatic and manual segmentations. The average Dice's Similarity Coefficient values were 0.96 +/- 0.0172 and 0.83 +/- 0.0636 for breast and parenchymal volumes, respectively. Bland-Altman plots showed the mean bias (%) +/- standard deviation equal 5.36 +/- 3.9 for breast volumes and -6.9 +/- 13.14 for parenchyma volumes. The automated framework produced sufficient results and has the potential to be applied for the analysis of breast volume and breast density of numerous data in clinical and research settings.	[Ivanovska, Tatyana; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Laqua, Rene; Hegenscheid, Katrin] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Wang, Lei] Fraunhofer Inst Med Image Comp MEVIS, Bremen, Germany; [Liebscher, Volkmar] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Fraunhofer Gesellschaft; Ernst Moritz Arndt Universitat Greifswald	Ivanovska, T (corresponding author), Univ Med Greifswald, Inst Community Med, Greifswald, Germany.	tetyana.ivanovska@uni-greifswald.de	Liebscher, Volkmar/R-6865-2019; Liebscher, Volkmar/P-3543-2018	Liebscher, Volkmar/0000-0003-1446-4423; Liebscher, Volkmar/0000-0003-1446-4423	Ministry of Education, Science and Culture of Mecklenburg-Vorpommern; European Social Fund [UG 11 035A]; Federal State of Mecklenburg-West Pomerania; Siemens Healthcare	Ministry of Education, Science and Culture of Mecklenburg-Vorpommern; European Social Fund(European Social Fund (ESF)); Federal State of Mecklenburg-West Pomerania; Siemens Healthcare(Siemens AG)	Study of Health in Pomerania is part of the Community Medicine Research net of the University Medicine Greifswald, Germany. MR examinations were funded by the Federal State of Mecklenburg-West Pomerania and Siemens Healthcare. Automated segmentation was supported by a grant of the Ministry of Education, Science and Culture of Mecklenburg-Vorpommern and the European Social Fund (Grant UG 11 035A). Contrast material for dynamic contrast enhanced MR mammography research (Gadovist) was provided by Bayer Healthcare (Leverkusen, Germany). They had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Balleyguier C, 2007, EUR J RADIOL, V61, P192, DOI 10.1016/j.ejrad.2006.08.033; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Gonzales R., 2002, DIGITAL IMAGE PROCES; Gubern-Merida A, 2014, IEEE J BIOMEDICAL HL; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Ivanovska T, 2013, INT SYMP IMAGE SIG, P667; KATO I, 1995, CANCER CAUSE CONTROL, V6, P431, DOI 10.1007/BF00052183; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Kuhl CK, 2007, RADIOLOGY, V244, P929, DOI 10.1148/radiol.2443070266; Lin MQ, 2011, MED PHYS, V38, P5, DOI 10.1118/1.3519869; Maskarinec G, 2006, CANCER EPIDEM BIOMAR, V15, P732, DOI 10.1158/1055-9965.EPI-05-0798; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Montgomery D. C., 2012, INTRO LINEAR REGRESS, V821; Nie K, 2008, MED PHYS, V35, P5253, DOI 10.1118/1.3002306; Ortiz CG, 2012, MED PHYS, V39, P5835, DOI 10.1118/1.4748504; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Thomas DB, 2002, CANCER EPIDEM BIOMAR, V11, P565; Torres-Mejia G, 2005, CANCER EPIDEM BIOMAR, V14, P1052, DOI 10.1158/1055-9965.EPI-04-0717; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; van Gils CH, 2000, EUR J CANCER PREV, V9, P105, DOI 10.1097/00008469-200004000-00006; Volzke H, 2010, INT J EPIDEMIOLOGY; Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486; Wang L, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1024, DOI 10.1109/ISBI.2012.6235732; Wu SD, 2013, MED PHYS, V40, DOI 10.1118/1.4829496	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112709	10.1371/journal.pone.0112709	http://dx.doi.org/10.1371/journal.pone.0112709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422942	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700012
J	Kong, FN; Li, H; Sun, PP; Zhou, Y; Mao, YX				Kong, Fanna; Li, Hong; Sun, Peipei; Zhou, Yang; Mao, Yunxiang			De Novo Assembly and Characterization of the Transcriptome of Seagrass Zostera marina Using Illumina Paired-End Sequencing	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PHYTOCHROME FAMILY; NA+ TRANSPORT; RNA-SEQ; LIGHT; EXPRESSION; MECHANISMS; SALINITY; DROUGHT; GENES	Background: The seagrass Zostera marina is a monocotyledonous angiosperm belonging to a polyphyletic group of plants that can live submerged in marine habitats. Zostera marina L. is one of the most common seagrasses and is considered a cornerstone of marine plant molecular ecology research and comparative studies. However, the mechanisms underlying its adaptation to the marine environment still remain poorly understood due to limited transcriptomic and genomic data. Principal Findings: Here we explored the transcriptome of Z. marina leaves under different environmental conditions using Illumina paired-end sequencing. Approximately 55 million sequencing reads were obtained, representing 58,457 transcripts that correspond to 24,216 unigenes. A total of 14,389 (59.41%) unigenes were annotated by blast searches against the NCBI non-redundant protein database. 45.18% and 46.91% of the unigenes had significant similarity with proteins in the Swiss-Prot database and Pfam database, respectively. Among these, 13,897 unigenes were assigned to 57 Gene Ontology (GO) terms and 4,745 unigenes were identified and mapped to 233 pathways via functional annotation against the Kyoto Encyclopedia of Genes and Genomes pathway database (KEGG). We compared the orthologous gene family of the Z. marina transcriptome to Oryza sativa and Pyropia yezoensis and 11,667 orthologous gene families are specific to Z. marina. Furthermore, we identified the photoreceptors sensing red/far-red light and blue light. Also, we identified a large number of genes that are involved in ion transporters and channels including Na+ efflux, K+ uptake, Cl- channels, and H+ pumping. Conclusions: Our study contains an extensive sequencing and gene-annotation analysis of Z. marina. This information represents a genetic resource for the discovery of genes related to light sensing and salt tolerance in this species. Our transcriptome can be further utilized in future studies on molecular adaptation to abiotic stress in Z. marina.	[Kong, Fanna; Li, Hong; Sun, Peipei; Zhou, Yang; Mao, Yunxiang] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China	Ocean University of China	Kong, FN (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Peoples R China.	fnkong@ouc.edu.cn			Key Science and Technology Program of Shandong Province [2012GHY11527]; Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China [201105021]	Key Science and Technology Program of Shandong Province; Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China	This work was supported by The Key Science and Technology Program of Shandong Province (Grant No. 2012GHY11527) and the Public Science and Technology Research Funds Projects of Ocean, State Oceanic Administration of China (Grant No. 201105021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Arana MV, 2014, PLANT CELL ENVIRON, V37, P2014, DOI 10.1111/pce.12286; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Ilut DC, 2012, AM J BOT, V99, P383, DOI 10.3732/ajb.1100312; Imaizumi T, 2002, PLANT CELL, V14, P373, DOI 10.1105/tpc.010388; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Junttila S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-870; Kaldy James, 2012, Aquat Biosyst, V8, P19, DOI 10.1186/2046-9063-8-19; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; Kong F, 2013, ACTA OCEANOL SIN, V32, P11; Leonova T, 2009, PLANT SIGNAL BEHAV, V4, P1059, DOI 10.4161/psb.4.11.9799; Les Donald H, 1997, SYSTEMATIC BOT, V22, P21; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Yinu, 2012, PLoS One, V7, pe43713, DOI 10.1371/journal.pone.0043713; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Ma JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065877; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muramatsu Y, 2002, PLANT CELL PHYSIOL, V43, P1137, DOI 10.1093/pcp/pcf139; Murphy LR, 2003, AQUAT BOT, V75, P293, DOI 10.1016/S0304-3770(02)00206-1; Nakamura A, 2006, PLANT CELL PHYSIOL, V47, P32, DOI 10.1093/pcp/pci220; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Reusch TBH, 2008, MAR BIOTECHNOL, V10, P297, DOI 10.1007/s10126-007-9065-6; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Shafer DJ, 2011, AQUAT BOT, V95, P7; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Silva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081058; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Touchette BW, 2007, J EXP MAR BIOL ECOL, V350, P194, DOI 10.1016/j.jembe.2007.05.037; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XS, 2012, MOL BIOL REP, V39, P8147, DOI 10.1007/s11033-012-1662-4; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Wissler L, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap009; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu P, 2009, PLANT SIGNAL BEHAV, V4, P200, DOI 10.4161/psb.4.3.7756; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; York PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076377; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080350	54	13	14	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112245	10.1371/journal.pone.0112245	http://dx.doi.org/10.1371/journal.pone.0112245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423588	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700010
J	Sham, A; Al-Azzawi, A; Al-Ameri, S; Al-Mahmoud, B; Awwad, F; Al-Rawashdeh, A; Iratni, R; AbuQamar, S				Sham, Arjun; Al-Azzawi, Ahmed; Al-Ameri, Salma; Al-Mahmoud, Bassam; Awwad, Falah; Al-Rawashdeh, Ahmed; Iratni, Rabah; AbuQamar, Synan			Transcriptome Analysis Reveals Genes Commonly Induced by Botrytis cinerea Infection, Cold, Drought and Oxidative Stresses in Arabidopsis	PLOS ONE			English	Article							ABIOTIC STRESS; 12-OXO-PHYTODIENOIC ACID; NECROTROPHIC FUNGI; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; PLANT-RESPONSES; SALICYLIC-ACID; JASMONIC ACID; RESISTANCE; DEFENSE	Signaling pathways controlling biotic and abiotic stress responses may interact synergistically or antagonistically. To identify the similarities and differences among responses to diverse stresses, we analyzed previously published microarray data on the transcriptomic responses of Arabidopsis to infection with Botrytis cinerea (a biotic stress), and to cold, drought, and oxidative stresses (abiotic stresses). Our analyses showed that at early stages after B. cinerea inoculation, 1498 genes were up-regulated (B. cinerea up-regulated genes; BUGs) and 1138 genes were down-regulated (B. cinerea down-regulated genes; BDGs). We showed a unique program of gene expression was activated in response each biotic and abiotic stress, but that some genes were similarly induced or repressed by all of the tested stresses. Of the identified BUGs, 25%, 6% and 12% were also induced by cold, drought and oxidative stress, respectively; whereas 33%, 7% and 5.5% of the BDGs were also down-regulated by the same abiotic stresses. Coexpression and protein-protein interaction network analyses revealed a dynamic range in the expression levels of genes encoding regulatory proteins. Analysis of gene expression in response to electrophilic oxylipins suggested that these compounds are involved in mediating responses to B. cinerea infection and abiotic stress through TGA transcription factors. Our results suggest an overlap among genes involved in the responses to biotic and abiotic stresses in Arabidopsis. Changes in the transcript levels of genes encoding components of the cyclopentenone signaling pathway in response to biotic and abiotic stresses suggest that the oxylipin signal transduction pathway plays a role in plant defense. Identifying genes that are commonly expressed in response to environmental stresses, and further analyzing the functions of their encoded products, will increase our understanding of the plant stress response. This information could identify targets for genetic modification to improve plant resistance to multiple stresses.	[Sham, Arjun; Al-Azzawi, Ahmed; Al-Ameri, Salma; Al-Mahmoud, Bassam; Iratni, Rabah; AbuQamar, Synan] United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates; [Awwad, Falah] United Arab Emirates Univ, Dept Elect Engn, Al Ain, U Arab Emirates; [Al-Rawashdeh, Ahmed] United Arab Emirates Univ, Dept Math Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	AbuQamar, S (corresponding author), United Arab Emirates Univ, Dept Biol, Al Ain, U Arab Emirates.	sabuqamar@uaeu.ac.ae	Awwad, Falah/Z-4155-2019; Sham, Arjun/K-3691-2019; Sham, Arjun/AAF-2531-2019; AbuQamar, Synan/AAV-1229-2021	Awwad, Falah/0000-0001-6154-2143; AbuQamar, Synan/0000-0002-2129-7689; Sham, Arjun/0000-0003-1762-3709; Al Rawashdeh, Ahmed/0000-0002-7009-8678	UAEU (United Arab Emirates University) [COS/IRG-05/14]; Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013]	UAEU (United Arab Emirates University); Khalifa Center for Biotechnology and Genetic Engineering-UAEU	This project was funded by the UAEU (United Arab Emirates University) [COS/IRG-05/14] and the Khalifa Center for Biotechnology and Genetic Engineering-UAEU [KCGEB-2-2013] to SAQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Alcazar R, 2011, TRENDS PLANT SCI, V16, P666, DOI 10.1016/j.tplants.2011.09.001; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Aubert Y, 2011, PLANT SIGNAL BEHAV, V6, P538, DOI 10.4161/psb.6.4.14836; Audebert A, 2000, PLANT SOIL, V220, P235, DOI 10.1023/A:1004734415254; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Barah P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-722; Block A, 2005, MOL PLANT PATHOL, V6, P79, DOI 10.1111/j.1364-3703.2004.00265.x; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; De Bodt S, 2010, PLANT PHYSIOL, V152, P1167, DOI 10.1104/pp.109.147215; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Elad Y, 1997, BIOL REV, V72, P381, DOI 10.1017/S0006323197005057; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Grun C, 2007, FUNCT PLANT BIOL, V34, P65, DOI 10.1071/FP06205; Gruszka D, 2013, INT J MOL SCI, V14, P8740, DOI 10.3390/ijms14058740; Janz D, 2012, NEW PHYTOL, V194, P129, DOI 10.1111/j.1469-8137.2011.03975.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082445; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Mulema JMK, 2012, MOL BIOL REP, V39, P4039, DOI 10.1007/s11033-011-1185-4; Mulema JMK, 2011, AFR J BIOTECHNOL, V10, P17551, DOI 10.5897/AJB10.2558; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Segarra G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056075; Seo JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055482; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 1999, PLANT PHYSIOL, V121, P1093, DOI 10.1104/pp.121.4.1093; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; Voelckel C, 2004, PLANT J, V38, P650, DOI 10.1111/j.1365-313X.2004.02077.x; Wang H, 2012, PLANT BIOTECHNOL J, V10, P31, DOI 10.1111/j.1467-7652.2011.00631.x; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	72	48	48	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113718	10.1371/journal.pone.0113718	http://dx.doi.org/10.1371/journal.pone.0113718			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422934	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700060
J	Bondi, R; Messina, M; De Fino, I; Bragonzi, A; Rampioni, G; Leoni, L				Bondi, Roslen; Messina, Marco; De Fino, Ida; Bragonzi, Alessandra; Rampioni, Giordano; Leoni, Livia			Affecting Pseudomonas aeruginosa Phenotypic Plasticity by Quorum Sensing Dysregulation Hampers Pathogenicity in Murine Chronic Lung Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; HOMOSERINE LACTONE ACYLASE; ANTIBIOTIC-RESISTANCE; GENE-EXPRESSION; REGULATOR RSAL; VIRULENCE; MUTANTS; MODEL; IDENTIFICATION; PATHOGENESIS	In Pseudomonas aeruginosa quorum sensing (QS) activates the production of virulence factors, playing a critical role in pathogenesis. Multiple negative regulators modulate the timing and the extent of the QS response either in the pre-quorum or post-quorum phases of growth. This regulation likely increases P. aeruginosa phenotypic plasticity and population fitness, facilitating colonization of challenging environments such as higher organisms. Accordingly, in addition to the factors required for QS signals synthesis and response, also QS regulators have been proposed as targets for anti-virulence therapies. However, while it is known that P. aeruginosa mutants impaired in QS are attenuated in their pathogenic potential, the effect of mutations causing a dysregulated timing and/or magnitude of the QS response has been poorly investigated so far in animal models of infection. In order to investigate the impact of QS dysregulation on P. aeruginosa pathogenesis in a murine model of lung infection, the QteE and RsaL proteins have been selected as representatives of negative regulators controlling P. aeruginosa QS in the pre-and post-quorum periods, respectively. Results showed that the qteE mutation does not affect P. aeruginosa lethality and ability to establish chronic infection in mice, despite causing a premature QS response and enhanced virulence factors production in test tube cultures compared to the wild type. Conversely, the post-quorum dysregulation caused by the rsaL mutation hampers the establishment of P. aeruginosa chronic lung infection in mice without affecting the mortality rate. On the whole, this study contributes to a better understanding of the impact of QS regulation on P. aeruginosa phenotypic plasticity during the infection process. Possible fallouts of these findings in the anti-virulence therapy field are also discussed.	[Bondi, Roslen; Messina, Marco; Rampioni, Giordano; Leoni, Livia] Univ Roma Tre, Dept Sci, Rome, Italy; [De Fino, Ida; Bragonzi, Alessandra] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Infect & Cyst Fibrosis Unit, Milan, Italy; [De Fino, Ida] Osped Maggiore, Italian Cyst Fibrosis Res Fdn, Verona, Italy	Italfarmaco; Roma Tre University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Leoni, L (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	livia.leoni@uniroma3.it	Bragonzi, Alessandra/AAC-6751-2022; Rampioni, Giordano/AAA-4045-2021; De Fino, Ida/AAN-5189-2020	De Fino, Ida/0000-0002-5747-7155; Rampioni, Giordano/0000-0002-1735-8565; Bragonzi, Alessandra/0000-0002-5808-7669	Ministry of University and Research of Italy [RBFR10LHD1]; Italian Cystic Fibrosis Research Foundation [FFC 14/2010, FFC 13/2011]	Ministry of University and Research of Italy(Ministry of Education, Universities and Research (MIUR)); Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This work was supported by grants from the Ministry of University and Research of Italy (Futuro in Ricerca 2010 - RBFR10LHD1; www.miur.it), and the Italian Cystic Fibrosis Research Foundation (FFC 14/2010 and FFC 13/2011; www.fibrosicisticaricerca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Cabeen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088743; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Facchini M, 2014, JOVE-J VIS EXP, V17, P85; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gupta R, 2013, ISME J, V7, P2159, DOI 10.1038/ismej.2013.109; Harrison F, 2014, INFECT IMMUN, V82, P3312, DOI 10.1128/IAI.01554-14; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hirakawa H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00114; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Imperi F, 2013, P NATL ACAD SCI USA, V110, P7458, DOI 10.1073/pnas.1222706110; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Liang HH, 2011, J MED MICROBIOL, V60, P22, DOI 10.1099/jmm.0.022350-0; Longo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069554; Massai F, 2011, BIOSENS BIOELECTRON, V26, P3444, DOI 10.1016/j.bios.2011.01.022; Mellbye B, 2011, MBIO, V2, DOI 10.1128/mBio.00131-11; OHMAN DE, 1980, J INFECT DIS, V142, P547, DOI 10.1093/infdis/142.4.547; Papaioannou E, 2013, INT J MOL SCI, V14, P19309, DOI 10.3390/ijms140919309; Pesci EC, 1999, CELL-CELL SIGNALING IN BACTERIA, P147; Rampioni G, 2006, J BACTERIOL, V188, P815, DOI 10.1128/JB.188.2.815-819.2006; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rampioni G, 2007, J BACTERIOL, V189, P1922, DOI 10.1128/JB.01552-06; Rampioni G, 2014, BIOORG CHEM, V55, P60, DOI 10.1016/j.bioorg.2014.04.005; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Seet Q, 2011, MOL MICROBIOL, V80, P951, DOI 10.1111/j.1365-2958.2011.07622.x; Siehnel R, 2010, P NATL ACAD SCI USA, V107, P7916, DOI 10.1073/pnas.0908511107; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105	60	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112105	10.1371/journal.pone.0112105	http://dx.doi.org/10.1371/journal.pone.0112105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420086	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900005
J	Mahler, N; Cheregi, O; Funk, C; Netotea, S; Hvidsten, TR				Mahler, Niklas; Cheregi, Otilia; Funk, Christiane; Netotea, Sergiu; Hvidsten, Torgeir R.			Synergy: A Web Resource for Exploring Gene Regulation in Synechocystis sp PCC6803	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; TRANSCRIPTIONAL REGULATION; EXPRESSION; CYANOBACTERIAL; DATABASE; NETWORK; STRESS; TEMPERATURE; CYANOBASE; PCC-6803	Despite being a highly studied model organism, most genes of the cyanobacterium Synechocystis sp. PCC 6803 encode proteins with completely unknown function. To facilitate studies of gene regulation in Synechocystis, we have developed Synergy (http://synergy.plantgenie.org), a web application integrating co-expression networks and regulatory motif analysis. Co-expression networks were inferred from publicly available microarray experiments, while regulatory motifs were identified using a phylogenetic footprinting approach. Automatically discovered motifs were shown to be enriched in the network neighborhoods of regulatory proteins much more often than in the neighborhoods of non-regulatory genes, showing that the data provide a sound starting point for studying gene regulation in Synechocystis. Concordantly, we provide several case studies demonstrating that Synergy can be used to find biologically relevant regulatory mechanisms in Synechocystis. Synergy can be used to interactively perform analyses such as gene/motif search, network visualization and motif/function enrichment. Considering the importance of Synechocystis for photosynthesis and biofuel research, we believe that Synergy will become a valuable resource to the research community.	[Mahler, Niklas; Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Cheregi, Otilia; Funk, Christiane; Netotea, Sergiu] Umea Univ, Dept Chem, Umea, Sweden; [Funk, Christiane; Netotea, Sergiu; Hvidsten, Torgeir R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Netotea, Sergiu] Umea Univ, Computat Life Sci Cluster, Umea, Sweden	Norwegian University of Life Sciences; Umea University; Umea University; Umea University	Netotea, S (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	sergiu.netotea@umu.se	Funk, Christiane/AAO-6041-2021; Cheregi, Otilia/AAP-2474-2021; Hvidsten, Torgeir R./A-3409-2009; Mähler, Niklas/K-4109-2019	Funk, Christiane/0000-0002-7897-4038; Hvidsten, Torgeir R./0000-0001-6097-2539; Mähler, Niklas/0000-0003-2673-9113	Swedish Research Council (VR) [2011-5811]; The Swedish Governmental Agency for Innovation Systems (VINNOVA) through UPSC Berzelii Centre for Forest Biotechnology; Swedish Energy Agency; Umea University (Solar Fuels)	Swedish Research Council (VR)(Swedish Research Council); The Swedish Governmental Agency for Innovation Systems (VINNOVA) through UPSC Berzelii Centre for Forest Biotechnology; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Umea University (Solar Fuels)	SN and TRH were funded by the Swedish Research Council (VR, http://www.vr.se/) grant number 2011-5811, and The Swedish Governmental Agency for Innovation Systems (VINNOVA, http://www.vinnova.se/) in parts through the UPSC Berzelii Centre for Forest Biotechnology. CF and OC are grateful for funding from the Swedish Energy Agency and Umea University (Solar Fuels, http://solarfuels.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aurora R, 2007, OMICS, V11, P166, DOI 10.1089/omi.2007.4323; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benjamini Y, 1995, J R STAT SOC B; Cipriano MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-213; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; Englund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090270; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fujisawa T, 2014, NUCLEIC ACIDS RES, V42, pD666, DOI 10.1093/nar/gkt1145; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hernandez-Prieto MA, 2012, BIOINFORMATION, V8, P634, DOI 10.6026/97320630008634; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kanesaki Y, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P15, DOI 10.1007/978-90-481-3112-9_2; Knoop H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003081; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lopez-Calcagno PE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00009; Los DA, 2010, SENSORS-BASEL, V10, P2386, DOI 10.3390/s100302386; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Marri L, 2014, BIOCHIMIE, V97, P228, DOI 10.1016/j.biochi.2013.10.018; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Miranda H, 2013, J PROTEOMICS, V78, P294, DOI 10.1016/j.jprot.2012.09.036; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Netotea S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-106; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Panichkin, 2008, SER THR PROTEIN KINA; Panichkin VB, 2006, J BACTERIOL, V188, P7696, DOI 10.1128/JB.00838-06; Prakash JSS, 2010, MICROBIOL-SGM, V156, P442, DOI 10.1099/mic.0.031823-0; Prakash JSS, 2009, MOL BIOSYST, V5, P1904, DOI [10.1039/b903022k, 10.1039/B903022k]; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Singh AK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-105; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley DN, 2013, PLANT PHYSIOL, V161, P824, DOI 10.1104/pp.112.210542; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki S, 2004, J BIOL CHEM, V279, P13234, DOI 10.1074/jbc.M313358200; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tozawa Y, 2007, PLANT J, V52, P124, DOI 10.1111/j.1365-313X.2007.03216.x; Yoshimura H, 2002, MOL MICROBIOL, V43, P843, DOI 10.1046/j.1365-2958.2002.02790.x	50	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113496	10.1371/journal.pone.0113496	http://dx.doi.org/10.1371/journal.pone.0113496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420108	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900041
J	Omland, T; Akre, H; Lie, KA; Jebsen, P; Sandvik, L; Brondbo, K				Omland, Turid; Akre, Harriet; Lie, Kathrine A.; Jebsen, Peter; Sandvik, Leiv; Brondbo, Kjell			Risk Factors for Aggressive Recurrent Respiratory Papillomatosis in Adults and Juveniles	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CLINICAL-COURSE; LARYNGEAL PAPILLOMATOSIS; NATIONAL REGISTRY; GENITAL WARTS; ONSET; POPULATION; CANCER; CHILDREN; IDENTIFICATION	In this cohort study we examined whether gender, age at onset, observation time or human papillomavirus (HPV) genotype are risk factors for an aggressive clinical course in Recurrent Respiratory Papillomatosis (RRP). Clinical data from patient records comprised gender, age at onset, date of first endolaryngeal procedure with biopsy, date of last follow-up, total number of endolaryngeal procedures, and complications during the observation period. Disease was defined as juvenile (JoRRP) or adult onset (AoRRP) according to whether the disease was acquired before or after the age of 18. Aggressive disease was defined as distal spread, tracheostomy, four surgical operations annually or >10 surgeries in total. DNA was extracted from formalin-fixed paraffin-embedded tissue. HPV genotyping was performed by quantitative PCR assay identifying 15 HPV genotypes. The study included 224 patients. The majority were males (141/174 in AoRRPs and 31/50 in JoRRPs; p=0.005). The median follow-up from initial diagnosis was 12.0 years (IQR 3.7-32.9) for JoRRPs and 4.0 years (IQR 0.8-11.7) for AoRRPs. The disease was more aggressive in juveniles than adults (p<0.001), a difference that disappeared after 10 years' observation. JoRRPs with aggressive disease were younger at onset (mean difference 4.6 years, 95% CI [2.4, 6.8], p=0.009). HPV6 or -11 was present in all HPV-positive papillomas. HPV11 was more prevalent in aggressive disease, and HPV6 in non-aggressive disease (p<0.001). Multiple logistic regression revealed that only age at onset (OR=0.69, 95% CI [0.53, 0.88], p=0.003) was associated with aggressive disease in juveniles, while HPV11 (OR=3.74, 95% CI [1.40, 9.97], p=0.008) and observation time >10 years (OR=13.41, 95% CI [5.46, 32.99[, p<001) were risk factors in adults. In conclusion, the only significant risk factor for developing aggressive disease in JoRRPs was age at onset, but both HPV11 and observation time >10 years were risk factors for an aggressive disease course in AoRRPs.	[Omland, Turid; Akre, Harriet; Brondbo, Kjell] Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway; [Lie, Kathrine A.; Jebsen, Peter] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Dept Biostat, Oslo, Norway; [Omland, Turid; Akre, Harriet; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Fac Dent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Omland, T (corresponding author), Oslo Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Oslo, Norway.	tuomland@ous-hf.no						Aaltonen LM, 1997, EUR ARCH OTO-RHINO-L, V254, P219, DOI 10.1007/BF00874092; Aaltonen LM, 1999, J INFECT DIS, V179, P682, DOI 10.1086/314624; ABRAMSON AL, 1987, LARYNGOSCOPE, V97, P678; [Anonymous], 2014, NUMB RAT AN WARTS DI; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; BOMHOLT A, 1988, ACTA OTO-LARYNGOL, V106, P140, DOI 10.3109/00016488809107381; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Campisi P, 2010, LARYNGOSCOPE, V120, P1233, DOI 10.1002/lary.20901; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Derkay CS, 1998, LARYNGOSCOPE, V108, P935, DOI 10.1097/00005537-199806000-00026; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; DOYLE DJ, 1994, LARYNGOSCOPE, V104, P523, DOI 10.1002/lary.5541040503; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Gabbott M, 1997, J CLIN MICROBIOL, V35, P3098, DOI 10.1128/JCM.35.12.3098-3103.1997; Gall S A, 2001, Infect Dis Obstet Gynecol, V9, P149, DOI 10.1155/S1064744901000278; Gillison ML, 2012, VACCINE, V30, pF34, DOI 10.1016/j.vaccine.2012.05.070; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; KASHIMA HK, 1992, LARYNGOSCOPE, V102, P9; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; LACK EE, 1980, LANCET, V2, P592; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; Maloney EM, 2006, ARCH OTOLARYNGOL, V132, P711, DOI 10.1001/archotol.132.7.711; Mork J, 2010, CANCER CAUSE CONTROL, V21, P1397, DOI 10.1007/s10552-010-9567-9; MOUNTS P, 1982, P NATL ACAD SCI-BIOL, V79, P5425, DOI 10.1073/pnas.79.17.5425; MOUNTS P, 1984, LARYNGOSCOPE, V94, P28, DOI 10.1002/lary.5540940106; Omland T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099114; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; PADAYACHEE A, 1993, INT J PEDIATR OTORHI, V26, P141, DOI 10.1016/0165-5876(93)90019-Y; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; POU AM, 1995, ANN OTO RHINOL LARYN, V104, P758, DOI 10.1177/000348949510401002; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reeves WC, 2003, ARCH OTOLARYNGOL, V129, P976, DOI 10.1001/archotol.129.9.976; Rimell FL, 1997, LARYNGOSCOPE, V107, P915, DOI 10.1097/00005537-199707000-00015; Ruiz R, 2014, LARYNGOSCOPE, V124, P2338, DOI 10.1002/lary.24730; Sanchez GI, 2013, HEAD NECK-J SCI SPEC, V35, P229, DOI 10.1002/hed.22953; Silverberg MJ, 2004, ARCH OTOLARYNGOL, V130, P711, DOI 10.1001/archotol.130.6.711; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Simms I, 1997, GENITOURIN MED, V73, P365; The Cancer Registry of Norway, 2013, CANC REG NORW; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f	46	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113584	10.1371/journal.pone.0113584	http://dx.doi.org/10.1371/journal.pone.0113584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419846	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900052
J	Yang, WL; Hu, BQ; Wu, W; Batra, S; Blackburn, MR; Alcorn, JL; Fallon, MB; Zhang, JL				Yang, Wenli; Hu, Bingqian; Wu, Wei; Batra, Sachin; Blackburn, Michael R.; Alcorn, Joseph L.; Fallon, Michael B.; Zhang, Junlan			Alveolar Type II Epithelial Cell Dysfunction in Rat Experimental Hepatopulmonary Syndrome (HPS)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LUNG PERFUSION SCAN; BILE-DUCT LIGATION; PULMONARY ANGIOGENESIS; LIVER-DISEASE; TNF-ALPHA; SURFACTANT; CIRRHOSIS; INJURY; MODEL	The hepatopulmonary syndrome (HPS) develops when pulmonary vasodilatation leads to abnormal gas exchange. However, in human HPS, restrictive ventilatory defects are also observed supporting that the alveolar epithelial compartment may also be affected. Alveolar type II epithelial cells (AT2) play a critical role in maintaining the alveolar compartment by producing four surfactant proteins (SPs, SP-A, SP-B, SP-C and SP-D) which also facilitate alveolar repair following injury. However, no studies have evaluated the alveolar epithelial compartment in experimental HPS. In this study, we evaluated the alveolar epithelial compartment and particularly AT2 cells in experimental HPS induced by common bile duct ligation (CBDL). We found a significant reduction in pulmonary SP production associated with increased apoptosis in AT2 cells after CBDL relative to controls. Lung morphology showed decreased mean alveolar chord length and lung volumes in CBDL animals that were not seen in control models supporting a selective reduction of alveolar airspace. Furthermore, we found that administration of TNF-alpha, the bile acid, chenodeoxycholic acid, and FXR nuclear receptor activation (GW4064) induced apoptosis and impaired SP-B and SP-C production in alveolar epithelial cells in vitro. These results imply that AT2 cell dysfunction occurs in experimental HPS and is associated with alterations in the alveolar epithelial compartment. Our findings support a novel contributing mechanism in experimental HPS that may be relevant to humans and a potential therapeutic target.	[Yang, Wenli; Hu, Bingqian; Wu, Wei; Batra, Sachin; Fallon, Michael B.; Zhang, Junlan] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Blackburn, Michael R.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Alcorn, Joseph L.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Zhang, JL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	Junlan.Zhang@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health [5DKR01DK056804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 5DKR01DK056804 (Michael B. Fallon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GA, 1995, GASTROENTEROLOGY, V109, P1283, DOI 10.1016/0016-5085(95)90589-8; Abrams GA, 1998, GASTROENTEROLOGY, V114, P305, DOI 10.1016/S0016-5085(98)70481-0; Adachi T, 2014, J CLIN BIOCHEM NUTR, V54, P129, DOI 10.3164/jcbn.13-46; Agusti AG, 1996, CLIN CHEST MED, V17, P49, DOI 10.1016/S0272-5231(05)70298-7; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; An SC, 2007, APOPTOSIS, V12, P1989, DOI 10.1007/s10495-007-0125-1; Bein K, 2013, AM J RESP CELL MOL, V49, P306, DOI 10.1165/rcmb.2012-0283OC; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Dobbs LG, 2010, CELL PHYSIOL BIOCHEM, V25, P55, DOI 10.1159/000272063; Dobbs LG, 1990, ISOLATION CULTURE AL; Fallon MB, 1997, GASTROENTEROLOGY, V113, P606, DOI 10.1053/gast.1997.v113.pm9247483; Fallon MB, 1997, AM J PHYSIOL-GASTR L, V272, pG779, DOI 10.1152/ajpgi.1997.272.4.G779; Fallon MB, 2008, GASTROENTEROLOGY, V135, P1168, DOI 10.1053/j.gastro.2008.06.038; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Foster DJ, 2010, AM J PHYSIOL-LUNG C, V298, pL392, DOI 10.1152/ajplung.00041.2009; Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5; Gayan-Ramirez G, 1998, J HEPATOL, V29, P241, DOI 10.1016/S0168-8278(98)80009-3; Gomez FP, 2004, HEPATOLOGY, V40, P660, DOI 10.1002/hep.20358; Gonzalez Robert F, 2013, Methods Mol Biol, V945, P145, DOI 10.1007/978-1-62703-125-7_10; Guo X, 2001, EUR RESPIR J, V18, P482, DOI 10.1183/09031936.01.00043401; Hohlfeld J, 1997, EUR RESPIR J, V10, P482, DOI 10.1183/09031936.97.10020482; HOURANI JM, 1991, AM J MED, V90, P693; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hu ZX, 2012, FREE RADICAL BIO MED, V53, P122, DOI 10.1016/j.freeradbiomed.2012.04.027; King BA, 2011, AM J RESP CELL MOL, V44, P709, DOI 10.1165/rcmb.2009-0436OC; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Lima BLG, 2004, MAYO CLIN PROC, V79, P42, DOI 10.4065/79.1.42; Liu J, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-2; Luo B, 2004, AM J PHYSIOL-GASTR L, V286, pG294, DOI 10.1152/ajpgi.00298.2003; Martinez GP, 2001, J HEPATOL, V34, P651, DOI 10.1016/S0168-8278(00)00108-2; Melo-Silva CA, 2011, RESP PHYSIOL NEUROBI, V179, P326, DOI 10.1016/j.resp.2011.10.001; Moller S, 2008, GUT, V57, P268, DOI 10.1136/gut.2006.112177; Nunes H, 2001, AM J RESP CRIT CARE, V164, P879, DOI 10.1164/ajrccm.164.5.2009008; Reinke C, 2011, AM J PHYSIOL-LUNG C, V300, pL266, DOI 10.1152/ajplung.00239.2010; Roberts KE, 2010, GASTROENTEROLOGY, V139, P130, DOI 10.1053/j.gastro.2010.03.044; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Scarlata S, 2011, LIVER INT, V31, P525, DOI 10.1111/j.1478-3231.2011.02467.x; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; Vlachaki EM, 2010, CHEST, V137, P37, DOI 10.1378/chest.09-1029; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yang SX, 2002, AM J RESP CELL MOL, V27, P297, DOI 10.1165/rcmb.2002-0035OC; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Zhang JL, 2003, GASTROENTEROLOGY, V125, P1441, DOI 10.1016/j.gastro.2003.07.005; Zhang JL, 2012, J HEPATOL, V57, P752, DOI 10.1016/j.jhep.2012.05.014; Zhang JL, 2012, NAT REV GASTRO HEPAT, V9, P539, DOI 10.1038/nrgastro.2012.123; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x	56	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113451	10.1371/journal.pone.0113451	http://dx.doi.org/10.1371/journal.pone.0113451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419825	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900038
J	Autengruber, A; Sydlik, U; Kroker, M; Hornstein, T; Ale-Agha, N; Stockmann, D; Bilstein, A; Albrecht, C; Paunel-Gorgulu, A; Suschek, CV; Krutmann, J; Unfried, K				Autengruber, Andrea; Sydlik, Ulrich; Kroker, Matthias; Hornstein, Tamara; Ale-Agha, Niloofar; Stoeckmann, Daniel; Bilstein, Andreas; Albrecht, Catrin; Paunel-Goerguelue, Adnana; Suschek, Christoph V.; Krutmann, Jean; Unfried, Klaus			Signalling-Dependent Adverse Health Effects of Carbon Nanoparticles Are Prevented by the Compatible Solute Mannosylglycerate (Firoin) In Vitro and In Vivo	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; AIR-POLLUTION; ECTOINE; STABILITY; APOPTOSIS; STRATEGY	The inhalation of combustion-derived nanoparticles leads to adverse health effects in the airways. In this context the induction of membrane-coupled signalling is considered as causative for changes in tissue homeostasis and pro-inflammatory reactions. The identification of these molecular cell reactions allowed to seek for strategies which interfere with these adverse effects. In the current study, we investigated the structurally different compatible solutes mannosylglycerate (firoin) from thermophilic bacteria and ectoine from halophilic bacteria for their capability to reduce signalling pathways triggered by carbon nanoparticles in target cells in the lung. The pre-treatment of lung epithelial cells with both substances decreased the particle-specific activation of mitogen-activated protein kinases and also the endpoints proliferation and apoptosis. Firoin applied into the lungs of animals, like ectoine, led to a significant reduction of the neutrophilic lung inflammation induced by particle exposure. The pro-inflammatory effect of carbon nanoparticles on human neutrophil granulocytes ex vivo was significantly reduced by both substances via the reduction of the anti-apoptotic membrane-dependent signalling. The data of this study together with earlier studies demonstrate that two structurally non-related compatible solutes are able to prevent pathogenic reactions of the airways to carbon nanoparticles by interfering with signalling events. The findings highlight the preventive or therapeutic potential of compatible solutes for adverse health effects caused by particle exposure of the airways.	[Autengruber, Andrea; Sydlik, Ulrich; Kroker, Matthias; Hornstein, Tamara; Ale-Agha, Niloofar; Stoeckmann, Daniel; Albrecht, Catrin; Krutmann, Jean; Unfried, Klaus] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Bilstein, Andreas] Bitop AG, Witten, Germany; [Paunel-Goerguelue, Adnana; Suschek, Christoph V.] Univ Dusseldorf, Dept Traumatol & Hand Surg, Dusseldorf, Germany; [Krutmann, Jean] Univ Dusseldorf, Zentrum Mol Med, Fac Med, Dusseldorf, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Unfried, K (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	klaus.unfried@uni-duesseldorf.de	Bilstein, Andreas/GSE-9960-2022		Heinrich-Heine-University (US); bitop AG	Heinrich-Heine-University (US); bitop AG	Funding: The work was funded by research grants from the Heinrich-Heine-University (FoKo received by US) and bitop AG. The funder bitop AG provided support in the form of a salary for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2002, TOXICOL APPL PHARM, V184, P37, DOI 10.1006/taap.2002.9500; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Avanti C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086244; Blanchet S, 2004, AM J RESP CELL MOL, V30, P421, DOI 10.1165/rcmb.2003-0281RC; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Buenger J, 2004, SKIN PHARMACOL PHYS, V17, P232, DOI 10.1159/000080216; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Faria TQ, 2004, J BIOL CHEM, V279, P48680, DOI 10.1074/jbc.M408806200; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Harishchandra RK, 2011, BBA-BIOMEMBRANES, V1808, P2830, DOI 10.1016/j.bbamem.2011.08.022; Janssen NAH, 2011, ENVIRON HEALTH PERSP, V119, P1691, DOI 10.1289/ehp.1003369; Kim YM, 2005, AM J PHYSIOL-LUNG C, V288, pL432, DOI 10.1152/ajplung.00285.2004; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Marini A, 2014, SKIN PHARMACOL PHYS, V27, P57, DOI 10.1159/000351381; Pais TM, 2012, PROTEIN SCI, V21, P1126, DOI 10.1002/pro.2100; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Peuschel H, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-48; Roychoudhury A, 2013, BIOL CHEM, V394, P1465, DOI 10.1515/hsz-2013-0173; Roychoudhury A, 2012, PROTEIN PEPTIDE LETT, V19, P791, DOI 10.2174/092986612801619570; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Serhan CN, 2005, NAT IMMUNOL, V120, P4236; Sydlik U, 2006, AM J PHYSIOL-LUNG C, V291, pL725, DOI 10.1152/ajplung.00131.2006; Sydlik U, 2013, EUR RESPIR J, V41, P433, DOI 10.1183/09031936.00132211; Sydlik U, 2009, AM J RESP CRIT CARE, V180, P29, DOI 10.1164/rccm.200812-1911OC; Unfried Klaus, 2014, J Allergy (Cairo), V2014, P708458, DOI 10.1155/2014/708458; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111485	10.1371/journal.pone.0111485	http://dx.doi.org/10.1371/journal.pone.0111485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415441	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600006
J	Helelo, TP; Gelaw, YA; Adane, AA				Helelo, Tsegab Paulose; Gelaw, Yalemzewod Assefa; Adane, Akilew Awoke			Prevalence and Associated Factors of Hypertension among Adults in Durame Town, Southern Ethiopia	PLOS ONE			English	Article							BLOOD-PRESSURE; POPULATION; AWARENESS; URBAN; GHANA	Background: To date, non-communicable diseases, such as cardiovascular diseases, are becoming severe public health challenges particularly in developing countries. Hypertension is a modifiable risk factor that contributes the leading role for mortality. The problem is significant in low-and middle-income countries like sub-Saharan Africa. However, there are limited studies in developing countries, particularly in Ethiopia. Hence, determining the magnitude of hypertension and identifying risk groups are important. Methods: A community based cross sectional study was conducted in April 2013 among adults (age. 31 years) old. A systematic sampling technique was used to select a total of 518 study participants. Data were collected after full verbal informed consent was obtained from each participant. Multivariable logistic regressions were fitted to control the effect of confounding. Adjusted Odds ratios (OR) with their 95% confidence intervals (95% CI) were calculated to measure associations. Variables having P-value,0.05 were considered as significant. Results: The overall prevalence of hypertension in Durame town was 22.4% (95% CI: 18.8-26.0). Nearly 40% of hypertensive patients were newly screened. Male sex [AOR =2.03, 95% CI; 1.05-3.93], age [AOR =29.49, 95% CI; 10.60-81.27], salt use [AOR =6.55, 95% CI; 2.31-18.53], eating vegetable three or fewer days per week [AOR =2.3,95% CI; 1.17-4.51], not continuously walking at least for 10 minutes per day [AOR =7.82, 95% CI; 2.37-25.82], having family history of hypertension [AOR =2.46, 95% CI; 1.31-4.61] and being overweight/obese [AOR =15.7, 95% CI 7.89-31.21)] were found to be risk factors for hypertension. Conclusions: The prevalence of hypertension is found to be high. Older age, male sex, having family history of hypertension, physical inactivity, poor vegetable diet, additional salt consumption and obesity were important risk factors associated with hypertension among adults. Community level intervention measures with a particular emphasis on prevention by introducing lifestyle modifications are recommended.	[Helelo, Tsegab Paulose] Southern Nations Nationalities & Peoples Hlth Bur, Zonal Hlth Dept, Durame, Ethiopia; [Gelaw, Yalemzewod Assefa; Adane, Akilew Awoke] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar	Helelo, TP (corresponding author), Southern Nations Nationalities & Peoples Hlth Bur, Zonal Hlth Dept, Durame, Ethiopia.	babytsegab@yahoo.com	Gelaw, Yalemzewod Assefa/ABF-5175-2020; Adane, Akilew/AAG-3286-2019; Gelaw, Yalemzewod Assefa/O-5291-2019	Gelaw, Yalemzewod Assefa/0000-0002-5338-586X; Adane, Akilew Awoke/0000-0002-3022-5230				Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; [Anonymous], 2005, PREV CHRON DIS VIT I; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; CSA, 2008, SUMM STAT REP 2007 P, P57; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Forrester T, 2005, J HUM HYPERTENS, V19, P55, DOI 10.1038/sj.jhh.1001782; Giday Araya, 2011, Ethiop Med J, V49, P139; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Kotcher T., 2008, HYPERTENSIVE VASCULA, V17th, P1549; Kunutsor S, 2009, RURAL REMOTE HEALTH, V9; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Longo-Mbenza B, 2007, NIGER J MED, V1, P42; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Olatunbosun ST, 2000, J HUM HYPERTENS, V14, P249, DOI 10.1038/sj.jhh.1000975; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Siziya S, 2012, J HYPERTENS, V1, P105; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; World Health Organization, WHO STEPWISE APPR CH	22	62	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112790	10.1371/journal.pone.0112790	http://dx.doi.org/10.1371/journal.pone.0112790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415321	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600016
J	Su, FH; Wu, CS; Sung, FC; Chang, SN; Su, CT; Shieh, YH; Yeh, CC				Su, Fu-Hsiung; Wu, Chien-Sheng; Sung, Fung-Chang; Chang, Shih-Ni; Su, Chien-Tien; Shieh, Ying-Hua; Yeh, Chih-Ching			Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; B-VIRUS; HEPATOCELLULAR-CARCINOMA; HCV INFECTION; MANIFESTATIONS; PREVALENCE; SEROPREVALENCE; AUTOANTIBODY; ANTIBODY; DISEASES	Objective: The association between chronic hepatitis virus infection and rheumatoid arthritis (RA) remains debatable. This nationwide population-based cohort study assessed the risk of RA among patients with a chronic infection of hepatitis B and/or C virus. Materials and Methods: We used data extracted from the claims of 1,000,000 randomly sampled individuals covered under the Taiwan National Health Insurance program. Among the 49,892 persons identified in 2000-2010 with chronic hepatitis virus infection, 35,652 had chronic HBV infection alone, 10,253 had chronic HCV infection alone, and 3,987 had chronic HBV/HCV dual infections. The comparison cohort comprised 199,568 persons matched on sex, age and calendar year without chronic hepatitis virus infection. All study participants were free of RA at baseline and traced through 2011 with new RA cases identified. Results: After adjusting for covariates, chronic HCV infection alone was significantly associated with an increased risk for RA (hazard ratio (HR) =2.03, 95% confidence interval (CI) =1.27-3.22). The increased risk for RA among participants with chronic HCV infection remained significant after restricting the analysis to those who were prescribed disease-modifying anti-rheumatic drugs. The corresponding HR for the overall sample was 1.89 (95% CI =1.15-3.11). However, HBV carriers did not appear to be at a significantly higher risk for RA. Conclusion: Our data imply that chronic HCV infection is associated with RA development.	[Su, Fu-Hsiung] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Su, Fu-Hsiung; Shieh, Ying-Hua] Taipei Med Univ, Sch Med, Dept Family Med, Taipei, Taiwan; [Wu, Chien-Sheng] Far Eastern Mem Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Sch Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang; Chang, Shih-Ni] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Su, Chien-Tien; Yeh, Chih-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Shieh, Ying-Hua] Taipei Med Univ, Wan Fang Hosp, Dept Family Med, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan	Yeh, CC (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan.	ccyeh@tmu.edu.tw	Wu, Chien-Sheng/M-9151-2013; Su, Fu-Hsiung/AAO-5468-2021	Wu, Chien-Sheng/0000-0003-2815-1743; Su, Fu-Hsiung/0000-0002-9867-7655	Taipei Medical University Hospital [101TMU-TMUH-13]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	Taipei Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center of Excellence	Funding was provided by 1. FHS: research grant from Taipei Medical University Hospital (101TMU-TMUH-13); 2. FCS: research grant from Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2009, J AUTOIMMUN, V32, P261, DOI 10.1016/j.jaut.2009.02.017; Agnello V, 2004, J HEPATOL, V40, P341, DOI 10.1016/j.jhep.2003.10.009; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Antonelli A, 2008, CLIN EXP RHEUMATOL, V26, pS39; Barbosa VS, 2005, BRAZ J MED BIOL RES, V38, P801, DOI 10.1590/S0100-879X2005000500020; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2009, RHEUM DIS CLIN N AM, V35, P125, DOI 10.1016/j.rdc.2009.03.006; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chi Zhao-Chun, 2003, Hepatobiliary Pancreat Dis Int, V2, P32; Csepregi A, 2004, J RHEUMATOL, V31, P1016; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elliott AC, 2006, P SAS US GROUP INT 3; Ezzat WM, 2011, RHEUMATOL INT, V31, P65, DOI 10.1007/s00296-009-1225-8; Fanchiang C., 2004, TAIWAN TODAY; Ferri C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3865; Hsu FC, 2003, J RHEUMATOL, V30, P455; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P110, DOI 10.1111/j.1365-2249.2006.03046.x; Hu CY, 2006, ANN RHEUM DIS, V65, P138, DOI 10.1136/ard.2005.039982; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P1017, DOI 10.1016/j.cgh.2010.08.026; Kemmer Nyingi M, 2010, J Musculoskelet Med, V27, P351; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lee SI, 2007, CLIN RHEUMATOL, V26, P1079, DOI 10.1007/s10067-006-0451-7; Lienesch D, 2005, J RHEUMATOL, V32, P489; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu FC, 2008, CLIN RHEUMATOL, V27, P463, DOI 10.1007/s10067-007-0729-4; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Mandrekar JN, 2004, SUGI 29 PAPER INTRO, P208; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Oliver JE, 2006, SCAND J RHEUMATOL, V35, P169, DOI 10.1080/03009740600718080; Palazzi C, 2008, AUTOIMMUN REV, V8, P48, DOI 10.1016/j.autrev.2008.07.025; PERMIN H, 1982, ANN RHEUM DIS, V41, P479, DOI 10.1136/ard.41.5.479; Rivera J, 1999, J RHEUMATOL, V26, P420; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS71; Tzang BS, 1999, ANN RHEUM DIS, V58, P630, DOI 10.1136/ard.58.10.630; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; WATANABE K, 1991, CLIN RHEUMATOL, V10, P31, DOI 10.1007/BF02208030; World Health Organization, 2002, WHOCDSCSRLYO20022, V54; Yeh H M, 1994, Gaoxiong Yi Xue Ke Xue Za Zhi, V10, P239; Yu KH, 2013, ARTHRIT CARE RES, V65, P244, DOI 10.1002/acr.21820; Zuckerman E, 2000, CLIN EXP RHEUMATOL, V18, P579	43	19	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113579	10.1371/journal.pone.0113579	http://dx.doi.org/10.1371/journal.pone.0113579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415338	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600059
J	Coutu, DL; Mahfouz, W; Loutochin, O; Galipeau, J; Corcos, J				Coutu, Daniel L.; Mahfouz, Wally; Loutochin, Oleg; Galipeau, Jacques; Corcos, Jacques			Tissue Engineering of Rat Bladder Using Marrow-Derived Mesenchymal Stem Cells and Bladder Acellular Matrix	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; URINARY-BLADDER; EXTRACELLULAR-MATRIX; IMMUNE-RESPONSE; DECELLULARIZATION; AUGMENTATION; REPLACEMENT	Bladder replacement or augmentation is required in congenital malformations or following trauma or cancer. The current surgical solution involves enterocystoplasty but is associated with high complication rates. Strategies for bladder tissue engineering are thus actively sought to address this unmet clinical need. Because of the poor efficacy of synthetic polymers, the use of bladder acellular matrix (BAM) has been proposed. Indeed when cellular components are removed from xenogenic or allogeneic bladders, the extracellular matrix scaffold thus obtained can be used alone or in combination with stem cells. In this study, we propose the use of BAM seeded with marrow-derived mesenchymal stem cells (MSCs) for bladder tissue engineering. We optimized a protocol for decellularization of bladder tissue from different species including rat, rabbit and swine. We demonstrate the use of non-ionic detergents followed by nuclease digestion results in efficient decellularization while preserving the extracellular matrix. When MSCs were seeded on acellular matrix scaffold, they remained viable and proliferative while adopting a cellular phenotype consistent with their microenvironment. Upon transplantation in rats after partial cystectomy, MSC-seeded BAM proved superior to unseeded BAM with animals recovering nearly 100% normal bladder capacity for up to six months. Histological analyses also demonstrated increased muscle regeneration.	[Coutu, Daniel L.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Mahfouz, Wally; Loutochin, Oleg; Corcos, Jacques] McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada; [Mahfouz, Wally] Univ Alexandria, Dept Urol, Alexandria, Egypt; [Galipeau, Jacques] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	ETH Zurich; McGill University; Egyptian Knowledge Bank (EKB); Alexandria University; Emory University	Corcos, J (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada.	jcorcos@uro.jgh.mcgill.ca	Galipeau, Jacques/R-9909-2019; Coutu, Daniel/AAD-5292-2022	Galipeau, Jacques/0000-0002-9374-1996; Coutu, Daniel/0000-0002-4641-0115; Mahfouz, Wally/0000-0002-0289-6758	Urology Department, Jewish General Hospital, Montreal, Canada; Canadian Institutes of Health Research	Urology Department, Jewish General Hospital, Montreal, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding: This project was funded by Urology Department, Jewish General Hospital, Montreal, Canada to WM, OL and JC. DLC holds a Canadian Institutes of Health Research postdoctoral fellowship. JG is a Georgia Cancer Coalition Distinguished Cancer Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202; Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Bergwerf I, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-1; Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005; Bono A V, 1966, Minerva Urol, V18, P43; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Comer MT, 1999, ADV EXP MED BIOL, V462, P43; Coutu DL, 2011, BLOOD, V117, P6801, DOI 10.1182/blood-2010-12-321539; Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296; Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5; Farhat WA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025015; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; KELAMI A, 1970, EUR SURG RES, V2, P195, DOI 10.1159/000127514; Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011; Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959	31	31	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111966	10.1371/journal.pone.0111966	http://dx.doi.org/10.1371/journal.pone.0111966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437001	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900010
J	Hollerhage, M; Deck, R; De Andrade, A; Respondek, G; Xu, H; Rosler, TW; Salama, M; Carlsson, T; Yamada, ES; El Hak, SAG; Goedert, M; Oertel, WH; Hoglinger, GU				Hoellerhage, Matthias; Deck, Roman; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Salama, Mohamed; Carlsson, Thomas; Yamada, Elizabeth S.; El Hak, Seham A. Gad; Goedert, Michel; Oertel, Wolfgang H.; Hoeglinger, Guenter U.			Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; PROGRESSIVE SUPRANUCLEAR PALSY; ATYPICAL PARKINSONISM; FRONTOTEMPORAL DEMENTIA; STREPTOMYCES PNEUMONIA; SYNAPSE LOSS; PROTEIN-TAU; MUTATION; GUADELOUPE; INHIBITOR	Objective: The P301S mutation in exon 10 of the tau gene causes a hereditary tauopathy. While mitochondrial complex I inhibition has been linked to sporadic tauopathies. Piericidin A is a prototypical member of the group of the piericidins, a class of biologically active natural complex I inhibitors, isolated from streptomyces spp. with global distribution in marine and agricultural habitats. The aim of this study was to determine whether there is a pathogenic interaction of the environmental toxin piericidin A and the P301S mutation. Methods: Transgenic mice expressing human tau with the P301S-mutation (P301S(+/+)) and wild-type mice at 12 weeks of age were treated subcutaneously with vehicle (N=10 P301S(+/+), N = 7 wild-type) or piericidin A (N = 9 P301S(+/+), N = 9 wild-type mice) at a dose of 0.5 mg/kg/d for a period of 28 days via osmotic minipumps. Tau pathology was measured by stereological counts of cells immunoreative with antibodies against phosphorylated tau (AD2, AT8, AT180, and AT100) and corresponding Western blot analysis. Results: Piericidin A significantly increased the number of phospho-tau immunoreactive cells in the cerebral cortex in P301S(+/+) mice, but only to a variable and mild extent in wild-type mice. Furthermore, piericidin A led to increased levels of pathologically phosphorylated tau only in P301S(+/+) mice. While we observed no apparent cell loss in the frontal cortex, the synaptic density was reduced by piericidin A treatment in P301S(+/+) mice. Discussion: This study shows that exposure to piericidin A aggravates the course of genetically determined tau pathology, providing experimental support for the concept of gene-environment interaction in the etiology of tauopathies.	[Hoellerhage, Matthias; Deck, Roman; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Salama, Mohamed; Carlsson, Thomas; Yamada, Elizabeth S.; Oertel, Wolfgang H.; Hoeglinger, Guenter U.] Univ Marburg, Dept Neurol, Marburg, Germany; [Hoellerhage, Matthias; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Hoeglinger, Guenter U.] German Ctr Neurodegenerat Dis, Dept Translat Neurodegenerat, Munich, Germany; [Hoellerhage, Matthias; Respondek, Gesine; Hoeglinger, Guenter U.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Salama, Mohamed; El Hak, Seham A. Gad] Mansoura Univ, Dept Toxicol, Mansoura, Egypt; [Carlsson, Thomas] Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Yamada, Elizabeth S.] Fed Univ Para, Expt Neuropathol Lab, BR-66059 Belem, Para, Brazil; [Goedert, Michel] Univ Cambridge, Div Neurobiol, Cambridge, England	Philipps University Marburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Egyptian Knowledge Bank (EKB); Mansoura University; University of Gothenburg; Universidade Federal do Para; University of Cambridge	Hoglinger, GU (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	guenter.hoeglinger@dzne.de	Höglinger, Günter U/F-2388-2015; Xu, Hong/AAP-6568-2020	Höglinger, Günter U/0000-0001-7587-6187; Carlsson, Thomas/0000-0003-3632-8959; Salama, Mohamed/0000-0003-1644-0273	Deutsche Forschungsgemeinschaft [HO2402/6-1, HO2402/8-1]; German Ministry of Education and Research [BMBF GEF 10-54]; Science and Technology Development Fund (Egypt) [GEF 1054]; German Academic Exchange Service (DAAD); MRC [MC_U105184291] Funding Source: UKRI; Medical Research Council [MC_U105184291] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Science and Technology Development Fund (Egypt)(Science and Technology Development Fund (STDF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (HO2402/6-1, HO2402/8-1), the German Ministry of Education and Research (BMBF GEF 10-54), Science and Technology Development Fund (Egypt, GEF 1054), and the German Academic Exchange Service (DAAD to ACdA, HX, MS). Wolfgang H. Oertel is Senior research Professor of the Charitable Hertie Foundation, Frankfurt/Main, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Baba Y, 2007, J NEURAL TRANSM, V114, P947, DOI 10.1007/s00702-007-0632-9; Bigio EH, 2001, J NEUROPATH EXP NEUR, V60, P403, DOI 10.1093/jnen/60.5.403; Bigio EH, 1999, J NEUROPATH EXP NEUR, V58, P359, DOI 10.1097/00005072-199904000-00006; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Caparros-Lefebvre D, 1999, LANCET, V354, P281, DOI 10.1016/S0140-6736(98)10166-6; Caparros-Lefebvre D, 2005, MOVEMENT DISORD, V20, pS114, DOI 10.1002/mds.20553; Cave A, 1997, Fortschr Chem Org Naturst, V70, P81; Champy P, 2005, MOVEMENT DISORD, V20, P1629, DOI 10.1002/mds.20632; Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Dunne EF, 1998, CLIN INFECT DIS, V27, P93, DOI 10.1086/514612; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Hollerhage M, 2009, EXP NEUROL, V220, P133, DOI 10.1016/j.expneurol.2009.08.004; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; JENG M, 1968, BIOCHEMISTRY-US, V7, P1311, DOI 10.1021/bi00844a010; Kofteridis DP, 2007, DIAGN MICR INFEC DIS, V59, P459, DOI 10.1016/j.diagmicrobio.2007.06.009; Lannuzel A, 2007, BRAIN, V130, P816, DOI 10.1093/brain/awl347; Lossos A, 2003, J NEUROL, V250, P733, DOI 10.1007/s00415-003-1074-4; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ostojic J, 2004, DEMENT GERIATR COGN, V17, P298, DOI 10.1159/000077158; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; TAKAHASHI N, 1965, J AM CHEM SOC, V87, P2066, DOI 10.1021/ja01087a050; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yamada ES, 2014, EXP NEUROL, V253, P113, DOI 10.1016/j.expneurol.2013.12.017; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; ZafraPolo MC, 1996, PHYTOCHEMISTRY, V42, P253, DOI 10.1016/0031-9422(95)00836-5	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113557	10.1371/journal.pone.0113557	http://dx.doi.org/10.1371/journal.pone.0113557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437199	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900052
J	Levett, PA; Hutmacher, DW; Malda, J; Klein, TJ				Levett, Peter A.; Hutmacher, Dietmar W.; Malda, Jos; Klein, Travis J.			Hyaluronic Acid Enhances the Mechanical Properties of Tissue-Engineered Cartilage Constructs	PLOS ONE			English	Article							STEM-CELLS; GELATIN; HYDROGELS; OSTEOARTHRITIS; CHONDROCYTES; DEFECTS; DESIGN; MATRIX; REPAIR	There is a need for materials that are well suited for cartilage tissue engineering. Hydrogels have emerged as promising biomaterials for cartilage repair, since, like cartilage, they have high water content, and they allow cells to be encapsulated within the material in a genuinely three-dimensional microenvironment. In this study, we investigated the mechanical properties of tissue-engineered cartilage constructs using in vitro culture models incorporating human chondrocytes from osteoarthritis patients. We evaluated hydrogels formed from mixtures of photocrosslinkable gelatin-methacrylamide (Gel-MA) and varying concentrations (0-2%) of hyaluronic acid methacrylate (HA-MA). Initially, only small differences in the stiffness of each hydrogel existed. After 4 weeks of culture, and to a greater extent 8 weeks of culture, HA-MA had striking and concentration dependent impact on the changes in mechanical properties. For example, the initial compressive moduli of cell-laden constructs with 0 and 1% HA-MA were 29 and 41 kPa, respectively. After 8 weeks of culture, the moduli of these constructs had increased to 66 and 147 kPa respectively, representing a net improvement of 69 kPa for gels with 1% HA-MA. Similarly the equilibrium modulus, dynamic modulus, failure strength and failure strain were all improved in constructs containing HA-MA. Differences in mechanical properties did not correlate with glycosaminoglycan content, which did not vary greatly between groups, yet there were clear differences in aggrecan intensity and distribution as assessed using immunostaining. Based on the functional development with time in culture using human chondrocytes, mixtures of Gel-MA and HA-MA are promising candidates for cartilage tissueengineering applications.	[Levett, Peter A.; Hutmacher, Dietmar W.; Malda, Jos; Klein, Travis J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Levett, Peter A.; Malda, Jos] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands; [Malda, Jos] Univ Utrecht, Dept Equine Sci, NL-3508 TD Utrecht, Netherlands	Queensland University of Technology (QUT); Utrecht University; Utrecht University Medical Center; Utrecht University	Klein, TJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.	t2.klein@qut.edu.au	Malda, Jos/ABA-9685-2021; Klein, Travis/J-1117-2012	Klein, Travis/0000-0002-6669-7766; Hutmacher, Dietmar Werner/0000-0001-5678-2134; Malda, Jos/0000-0002-9241-7676	Australian Research Council [DP110103543, FT110100166, FT110101117]; European Union [309962]; National Health and Medical Research Council Australian - European Union Health Research Collaboration [APP1067108]	Australian Research Council(Australian Research Council); European Union(European Commission); National Health and Medical Research Council Australian - European Union Health Research Collaboration(National Health and Medical Research Council (NHMRC) of Australia)	Funding: The research leading to these results has received funding from the Australian Research Council (TK, DH and PL; DP110103543, FT110100166, FT110101117, http://.arc.gov.au/), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 309962 (project HydroZONES), and a National Health and Medical Research Council Australian - European Union Health Research Collaboration (APP1067108).	Abate M, 2010, CURR PHARM DESIGN, V16, P631, DOI 10.2174/138161210790883859; Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Ahearne M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035004; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Benders KEM, 2010, OSTEOARTHR CARTILAGE, V18, P1586, DOI 10.1016/j.joca.2010.10.005; Boere KWM, 2014, ACTA BIOMAT IN PRESS; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; Camci-Unal G, 2013, BIOMACROMOLECULES, V14, P1085, DOI 10.1021/bm3019856; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Erickson IE, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024110; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037; Gobbi A, 2014, AM J SPORT MED, V42, P648, DOI 10.1177/0363546513518007; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI 10.1089/ten.tea.2010.0666; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kim M, 2012, BIOMACROMOLECULES, V13, P2287, DOI 10.1021/bm3005353; Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a; Levett PA, 2013, J BIOMEDI A IN PRESS; Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; Mastbergen SC, 2013, NAT REV RHEUMATOL, V9, P277, DOI 10.1038/nrrheum.2013.29; McCormick F, 2008, SPORTS MED ARTHROSC, V16, P217, DOI 10.1097/JSA.0b013e31818e0e4a; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; O'Brien AK, 2006, J POLYM SCI POL CHEM, V44, P2007, DOI 10.1002/pola.21304; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Roberts JJ, 2013, BIOMATERIAL IN PRESS; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; Wilson W, 2007, BIOMECH MODEL MECHAN, V6, P43, DOI 10.1007/s10237-006-0044-z; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056	46	91	92	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113216	10.1371/journal.pone.0113216	http://dx.doi.org/10.1371/journal.pone.0113216			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438040	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900034
J	Ottone, VD; Magalhaes, FD; de Paula, F; Avelar, NCP; Aguiar, PF; Sampaio, PFD; Duarte, TC; Costa, KB; Araujo, TL; Coimbra, CC; Nakamura, FY; Amorim, FT; Rocha-Vieira, E				Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; de Paula, Fabricio; Pereira Avelar, Nubia Carelli; Aguiar, Paula Fernandes; da Matta Sampaio, Pamela Fiche; Duarte, Tamiris Campos; Costa, Karine Beatriz; Araujo, Tatiane Liliam; Coimbra, Candido Celso; Nakamura, Fabio Yuzo; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel			The Effect of Different Water Immersion Temperatures on Post-Exercise Parasympathetic Reactivation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RATE RECOVERY; VENTRICULAR-FIBRILLATION; EXERCISE PERFORMANCE; RATE DYNAMICS; BLOOD-FLOW; COLD; INTENSITY; ENDURANCE; HUMANS	Purpose: We evaluated the effect of different water immersion (WI) temperatures on post-exercise cardiac parasympathetic reactivation. Methods: Eight young, physically active men participated in four experimental conditions composed of resting (REST), exercise session (resistance and endurance exercises), post-exercise recovery strategies, including 15 min of WI at 15 degrees C (CWI), 28 degrees C (TWI), 38 degrees C (HWI) or control (CTRL, seated at room temperature), followed by passive resting. The following indices were assessed before and during WI, 30 min post-WI and 4 hours post-exercise: mean R-R (mRR), the natural logarithm (ln) of the square root of the mean of the sum of the squares of differences between adjacent normal R-R (ln rMSSD) and the ln of instantaneous beat-to-beat variability (ln SD1). Results: The results showed that during WI mRR was reduced for CTRL, TWI and HWI versus REST, and ln rMSSD and ln SD1 were reduced for TWI and HWI versus REST. During post-WI, mRR, ln rMSSD and ln SD1 were reduced for HWI versus REST, and mRR values for CWI were higher versus CTRL. Four hours post exercise, mRR was reduced for HWI versus REST, although no difference was observed among conditions. Conclusions: We conclude that CWI accelerates, while HWI blunts post-exercise parasympathetic reactivation, but these recovery strategies are short-lasting and not evident 4 hours after the exercise session.	[Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; de Paula, Fabricio; Aguiar, Paula Fernandes; da Matta Sampaio, Pamela Fiche; Duarte, Tamiris Campos; Costa, Karine Beatriz; Araujo, Tatiane Liliam; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel] Univ Fed Vales Jequitinhonha & Mucuri, Lab Biol Exercicio, Ctr Integrado Pesquisa Saude, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil; [Pereira Avelar, Nubia Carelli] Univ Fed Santa Catarina, Nucleo Estudos Reumatol Esport & Recursos Terapeu, Ararangua, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Endocrinol, Belo Horizonte, MG, Brazil; [Nakamura, Fabio Yuzo] Univ Estadual Londrina, Dept Educ Fis, Londrina, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais; Universidade Estadual de Londrina	Magalhaes, FD (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Lab Biol Exercicio, Ctr Integrado Pesquisa Saude, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil.	flavio.magalhaes@ufvjm.edu.br	Rocha-Vieira, Etel/A-2524-2017; Nakamura, Fábio Yuzo/AAC-3069-2020; Magalhães, Flávio/AAE-9680-2020; de Castro Magalhaes, Flavio/AAB-5540-2022	Rocha-Vieira, Etel/0000-0001-6908-7237; Nakamura, Fábio Yuzo/0000-0002-5336-3652; de Castro Magalhaes, Flavio/0000-0002-1963-982X	FAPEMIG (the Minas Gerais State Research Fundation, Brazil) [CDS - APQ-00908-08]; CNPq (The National Council for Scientific and Technological Development, Brazil); FAPEMIG	FAPEMIG (the Minas Gerais State Research Fundation, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (The National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was financially supported by FAPEMIG (the Minas Gerais State Research Fundation, Brazil - http://www.fapemig.br/), process number CDS - APQ-00908-08. V. O. O. was a recipient of an undergraduate scholarship from the CNPq (The National Council for Scientific and Technological Development, Brazil); F. C. M. is a post-doctoral fellow (CAPES 2455/2011 - http://.www.capes.gov.br/), F. P. and N. C. P. A. were recipients of master's scholarships from FAPEMIG; P. F. A., P. F. M. S., T. C. D., K. B. C. and T. L. A. were recipients of an undergraduate scholarship from FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2012, INT J SPORT PHYSIOL, V7, P33, DOI 10.1123/ijspp.7.1.33; Al Haddad H, 2010, AUTON NEUROSCI-BASIC, V156, P111, DOI 10.1016/j.autneu.2010.03.017; Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Bastos FN, 2012, INT J SPORTS MED, V33, P873, DOI 10.1055/s-0032-1301905; Billman GE, 2002, J APPL PHYSIOL, V92, P446, DOI 10.1152/japplphysiol.00874.2001; Billman GE, 2006, AM J PHYSIOL-HEART C, V291, pH429, DOI 10.1152/ajpheart.00020.2006; BONDEPETERSEN F, 1992, AVIAT SPACE ENVIR MD, V63, P346; Boullosa DA, 2013, INT J SPORT PHYSIOL, V8, P400, DOI 10.1123/ijspp.8.4.400; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2010, EUR J APPL PHYSIOL, V108, P1153, DOI 10.1007/s00421-009-1317-x; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; FORTNEY SM, 1985, SPORTS MED, V2, P8, DOI 10.2165/00007256-198502010-00002; Gabrielsen A, 1996, J Gravit Physiol, V3, P22; Hautala A, 2001, CLIN PHYSIOL, V21, P238, DOI 10.1046/j.1365-2281.2001.00309.x; Heffernan KS, 2006, EUR J CARDIOV PREV R, V13, P80; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kiviniemi AM, 2010, MED SCI SPORT EXER, V42, P1355, DOI 10.1249/MSS.0b013e3181cd5f39; KNIGHT KL, 1980, MED SCI SPORT EXER, V12, P76; Lamberts RP, 2009, EUR J APPL PHYSIOL, V105, P705, DOI 10.1007/s00421-008-0952-y; Leicht AS, 2009, EXP PHYSIOL, V94, P695, DOI 10.1113/expphysiol.2009.046714; Leveritt M, 1999, SPORTS MED, V28, P413, DOI 10.2165/00007256-199928060-00004; Maresh CM, 2006, INT J SPORTS MED, V27, P765, DOI 10.1055/s-2005-872932; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Parouty J, 2010, EUR J APPL PHYSIOL, V109, P483, DOI 10.1007/s00421-010-1381-2; PERINI R, 1990, EUR J APPL PHYSIOL O, V61, P143, DOI 10.1007/BF00236709; PERINI R, 1989, EUR J APPL PHYSIOL, V58, P879, DOI 10.1007/BF02332222; PERINI R, 1993, EUR J APPL PHYSIOL O, V66, P500, DOI 10.1007/BF00634299; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Quintana DS, 2012, EUR J APPL PHYSIOL, V112, P4179, DOI 10.1007/s00421-012-2453-2; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; Seiler S, 2007, MED SCI SPORT EXER, V39, P1366, DOI 10.1249/mss.0b013e318060f17d; Smith LL, 2005, AM J PHYSIOL-HEART C, V288, pH1763, DOI 10.1152/ajpheart.00785.2004; Spinelli L, 1999, AM J PHYSIOL-HEART C, V277, pH1361, DOI 10.1152/ajpheart.1999.277.4.H1361; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Vaile J, 2008, EUR J APPL PHYSIOL, V102, P447, DOI 10.1007/s00421-007-0605-6; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Versey N, 2011, EUR J APPL PHYSIOL, V111, P37, DOI 10.1007/s00421-010-1614-4; Versey NG, 2013, SPORTS MED, V43, P1101, DOI 10.1007/s40279-013-0063-8; Watanabe N, 2007, CHIROPRACTIC OSTEOPA, V15, P19, DOI DOI 10.1186/1746-1340-15-19; Weippert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083690; WESTON CFM, 1987, CLIN SCI, V73, P613, DOI 10.1042/cs0730613; WHIPP BJ, 1981, J APPL PHYSIOL, V50, P217, DOI 10.1152/jappl.1981.50.1.217; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Yamane M, 2006, EUR J APPL PHYSIOL, V96, P572, DOI 10.1007/s00421-005-0095-3	50	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113730	10.1371/journal.pone.0113730	http://dx.doi.org/10.1371/journal.pone.0113730			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437181	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900071
J	Sanger, PC; Hartzler, A; Han, SM; Armstrong, CAL; Stewart, MR; Lordon, RJ; Lober, WB; Evans, HL				Sanger, Patrick C.; Hartzler, Andrea; Han, Sarah M.; Armstrong, Cheryl A. L.; Stewart, Mark R.; Lordon, Ross J.; Lober, William B.; Evans, Heather L.			Patient Perspectives on Post-Discharge Surgical Site Infections: Towards a Patient-Centered Mobile Health Solution	PLOS ONE			English	Article							IMPACT; CARE; SURVEILLANCE	Background: Post-discharge surgical site infections (SSI) are a major source of morbidity, expense and anxiety for patients. However, patient perceptions about barriers experienced while seeking care for post-discharge SSI have not been assessed in depth. We explored patient experience of SSI and openness to a mobile health (mHealth) wound monitoring "app'' as a novel solution to address this problem. Methods: Mixed method design with semi-structured interviews and surveys. Participants were patients who had post-discharge surgical wound complications after undergoing operations with high risk of SSI, including open colorectal or ventral hernia repair surgery. The study was conducted at two affiliated teaching hospitals, including an academic medical center and a level 1 trauma center. Results: From interviews with 13 patients, we identified 3 major challenges that impact patients' ability to manage post-discharge surgical wound complications, including required knowledge for wound monitoring from discharge teaching, self-efficacy for wound monitoring at home, and accessible communication with their providers about wound concerns. Patients found an mHealth wound monitoring application highly acceptable and articulated its potential to provide more frequent, thorough, and convenient follow-up that could reduce post-discharge anxiety compared to the current practice. Major concerns with mHealth wound monitoring were lack of timely response from providers and inaccessibility due to either lack of an appropriate device or usability challenges. Conclusions: Our findings reveal gaps and frustrations with post-discharge care after surgery which could negatively impact clinical outcomes and quality of life. To address these issues, we are developing mPOWEr, a patient-centered mHealth wound monitoring application for patients and providers to collaboratively bridge the care transition between hospital and home.	[Sanger, Patrick C.; Lordon, Ross J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Hartzler, Andrea] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Han, Sarah M.; Armstrong, Cheryl A. L.; Evans, Heather L.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Stewart, Mark R.; Lober, William B.] Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sanger, PC (corresponding author), Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA.	psanger@uw.edu	Evans, Heather/F-9113-2014	Evans, Heather/0000-0002-3661-0666; HARTZLER, ANDREA/0000-0003-4932-7314	University of Washington Department of Surgery; University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award [K12 HS019482]; University of Washington/National Center for Advancing Translational Sciences [TL1 TR000422]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007442] Funding Source: NIH RePORTER	University of Washington Department of Surgery; University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award; University of Washington/National Center for Advancing Translational Sciences; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the University of Washington Department of Surgery (HLE), the University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award (HLE; K12 HS019482; www.ahrq.gov) and University of Washington/National Center for Advancing Translational Sciences Training Grant (PCS; TL1 TR000422; www.ncats.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilimoria KY, 2014, JAMA SURG, V149, P505, DOI 10.1001/jamasurg.2013.5285; Chell E., 1998, QUALITATIVE METHODS, P51; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneman N, 2010, J HOSP INFECT, V75, P188, DOI 10.1016/j.jhin.2010.01.029; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; Gibson A, 2014, AM J SURG, V207, P832, DOI 10.1016/j.amjsurg.2013.05.017; HALEY RW, 1995, J HOSP INFECT, V30, P3, DOI 10.1016/0195-6701(95)90001-2; Hoch D, 2005, PLOS MED, V2, P728, DOI 10.1371/journal.pmed.0020206; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kazaure HS, 2012, ARCH SURG-CHICAGO, V147, P1000, DOI 10.1001/2013.jamasurg.114; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Krieger BR, 2011, DIS COLON RECTUM, V54, P1014, DOI 10.1097/DCR.0b013e31821c495d; Limon E, 2014, J HOSP INFECT, V86, P127, DOI 10.1016/j.jhin.2013.11.004; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Petherick ES, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-170; Pew, 2013, TRACK HLTH; PEW, 2013, HLTH ONL 2013; Pieper B, 2007, J WOUND OSTOMY CONT, V34, P245, DOI 10.1097/01.WON.0000270817.06942.00; Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; Rhodes KV, 2013, JAMA INTERN MED, V173, P1723, DOI 10.1001/jamainternmed.2013.7854; Sanger P, 2013, P AMIA ANN S WASH DC, P1236; Sanger PC, 2014, P AMIA ANN IN PRESS; Saunders RS, 2014, SURGERY, V156, P949, DOI 10.1016/j.surg.2014.06.041; SEAMAN M, 1991, Journal of Emergency Medicine, V9, P215, DOI 10.1016/0736-4679(91)90416-D; Stewart M, 2000, J FAM PRACTICE, V49, P796; Strauss A., 1990, BASICS QUALITATIVE R; Tanner J, 2013, J HOSP INFECT, V83, P41, DOI 10.1016/j.jhin.2012.07.025; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	29	71	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114016	10.1371/journal.pone.0114016	http://dx.doi.org/10.1371/journal.pone.0114016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436912	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900110
J	Kim, YG; Suh, JW; Park, JJ; Oh, IY; Yoon, CH; Cho, YS; Youn, TJ; Chae, IH; Choi, DJ				Kim, Yun Gi; Suh, Jung-Won; Park, Jin Joo; Oh, Il-Young; Yoon, Chang-Hwan; Cho, Young-Seok; Youn, Tae-Jin; Chae, In-Ho; Choi, Dong-Ju			Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; CLOPIDOGREL RESPONSIVENESS; CLINICAL-OUTCOMES; HEMOGLOBIN LEVELS; REACTIVITY; COMPLICATIONS; IMPLANTATION	Objective: Previous studies have reported a considerable association between the VerifyNow (Accumetrics, San Diego, CA, USA) P2Y12 assay results and hematocrit. No reports, however, have described an association between the multiple electrode platelet aggregometry (MEA; Dynabyte, Munich, Germany) adenosine diphosphate (ADP) assay results and hematocrit. This study was conducted to evaluate the influence of hematocrit on the results of 2 different point-of-care platelet function tests. Methods: A total of 462 consecutive patients who were undergoing percutaneous coronary intervention were enrolled. Platelet function was evaluated with both the VerifyNow P2Y12 and MEA ADP assays. Results: Anemic patients (n=152, 32.9%) demonstrated a significantly higher rate of cardiac death, myocardial infarction, and stroke (5.3% vs. 2.3%, p=0.046) during the follow-up (median: 18.8 months). Although the VerifyNow P2Y12 assay results demonstrated a significant inverse correlation with hematocrit (r=-0.409, p<0.001), there was no such correlation between the MEA ADP assay results and hematocrit (r=0.039, p=0.401). In the multivariate analysis, anemia was an independent predictor of high on-treatment platelet reactivity, defined as a VerifyNow P2Y12 reaction unit level of >= 252.5 (odds ratio=2.21, 95% confidence interval=1.39-3.52; p=0.001). Importantly, this association was independent of an intrinsic change in platelet reactivity as measured by the MEA ADP assay. Adjusting for the influence of hematocrit improved the strength of the correlation between the VerifyNow P2Y12 and MEA ADP assay results. Conclusions: Hematocrit significantly influenced the VerifyNow P2Y12 assay results, a phenomenon that was presumably in-vitro. Hematocrit level should therefore be considered when interpreting results of the VerifyNow P2Y12 assay.	[Kim, Yun Gi; Suh, Jung-Won; Park, Jin Joo; Oh, Il-Young; Yoon, Chang-Hwan; Cho, Young-Seok; Youn, Tae-Jin; Chae, In-Ho; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Songnam, Gyeonggi Do, South Korea	Seoul National University (SNU)	Suh, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Cardiovasc Ctr, Songnam, Gyeonggi Do, South Korea.	dasome2@snu.ac.kr		Yoon, Chang-Hwan/0000-0001-6305-4442	Seoul National University Bundang Hospital Research Fund [04-2012-001]	Seoul National University Bundang Hospital Research Fund	This work was supported by grant no 04-2012-001 from the Seoul National University Bundang Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Elsenberg EHAM, 2009, THROMB HAEMOSTASIS, V102, P719, DOI 10.1160/TH09-05-0285; Kakouros N, 2013, J THROMB HAEMOST, V11, P1814, DOI 10.1111/jth.12376; Kim YG, 2014, J ATHEROSCLER THROMB, V21, P445, DOI 10.5551/jat.20156; Ko YG, 2011, AM HEART J, V161, P383, DOI 10.1016/j.ahj.2010.10.036; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Toma C, 2012, AM J CARDIOL, V109, P1148, DOI 10.1016/j.amjcard.2011.11.049; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Tsujita K, 2010, AM J CARDIOL, V105, P1385, DOI 10.1016/j.amjcard.2010.01.001; Voisin S, 2011, THROMB HAEMOSTASIS, V106, P227, DOI 10.1160/TH11-01-0046; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, WHO TECH REP SER, V405, P5; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019	19	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114053	10.1371/journal.pone.0114053	http://dx.doi.org/10.1371/journal.pone.0114053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427105	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400109
J	Lundstrom, SL; Fernandes-Cerqueira, C; Ytterberg, AJ; Ossipova, E; Hensvold, AH; Jakobsson, PJ; Malmstrom, V; Catrina, AI; Klareskog, L; Lundberg, K; Zubarev, RA				Lundstrom, Susanna L.; Fernandes-Cerqueira, Catia; Ytterberg, A. Jimmy; Ossipova, Elena; Hensvold, Aase H.; Jakobsson, Per-Johan; Malmstrom, Vivianne; Catrina, Anca I.; Klareskog, Lars; Lundberg, Karin; Zubarev, Roman A.			IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; ANTIINFLAMMATORY ACTIVITY; IMMUNOGLOBULIN PEPTIDES; PROTEIN ANTIBODIES; CONSTANT-REGION; SYNOVIAL-FLUID; GAMMA-RIII; DISEASE; BINDING; SERUM	The Fc-glycan profile of IgG(1) anti-citrullinated peptide antibodies (ACPA) in rheumatoid arthritis (RA) patients has recently been reported to be different from non-ACPA IgG(1), a phenomenon which likely plays a role in RA pathogenesis. Herein we investigate the Fc-glycosylation pattern of all ACPA-IgG isotypes and simultaneously investigate in detail the IgG protein-chain sequence repertoire. IgG from serum or plasma (S/P, n=14) and synovial fluid (SF, n=4) from 18 ACPA-positive RA-patients was enriched using Protein G columns followed by ACPA-purification on cyclic citrullinated peptide-2 (CCP2)-coupled columns. Paired ACPA (anti-CCP2 eluted IgG) and IgG flow through (FT) fractions were analyzed by LC-MS/MS-proteomics. IgG peptides, isotypes and corresponding Fc-glycopeptides were quantified and interrogated using uni- and multivariate statistics. The Fc-glycans from the IgG(4) peptide EEQFNSTYR was validated using protein A column purification. Relative to FT-IgG(4), the ACPA-IgG(4) Fc-glycan-profile contained lower amounts (p=0.002) of the agalacto and asialylated core-fucosylated biantennary form (FA2) and higher content (p=0.001) of sialylated glycans. Novel differences in the Fc-glycan-profile of ACPA-IgG(1) compared to FT-IgG(1) were observed in the distribution of bisected forms (n=5, p=0.0001, decrease) and mono-antennnary forms (n=3, p=0.02, increase). Our study also confirmed higher abundance of FA2 (p=0.002) and lower abundance of afucosylated forms (n=4, p=0.001) in ACPA-IgG(1) relative to FT-IgG(1) as well as lower content of IgG2 (p=0.0000001) and elevated content of IgG(4) (p=0.004) in ACPA compared to FT. One lambda-variable peptide sequence was significantly increased in ACPA (p=0.0001). In conclusion, the Fc-glycan profile of both ACPA-IgG(1) and ACPA-IgG(4) are distinct. Given that IgG(1) and IgG(4) have different Fcreceptor and complement binding affinities, this phenomenon likely affects ACPA effector-and immune-regulatory functions in an IgG isotype-specific manner. These findings further highlight the importance of antibody characterization in relation to functional in vivo and in vitro studies.	[Lundstrom, Susanna L.; Ytterberg, A. Jimmy; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden; [Lundstrom, Susanna L.; Fernandes-Cerqueira, Catia; Ytterberg, A. Jimmy; Ossipova, Elena; Hensvold, Aase H.; Jakobsson, Per-Johan; Malmstrom, Vivianne; Catrina, Anca I.; Klareskog, Lars; Lundberg, Karin] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lundstrom, SL (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden.	Susanna.Lundstrom@ki.se; Roman.Zubarev@ki.se	Zubarev, Roman A/W-7891-2018; Jakobsson, Per-Johan/ABC-5594-2021; Cerqueira, Catia/AAU-6375-2020; Ytterberg, Anders/E-1773-2016	Zubarev, Roman A/0000-0001-9839-2089; Cerqueira, Catia/0000-0001-7020-0954; Ytterberg, Anders/0000-0002-1485-2314; Klareskog, Lars/0000-0001-9601-6186; Ossipova, Elena/0000-0002-2090-7705; Lundstrom, Susanna/0000-0003-2363-4287	Swedish Strategic Research Funds (SSF); Swedish Research Council (VR); European Research Council (ERC); EU [261460, 306029, 305549-2]; Innovative Medicine Initiative BTCure [115142-2]	Swedish Strategic Research Funds (SSF); Swedish Research Council (VR)(Swedish Research Council); European Research Council (ERC)(European Research Council (ERC)European Commission); EU(European Commission); Innovative Medicine Initiative BTCure	This study was supported by funds from the Swedish Strategic Research Funds (SSF), from the Swedish Research Council (VR), from the European Research Council (ERC), the EU projects Gums&Joints (contract No. 261460) and Trigger (contract No. 306029) as well as Innovative Medicine Initiative BTCure (115142-2) and EU project FP7-HEALTH-2012-INNOVATION-1 Euro-TEAM (305549-2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; ABEL CA, 1968, BIOCHEMISTRY-US, V7, P1271, DOI 10.1021/bi00844a004; Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; BALBIN M, 1994, IMMUNOGENETICS, V39, P187, DOI 10.1007/BF00241259; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; COHEN PL, 1987, J IMMUNOL, V139, P1466; Conrad K, 2010, AUTOIMMUN REV, V9, P431, DOI 10.1016/j.autrev.2009.11.017; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; Engelmann R, 2008, RHEUMATOLOGY, V47, P1489, DOI 10.1093/rheumatology/ken336; Gornik I, 1999, CLIN BIOCHEM, V32, P605, DOI 10.1016/S0009-9120(99)00060-0; Hoogeboom R, 2013, J EXP MED, V210, P59, DOI 10.1084/jem.20121801; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001637; Klareskog L, 2013, ADV IMMUNOL, V118, P129, DOI 10.1016/B978-0-12-407708-9.00003-0; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Lundstrom SL, 2014, J ALZHEIMERS DIS, V38, P567, DOI 10.3233/JAD-131088; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Maat P, 2012, J AUTOIMMUN, V38, P354, DOI 10.1016/j.jaut.2012.02.002; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nakagawa H, 2007, J CHROMATOGR B, V853, P133, DOI 10.1016/j.jchromb.2007.03.003; Ossipova E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4683; Oxelius VA, 1996, CLIN EXP IMMUNOL, V106, P203, DOI 10.1046/j.1365-2249.1996.d01-851.x; PAREKH RB, 1988, LANCET, V1, P966; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2012, ANN RHEUM DIS, V71, P1921, DOI 10.1136/annrheumdis-2012-201893; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Rombouts Y., 2013, ANN RHEUM DIS; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Singh V, 2013, MOL CELL PROTEOMICS, V12, P3924, DOI 10.1074/mcp.M113.030346; SKINNER M, 1975, J IMMUNOL, V114, P1433; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; SLETTEN K, 1981, BIOCHEM J, V195, P561, DOI 10.1042/bj1950561; Thurgood LA, 2013, CLIN EXP IMMUNOL, V174, P237, DOI 10.1111/cei.12171; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; VanDuijn MM, 2010, J BIOL CHEM, V285, P29247, DOI 10.1074/jbc.M110.139071; Willemze A, 2013, ANN RHEUM DIS, V72, P1059, DOI 10.1136/annrheumdis-2012-202747; ZACK DJ, 1995, J IMMUNOL, V155, P5057	52	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113924	10.1371/journal.pone.0113924	http://dx.doi.org/10.1371/journal.pone.0113924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426976	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400102
J	Nishiwaki, M; Kurobe, K; Kiuchi, A; Nakamura, T; Matsumoto, N				Nishiwaki, Masato; Kurobe, Kazumichi; Kiuchi, Atsushi; Nakamura, Tomohiro; Matsumoto, Naoyuki			Sex Differences in Flexibility-Arterial Stiffness Relationship and Its Application for Diagnosis of Arterial Stiffening: A Cross-Sectional Observational Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ANKLE VASCULAR INDEX; BLOOD-PRESSURE; AGE; INDICATOR; STRENGTH; EXERCISE; REFLECTION; PARAMETER; DISEASE	Purpose: Arterial stiffness might be related to trunk flexibility in middle-aged and older participants, but it is also affected by age, sex, and blood pressure. This cross-sectional observational study investigated whether trunk flexibility is related to arterial stiffness after considering the major confounding factors of age, sex, and blood pressure. We further investigated whether a simple diagnostic test of flexibility could be helpful to screen for increased arterial stiffening. Methods: According to age and sex, we assigned 1150 adults (male, n=536; female, n=614; age, 18-89 y) to groups with either high-or poor-flexibility based on the sit-and-reach test. Arterial stiffness was assessed by cardio-ankle vascular index. Results: In all categories of men and in older women, arterial stiffness was higher in poor-flexibility than in high-flexibility (P<0.05). This difference remained significant after normalizing arterial stiffness for confounding factors such as blood pressure, but it was not found among young and middle-aged women. Stepwise multiple-regression analysis also supported the notion of the sex differences in flexibility-arterial stiffness relationship. Receiver operating characteristic curve analysis revealed that cut-off values for sit-and-reach among men and women were 33.2 (area under the curve [AUC], 0.711; 95% confidence interval [CI], 0.666-0.756; sensitivity, 61.7%; specificity, 69.7%) and 39.2 (AUC, 0.639; 95% CI, 0.592-0.686; sensitivity, 61.1%; specificity, 62.0%) cm, respectively. Conclusion: Our results indicate that flexibility-arterial stiffness relationship is not affected by BP, which is a major confounding factor. In addition, sex differences are observed in this relationship; poor trunk flexibility increases arterial stiffness in young, middle-aged, and older men, whereas the relationship in women is found only in the elderly. Also, the sit-and-reach test can offer a simple method of predicting arterial stiffness at home or elsewhere.	[Nishiwaki, Masato; Nakamura, Tomohiro] Osaka Inst Technol, Fac Engn, Osaka 535, Japan; [Kurobe, Kazumichi] Hannan Univ, Fac Business, Sports Management Course, Osaka, Japan; [Kiuchi, Atsushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Matsumoto, Naoyuki] Prefectural Univ Kumamoto, Fac Environm Symbiot Sci, Kumamoto, Japan	Osaka Institute of Technology; University of Tsukuba	Nishiwaki, M (corresponding author), Osaka Inst Technol, Fac Engn, Osaka 535, Japan.	masato.nishiwaki@oit.ac.jp		Nakamura, Tomohiro/0000-0002-2501-3380				AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90, DOI 10.1161/01.ATV.13.1.90; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Christensen K, 2009, BMJ, V339, pb5262; Cortez-Cooper MY, 2008, EUR J CARDIOV PREV R, V15, P149, DOI 10.1097/HJR.0b013e3282f02fe2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Galiano-Castillo N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-187; Hagins M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/649836; Hayashi K, 2006, EXP PHYSIOL, V91, P465, DOI 10.1113/expphysiol.2005.032011; Hu HQ, 2013, HYPERTENS RES, V36, P334, DOI 10.1038/hr.2012.192; Hu QF, 2012, EUR J APPL PHYSIOL, V112, P1261, DOI 10.1007/s00421-011-2066-1; Inaba H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083977; Kawai T, 2013, J ATHEROSCLER THROMB, V20, P391, DOI 10.5551/jat.15040; Laurent S, 2007, HYPERTENSION, V49, P1202, DOI 10.1161/HYPERTENSIONAHA.106.076166; Leenders M, 2013, MED SCI SPORT EXER, V45, P542, DOI 10.1249/MSS.0b013e318272fcdb; Liu YP, 2010, HYPERTENSION, V55, pE24, DOI 10.1161/HYPERTENSIONAHA.110.152553; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Miura H, 2012, J PHYS FITNESS SPORT, V1, P191; Moreau KL, 2003, CARDIOVASC RES, V57, P861, DOI 10.1016/S0008-6363(02)00777-0; Namekata T, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-51; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Radtke T, 2014, EUR J APPL PHYSIOL, V114, P49, DOI 10.1007/s00421-013-2753-1; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Sun CK, 2013, INTEGR BLOOD PRESS C, V6, P27, DOI 10.2147/IBPC.S34423; Takaki A, 2007, CIRC J, V71, P1710, DOI 10.1253/circj.71.1710; Tanaka H, 1998, ARTERIOSCL THROM VAS, V18, P127, DOI 10.1161/01.ATV.18.1.127; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; van de Laar RJ, 2010, HYPERTENSION, V55, P33, DOI 10.1161/HYPERTENSIONAHA.109.138289; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Yamamoto K, 2009, AM J PHYSIOL-HEART C, V297, pH1314, DOI 10.1152/ajpheart.00061.2009; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	40	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113646	10.1371/journal.pone.0113646	http://dx.doi.org/10.1371/journal.pone.0113646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427157	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400073
J	Rosenthal, JA; Huang, CJ; Doody, AM; Leung, T; Mineta, K; Feng, DD; Wayne, EC; Nishimura, N; Leifer, C; DeLisa, MP; Mendez, S; Putnam, D				Rosenthal, Joseph A.; Huang, Chung-Jr; Doody, Anne M.; Leung, Tiffany; Mineta, Kaho; Feng, Danielle D.; Wayne, Elizabeth C.; Nishimura, Nozomi; Leifer, Cynthia; DeLisa, Matthew P.; Mendez, Susana; Putnam, David			Mechanistic Insight into the T(H)1-Biased Immune Response to Recombinant Subunit Vaccines Delivered by Probiotic Bacteria-Derived Outer Membrane Vesicles	PLOS ONE			English	Article							EXPRESSION; LIPOPOLYSACCHARIDE; INDUCTION; VIRULENCE; ANTIGENS; MUTANTS; PATHWAY; DESIGN; CELLS; MICE	Recombinant subunit vaccine engineering increasingly focuses on the development of more effective delivery platforms. However, current recombinant vaccines fail to sufficiently stimulate protective adaptive immunity against a wide range of pathogens while remaining a cost effective solution to global health challenges. Taking an unorthodox approach to this fundamental immunological challenge, we isolated the TLR-targeting capability of the probiotic E. coli Nissle 1917 bacteria (EcN) by engineering bionanoparticlate antigen carriers derived from EcN outer membrane vesicles (OMVs). Exogenous model antigens expressed by these modified bacteria as protein fusions with the bacterial enterotoxin ClyA resulted in their display on the surface of the carrier OMVs. Vaccination with the engineered EcN OMVs in a BALB/c mouse model, and subsequent mechanism of action analysis, established the EcN OMV's ability to induce self-adjuvanted robust and protective humoral and TH1-biased cellular immunity to model antigens. This finding appears to be strain-dependent, as OMV antigen carriers similarly engineered from a standard K12 E. coli strain derivative failed to generate a comparably robust antigen-specific TH1 bias. The results demonstrate that unlike traditional subunit vaccines, these biomolecularly engineered "pathogen-like particles'' derived from traditionally overlooked, naturally potent immunomodulators have the potential to effectively couple recombinant antigens with meaningful immunity in a broadly applicable fashion.	[Rosenthal, Joseph A.; Doody, Anne M.; Leung, Tiffany; Feng, Danielle D.; Wayne, Elizabeth C.; Nishimura, Nozomi; Putnam, David] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Huang, Chung-Jr; DeLisa, Matthew P.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Mineta, Kaho] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Leifer, Cynthia; Mendez, Susana] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Putnam, D (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	dap43@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Nishimura, Nozomi/P-8908-2015; Nishimura, Nozomi/AAV-2425-2020	Nishimura, Nozomi/0000-0003-4342-9416; Nishimura, Nozomi/0000-0003-4342-9416; DeLisa, Matthew/0000-0003-3226-1566; Putnam, David/0000-0002-0794-4915; Wayne, Elizabeth/0000-0002-8526-9732	Hertz Foundation Graduate Fellowship; National Science Foundation Graduate Fellowship; National Institutes of Health [EB005669-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB005669] Funding Source: NIH RePORTER; Directorate For Engineering [1264701] Funding Source: National Science Foundation	Hertz Foundation Graduate Fellowship; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding: This work was supported by a coordinated Hertz Foundation Graduate Fellowship (JAR), National Science Foundation Graduate Fellowship (JAR), National Institutes of Health, grant number EB005669-02 (DP and MPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad Neelam, 2006, Current Drug Delivery, V3, P137, DOI 10.2174/156720106776359249; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Beverley PCL, 2002, BRIT MED BULL, V62, P15, DOI 10.1093/bmb/62.1.15; Bryan JT, 2007, VACCINE, V25, P3001, DOI 10.1016/j.vaccine.2007.01.013; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Carlo DJ, 1978, ANAL BIOCHEM, V85, P595; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cuellar C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000439; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Guzy C, 2008, INT IMMUNOL, V20, P829, DOI 10.1093/intimm/dxn041; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Herlax V, 2005, CHEM PHYS LIPIDS, V135, P107, DOI 10.1016/j.chemphyslip.2005.02.009; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang CJ, 2010, APPL MICROBIOL BIOT, V87, P401, DOI 10.1007/s00253-010-2590-7; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Kim JY, 2008, J MOL BIOL, V380, P51, DOI 10.1016/j.jmb.2008.03.076; Kim OY, 2013, J IMMUNOL, V190, P4092, DOI 10.4049/jimmunol.1200742; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Klier J, 2011, VET IMMUNOL IMMUNOP, P1; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Mbulaiteye Sam M, 2006, Infect Agent Cancer, V1, P3, DOI 10.1186/1750-9378-1-3; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Metcalfe SM, 2012, TRENDS MOL MED, V18, P72, DOI 10.1016/j.molmed.2011.11.002; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muralinath M, 2011, INFECT IMMUN, V79, P887, DOI 10.1128/IAI.00950-10; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sanders MT, 2005, IMMUNOL CELL BIOL, V83, P119, DOI 10.1111/j.1440-1711.2005.01319.x; Schijns VEJC, 2007, CLIN PHARMACOL THER, V82, P750, DOI 10.1038/sj.clpt.6100394; Shah B, 2012, SHOCK, V37, P621, DOI 10.1097/SHK.0b013e318250de5d; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763; Trebichavsky I, 2010, NUTR REV, V68, P459, DOI 10.1111/j.1753-4887.2010.00305.x; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; Vos Q, 2000, IMMUNOL REV, V176, P154; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zheng Y, 2004, J IMMUNOL, V172, P2778, DOI 10.4049/jimmunol.172.5.2778; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006	57	31	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112802	10.1371/journal.pone.0112802	http://dx.doi.org/10.1371/journal.pone.0112802			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426709	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400025
J	Shaw, EC; Phinn, SR; Tilbrook, B; Steven, A				Shaw, Emily C.; Phinn, Stuart R.; Tilbrook, Bronte; Steven, Andy			Comparability of Slack Water and Lagrangian Flow Respirometry Methods for Community Metabolic Measurements	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEF; CARBONATE CHEMISTRY; OCEAN ACIDIFICATION; GAS-EXCHANGE; WIND-SPEED; CALCIFICATION; SEA; SEAWATER; PHOTOSYNTHESIS	Coral reef calcification is predicted to decline as a result of ocean acidification and other anthropogenic stressors. The majority of studies predicting declines based on in situ relationships between environmental parameters and net community calcification rate have been location-specific, preventing accurate predictions for coral reefs globally. In this study, net community calcification and production were measured on a coral reef flat at One Tree Island, Great Barrier Reef, using Lagrangian flow respirometry and slack water methods. Net community calcification, daytime net photosynthesis and nighttime respiration were higher under the flow respirometry method, likely due to increased water flow relative to the slack water method. The two methods also varied in the degrees to which they were influenced by potential measurement uncertainties. The difference in the results from these two commonly used methods implies that some of the location-specific differences in coral reef community metabolism may be due to differences in measurement methods.	[Shaw, Emily C.; Phinn, Stuart R.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Tilbrook, Bronte] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Steven, Andy] CSIRO, Oceans & Atmosphere Flagship, Brisbane, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Shaw, EC (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	e.shaw5@uq.edu.au	Tilbrook, Bronte/A-1522-2012; Shaw, Emily/L-4065-2013; Tilbrook, Bronte/W-4007-2019; Steven, Andrew D.L./I-5887-2012; Phinn, Stuart R/J-8457-2013	Tilbrook, Bronte/0000-0001-9385-3827; Shaw, Emily/0000-0002-4148-3526; Tilbrook, Bronte/0000-0001-9385-3827; Steven, Andrew D.L./0000-0002-3012-240X; Phinn, Stuart R/0000-0002-2605-6104	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Australian Climate Change Science Program	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Climate Change Science Program	Funding: Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Wealth From Oceans Flagship. Sample analyses were supported through an Australian Climate Change Science Program grant awarded to Dr B. Tilbrook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Falter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053303; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Falter JL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004663; Frankignoulle M, 1996, MAR ECOL PROG SER, V145, P123, DOI 10.3354/meps145123; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; Gattuso JP, 1999, AM ZOOL, V39, P160; Hill J., 2004, METHODS ECOLOGICAL M, DOI DOI 10.1017/CBO9781107415324.004; Ho DT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026817; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IMOS, 2013, WEATH STAT INST RP3; Johnson HK, 1999, COAST ENG, V36, P263, DOI 10.1016/S0378-3839(99)00016-2; Kinsey D.W., 1978, Monographs on Oceanographic Methodology, P439; Kinsey D.W., 1972, P 1 INT S COR COR RE, P13; Langdon C., 2010, GUIDE BEST PRACTICES, P213, DOI DOI 10.7717/PEERJ.411; McDougall T.J., 2011, GETTING STARTED TEOS; McGillis WR, 2011, GEOPHYS RES LETT, V38; McMahon A, 2013, GEOPHYS RES LETT, V40, P4675, DOI 10.1002/grl.50802; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Ohde S, 1999, B MAR SCI, V65, P559; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shaw E. C., 2014, CARBONATE CHEM COMMU, DOI [10.1594/PANGAEA. 835109, DOI 10.1594/PANGAEA.835109]; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Silverman J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001974; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Smith S.V., 1978, Monographs on Oceanographic Methodology, P397; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P106, DOI 10.4319/lo.1973.18.1.0106; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Teneva L, 2013, LIMNOL OCEANOGR, V58, P1851, DOI 10.4319/lo.2013.58.5.1851; van Heuven S, 2011, 1 1 ED ORNL CDIAC 10; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; WILSON PR, 1985, AUST J MAR FRESH RES, V36, P139; Yates KK, 2003, CORAL REEFS, V22, P247, DOI 10.1007/s00338-003-0314-5	44	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112161	10.1371/journal.pone.0112161	http://dx.doi.org/10.1371/journal.pone.0112161			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426626	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400010
J	Wang, GC; Wang, YW; Li, H; Chen, XQ; Lu, HT; Ma, YP; Peng, C; Wang, YJ; Tang, LY				Wang, Guocheng; Wang, Yiwen; Li, Hui; Chen, Xuanqi; Lu, Haitao; Ma, Yanpeng; Peng, Chun; Wang, Yijun; Tang, Linyao			Morphological Background Detection and Illumination Normalization of Text Image with Poor Lighting	PLOS ONE			English	Article							ENHANCEMENT	In this paper, some morphological transformations are used to detect the unevenly illuminated background of text images characterized by poor lighting, and to acquire illumination normalized result. Based on morphologic Top-Hat transform, the uneven illumination normalization algorithm has been carried out, and typically verified by three procedures. The first procedure employs the information from opening based Top-Hat operator, which is a classical method. In order to optimize and perfect the classical Top-Hat transform, the second procedure, featuring the definition of multi direction illumination notion, utilizes opening by reconstruction and closing by reconstruction based on multi direction structuring elements. Finally, multi direction images are merged to the final even illumination image. The performance of the proposed algorithm is illustrated and verified through the processing of different ideal synthetic and camera collected images, with backgrounds characterized by poor lighting conditions.	[Wang, Guocheng; Wang, Yiwen; Li, Hui; Chen, Xuanqi; Lu, Haitao; Peng, Chun; Wang, Yijun; Tang, Linyao] Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Sichuan, Peoples R China; [Ma, Yanpeng] Kaiserslautern Univ Technol, Kaiserslautern, Germany	University of Electronic Science & Technology of China; University of Kaiserslautern	Wang, YW (corresponding author), Univ Elect Sci & Technol China, Sch Microelect & Solid State Elect, State Key Lab Elect Thin Films & Integrated Devic, Chengdu, Sichuan, Peoples R China.	yiwen@uestc.edu.cn	Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022	Chen, Xuanqi/0000-0003-0276-1199				Bangham JA, 1996, J ELECTRON IMAGING, V5, P283, DOI 10.1117/12.243349; Bibina VC, 2012, ANNU IEEE IND CONF, P1100; Caliman A, 2014, PATTERN RECOGN, V47, P721, DOI 10.1016/j.patcog.2013.08.021; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Cheng Li, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010), P578, DOI 10.1109/CISP.2010.5647269; Gonzlez CR, 1992, DIGITAL IMAGE PROCES; Han H, 2013, PATTERN RECOGN, V46, P1691, DOI 10.1016/j.patcog.2012.11.022; Jimenez-Sanchez AR, 2009, IEEE T IMAGE PROCESS, V18, P613, DOI 10.1109/TIP.2008.2010152; JUANG BH, 1992, IEEE T SIGNAL PROCES, V40, P3043, DOI 10.1109/78.175747; Kim JY, 2001, IEEE T CIRC SYST VID, V11, P475, DOI 10.1109/76.915354; KinTak U., 2010, Proceedings 2010 International Conference on Multimedia Communications (Mediacom 2010), P9, DOI 10.1109/MEDIACOM.2010.25; [李永华 Li Yonghua], 2005, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V28, P549; Liang J., 2005, International Journal on Document Analysis and Recognition, V7, P84, DOI 10.1007/s10032-004-0138-z; Pafilis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065390; Pan YF, 2011, IEEE T IMAGE PROCESS, V20, P800, DOI 10.1109/TIP.2010.2070803; Pesaresi M, 2001, IEEE T GEOSCI REMOTE, V39, P309, DOI 10.1109/36.905239; Ramabai M., 2010, INT J ENG SCI TECHNO, V2, P3832; SALEMBIER P, 1995, IEEE T IMAGE PROCESS, V4, P1153, DOI 10.1109/83.403422; SALEMBIER P, 1994, IEEE T IMAGE PROCESS, V3, P639, DOI 10.1109/83.334980; Serra J, 1983, IMAGE ANAL MATH MORP; Shan SG, 2003, IEEE INTERNATIONAL WORKSHOP ON ANALYSIS AND MODELING OF FACE AND GESTURES, P157; SHERRIER RH, 1987, IEEE T MED IMAGING, V6, P1, DOI 10.1109/TMI.1987.4307791; Short J, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P254, DOI 10.1109/AFGR.2004.1301540; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Vincent L, 1994, DIGITAL IMAGE PROCES, V43 C, P102; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064116; Xu GB, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL II, PROCEEDINGS, P399, DOI 10.1109/IITA.2008.359; Zhong B, 2013, ELSEVIER PATTERN REC, V47, P1395; Zhong B, 2013, ELSEVIER NEUROCOMPUT, P344; Zhong B, 2012, ELSEVIER NEUROCOMPUT, P132; Zhong BN, 2014, NEUROCOMPUTING, V133, P317, DOI 10.1016/j.neucom.2013.11.004	32	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e110991	10.1371/journal.pone.0110991	http://dx.doi.org/10.1371/journal.pone.0110991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426639	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400003
J	Bai, X; Hu, H; Chen, HP; Wei, QB; Yang, ZS; Huang, QM				Bai, Xi; Hu, Hong; Chen, Huaping; Wei, Quanbin; Yang, Zeshen; Huang, Qianming			Expression of a beta-Mannosidase from Paenibacillus polymyxa A-8 in Escherichia coli and Characterization of the Recombinant Enzyme	PLOS ONE			English	Article							ASPERGILLUS-NIGER; PURIFICATION; CLONING; GENE; SPECIFICITY; MANNANASE	Paenibacillus polymyxa A-8, which secretes beta-mannosidase, was isolated from the soil sample under a pine tree located in the "Laoban" mountain region of Sichuan, China. The beta-mannosidase gene (MANB) was isolated from P. polymyxa A-8, using primers according to the complete genome. The MANB (2,550 bp) encoding 849 amino acid residues was expressed in Escherichia coli. The specific activities of beta-mannosidase produced by P. polymyxa A-8 and E. coli pET30a-MANB were 12 nkat/mg and 635 nkat/mg respectively. SDS-PAGE analysis indicated that the molecular mass of the recombinant MANB was approximately 96 kDa. The recombinant MANB was active between pH 7.0-8.5 with the maximum activity at pH 7.0. It had good pH stability and adaptability. The MANB had the optimal temperature of 35 degrees C and was relatively stable at 35-40 degrees C. In addition, the MANB activity was enhanced by K+, Ca2+, Mn2+, and Mg2+ and inhibited by Zn2+, Cu2+, and Hg2+.	[Bai, Xi; Hu, Hong; Chen, Huaping; Wei, Quanbin; Huang, Qianming] Sichuan Agr Univ, Coll Sci, Yaan 625000, Sichuan, Peoples R China; [Hu, Hong] Anhui Sci & Technol Univ, Coll Anim Sci, Fengyang 233100, Anhui, Peoples R China; [Yang, Zeshen] Liang Shan Zhong Ze New Technol Dev Co Ltd, Xichang 615000, Sichuan, Peoples R China	Sichuan Agricultural University; Anhui Science & Technology University	Huang, QM (corresponding author), Sichuan Agr Univ, Coll Sci, Yaan 625000, Sichuan, Peoples R China.	huangqianming666@aliyun.com			Technology Program of Sichuan Provincial Science and Technology Department [12ZC2220]	Technology Program of Sichuan Provincial Science and Technology Department	This study was supported by the Technology Program of Sichuan Provincial Science and Technology Department (12ZC2220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademark P, 1999, J BIOTECHNOL, V75, P281, DOI 10.1016/S0168-1656(99)00172-8; Andreotti G, 2005, J BIOTECHNOL, V119, P26, DOI 10.1016/j.jbiotec.2005.06.003; Beki E, 2003, APPL ENVIRON MICROB, V69, P1944, DOI 10.1128/AEM.69.4.1944-1952.2003; Chen XJ, 2012, EXP APPL ACAROL, V56, P143, DOI 10.1007/s10493-011-9507-8; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Duffaud GD, 1997, APPL ENVIRON MICROB, V63, P169, DOI 10.1128/AEM.63.1.169-177.1997; Eneyskaya EV, 2009, BIOCHIMIE, V91, P632, DOI 10.1016/j.biochi.2009.03.009; Eum JH, 2010, INSECT BIOCHEM MOLEC, V40, P690, DOI 10.1016/j.ibmb.2010.07.003; Fliedrova B, 2012, PROTEIN EXPRES PURIF, V85, P159, DOI 10.1016/j.pep.2012.07.012; Gomes J, 2007, ENZYME MICROB TECH, V40, P969, DOI 10.1016/j.enzmictec.2006.08.011; Hu H, 2013, BIOTECHNOL LETT, V35, P239, DOI 10.1007/s10529-012-1064-7; Kanamasa S, 2007, LETT APPL MICROBIOL, V45, P142, DOI 10.1111/j.1472-765X.2007.02160.x; Kurakake M, 2001, CURR MICROBIOL, V42, P377, DOI 10.1007/s002840010233; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroux O, 2013, PLANTA, P1; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Mo BX, 2002, PLANTA, V215, P141, DOI 10.1007/s00425-001-0725-x; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nashiru O., 2001, ANGEW CHEM, V113, P431; Niu B, 2011, J BACTERIOL, V193, P5862, DOI 10.1128/JB.05806-11; Offen WA, 2009, CHEM COMMUN, P2484, DOI 10.1039/b902240f; Reddy SK, 2013, FEBS LETT, V587, P3444, DOI 10.1016/j.febslet.2013.08.029; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; Sreedevi S., 2013, International Journal of Biosciences (IJB), V3, P76; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Zahura UA, 2012, COMP BIOCHEM PHYS B, V162, P24, DOI 10.1016/j.cbpb.2012.02.003; Zhang M, 2009, J MOL CATAL B-ENZYM, V60, P119, DOI 10.1016/j.molcatb.2009.04.005	27	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111622	10.1371/journal.pone.0111622	http://dx.doi.org/10.1371/journal.pone.0111622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423086	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700006
J	Drew, JE; Farquharson, AJ; Mayer, CD; Vase, HF; Coates, PJ; Steele, RJ; Carey, FA				Drew, Janice E.; Farquharson, Andrew J.; Mayer, Claus Dieter; Vase, Hollie F.; Coates, Philip J.; Steele, Robert J.; Carey, Francis A.			Predictive Gene Signatures: Molecular Markers Distinguishing Colon Adenomatous Polyp and Carcinoma	PLOS ONE			English	Article							HOMEOBOX TRANSCRIPTION FACTOR; COLORECTAL-CARCINOMA; MULTIPLEX PCR; STEM-CELLS; EXPRESSION; CANCER; IDENTIFICATION; MS4A12; GROWTH; NOX1	Cancers exhibit abnormal molecular signatures associated with disease initiation and progression. Molecular signatures could improve cancer screening, detection, drug development and selection of appropriate drug therapies for individual patients. Typically only very small amounts of tissue are available from patients for analysis and biopsy samples exhibit broad heterogeneity that cannot be captured using a single marker. This report details application of an in-house custom designed GenomeLab System multiplex gene expression assay, the hCellMarkerPlex, to assess predictive gene signatures of normal, adenomatous polyp and carcinoma colon tissue using archived tissue bank material. The hCellMarkerPlex incorporates twenty-one gene markers: epithelial (EZR, KRT18, NOX1, SLC9A2), proliferation (PCNA, CCND1, MS4A12), differentiation (B4GANLT2, CDX1, CDX2), apoptotic (CASP3, NOX1, NTN1), fibroblast (FSP1, COL1A1), structural (ACTG2, CNN1, DES), gene transcription (HDAC1), stem cell (LGR5), endothelial (VWF) and mucin production (MUC2). Gene signatures distinguished normal, adenomatous polyp and carcinoma. Individual gene targets significantly contributing to molecular tissue types, classifier genes, were further characterised using real-time PCR, in-situ hybridisation and immunohistochemistry revealing aberrant epithelial expression of MS4A12, LGR5 CDX2, NOX1 and SLC9A2 prior to development of carcinoma. Identified gene signatures identify aberrant epithelial expression of genes prior to cancer development using in-house custom designed gene expression multiplex assays. This approach may be used to assist in objective classification of disease initiation, staging, progression and therapeutic responses using biopsy material.	[Drew, Janice E.; Farquharson, Andrew J.; Vase, Hollie F.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland; [Mayer, Claus Dieter] Univ Aberdeen, Biomath & Stat Scotland, Aberdeen AB21 9SB, Scotland; [Coates, Philip J.; Steele, Robert J.; Carey, Francis A.] Ninewells Hosp & Med Sch, Dundee DD1 9SU, Scotland	University of Aberdeen; James Hutton Institute; University of Aberdeen; University of Dundee	Drew, JE (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland.	j.drew@abdn.ac.uk	Coates, Philip J/H-6854-2019; Mayer, Claus-Dieter/L-9353-2013	Coates, Philip J/0000-0003-1518-6306; Steele, Robert JC/0000-0003-4248-6785; Mayer, Claus-Dieter/0000-0001-8788-3149	Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme [GT403]; Scottish Universities Life Science Alliance Translational Biology Studentship [10/09]; NHS Grampian Endowment Fund [12/07]	Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme; Scottish Universities Life Science Alliance Translational Biology Studentship; NHS Grampian Endowment Fund	This study was supported by the Scottish Government's Rural and Environment Science and Analytical Services Division Food, Land and People Programme GT403 (http://www.scotland.gov.uk/Topics/Research/About/EBAR/StrategicResearch/future-research-strategy/Themes), Scottish Universities Life Science Alliance Translational Biology Studentship 10/09, (http://www.sulsa.ac.uk/), NHS Grampian Endowment Fund 12/07 (http://www.nhsgrampian.co.uk/nhsgrampian/gra_display_hospital.jsp?pContentID=65&p_applic=CCC&p_service=Content.show&). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Drew JE, 2011, J MOL DIAGN, V13, P233, DOI 10.1016/j.jmoldx.2010.10.001; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Ferlay J, 2008, V1 2 CANC INCIDENCE; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Koslowski M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-77; Lin LJ, 2013, MOL MED REP, V8, P61, DOI 10.3892/mmr.2013.1490; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Ropenga A, 2004, RADIAT RES, V161, P597, DOI 10.1667/RR3173; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; Takemasa I, 2001, BIOCHEM BIOPH RES CO, V285, P1244, DOI 10.1006/bbrc.2001.5277; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu XS, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-244; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3	33	34	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113071	10.1371/journal.pone.0113071	http://dx.doi.org/10.1371/journal.pone.0113071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423035	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700021
J	Deroost, K; Lays, N; Pham, TT; Baci, D; Van den Eynde, K; Komuta, M; Prato, M; Roskams, T; Schwarzer, E; Opdenakker, G; Van den Steen, PE				Deroost, Katrien; Lays, Natacha; Thao-Thy Pham; Baci, Denisa; Van den Eynde, Kathleen; Komuta, Mina; Prato, Mauro; Roskams, Tania; Schwarzer, Evelin; Opdenakker, Ghislain; Van den Steen, Philippe E.			Hemozoin Induces Hepatic Inflammation in Mice and Is Differentially Associated with Liver Pathology Depending on the Plasmodium Strain	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BLOOD MONONUCLEAR-CELLS; MALARIAL PIGMENT; CEREBRAL MALARIA; MURINE MALARIA; KAPPA-B; IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; FALCIPARUM	Malaria is a global disease that clinically affects more than two hundred million people annually. Despite the availability of effective antimalarials, mortality rates associated with severe complications are high. Hepatopathy is frequently observed in patients with severe malarial disease and its pathogenesis is poorly understood. Previously, we observed high amounts of hemozoin or malaria pigment in livers from infected mice. In this study, we investigated whether hemozoin is associated with liver injury in different mouse malaria models. C57BL/6J mice infected with the rodent parasites Plasmodium berghei ANKA, P. berghei NK65 or P. chabaudi AS had elevated serum liver enzymes without severe histological changes in the liver, in line with the observations in most patients. Furthermore, liver enzymes were significantly higher in serum of P. chabaudi AS-infected mice compared to mice infected with the P. berghei parasite strains and a strong positive correlation was found between hepatic hemozoin levels, hepatocyte damage and inflammation in the liver with P. chabaudi AS. The observed liver injury was only marginally influenced by the genetic background of the host, since similar serum liver enzyme levels were measured in infected C57BL/6J and BALB/c mice. Intravenous injection of P. falciparum-derived hemozoin in malaria-free C57BL/6J mice induced inflammatory gene transcription in the liver, suggesting that hemozoin may be involved in the pathogenesis of malaria hepatopathy by inducing inflammation.	[Deroost, Katrien; Lays, Natacha; Thao-Thy Pham; Opdenakker, Ghislain; Van den Steen, Philippe E.] KU Leuven Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Dept Microbiol & Immunol, Leuven, Belgium; [Baci, Denisa; Schwarzer, Evelin] Univ Turin, Dept Oncol, Turin, Italy; [Baci, Denisa] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Van den Eynde, Kathleen; Komuta, Mina; Roskams, Tania] KU Leuven Univ Leuven, Leuven, Belgium; [Prato, Mauro] Univ Turin, Dept Neurosci, Turin, Italy; [Schwarzer, Evelin] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	KU Leuven; University of Turin; University of Rome Tor Vergata; KU Leuven; University of Turin; University of Turin	Van den Steen, PE (corresponding author), KU Leuven Univ Leuven, Rega Inst Med Res, Immunobiol Lab, Dept Microbiol & Immunol, Leuven, Belgium.	philippe.vandensteen@rega.kuleuven.be	Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/Q-3130-2017; Opdenakker, Ghislain/V-8562-2019; Baci, Denisa/J-2929-2018; Pham, Thao-Thy/T-5673-2017; Baci, Denisa/AAE-4344-2022	Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Baci, Denisa/0000-0001-6474-0970; Pham, Thao-Thy/0000-0003-3728-6455; Baci, Denisa/0000-0001-6474-0970; Roskams, Tania/0000-0002-2816-1530; KOMUTA, MINA/0000-0002-3999-1417; Deroost, Katrien/0000-0001-7580-2479	Agency for Innovation by Science and Technology (IWT); "Geconcerteerde OnderzoeksActies'' of the Research Fund of the KU Leuven [GOA 2012/017, GOA 2013/014]; Fund for Scientific Research (F.W.O.-Vlaanderen); European Virtual Institute [242095]; Italian Ministry of Education, University and Research (MIUR) [2010C2LKKJ]	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); "Geconcerteerde OnderzoeksActies'' of the Research Fund of the KU Leuven; Fund for Scientific Research (F.W.O.-Vlaanderen)(FWO); European Virtual Institute; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT) to Katrien Deroost, the "Geconcerteerde OnderzoeksActies'' (GOA 2012/017 and GOA 2013/014) of the Research Fund of the KU Leuven, and the Fund for Scientific Research (F.W.O.-Vlaanderen). Philippe Van den Steen is a Research Professor of the KU Leuven. Evelin Schwarzer and Denisa Baci were supported by the European Virtual Institute dedicated to Malaria Research (EVIMALAR, FP7 Project No. 242095) and the Italian Ministry of Education, University and Research (MIUR, PRIN project 2010C2LKKJ). Mauro Prato holds a professorship granted by University of Torino and Azienda Sanitaria Locale-19 (ASL-19), along with Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Boura M, 2013, TRENDS PARASITOL, V29, P469, DOI 10.1016/j.pt.2013.07.005; Brugat T, 2014, CELL MICROBIOL, V16, P687, DOI 10.1111/cmi.12212; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dasari P, 2011, BLOOD, V118, P4946, DOI 10.1182/blood-2011-05-353920; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Deroost K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-166; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Findlay EG, 2010, J IMMUNOL, V185, P2482, DOI 10.4049/jimmunol.0904019; Frita R, 2012, MALAR RES TREAT, V2012, DOI DOI 10.1155/2012/373086; Geurts N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027131; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Jacobs T, 2004, EUR J IMMUNOL, V34, P972, DOI 10.1002/eji.200324477; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2004, J IMMUNOL, V172, P3101, DOI 10.4049/jimmunol.172.5.3101; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Khadjavi A, 2014, CELL BIOCHEM FUNCT, V32, P5, DOI 10.1002/cbf.2963; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Levesque MA, 1999, J PARASITOL, V85, P570, DOI 10.2307/3285800; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Murthy G L, 1998, Trop Gastroenterol, V19, P152; Nacher M, 2001, AM J TROP MED HYG, V65, P828, DOI 10.4269/ajtmh.2001.65.828; Niikura M, 2008, J IMMUNOL, V180, P6877, DOI 10.4049/jimmunol.180.10.6877; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perkins DJ, 2003, BIOCHEM BIOPH RES CO, V311, P839, DOI 10.1016/j.bbrc.2003.10.073; PLAYFAIR JHL, 1979, NATURE, V282, P731, DOI 10.1038/282731a0; Polimeni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039497; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Punsawad C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-191; Rodriguez-Acosta A, 1998, J SUBMICR CYTOL PATH, V30, P299; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Singh RP, 2002, J IMMUNOL, V168, P4674, DOI 10.4049/jimmunol.168.9.4674; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Tyberghein A, 2013, BIOFACTORS IN PRESS; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Whitten R, 2011, HUM PATHOL, V42, P1230, DOI 10.1016/j.humpath.2010.11.019; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824	55	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113519	10.1371/journal.pone.0113519	http://dx.doi.org/10.1371/journal.pone.0113519			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419977	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900046
J	Luan, XH; Liu, DW; Cao, ZZ; Luo, LN; Liu, M; Gao, M; Zhang, XY				Luan, Xinhong; Liu, Dawei; Cao, Zhongzan; Luo, Lina; Liu, Mei; Gao, Ming; Zhang, Xiaoying			Transcriptome Profiling Identifies Differentially Expressed Genes in Huoyan Goose Ovaries between the Laying Period and Ceased Period	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; RECEPTOR MESSENGER-RNA; HEN GRANULOSA-CELLS; PROGESTERONE-RECEPTOR; PITUITARY-GLAND; NEUROPEPTIDE-Y; MOLECULAR CHARACTERIZATION; TISSUE DISTRIBUTION; RIBONUCLEIC-ACID; EGG-PRODUCTION	The Huoyan goose is famous for its high egg-laying performance and is listed as a nationally protected domestic animal by the Chinese government. To elucidate the key regulatory genes involved in Huoyan goose egg laying, RNA from ovarian tissue during the ceased and laying periods was sequenced using the Illumina HiSeq 2000 sequencing platform. More than 12 million reads were produced in ceased and laying libraries that included 11,896,423 and 12,534,799 clean reads, respectively. More than 20% of the reads were matched to the reference genome, and 23% of the reads were matched to reference genes. Genes with a false discovery rate (FDR) <= 0.001 and log(2)ratio >= 1 or <=-1 were characterized as differentially expressed, and 344 up-regulated and 344 down-regulated genes were classified into functional categories. Twelve genes that are mainly involved in pathways for reproduction regulation, such as steroid hormone biosynthesis, GnRH signaling pathways, oocyte meiosis, progesterone-mediated oocyte maturation, steroid biosynthesis, calcium signaling pathways, and G-protein coupled receptor signaling pathway were selected for validation by a quantitative real-time polymerase chain reaction (qRT-PCR) analysis, the qRT-PCR results are consistent with the general expression patterns of those genes from the Illumina sequencing. These data provide comprehensive gene expression information at the transcriptional level that might increase our understanding of the Huoyan goose's reproductive biology.	[Luan, Xinhong; Liu, Dawei; Cao, Zhongzan; Luo, Lina; Liu, Mei; Gao, Ming] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110866, Peoples R China; [Zhang, Xiaoying] Liaoning Prov Livestock & Poultry Genet Resources, Liaoyang 111000, Peoples R China	Shenyang Agricultural University	Luan, XH (corresponding author), Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110866, Peoples R China.	xhluan@163.com	Xinhong, Luan/U-8480-2019		National Natural Science Foundation of China [31172286]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31172286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Bu GX, 2013, MOL CELL ENDOCRINOL, V370, P149, DOI 10.1016/j.mce.2013.03.001; Camacho-Arroyo I, 2003, COMP BIOCHEM PHYS A, V136, P447, DOI 10.1016/S1095-6433(03)00204-6; Camacho-Arroyo I, 2007, COMP BIOCHEM PHYS A, V146, P644, DOI 10.1016/j.cbpa.2006.04.023; Chaiseha Y, 2004, BIOL REPROD, V70, P593, DOI 10.1095/biolreprod.103.022715; Chaiseha Y, 2005, J POULTRY SCI, V42; Chen J, 2012, MOL BIOL REP, V39, P475, DOI 10.1007/s11033-011-0761-y; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chowdhury VS, 2013, GEN COMP ENDOCR, V181, P175, DOI 10.1016/j.ygcen.2012.08.005; [褚晓红 CHU Xiaohong], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P823; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONTIJOCH AM, 1993, NEUROENDOCRINOLOGY, V57, P135, DOI 10.1159/000126353; Donath J, 2000, ANN ANAT, V182, P143, DOI 10.1016/S0940-9602(00)80073-4; Fekete C, 2002, ENDOCRINOLOGY, V143, P4513, DOI 10.1210/en.2002-220574; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freking F, 2000, GEN COMP ENDOCR, V119, P140, DOI 10.1006/gcen.2000.7503; GALLO RV, 1981, BIOL REPROD, V24, P100, DOI 10.1095/biolreprod24.1.100; Gonzales C, 2004, FASEB J, V18, P137, DOI 10.1096/fj.03-0189fje; Gonzalez-Moran G, 2002, COMP BIOCHEM PHYS A, V132, P519, DOI 10.1016/S1095-6433(02)00096-X; Grzesiak M, 2012, THERIOGENOLOGY, V78, P2050, DOI 10.1016/j.theriogenology.2012.07.026; He H, 2014, ANIM REPROD SCI, V145, P62, DOI 10.1016/j.anireprosci.2013.12.012; Houk CP, 2004, ENDOCRINOLOGY, V145, P1269, DOI 10.1210/en.2003-1046; Hrabia A, 2004, FOLIA BIOL-KRAKOW, V52, P197, DOI 10.3409/1734916044527494; ISOLA J, 1987, ENDOCRINOLOGY, V121, P1034, DOI 10.1210/endo-121-3-1034; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Johnson AL, 2002, BIOL REPROD, V67, P1313, DOI 10.1095/biolreprod67.4.1313; Johnson AL, 2001, ENDOCRINOLOGY, V142, P3116, DOI 10.1210/en.142.7.3116; Kahtane AA, 2003, J MOL ENDOCRINOL, V31, P185, DOI 10.1677/jme.0.0310185; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Kansaku N, 2001, BIOL REPROD, V64, P1575, DOI 10.1095/biolreprod64.5.1575; KAWASHIMA M, 1978, ENDOCRINOLOGY, V102, P1207, DOI 10.1210/endo-102-4-1207; KAWASHIMA M, 1979, ENDOCRINOL JAPON, V26, P501; Leclerc B, 2007, GEN COMP ENDOCR, V150, P319, DOI 10.1016/j.ygcen.2006.08.007; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LI Z, 1993, BIOL REPROD, V49, P463, DOI 10.1095/biolreprod49.3.463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan XH, 2014, MOL BIOL REP, V41, P3401, DOI 10.1007/s11033-014-3202-x; Luan XH, 2013, ASIAN AUSTRAL J ANIM, V26, P921, DOI 10.5713/ajas.2013.13083; MARRONE BL, 1989, BIOL REPROD, V40, P1007, DOI 10.1095/biolreprod40.5.1007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Onmus-Leone F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061762; Ortega I, 2013, FERTIL STERIL, V99, P889, DOI 10.1016/j.fertnstert.2012.11.006; Padmanabhan V, 2002, REPRODUCTION, P67; Park JH, 2014, GENE, V534, P107, DOI 10.1016/j.gene.2013.09.088; Paul S, 2010, J MOL ENDOCRINOL, V45, P207, DOI 10.1677/JME-10-0061; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Rada JAS, 2006, INVEST OPHTH VIS SCI, V47, P25, DOI 10.1167/iovs.05-0195; Schnell SA, 1999, J COMP NEUROL, V407, P543, DOI 10.1002/(SICI)1096-9861(19990517)407:4<543::AID-CNE6>3.0.CO;2-O; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; Sharp PJ, 2003, CAN J PHYSIOL PHARM, V81, P350, DOI 10.1139/Y03-025; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shi ZD, 2007, DOMEST ANIM ENDOCRIN, V32, P190, DOI 10.1016/j.domaniend.2006.03.002; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Shiue YL, 2006, THERIOGENOLOGY, V66, P1274, DOI 10.1016/j.theriogenology.2006.03.037; Syvala H, 1996, J STEROID BIOCHEM, V58, P517, DOI 10.1016/0960-0760(96)00073-8; Tsai SJ, 2001, J CLIN ENDOCR METAB, V86, P5765, DOI 10.1210/jc.86.12.5765; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wang C, 2014, GENE, V535, P177, DOI 10.1016/j.gene.2013.11.037; Wang K. H., 2004, POULTRY GENETIC RESO; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Woods DC, 2005, BIOCHEM BIOPH RES CO, V336, P450, DOI 10.1016/j.bbrc.2005.08.107; Woods DC, 2005, BIOL REPROD, V72, P643, DOI 10.1095/biolreprod.104.033902; Woods DC, 2007, BIOL REPROD, V77, P61, DOI 10.1095/biolreprod.106.059394; Woods DC, 2007, REPRODUCTION, V133, P733, DOI 10.1530/REP-06-0261; Wu Xu, 2007, Agricultural Sciences in China, V6, P499, DOI 10.1016/S1671-2927(07)60075-3; Xiao YQ, 2011, PEPTIDES, V32, P2091, DOI 10.1016/j.peptides.2011.09.001; Xing G, 2011, POULTRY SCI, V90, P1050, DOI 10.3382/ps.2010-01300; Xu HP, 2010, POULTRY SCI, V89, P428, DOI 10.3382/ps.2009-00428; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yen CF, 2006, POULTRY SCI, V85, P2265, DOI 10.1093/ps/85.12.2265; Zawilska JB, 2005, PHARMACOL REP, V57, P188; Zhang X, 2013, FOLIA BIOL, V61, P1; Zhang Y, 2013, ANIMAL PRODUCTION SC; Zhou M, 2008, POULTRY SCI, V87, P893, DOI 10.3382/ps.2007-00495	80	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113211	10.1371/journal.pone.0113211	http://dx.doi.org/10.1371/journal.pone.0113211			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419838	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900024
J	Schwimmer, JB; Zepeda, A; Newton, KP; Xanthakos, SA; Behling, C; Hallinan, EK; Donithan, M; Tonascia, J				Schwimmer, Jeffrey B.; Zepeda, Anne; Newton, Kimberly P.; Xanthakos, Stavra A.; Behling, Cynthia; Hallinan, Erin K.; Donithan, Michele; Tonascia, James		Nonalcoholic Steatohepatitis	Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; URIC-ACID; METABOLIC SYNDROME; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; OBESE CHILDREN; VITAMIN-E; ADOLESCENTS; CHILDHOOD	Objective: Nonalcoholic fatty liver disease (NAFLD) affects 9.6% of children and may put these children at elevated risk of high blood pressure and subsequent cardiovascular morbidity and mortality. Therefore, we sought to determine the prevalence of and risk factors for high blood pressure in children with NAFLD. Methods: Cohort study performed by the NIDDK NASH Clinical Research Network. There were 484 children with NAFLD ages 2 to 17 at enrollment; 382 children were assessed both at enrollment and 48 weeks afterwards. The main outcomes were high blood pressure at baseline and persistent high blood pressure at both baseline and 48 weeks. Results: Prevalence of high blood pressure at baseline was 35.8% and prevalence of persistent high blood pressure was 21.4%. Children with high blood pressure were significantly more likely to have worse steatosis than children without high blood pressure (mild 19.8% vs. 34.2%, moderate 35.0% vs. 30.7%, severe 45.2% vs. 35.1%; P=0.003). Higher body mass index, low-density lipoprotein, and uric acid were independent risk factors for high blood pressure (Odds Ratios: 1.10 per kg/m(2), 1.09 per 10 mg/dL, 1.25 per mg/dL, respectively). Compared to boys, girls with NAFLD were significantly more likely to have persistent high blood pressure (28.4% vs. 18.9%; P=0.05). Conclusions: In conclusion, NAFLD is a common clinical problem that places children at substantial risk for high blood pressure, which may often go undiagnosed. Thus blood pressure evaluation, control, and monitoring should be an integral component of the clinical management of children with NAFLD.	[Schwimmer, Jeffrey B.; Zepeda, Anne; Newton, Kimberly P.] Univ Calif San Diego, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA; [Schwimmer, Jeffrey B.; Newton, Kimberly P.] Rady Childrens Hosp San Diego, Dept Gastroenterol, San Diego, CA USA; [Schwimmer, Jeffrey B.] Univ Calif San Diego, Sch Med, Dept Radiol, Liver Imaging Grp, San Diego, CA 92103 USA; [Zepeda, Anne] Univ Calif San Diego, San Diego, CA 92103 USA; [Xanthakos, Stavra A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Behling, Cynthia] Sharp Med Ctr, Dept Pathol, San Diego, CA USA; [Hallinan, Erin K.; Donithan, Michele; Tonascia, James] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schwimmer, JB (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, San Diego, CA 92103 USA.	jschwimmer@ucsd.edu	Kleiner, David E/N-2770-2013; Vaughn, Ivana/B-6138-2016	Kleiner, David E/0000-0003-3442-4453; Vaughn, Ivana/0000-0002-7201-0289; Schwimmer, Jeffrey/0000-0001-8538-2877	National Institute of Diabetes and Digestive and Kidney Diseases [U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713]; National Center for Advancing Translational Sciences [UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL RR031980, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000067, UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000454, UL1TR000436, UL1TR000150, UL1TR000058, UL1TR000004, UL1TR000423, UL1TR000040, UL1TR000006, UL1TR000100, UL1TR000424, UL1TR000067, UL1TR000448, UL1TR000077, UL1TR002319] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061734, P30DK026743, P30DK078392, U01DK061718, U01DK061728, U01DK061730, U01DK061731, U01DK061732, U01DK061713, U01DK061738, U01DK061737] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) grant numbers U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, and U01DK061713. Role of the sponsor: The National Institute of Diabetes and Digestive and Kidney Diseases provided scientific advice for the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, and approval of the manuscript. However, the content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by the National Center for Advancing Translational Sciences (www.ncats.nih.gov) grant numbers UL1TR000439, UL1TR000077, UL1TR000436, UL1TR000150, UL1TR000424, UL1TR000006, UL1TR000448, UL1TR000040, UL RR031980, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058, UL1TR000067, and UL1TR000454. The National Center for Advancing Translational Sciences had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AA, 2012, J PEDIATR-US, V160, P757, DOI 10.1016/j.jpeds.2011.10.033; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Balligand J L, 2002, Bull Mem Acad R Med Belg, V157, P427; Balligand JL, 2002, B MEM ACAD R MED BEL, V157, P431; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Catar RA, 2007, HORM METAB RES, V39, P801, DOI 10.1055/s-2007-991158; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Flynn JT, 2014, HYPERTENSION, V63, P1116, DOI 10.1161/HYP.0000000000000007; Hartiala O, 2012, J AM COLL CARDIOL, V60, P1364, DOI 10.1016/j.jacc.2012.05.045; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Manco M, 2008, INT J OBESITY, V32, P381, DOI 10.1038/sj.ijo.0803711; McGill HC, 2000, CIRCULATION, V102, P374; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Obarzanek E, 2010, J PEDIATR-US, V157, P461, DOI 10.1016/j.jpeds.2010.03.032; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Pacifico L, 2008, PEDIATR RES, V63, P423, DOI 10.1203/PDR.0b013e318165b8e7; Pacifico L, 2014, HEPATOLOGY, V59, P461, DOI 10.1002/hep.26610; Park JH, 2013, NITRIC OXIDE-BIOL CH, V32, P36, DOI 10.1016/j.niox.2013.04.003; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Patton HM, 2010, AM J GASTROENTEROL, V105, P2093, DOI 10.1038/ajg.2010.152; Patton HM, 2008, GASTROENTEROLOGY, V135, P1961, DOI 10.1053/j.gastro.2008.08.050; Rosner B, 2013, HYPERTENSION, V62, P247, DOI 10.1161/HYPERTENSIONAHA.111.00831; Sander M, 1999, HYPERTENSION, V33, P937, DOI 10.1161/01.HYP.33.4.937; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Schwimmer JB, 2013, ALIMENT PHARM THER, V38, P1267, DOI 10.1111/apt.12518; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Singh GK, 2013, J PEDIATR-US, V162, P1160, DOI 10.1016/j.jpeds.2012.11.024; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Viazzi F, 2013, PEDIATRICS, V132, pE93, DOI 10.1542/peds.2013-0047; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Woodman RJ, 2005, DIABETES OBES METAB, V7, P612, DOI 10.1111/j.1463-1326.2005.00478.x; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	44	59	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112569	10.1371/journal.pone.0112569	http://dx.doi.org/10.1371/journal.pone.0112569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419656	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900008
J	Skrbo, N; Hjortland, GO; Kristian, A; Holm, R; Nord, S; Prasmickaite, L; Engebraaten, O; Maelandsmo, GM; Sorlie, T; Andersen, K				Skrbo, Nirma; Hjortland, Geir-Olav; Kristian, Alexandr; Holm, Ruth; Nord, Silje; Prasmickaite, Lina; Engebraaten, Olav; Maelandsmo, Gunhild M.; Sorlie, Therese; Andersen, Kristin			Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft	PLOS ONE			English	Article							BASAL-LIKE; CELLS; HETEROGENEITY; METASTASIS; MODELS; MARKER; TUMORS; GENES	Intratumor heterogeneity caused by genetic, phenotypic or functional differences between cancer cell subpopulations is a considerable clinical challenge. Understanding subpopulation dynamics is therefore central for both optimization of existing therapy and for development of new treatment. The aim of this study was to isolate subpopulations from a primary tumor and by comparing molecular characteristics of these subpopulations, find explanations to their differing tumorigenicity. Cell subpopulations from two patient derived in vivo models of primary breast cancer, ER+ and ER-, were identified. EpCAM+ cells from the ER+ model gave rise to tumors independently of stroma cell support. The tumorigenic fraction was further divided based on SSEA-4 and CD24 expression. Both markers were expressed in ER+ breast cancer biopsies. FAC-sorted cells based on EpCAM, SSEA-4 and CD24 expression were subsequently tested for differences in functionality by in vivo tumorigenicity assay. Three out of four subpopulations of cells were tumorigenic and showed variable ability to recapitulate the marker expression of the original tumor. Whole genome expression analysis of the sorted populations disclosed high similarity in the transcriptional profiles between the tumorigenic populations. Comparing the non-tumorigenic vs the tumorigenic populations, 44 transcripts were, however, significantly differentially expressed. A subset of these, 26 identified and named genes, highly expressed in the non-tumorigenic population, predicted longer overall survival (N=737, p<0.0001) and distant metastasis free survival (DMFS) (N=1379, p<0.0001) when performing Kaplan-Meier survival analysis using the GOBO online database. The 26 gene set correlated with longer DMFS in multiple breast cancer subgroups. Copy number profiling revealed no aberrations that could explain the observed differences in tumorigenicity. This study emphasizes the functional variability among cell populations that are otherwise genomically similar, and that the risk of breast cancer recurrence can only be eliminated if the tumorigenic abilities in multiple cancer cell subpopulations are inhibited.	[Skrbo, Nirma; Hjortland, Geir-Olav; Kristian, Alexandr; Prasmickaite, Lina; Engebraaten, Olav; Maelandsmo, Gunhild M.; Andersen, Kristin] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Skrbo, Nirma; Nord, Silje; Sorlie, Therese] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Holm, Ruth] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Maelandsmo, Gunhild M.; Sorlie, Therese; Andersen, Kristin] Norwegian Radium Hosp, Oslo Univ Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Maelandsmo, Gunhild M.] Univ Tromso, Fac Hlth Sci, Dept Pharm, Tromso, Norway; [Hjortland, Geir-Olav; Engebraaten, Olav] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Skrbo, Nirma; Kristian, Alexandr; Engebraaten, Olav] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kristian, Alexandr; Nord, Silje; Engebraaten, Olav; Maelandsmo, Gunhild M.; Sorlie, Therese] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; University of Oslo	Andersen, K (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	Kristin.Andersen@rr-research.no	Sørlie, Therese/B-1413-2015; Mælandsmo, Gunhild Mari/AFV-4446-2022; Nord, Silje/R-5212-2016	Sørlie, Therese/0000-0002-5995-2319; Nord, Silje/0000-0002-3271-5356	Norwegian South East Health Authorities; Norwegian Cancer Society; Norwegian Research Council (through SFI-CAST); K.G. Jebsen Centre for Breast Cancer Research	Norwegian South East Health Authorities; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council (through SFI-CAST); K.G. Jebsen Centre for Breast Cancer Research	This work was financially supported by the Norwegian South East Health Authorities (to TS and NS), the Norwegian Cancer Society, and the Norwegian Research Council (through SFI-CAST to GMM, TS, NS and KA), and by the K.G. Jebsen Centre for Breast Cancer Research (to GMM and AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bergamaschi A, 2009, MOL ONCOL; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Flatmark K, 2004, TUMOR BIOL, V25, P31, DOI 10.1159/000077721; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grinde MT, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3597; Hendrix A, 2011, CLIN RES HEPATOL GAS, V35, P714, DOI 10.1016/j.clinre.2011.05.003; Hines WC, 2014, CELL REP, V6, P779, DOI 10.1016/j.celrep.2014.02.021; Huuse EM, 2012, J MAGN RESON IMAGING, V35, P1098, DOI 10.1002/jmri.23507; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Lindholm EM, 2013, CLIN CANC RES; Lindholm EM, 2012, MOL ONCOL, V6, P418, DOI 10.1016/j.molonc.2012.03.006; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Merlino G, 2013, PIGM CELL MELANOMA R, V26, pE8, DOI 10.1111/pcmr.12099; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Moestue SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-433; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113278	10.1371/journal.pone.0113278	http://dx.doi.org/10.1371/journal.pone.0113278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419568	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900028
J	Hong, SY; Lee, JS; Sun, IO; Lee, KY; Gil, HW				Hong, Sae-Yong; Lee, Ji-Sung; Sun, In O.; Lee, Kwang-Young; Gil, Hyo-Wook			Prediction of Patient Survival in Cases of Acute Paraquat Poisoning	PLOS ONE			English	Article							ARTERIAL LACTATE; INTOXICATION; MORTALITY; INJURY; LEVEL	Paraquat concentration-time data have been used to predict the clinical outcome following ingestion. However, these studies have included only small populations, although paraquat poisoning has a very high mortality rate. The purpose of this study was to develop a simple and reliable model to predict survival according to the time interval post-ingestion in patients with acute paraquat poisoning. Data were retrospectively collected for patients who were admitted with paraquat poisoning to Soonchunhyang University Choenan Hospital between January 2005 and December 2012. Plasma paraquat levels were measured using high-performance liquid chromatography. To validate the model we developed, we used external data from 788 subjects admitted to the Presbyterian Medical Center, Jeonju, Korea, between January 2007 and December 2012. Two thousand one hundred thirty six patients were included in this study. The overall survival rate was 44% (939/2136). The probability of survival for any specified time and concentration could be predicted as (exp(logit))/(1+exp(logit)), where logit=1.3544+[-3.4688 x log10(plasma paraquat mu g/Ml)]+[-2.3169 x log10(hours since ingestion)]. The external validation study showed that our model was highly accurate for the prediction of survival (C statics 0.964; 95% CI [0.952-0.975]). We have developed a model that is effective for predicting survival after paraquat intoxication.	[Hong, Sae-Yong; Gil, Hyo-Wook] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Lee, Ji-Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Sun, In O.; Lee, Kwang-Young] Presbyterian Med Ctr, Dept Internal Med, Jeonju, South Korea	Soonchunhyang University; Soonchunhyang University	Gil, HW (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	hwgil@schmc.ac.kr		hong, saeyong/0000-0001-7854-3871	Soonchunhyang University	Soonchunhyang University	Funding: This study was supported by Soonchunhyang University Research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2013, MED SCI MONITOR, V19, P28; Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403; Gil HW, 2007, CLIN TOXICOL, V45, P463, DOI 10.1080/15563650701338138; Gil HW, 2010, CLIN TOXICOL, V48, P115, DOI 10.3109/15563650903468803; HART TB, 1984, LANCET, V2, P1222; Hong SY, 2005, CHEST, V128, P1506, DOI 10.1378/chest.128.3.1506; HOUZE P, 1990, HUM EXP TOXICOL, V9, P5, DOI 10.1177/096032719000900103; Jones AL, 1999, QJM-MON J ASSOC PHYS, V92, P573, DOI 10.1093/qjmed/92.10.573; Kim SJ, 2009, NEPHROL DIAL TRANSPL, V24, P1226, DOI 10.1093/ndt/gfn615; Koo JR, 2009, AM J MED SCI, V338, P373, DOI 10.1097/MAJ.0b013e3181b4deee; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lee Y, 2012, CLIN TOXICOL, V50, P52, DOI 10.3109/15563650.2011.639716; Liu XW, 2013, AM J EMERG MED, V31, P1230, DOI 10.1016/j.ajem.2013.04.019; PROUDFOOT AT, 1979, LANCET, V2, P330; SAWADA Y, 1988, LANCET, V1, P1333; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Shi YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040911; Weng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082695; Yeo CD, 2012, TOXICOL LETT, V212, P157, DOI 10.1016/j.toxlet.2011.12.007	19	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111674	10.1371/journal.pone.0111674	http://dx.doi.org/10.1371/journal.pone.0111674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415592	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600007
J	Aharon, R; Janes, PW; Burgess, AW; Hamza, K; Klebaner, F; Lackmann, M				Aharon, Rotem; Janes, Peter W.; Burgess, Anthony W.; Hamza, Kais; Klebaner, Fima; Lackmann, Martin			A Mathematical Model for Eph/Ephrin-Directed Segregation of Intermingled Cells	PLOS ONE			English	Article							EPH RECEPTOR FUNCTION; DIFFERENTIAL ADHESION; NEURAL MAP; E-CADHERIN; MOTILITY; EPHRINS; MIGRATION; CANCER; POPULATIONS; ACTIVATION	Eph receptors, the largest family of receptor tyrosine kinases, control cell-cell adhesion/de-adhesion, cell morphology and cell positioning through interaction with cell surface ephrin ligands. Bi-directional signalling from the Eph and ephrin complexes on interacting cells have a significant role in controlling normal tissue development and oncogenic tissue patterning. Eph-mediated tissue patterning is based on the fine-tuned balance of adhesion and de-adhesion reactions between distinct Eph- and ephrin-expressing cell populations, and adhesion within like populations (expressing either Eph or ephrin). Here we develop a stochastic, Lagrangian model that is based on Eph/ephrin biology: incorporating independent Brownian motion to describe cell movement and a deterministic term (the drift term) to represent repulsive and adhesive interactions between neighbouring cells. Comparison between the experimental and computer simulated Eph/ephrin cell patterning events shows that the model recapitulates the dynamics of cell-cell segregation and cell cluster formation. Moreover, by modulating the term for Eph/ephrin-mediated repulsion, the model can be tuned to match the actual behaviour of cells with different levels of Eph expression or activity. Together the results of our experiments and modelling suggest that the complexity of Eph/ephrin signalling mechanisms that control cell-cell interactions can be described well by a mathematical model with a single term balancing adhesion and de-adhesion between interacting cells. This model allows reliable prediction of Eph/ephrindependent control of cell patterning behaviour.	[Aharon, Rotem; Hamza, Kais; Klebaner, Fima] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Janes, Peter W.; Lackmann, Martin] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Burgess, Anthony W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia	Monash University; Monash University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Aharon, R (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	rotem.aharon@monash.edu; peter.janes@monash.edu	Klebaner, Fima C/G-2556-2010	Klebaner, Fima C/0000-0001-8044-9761; Hamza, Kais/0000-0001-9444-3600; Janes, Peter/0000-0002-9039-1097	Australian Research Council [1201022728]; Human Frontiers in Science Program [RGP0039/2009-C]; National Health and Medical Research Council of Australia [487922, 1003908]	Australian Research Council(Australian Research Council); Human Frontiers in Science Program(Human Frontier Science Program); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was funded by the Australian Research Council #1201022728, www.arc.gov.au; Human Frontiers in Science Program #RGP0039/2009-C, www.hfsp.org to ML; National Health and Medical Research Council of Australia #487922 and #1003908, www.nhmrc.gov.au to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Bindschadler M, 2004, BIOPHYS J, V86, P2720, DOI 10.1016/S0006-3495(04)74326-X; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Deroulers C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031917; DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199; Fernando AE, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011903; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Gatenby RA, 1996, CANCER RES, V56, P5745; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Ionides EL, 2004, J MATH BIOL, V48, P23, DOI 10.1007/s00285-003-0220-z; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Janes PW, 2008, CURR CANCER DRUG TAR, V8, P473, DOI 10.2174/156800908785699315; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orsulic S, 2000, J CELL SCI, V113, P1793; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; Shaw G, 2002, FASEB J; Simpson MJ, 2010, PHYSICA A, V389, P1412, DOI 10.1016/j.physa.2009.12.010; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Taylor W, 2011, J BIOINF COMPUT BIOL, V9, P91, DOI 10.1142/S0219720011005318; Taylor WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043226; Tognolini M, 2014, DRUG DISCOV TODAY, V19, P661, DOI 10.1016/j.drudis.2013.11.017; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Xu QL, 2000, PHILOS T ROY SOC B, V355, P993, DOI 10.1098/rstb.2000.0635	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111803	10.1371/journal.pone.0111803	http://dx.doi.org/10.1371/journal.pone.0111803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436892	Green Published, gold			2022-12-27	WOS:000347114900009
J	Heyland, A; Hodin, J; Bishop, C				Heyland, Andreas; Hodin, Jason; Bishop, Cory			Manipulation of Developing Juvenile Structures in Purple Sea Urchins (Strongylocentrotus purpuratus) by Morpholino Injection into Late Stage Larvae	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; CONNECTIVE-TISSUE; ECHINODERMATA; CLONING	Sea urchins have been used as experimental organisms for developmental biology for over a century. Yet, as is the case for many other marine invertebrates, understanding the development of the juveniles and adults has lagged far behind that of their embryos and larvae. The reasons for this are, in large part, due to the difficulty of experimentally manipulating juvenile development. Here we develop and validate a technique for injecting compounds into juvenile rudiments of the purple sea urchin, Strongylocentrotus purpuratus. We first document the distribution of rhodaminated dextran injected into different compartments of the juvenile rudiment of sea urchin larvae. Then, to test the potential of this technique to manipulate development, we injected Vivo-Morpholinos (vMOs) designed to knock down p58b and p16, two proteins involved in the elongation of S. purpuratus larval skeleton. Rudiments injected with these vMOs showed a delay in the growth of some juvenile skeletal elements relative to controls. These data provide the first evidence that vMOs, which are designed to cross cell membranes, can be used to transiently manipulate gene function in later developmental stages in sea urchins. We therefore propose that injection of vMOs into juvenile rudiments, as shown here, is a viable approach to testing hypotheses about gene function during development, including metamorphosis.	[Heyland, Andreas] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Hodin, Jason] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Bishop, Cory] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada	University of Guelph; Stanford University; Saint Francis Xavier University - Canada	Heyland, A (corresponding author), Univ Guelph, Guelph, ON N1G 2W1, Canada.	aheyland@uoguelph.ca			Evo-Devo-Eco Network (EDEN) Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [NSF 1357033]; Directorate For Geosciences [1357077, 1357033] Funding Source: National Science Foundation	Evo-Devo-Eco Network (EDEN) Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by an Evo-Devo-Eco Network (EDEN; http://edenrcn.com) Fellowship (AH), Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, CB and AH; http://www.nserc-crsng.gc.ca) and the National Science Foundation (NSF 1357033, JH and Christopher Lowe; http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomako-Ankomah A, 2011, DEV BIOL, V353, P81, DOI 10.1016/j.ydbio.2011.02.021; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Bishop CD, 2006, INTEGR COMP BIOL, V46, P655, DOI 10.1093/icb/icl004; CAMERON RA, 1978, J MORPHOL, V157, P21, DOI 10.1002/jmor.1051570103; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; CHINO Y, 1994, DEV BIOL, V161, P1, DOI 10.1006/dbio.1994.1001; Driesch H., 1893, Anatomischer Anzeiger, Vviii, P348; Driesch H., 1892, POTENCY 1 2 CLEAVAGE; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Eaves AA, 2005, INVERTEBR BIOL, V124, P174, DOI 10.1111/j.1744-7410.2005.00017.x; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Emlet RB, 2010, INTEGR COMP BIOL, V50, P571, DOI 10.1093/icb/icq073; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Gordon I, 1926, PHILOS T R SOC LON B, V214, P259, DOI 10.1098/rstb.1926.0007; Gordon I, 1929, PHILOS T R SOC LON B, V217, P289, DOI 10.1098/rstb.1929.0005; Hadfield MG, 2000, AM ZOOL, V40, P1038; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Heyland A, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-22; Heyland A, 2012, ENDOCRINOLOGY, V153, P5440, DOI 10.1210/en.2012-1677; HINEGARDNER RT, 1969, BIOL BULL-US, V137, P465, DOI 10.2307/1540168; Hodin J, 2006, INTEGR COMP BIOL, V46, P719, DOI 10.1093/icb/icl038; Howard EW, 2001, DEVELOPMENT, V128, P365; Hyman L.H., 1955, ECHINODERMATA; Jasny BR, 2006, SCIENCE, V314, P938, DOI 10.1126/science.314.5801.938; Luo YJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001402; MacBride EW, 1903, PHILOS T R SOC LON B, V195, P285, DOI 10.1098/rstb.1903.0006; MacBride EW, 1918, DEV ECHINOCARDIUM 1, P471; MacBride EW, 1914, P R SOC B, V90, P259; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; McHugh D, 1998, TRENDS ECOL EVOL, V13, P182, DOI 10.1016/S0169-5347(97)01285-8; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; Muller W, 1997, DEV BIOL; Raff RA, 2008, PHILOS T R SOC B, V363, P1473, DOI 10.1098/rstb.2007.2237; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; Smith AB, 2001, T ROY SOC EDIN-EARTH, V92, P137, DOI 10.1017/S0263593300000109; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Smith MM, 2008, J MORPHOL, V269, P713, DOI 10.1002/jmor.10618; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Strathmann MF, 1987, REPROD DEV MARINE IN; STRATHMANN RR, 1978, EVOLUTION, V32, P894, DOI 10.1111/j.1558-5646.1978.tb04642.x; STRATHMANN RR, 1994, AM ZOOL, V34, P502; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Sugni M, 2014, MAR ENVIRON RES, V93, P123, DOI 10.1016/j.marenvres.2013.07.010; Sutherby J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-14; Vaughn D, 2008, SCIENCE, V319, P1503, DOI 10.1126/science.1151995; Vaughn D, 2010, MAR BIOL, V157, P1301, DOI 10.1007/s00227-010-1410-z; von Ubisch L, 1913, Z WISS ZOOL ABT A, V106, P409; Williams H, 2002, SEA URCHIN FISHERIES	51	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113866	10.1371/journal.pone.0113866	http://dx.doi.org/10.1371/journal.pone.0113866			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436992	gold, Green Published			2022-12-27	WOS:000347114900090
J	Suarez, C; Soba, A; Maglietti, F; Olaiz, N; Marshall, G				Suarez, Cecilia; Soba, Alejandro; Maglietti, Felipe; Olaiz, Nahuel; Marshall, Guillermo			The Role of Additional Pulses in Electropermeabilization Protocols	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; ELECTRIC-FIELD; IRREVERSIBLE ELECTROPORATION; CONDUCTIVITY CHANGES; GENE-TRANSFER; CELL PERMEABILIZATION; ELECTROCHEMOTHERAPY; TISSUE; ELECTROTRANSFER; FREQUENCY	Electropermeabilization (EP) based protocols such as those applied in medicine, food processing or environmental management, are well established and widely used. The applied voltage, as well as tissue electric conductivity, are of utmost importance for assessing final electropermeabilized area and thus EP effectiveness. Experimental results from literature report that, under certain EP protocols, consecutive pulses increase tissue electric conductivity and even the permeabilization amount. Here we introduce a theoretical model that takes into account this effect in the application of an EP-based protocol, and its validation with experimental measurements. The theoretical model describes the electric field distribution by a nonlinear Laplace equation with a variable conductivity coefficient depending on the electric field, the temperature and the quantity of pulses, and the Penne's Bioheat equation for temperature variations. In the experiments, a vegetable tissue model (potato slice) is used for measuring electric currents and tissue electropermeabilized area in different EP protocols. Experimental measurements show that, during sequential pulses and keeping constant the applied voltage, the electric current density and the blackened (electropermeabilized) area increase. This behavior can only be attributed to a rise in the electric conductivity due to a higher number of pulses. Accordingly, we present a theoretical modeling of an EP protocol that predicts correctly the increment in the electric current density observed experimentally during the addition of pulses. The model also demonstrates that the electric current increase is due to a rise in the electric conductivity, in turn induced by temperature and pulse number, with no significant changes in the electric field distribution. The EP model introduced, based on a novel formulation of the electric conductivity, leads to a more realistic description of the EP phenomenon, hopefully providing more accurate predictions of treatment outcomes.	[Suarez, Cecilia; Maglietti, Felipe; Olaiz, Nahuel; Marshall, Guillermo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Sistemas Complejos, Dept Comp, Buenos Aires, DF, Argentina; [Soba, Alejandro] Consejo Nacl Invest Cient & Tecn, Ctr Simulac Computac, RA-1033 Buenos Aires, DF, Argentina; [Soba, Alejandro] Comis Nacl Energia Atom, RA-1429 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Marshall, G (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Sistemas Complejos, Dept Comp, Buenos Aires, DF, Argentina.	marshall.guillermo@gmail.com	, Cecilia/I-5244-2016	, Cecilia/0000-0003-0134-8618; Maglietti, Felipe Horacio/0000-0002-0860-6854	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICET (PIP); Universidad de Buenos Aires (UBACyT); International European Cooperation in Science and Technology (COST Action) [TD1104T]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); International European Cooperation in Science and Technology (COST Action)	F. Maglietti has a fellowship from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). C. Suarez, A. Soba, N. Olaiz and G. Marshall are researchers at CONICET. This work was supported by grants from CONICET (PIP 2012), Universidad de Buenos Aires (UBACyT 2011) and the International European Cooperation in Science and Technology ( COST Action TD1104T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena CB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-102; Ben Ammar J, 2011, J FOOD SCI, V76, pE90, DOI 10.1111/j.1750-3841.2010.01893.x; Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; CRIDDLE RS, 1988, PLANT CELL ENVIRON, V11, P695, DOI 10.1111/j.1365-3040.1988.tb01152.x; Escoffre JM, 2009, MOL BIOTECHNOL, V41, P286, DOI 10.1007/s12033-008-9121-0; Galindo FG, 2009, PLANTA, V230, P469, DOI 10.1007/s00425-009-0950-2; Garcia PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103083; Garcia PA, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-34; Gehl J, 1999, BIOCHEM BIOPH RES CO, V261, P377, DOI 10.1006/bbrc.1999.1014; Hjouj M, 2010, J MEMBRANE BIOL, V236, P137, DOI 10.1007/s00232-010-9281-2; Ivorra A, 2009, IFMBE PROC, V25, P59, DOI 10.1007/978-3-642-03895-2_18; Ivorra A, 2010, PHYS CHEM CHEM PHYS, V12, P10055, DOI 10.1039/c004419a; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; Knorr D, 2002, P NUTR SOC, V61, P311, DOI 10.1079/PNS2002162; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Kotnik T, 2005, MED RAZGL, V44, P81; Kranjc M, 2014, PHYSIOL MEAS, V35, P985, DOI 10.1088/0967-3334/35/6/985; Kranjc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045737; Lackovic I, 2009, IEEE T DIELECT EL IN, V16, P1338, DOI 10.1109/TDEI.2009.5293947; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Mezeme ME, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3700727; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005; Mir LM, 2009, MOL BIOTECHNOL, V43, P167, DOI 10.1007/s12033-009-9192-6; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Neal RE, 2012, IEEE T BIO-MED ENG, V59, P1076, DOI 10.1109/TBME.2012.2182994; Neal RE, 2011, IEEE ENG MED BIO, P5581, DOI 10.1109/IEMBS.2011.6091350; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Pavliha D, 2013, J MEMBRANE BIOL, V246, P833, DOI 10.1007/s00232-013-9567-2; Pavlin M, 2007, BBA-GEN SUBJECTS, V1770, P12, DOI 10.1016/j.bbagen.2006.06.014; Poyatos JM, 2011, WATER ENVIRON RES, V83, P233, DOI 10.2175/106143010X12780288628570; Pucihar G, 2002, BIOELECTROCHEMISTRY, V57, P167, DOI 10.1016/S1567-5394(02)00116-0; Rajkovic A, 2010, INT J FOOD MICROBIOL, V141, pS29, DOI 10.1016/j.ijfoodmicro.2009.12.019; ROLS MP, 1989, EUR J BIOCHEM, V179, P109, DOI 10.1111/j.1432-1033.1989.tb14527.x; Sel D, 2005, IEEE T BIO-MED ENG, V52, P816, DOI 10.1109/TBME.2005.845212; Sersa G, 2010, J MEMBRANE BIOL, V236, P155, DOI 10.1007/s00232-010-9268-z; Sun X, 1994, J FOOD P ENG, V17, P423; Sundararajan Raji, 2008, V423, P109, DOI 10.1007/978-1-59745-194-9_7; Turjanski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017303; WANG N, 1995, J FOOD ENG, V24, P61, DOI 10.1016/0260-8774(94)P1608-Z; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zhu S, 2007, J FOOD SCI, V72, pE49, DOI 10.1111/j.1750-3841.2006.00243.x; Zupanic A, 2012, PHYS MED BIOL, V57, P5425, DOI 10.1088/0031-9155/57/17/5425	44	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113413	10.1371/journal.pone.0113413	http://dx.doi.org/10.1371/journal.pone.0113413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437512	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900043
J	Blythe, RA; Scott-Phillips, TC				Blythe, Richard A.; Scott-Phillips, Thomas C.			Simulating the Real Origins of Communication	PLOS ONE			English	Article								How communication systems emerge is a topic of relevance to several academic disciplines. Numerous existing models, both mathematical and computational, study this emergence. However, with few exceptions, these models all build some form of communication into their initial specification. Consequently, what these models study is how communication systems transition from one form to another, and not how communication itself emerges in the first place. Here we present a new computational model of the emergence of communication which, unlike previous models, does not pre-specify the existence of communication. We conduct two experiments using this model, in order to derive general statements about how communication systems emerge. The two main routes to communication that we identify correspond with findings from the empirical literature on the evolution of animal signals. We use this finding to explain when and why we should expect communication to emerge in nature. We also compare our model to experimental research on the origins of human communication systems, and hence show that humans are an important exception to the general trends we observe. We argue that this is because humans, and probably only humans, are able to 'signal signalhood', i.e. to express communicative intentions.	[Blythe, Richard A.] Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Scott-Phillips, Thomas C.] Univ Durham, Dept Anthropol, Durham, England	University of Edinburgh; Durham University	Scott-Phillips, TC (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	t.c.scott-phillips@durham.ac.uk	Blythe, Richard A/G-6273-2013	Blythe, Richard A/0000-0001-8160-5068	Research Councils UK; Economic and Social Research Council	Research Councils UK(UK Research & Innovation (UKRI)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by Research Councils UK (RB) and Economic and Social Research Council (TSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SPEAKING OUR MINDS; Arranz J, 2011, ADV ARTIFICIAL LIFE, P47; de Ruiter JP, 2010, INTERACT STUD, V11, P51, DOI 10.1075/is.11.1.05rui; Galantucci B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00011; Hauser, 1996, EVOL COMMUN; Kirby S, 2002, ARTIF LIFE, V8, P185, DOI 10.1162/106454602320184248; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Nolfi S, 2010, EVOLUTION OF COMMUNICATION AND LANGUAGE IN EMBODIED AGENTS, P1, DOI 10.1007/978-3-642-01250-1; Nowak MA, 2001, TRENDS COGN SCI, V5, P288, DOI 10.1016/S1364-6613(00)01683-1; Oliphant M, 1996, BIOSYSTEMS, V37, P31, DOI 10.1016/0303-2647(95)01543-4; Oller D. K., 2004, EVOLUTION COMMUNICAT; Quinn M, 2001, LECT NOTES ARTIF INT, V2159, P357; Scott-Phillips TC, 2014, CURR ANTHR IN PRESS; Scott-Phillips TC, 2012, P ROY SOC B-BIOL SCI, V279, P1943, DOI 10.1098/rspb.2011.2181; Scott-Phillips TC, 2010, TRENDS COGN SCI, V14, P411, DOI 10.1016/j.tics.2010.06.006; Scott-Phillips TC, 2009, COGNITION, V113, P226, DOI 10.1016/j.cognition.2009.08.009; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Skyrms B., 2010, SIGNALS EVOLUTION LE, DOI [DOI 10.1093/ACPROF:OSO/9780199580828.001.0001, 10.1093/acprof:oso/9780199580828.001.0001]; Sperber D, 2000, METAREPRESENTATIONS; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Steels L, 2011, PHYS LIFE REV, V8, P339, DOI 10.1016/j.plrev.2011.10.014; Stolk A, 2013, P NATL ACAD SCI USA, V110, P14574, DOI 10.1073/pnas.1303170110	22	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113636	10.1371/journal.pone.0113636	http://dx.doi.org/10.1371/journal.pone.0113636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426990	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000349145400070
J	Du, QX; Sun, YC; Ding, N; Lu, LJ; Chen, Y				Du, Qingxia; Sun, Yongchang; Ding, Ning; Lu, Lijin; Chen, Ying			Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; ELDERLY PATIENTS; CORONARY; THERAPY; ASTHMA; EPIDEMIOLOGY; ASSOCIATION; ACTIVATION	Background: Cardiovascular disease is a primary cause of death in patients with chronic obstructive pulmonary disease (COPD). Beta-blockers have been proved to reduce morbidity and improve survival in patients with cardiac diseases. But the effects of beta-blockers on outcomes in patients with COPD remain controversial. The objective of this meta-analysis was to assess the effect of beta-blockers on mortality and exacerbation in patients with COPD. Methods: An extensive search of the EMBASE, MEDLINE and Cochrane was performed to retrieve the studies of beta-blockers treatment in patients with COPD. The random effects model meta-analysis was used to evaluate effect on overall mortality and exacerbation of COPD. Results: Fifteen original observational cohort studies with a follow-up time from 1 to 7.2 years were included. The results revealed that beta-blockers treatment significantly decreased the risk of overall mortality and exacerbation of COPD. The relative risk (RR) for overall mortality was 0.72 (0.63 to 0.83), and for exacerbation of COPD was 0.63 (0.57 to 0.71). In subgroup analysis of COPD patients with coronary heart disease or heart failure, the risk for overall mortality was 0.64 (0.54-0.76) and 0.74 (0.58-0.93), respectively. Conclusion: The findings of this meta-analysis confirmed that beta-blocker use in patients with COPD may not only decrease the risk of overall mortality but also reduce the risk of exacerbation of COPD. Beta-blocker prescription for cardiovascular diseases needs to improve in COPD patients.	[Sun, Yongchang] Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China; Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing 100730, Peoples R China	Capital Medical University; Capital Medical University	Sun, YC (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China.	suny@ccmu.edu.cn			National Natural Science Foundation of China [81170039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Natural Science Foundation of China (81170039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas S, 2005, CHEST, V128, P3618, DOI 10.1378/chest.128.5.3618; Andrikopoulos G, 2012, HELL J CARDIOL, V53, P118; Angeloni E, 2012, ANN THORACIC SURG; Asano K, 1997, AVIAT SPACE ENVIR MD, V68, P104; Au DH, 2004, AM J MED, V117, P925, DOI 10.1016/j.amjmed.2004.07.043; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belli G, 1995, CONT INTERN MED, V7, P51; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Chen J, 2001, J AM COLL CARDIOL, V37, P1950, DOI 10.1016/S0735-1097(01)01225-6; Craig Timothy, 1996, Comprehensive Therapy, V22, P339; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Egred M, 2005, QJM-INT J MED, V98, P493, DOI 10.1093/qjmed/hci080; Ekstrom MP, 2013, AM J RESP CRIT CARE, V187, P715, DOI 10.1164/rccm.201208-1565OC; Etminan M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-48; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; Hawkins NM, 2009, EUR J HEART FAIL, V11, P292, DOI 10.1093/eurjhf/hfp001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Kendall MJ, 1997, AM J CARDIOL, V80, pJ15, DOI 10.1016/S0002-9149(97)00833-3; KULLER LH, 1989, AM REV RESPIR DIS, V140, pS76, DOI 10.1164/ajrccm/140.3_Pt_2.S76; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; Ling Y, 2008, EUR RESPIR J, V31, P905, DOI 10.1183/09031936.00153707; Mentz RJ, 2013, AM J CARDIOL, V111, P582, DOI 10.1016/j.amjcard.2012.10.041; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Olenchock BA, 2009, AM J CARDIOL, V103, P295, DOI 10.1016/j.amjcard.2008.09.081; OMALLEY K, 1991, AM J MED, V90, pS27, DOI 10.1016/0002-9343(91)90433-X; Palatini P, 1997, J HUM HYPERTENS, V11, pS19; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Staszewsky L, 2007, J CARD FAIL, V13, P797, DOI 10.1016/j.cardfail.2007.07.012; Stefan MS, 2012, THORAX, V67, P977, DOI 10.1136/thoraxjnl-2012-201945; Tatters field AE, 1986, J CARDIOVASC PHAR S4, pS35; TATTERSFIELD A E, 1991, Cardiovascular Drugs and Therapy, V4, P1229, DOI 10.1007/BF00114225; Tjugen TB, 2010, CURR HYPERTENS REP, V12, P162, DOI 10.1007/s11906-010-0104-8; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC	46	95	99	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113048	10.1371/journal.pone.0113048	http://dx.doi.org/10.1371/journal.pone.0113048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427000	gold, Green Submitted, Green Published			2022-12-27	WOS:000349145400029
J	Glushakov, AV; Fazal, JA; Narumiya, S; Dore, S				Glushakov, Alexander V.; Fazal, Jawad A.; Narumiya, Shuh; Dore, Sylvain			Role of the Prostaglandin E-2 EP1 Receptor in Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MODEL; CYCLOOXYGENASE-2; RAT; CONTRIBUTES; INHIBITION; ISCHEMIA; SEIZURES; EPILEPSY; DAMAGE	Brain injuries promote upregulation of so-called proinflammatory prostaglandins, notably prostaglandin E-2 (PGE(2)), leading to overactivation of a class of its cognate G-protein-coupled receptors, including EP1, which is considered a promising target for treatment of ischemic stroke. However, the role of the EP1 receptor is complex and depends on the type of brain injury. This study is focused on the investigation of the role of the EP1 receptor in a controlled cortical impact (CCI) model, a preclinical model of traumatic brain injury (TBI). The therapeutic effects of post-treatments with a widely studied EP1 receptor antagonist, SC-51089, were examined in wildtype and EP1 receptor knockout C57BL/6 mice. Neurological deficit scores (NDS) were assessed 24 and 48 h following CCI or sham surgery, and brain immunohistochemical pathology was assessed 48 h after surgery. In wildtype mice, CCI resulted in an obvious cortical lesion and localized hippocampal edema with an associated significant increase in NDS compared to sham-operated animals. Post-treatments with the selective EP1 receptor antagonist SC-51089 or genetic knockout of EP1 receptor had no significant effects on cortical lesions and hippocampal swelling or on the NDS 24 and 48 h after CCI. Immunohistochemistry studies revealed CCI-induced gliosis and microglial activation in selected ipsilateral brain regions that were not affected by SC-51089 or in the EP1 receptor-deleted mice. This study provides further clarification on the respective contribution of the EP1 receptor in TBI and suggests that, under this experimental paradigm, the EP1 receptor would have limited effects in modulating acute neurological and anatomical pathologies following contusive brain trauma. Findings from this protocol, in combination with previous studies demonstrating differential roles of EP1 receptor in ischemic, neurotoxic, and hemorrhagic conditions, provide scientific background and further clarification of potential therapeutic application of prospective prostaglandin G-protein-coupled receptor drugs in the clinic for treatment of TBI and other acute brain injuries.	[Glushakov, Alexander V.; Fazal, Jawad A.; Dore, Sylvain] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 606, Japan; [Dore, Sylvain] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Dore, Sylvain] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	State University System of Florida; University of Florida; Kyoto University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Glushakov, AV (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32611 USA.	glushav@ufl.edu; sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020; Glushakov, Alexander V/B-5452-2008	Dore, Sylvain/0000-0003-3771-5109; Glushakov, Alexander V/0000-0003-2872-8960	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of Health [NS046400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046400] Funding Source: NIH RePORTER	McKnight Brain Research Foundation; Brain and Spinal Cord Injury Research Trust Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund (http://mbi.ufl.edu/2011/06/13/brain-and-spinal-cord-injury-research-trust-fund-bscirtf-awards/) (AVG, SD) and a grant from the National Institutes of Health NS046400 (http://www.nih.gov/) (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad Muzamil, 2010, Exp Transl Stroke Med, V2, P12, DOI 10.1186/2040-7378-2-12; Anglada-Huguet M, 2014, MOL NEUROBIOL, V49, P784, DOI 10.1007/s12035-013-8556-x; Audoly LP, 1999, AM J PHYSIOL-HEART C, V277, pH924, DOI 10.1152/ajpheart.1999.277.3.H924; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doi T, 2001, MOL BRAIN RES, V92, P107, DOI 10.1016/S0169-328X(01)00159-0; Dore S, 2006, TRENDS PHARMACOL SCI, V27, P458, DOI 10.1016/j.tips.2006.07.001; Fischborn SV, 2010, EPILEPSY RES, V91, P57, DOI 10.1016/j.eplepsyres.2010.06.012; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Govoni S, 2001, NEUROSCI LETT, V303, P91, DOI 10.1016/S0304-3940(01)01675-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Homayoun P, 1997, J NEUROCHEM, V69, P199; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kang YJ, 2008, KOREAN J PHYSIOL PHA, V12, P275, DOI 10.4196/kjpp.2008.12.5.275; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P277, DOI 10.1007/978-3-7091-0693-8_46; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Kinirons P, 2006, SEIZURE-EUR J EPILEP, V15, P387, DOI 10.1016/j.seizure.2006.05.001; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McIntosh TK, 1996, LAB INVEST, V74, P315; Michelucci R, 2006, NEUROLOGY, V67, pS14, DOI 10.1212/WNL.67.12_suppl_4.S14; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Mohan Shekher, 2012, Front Neurol, V3, P145, DOI 10.3389/fneur.2012.00145; Oliveira MS, 2008, NEUROSCIENCE, V152, P1110, DOI 10.1016/j.neuroscience.2008.01.005; Pagni CA, 2005, ACT NEUR S, V93, P27; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; Saleem S, 2009, NEUROTOX RES, V15, P62, DOI 10.1007/s12640-009-9007-3; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WILLMORE LJ, 1991, INT J DEV NEUROSCI, V9, P175, DOI 10.1016/0736-5748(91)90009-B; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	65	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113689	10.1371/journal.pone.0113689	http://dx.doi.org/10.1371/journal.pone.0113689			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426930	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400078
J	Gomez, G; Lopez, PH; Link, D; Eskofier, B				Gomez, Gabriel; Herrera Lopez, Patricia; Link, Daniel; Eskofier, Bjoern			Tracking of Ball and Players in Beach Volleyball Videos	PLOS ONE			English	Article								This paper presents methods for the determination of players' positions and contact time points by tracking the players and the ball in beach volleyball videos. Two player tracking methods are compared, a classical particle filter and a rigid grid integral histogram tracker. Due to mutual occlusion of the players and the camera perspective, results are best for the front players, with 74,6% and 82,6% of correctly tracked frames for the particle method and the integral histogram method, respectively. Results suggest an improved robustness against player confusion between different particle sets when tracking with a rigid grid approach. Faster processing and less player confusions make this method superior to the classical particle filter. Two different ball tracking methods are used that detect ball candidates from movement difference images using a background subtraction algorithm. Ball trajectories are estimated and interpolated from parabolic flight equations. The tracking accuracy of the ball is 54,2% for the trajectory growth method and 42,1% for the Hough line detection method. Tracking results of over 90% from the literature could not be confirmed. Ball contact frames were estimated from parabolic trajectory intersection, resulting in 48,9% of correctly estimated ball contact points.	[Gomez, Gabriel; Eskofier, Bjoern] Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Herrera Lopez, Patricia] Univ Politecn Madrid, Dept Ingn Telecomunicac, Madrid, Spain; [Link, Daniel] Tech Univ Munich, Dept Training Sci & Sport Informat, D-80290 Munich, Germany	University of Erlangen Nuremberg; Universidad Politecnica de Madrid; Technical University of Munich	Gomez, G (corresponding author), Univ Erlangen Nurnberg, Digital Sports Grp, Pattern Recognit Lab, D-91054 Erlangen, Germany.	gabriel.gomez@cs.fau.de	Eskofier, Bjoern/ABF-1284-2021; López, Pablo/GXA-3179-2022	Eskofier, Bjoern/0000-0002-0417-0336; Link, Daniel/0000-0003-3606-2986	Bundesinstitut fur Sportwissenschaft, BISp	Bundesinstitut fur Sportwissenschaft, BISp	Funding: GG was funded by the Bundesinstitut fur Sportwissenschaft, BISp (www.bisp.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron JL, 2005, 2004012 U MANCH MED; Chen HT, 2007, INT CONF ACOUST SPEE, P1097; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Gao Y, 2014, IEEE T CIRC SYST VID, V24, P1122, DOI 10.1109/TCSVT.2014.2302366; Gomez G, 2012, SEMIAUTOMATIC TRACKI, P22; Grauman K., 2011, SYNTH LECT ARTIF INT, V5, P1, DOI [10. 2200/S00332ED1V01Y201103AIM011, 10.2200/S00332ED1V01Y201103AIM011, DOI 10.2200/S00332ED1V01Y201103AIM011]; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kristan M, 2009, COMPUT VIS IMAGE UND, V113, P598, DOI 10.1016/j.cviu.2008.01.009; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Mauthner T, 2007, INT J COMPUTER SCI S, V6, P21; Perez P, 2002, LECT NOTES COMPUT SC, V2350, P661; Porikli F, 2005, PROC CVPR IEEE, P829, DOI 10.1109/CVPR.2005.188; Sonka M., 1993, IMAGE PROCESSING ANA, P193; Thrun S, 2012, UD LECT ART INT; Vermaak J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1110; Welch G., 2001, P SIGGRAPH; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Zhao T., 2004, COMPUTER VISION PATT, V2, P406; Zivkovic Z, 2006, PATTERN RECOGN LETT, V27, P773, DOI 10.1016/j.patrec.2005.11.005	21	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111730	10.1371/journal.pone.0111730	http://dx.doi.org/10.1371/journal.pone.0111730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426936	Green Published, gold			2022-12-27	WOS:000349145400006
J	Jaffe, K				Jaffe, Klaus			Social and Natural Sciences Differ in Their Research Strategies, Adapted to Work for Different Knowledge Landscapes	PLOS ONE			English	Article							ACTIVE WALKS; RECRUITMENT	Do different fields of knowledge require different research strategies? A numerical model exploring different virtual knowledge landscapes, revealed two diverging optimal search strategies. Trend following is maximized when the popularity of new discoveries determine the number of individuals researching it. This strategy works best when many researchers explore few large areas of knowledge. In contrast, individuals or small groups of researchers are better in discovering small bits of information in dispersed knowledge landscapes. Bibliometric data of scientific publications showed a continuous bipolar distribution of these strategies, ranging from natural sciences, with highly cited publications in journals containing a large number of articles, to the social sciences, with rarely cited publications in many journals containing a small number of articles. The natural sciences seem to adapt their research strategies to landscapes with large concentrated knowledge clusters, whereas social sciences seem to have adapted to search in landscapes with many small isolated knowledge clusters. Similar bipolar distributions were obtained when comparing levels of insularity estimated by indicators of international collaboration and levels of country-self citations: researchers in academic areas with many journals such as social sciences, arts and humanities, were the most isolated, and that was true in different regions of the world. The work shows that quantitative measures estimating differences between academic disciplines improve our understanding of different research strategies, eventually helping interdisciplinary research and may be also help improve science policies worldwide.	Univ Simon Bolivar, Dept Biol Organismos, Caracas, Estado Miranda, Venezuela		Jaffe, K (corresponding author), Univ Simon Bolivar, Dept Biol Organismos, Caracas, Estado Miranda, Venezuela.	kjaffe@usb.ve						Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Fanelli D, 2010, PLOS ONE; Fanelli D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066938; Filipi NS, 2012, ARXIV12034807V1; Hayek FA, 1952, STUDIES ABUSE REASON; JAFFE K, 1980, J THEOR BIOL, V84, P589, DOI 10.1016/S0022-5193(80)80022-1; JAFFE K, 1992, INSECT SOC, V39, P201, DOI 10.1007/BF01249295; Jaffe K, 2014, ARXIV14035107; Jaffe K, 2010, WHAT IS SCI INTERDIS; Jaffe Klaus, 2011, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/694910; Jaffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066239; Jaffe K, 2013, INTERCIENCIA, V38, P150; Jaffe K, 2011, INTERCIENCIA, V36, P694; Jaffe K, 2010, INTERCIENCIA, V35, P545; Lam L, 2006, INT J BIFURCAT CHAOS, V16, P239, DOI 10.1142/S0218127406014782; Lam L, 2005, INT J BIFURCAT CHAOS, V15, P2317, DOI 10.1142/S0218127405013344; Lam L, 2014, ALL SCI PHILOS HIST; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; Sarigol E, 2014, ARXIV14027268V1; SCImago, 2007, SJR SCIMAGO J COUNTR	20	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113901	10.1371/journal.pone.0113901	http://dx.doi.org/10.1371/journal.pone.0113901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426723	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400098
J	Werner, S; Rink, JC; Riedel-Kruse, IH; Friedrich, BM				Werner, Steffen; Rink, Jochen C.; Riedel-Kruse, Ingmar H.; Friedrich, Benjamin M.			Shape Mode Analysis Exposes Movement Patterns in Biology: Flagella and Flatworms as Case Studies	PLOS ONE			English	Article							PLANARIAN; REGENERATION; LOCOMOTION; PROPULSION; SYSTEM	We illustrate shape mode analysis as a simple, yet powerful technique to concisely describe complex biological shapes and their dynamics. We characterize undulatory bending waves of beating flagella and reconstruct a limit cycle of flagellar oscillations, paying particular attention to the periodicity of angular data. As a second example, we analyze non-convex boundary outlines of gliding flatworms, which allows us to expose stereotypic body postures that can be related to two different locomotion mechanisms. Further, shape mode analysis based on principal component analysis allows to discriminate different flatworm species, despite large motion-associated shape variability. Thus, complex shape dynamics is characterized by a small number of shape scores that change in time. We present this method using descriptive examples, explaining abstract mathematics in a graphic way.	[Werner, Steffen; Friedrich, Benjamin M.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Rink, Jochen C.] Max Planck Inst Cell Biol & Genet, Dresden, Germany; [Riedel-Kruse, Ingmar H.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Max Planck Society; Max Planck Society; Stanford University	Friedrich, BM (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	benjamin.friedrich@pks.mpg.de	Friedrich, Benjamin/B-2755-2017; Friedrich, Benjamin M/AAC-8204-2020	Friedrich, Benjamin/0000-0002-9742-6555; Friedrich, Benjamin M/0000-0002-9742-6555; Riedel-Kruse, Ingmar/0000-0002-6068-5561; Werner, Steffen/0000-0002-8764-1366	BMBF [031 A 099]	BMBF(Federal Ministry of Education & Research (BMBF))	Funding: SW and BMF received funding from the BMBF grant 031 A 099 (http://www.bmbf.de/en/1398.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarez L, 2014, TRENDS CELL BIOL, V24, P198, DOI 10.1016/j.tcb.2013.10.004; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; BENAZZI M, 1972, CARYOLOGIA, V25, P59, DOI 10.1080/00087114.1972.10796465; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Driscoll MK, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055001; Friedrich BM, 2010, J EXP BIOL, V213, P1226, DOI 10.1242/jeb.039800; Gallagher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059865; Geyer VF, 2013, P NATL ACAD SCI USA, V110, P18058, DOI 10.1073/pnas.1300895110; GRAY J, 1955, J EXP BIOL, V32, P802; Howard J, 2001, MECH MOTOR PROTEINS; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Jackson J. E., 1991, USERS GUIDE PRINCIPA; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kralemann B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066205; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Liu SY, 2013, NATURE, V500, P81, DOI 10.1038/nature12414; Ma R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.048101; MATLAB, 2013, VERS 8 2 0 701 R2013; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Peters J, 2017, ADAPT COMPUT MACH LE; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Raviv TR, 2010, LECT NOTES COMPUT SC, V6363, P634; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; SANDERSON MJ, 1981, J CELL SCI, V47, P331; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; SHAPERE A, 1987, PHYS REV LETT, V58, P2051, DOI 10.1103/PhysRevLett.58.2051; Shomrat T, 2013, J EXP BIOL, V216, P3799, DOI 10.1242/jeb.087809; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stephens GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013914; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Wan KY, 2014, STABILITY EUKARYOTIC, P5; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001	43	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113083	10.1371/journal.pone.0113083	http://dx.doi.org/10.1371/journal.pone.0113083			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426857	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400033
J	Almajhdi, FN; Senger, T; Amer, HM; Gissmann, L; Ohlschlager, P				Almajhdi, Fahad N.; Senger, Tilo; Amer, Haitham M.; Gissmann, Lutz; Oehlschlaeger, Peter			Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; T-CELLS; GRADE 3; PROTEIN; TUMOR; E6; IMMUNOGENICITY; IMMUNOTHERAPY; PREVALENCE; PARTICLES	Persistent infection with the high-risk Human Papillomavirus type 16 (HPV 16) is the causative event for the development of cervical cancer and other malignant tumors of the anogenital tract and of the head and neck. Despite many attempts to develop therapeutic vaccines no candidate has entered late clinical trials. An interesting approach is a DNA based vaccine encompassing the nucleotide sequence of the E6 and E7 viral oncoproteins. Because both proteins are consistently expressed in HPV infected cells they represent excellent targets for immune therapy. Here we report the development of 8 DNA vaccine candidates consisting of differently rearranged HPV-16 E6 and E7 sequences within one molecule providing all naturally occurring epitopes but supposedly lacking transforming activity. The HPV sequences were fused to the J-domain and the SV40 enhancer in order to increase immune responses. We demonstrate that one out of the 8 vaccine candidates induces very strong cellular E6- and E7-specific cellular immune responses in mice and, as shown in regression experiments, efficiently controls growth of HPV 16 positive syngeneic tumors. This data demonstrates the potential of this vaccine candidate to control persistent HPV 16 infection that may lead to malignant disease. It also suggests that different sequence rearrangements influence the immunogenecity by an as yet unknown mechanism.	[Almajhdi, Fahad N.; Amer, Haitham M.; Gissmann, Lutz] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Senger, Tilo; Gissmann, Lutz] German Canc Res Ctr, Heidelberg, Germany; [Amer, Haitham M.] Cairo Univ, Dept Virol, Fac Vet Med, Giza, Egypt; [Oehlschlaeger, Peter] Aachen Univ Appl Sci, Dept Chem & Biotechnol, Julich, Germany	King Saud University; Helmholtz Association; German Cancer Research Center (DKFZ); Egyptian Knowledge Bank (EKB); Cairo University	Almajhdi, FN (corresponding author), King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.	majhdi@ksu.edu.sa	Almajhdi, Fahad/AAM-4403-2020	Almajhdi, Fahad/0000-0002-0135-7015	Distinguished Scientist Fellowship Program	Distinguished Scientist Fellowship Program	This work was supported by Distinguished Scientist Fellowship Program (no specific grant number, http://dsfp.ksu.edu.sa/content/research-projects). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cassetti MC, 2004, VACCINE, V22, P520, DOI 10.1016/j.vaccine.2003.07.003; Chu NR, 2000, CLIN EXP IMMUNOL, V121, P216, DOI 10.1046/j.1365-2249.2000.01293.x; Daayana S, 2010, BRIT J CANCER, V102, P1129, DOI 10.1038/sj.bjc.6605611; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Henken FE, 2012, VACCINE, V30, P4259, DOI 10.1016/j.vaccine.2012.04.013; Hopfl R, 2000, LANCET, V356, P1985, DOI 10.1016/S0140-6736(00)03315-8; Jochmus I, 1999, ARCH MED RES, V30, P269, DOI 10.1016/S0188-0128(99)00026-3; Kammerer R, 2002, J IMMUNOL, V168, P108, DOI 10.4049/jimmunol.168.1.108; Kanodia S, 2008, INT J CANCER, V122, P247, DOI 10.1002/ijc.23252; Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li S, 2001, GENE THER, V8, P494, DOI 10.1038/sj.gt.3301419; Lin K, 2010, IMMUNOL RES, V47, P86, DOI 10.1007/s12026-009-8141-6; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; MCLEAN CS, 1990, J CLIN PATHOL, V43, P488, DOI 10.1136/jcp.43.6.488; Michel N, 2002, VIROLOGY, V294, P47, DOI 10.1006/viro.2001.1321; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Nieto K, 2010, ANTIVIR THER, V15, P951, DOI 10.3851/IMP1665; Ohlschlager P, 2011, INT J CANCER, V128, P473, DOI 10.1002/ijc.25344; Ohlschlager P, 2006, VACCINE, V24, P2880, DOI 10.1016/j.vaccine.2005.12.061; Oosterhuis K, 2011, INT J CANCER, V129, P397, DOI 10.1002/ijc.25894; Osen W, 2001, VACCINE, V19, P4276, DOI 10.1016/S0264-410X(01)00154-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PATEL D, 1989, J GEN VIROL, V70, P69, DOI 10.1099/0022-1317-70-1-69; Polakova I, 2010, VACCINE, V28, P1506, DOI 10.1016/j.vaccine.2009.11.069; Schirmbeck R, 2002, FASEB J, V16, P1108, DOI 10.1096/fj.01-0993fje; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Shi W, 1999, J VIROL, V73, P7877, DOI 10.1128/JVI.73.9.7877-7881.1999; Stern PL, 2005, J CLIN VIROL, V32, pS72, DOI 10.1016/j.jcv.2004.12.005; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; van Driel WJ, 1999, EUR J CANCER, V35, P946, DOI 10.1016/S0959-8049(99)00048-9; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WILDEMAN AG, 1988, BIOCHEM CELL BIOL, V66, P567, DOI 10.1139/o88-067; Williams SG, 1998, NUCLEIC ACIDS RES, V26, P2120, DOI 10.1093/nar/26.9.2120; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025	47	13	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113461	10.1371/journal.pone.0113461	http://dx.doi.org/10.1371/journal.pone.0113461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422946	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700036
J	Chouvenc, T; Basille, M; Li, HF; Su, NY				Chouvenc, Thomas; Basille, Mathieu; Li, Hou-Feng; Su, Nan-Yao			Developmental Instability in Incipient Colonies of Social Insects	PLOS ONE			English	Article							SUBTERRANEAN TERMITE ISOPTERA; COPTOTERMES-FORMOSANUS; FLUCTUATING ASYMMETRY; INVASIVE TERMITES; APIS-MELLIFERA; HONEY-BEE; RHINOTERMITIDAE; POPULATION; BIOLOGY; HETEROZYGOSITY	Social insect colonies can provide homeostatic conditions that buffer the incidence of environmental fluctuations on individuals, which have contributed to their ecological success. Coptotermes (Isoptera: Rhinotermitidae) is a highly invasive termite genus and several species have important economic impact in many areas of the world. Mature Coptotermes colonies with millions of individuals can provide optimal environmental condition and nurturing capacity for the developing brood. However, it was previously suggested that contrary to mature colonies, incipient colonies may be exposed to critical stress, which may explain for the low success rate of establishment within the first year of the life of a termite colony. We here investigated the stress imposed on individuals of incipient colonies by comparing the developmental instability of individuals between incipient and mature colonies of two Coptotermes species, C. formosanus Shiraki and C. gestroi (Wasmann). We assessed the developmental instability by measuring the asymmetry of morphological traits from the head capsule of the soldier caste. Soldiers from incipient colonies of both species displayed strong asymmetrical traits in comparison to soldiers from mature colonies. We suggest that homeostatic conditions for optimal development are reached as the colony matures, and confirmed that the incipient colony remains a critical bottleneck where individuals are exposed to high developmental stress.	[Chouvenc, Thomas; Su, Nan-Yao] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA; [Basille, Mathieu] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Wildlife Ecol & Conservat, Ft Lauderdale, FL 33314 USA; [Li, Hou-Feng] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Chung Hsing University	Chouvenc, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA.	tomchouv@ufl.edu	Basille, Mathieu/A-6133-2017; su, nan/GRS-5213-2022	Basille, Mathieu/0000-0001-9366-7127; Li, Hou-Feng/0000-0002-9444-8716				[Anonymous], 2014, R LANG ENV STAT COMP; BRUCKNER D, 1976, EVOLUTION, V30, P100, DOI [10.2307/2407677, 10.1111/j.1558-5646.1976.tb00886.x]; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chouvenc T, 2015, INSECT SOC, V62, P23, DOI 10.1007/s00040-014-0369-z; Chouvenc T, 2014, INSECT SOC, V61, P171, DOI 10.1007/s00040-014-0343-9; CLARKE GM, 1992, EVOLUTION, V46, P753, DOI [10.2307/2409643, 10.1111/j.1558-5646.1992.tb02081.x]; Costa-Leonardo AM, 2001, SOCIOBIOLOGY, V37, P551; Crespi BJ, 1997, HEREDITY, V79, P624, DOI 10.1038/hdy.1997.208; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; Evans TA, 2013, ANNU REV ENTOMOL, V58, P455, DOI 10.1146/annurev-ento-120811-153554; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; GRAHAM JH, 1993, AM SOC TEST MATER, V1179, P136, DOI 10.1520/STP19239S; GRASSE PP, 1947, CR HEBD ACAD SCI, V224, P219; Grasse PP, 1982, TERMITOLOGIA, V1; HAVERTY M I, 1977, Sociobiology, V2, P199; HAVERTY MI, 1979, INSECT SOC, V26, P69, DOI 10.1007/BF02283914; HIGA S Y, 1983, Proceedings of the Hawaiian Entomological Society, V24, P233; Higa SY, 1981, THESIS U HAWAII HONO; Hochmair HH, 2010, J ECON ENTOMOL, V103, P1338, DOI 10.1603/EC09428; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Jones DT, 2005, METH ECOL, P221, DOI 10.1002/9780470750513.ch10; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; KING EG, 1969, ANN ENTOMOL SOC AM, V62, P536, DOI 10.1093/aesa/62.3.536; Korb J, 2003, INSECT SOC, V50, P299, DOI 10.1007/s00040-003-0674-4; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Korb J, 2009, EVOL DEV, V11, P269, DOI 10.1111/j.1525-142X.2009.00329.x; LEAMY L, 1984, AM NAT, V123, P579, DOI 10.1086/284225; Lee CY, 2007, SOCIOBIOLOGY, V50, P213; Li Hou-Feng, 2010, American Entomologist, V56, P222; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P684, DOI 10.1603/008.102.0413; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P333, DOI 10.1603/008.102.0216; Light SF, 1943, Q REV BIOL, V18, P46, DOI 10.1086/394668; Lowe S, 2000, 100 WORLDS WORST INV, P12; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Miura T, 2005, EVOL DEV, V7, P122, DOI 10.1111/j.1525-142X.2005.05014.x; Moller AP, 1997, ASYMMETRY DEV STABIL; NOIROT C, 1985, CASTE DIFFERENTIATIO, P00041; Nutting W. L., 1969, P233; Oster G.F., 1978, Monographs in Population Biology, pi; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; PRESTWICH GD, 1979, J CHEM ECOL, V5, P459, DOI 10.1007/BF00987930; Rabitsch WB, 1997, ENVIRON TOXICOL CHEM, V16, P1433, DOI [10.1897/1551-5028(1997)016&lt;1433:LOAIFP&gt;2.3.CO;2, 10.1002/etc.5620160716]; ROSS KG, 1990, HEREDITY, V64, P93, DOI 10.1038/hdy.1990.12; Rust MK, 2012, ANNU REV ENTOMOL, V57, P355, DOI 10.1146/annurev-ento-120710-100634; SCHEFFRAHN RH, 1990, FLA ENTOMOL, V73, P622, DOI 10.2307/3495276; Scheffrahn RH, 2005, FLA ENTOMOL, V88, P201, DOI 10.1653/0015-4040(2005)088[0201:DOTTGC]2.0.CO;2; Scheffrahn RH, 2013, FLA ENTOMOL, V96, P781, DOI 10.1653/024.096.0311; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; SU NY, 1988, SOCIOBIOLOGY, V14, P353; Su NY, 1997, FLA ENTOMOL, V80, P408, DOI 10.2307/3495774; TSCHINKEL WR, 1992, ECOL ENTOMOL, V17, P179, DOI 10.1111/j.1365-2311.1992.tb01176.x; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Vargo EL, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P321, DOI 10.1007/978-90-481-3977-4_12; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Wasmann E, 1896, ANN MUSEO CIVICO STO, V16, P613; WOOD TG, 1988, BIOL FERT SOILS, V6, P228, DOI 10.1007/BF00260819; Woodrow RJ, 2001, SOCIOBIOLOGY, V38, P667; Xing L, 2013, ANN ENTOMOL SOC AM, V106, P619, DOI 10.1603/AN13007; Yang Rou-Ling, 2012, Formosan Entomologist, V32, P169	65	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113949	10.1371/journal.pone.0113949	http://dx.doi.org/10.1371/journal.pone.0113949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423502	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700081
J	Kovacova, V; Zluvova, J; Janousek, B; Talianova, M; Vyskot, B				Kovacova, Viera; Zluvova, Jitka; Janousek, Bohuslav; Talianova, Martina; Vyskot, Boris			The Evolutionary Fate of the Horizontally Transferred Agrobacterial Mikimopine Synthase Gene in the Genera Nicotiana and Linaria	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; SEQUENCE ALIGNMENT; PLANTS; GENOME; RHIZOGENES; TOBACCO; OPINES; SUPPRESSION; POPULATIONS; MECHANISMS	Few cases of spontaneously horizontally transferred bacterial genes into plant genomes have been described to date. The occurrence of horizontally transferred genes from the T-DNA of Agrobacterium rhizogenes into the plant genome has been reported in the genus Nicotiana and in the species Linaria vulgaris. Here we compare patterns of evolution in one of these genes (a gene encoding mikimopine synthase, mis) following three different events of horizontal gene transfer (HGT). As this gene plays an important role in Agrobacterium, and there are known cases showing that genes from pathogens can acquire plant protection function, we hypothesised that in at least some of the studied species we will find signs of selective pressures influencing mis sequence. The mikimopine synthase (mis) gene evolved in a different manner in the branch leading to Nicotiana tabacum and N. tomentosiformis, in the branch leading to N. glauca and in the genus Linaria. Our analyses of the genus Linaria suggest that the mis gene began to degenerate soon after the HGT. In contrast, in the case of N. glauca, the mis gene evolved under significant selective pressures. This suggests a possible role of mikimopine synthase in current N. glauca and its ancestor(s). In N. tabacum and N. tomentosiformis, the mis gene has a common frameshift mutation that disrupted its open reading frame. Interestingly, our results suggest that in spite of the frameshift, the mis gene could evolve under selective pressures. This sequence may still have some regulatory role at the RNA level as suggested by coverage of this sequence by small RNAs in N. tabacum.	[Kovacova, Viera; Zluvova, Jitka; Janousek, Bohuslav; Talianova, Martina; Vyskot, Boris] Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Janousek, B (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Plant Dev Genet, Vvi, Kralovopolska 135, CS-61265 Brno, Czech Republic.	janousek@ibp.cz	Janousek, Bohuslav/ABG-1000-2021; Kovacova, Viera/AAY-3676-2021	Janousek, Bohuslav/0000-0003-1789-8008; Kovacova, Viera/0000-0003-4581-4254	Czech Science Foundation [P501/12/G090]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Science Foundation (URL: http://www.gacr.cz/en/) grant no. P501/12/G090 to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bulgakov VP, 2008, MOL PLANT MICROBE IN, V21, P1561, DOI 10.1094/MPMI-21-12-1561; Chen L-H, 1995, PLANT TISSUE CULT LE, V12, P94; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Daimon H, 1984, PLANT TISSUE CULT LE, V7, P31; Danchin Etienne G J, 2011, Mob Genet Elements, V1, P269; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Escobar MA, 2001, P NATL ACAD SCI USA, V98, P13437, DOI 10.1073/pnas.241276898; Fernandez-Mazuecos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022234; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUYON P, 1993, MOL PLANT MICROBE IN, V6, P92, DOI 10.1094/MPMI-6-092; Juhas M, 2013, CRIT REV MICROBIOL; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kovarik A., 2012, POLYPLOIDY GENOME EV; Krimi Z, 2002, APPL ENVIRON MICROB, V68, P3358, DOI 10.1128/AEM.68.7.3358-3365.2002; Kubat Z, 2014, NEW PHYTOL, V202, P662, DOI 10.1111/nph.12669; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Matveeva TV, 2012, MOL PLANT MICROBE IN, V25, P1542, DOI 10.1094/MPMI-07-12-0169-R; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Mohajjel-Shoja H, 2011, MOL PLANT MICROBE IN, V24, P44, DOI 10.1094/MPMI-06-10-0139; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Oger P, 1997, NAT BIOTECHNOL, V15, P369, DOI 10.1038/nbt0497-369; Palmieri N, 2014, ELIFE, V3, DOI 10.7554/eLife.01311; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; Pelaez P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00343; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2012, FIGTREE V1 4 0; Rambaut A, 2013, TRACER V1 5; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ros VID, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-20; SAUERWEIN M, 1993, J PLANT PHYSIOL, V142, P446, DOI 10.1016/S0176-1617(11)81250-2; Savka MA, 1997, NAT BIOTECHNOL, V15, P363, DOI 10.1038/nbt0497-363; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sierro N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r60; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; Subramoni S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00322; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki K, 2002, PLANT J, V32, P775, DOI 10.1046/j.1365-313X.2002.01468.x; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Talianova M, 2011, AM J BOT, V98, P1231, DOI 10.3732/ajb.1000370; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vogan AA, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-1; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YE D, 1990, SEX PLANT REPROD, V3, P179, DOI 10.1007/BF00205227; Yue JP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2148; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhaxybayeva O, 2011, CURR BIOL, V21, pR242, DOI 10.1016/j.cub.2011.01.045; Zwickl D. J, 2006, GENETIC ALGORITHM AP	81	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113872	10.1371/journal.pone.0113872	http://dx.doi.org/10.1371/journal.pone.0113872			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420106	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900076
J	Park, H; Lee, GR; Heo, L; Seok, C				Park, Hahnbeom; Lee, Gyu Rie; Heo, Lim; Seok, Chaok			Protein Loop Modeling Using a New Hybrid Energy Function and Its Application to Modeling in Inaccurate Structural Environments	PLOS ONE			English	Article							FORCE-FIELD; WEB SERVER; REFINEMENT; PREDICTION; FRAGMENT; DOCKING; ENERGETICS; SOLVATION; LANDSCAPE; MECHANICS	Protein loop modeling is a tool for predicting protein local structures of particular interest, providing opportunities for applications involving protein structure prediction and de novo protein design. Until recently, the majority of loop modeling methods have been developed and tested by reconstructing loops in frameworks of experimentally resolved structures. In many practical applications, however, the protein loops to be modeled are located in inaccurate structural environments. These include loops in model structures, low-resolution experimental structures, or experimental structures of different functional forms. Accordingly, discrepancies in the accuracy of the structural environment assumed in development of the method and that in practical applications present additional challenges to modern loop modeling methods. This study demonstrates a new strategy for employing a hybrid energy function combining physics-based and knowledge-based components to help tackle this challenge. The hybrid energy function is designed to combine the strengths of each energy component, simultaneously maintaining accurate loop structure prediction in a high-resolution framework structure and tolerating minor environmental errors in low-resolution structures. A loop modeling method based on global optimization of this new energy function is tested on loop targets situated in different levels of environmental errors, ranging from experimental structures to structures perturbed in backbone as well as side chains and template-based model structures. The new method performs comparably to force field-based approaches in loop reconstruction in crystal structures and better in loop prediction in inaccurate framework structures. This result suggests that higher-accuracy predictions would be possible for a broader range of applications. The web server for this method is available at http://galaxy.seoklab.org/loop with the PS2 option for the scoring function.	[Park, Hahnbeom; Lee, Gyu Rie; Heo, Lim; Seok, Chaok] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Seoul National University (SNU)	Seok, C (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	chaok@snu.ac.kr	Heo, Lim/AAB-9210-2022; Park, Hahnbeom/AAL-7208-2021	Heo, Lim/0000-0002-3153-2363; Park, Hahnbeom/0000-0002-7129-1912; Lee, Gyu Rie/0000-0002-9119-5303	National Research Foundation of Korea [NRF-2013R1A2A1A09012229, NRF2012M3C1A6035362]; Research Institute for Basic Sciences, Seoul National University [2013-IRP-01]; Korea Institute of Science and Technology Information supercomputing center [KSC-2013-C2-038]	National Research Foundation of Korea(National Research Foundation of Korea); Research Institute for Basic Sciences, Seoul National University; Korea Institute of Science and Technology Information supercomputing center	The work was supported by National Research Foundation of Korea (NRF-2013R1A2A1A09012229 and NRF2012M3C1A6035362, to CS, http://nrf.re.kr), Interdisciplinary Research Program from the Research Institute for Basic Sciences, Seoul National University (2013-IRP-01, to CS, http://science.snu.ac.kr/), and Korea Institute of Science and Technology Information supercomputing center (KSC-2013-C2-038, to CS, http://www.kisti.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Case DA, 2012, AMBER 12; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; de Bakker PIW, 2003, PROTEINS, V51, P21, DOI 10.1002/prot.10235; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Ding F, 2013, J CHEM INF MODEL, V53, P1871, DOI 10.1021/ci300478y; Ferrari AM, 2004, J MED CHEM, V47, P5076, DOI 10.1021/jm049756p; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gallicchio E, 2002, J COMPUT CHEM, V23, P517, DOI 10.1002/jcc.10045; Geney R, 2006, J CHEM THEORY COMPUT, V2, P115, DOI 10.1021/ct050183l; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Holtby D, 2013, J COMPUT BIOL, V20, P212, DOI 10.1089/cmb.2012.0078; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; 신웅희, 2014, Biodesign, V2, P1; Lee J, 1999, P NATL ACAD SCI USA, V96, P2025, DOI 10.1073/pnas.96.5.2025; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Liang SD, 2012, J CHEM THEORY COMPUT, V8, P1820, DOI 10.1021/ct300131p; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; MAS MT, 1992, PROTEINS, V14, P483, DOI 10.1002/prot.340140409; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Park H, 2012, PROTEINS, V80, P1974, DOI 10.1002/prot.24086; Park H, 2011, PROTEINS, V79, P2725, DOI 10.1002/prot.23101; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Ravagnani A, 1997, EMBO J, V16, P3974, DOI 10.1093/emboj/16.13.3974; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Subramani A, 2012, J PHYS CHEM B, V116, P6670, DOI 10.1021/jp2113957; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Zhou RH, 2002, P NATL ACAD SCI USA, V99, P12777, DOI 10.1073/pnas.142430099; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040	52	54	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113811	10.1371/journal.pone.0113811	http://dx.doi.org/10.1371/journal.pone.0113811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419655	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900071
J	Wang, JZ; Yi, YG; Zhou, W; Shi, YJ; Qi, M; Zhang, M; Zhang, BX; Kong, J				Wang, Jianzhong; Yi, Yugen; Zhou, Wei; Shi, Yanjiao; Qi, Miao; Zhang, Ming; Zhang, Baoxue; Kong, Jun			Locality Constrained Joint Dynamic Sparse Representation for Local Matching Based Face Recognition	PLOS ONE			English	Article							ILLUMINATION; GABOR	Recently, Sparse Representation-based Classification (SRC) has attracted a lot of attention for its applications to various tasks, especially in biometric techniques such as face recognition. However, factors such as lighting, expression, pose and disguise variations in face images will decrease the performances of SRC and most other face recognition techniques. In order to overcome these limitations, we propose a robust face recognition method named Locality Constrained Joint Dynamic Sparse Representation-based Classification (LCJDSRC) in this paper. In our method, a face image is first partitioned into several smaller sub-images. Then, these sub-images are sparsely represented using the proposed locality constrained joint dynamic sparse representation algorithm. Finally, the representation results for all sub-images are aggregated to obtain the final recognition result. Compared with other algorithms which process each sub-image of a face image independently, the proposed algorithm regards the local matching-based face recognition as a multi-task learning problem. Thus, the latent relationships among the sub-images from the same face image are taken into account. Meanwhile, the locality information of the data is also considered in our algorithm. We evaluate our algorithm by comparing it with other state-of-the-art approaches. Extensive experiments on four benchmark face databases (ORL, Extended YaleB, AR and LFW) demonstrate the effectiveness of LCJDSRC.	[Wang, Jianzhong; Yi, Yugen; Zhou, Wei; Qi, Miao; Kong, Jun] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China; [Yi, Yugen; Shi, Yanjiao; Zhang, Baoxue] NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China; [Wang, Jianzhong] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Zhou, Wei; Zhang, Ming; Kong, Jun] NE Normal Univ, Key Lab Intelligent Informat Proc Jilin Univ, Changchun, Peoples R China; [Zhang, Baoxue] Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Capital University of Economics & Business	Zhang, BX (corresponding author), NE Normal Univ, Sch Math & Stat, Changchun, Peoples R China.	bxzhang@nenu.edu.cn; kongjun@nenu.edu.cn	Zhang, Bao/B-3926-2012	Yi, Yugen/0000-0001-9828-0319; Yi, Yugen/0000-0002-1049-5022	Fund of Jilin Provincial Science & Technology Department [20130206042GX, 20111804]; Young scientific research fund of Jilin province science and technology development project [20130522115JH, 201201070, 201201063]; National Natural Science Foundation of China [11271064, 61403078]	Fund of Jilin Provincial Science & Technology Department; Young scientific research fund of Jilin province science and technology development project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Fund of Jilin Provincial Science & Technology Department (20130206042GX, 20111804), Young scientific research fund of Jilin province science and technology development project (No. 20130522115JH, 201201070, 201201063) and National Natural Science Foundation of China (No. 11271064, 61403078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao YW, 2011, IEEE IMAGE PROC, P761, DOI 10.1109/ICIP.2011.6116666; Chen SC, 2004, PATTERN RECOGN, V37, P1081, DOI 10.1016/j.patcog.2003.09.004; Chen Y, 2013, NEURAL PROCESS LETT, V37, P355, DOI 10.1007/s11063-012-9252-y; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Duarte MF, 2009, P ALL C COMM CONTR C, P585; Elhamifar E., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P1873, DOI 10.1109/CVPR.2011.5995664; Gao SH, 2010, LECT NOTES COMPUT SC, V6314, P1; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Huang G.B., 2007, LABELED FACE WILD DA; Jafri R, 2009, J INF PROCESS SYST, V5, P41, DOI 10.3745/JIPS.2009.5.2.041; Jain A.K., 2011, HDB FACE RECOGNITION, V1; Kumar KV, 2008, PATTERN RECOGN, V41, P1398, DOI 10.1016/j.patcog.2007.08.006; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Martinez A., 1998, AR FACE DATABASE CVC; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Nanni L, 2007, PATTERN RECOGN LETT, V28, P487, DOI 10.1016/j.patrec.2006.09.002; PENTLAND A, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P84, DOI 10.1109/CVPR.1994.323814; Ramirez I, 2010, TECHNICAL REPORT; Ramirez I, 2012, IEEE T SIGNAL PROCES, V60, P2913, DOI 10.1109/TSP.2012.2187203; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; Subban R., 2014, RECENT ADV INTELLIGE, P455; Tan KR, 2005, NEUROCOMPUTING, V64, P505, DOI 10.1016/j.neucom.2004.10.113; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tosic I, 2011, IEEE SIGNAL PROC MAG, V28, P27, DOI 10.1109/MSP.2010.939537; Wagner A, 2009, PROC CVPR IEEE, P597, DOI 10.1109/CVPRW.2009.5206654; Wang FAZ, 2010, J NETW COMPUT APPL, V33, P323, DOI 10.1016/j.jnca.2009.12.013; Wang JZ, 2011, PATTERN RECOGN LETT, V32, P494, DOI 10.1016/j.patrec.2010.11.014; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Wei CP, 2013, PATTERN RECOGN, V46, P1277, DOI 10.1016/j.patcog.2012.11.014; Wolf L., 2009, ASIAN C COMPUT VIS, V5995, P88; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2012, PROC CVPR IEEE, P2224, DOI 10.1109/CVPR.2012.6247931; Yang M, 2011, PROC CVPR IEEE, P625, DOI 10.1109/CVPR.2011.5995393; Yang M, 2010, LECT NOTES COMPUT SC, V6316, P448, DOI 10.1007/978-3-642-15567-3_33; Yu Kai, 2009, ADV NEURAL INFORM PR, P2223; Yuan XT, 2010, PROC CVPR IEEE, P3493, DOI 10.1109/CVPR.2010.5539967; Zhang HC, 2012, PATTERN RECOGN, V45, P1290, DOI 10.1016/j.patcog.2011.09.009; Zhu PF, 2012, LECT NOTES COMPUT SC, V7572, P822, DOI 10.1007/978-3-642-33718-5_59; Zou J, 2007, IEEE T IMAGE PROCESS, V16, P2617, DOI 10.1109/TIP.2007.904421	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113198	10.1371/journal.pone.0113198	http://dx.doi.org/10.1371/journal.pone.0113198			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419662	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900022
J	Dong, FM; Mo, ZC; Eid, W; Courtney, KC; Zha, XH				Dong, Fumin; Mo, Zhongcheng; Eid, Walaa; Courtney, Kevin C.; Zha, Xiaohui			Akt Inhibition Promotes ABCA1-Mediated Cholesterol Efflux to ApoA-I through Suppressing mTORC1	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A1; PROTEIN-KINASE CK2; TANGIER-DISEASE; CELLULAR CHOLESTEROL; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS; TUBEROUS-SCLEROSIS; PLASMA-MEMBRANE	ATP-binding cassette transporter A1 (ABCA1) plays an essential role in mediating cholesterol efflux to apolipoprotein A-I (apoA-I), a major housekeeping mechanism for cellular cholesterol homeostasis. After initial engagement with ABCA1, apoA-I directly interacts with the plasma membrane to acquire cholesterol. This apoA-I lipidation process is also known to require cellular signaling processes, presumably to support cholesterol trafficking to the plasma membrane. We report here that one of major signaling pathways in mammalian cells, Akt, is also involved. In several cell models that express ABCA1 including macrophages, pancreatic beta cells and hepatocytes, inhibition of Akt increases cholesterol efflux to apoA-I. Importantly, Akt inhibition has little effect on cells expressing nonfunctional mutant of ABCA1, implicating a specific role of Akt in ABCA1 function. Furthermore, we provide evidence that mTORC1, a major downstream target of Akt, is also a negative regulator of cholesterol efflux. In cells where mTORC1 is constitutively activated due to tuberous sclerosis complex 2 deletion, cholesterol efflux to apoA-I is no longer sensitive to Akt activity. This suggests that Akt suppresses cholesterol efflux through mTORC1 activation. Indeed, inhibition of mTORC1 by rapamycin or Torin-1 promotes cholesterol efflux. On the other hand, autophagy, one of the major pathways of cholesterol trafficking, is increased upon Akt inhibition. Furthermore, Akt inhibition disrupts lipid rafts, which is known to promote cholesterol efflux to apoA-I. We therefore conclude that Akt, through its downstream targets, mTORC1 and hence autophagy, negatively regulates cholesterol efflux to apoA-I.	[Dong, Fumin; Mo, Zhongcheng; Zha, Xiaohui] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Eid, Walaa; Courtney, Kevin C.; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Zha, XH (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada.	xzha@ohri.ca	莫, 中成/AAY-8561-2020	Courtney, Kevin/0000-0003-1315-4917	Heart & Stroke Foundation of Ontario [T-7054]; Canadian Institutes of Health Research [MOP-130453]	Heart & Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by a grant from Heart & Stroke Foundation of Ontario(T-7054) to XZ (http://www.hsf.ca/research/en/grants-aid) and in part by an operating grant from Canadian Institutes of Health Research (MOP-130453) to XZ (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Luu W, 2013, IUBMB LIFE, V65, P675, DOI 10.1002/iub.1182; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711; Moscat J, 2011, CELL, V147, P724, DOI 10.1016/j.cell.2011.10.021; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; O'Farrell F, 2013, FEBS J, V280, P6322, DOI 10.1111/febs.12486; Oram JF, 1996, J LIPID RES, V37, P2473; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Potter CJ, 2003, BIOCHEM SOC T, V31, P584, DOI 10.1042/BST0310584; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	54	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113789	10.1371/journal.pone.0113789	http://dx.doi.org/10.1371/journal.pone.0113789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415591	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600079
J	Fereres, S; Simon, R; Mohd-Sarip, A; Verrijzer, CP; Busturia, A				Fereres, Sol; Simon, Rocio; Mohd-Sarip, Adone; Verrijzer, C. Peter; Busturia, Ana			dRYBP Counteracts Chromatin-Dependent Activation and Repression of Transcription	PLOS ONE			English	Article							POLYCOMB GROUP; H2A UBIQUITYLATION; BITHORAX COMPLEX; RYBP; GENE; PRC2; MONOUBIQUITINATION; UBIQUITINATION; RECRUITMENT; TRITHORAX	Chromatin dependent activation and repression of transcription is regulated by the histone modifying enzymatic activities of the trithorax (trxG) and Polycomb (PcG) proteins. To investigate the mechanisms underlying their mutual antagonistic activities we analyzed the function of Drosophila dRYBP, a conserved PcG- and trxG-associated protein. We show that dRYBP is itself ubiquitylated and binds ubiquitylated proteins. Additionally we show that dRYBP maintains H2A monoubiquitylation, H3K4 monomethylation and H3K36 dimethylation levels and does not affect H3K27 trimethylation levels. Further we show that dRYBP interacts with the repressive SCE and dKDM2 proteins as well as the activating dBRE1 protein. Analysis of homeotic phenotypes and post-translationally modified histones levels show that dRYBP antagonizes dKDM2 and dBRE1 functions by respectively preventing H3K36me2 demethylation and H2B monoubiquitylation. Interestingly, our results show that inactivation of dBRE1 produces trithorax-like related homeotic transformations, suggesting that dBRE1 functions in the regulation of homeotic genes expression. Our findings indicate that dRYBP regulates morphogenesis by counteracting transcriptional repression and activation. Thus, they suggest that dRYBP may participate in the epigenetic plasticity important during normal and pathological development.	[Fereres, Sol; Simon, Rocio; Busturia, Ana] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Mohd-Sarip, Adone; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Dept Biochem, NL-3015 CN Rotterdam, Netherlands; [Mohd-Sarip, Adone; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Ctr Biomed Genet, NL-3015 CN Rotterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Busturia, A (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, Madrid 28049, Spain.	abusturia@cbm.csic.es	Mohd-Sarip, Adone/AAI-7912-2020; Simón, Rocío/ABF-5138-2021; Simón, Rocío/CAJ-5686-2022	Mohd-Sarip, Adone/0000-0003-2932-954X; Simón, Rocío/0000-0001-6584-5141	Direccion General de Investigacion [BFU-01154]; Ministerio de Ciencia e Innovacion [CSD 2007-00008]; Fundacion Ramon Areces; Netherlands Institute for Regenerative Medicine consortium [FES0908]; EMBO [229-2013]	Direccion General de Investigacion(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Netherlands Institute for Regenerative Medicine consortium; EMBO(European Molecular Biology Organization (EMBO))	Funding: This work was supported by grants from the Direccion General de Investigacion (BFU-01154) to A.B, the Consolider Ingenio 2010 Program of the Ministerio de Ciencia e Innovacion (CSD 2007-00008) to A.B, by an institutional grant to the CBMSO from the Fundacion Ramon Areces, and by the Netherlands Institute for Regenerative Medicine consortium (FES0908) to CPV. We thank EMBO for the short-term EMBO fellowship (229-2013) granted to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Aparicio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062052; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; BREEN TR, 1986, DEV BIOL, V118, P442, DOI 10.1016/0012-1606(86)90015-1; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chalkley GE, 2004, METHOD ENZYMOL, V377, P421; Comet I, 2014, NAT STRUCT MOL BIOL, V21, P573, DOI 10.1038/nsmb.2848; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fereres S, 2013, APOPTOSIS, V18, P1500, DOI 10.1007/s10495-013-0897-4; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gildea JJ, 2000, GENETICS, V156, P645; Gonzalez I, 2008, GENETICS, V179, P1373, DOI 10.1534/genetics.107.082966; Gonzalez I, 2009, CELL RES, V19, P747, DOI 10.1038/cr.2009.29; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohd-Sarip A, 2012, SCIENCE, V336, P744, DOI 10.1126/science.1215927; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Moshkin YM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003719; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; van der Knaap JA, 2010, MOL CELL BIOL, V30, P736, DOI 10.1128/MCB.01121-09; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113255	10.1371/journal.pone.0113255	http://dx.doi.org/10.1371/journal.pone.0113255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415640	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600037
J	Into, T; Takigawa, T; Niida, S; Shibata, K				Into, Takeshi; Takigawa, Toshiya; Niida, Shumpei; Shibata, Ken-ichiro			MyD88 Deficiency Alters Expression of Antimicrobial Factors in Mouse Salivary Glands	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; B-CELLS; INTESTINAL MICROBIOTA; DENDRITIC CELLS; IGA; RECOGNITION; DISEASE; FAMILY; SLPI	The surfaces of oral mucosa are protected from infections by antimicrobial proteins and natural immunoglobulins that are constantly secreted in saliva, serving as principal innate immune defense in the oral cavity. MyD88 is an important adaptor protein for signal transduction downstream of Toll-like receptors and TACI, receptors for regulation of innate immunity and B cell responses, respectively. Although MyD88-mediated signaling has a regulatory role in the intestinal mucosal immunity, its specific role in the oral cavity has remained elusive. In the present study, we assessed the influence of MyD88 deficiency on the oral innate defense, particularly the expression of antimicrobial proteins in salivary glands and production of salivary basal immunoglobulins, in mice. Microarray analysis of the whole tissues of submandibular glands revealed that the expression of several genes encoding salivary antimicrobial proteins, such as secretory leukocyte peptidase inhibitor (SLPI), S100A8, and lactotransferrin, was reduced due to MyD88 deficiency. Histologically, SLPI-expressing acinar cells were evidently decreased in the glands from MyD88 deficient mice compared to wild-type mice. Flow cytometric analysis revealed that B cell populations, including B-1 cells and IgA(+) plasma cells, residing in submandibular glands were increased by MyD88 deficiency. The level of salivary anti-phosphorylcholine IgA was elevated in MyD88 deficient mice compared to wild-type mice. Thus, this study provides a detailed description of the effect of MyD88 deficiency on expression of several salivary antimicrobial factors in mice, illustrating the role for MyD88-mediated signaling in the innate immune defense in the oral cavity.	[Into, Takeshi] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan; [Takigawa, Toshiya] Asahi Univ, Sch Dent, Dept Oral Anat, Div Oral Struct Funct & Dev, Gifu, Japan; [Niida, Shumpei] NCGG, Lab Genom & Prote, Aichi, Japan; [Shibata, Ken-ichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Lab Oral Mol Microbiol, Sapporo, Hokkaido 060, Japan	Asahi University; Asahi University; Hokkaido University	Into, T (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci, Gifu, Japan.	into@dent.asahi-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23390431, 26462803]; Grants-in-Aid for Scientific Research [26462803] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B: 23390431 and C: 26462803 to T.I.) from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2012, IMMUNOL RES, V52, P224, DOI 10.1007/s12026-012-8324-4; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Brandtzaeg P, 2007, ANN NY ACAD SCI, V1098, P288, DOI 10.1196/annals.1384.012; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Gorr SU, 2011, J CLIN PERIODONTOL, V38, P126, DOI 10.1111/j.1600-051X.2010.01664.x; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hiroi T, 1999, J IMMUNOL, V162, P821; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kataoka K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025396; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; McKiernan PJ, 2011, BIOCHEM SOC T, V39, P1421, DOI 10.1042/BST0391421; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tarlinton DM, 1995, EUR J IMMUNOL, V25, P3388, DOI 10.1002/eji.1830251228; TENOVUO J, 1987, J DENT RES, V66, P475, DOI 10.1177/00220345870660021501; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Thurnheer MC, 2003, J IMMUNOL, V170, P4564, DOI 10.4049/jimmunol.170.9.4564; TORNBERG UC, 1995, EMBO J, V14, P1680, DOI 10.1002/j.1460-2075.1995.tb07157.x; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113333	10.1371/journal.pone.0113333	http://dx.doi.org/10.1371/journal.pone.0113333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415419	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600042
J	Tehseen, M; Dumancic, M; Briggs, L; Wang, J; Berna, A; Anderson, A; Trowell, S				Tehseen, Muhammad; Dumancic, Mira; Briggs, Lyndall; Wang, Jian; Berna, Amalia; Anderson, Alisha; Trowell, Stephen			Functional Coupling of a Nematode Chemoreceptor to the Yeast Pheromone Response Pathway	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; SOMATOSTATIN RECEPTOR; MAMMALIAN RECEPTORS; SPLIT-UBIQUITIN; GENE; ASSAY; MEMBRANE; IDENTIFICATION	Sequencing of the Caenorhabditis elegans genome revealed sequences encoding more than 1,000 G-protein coupled receptors, hundreds of which may respond to volatile organic ligands. To understand how the worm's simple olfactory system can sense its chemical environment there is a need to characterise a representative selection of these receptors but only very few receptors have been linked to a specific volatile ligand. We therefore set out to design a yeast expression system for assigning ligands to nematode chemoreceptors. We showed that while a model receptor ODR-10 binds to C. elegans G alpha subunits ODR-3 and GPA-3 it cannot bind to yeast G alpha. However, chimaeras between the nematode and yeast G alpha subunits bound to both ODR-10 and the yeast G beta gamma subunits. FIG2 was shown to be a superior MAP-dependent promoter for reporter expression. We replaced the endogenous G alpha subunit (GPA1) of the Saccharomyces cerevisiae (ste2 Delta sst2 Delta far1 Delta) triple mutant ("Cyb'') with a Gpa1/ODR-3 chimaera and introduced ODR-10 as a model nematode GPCR. This strain showed concentration-dependent activation of the yeast MAP kinase pathway in the presence of diacetyl, the first time that the native form of a nematode chemoreceptor has been functionally expressed in yeast. This is an important step towards en masse de-orphaning of C. elegans chemoreceptors.	[Trowell, Stephen] CSIRO Food Futures Natl Res Flagship, Canberra, ACT 2601, Australia; CSIRO Ecosyst Sci, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Trowell, S (corresponding author), CSIRO Food Futures Natl Res Flagship, POB 1700, Canberra, ACT 2601, Australia.	stephen.trowell@csiro.au	Anderson, Alisha R/C-1499-2008; Perez, Amalia Berna/C-2139-2008; Anderson, Alisha/AAC-3505-2021; Trowell, Stephen C/B-8043-2008; Briggs, Lyndall J/A-7549-2011; Trowell, Stephen/AAG-8943-2019	Anderson, Alisha R/0000-0001-7013-116X; Perez, Amalia Berna/0000-0003-4932-5415; Anderson, Alisha/0000-0001-7013-116X; Trowell, Stephen C/0000-0002-0505-8741; 	CSIRO; Australian Department of Defence's Capability and Technology Demonstrator Program	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Department of Defence's Capability and Technology Demonstrator Program(Australian Government)	Funding: This work was funded jointly by CSIRO (http://www.csiro.au) and the Australian Department of Defence's Capability and Technology Demonstrator Program (http://www.dsto.defence.gov.au/. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Brouchon-Macari L, 2003, BIOTECHNIQUES, V35, P446, DOI 10.2144/03353bm01; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Choudhury SR, 2014, BIOCHEM J, V461, P75, DOI 10.1042/BJ20131341; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Eifler N, 2007, J STRUCT BIOL, V159, P179, DOI 10.1016/j.jsb.2007.01.014; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P3143, DOI 10.1002/bit.24589; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Iyer K., 2005, SCI STKE, V2005, P13; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liao CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012615; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Pandey Pratima, 2012, J Mol Signal, V7, P3, DOI 10.1186/1750-2187-7-3; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; Sanz G, 2009, EUR CHEM RES ORG 19; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taniguchi G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005136; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; White JM, 2001, CURR BIOL, V11, pR16, DOI 10.1016/S0960-9822(00)00036-1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JH, 2000, J COMB CHEM, V2, P258, DOI 10.1021/cc9900706; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P378, DOI 10.1177/1087057108317145; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zuck P, 2004, ANAL BIOCHEM, V334, P344, DOI 10.1016/j.ab.2004.07.031	57	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111429	10.1371/journal.pone.0111429	http://dx.doi.org/10.1371/journal.pone.0111429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415379	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600005
J	Coluzza, I				Coluzza, Ivan			Transferable Coarse-Grained Potential for De Novo Protein Folding and Design	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SEQUENCES; MODELS; STATE	Protein folding and design are major biophysical problems, the solution of which would lead to important applications especially in medicine. Here we provide evidence of how a novel parametrization of the Caterpillar model may be used for both quantitative protein design and folding. With computer simulations it is shown that, for a large set of real protein structures, the model produces designed sequences with similar physical properties to the corresponding natural occurring sequences. The designed sequences require further experimental testing. For an independent set of proteins, previously used as benchmark, the correct folded structure of both the designed and the natural sequences is also demonstrated. The equilibrium folding properties are characterized by free energy calculations. The resulting free energy profiles not only are consistent among natural and designed proteins, but also show a remarkable precision when the folded structures are compared to the experimentally determined ones. Ultimately, the updated Caterpillar model is unique in the combination of its fundamental three features: its simplicity, its ability to produce natural foldable designed sequences, and its structure prediction precision. It is also remarkable that low frustration sequences can be obtained with such a simple and universal design procedure, and that the folding of natural proteins shows funnelled free energy landscapes without the need of any potentials based on the native structure.	Univ Vienna, Fac Phys, Vienna, Austria	University of Vienna	Coluzza, I (corresponding author), Univ Vienna, Fac Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Coluzza, Ivan/I-4170-2015	Coluzza, Ivan/0000-0001-7728-6033	Austrian Science Fund (FWF) [P23846-N16]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: We acknowledge support from the Austrian Science Fund (FWF) project P23846-N16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000241; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bereau T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152842; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2012, SOFT MATTER, DOI [10.1039/c2sm26967h, DOI 10.1039/C2SM26967H.]; Coluzza I, 2007, BIOPHYS J, V92, P1150, DOI 10.1529/biophysj.106.084236; Coluzza I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075501; Coluzza I, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/28/284111; Coluzza I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034228; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Dahiyat BI, 1997, P NATL ACAD SCI USA, V94, P10172, DOI 10.1073/pnas.94.19.10172; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; DiStasio RA, 2012, P NATL ACAD SCI USA, V109, P14791, DOI 10.1073/pnas.1208121109; Dolittle RF, 1989, PREDICTION PROTEIN S, P599; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; GUTIN AM, 1993, J CHEM PHYS, V98, P8174, DOI 10.1063/1.464522; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huang XH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908251; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikebe J, 2011, PROTEIN SCI, V20, P187, DOI 10.1002/pro.553; Kapoor A, 2013, PROTEINS, V81, P1200, DOI 10.1002/prot.24269; Kellogg EH, 2012, J PHYS CHEM B, V116, P11405, DOI 10.1021/jp3044303; Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Mu Y, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768062; Pande VS, 2003, BIOPOLYMERS, V68, P91, DOI 10.1002/bip.10219; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Seibert MM, 2005, J MOL BIOL, V354, P173, DOI 10.1016/j.jmb.2005.09.030; Seno F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078102; SHAKHNOVICH EI, 1990, NATURE, V346, P773, DOI 10.1038/346773a0; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Smith AV, 2001, PROTEINS, V44, P344, DOI 10.1002/prot.1100; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Wolynes PG, 2012, P NATL ACAD SCI USA, V109, P17770, DOI 10.1073/pnas.1215733109; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang C, 2012, P NATL ACAD SCI USA, V109, P8139, DOI 10.1073/pnas.1112143109; Zhang C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3435332; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	53	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112852	10.1371/journal.pone.0112852	http://dx.doi.org/10.1371/journal.pone.0112852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436908	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900020
J	Erlandson, KM; Reynolds, SM; Cox, C; Palella, FJ; Witt, MD; Kingsley, LA; Brown, TT; Plankey, M				Erlandson, Kristine M.; Reynolds, Sandra M.; Cox, Christopher; Palella, Frank J.; Witt, Mallory D.; Kingsley, Lawrence A.; Brown, Todd T.; Plankey, Michael			Self-Reported Body Fat Change in HIV-Infected Men Is a Marker of Decline in Physical Health-Related Quality of Life with Aging, Independent of Co-Morbidity	PLOS ONE			English	Article							MULTICENTER AIDS COHORT; ANTIRETROVIRAL THERAPY; LIPODYSTROPHY SYNDROME; DISEASE PROGRESSION; FACIAL LIPOATROPHY; IMPACT; RESILIENCE; DEPRESSION; PREDICTION; STAVUDINE	Objective: Self-perception of changes in body fat among HIV+ persons is associated with decreased health related quality of life in cross-sectional studies. The longitudinal impact of body fat changes on health related quality of life, while accounting for comorbidity and anatomic location or severity of body fat changes, is unknown. Design: This was a longitudinal analysis of HIV+ and HIV-Multicenter AIDS Cohort Study (MACS) participants who completed questionnaires assessing self-perceived body fat changes (baseline visit) and a health related quality of life (Short Form-36) at baseline and then >= 5 years later. Methods: Relationships between body fat changes and change in Short Form-36 Physical and Mental Component Summary scores were investigated using mixed-model regression. Results: We studied 270 HIV+ and 247 HIV-men. At baseline, >= 50% of HIV+ men reported body fat changes; physical component but not mental component summary scores were lower among HIV+ men who reported moderate/severe leg or abdominal fat changes (p<0.05). At follow-up, physical component summary scores were significantly lower among men with face, leg, or abdominal fat changes compared to men without perceived fat changes (p<0.05). No significant changes were seen in mental component scores by fat change location or severity. In the final model, body fat changes at any site or severity were significant predictors of a decline in physical component summary score (p<0.05), independent of demographics or comorbidities. Mental component summary score was not associated with body fat changes, but higher mental component summary score was associated with increasing age and time. Conclusions: Negative self-perceived body fat changes were associated with decline in physical health related quality of life, independent of comorbidities, and may be a marker of an increased risk for physical function decline with aging.	[Erlandson, Kristine M.] Univ Colorado, Dept Med, Div Infect Dis & Geriatr Med, Aurora, CO 80045 USA; [Reynolds, Sandra M.; Cox, Christopher] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Palella, Frank J.] Northwestern Univ, Dept Med, Div Infect Dis, Chicago, IL 60611 USA; [Witt, Mallory D.] Univ Calif Los Angeles, Dept Med, Div HIV Med, Los Angeles Biomed Res Inst Harbor, Torrance, CA USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Brown, Todd T.] Johns Hopkins Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA; [Plankey, Michael] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Northwestern University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Georgetown University	Erlandson, KM (corresponding author), Univ Colorado, Dept Med, Div Infect Dis & Geriatr Med, Aurora, CO 80045 USA.	kristine.erlandson@ucdenver.edu		Kingsley, Lawrence/0000-0002-7000-8556	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI) [UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UL1TR000124]; National Institutes of Health, National Institute on Aging [R03AG040594]; John A. Hartford Foundation, Centers of Excellence in Aging; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035039, U01AI035040, U01AI035042, UM1AI035043, U01AI035043, U01AI035041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG040594, K23AG050260] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John A. Hartford Foundation, Centers of Excellence in Aging; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Multicenter AIDS Cohort Study (MACS) is supported through the following grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID), with additional supplemental funding from the National Cancer Institute (NCI): UO1-AI-35042, UL1-RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041, UL1TR000124. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. KME received funding from the National Institutes of Health, National Institute on Aging (R03AG040594), and the John A. Hartford Foundation, Centers of Excellence in Aging (http://www.jhartfound.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanch J, 2004, CLIN INFECT DIS, V38, P1469; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Broholm C, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.60; Broomhead DS, 2000, BIOL CYBERN, V82, P391, DOI 10.1007/s004220050593; Buehring B, 2012, J CLIN DENSITOM, V15, P224, DOI 10.1016/j.jocd.2011.10.003; Burgoyne R, 2005, QUAL LIFE RES, V14, P981, DOI 10.1007/s11136-004-2580-2; Calmy A, 2007, LANCET, V370, P12, DOI 10.1016/S0140-6736(07)61027-7; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Coleman S, 2009, AESTHET PLAST SURG, V33, P14, DOI 10.1007/s00266-008-9258-z; Collins E, 2000, AIDS Read, V10, P546; Crane HM, 2008, HIV MED, V9, P780, DOI 10.1111/j.1468-1293.2008.00631.x; Crawford KW, 2013, AIDS RES HUM RETROV, V29, P1138, DOI [10.1089/AID.2013.0020, 10.1089/aid.2013.0020]; DUDLEY J, 1995, AM J EPIDEMIOL, V142, P323, DOI 10.1093/oxfordjournals.aje.a117638; Duong M, 2007, HIV MED, V8, P105, DOI 10.1111/j.1468-1293.2007.00439.x; Duran S, 2001, AIDS, V15, P2441, DOI 10.1097/00002030-200112070-00012; Emlet CA, 2011, GERONTOLOGIST, V51, P101, DOI 10.1093/geront/gnq060; Guaraldi G, 2008, AIDS REV, V10, P152; Guaraldi G, 2008, AIDS PATIENT CARE ST, V22, P577, DOI 10.1089/apc.2007.0173; Guaraldi G, 2013, JAIDS-J ACQ IMM DEF, V64, P360, DOI 10.1097/QAI.0000000000000001; Hadigan C, 2003, CLIN INFECT DIS, V36, P909, DOI 10.1086/368185; Hammond E, 2010, CLIN INFECT DIS, V51, P591, DOI 10.1086/655765; Herrick AL, 2013, AIDS BEHAV, V17, P1423, DOI 10.1007/s10461-012-0392-x; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Justice AC, 2004, J CLIN EPIDEMIOL, V57, P89, DOI 10.1016/S0895-4356(03)00245-2; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kosmiski LA, 2009, AM J CLIN NUTR, V90, P1525, DOI 10.3945/ajcn.2009.28103; Kroenke CH, 2008, AM J PUBLIC HEALTH, V98, P2085, DOI 10.2105/AJPH.2007.114041; Lenert LA, 2002, AM J MED, V113, P229, DOI 10.1016/S0002-9343(02)01156-7; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lichtenstein KA, 2005, JAIDS-J ACQ IMM DEF, V39, P395, DOI 10.1097/01.qai.0000167478.28051.3a; Mallon PWG, 2005, JAIDS-J ACQ IMM DEF, V38, P156, DOI 10.1097/01.qai.0000147527.64863.1a; McComsey GA, 2005, AIDS, V19, P15, DOI 10.1097/00002030-200501030-00002; Oette M, 2002, AIDS PATIENT CARE ST, V16, P413, DOI 10.1089/108729102760330254; Otero-Rodriguez A, 2010, QUAL LIFE RES, V19, P15, DOI 10.1007/s11136-009-9561-4; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Poindexter C, 2008, AIDS PATIENT CARE ST, V22, P723, DOI 10.1089/apc.2007.0260; Quintas RCS, 2014, INT J DERMATOL, V53, P497, DOI 10.1111/ijd.12400; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reynolds NR, 2006, AIDS CARE, V18, P663, DOI 10.1080/09540120500287051; Samaras K, 2009, OBESITY, V17, P53, DOI 10.1038/oby.2008.500; Shah K, 2012, J AM GERIATR SOC, V60, P545, DOI 10.1111/j.1532-5415.2011.03819.x; Shippy RA, 2005, AGING MENT HEALTH, V9, P246, DOI 10.1080/13607860412331336850; Steel JL, 2006, AIDS PATIENT CARE ST, V20, P565, DOI 10.1089/apc.2006.20.565; van Hall G, 2008, J CLIN ENDOCR METAB, V93, P2851, DOI 10.1210/jc.2007-2223; Warde M, 2011, INT J STD AIDS, V22, P596, DOI 10.1258/ijsa.2009.009086; Ware JE, 2001, SF 36 PHYS MENTAL HL	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114166	10.1371/journal.pone.0114166	http://dx.doi.org/10.1371/journal.pone.0114166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25436612	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000347114900128
J	Feng, L; Li, P; Lu, C; Tang, WM; Mahapatra, T; Wang, Y; Wang, XH; Ma, Y; Ben, YL; Cao, XL; Mahapatra, S; Ling, M; Gou, AS; Wang, YM; Xiao, JQ; Hou, M; Wang, XL; Lin, B; Chen, RL; Wang, FX; Hu, Z				Feng, Lei; Li, Ping; Lu, Chen; Tang, Weiming; Mahapatra, Tanmay; Wang, Yu; Wang, Xihua; Ma, Ying; Ben, Yanli; Cao, Xiaolin; Mahapatra, Sanchita; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Chen, Ruoling; Wang, Faxing; Hu, Zhi			Burden and Correlates of Geriatric Depression in the Uyghur Elderly Population, Observation from Xinjiang, China	PLOS ONE			English	Article							RURAL-URBAN DIFFERENCES; LIFE SATISFACTION; RELIGIOUS BELIEF; RISK-FACTORS; COMMUNITY; DISEASE; PREVALENCE; DIAGNOSIS; INCOME	Background: With the gradual aging of the population, geriatric depression has become a major public health issue in China owing to its overall upward trend and associated negative socio-economic impact. Dearth of information regarding the burden and correlates of geriatric depression among Uyghur minority population in Xinjiang Autonomous Region, called for a comprehensive survey involving representative sample for designing efficient targeted intervention to control this disabling disease. Methods: A cross-sectional study was conducted among 1329 consenting Uyghur elderly in 2011 in six randomly selected communities/villages in Xinjiang. Information about socio-demographics, behavior, negative life-events, satisfaction regarding income/quality of life and other chronic diseases were collected while assessment of geriatric depression was done using Geriatric Mental State Schedule (GMS). Results: Among these participants, majority were currently married, had attended elementary school or less, had an average annual family income of less than 3000 Yuan/person, had strong religious beliefs while 10.61% (2.77% in urban and 23.60% in rural area) had geriatric depression (5.91% among male and 14.58% among females). 61.83% were suffering from other chronic diseases, 96.16% could take care of themselves and 39.28% had experienced negative events during last two years. Religious belief (AOR=3.92, 95% CI 1.18-13.03), satisfaction regarding quality of life (AOR=0.53, 95% CI 0.37-0.84) and income (AOR=0.75, 95% CI 0.35-1.60), suffering from more chronic diseases (AOR=1.70, 95% CI 1.42-2.04), experiencing three or more negative events (AOR=1.72, 95% CI 0.92-3.22) and lack of ability to take self-care (AOR=2.20, 95% CI 1.09-4.48) were all associated with having geriatric depression with or without adjustment for gender, education and occupation. Conclusion: High prevalence of geriatric depression among Uyghur elderly in Xinjiang seemed to call for urgent interventions, specifically targeting rural residents, who experienced more negative life-events, were suffering from chronic diseases and were dissatisfied with their income and quality of life.	[Feng, Lei; Li, Ping; Lu, Chen; Wang, Yu; Wang, Xihua; Ben, Yanli; Cao, Xiaolin; Ling, Min; Gou, Anshuan; Wang, Yanmei; Xiao, Jiangqin; Hou, Ming; Wang, Xiuli; Lin, Bo; Wang, Faxing] Peoples Hosp Xinjiang Uyghur Autonomous Reg, Urumqi 830000, Xinjiang, Peoples R China; [Tang, Weiming] Univ North Carolina Project China, Guangzhou 510095, Guangdong, Peoples R China; [Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90066 USA; [Ma, Ying; Hu, Zhi] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China; [Chen, Ruoling] Wolverhampton Univ, Fac Educ Hlth & Wellbeing, CHSCI, Wolverhampton WV1 1DT, England	University of California System; University of California Los Angeles; Anhui Medical University; University of Wolverhampton	Wang, FX (corresponding author), Peoples Hosp Xinjiang Uyghur Autonomous Reg, Urumqi 830000, Xinjiang, Peoples R China.	wfx116@126.com; aywghz@126.com		Chen, Ruoling/0000-0002-3033-8753; Tang, Weiming/0000-0002-9026-707X	Natural Science Fund Regional Fund of China [8126212]; Science and Technology Project of Xinjiang Autonomous Region [201242178]	Natural Science Fund Regional Fund of China; Science and Technology Project of Xinjiang Autonomous Region	This work was supported by the Natural Science Fund Regional Fund of China (8126212) and Science and Technology Project of Xinjiang Autonomous Region (201242178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; [Anonymous], 2013, CHINAS RICH POOR URB; [Anonymous], 1996, SAS SYST WIND; [Anonymous], 2010, 6 NAT POP CENS PEOPL; Berghaus RD, 2005, PREV VET MED, V72, P291, DOI 10.1016/j.prevetmed.2005.07.011; Bruus M., 2003, EPIDATA VERSION 3 CO; Casey DA, 2012, ASIA-PAC PSYCHIAT, V4, P160, DOI 10.1111/j.1758-5872.2012.00191.x; COPELAND JRM, 1988, PSYCHOL MED, V18, P219, DOI 10.1017/S003329170000204X; DECKER SD, 1985, AM J OCCUP THER, V39, P740, DOI 10.5014/ajot.39.11.740; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105536; Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x; Haidong Zhang PL, 2010, CHIN J CARDIOVASC RE, P19; Joubert L, 2013, SOC WORK HEALTH CARE, V52, P222, DOI 10.1080/00981389.2012.737896; Krishnan KRR, 2002, BIOL PSYCHIAT, V52, P185, DOI 10.1016/S0006-3223(02)01349-5; Marty MA, 2011, PRINCIPLES PRACTICE, P152; Mascie-Taylor CGN, 2003, SCIENCE, V302, P1921, DOI 10.1126/science.1092488; Murphy JM, 2000, PSYCHOL MED, V30, P505, DOI 10.1017/S0033291799002044; Murphy PE, 2000, J CONSULT CLIN PSYCH, V68, P1102, DOI 10.1037/0022-006X.68.6.1102; PRESSMAN P, 1990, AM J PSYCHIAT, V147, P758; Qi-min M, 2008, CHINESE GEN PRACTICE, V6; Rogers A, 1999, J GERONTOL SOC WORK, V31, P167, DOI 10.1300/J083v31n01_10; Rost K, 1998, MED CARE, V36, P1098, DOI 10.1097/00005650-199807000-00015; Schoevers RA, 2000, J AFFECT DISORDERS, V59, P127, DOI 10.1016/S0165-0327(99)00124-X; Shuhong Zhao RW, 2009, SCI FORUM, V5, P2; Shuran Li CC, 1999, CHINESE MENTAL HLTH, V5, P3; Sicular T, 2007, REV INCOME WEALTH, V53, P93, DOI 10.1111/j.1475-4991.2007.00219.x; Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7; van Manen JG, 2002, THORAX, V57, P412, DOI 10.1136/thorax.57.5.412; Wang JL, 2004, SOC PSYCH PSYCH EPID, V39, P19, DOI 10.1007/s00127-004-0698-8; Zhang H-Y, 2012, CHINESE GEN PRACTICE, V16; Zhi H, 2004, CHINESE PRIMARY HLTH, V4	31	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114139	10.1371/journal.pone.0114139	http://dx.doi.org/10.1371/journal.pone.0114139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437860	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900124
J	Gong, ZJ; Zhang, SS; Zeng, ZY; Wu, HJ; Yang, Q; Xiong, F; Shi, L; Yang, JB; Zhang, WL; Zhou, YH; Zeng, Y; Li, XY; Xiang, B; Peng, SP; Zhou, M; Li, XL; Tan, M; Li, Y; Xiong, W; Li, GY				Gong, Zhaojian; Zhang, Shanshan; Zeng, Zhaoyang; Wu, Hanjiang; Yang, Qian; Xiong, Fang; Shi, Lei; Yang, Jianbo; Zhang, Wenling; Zhou, Yanhong; Zeng, Yong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan			LOC401317, a p53-Regulated Long Non-Coding RNA, Inhibits Cell Proliferation and Induces Apoptosis in the Nasopharyngeal Carcinoma Cell Line HNE2	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; SUSCEPTIBILITY LOCUS; TREATMENT OPTIONS; TUMOR-SUPPRESSOR; CHROMOSOME 3P21; CANCER; P53; MICRORNAS; TRANSCRIPTION	Recent studies have revealed that long non-coding RNAs participate in all steps of cancer initiation and progression by regulating protein-coding genes at the epigenetic, transcriptional, and post-transcriptional levels. Long non-coding RNAs are in turn regulated by other genes, forming a complex regulatory network. The regulation networks between the p53 tumor suppressor and these RNAs in nasopharyngeal carcinoma remains unclear. The aims of this study were to investigate the regulatory roles of the TP53 gene in regulating long non-coding RNA expression profiles and to study the function of a TP53-regulated long non-coding RNA (LOC401317) in the nasopharyngeal carcinoma cell line HNE2. Long non-coding RNA expression profiling indicated that 133 long non-coding RNAs were upregulated in the human NPC cell line HNE2 cells following TP53 overexpression, while 1057 were downregulated. Among these aberrantly expressed long non-coding RNAs, LOC401317 was the most significantly upregulated one. Further studies indicated that LOC401317 is directly regulated by p53 and that ectopic expression of LOC401317 inhibits HNE2 cell proliferation in vitro and in vivo by inducing cell cycle arrest and apoptosis. LOC401317 inhibited cell cycle progression by increasing p21 expression and decreasing cyclin D1 and cyclin E1 expression and promoted apoptosis through the induction of poly(ADP-ribose) polymerase and caspase-3 cleavage. Collectively, these results suggest that LOC401317 is directly regulated by p53 and exerts antitumor effects in HNE2 nasopharyngeal carcinoma cells.	[Gong, Zhaojian; Zeng, Zhaoyang; Yang, Jianbo; Zhou, Yanhong; Zeng, Yong; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Hunan Canc Hosp, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Jianbo; Zhou, Yanhong; Zeng, Yong; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Xiong, Wei; Li, Guiyuan] Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Qian; Xiong, Fang; Shi, Lei; Zhang, Wenling; Zhou, Yanhong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis, Minist Hlth, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Zeng, Zhaoyang; Yang, Qian; Xiong, Fang; Shi, Lei; Zhang, Wenling; Zhou, Yanhong; Li, Xiayu; Xiang, Bo; Peng, Shuping; Zhou, Ming; Li, Xiaoling; Tan, Ming; Li, Yong; Xiong, Wei; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Gong, Zhaojian; Wu, Hanjiang; Shi, Lei] Cent S Univ, Dept Oral & Maxillofacial Surg, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhang, Shanshan; Xiong, Fang] Cent S Univ, Xiangya Hosp, Dept Stomatol, Changsha, Hunan, Peoples R China; [Zeng, Zhaoyang; Li, Xiayu; Xiong, Wei; Li, Guiyuan] Cent S Univ, Hunan Key Lab Nonresolving Inflammat & Canc, Dis Genome Res Ctr, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Yang, Jianbo] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Yang, Jianbo] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Zhang, Wenling; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Li, Yong] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of South Alabama; University of Louisville	Xiong, W (corresponding author), Cent S Univ, Hunan Canc Hosp, Changsha, Hunan, Peoples R China.	xiongwei@csu.edu.cn; lgy@csu.edu.cn	li, xia/HHZ-7468-2022; Tan, Ming/ABD-5847-2021; yang, jian/HIK-0188-2022	Tan, Ming/0000-0003-2007-9898; 	National Natural Science Foundation of China [81171930, 81172189, 81101509, 81272298, 81372907, 81301757]; Natural Science Foundation of Hunan Province [14JJ1010]; Research Fund for the Doctoral Program of Higher Education [20130162120083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from The National Natural Science Foundation of China (81171930, 81172189, 81101509, 81272298, 81372907 and 81301757), the Natural Science Foundation of Hunan Province (14JJ1010), and the Research Fund for the Doctoral Program of Higher Education (20130162120083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Gao W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404567; Geng YJ, 2011, J INT MED RES, V39, P2119, DOI 10.1177/147323001103900608; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong ZJ, 2012, PROG BIOCHEM BIOPHYS, V39, P1133, DOI 10.3724/SP.J.1206.2012.00015; Gong ZJ, 2012, SCI CHINA LIFE SCI, V55, P1120, DOI 10.1007/s11427-012-4413-9; Guigay J, 2008, CURR OPIN ONCOL, V20, P264, DOI 10.1097/CCO.0b013e3282fad846; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He ML, 2012, BBA-REV CANCER, V1825, P1, DOI 10.1016/j.bbcan.2011.09.001; Hock AK, 2012, CELL, V149, P1183, DOI 10.1016/j.cell.2012.05.024; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Levine AJ, 2004, CELL, V116, pS69; Levine AJ, 2004, CELL, V116, P61; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Liao QJ, 2012, J CANCER RES CLIN, V138, P57, DOI 10.1007/s00432-011-1066-1; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Spratt DE, 2012, ONCOTARGETS THER, V5, P297, DOI 10.2147/OTT.S28032; Stoker SD, 2013, CURR TREAT OPTION ON, V14, P475, DOI 10.1007/s11864-013-0261-5; Tang K, 2014, PROG BIOCHEM BIOPHYS, V41, P153, DOI 10.3724/SP.J.1206.2012.00613; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062869; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zeng ZY, 2006, GENET MED, V8, P156, DOI 10.1097/01.gim.0000196821.87655.d0; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x	51	93	101	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e110674	10.1371/journal.pone.0110674	http://dx.doi.org/10.1371/journal.pone.0110674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422887	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700003
J	Paisie, TK; Miller, TE; Mason, OU				Paisie, Taylor K.; Miller, Thomas E.; Mason, Olivia U.			Effects of a Ciliate Protozoa Predator on Microbial Communities in Pitcher Plant (Sarracenia purpurea) Leaves	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BACTERIAL COMMUNITIES; SP-NOV.; GENUS PHENYLOBACTERIUM; EMENDED DESCRIPTION; DIVERSITY; TAXONOMY; PROTEOBACTERIA; ACIDOBACTERIA; GROUNDWATER	The aquatic communities found within the water filled leaves of the pitcher plant, Sarracenia purpurea, have a simple trophic structure providing an ideal system to study microscale interactions between protozoan predators and their bacterial prey. In this study, replicate communities were maintained with and without the presence of the bactivorous protozoan, Colpoda steinii, to determine the effects of grazing on microbial communities. Changes in microbial (Archaea and Bacteria) community structure were assessed using iTag sequencing of 16S rRNA genes. The microbial communities were similar with and without the protozoan predator, with > 1000 species. Of these species, Archaea were negligible, with Bacteria comprising 99.99% of the microbial community. The Proteobacteria and Bacteroidetes were the most dominant phyla. The addition of a protozoan predator did not have a significant effect on microbial evenness nor richness. However, the presence of the protozoan did cause a significant shift in the relative abundances of a number of bacterial species. This suggested that bactivorous protozoan may target specific bacterial species and/or that certain bacterial species have innate mechanisms by which they evade predators. These findings help to elucidate the effect that trophic structure perturbations have on predator prey interactions in microbial systems.	[Paisie, Taylor K.; Mason, Olivia U.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Mason, OU (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	omason@fsu.edu	Mason, Olivia/AAP-2627-2021					Achari G.A., 2014, INT J MICROBIOL, V2014; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Bouali M, 2014, APPL MICROBIOL BIOT, V98, P3191, DOI 10.1007/s00253-013-5341-8; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Das SK, 1996, INT J SYST BACTERIOL, V46, P981, DOI 10.1099/00207713-46-4-981; Davidson SK, 2010, ENVIRON MICROBIOL, V12, P2277, DOI 10.1111/j.1462-2920.2010.02231.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gray SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050969; Hahn MW, 2001, FEMS MICROBIOL ECOL, V35, P113, DOI 10.1111/j.1574-6941.2001.tb00794.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; JURGENS K, 1995, FRESHWATER BIOL, V33, P27, DOI 10.1111/j.1365-2427.1995.tb00383.x; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Kanso S, 2004, INT J SYST EVOL MICR, V54, P2141, DOI 10.1099/ijs.0.63138-0; Kerfoot C. W., 1987, PREDATION DIRECT IND; Kim SJ, 2012, J MICROBIOL, V50, P207, DOI 10.1007/s12275-012-1342-z; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; Lin YT, 2010, MICROB ECOL, V59, P369, DOI 10.1007/s00248-009-9574-0; Liu QM, 2008, INT J SYST EVOL MICR, V58, P1100, DOI 10.1099/ijs.0.65386-0; Matz C, 2003, MICROB ECOL, V45, P384, DOI 10.1007/s00248-003-2000-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Michalsen MM, 2009, ENVIRON SCI TECHNOL, V43, P1952, DOI 10.1021/es8012485; Miki T, 2008, AQUAT MICROB ECOL, V51, P195, DOI 10.3354/ame01190; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; Miller TE, 2014, AM NAT, V184, P277, DOI 10.1086/676943; Miller TE, 2012, OECOLOGIA, V170, P243, DOI 10.1007/s00442-012-2292-1; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Pankratov TA, 2008, ISME J, V2, P551, DOI 10.1038/ismej.2008.7; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Rawat SR, 2012, STAND GENOMIC SCI, V7, P59, DOI 10.4056/sigs.3036810; Ryu H, 2014, APPL ENVIRON MICROB, V80, P1838, DOI 10.1128/AEM.03793-13; Salcher MM, 2005, AQUAT MICROB ECOL, V38, P215, DOI 10.3354/ame038215; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Simek K, 1997, APPL ENVIRON MICROB, V63, P587, DOI 10.1128/AEM.63.2.587-595.1997; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Siragusa AJ, 2007, MICROB ECOL, V54, P324, DOI 10.1007/s00248-006-9205-y; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Suyama T, 1999, INT J SYST BACTERIOL, V49, P449, DOI 10.1099/00207713-49-2-449; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tiago I, 2005, SYST APPL MICROBIOL, V28, P295, DOI 10.1016/j.syapm.2005.02.005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x	51	14	14	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113384	10.1371/journal.pone.0113384	http://dx.doi.org/10.1371/journal.pone.0113384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423622	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700034
J	Tamasi, V; Petschner, P; Adori, C; Kirilly, E; Ando, RD; Tothfalusi, L; Juhasz, G; Bagdy, G				Tamasi, Viola; Petschner, Peter; Adori, Csaba; Kirilly, Eszter; Ando, Romeo D.; Tothfalusi, Laszlo; Juhasz, Gabriella; Bagdy, Gyorgy			Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes	PLOS ONE			English	Article							GENE-EXPRESSION; MEMBRANE EXPRESSION; REUPTAKE INHIBITORS; MAJOR DEPRESSION; BIPOLAR DISORDER; BRAIN; RECEPTOR; SEROTONIN; CORTEX; ANTIDEPRESSANTS	Objectives: Venlafaxine (VLX), a serotonine-noradrenaline reuptake inhibitor, is one of the most commonly used antidepressant drugs in clinical practice for the treatment of major depressive disorder (MDD). Despite being more potent than its predecessors, similarly to them, the therapeutical effect of VLX is visible only 3-4 weeks after the beginning of treatment. Furthermore, recent papers show that antidepressants, including also VLX, enhance the motor recovery after stroke even in non depressed persons. In the present, transcriptomic-based study we looked for changes in gene expressions after a long-term VLX administration. Methods: Osmotic minipumps were implanted subcutaneously into Dark Agouti rats providing a continuous (40 mg/kg/day) VLX delivery for three weeks. Frontal regions of the cerebral cortex were isolated and analyzed using Illumina bead arrays to detect genes showing significant chances in expression. Gene set enrichment analysis was performed to identify specific regulatory networks significantly affected by long term VLX treatment. Results: Chronic VLX administration may have an effect on neurotransmitter release via the regulation of genes involved in vesicular exocytosis and receptor endocytosis (such as Kif proteins, Myo5a, Sv2b, Syn2 or Synj2). Simultaneously, VLX activated the expression of genes involved in neurotrophic signaling (Ntrk2, Ntrk3), glutamatergic transmission (Gria3, Grin2b and Grin2a), neuroplasticity (Camk2g/b, Cd47), synaptogenesis (Epha5a, Gad2) and cognitive processes (Clstn2). Interestingly, VLX increased the expression of genes involved in mitochondrial antioxidant activity (Bcl2 and Prdx1). Additionally, VLX administration also modulated genes related to insulin signaling pathway (Negr1, Ppp3r1, Slc2a4 and Enpp1), a mechanism that has recently been linked to neuroprotection, learning and memory. Conclusions: Our results strongly suggest that chronic VLX treatment improves functional reorganization and brain plasticity by influencing gene expression in regulatory networks of motor cortical areas. These results are consonant with the synaptic (network) hypothesis of depression and antidepressant-induced motor recovery after stroke.	[Tamasi, Viola] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Petschner, Peter; Adori, Csaba; Kirilly, Eszter; Ando, Romeo D.; Tothfalusi, Laszlo; Juhasz, Gabriella; Bagdy, Gyorgy] Semmelweis Univ, Dept Pharmacodynam, H-1085 Budapest, Hungary; [Tamasi, Viola; Petschner, Peter; Juhasz, Gabriella; Bagdy, Gyorgy] MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary; [Juhasz, Gabriella] Univ Manchester, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Adori, Csaba] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Semmelweis University; Semmelweis University; University of Manchester; Karolinska Institutet	Tamasi, V (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary.	vtamasi@mac.com	Juhasz, Gabriella/O-1753-2017; Andó, Rómeó D./E-1228-2011; Petschner, Peter/O-1697-2017; Bagdy, György/O-3893-2017	Juhasz, Gabriella/0000-0002-5975-4267; Andó, Rómeó D./0000-0002-7342-9401; Petschner, Peter/0000-0002-3198-858X; Bagdy, György/0000-0001-8141-3410	Sixth framework program of the European Union, NewMood [LSHM-CT-2004-503474]; Hungarian Brain Research Program [KTIA_13_NAP-A-II/14]; National Development Agency [KTIA_NAP_13-1-2013-0001]; Hungarian Scientific Research Fund [OTKA-PD 108297]	Sixth framework program of the European Union, NewMood; Hungarian Brain Research Program; National Development Agency; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the Sixth framework program of the European Union, NewMood, LSHM-CT-2004-503474; by the Hungarian Brain Research Program (Grant KTIA_13_NAP-A-II/14), by the National Development Agency (Grant KTIA_NAP_13-1-2013-0001) and by the Hungarian Scientific Research Fund (Grant: OTKA-PD 108297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adori C, 2006, J COMP NEUROL, V497, P251, DOI 10.1002/cne.20994; Alttoa A, 2010, EUR NEUROPSYCHOPHARM, V20, P288, DOI 10.1016/j.euroneuro.2009.09.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2002, FACT SHEET; Aragam N, 2013, J MOL NEUROSCI, V50, P250, DOI 10.1007/s12031-012-9931-1; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bakshi R, 2000, NEUROREPORT, V11, P1153, DOI 10.1097/00001756-200004270-00003; Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Becher A, 1999, J NEUROSCI, V19, P1922; Beique JC, 2000, NEUROPHARMACOLOGY, V39, P1800, DOI 10.1016/S0028-3908(00)00017-4; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; BOLSTAD BM, PREPROCESSCORE COLLE; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Carlson M, R PACKAGE VERSION 2; Castellani V, 1998, J NEUROSCI, V18, P4663; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Charalambous DC, 2013, CELL MOL LIFE SCI, V70, P335, DOI 10.1007/s00018-012-1108-0; Cheng CM, 2001, FASEB J, V15, P907, DOI 10.1096/fj.00-0398com; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cunha MP, 2013, MED SCI SPORT EXER, V45, P851, DOI 10.1249/MSS.0b013e31827b23e6; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Dharmshaktu P, 2012, J CLIN PHARMACOL, V52, P6, DOI 10.1177/0091270010394852; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egede LE, 2013, EXPERT REV PHARM OUT, V13, P83, DOI [10.1586/ERP.12.86, 10.1586/erp.12.86]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Feng Y, 2008, AM J PSYCHIAT, V165, P610, DOI 10.1176/appi.ajp.2007.07050805; Fragkouli A, 2012, J NEUROCHEM, V121, P239, DOI 10.1111/j.1471-4159.2011.07637.x; Frederick AL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00029; Gely-Pernot A, 2012, STEM CELLS, V30, P719, DOI 10.1002/stem.1045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gex-Fabry M, 2004, EUR J CLIN PHARMACOL, V59, P883, DOI 10.1007/s00228-003-0710-3; Goemaere J, 2012, J COMP NEUROL, V520, P258, DOI 10.1002/cne.22689; Gruden MA, 2013, BEHAV BRAIN RES, V252, P230, DOI 10.1016/j.bbr.2013.06.024; Juhasz G, 2014, P NATL ACAD SCI USA, V111, pE1666, DOI 10.1073/pnas.1403649111; Karle KN, 2012, NEUROGENETICS, V13, P169, DOI 10.1007/s10048-012-0324-y; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kim HW, 2010, NEUROBIOL DIS, V37, P596, DOI 10.1016/j.nbd.2009.11.010; KIM J, 2013, NATL GEOGR, V224, P8; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; Kroeze Y, 2012, PHARMACOL THERAPEUT, V136, P375, DOI 10.1016/j.pharmthera.2012.08.015; Kumar A, 2000, PSYCHIAT RES-NEUROIM, V100, P41, DOI 10.1016/S0925-4927(00)00067-6; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Li CY, 2014, J CLIN PSYCHOPHARM, V34, P93, DOI 10.1097/JCP.0000000000000056; Lonart G, 2002, TRENDS NEUROSCI, V25, P329, DOI 10.1016/S0166-2236(02)02193-8; Ma Qiang, 2008, Asian Journal of Ecotoxicology, V3, P1; Maccarrone G, 2013, J PSYCHIATR RES, V47, P1572, DOI 10.1016/j.jpsychires.2013.07.021; Manczak M, 2013, J ALZHEIMERS DIS, V37, P679, DOI 10.3233/JAD-130761; Mandelli L, 2013, NEUROSCI BIOBEHAV R, V37, P2375, DOI 10.1016/j.neubiorev.2013.07.011; Martinez-Turrillas R, 2002, NEUROPHARMACOLOGY, V43, P1230, DOI 10.1016/S0028-3908(02)00299-X; Marucci A, 2009, J MOL MED, V87, P139, DOI 10.1007/s00109-008-0429-9; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mayer M, 2010, GENE EXPR PATTERNS, V10, P351, DOI 10.1016/j.gep.2010.08.002; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mitchell HA, 2006, BIOL PSYCHIAT, V60, P1046, DOI 10.1016/j.biopsych.2006.03.057; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; MUTH EA, 1986, BIOCHEM PHARMACOL, V35, P4493, DOI 10.1016/0006-2952(86)90769-0; Myung W, 2012, PSYCHIAT RES, V198, P400, DOI 10.1016/j.psychres.2011.12.037; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Nowakowska E, 2003, ARZNEIMITTEL-FORSCH, V53, P237; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Petschner P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-930; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; R Core Team, 2021, R LANGUAGE ENV STAT; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rosenberg DR, 2004, J AM ACAD CHILD PSY, V43, P1146, DOI 10.1097/01.chi.0000132812.44664.2d; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schafer M, 2005, MOL CELL NEUROSCI, V29, P580, DOI 10.1016/j.mcn.2005.04.010; Seimandi M, 2013, J NEUROSCI, V33, P16189, DOI 10.1523/JNEUROSCI.0076-13.2013; Shah MM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003593; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Smith D, 2002, BRIT J PSYCHIAT, V180, P396, DOI 10.1192/bjp.180.5.396; Smitherman TA, 2011, CNS NEUROSCI THER, V17, P462, DOI 10.1111/j.1755-5949.2010.00170.x; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Speer N, 2005, LECT NOTES COMPUT SC, V3692, P1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTOR B, 1989, NEUROSCI LETT, V97, P111, DOI 10.1016/0304-3940(89)90148-1; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Umehara M, 2013, EUR J PHARMACOL, V702, P250, DOI 10.1016/j.ejphar.2013.01.033; Vincent AM, 2004, DIABETES, V53, P726, DOI 10.2337/diabetes.53.3.726; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Wang YM, 2011, HUM PSYCHOPHARM CLIN, V26, P95, DOI 10.1002/hup.1177; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wittchen HU, 2012, SCIENCE, V338, P15, DOI 10.1126/science.1230817; Yagi T, 2013, J NEUROGENET, V27, P97, DOI 10.3109/01677063.2013.801969; Yamada M, 2002, Pharmacogenomics J, V2, P377, DOI 10.1038/sj.tpj.6500135; Yu JJ, 2013, PSYCHOPHARMACOLOGY, V225, P361, DOI 10.1007/s00213-012-2823-9; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; ZUBENKO GS, 1984, AM J PSYCHIAT, V141, P110	109	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113662	10.1371/journal.pone.0113662	http://dx.doi.org/10.1371/journal.pone.0113662			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423262	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000345899700048
J	Toro, N; Nisa-Martinez, R				Toro, Nicolas; Nisa-Martinez, Rafael			Comprehensive Phylogenetic Analysis of Bacterial Reverse Transcriptases	PLOS ONE			English	Article							GROUP-II INTRONS; DEPENDENT DNA-POLYMERASE; ADAPTIVE IMMUNITY; PHAGE RESISTANCE; ORF-LESS; RNA; DIVERSITY; IDENTIFICATION; CRISPR/CAS; EVOLUTION	Much less is known about reverse transcriptases (RTs) in prokaryotes than in eukaryotes, with most prokaryotic enzymes still uncharacterized. Two surveys involving BLAST searches for RT genes in prokaryotic genomes revealed the presence of large numbers of diverse, uncharacterized RTs and RT-like sequences. Here, using consistent annotation across all sequenced bacterial species from GenBank and other sources via RAST, available from the PATRIC (Pathogenic Resource Integration Center) platform, we have compiled the data for currently annotated reverse transcriptases from completely sequenced bacterial genomes. RT sequences are broadly distributed across bacterial phyla, but green sulfur bacteria and cyanobacteria have the highest levels of RT sequence diversity (<= 85% identity) per genome. By contrast, phylum Actinobacteria, for which a large number of genomes have been sequenced, was found to have a low RT sequence diversity. Phylogenetic analyses revealed that bacterial RTs could be classified into 17 main groups: group II introns, retrons/retron-like RTs, diversity-generating retroelements (DGRs), Abi-like RTs, CRISPR-Cas-associated RTs, group II-like RTs (G2L), and 11 other groups of RTs of unknown function. Proteobacteria had the highest potential functional diversity, as they possessed most of the RT groups. Group II introns and DGRs were the most widely distributed RTs in bacterial phyla. Our results provide insights into bacterial RT phylogeny and the basis for an update of annotation systems based on sequence/domain homology.	[Toro, Nicolas; Nisa-Martinez, Rafael] CSIC, Grp Ecol Genet Rizosfera, Estn Expt Zaidin, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Grp Ecol Genet Rizosfera, Estn Expt Zaidin, Granada, Spain.	nicolas.toro@eez.csic.es	Toro, Nicolas/K-4909-2014	Toro, Nicolas/0000-0002-3614-807X	CSD [2009-0006]; ERDF (European Regional Development Funds); Spanish Ministerio de Ciencia e Innovacion [BIO2011-24401]	CSD; ERDF (European Regional Development Funds)(European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the CSD 2009-0006 for the Consolider-Ingenio program, including ERDF (European Regional Development Funds), and BIO2011-24401 from the Spanish Ministerio de Ciencia e Innovacion, which has been renamed the Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Dai LX, 2003, RNA, V9, P14, DOI 10.1261/rna.2126203; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Durmaz E, 2007, J BACTERIOL, V189, P1417, DOI 10.1128/JB.00904-06; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Eickbush Thomas H., 1994, P121; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Fortier LC, 2005, J BACTERIOL, V187, P3721, DOI 10.1128/JB.187.11.3721-3730.2005; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Inouye S, 1999, J BIOL CHEM, V274, P31236, DOI 10.1074/jbc.274.44.31236; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; LAMPSON BC, 1989, CELL, V56, P701, DOI 10.1016/0092-8674(89)90592-8; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Miller M.A., 2010, P GAT COMP ENV WORKS; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Odegrip R, 2006, J BACTERIOL, V188, P1643, DOI 10.1128/JB.188.4.1643-1647.2006; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Schillinger T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-430; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Simon DM, 2008, RNA, V14, P1704, DOI 10.1261/rna.1056108; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Toro N, 2014, HEREDITY, V113, P306, DOI 10.1038/hdy.2014.32; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Toro N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055102; Wang C, 2011, NUCLEIC ACIDS RES, V39, P7620, DOI 10.1093/nar/gkr397; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099	46	41	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114083	10.1371/journal.pone.0114083	http://dx.doi.org/10.1371/journal.pone.0114083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423096	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700086
J	Tietje, A; Maron, KN; Wei, YZ; Feliciano, DM				Tietje, Ashlee; Maron, Kourtney N.; Wei, Yanzhang; Feliciano, David M.			Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs	PLOS ONE			English	Article							MEMBRANE-PARTICLES; EXOSOMES; MICROVESICLES; PEPTIDES; RELEASE; PROVIDE; BINDING	Brain development requires precise orchestration of cellular events through the coordinate exchange of information between distally located cells. One mechanism by which intercellular communication is achieved is through the transfer of extracellular vesicles (EVs). Exosomes are EVs that carry lipids, nucleic acids, and proteins and are detectable in most biological fluids including cerebrospinal fluid (CSF). Here we report that CSF EV concentrations undergo age dependent fluctuations. We characterized EV RNA content by next generation small RNA sequencing and miRNA microarray analysis and identified a temporal shift in CSF EV content. CSF EVs encapsulated miRNAs that contain a conserved hnRNPA2/B1 recognition sequence. We found that hnRNPA2/B1-containing EVs were produced by choroid plexus epithelial cells and that hnRNPA2/B1 containing EVs decreased with age. These results provide insight into EV exchange of miRNAs within the central nervous system and a framework to understand how changes in EVs may have an important impact on brain development.	[Tietje, Ashlee; Maron, Kourtney N.; Wei, Yanzhang; Feliciano, David M.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Feliciano, DM (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	dfelici@clemson.edu	Feliciano, David/ADM-6724-2022	Feliciano, David/0000-0001-5985-9109	Clemson University; Clemson University Creative Inquiry Program	Clemson University; Clemson University Creative Inquiry Program	This work was supported in part by Clemson University and the Clemson University Creative Inquiry Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078115; Anderson W, 2013, J COLLOID INTERF SCI, V405, P322, DOI 10.1016/j.jcis.2013.02.030; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Feliciano DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088810; Fraser KB, 2013, HUM MOL GENET, V22, P4988, DOI 10.1093/hmg/ddt346; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; MAXWELL DS, 1956, J BIOPHYS BIOCHEM CY, V2, P467, DOI 10.1083/jcb.2.4.467; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980	27	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113116	10.1371/journal.pone.0113116	http://dx.doi.org/10.1371/journal.pone.0113116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420022	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900019
J	Atherton, MA; Bates, RA; Wynn, HP				Atherton, Mark A.; Bates, Ronald A.; Wynn, Henry P.			Dimensional Analysis Using Toric Ideals: Primitive Invariants	PLOS ONE			English	Article								Classical dimensional analysis in its original form starts by expressing the units for derived quantities, such as force, in terms of power products of basic units M, L, T etc. This suggests the use of toric ideal theory from algebraic geometry. Within this the Graver basis provides a unique primitive basis in a well-defined sense, which typically has more terms than the standard Buckingham approach. Some textbook examples are revisited and the full set of primitive invariants found. First, a worked example based on convection is introduced to recall the Buckingham method, but using computer algebra to obtain an integer K matrix from the initial integer A matrix holding the exponents for the derived quantities. The K matrix defines the dimensionless variables. But, rather than this integer linear algebra approach it is shown how, by staying with the power product representation, the full set of invariants (dimensionless groups) is obtained directly from the toric ideal defined by A. One candidate for the set of invariants is a simple basis of the toric ideal. This, although larger than the rank of K, is typically not unique. However, the alternative Graver basis is unique and defines a maximal set of invariants, which are primitive in a simple sense. In addition to the running example four examples are taken from: a windmill, convection, electrodynamics and the hydrogen atom. The method reveals some named invariants. A selection of computer algebra packages is used to show the considerable ease with which both a simple basis and a Graver basis can be found.	[Atherton, Mark A.; Bates, Ronald A.] Brunel Univ, Dept Mech Engn, London, England; [Wynn, Henry P.] London Sch Econ, Dept Stat, London WC2A 2AE, England	Brunel University; University of London; London School Economics & Political Science	Wynn, HP (corresponding author), London Sch Econ, Dept Stat, London WC2A 2AE, England.	h.wynn@lse.ac.uk	Atherton, Mark/C-3310-2017	Atherton, Mark/0000-0002-3293-4241; Wynn, Henry/0000-0002-6448-1080	Leverhulme Trust Emeritus Fellowship [1-SST-U445]; United Kingdom EPSRC [MUCM EP/D049993/1]	Leverhulme Trust Emeritus Fellowship(Leverhulme Trust); United Kingdom EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: The third author received funding from Leverhulme Trust Emeritus Fellowship (1-SST-U445) and United Kingdom EPSRC grant: MUCM EP/D049993/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MC, 2013, TECHNOMETRICS, V55, P257, DOI 10.1080/00401706.2012.746207; Barnett W, 2007, Q J AUSTRIAN EC, V1, P95; BHASKAR R, 1990, ARTIF INTELL, V45, P73, DOI 10.1016/0004-3702(90)90038-2; Bolster D, 2011, PHYS TODAY, V64, P42, DOI 10.1063/PT.3.1258; Buckingham E, 1916, NATURE, V96, P396, DOI 10.1038/096396d0; Buckingham E, 1914, PHYS REV, V4, P345, DOI 10.1103/PhysRev.4.345; Buckingham E., 1915, T AM SOC MECH ENG, V37, P263; Chapman SC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124006; Chapman SC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3057392; Cox D. A., 2007, IDEALS VARIETIES ALG; Cox D. A., 2011, GRADUATE STUDIES MAT, V124; D'Agostino S, 2002, HIST IDEAS THEORETIC; Davis T, 2013, TECHNOMETRICS, V55, P271, DOI 10.1080/00401706.2013.804881; Gibbings JC, 2011, DIMENSIONAL ANALYSIS, P1, DOI 10.1007/978-1-84996-317-6; Gibbings JC, 1986, SYSTEMATIC EXPT; Grove DM, 1992, ENG QUALITY EXPT DES; Hubert E, 2013, JOURNEES NATL CALCUL, V3; Hubert E, 2007, J SYMB COMPUT, V42, P203, DOI 10.1016/j.jsc.2006.03.005; Hubert E, 2013, FOUND COMPUT MATH, V13, P479, DOI 10.1007/s10208-013-9165-9; Jensen A.N, 2011, GFAN SOFTWARE SYSTEM; Margaria G, 2001, MATH BIOSCI, V174, P1, DOI 10.1016/S0025-5564(01)00079-7; Olver P.J., 1986, APPL LIE GROUPS DIFF; Smith H., 1991, INTRO QUANTUM MECH; Sturmfels B, 1996, U LECT NOTE SERIES, V8; Szirtes T, 2007, APPLIED DIMENSIONAL ANALYSIS AND MODELING, 2ND EDITION, P1	25	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112827	10.1371/journal.pone.0112827	http://dx.doi.org/10.1371/journal.pone.0112827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436774	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347114900019
J	Marchetti, L; De Nadai, T; Bonsignore, F; Calvello, M; Signore, G; Viegi, A; Beltram, F; Luin, S; Cattaneo, A				Marchetti, Laura; De Nadai, Teresa; Bonsignore, Fulvio; Calvello, Mariantonietta; Signore, Giovanni; Viegi, Alessandro; Beltram, Fabio; Luin, Stefano; Cattaneo, Antonino			Site-Specific Labeling of Neurotrophins and Their Receptors via Short and Versatile Peptide Tags	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SINGLE-PARTICLE TRACKING; AXONAL-TRANSPORT; NGF-RECEPTOR; QUANTUM DOTS; LIVING CELLS; TRAFFICKING; COMPLEXES; DYNAMICS; MOLECULE	We present a toolbox for the study of molecular interactions occurring between NGF and its receptors. By means of a suitable insertional mutagenesis method we show the insertion of an 8 amino acid tag (A4) into the sequence of NGF and of 12 amino acid tags (A1 and S6) into the sequence of TrkA and P75NTR NGF-receptors. These tags are shortened versions of the acyl and peptidyl carrier proteins; they are here covalently conjugated to the biotin-substituted arm of a coenzyme A (coA) substrate by phosphopantetheinyl transferase enzymes (PPTases). We demonstrate site-specific biotinylation of the purified recombinant tagged neurotrophin, in both the immature proNGF and mature NGF forms. The resulting tagged NGF is fully functional: it can signal and promote PC12 cells differentiation similarly to recombinant wild-type NGF. Furthermore, we show that the insertion of A1 and S6 tags into human TrkA and P75NTR sequences leads to the site-specific biotinylation of these receptors at the cell surface of living cells. Crucially, the two tags are labeled selectively by two different PPTases: this is exploited to reach orthogonal fluorolabeling of the two receptors co-expressed at low density in living cells. We describe the protocols to obtain the enzymatic, site-specific biotinylation of neurotrophins and their receptors as an alternative to their chemical, nonspecific biotinylation. The present strategy has three main advantages: i) it yields precise control of stoichiometry and site of biotin conjugation; ii) the tags used can be functionalized with virtually any small probe that can be carried by coA substrates, besides (and in addition to) biotin; iii) above all it makes possible to image and track interacting molecules at the single-molecule level in living systems.	[Marchetti, Laura; Bonsignore, Fulvio; Beltram, Fabio; Luin, Stefano] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Marchetti, Laura; De Nadai, Teresa; Bonsignore, Fulvio; Calvello, Mariantonietta; Viegi, Alessandro; Beltram, Fabio; Luin, Stefano; Cattaneo, Antonino] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Marchetti, Laura; De Nadai, Teresa; Calvello, Mariantonietta; Viegi, Alessandro; Cattaneo, Antonino] Scuola Normale Super Pisa, BioSNS Lab, Pisa, Italy; [Signore, Giovanni; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Istituto Italiano di Tecnologia - IIT	Luin, S (corresponding author), Scuola Normale Super Pisa, NEST, Pisa, Italy.	s.luin@sns.it; antonino.cattaneo@sns.it	Signore, Giovanni/J-8465-2019; Cattaneo, Antonino/AAA-7252-2019; Cattaneo, Antonino/K-4471-2016; Beltram, Fabio/L-9486-2019; Marchetti, Laura/AAB-9843-2019; signore, giovanni/GOV-6118-2022; Beltram, Fabio/F-2920-2013; Luin, Stefano/B-5532-2012	Signore, Giovanni/0000-0002-0067-2240; Cattaneo, Antonino/0000-0002-6975-8923; Beltram, Fabio/0000-0002-6081-436X; Marchetti, Laura/0000-0002-2110-9481; Beltram, Fabio/0000-0002-6081-436X; Luin, Stefano/0000-0003-2673-366X	MIUR [FIRB RBAP10L8TY, PRIN 2010N8PBAA_006]; Regione Toscana	MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Toscana(Regione Toscana)	Support from MIUR (grants FIRB RBAP10L8TY and PRIN 2010N8PBAA_006 to AC) and from Regione Toscana (grant POR FSE 2007-2013 to SL) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Callegari A, 2012, J NEUROSCI METH, V204, P82, DOI 10.1016/j.jneumeth.2011.10.019; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Johnsson N, 2005, CHEMBIOCHEM, V6, P47, DOI 10.1002/cbic.200400290; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Luna EJ, 2001, CURR PROTOC PROTEIN; Marchetti L, 2013, J CELL SCI, V126, P4445, DOI 10.1242/jcs.129916; Nomura M, 2011, DEV NEUROBIOL, V71, P634, DOI 10.1002/dneu.20879; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Rajan SS, 2008, ACS NANO, V2, P1153, DOI 10.1021/nn700399e; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Shibata SC, 2006, BIOCHEM BIOPH RES CO, V342, P316, DOI 10.1016/j.bbrc.2006.01.126; Sung KJ, 2011, J NEUROSCI METH, V200, P121, DOI 10.1016/j.jneumeth.2011.06.020; Tani T, 2005, J NEUROSCI, V25, P2181, DOI 10.1523/JNEUROSCI.4570-04.2005; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wombacher R, 2011, J BIOPHOTONICS, V4, P391, DOI 10.1002/jbio.201100018; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhou Z, 2008, J AM CHEM SOC, V130, P9925, DOI 10.1021/ja802657n; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	28	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113708	10.1371/journal.pone.0113708	http://dx.doi.org/10.1371/journal.pone.0113708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426999	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400080
J	Song, A; Li, P; Fan, FL; Li, ZJ; Liang, YC				Song, Alin; Li, Ping; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao			The Effect of Silicon on Photosynthesis and Expression of Its Relevant Genes in Rice (Oryza sativa L.) under High-Zinc Stress	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDIATED ALLEVIATION; A FLUORESCENCE; PHOTOSYSTEM-I; PSI-H; CADMIUM; PLANTS; TOXICITY; IRON; GROWTH	The main objectives of this study were to elucidate the roles of silicon (Si) in alleviating the effects of 2 mM zinc (high Zn) stress on photosynthesis and its related gene expression levels in leaves of rice (Oryza sativa L.) grown hydroponically with high-Zn stress. The results showed that photosynthetic parameters, including net photosynthetic rate, transpiration rate, stomatal conductance, intercellular CO2 concentration, chlorophyll concentration and the chlorophyll fluorescence, were decreased in rice exposed to high-Zn treatment. The leaf chloroplast structure was disordered under high-Zn stress, including uneven swelling, disintegrated and missing thylakoid membranes, and decreased starch granule size and number, which, however, were all counteracted by the addition of 1.5 mM Si. Furthermore, the expression levels of Os08g02630 (PsbY), Os05g48630 (PsaH), Os07g37030 (PetC), Os03g57120 (PetH), Os09g26810 and Os04g38410 decreased in Si-deprived plants under high-Zn stress. Nevertheless, the addition of 1.5 mM Si increased the expression levels of these genes in plants under high-Zn stress at 72 h, and the expression levels were higher in Si-treated plants than in Si-deprived plants. Therefore, we conclude that Si alleviates the Zn-induced damage to photosynthesis in rice. The decline of photosynthesis in Zn-stressed rice was attributed to stomatal limitation, and Si activated and regulated some photosynthesis-related genes in response to high-Zn stress, consequently increasing photosynthesis.	[Song, Alin; Li, Ping; Fan, Fenliang; Li, Zhaojun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Liang, YC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China.	ycliang@zju.edu.cn	Fan, Fenliang/G-6090-2012; Liang, Yongchao/D-5809-2012; Liang, Yongchao/S-9281-2019; Li, Ping/GYV-4914-2022; Li, zhaojun/E-5735-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823; 	Ministry of Science and Technology, China; Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences	This research was jointly supported by The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration" and "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-yield Cropland" supported by Ministry of Science and Technology, China, and the funding entitled "Study of long term straw returning on release of soil silicon in typical rice paddy soil in China" from Institute of Agricultural Resources and Regional Planning of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway B. J., 2008, ZINC SOILS CROP NUTR, DOI DOI 10.1016/S0065-2113(06)94003-6; Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; ARNON DI, 1956, BIOCHIM BIOPHYS ACTA, V20, P449, DOI 10.1016/0006-3002(56)90339-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Azzarello E, 2012, ENVIRON EXP BOT, V81, P11, DOI 10.1016/j.envexpbot.2012.02.008; Balakrishnan K, 2000, PHOTOSYNTHETICA, V38, P477, DOI 10.1023/A:1010958512210; Bogdan K, 2008, ENVIRON SCI TECHNOL, V42, P7885, DOI 10.1021/es801194q; Bogdan K, 2009, ENVIRON POLLUT, V157, P2617, DOI 10.1016/j.envpol.2009.05.008; Bonnet M, 2000, J EXP BOT, V51, P945, DOI 10.1093/jexbot/51.346.945; BREYTON C, 1994, J BIOL CHEM, V269, P7597; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Burzynski M, 2007, PHOTOSYNTHETICA, V45, P239, DOI 10.1007/s11099-007-0038-9; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Chen WR, 2008, PHYSIOL PLANTARUM, V132, P89, DOI 10.1111/j.1399-3054.2007.00992.x; Chung NJ, 2005, TOXICOL APPL PHARM, V205, P225, DOI 10.1016/j.taap.2004.10.008; Corcoll N, 2011, HYDROBIOLOGIA, V673, P119, DOI 10.1007/s10750-011-0763-8; Detmann KC, 2012, NEW PHYTOL, V196, P752, DOI 10.1111/j.1469-8137.2012.04299.x; Egea I, 2011, ANN BOT-LONDON, V108, P291, DOI 10.1093/aob/mcr140; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Funk C, 2000, PLANT MOL BIOL, V44, P815, DOI 10.1023/A:1026764728846; Gau AE, 1998, MOL GEN GENET, V260, P56, DOI 10.1007/s004380050870; Gu HH, 2012, PLANT SOIL, V350, P193, DOI 10.1007/s11104-011-0894-8; Guo W, 2007, ENVIRON POLLUT, V148, P251, DOI 10.1016/j.envpol.2006.10.021; Guo W, 2005, PLANT SOIL, V272, P173, DOI 10.1007/s11104-004-4732-0; Hacisalihoglu G, 2003, PLANT PHYSIOL, V131, P595, DOI 10.1104/pp.011825; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hoffmann H, 2011, ENVIRON POLLUT, V159, P2398, DOI 10.1016/j.envpol.2011.06.038; Jiang HM, 2007, ENVIRON POLLUT, V147, P750, DOI 10.1016/j.envpol.2006.09.006; JONES L. H. P., 1967, Advances in agronomy. Vol. 19., P107, DOI 10.1016/S0065-2113(08)60734-8; Kawakami K, 2007, FEBS LETT, V581, P4983, DOI 10.1016/j.febslet.2007.09.036; Kawakami K, 2011, BBA-BIOENERGETICS, V1807, P319, DOI 10.1016/j.bbabio.2010.12.013; Kaya C, 2009, J PLANT NUTR, V32, P1788, DOI 10.1080/01904160903152624; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; KRAUSE GH, 1989, PHILOS T ROY SOC B, V323, P281, DOI 10.1098/rstb.1989.0010; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Li P, 2012, PLANT SOIL, V354, P407, DOI 10.1007/s11104-011-1076-4; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; Liang YC, 1999, PLANT SOIL, V209, P217, DOI 10.1023/A:1004526604913; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Liang YC, 2006, NEW PHYTOL, V172, P63, DOI 10.1111/j.1469-8137.2006.01797.x; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Mitani N, 2005, J EXP BOT, V56, P1255, DOI 10.1093/jxb/eri121; Mortvedt J.J., 2000, HDB SOIL SCI, P2148; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Nikolic M, 2007, PLANT PHYSIOL, V143, P495, DOI 10.1104/pp.106.090845; Nwugo CC, 2008, PLANT SOIL, V311, P73, DOI 10.1007/s11104-008-9659-4; Pfannschmidt T, 2012, PROTOPLASMA, V249, P125, DOI 10.1007/s00709-012-0398-2; Picco C, 2004, BIOPHYS J, V86, P224, DOI 10.1016/S0006-3495(04)74098-9; Prabagar S, 2011, ENVIRON EXP BOT, V70, P266, DOI 10.1016/j.envexpbot.2010.10.001; Radic S, 2010, ECOTOX ENVIRON SAFE, V73, P336, DOI 10.1016/j.ecoenv.2009.10.014; Rizwan M, 2012, J HAZARD MATER, V209, P326, DOI 10.1016/j.jhazmat.2012.01.033; Sanglard LMVP, 2014, PHYSIOL PLANTARUM, V152, P355, DOI 10.1111/ppl.12178; Shi QH, 2005, PHYTOCHEMISTRY, V66, P1551, DOI 10.1016/j.phytochem.2005.05.006; Song A, 2009, J HAZARD MATER, V172, P74, DOI 10.1016/j.jhazmat.2009.06.143; Song A, 2011, PLANT SOIL, V344, P319, DOI 10.1007/s11104-011-0749-3; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; Tan BP, 2001, AQUACULTURE, V192, P67, DOI 10.1016/S0044-8486(00)00435-X; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; da Cunha KPV, 2009, WATER AIR SOIL POLL, V197, P323, DOI 10.1007/s11270-008-9814-9; Wang C, 2009, CHEMOSPHERE, V75, P1468, DOI 10.1016/j.chemosphere.2009.02.033; Wang YX, PLANT PHYSL, V136, P3762; Wani P.A., 2012, TOXICITY HEAVY METAL, P45; Wu J, 2007, PLANT SOIL, V291, P167, DOI 10.1007/s11104-006-9184-2; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P359, DOI 10.1007/s10653-005-4670-7	73	112	122	9	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113782	10.1371/journal.pone.0113782	http://dx.doi.org/10.1371/journal.pone.0113782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426937	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400086
J	Al-Alem, U; Rauscher, G; Shah, E; Batai, K; Mahmoud, A; Beisner, E; Silva, A; Peterson, C; Kittles, R				Al-Alem, Umaima; Rauscher, Garth; Shah, Ebony; Batai, Ken; Mahmoud, Abeer; Beisner, Erin; Silva, Abigail; Peterson, Caryn; Kittles, Rick			Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago	PLOS ONE			English	Article							DETERMINING CONTINENTAL ORIGIN; HORMONE-RECEPTOR STATUS; AFRICAN-AMERICAN; POPULATION-STRUCTURE; WHITE WOMEN; RACE; SURVIVAL; SUBTYPES; RISK; ADMIXTURE	Introduction: Non-Hispanic (nH) Black and Hispanic women are disproportionately affected by early onset disease, later stage, and with more aggressive, higher grade and ER/PR negative breast cancers. The purpose of this analysis was to examine whether genetic ancestry could account for these variation in breast cancer characteristics, once data were stratified by self-reported race/ethnicity and adjusted for potential confounding by social and behavioral factors. Methods: We used a panel of 100 ancestry informative markers (AIMs) to estimate individual genetic ancestry in 656 women from the "Breast Cancer Care in Chicago" study, a multi-ethnic cohort of breast cancer patients to examine the association between individual genetic ancestry and breast cancer characteristics. In addition we examined the association of individual AIMs and breast cancer to identify genes/regions that may potentially play a role in breast cancer disease disparities. Results: As expected, nH Black and Hispanic patients were more likely than nH White patients to be diagnosed at later stages, with higher grade, and with ER/PR negative tumors. Higher European genetic ancestry was protective against later stage at diagnosis (OR 0.7 95% CI: 0.54-0.92) among Hispanic patients, and higher grade (OR 0.73, 95% CI: 0.56-0.95) among nH Black patients. After adjustment for multiple social and behavioral risk factors, the association with later stage remained, while the association with grade was not significant. We also found that the AIM SNP rs10954631 on chromosome 7 was associated with later stage (p=0.02) and higher grade (p=0.012) in nH Whites and later stage (p=0.03) in nH Blacks. Conclusion: Non-European genetic ancestry was associated with later stage at diagnosis in ethnic minorities. The relation between genetic ancestry and stage at diagnosis may be due to genetic factors and/or unmeasured environmental factors that are overrepresented within certain racial/ethnic groups.	[Al-Alem, Umaima; Rauscher, Garth; Mahmoud, Abeer; Silva, Abigail; Peterson, Caryn] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Shah, Ebony; Batai, Ken; Kittles, Rick] Univ Arizona, Dept Surg, Div Urol, Tucson, AZ 85721 USA; [Mahmoud, Abeer] Univ Illinois, Dept Pathol, Chicago, IL USA; [Beisner, Erin] Univ Illinois, Coll Med, Chicago, IL USA; [Silva, Abigail] Edward Hines Jr VA Hosp, Hines, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kittles, R (corresponding author), Univ Arizona, Dept Surg, Div Urol, Tucson, AZ 85721 USA.	rkittles@email.arizona.edu	Al-alem, Umaima/AHD-0666-2022; Al-alem, Umaima/AAW-2584-2021	Al-alem, Umaima/0000-0003-2984-076X; Batai, Ken/0000-0002-0317-1118; Rauscher, Garth/0000-0003-0374-944X; Silva, Abigail/0000-0002-1112-1209; Peterson, Caryn/0000-0002-9868-9576; Shanker, Erin/0000-0003-4688-6129	National Institutes of Health [2P50CA106743]; National Center for Minority Health Disparities [1 P60MD003424-01]; National Institutes of Health-Illinois at Chicago from the National Cancer Institute [2P50CA106743-06]; NATIONAL CANCER INSTITUTE [R25CA057699, P50CA106743] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD003424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Minority Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health-Illinois at Chicago from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The parent study was funded by a grant from the National Institutes of Health (2P50CA106743-Illinois at Chicago from the National Cancer Institute [Grant # 2P50CA106743-06]); and the National Center for Minority Health Disparities (Grant # 1 P60MD003424-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademuyiwa FO, 2011, CANCER RES, V71, P640, DOI 10.1158/0008-5472.CAN-10-3021; Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; Amirian E, 2010, NEURO-ONCOLOGY, V12, P444, DOI 10.1093/neuonc/nop057; Barcenas CH, 2010, CLIN BREAST CANCER, V10, P59, DOI 10.3816/CBC.2010.n.008; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Chambon M, 2011, AM J PATHOL, V178, P1461, DOI 10.1016/j.ajpath.2010.12.026; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cunningham JE, 2010, CANCER CAUSE CONTROL, V21, P399, DOI 10.1007/s10552-009-9472-2; Darb-Esfahani S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-546; Falush D, 2003, GENETICS, V164, P1567; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2010, CANCER EPIDEM BIOMAR, V19, P1074, DOI 10.1158/1055-9965.EPI-09-1193; Fejerman L, 2009, CANCER EPIDEM BIOMAR, V18, P3110, DOI 10.1158/1055-9965.EPI-09-0464; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Giri VN, 2009, CANCER PREV RES, V2, P244, DOI 10.1158/1940-6207.CAPR-08-0150; Haile RW, 2012, CANCER PREV RES, V5, P150, DOI 10.1158/1940-6207.CAPR-11-0447; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Lantz PM, 2006, AM J PUBLIC HEALTH, V96, P2173, DOI 10.2105/AJPH.2005.072132; Lehen'kyi V, 2012, J PHYSIOL-LONDON, V590, P1369, DOI 10.1113/jphysiol.2011.225862; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Palmer JR, 2013, CANCER EPIDEM BIOMAR, V22, P127, DOI 10.1158/1055-9965.EPI-12-0769; Rauscher GH, 2010, CANCER EPIDEM BIOMAR, V19, P640, DOI 10.1158/1055-9965.EPI-09-0997; Reding KW, 2012, BREAST CANCER RES TR, V134, P801, DOI 10.1007/s10549-012-2099-0; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Sawyer E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004285; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Torres JB, 2013, AM J PHYS ANTHROPOL, V151, P135, DOI 10.1002/ajpa.22261; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; Wallace TA, 2011, CARCINOGENESIS, V32, P1107, DOI 10.1093/carcin/bgr066; Whitman S, 2011, J COMMUN HEALTH, V36, P588, DOI 10.1007/s10900-010-9346-2	42	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112916	10.1371/journal.pone.0112916	http://dx.doi.org/10.1371/journal.pone.0112916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423363	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700017
J	Chao, YJ; Chang, WH; Ting, HC; Chao, WT; Hsu, YHH				Chao, Yu-Jen; Chang, Wan-Hsin; Ting, Hsiu-Chi; Chao, Wei-Ting; Hsu, Yuan-Hao Howard			Cell Cycle Arrest and Cell Survival Induce Reverse Trends of Cardiolipin Remodeling	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); ENERGY-METABOLISM; BARTH-SYNDROME; MITOCHONDRIA; CANCER; HEART; MECHANISM; BIOSYNTHESIS; INHIBITION; BIOGENESIS	Cell survival from the arrested state can be a cause of the cancer recurrence. Transition from the arrest state to the growth state is highly regulated by mitochondrial activity, which is related to the lipid compositions of the mitochondrial membrane. Cardiolipin is a critical phospholipid for the mitochondrial integrity and functions. We examined the changes of cardiolipin species by LC-MS in the transition between cell cycle arrest and cell reviving in HT1080 fibrosarcoma cells. We have identified 41 cardiolipin species by MS/MS and semi-quantitated them to analyze the detailed changes of cardiolipin species. The mass spectra of cardiolipin with the same carbon number form an envelope, and the C64, C66, C68, C70 C72 and C74 envelopes in HT1080 cells show a normal distribution in the full scan mass spectrum. The cardiolipin quantity in a cell decreases while entering the cell cycle arrest, but maintains at a similar level through cell survival. While cells awakening from the arrested state and preparing itself for replication, the groups with short acyl chains, such as C64, C66 and C68 show a decrease of cardiolipin percentage, but the groups with long acyl chains, such as C70 and C72 display an increase of cardiolipin percentage. Interestingly, the trends of the cardiolipin species changes during the arresting state are completely opposite to cell growing state. Our results indicate that the cardiolipin species shift from the short chain to long chain cardiolipin during the transition from cell cycle arrest to cell progression.	[Chao, Yu-Jen; Chang, Wan-Hsin; Ting, Hsiu-Chi; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung 40704, Taiwan; [Chao, Wei-Ting] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chao, Wei-Ting] Tunghai Univ, Life Sci Res Ctr, Taichung 40704, Taiwan	Tunghai University; Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung 40704, Taiwan.	howardhsu@thu.edu.tw	hsu, yuan-hao/B-5744-2009		National Science Council, Taiwan [101-2113-M-029-001-MY2]; National Health Research Institutes, Taiwan [NHRI-EX102-10236SC]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by National Science Council, Taiwan (101-2113-M-029-001-MY2) and National Health Research Institutes, Taiwan (NHRI-EX102-10236SC) to YHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, BIOCHEMISTRY-US, V50, P8383, DOI 10.1021/bi2010202; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Dumas JF, 2013, BIOCHIMIE, V95, P27, DOI 10.1016/j.biochi.2012.07.009; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hauff K, 2009, BIOCHEM J, V417, P573, DOI 10.1042/BJ20080650; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kraffe E, 2008, LIPIDS, V43, P961, DOI 10.1007/s11745-008-3219-9; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Monteiro JP, 2013, PROG LIPID RES, V52, P513, DOI 10.1016/j.plipres.2013.06.002; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Xiong W, 2012, ACTA BIOCH BIOPH SIN, V44, P347, DOI 10.1093/abbs/gms006; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yoshinaga MY, 2012, ARCHAEA, V2012, DOI 10.1155/2012/832097; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	55	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113680	10.1371/journal.pone.0113680	http://dx.doi.org/10.1371/journal.pone.0113680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422939	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700052
J	Danigo, A; Magy, L; Richard, L; Desmouliere, A; Bourthoumieu, S; Funalot, B; Demiot, C				Danigo, Aurore; Magy, Laurent; Richard, Laurence; Desmouliere, Alexis; Bourthoumieu, Sylvie; Funalot, Benoit; Demiot, Claire			Neuroprotective Effect of Erythropoietin against Pressure Ulcer in a Mouse Model of Small Fiber Neuropathy	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; IMPAIRS POSTISCHEMIC RECOVERY; ISCHEMIA-REPERFUSION INJURY; SUBSTANCE-P; FOOT ULCERATION; NERVE-FIBERS; SKIN; ACTIVATION; MECHANISMS; HEART	An increased risk of skin pressure ulcers (PUs) is common in patients with sensory neuropathies, including those caused by diabetes mellitus. Recombinant human erythropoietin (rhEPO) has been shown to protect the skin against PUs developed in animal models of long-term diabetes. The aim of this work was to determine whether rhEPO could prevent PU formation in a mouse model of drug-inducedSFN. Functional SFN was induced by systemic injection of resiniferatoxin (RTX, 50 mu g/kg, i.p.). RhEPO (3000 UI/kg, i.p.) was given the day before RTX injection and then every other day. Seven days after RTX administration, PUs were induced by applying two magnetic plates on the dorsal skin. RTX-treated mice expressed thermal and mechanical hypoalgesia and showed calcitonin gene-related peptide (CGRP) and substance P (SP) depletion without nerve degeneration or vascular dysfunction. RTX mice developed significantly larger stage 2 PUs than Vehicle mice. RhEPO prevented thermal and mechanical hypoalgesia and neuropeptide depletion in small nerve fibers. RhEPO increased hematocrit and altered endothelium-dependent vasodilatation without any effect on PU formation in Vehicle mice. The characteristics of PUs in RTX mice treated with rhEPO and Vehicle mice were found similar. In conclusion, RTX appeared to increased PU development through depletion of CGRP and SP in small nerve fibers, whereas systemic rhEPO treatment had beneficial effect on peptidergic nerve fibers and restored skin protective capacities against ischemic pressure. Our findings support the evaluation of rhEPO and/or its non-hematopoietic analogs in preventing to prevent PUs in patients with SFN.	[Danigo, Aurore; Magy, Laurent; Richard, Laurence; Desmouliere, Alexis; Bourthoumieu, Sylvie; Funalot, Benoit; Demiot, Claire] Univ Limoges, GEIST Inst Genom Environm Immun Sante & Therapeut, EA Equipe Accueil Maintenance Myelin & Neuropathi, Fac Med & Pharm, Limoges, France; [Magy, Laurent; Richard, Laurence; Funalot, Benoit] CHU Ctr Hosp Univ Limoges, Serv Neurol, Ctr Reference Natl Neuropathies Peripher Rares, Limoges, France	Universite de Limoges; CHU Limoges	Demiot, C (corresponding author), Univ Limoges, GEIST Inst Genom Environm Immun Sante & Therapeut, EA Equipe Accueil Maintenance Myelin & Neuropathi, Fac Med & Pharm, Limoges, France.	claire.demiot@unilim.fr		Magy, Laurent/0000-0003-1784-2901; Funalot, Benoit/0000-0001-6352-6518	Conseil Regional du Limousin	Conseil Regional du Limousin(Region Nouvelle-Aquitaine)	A. Danigo was the recipient of a fellowship from the "Conseil Regional du Limousin.'' No other authors received specific funding for this work. The funder had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763; Andoh T, 2011, BRAIN RES, V1387, P8, DOI 10.1016/j.brainres.2011.02.077; Aubdool AA, 2011, J INVEST DERM SYMP P, V15, P33, DOI 10.1038/jidsymp.2011.8; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; Beiswenger KK, 2008, NEUROSCI LETT, V442, P267, DOI 10.1016/j.neulet.2008.06.079; Bianchi R, 2006, CLIN CANCER RES, V12, P2607, DOI 10.1158/1078-0432.CCR-05-2177; Bianchi R, 2004, P NATL ACAD SCI USA, V101, P823, DOI 10.1073/pnas.0307823100; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Campana WM, 2001, FASEB J, V15, P1804, DOI 10.1096/fj.00-0857fje; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cervellini I, 2010, NEUROTOX RES, V18, P151, DOI 10.1007/s12640-009-9127-9; Chattopadhyay M, 2009, BRAIN, V132, P879, DOI 10.1093/brain/awp014; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; DANIGO A, J MED SCI, V29, P597, DOI DOI 10.1051/MEDSCI/2013296012; Danigo A, 2014, NEUROSCI LETT, V571, P39, DOI 10.1016/j.neulet.2014.04.026; Demiot C, 2006, DIABETES, V55, P1478, DOI 10.2337/db05-1433; Demiot C, 2011, J INVEST DERMATOL, V131, P2316, DOI 10.1038/jid.2011.211; Hamed S, 2014, WOUND REPAIR REGEN, V22, P23, DOI 10.1111/wrr.12135; Hamed S, 2010, J INVEST DERMATOL, V130, P287, DOI 10.1038/jid.2009.219; Hartmann P, 2011, N-S ARCH PHARMACOL, V383, P179, DOI 10.1007/s00210-010-0588-4; Hsieh YL, 2008, J NEUROPATH EXP NEUR, V67, P93, DOI 10.1097/nen.0b013e3181630bb8; Kassem LA, 2011, DRUG DISCOV THER, V5, P136, DOI 10.5582/ddt.2011.v5.3.136; Kissin I, 2008, ANESTH ANALG, V107, P271, DOI 10.1213/ane.0b013e318162cfa3; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Koskinen MJ, 2011, ANTICANCER RES, V31, P4413; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Li JP, 2013, REGUL PEPTIDES, V185, P20, DOI 10.1016/j.regpep.2013.06.008; Liao FY, 2013, J TISSUE VIABILITY, V22, P25, DOI 10.1016/j.jtv.2013.03.001; LINDBERGER M, 1989, J NEUROL SCI, V93, P289, DOI 10.1016/0022-510X(89)90198-6; Melli G, 2006, NEUROBIOL DIS, V24, P525, DOI 10.1016/j.nbd.2006.08.014; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Peters EMJ, 2006, J INVEST DERMATOL, V126, P1937, DOI 10.1038/sj.jid.5700429; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Sauseng S, 1999, DIABETES NUTR METAB, V12, P189; Sexton A, 2007, FASEB J, V21, P2695, DOI 10.1096/fj.06-7828com; Siddle HJ, 2012, CLIN RHEUMATOL, V31, P541, DOI 10.1007/s10067-011-1886-z; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Stadler I, 2004, J INVEST SURG, V17, P221, DOI 10.1080/08941930490472046; Steagall RJ, 2012, NEUROSCIENCE, V214, P106, DOI 10.1016/j.neuroscience.2012.04.023; Steinhoff M, 2003, ARCH DERMATOL, V139, P1479, DOI 10.1001/archderm.139.11.1479; Stekelenburg A, 2008, ARCH PHYS MED REHAB, V89, P1410, DOI 10.1016/j.apmr.2008.01.012; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Swartjes M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-13; Tan IL, 2012, ARCH NEUROL-CHICAGO, V69, P265, DOI 10.1001/archneurol.2011.1120; Tin SNW, 2014, CLIN NEUROPHYSIOL, V125, P1048, DOI 10.1016/j.clinph.2013.09.038; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Tsuji S, 2005, WOUND REPAIR REGEN, V13, P209, DOI 10.1111/j.1067-1927.2005.130213.x; USTINOVA EE, 1995, CARDIOVASC RES, V30, P55, DOI 10.1016/0008-6363(95)00010-0; van Velzen M, 2014, EXPERT OPIN INV DRUG, V23, P541, DOI 10.1517/13543784.2014.892072; Wang LH, 2005, CIRCULATION, V112, P3617, DOI 10.1161/CIRCULATIONAHA.105.556274; Weidner C, 2000, J INVEST DERMATOL, V115, P1015, DOI 10.1046/j.1523-1747.2000.00142.x; Wolfrum S, 2005, REGUL PEPTIDES, V127, P217, DOI 10.1016/j.regpep.2004.12.008; Yoon MS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-77; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296; Zhong BH, 2009, AM J PHYSIOL-REG I, V297, pR1681, DOI 10.1152/ajpregu.90746.2008	59	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113454	10.1371/journal.pone.0113454	http://dx.doi.org/10.1371/journal.pone.0113454			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422898	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700035
J	Nie, HY; Liu, C; Zhang, YX; Zhou, MT; Huang, XF; Peng, L; Xia, QY				Nie, Hongyi; Liu, Chun; Zhang, Yinxia; Zhou, Mengting; Huang, Xiaofeng; Peng, Li; Xia, Qingyou			Transcriptome Analysis of Neonatal Larvae after Hyperthermia-Induced Seizures in the Contractile Silkworm, Bombyx mori	PLOS ONE			English	Article							CA2+ RELEASE; GENE-EXPRESSION; RECEPTOR; CHANNEL; PROTEIN; EPILEPSY; MUTANT; DYSFUNCTION; ACTIVATION; MUTATIONS	The ability to respond quickly and efficiently to transient extreme environmental conditions is an important property of all biota. However, the physiological basis of thermotolerance in different species is still unclear. Here, we found that the cot mutant showed a seizure phenotype including contraction of the body, rolling, vomiting gut juice and a momentary cessation of movement, and the heartbeat rhythm of the dorsal vessel significantly increases after hyperthermia. To comprehensively understand this process at the molecular level, the transcriptomic profile of cot mutant, which is a behavior mutant that exhibits a seizure phenotype, was investigated after hyperthermia (42 degrees C) that was induced for 5 min. By digital gene expression profiling, we determined the gene expression profile of three strains (cot/cot ok/ok, +/+ ok/ok and +/+ +/+) under hyperthermia (42 degrees C) and normal (25 degrees C) conditions. A Venn diagram showed that the most common differentially expressed genes (DEGs, FDR<0.01 and log2 Ratio >= 1) were up-regulated and annotated with the heat shock proteins (HSPs) in 3 strains after treatment with hyperthermia, suggesting that HSPs rapidly increased in response to high temperature; 110 unique DEGs, could be identified in the cot mutant after inducing hyperthermia when compared to the control strains. Of these 110 unique DEGs, 98.18% (108 genes) were up-regulated and 1.82% (two genes) were down-regulated in the cot mutant. KEGG pathways analysis of these unique DEGs suggested that the top three KEGG pathways were "Biotin metabolism," "Fatty acid biosynthesis" and "Purine metabolism," implying that diverse metabolic processes are active in cot mutant induced-hyperthermia. Unique DEGs of interest were mainly involved in the ubiquitin system, nicotinic acetylcholine receptor genes, cardiac excitation-contraction coupling or the Notch signaling pathway. Insights into hyperthermia-induced alterations in gene expression and related pathways could yield hints for understanding the relationship between behaviors and environmental stimuli (hyperthermia) in insects.	[Nie, Hongyi; Liu, Chun; Zhang, Yinxia; Zhou, Mengting; Huang, Xiaofeng; Peng, Li; Xia, Qingyou] State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Liu, Chun; Xia, Qingyou] Southwest Univ, Minist Agr, Key Sericultural Lab, Chongqing, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Xia, QY (corresponding author), State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886	National Basic Research Program of China [2012CB114600]; Program for New Century Excellent Talents [NCET-11-0699]; National Natural Science Foundation of China [31372380]; Fundamental Research Funds for the Central Universities of China [XDJK2013A026]; Doctorial Innovation Fund of Southwest University [ky2010001]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Doctorial Innovation Fund of Southwest University	This work was supported by the National Basic Research Program of China (No. 2012CB114600), the Program for New Century Excellent Talents (No. NCET-11-0699), the National Natural Science Foundation of China (No. 31372380), the Fundamental Research Funds for the Central Universities of China (No. XDJK2013A026); the Doctorial Innovation Fund of Southwest University (No. ky2010001).	Abou-Saleh H, 2013, J BIOL CHEM, V288, P32941, DOI 10.1074/jbc.M113.496802; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459; Arikkath J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00061; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Ayyub C, 2011, J GENET, V90, P239, DOI 10.1007/s12041-011-0062-1; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Bers DM, 2002, CARDIAC EXCITATION C; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brand N, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-35; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; David GNS, 2001, BIOCHEMICAL ADAPTATI; De Fusco M, 2000, NAT GENET, V26, P275; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Fill M, 2002, PHYSL REV, V82; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fujii Hiroshi, 1996, Journal of Sericultural Science of Japan, V65, P452; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Jallon P, 1997, REV NEUROL, V153, P173; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kurzik-Dumke U, 1995, SEQUENCE NEW DROSOPH; Lee D, 1999, J NEUROSCI, V19, P5311; Lehmann T, 2014, J MED ENTOMOL, V51, P27, DOI 10.1603/ME13094; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Matthews RW, 2010, INSECT BEHAVIOR, SECOND EDITION, P1, DOI 10.1007/978-90-481-2389-6; Maximov A, 2003, MOL CELL NEUROSCI, V22, P271, DOI 10.1016/S1044-7431(02)00027-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nielsen MM, 2005, J INSECT PHYSIOL, V51, P1320, DOI 10.1016/j.jinsphys.2005.08.002; Peng R, 2012, ACTA BIOCH BIOPH SIN, V44, P614, DOI 10.1093/abbs/gms040; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Poelchau MF, 2013, J EXPT BIOL JEB; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Priori SG, 2001, CIRCULATION, V103, P196; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walensky LD, 1998, CURR BIOL, V8, P1269, DOI 10.1016/S0960-9822(07)00536-2; Zhou X, 2013, BRAZILIAN J MED BIOL	53	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113214	10.1371/journal.pone.0113214	http://dx.doi.org/10.1371/journal.pone.0113214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423472	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700026
J	Shpyleva, S; Ivanovsky, S; de Conti, A; Melnyk, S; Tryndyak, V; Beland, FA; James, SJ; Pogribny, IP				Shpyleva, Svitlana; Ivanovsky, Samuil; de Conti, Aline; Melnyk, Stepan; Tryndyak, Volodymyr; Beland, Frederick A.; James, S. Jill; Pogribny, Igor P.			Cerebellar Oxidative DNA Damage and Altered DNA Methylation in the BTBR T plus tf/J Mouse Model of Autism and Similarities with Human Post Mortem Cerebellum	PLOS ONE			English	Article							GLUTATHIONE REDOX IMBALANCE; SPECTRUM DISORDERS; EXPRESSION; STRESS; GENE; 5-HYDROXYMETHYLCYTOSINE; INFLAMMATION; PHENOTYPES; PROMOTER; CHILDREN	The molecular pathogenesis of autism is complex and involves numerous genomic, epigenomic, proteomic, metabolic, and physiological alterations. Elucidating and understanding the molecular processes underlying the pathogenesis of autism is critical for effective clinical management and prevention of this disorder. The goal of this study is to investigate key molecular alterations postulated to play a role in autism and their role in the pathophysiology of autism. In this study we demonstrate that DNA isolated from the cerebellum of BTBR T+tf/J mice, a relevant mouse model of autism, and from human post-mortem cerebellum of individuals with autism, are both characterized by an increased levels of 8-oxo-7-hydrodeoxyguanosine (8-oxodG), 5-methylcytosine (5mC), and 5-hydroxymethylcytosine (5hmC). The increase in 8-oxodG and 5mC content was associated with a markedly reduced expression of the 8-oxoguanine DNA-glycosylase 1 (Ogg1) and increased expression of de novo DNA methyltransferases 3a and 3b (Dnmt3a and Dnmt3b). Interestingly, a rise in the level of 5hmC occurred without changes in the expression of ten-eleven translocation expression 1 (Tet1) and Tet2 genes, but significantly correlated with the presence of 8-oxodG in DNA. This finding and similar elevation in 8-oxodG in cerebellum of individuals with autism and in the BTBR T+tf/J mouse model warrant future large-scale studies to specifically address the role of OGG1 alterations in pathogenesis of autism.	[Shpyleva, Svitlana; de Conti, Aline; Melnyk, Stepan; James, S. Jill] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Shpyleva, Svitlana; Ivanovsky, Samuil; Tryndyak, Volodymyr; Beland, Frederick A.; Pogribny, Igor P.] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Food & Drug Administration (FDA)	James, SJ (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA.	james.jill@uams.edu; igor.pogribny@fda.hhs.gov		Tryndyak, Volodymyr/0000-0002-8319-2954; Beland, Frederick/0000-0002-2113-6260	Jane Botsford Johnson Foundation	Jane Botsford Johnson Foundation	Funding support for this study was provided by the Jane Botsford Johnson Foundation. Recipient of funding - SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Araghi-Niknam M, 2003, CELL MOL NEUROBIOL, V23, P945, DOI 10.1023/B:CEMN.0000005322.27203.73; Becker EBE, 2013, INT REV NEUROBIOL, V113, P1, DOI 10.1016/B978-0-12-418700-9.00001-0; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bowers K, 2011, J NEURODEV DISORD, V3, P132, DOI 10.1007/s11689-011-9077-4; Chadman KK, 2012, AUTISM S, VS1, P009, DOI DOI 10.4172/2165-7890.S1-009; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223; Crino PB, 2013, ACTA NEUROPATHOL, V125, P317, DOI 10.1007/s00401-013-1085-x; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Habib SL, 2008, AM J PHYSIOL-RENAL, V294, pF281, DOI 10.1152/ajprenal.00370.2007; Hirano T, 2008, J RADIAT RES, V49, P329, DOI 10.1269/jrr.08049; Hyun JW, 2006, INT J CANCER, V118, P302, DOI 10.1002/ijc.21329; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; James SJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.87; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Kinoshita A, 2002, FORMATION 8 HYDROXYD; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Liu D, 2011, J CEREBR BLOOD F MET, V31, P680, DOI 10.1038/jcbfm.2010.147; Main PAE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-35; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Meyza KZ, 2013, BEHAV BRAIN RES, V251, P25, DOI 10.1016/j.bbr.2012.07.021; Miyake K, 2012, ADV EXP MED BIOL, V724, P91, DOI 10.1007/978-1-4614-0653-2_7; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Napoli E, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-2; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Onore CE, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00158; Park GB, 2013, INT J ONCOL, V43, P29, DOI 10.3892/ijo.2013.1949; Parrish R Ryley, 2012, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0724s60; Persico AM, 2013, BEHAV BRAIN RES, V251, P95, DOI 10.1016/j.bbr.2013.06.012; Piccolo FM, 2014, TRENDS CELL BIOL, V24, P136, DOI 10.1016/j.tcb.2013.09.001; Powell CL, 2005, CANCER LETT, V229, P1, DOI 10.1016/j.canlet.2004.12.002; Reith RM, 2013, NEUROBIOL DIS, V51, P93, DOI 10.1016/j.nbd.2012.10.014; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Schaevitz LR, 2012, ILAR J, V53, P322, DOI 10.1093/ilar.53.3-4.322; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shastry BS, 2003, J HUM GENET, V48, P495, DOI 10.1007/s10038-003-0064-9; Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053; Tryndyak VP, 2006, CARCINOGENESIS, V27, P1713, DOI 10.1093/carcin/bgl050; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Wong AW, 2008, J NEUROSCI, V28, P9047, DOI 10.1523/JNEUROSCI.2557-08.2008	57	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113712	10.1371/journal.pone.0113712	http://dx.doi.org/10.1371/journal.pone.0113712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423485	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700058
J	Sulyok, KM; Hornok, S; Abichu, G; Erdelyi, K; Gyuranecz, M				Sulyok, Kinga M.; Hornok, Sandor; Abichu, Getachew; Erdelyi, Karoly; Gyuranecz, Miklos			Identification of Novel Coxiella burnetii Genotypes from Ethiopian Ticks	PLOS ONE			English	Article							Q-FEVER OUTBREAK; DOMESTIC RUMINANTS; PREVALENCE; DIVERSITY; HUMANS; AGENTS; PCR	Background: Coxiella burnetii, the etiologic agent of Q fever, is a highly infectious zoonotic bacterium. Genetic information about the strains of this worldwide distributed agent circulating on the African continent is limited. The aim of the present study was the genetic characterization of C. burnetii DNA samples detected in ticks collected from Ethiopian cattle and their comparison with other genotypes found previously in other parts of the world. Methodology/Principal Findings: A total of 296 tick samples were screened by real-time PCR targeting the IS1111 region of C. burnetii genome and from the 32 positive samples, 8 cases with sufficient C. burnetii DNA load (Amblyomma cohaerens, n=6; A. variegatum, n=2) were characterized by multispacer sequence typing (MST) and multiple-locus variable-number tandem repeat analysis (MLVA). One novel sequence type (ST), the proposed ST52, was identified by MST. The MLVA-6 discriminated the proposed ST52 into two newly identified MLVA genotypes: type 24 or AH was detected in both Amblyomma species while type 26 or AI was found only in A. cohaerens. Conclusions/Significance: Both the MST and MLVA genotypes of the present work are closely related to previously described genotypes found primarily in cattle samples from different parts of the globe. This finding is congruent with the source hosts of the analyzed Ethiopian ticks, as these were also collected from cattle. The present study provides genotype information of C. burnetii from this seldom studied East-African region as well as further evidence for the presumed host-specific adaptation of this agent.	[Sulyok, Kinga M.; Gyuranecz, Miklos] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Hornok, Sandor; Abichu, Getachew] Szent Istvan Univ, Fac Vet Sci, Budapest, Hungary; [Abichu, Getachew] Natl Res Ctr, Dept Parasitol, Sebeta, Ethiopia; [Erdelyi, Karoly] Natl Food Chain Safety Off, Vet Diagnost Directorate, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Hungarian University of Agriculture & Life Sciences	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	m.gyuranecz@gmail.com	Erdélyi, Károly/A-9600-2016; Erdélyi, Károly/AAB-6540-2022	Gyuranecz, Miklos/0000-0002-5698-5713	Lendulet/Momentum program of the Hungarian Academy of Sciences [LP2012-22]	Lendulet/Momentum program of the Hungarian Academy of Sciences	KMS, MG and the study were supported by the Lendulet/Momentum program (LP2012-22) of the Hungarian Academy of Sciences (http://mta.hu/articles/momentum-program-of-the-hungarian-academy-of-sciences-130009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEBE A, 1990, ETHIOPIAN MED J, V28, P119; Angelakis E, 2014, EMERG INFECT DIS, V20, P726, DOI 10.3201/eid2004.131603; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Astobiza I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-241; Chmielewski T, 2009, POL J MICROBIOL, V58, P9; Cutler SJ, 2007, J INFECTION, V54, P313, DOI 10.1016/j.jinf.2006.10.048; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gumi Balako, 2013, J Vet Sci Med Diagn, V2, DOI 10.4172/2325-9590.1000109; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoogstraal H, 1956, TICKS SUDAN SPECIAL, V3; Hornok S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106452; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Kazar J, 2005, ANN NY ACAD SCI, V1063, P105, DOI 10.1196/annals.1355.018; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Mahamat A, 2013, EMERG INFECT DIS, V19, P1102, DOI 10.3201/eid1907.130044; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Pearson T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-41; PHILIP CB, 1966, B WORLD HEALTH ORGAN, V35, P127; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Reichel R, 2012, RES VET SCI, V93, P1217, DOI 10.1016/j.rvsc.2012.04.007; Santos AS, 2012, INT J MED MICROBIOL, V302, P253, DOI 10.1016/j.ijmm.2012.08.003; Sulyok KM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-107; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P2156, DOI 10.1128/JCM.06831-11; Tilburg JJHC, 2012, EMERG INFECT DIS, V18, P887, DOI 10.3201/eid1805.111907; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11	29	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113213	10.1371/journal.pone.0113213	http://dx.doi.org/10.1371/journal.pone.0113213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423309	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700025
J	Businger, AP; Kaderli, RM				Businger, Adrian P.; Kaderli, Reto M.			Different Views about Work-Hour Limitations in Medicine: A Qualitative Content Analysis of Surgeons', Lawyers', and Pilots' Positive and Negative Arguments	PLOS ONE			English	Article							SURGICAL RESIDENTS; CARE; REFORM; PERFORMANCE; EXPERIENCE; MORTALITY; IMPACT	Background: Whereas work-hour regulations have been taken for granted since 1940 in other occupational settings, such as commercial aviation, they have been implemented only recently in medical professions, where they lead to a lively debate. The aim of the present study was to evaluate arguments in favour of and against work-hour limitations in medicine given by Swiss surgeons, lawyers, and pilots. Methods: An electronic questionnaire survey with four free-response items addressing the question of what arguments speak in favour of or against work-hour limitations in general and in medicine was sent to a random sample of board-certified surgeons, lawyers in labour law, and pilots from SWISS International Airlines Ltd. Results: In all, 279/497 (56%) of the respondents answered the survey: 67/117 surgeons, 92/226 lawyers, and 120/154 pilots. Support for work-hour limitations in general and in medicine was present and higher among lawyers and pilots than it was in surgeons (p<0.001). The latter agreed more with work-hour limitations in general than in medicine (p<0.001). The most often cited arguments in favour of work-hour limitations were "quality and patient safety," "health and fitness," and "leisure and work-family balance," whereas the lack of "flexibility" was the most important argument against. Surgeons expected more often that their "education" and the "quality of their work" would be threatened (p<0.001). Conclusions: Work-hour limitations should be supported in medicine also, but a way must be found to reduce problems resulting from discontinuity in patient care and to minimise the work in medicine, which has no education value.	[Businger, Adrian P.] Swiss Armed Forces, Mil Med Serv, Ittigen Bern, Switzerland; [Businger, Adrian P.] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Kaderli, Reto M.] Univ Bern, Univ Hosp Bern, Dept Visceral Surg & Med, Bern, Switzerland	University of Bern; University Hospital of Bern	Businger, AP (corresponding author), Swiss Armed Forces, Mil Med Serv, Ittigen Bern, Switzerland.	adrian.businger@gmx.ch		Kaderli, Reto/0000-0001-8190-8771				*ACCR COUNC GRAD M, 2002, REP ACGME WORK GROUP; ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; Businger A, 2010, ARCH SURG-CHICAGO, V145, P558, DOI 10.1001/archsurg.2010.88; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Debas HT, 2002, ANN SURG, V236, P263, DOI 10.1097/00000658-200209000-00002; Dumelow C, 2000, BRIT MED J, V320, P1437, DOI 10.1136/bmj.320.7247.1437; Federal Aviation Administration, PIL FLIGHT TIM REST; Fischer JE, 2004, ACAD MED, V79, P381, DOI 10.1097/00001888-200405000-00004; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Halsted WS, 1991, MED TREASURY ART LIT, P267; Hutter MM, 2006, ANN SURG, V243, P864, DOI 10.1097/01.sla.0000220042.48310.66; Jarman Benjamin T, 2004, Curr Surg, V61, P612, DOI 10.1016/j.cursur.2004.06.016; Kaderli R, 2012, SWISS MED WEEKLY, V142; Kort KC, 2004, SURGERY, V136, P861, DOI 10.1016/j.surg.2004.07.005; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leece P, 2006, CAN J SURG, V49, P90; Mache S, 2010, LANGENBECK ARCH SURG, V395, P81, DOI 10.1007/s00423-009-0541-5; Mayring P., 2000, QUALITATIVE INHALTSA, P53; Mendoza KA, 2005, ARCH SURG-CHICAGO, V140, P137, DOI 10.1001/archsurg.140.2.137; Payette M, 2009, AM J SURG, V197, P820, DOI 10.1016/j.amjsurg.2008.05.013; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Stamp Thomas, 2005, Curr Surg, V62, P117, DOI 10.1016/j.cursur.2004.09.013; State Secretariat for Economic Affairs SECO, APPL LAB LAW RES WOR; Swiss Bar Association, FIND LAWY; Taffinder N, 1999, J ROY SOC MED, V92, P329, DOI 10.1177/014107689909200701; Theorell T, 2000, BRIT MED J, V320, P1417, DOI 10.1136/bmj.320.7247.1417; Van Eaton EG, 2005, ARCH SURG-CHICAGO, V140, P230, DOI 10.1001/archsurg.140.3.230; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Wallack MK, 2001, ARCH SURG-CHICAGO, V136, P1426, DOI 10.1001/archsurg.136.12.1426; Whang EE, 2003, ANN SURG, V237, P449, DOI 10.1097/00000658-200304000-00001	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113578	10.1371/journal.pone.0113578	http://dx.doi.org/10.1371/journal.pone.0113578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419712	gold, Green Published			2022-12-27	WOS:000346766900051
J	Guipponi, M; Santoni, FA; Setola, V; Gehrig, C; Rotharmel, M; Cuenca, M; Guillin, O; Dikeos, D; Georgantopoulos, G; Papadimitriou, G; Curtis, L; Meary, A; Schurhoff, F; Jamain, S; Avramopoulos, D; Leboyer, M; Rujescu, D; Pulver, A; Campion, D; Siderovski, DP; Antonarakis, SE				Guipponi, Michel; Santoni, Federico A.; Setola, Vincent; Gehrig, Corinne; Rotharmel, Maud; Cuenca, Macarena; Guillin, Olivier; Dikeos, Dimitris; Georgantopoulos, Georgios; Papadimitriou, George; Curtis, Logos; Meary, Alexandre; Schuerhoff, Franck; Jamain, Stephane; Avramopoulos, Dimitri; Leboyer, Marion; Rujescu, Dan; Pulver, Ann; Campion, Dominique; Siderovski, David P.; Antonarakis, Stylianos E.			Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; ASSOCIATION; VARIANTS; PATTERNS; DISEASE; FITNESS; RISK; AGE	Schizophrenia (SCZ) is a severe, debilitating mental illness which has a significant genetic component. The identification of genetic factors related to SCZ has been challenging and these factors remain largely unknown. To evaluate the contribution of de novo variants (DNVs) to SCZ, we sequenced the exomes of 53 individuals with sporadic SCZ and of their non-affected parents. We identified 49 DNVs, 18 of which were predicted to alter gene function, including 13 damaging missense mutations, 2 conserved splice site mutations, 2 nonsense mutations, and 1 frameshift deletion. The average number of exonic DNV per proband was 0.88, which corresponds to an exonic point mutation rate of 1.7x10(-8) per nucleotide per generation. The non-synonymous-to-synonymous mutation ratio of 2.06 did not differ from neutral expectations. Overall, this study provides a list of 18 putative candidate genes for sporadic SCZ, and when combined with the results of similar reports, identifies a second proband carrying a non-synonymous DNV in the RGS12 gene.	[Guipponi, Michel; Santoni, Federico A.; Gehrig, Corinne; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Guipponi, Michel; Santoni, Federico A.; Gehrig, Corinne; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Setola, Vincent; Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA; [Rotharmel, Maud; Cuenca, Macarena; Guillin, Olivier; Campion, Dominique] Ctr Hosp Rouvray, Sotteville Les Rouen, France; [Rotharmel, Maud; Cuenca, Macarena; Guillin, Olivier; Campion, Dominique] INSERM, U1079, F-75654 Paris 13, France; [Dikeos, Dimitris; Georgantopoulos, Georgios; Papadimitriou, George] Univ Athens, Sch Med, Dept Psychiat 1, GR-11527 Athens, Greece; [Curtis, Logos] Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Meary, Alexandre; Schuerhoff, Franck; Jamain, Stephane; Leboyer, Marion] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Meary, Alexandre; Schuerhoff, Franck; Jamain, Stephane; Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France; [Meary, Alexandre; Schuerhoff, Franck; Jamain, Stephane; Leboyer, Marion] Hop A Chenevier H Mondor, Assistance Publ Hop Paris, Creteil, France; [Meary, Alexandre; Schuerhoff, Franck; Jamain, Stephane; Leboyer, Marion] Fdn Fondamental, Creteil, France; [Avramopoulos, Dimitri; Pulver, Ann] Johns Hopkins Sch Med, Epidemiol & Genet Program Psychiat, Baltimore, MD USA; [Rujescu, Dan] Univ Halle, Dept Psychiat, Halle, Germany; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; University of Geneva; West Virginia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Athens Medical School; National & Kapodistrian University of Athens; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Johns Hopkins University; Johns Hopkins Medicine; Martin Luther University Halle Wittenberg	Guipponi, M (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland.	Michel.Guipponi@unige.ch	Siderovski, David Peter/AAA-9603-2019; Jamain, Stéphane/P-3710-2017; Jamain, Stéphane/L-1822-2019; Leboyer, Marion/AAW-3648-2021; Antonarakis, Stylianos E/N-8866-2014; Rujescu, Dan/GRS-3875-2022	Siderovski, David Peter/0000-0002-0688-8210; Jamain, Stéphane/0000-0002-4321-4100; Leboyer, Marion/0000-0001-5473-3697; Antonarakis, Stylianos E/0000-0001-8907-5823; Setola, Vincent/0000-0002-9791-2270; Santoni, Federico/0000-0002-3258-4747	Swiss National Center of Competence in Research (NCCR) SYNAPSY - The Synaptic Bases of Mental Diseases - of the Swiss National Science Foundation; ERC; NIH [R01 GM082892]; UNC IDDRC, NICHD [P30 HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	Swiss National Center of Competence in Research (NCCR) SYNAPSY - The Synaptic Bases of Mental Diseases - of the Swiss National Science Foundation; ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC IDDRC, NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Swiss National Center of Competence in Research (NCCR) SYNAPSY - The Synaptic Bases of Mental Diseases - of the Swiss National Science Foundation and ERC grant to SEA. Work in the Siderovski lab was funded by NIH grant R01 GM082892 and behavioral studies were supported by the UNC IDDRC, NICHD grant P30 HD03110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; Butko MT, 2013, P NATL ACAD SCI USA, V110, pE726, DOI 10.1073/pnas.1300424110; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santoni FA, 2014, GENOME RES, V24, P349, DOI 10.1101/gr.163832.113; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yang JA, 2010, EUR J HUM GENET, V18, P1039, DOI 10.1038/ejhg.2009.177	37	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112745	10.1371/journal.pone.0112745	http://dx.doi.org/10.1371/journal.pone.0112745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420024	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900012
J	Wang, QF; Zhang, ZW; Dong, F; Chen, LG; Zheng, L; Guo, XY; Li, JQ				Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Zheng, Li; Guo, Xiuyan; Li, Jianqi			Anterior Insula GABA Levels Correlate with Emotional Aspects of Empathy: A Proton Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; MR SPECTROSCOPY; PAIN; CINGULATE; RESPONSES; REPRODUCIBILITY; ORGANIZATION; QUANTITATION; ASSOCIATION; DYSFUNCTION	Background: Empathy is a multidimensional construct referring to the capacity to understand and share the emotional and affective states of another person. Cerebral c-aminobutyric acid (GABA)-ergic levels are associated with a variety of neurological and psychiatric disorders. However, the role of the GABA system in different dimensions of empathy has not been investigated. Materials and Methods: Thirty-two right-handed healthy volunteers took part in this study. We used proton magnetic resonance spectroscopy to determine GABA concentrations in the anterior insula (AI) and the anterior cingulate cortex (ACC) and to examine the relationship between the GABA concentrations and the subcomponents of empathy evaluated by the Interpersonal Reactivity Index (IRI). Result: Pearson correlation analyses (two-tailed) showed that AI GABA was significantly associated with the empathy concern score (r=0.584, p<0.05) and the personal distress score (r=0.538, p<0.05) but not significantly associated with other empathy subscales. No significant correlation was found between ACC GABA and empathy subscores. Conclusion: Left AI GABA was positively correlated with the emotional aspects of empathy. These preliminary findings call into question whether AI GABA alterations might predict empathy dysfunction in major psychiatric disorders such as autism and schizophrenia, which have been described as deficits in emotional empathic abilities.	[Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Guo, Xiuyan; Li, Jianqi] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wang, Qianfeng; Zhang, Zhuwei; Dong, Fang; Chen, Luguang; Guo, Xiuyan; Li, Jianqi] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Zheng, Li; Guo, Xiuyan] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; East China Normal University	Li, JQ (corresponding author), E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	jqli@phy.ecnu.edu.cn	Wang, Qianfeng/ABB-1183-2021	Wang, Qianfeng/0000-0003-1352-4295	The National Natural Science Foundation of China [81271533]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from The National Natural Science Foundation of China (81271533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bora E, 2008, PSYCHIAT RES, V160, P23, DOI 10.1016/j.psychres.2007.05.017; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Citron FMM, 2014, NEUROPSYCHOLOGIA, V56, P79, DOI 10.1016/j.neuropsychologia.2014.01.002; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Danziger N, 2009, NEURON, V61, P203, DOI 10.1016/j.neuron.2008.11.023; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, J COGNITIVE NEUROSCI, V22, P985, DOI 10.1162/jocn.2009.21266; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Ernst J, 2014, SOC COGN AFFECT NEUR, V9, P857, DOI 10.1093/scan/nst058; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Fujiwara H, 2008, PROG NEURO-PSYCHOPH, V32, P1728, DOI 10.1016/j.pnpbp.2008.07.013; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Guo XY, 2012, SOC COGN AFFECT NEUR, V7, P535, DOI 10.1093/scan/nsr034; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kleppner S R, 2001, Expert Opin Ther Targets, V5, P219, DOI 10.1517/14728222.5.2.219; Lanctot KL, 2004, CAN J PSYCHIAT, V49, P439, DOI 10.1177/070674370404900705; Lee SJ, 2010, PSYCHIAT RES-NEUROIM, V181, P121, DOI 10.1016/j.pscychresns.2009.08.003; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Long Z, 2013, PROG NEURO-PSYCHOPH, V44, P131, DOI 10.1016/j.pnpbp.2013.01.020; Marsman A, 2013, SCHIZOPHRENIA BULL, V39, P120, DOI 10.1093/schbul/sbr069; Martin WRW, 2007, MOL IMAGING BIOL, V9, P196, DOI 10.1007/s11307-007-0087-2; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Michalska KJ, 2013, DEV COGN NEUROS-NETH, V3, P22, DOI 10.1016/j.dcn.2012.08.001; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003890; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Near J, 2014, MAGN RESON MED; Near J, 2014, NEUROIMAGE, V99, P191, DOI 10.1016/j.neuroimage.2014.05.059; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; Preis MA, 2013, PAIN, V154, P411, DOI 10.1016/j.pain.2012.11.014; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rosso IM, 2014, DEPRESS ANXIETY, V31, P115, DOI 10.1002/da.22155; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Sandberg K, 2014, NEUROIMAGE, V87, P55, DOI 10.1016/j.neuroimage.2013.10.059; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Vanhamme L, 2001, NMR BIOMED, V14, P233, DOI 10.1002/nbm.695; Wiebking C, 2014, NEUROIMAGE, V86, P10, DOI 10.1016/j.neuroimage.2013.04.042; Zhu L, 2013, EXP BRAIN RES, V228, P1, DOI 10.1007/s00221-013-3531-3	49	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113845	10.1371/journal.pone.0113845	http://dx.doi.org/10.1371/journal.pone.0113845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419976	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900074
J	Kurapati, KRV; Samikkannu, T; Atluri, VSR; Kaftanovskaya, E; Yndart, A; Nair, MPN				Kurapati, Kesava Rao Venkata; Samikkannu, Thangavel; Atluri, Venkata Subba Rao; Kaftanovskaya, Elena; Yndart, Adriana; Nair, Madhavan P. N.			beta-Amyloid(1-42), HIV-1(Ba-L) (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; ALZHEIMERS-DISEASE; IN-VITRO; NEUROCOGNITIVE DISORDERS; MEDICINAL-PLANTS; ROOT EXTRACT; PEPTIDE; NEURODEGENERATION; AGGREGATION; DEPOSITION	Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. Withania somnifera (WS) also known as ` ashwagandha' (ASH) is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is paucity of data on potential neuroprotective effects of ASH against bAmyloid (1-42) (Ab) induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of Methanol: Chloroform (3: 1) extract of ASH and its constituent Withanolide A (WA) against Ab induced toxicity, HIV-1(Ba-L) (clade B) infection and the effects of drugs of abuse using a human neuronal SK-N-MC cell line. Ab when tested individually, induced cytotoxic effects in SK-N-MC cells as shown by increased trypan blue stained cells. However, when ASH was added to Ab treated cells the toxic effects were neutralized. This observation was supported by cellular localization of Ab, MTT formazan exocytosis, and the levels of acetylcholinesterase activity, confirming the chemopreventive or protective effects of ASH against Ab induced toxicity. Further, the levels of MAP2 were significantly increased in cells infected with HIV-1(Ba-L) (clade B) as well as in cells treated with Cocaine (COC) and Methamphetamine (METH) compared with control cells. In ASH treated cells the MAP2 levels were significantly less compared to controls. Similar results were observed in combination experiments. Also, WA, a purified constituent of ASH, showed same pattern using MTT assay as a parameter. These results suggests that neuroprotective properties of ASH observed in the present study may provide some explanation for the ethnopharmacological uses of ASH in traditional medicine for cognitive and other HIV associated neurodegenerative disorders and further ASH could be a potential novel drug to reduce the brain amyloid burden and/or improve the HIV-1 associated neurocognitive impairments	[Kurapati, Kesava Rao Venkata; Samikkannu, Thangavel; Atluri, Venkata Subba Rao; Yndart, Adriana; Nair, Madhavan P. N.] Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Modesto A Maidique Campus, Miami, FL 33199 USA; [Kaftanovskaya, Elena] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Inst NeuroImmune Pharmacol, Dept Immunol, Modesto A Maidique Campus, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institutes Health [1R01MH085259, 1RO37DA025576, 5RO1DA021537, 1RO1DA027049]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA021537, R01DA027049] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This study was supported by grants from the National Institutes Health (1R01MH085259, 1RO37DA025576, 5RO1DA021537, and 1RO1DA027049 to Prof. Madhavan Nair). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 2009, J NEUROIMMUNE PHARM, V4, P190, DOI 10.1007/s11481-009-9152-8; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Atluri VSR, 2014, AUSTIN J DRUG ABUSE, V1, P1; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; BURDICK D, 1992, J BIOL CHEM, V267, P546; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Kumar V, 2006, PHYTOTHER RES, V20, P1023, DOI 10.1002/ptr.1970; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; London JA, 1996, P NATL ACAD SCI USA, V93, P4147, DOI 10.1073/pnas.93.9.4147; Melo JB, 2003, NEUROSCI RES, V45, P117, DOI 10.1016/S0168-0102(02)00201-8; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; Mishra L C, 2000, Altern Med Rev, V5, P334; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514; Ohyagi Y, 2006, MINI-REV MED CHEM, V6, P1075, DOI 10.2174/138955706778560175; Patil S, 2007, EUR J NEUROSCI, V26, P2131, DOI 10.1111/j.1460-9568.2007.05797.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Prabhulkar S, 2012, J NEUROCHEM, V122, P374, DOI 10.1111/j.1471-4159.2012.07709.x; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Soltani MH, 2005, AM J PATHOL, V166, P1841, DOI 10.1016/S0002-9440(10)62493-5; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang C, 2012, Curr Alzheimer Res; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	56	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112818	10.1371/journal.pone.0112818	http://dx.doi.org/10.1371/journal.pone.0112818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415340	Green Published, gold			2022-12-27	WOS:000346906600017
J	Savino, F; Rossi, L; Benetti, S; Petrucci, E; Sorrenti, M; Silvestro, L				Savino, Francesco; Rossi, Lorenza; Benetti, Stefania; Petrucci, Elisa; Sorrenti, Miriam; Silvestro, Leandra			Serum Reference Values for Leptin in Healthy Infants	PLOS ONE			English	Article							FORMULA-FED INFANTS; BREAST-FED INFANTS; CORD BLOOD LEPTIN; REFERENCE INTERVALS; LACTATING MOTHERS; PREVENTS OBESITY; TERM INFANTS; FOOD-INTAKE; LATER LIFE; MILK	Objective: Reports on leptin concentrations in pediatric populations lack reference values for infants in the first months of life. Our study was conducted on healthy full-term infants between 2002 and 2012 to determine serum leptin reference values in subjects less than 18 months old. Methods: Routine outpatient blood tests for serum leptin were performed on 317 infants using a radioimmunoassay method. The median and 10th-90th percentiles were calculated to obtain reference values using quantile regression. Values established in this study were compared with another independent cohort of 110 infants. Results: The median (IQR) serum leptin concentration in the infants was 2.37 (3.26) ng/ml (n = 317). The median leptin concentration was 2.81 (3.49) ng/ml (n = 202) in infants younger than 6 months of age, 1.44 (2.27) ng/ml (n = 59) in infants between 6-12 months of age and 1.77 (2.05) ng/ml (n = 56) in infants between 12-18 months of age. We obtained leptin reference values based on age by estimating the lower and upper percentiles. In the entire cohort, the median (IQR) leptin concentration was 2.22 (3.11) ng/ml in males (n = 168) and 2.60 (3.32) ng/ml in females (n = 149). According to the type of feeding median serum leptin concentration was higher in breast-fed infants (n = 188) than in formula-fed infants (n = 129) (2.63 (3.34) ng/ml vs. 2.12 (2.77) ng/ml; p<0.05). Conclusions: Our data revealed no gender difference in leptin concentration in early infancy. After 6 months of life, leptin concentrations decreased slightly. We used a large cohort to confirm that breast-fed infants had significantly higher serum leptin levels than formula-fed infants during the first 6 months of life, although this difference disappeared later in life. In this study, we defined the leptin reference range in healthy infants in the first 18 months of life according to the Clinical and Laboratory Standards Institute (CLSI).	[Savino, Francesco; Rossi, Lorenza; Benetti, Stefania; Petrucci, Elisa; Sorrenti, Miriam; Silvestro, Leandra] Univ Turin, Regina Margherita Childrens Hosp, Dept Paediat, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Savino, F (corresponding author), Univ Turin, Regina Margherita Childrens Hosp, Dept Paediat, Turin, Italy.	francesco.savino@unito.it	Savino, Francesco/J-6935-2019	Savino, Francesco/0000-0001-9163-1016; SILVESTRO, LEANDRA/0000-0002-5564-1580				Aparicio T, 2005, J CLIN ENDOCR METAB, V90, P6177, DOI 10.1210/jc.2005-1498; Bouret SG, 2010, FORUM NUTR, V63, P84, DOI 10.1159/000264396; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Clapp JF, 1998, J SOC GYNECOL INVEST, V5, P300, DOI 10.1016/S1071-5576(98)00028-8; Dundar NO, 2005, J PEDIATR ENDOCR MET, V18, P181; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Karakosta P, 2012, EUR J PEDIATR, V171, P1563, DOI 10.1007/s00431-012-1804-7; Kawamata R, 2014, J PEDIATR ENDOCR MET, V27, P717, DOI 10.1515/jpem-2013-0385; Mansoub S, 2006, CLIN BIOCHEM, V39, P569, DOI 10.1016/j.clinbiochem.2006.02.013; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; O'Connor D, 2003, J ENDOCRINOL INVEST, V26, P490, DOI 10.1007/BF03345207; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Roubos EW, 2012, GEN COMP ENDOCR, V177, P28, DOI 10.1016/j.ygcen.2012.01.009; Sagawa N, 2002, ENDOCRINE, V19, P65, DOI 10.1385/ENDO:19:1:65; Savino F, 2004, J PEDIATR ENDOCR MET, V17, P1527; Savino F, 2013, ACTA PAEDIATR, V102, pE455, DOI 10.1111/apa.12354; Savino F, 2010, EUR J CLIN NUTR, V64, P972, DOI 10.1038/ejcn.2010.105; Savino F, 2002, ACTA PAEDIATR, V91, P897, DOI 10.1080/080352502760272551; Savino F, 2008, J PEDIATR GASTR NUTR, V46, P348, DOI 10.1097/MPG.0b013e318159e6bf; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Tsai PJ, 2004, CLIN ENDOCRINOL, V61, P88, DOI 10.1111/j.1365-2265.2004.02057.x; Venner AA, 2009, ANN CLIN BIOCHEM, V46, P65, DOI 10.1258/acb.2008.008168; Wilasco MIA, 2012, REGUL PEPTIDES, V173, P21, DOI 10.1016/j.regpep.2011.08.013; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113024	10.1371/journal.pone.0113024	http://dx.doi.org/10.1371/journal.pone.0113024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415449	Green Published, gold			2022-12-27	WOS:000346906600025
J	Song, H; Wang, XY; Cai, QQ; Ding, WJ; Huang, SP; Zhuo, L				Song, Hui; Wang, Xiuying; Cai, Qingqing; Ding, Weijie; Huang, Shuiping; Zhuo, Lang			Association of Metabolic Syndrome with Decreased Glomerular Filtration Rate among 75,468 Chinese Adults: A Cross-Sectional Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; HYPERTENSION; POPULATION; HEALTH	Background: The impact of the various elements of metabolic syndrome (MetS) on chronic kidney disease (CKD) has been conflicting. Therefore, in the present study we aimed to examine the association of MetS and its components with decreased glomerular filtration rate (GFR). Methods: A total of 75,468 urban workers who underwent annual health examinations under the auspices of the local governments between March 2010 and September 2012 at the health examination center of Xuzhou center hospital were enrolled in the cross-sectional survey. Decreased GFR was defined as an estimated GFR <60 mL/min per 1.73 m(2). The definition of MetS was based on the most-recent interim joint consensus definition, requiring any three of the five components, consisting of elevated blood pressure (BP), fasting plasma glucose (FPG), or triglycerides (TG), reduced high density lipoprotein-cholesterol (HDL-c), and obesity. Results: MetS was related to the reduced GFR with an odds ratio [95% confidence interval (CI)] of 1.43 (1.13-1.83). In multivariable analyses, individual components of MetS that were independently associated with decreased GFR were elevated BP (OR 1.34, 95% CI 1.00-1.78), low HDL-c (OR 1.88, 95% CI 1.44-2.43), and elevated FPG (OR 1.42, 95% CI 1.09-1.85). The age-adjusted population-attributable risk percent (PARP) for reduced GFR was 27.55%, 19.67% and14.31% for elevated BP, low HDL-c and elevated FPG respectively. The multivariate-adjusted odds ratios (95% CI) of decreased GFR were 1.70(1.11-2.60), 2.38(1.53-3.71), or 4.11(2.42-6.98) for those with 1, 2, or 3 critical elements (versus zero), respectively. The corresponding multivariate-adjusted odds ratios (95% CI) of decreased GFR were 1.11(0.84-1.48) and 0.89(0.63-1.27) for those with 1 or 2 noncritical components (versus zero), respectively. Conclusions: We concluded that various elements of MetS and the cumulative number of MetS should not be considered indiscriminately as risk factors for reduced GFR.	[Song, Hui; Cai, Qingqing; Ding, Weijie; Huang, Shuiping; Zhuo, Lang] Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol, Xuzhou, Jiangsu, Peoples R China; [Wang, Xiuying] Xuzhou Cent Hosp, Div Nephrol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University	Zhuo, L (corresponding author), Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol, Xuzhou, Jiangsu, Peoples R China.	zhuolang@xzmc.edu.cn			Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province [CXLX13_998]; Xuzhou science and Technology Project [XZZD1239]; Fund of Philosophy and Social Science of Jiangsu Province [13SQB-058]	Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province; Xuzhou science and Technology Project; Fund of Philosophy and Social Science of Jiangsu Province	This work was supported by grants from Postgraduate Research and Innovation Project of Colleges and Universities of Jiangsu Province (No. CXLX13_998), by Xuzhou science and Technology Project (NO. XZZD1239), and by Fund of Philosophy and Social Science of Jiangsu Province (No. 13SQB-058). The specific role of the funding organization or sponsor is as follows: design and conduct of the study, collection of the data, management of the data.	Bandgar Tushar R, 2012, Indian J Endocrinol Metab, V16, P151, DOI 10.4103/2230-8210.93728; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chen J, 2007, NEPHROL DIAL TRANSPL, V22, P1100, DOI 10.1093/ndt/gfl759; Cho JA, 2013, MATURITAS, V75, P74, DOI 10.1016/j.maturitas.2013.02.006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Hanratty R, 2011, CLIN J AM SOC NEPHRO, V6, P2605, DOI 10.2215/CJN.02240311; Hollenberg NK, 2007, KIDNEY INT, V71, P187, DOI 10.1038/sj.ki.5002029; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kitiyakara C, 2007, KIDNEY INT, V71, P693, DOI 10.1038/sj.ki.5002128; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Li YQ, 2014, NEPHROLOGY, V19, P325, DOI 10.1111/nep.12219; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Organization WH, 2000, ASIA PACIFIC PERSPEC; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; Ryu S, 2009, AM J KIDNEY DIS, V53, P59, DOI 10.1053/j.ajkd.2008.07.027; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yoon YS, 2009, METABOLISM, V58, P1737, DOI 10.1016/j.metabol.2009.05.029; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	27	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113450	10.1371/journal.pone.0113450	http://dx.doi.org/10.1371/journal.pone.0113450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415451	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600049
J	Adduri, RSR; Katamoni, R; Pandilla, R; Madana, SN; Paripati, AK; Kotapalli, V; Bashyam, MD				Adduri, Raju S. R.; Katamoni, Rajender; Pandilla, Ramaswamy; Madana, Sandeep N.; Paripati, Arun Kumar; Kotapalli, Viswakalyan; Bashyam, Murali Dharan			TP53 Pro72 Allele Is Enriched in Oral Tongue Cancer and Frequently Mutated in Esophageal Cancer in India	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; P53 CODON-72 POLYMORPHISM; HUMAN-PAPILLOMAVIRUS INFECTION; HIGH-RISK AREA; NASOPHARYNGEAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; GENETIC POLYMORPHISMS; NECK-CANCER; MUTATIONS; ASSOCIATION	Purpose: The tumor suppressor p53 is known to be inactivated frequently in various cancers. In addition, germline polymorphisms in TP53 are known to affect protein function and influence risk of developing different types of cancers. In this study, we analyzed the association of TP53 Pro72Arg polymorphism with squamous cell carcinoma of oral tongue (SCCOT) and esophagus (ESCC) in India. Methods: We assessed the distribution of TP53 Pro72Arg polymorphism in one hundred and fifteen and eighty two SCCOT and ESCC patients, respectively, with respect to one hundred and ten healthy controls from the same population. In addition, we analyzed association of the polymorphism with several clinicopathological and molecular parameters. Results: Pro72 allele was significantly enriched in SCCOT patients compared to the healthy control group but neither allele was enriched in ESCC. Interestingly, Pro72 allele was preferentially mutated in ESCC which was confirmed by analysis of samples heterozygous for Pro72Arg. Conclusions: Our study revealed the association of Pro72 allele with SCCOT suggesting the effect of this polymorphism on SCCOT risk. Preferential mutation of Pro72 allele exclusively in ESCC indicates the need for further studies to understand the tissue specific effect of p53 polymorphism.	[Adduri, Raju S. R.; Katamoni, Rajender; Pandilla, Ramaswamy; Madana, Sandeep N.; Paripati, Arun Kumar; Kotapalli, Viswakalyan; Bashyam, Murali Dharan] Ctr DNA Fingerprinting & Diagnost, Mol Oncol Lab, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Bashyam, MD (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Oncol Lab, Hyderabad, Andhra Pradesh, India.	bashyam@cdfd.org.in	Adduri, Sitaramaraju/AAW-7232-2021	Adduri, Sitaramaraju/0000-0003-2529-2196	Indian Council for Medical Research (ICMR), Govt. of India [5/13/129/2009-NCD-III]; Council of Scientific and Industrial Research (CSIR), Govt. of India [27(265)/12/EMR-II]; Department of Biotechnology, Govt. of India [BT/PR11873/MED/30/173/2009]; Department of Biotechnology, Govt. of India	Indian Council for Medical Research (ICMR), Govt. of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	MDB received Indian Council for Medical Research (ICMR), Govt. of India (Grant No. 5/13/129/2009-NCD-III), Council of Scientific and Industrial Research (CSIR), Govt. of India (Grant No. 27(265)/12/EMR-II), Department of Biotechnology, Govt. of India (Grant No. BT/PR11873/MED/30/173/2009) and a core grant from the Department of Biotechnology, Govt. of India to Centre for DNA Fingerprinting and Diagnostics (CDFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029488; Adduri RSR, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-37; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; BAKER SJ, 1990, CANCER RES, V50, P7717; Bello IO, 2010, ORAL ONCOL, V46, P630, DOI 10.1016/j.oraloncology.2010.06.006; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Cai L, 2006, CANCER EPIDEM BIOMAR, V15, P294, DOI 10.1158/1055-9965.EPI-05-0680; Cai YYC, 2000, CARCINOGENESIS, V21, P683, DOI 10.1093/carcin/21.4.683; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dong HJ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0908-5; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Gaur D, 1997, CLIN CANCER RES, V3, P2129; Gloria-Bottini F, 2012, AM J MED SCI, V343, P127, DOI 10.1097/MAJ.0b013e318223ac71; GROENEN PJ, 1988, FOOD CHEM TOXICOL, V26, P215, DOI 10.1016/0278-6915(88)90122-6; Guimaraes DP, 2001, CANCER LETT, V162, P231, DOI 10.1016/S0304-3835(00)00643-1; HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamel N, 2000, BRIT J CANCER, V82, P757, DOI 10.1054/bjoc.1999.0993; Hammarstedt L, 2011, ORAL ONCOL, V47, P636, DOI 10.1016/j.oraloncology.2011.04.012; Ho KY, 2011, J GASTROEN HEPATOL, V26, P816, DOI 10.1111/j.1440-1746.2011.06669.x; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Ji XM, 2008, CARCINOGENESIS, V29, P875, DOI 10.1093/carcin/bgn039; Jia ST, 2012, ARCH GYNECOL OBSTET, V285, P1657, DOI 10.1007/s00404-012-2226-5; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kankova K, 2014, J NEPHROLOGY THERAPE, V04; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Larsson SC, 2006, INT J CANCER, V119, P915, DOI 10.1002/ijc.21925; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Lee YH, 2012, LUPUS, V21, P430, DOI 10.1177/0961203311434941; Lin HJ, 2002, BRIT J OPHTHALMOL, V86, P767, DOI 10.1136/bjo.86.7.767; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; McWilliams JE, 2000, HEAD NECK-J SCI SPEC, V22, P609, DOI 10.1002/1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-L; Mir MM, 2005, INT J CANCER, V116, P62, DOI 10.1002/ijc.21002; Miyaki M, 2002, ONCOGENE, V21, P6689, DOI 10.1038/sj.onc.1205887; Moore SR, 2000, ORAL DIS, V6, P75; Myers JN, 2000, OTOLARYNG HEAD NECK, V122, P44, DOI 10.1016/S0194-5998(00)70142-2; Pandilla R, 2013, EUR J CLIN INVEST, V43, P1233, DOI 10.1111/eci.12163; Pantelis A, 2007, ONCOL REP, V17, P1243; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Putz A, 2002, INT J CANCER, V98, P99, DOI 10.1002/ijc.10128; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Schneider-Stock R, 2004, AM J PATHOL, V164, P1233, DOI 10.1016/S0002-9440(10)63211-7; Shao Y, 2008, DIS ESOPHAGUS, V21, P139, DOI 10.1111/j.1442-2050.2007.00746.x; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Sousa H, 2006, EUR J CANCER PREV, V15, P362, DOI 10.1097/00008469-200608000-00010; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Summersgill KF, 2000, ORAL SURG ORAL MED O, V90, P334, DOI 10.1067/moe.2000.107359; Tada M, 2001, CARCINOGENESIS, V22, P515, DOI 10.1093/carcin/22.3.515; Tiwawech D, 2003, CANCER LETT, V198, P69, DOI 10.1016/S0304-3835(03)00283-0; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tsai MH, 2002, LARYNGOSCOPE, V112, P116, DOI 10.1097/00005537-200201000-00020; Vaji S, 2011, INT J COLORECTAL DIS, V26, P235, DOI 10.1007/s00384-010-1021-7; WALKER EA, 1979, J NATL CANCER I, V63, P947; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507; Yang WJ, 2008, MOL CARCINOGEN, V47, P100, DOI 10.1002/mc.20368; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114002	10.1371/journal.pone.0114002	http://dx.doi.org/10.1371/journal.pone.0114002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436609	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900108
J	Puttamuk, T; Zhou, LJ; Thaveechai, N; Zhang, SA; Armstrong, CM; Duan, YP				Puttamuk, Thamrongjet; Zhou, Lijuan; Thaveechai, Niphone; Zhang, Shouan; Armstrong, Cheryl M.; Duan, Yongping			Genetic Diversity of Candidatus Liberibacter asiaticus Based on Two Hypervariable Effector Genes in Thailand	PLOS ONE			English	Article							REAL-TIME PCR; GREENING DISEASE; CITRUS; SEQUENCE; PROPHAGE; IDENTIFICATION; BACTERIUM; CLUSTER; GENOME	Huanglongbing (HLB), also known as citrus greening, is one of the most destructive diseases of citrus worldwide. HLB is associated with three species of 'Candidatus Liberibacter' with 'Ca. L. asiaticus' (Las) being the most widely distributed around the world, and the only species detected in Thailand. To understand the genetic diversity of Las bacteria in Thailand, we evaluated two closely-related effector genes, lasA(I) and lasA(II), found within the Las prophages from 239 infected citrus and 55 infected psyllid samples collected from different provinces in Thailand. The results indicated that most of the Las-infected samples collected from Thailand contained at least one prophage sequence with 48.29% containing prophage 1 (FP1), 63.26% containing prophage 2 (FP2), and 19.38% containing both prophages. Interestingly, FP2 was found to be the predominant population in Las-infected citrus samples while Las-infected psyllids contained primarily FP1. The multiple banding patterns that resulted from amplification of lasAI imply extensive variation exists within the full and partial repeat sequence while the single band from lasAII indicates a low amount of variation within the repeat sequence. Phylogenetic analysis of Las-infected samples from 22 provinces in Thailand suggested that the bacterial pathogen may have been introduced to Thailand from China and the Philippines. This is the first report evaluating the genetic variation of a large population of Ca. L. asiaticus infected samples in Thailand using the two effector genes from Las prophage regions.	[Puttamuk, Thamrongjet; Thaveechai, Niphone] Kasetsart Univ, Dept Plant Pathol, Fac Agr, Bangkok, Thailand; [Puttamuk, Thamrongjet; Zhou, Lijuan; Armstrong, Cheryl M.; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA; [Zhang, Shouan] Univ Florida, Ctr Trop Res & Educ, Homestead, FL 33031 USA	Kasetsart University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Duan, YP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA.	yongping.duan@ars.usda.gov	Zhou, Li/GSE-4531-2022		Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF); USDA-ARS-USHRL, Ft. Pierce, Florida; ARS [ARS-0423073] Funding Source: Federal RePORTER	Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF); USDA-ARS-USHRL, Ft. Pierce, Florida; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by the Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF), and the USDA-ARS-USHRL, Ft. Pierce, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Boykin LM, 2012, B ENTOMOL RES, V102, P573, DOI 10.1017/S0007485312000181; CHEETHAM BF, 1995, GENE, V162, P53, DOI 10.1016/0378-1119(95)00315-W; Ding F, 2009, EUR J PLANT PATHOL, V124, P495, DOI 10.1007/s10658-009-9436-0; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Duan Y, 2014, DIVERSITY PLASTICITY; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068921; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Lee HA, 1912, PHILIPP J SCI, V18, P85; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Liu R, 2011, PLANT DIS, V95, P431, DOI 10.1094/PDIS-04-10-0300; Maddison W., 2018, MESQUITE MODULAR SYS; Miller M.A., 2010, P GAT COMP ENV WORKS; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Ohtsu Yoshihiro, 1998, Annals of the Phytopathological Society of Japan, V64, P539; Reinking O, 1919, PHYTOPATHOLOGY, V9, P114; Roistacher CN, 1994, REPORT TECHNICAL VIS; Roistacher CN, 1996, EC LIVING CITRUS DIS, P279; Schwarz R. E., 1973, B PPST, V20, P17; SCHWARZ RE, 1973, FAO PLANT PROTECT B, V21, P132; Teixeira DC, 2008, INT J SYST EVOL MICR, V58, P1414, DOI 10.1099/ijs.0.65641-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Varani AM, 2013, ANNU REV PHYTOPATHOL, V51, P429, DOI 10.1146/annurev-phyto-081211-173010; VILLECHANOUX S, 1993, CURR MICROBIOL, V26, P161, DOI 10.1007/BF01577372; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; ZHOU L, 2013, PLOS ONE, V8; Zhou LJ, 2007, PLANT DIS, V91, P227, DOI 10.1094/PDIS-91-2-0227B; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	36	16	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112968	10.1371/journal.pone.0112968	http://dx.doi.org/10.1371/journal.pone.0112968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437428	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900023
J	Burkova, EE; Dmitrenok, PS; Sedykh, SE; Buneva, VN; Soboleva, SE; Nevinsky, GA				Burkova, Evgeniya E.; Dmitrenok, Pavel S.; Sedykh, Sergey E.; Buneva, Valentina N.; Soboleva, Svetlana E.; Nevinsky, Georgy A.			Extremely Stable Soluble High Molecular Mass Multi-Protein Complex with DNase Activity in Human Placental Tissue	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; CALCIUM-BINDING; AMELOGENINS; GROWTH; FLUID; CELL	Human placenta is an organ which protects, feeds, and regulates the grooving of the embryo. Therefore, identification and characterization of placental components including proteins and their multi-protein complexes is an important step to understanding the placenta function. We have obtained and analyzed for the first time an extremely stable multi-protein complex (SPC,,1000 kDa) from the soluble fraction of three human placentas. By gel filtration on Sepharose-4B, the SPC was well separated from other proteins of the placenta extract. Light scattering measurements and gel filtration showed that the SPC is stable in the presence of NaCl, MgCl2, acetonitrile, guanidinium chloride, and Triton in high concentrations, but dissociates efficiently in the presence of 8 M urea, 50 mM EDTA, and 0.5 M NaCl. Such a stable complex is unlikely to be a casual associate of different proteins. According to SDS-PAGE and MALDI mass spectrometry data, this complex contains many major glycosylated proteins with low and moderate molecular masses (MMs) 4-14 kDa and several moderately abundant (79.3, 68.5, 52.8, and 27.2 kDa) as well as minor proteins with higher MMs. The SPC treatment with dithiothreitol led to a disappearance of some protein bands and revealed proteins with lower MMs. The SPCs from three placentas efficiently hydrolyzed plasmid supercoiled DNA with comparable rates and possess at least two DNA-binding sites with different affinities for a 12-mer oligonucleotide. Progress in study of placental protein complexes can promote understanding of their biological functions.	[Burkova, Evgeniya E.; Sedykh, Sergey E.; Buneva, Valentina N.; Soboleva, Svetlana E.; Nevinsky, Georgy A.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Dmitrenok, Pavel S.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far East Div, Vladivostok 690022, Russia; [Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Novosibirsk State University	Nevinsky, GA (corresponding author), SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Nevinsky, Georgy/E-6053-2012; Dmitrenok, Pavel S/N-3307-2013; Soboleva, Svetlana/G-6315-2013; Buneva, Valentina Nikolaevna/I-6329-2012; Sedykh, Sergey/C-9881-2013; Evgeniya, Burkova/AAE-1501-2021	Dmitrenok, Pavel S/0000-0002-4416-7844; Soboleva, Svetlana/0000-0002-7430-3683; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Sedykh, Sergey/0000-0003-0882-8171; Menzorova, Natalia/0000-0002-2616-7023; Burkova, Evgeniya/0000-0002-5201-7352	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program) [6.2]; Russian Foundation for Basic Research [13-04-00210]; Siberian Division of the Russian Academy of Sciences	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences)	Funding: This research was made possible in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2); Russian Foundation for Basic Research (13-04-00210), and funds from the Siberian Division of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; BOHN H, 1991, ARCH GYNECOL OBSTET, V249, P107, DOI 10.1007/BF02391577; Burger O, 2004, PLACENTA, V25, P608, DOI 10.1016/j.placenta.2003.12.009; Chung LP, 2009, J CLIN ENDOCR METAB, V94, P3038, DOI 10.1210/jc.2009-0778; Dischof P, 1984, PROTEINS PLACENTA BI, P1; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fersht A., 1985, ENZYME STRUCTURE MEC; FINCHAM AG, 1989, CALCIFIED TISSUE INT, V45, P243, DOI 10.1007/BF02556044; Garnica AD, 1996, J AM COLL NUTR, V15, P206; GOLOLOBOV GV, 1995, P NATL ACAD SCI USA, V92, P254, DOI 10.1073/pnas.92.1.254; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Koudinov AR, 1996, BIOCHEM BIOPH RES CO, V223, P592, DOI 10.1006/bbrc.1996.0940; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; NIELSEN FC, 1993, MOL CELL ENDOCRINOL, V93, P87, DOI 10.1016/0303-7207(93)90143-8; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCOPSI L, 1986, HISTOCHEMISTRY, V84, P221, DOI 10.1007/BF00495786; Simmer JP, 1995, CONNECT TISSUE RES, V32, P131, DOI 10.3109/03008209509013715; Than NG, 1999, PLACENTA, V20, P703, DOI 10.1053/plac.1999.0436; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang F, 2013, PLOS ONE, V138; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X; Ye L, 2006, J DENT RES, V85, P814, DOI 10.1177/154405910608500907; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294; Zhou L, 2009, INVEST OPHTH VIS SCI, V50, P2077, DOI 10.1167/iovs.08-2604; Zykova NA, MOL BIOL MOSK, V16, P1165	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111234	10.1371/journal.pone.0111234	http://dx.doi.org/10.1371/journal.pone.0111234			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426722	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400004
J	Chen, Y; Takeda, T; Aoki, Y; Fujita, K; Suzuki, S; Igarashi, D				Chen, Yang; Takeda, Taito; Aoki, Yoshinao; Fujita, Keiko; Suzuki, Shunji; Igarashi, Daisuke			Peptidoglycan from Fermentation By-Product Triggers Defense Responses in Grapevine	PLOS ONE			English	Article							INNATE IMMUNITY; GLUTAMATE PRODUCTION; EF-TU; ARABIDOPSIS; PERCEPTION; RECEPTOR; RESISTANCE; FLAGELLIN; PROTEINS; KINASE	Plants are constantly under attack from a variety of microorganisms, and rely on a series of complex detection and response systems to protect themselves from infection. Here, we found that a by-product of glutamate fermentation triggered defense responses in grapevine, increasing the expression of defense response genes in cultured cells, foliar chitinase activity, and resistance to infection by downy mildew in leaf explants. To identify the molecule that triggered this innate immunity, we fractionated and purified candidates extracted from Corynebacterium glutamicum, a bacterium used in the production of amino acids by fermentation. Using hydrolysis by lysozyme, a silkworm larva plasma detection system, and gel filtration analysis, we identified peptidoglycan as inducing the defense responses. Peptidoglycans of Escherichia coli, Bacillus subtilis, and Staphylococcus aureus also generated similar defensive responses.	[Chen, Yang; Takeda, Taito; Igarashi, Daisuke] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Aoki, Yoshinao; Fujita, Keiko; Suzuki, Shunji] Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi, Japan; [Fujita, Keiko] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima, Japan	Ajinomoto Co Inc; University of Yamanashi	Igarashi, D (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.	daisuke_igarashi@ajinomoto.com	Fujita, Keiko/HGU-4137-2022		Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	Yang Chen, Taito Takeda, and Daisuke Igarashi are the employees of Ajinomoto Co., Inc. Ajinomoto Co., Inc. provided support in the form of salaries for these authors [YC, TT, DI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There is no further employment, consultancy, patents, products in development or marketed products to declare. This does not alter our adherence to all of the PLOS ONE policies on sharing data and materials.''	Chinen A, 2007, J BIOSCI BIOENG, V103, P262, DOI 10.1263/jbb.103.262; Desaki Y, 2006, PLANT CELL PHYSIOL, V47, P1530, DOI 10.1093/pcp/pcl019; Desaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051953; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Faurie B, 2009, J PLANT PHYSIOL, V166, P1863, DOI 10.1016/j.jplph.2009.05.015; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Furukawa T, 2014, MOL PLANT MICROBE IN, V27, P113, DOI 10.1094/MPMI-10-13-0304-R; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Igarashi D, 2010, J PHYTOPATHOL, V158, P668, DOI 10.1111/j.1439-0434.2010.01678.x; Iketani M, 1999, INSECT BIOCHEM MOLEC, V29, P19, DOI 10.1016/S0965-1748(98)00099-X; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; LISWIDOWATI F, 1991, PLANTA, V183, P307; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Sano C, 2009, AM J CLIN NUTR, V90, p728S, DOI 10.3945/ajcn.2009.27462F; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Wuisman Yimiti, 2006, Grassland Science, V52, P73, DOI 10.1111/j.1744-697X.2006.00050.x; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	30	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113340	10.1371/journal.pone.0113340	http://dx.doi.org/10.1371/journal.pone.0113340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427192	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400044
J	Faisal, A; Peltonen, J; Georgii, E; Rung, J; Kaski, S				Faisal, Ali; Peltonen, Jaakko; Georgii, Elisabeth; Rung, Johan; Kaski, Samuel			Toward Computational Cumulative Biology by Combining Models of Biological Datasets	PLOS ONE			English	Article							EXPRESSION; VISUALIZATION; RETRIEVAL	A main challenge of data-driven sciences is how to make maximal use of the progressively expanding databases of experimental datasets in order to keep research cumulative. We introduce the idea of a modeling-based dataset retrieval engine designed for relating a researcher's experimental dataset to earlier work in the field. The search is (i) data-driven to enable new findings, going beyond the state of the art of keyword searches in annotations, (ii) modeling-driven, to include both biological knowledge and insights learned from data, and (iii) scalable, as it is accomplished without building one unified grand model of all data. Assuming each dataset has been modeled beforehand, by the researchers or automatically by database managers, we apply a rapidly computable and optimizable combination model to decompose a new dataset into contributions from earlier relevant models. By using the data-driven decomposition, we identify a network of interrelated datasets from a large annotated human gene expression atlas. While tissue type and disease were major driving forces for determining relevant datasets, the found relationships were richer, and the model-based search was more accurate than the keyword search; moreover, it recovered biologically meaningful relationships that are not straightforwardly visible from annotations for instance, between cells in different developmental stages such as thymocytes and T-cells. Data-driven links and citations matched to a large extent; the data-driven links even uncovered corrections to the publication data, as two of the most linked datasets were not highly cited and turned out to have wrong publication entries in the database.	[Faisal, Ali; Peltonen, Jaakko; Georgii, Elisabeth; Kaski, Samuel] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Rung, Johan] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Kaski, Samuel] Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland	Aalto University; University of Helsinki; European Molecular Biology Laboratory (EMBL); University of Helsinki	Kaski, S (corresponding author), Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland.	samuel.kaski@aalto.fi	Faisal, Ali/A-4613-2012; Kaski, Samuel/B-6684-2008; Peltonen, Jaakko T/O-5172-2016; Peltonen, Jaakko/ABD-1698-2020; Faisal, Aldo/A-2367-2009	Faisal, Ali/0000-0001-9607-9371; Kaski, Samuel/0000-0003-1925-9154; Peltonen, Jaakko T/0000-0003-3485-8585; Peltonen, Jaakko/0000-0003-3485-8585; Rung, Johan/0000-0001-5875-8429; Faisal, Aldo/0000-0003-0813-7207; Al-khazraji, Ali M. A./0000-0003-0756-0556	Academy of Finland, Finnish Centre of Excellence in Computational Inference Research COIN [251170]	Academy of Finland, Finnish Centre of Excellence in Computational Inference Research COIN(Academy of Finland)	Funding: Academy of Finland (http://www.aka.fi), Finnish Centre of Excellence in Computational Inference Research COIN, 251170, to AF, JP, EG, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baxter J, 1997, MACH LEARN, V28, P7, DOI 10.1023/A:1007327622663; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Caldas J, 2012, BIOINFORMATICS, V28, P246, DOI 10.1093/bioinformatics/btr634; Caldas J, 2009, BIOINFORMATICS, V25, pI145, DOI 10.1093/bioinformatics/btp215; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Culligan K, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-2; Engreitz JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-603; Gerber GK, 2007, PLOS COMPUT BIOL, V3, P1426, DOI 10.1371/journal.pcbi.0030148; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Greene CS, 2011, NUCLEIC ACIDS RES, V39, pW368, DOI 10.1093/nar/gkr440; Huttenhower C, 2008, BIOINFORMATICS, V24, pI330, DOI 10.1093/bioinformatics/btn160; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kitazawa M, 2008, ANN NEUROL, V64, P15, DOI 10.1002/ana.21325; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinsson L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.37; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pritchard JK, 2000, GENETICS, V155, P945; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Russ J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-305; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schmid PR, 2012, P NATL ACAD SCI USA, V109, P5594, DOI 10.1073/pnas.1118792109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Tanay A, 2005, MOL SYST BIOL, V1, pe1; Tripathi A, 2011, DATA MIN KNOWL DISC, V23, P300, DOI 10.1007/s10618-010-0205-7; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; van Dongen S, 2000, THESIS U UTRECHT; Virtanen S., 2012, P 15 INT C ARTIFICIA, V22, P1269; Wise A, 2012, BIOINFORMATICS, V28, pI258, DOI 10.1093/bioinformatics/bts205; Zheng J, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar045; Zhu YL, 2008, BIOINFORMATICS, V24, P2798, DOI 10.1093/bioinformatics/btn520	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113053	10.1371/journal.pone.0113053	http://dx.doi.org/10.1371/journal.pone.0113053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427176	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400030
J	Gregoricka, LA; Betsinger, TK; Scott, AB; Polcyn, M				Gregoricka, Lesley A.; Betsinger, Tracy K.; Scott, Amy B.; Polcyn, Marek			Apotropaic Practices and the Undead: A Biogeochemical Assessment of Deviant Burials in Post-Medieval Poland	PLOS ONE			English	Article							STRONTIUM ISOTOPE ANALYSIS; HUMAN MIGRATION; MOBILITY; DEATH; CEMETERY; AGE	Apotropaic observances-traditional practices intended to prevent evil-were not uncommon in post-medieval Poland, and included specific treatment of the dead for those considered at risk for becoming vampires. Excavations at the Drawsko 1 cemetery (17th-18th c. AD) have revealed multiple examples (n=6) of such deviant burials amidst hundreds of normative interments. While historic records describe the many potential reasons why some were more susceptible to vampirism than others, no study has attempted to discern differences in social identity between individuals within standard and deviant burials using biogeochemical analyses of human skeletal remains. The hypothesis that the individuals selected for apotropaic burial rites were non-local immigrants whose geographic origins differed from the local community was tested using radiogenic strontium isotope ratios from archaeological dental enamel. Sr-87/Sr-86 ratios (=0.7112+/-0.0006, 1 sigma) from the permanent molars of 60 individuals reflect a predominantly local population, with all individuals interred as potential vampires exhibiting local strontium isotope ratios. These data indicate that those targeted for apotropaic practices were not migrants to the region, but instead, represented local individuals whose social identity or manner of death marked them with suspicion in some other way. Cholera epidemics that swept across much of Eastern Europe during the 17th century may provide one alternate explanation as to the reason behind these apotropaic mortuary customs, as the first person to die from an infectious disease outbreak was presumed more likely to return from the dead as a vampire.	[Gregoricka, Lesley A.] Univ S Alabama, Dept Sociol Anthropol & Social Work, Mobile, AL 36688 USA; [Betsinger, Tracy K.] SUNY Coll Oneonta, Dept Anthropol, Oneonta, NY 13820 USA; [Scott, Amy B.] Univ Manitoba, Dept Anthropol, Winnipeg, MB, Canada; [Polcyn, Marek] Lakehead Univ, Dept Anthropol, Thunder Bay, ON P7B 5E1, Canada	University of South Alabama; State University of New York (SUNY) System; University of Manitoba; Lakehead University	Gregoricka, LA (corresponding author), Univ S Alabama, Dept Sociol Anthropol & Social Work, Mobile, AL 36688 USA.	lgregoricka@southalabama.edu			University of South Alabama (USA) Faculty Development Council; USA Arts & Sciences Support and Development Award; USA Arts & Sciences Summer Professional Development Award; Slavia Project	University of South Alabama (USA) Faculty Development Council; USA Arts & Sciences Support and Development Award; USA Arts & Sciences Summer Professional Development Award; Slavia Project	This research was supported by a University of South Alabama (USA) Faculty Development Council Grant, USA Arts & Sciences Support and Development Award, USA Arts & Sciences Summer Professional Development Award, and the Slavia Project (http://www.slavia.org/slavia_project.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasev A. N., 1976, VAMPIRES SLAVS, P160; Agarwal S. C., 2011, SOCIAL BIOARCHAEOLOG; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; [Anonymous], 1988, VAMPIRES BURIAL DEAT; [Anonymous], 2010, ACTA ARCHEOLOGICA LO, V56, P51; [Anonymous], 2010, ACTA ARCHAEOLOGICAL, V56, P65; [Anonymous], 1880, MEDAL CROSS ST BENED; [Anonymous], 2012, BBC NEWS; Armelagos GJ, 2003, AM ANTHROPOL, V105, P53, DOI 10.1525/aa.2003.105.1.53; Aspock Edeltraud, 2009, THESIS U READING REA; Bentley, 2006, EUR J ARCHAEOL, V2-3, P259; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Beresford Matthew, 2008, DEMONS DRACULA; Betsinger TK, 2014, CAMBRIDGE A IN PRESS; Betsinger TK, 2012, AM J PHYS ANTHROPOL, V147, P99; Blackburn A, 2012, CAN ASS PHYS ANTH AN; BLUSZTAJN J, 1989, GEOCHIM COSMOCHIM AC, V53, P2689, DOI 10.1016/0016-7037(89)90140-3; Borowy W., 1949, ANGLICY SZKOCI IRLAN; Budnik A, 2006, AM J PHYS ANTHROPOL, V129, P294, DOI 10.1002/ajpa.20288; Buikstra J.E., 1994, STANDARDS DATA COLLE, DOI 10.1002/ajhb.1310070519; Buko A, 2013, ARCHAOL KORRESPONDEN, V43, P423; Corrales S, 2001, VAMPIRES OLD CZECHOS; Davies Norman, 1982, GODS PLAYGROUND HIST, VI; Diaz-Andreu M., 2005, ARCHAEOLOGY IDENTITY; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; EZZO JA, 1994, J ANTHROPOL ARCHAEOL, V13, P1, DOI 10.1006/jaar.1994.1002; Falis A, 2013, ZABIEGI ANTYWAMPIRYC; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Giblin JI, 2013, J ARCHAEOL SCI, V40, P227, DOI 10.1016/j.jas.2012.08.024; Gierowski J. A., 1984, HIST POLSKI 1505 186; Gowland RL, 2005, ANTIQUITY, V79, P146, DOI 10.1017/S0003598X00113766; Guldon Z, 1982, KWARTALNIK HIST KULT, V30; Guldon Z, 1990, ZYDYZI SZKOCI POLSCE; Hickman L, 2013, GUARDIAN; Janowski Andrzej, 2010, ACTA ARCHAEOLOGICAL, V56, P79; Kloczowski Jerzy, 2000, HIST POLISH CHRISTIA; Kopczynski Michal, 2010, POD WSPOLNYM NIEBEM; Kruger K, 2001, SPOLECZENSTWO TZW MA; LOFVENDAHL R, 1990, AQUAT SCI, V52, P315, DOI 10.1007/BF00879760; Machal J, 1976, VAMPIRES SLAVS, P19; Margerison BJ, 2002, AM J PHYS ANTHROPOL, V119, P134, DOI 10.1002/ajpa.10082; Moszynski Kazimierz, 1976, VAMPIRES SLAVS, P180; Nuzzolese E, 2010, J FORENSIC SCI, V55, P1634, DOI 10.1111/j.1556-4029.2010.01525.x; Olszanski T, 2000, ALMANACH KARPACKI, V21; Parker Pearson M, 1999, ARCHAEOLOGY DEATH BU; Perkowski Jan L, 1989, DARKLING TREATISE SL; Perkowski Jan L., 1976, VAMPIRES SLAVS, P9; Perry MA, 2008, GEOARCHAEOLOGY, V23, P528, DOI 10.1002/gea.20230; Pokutta DA, 2012, ANTIQUA, V47, P71; Pokutta DA, 2013, THESIS GOTEBORGS U; Portal R, 1969, THE SLAYS; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Price TD, 2011, ANTIQUITY, V85, P476, DOI 10.1017/S0003598X00067880; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; PRICE TD, 1994, APPL GEOCHEM, V9, P413; Price TD, 2001, ANTIQUITY, V75, P593, DOI 10.1017/S0003598X00088827; PRICE TD, 1994, J ARCHAEOL SCI, V21, P315, DOI 10.1006/jasc.1994.1031; Reynolds A, 2009, ANGLOSAXON DEVIANT C; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Rossmann A, 2000, EUR FOOD RES TECHNOL, V211, P32, DOI 10.1007/s002170050585; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schutkowski H., 2008, BIOL CULTURE; Staff Herald Scotland, 2008, HERALD SCOTLAND; Stone Daniel, 2001, POLISH LITHUANIAN ST; Topolski J, 1992, HIST POLSKI OD CZASO; Tsaliki A., 2008, DEVIANT BURIAL ARCHA, P1; Tsaliki Anastasia, 2001, P 13 EUR M PAL ASS C, P295; Ukrainski P, 2014, POCHOWEK WAMPIRYCZNY; Urbanczyk P, 1997, EARLY CHRISTIANITY C, P31; Urbanczyk P, 2004, POLISH LANDS TURN 1, P5; VEIZER J, 1989, ANNU REV EARTH PL SC, V17, P141, DOI 10.1146/annurev.earth.17.1.141; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Wandycz PS, 1974, LANDS PARTIONED POLA; Williams Hector, 1994, ARCHAEOLOGY, P22; Witkowski R, 2011, STUDIA HIST SLAV GER, V28, P87; Wyrwa Andrzej M., 2004, ZIEMIA NADNOTECKA WC, P123; Wyrwa Andrzej M, 2005, FONTES ARCHAEOLOGICI, V41, P275; Zamojski A, 1987, THE POLISH WAY; Zolfagharifard E., 2013, DAILY MAIL; Zybura M, 2001, NIEMCY W POLSCEE	80	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113564	10.1371/journal.pone.0113564	http://dx.doi.org/10.1371/journal.pone.0113564			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25427197	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400065
J	Lelliott, CJ; Ahnmark, A; Admyre, T; Ahlstedt, I; Irving, L; Keyes, F; Patterson, L; Mumphrey, MB; Bjursell, M; Gorman, T; Bohlooly-Y, M; Buchanan, A; Harrison, P; Vaughan, T; Berthoud, HR; Linden, D				Lelliott, Christopher J.; Ahnmark, Andrea; Admyre, Therese; Ahlstedt, Ingela; Irving, Lorraine; Keyes, Feenagh; Patterson, Laurel; Mumphrey, Michael B.; Bjursell, Mikael; Gorman, Tracy; Bohlooly-Y, Mohammad; Buchanan, Andrew; Harrison, Paula; Vaughan, Tristan; Berthoud, Hans-Rudolf; Linden, Daniel			Monoclonal Antibody Targeting of Fibroblast Growth Factor Receptor 1c Ameliorates Obesity and Glucose Intolerance via Central Mechanisms	PLOS ONE			English	Article							FOOD-INTAKE; RAT-BRAIN; INDUCED SUPPRESSION; ENERGY HOMEOSTASIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; SUBFORNICAL ORGAN; FGF FAMILY; LEPTIN; MICE	We have generated a novel monoclonal antibody targeting human FGFR1c (R1c mAb) that caused profound body weight and body fat loss in diet-induced obese mice due to decreased food intake (with energy expenditure unaltered), in turn improving glucose control. R1c mAb also caused weight loss in leptin-deficient ob/ob mice, leptin receptor-mutant db/db mice, and in mice lacking either the melanocortin 4 receptor or the melanin-concentrating hormone receptor 1. In addition, R1c mAb did not change hypothalamic mRNA expression levels of Agrp, Cart, Pomc, Npy, Crh, Mch, or Orexin, suggesting that R1c mAb could cause food intake inhibition and body weight loss via other mechanisms in the brain. Interestingly, peripherally administered R1c mAb accumulated in the median eminence, adjacent arcuate nucleus and in the circumventricular organs where it activated the early response gene c-Fos. As a plausible mechanism and coinciding with the initiation of food intake suppression, R1c mAb induced hypothalamic expression levels of the cytokines Monocyte chemoattractant protein 1 and 3 and ERK1/2 and p70 S6 kinase 1 activation.	[Lelliott, Christopher J.; Ahnmark, Andrea; Ahlstedt, Ingela; Linden, Daniel] AstraZeneca, Dept Biosci Diabet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Admyre, Therese; Bjursell, Mikael; Bohlooly-Y, Mohammad] AstraZeneca, Discovery Sci Transgen, Molndal, Sweden; [Irving, Lorraine; Keyes, Feenagh; Buchanan, Andrew; Harrison, Paula; Vaughan, Tristan] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Patterson, Laurel; Mumphrey, Michael B.; Berthoud, Hans-Rudolf] Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA 70808 USA; [Gorman, Tracy] AstraZeneca, Discovery Sci, Macclesfield, Cheshire, England	AstraZeneca; Medimmune; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; AstraZeneca	Linden, D (corresponding author), AstraZeneca, Dept Biosci Diabet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden.	daniel.linden@astrazeneca.com	Berthoud, Hans-Rudolf/N-1950-2017	Mumphrey, Michael/0000-0003-3150-8694; Buchanan, Andrew/0000-0002-5191-7682	AstraZeneca; MedImmune	AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune)	Funding: The study was funded by AstraZeneca and MedImmune. The funders provided support in the form of salaries for authors (all authors except L.P., M.B.M., and H-R.B) and a research grant for author H-R.B, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Balland E, 2014, CELL METAB, V19, P293, DOI 10.1016/j.cmet.2013.12.015; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; DeBoer MD, 2009, PEPTIDES, V30, P210, DOI 10.1016/j.peptides.2008.10.019; Dobson CL, 2009, MABS-AUSTIN, V1, P552, DOI 10.4161/mabs.1.6.10057; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Fry M, 2007, EXP BIOL MED, V232, P14; Garcia-Maya M, 2006, J CELL PHYSIOL, V206, P386, DOI 10.1002/jcp.20483; Gayle D, 1998, BRAIN RES, V795, P77, DOI 10.1016/S0006-8993(98)00280-7; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Grossberg AJ, 2010, PHYSIOL BEHAV, V100, P478, DOI 10.1016/j.physbeh.2010.03.011; HANAI K, 1989, AM J PHYSIOL, V256, pR217, DOI 10.1152/ajpregu.1989.256.1.R217; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hotta M, 2001, EUR J PHARMACOL, V416, P101, DOI 10.1016/S0014-2999(01)00767-1; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jiao H, 2011, J CLIN ENDOCR METAB, V96, pE962, DOI 10.1210/jc.2010-2639; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Li AJ, 1996, EXP NEUROL, V137, P318, DOI 10.1006/exnr.1996.0032; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; OOMURA Y, 1992, American Journal of Clinical Nutrition, V55, p278S, DOI 10.1093/ajcn/55.1.278s; PLATASALAMAN CR, 1994, AM J PHYSIOL, V266, pR1711, DOI 10.1152/ajpregu.1994.266.5.R1711; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Potes CS, 2012, AM J PHYSIOL-REG I, V302, pR340, DOI 10.1152/ajpregu.00380.2011; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Romero-Fernandez W, 2011, BIOCHEM BIOPH RES CO, V409, P764, DOI 10.1016/j.bbrc.2011.05.085; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirazi R, 2013, P NATL ACAD SCI USA, V110, P16199, DOI 10.1073/pnas.1306799110; Smith PM, 2009, AM J PHYSIOL-REG I, V296, pR512, DOI 10.1152/ajpregu.90858.2008; Smith PM, 2010, PHYSIOL BEHAV, V99, P534, DOI 10.1016/j.physbeh.2010.01.013; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Sutton GM, 2004, J NEUROSCI, V24, P10240, DOI 10.1523/JNEUROSCI.2764-04.2004; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112109	10.1371/journal.pone.0112109	http://dx.doi.org/10.1371/journal.pone.0112109			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427253	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400009
J	Maatallah, M; Vading, M; Kabir, MH; Bakhrouf, A; Kalin, M; Naucler, P; Brisse, S; Giske, CG				Maatallah, Makaoui; Vading, Malin; Kabir, Muhammad Humaun; Bakhrouf, Amina; Kalin, Mats; Naucler, Pontus; Brisse, Sylvain; Giske, Christian G.			Klebsiella variicola Is a Frequent Cause of Bloodstream Infection in the Stockholm Area, and Associated with Higher Mortality Compared to K. pneumoniae	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; CHROMOSOMAL BETA-LACTAMASE; PYOGENIC LIVER-ABSCESS; PHYLOGENETIC GROUPS; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; VIRULENCE; IDENTIFICATION; BACTEREMIA; GENE	Clinical isolates of Klebsiella pneumoniae are divided into three phylogroups and differ in their virulence factor contents. The aim of this study was to determine an association between phylogroup, virulence factors and mortality following bloodstream infection (BSI) caused by Klebsiella pneumoniae. Isolates from all adult patients with BSI caused by K. pneumoniae admitted to Karolinska University Hospital, Solna between 2007 and 2009 (n=139) were included in the study. Phylogenetic analysis was performed based on multilocus sequence typing (MLST) data. Testing for mucoid phenotype, multiplex PCR determining serotypes K1, K2, K5, K20, K54 and K57, and testing for virulence factors connected to more severe disease in previous studies, was also performed. Data was retrieved from medical records including age, sex, comorbidity, central and urinary catheters, time to adequate treatment, hospital-acquired infection, and mortality, to identify risk factors. The primary end-point was 30-day mortality. The three K. pneumoniae phylogroups were represented: KpI (n=96), KpII (corresponding to K. quasipneumoniae, n=9) and KpIII (corresponding to K. variicola, n=34). Phylogroups were not significantly different in baseline characteristics. Overall, the 30-day mortality was 24/139 (17.3%). Isolates belonging to KpIII were associated with the highest 30-day mortality (10/34 cases, 29.4%), whereas KpI isolates were associated with mortality in 13/96 cases (13.5%). This difference was significant both in univariate statistical analysis (P=0.037) and in multivariate analysis adjusting for age and comorbidity (OR 3.03 (95% CI: 1.10-8.36). Only three of the isolates causing mortality within 30 days belonged to any of the virulent serotypes (K54, n=1), had a mucoid phenotype (n=1) and/or contained virulence genes (wcaG n=1 and wcaG/allS n=1). In conclusion, the results indicate higher mortality among patients infected with isolates belonging to K. variicola. The increased mortality could not be related to any known virulence factors, including virulent capsular types or mucoid phenotype.	[Maatallah, Makaoui; Bakhrouf, Amina] Univ Monastir, Lab Anal Traitement & Valorisat Polluants Environ, Fac Pharm, Montasir, Tunisia; [Vading, Malin; Kabir, Muhammad Humaun; Giske, Christian G.] Karolinska Univ, Hosp Solna, MTC Karolinska Inst, Stockholm, Sweden; [Vading, Malin; Kalin, Mats; Naucler, Pontus] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden; [Brisse, Sylvain] Inst Pasteur, Paris, France; [Brisse, Sylvain] CNRS, Paris, France	Universite de Monastir; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Giske, CG (corresponding author), Karolinska Univ, Hosp Solna, MTC Karolinska Inst, Stockholm, Sweden.	christian.giske@karolinska.se	Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Vading, Malin/0000-0003-4221-8828	European Society for Clinical Microbiology and Infectious Diseases	European Society for Clinical Microbiology and Infectious Diseases	This study was supported by a grant from The European Society for Clinical Microbiology and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak A, 2011, ANTIMICROB AGENTS CH, V55, P5493, DOI 10.1128/AAC.05118-11; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Brisse S, 2004, CLIN MICROBIOL INFEC, V10, P942, DOI 10.1111/j.1469-0691.2004.00973.x; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915, DOI 10.1099/00207713-51-3-915; Brisse S, 2014, INT J SYST EVOL MICR; Brisse S GF, 2006, HDB BIOL BACTERIA; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cagnacci S, 2008, J ANTIMICROB CHEMOTH, V61, P296, DOI 10.1093/jac/dkm471; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen ZH, 2014, FUTURE MICROBIOL, V9, P21, DOI 10.2217/fmb.13.137; Cheng Hsiao-Pei, 2002, Journal of Microbiology Immunology and Infection, V35, P85; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Decre D, 2011, J CLIN MICROBIOL, V49, P3012, DOI 10.1128/JCM.00676-11; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Donnarumma F, 2012, EUR J CLIN MICROBIOL, V31, P371, DOI 10.1007/s10096-011-1319-6; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fevre C, 2005, ANTIMICROB AGENTS CH, V49, P5149, DOI 10.1128/AAC.49.12.5149-5152.2005; Fevre C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001052; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; Grimont F., 2005, BERGEYS MANUAL SYSTE, P685; Gundestrup S, 2014, OPEN MICROBIOL J, P822; Haeggman S, 2004, ANTIMICROB AGENTS CH, V48, P2400, DOI 10.1128/AAC.48.7.2400-2408.2004; Hasan CM, 2013, CLIN MICROBIOL INFEC; Hsu CR, 2011, MICROBIOL-SGM, V157, P3446, DOI 10.1099/mic.0.050336-0; Jung Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-239; Kjellander C, 2012, EUR J HAEMATOL, V88, P422, DOI 10.1111/j.1600-0609.2012.01768.x; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; LEE KH, 1994, J HOSP INFECT, V27, P299, DOI 10.1016/0195-6701(94)90117-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin WH, 2010, INFECTION, V38, P459, DOI 10.1007/s15010-010-0049-5; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Lu CH, 2002, J CLIN NEUROSCI, V9, P533, DOI 10.1054/jocn.2001.1032; Ma LC, 2005, J INFECT DIS, V192, P117, DOI 10.1086/430619; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Meatherall BL, 2009, AM J MED, V122, P866, DOI 10.1016/j.amjmed.2009.03.034; Merlet A, 2012, CLIN MICROBIOL INFEC, V18, pE338, DOI 10.1111/j.1469-0691.2012.03953.x; Olsson-Liljequist B, 1997, SCAND J INFECT DIS, P13; Orskov I, 1984, SEROTYPING KLEBSIELL; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Peirano G, 2012, J ANTIMICROB CHEMOTH, V67, P1114, DOI 10.1093/jac/dks026; Podschun R, 2001, APPL ENVIRON MICROB, V67, P3325, DOI 10.1128/AEM.67.7.3325-3327.2001; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rosenblueth M, 2004, SYST APPL MICROBIOL, V27, P27, DOI 10.1078/0723-2020-00261; Samuelsen O, 2011, CLIN MICROBIOL INFEC, V17, P1811, DOI 10.1111/j.1469-0691.2011.03532.x; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Seki M, 2013, J MED MICROBIOL, V62, P801, DOI 10.1099/jmm.0.051334-0; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Shon AS, 2012, FUTURE MICROBIOL, V7, P669, DOI [10.2217/FMB.12.43, 10.2217/fmb.12.43]; de Melo MES, 2011, CURR MICROBIOL, V62, P1596, DOI 10.1007/s00284-011-9903-7; Lima AMS, 2014, REV SOC BRAS MED TRO, V47, P165, DOI 10.1590/0037-8682-0021-2014; Alves MS, 2006, J CLIN MICROBIOL, V44, P3640, DOI 10.1128/JCM.00940-06; Skogberg K, 2008, EPIDEMIOL INFECT, V136, P108, DOI 10.1017/S0950268807008138; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Suh JY, 2010, ANTIMICROB AGENTS CH, V54, P560, DOI 10.1128/AAC.00762-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thom KA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-116; TOMAS JM, 1991, INFECT IMMUN, V59, P2006; Tsai Sung-Sheng, 2010, Chang Gung Med J, V33, P532; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Turton JF, 2007, J MED MICROBIOL, V56, P593, DOI 10.1099/jmm.0.46964-0; Turton JF, 2010, J MED MICROBIOL, V59, P541, DOI 10.1099/jmm.0.015198-0; Valverde A, 2008, J ANTIMICROB CHEMOTH, V61, P64, DOI 10.1093/jac/dkm403; VATOPOULOS A, 2008, EURO SURVEILL, V13; Villegas MV, 2006, ANTIMICROB AGENTS CH, V50, P2880, DOI 10.1128/AAC.00186-06; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wang L S, 1990, J Formos Med Assoc, V89, P756; Wang M, 2008, J CLIN MICROBIOL, V46, P3555, DOI 10.1128/JCM.00927-08; Warburg G, 2012, J ANTIMICROB CHEMOTH, V67, P898, DOI 10.1093/jac/dkr552; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Yeh KM, 2010, J INFECT DIS, V201, P1259, DOI 10.1086/606010; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187	80	98	102	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113539	10.1371/journal.pone.0113539	http://dx.doi.org/10.1371/journal.pone.0113539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426853	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400061
J	Phillips-Howard, PA; Laserson, KF; Amek, N; Beynon, CM; Angell, SY; Khagayi, S; Byass, P; Hamel, MJ; van Eijk, AM; Zielinski-Gutierrez, E; Slutsker, L; De Cock, KM; Vulule, J; Odhiambo, FO				Phillips-Howard, Penelope A.; Laserson, Kayla F.; Amek, Nyaguara; Beynon, Caryl M.; Angell, Sonia Y.; Khagayi, Sammy; Byass, Peter; Hamel, Mary J.; van Eijk, Anne M.; Zielinski-Gutierrez, Emily; Slutsker, Laurence; De Cock, Kevin M.; Vulule, John; Odhiambo, Frank O.			Deaths Ascribed to Non-Communicable Diseases among Rural Kenyan Adults Are Proportionately Increasing: Evidence from a Health and Demographic Surveillance System, 2003-2010	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; SUB-SAHARAN AFRICA; VERBAL AUTOPSY; WESTERN KENYA; BREAST-CANCER; GLOBAL BURDEN; MORTALITY; CARE; HYPERTENSION; METAANALYSIS	Background: Non-communicable diseases (NCDs) result in more deaths globally than other causes. Monitoring systems require strengthening to attribute the NCD burden and deaths in low and middle-income countries (LMICs). Data from health and demographic surveillance systems (HDSS) can contribute towards this goal. Methods and Findings: Between 2003 and 2010, 15,228 deaths in adults aged 15 years (y) and older were identified retrospectively using the HDSS census and verbal autopsy in rural western Kenya, attributed into broad categories using InterVA-4 computer algorithms; 37% were ascribed to NCDs, 60% to communicable diseases (CDs), 3% to injuries, and,1% maternal causes. Median age at death for NCDs was 66y and 71y for females and males, respectively, with 43% (39% male, 48% female) of NCD deaths occurring prematurely among adults aged below 65y. NCD deaths were mainly attributed to cancers (35%) and cardiovascular diseases (CVDs; 29%). The proportionate mortality from NCDs rose from 35% in 2003 to 45% in 2010 (chi(2) linear trend 93.4; p<0.001). While overall annual mortality rates (MRs) for NCDs fell, cancer-specific MRs rose from 200 to 262 per 100,000 population, mainly due to increasing deaths in adults aged 65y and older, and to respiratory neoplasms in all age groups. The substantial fall in CD MRs resulted in similar MRs for CDs and NCDs among all adult females by 2010. NCD MRs for adults aged 15y to <65y fell from 409 to 183 per 100,000 among females and from 517 to 283 per 100,000 population among males. NCD MRs were higher among males than females aged both below, and at or above, 65y. Conclusions: NCDs constitute a significant proportion of deaths in rural western Kenya. Evidence of the increasing contribution of NCDs to overall mortality supports international recommendations to introduce or enhance prevention, screening, diagnosis and treatment programmes in LMICs.	[Phillips-Howard, Penelope A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Phillips-Howard, Penelope A.; Laserson, Kayla F.; Amek, Nyaguara; Khagayi, Sammy; Zielinski-Gutierrez, Emily; Vulule, John; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Laserson, Kayla F.; De Cock, Kevin M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Beynon, Caryl M.] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Angell, Sonia Y.] Ctr Dis Control & Prevent, Dept Noncommunicable Dis, Div Global Hlth Protect, Atlanta, GA USA; [Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Hamel, Mary J.; Slutsker, Laurence] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Zielinski-Gutierrez, Emily] Ctr Dis Control & Prevent, Div Global HIV & AIDS, Kisumu, Kenya; [De Cock, Kevin M.] Ctr Dis Control & Prevent Kenya, Ctr Global Hlth, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Liverpool John Moores University; Centers for Disease Control & Prevention - USA; Umea University; Centers for Disease Control & Prevention - USA	Phillips-Howard, PA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	Penelope.Phillips-Howard@lstmed.ac.uk	van Eijk, Anna Maria/AAQ-9894-2021	Byass, Peter/0000-0001-5474-4361; Phillips-Howard, Penelope A/0000-0003-1018-116X; van Eijk, Anna Maria/0000-0003-1635-1289	CDC; KEMRI	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); KEMRI	The HDSS has been funded through the CDC Cooperative Agreement grant with KEMRI, with supplemental support from project grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Asaria P, 2010, INT J EPIDEMIOL, V39, P309, DOI 10.1093/ije/dyn245; Azim HA, 2012, CANCER TREAT REV, V38, P834, DOI 10.1016/j.ctrv.2012.06.004; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Coghill AE, 2013, CONTRIBUTION HIV INF, V6; Cohen David William, 1989, SIAYA HISTORICAL ANT; Cooper RS, 2013, PROG CARDIOVASC DIS, V56, P270, DOI 10.1016/j.pcad.2013.09.020; Copson E, 2013, BR J CANC; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Desai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068733; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Feikin DR, 2010, B WORLD HEALTH ORGAN, V88, P601, DOI 10.2471/BLT.09.069732; Foote EM, 2013, AM J TROP MED HYG, V88, P132, DOI 10.4269/ajtmh.2012.12-0496; Gargano JW, 2012, AIDS, V26, P1545, DOI 10.1097/QAD.0b013e328353b7b9; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Harding R, 2013, J PAIN SYMPTOM MANAG, V45, P746, DOI 10.1016/j.jpainsymman.2012.04.007; Institute NC, 2012, RES SEAE; Jemal A, 2012, LANCET; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Lau K, 2008, ALCOHOL ALCOHOLISM, V43, P34, DOI [10.1093/alcalc/afm154, 10.1093/alcalc/agm154]; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lo TQ, 2013, TROP MED INT HEALTH, V18, P506, DOI 10.1111/tmi.12066; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; MOH, 2013, NAT GUID CANC MAN KE; MOH, 2012, NAT GUID PREV MAN CE; MOH, 2011, NAT CANC CONTR STRAT; Morhason-Bello IO, 2013, LANCET ONCOL, V14, pE142, DOI 10.1016/S1470-2045(12)70482-5; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Mutuma G, 2006, CANC NATL INCIDENCE; Ng N, 2009, GLOB HLTH ACTION, V2; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; Odhiambo F, 2013, PLOS ONE IN PRESS; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Parkin DM, 2014, CANC EPIDEMIOL BIOMA; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Person B, 2012, INT J ENV RES PUB HE, V9, P1566, DOI 10.3390/ijerph9051566; Phillips-Howard PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047017; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25365; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Varmus H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002321; Vento S, 2013, LANCET ONCOL, V14, P277, DOI 10.1016/S1470-2045(13)70022-6; WHO, 2011, WHO COUNTR PROF REP; WHO, 2011, GLOB STRAT RED HARMF; WHO, 2012, COMPR GLOB MON FRAM; World Health Organization, 2012, VERB AUT STAND 2012; World Health Organization, 2013, DRAFT COMPR GLOB MON; World Health Organization, 2013, NONC DIS FACT SHEET; World Health Organization, 2013, ACT PLAN PR IN PRESS; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]	69	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114010	10.1371/journal.pone.0114010	http://dx.doi.org/10.1371/journal.pone.0114010			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426945	Green Published, Green Accepted, gold			2022-12-27	WOS:000349145400107
J	Pierson, E; Goodman, N				Pierson, Emma; Goodman, Noah			Uncertainty and Denial: A Resource-Rational Model of the Value of Information	PLOS ONE			English	Article							HUNTINGTON DISEASE; PROSPECT-THEORY; LOSS AVERSION; CHOICE; PROBABILITY; RESOLUTION; ATTITUDES; RISK; GENE	Classical decision theory predicts that people should be indifferent to information that is not useful for making decisions, but this model often fails to describe human behavior. Here we investigate one such scenario, where people desire information about whether an event (the gain/loss of money) will occur even though there is no obvious decision to be made on the basis of this information. We find a curious dual trend: if information is costless, as the probability of the event increases people want the information more; if information is not costless, people's desire for the information peaks at an intermediate probability. People also want information more as the importance of the event increases, and less as the cost of the information increases. We propose a model that explains these results, based on the assumption that people have limited cognitive resources and obtain information about which events will occur so they can determine whether to expend effort planning for them.	[Pierson, Emma] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Goodman, Noah] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, N (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	ngoodman@stanford.edu			James S. McDonnell Foundation [SPO 50308]	James S. McDonnell Foundation	This research was supported by a grant from the James S. McDonnell Foundation, SPO 50308, to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich J.H., 1984, SAGE U PAPER SERIES; ASCH DA, 1990, MED DECIS MAKING, V10, P47, DOI 10.1177/0272989X9001000108; BABUL R, 1993, JAMA-J AM MED ASSOC, V270, P2321, DOI 10.1001/jama.270.19.2321; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; CAMERER CF, 1994, J RISK UNCERTAINTY, V8, P167, DOI 10.1007/BF01065371; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Cappelli M, 2001, QUAL LIFE RES, V10, P595, DOI 10.1023/A:1013123915272; Crampton P, RISK THEORY; Dumanovsky T, 2004, BMJ-BRIT MED J, V343, pd4464; Genesove D, 2001, Q J ECON, V116, P1233, DOI 10.1162/003355301753265561; Golman R, 2013, CURIOSITY INFORM GAP; Griffiths T.L., 2008, PROBABILISTIC MIND P; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KESSLER S, 1987, AM J MED GENET, V26, P259, DOI 10.1002/ajmg.1320260204; KOLLER D., 2009, PROBABILISTIC GRAPHI; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lieder F, 2012, NEURAL INFORM PROCES; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Marr D, 1983, VISION COMPUTATIONAL; MONAT A, 1972, J PERS SOC PSYCHOL, V24, P237, DOI 10.1037/h0033297; Nelson JD, 2005, PSYCHOL REV, V112, P979, DOI 10.1037/0033-295X.112.4.979; Norstad J., 2011, INTRO UTILITY THEORY; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Shipp TD, 2004, BIRTH-ISS PERINAT C, V31, P272, DOI 10.1111/j.0730-7659.2004.00319.x; TVERSKY A, 1992, PSYCHOL SCI, V3, P305, DOI 10.1111/j.1467-9280.1992.tb00678.x; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Vohs KD, 2007, REV GEN PSYCHOL, V11, P127, DOI 10.1037/1089-2680.11.2.127; Williams JK, 2000, RES NURS HEALTH, V23, P260, DOI 10.1002/1098-240X(200008)23:4<260::AID-NUR2>3.3.CO;2-3; Wu G, 1996, MANAGE SCI, V42, P1676, DOI 10.1287/mnsc.42.12.1676	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113342	10.1371/journal.pone.0113342	http://dx.doi.org/10.1371/journal.pone.0113342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426631	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400045
J	Zhang, JY; Cui, L; Xu, MH; Zheng, YL				Zhang, Junye; Cui, Lei; Xu, Minhua; Zheng, Yuanli			Restoring the Secretory Function of Irradiation-Damaged Salivary Gland by Administrating Deferoxamine in Mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; IRON CHELATORS; GROWTH-FACTOR; CELLS; INHIBITION; PROTECTION; HEAD; PREVENTION; RESCUE	Objectives: One of the major side effects of radiotherapy for treatments of the head and neck cancer is the radiation-induced dysfunction of salivary glands. The aim of the present study is to investigate the efficacy of deferoxamine (DFO) to restore the secretory function of radiation-damaged salivary glands in mice. Methods: DFO (50 mg/kg/d) was administered intraperitoneally in C57BL/6 mice for 3 days before and/or after point-fixed irradiation (18 Gy) of submandibular glands. The total 55 mice were randomly divided into: (1) Normal group: mice received no treatment (n=5); (2) Irradiation group (IR): mice only received irradiation (n=5); (3) Pre-DFO group (D+IR) (n=10); (4) Pre+Post DFO group (D+IR+D) (n=10); (5) Post-DFO group (IR+D) (n=10); (6) For each DFO-treated group, the mice were intraperitoneally injected with 0.1 ml sterilized water alone (by which DFO was dissolved) for 3 days before and/or after irradiation, and served as control. Sham1: Pre-sterilized water group (n=5); sham2: Pre+Post sterilized water group (n=5); sham3: Post-sterilized water group (n=5). The salivary flow rate (SFR) was assessed at 30th, 60th an d 90th day after irradiation, respectively. After 90 days, all mice were sacrificed and their submandibular glands were removed for further examinations. Results: The salivary glands showed remarkable dysfunction and tissue damage after irradiation. DFO restored SFR in the irradiated glands to a level comparable to that in normal glands and angiogenesis in damaged tissue was greatly increased. DFO also increased the expression levels of HIF-1 alpha and VEGF while reduced apoptotic cells. Furthermore, Sca-1-(+)cells were preserved in the salivary glands treated with DFO before IR. Conclusions: Our results indicate DFO could prevent the radiation-induced dysfunction of salivary glands in mice. The mechanism of this protective effect may involve increased angiogenesis, reduced apoptosis of acinar cells and more preserved stem cells.	[Zhang, Junye; Zheng, Yuanli] Shanghai Jiao Tong Univ, Stomatol Special Consultat Clin, Shanghai Key Lab Stomatol, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Junye; Xu, Minhua] Branch Shanghai First Peoples Hosp, Dept Stomatol, Shanghai, Peoples R China; [Cui, Lei] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, YL (corresponding author), Shanghai Jiao Tong Univ, Stomatol Special Consultat Clin, Shanghai Key Lab Stomatol, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China.	zhengyuanli@yahoo.com			Science and Technology Commission of Shanghai Municipality Foundation [0941195470]	Science and Technology Commission of Shanghai Municipality Foundation(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was financially supported by the Science and Technology Commission of Shanghai Municipality Foundation (grant no. 0941195470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CHINESE SOC ORAL MAX, V03, P395; BECTON DL, 1988, CANCER RES, V48, P7189; Beerepoot LV, 1996, CANCER RES, V56, P3747; BRODIE C, 1993, CANCER RES, V53, P3968; Burlage FR, 2001, RADIOTHER ONCOL, V61, P271, DOI 10.1016/S0167-8140(01)00427-3; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; ESTROV Z, 1987, BLOOD, V69, P757; FUKUCHI K, 1994, FEBS LETT, V350, P139, DOI 10.1016/0014-5793(94)00755-1; HANN HWL, 1990, HEPATOLOGY, V11, P566, DOI 10.1002/hep.1840110407; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Kojima T, 2011, LARYNGOSCOPE, V121, P1864, DOI 10.1002/lary.22080; Lee SK, 2006, LIFE SCI, V79, P1419, DOI 10.1016/j.lfs.2006.04.011; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Nagler R, 1998, RADIAT RES, V149, P271, DOI 10.2307/3579960; NAGLER RM, 1993, RADIAT RES, V136, P42, DOI 10.2307/3578638; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Oki T, 2006, BIOL PHARM BULL, V29, P1397, DOI 10.1248/bpb.29.1397; Pahl PMB, 2005, CANCER INVEST, V23, P683, DOI 10.1080/07357900500359976; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; RIAZULHAQ, 1995, EXP HEMATOL, V23, P428; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Simonart T, 2002, GYNECOL ONCOL, V85, P95, DOI 10.1006/gyno.2001.6570; Song DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065721; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113721	10.1371/journal.pone.0113721	http://dx.doi.org/10.1371/journal.pone.0113721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427160	gold, Green Submitted, Green Published			2022-12-27	WOS:000349145400081
J	Das, P; Kang, SG; Temple, S; Belfort, G				Das, Payel; Kang, Seung-gu; Temple, Sally; Belfort, Georges			Interaction of Amyloid Inhibitor Proteins with Amyloid Beta Peptides: Insight from Molecular Dynamics Simulations	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; NATURAL OLIGOMERS; ION CHANNELS; IN-VITRO; AGGREGATION; CHAPERONE; DOMAIN	Knowledge of the detailed mechanism by which proteins such as human alpha B- crystallin and human lysozyme inhibit amyloid beta (A beta) peptide aggregation is crucial for designing treatment for Alzheimer's disease. Thus, unconstrained, atomistic molecular dynamics simulations in explicit solvent have been performed to characterize the A beta(17-42) assembly in presence of the alpha B-crystallin core domain and of lysozyme. Simulations reveal that both inhibitor proteins compete with inter-peptide interaction by binding to the peptides during the early stage of aggregation, which is consistent with their inhibitory action reported in experiments. However, the A beta binding dynamics appear different for each inhibitor. The binding between crystallin and the peptide monomer, dominated by electrostatics, is relatively weak and transient due to the heterogeneous amino acid distribution of the inhibitor surface. The crystallin-bound A beta oligomers are relatively long-lived, as they form more extensive contact surface with the inhibitor protein. In contrast, a high local density of arginines from lysozyme allows strong binding with A beta peptide monomers, resulting in stable complexes. Our findings not only illustrate, in atomic detail, how the amyloid inhibitory mechanism of human alpha B-crystallin, a natural chaperone, is different from that of human lysozyme, but also may aid de novo design of amyloid inhibitors.	[Das, Payel; Kang, Seung-gu] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Temple, Sally] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	International Business Machines (IBM); Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Das, P (corresponding author), IBM Thomas J Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	daspa@us.ibm.com	Kang, Seung-gu/AAC-2047-2021	Kang, Seung-gu/0000-0002-4010-0829	IBM BlueGene Science Program; New York Capital Alliance RPI [J50552]	IBM BlueGene Science Program(International Business Machines (IBM)); New York Capital Alliance RPI	This work was funded by IBM BlueGene Science Program. The funder provided support in the form of salaries for authors [PD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. GB acknowledges support from New York Capital Alliance RPI # J50552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Assarsson A, 2014, ACS CHEM NEUROSCI, V5, P266, DOI 10.1021/cn400124r; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Ball KA, 2011, BIOCHEMISTRY-US, V50, P7612, DOI 10.1021/bi200732x; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Bertz M, 2010, J MOL BIOL, V400, P1046, DOI 10.1016/j.jmb.2010.05.065; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Chebaro Y, 2012, J PHYS CHEM B, V116, P8412, DOI 10.1021/jp2118778; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Dai B, 2013, P NATL ACAD SCI USA, V110, P8543, DOI 10.1073/pnas.1220711110; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Deserno M, 1998, J CHEM PHYS, V109, P7694, DOI 10.1063/1.477415; Eleftheriou M, 2006, J AM CHEM SOC, V128, P13388, DOI 10.1021/ja060972s; Eskici G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066178; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Flock D, 2006, PROTEINS, V62, P183, DOI 10.1002/prot.20683; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garcia AE, 2000, PROTEINS, V38, P261, DOI 10.1002/(SICI)1097-0134(20000215)38:3<261::AID-PROT3>3.3.CO;2-H; Ghosh JG, 2008, INT J BIOCHEM CELL B, V40, P954, DOI 10.1016/j.biocel.2007.10.035; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; GOWING E, 1994, J BIOL CHEM, V269, P10987; Han W, 2005, J AM CHEM SOC, V127, P15408, DOI 10.1021/ja051699h; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Houck SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025859; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2013, J CHEM THEORY COMPUT, V9, P822, DOI 10.1021/ct300916f; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kent A, 2008, J PHYS CHEM B, V112, P6175, DOI 10.1021/jp077099h; KIRSHENBAUM K, 1995, BIOCHEMISTRY-US, V34, P7629, DOI 10.1021/bi00023a009; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Kumar S, 2008, IBM J RES DEV, V52, P177, DOI 10.1147/rd.521.0177; Lalowski M, 1996, J BIOL CHEM, V271, P33623, DOI 10.1074/jbc.271.52.33623; Lemmin T, 2014, J BIOL CHEM; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Lockhart C, 2012, J PHYS CHEM B, V116, P12922, DOI 10.1021/jp306208n; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Nahomi RB, 2013, J BIOL CHEM, V288, P13022, DOI 10.1074/jbc.M112.440214; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Narayanan S, 2006, FEBS LETT, V580, P5941, DOI 10.1016/j.febslet.2006.09.063; Nguyen PH, 2014, J PHYS CHEM B, V118, P501, DOI 10.1021/jp4115404; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rojas AV, 2011, J PHYS CHEM B, V115, P12978, DOI 10.1021/jp2050993; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Tycko R, 2001, METHOD ENZYMOL, V339, P390, DOI 10.1016/S0076-6879(01)39324-2; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Wen-Hui X, 2012, CHINESE PHYS LETT, V29; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhu XX, 2012, J PHYS CHEM B, V116, P4405, DOI 10.1021/jp210019h; Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002	97	32	32	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113041	10.1371/journal.pone.0113041	http://dx.doi.org/10.1371/journal.pone.0113041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422897	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700019
J	Erickson, KE; Gill, RT; Chatterjee, A				Erickson, Keesha E.; Gill, Ryan T.; Chatterjee, Anushree			CONSTRICTOR: Constraint Modification Provides Insight into Design of Biochemical Networks	PLOS ONE			English	Article							ETHYLENE-FORMING ENZYME; FLUX BALANCE ANALYSIS; ESCHERICHIA-COLI; ETHANOL-PRODUCTION; GENE; STRAIN; BIOSYNTHESIS; OPTIMIZATION; METABOLISM; FRAMEWORK	Advances in computational methods that allow for exploration of the combinatorial mutation space are needed to realize the potential of synthetic biology based strain engineering efforts. Here, we present Constrictor, a computational framework that uses flux balance analysis (FBA) to analyze inhibitory effects of genetic mutations on the performance of biochemical networks. Constrictor identifies engineering interventions by classifying the reactions in the metabolic model depending on the extent to which their flux must be decreased to achieve the overproduction target. The optimal inhibition of various reaction pathways is determined by restricting the flux through targeted reactions below the steady state levels of a baseline strain. Constrictor generates unique in silico strains, each representing an "expression state'', or a combination of gene expression levels required to achieve the overproduction target. The Constrictor framework is demonstrated by studying overproduction of ethylene in Escherichia coli network models iAF1260 and iJO1366 through the addition of the heterologous ethylene-forming enzyme from Pseudomonas syringae. Targeting individual reactions as well as combinations of reactions reveals in silico mutants that are predicted to have as high as 25% greater theoretical ethylene yields than the baseline strain during simulated exponential growth. Altering the degree of restriction reveals a large distribution of ethylene yields, while analysis of the expression states that return lower yields provides insight into system bottlenecks. Finally, we demonstrate the ability of Constrictor to scan networks and provide targets for a range of possible products. Constrictor is an adaptable technique that can be used to generate and analyze disparate populations of in silico mutants, select gene expression levels and provide non-intuitive strategies for metabolic engineering.	[Erickson, Keesha E.; Gill, Ryan T.; Chatterjee, Anushree] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Chatterjee, Anushree] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chatterjee, A (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	chatterjee@colorado.edu		Erickson, Keesha/0000-0001-7482-457X	University of Colorado; US Department of Energy [DE-SCOOO8812]; NIH [5T32GM008732]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008732] Funding Source: NIH RePORTER	University of Colorado; US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the University of Colorado start-up funds and US Department of Energy grant (DE-SCOOO8812). KE was partially supported by NIH Pharmaceutical Biotechnology training grant 5T32GM008732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldor AS, 2002, APPL ENVIRON MICROB, V68, P3848, DOI 10.1128/AEM.68.8.3848-3854.2002; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; ALTERTHUM F, 1989, APPL ENVIRON MICROB, V55, P1943, DOI 10.1128/AEM.55.8.1943-1948.1989; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Boyle NR, 2012, CURR OPIN BIOTECH, V23, P666, DOI 10.1016/j.copbio.2012.01.012; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Deb K., 2006, INT J COMPUT INTELL, V2, P273, DOI DOI 10.5019/J.IJCIR.2006.67; Dong HongJun, 2007, Journal of Agricultural Biotechnology, V15, P698; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Eckert C, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-33; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; FUKUDA H, 1992, BIOCHEM BIOPH RES CO, V188, P483, DOI 10.1016/0006-291X(92)91081-Z; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guerrero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050470; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; ISHIHARA K, 1995, J FERMENT BIOENG, V79, P205, DOI 10.1016/0922-338X(95)90604-X; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024162; Larsson C, 2011, IET SYST BIOL, V5, P245, DOI 10.1049/iet-syb.2010.0027; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; Lutke-Eversloh T, 2002, NAT MATER, V1, P236, DOI 10.1038/nmat773; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pirkov I, 2008, METAB ENG, V10, P276, DOI 10.1016/j.ymben.2008.06.006; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Rhodius VA, 2012, NUCLEIC ACIDS RES, V40, P2907, DOI 10.1093/nar/gkr1190; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Rockwell G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002882; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Takahama K, 2003, J BIOSCI BIOENG, V95, P302, DOI 10.1016/S1389-1723(03)80034-8; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Ungerer J, 2012, ENERG ENVIRON SCI, V5, P8998, DOI 10.1039/c2ee22555g; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JP, 2010, BIORESOURCE TECHNOL, V101, P6404, DOI 10.1016/j.biortech.2010.03.030; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Woodruff LBA, 2013, BIOTECHNOL BIOENG, V110, P1520, DOI 10.1002/bit.24840; Xu M, 2009, COMPUT CHEM ENG, V33, P1438, DOI 10.1016/j.compchemeng.2009.03.008; Yadav VG, 2012, METAB ENG, V14, P233, DOI 10.1016/j.ymben.2012.02.001; Yang L, 2011, METAB ENG, V13, P272, DOI 10.1016/j.ymben.2011.03.002	71	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113820	10.1371/journal.pone.0113820	http://dx.doi.org/10.1371/journal.pone.0113820			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422896	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700067
J	Hao, J; Zhen, Y; Wang, H; Yang, DY; Wang, NL				Hao, Jie; Zhen, Yi; Wang, Hao; Yang, Diya; Wang, Ningli			The Effect of Lateral Decubitus Position on Nocturnal Intraocular Pressure over a Habitual 24-Hour Period in Healthy Adults	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TENSION GLAUCOMA; POSTURAL CHANGE; YOUNG SUBJECTS; BODY POSITION; PATTERN; POPULATION; SLEEP; EYE	Purpose: To investigate the effect of lateral decubitus position (LDP) on nocturnal intraocular pressure (IOP) and the effect of LDP on 24-hour habitual IOP pattern in healthy subjects. Methods: Intraocular pressure was measured every 2-hours using an Accupen Applanation Tonometer (Accutome, USA). During the diurnal period (7:30 am, 9:30 am, 11:30 am, 1:30 pm, 3:30 pm, 5:30 pm, 7:30 pm, and 9:30 pm), IOP was measured in the sitting position under bright light (500-1000 lux) after the subjects had been seated for 5 min. The nocturnal IOP was measured in the supine position, right LDP, and left LDP, with randomized sequences, under dim light (<10 lux) at 11:30 pm, 1:30 am, 3:30 am, and 5:30 am. The subjects were awakened and maintained each position for 5 min before the measurement. The 24-hour habitual IOP patterns were obtained according to the nocturnal position (supine, right LDP and left LDP) for either eye. P < 0.05 was considered to be significant. Results: Nineteen healthy subjects were included with a mean age of 51.3 +/- 5.8 years. During the nocturnal period, a significant IOP difference was found between the dependent eye (the eye on the lower side) of LDP and the supine position, but not for all the nocturnal time points. Over a 24-hour period, the effect of LDP on habitual IOP pattern was not statistically significant, although the mean nocturnal IOP and the diurnal-nocturnal IOP change for the right and the left eye in the LDP pattern was slightly higher than that in the sitting-supine pattern. Conclusion: Significant nocturnal IOP differences existed between the dependent eye and the supine, but did not occur consistently for all time points. Over a 24-hour period, the effect of LDP on habitual IOP pattern was not statistically significant in healthy subjects.	[Hao, Jie; Zhen, Yi; Yang, Diya; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Wang, Hao] Hebei Eye Hosp, Hebei Key Lab Ophthalmol, Xingtai, Peoples R China	Capital Medical University	Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	wningli@vip.163.com			Research Special Fund of Ministry of Health of the People's Republic of China [201002019]	Research Special Fund of Ministry of Health of the People's Republic of China	This study was supported by a grant from the Research Special Fund of Ministry of Health of the People's Republic of China. Grant number: 201002019. URL: http://wsb.moh.gov.cn/mohkjjys/index.shtml. NW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkana Y, 2014, J GLAUCOMA, V23, pE23, DOI 10.1097/IJG.0b013e3182a0762f; BILL A, 1978, GLAUCOMA CONCEPTIONS, P97; Blondeau P, 2001, J GLAUCOMA, V10, P18, DOI 10.1097/00061198-200102000-00005; DEKONINCK J, 1992, SLEEP, V15, P143, DOI 10.1093/sleep/15.2.143; DZVONIK ML, 1986, SLEEP, V9, P484, DOI 10.1093/sleep/9.4.484; Fogagnolo P, 2009, INVEST OPHTH VIS SCI, V50, P2209, DOI 10.1167/iovs.08-2889; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Lee JY, 2013, AM J OPHTHALMOL, V155, P329, DOI 10.1016/j.ajo.2012.08.003; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Lee TE, 2013, OPHTHALMOLOGY, V120, P1565, DOI 10.1016/j.ophtha.2013.01.011; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8672, DOI 10.1167/iovs.11-7480; Liu JHK, 2005, OPHTHALMOLOGY, V112, P1670, DOI 10.1016/j.ophtha.2005.05.007; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Prata TS, 2010, SURV OPHTHALMOL, V55, P445, DOI 10.1016/j.survophthal.2009.12.002; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113590	10.1371/journal.pone.0113590	http://dx.doi.org/10.1371/journal.pone.0113590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423190	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700040
J	Krober, W; Zhang, SR; Ehmig, M; Bruelheide, H				Kroeber, Wenzel; Zhang, Shouren; Ehmig, Merten; Bruelheide, Helge			Linking Xylem Hydraulic Conductivity and Vulnerability to the Leaf Economics Spectrum-A Cross-Species Study of 39 Evergreen and Deciduous Broadleaved Subtropical Tree Species	PLOS ONE			English	Article							STOMATAL CONTROL; FOREST BIODIVERSITY; TRAIT RELATIONSHIPS; INDUCED EMBOLISM; LIFE-HISTORY; GROWTH-RATES; DROUGHT; CAVITATION; STEM; COORDINATION	While the fundamental trade-off in leaf traits related to carbon capture as described by the leaf economics spectrum is well-established among plant species, the relationship of the leaf economics spectrum to stem hydraulics is much less known. Since carbon capture and transpiration are coupled, a close connection between leaf traits and stem hydraulics should be expected. We thus asked whether xylem traits that describe drought tolerance and vulnerability to cavitation are linked to particular leaf traits. We assessed xylem vulnerability, using the pressure sleeve technique, and anatomical xylem characteristics in 39 subtropical tree species grown under common garden conditions in the BEF-China experiment and tested for correlations with traits related to the leaf economics spectrum as well as to stomatal control, including maximum stomatal conductance, vapor pressure deficit at maximum stomatal conductance and vapor pressure deficit at which stomatal conductance is down-regulated. Our results revealed that specific xylem hydraulic conductivity and cavitation resistance were closely linked to traits represented in the leaf economic spectrum, in particular to leaf nitrogen concentration, as well as to log leaf area and leaf carbon to nitrogen ratio but not to any parameter of stomatal conductance. The study highlights the potential use of well-known leaf traits from the leaf economics spectrum to predict plant species' drought resistance.	[Kroeber, Wenzel; Ehmig, Merten; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany; [Zhang, Shouren] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Chinese Academy of Sciences; Institute of Botany, CAS	Krober, W (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany.	wenzel.kroeber@botanik.uni-halle.de	Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356	German Research Foundation [DFG FOR 891/1, 891/2, DFG BR 1698/9-2]; Sino-German Centre for Research Promotion in Beijing [GZ 524, 592, 698, 699, 785, 970, 1020]; National Natural Science Foundation of China [31170457]	German Research Foundation(German Research Foundation (DFG)); Sino-German Centre for Research Promotion in Beijing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge funding by the German Research Foundation (DFG FOR 891/1 and 891/2) with a grant to H.B. (DFG BR 1698/9-2) and the Sino-German Centre for Research Promotion in Beijing (GZ 524, 592, 698, 699, 785, 970 and 1020) as well as a grant to S.Z. of the National Natural Science Foundation of China (No. 31170457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bell P. R., 2000, GREEN PLANTS THEIR O; Bohnke M, 2014, J VEG SCI, V25, P897, DOI 10.1111/jvs.12114; Box E, 1995, VEGETATION SCI FORES; Brodribb TJ, 2008, PLANT CELL ENVIRON, V31, P1557, DOI 10.1111/j.1365-3040.2008.01865.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2003, PLANT CELL ENVIRON, V26, P443, DOI 10.1046/j.1365-3040.2003.00975.x; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chen JW, 2009, ECOL RES, V24, P65, DOI 10.1007/s11284-008-0482-4; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Choat B, 2007, NEW PHYTOL, V175, P686, DOI 10.1111/j.1469-8137.2007.02137.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Cochard H, 1996, ANN SCI FOREST, V53, P197, DOI 10.1051/forest:19960203; Cochard H, 2013, J EXP BOT, V64, P4779, DOI 10.1093/jxb/ert193; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; Domec JC, 2003, PLANT CELL ENVIRON, V26, P471, DOI 10.1046/j.1365-3040.2003.00978.x; Domec JC, 2001, TREES-STRUCT FUNCT, V15, P204, DOI 10.1007/s004680100095; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; Ennajeh M, 2011, PHYSIOL PLANTARUM, V142, P205, DOI 10.1111/j.1399-3054.2011.01470.x; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Fu PL, 2012, ANN BOT-LONDON, V110, P189, DOI 10.1093/aob/mcs092; Gerlach D., 1984, BOT MIKROTECHNIK, V3; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Hacke U, 2000, PPEES, V4, P97; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; HARGRAVE KR, 1994, NEW PHYTOL, V126, P695, DOI 10.1111/j.1469-8137.1994.tb02964.x; Hendry G.A.F., 1993, METHODS COMP PLANT E, P148, DOI DOI 10.1007/978-94-011-1494-3; JARBEAU JA, 1995, PLANT CELL ENVIRON, V18, P189, DOI 10.1111/j.1365-3040.1995.tb00352.x; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Litvak E, 2012, TREE PHYSIOL, V32, P373, DOI 10.1093/treephys/tps015; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Vilalta J, 2002, OECOLOGIA, V133, P19, DOI 10.1007/s00442-002-1009-2; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Melcher PJ, 2012, METHODS ECOL EVOL, V3, P685, DOI 10.1111/j.2041-210X.2012.00204.x; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Rosner S, 2008, TREE PHYSIOL, V28, P1179, DOI 10.1093/treephys/28.8.1179; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Santiago LS, 2007, ECOLOGY, V88, P1126, DOI 10.1890/06-1841; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Skarpe C, 1996, J VEG SCI, V7, P397, DOI 10.2307/3236283; SPERRY JS, 1994, ECOLOGY, V75, P1736, DOI 10.2307/1939633; SPERRY JS, 1988, PLANT CELL ENVIRON, V11, P35, DOI 10.1111/j.1365-3040.1988.tb01774.x; Tyree M. T., 2002, SPR S WOOD; TYREE MT, 1994, IAWA J, V15, P335, DOI 10.1163/22941932-90001369; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Vander Willigen C, 2000, NEW PHYTOL, V145, P51, DOI 10.1046/j.1469-8137.2000.00549.x; Vinya R, 2012, ACTA PHYSIOL PLANT, V34, P1701, DOI 10.1007/s11738-012-0965-3; Walter H., 1967, KLIMA DIAGRAMM WELTA; Willson CJ, 2008, AM J BOT, V95, P299, DOI 10.3732/ajb.95.3.299; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yang XF, 2013, EUR J FOREST RES, V132, P593, DOI 10.1007/s10342-013-0696-z	67	35	37	6	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e109211	10.1371/journal.pone.0109211	http://dx.doi.org/10.1371/journal.pone.0109211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423316	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700001
J	Nasuno, R; Aitoku, M; Manago, Y; Nishimura, A; Sasano, Y; Takagi, H				Nasuno, Ryo; Aitoku, Miho; Manago, Yuki; Nishimura, Akira; Sasano, Yu; Takagi, Hiroshi			Nitric Oxide-Mediated Antioxidative Mechanism in Yeast through the Activation of the Transcription Factor Mac1	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; SACCHAROMYCES-CEREVISIAE; REGULATORY ASSOCIATIONS; DEPENDENT APOPTOSIS; NITROSATIVE STRESS; GUANYLATE-CYCLASE; OXIDATIVE STRESS; COPPER UPTAKE; FACTOR ACE1; CELL-DEATH	The budding yeast Saccharomyces cerevisiae possesses various defense mechanisms against environmental stresses that generate reactive oxygen species, leading to growth inhibition or cell death. Our recent study showed a novel antioxidative mechanism mediated by nitric oxide (NO) in yeast cells, but the mechanism underlying the oxidative stress tolerance remained unclear. We report here one of the downstream pathways of NO involved in stress-tolerance mechanism in yeast. Our microarray and real-time quantitative PCR analyses revealed that exogenous NO treatment induced the expression of genes responsible for copper metabolism under the control of the transcription factor Mac1, including the CTR1 gene encoding high-affinity copper transporter. Our ChIP analysis also demonstrated that exogenous NO enhances the binding of Mac1 to the promoter region of target genes. Interestingly, we found that NO produced under high-temperature stress conditions increased the transcription level of the CTR1 gene. Furthermore, NO produced during exposure to high temperature also increased intracellular copper content, the activity of Cu, Zn-superoxide dismutase Sod1, and cell viability after exposure to high-temperature in a manner dependent on Mac1. NO did not affect the expression of the MAC1 gene, indicating that NO activates Mac1 through its post-translational modification. Based on the results shown here, we propose a novel NO-mediated antioxidative mechanism that Mac1 activated by NO induces the CTR1 gene, leading to an increase in cellular copper level, and then Cu(I) activates Sod1. This is the first report to unveil the mechanism of NO-dependent antioxidative system in yeast.	[Nasuno, Ryo; Aitoku, Miho; Manago, Yuki; Nishimura, Akira; Sasano, Yu; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Takagi, H (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	hiro@bs.naist.jp	Nasuno, Ryo/AAD-7128-2022; Nishimura, Akira/O-3512-2015	Nasuno, Ryo/0000-0002-4456-2801; Nishimura, Akira/0000-0002-0168-9829; Takagi, Hiroshi/0000-0002-1786-3174	Japan Society for the Promotion of Science [25252065]; Ministry of Education, Science, Culture, Sports and Technology of Japan [23117711, 14430289]; Skylark Food Science Institute; Grants-in-Aid for Scientific Research [25252065] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Skylark Food Science Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants for a Grant-in-Aid for Scientific Research (A) (25252065) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Area (ROS Signal) (23117711) and (Oxygen Biology) (14430289) from the Ministry of Education, Science, Culture, Sports and Technology of Japan, and the Skylark Food Science Institute to H.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Almeida B, 2007, J CELL SCI, V120, P3279, DOI 10.1242/jcs.010926; Bosca L, 1999, CELL SIGNAL, V11, P239, DOI 10.1016/S0898-6568(98)00064-3; Brown KR, 2002, BIOCHEMISTRY-US, V41, P6469, DOI 10.1021/bi0160664; Chiang KT, 2000, ARCH BIOCHEM BIOPHYS, V377, P296, DOI 10.1006/abbi.2000.1785; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Heredia J, 2001, J BIOL CHEM, V276, P8793, DOI 10.1074/jbc.M008179200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kig C, 2009, PROTOPLASMA, V238, P59, DOI 10.1007/s00709-009-0074-3; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Kuo WN, 1998, BIOCHEM MOL BIOL INT, V45, P125; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Martin M, 2009, FEBS LETT, V583, P542, DOI 10.1016/j.febslet.2008.12.039; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nishimura A, 2013, BIOCHEM BIOPH RES CO, V430, P137, DOI 10.1016/j.bbrc.2012.11.023; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park JI, 1998, J BIOL CHEM, V273, P22921, DOI 10.1074/jbc.273.36.22921; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Perez-Gallardo RV, 2013, FEMS YEAST RES, V13, P804, DOI 10.1111/1567-1364.12090; Rikhvanov EG, 2014, BIOCHEMISTRY-MOSCOW+, V79, P16, DOI 10.1134/S0006297914010039; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shinyashiki M, 2000, P NATL ACAD SCI USA, V97, P2491, DOI 10.1073/pnas.050586597; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Takahashi S, 2009, APPL ENVIRON MICROB, V75, P6706, DOI 10.1128/AEM.00905-09; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Woo JM, 2014, APPL MICROBIOL BIOT, V98, P6085, DOI 10.1007/s00253-014-5691-x; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200	47	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113788	10.1371/journal.pone.0113788	http://dx.doi.org/10.1371/journal.pone.0113788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423296	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700065
J	Kwon, YK; Ha, IJ; Bae, HW; Jang, WG; Yun, HJ; Kim, SR; Lee, EK; Kang, CM; Hwang, GS				Kwon, Yong-Kook; Ha, In Jin; Bae, Hyun-Whee; Jang, Won Gyo; Yun, Hyun Jin; Kim, So Ra; Lee, Eun Kyeong; Kang, Chang-Mo; Hwang, Geum-Sook			Dose-Dependent Metabolic Alterations in Human Cells Exposed to Gamma Irradiation	PLOS ONE			English	Article							IONIZING-RADIATION EXPOSURE; ACID TARGET ANALYSIS; LEUCYL AMINOPEPTIDASE; BIOMARKER DISCOVERY; PANTOTHENIC-ACID; EARLY TRIAGE; DNA-DAMAGE; RAT MODEL; IDENTIFICATION; MICE	Radiation exposure is a threat to public health because it causes many diseases, such as cancers and birth defects, due to genetic modification of cells. Compared with the past, a greater number of people are more frequently exposed to higher levels of radioactivity today, not least due to the increased use of diagnostic and therapeutic radiation-emitting devices. In this study, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS)-based metabolic profiling was used to investigate radiation-induced metabolic changes in human fibroblasts. After exposure to 1 and 5 Gy of c-radiation, the irradiated fibroblasts were harvested at 24, 48, and 72 h and subjected to global metabolite profiling analysis. Mass spectral peaks of cell extracts were analyzed by pattern recognition using principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA). The results showed that the cells irradiated with 1 Gy returned to control levels at 72 h post radiation, whereas cells irradiated with 5 Gy were quite unlike the controls; therefore, cells irradiated with 1 Gy had recovered, whereas those irradiated with 5 Gy had not. Lipid and amino acid levels increased after the higher-level radiation, indicating degradation of membranes and proteins. These results suggest that MS-based metabolite profiling of c-radiation-exposed human cells provides insight into the global metabolic alterations in these cells.	[Kwon, Yong-Kook; Ha, In Jin; Bae, Hyun-Whee; Jang, Won Gyo; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul 120140, South Korea; [Yun, Hyun Jin; Kim, So Ra; Lee, Eun Kyeong; Kang, Chang-Mo] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Bae, Hyun-Whee; Jang, Won Gyo; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon 305764, South Korea	Korea Basic Science Institute (KBSI); Korea Institute of Radiological & Medical Sciences; Chungnam National University	Kang, CM (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea.	kangcm@kirams.re.kr; gshwang@kbsi.re.kr		Bae, Hyun/0000-0002-6386-344X; Ha, In Jin/0000-0002-9210-1401	Korea Basic Science Institute [C34705]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2012M2A2A7012494, 2010-0019394, 2013M3A9B6046418]; Creative Allied Project (CAP)	Korea Basic Science Institute; National Research Foundation of Korea (NRF) - Korean Government (MSIP); Creative Allied Project (CAP)	This study was supported by a grant from the Korea Basic Science Institute (C34705) and the National Research Foundation of Korea (NRF) grant, funded by the Korean Government (MSIP) (2012M2A2A7012494, 2010-0019394, 2013M3A9B6046418, and the Creative Allied Project (CAP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Cadet J, 2004, J ENVIRON PATHOL TOX, V23, P33, DOI 10.1615/JEnvPathToxOncol.v23.i1.30; Chu LR, 2008, J BIOL CHEM, V283, P19351, DOI 10.1074/jbc.M801034200; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Couto N, 2013, J PROTEOME RES, V12, P2885, DOI 10.1021/pr4001948; DOUSSET N, 1984, BIOCHIM BIOPHYS ACTA, V794, P444, DOI 10.1016/0005-2760(84)90011-0; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; GOODWIN PM, 1978, BIOCHIM BIOPHYS ACTA, V543, P576, DOI 10.1016/0304-4165(78)90312-4; Holecek M, 2002, AMINO ACIDS, V22, P95, DOI 10.1007/s726-002-8203-0; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lanz C, 2009, RADIAT RES, V172, P198, DOI 10.1667/RR1796.1; LEYKO W, 1986, INT J RADIAT BIOL, V49, P743, DOI 10.1080/09553008514552971; Liu HX, 2013, RADIAT PROT DOSIM, V154, P9, DOI 10.1093/rpd/ncs138; Menard C, 2006, CANCER RES, V66, P1844, DOI 10.1158/0008-5472.CAN-05-3466; Morgan WF, 2005, P NATL ACAD SCI USA, V102, P14127, DOI 10.1073/pnas.0507119102; Nair BC, 2014, CELL DEATH DIFFER, V21, P1409, DOI 10.1038/cdd.2014.55; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Pathak CM, 2007, J RADIAT RES, V48, P113, DOI 10.1269/jrr.06063; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Schittl H, 2007, RADIAT PHYS CHEM, V76, P1594, DOI 10.1016/j.radphyschem.2007.01.009; SCHWENEN M, 1989, INT J RADIAT BIOL, V55, P257, DOI 10.1080/09553008914550291; SEDLAKOVA A, 1986, PHYSIOL BOHEMOSLOV, V35, P400; Shi YQ, 2001, RADIAT ENVIRON BIOPH, V40, P301, DOI 10.1007/s00411-001-0124-5; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sreekumar A, 2001, CANCER RES, V61, P7585; Tang XX, 2013, METABOLOMICS, V9, P853, DOI 10.1007/s11306-013-0502-4; Tchantchou F, 2008, J ALZHEIMERS DIS, V14, P323; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Zhang YY, 2014, MOL BIOSYST, V10, P1441, DOI 10.1039/c3mb70526a	43	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113573	10.1371/journal.pone.0113573	http://dx.doi.org/10.1371/journal.pone.0113573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419661	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900050
J	Pircher, J; Czermak, T; Merkle, M; Mannell, H; Krotz, F; Ribeiro, A; Vielhauer, V; Nadjiri, J; Gaitzsch, E; Niemeyer, M; Porubsky, S; Grone, HJ; Wornle, M				Pircher, Joachim; Czermak, Thomas; Merkle, Monika; Mannell, Hanna; Kroetz, Florian; Ribeiro, Andrea; Vielhauer, Volker; Nadjiri, Jonathan; Gaitzsch, Erik; Niemeyer, Markus; Porubsky, Stefan; Groene, Hermann-Josef; Woernle, Markus			Hepatitis C Virus Induced Endothelial Inflammatory Response Depends on the Functional Expression of TNF alpha Receptor Subtype 2	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; MIXED CRYOGLOBULINEMIA; SERUM-LEVELS; IN-VIVO; INFECTION; VASCULITIS; ACTIVATION; CELLS; MANIFESTATIONS	In hepatitis C virus (HCV) infection, morbidity and mortality often result from extrahepatic disease manifestations. We provide evidence for a role of receptors of the innate immune system in virally induced inflammation of the endothelium in vitro and in vivo. Corresponding to the in vitro finding of an HCV-dependent induction of proinflammatory mediators in endothelial cells, mice treated with poly (I: C) exhibit a significant reduction in leukocyte rolling velocity, an increase in leukocyte adhesion to the vessel wall and an increased extravasation of leukocytes. HCV directly promotes activation, adhesion and infiltration of inflammatory cells into the vessel wall by activation of endothelial viral receptors. Poly (I: C) induces the expression of TLR3 in vivo and hereby allows for amplification of all of the aforementioned responses upon viral infection. Proinflammatory effects of viral RNA are specifically mediated by TLR3 and significantly enhanced by tumor necrosis factor alpha (TNFa). HCV-RNA induces the endothelial expression of TNFa and TNFa receptor subtype 2 and we provide evidence that leucocyte adhesion and transmigration in response to activation of viral RNA receptors seem to depend on expression of functional TNFR2. Our results demonstrate that endothelial cells actively participate in immune mediated vascular inflammation caused by viral infections.	[Pircher, Joachim] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Pircher, Joachim; Czermak, Thomas; Mannell, Hanna; Kroetz, Florian; Gaitzsch, Erik] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Pircher, Joachim; Czermak, Thomas; Mannell, Hanna; Kroetz, Florian; Gaitzsch, Erik] Univ Munich, Munich Heart Alliance, Munich, Germany; [Czermak, Thomas; Merkle, Monika; Ribeiro, Andrea; Vielhauer, Volker; Nadjiri, Jonathan; Gaitzsch, Erik; Woernle, Markus] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Niemeyer, Markus] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-80290 Munich, Germany; [Porubsky, Stefan; Groene, Hermann-Josef] German Canc Res Ctr, Heidelberg, Germany	University of Munich; University of Munich; Munich Heart Alliance; University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Wornle, M (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.	Markus.Woernle@med.uni-muenchen.de	Porubsky, Stefan/J-5738-2015; Mannell, Hanna/AAD-4282-2020; Porubsky, Stefan/AAX-9682-2021	Porubsky, Stefan/0000-0002-7647-7265; Porubsky, Stefan/0000-0002-7647-7265; Nadjiri, Jonathan/0000-0003-0698-965X	Deutsche Forschungsgemeinschaft (DFG) [WO 1716/1-1]; Else Kroner-Fresenius-Stiftung; Wilhelm-Vaillant-Stiftung; Friedrich Baur Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Wilhelm-Vaillant-Stiftung; Friedrich Baur Stiftung	This work was supported by grant WO 1716/1-1 from the Deutsche Forschungsgemeinschaft (DFG), a grant from the Else Kroner-Fresenius-Stiftung and the Wilhelm-Vaillant-Stiftung to MW and a grant from The Friedrich Baur Stiftung to JP. This paper contains part of Thomas Czermak's and Jonathan Nadjiri's doctoral thesis, which was approved by the medical faculty of the Ludwig Maximilians University Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Antonelli A, 2008, AM J GASTROENTEROL, V103, P2488, DOI 10.1111/j.1572-0241.2008.02040.x; Antonelli A, 2009, CLIN RHEUMATOL, V28, P1179, DOI 10.1007/s10067-009-1218-8; Antonelli A, 2009, NAT CLIN PRACT ENDOC, V5, P26, DOI 10.1038/ncpendmet1027; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; CACOUB P, 1994, AM J MED, V96, P124, DOI 10.1016/0002-9343(94)90132-5; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Farina G, 2011, ANN RHEUM DIS, V70, P544, DOI 10.1136/ard.2010.132464; Feldmann G, 2006, CLIN CANCER RES, V12, P4491, DOI 10.1158/1078-0432.CCR-06-0154; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; Fletcher NF, 2012, GASTROENTEROLOGY, V142, P634, DOI 10.1053/j.gastro.2011.11.028; Hagele H, 2009, NEPHROL DIAL TRANSPL, V24, P3312, DOI 10.1093/ndt/gfp339; Kaplanski G, 2005, J HEPATOL, V42, P334, DOI 10.1016/j.jhep.2004.11.034; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Mannell H, 2010, CELL SIGNAL, V22, P88, DOI 10.1016/j.cellsig.2009.09.015; Mannell HK, 2012, CARDIOVASC RES, V93, P111, DOI 10.1093/cvr/cvr265; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; Merkle M, 2011, AM J PHYSIOL-RENAL, V301, pF57, DOI 10.1152/ajprenal.00083.2011; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008; Pircher J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4064; Popvic ZV, 2011, J IMMUNOL, V15, P6217; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Terrier B, 2011, ARTHRITIS RHEUM-US, V63, P1748, DOI 10.1002/art.30319; Terrier B, 2011, J RHEUMATOL, V38, P104, DOI 10.3899/jrheum.100191; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Vassilopoulos D, 2002, ARTHRITIS RHEUM-US, V46, P585, DOI 10.1002/art.10107; Vitour D, 2007, SCI STKE, V384, P20; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wornle M, 2009, NEPHROL DIAL TRANSPL, V24, P1113, DOI 10.1093/ndt/gfn627; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Wornle Markus, 2004, BMC Nephrol, V5, P8, DOI 10.1186/1471-2369-5-8; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113351	10.1371/journal.pone.0113351	http://dx.doi.org/10.1371/journal.pone.0113351			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419735	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900030
J	Salari, N; Shohaimi, S; Najafi, F; Nallappan, M; Karishnarajah, I				Salari, Nader; Shohaimi, Shamarina; Najafi, Farid; Nallappan, Meenakshii; Karishnarajah, Isthrinayagy			A Novel Hybrid Classification Model of Genetic Algorithms, Modified k-Nearest Neighbor and Developed Backpropagation Neural Network	PLOS ONE			English	Article							FEATURE-SELECTION; ACCURACY; PERFORMANCE; CANCER; FOREST; TESTS	Among numerous artificial intelligence approaches, k-Nearest Neighbor algorithms, genetic algorithms, and artificial neural networks are considered as the most common and effective methods in classification problems in numerous studies. In the present study, the results of the implementation of a novel hybrid feature selection-classification model using the above mentioned methods are presented. The purpose is benefitting from the synergies obtained from combining these technologies for the development of classification models. Such a combination creates an opportunity to invest in the strength of each algorithm, and is an approach to make up for their deficiencies. To develop proposed model, with the aim of obtaining the best array of features, first, feature ranking techniques such as the Fisher's discriminant ratio and class separability criteria were used to prioritize features. Second, the obtained results that included arrays of the top-ranked features were used as the initial population of a genetic algorithm to produce optimum arrays of features. Third, using a modified k-Nearest Neighbor method as well as an improved method of backpropagation neural networks, the classification process was advanced based on optimum arrays of the features selected by genetic algorithms. The performance of the proposed model was compared with thirteen well-known classification models based on seven datasets. Furthermore, the statistical analysis was performed using the Friedman test followed by post-hoc tests. The experimental findings indicated that the novel proposed hybrid model resulted in significantly better classification performance compared with all 13 classification methods. Finally, the performance results of the proposed model was benchmarked against the best ones reported as the state-of-the-art classifiers in terms of classification accuracy for the same data sets. The substantial findings of the comprehensive comparative study revealed that performance of the proposed model in terms of classification accuracy is desirable, promising, and competitive to the existing state-of-the-art classification models.	[Salari, Nader; Shohaimi, Shamarina; Nallappan, Meenakshii] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia; [Salari, Nader; Najafi, Farid] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Kermanshah, Iran; [Karishnarajah, Isthrinayagy] Univ Putra Malaysia, Fac Sci, Dept Math, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Kermanshah University of Medical Sciences; Universiti Putra Malaysia	Salari, N (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia.	nader.salari.1344@gmail.com	Shohaimi, Shamarina/AAL-2810-2020; Salari, Nader/AAN-4849-2020; Najafi, Farid/I-3830-2015; Salari, Nader/U-7761-2017	Shohaimi, Shamarina/0000-0003-0591-6627; Salari, Nader/0000-0003-3550-405X; Najafi, Farid/0000-0002-0534-6444; Nallappan, Meenakshii/0000-0002-0953-2295; Salari, Nader/0000-0002-6448-5313				Acharya UR, 2003, PATTERN RECOGN, V36, P61, DOI 10.1016/S0031-3203(02)00063-8; Aci M, 2010, EXPERT SYST APPL, V37, P5061, DOI 10.1016/j.eswa.2009.12.004; Alberg AJ, 2004, J GEN INTERN MED, V19, P460, DOI 10.1111/j.1525-1497.2004.30091.x; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bishop C.M., 1995, NEURAL NETWORKS PATT; Borra S, 2010, COMPUT STAT DATA AN, V54, P2976, DOI 10.1016/j.csda.2010.03.004; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Casella G., 2021, STAT INFERENCE; Chakraborty S, 2009, COMPUT STAT DATA AN, V53, P1462, DOI 10.1016/j.csda.2008.10.012; Cho BH, 2008, ARTIF INTELL MED, V42, P37, DOI 10.1016/j.artmed.2007.09.005; Demsar J, 2006, J MACH LEARN RES, V7, P1; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Dougherty G., 2013, PATTERN RECOGN, P157; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Dybowski R., 2001, CLIN APPL ARTIFICIAL; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forghani Y, 2014, NEURAL NETWORKS, V50, P154, DOI 10.1016/j.neunet.2013.11.013; Garcia S, 2009, SOFT COMPUT, V13, P959, DOI 10.1007/s00500-008-0392-y; Garcia S., 2008, J MACHINE LEARNING R, V9; Ghaemi M, 2014, EXPERT SYST APPL, V41, P6676, DOI 10.1016/j.eswa.2014.05.009; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Gu Q, 2009, COMM COM INF SC, V51, P461, DOI 10.1007/978-3-642-04962-0_53; Guo JM, 2011, J SYST SOFTWARE, V84, P2208, DOI 10.1016/j.jss.2011.06.026; Gupta MM, 1979, ADV FUZZY SET THEORY; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoef JMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059129; Holland J.H., 1975, ADAPTATION NATURAL A; HOLM S, 1979, SCAND J STAT, V6, P65; Hur J, 2008, EXPERT SYST APPL, V34, P231, DOI 10.1016/j.eswa.2006.09.015; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; KANDEL A, 1982, FUZZY TECHNIQUES PAT; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Khashei M, 2008, FUZZY SET SYST, V159, P769, DOI 10.1016/j.fss.2007.10.011; Kubota R, 2008, IEICE ELECTRON EXPR, V5, P114, DOI 10.1587/elex.5.114; Lu Y, 2014, PATTERN RECOGNITION; Mitchell T.M, 2003, MACH LEARN; Olmez T, 2003, PATTERN RECOGN LETT, V24, P617, DOI 10.1016/S0167-8655(02)00281-7; Ostermark R, 2000, FUZZY SET SYST, V114, P311, DOI 10.1016/S0165-0114(98)00057-8; Premaratne P, 2014, HUMAN COMPUTER INTER, P105; Raudys S., 2001, STAT NEURAL CLASSIFI, P209, DOI [10.1007/978-1-4471-0359-2_6, DOI 10.1007/978-1-4471-0359-2_6]; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Salari N, 2012, LIFE SCI J, V9; Salari N, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-57; Seera M, 2014, EXPERT SYST APPL, V41, P2239, DOI 10.1016/j.eswa.2013.09.022; Segovia F, 2012, FRONT ARTIF INTEL AP, V243, P2241, DOI 10.3233/978-1-61499-105-2-2241; Fermin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088687; Shao YE, 2014, APPL SOFT COMPUT, V14, P47, DOI 10.1016/j.asoc.2013.09.020; Shapiro AF, 2002, INSUR MATH ECON, V31, P115, DOI 10.1016/S0167-6687(02)00124-5; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Song Y, 2007, LECT NOTES ARTIF INT, V4702, P248; Wang P, 1980, FUZZY SETS THEORY AP; Webb A.R., 2011, STAT PATTERN RECOGNI, V3rd ed.; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Werbos P.J., 1974, REGRESSION NEW TOOLS; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Qiu XP, 2007, EXPERT SYST APPL, V32, P1094, DOI 10.1016/j.eswa.2006.02.020; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeng Y, 2009, EXPERT SYST APPL, V36, P8443, DOI 10.1016/j.eswa.2008.10.041; Zhang CX, 2008, PATTERN RECOGN LETT, V29, P1524, DOI 10.1016/j.patrec.2008.03.006; Zhang S, 2014, COMPUTER INFORM SCI, V7, P94	64	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112987	10.1371/journal.pone.0112987	http://dx.doi.org/10.1371/journal.pone.0112987			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419659	Green Accepted, Green Published, gold			2022-12-27	WOS:000346766900015
J	Nilsson, H; Grove, EL; Larsen, TB; Nielsen, PB; Skjoth, F; Maegaard, M; Christensen, TD				Nilsson, Hanna; Grove, Erik Lerkevang; Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum; Skjoth, Flemming; Maegaard, Marianne; Christensen, Thomas Decker			Sex Differences in Treatment Quality of Self-Managed Oral Anticoagulant Therapy: 6,900 Patient-Years of Follow-Up	PLOS ONE			English	Article							WARFARIN; DABIGATRAN; METAANALYSIS; ASSOCIATION; OUTCOMES; COHORT; TRIAL	Background: Patient-self-management (PSM) of oral anticoagulant therapy with vitamin K antagonists has demonstrated efficacy in randomized, controlled trials. However, the effectiveness and efficacy of PSM in clinical practice and whether outcomes are different for females and males has been sparsely investigated. The objective is to evaluate the sex-dependent effectiveness of PSM of oral anticoagulant therapy in everyday clinical practice. Methods: All patients performing PSM affiliated to Aarhus University Hospital and Aalborg University Hospital, Denmark in the period 1996-2012 were included in a case-series study. The effectiveness was estimated using the following parameters: stroke, systemic embolism, major bleeding, intracranial bleeding, gastrointestinal bleeding, death and time spent in the therapeutic international normalized ratio (INR) target range. Prospectively registered patient data were obtained from two databases in the two hospitals. Cross-linkage between the databases and national registries provided detailed information on the incidence of death, bleeding and thromboembolism on an individual level. Results: A total of 2068 patients were included, representing 6,900 patient-years in total. Males achieved a significantly better therapeutic INR control than females; females spent 71.1% of the time within therapeutic INR target range, whereas males spent 76.4% (p<0.0001). Importantly, death, bleeding and thromboembolism were not significantly different between females and males. Conclusions: Among patients treated with self-managed oral anticoagulant therapy, males achieve a higher effectiveness than females in terms of time spent in therapeutic INR range, but the incidence of major complications is low and similar in both sexes.	[Nilsson, Hanna; Maegaard, Marianne; Christensen, Thomas Decker] Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8000 Aarhus, Denmark; [Nilsson, Hanna; Maegaard, Marianne; Christensen, Thomas Decker] Aarhus Univ Hosp, Inst Clin Med, DK-8000 Aarhus, Denmark; [Grove, Erik Lerkevang] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark; [Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum; Skjoth, Flemming] Aalborg Univ, Fac Med, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Christensen, TD (corresponding author), Aarhus Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-8000 Aarhus, Denmark.	tdc@ki.au.dk	Skjøth, Flemming/AAI-9954-2020; Larsen, Torben Bjerregaard/I-5081-2012	Larsen, Torben Bjerregaard/0000-0002-8485-8674; Nielsen, Peter Bronnum/0000-0003-2922-6970; Skjoth, Flemming/0000-0003-2975-647X; Grove, Erik/0000-0002-1466-0865	Takeda, Denmark; Helga og Peter Kornings Fond	Takeda, Denmark; Helga og Peter Kornings Fond	This project funded by a non-restricted grant from Takeda, Denmark. In addition, the authors wish to thank Helga og Peter Kornings Fond for their financial contribution to the project. None of the funding sources had any role in: the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. The authors gratefully acknowledge the nurses and clinical staff from the Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, and the Department of Cardiology, Aalborg University hospital, for their important role in patient education and continuous registration of patient data.	Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Bloomfield HE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00005; Christensen TD, 2006, EUR J INTERN MED, V17, P260, DOI 10.1016/j.ejim.2005.11.021; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Fitzmaurice DA, 2005, BRIT MED J, V331, P1057, DOI 10.1136/bmj.38618.580903.AE; Fritschi J, 2007, SWISS MED WKLY, V137, P252; Gardiner C, 2006, BRIT J HAEMATOL, V132, P598, DOI 10.1111/j.1365-2141.2005.05899.x; Gardiner C, 2009, J CLIN PATHOL, V62, P168, DOI 10.1136/jcp.2008.059634; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heneghan C, 2012, LANCET, V379, P322, DOI 10.1016/S0140-6736(11)61294-4; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Johnston M, 1996, J LAB CLIN MED, V128, P214, DOI 10.1016/S0022-2143(96)90014-1; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mair H, 2012, INTERACT CARDIOV TH, V14, P253, DOI 10.1093/icvts/ivr088; McCahon D, 2007, J CLIN PATHOL, V60, P1263, DOI 10.1136/jcp.2006.044008; Nagler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095761; Oake N, 2007, CAN MED ASSOC J, V176, P1589, DOI 10.1503/cmaj.061523; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pedersen CB, 2006, DAN MED BULL, V53, P441; Poller L, 2014, J THROMB HAEMOST, V12, P1193, DOI 10.1111/jth.12590; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ru San T, 2012, THROMBOSIS, V2012, DOI DOI 10.1155/2012/108983; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Wagstaff AJ, 2014, QJM; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239	30	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113627	10.1371/journal.pone.0113627	http://dx.doi.org/10.1371/journal.pone.0113627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415603	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600067
J	Zhou, P; Deng, Y; Lyu, B; Zhang, RR; Zhang, H; Ma, HW; Lyu, YL; Wei, SC				Zhou, Ping; Deng, Yi; Lyu, Beier; Zhang, Ranran; Zhang, Hai; Ma, Hongwei; Lyu, Yalin; Wei, Shicheng			Rapidly-Deposited Polydopamine Coating via High Temperature and Vigorous Stirring: Formation, Characterization and Biofunctional Evaluation	PLOS ONE			English	Article							IMMOBILIZATION; ANTIBACTERIAL; INTERFACES; SURFACES; GROWTH	Polydopamine (PDA) coating provides a promising approach for immobilization of biomolecules onto almost all kinds of solid substrates. However, the deposition kinetics of PDA coating as a function of temperature and reaction method is not well elucidated. Since dopamine self-polymerization usually takes a long time, therefore, rapid-formation of PDA film becomes imperative for surface modification of biomaterials and medical devices. In the present study, a practical method for preparation of rapidly-deposited PDA coating was developed using a uniquely designed device, and the kinetics of dopamine self-polymerization was investigated by QCM sensor system. It was found that high temperature and vigorous stirring could dramatically speed up the formation of PDA film on QCM chip surface. Surface characterization, BSA binding study, cell viability assay and antibacterial test demonstrates that the polydopamine coating after polymerization for 30 min by our approach exhibits similar properties to those of 24 h counterpart. The method has a great potential for rapid-deposition of polydopamine films to modify biomaterial surfaces.	[Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China; [Lyu, Beier; Ma, Hongwei] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China; [Zhang, Ranran; Zhang, Hai; Wei, Shicheng] Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China; [Zhang, Hai] Univ Washington, Sch Dent, Dept Restorat Dent, Washington, DC USA	Peking University; Peking University; Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Capital Medical University; University of Washington	Lyu, YL (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China.	lvyalin@vip.sina.com; sc-wei@pku.edu.cn	Zhou, Ping/AAX-7041-2021; Wei, Shicheng/F-9552-2017; Zhou, Ping/N-4224-2016	Zhou, Ping/0000-0002-6128-3951; Wei, Shicheng/0000-0001-6024-9615; 	National Natural Science Foundation [81371697]; Beijing Natural Science Foundation [7132124]; Peking University [985]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University)	This work was supported by the National Natural Science Foundation (81371697), www.nsfc.gov.cn, to SCW; Beijing Natural Science Foundation (7132124), www.bjnsf.org, to SCW; Peking University's 985 Grant, www.pku.edu.cn, to SCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030; Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h; Bhang SH, 2013, BIOCHEM BIOPH RES CO, V430, P1294, DOI 10.1016/j.bbrc.2012.11.123; Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v; Cho JH, 2013, ACS APPL MATER INTER, V5, P3794, DOI 10.1021/am400455p; Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r; Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5; Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; Fatisson J, 2011, BIOSENS BIOELECTRON, V26, P3207, DOI 10.1016/j.bios.2010.12.027; He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169; HERLINGER E, 1995, J CHEM SOC PERK T 2, P259, DOI 10.1039/p29950000259; Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k; Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028; Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011; Li H, 2013, BIOSENS BIOELECTRON, V41, P809, DOI 10.1016/j.bios.2012.10.021; Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p; Ou JF, 2009, J PHYS CHEM C, V113, P20429, DOI 10.1021/jp9073416; Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r; Peng HP, 2013, BIOSENS BIOELECTRON, V42, P293, DOI 10.1016/j.bios.2012.10.074; Pop-Georgievski O, 2012, LANGMUIR, V28, P14273, DOI 10.1021/la3029935; Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Shin YM, 2011, COLLOID SURFACE B, V87, P79, DOI 10.1016/j.colsurfb.2011.05.004; Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h; Tsai WB, 2011, ACTA BIOMATER, V7, P4187, DOI 10.1016/j.actbio.2011.07.024; Wang LQ, 2011, INVEST OPHTH VIS SCI, V52, P7392, DOI 10.1167/iovs.11-7601; Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956; Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a; Zheng LZ, 2012, THIN SOLID FILMS, V520, P2776, DOI 10.1016/j.tsf.2011.12.017; Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b; Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027	36	68	69	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113087	10.1371/journal.pone.0113087	http://dx.doi.org/10.1371/journal.pone.0113087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415328	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600028
J	Frank, CL; Michalski, A; McDonough, AA; Rahimian, M; Rudd, RJ; Herzog, C				Frank, Craig L.; Michalski, Andrew; McDonough, Anne A.; Rahimian, Marjon; Rudd, Robert J.; Herzog, Carl			The Resistance of a North American Bat Species (Eptesicus fuscus) to White-Nose Syndrome (WNS)	PLOS ONE			English	Article							HIBERNATION; PATHOGEN	White-nose Syndrome (WNS) is the primary cause of over-winter mortality for little brown (Myotis lucifugus), northern (Myotis septentrionalis), and tricolored (Perimyotis subflavus) bats, and is due to cutaneous infection with the fungus Pseudogymnoascus (Geomyces) destructans (Pd). Cutaneous infection with P. destructans disrupts torpor patterns, which is thought to lead to a premature depletion of body fat reserve. Field studies were conducted at 3 WNS-affected hibernation sites to determine if big brown bats (Eptesicus fuscus) are resistant to Pd. Radio telemetry studies were conducted during 2 winters to determine the torpor patterns of 23 free-ranging E. fuscus hibernating at a site where Pd occurs. The body fat contents of free-ranging E. fuscus and M. lucifugus during hibernation at 2 different WNS-affected sites were also determined. The numbers of bats hibernating at the same site was determined during both: a) 4-7 years prior to the arrival of Pd, and, b) 2-3 years after it first appeared at this site. The torpor bouts of big brown bats hibernating at a WNS-affected site were not significantly different in length from those previously reported for this species. The mean body fat content of E. fuscus in February was nearly twice that of M. lucifugus hibernating at the same WNS-affected sites during this month. The number of M. lucifugus hibernating at one site decreased by 99.6% after P. destructans first appeared, whereas the number of E. fuscus hibernating there actually increased by 43% during the same period. None of the E. fuscus collected during this study had any visible fungal growth or lesions on their skin, whereas virtually all the M. lucifugus collected had visible fungal growth on their wings, muzzle, and ears. These findings indicate that big brown bats are resistant to WNS.	[Frank, Craig L.; McDonough, Anne A.; Rahimian, Marjon] Fordham Univ, Louis Calder Ctr, Dept Biol Sci, Armonk, NY 10504 USA; [Michalski, Andrew] Fordham Univ, Environm Sci Program, Bronx, NY 10458 USA; [Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Herzog, Carl] New York State Dept Environm Conservat, Albany, NY 12233 USA	Fordham University; Fordham University; State University of New York (SUNY) System; Wadsworth Center	Frank, CL (corresponding author), Fordham Univ, Louis Calder Ctr, Dept Biol Sci, POB 887, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Frank, Craig/0000-0002-4340-4422	National Science Foundation (NSF) [IOS-0818222]; Fordham University	National Science Foundation (NSF)(National Science Foundation (NSF)); Fordham University	This study was supported by National Science Foundation (NSF) grant IOS-0818222 awarded to C.L.F. (www.nsf.gov) and a Fordham University Summer Science Internship awarded to M.R. (www.fordham.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Blanton JD, 2009, JAVMA-J AM VET MED A, V235, P676, DOI 10.2460/javma.235.6.676; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; Feldhamer GA, 2007, MAMMALOGY ADAPTATION, P643; Frank Craig L., 2012, P271; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Hood WR, 2006, J COMP PHYSIOL B, V176, P807, DOI 10.1007/s00360-006-0102-y; Karpovich SA, 2009, J COMP PHYSIOL B, V179, P691, DOI 10.1007/s00360-009-0350-8; Kayser C, 1965, PHYSL MAMMALOGY, P180; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Lorch JM, 2011, NATURE, P10590; Mondul A, 2003, J AM VET MED ASSOC, V222, P633, DOI 10.2460/javma.2003.222.633; Moosman PR, 2013, NORTHEAST NAT, V20, P552, DOI 10.1656/045.020.0405; Pond C.M., 1998, FATS LIFE; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; Turner Gregory G., 2011, Bat Research News, V52, P13; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wilcox A, 2014, ANIM BEHAV, V88, P157, DOI 10.1016/j.anbehav.2013.11.026; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y	35	40	42	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113958	10.1371/journal.pone.0113958	http://dx.doi.org/10.1371/journal.pone.0113958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437448	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900103
J	Zhou, W; Zhao, M; Wang, X; Schilling, RF; Zhou, S; Qiu, HY; Xie, NH; Liu, MQ; Dong, HS; Yao, ZZ; Cai, T				Zhou, Wang; Zhao, Min; Wang, Xia; Schilling, Robert F.; Zhou, Sheng; Qiu, Hong-Yan; Xie, Nian-Hua; Liu, Man-Qing; Dong, Han-Sheng; Yao, Zhong-Zhao; Cai, Thomas			Treatment Adherence and Health Outcomes in MSM with HIV/AIDS: Patients Enrolled in "One-Stop'' and Standard Care Clinics in Wuhan China	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; LOW-INCOME; SEX; PREVENTION; STRATEGIES; MORTALITY; BARRIERS; MEN	Background: Conducted in Wuhan China, this study examined follow-up and health markers in HIV patients receiving care in two treatment settings. Participants, all men who have sex with men, were followed for18-24 months. Method: Patients in a "one-stop'' service (ACC; N589) vs those in standard care clinics (CDC; N5243) were compared on HIV treatment and retention in care outcomes. Results: Among patients with CD4 cell count 350 cells/mL, the proportion receiving cART did not differ across clinic groups. The ACC was favored across five other indicators: proportion receiving tests for CD4 cell count at the six-month interval (98.2% vs. 79.4%, 95% CI 13.3-24.3, p=0.000), proportion with HIV suppression for patients receiving cART for 6 months (86.5% vs. 57.1%, 95% CI 14.1-44.7, p=0.000), proportion with CD4 cell recovery for patients receiving cART for 12 months (55.8% vs. 22.2%, 95% CI 18.5-48.6, p=0.000), median time from HIV confirmation to first test for CD4 cell count (7 days, 95% CI 4-8 vs. 10 days, 95% CI 9-12, log-rank p=0.000) and median time from first CD4 cell count 350 cells/mL to cART initiation (26 days, 95% CI 16-37 vs. 41.5 days, 95% CI 35-46, log-rank p=0.031). Clinic groups did not differ on any biomedical indicator at baseline, and no baseline biomedical or demographic variables remained significant in the multivariate analysis. Nonetheless, post-hoc analyses suggest the possibility of self-selection bias. Conclusions: Study findings lend preliminary support to a one-stop patient-centered care model that may be useful across various HIV care settings.	[Zhou, Wang; Wang, Xia; Xie, Nian-Hua; Liu, Man-Qing; Yao, Zhong-Zhao] Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Zhao, Min; Qiu, Hong-Yan; Dong, Han-Sheng] Wuhan Inst Dermatovenereol, Wuhan, Hubei, Peoples R China; [Schilling, Robert F.] Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA; [Zhou, Sheng] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cai, Thomas] AIDS Care China, Nanning, Guangxi, Peoples R China	University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhou, W (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China.	rising-up@hotmail.com	Liu, Man-Qing/M-9598-2014	Liu, Man-Qing/0000-0002-9754-3102	Wuhan Municipal Health Bureau, China; Pangaea Global AIDS Foundation, USA [OPPGH5180]	Wuhan Municipal Health Bureau, China; Pangaea Global AIDS Foundation, USA	This study was supported by the Wuhan Municipal Health Bureau, China (to WZ) and the Pangaea Global AIDS Foundation, USA (grant number OPPGH5180 to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Amico K Rivet, 2008, Curr HIV/AIDS Rep, V5, P172, DOI 10.1007/s11904-008-0026-0; [Anonymous], 2011, CHINA AIDS EPIDEMIC; [Anonymous], 2012, CHINA AIDS REPORT; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.102/14651858.CD009987; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ortego C, 2012, AIDS CARE, V24, P1519, DOI 10.1080/09540121.2012.672722; Podlekareva DN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-229; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robiner WN, 2005, CONTEMP CLIN TRIALS, V26, P59, DOI 10.1016/j.cct.2004.11.015; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shah B, 2007, CLIN INFECT DIS, V44, P1235, DOI 10.1086/513429; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Tassie JM, 2011, CURR OPIN HIV AIDS, V6, P233, DOI 10.1097/COH.0b013e328347798d; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, STRAT US ANT HELP EN; Zhang FJ, 2012, HDB CHINAS NATL FREE; Zhang Y, 2012, JAIDS-J ACQ IMM DEF, V60, P59, DOI 10.1097/QAI.0b013e31824c3d9f; Zhang Y, 2011, CHINESE MED J-PEKING, V124, P1488, DOI 10.3760/cma.j.issn.0366-6999.2011.10.009; Zhao Y, 2012, CHINESE MED J-PEKING, V125, P1331, DOI 10.3760/cma.j.issn.0366-6999.2012.07.025; Zhou JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-361	36	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113736	10.1371/journal.pone.0113736	http://dx.doi.org/10.1371/journal.pone.0113736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438039	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900074
J	Wan, WB; Cao, L; Liu, LM; Kalionis, B; Chen, C; Tai, XT; Li, YM; Xia, SJ				Wan, Wen-bin; Cao, Lan; Liu, Lu-mei; Kalionis, Bill; Chen, Chuan; Tai, Xian-tao; Li, Ya-ming; Xia, Shi-jin			EGb761 Provides a Protective Effect against A beta(1-42) Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; AMYLOID-BETA PEPTIDE; GINKGO-BILOBA; TIGHT JUNCTIONS; MOUSE MODEL; EXPRESSION; RAGE; RECEPTOR; ASTROCYTES; DEPOSITION	Alzheimer's disease (AD) is the most common form of senile dementia which is characterized by abnormal amyloid beta (A beta) accumulation and deposition in brain parenchyma and cerebral capillaries, and leads to blood-brain barrier (BBB) disruption. Despite great progress in understanding the etiology of AD, the underlying pathogenic mechanism of BBB damage is still unclear, and no effective treatment has been devised. The standard Ginkgo biloba extract EGb761 has been widely used as a potential cognitive enhancer for the treatment of AD. However, the cellular mechanism underlying the effect remain to be clarified. In this study, we employed an immortalized endothelial cell line (bEnd.3) and incubation of A beta(1-42) oligomer, to mimic a monolayer BBB model under conditions found in the AD brain. We investigated the effect of EGb761 on BBB and found that A beta(1-42) oligomer-induced cell injury, apoptosis, and generation of intracellular reactive oxygen species (ROS), were attenuated by treatment with EGb761. Moreover, treatment of the cells with EGb761 decreased BBB permeability and increased tight junction scaffold protein levels including ZO-1, Claudin-5 and Occludin. We also found that the A beta(1-42) oligomer-induced upregulation of the receptor for advanced glycation end-products (RAGE), which mediates Ab cytotoxicity and plays an essential role in AD progression, was significantly decreased by treatment with EGb761. To our knowledge, we provide the first direct in vitro evidence of an effect of EGb761 on the brain endothelium exposed to A beta(1-42) oligomer, and on the expression of tight junction (TJ) scaffold proteins and RAGE. Our results provide a new insight into a possible mechanism of action of EGb761. This study provides a rational basis for the therapeutic application of EGb761 in the treatment of AD.	[Wan, Wen-bin] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Cao, Lan] Fudan Univ, Sch Basic Med Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Liu, Lu-mei; Li, Ya-ming] Fudan Univ, Huadong Hosp, Geriatr Dept Tradit Chinese Med, Shanghai 200433, Peoples R China; [Kalionis, Bill] Pregnancy Res Ctr, Dept Perinatal Med, Parkville, Vic, Australia; [Kalionis, Bill] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Chen, Chuan] Shanghai Geriatr Inst Chinese Med, Shanghai, Peoples R China; [Tai, Xian-tao] Yunnan Univ Tradit Chinese Med, Sch Acupuncture Massage & Rehabil, Kunming, Peoples R China; [Xia, Shi-jin] Fudan Univ, Huadong Hosp, Shanghai Inst Geriatr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; University of Melbourne; Yunnan University of Chinese Medicine; Fudan University	Li, YM (corresponding author), Fudan Univ, Huadong Hosp, Geriatr Dept Tradit Chinese Med, Shanghai 200433, Peoples R China.	doctorymli@163.com; xiashijinhd@163.com	KALIONIS, BILL/B-4766-2011		National Natural Science Foundation of China [81473739, 31171129, 81460748]; Shanghai Committee of Science and Technology, China [12401904500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	The authors gratefully acknowledge the financial support of this study by National Natural Science Foundation of China (Grant No. 81473739), and Shanghai Committee of Science and Technology, China (Grant No. 12401904500), YML received the funding, (http://www.nsfc.gov.cn/) and (http://www.stcsm.gov.cn/), respectively; by National Natural Science Foundation of China (Grant No. 31171129, Grant No. 81460748), SJX received the funding, (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarczyk J, 2011, ACTA NEUROBIOL EXP, V71, P393; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Chen X, 2012, NEUROSCIENCE, V226, P89, DOI 10.1016/j.neuroscience.2012.08.043; Chen Y, 2012, PLANTA MED, V78, P1337, DOI 10.1055/s-0032-1314965; Choi BR, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.147; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deane RJ, 2012, FUTURE MED CHEM, V4, P915, DOI [10.4155/FMC.12.51, 10.4155/fmc.12.51]; Evans JR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001775.pub2; Gonzalez-Mariscal L, 2011, ANTIOXID REDOX SIGN, V15, P1235, DOI 10.1089/ars.2011.3913; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Jahanshahi M, 2012, ANAT CELL BIOL, V45, P92, DOI 10.5115/acb.2012.45.2.92; Kehr J, 2012, INT PSYCHOGERIATR, V24, pS25, DOI 10.1017/S1041610212000567; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Kook SY, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23993; Kook SY, 2012, J NEUROSCI, V32, P8845, DOI 10.1523/JNEUROSCI.6102-11.2012; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Love S, 2009, FRONT BIOSCI-LANDMRK, V14, P4778, DOI 10.2741/3567; Marco S, 2006, NEUROSCI LETT, V401, P219, DOI 10.1016/j.neulet.2006.03.047; Mashayekh A, 2011, NEURORADIOLOGY, V53, P185, DOI 10.1007/s00234-010-0790-6; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Muller WE, 2012, INT PSYCHOGERIATR, V24, pS21, DOI 10.1017/S1041610212000592; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Perrone Lorena, 2012, Int J Alzheimers Dis, V2012, P734956, DOI 10.1155/2012/734956; Pomara N, 2010, NEW ENGL J MED, V362, P1844, DOI 10.1056/NEJMc1002323; Ramasamy R, 2012, AMINO ACIDS, V42, P1151, DOI 10.1007/s00726-010-0773-2; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Wan WB, 2014, INT J NEUROSCI, V124, P75, DOI 10.3109/00207454.2013.825258; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Xiao QA, 2010, EUR J PHARMACOL, V647, P48, DOI 10.1016/j.ejphar.2010.08.002; Yan FL, 2008, ACTA NEUROPATHOL, V116, P529, DOI 10.1007/s00401-008-0435-6; Yan SD, 2000, BBA-MOL BASIS DIS, V1502, P145, DOI 10.1016/S0925-4439(00)00041-7; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang CY, 2013, BIOL TRACE ELEM RES, V153, P229, DOI 10.1007/s12011-013-9645-4; Zhou T, 2014, BIOCHEM BIOPH RES CO, V445, P352, DOI 10.1016/j.bbrc.2014.01.194	42	34	39	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113126	10.1371/journal.pone.0113126	http://dx.doi.org/10.1371/journal.pone.0113126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426944	Green Published, gold			2022-12-27	WOS:000349145400034
J	Darling, ES				Darling, Emily S.			Assessing the Effect of Marine Reserves on Household Food Security in Kenyan Coral Reef Fishing Communities	PLOS ONE			English	Article							PROTECTED AREAS; DIETARY DIVERSITY; FISHERIES; POVERTY; MANAGEMENT; HEALTH; FUTURE; CONSERVATION; INSECURITY; SPILLOVER	Measuring the success or failure of natural resource management is a key challenge to evaluate the impact of conservation for ecological, economic and social outcomes. Marine reserves are a popular tool for managing coastal ecosystems and resources yet surprisingly few studies have quantified the social-economic impacts of marine reserves on food security despite the critical importance of this outcome for fisheries management in developing countries. Here, I conducted semi-structured household surveys with 113 women heads-of-households to investigate the influence of two old, well-enforced, no-take marine reserves on food security in four coastal fishing communities in Kenya, East Africa. Multi-model information-theoretic inference and matching methods found that marine reserves did not influence household food security, as measured by protein consumption, diet diversity and food coping strategies. Instead, food security was strongly influenced by fishing livelihoods and household wealth: fishing families and wealthier households were more food secure than non-fishing and poorer households. These findings highlight the importance of complex social and economic landscapes of livelihoods, urbanization, power and gender dynamics that can drive the outcomes of marine conservation and management.	[Darling, Emily S.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Darling, Emily S.] Wildlife Conservat Soc, Mombasa, Kenya	Simon Fraser University	Darling, ES (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	esdarling@gmail.com		Darling, Emily/0000-0002-1048-2838	Doctoral Research Award from the International Development Research Centre of Canada; Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund	Doctoral Research Award from the International Development Research Centre of Canada; Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund	This study was funded by a Doctoral Research Award from the International Development Research Centre of Canada and a Kathryn Fuller Doctoral Fellowship from the World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abunge C, 2013, AMBIO, V42, P1010, DOI 10.1007/s13280-013-0456-9; Allison EH, 2011, 201165 WORLDF CTR; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Aswani S, 2007, COAST MANAGE, V35, P545, DOI 10.1080/08920750701593394; Barrett CB, 2010, SCIENCE, V327, P825, DOI 10.1126/science.1182768; Barton K, 2013, MUMIN MULTIMODEL SEL; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Christie P, 2004, AM FISH S S, V42, P155; Cinner JE, 2010, MAR POLICY, V34, P22, DOI 10.1016/j.marpol.2009.04.003; Cinner JE, 2004, OCEAN COAST MANAGE, V47, P479, DOI 10.1016/j.ocecoaman.2004.09.002; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Diamond A, 2006, WORKING PAPER; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Gaynor JL, 2010, RADICAL HIST REV, P74, DOI 10.1215/01636545-2009-035; Geheb K, 2008, FOOD POLICY, V33, P85, DOI 10.1016/j.foodpol.2007.06.001; Gjertsen H, 2005, WORLD DEV, V33, P199, DOI 10.1016/j.worlddev.2004.07.009; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Hoorweg JC, 2009, AFRIKA STUDIECENTRUM, V14; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Johnson AE, 2013, FISH FISH, V14, P281, DOI 10.1111/j.1467-2979.2012.00468.x; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Kapos V, 2008, CONSERV LETT, V1, P155, DOI 10.1111/j.1755-263X.2008.00025.x; KAWARAZUKA N, 2010, 2106 WORLDF CTR; Kawarazuka N, 2010, FOOD SECUR, V2, P343, DOI 10.1007/s12571-010-0079-y; Kleiber D, 2015, FISH FISH, V16, P547, DOI 10.1111/faf.12075; Kleiber D, 2014, CAN J FISH AQUAT SCI, V71, P656, DOI 10.1139/cjfas-2013-0177; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Malleret-King D, 2000, THESIS U WARWICK; Mangi SC, 2007, FISHERIES MANAG ECOL, V14, P245, DOI 10.1111/j.1365-2400.2007.00549.x; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; McClanahan T, 2015, FISH FISH, V16, P78, DOI 10.1111/faf.12045; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2005, OCEAN COAST MANAGE, V48, P901, DOI 10.1016/j.ocecoaman.2005.03.005; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Meinzen-Dick R., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P135; Misselhorn AA, 2005, GLOBAL ENVIRON CHANG, V15, P33, DOI 10.1016/j.gloenvcha.2004.11.003; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Niemeijer R, 1991, 38 FOOD NUTR PLANN U; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Pollnac R. B., 2000, ASSESSING BEHAV ASPE; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Development Core Team, 2014, R LANG ENV STAT COMP; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sala E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058799; Savy M, 2007, PUBLIC HEALTH NUTR, V10, P71, DOI 10.1017/S1368980007219627; Sekhon JS, 2013, MATCHING MULTIVARIAT; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Souter DW, 2000, OCEAN COAST MANAGE, V43, P657, DOI 10.1016/S0964-5691(00)00053-3; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tobey J, 2006, OCEAN COAST MANAGE, V49, P834, DOI 10.1016/j.ocecoaman.2006.08.002; Weiant P., 2006, SPC TRADITIONAL MARI, V19, P16; Weigel J-Y, FISHERIES RES, V161, P64; Wells S, 2007, OCEAN COAST MANAGE, V50, P67, DOI 10.1016/j.ocecoaman.2006.08.012; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	71	30	32	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113614	10.1371/journal.pone.0113614	http://dx.doi.org/10.1371/journal.pone.0113614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422888	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700043
J	Mahto, KK; Singh, A; Khandelwal, NK; Bhardwaj, N; Jha, J; Prasad, R				Mahto, Kaushal Kumar; Singh, Ashutosh; Khandelwal, Nitesh Kumar; Bhardwaj, Nitin; Jha, Jaykar; Prasad, Rajendra			An Assessment of Growth Media Enrichment on Lipid Metabolome and the Concurrent Phenotypic Properties of Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; MASS-SPECTROMETRY; CELL-FUSION; YEAST; VIRULENCE; SYNTHASE; REVEALS; GENES; WALL	A critical question among the researchers working on fungal lipid biology is whether the use of an enriched growth medium can affect the lipid composition of a cell and, therefore, contribute to the observed phenotypes. One presumption is that enriched medias, such as YPD (yeast extract, peptone and dextrose), are likely to contain lipids, which may homogenize with the yeast lipids and play a role in masking the actual differences in the observed phenotypes or lead to an altered phenotype altogether. To address this issue, we compared the lipids of Candida albicans, our fungus of interest, grown in YPD or in a defined media such as YNB (yeast nitrogen base). Mass spectrometry-based lipid analyses showed differences in the levels of phospholipids, including phosphatidylinositol, phosphatidylglycerol, lyso-phospholipids; sphingolipids, such as mannosyldiinositolphosphorylceramide; and sterols, such as ergostatetraenol. Significant differences were observed in 70 lipid species between the cells grown in the two media, but the two growth conditions did not affect the morphological characteristics of C. albicans. The lipid profiles of the YNB-and YPD-grown C. albicans cells did vary, but these differences did not influence their response to the majority of the tested agents. Rather, the observed differences could be attributed to the slow growth rate of the Candida cells in YNB compared to YPD. Notably, the altered lipid changes between the two media did impact the susceptibility to some drugs. This data provided evidence that changes in media can lead to certain lipid alterations, which may affect specific pathways but, in general, do not affect the majority of the phenotypic properties of C. albicans. It was determined that either YNB or YPD may be suitable for the growth and lipid analysis of C. albicans, depending upon the experimental requirements, but additional precautions are necessary when correlating the phenotypes with the lipids.	[Mahto, Kaushal Kumar; Singh, Ashutosh; Khandelwal, Nitesh Kumar; Bhardwaj, Nitin; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India; [Mahto, Kaushal Kumar; Jha, Jaykar] Lalit Narayan Mithila Univ, Dept Biotechnol, Kameshwarnagar, Darbhanga, India	Jawaharlal Nehru University, New Delhi	Prasad, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India.	rp47@mail.jnu.ac.in	Khandelwal, Nitesh Kumar/AAX-6273-2021; SINGH, ASHUTOSH/AAR-1283-2021	Khandelwal, Nitesh Kumar/0000-0002-6319-8048; SINGH, ASHUTOSH/0000-0002-0995-6696; Mahto, Kaushal Kumar/0000-0002-7890-7775	Department of Biotechnology [BT/PR13641/Med/29/175/2010, BT/PR14879/BRB10/885/2010, BT/01/CEIB/10/III/02]; Department of Science and Technology [SR/SO/BB-34/2008]; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented in this paper has been supported in part by grants to R.P. from Department of Biotechnology (BT/PR13641/Med/29/175/2010, BT/PR14879/BRB10/885/2010, and BT/01/CEIB/10/III/02) and Department of Science and Technology (SR/SO/BB-34/2008). The ESI-MS/MS analyses described in this work were performed at the Kansas Lipidomics Research Center Analytical Laboratory, where equipment acquisition and method development were funded by National Science Foundation (EPS 0236913, MCB 0455318, and DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475), the Johnson Cancer Center, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; CLSI, 2008, M27A3 CLSI; Del Poeta M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003832; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fei Q, 2011, BIORESOURCE TECHNOL, V102, P2695, DOI 10.1016/j.biortech.2010.10.141; Georgopapadakou NH, 2001, EXPERT OPIN INV DRUG, V10, P269, DOI 10.1517/13543784.10.2.269; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; HALL SS, 1983, J MED CHEM, V26, P469, DOI 10.1021/jm00358a003; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Huang C, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-4; Huang YT, 2014, ANTIMICROB AGENTS CH, V58, P3814, DOI 10.1128/AAC.01035-13; Jackson BE, 2007, INVEST OPHTH VIS SCI, V48, P2535, DOI 10.1167/iovs.06-0909; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Lattif AA, 2011, MICROBIOL-SGM, V157, P3232, DOI 10.1099/mic.0.051086-0; Ma Lijuan, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P55; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Nielsen J, 2009, FEBS LETT, V583, P3905, DOI 10.1016/j.febslet.2009.10.054; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Papan C, 2014, ANAL CHEM, V86, P2703, DOI 10.1021/ac404083u; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; Prasad R, 2005, INT REV CYTOL, V242, P215; Prasad R, 2013, CURR GENET, V59, P243, DOI 10.1007/s00294-013-0402-1; Rhome R, 2009, ANNU REV MICROBIOL, V63, P119, DOI 10.1146/annurev.micro.091208.073431; Rieg G, 1999, INFECT IMMUN, V67, P3193, DOI 10.1128/IAI.67.7.3193-3198.1999; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; SENA EP, 1973, P NATL ACAD SCI USA, V70, P1373, DOI 10.1073/pnas.70.5.1373; Shah AH, 2014, BIOCHEM J, V460, P223, DOI 10.1042/BJ20140010; Sharma Monika, 2012, Front Biosci (Elite Ed), V4, P1195; Sharma S, 2014, ANTIMICROB AGENTS CH, V58, P2409, DOI 10.1128/AAC.02130-13; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Singh A, 2013, OMICS, V17, P84, DOI 10.1089/omi.2012.0075; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039812; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019266; Singh A, 2010, OMICS, V14, P665, DOI 10.1089/omi.2010.0041; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tuite Nina L, 2013, Methods Mol Biol, V968, P1, DOI 10.1007/978-1-62703-257-5_1; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zuo XM, 2011, MOL PHARMACOL, V80, P476, DOI 10.1124/mol.111.072322	48	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113664	10.1371/journal.pone.0113664	http://dx.doi.org/10.1371/journal.pone.0113664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423360	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700049
J	Phadraig, CM; Nunn, J; Dougall, A; O'Neill, E; McLoughlin, J; Guerin, S				Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; O'Neill, Eunan; McLoughlin, Jacinta; Guerin, Suzanne			What Should Dental Services for People with Disabilities Be Like? Results of an Irish Delphi Panel Survey	PLOS ONE			English	Article							SPECIAL CARE DENTISTRY; HEALTH-CARE; ORAL-HEALTH	Background: This study aimed to generate prioritised goals for oral health services for people with disabilities as a first step in meeting the need for evidence based oral health services for people with disabilities in Ireland. Methods: The study used a three round modified e-Delphi method, involving dental service professionals and people with disabilities or their representatives, in Ireland. Three rounds were completed online using SurveyMonkey. Round 1 asked: "List what you think dental services for people with disabilities in Ireland should be like.'' Items for subsequent rounds were generated from responses to Round 1. Round 2 and Round 3 used 5 point Likert scales to rank these items by priority: from No Priority (1) to Top Priority (5). Consensus was achieved on each item where at least 80% of respondents considered an item either High or Top Priority. A consensus meeting concluded the process. Results: Sixty-one panelists started and 48 completed the survey. The Delphi panel agreed on level of priority for 69 items and generated 16 consensus statements. These statements covered a range of topics such as access to care, availability of information and training, quality of care, dental treatment and cost. A recurrent theme relating to the appropriateness of care to individual need arose across topics suggesting a need to match service delivery according to the individual's needs, wants and expectations rather than the disability type/diagnosis based service which predominates today. Conclusions: This process produced a list of prioritised goals for dental services for people with disabilities. This creates a foundation for building evidence-based service models for people with disabilities in Ireland.	[Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; McLoughlin, Jacinta] Dublin Dent Univ Hosp, Dept Publ & Child Dent Hlth, Dublin, Ireland; [Phadraig, Caoimhin Mac Giolla; Nunn, June; Dougall, Alison; McLoughlin, Jacinta] Univ Dublin Trinity Coll, Dublin 2, Ireland; [O'Neill, Eunan] Oxfordshire Cty Council, Oxford, England; [Guerin, Suzanne] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin	Phadraig, CM (corresponding author), Dublin Dent Univ Hosp, Dept Publ & Child Dent Hlth, Dublin, Ireland.	macgiolla@dental.tcd.ie	Phadraig, Caoimhin Mac Giolla/AFP-3065-2022; Guerin, Suzanne/Q-9014-2017	Phadraig, Caoimhin Mac Giolla/0000-0002-7797-1126; Guerin, Suzanne/0000-0002-6744-7590; Nunn, June/0000-0003-4481-544X; Dougall, Alison/0000-0003-0543-3940				Anders PL, 2010, SPEC CARE DENT, V30, P110, DOI 10.1111/j.1754-4505.2010.00136.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Costello P J, 1990, J Ir Dent Assoc, V36, P99; Cramer Carl K, 2008, J Evid Based Dent Pract, V8, P211, DOI 10.1016/j.jebdp.2008.09.002; Crowley E, 2005, ORAL HLTH ADULTS INT; Dalkey NC, 1969, DELPHI METHOD EXPT S; Disability Federation Ireland, 2012, DIS IR SOME FACTS FI; Dougall A, 2013, EUR J DENT EDUC, V17, P46, DOI 10.1111/eje.12011; Efstathiou N, 2011, EUR J CANCER CARE, V20, P179, DOI 10.1111/j.1365-2354.2009.01176.x; Elliot I, 2005, ORAL HLTH DISABILITY; Faulks D, 2012, EUR J DENT EDUC, V16, P195, DOI 10.1111/j.1600-0579.2012.00736.x; Faulks D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061993; Glassman Paul, 2003, J Calif Dent Assoc, V31, P149; Holland T J, 1997, J Ir Dent Assoc, V43, P72; Holland T J, 1990, Community Dent Health, V7, P285; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hsu C-C, 2007, PRACTICAL ASSESSMENT, V12, P8; Irish Society of Disability and Oral Health, 2012, ACC SPEC CAR GEN AN; Jones JA, 2000, J PUBLIC HEALTH DENT, V60, P330, DOI 10.1111/j.1752-7325.2000.tb03344.x; Kaplan G, 2015, HEALTH EXPECT, V18, P904, DOI 10.1111/hex.12064; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Ludwig B., 1997, J EXT, V36, P5; McGeown D, 2012, J DISAB ORAL HLTH, V13, P101; National Disability Authority, 2006, PROP DIS PEOPL SET R; Owens J, 2010, BRIT DENT J, V208, P203, DOI 10.1038/sj.bdj.2010.204; PA Consulting Group, 2010, STRAT REV DEL MAN HS; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Phadraig CM, 2015, J PUBLIC HEALTH DENT, V75, P101, DOI 10.1111/jphd.12077; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Prabhu NT, 2008, SPEC CARE DENT, V28, P145, DOI 10.1111/j.1754-4505.2008.00034.x; Sagheri D, 2013, QUINTESSENCE INT, V44, P159, DOI 10.3290/j.qi.a28927; Smith G, 2010, J Ir Dent Assoc, V56, P80; Turoff M, 1996, GAZING ORACLE DELPHI, P56; WHO, 2001, WHO INT CLASS FUNCT	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113393	10.1371/journal.pone.0113393	http://dx.doi.org/10.1371/journal.pone.0113393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420015	Green Published, gold			2022-12-27	WOS:000346766900032
J	Wang, ZJ; Sun, LQ; Heinbockel, T				Wang, Ze-Jun; Sun, Liqin; Heinbockel, Thomas			Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; LIU-SHEN-WAN; TOAD VENOM; NA+-CHANNELS; NA/K-ATPASE; K-ATPASE; INHIBITION; DIGOXIN; BUFALIN; PUMP	Cinobufagin and resibufogenin are two major effective bufadienolides of Chan su (toad venom), which is a Chinese medicine obtained from the skin venom gland of toads and is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. Many clinical cases showed that Chan su has severe side-effects on the CNS, causing shortness of breath, breathlessness, seizure, coma and cardiac arrhythmia. We used whole-cell recordings from brain slices to determine the effects of bufadienolides on excitability of a principal neuron in main olfactory bulb (MOB), mitral cells (MCs), and the cellular mechanism underlying the excitation. At higher concentrations, cinobufagin and resibufogenin induced irreversible over-excitation of MCs indicating a toxic effect. At lower concentrations, they concentration-dependently increased spontaneous firing rate, depolarized the membrane potential of MCs, and elicited inward currents. The excitatory effects were due to a direct action on MCs rather than an indirect phasic action. Bufadienolides and ouabain had similar effects on firing of MCs which suggested that bufadienolides activated neuron through a ouabain-like effect, most likely by inhibiting Na+/K+-ATPase. The direct action of bufadienolide on brain Na+ channels was tested by recordings from stably Na(v)1.2-transfected cells. Bufadienolides failed to make significant changes of the main properties of Na(v)1.2 channels in current amplitude, current-voltage (I-V) relationships, activation and inactivation. Our results suggest that inhibition of Na+/K+-ATPase may be involved in both the pharmacological and toxic effects of bufadienolide-evoked CNS excitation.	[Wang, Ze-Jun; Sun, Liqin; Heinbockel, Thomas] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Howard University	Wang, ZJ (corresponding author), Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA.	zejunwang@hotmail.com; theinbockel@howard.edu		Heinbockel, Thomas/0000-0003-4347-2131	U.S. PHS [GM08016, MD07597]; Foundation of Selected Item Support for Researcher Back from Overseas; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1355034] Funding Source: National Science Foundation	U.S. PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Selected Item Support for Researcher Back from Overseas; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by U.S. PHS grants (GM08016 and MD07597 to T.H., www.usphs.gov/) and Foundation of Selected Item Support for Researcher Back from Overseas to Z.J.W. (http://www.mohrss.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; [Anonymous], 1999, CHINESE MAT MED, V9, P362; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bagrov AY, 1998, HYPERTENSION, V31, P1097, DOI 10.1161/01.HYP.31.5.1097; de Vasconcelos DIB, 2011, MEDIAT INFLAMM, V2011, P1, DOI 10.1155/2011/912925; Bick RJ, 2002, LIFE SCI, V72, P699, DOI 10.1016/S0024-3205(02)02302-0; Brubacher JR, 1999, TOXICON, V37, P931, DOI 10.1016/S0041-0101(98)00224-4; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE, VI; COHENLURIA R, 1994, AM J PHYSIOL, V267, pF94, DOI 10.1152/ajprenal.1994.267.1.F94; CRUZ JD, 1993, EUR J PHARMACOL, V239, P223; Danchuk S, 2008, AM J NEPHROL, V28, P8, DOI 10.1159/000108756; Dasgupta A, 2000, AM J CLIN PATHOL, V114, P174, DOI 10.1309/BTFH-L0UH-P326-UB5D; Dasgupta A, 2003, AM J CLIN PATHOL, V120, P127, DOI 10.1309/P024K7VRDDPJCTVN; Del Giaccio A, 2010, INVEST CLIN, V51, P77; Ennis M., 2007, HDB NEUROCHEMISTRY M, P137, DOI [DOI 10.1007/978-0-387-30374-1_6, 10.1007/978-0-387-30374-1_6]; Fedorova OV, 2002, HYPERTENSION, V39, P298, DOI 10.1161/hy0202.104344; Fedorova OV, 1997, AM J HYPERTENS, V10, P929, DOI 10.1016/S0895-7061(97)00096-4; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Fushimi R, 1995, Rinsho Byori, V43, P34; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hao S, 2011, TOXICOL IN VITRO, V25, P1644, DOI 10.1016/j.tiv.2011.07.001; Hao S, 2011, NEUROSCI LETT, V501, P112, DOI 10.1016/j.neulet.2011.06.059; Heinbockel T, 2004, J NEUROPHYSIOL, V92, P3085, DOI 10.1152/jn.00349.2004; HONG Z, 1992, J PHARM PHARMACOL, V44, P1023, DOI 10.1111/j.2042-7158.1992.tb07086.x; Jiangsu New Medical College, 1979, ZHONG YAO DA CI DIAN, P2714; Kau MM, 2012, BRIT J PHARMACOL, V165, P1868, DOI 10.1111/j.1476-5381.2011.01671.x; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Ko RJ, 1996, WESTERN J MED, V164, P71; Kostakis C, 2009, FORENSIC SCI INT, V188, pE1, DOI 10.1016/j.forsciint.2009.02.006; Lacroix-Lamande S, 2012, J IMMUNOL, V188, P2805, DOI 10.4049/jimmunol.1101987; Lu Wen-juan, 2011, Yaoxue Xuebao, V46, P1187; Ma HY, 2007, J ETHNOPHARMACOL, V112, P108, DOI 10.1016/j.jep.2007.02.008; McGowan MH, 1999, J PHARMACOL EXP THER, V289, P1559; MORISHITA S, 1992, AM J CHINESE MED, V20, P245, DOI 10.1142/S0192415X92000254; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; PANESAR NS, 1992, CLIN CHEM, V38, P2155; Puschett JB, 2010, AM J KIDNEY DIS, V56, P359, DOI 10.1053/j.ajkd.2010.01.023; Qiu DZ, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-185; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; Rodrigues-Mascarenhas S, 2009, ANN NY ACAD SCI, V1153, P153, DOI 10.1111/j.1749-6632.2008.03969.x; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Song HT, 2000, BIOMED CHROMATOGR, V14, P130, DOI 10.1002/(SICI)1099-0801(200004)14:2<130::AID-BMC929>3.0.CO;2-1; Takai N, 2012, ASIAN PAC J CANCER P, V13, P399, DOI 10.7314/APJCP.2012.13.1.399; Wang ZJ, 2011, J PHARMACOL EXP THER, V336, P916, DOI 10.1124/jpet.110.173740; Wang ZJ, 2002, EXP NEUROL, V178, P129, DOI 10.1006/exnr.2002.8029; Wansapura AN, 2009, AM J PHYSIOL-HEART C, V296, pH1833, DOI 10.1152/ajpheart.00285.2009; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; Xie JT, 2000, AM J CHINESE MED, V28, P187, DOI 10.1142/S0192415X00000234; Xie JT, 2001, ACTA PHARMACOL SIN, V22, P289; Zhang L, 2009, FUND CLIN PHARM, V22, P615	51	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113272	10.1371/journal.pone.0113272	http://dx.doi.org/10.1371/journal.pone.0113272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420080	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900027
J	Zhang, C; Mulpuri, N; Hannan, FM; Nesbit, MA; Thakker, RV; Hamelberg, D; Brown, EM; Yang, JJ				Zhang, Chen; Mulpuri, Nagaraju; Hannan, Fadil M.; Nesbit, M. Andrew; Thakker, Rajesh V.; Hamelberg, Donald; Brown, Edward M.; Yang, Jenny J.			Role of Ca2+ and L-Phe in Regulating Functional Cooperativity of Disease-Associated "Toggle" Calcium-Sensing Receptor Mutations	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; LIGAND SPECIFICITY; CA2+-BINDING SITES; BINDING-SITE; AMINO-ACIDS; PROTEIN; DOMAIN; OSCILLATIONS; IDENTIFICATION; ACTIVATION	The Ca2+-sensing receptor (CaSR) regulates Ca2+ homeostasis in the body by monitoring extracellular levels of Ca2+ ([Ca2+](o)) and amino acids. Mutations at the hinge region of the N-terminal Venus flytrap domain (VFTD) produce either receptor inactivation (L173P, P221Q) or activation (L173F, P221L) related to hypercalcemic or hypocalcemic disorders. In this paper, we report that both L173P and P221Q markedly impair the functional positive cooperativity of the CaSR as reflected by [Ca2+](o)-induced [Ca2+](i) oscillations, inositol-1-phosphate (IP1) accumulation and extracellular signal-regulated kinases (ERK1/2) activity. In contrast, L173F and P221L show enhanced responsiveness of these three functional readouts to [Ca2+](o). Further analysis of the dynamics of the VFTD mutants using computational simulation studies supports disruption in the correlated motions in the loss-of-function CaSR mutants, while these motions are enhanced in the gain-of-function mutants. Wild type (WT) CaSR was modulated by L-Phe in a heterotropic positive cooperative way, achieving an EC50 similar to those of the two activating mutations. The response of the inactivating P221Q mutant to [Ca2+](o) was partially rescued by L-Phe, illustrating the capacity of the L-Phe binding site to enhance the positive homotropic cooperativity of CaSR. L-Phe had no effect on the other inactivating mutant. Moreover, our results carried out both in silico and in intact cells indicate that residue Leu173, which is close to residues that are part of the L-Phe-binding pocket, exhibited impaired heterotropic cooperativity in the presence of L-Phe. Thus, Pro(221) and Leu(173) are important for the positive homo- and heterotropic cooperative regulation elicited by agonist binding.	[Zhang, Chen; Mulpuri, Nagaraju; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Zhang, Chen; Hamelberg, Donald; Yang, Jenny J.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Hannan, Fadil M.; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, Acad Endocrine Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Oxford; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu		Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220	National Institutes of Health [GM081749, EB007268]; National Science Foundation [MCB-0953061]; Center for Diagnostic Technology - Georgia State University; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Center for Diagnostic Technology - Georgia State University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health (http://www.nih.gov/) grants GM081749 and EB007268 to JJY; National Science Foundation (http://www.nsf.gov/) grant MCB-0953061 to DH; and a Center for Diagnostic Technology - Georgia State University (http://cdt.gsu.edu/) fellowship to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; BERRIDGE MJ, 1990, CELL REGUL, V1, P675, DOI 10.1091/mbc.1.9.675; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dong Q, 2010, J CLIN ENDOCR METAB, V95, pE245, DOI 10.1210/jc.2010-0559; Doshi U, 2009, J PHYS CHEM B, V113, P16590, DOI 10.1021/jp907388m; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hannan FM, 2010, CLIN ENDOCRINOL, V73, P715, DOI 10.1111/j.1365-2265.2010.03870.x; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2003, TRENDS ENDOCRIN MET, V14, P282, DOI 10.1016/S1043-2760(03)00104-8; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miedlich S, 2002, J BIOL CHEM, V277, P49691, DOI 10.1074/jbc.M205578200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pidasheva S, 2005, HUM MOL GENET, V14, P1679, DOI 10.1093/hmg/ddi176; RIDEFELT P, 1995, BIOCHEM BIOPH RES CO, V215, P903, DOI 10.1006/bbrc.1995.2549; RIDEFELT P, 1994, FEBS LETT, V337, P243, DOI 10.1016/0014-5793(94)80200-9; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHORTE SL, 1995, CELL CALCIUM, V18, P440, DOI 10.1016/0143-4160(95)90059-4; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Zhang C, 2014, J BIOL CHEM, V289, P5296, DOI 10.1074/jbc.M113.537357; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	55	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113622	10.1371/journal.pone.0113622	http://dx.doi.org/10.1371/journal.pone.0113622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420019	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900061
J	Fonseca, JP; Dong, XN				Fonseca, Jose Pedro; Dong, Xinnian			Functional Characterization of a Nudix Hydrolase AtNUDX8 upon Pathogen Attack Indicates a Positive Role in Plant Immune Responses	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FAMILY; RESISTANCE; DEFENSE; SYSTEM; NPR1; PYROPHOSPHOHYDROLASE; TRANSCRIPTION	Nudix hydrolases comprise a large gene family of twenty nine members in Arabidopsis, each containing a conserved motif capable of hydrolyzing specific substrates like ADP-glucose and NADH. Until now only two members of this family, AtNUDX6 and AtNUDX7, have been shown to be involved in plant immunity. RPP4 is a resistance gene from a multigene family that confers resistance to downy mildew. A time course expression profiling after Hyaloperonospora arabidopsidis inoculation in both wild-type (WT) and the rpp4 mutant was carried out to identify differentially expressed genes in RPP4-mediated resistance. AtNUDX8 was one of several differentially expressed, downregulated genes identified. A T-DNA knockout mutant (KO-nudx8) was obtained from a Salk T-DNA insertion collection, which exhibited abolished AtNUDX8 expression. The KO-nudx8 mutant was infected separately from the oomycete pathogen Hpa and the bacterial pathogen Pseudomonas syringae pv. maculicola ES4326. The mutant displayed a significantly enhanced disease susceptibility to both pathogens when compared with the WT control. We observed a small, stunted phenotype for KO-nudx8 mutant plants when grown over a 12/12 hour photoperiod but not over a 16/8 hour photoperiod. AtNUDX8 expression peaked at 8 hours after the lights were turned on and this expression was significantly repressed four-fold by salicylic acid (SA). The expression of three pathogen-responsive thioredoxins (TRX-h2, TRX-h3 and TRX-h5) were downregulated at specific time points in the KO-nudx8 mutant when compared with the WT. Furthermore, KO-nudx8 plants like the npr1 mutant, displayed SA hypersensitivity. Expression of a key SA biosynthetic gene ICS1 was repressed at specific time points in the KO-nudx8 mutant suggesting that AtNUDX8 is involved in SA signaling in plants. Similarly, NPR1 and PR1 transcript levels were also downregulated at specific time points in the KO-nudx8 mutant. This study shows that AtNUDX8 is involved in plant immunity as a positive regulator of defense in Arabidopsis.	[Fonseca, Jose Pedro; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Fonseca, Jose Pedro] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, RJ, Brazil; [Dong, Xinnian] Duke Univ, Dept Biol, Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Durham, NC USA	Duke University; Universidade Federal do Rio de Janeiro; Duke University; Howard Hughes Medical Institute	Fonseca, JP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zepedrof@gmail.com		Fonseca, Jose Pedro/0000-0002-6402-8219	Hargitt Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099839, R01GM069594] Funding Source: NIH RePORTER	Hargitt Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hargitt Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gunawardana D, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/820381; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Jambunathan N, 2006, PLANTA, V224, P1, DOI 10.1007/s00425-005-0183-y; Jambunathan N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-173; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kraszewska E, 2008, ACTA BIOCHIM POL, V55, P663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee OR, 2012, GENE, V506, P85, DOI 10.1016/j.gene.2012.06.039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Munoz FJ, 2006, PLANT CELL PHYSIOL, V47, P926, DOI 10.1093/pcp/pcj065; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Patykowski J, 2003, J PHYTOPATHOL, V151, P153, DOI 10.1046/j.1439-0434.2003.00697.x; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xu WL, 2004, J BIOL CHEM, V279, P24861, DOI 10.1074/jbc.M403272200; Yoshimura K, 2007, PLANT CELL PHYSIOL, V48, P1438, DOI 10.1093/pcp/pcm112; Zhang XD, 2010, J PLANT PHYSIOL, V167, P144, DOI 10.1016/j.jplph.2009.08.002	33	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114119	10.1371/journal.pone.0114119	http://dx.doi.org/10.1371/journal.pone.0114119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436909	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900120
J	Gao, L; Sun, YP; Si, JY; Liu, JH; Sun, GB; Sun, XB; Cao, L				Gao, Li; Sun, Yipeng; Si, Jianyong; Liu, Jinhua; Sun, Guibo; Sun, Xiaobo; Cao, Li			Cryptoporus volvatus Extract Inhibits Influenza Virus Replication In Vitro and In Vivo	PLOS ONE			English	Article							LUNG INJURY; A VIRUS; POLYSACCHARIDE; VACCINE; PATHOGENESIS; EXPRESSION; RESISTANT; MUSHROOMS; INFECTION; THERAPY	Influenza virus is the cause of significant morbidity and mortality, posing a serious health threat worldwide. Here, we evaluated the antiviral activities of Cryptoporus volvatus extract on influenza virus infection. Our results demonstrated that the Cryptoporus volvatus extract inhibited different influenza virus strain replication in MDCK cells. Time course analysis indicated that the extract exerted its inhibition at earlier and late stages in the replication cycle of influenza virus. Subsequently, we confirmed that the extract suppressed virus internalization into and released from cells. Moreover, the extract significantly reduced H1N1/09 influenza virus load in lungs and dramatically decreased lung lesions in mice. And most importantly, the extract protected mice from lethal challenge with H1N1/09 influenza virus. Our results suggest that the Cryptoporus volvatus extract could be a potential candidate for the development of a new anti- influenza virus therapy.	[Gao, Li; Si, Jianyong; Sun, Guibo; Sun, Xiaobo; Cao, Li] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Gao, Li; Si, Jianyong; Sun, Guibo; Sun, Xiaobo; Cao, Li] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yipeng; Liu, Jinhua] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Agricultural University; Ministry of Agriculture & Rural Affairs	Cao, L (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lcao@implad.ac.cn			Program for Innovative Research Team in IMPLAD (PIRTI)	Program for Innovative Research Team in IMPLAD (PIRTI)	This work was supported by the Program for Innovative Research Team in IMPLAD (PIRTI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotey G, 2011, INT J MED MUSHROOMS, V13, P109, DOI 10.1615/IntJMedMushr.v13.i2.20; Arguedas A, 2011, HUM VACCINES, V7, P58, DOI 10.4161/hv.7.1.13411; Balzarini J, 1996, P NATL ACAD SCI USA, V93, P13152, DOI 10.1073/pnas.93.23.13152; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Cristiani C, 2011, VACCINE, V29, P3443, DOI 10.1016/j.vaccine.2011.02.068; Cross K J, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003453; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Faccin LC, 2007, LETT APPL MICROBIOL, V45, P24, DOI 10.1111/j.1472-765X.2007.02153.x; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063767; Griffin MR, 2013, S D MED; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Inoue M, 2010, EMERG INFECT DIS, V16, P1633, DOI 10.3201/eid1610.100688; Jin Sai-hong, 2003, Zhongguo Zhongyao Zazhi, V28, P650; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Monto AS, 2008, CLIN INFECT DIS, V47, P346, DOI 10.1086/589749; Mothana RAA, 2003, FITOTERAPIA, V74, P177, DOI 10.1016/S0367-326X(02)00305-2; Oldstone MBA, 2013, VIROLOGY, V435, P92, DOI 10.1016/j.virol.2012.09.039; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Stamets P, 2006, COMMUNICATION, V2, P152; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Wang C, 2011, ANN INTERN MED, V155, P217, DOI 10.7326/0003-4819-155-4-201108160-00005; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wu JZ, 1999, J FUJIAN COLL TCM, V9, P33; Wu ZY, 1990, XIN HUA COMPENDIUM M; Xie QM, 2006, J ETHNOPHARMACOL, V107, P424, DOI 10.1016/j.jep.2006.03.040; Xu J.T., 1997, CHINESE MED MYCOLOGY; Yamamoto KA, 2013, INT J BIOL MACROMOL, V52, P9, DOI 10.1016/j.ijbiomac.2012.09.029; Yao HY, 2011, J ETHNOPHARMACOL, V137, P1267, DOI 10.1016/j.jep.2011.07.058; Zhao XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022091; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zhu LQ, 2014, J VIROL, V88, P417, DOI 10.1128/JVI.02591-13; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	36	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113604	10.1371/journal.pone.0113604	http://dx.doi.org/10.1371/journal.pone.0113604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437846	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900054
J	Mittal, S; Singh, LR				Mittal, Shruti; Singh, Laishram Rajendrakumar			Macromolecular Crowding Induces Holo alpha-Lactalbumin Aggregation by Converting to Its Apo Form	PLOS ONE			English	Article							PROTEIN AGGREGATION; CALCIUM-CONCENTRATION; FIBRIL FORMATION; EXCLUDED-VOLUME; MUTANT P53; STABILITY; BINDING; BOVINE; EQUILIBRIUM; EXPRESSION	Macromolecular crowding has been shown to have an exacerbating effect on the aggregation propensity of amyloidogenic proteins; while having an inhibitory effect on the non-amyloidogenic proteins. However, the results concerning aggregation propensity of non-amyloidogenic proteins have not been convincing due to the contrasting effect on holo-LA, which despite being a non-amyloidogenic protein was observed to aggregate under crowded conditions. In the present study, we have extensively characterized the crowding-induced holo-LA aggregates and investigated the possible mechanism responsible for the aggregation process. We discovered that macromolecular crowding reduces the calcium binding affinity of holo-LA resulting in the formation of apo-LA (the calcium-depleted form of holo-LA) leading to aggregate formation. Another finding is that calcium acts as a chaperone capable of inhibiting and dissociating crowding-induced holo-LA aggregates. The study has a direct implication to Alzheimer Disease as the results invoke a new mechanism to prevent Ab fibrillation.	[Mittal, Shruti; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Mittal, Shruti/0000-0002-5318-2763	Department of Science and Technology [SR/SO/BB-0003/2011]; Council of Scientific and Industrial Research [09/045(1047)/2011-EMR-1]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by grant from Department of Science and Technology (Ref No.: SR/SO/BB-0003/2011). SM and LRS acknowledge Council of Scientific and Industrial Research for the financial assistance provided in the form of research fellowship (File No.: 09/045(1047)/2011-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chrysina ED, 2000, J BIOL CHEM, V275, P37021, DOI 10.1074/jbc.M004752200; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Greene LH, 1999, PROTEIN ENG, V12, P581, DOI 10.1093/protein/12.7.581; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; Hayden MR, 2005, J PANCREAS, V6, P287; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; KASHKET ER, 1987, FEMS MICROBIOL LETT, V46, P233, DOI 10.1111/j.1574-6968.1987.tb02463.x; Kataoka M, 1997, PROTEIN SCI, V6, P422; Kholova I, 2005, J CLIN PATHOL, V58, P125, DOI 10.1136/jcp.2004.017293; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; KUWAJIMA K, 1986, INT J PEPT PROT RES, V27, P18; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Martin J, 2002, BIOCHEMISTRY-US, V41, P5050, DOI 10.1021/bi015925l; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Mittal S, 2014, J BIOCH; Mittal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078936; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; MURRAY FES, 1992, CIBA F SYMP, V169, P201; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Permyakov SE, 2001, PROTEIN ENG, V14, P785, DOI 10.1093/protein/14.10.785; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarkar M, 2014, BIOCHEMISTRY-US, V53, P1601, DOI 10.1021/bi4016346; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wall J, 1999, METHOD ENZYMOL, V309, P204; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	62	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114029	10.1371/journal.pone.0114029	http://dx.doi.org/10.1371/journal.pone.0114029			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437004	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900111
J	Palermo, GD; Neri, QV; Schlegel, PN; Rosenwaks, Z				Palermo, Gianpiero D.; Neri, Queenie V.; Schlegel, Peter N.; Rosenwaks, Zev			Intracytoplasmic Sperm Injection (ICSI) in Extreme Cases of Male Infertility	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; TESTICULAR SPERM; DNA FRAGMENTATION; HUMAN SPERMATOZOA; EXTRACTION; FERTILIZATION; MEN; PREGNANCIES; INTEGRITY; EJACULATE	Introduction: Severely compromised spermatogenesis typical of men with virtual azoospermia or non-obstructive azoospermia requires an extreme search for spermatozoa. Our goal was to evaluate the usefulness of a meticulous search carried out in ejaculated or surgically retrieved specimens in achieving pre-and post-implantation embryo development. Patients and Methods: In a retrospective cohort study carried out in an academic institution, intracytoplasmic sperm injection (ICSI) outcomes were reviewed as a function of length of microscopic sperm search in ejaculated and surgically retrieved specimens. Couples whose male partner presented with either virtual or non-obstructive azoospermia were treated by ICSI and categorized according to the time spent in identifying and retrieving enough spermatozoa to inject all the oocyte cohort. Semen parameter, fertilization, pregnancies, deliveries, and child welfare in relation to increasing search time were analyzed and compared. Result(s): The maternal and paternal ages were comparable in both ejaculated and testicular sperm extraction (TESE) groups along with the oocytes retrieved. The fertilization rates for both ejaculated and TESE progressively decreased with increasing time (P<0.0001). Clinical pregnancies in the ejaculated cohort remained satifactory. In the TESE cohort, there was a decrease in pregnancy rate with increasing time, from 44% to 23%. In a limited number of cases, offspring health was evaluated in both semen sources and appeared reassuring. Conclusion(s): An extensive and at time exhaustive sperm quest yields kinetically and morphologically impaired spermatozoa without apparent impact on embryo developmental competence. Retrieval of spermatozoa from the seminiferous tubules provided more consistent fertilization and pregnancy outcomes than those retrieved from the ejaculate. A trend indicated that pregnancy rate decreased as search time increased in the TESE group. The utilization of the scarce and unselected spermatozoa did not obviously impair embryo development or cause post-implantation errors.	[Neri, Queenie V.; Rosenwaks, Zev] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Schlegel, Peter N.] Weill Cornell Med Coll, Dept Urol, New York, NY USA	Cornell University; Cornell University		gdpalerm@med.cornell.edu						Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; [Anonymous], 2012, WORLDS NUMB IVF ICSI; Ben-Ami I, 2013, FERTIL STERIL, V99, P1867, DOI 10.1016/j.fertnstert.2013.02.025; Bendikson K, 2006, HUM REPROD, V21, pI105; Bendikson KA, 2008, J UROLOGY, V180, P1060, DOI 10.1016/j.juro.2008.05.025; Berkovitz A, 2006, REPROD BIOMED ONLINE, V12, P634, DOI 10.1016/S1472-6483(10)61191-1; Bungum M, 2011, ASIAN J ANDROL, V13, P69, DOI 10.1038/aja.2010.73; Chen C, 2011, HUM REPROD, V26, pI30; Dabaja AA, 2013, ASIAN J ANDROL, V15, P35, DOI 10.1038/aja.2012.141; De Jonge C, 2012, FERTIL STERIL, V97, P260, DOI 10.1016/j.fertnstert.2011.12.045; De Rycke M, 2002, HUM REPROD, V17, P2487, DOI 10.1093/humrep/17.10.2487; Desai NR, 2010, FERTIL STERIL, V94, P1541, DOI 10.1016/j.fertnstert.2009.12.041; Evenson DP, 2006, THERIOGENOLOGY, V65, P979, DOI 10.1016/j.theriogenology.2005.09.011; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Harvey L, 2013, HUM REPROD, V28, P67; HOLMES LB, 1976, NEW ENGL J MED, V295, P204, DOI 10.1056/NEJM197607222950406; Hu JCY, 2012, HUM REPROD, V27; Hu JCY, 2010, FERTIL STERIL, V94, pS118, DOI 10.1016/j.fertnstert.2010.07.482; Huang JYJ, 2012, BEST PRACT RES CL OB, V26, P777, DOI 10.1016/j.bpobgyn.2012.08.017; Isachenko E, 2004, HUM REPROD, V19, P932, DOI 10.1093/humrep/deh194; Just A, 2004, FERTIL STERIL, V82, P445, DOI 10.1016/j.fertnstert.2003.12.050; Kocent J, 2011, HUM REPROD, V26, pI248; Kupker W, 2002, SEMIN REPROD MED, V20, P25, DOI 10.1055/s-2002-23517; Lee R, 2009, FERTIL STERIL, V92, P188, DOI 10.1016/j.fertnstert.2008.05.053; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; Monahan D, 2011, HUM REPROD, V26, pI74; Neri QV, 2004, FERTIL STERIL, V82, pS132, DOI 10.1016/j.fertnstert.2004.07.333; Neri QV, 2012, INTRACYTOPLASMIC SPE; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 1996, HUM REPROD, V11, P1023; Palermo GD, 1996, JAMA-J AM MED ASSOC, V276, P1893, DOI 10.1001/jama.276.23.1893; Palermo GD, 1999, HUM REPROD, V14, P741, DOI 10.1093/humrep/14.3.741; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; PALERMO GD, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.suppl_1.120; Palermo GD, 2011, THOUGHTS ON IMSI; Palermo GD, 2014, FERTIL STERIL; Palermo GD, 2012, FERTIL STERIL, V97, P248, DOI 10.1016/j.fertnstert.2011.12.037; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Parmegiani L, 2010, FERTIL STERIL, V93, P598, DOI 10.1016/j.fertnstert.2009.03.033; Ramasamy R, 2011, FERTIL STERIL, V96, P299, DOI 10.1016/j.fertnstert.2011.05.033; Ramasamy R, 2011, J UROLOGY, V185, P1027, DOI 10.1016/j.juro.2010.10.066; RonEl R, 1997, HUM REPROD, V12, P1222; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Squires J, 2003, FERTIL STERIL, V79, P453, DOI 10.1016/S0015-0282(02)04685-X; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Tournaye H, 1997, HUM REPROD, V12, P80, DOI 10.1093/humrep/12.1.80; Veeck LL, 1999, ATLAS HUMAN GEMETES; Vernaeve V, 2005, INT J ANDROL, V28, P22, DOI 10.1111/j.1365-2605.2004.00501.x; Vernaeve V, 2006, HUM REPROD, V21, P1551, DOI 10.1093/humrep/del012; Vutyavanich T, 2012, ASIAN J ANDROL, V14, P850, DOI 10.1038/aja.2012.106; Walis G, 2010, HUM REPROD, V25, pI145; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Zou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061593	55	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113671	10.1371/journal.pone.0113671	http://dx.doi.org/10.1371/journal.pone.0113671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437298	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900062
J	Yang, JH; Li, WD; Long, YF; Song, SH; Liu, J; Zhang, XW; Wang, XG; Jiang, SD; Liao, GY				Yang, Jinghui; Li, Weidong; Long, Yunfeng; Song, Shaohui; Liu, Jing; Zhang, Xinwen; Wang, Xiaoguang; Jiang, Shude; Liao, Guoyang			Reliability of Pseudotyped Influenza Viral Particles in Neutralizing Antibody Detection	PLOS ONE			English	Article							MATCHING PATTERNS; VIRUS; HEMAGGLUTININ; NEURAMINIDASE; INFECTION; CHINA; ASSAY; POPULATION; HEPATITIS; IMMUNITY	Background: Current influenza control strategies require an active surveillance system. Pseudotyped viral particles (pp) together with the evaluation of pre-existing immunity in a population might satisfy this requirement. However, the reliability of using pp in neutralizing antibody (nAb) detection are undefined. Methodology/Principal Findings: Pseudotyped particles of A(H1N1) pmd09 (A/California/7/2009) and HPAI H5N1 (A/Anhui/1/2005), as well as their reassortants, were generated. The reliability of using these pp in nAb detection were compared concurrently with the corresponding viruses by a hemagglutination inhibition test, as well as ELISA-, cytopathic effect-, and fluorescence-based microneutralization assays. In the qualitative detection on nAbs, the pp and their corresponding viruses were in complete agreement, with an R-2 value equal to or near 1 in two different populations. In the quantitative detection on nAbs, although the geometric mean titers (95% confidence interval) differed between the pp and viruses, no significant difference was observed. Furthermore, humoral immunity against the reassortants was evaluated; our results indicated strong consistency between the nAbs against reassortant pp and those against naive pp harboring the same hemagglutinin. Conclusion/Significance: The pp displayed high reliability in influenza virus nAb detection. The use of reassortant pp is a safe and convenient strategy for characterizing emerging influenza viruses and surveying the disease burden.	[Yang, Jinghui; Li, Weidong; Long, Yunfeng; Song, Shaohui; Liu, Jing; Zhang, Xinwen; Jiang, Shude; Liao, Guoyang] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Yang, Jinghui; Li, Weidong; Long, Yunfeng; Song, Shaohui; Liu, Jing; Zhang, Xinwen; Jiang, Shude; Liao, Guoyang] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Wang, Xiaoguang] Minhang Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Center for Disease Control & Prevention	Li, WD (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China.	lwd@imbcams.com.cn; wxg2479038@sina.com; liaogy@imbcams.com.cn			International Cooperation Project [2011DFR30420]; Scientific Research Projects of Health Care [200802023]; National 863 Program [2012AA02A404]; National Science and Technology Major Project [2013ZX10004003-003-002]	International Cooperation Project; Scientific Research Projects of Health Care; National 863 Program; National Science and Technology Major Project	This work was supported by International Cooperation Project (2011DFR30420), Scientific Research Projects of Health Care (200802023), National 863 Program (2012AA02A404), and National Science and Technology Major Project (2013ZX10004003-003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; [Anonymous], 2010, WHO GUID PHARM MAN P; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P1032; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; Gavrilov V, 2011, J VIROL METHODS, V173, P364, DOI 10.1016/j.jviromet.2011.03.011; Goff PH, 2013, J VIROL, V87, P8235, DOI 10.1128/JVI.01085-13; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Liu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058810; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Qiu C, 2013, EMERG INFECT DIS, V19, P1685, DOI 10.3201/eid1910.130728; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; WHO, 2021, REP IND ALL VACC GRO; *WHO, 2009, PAND H1N1 2009 UPD 5; WHO, 2007, INF PREV CONTR EP PA, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/s41598-019-38808-z]; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2010, SER DIAGN INFL MICR; World Health Organization, 2014, CUM NUMB CONF HUM CA; Wu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015825; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	33	3	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113629	10.1371/journal.pone.0113629	http://dx.doi.org/10.1371/journal.pone.0113629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436460	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900057
J	Chan, WL; Zhou, AW; Read, RJ				Chan, Wee Lee; Zhou, Aiwu; Read, Randy J.			Towards Engineering Hormone-Binding Globulins as Drug Delivery Agents	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MEGESTROL-ACETATE; COMPUTATIONAL DESIGN; PROTEASE INHIBITORS; CANCER; MECHANISM; THERAPY; RELEASE; FUTURE; TUMOR	The treatment of many diseases such as cancer requires the use of drugs that can cause severe side effects. Off-target toxicity can often be reduced simply by directing the drugs specifically to sites of diseases. Amidst increasingly sophisticated methods of targeted drug delivery, we observed that Nature has already evolved elegant means of sending biological molecules to where they are needed. One such example is corticosteroid binding globulin (CBG), the major carrier of the anti-inflammatory hormone, cortisol. Targeted release of cortisol is triggered by cleavage of CBG's reactive centre loop by elastase, a protease released by neutrophils in inflamed tissues. This work aimed to establish the feasibility of exploiting this mechanism to carry therapeutic agents to defined locations. The reactive centre loop of CBG was altered with site-directed mutagenesis to favour cleavage by other proteases, to alter the sites at which it would release its cargo. Mutagenesis succeeded in making CBG a substrate for either prostate specific antigen (PSA), a prostate-specific serine protease, or thrombin, a key protease in the blood coagulation cascade. PSA is conspicuously overproduced in prostatic hyperplasia and is, therefore, a good way of targeting hyperplastic prostate tissues. Thrombin is released during clotting and consequently is ideal for conferring specificity to thrombotic sites. Using fluorescence-based titration assays, we also showed that CBG can be engineered to bind a new compound, thyroxine-6-carboxyfluorescein, instead of its physiological ligand, cortisol, thereby demonstrating that it is possible to tailor the hormone binding site to deliver a therapeutic drug. In addition, we proved that the efficiency with which CBG releases bound ligand can be increased by introducing some well-placed mutations. This proof-of-concept study has raised the prospect of a novel means of targeted drug delivery, using the serpin conformational change to combat the problem of off-target effects in the treatment of diseases.	[Chan, Wee Lee; Read, Randy J.] Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Zhou, Aiwu] Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis, Minist Educ China, Sch Med, Shanghai 200030, Peoples R China	Addenbrooke's Hospital; University of Cambridge; Ministry of Education, China; Shanghai Jiao Tong University	Read, RJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.	rjr27@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; Chan, Wee Lee/0000-0001-9672-3841; ZHOU, Aiwu/0000-0002-2555-5091	Wellcome Trust [082961/Z/07/Z]; Singapore government's Agency for Science, Technology and Research; British Heart Foundation; Wellcome Trust; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Singapore government's Agency for Science, Technology and Research; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	The research was funded by the Wellcome Trust (http://www.wellcome.ac.uk/) grant no. 082961/Z/07/Z to RJR and was facilitated by a Wellcome Trust Strategic Award to the Cambridge Institute for Medical Research. WLC was supported by the Singapore government's Agency for Science, Technology and Research (http://www.astar.edu.sg/). AZ was supported by a Senior Research Fellowship from the British Heart Foundation (http://www.bhf.org.uk). RJR is supported by a Principal Research Fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AKIYAMA K, 1987, FEBS LETT, V225, P168, DOI 10.1016/0014-5793(87)81151-1; AVVAKUMOV GV, 1994, J STEROID BIOCHEM, V49, P191, DOI 10.1016/0960-0760(94)90010-8; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bernett MJ, 2010, J MOL BIOL, V396, P1474, DOI 10.1016/j.jmb.2009.12.046; Brooks DA, 2003, TRENDS MOL MED, V9, P450, DOI 10.1016/j.molmed.2003.08.004; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Chambers JD, 2011, NEW ENGL J MED, V364, P1687, DOI 10.1056/NEJMp1103057; Chan WL, 2013, J CLIN ENDOCR METAB, V98, P3315, DOI 10.1210/jc.2012-4280; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dawson NA, 2000, CANCER, V88, P825, DOI 10.1002/(SICI)1097-0142(20000215)88:4<825::AID-CNCR13>3.3.CO;2-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fojo T, 2010, CLIN CANCER RES, V16, P5972, DOI 10.1158/1078-0432.CCR-10-1277; Gardill BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052759; GELLER J, 1982, PROSTATE, V3, P11, DOI 10.1002/pros.2990030103; GELLER J, 1978, Urology, V12, P537, DOI 10.1016/0090-4295(78)90467-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILMAN A, 1946, SCIENCE, V103, P409, DOI 10.1126/science.103.2675.409; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Heidenreich A, 2008, GUIDELINES PROSTATE, P1; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Kumar V, 2009, CLIN CHIM ACTA, V403, P17, DOI 10.1016/j.cca.2008.11.020; Lemmermann NAW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812742; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Litvak-Greenfeld D, 2012, ADV DRUG DELIVER REV, V64, P1782, DOI 10.1016/j.addr.2012.05.013; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MAEDA H, 1979, INT J PEPT PROT RES, V14, P81; MATSUMURA Y, 1986, CANCER RES, V46, P6387; May KF, 2011, CLIN CANCER RES, V17, P5233, DOI 10.1158/1078-0432.CCR-10-3402; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McVary K, 2006, BJU INT, V97, P23, DOI 10.1111/j.1464-410X.2006.06102.x; Morin A, 2011, PROTEIN ENG DES SEL, V24, P503, DOI 10.1093/protein/gzr006; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Nagata S, 2009, ADV DRUG DELIVER REV, V61, P977, DOI 10.1016/j.addr.2009.07.014; Nicholson TM, 2011, DIFFERENTIATION, V82, P184, DOI 10.1016/j.diff.2011.04.006; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Ricciardi S, 2009, CLIN LUNG CANCER, V10, P28, DOI 10.3816/CLC.2009.n.004; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; SCHACTER L, 1989, CANCER TREAT REV, V16, P49, DOI 10.1016/0305-7372(89)90004-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STROUPE SD, 1978, FEBS LETT, V86, P61, DOI 10.1016/0014-5793(78)80099-4; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; WESTPHAL U, 1983, MOL CELL BIOCHEM, V55, P145, DOI 10.1007/BF00673709; Ye S, 2001, CURR OPIN STRUC BIOL, V11, P740, DOI 10.1016/S0959-440X(01)00275-5; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	65	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113402	10.1371/journal.pone.0113402	http://dx.doi.org/10.1371/journal.pone.0113402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426859	Green Published, gold			2022-12-27	WOS:000349145400047
J	Irles, P; Piulachs, MD				Irles, Paula; Piulachs, Maria-Dolors			Unlike in Drosophila Meroistic Ovaries, Hippo Represses Notch in Blattella germanica Panoistic Ovaries, Triggering the Mitosis-Endocycle Switch in the Follicular Cells	PLOS ONE			English	Article							ORGAN SIZE CONTROL; PROMOTES APOPTOSIS; F-ACTIN; OOGENESIS; PATHWAY; PROLIFERATION; COCKROACH; DIFFERENTIATION; SALVADOR; GROWTH	During insect oogenesis, the follicular epithelium undergoes both cell proliferation and apoptosis, thus modulating ovarian follicle growth. The Hippo pathway is key in these processes, and has been thoroughly studied in the meroistic ovaries of Drosophila melanogaster. However, nothing is known about the role of the Hippo pathway in primitive panoistic ovaries. This work examines the mRNA expression levels of the main components of the Hippo pathway in the panoistic ovary of the basal insect species Blattella germanica, and demonstrates the function of Hippo through RNAi. In Hippo-depleted specimens, the follicular cells of the basal ovarian follicles proliferate without arresting cytokinesis; the epithelium therefore becomes bilayered, impairing ovarian follicle growth. This phenotype is accompanied by long stalks between the ovarian follicles. In D. melanogaster loss of function of Notch determines that the stalk is not developed. With this in mind, we tested whether Hippo and Notch pathways are related in B. germanica. In Notch (only)-depleted females, no stalks were formed between the ovarian follicles. Simultaneous depletion of Hippo and Notch rescued partially the stalk to wild-type. Unlike in the meroistic ovaries of D. melanogaster, in panoistic ovaries the Hippo pathway appears to regulate follicular cell proliferation by acting as a repressor of Notch, triggering the switch from mitosis to the endocycle in the follicular cells. The phylogenetically basal position of B. germanica suggests that this might be the ancestral function of Hippo in insect ovaries.	[Irles, Paula; Piulachs, Maria-Dolors] Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Piulachs, MD (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Spain.	mdolors.piulachs@ibe.upf-csic.es	Piulachs, Maria-Dolors/C-3992-2011	Piulachs, Maria-Dolors/0000-0002-4500-2718; Irles, Paula/0000-0003-1968-1902	Ministry of Science and Innovation, Spain [BFU2011-22404]; CONICYT, Chile	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Ministry of Science and Innovation, Spain (grant number BFU2011-22404). PI is recipient of a postdoctoral research grant (BECAS CHILE) from CONICYT, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer D, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-15; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Buning J., 1994, THE INSECT OVARY; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Ciudad L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-53; Deng WM, 2001, DEVELOPMENT, V128, P4737; Tanaka ED, 2012, BIOL CELL, V104, P452, DOI 10.1111/boc.201100044; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Grammont M, 2001, DEVELOPMENT, V128, P2243; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Irles P, 2013, INSECT BIOCHEM MOLEC, V43, P178, DOI 10.1016/j.ibmb.2012.12.003; Irles P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-206; Klusza S, 2011, BIOESSAYS, V33, P124, DOI 10.1002/bies.201000089; Larkin MK, 1999, DEV GENES EVOL, V209, P301, DOI 10.1007/s004270050256; Larkin MK, 1996, DEVELOPMENT, V122, P3639; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; PASCUAL N, 1992, J INSECT PHYSIOL, V38, P339, DOI 10.1016/0022-1910(92)90058-L; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Rosales-Nieves AE, 2014, SEMIN CELL DEV BIOL, V28, P104, DOI 10.1016/j.semcdb.2014.03.031; Rozen S, 2000, Methods Mol Biol, V132, P365; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Sun JJ, 2008, J CELL BIOL, V182, P885, DOI 10.1083/jcb.200802084; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xu JX, 2012, GENET RES INT, V2012, DOI 10.1155/2012/648207; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761; ZHANG YJ, 1992, TISSUE CELL, V24, P905, DOI 10.1016/0040-8166(92)90025-3; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	40	11	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113850	10.1371/journal.pone.0113850	http://dx.doi.org/10.1371/journal.pone.0113850			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426635	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400090
J	McMahon, M; Campbell, KH; MacLeod, AK; McLaughlin, LA; Henderson, CJ; Wolf, CR				McMahon, Michael; Campbell, Kathryn H.; MacLeod, A. Kenneth; McLaughlin, Lesley A.; Henderson, Colin J.; Wolf, C. Roland			HDAC Inhibitors Increase NRF2-Signaling in Tumour Cells and Blunt the Efficacy of Co-Adminstered Cytotoxic Agents	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; KEAP1-NRF2 PATHWAY; ADAPTIVE RESPONSE; CANCER; ACTIVATION; STRESS; KERATINOCYTES; ELECTROPHILES	The NRF2 signalling cascade provides a primary response against electrophilic chemicals and oxidative stress. The activation of NRF2-signaling is anticipated to have adverse clinical consequences; NRF2 is activated in a number of cancers and, additionally, its pharmacological activation by one compound can reduce the toxicity or efficiency of a second agent administered concomitantly. In this work, we have analysed systematically the ability of 152 research, pre-clinical or clinically used drugs to induce an NRF2 response using the MCF7-AREc32 NRF2 reporter. Ten percent of the tested drugs induced an NRF2 response. The NRF2 activators were not restricted to classical cytotoxic alkylating agents but also included a number of emerging anticancer drugs, including an IGF1-R inhibitor (NVP-AEW541), a PIM-1 kinase inhibitor (Pim1 inhibitor 2), a PLK1 inhibitor (BI 2536) and most strikingly seven of nine tested HDAC inhibitors. These findings were further confirmed by demonstrating NRF2-dependent induction of endogenous AKR genes, biomarkers of NRF2 activity. The ability of HDAC inhibitors to stimulate NRF2-signalling did not diminish their own potency as antitumour agents. However, when used to pre-treat cells, they did reduce the efficacy of acrolein. Taken together, our data suggest that the ability of drugs to stimulate NRF2 activity is common and should be investigated as part of the drug-development process.	[McMahon, Michael; Campbell, Kathryn H.; MacLeod, A. Kenneth; McLaughlin, Lesley A.; Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Med Res Inst, Dundee, Scotland	University of Dundee	Wolf, CR (corresponding author), Univ Dundee, Med Res Inst, Dundee, Scotland.	c.r.wolf@dundee.ac.uk	Henderson, Colin/AAE-7141-2019; McMahon, Michael J/F-7070-2010	Henderson, Colin/0000-0002-4764-639X; McMahon, Michael J/0000-0001-8615-9351; Wolf, Charles Roland/0000-0002-6969-0113	Cancer Research UK [C4639/A12330]; Cancer Research UK [10822] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by a grant C4639/A12330 awarded to CRW by Cancer Research UK (www.cancerresearchuk.org/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164; Connor TO, 1999, BIOCHEM J, V504, P487; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Mathijssen RHJ, 2014, NAT REV CLIN ONCOL; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sporn M, 2012, NAT REV CANCER, V3, P1; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Suzuki T, 2013, TRENDS PHARMACOL SCI, P1; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wolf CR, 2001, P NATL ACAD SCI USA, V98, P2941, DOI 10.1073/pnas.071042698	27	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114055	10.1371/journal.pone.0114055	http://dx.doi.org/10.1371/journal.pone.0114055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427220	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400110
J	Teilmann, AC; Madsen, AN; Holst, B; Hau, J; Rozell, B; Abelson, KSP				Teilmann, Anne Charlotte; Madsen, Andreas Nygaard; Holst, Birgitte; Hau, Jann; Rozell, Bjorn; Abelson, Klas Stig Peter			Physiological and Pathological Impact of Blood Sampling by Retro-Bulbar Sinus Puncture and Facial Vein Phlebotomy in Laboratory Mice	PLOS ONE			English	Article							PLASMA-CORTICOSTERONE LEVELS; STRESS-RESPONSE; BODY-WEIGHT; RATS; COLLECTION; PARAMETERS; BEHAVIOR; PAIN; GLUCOCORTICOIDS; HEMORRHAGE	Retro-bulbar sinus puncture and facial vein phlebotomy are two widely used methods for blood sampling in laboratory mice. However, the animal welfare implications associated with these techniques are currently debated, and the possible physiological and pathological implications of blood sampling using these methods have been sparsely investigated. Therefore, this study was conducted to assess and compare the impacts of blood sampling by retro-bulbar sinus puncture and facial vein phlebotomy. Blood was obtained from either the retro-bulbar sinus or the facial vein from male C57BL/6J mice at two time points, and the samples were analyzed for plasma corticosterone. Body weights were measured at the day of blood sampling and the day after blood sampling, and the food consumption was recorded automatically during the 24 hours post-procedure. At the end of study, cheeks and orbital regions were collected for histopathological analysis to assess the degree of tissue trauma. Mice subjected to facial vein phlebotomy had significantly elevated plasma corticosterone levels at both time points in contrast to mice subjected to retro-bulbar sinus puncture, which did not. Both groups of sampled mice lost weight following blood sampling, but the body weight loss was higher in mice subjected to facial vein phlebotomy. The food consumption was not significantly different between the two groups. At gross necropsy, subcutaneous hematomas were found in both groups and the histopathological analyses revealed extensive tissue trauma after both facial vein phlebotomy and retro-bulbar sinus puncture. This study demonstrates that both blood sampling methods have a considerable impact on the animals' physiological condition, which should be considered whenever blood samples are obtained.	[Teilmann, Anne Charlotte; Hau, Jann; Rozell, Bjorn; Abelson, Klas Stig Peter] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark; [Madsen, Andreas Nygaard; Holst, Birgitte] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Teilmann, AC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Copenhagen, Denmark.	annete@sund.ku.dk	Hau, Jann/C-8692-2012	Hau, Jann/0000-0001-8586-5705; Holst, Birgitte/0000-0001-7432-097X; Abelson, Klas/0000-0002-4986-7882				Abatan OI, 2008, J AM ASSOC LAB ANIM, V47, P8; Abelson KSP, 2005, IN VIVO, V19, P815; Altholtz LY, 2006, J AM ASSOC LAB ANIM, V45, P17; Anderson G, 2002, THEORY PRACTICE HIST, P85; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; [Anonymous], 2011, GUID CAR US LAB AN, P1; Arras M, 2007, LAB ANIM-UK, V41, P30, DOI 10.1258/002367707779399446; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barriga C, 2000, J PINEAL RES, P180; BARTON RN, 1982, AM J PHYSIOL, V243, pR416, DOI 10.1152/ajpregu.1982.243.3.R416; Baumans V, 2011, HDB LAB ANIMAL SCI, V1, P401; Baumnas V., 2001, PRINCIPLES LAB ANIMA, P313; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Cunliffe-Beamer TL, 1983, MOUSE BIOMEDICAL RES, VIII, P401; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Forbes N, 2010, LAB ANIMAL, V39, P236, DOI 10.1038/laban0810-236; GARTNER K, 1980, LAB ANIM, V14, P267, DOI 10.1258/002367780780937454; Goldkuhl R, 2010, IN VIVO, V24, P131; Grouzmann E, 2003, PFLUG ARCH EUR J PHY, V447, P254, DOI 10.1007/s00424-003-1140-x; Heimann M, 2009, LAB ANIM-UK, V43, P255, DOI 10.1258/la.2008.007073; Herck H. van, 1992, Scandinavian Journal of Laboratory Animal Science, V19, P189; Hui Yu-Hua, 2007, Journal of Pharmacological and Toxicological Methods, V56, P256, DOI 10.1016/j.vascn.2007.05.006; Iwaki T, 2001, COLOR ATLAS SECTIONA; Jacobsen KR, 2012, J AM ASSOC LAB ANIM, V51, P69; KANNAN Y, 2004, HDB EXPT ANIMALS LAB, P301; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kohn DF, 2007, J AM ASSOC LAB ANIM, V46, P97; Kopp C, 1998, PHYSIOL BEHAV, V63, P577, DOI 10.1016/S0031-9384(97)00491-5; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mahl A, 2000, LAB ANIM-UK, V34, P351, DOI 10.1258/002367700780387787; Martini L, 2000, J SURG RES, V88, P114, DOI 10.1006/jsre.1999.5789; McGuill M. W., 1989, ILAR News, V31, P5; Popesko P., 1990, COLOUR ATLAS ANATOMY, V1, P89; Requena L, 2012, DERMATOL CLIN, V30, P731, DOI 10.1016/j.det.2012.06.006; Russell WMS., 1959, MED J AUSTRALIA; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharma A, 2014, LAB ANIMAL, V43, P63, DOI 10.1038/laban.432; Smith RS, 2002, RES METH MUT M SER, P25; SPACKMAN DH, 1978, SCIENCE, V200, P87, DOI 10.1126/science.635580; Teilmann AC, 2014, LAB ANIM-UK, V48, P278, DOI 10.1177/0023677214541438; Teilmann AC, 2012, IN VIVO, V26, P577; Thanos PK, 2009, PHYSIOL RES, V58, P219, DOI 10.33549/physiolres.931434; THRIVIKRAMAN KV, 1993, AM J PHYSIOL, V264, pE497, DOI 10.1152/ajpendo.1993.264.4.E497; Treuting P. M., 2012, COMP ANATOMY HISTOLO, P395, DOI [10.1016/8978-0-12-802900-8.00021-X, DOI 10.1016/8978-0-12-802900-8.00021-X]; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; van Herck H, 2001, LAB ANIM-UK, V35, P131, DOI 10.1258/0023677011911499; VANHERCK H, 1992, LAB ANIM, V26, P53, DOI 10.1258/002367792780809048; VANHERCK H, 1991, LAB ANIM, V25, P325, DOI 10.1258/002367791780809931; VANHERCK H, 1994, AUTOIMMUNE DIS MODEL, P303; Voigt CC, 2013, ANIM WELFARE, V22, P449, DOI 10.7120/09627286.22.4.449	54	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113225	10.1371/journal.pone.0113225	http://dx.doi.org/10.1371/journal.pone.0113225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426941	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400041
J	Ran, GM; Zhang, Q; Chen, X; Pan, YG				Ran, Guangming; Zhang, Qi; Chen, Xu; Pan, Yangu			The Effects of Prediction on the Perception for Own-Race and Other-Race Faces	PLOS ONE			English	Article							TOP-DOWN FACILITATION; PROACTIVE BRAIN; RECOGNITION; ANTICIPATION; ATTENTION; BIAS; CATEGORIZATION; RESPONSES; ELICIT	Human beings do not passively perceive important social features about others such as race and age in social interactions. Instead, it is proposed that humans might continuously generate predictions about these social features based on prior similar experiences. Pre-awareness of racial information conveyed by others' faces enables individuals to act in "culturally appropriate" ways, which is useful for interpersonal relations in different ethnicity groups. However, little is known about the effects of prediction on the perception for own-race and other-race faces. Here, we addressed this issue using high temporal resolution event-related potential techniques. In total, data from 24 participants (13 women and 11 men) were analyzed. It was found that the N170 amplitudes elicited by other-race faces, but not own-race faces, were significantly smaller in the predictable condition compared to the unpredictable condition, reflecting a switch to holistic processing of other-race faces when those faces were predictable. In this respect, top-down prediction about face race might contribute to the elimination of the other-race effect (one face recognition impairment). Furthermore, smaller P300 amplitudes were observed for the predictable than for unpredictable conditions, which suggested that the prediction of race reduced the neural responses of human brains.	[Ran, Guangming; Chen, Xu; Pan, Yangu] Southwest Univ SWU, Fac Psychol, Chongqing 400715, Peoples R China; [Ran, Guangming; Chen, Xu; Pan, Yangu] Southwest Univ SWU, Res Ctr Mental Hlth Educ, Chongqing 400715, Peoples R China; [Zhang, Qi] GNU, Sch Educ Sci, Guiyang 550001, Guizhou, Peoples R China	Southwest University - China; Southwest University - China	Chen, X (corresponding author), Southwest Univ SWU, Fac Psychol, Chongqing 400715, Peoples R China.	chenxu@swu.edu.cn	Chen, Xu/M-7975-2019; Pan, Yangu/GQP-2983-2022					Abundis-Gutierrez A, 2014, NEUROPSYCHOLOGIA, V57, P78, DOI 10.1016/j.neuropsychologia.2014.02.013; Aifanti N, 2010, 11 INT WORKSH IM AN, P1; Alink A, 2010, J NEUROSCI, V30, P2960, DOI 10.1523/JNEUROSCI.3730-10.2010; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Caharel S, 2011, INT J PSYCHOPHYSIOL, V79, P266, DOI 10.1016/j.ijpsycho.2010.10.018; Craig BM, 2014, EMOTION, V14, P865, DOI 10.1037/a0037270; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; GILDER S, 1964, BRIT MED J, V2, P299, DOI 10.1136/bmj.2.5404.299; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Herrmann MJ, 2007, J NEURAL TRANSM, V114, P951, DOI 10.1007/s00702-007-0624-9; Hsu YF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00152; Hugenberg K, 2007, J EXP SOC PSYCHOL, V43, P334, DOI 10.1016/j.jesp.2006.02.010; Ito TA, 2009, TRENDS COGN SCI, V13, P524, DOI 10.1016/j.tics.2009.10.002; Kancherla V, 2013, RES DEV DISABIL, V34, P1630, DOI 10.1016/j.ridd.2013.02.006; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lin HY, 2012, NEUROSCI LETT, V522, P123, DOI 10.1016/j.neulet.2012.06.022; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Nijs IMT, 2009, APPETITE, V53, P376, DOI 10.1016/j.appet.2009.07.022; Onoda K, 2007, BRAIN RES, V1151, P134, DOI 10.1016/j.brainres.2007.03.026; Peng M, 2012, NEUROSCI LETT, V526, P85, DOI 10.1016/j.neulet.2012.08.009; Ran GM, 2014, PERCEPT MOTOR SKILL, V118, P195, DOI 10.2466/24.PMS.118k13w4; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Stahl J, 2008, NEUROREPORT, V19, P583, DOI 10.1097/WNR.0b013e3282f97b4d; Stahl J, 2010, NEUROPSYCHOLOGIA, V48, P2027, DOI 10.1016/j.neuropsychologia.2010.03.024; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Tortosa MI, 2013, BRAIN RES, V1494, P44, DOI 10.1016/j.brainres.2012.11.037; Van de Cruys S., 2011, GESTALT THEORY, V33, P325; Vizioli L, 2010, P NATL ACAD SCI USA, V107, P20081, DOI 10.1073/pnas.1005751107; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Ye J, 2009, RACE EFFECT EMOTION, P1; Ziv M, 2010, HUM BRAIN MAPP, V31, P326, DOI 10.1002/hbm.20867	48	19	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114011	10.1371/journal.pone.0114011	http://dx.doi.org/10.1371/journal.pone.0114011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25422892	gold, Green Submitted, Green Published			2022-12-27	WOS:000345899700083
J	Santillan, BA; Moye, C; Mittelman, D; Wilson, JH				Santillan, Beatriz A.; Moye, Christopher; Mittelman, David; Wilson, John H.			GFP-Based Fluorescence Assay for CAG Repeat Instability in Cultured Human Cells	PLOS ONE			English	Article							T7 RNA-POLYMERASE; EXONIC SPLICING ENHANCERS; FRAGILE-X LOCI; TRINUCLEOTIDE REPEATS; MAMMALIAN-CELLS; TRIPLET REPEATS; TRANSCRIPTION ELONGATION; MYOTONIC-DYSTROPHY; SELECTABLE SYSTEM; FORMING SEQUENCE	Trinucleotide repeats can be highly unstable, mutating far more frequently than point mutations. Repeats typically mutate by addition or loss of units of the repeat. CAG repeat expansions in humans trigger neurological diseases that include myotonic dystrophy, Huntington disease, and several spinocerebellar ataxias. In human cells, diverse mechanisms promote CAG repeat instability, and in mice, the mechanisms of instability are varied and tissue-dependent. Dissection of mechanistic complexity and discovery of potential therapeutics necessitates quantitative and scalable screens for repeat mutation. We describe a GFP-based assay for screening modifiers of CAG repeat instability in human cells. The assay exploits an engineered intronic CAG repeat tract that interferes with expression of an inducible GFP minigene. Like the phenotypes of many trinucleotide repeat disorders, we find that GFP function is impaired by repeat expansion, in a length-dependent manner. The intensity of fluorescence varies inversely with repeat length, allowing estimates of repeat tract changes in live cells. We validate the assay using transcription through the repeat and engineered CAG-specific nucleases, which have previously been reported to induce CAG repeat instability. The assay is relatively fast and should be adaptable to large-scale screens of chemical and shRNA libraries.	[Santillan, Beatriz A.; Moye, Christopher; Wilson, John H.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Santillan, Beatriz A.; Wilson, John H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mittelman, David] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Mittelman, David] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Baylor College of Medicine; Baylor College of Medicine; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Wilson, JH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	jwilson@bcm.edu			Baylor Research Advocates for Student Scientists; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health [AI036211, CA125123, RR024574, NS079926, GM38219, EY11731]; National Institutes of General Medical Sciences [T32 GM08307]; National Eye Institute [T32 EY07001]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007001, R01EY011731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079926] Funding Source: NIH RePORTER	Baylor Research Advocates for Student Scientists; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: Baylor Research Advocates for Student Scientists to BAS (https://www.bcm.edu/giving/get-involved/brass); The Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health (AI036211, CA125123, and RR024574) (http://www.nih.gov/); A National Institutes of General Medical Sciences training grant (T32 GM08307) to BAS (http://www.nih.gov/); A National Eye Institute training grant (T32 EY07001) to CM (http://www.nih.gov/); grants from the National Institutes of Health (NS079926) to DM (http://www.nih.gov/); and a grant from the National Institutes of Health (GM38219 and EY11731) to JHW (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Belotserkovskii BP, 2013, CHEM REV, V113, P8620, DOI 10.1021/cr400078y; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Concannon C, 2013, NUCLEIC ACIDS RES, V41, P6098, DOI 10.1093/nar/gkt295; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Debacker K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001257; Dion V, 2008, HUM MOL GENET, V17, P1306, DOI 10.1093/hmg/ddn019; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; Doi K., 2013, BIOINFORMATICS; Fondon JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033036; GACY AM, 1995, CELL, V81, P533; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gersappe A, 1999, MOL CELL BIOL, V19, P364; Gomes-Pereira M, 2006, MUTAT RES-FUND MOL M, V598, P15, DOI 10.1016/j.mrfmmm.2006.01.011; Gorbunova V, 2004, HUM MOL GENET, V13, P2979, DOI 10.1093/hmg/ddh317; Gorbunova V, 2003, MOL CELL BIOL, V23, P4485, DOI 10.1128/MCB.23.13.4485-4493.2003; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; Hubert L, 2011, MOL CELL BIOL, V31, P3105, DOI 10.1128/MCB.05158-11; Iyer RR, 2000, J BIOL CHEM, V275, P2174, DOI 10.1074/jbc.275.3.2174; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun IV, 2011, AGING-US, V3, P509, DOI 10.18632/aging.100324; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2005, MUTAT RES-FUND MOL M, V572, P123, DOI 10.1016/j.mrfmmm.2005.01.013; Lin YF, 2007, MOL CELL BIOL, V27, P6209, DOI 10.1128/MCB.00739-07; Lin YF, 2010, MOL CELL BIOL, V30, P4435, DOI 10.1128/MCB.00332-10; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu CR, CELL, V148, P690; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Mittelman D, 2009, P NATL ACAD SCI USA, V106, P9607, DOI 10.1073/pnas.0902420106; Moye C, 2013, THESIS BAYLOR COLL M; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richard GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095611; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shah KA, 2012, CELL REP, V2, P1088, DOI 10.1016/j.celrep.2012.10.006; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; TIAN M, 1992, SCIENCE, V256, P237, DOI 10.1126/science.1566072; Tome S, 2011, HUM MOL GENET, V20, P2131, DOI 10.1093/hmg/ddr099; Tornaletti S, 2008, J BIOL CHEM, V283, P12756, DOI 10.1074/jbc.M705003200; WANG Z, 1995, RNA, V1, P21; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531	56	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113952	10.1371/journal.pone.0113952	http://dx.doi.org/10.1371/journal.pone.0113952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423602	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700082
J	Stein, ML; van Steenbergen, JE; Buskens, V; van der Heijden, PGM; Chanyasanha, C; Tipayamongkholgul, M; Thorson, AE; Bengtsson, L; Lu, X; Kretzschmar, MEE				Stein, Mart L.; van Steenbergen, Jim E.; Buskens, Vincent; van der Heijden, Peter G. M.; Chanyasanha, Charnchudhi; Tipayamongkholgul, Mathuros; Thorson, Anna E.; Bengtsson, Linus; Lu, Xin; Kretzschmar, Mirjam E. E.			Comparison of Contact Patterns Relevant for Transmission of Respiratory Pathogens in Thailand and the Netherlands Using Respondent-Driven Sampling	PLOS ONE			English	Article							INFECTIOUS-DISEASE; SOCIAL CONTACTS; NETWORK; SPREAD; INFLUENZA; DURATION; MODELS	Understanding infection dynamics of respiratory diseases requires the identification and quantification of behavioural, social and environmental factors that permit the transmission of these infections between humans. Little empirical information is available about contact patterns within real-world social networks, let alone on differences in these contact networks between populations that differ considerably on a socio-cultural level. Here we compared contact network data that were collected in the Netherlands and Thailand using a similar online respondent-driven method. By asking participants to recruit contact persons we studied network links relevant for the transmission of respiratory infections. We studied correlations between recruiter and recruited contacts to investigate mixing patterns in the observed social network components. In both countries, mixing patterns were assortative by demographic variables and random by total numbers of contacts. However, in Thailand participants reported overall more contacts which resulted in higher effective contact rates. Our findings provide new insights on numbers of contacts and mixing patterns in two different populations. These data could be used to improve parameterisation of mathematical models used to design control strategies. Although the spread of infections through populations depends on more factors, found similarities suggest that spread may be similar in the Netherlands and Thailand.	[Stein, Mart L.; Kretzschmar, Mirjam E. E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Stein, Mart L.; van Steenbergen, Jim E.; Kretzschmar, Mirjam E. E.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van Steenbergen, Jim E.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands; [Buskens, Vincent; van der Heijden, Peter G. M.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [van der Heijden, Peter G. M.] Univ Southampton, Southampton Stat Sci Res Inst, Southampton, Hants, England; [Chanyasanha, Charnchudhi] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10700, Thailand; [Tipayamongkholgul, Mathuros] Mahidol Univ, Fac Publ Hlth, Dept Epidemiol, Bangkok 10700, Thailand; [Thorson, Anna E.; Bengtsson, Linus; Lu, Xin] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lu, Xin] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China; [Bengtsson, Linus; Lu, Xin] Flowminder Fdn, Stockholm, Sweden	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; University of Southampton; Mahidol University; Mahidol University; Karolinska Institutet; National University of Defense Technology - China	Stein, ML (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.l.stein-2@umcutrecht.nl	lu, xin/C-1940-2009; Buskens, Vincent/N-8762-2019; Stein, Mart/U-8914-2019; Buskens, Vincent/B-3134-2012	lu, xin/0000-0002-3547-6493; Buskens, Vincent/0000-0002-4483-7238; Buskens, Vincent/0000-0002-4483-7238; Kretzschmar, Mirjam/0000-0002-4394-7697; Tipayamongkholgul, Mathuros/0000-0002-2585-1659; Stein, Mart L./0000-0003-0502-7993; van der Heijden, Peter/0000-0002-3345-096X; Thorson, Anna/0000-0002-8703-6561	Swedish Research Council (vr.se)	Swedish Research Council (vr.se)(Swedish Research Council)	The Swedish Research Council (vr.se) has financed the programming of the RDS websurvey system and the technical implementation of the surveys in the Netherlands and Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABF Research, 2012, LAND MON STUD 2012; Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; ANDERSON R M, 1991; Ball F, 2013, J MATH BIOL, V66, P979, DOI 10.1007/s00285-012-0609-7; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Bengtsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049417; Bolton KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030893; Brandsema P, 2013, JAARRAPPORTAGE SURVE, P90; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Centraal Bureau voor de Statistiek, 2013, HUISH GROOTT SAM POS; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; Duerr HP, 2007, EPIDEMIOL INFECT, V135, P1124, DOI 10.1017/S0950268807007959; Farrington CP, 2013, BIOSTATISTICS, V14, P528, DOI 10.1093/biostatistics/kxs054; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; HANKS LM, 1962, AM ANTHROPOL, V64, P1247; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Kaewyeam K, 1996, CURRENT HOUSING SITU; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; McDonald SA, 2014, INFLUENZA OTHER RESP, V8, P33, DOI 10.1111/irv.12201; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; National Influenza Centres Global Influenza Surveillance and Response System, 2014, FLUNET; National Statistical Office Thailand, 2010, 2010 POP HOUS CENS; Nationale Atlas Volksgezondheid, 2012, BEV GEM 2012; Newman M. E. J., 2003, STAT MECH COMPLEX NE; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Socialbakers, 2013, CHECKF FAC STAT THAI; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085256; Truong HHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070344; Utrecht Center for Infection Dynamics, 2013, YOURSPACE; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wejnert C, 2010, SOC NETWORKS, V32, P112, DOI 10.1016/j.socnet.2009.09.002	47	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113711	10.1371/journal.pone.0113711	http://dx.doi.org/10.1371/journal.pone.0113711			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423343	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000345899700057
J	Sun, LL; Tanida, M; Wang, MF; Kuda, Y; Kurata, Y; Shibamoto, T				Sun, Lingling; Tanida, Mamoru; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka; Shibamoto, Toshishige			Effects of Anesthetics on the Renal Sympathetic Response to Anaphylactic Hypotension in Rats	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ROSTRAL VENTROLATERAL MEDULLA; NERVE ACTIVITY; ACTIVATION; SYSTEM; STIMULATION; MECHANISMS; RECEPTORS; KETAMINE; NEURONS	The autonomic nervous system plays an important role in rat anaphylactic hypotension. It is well known that sympathetic nerve activity and cardiovascular function are affected by anesthetics. However, the effects of different types of anesthesia on the efferent renal sympathetic nerve activity (RSNA) during anaphylactic hypotension remain unknown. Therefore, we determined the renal sympathetic responses to anaphylactic hypotension in anesthetized and conscious rats and the roles of baroreceptors in these responses. Sprague-Dawley rats were randomly allocated to anesthetic groups that were given pentobarbital, urethane, or ketamine-xylazine and to a conscious group. The rats were sensitized using subcutaneously injected ovalbumin. The systemic arterial pressure (SAP), RSNA and heart rate (HR) were measured. The effects of sinoaortic baroreceptor denervation on RSNA during anaphylaxis were determined in pentobarbital-anesthetized and conscious rats. In all of the sensitized rats, the RSNA increased and SAP decreased after antigen injection. At the early phase within 35 min of the antigen injection, the antigen-induced sympathoexcitation in the conscious rats was significantly greater than that in the anesthetized rats. Anaphylactic hypotension was attenuated in the conscious rats compared to the anesthetized rats. The anesthetic-induced suppression of SAP and RSNA was greater in the order ketamine-xylazine. urethane5pentobarbital. Indeed, in the rats treated with ketamine-xylazine, RSNA did not increase until 40 min, and SAP remained at low levels after the antigen injection. The baroreceptor reflex, as evaluated by increases in RSNA and HR in response to the decrease in SAP induced by sodium nitroprusside (SNP), was suppressed in the anesthetized rats compared with the conscious rats. Consistent with this finding, baroreceptor denervation attenuated the excitatory responses of RSNA to anaphylaxis in the conscious rats but not in the pentobarbital- anesthetized rats. RSNA was increased markedly in conscious rats during anaphylactic hypotension. Anesthetics attenuated this antigen-induced renal sympathoexcitation through the suppression of baroreceptor function.	[Sun, Lingling; Tanida, Mamoru; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka; Shibamoto, Toshishige] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan; [Sun, Lingling] China Med Univ, Affiliated Hosp 4, Dept Hematol, Shenyang, Peoples R China; [Wang, Mofei] China Med Univ, Affiliated Hosp 4, Dept Colorectal Surg, Shenyang, Peoples R China	Kanazawa Medical University; China Medical University; China Medical University	Tanida, M (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan.	mtanida@kanazawa-med.ac.jp			Kanazawa Medical University [2013-205]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25462839]	Kanazawa Medical University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	MT is supported by grants from Grant for Promoted Research from Kanazawa Medical University (2013-205). TS is supported by a Grant-in-Aid for Scientific Research (25462839) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akine A, 2001, AUTON NEUROSCI-BASIC, V87, P201, DOI 10.1016/S1566-0702(00)00271-X; Bencze M, 2013, PHYSIOL RES, V62, P471, DOI 10.33549/physiolres.932637; Fisher MT, 2010, NEUROSCI LETT, V471, P195, DOI 10.1016/j.neulet.2010.01.041; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Helwig BG, 2008, AUTON NEUROSCI-BASIC, V141, P104, DOI 10.1016/j.autneu.2008.04.008; HSU WH, 1981, J PHARMACOL EXP THER, V218, P188; JACOBSEN J, 1995, CLIN PHYSIOL, V15, P81; KANNAN H, 1989, AM J PHYSIOL, V256, pR1325, DOI 10.1152/ajpregu.1989.256.6.R1325; KANNAN H, 1987, J AUTONOM NERV SYST, V21, P83, DOI 10.1016/0165-1838(87)90094-4; KOYAMA S, 1990, AM J PHYSIOL, V258, pR383, DOI 10.1152/ajpregu.1990.258.2.R383; MATSUKAWA K, 1989, AM J PHYSIOL, V256, pR371, DOI 10.1152/ajpregu.1989.256.2.R371; MEELEY MP, 1985, NEUROSCI LETT, V58, P83, DOI 10.1016/0304-3940(85)90333-7; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Moreira TS, 2011, BRAZ J MED BIOL RES, V44, P883, DOI 10.1590/S0100-879X2011000900009; Nel L, 2011, BRIT J CLIN PHARMACO, V71, P647, DOI 10.1111/j.1365-2125.2011.03913.x; NORN S, 1976, CLIN EXP IMMUNOL, V26, P162; Potas JR, 2004, AUTON NEUROSCI-BASIC, V112, P25, DOI 10.1016/j.autneu.2004.03.004; Shibamoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1436, DOI 10.1152/ajpheart.00368.2005; Shibamoto T, 1996, NEUROSCI LETT, V212, P99, DOI 10.1016/0304-3940(96)12782-8; TAKAYAMA K, 1994, NEUROSCI LETT, V176, P59, DOI 10.1016/0304-3940(94)90871-0; Tanida M, 2007, NEUROSCI LETT, V413, P88, DOI 10.1016/j.neulet.2006.11.035; Tanida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056660; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Wang WZ, 2001, ACTA PHARMACOL SIN, V22, P97; WATKINS L, 1991, J AUTONOM NERV SYST, V36, P107, DOI 10.1016/0165-1838(91)90106-D; Zhang W, 2009, SHOCK, V31, P201, DOI 10.1097/SHK.0b013e31817c05bc; Zhang ZH, 2011, AM J PHYSIOL-HEART C, V301, pH1559, DOI 10.1152/ajpheart.00262.2011	27	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113945	10.1371/journal.pone.0113945	http://dx.doi.org/10.1371/journal.pone.0113945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423366	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700080
J	Hillman, NH; Kemp, MW; Miura, Y; Kallapur, SG; Jobe, AH				Hillman, Noah H.; Kemp, Matthew W.; Miura, Yuichiro; Kallapur, Suhas G.; Jobe, Alan H.			Sustained Inflation at Birth Did Not Alter Lung Injury from Mechanical Ventilation in Surfactant-Treated Fetal Lambs	PLOS ONE			English	Article							PRETERM INFANTS; INITIATION; RESUSCITATION; INFLAMMATION; MATURATION; ENDOTOXIN; PRESSURE; IMPROVES; RISK	Background: Sustained inflations (SI) are used with the initiation of ventilation at birth to rapidly recruit functional residual capacity and may decrease lung injury and the need for mechanical ventilation in preterm infants. However, a 20 second SI in surfactant-deficient preterm lambs caused an acute phase injury response without decreasing lung injury from subsequent mechanical ventilation. Hypothesis: A 20 second SI at birth will decrease lung injury from mechanical ventilation in surfactant-treated preterm fetal lambs. Methods: The head and chest of fetal sheep at 126 +/- 1 day GA were exteriorized, with tracheostomy and removal of fetal lung fluid prior to treatment with surfactant (300 mg in 15 ml saline). Fetal lambs were randomized to one of four 15 minute interventions: 1) PEEP 8 cmH(2)O; 2) 20 sec SI at 40 cmH(2)O, then PEEP 8 cmH(2)O; 3) mechanical ventilation with 7 ml/kg tidal volume; or 4) 20 sec SI then mechanical ventilation at 7 ml/kg. Fetal lambs remained on placental support for the intervention and for 30 min after the intervention. Results: SI recruited a mean volume of 6.8 +/- 0.8 mL/kg. SI did not alter respiratory physiology during mechanical ventilation. Heat shock protein (HSP) 70, HSP60, and total protein in lung fluid similarly increased in both ventilation groups. Modest pro-inflammatory cytokine and acute phase responses, with or without SI, were similar with ventilation. SI alone did not increase markers of injury. Conclusion: In surfactant treated fetal lambs, a 20 sec SI did not alter ventilation physiology or markers of lung injury from mechanical ventilation.	[Hillman, Noah H.] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Neonatol, St Louis, MO 63103 USA; [Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Kemp, Matthew W.; Miura, Yuichiro; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia	Saint Louis University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia	Hillman, NH (corresponding author), St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Neonatol, St Louis, MO 63103 USA.	Hillman@slu.edu	Miura, Yuichiro/M-3838-2013	Miura, Yuichiro/0000-0002-6693-4119	NIH [R01-HD072842, K08 HL097085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01-HD072842 (AHJ) and K08 HL097085 (NHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund LJ, 2001, ACTA ANAESTH SCAND, V45, P986, DOI 10.1034/j.1399-6576.2001.450811.x; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2013, AM J PHYSIOL-LUNG C, V305, pL446, DOI 10.1152/ajplung.00162.2013; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hillman NH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-151; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; IKEGAMI M, 1989, AM REV RESPIR DIS, V139, P367, DOI 10.1164/ajrccm/139.2.367; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lista G, 2011, NEONATOLOGY, V99, P45, DOI 10.1159/000298312; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mulrooney N, 2005, AM J RESP CRIT CARE, V171, P488, DOI 10.1164/rccm.200406-774OC; Polglase GR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-43; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Scarpelli EM, 1996, ANAT REC, V246, P245, DOI 10.1002/(SICI)1097-0185(199610)246:2<245::AID-AR12>3.0.CO;2-O; Schilleman K, 2013, J PEDIATR-US, V162, P457, DOI 10.1016/j.jpeds.2012.09.036; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Pas ABT, 2007, PEDIATRICS, V120, P322, DOI 10.1542/peds.2007-0114; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; Tingay DG, 2014, J APPL PHYSIOL, V116, P251, DOI 10.1152/japplphysiol.01142.2013; van Vonderen JJ, 2014, J PEDIAT; VYAS H, 1981, J PEDIATR-US, V99, P787, DOI 10.1016/S0022-3476(81)80412-X; Wada K, 1997, J APPL PHYSIOL, V83, P1054, DOI 10.1152/jappl.1997.83.4.1054	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113473	10.1371/journal.pone.0113473	http://dx.doi.org/10.1371/journal.pone.0113473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419969	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900039
J	Kozina, A; Opresnik, S; Wong, MSK; Hallstrom, S; Graier, WF; Malli, R; Schroder, K; Schmidt, K; Frank, S				Kozina, Andrijana; Opresnik, Stefan; Wong, Michael Sze Ka; Hallstroem, Seth; Graier, Wolfgang F.; Malli, Roland; Schroeder, Katrin; Schmidt, Kurt; Frank, Sasa			Oleoyl-Lysophosphatidylcholine Limits Endothelial Nitric Oxide Bioavailability by Induction of Reactive Oxygen Species	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NADPH OXIDASE; SUPEROXIDE-PRODUCTION; CELLS; SYNTHASE; LIPASE; LYSOPHOSPHOLIPIDS; ACTIVATION; RELAXATION; ALBUMIN	Previously we reported modulation of endothelial prostacyclin and interleukin-8 production, cyclooxygenase-2 expression and vasorelaxation by oleoyllysophosphatidylcholine (LPC 18: 1). In the present study, we examined the impact of this LPC on nitric oxide (NO) bioavailability in vascular endothelial EA. hy926 cells. Basal NO formation in these cells was decreased by LPC 18: 1. This was accompanied with a partial disruption of the active endothelial nitric oxide synthase (eNOS)-dimer, leading to eNOS uncoupling and increased formation of reactive oxygen species (ROS). The LPC 18: 1-induced ROS formation was attenuated by the superoxide scavenger Tiron, as well as by the pharmacological inhibitors of eNOS, NADPH oxidases, flavin-containing enzymes and superoxide dismutase (SOD). Intracellular ROS-formation was most prominent in mitochondria, less pronounced in cytosol and undetectable in endoplasmic reticulum. Importantly, Tiron completely prevented the LPC 18: 1-induced decrease in NO bioavailability in EA. hy926 cells. The importance of the discovered findings for more in vivo like situations was analyzed by organ bath experiments in mouse aortic rings. LPC 18: 1 attenuated the acetylcholine-induced, endothelium dependent vasorelaxation and massively decreased NO bioavailability. We conclude that LPC 18: 1 induces eNOS uncoupling and unspecific superoxide production. This results in NO scavenging by ROS, a limited endothelial NO bioavailability and impaired vascular function.	[Kozina, Andrijana; Opresnik, Stefan; Graier, Wolfgang F.; Malli, Roland; Frank, Sasa] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Wong, Michael Sze Ka; Schroeder, Katrin] Goethe Univ Frankfurt, Fac Med, Inst Cardiovasc Physiol, D-60590 Frankfurt, Germany; [Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, A-8010 Graz, Austria; [Schmidt, Kurt] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria	Medical University of Graz; Goethe University Frankfurt; Medical University of Graz; University of Graz	Frank, S (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria.	sasa.frank@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Schröder, Katrin/E-6874-2013	Graier, Wolfgang F./0000-0003-1871-3298; Schröder, Katrin/0000-0002-3099-526X; Malli, Roland/0000-0001-6327-8729; Kirsch, Andrijana/0000-0002-6623-0234	Medical University of Graz; Deutsche Forschungsgemeinschaft [SFB815, TP1]; Alexander von Humbolt fellowship; Austrian Science Fund FWF [P22553-B18]; Lanyar Foundation [369, 386]; Ph.D. Program "Molecular Medicine" at the Medical University of Graz; Austrian Science Fund (FWF) [P 22553] Funding Source: researchfish	Medical University of Graz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humbolt fellowship; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Lanyar Foundation; Ph.D. Program "Molecular Medicine" at the Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Medical University of Graz (Ph.D. Program "Molecular Medicine"), by the Deutsche Forschungsgemeinschaft (SFB815, TP1 to K.Schr.), Alexander von Humbolt fellowship to M.S.K.W., The Austrian Science Fund FWF (Grant P22553-B18 to R.M.) and Lanyar Foundation Grants 369 and 386 (S.F.). Andrijana Kozina was funded by the Ph.D. Program "Molecular Medicine" at the Medical University of Graz. The funding sources had no involvement in study design; collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	BHAMIDIPATI SP, 1995, BIOCHEMISTRY-US, V34, P5666, DOI 10.1021/bi00016a043; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Chen L, 1997, J LIPID RES, V38, P546; Choi S, 2010, CELL PHYSIOL BIOCHEM, V25, P233, DOI 10.1159/000276557; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Dart AM, 1999, CARDIOVASC RES, V43, P308, DOI 10.1016/S0008-6363(99)00150-9; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gauster M, 2005, J LIPID RES, V46, P1517, DOI 10.1194/jlr.M500054-JLR200; Gorren ACF, 2001, NITRIC OXIDE-BIOL CH, V5, P176, DOI 10.1006/niox.2001.0332; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; HABERLAND ME, 1975, J BIOL CHEM, V250, P6636; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; Hemmens B, 1998, METH MOL B, V100, P1; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; HIRATA K, 1995, CIRC RES, V76, P958, DOI 10.1161/01.RES.76.6.958; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096735; Kim YL, 2007, PROSTAG OTH LIPID M, V83, P130, DOI 10.1016/j.prostaglandins.2006.10.006; Konopatskaya O, 2003, DIABETIC MED, V20, P838, DOI 10.1046/j.1464-5491.2003.01039.x; Kugiyama K, 1999, ATHEROSCLEROSIS, V143, P201, DOI 10.1016/S0021-9150(98)00288-3; KUGIYAMA K, 1990, NATURE, V344, P160, DOI 10.1038/344160a0; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Laurindo FRM, 2008, METHOD ENZYMOL, V441, P237, DOI 10.1016/S0076-6879(08)01213-5; Li H, 2000, J CHROMATOGR B, V746, P199, DOI 10.1016/S0378-4347(00)00328-5; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Ojala PJ, 2007, J LEUKOCYTE BIOL, V82, P1501, DOI 10.1189/jlb.0507292; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; Rao SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065155; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Riederer M, 2012, BBA-MOL CELL BIOL L, V1821, P1003, DOI 10.1016/j.bbalip.2012.03.006; Riederer M, 2011, ATHEROSCLEROSIS, V214, P338, DOI 10.1016/j.atherosclerosis.2010.11.007; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; SAITO T, 1988, P NATL ACAD SCI USA, V85, P8246, DOI 10.1073/pnas.85.21.8246; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Sasagawa T, 1998, J NUTR SCI VITAMINOL, V44, P809, DOI 10.3177/jnsv.44.809; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schmidt K, 1999, EUR J BIOCHEM, V259, P25, DOI 10.1046/j.1432-1327.1999.00003.x; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; STOLL LL, 1992, AM J PHYSIOL, V262, pH1853, DOI 10.1152/ajpheart.1992.262.6.H1853; Takeshita S, 2000, J Atheroscler Thromb, V7, P238; Tardivel S, 2009, LIPIDS, V44, P225, DOI 10.1007/s11745-009-3284-8; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Virdis A, 2013, HYPERTENSION, V62, P337, DOI 10.1161/HYPERTENSIONAHA.111.00995; Waldeck-Weiermair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045917; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; ZEMBOWICZ A, 1995, J BIOL CHEM, V270, P17006, DOI 10.1074/jbc.270.28.17006	56	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113443	10.1371/journal.pone.0113443	http://dx.doi.org/10.1371/journal.pone.0113443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419657	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900036
J	Vernouillet, A; Villard, MA; Hache, S				Vernouillet, Alizee; Villard, Marc-Andre; Hache, Samuel			ENSO, Nest Predation Risk, Food Abundance, and Male Status Fail to Explain Annual Variations in the Apparent Survival Rate of a Migratory Songbird	PLOS ONE			English	Article							OVENBIRDS SEIURUS-AUROCAPILLA; NINO-SOUTHERN OSCILLATION; WINTER HABITAT LOSS; BREEDING DISPERSAL; BODY CONDITION; UNIFIED APPROACH; SITE FIDELITY; BIRD; POPULATION; AGE	Adult mortality can be a major driver of population decline in species whose productivity is relatively low. Yet, little is known about the factors influencing adult survival rates in migratory bird species, nor do we know much about the longer-term effects of habitat disturbance on the fitness of individuals. The Ovenbird (Seiurus aurocapilla) is one of the vertebrate species most sensitive to forest management, yet it is still common and widespread. We monitored the fate of 330 colour-banded Ovenbird males in four pairs of 25-ha plots during 9 successive breeding seasons. One plot of each pair was treated through selection harvesting (30-40% basal area removed) during the first winter. We tested the following hypotheses: (1) higher physiological costs in harvested plots as a result of lower food abundance will reduce apparent survival rate (ASR) relative to controls; (2) lower ASR following years with low nest survival and higher probability of renesting; (3) fluctuations in ASR reflecting El Nino Southern Oscillation (ENSO); and (4) higher ASR in returning males than in recruits (unbanded immigrants) owing to greater site familiarity in the former. We tested the relative importance of these hypotheses, or combinations thereof, by generating 23 models explaining variation in ASR. The year-dependent model received the most support, showing a 41% decrease in ASR from 2007 to 2014. The important year-to-year variation we observed in ASR (Sigma w(i)=0.99) was not explained by variation in nest predation risk nor by ENSO. There was also little evidence for an effect of selection harvesting on ASR of Ovenbird males, despite a slight reduction in lifespan relative to males from control plots (2.7 vs 2.9 years). An avenue worth exploring to explain this intriguing pattern would be to determine whether conditions at migratory stopover sites or in the wintering area of our focal population have gradually worsened over the past decade.	[Vernouillet, Alizee; Villard, Marc-Andre] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [Hache, Samuel] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Moncton; University of Alberta	Villard, MA (corresponding author), Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada.	marc-andre.villard@umoncton.ca	Vernouillet, Alizée/ABC-5045-2021	Vernouillet, Alizée/0000-0003-2525-2936	Natural Sciences and Engineering Research Council of Canada [170643]; New Brunswick Wildlife Trust Fund; J.D. Irving Ltd.	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Wildlife Trust Fund; J.D. Irving Ltd.	This work was supported by the Natural Sciences and Engineering Research Council of Canada - Grant #170643 (www.nserc-crsng.gc.ca), New Brunswick Wildlife Trust Fund (www.nbwtf.ca), and J.D. Irving Ltd. The study was designed in collaboration with J.D. Irving's Forest Research Advisory Committee. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2005, CONSERV BIOL, V19, P66, DOI 10.1111/j.1523-1739.2005.00543.x; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Bayne EM, 2002, ECOLOGY, V83, P1307, DOI 10.1890/0012-9658(2002)083[1307:ASOMOI]2.0.CO;2; Bayne EM, 2002, WILSON BULL, V114, P358, DOI 10.1676/0043-5643(2002)114[0358:ASOAAR]2.0.CO;2; Benson TJ, 2010, CONDOR, V112, P138, DOI 10.1525/cond.2010.080089; Bernard MJ, 2011, AUK, V128, P633, DOI 10.1525/auk.2011.10206; BROWN CR, 1997, BIRDS N AM, V287; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown WP, 2009, ECOLOGY, V90, P218, DOI 10.1890/07-2061.1; Brown WP, 2002, ECOLOGY, V83, P958, DOI 10.2307/3071905; Burton NHK, 2006, J APPL ECOL, V43, P464, DOI 10.1111/j.1365-2664.2006.01156.x; Burton NHK, 2008, ARDEA, V96, P191, DOI 10.5253/078.096.0205; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cooch E, 2012, PROGRAM MARK GENTLE; Cresswell W, 2014, IBIS, V156, P493, DOI 10.1111/ibi.12168; CURIO E, 1987, ARDEA, V75, P35; D'Astous E, 2012, ECOSCIENCE, V19, P106, DOI 10.2980/19-2-3472; DONOVAN TM, 1995, J FIELD ORNITHOL, V66, P247; Duriez O, 2009, J APPL ECOL, V46, P144, DOI 10.1111/j.1365-2664.2008.01592.x; Environment Canada, 2014, N AM BREED BIRD SURV; Faaborg J, 2013, BIODIVERS CONSERV, V22, P63, DOI 10.1007/s10531-012-0399-7; Fisher RJ, 2006, IBIS, V148, P772, DOI 10.1111/j.1474-919X.2006.00582.x; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Griesser M, 2007, CONSERV BIOL, V21, P767, DOI 10.1111/j.1523-1739.2007.00675.x; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Hache S, 2014, CONDOR, V116, P102, DOI 10.1650/CONDOR-13-002-R2.1; Hache S, 2013, ECOLOGY, V94, P861, DOI 10.1890/12-1025.1; Hache S, 2010, J ANIM ECOL, V79, P897, DOI 10.1111/j.1365-2656.2010.01694.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones J, 2003, ECOLOGY, V84, P3024, DOI 10.1890/02-0639; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leshyk R, 2013, GEN COMP ENDOCR, V194, P295, DOI 10.1016/j.ygcen.2013.10.001; Lindberg M., 2002, ENCY ENV, V1, P251; Longcore T, 2013, BIOL CONSERV, V158, P410, DOI 10.1016/j.biocon.2012.09.019; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Marshall MR, 2002, ECOL APPL, V12, P261, DOI 10.1890/1051-0761(2002)012[0261:EOERPA]2.0.CO;2; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Mattsson BJ, 2006, AUK, V123, P82, DOI 10.1642/0004-8038(2006)123[0082:FIPOOS]2.0.CO;2; Mazerolle DF, 2005, J AVIAN BIOL, V36, P155, DOI 10.1111/j.0908-8857.2005.03289.x; National Oceanic and Atmospheric Administration Climate Prediction Center, 2013, SO OSC IND SOI; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Nystrand M, 2010, J ANIM ECOL, V79, P266, DOI 10.1111/j.1365-2656.2009.01627.x; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; Perot A, 2009, CONSERV BIOL, V23, P1550, DOI 10.1111/j.1523-1739.2009.01272.x; Piper WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1329, DOI 10.1007/s00265-011-1195-1; Porneluzi P, 2011, BIRDS N AM, V88; Porneluzi PA, 1999, CONSERV BIOL, V13, P1151, DOI 10.1046/j.1523-1739.1999.98455.x; Prevot-Julliard AC, 1998, AUK, V115, P85; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Santisteban L, 2012, J ANIM ECOL, V81, P352, DOI 10.1111/j.1365-2656.2011.01918.x; Saracco JF, 2008, J WILDLIFE MANAGE, V72, P1665, DOI 10.2193/2008-129; Saracco JF, 2006, ANAL MONITORING AVIA; Sauer J.R., 2008, N AM BREEDING BIRD S; Shabbar A, 2006, ADV GEOPHYS, V6, P149, DOI [10.5194/adgeo-6-149-2006, DOI 10.5194/ADGEO-6-149-2006]; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherry Thomas W., 1995, P85; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; SMITH TM, 1987, ECOLOGY, V68, P695, DOI 10.2307/1938475; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Stutchbury BJM, 2009, AUK, V126, P278, DOI 10.1525/auk.2009.08038; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Theriault S, 2012, BEHAV ECOL, V23, P1289, DOI 10.1093/beheco/ars119; Tourigny E, 2009, TELLUS A, V61, P323, DOI [10.1111/J.1600-0870.2008.00386.x, 10.1111/j.1600-0870.2008.00386.x]; Vander Haegen WM, 2002, AUK, V119, P1173, DOI 10.1642/0004-8038(2002)119[1173:DEEOOS]2.0.CO;2; Vanderwel MC, 2007, CONSERV BIOL, V21, P1230, DOI 10.1111/j.1523-1739.2007.00756.x; Villard MA, 2012, CAN J FOREST RES, V42, P1213, DOI [10.1139/X2012-047, 10.1139/x2012-047]; Whitaker DM, 2008, ACE, P3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolfe JD, 2009, AUK, V126, P809, DOI 10.1525/auk.2009.08018; Zitske BP, 2011, CONSERV BIOL, V25, P993, DOI 10.1111/j.1523-1739.2011.01709.x	76	4	4	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113844	10.1371/journal.pone.0113844	http://dx.doi.org/10.1371/journal.pone.0113844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419839	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900073
J	Hua, HF; Luo, HY; Bai, YG; Wang, K; Niu, CF; Huang, HQ; Shi, PJ; Wang, CH; Yang, PL; Yao, B				Hua, Huifang; Luo, Huiying; Bai, Yingguo; Wang, Kun; Niu, Canfang; Huang, Huoqing; Shi, Pengjun; Wang, Caihong; Yang, Peilong; Yao, Bin			A Thermostable Glucoamylase from Bispora sp MEY-1 with Stability over a Broad pH Range and Significant Starch Hydrolysis Capacity	PLOS ONE			English	Article							ASPERGILLUS-AWAMORI GLUCOAMYLASE; ALPHA-AMYLASE; RAW STARCH; BIOCHEMICAL-CHARACTERIZATION; THERMOACTIVE GLUCOAMYLASE; EXPRESSION; CLONING; IDENTIFICATION; GALACTOSIDASE; PURIFICATION	Background: Glucoamylase is an exo-type enzyme that converts starch completely into glucose from the non-reducing ends. To meet the industrial requirements for starch processing, a glucoamylase with excellent thermostability, raw-starch degradation ability and high glucose yield is much needed. In the present study we selected the excellent Carbohydrate-Activity Enzyme (CAZyme) producer, Bispora sp. MEY-1, as the microbial source for glucoamylase gene exploitation. Methodology/Principal Findings: A glucoamylase gene (gla15) was cloned from Bispora sp. MEY-1 and successfully expressed in Pichia pastoris with a high yield of 34.1 U/ml. Deduced GLA15 exhibits the highest identity of 64.2% to the glucoamylase from Talaromyces (Rasamsonia) emersonii. Purified recombinant GLA15 was thermophilic and showed the maximum activity at 70 degrees C. The enzyme was stable over a broad pH range (2.2-11.0) and at high temperature up to 70 degrees C. It hydrolyzed the breakages of both alpha-1,4- and alpha-1,6-glycosidic linkages in amylopectin, soluble starch, amylose, and maltooligosaccharides, and had capacity to degrade raw starch. TLC and H-1-NMR analysis showed that GLA15 is a typical glucoamylase of GH family 15 that releases glucose units from the non-reducing ends of alpha-glucans. The combination of Bacillus licheniformis amylase and GLA15 hydrolyzed 96.14% of gelatinized maize starch after 6 h incubation, which was about 9% higher than that of the combination with a commercial glucoamylase from Aspergillus niger. Conclusion/Significance: GLA15 has a broad pH stability range, high-temperature thermostability, high starch hydrolysis capacity and high expression yield. In comparison with the commercial glucoamylase from A. niger, GLA15 represents a better candidate for application in the food industry including production of glucose, glucose syrups, and high-fructose corn syrups.	[Hua, Huifang; Luo, Huiying; Bai, Yingguo; Wang, Kun; Niu, Canfang; Huang, Huoqing; Shi, Pengjun; Wang, Caihong; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100081, Peoples R China; [Yang, Peilong] Chinese Acad Agr Sci, ICRAF, Joint Lab Agroforestry & Sustainable Anim Husb, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences	Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing 100081, Peoples R China.	binyao@caas.cn		Wang, Caihong/0000-0003-3298-0659	National High-Tech Research and Development Program of China (863 Program) [2013AA102803, 2012AA022208]; National Science Fund for Distinguished Young Scholars of China [31225026]; National Science and Technology Support Program of China [2011BADB02]	National High-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science and Technology Support Program of China	This work was supported by the National High-Tech Research and Development Program of China (863 Program, no. 2013AA102803), the National High-Tech Research and Development Program of China (863 Program, no. 2012AA022208), the National Science Fund for Distinguished Young Scholars of China (no. 31225026) and the National Science and Technology Support Program of China (2011BADB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIN AE, 1994, J BIOL CHEM, V269, P15631; Bagheri A, 2014, FOOD CHEM, V161, P270, DOI 10.1016/j.foodchem.2014.03.095; Bai YG, 2012, FOOD CHEM, V131, P1473, DOI 10.1016/j.foodchem.2011.10.036; Bentley I, 1996, IND ENZYMOL, P341; Bott R, 2008, BIOCHEMISTRY-US, V47, P5746, DOI 10.1021/bi702413k; Chen J, 2007, J APPL MICROBIOL, V103, P2277, DOI 10.1111/j.1365-2672.2007.03475.x; da Silva TM, 2009, J IND MICROBIOL BIOT, V36, P1439, DOI 10.1007/s10295-009-0630-z; Dock C, 2008, APPL MICROBIOL BIOT, V78, P105, DOI 10.1007/s00253-007-1293-1; Goyal N, 2005, ENZYME MICROB TECH, V37, P723, DOI 10.1016/j.enzmictec.2005.04.017; HYUN HH, 1985, APPL ENVIRON MICROB, V49, P1168, DOI 10.1128/AEM.49.5.1168-1173.1985; Imen BA, 2008, J MICROBIOL BIOTECHN, V18, P1555; Kim MS, 2004, APPL ENVIRON MICROB, V70, P3933, DOI 10.1128/AEM.70.7.3933-3940.2004; Kovalenko GA, 2002, J MOL CATAL A-CHEM, V182, P73, DOI 10.1016/S1381-1169(01)00479-4; Li YX, 1998, PROTEIN ENG, V11, P661, DOI 10.1093/protein/11.8.661; Liu HL, 1998, PROTEIN ENG, V11, P389, DOI 10.1093/protein/11.5.389; Liu HL, 2000, PROTEIN ENG, V13, P655, DOI 10.1093/protein/13.9.655; Liu HL, 2003, PROTEIN ENG, V16, P19, DOI 10.1093/proeng/gzg007; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; Luo HY, 2009, EXTREMOPHILES, V13, P849, DOI 10.1007/s00792-009-0272-0; Luo HY, 2009, ENZYME MICROB TECH, V45, P126, DOI 10.1016/j.enzmictec.2009.05.002; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P1267, DOI 10.1007/s00253-010-3034-0; Nielsen BR, 2002, PROTEIN EXPRES PURIF, V26, P1, DOI 10.1016/S1046-5928(02)00505-3; Norouzian D, 2006, BIOTECHNOL ADV, V24, P80, DOI 10.1016/j.biotechadv.2005.06.003; O'Rourke T, 1996, IND ENZYMOLOGY; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Serour E, 2002, ANTON LEEUW INT J G, V81, P73, DOI 10.1023/A:1020525525490; Sevcik J, 2006, FEBS J, V273, P2161, DOI 10.1111/j.1742-4658.2006.05230.x; SPECKA U, 1991, APPL ENVIRON MICROB, V57, P2317, DOI 10.1128/AEM.57.8.2317-2323.1991; Tangngamsakul P, 2011, APPL BIOCHEM MICRO+, V47, P412, DOI 10.1134/S000368381104017X; Thorsen TS, 2006, BBA-PROTEINS PROTEOM, V1764, P671, DOI 10.1016/j.bbapap.2006.01.009; Wang H, 2010, BIORESOURCE TECHNOL, V101, P8376, DOI 10.1016/j.biortech.2010.06.045; Wang H, 2009, J AGR FOOD CHEM, V57, P5535, DOI 10.1021/jf900369e; Xiao ZZ, 2014, APPL BIOCHEM BIOTECH, V172, P73, DOI 10.1007/s12010-013-0460-3; Zheng YY, 2010, APPL MICROBIOL BIOT, V87, P225, DOI 10.1007/s00253-010-2439-0	35	18	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113581	10.1371/journal.pone.0113581	http://dx.doi.org/10.1371/journal.pone.0113581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415468	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600061
J	Graham, KL; Zhang, JV; Lewen, S; Burke, TM; Dang, T; Zoudilova, M; Sobel, RA; Butcher, EC; Zabel, BA				Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Dang, Ton; Zoudilova, Maria; Sobel, Raymond A.; Butcher, Eugene C.; Zabel, Brian A.			A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL; ORAL FINGOLIMOD; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; COMPLICATING TREATMENT; CHEMOKINE RECEPTORS; DENDRITIC CELLS; INHIBITION DATA	Therapies that target leukocyte trafficking pathways can reduce disease activity and improve clinical outcomes in multiple sclerosis (MS). Experimental autoimmune encephalomyelitis (EAE) is a widely studied animal model that shares many clinical and histological features with MS. Chemokine-like receptor-1 (CMKLR1) is a chemoattractant receptor that is expressed by key effector cells in EAE and MS, including macrophages, subsets of dendritic cells, natural killer cells and microglia. We previously showed that CMKLR1-deficient (CMKLR1 KO) mice develop less severe clinical and histological EAE than wild-type mice. In this study, we sought to identify CMKLR1 inhibitors that would pharmaceutically recapitulate the CMKLR1 KO phenotype in EAE. We identified 2-(alpha-naphthoyl) ethyltrimethylammonium iodide (alpha-NETA) as a CMKLR1 small molecule antagonist that inhibits chemerin-stimulated beta-arrestin2 association with CMKLR1, as well as chemerin-triggered CMKLR1(+) cell migration. alpha-NETA significantly delayed the onset of EAE induced in C57BL/6 mice by both active immunization with myelin oligodendrocyte glycoprotein peptide 35-55 and by adoptive transfer of encephalitogenic T cells. In addition, alpha-NETA treatment significantly reduced mononuclear cell infiltrates within the CNS. This study provides additional proof-of-concept data that targeting CMKLR1:chemerin interactions may be beneficial in preventing or treating MS.	[Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Zabel, Brian A.] Palo Alto Vet Inst Res, Palo Alto, CA 94306 USA; [Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Dang, Ton] ChemoCentryx Inc, Mountain View, CA USA; [Zoudilova, Maria; Sobel, Raymond A.; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Zabel, BA (corresponding author), Palo Alto Vet Inst Res, Palo Alto, CA 94306 USA.	bazabel@alum.mit.edu		Sobel, Raymond/0000-0002-0477-9002; Burke, Thomas/0000-0003-0942-7580	DoD [W81XWH-11-1-0512]; NIH [R01 AI-079320, R01CAI69354, R01 AI093981, AI059635, R37 AI047822, K22AI87818, 5 T32 AI07290, T32CA09151, AI-079320]; Stanford SPARK award; Department of Veterans Affairs; FACS Core Facility of the Stanford Digestive Disease Center [P30 DK056339]; One hundred Talent Program of CAS; NSFC [31100850];  [GJHZ20130417171414743]; NATIONAL CANCER INSTITUTE [R01CA169354, T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, K22AI087818, R01AI079320, R01AI059635, T32AI007290, R21AI059635, R01AI093981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford SPARK award; Department of Veterans Affairs(US Department of Veterans Affairs); FACS Core Facility of the Stanford Digestive Disease Center; One hundred Talent Program of CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by DoD grant W81XWH-11-1-0512, NIH grant R01 AI-079320, and a Stanford SPARK award to B.A.Z.; by grants R01CAI69354, R01 AI093981 and AI059635 and R37 AI047822 from the NIH and a Merit Award from the Department of Veterans Affairs to E.C.B.; by Research Scholar Development Award K22AI87818 from the NIH to K.L.G.; and by the FACS Core Facility of the Stanford Digestive Disease Center under P30 DK056339. M.Z. was a recipient of fellowship support under NIH training grants 5 T32 AI07290 and T32CA09151. K.L.G. and T.M.B. were supported by diversity supplements from the NIH awarded to parent grant AI-079320. J.V.Z. was supported by the following grants: One hundred Talent Program of CAS, NSFC 31100850, and GJHZ20130417171414743.	Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cruz-Orengo L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-170; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Graham KL, 2009, J IMMUNOL, V183, P6717, DOI 10.4049/jimmunol.0803435; Horn JR, 2008, PHARM TIMES, P40; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Mullen JT, 2008, NEW ENGL J MED, V358, P647, DOI 10.1056/NEJMc0706103; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardridge William M, 2005, NeuroRx, V2, P3; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PubChem, 2009, NAT CTR BIOT INF PUB; PubChem, 2011, NAT CTR BIOT INF PUB; RACKE MK, 1995, J IMMUNOL, V154, P450; Redfern WS, 2002, FUND CLIN PHARMACOL, V16, P161, DOI 10.1046/j.1472-8206.2002.00098.x; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SASTRY BVR, 1988, J PHARMACOL EXP THER, V245, P72; SASTRY BVR, 1988, PHARMACOL RES, V20, P751; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Springer C, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-167; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Venci JV, 2013, ANN PHARMACOTHER, V47, P1697, DOI 10.1177/1060028013509232; von Degenfeld G, 2007, FASEB J, V21, P3819, DOI 10.1096/fj.07-9597com; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	50	41	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112925	10.1371/journal.pone.0112925	http://dx.doi.org/10.1371/journal.pone.0112925			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437209	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900022
J	Guo, DQ; Zhang, H; Tan, SJ; Gu, YC				Guo, Dong-Qing; Zhang, Hao; Tan, Sheng-Jiang; Gu, Yu-Chun			Nifedipine Promotes the Proliferation and Migration of Breast Cancer Cells	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; RISK; GROWTH; ANTAGONISTS; METASTASIS; INHIBITION; CARCINOMA; INVASION; ANGIOPOIETIN-LIKE-4; PROGRESSION	Nifedipine is widely used as a calcium channel blocker (CCB) to treat angina and hypertension, but it is controversial with respect the risk of stimulation of cancers. In this study, we demonstrated that nifedipine promoted the proliferation and migration of breast cancer cells both invivo and invitro. However, verapamil, another calcium channel blocker, didn't exert the similar effects. Nifedipine and high concentration KCl failed to alter the [Ca2+](i) in MDA-MB-231 cells, suggesting that such nifedipine effect was not related with calcium channel. Moreover, nifedipine decreased miRNA-524-5p, resulting in the up-regulation of brain protein I3 (BRI3). Erk pathway was consequently activated and led to the proliferation and migration of breast cancer cells. Silencing BRI3 reversed the promoting effect of nifedipine on the breast cancer. In a summary, nifedipine stimulated the proliferation and migration of breast cancer cells via the axis of miRNA-524-5p-BRI3-Erk pathway independently of its calcium channel-blocking activity. Our findings highlight that nifedipine but not verapamil is conducive for breast cancer growth and metastasis, urging that the caution should be taken in clinic to prescribe nifedipine to women who suffering both hypertension and breast cancer, and hypertension with a tendency in breast cancers.	[Guo, Dong-Qing; Gu, Yu-Chun] Peking Univ, Mol Pharmacol Lab, Inst Mol Med, Beijing 100871, Peoples R China; [Zhang, Hao] Fudan Univ, Dept Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Tan, Sheng-Jiang] Univ Cambridge, Dept Haematol, Cambridge, England	Peking University; Fudan University; University of Cambridge	Gu, YC (corresponding author), Peking Univ, Mol Pharmacol Lab, Inst Mol Med, Beijing 100871, Peoples R China.	ycgu@pku.edu.cn		gu, yuchun/0000-0002-7558-0447	Science Foundation of China [81170236]; 973 Project [2013CB531206, 2012CB517803]	Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China)	This work is supported by the research grants held by YG (National Natural Science Foundation of China No. 81170236, 973 Project No. 2013CB531206 and 973 Project No. 2012CB517803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr HJ, 1998, CARDIOVASC DRUG THER, V12, P157, DOI 10.1023/A:1007727010076; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bandres E, 2007, ONCOL REP, V17, P1089; Bandyopadhyay S, 2013, IEEE ACM T COMPUT BI; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brellier F, 2011, MATRIX BIOL, V30, P225, DOI 10.1016/j.matbio.2011.02.001; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Daling JR, 1996, AM J HYPERTENS, V9, P713; Davis S, 2007, EUR J EPIDEMIOL, V22, P319, DOI 10.1007/s10654-007-9135-0; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fitzpatrick AL, 1997, CANCER, V80, P1438, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jensen RL, 2001, SURG NEUROL, V55, P275, DOI 10.1016/S0090-3019(01)00444-X; Kaplan NM, 1996, LANCET, V348, P541, DOI 10.1016/S0140-6736(96)24034-6; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Lew TS, 2004, J ORAL PATHOL MED, V33, P543, DOI 10.1111/j.1600-0714.2004.00236.x; Louie E, 2013, ONCOGENE, V32, P4064, DOI 10.1038/onc.2012.417; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Nie L, 1997, CELL CALCIUM, V22, P75, DOI 10.1016/S0143-4160(97)90107-X; OPIE L H, 1987, Cardiovascular Drugs and Therapy, V1, P411, DOI 10.1007/BF02209083; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Rosenberg L, 1998, JAMA-J AM MED ASSOC, V279, P1000, DOI 10.1001/jama.279.13.1000; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Shimada H, 2007, INT J ONCOL, V30, P97; Sorensen HT, 2000, CANCER-AM CANCER SOC, V89, P165, DOI 10.1002/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TAYLOR JM, 1992, CANCER RES, V52, P2413; Timcheva CV, 1996, J CHEMOTHERAPY, V8, P295, DOI 10.1179/joc.1996.8.4.295; Wu HQ, 2003, BIOCHEM BIOPH RES CO, V311, P518, DOI 10.1016/j.bbrc.2003.10.038	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113649	10.1371/journal.pone.0113649	http://dx.doi.org/10.1371/journal.pone.0113649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436889	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347114900059
J	Zavodna, M; Bagshaw, A; Brauning, R; Gemmell, NJ				Zavodna, Monika; Bagshaw, Andrew; Brauning, Rudiger; Gemmell, Neil J.			The Accuracy, Feasibility and Challenges of Sequencing Short Tandem Repeats Using Next-Generation Sequencing Platforms	PLOS ONE			English	Article							QUALITY ASSESSMENT; STR ANALYSIS; MICROSATELLITES; DNA; POPULATION; REVEALS; GENOMES; LENGTH; GENES; SCALE	To date we have little knowledge of how accurate next-generation sequencing (NGS) technologies are in sequencing repetitive sequences beyond known limitations to accurately sequence homopolymers. Only a handful of previous reports have evaluated the potential of NGS for sequencing short tandem repeats (microsatellites) and no empirical study has compared and evaluated the performance of more than one NGS platform with the same dataset. Here we examined yeast microsatellite variants from both long-read (454-sequencing) and short-read (Illumina) NGS platforms and compared these to data derived through Sanger sequencing. In addition, we investigated any locus-specific biases and differences that might have resulted from variability in microsatellite repeat number, repeat motif or type of mutation. Out of 112 insertion/deletion variants identified among 45 microsatellite amplicons in our study, we found 87.5% agreement between the 454-platform and Sanger sequencing in frequency of variant detection after Benjamini-Hochberg correction for multiple tests. For a subset of 21 microsatellite amplicons derived from Illumina sequencing, the results of short-read platform were highly consistent with the other two platforms, with 100% agreement with 454-sequencing and 93.6% agreement with the Sanger method after Benjamini-Hochberg correction. We found that the microsatellite attributes copy number, repeat motif and type of mutation did not have a significant effect on differences seen between the sequencing platforms. We show that both long-read and short-read NGS platforms can be used to sequence short tandem repeats accurately, which makes it feasible to consider the use of these platforms in high-throughput genotyping. It appears the major requirement for achieving both high accuracy and rare variant detection in microsatellite genotyping is sufficient read depth coverage. This might be a challenge because each platform generates a consistent pattern of non-uniform sequence coverage, which, as our study suggests, may affect some types of tandem repeats more than others.	[Zavodna, Monika; Gemmell, Neil J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Bagshaw, Andrew] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Brauning, Rudiger] AgResearch Ltd, Invermay Agr Ctr, Mosgiel, New Zealand; [Gemmell, Neil J.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; University of Otago; AgResearch - New Zealand; University of Otago	Zavodna, M (corresponding author), Univ Otago, Dept Anat, Dunedin, New Zealand.	z_monika@hotmail.com	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637; Bagshaw, Andrew/0000-0002-2930-7298; Brauning, Rudiger/0000-0001-5068-9166	Marsden Fund [UOO0721]; University of Otago	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Otago	The research was supported by Marsden Fund Grant UOO0721 and the University of Otago granted to NJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; [Anonymous], 2006, 454 SEQ TECHN B; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornman Daniel M, 2012, Biotech Rapid Dispatches, V2012, P1; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029582; Butler JM, 2004, ELECTROPHORESIS, V25, P1397, DOI 10.1002/elps.200305822; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dunning LT, 2013, COMP BIOCHEM PHYS D, V8, P24, DOI 10.1016/j.cbd.2012.10.005; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTOUP A, 1995, MOL BIOL EVOL, V12, P1074; Fordyce SL, 2011, BIOTECHNIQUES, V51, P127, DOI 10.2144/000113721; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; McIver LJ, 2013, GENE, V516, P328, DOI 10.1016/j.gene.2012.12.068; Cao MD, 2015, BRIEF BIOINFORM, V16, P193, DOI 10.1093/bib/bbu001; Cao MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1313; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rockenbauer E, 2014, FORENSIC SCI INT-GEN, V8, P68, DOI 10.1016/j.fsigen.2013.06.011; Rozen S, 2000, Methods Mol Biol, V132, P365; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Van Neste C, 2012, FORENSIC SCI INT-GEN, V6, P810, DOI 10.1016/j.fsigen.2012.03.004; Zar JH., 2010, BIOSTAT ANAL, V5th; Zavodna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061471	37	20	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113862	10.1371/journal.pone.0113862	http://dx.doi.org/10.1371/journal.pone.0113862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436869	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900089
J	Zhao, HY; Xie, CY; Lin, XY; Zhao, Y; Han, Y; Fan, CF; Zhang, XP; Du, J; Han, Y; Han, Q; Wu, GP; Wang, EH				Zhao, Huanyu; Xie, Chengyao; Lin, Xuyong; Zhao, Yue; Han, Yang; Fan, Chuifeng; Zhang, Xiupeng; Du, Jiang; Han, Yong; Han, Qiang; Wu, Guangping; Wang, Enhua			Coexpression of IQ-Domain GTPase-Activating Protein 1 (IQGAP1) and Dishevelled (Dvl) Is Correlated with Poor Prognosis in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CDC42; BINDING; PATHWAY; RAC1	Background: IQ-domain GTPase-activating protein 1 (IQGAP1) binds to Dishevelled (Dvl) and functions as a modulator of Dvl nuclear localization in Xenopus embryos. However, the relationship between IQGAP1 and Dvl in tumor tissues is unclear. Materials and Methods: We used immunohistochemistry to assess the expressions of IQGAP1 and Dvl in a cohort of 111 non-small cell lung cancer (NSCLC) patients. Association of their localization expressions with clinicopathological factors was also analyzed. Results: The positive rate of IQGAP1 in primary tumors was 48.6% (54/111) for its cytoplamic expression, 9.0% (10/111) for nuclear expression and 31.5% (35/111) for membranous expression; the positive rate of Dvl was 65.8% (73/111) for cytoplamic expression, 9.9% (11/111) for nuclear expression and 10.8% (12/111) for membranous expression. Coexpression rate of IQGAP1 and Dvl was 77.8% (42/54) in the cytoplasm, 80.0% (8/10) in the nucleus and 8.6% (3/35) in the membrane. Coexpression of IQGAP1 and Dvl in the cytoplasm and nucleus were significantly correlated (P<0.05), but not in the membrane (P>0.05). The positive expression rates of cyclin D1 and c-myc were significantly higher in the group of IQGAP1 and Dvl coexpression in the nucleus than that in the cytoplasm. Coexpression rate of IQGAP1 and Dvl in the cytoplasm and nucleus was significantly higher in lymph nodal metastases (63.3%, 19/30) than in primary growths (38.3%, 31/81), correlating with poor prognosis. Five-year survival time after resection in the group with their coexpression in the cytoplasm and nucleus was significantly lower than that with no coexpression (44.705+/-3.355 vs 58.403+/-2.543 months, p<0.05). Conclusions: Coexpression of IQGAP1 and Dvl in the cytoplasm and nucleus was correlated with the lymph nodal metastase and poor prognosis of NSCLC, and coexpression in nucleus might play a critical role in the activation of canonical Wnt pathway.	[Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	wangeh@hotmail.com	han, yang/GRS-2388-2022; Zhao, Yue/AGZ-4412-2022	Zhao, Yue/0000-0002-0110-0359				Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Goto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060865; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Liu Y, 2011, HISTOPATHOLOGY, V59, P882, DOI 10.1111/j.1365-2559.2011.04013.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Nakamura H, 2005, ONCOL REP, V13, P427; Wang XX, 2013, HEPATOB PANCREAT DIS, V12, P540, DOI 10.1016/S1499-3872(13)60085-5; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							0113713	10.1371/journal.pone.0113713	http://dx.doi.org/10.1371/journal.pone.0113713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436461	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900067
J	Fang, J; Zou, LL; Zhou, X; Cheng, BJ; Fan, J				Fang, Jie; Zou, Lingling; Zhou, Xuan; Cheng, Beijiu; Fan, Jun			Synonymous Rare Arginine Codons and tRNA Abundance Affect Protein Production and Quality of TEV Protease Variant	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; HETEROLOGOUS PROTEINS; SOLUBLE-PROTEINS; IN-VIVO; SOLUBILITY; EXPRESSION; STABILITY; BACTERIAL	It has been identified that a TEV protease (TEVp) variant, TEVp(5M), displays improved solubility. Here, we constructed fifteen TEVp(5M) variants with one or more of six rare arginine codons in the coding sequence replaced with abundant E. coli arginine codons. These codon variants expressed in either E. coli BL21 (DE3) or Rossetta (DE3) showed different solubility and activity. Supply of rare tRNAs increased the tendency of certain codon variants to form insoluble aggregates at early induction stage, as determined by the fused S-tag. About 32% increase in soluble protein production of M5 variant with four synonymously mutated arginine codons was identified in Rossetta (DE3) cells using GFP fusion reporter, comparable to that of TEVp(5M). After purification, two other codon variants from both E. coli strains exhibited less activity than TEVp(5M) on cleaving the native or modified recognition sequence incorporated between GST and E. coli diaminopropionate ammonialyase by enzyme-coupled assay, whereas purified M5 variant showed activity similar to the TEVp5M. Supply of rare tRNAs caused the decrease of activity of TEVp(5M) and M5 by about 21%. Our results revealed that engineering of highly soluble TEVp variants can be achieved by the combined mutations of amino acid residues and optimization of specific rare codons, whereas simple augment of rare tRNAs abundance resulted in partial loss of activity.	[Fang, Jie; Zou, Lingling; Zhou, Xuan; Cheng, Beijiu; Fan, Jun] Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Fan, J (corresponding author), Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China.	fanjun@ahau.edu.cn			Chinese Ministry of Sicence and Technology [2009ZX08010-002B]	Chinese Ministry of Sicence and Technology	Funding: This work is partly supported by Project of Chinese Ministry of Sicence and Technology (Grant No. 2009ZX08010-002B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Fang J, 2013, PROTEIN EXPRES PURIF, V92, P29, DOI 10.1016/j.pep.2013.08.015; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hu SL, 2013, J BIOL CHEM, V288, P30855, DOI 10.1074/jbc.M113.467977; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kapust RB, 2002, PROTEIN EXPRES PURIF, V24, P61, DOI 10.1006/prep.2001.1545; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Martinez-Alonso M, 2008, BIOTECHNOL BIOENG, V101, P1353, DOI 10.1002/bit.21996; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Teerawanichpan P, 2007, BBA-GEN SUBJECTS, V1770, P1360, DOI 10.1016/j.bbagen.2007.06.005; Verhoeven KD, 2012, APPL BIOCHEM BIOTECH, V166, P1340, DOI 10.1007/s12010-011-9522-6; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wei LL, 2012, PROTEIN EXPRES PURIF, V83, P157, DOI 10.1016/j.pep.2012.03.011; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zerbs S, 2009, METHOD ENZYMOL, V463, P149, DOI 10.1016/S0076-6879(09)63012-3	24	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112254	10.1371/journal.pone.0112254	http://dx.doi.org/10.1371/journal.pone.0112254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426854	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400012
J	Park, JY; Duong, CT; Sharma, AR; Son, KM; Thompson, MS; Park, S; Chang, JD; Nam, JS; Park, S; Lee, SS				Park, Jae-Yong; Cong-Truyen Duong; Sharma, Ashish Ranjan; Son, Kyeong-Min; Thompson, Mark S.; Park, Sungchan; Chang, Jun-Dong; Nam, Ju-Suk; Park, Seonghun; Lee, Sang-Soo			Effects of Hyaluronic Acid and gamma-Globulin Concentrations on the Frictional Response of Human Osteoarthritic Articular Cartilage	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INNOVATIVE CHONDROPLASTY MATERIALS; INTERSTITIAL FLUID PRESSURIZATION; SYNOVIAL-FLUID; MOLECULAR-WEIGHT; LUBRICATING ABILITY; BOUNDARY LUBRICATION; PROTEOGLYCAN 4; JOINTS; WEAR	Synovial fluid plays an important role in lubricating synovial joints. Its main constituents are hyaluronic acid (HA) and gamma-globulin, acting as boundary lubricants for articular cartilage. The aim of the study was to demonstrate the concentration-dependent effect of HA and gamma-globulin on the boundary-lubricating ability of human osteoarthritis (OA) cartilage. Normal, early and advance stage articular cartilage samples were obtained from human femoral heads and in presence of either HA or gamma-globulin, cartilage frictional coefficient (mu) was measured by atomic force microscopy (AFM). In advanced stage OA, the cartilage superficial layer was observed to be completely removed and the damaged cartilage surface showed a higher m value (similar to 0.409) than the normal cartilage surface (similar to 0.119) in PBS. Adsorbed HA and gamma-globulin molecules significantly improved the frictional behavior of advanced OA cartilage, while they were ineffective for normal and early OA cartilage. In advanced-stage OA, the concentration-dependent frictional response of articular cartilage was observed with gamma-globulin, but not with HA. Our result suggested that HA and gamma-globulin may play a significant role in improving frictional behavior of advanced OA cartilage. During early-stage OA, though HA and gamma-globulin had no effect on improving frictional behavior of cartilage, however, they might contribute to disease modifying effects of synovial fluid as observed in clinical settings.	[Park, Jae-Yong; Sharma, Ashish Ranjan; Son, Kyeong-Min; Chang, Jun-Dong; Nam, Ju-Suk; Park, Seonghun; Lee, Sang-Soo] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chunchon, South Korea; [Cong-Truyen Duong; Park, Seonghun] Pusan Natl Univ, Sch Mech Engn, Pusan, South Korea; [Cong-Truyen Duong] Ind Univ Ho Chi Minh City, Dept Mech Engn, Ho Chi Minh, Vietnam; [Thompson, Mark S.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Park, Sungchan] Univ Ulsan, Coll Med, Dept Urol, Ulsan 680749, South Korea	Hallym University; Pusan National University; Industrial University of Ho Chi Minh City; University of Oxford; University of Ulsan	Park, S (corresponding author), Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chunchon, South Korea.	paks@pusan.ac.kr; totalhip@hallym.ac.kr	Sharma, Ashish Ranjan/W-4816-2019; Thompson, Mark/B-9261-2009	Sharma, Ashish Ranjan/0000-0003-3973-6755; Thompson, Mark/0000-0001-8958-0336	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2062436, NRF-2014R1A1A4A03009388]; Leading Foreign Research Institute Recruitment Program through NRF - Ministry of Science, ICT & Future Planning [2009-00495]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Leading Foreign Research Institute Recruitment Program through NRF - Ministry of Science, ICT & Future Planning	Funding: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, (NRF-2013R1A1A2062436 & NRF-2014R1A1A4A03009388) and by Leading Foreign Research Institute Recruitment Program through the NRF grant funded by the Ministry of Science, ICT & Future Planning (No. 2009-00495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacci JM, 2012, ARTHRITIS RHEUM-US, V64, P2917, DOI 10.1002/art.34520; Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060; Berenbaum F, 2012, ANN RHEUM DIS, V71, P1454, DOI 10.1136/annrheumdis-2011-200972; BUTT HJ, 1993, J MICROSC-OXFORD, V169, P75, DOI 10.1111/j.1365-2818.1993.tb03280.x; Caligaris M, 2009, OSTEOARTHR CARTILAGE, V17, P1327, DOI 10.1016/j.joca.2009.03.020; Cameron ML, 2003, AM J SPORT MED, V31, P83, DOI 10.1177/03635465030310012601; Chan SMT, 2010, OSTEOARTHR CARTILAGE, V18, P956, DOI 10.1016/j.joca.2010.03.012; CHAPPUIS J, 1983, ANN BIOMED ENG, V11, P435, DOI 10.1007/BF02584218; Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013; Duong CT, 2010, P I MECH ENG H, V224, P541, DOI 10.1243/09544119JEIM709; Forsey RW, 2006, BIOMATERIALS, V27, P4581, DOI 10.1016/j.biomaterials.2006.04.018; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Higaki H, 1998, P I MECH ENG H, V212, P337, DOI 10.1243/0954411981534114; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Katta J, 2008, MED ENG PHYS, V30, P1349, DOI 10.1016/j.medengphy.2008.09.004; Kawano T, 2003, ARTHRITIS RHEUM-US, V48, P1923, DOI 10.1002/art.11172; Krishnan R, 2004, OSTEOARTHR CARTILAGE, V12, P947, DOI 10.1016/j.joca.2004.08.009; Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019; Lee SS, 2012, P I MECH H IN PRESS; Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Mabuchi K, 1999, CLIN BIOMECH, V14, P352, DOI 10.1016/S0268-0033(98)00084-9; MACKIEWICZ S, 1961, ANN RHEUM DIS, V20, P265, DOI 10.1136/ard.20.3.265; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; McPherson RA., 2006, HENRYS CLIN DIAGNOSI; Mori S, 2002, INT ORTHOP, V26, P116, DOI 10.1007/s00264-002-0330-z; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Murakami T, 2011, P I MECH ENG J-J ENG, V225, P1174, DOI 10.1177/1350650111415756; Nagaoka I, 2012, ADV FOOD NUTR RES, V65, P337, DOI 10.1016/B978-0-12-416003-3.00022-6; Nakashima K, 2007, TRIBOL INT, V40, P1423, DOI 10.1016/j.triboint.2007.02.010; Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178; Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008; Outerbridge RE, 2001, CLIN ORTHOP RELAT R, P5; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Pickard J, 1998, P I MECH ENG H, V212, P177, DOI 10.1243/0954411981533953; ROBERTS BJ, 1982, ANN RHEUM DIS, V41, P217, DOI 10.1136/ard.41.3.217; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; STACHOWIAK GW, 1994, WEAR, V171, P135, DOI 10.1016/0043-1648(94)90356-5; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Vincent Heather K, 2013, Open Orthop J, V7, P378, DOI 10.2174/1874325001307010378; Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012	44	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112684	10.1371/journal.pone.0112684	http://dx.doi.org/10.1371/journal.pone.0112684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426992	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400022
J	Li, L; Yin, QH; Tang, X; Bai, L; Zhang, J; Gou, SJ; Zhu, HP; Cheng, JQ; Fu, P; Liu, F				Li, Ling; Yin, Qinghua; Tang, Xi; Bai, Lin; Zhang, Jie; Gou, Shenju; Zhu, Hongping; Cheng, Jingqiu; Fu, Ping; Liu, Fang			C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-beta/smad3 and IKB alpha Pathway	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; RENAL FIBROSIS; COMPLEMENT; INJURY; C5A; PATHOGENESIS; MECHANISMS; INHIBITOR; DISEASE; STRESS	Objective: Diabetic nephropathy (DN) is a serious complication for patients with diabetes mellitus (DM). Emerging evidence suggests that complement C3a is involved in the progression of DN. The aim of this study was to investigate the effect of C3a Receptor Agonist (C3aRA) on DN and its potential mechanism of action in rats with type 2 diabetes mellitus (T2DM). Methods: T2DM was induced in SD rats by a high fat diet (HFD) plus repeated low dose streptozocin (STZ) injections. T2DM rats were treated with vehicle or C3aRA for 8 weeks. Biochemical analysis, HE and PAS stains were performed to evaluate the renal function and pathological changes. Human renal glomerular endothelial cells (HRGECs) were cultured and treated with normal glucose (NG), high glucose (HG), HG+ C3a, HG+ C3a+ C3aRA and HG+ C3a+ BAY-11-7082 (p-IKBa Inhibitor) or SIS3 (Smad3 Inhibitor), respectively. Real-time PCR, immunofluorescent staining and western blot were performed to detect the mRNA and protein levels, respectively. Results: T2DM rats showed worse renal morphology and impaired renal function compared with control rats, including elevated levels of serum creatinine (CREA), blood urea nitrogen (BUN) and urine albumin excretion (UACR), as well as increased levels of C3a, C3aR, IL-6, p-IKB alpha, collagen I, TGF-beta and p-Smad3 in the kidney of T2DM rats and C3 alpha-treated HRGECs. In contrast, C3aRA treatment p-IKB alpha, IL-6, TGF-beta, p-Smad3 and collagen I expressions in HRGECs and T2DM rats. Conclusion: C3a mediated pro-inflammatory and pro-fibrotic responses and aggravated renal injury in T2DM rats. C3aRA ameliorated T2DN by inhibiting IKBa phosphorylation and cytokine release, and also TGF-beta/Smad3 signaling and ECM deposition. Therefore, complement C3a receptor is a potential therapeutic target for DN.	[Li, Ling; Yin, Qinghua; Tang, Xi; Gou, Shenju; Zhu, Hongping; Fu, Ping; Liu, Fang] Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610064, Sichuan, Peoples R China; [Bai, Lin; Zhang, Jie; Cheng, Jingqiu] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Key Lab Transplant Engn & Immunol,Minist Hlth, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Fu, P (corresponding author), Sichuan Univ, West China Hosp, Div Nephrol, Chengdu 610064, Sichuan, Peoples R China.	fupinghx@163.com; liufangfh@163.com			Technology Research Infrastructure Projects of Sichuan Province [2013JCPT001]	Technology Research Infrastructure Projects of Sichuan Province	This work was supported by Technology Research Infrastructure Projects of Sichuan Province (No. 2013JCPT001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bao LH, 2005, J IMMUNOL, V175, P1947, DOI 10.4049/jimmunol.175.3.1947; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Brown KM, 2007, NAT CLIN PRACT NEPHR, V3, P277, DOI 10.1038/ncpneph0465; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Hansen TK, 2010, DIABETOLOGIA, V53, P1517, DOI 10.1007/s00125-010-1742-8; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Liu F, 2011, CHINESE MED J-PEKING, V124, P4039, DOI 10.3760/cma.j.issn.0366-6999.2011.23.036; Liu JP, 2013, MOL BIOSYST, V9, P2645, DOI 10.1039/c3mb70212j; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Locatelli M, 2014, J AM SOC NEPHROL, V25, P1786, DOI 10.1681/ASN.2013050450; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; Peake PW, 1999, KIDNEY INT, V56, P1729, DOI 10.1046/j.1523-1755.1999.00722.x; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434	31	50	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113639	10.1371/journal.pone.0113639	http://dx.doi.org/10.1371/journal.pone.0113639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422985	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700045
J	Alqudah, AM; Sharma, R; Pasam, RK; Graner, A; Kilian, B; Schnurbusch, T				Alqudah, Ahmad M.; Sharma, Rajiv; Pasam, Raj K.; Graner, Andreas; Kilian, Benjamin; Schnurbusch, Thorsten			Genetic Dissection of Photoperiod Response Based on GWAS of Pre-Anthesis Phase Duration in Spring Barley	PLOS ONE			English	Article							FLOWERING-LOCUS-T; HORDEUM-VULGARE; GROWTH HABIT; POPULATION-STRUCTURE; FLORAL MERISTEM; TIME; ARABIDOPSIS; VERNALIZATION; ADAPTATION; HOMOLOG	Heading time is a complex trait, and natural variation in photoperiod responses is a major factor controlling time to heading, adaptation and grain yield. In barley, previous heading time studies have been mainly conducted under field conditions to measure total days to heading. We followed a novel approach and studied the natural variation of time to heading in a world-wide spring barley collection (218 accessions), comprising of 95 photoperiod-sensitive (Ppd-H1) and 123 accessions with reduced photoperiod sensitivity (ppd-H1) to long-day (LD) through dissecting pre-anthesis development into four major stages and sub-phases. The study was conducted under greenhouse (GH) conditions (LD; 16/8 h;,20/similar to 16 degrees C day/night). Genotyping was performed using a genome-wide high density 9K single nucleotide polymorphisms (SNPs) chip which assayed 7842 SNPs. We used the barley physical map to identify candidate genes underlying genome-wide association scans (GWAS). GWAS for pre-anthesis stages/sub-phases in each photoperiod group provided great power for partitioning genetic effects on floral initiation and heading time. In addition to major genes known to regulate heading time under field conditions, several novel QTL with medium to high effects, including new QTL having major effects on developmental stages/sub-phases were found to be associated in this study. For example, highly associated SNPs tagged the physical regions around HvCO1 (barley CONSTANS1) and BFL (BARLEY FLORICAULA/LEAFY) genes. Based upon our GWAS analysis, we propose a new genetic network model for each photoperiod group, which includes several newly identified genes, such as several HvCO-like genes, belonging to different heading time pathways in barley.	[Alqudah, Ahmad M.; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Plant Architecture, OT Gatersleben, D-06466 Stadt Seeland, Germany; [Sharma, Rajiv; Pasam, Raj K.; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Genome Divers, OT Gatersleben, Genebank Dept, D-06466 Stadt Seeland, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schnurbusch, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Res Grp Plant Architecture, OT Gatersleben, Corrensstr 3, D-06466 Stadt Seeland, Germany.	thor@ipk-gatersleben.de	Schnurbusch, Thorsten/B-2249-2009; Sharma, Rajiv/W-9683-2019; Alqudah, Ahmad M./I-7062-2012	Schnurbusch, Thorsten/0000-0002-5267-0677; Sharma, Rajiv/0000-0003-3488-8688; Alqudah, Ahmad M./0000-0002-0436-9724; Kilian, Benjamin/0000-0002-9145-6980; Pasam, Raj/0000-0003-0908-1882; Graner, Andreas/0000-0003-3246-6393	DFG (Deutsche Forschungsgemeinschaft) [SCHN 768/4-1]; BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program [0315071]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program	This work was financially supported from DFG (Deutsche Forschungsgemeinschaft) grant number SCHN 768/4-1, and BMBF (German Federal Ministry of Education and Research) GABI-FUTURE Start Program grant number 0315071 to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029456; Alqudah AM, 2014, FUNCT PLANT BIOL, V41, P424, DOI 10.1071/FP13248; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Bonnett OT, 1935, J AGRIC RES, V51, P0451; Borras G, 2009, FIELD CROP RES, V113, P95, DOI 10.1016/j.fcr.2009.03.012; Borras-Gelonch G, 2012, EUPHYTICA, V183, P303, DOI 10.1007/s10681-011-0526-7; Borras-Gelonch G, 2010, FIELD CROP RES, V119, P36, DOI 10.1016/j.fcr.2010.06.013; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Casao MC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-164; Casao MC, 2011, J EXP BOT, V62, P1939, DOI 10.1093/jxb/erq382; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; GenStat, 2014, GENSTAT WINDOWS; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Oliver SN, 2013, J EXP BOT, V64, P2413, DOI 10.1093/jxb/ert095; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pasam RK, 2012, DEV STRATIFIED BARLE; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; SAS, 2013, STAT AN SOFTW SAS WI; Sreenivasulu N, 2012, TRENDS PLANT SCI, V17, P91, DOI 10.1016/j.tplants.2011.11.003; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stracke S, 1998, THEOR APPL GENET, V97, P797, DOI 10.1007/s001220050958; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Tondelli A, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0007; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waugh R, 2009, CURR OPIN PLANT BIOL, V12, P218, DOI 10.1016/j.pbi.2008.12.007; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	48	80	85	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113120	10.1371/journal.pone.0113120	http://dx.doi.org/10.1371/journal.pone.0113120			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420105	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900020
J	Risteli, M; Ruotsalainen, H; Bergmann, U; Girija, UV; Wallis, R; Myllyla, R				Risteli, Maija; Ruotsalainen, Heli; Bergmann, Ulrich; Girija, Umakhanth Venkatraman; Wallis, Russell; Myllyla, Raili			Lysyl Hydroxylase 3 Modifies Lysine Residues to Facilitate Oligomerization of Mannan-Binding Lectin	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; EXTRACELLULAR-SPACE; COLLAGEN; PROTEIN; COMPLEMENT; MUTATIONS; GLYCOSYLATION; SECRETION; INSIGHTS; LH3	Lysyl hydroxylase 3 (LH3) is a multifunctional protein with lysyl hydroxylase, galactosyltransferase and glucosyltransferase activities. The LH3 has been shown to modify the lysine residues both in collagens and also in some collagenous proteins. In this study we show for the first time that LH3 is essential for catalyzing formation of the glucosylgalactosylhydroxylysines of mannan-binding lectin (MBL), the first component of the lectin pathway of complement activation. Furthermore, loss of the terminal glucose units on the derivatized lysine residues in mouse embryonic fibroblasts lacking the LH3 protein leads to defective disulphide bonding and oligomerization of rat MBL-A, with a decrease in the proportion of the larger functional MBL oligomers. The oligomerization could be completely restored with the full length LH3 or the amino-terminal fragment of LH3 that possesses the glycosyltransferase activities. Our results confirm that LH3 is the only enzyme capable of glucosylating the galactosylhydroxylysine residues in proteins with a collagenous domain. In mice lacking the lysyl hydroxylase activity of LH3, but with untouched galactosyltransferase and glucosyltransferase activities, reduced circulating MBL-A levels were observed. Oligomerization was normal, however and residual lysyl hydroxylation was compensated in part by other lysyl hydroxylase isoenzymes. Our data suggest that LH3 is commonly involved in biosynthesis of collagenous proteins and the glucosylation of galactosylhydroxylysines residues by LH3 is crucial for the formation of the functional high-molecular weight MBL oligomers.	[Risteli, Maija; Ruotsalainen, Heli; Bergmann, Ulrich; Myllyla, Raili] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Risteli, Maija] Univ Oulu, Dept Diagnost & Oral Med, Inst Dent, Oulu, Finland; [Risteli, Maija] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Risteli, Maija] Univ Oulu, Oulu, Finland; [Ruotsalainen, Heli] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Bergmann, Ulrich] Univ Oulu, Bioctr Oulu, Mass Spectrometry Core Facil, Oulu, Finland; [Girija, Umakhanth Venkatraman; Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Wallis, Russell] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Leicester; University of Leicester	Risteli, M (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	maija.risteli@gmail.com		Ruotsalainen, Heli/0000-0003-4923-5196; Wallis, Russell/0000-0002-8705-5295; VENKATRAMAN GIRIJA, UMAKHANTH/0000-0002-0761-5994	Academy of Finland [121700, 137659]; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Academy of Finland (grants 121700 and 137659 to MR and HR) http://www.aka.fi/en-GB/A/) and the Finnish Cultural Foundation (http://www.skr.fi/en121700) (HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Endo Y, 2006, IMMUNOBIOLOGY, V211, P283, DOI 10.1016/j.imbio.2006.01.003; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jensen PH, 2005, J BIOL CHEM, V280, P11043, DOI 10.1074/jbc.M412472200; Jensen PH, 2007, BBA-PROTEINS PROTEOM, V1774, P335, DOI 10.1016/j.bbapap.2006.12.008; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050045; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]; Tang YT, 2005, GENOMICS, V86, P100, DOI 10.1016/j.ygeno.2005.03.001; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113498	10.1371/journal.pone.0113498	http://dx.doi.org/10.1371/journal.pone.0113498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419660	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900043
J	Zhou, H; Qu, Z; Mossine, VV; Nknolise, DL; Li, JL; Chen, ZZ; Cheng, JL; Greenlief, CM; Mawhinney, TP; Brown, PN; Fritsche, KL; Hannink, M; Lubahn, DB; Sun, GY; Gu, ZZ				Zhou, Hui; Qu, Zhe; Mossine, Valeri V.; Nknolise, Dineo L.; Li, Jilong; Chen, Zhenzhou; Cheng, Jianlin; Greenlief, C. Michael; Mawhinney, Thomas P.; Brown, Paula N.; Fritsche, Kevin L.; Hannink, Mark; Lubahn, Dennis B.; Sun, Grace Y.; Gu, Zezong			Proteomic Analysis of the Effects of Aged Garlic Extract and Its FruArg Component on Lipopolysaccharide-Induced Neuroinflammatory Response in Microglial Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; ANTIOXIDANT PROPERTIES; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; S-ALLYLCYSTEINE; IN-VITRO; INFLAMMATION	Aged garlic extract (AGE) is widely used as a dietary supplement, and is claimed to promote human health through anti-oxidant/anti-inflammatory activities with hypolipidemic, antiplatelet and neuroprotective effects. Prior studies of AGE have mainly focused on its organosulfur compounds, with little attention paid to its carbohydrate derivatives, such as N-alpha-(1-deoxy-D-fructos-1-yl)-L-arginine (FruArg). The goal of this study is to investigate actions of AGE and FruArg on antioxidative and neuroinflammatory responses in lipopolysaccharide (LPS)-activated murine BV-2 microglial cells using a proteomic approach. Our data show that both AGE and FruArg can significantly inhibit LPS-induced nitric oxide (NO) production in BV-2 cells. Quantitative proteomic analysis by combining two dimensional differential in-gel electrophoresis (2D-DIGE) with mass spectrometry revealed that expressions of 26 proteins were significantly altered upon LPS exposure, while levels of 20 and 21 proteins exhibited significant changes in response to AGE and FruArg treatments, respectively, in LPS-stimulated BV-2 cells. Notably, approximate78% of the proteins responding to AGE and FruArg treatments are in common, suggesting that FruArg is a major active component of AGE. MULTICOM-PDCN and Ingenuity Pathway Analyses indicate that the proteins differentially affected by treatment with AGE and FruArg are involved in inflammatory responses and the Nrf2-mediated oxidative stress response. Collectively, these results suggest that AGE and FruArg attenuate neuroinflammatory responses and promote resilience in LPS-activated BV-2 cells by suppressing NO production and by regulating expression of multiple protein targets associated with oxidative stress.	[Zhou, Hui; Qu, Zhe; Nknolise, Dineo L.; Chen, Zhenzhou; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Mossine, Valeri V.; Mawhinney, Thomas P.; Hannink, Mark; Lubahn, Dennis B.; Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Zhou, Hui; Qu, Zhe; Nknolise, Dineo L.; Chen, Zhenzhou; Sun, Grace Y.; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Inst Informat, Columbia, MO USA; [Greenlief, C. Michael] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Fritsche, Kevin L.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Gu, Zezong] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Brown, Paula N.] British Columbia Inst Technol, Vancouver, BC, Canada	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; British Columbia Institute of Technology	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@health.missouri.edu	Cheng, Jianlin/N-8209-2013	Cheng, Jianlin/0000-0003-0305-2853; Mawhinney, Thomas/0000-0002-1807-2550	National Institute of Environmental Health Sciences Centers for Neurodegeneration Science [P01 1P01ES016738]; University of Missouri Department of Pathology and Anatomical Sciences; University of Missouri South African Education Program; National Center for Complementary and Alternative Medicines (NCCAM) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences Centers for Neurodegeneration Science; University of Missouri Department of Pathology and Anatomical Sciences; University of Missouri South African Education Program; National Center for Complementary and Alternative Medicines (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by funding from the National Institute of Environmental Health Sciences Centers for Neurodegeneration Science P01 1P01ES016738 Missouri Consortium and the University of Missouri Department of Pathology and Anatomical Sciences (to ZG), and the University of Missouri South African Education Program (to DLN). This project was made possible by Grant Number P50AT006273 from the National Center for Complementary and Alternative Medicines (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2006, J NUTR, V136, p716S, DOI 10.1093/jn/136.3.716S; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; DENISEVITCH TV, 1995, EXP ONCOL, V17, P111; Dillon SA, 2002, J NUTR, V132, P168, DOI 10.1093/jn/132.2.168; Dillon SA, 2003, LIFE SCI, V72, P1583, DOI 10.1016/S0024-3205(02)02475-X; Gao FF, 2012, LWT-FOOD SCI TECHNOL, V49, P34, DOI 10.1016/j.lwt.2012.04.022; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Geng ZH, 1997, FREE RADICAL BIO MED, V23, P345, DOI 10.1016/S0891-5849(97)00006-3; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Gu Z, 2005, CELL DEATH DIFFER, V12, P1202, DOI 10.1038/sj.cdd.4401705; Gu ZZ, 2010, MOL NEUROBIOL, V41, P55, DOI 10.1007/s12035-010-8113-9; Guijarro-Munoz I, 2014, J BIOL CHEM, V289, P2457, DOI 10.1074/jbc.M113.521161; Ide N, 1999, J NUTR BIOCHEM, V10, P372, DOI 10.1016/S0955-2863(99)00021-2; Ide N, 2001, J NUTR, V131, p1020S, DOI 10.1093/jn/131.3.1020S; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Jung JS, 2013, BBA-MOL CELL BIOL L, V1831, P1016, DOI 10.1016/j.bbalip.2013.01.020; Kalayarasan S, 2008, J APPL TOXICOL, V28, P908, DOI 10.1002/jat.1355; Kaneko YS, 2012, NEURODEGENER DIS, V10, P100, DOI 10.1159/000332936; Kannappan R, 2011, MOL NEUROBIOL, V44, P142, DOI 10.1007/s12035-011-8168-2; Karp NA, 2008, PROTEOMICS, V8, P948, DOI 10.1002/pmic.200700812; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; Lawal AO, 2011, ENVIRON TOXICOL PHAR, V32, P266, DOI 10.1016/j.etap.2011.05.012; Lawson LD, 2005, J AGR FOOD CHEM, V53, P6254, DOI 10.1021/jf050536+; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; LOWY PH, 1956, J AM CHEM SOC, V78, P3175, DOI 10.1021/ja01594a054; Maldonado PD, 2011, J PHYS CHEM B, V115, P13408, DOI 10.1021/jp208233f; Matsutomo T, 2013, J AGR FOOD CHEM, V61, P3059, DOI 10.1021/jf305549g; Matsuura Y., 1994, J TRAD MED, V18, P204; Morihara N, 2006, J NUTR, V136, p777S, DOI 10.1093/jn/136.3.777S; Morihara N, 2002, LIFE SCI, V71, P509, DOI 10.1016/S0024-3205(02)01706-X; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Mossine VV, 2010, MAILLARD REACTION: INTERFACE BETWEEN AGING, NUTRITION AND METABOLISM, P170; Mossine VV, 2008, CANCER RES, V68, P4384, DOI 10.1158/0008-5472.CAN-08-0108; Mossine VV, 2007, J AGR FOOD CHEM, V55, P10373, DOI 10.1021/jf072092i; Mossine VV, 2010, ADV CARBOHYD CHEM BI, V64, P291, DOI 10.1016/S0065-2318(10)64006-1; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park HJ, 2012, ACTA PHYSIOL, V205, P61, DOI 10.1111/j.1748-1716.2012.02425.x; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Ryu K, 2003, ACS SYM SER, V859, P258; Ryu K, 2001, J NUTR, V131, p972S, DOI 10.1093/jn/131.3.972S; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sethy NK, 2011, FUNCT INTEGR GENOMIC, V11, P119, DOI 10.1007/s10142-010-0195-y; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sumi S, 2001, J NUTR, V131, p1096S, DOI 10.1093/jn/131.3.1096S; Tamawski M, 2007, INT IMMUNOPHARMACOL, V7, P1577, DOI 10.1016/j.intimp.2007.08.004; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x	57	14	15	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113531	10.1371/journal.pone.0113531	http://dx.doi.org/10.1371/journal.pone.0113531			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420111	gold, Green Submitted, Green Published			2022-12-27	WOS:000346766900048
J	Darby, JF; Krysztofinska, EM; Simpson, PJ; Simon, AC; Leznicki, P; Sriskandarajah, N; Bishop, DS; Hale, LR; Alfano, C; Conte, MR; Martinez-Lumbreras, S; Thapaliya, A; High, S; Isaacson, RL				Darby, John F.; Krysztofinska, Ewelina M.; Simpson, Peter J.; Simon, Aline C.; Leznicki, Pawel; Sriskandarajah, Newran; Bishop, David S.; Hale, Lisa R.; Alfano, Caterina; Conte, Maria R.; Martinez-Lumbreras, Santiago; Thapaliya, Arjun; High, Stephen; Isaacson, Rivka L.			Solution Structure of the SGTA Dimerisation Domain and Investigation of Its Interactions with the Ubiquitin-Like Domains of BAG6 and UBL4A	PLOS ONE			English	Article							ANCHORED MEMBRANE-PROTEINS; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MICROSCALE THERMOPHORESIS; CHAPERONE; COMPLEX; EXPRESSION; INSERTION; RETROTRANSLOCATION; PROLIFERATION	Background: The BAG6 complex resides in the cytosol and acts as a sorting point to target diverse hydrophobic protein substrates along their appropriate paths, including proteasomal degradation and ER membrane insertion. Composed of a trimeric complex of BAG6, TRC35 and UBL4A, the BAG6 complex is closely associated with SGTA, a co-chaperone from which it can obtain hydrophobic substrates. Methodology and Principal Findings: SGTA consists of an N-terminal dimerisation domain (SGTA_NT), a central tetratricopeptide repeat (TPR) domain, and a glutamine rich region towards the C-terminus. Here we solve a solution structure of the SGTA dimerisation domain and use biophysical techniques to investigate its interaction with two different UBL domains from the BAG6 complex. The SGTA_NTstructure is a dimer with a tight hydrophobic interface connecting two sets of four alpha helices. Using a combination of NMR chemical shift perturbation, isothermal titration calorimetry (ITC) and microscale thermophoresis (MST) experiments we have biochemically characterised the interactions of SGTA with components of the BAG6 complex, the ubiquitin-like domain (UBL) containing proteins UBL4A and BAG6. We demonstrate that the UBL domains from UBL4A and BAG6 directly compete for binding to SGTA at the same site. Using a combination of structural and interaction data we have implemented the HADDOCK protein-protein interaction docking tool to generate models of the SGTA-UBL complexes. Significance: This atomic level information contributes to our understanding of the way in which hydrophobic proteins have their fate decided by the collaboration between SGTA and the BAG6 complex.	[Darby, John F.; Krysztofinska, Ewelina M.; Alfano, Caterina; Martinez-Lumbreras, Santiago; Thapaliya, Arjun; Isaacson, Rivka L.] Kings Coll London, Dept Chem, London SE1 1DB, England; [Simpson, Peter J.; Simon, Aline C.; Sriskandarajah, Newran; Bishop, David S.; Hale, Lisa R.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Simpson, Peter J.] Bruker UK Ltd, Coventry CV4 9GH, W Midlands, England; [Leznicki, Pawel; High, Stephen] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Conte, Maria R.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London; Imperial College London; University of Manchester; University of London; King's College London	Isaacson, RL (corresponding author), Kings Coll London, Dept Chem, Britannia House,7 Trinity St, London SE1 1DB, England.	rivka.isaacson@imperial.ac.uk	Martínez Lumbreras, Santiago/AHA-6695-2022; Conte, Maria R/C-4102-2008; Conte, Maria/W-3088-2019	Conte, Maria R/0000-0001-8558-2051; Conte, Maria/0000-0001-8558-2051; Martinez-Lumbreras, Santiago/0000-0002-8617-0566; Thapaliya, Arjun/0000-0001-5267-0581; High, Stephen/0000-0002-4532-8152; Simpson, Pete/0000-0002-2679-9303; Darby, John/0000-0003-2754-6348; Alfano, Caterina/0000-0003-0374-5852; Leznicki, Pawel/0000-0002-2687-107X; Isaacson, Rivka Leah/0000-0002-9978-8904	MRC [G0900936]; MST machine by an MRC Centenary award; Wellcome Trust [092107/Z/10/Z]; BBSRC [BB/L006952/1, BB/J014567/1]; Wellcome Trust Joint Infrastructure Fund (JIF); E.P. Abraham Fund; BBSRC [BB/L006510/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L006952/1, BB/L006510/1, 1352054] Funding Source: researchfish; Medical Research Council [G0900936] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MST machine by an MRC Centenary award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Joint Infrastructure Fund (JIF); E.P. Abraham Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: RLI was supported by MRC New Investigator Research Grant: G0900936, and the MST machine was part-purchased by an MRC Centenary award to RLI. SH and PL were supported by Wellcome Trust project grant 092107/Z/10/Z. RLI, SH and SM-L are funded by BBSRC grant: BB/L006952/1. AT is funded by BBSRC grant: BB/J014567/1. ITC and some of the NMR experiments described in this paper were produced using the facilities of the Centre for Biomolecular Spectroscopy, King's College London, established with a Capital Award from the Wellcome Trust. The 950 MHz NMR facility at the University of Oxford was funded by the Wellcome Trust Joint Infrastructure Fund (JIF) and the E.P. Abraham Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MS, 2013, HORM CANCER-US, V4, P154, DOI 10.1007/s12672-013-0135-0; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gristick HB, 2014, NAT STRUCT MOL BIOL; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hands-Taylor KLD, 2010, NUCLEIC ACIDS RES, V38, P4052, DOI 10.1093/nar/gkq141; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Krenciute G, 2013, J BIOL CHEM, V288, P20547, DOI 10.1074/jbc.M112.443416; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Leznicki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059590; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Liou ST, 2005, ARCH BIOCHEM BIOPHYS, V435, P253, DOI 10.1016/j.abb.2004.12.020; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Lu CH, 2014, PATHOL ONCOL RES, V20, P51, DOI 10.1007/s12253-013-9657-6; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Simon AC, 2013, BIOMOL NMR ASSIGN, V7, P271, DOI 10.1007/s12104-012-9425-7; Simon AC, 2013, P NATL ACAD SCI USA, V110, P1327, DOI 10.1073/pnas.1207518110; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tung JY, 2013, ACTA CRYSTALLOGR D, V69, P2081, DOI 10.1107/S0907444913019379; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Xue Q, 2013, J CANCER RES CLIN, V139, P1539, DOI 10.1007/s00432-013-1474-5; Yang XJ, 2014, J CELL BIOCHEM, V115, P141, DOI 10.1002/jcb.24641	38	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							0113281	10.1371/journal.pone.0113281	http://dx.doi.org/10.1371/journal.pone.0113281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415308	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600039
J	Fernandes, VS; Ribeiro, ASF; Martinez, P; Lopez-Oliva, ME; Barahona, MV; Orensanz, LM; Martinez-Saenz, A; Recio, P; Benedito, S; Bustamante, S; Garcia-Sacristan, A; Prieto, D; Hernandez, M				Fernandes, Vitor S.; Ribeiro, Ana S. F.; Martinez, Pilar; Lopez-Oliva, Maria Elvira; Barahona, Maria Victoria; Orensanz, Luis M.; Martinez-Saenz, Ana; Recio, Paz; Benedito, Sara; Bustamante, Salvador; Garcia-Sacristan, Albino; Prieto, Dolores; Hernandez, Medardo			Hydrogen Sulfide Plays a Key Role in the Inhibitory Neurotransmission to the Pig Intravesical Ureter	PLOS ONE			English	Article							URINARY-BLADDER NECK; K-ATP CHANNELS; NITRERGIC NEUROTRANSMISSION; EQUINE URETER; NITRIC-OXIDE; H2S; MUSCLE; BIOLOGY; VASORELAXANT; INNERVATION	According to previous observations nitric oxide (NO), as well as an unknown nature mediator are involved in the inhibitory neurotransmission to the intravesical ureter. This study investigates the hydrogen sulfide (H2S) role in the neurogenic relaxation of the pig intravesical ureter. We have performed western blot and immunohistochemistry to study the expression of the H2S synthesis enzymes cystathionine gamma-lyase (CSE) and cystathionine beta-synthase (CBS), measurement of enzymatic production of H2S and myographic studies for isometric force recording. Immunohistochemical assays showed a high CSE expression in the intravesical ureter muscular layer, as well as a strong CSE-immunoreactivity within nerve fibres distributed along smooth muscle bundles. CBS expression, however, was not consistently observed. On ureteral strips precontracted with thromboxane A(2) analogue U46619, electrical field stimulation (EFS) and the H2S donor P-(4-methoxyphenyl)-P-4-morpholinylphosphinodithioic acid (GYY4137) evoked frequency-and concentration-dependent relaxations. CSE inhibition with DL-propargylglycine (PPG) reduced EFS-elicited responses and a combined blockade of both CSE and NO synthase (NOS) with, respectively, PPG and N-G-nitro-L-arginine (L-NOARG), greatly reduced such relaxations. Endogenous H2S production rate was reduced by PPG, rescued by addition of GYY4137 and was not changed by L-NOARG. EFS and GYY4137 relaxations were also reduced by capsaicin-sensitive primary afferents (CSPA) desensitization with capsaicin and blockade of ATP-dependent K+ (K-ATP) channels, transient receptor potential A1 (TRPA(1)), transient receptor potential vanilloid 1 (TRPV1), vasoactive intestinal peptide/pituitary adenylyl cyclase-activating polypeptide (VIP/PACAP) and calcitonin gene-related peptide (CGRP) receptors with glibenclamide, HC030031, AMG9810, PACAP(6-38) and CGRP(8-37), respectively. These results suggest that H2S, synthesized by CSE, is involved in the inhibitory neurotransmission to the pig intravesical ureter, through an NO-independent pathway, producing smooth muscle relaxation via K-ATP channel activation. H2S also promotes the release of inhibitory neuropeptides, as PACAP 38 and/or CGRP from CSPA through TRPA(1), TRPV1 and related ion channel activation.	[Fernandes, Vitor S.; Ribeiro, Ana S. F.; Lopez-Oliva, Maria Elvira; Martinez-Saenz, Ana; Recio, Paz; Benedito, Sara; Garcia-Sacristan, Albino; Prieto, Dolores; Hernandez, Medardo] Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain; [Martinez, Pilar] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, Madrid, Spain; [Barahona, Maria Victoria] Univ Complutense Madrid, Fac Vet, Dept Toxicol & Farmacol, Madrid, Spain; [Orensanz, Luis M.] Hosp Univ Ramon y Cajal, Dept Invest, Madrid, Spain; [Bustamante, Salvador] Hosp Univ Puerta Hierro Majadahonda, Dept Urol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda	Hernandez, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, Madrid, Spain.	medardo@ucm.es	BENEDITO, SARA/H-9730-2015; Ribeiro, Ana Sofia F/F-3428-2013; Pilar Martinez, P Martinez/E-8591-2016; López-Oliva, Elvira ELO/L-1660-2014; PRIETO, DOLORES/S-8172-2018; Fernandes, Vitor Samuel/F-3437-2013	BENEDITO, SARA/0000-0001-9660-2409; Ribeiro, Ana Sofia F/0000-0003-3913-7859; Pilar Martinez, P Martinez/0000-0001-9063-3191; López-Oliva, Elvira ELO/0000-0002-0615-9149; PRIETO, DOLORES/0000-0001-7049-5991; Fernandes, Vitor Samuel/0000-0001-6060-9035	Ministerio de Ciencia e Innovacion [PS09/00044]; Universidad Complutense de Madrid (Santander-UCM) [PR6/13-18858]; Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Complutense de Madrid (Santander-UCM); Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain	This work was supported by grants no. PS09/00044 from the Ministerio de Ciencia e Innovacion and PR6/13-18858 from the Universidad Complutense de Madrid (Santander-UCM) and by the Fundacion para la Investigacion en Urologia from the Asociacion Espanola de Urologia, Spain. Vitor S. Fernandes is a research fellow (SFRH/BD/68460/2010) of Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, NEUROUROL URODYNAM, V29, P97, DOI 10.1002/nau.20784; Bhatia M, 2005, IUBMB LIFE, V57, P603, DOI 10.1080/15216540500217875; BLOK C, 1985, J UROLOGY, V134, P175, DOI 10.1016/S0022-5347(17)47051-0; Bustamante S, 2000, J UROLOGY, V164, P1371, DOI 10.1016/S0022-5347(05)67201-1; de Jongh R, 2007, BJU INT, V100, P419, DOI 10.1111/j.1464-410X.2007.07011.x; Di Benedetto A, 2013, NEUROUROL URODYNAM, V32, P349, DOI 10.1002/nau.22310; EDYVANE KA, 1992, J AUTONOM NERV SYST, V39, P127, DOI 10.1016/0165-1838(92)90053-J; Fernandes VS, 2013, J UROLOGY, V190, P746, DOI 10.1016/j.juro.2013.02.103; Fernandes VS, 2013, J UROLOGY, V189, P1567, DOI 10.1016/j.juro.2012.10.006; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hernandez M, 2008, BRIT J PHARMACOL, V153, P1251, DOI 10.1038/sj.bjp.0707669; Hernandez M, 1997, BRIT J PHARMACOL, V120, P609, DOI 10.1038/sj.bjp.0700952; HERNANDEZ M, 1995, NEUROSCI LETT, V186, P33, DOI 10.1016/0304-3940(94)11275-N; HERNANDEZ M, 1992, BRIT J PHARMACOL, V107, P924, DOI 10.1111/j.1476-5381.1992.tb13387.x; Hernandez M, 2004, BRIT J PHARMACOL, V141, P123, DOI 10.1038/sj.bjp.0705582; Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li Q, 2013, NITRIC OXIDE-BIOL CH, V35, P21, DOI 10.1016/j.niox.2013.07.001; Lowicka E, 2007, PHARMACOL REP, V59, P4; Martinez-Saenz A, 2011, NEUROUROL URODYNAM, V30, P151, DOI 10.1002/nau.20960; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P984, DOI 10.1038/bjp.2008.326; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Patacchini R, 2005, EUR J PHARMACOL, V509, P171, DOI 10.1016/j.ejphar.2005.01.005; Patacchini R, 2004, BRIT J PHARMACOL, V142, P31, DOI 10.1038/sj.bjp.0705764; Porpiglia F, 2000, UROLOGY, V56, P579, DOI 10.1016/S0090-4295(00)00732-9; PRIETO D, 1993, RES VET SCI, V54, P312, DOI 10.1016/0034-5288(93)90128-3; PRIETO D, 1994, J AUTONOM NERV SYST, V47, P159, DOI 10.1016/0165-1838(94)90177-5; Santicioli P, 1998, PHARMACOL REV, V50, P683; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113580	10.1371/journal.pone.0113580	http://dx.doi.org/10.1371/journal.pone.0113580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415381	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600060
J	Kang, J; Chung, WY; Kang, SW; Kwon, HJ; Yoo, J; Kim, EK; Chang, JH; Song, TK; Lee, S; Kwak, JY				Kang, Jeeun; Chung, Woong Youn; Kang, Sang-Wook; Kwon, Hyeong Ju; Yoo, Jaeheung; Kim, Eun-Kyung; Chang, Jin Ho; Song, Tai-Kyong; Lee, Sohee; Kwak, Jin Young			Ex Vivo Estimation of Photoacoustic Imaging for Detecting Thyroid Microcalcifications	PLOS ONE			English	Article							NODULES; US; FEATURES; CANCER; SYSTEM; PERFORMANCE; MANAGEMENT	Background: The aim of this study was to evaluate the diagnostic utility of PAI at detecting thyroid microcalcifications at 700 nm laser wavelengths. Methods: This study included 36 resected samples in 18 patients. To evaluate the PA manifestation of microcalcifications in PAI, gray level histogram and co-occurrence matrix (COM) texture parameters were extracted from the 3 fixed ROI US and PA images, respectively, per sample. We compared the textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without microcalcifications. Results: On specimen US, the mean value (2748.4 +/- 862.5) of samples with microcalcifications on specimen radiography was higher than that (1961.9 +/- 780.2) of those without microcalcifications (P = 0.007). However, there were no significant differences in textural parameters obtained from specimen PAIs between samples with punctate microcalcifications on specimen radiography and those without when applying both the mean value of the three slices of thyroid specimens and the value of the thyroid specimen slice which had the highest value of the mean values in specimen US. Conclusion: PAI did not show significant PA contrast on thyroid microcalcifications indicating that the experimental setup and protocols should be enhanced, e. g., method of complete blood rejection from ex vivo specimens, the multi-wavelength spectroscopic PA imaging method which can solely extract the PA signal from microcalcifications even with high spectral interferences, or PA imaging with narrower slice thickness using 2-dimensional array transducer, etc.	[Kang, Jeeun; Chang, Jin Ho; Song, Tai-Kyong] Sogang Univ, Dept Elect Engn, Seoul, South Korea; [Chung, Woong Youn; Kang, Sang-Wook] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Kwon, Hyeong Ju] Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, Seoul, South Korea; [Yoo, Jaeheung] Yonsei Univ, Coll Med, Seoul, South Korea; [Kim, Eun-Kyung; Kwak, Jin Young] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Chang, Jin Ho] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea; [Lee, Sohee] Catholic Univ Korea, Dept Surg, Seoul, South Korea	Sogang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Catholic University of Korea	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea.	docjin@yuhs.ac	Kang, Jeeun/I-1149-2019; Kim, Eun-Kyung/E-5211-2017	Kang, Jeeun/0000-0001-6678-2744; Kim, Eun-Kyung/0000-0002-3368-5013; Kwak, Jin Young/0000-0002-6212-1495; CHANG, JIN HO/0000-0002-8323-4202; Kang, Sang-Wook/0000-0001-5355-833X; Song, Tai-kyong/0000-0002-1530-4002	Yonsei University College of Medicine [6-2012-0140]; National Research Foundation of Korea (NRF) by the Ministry of Education [2013R1A1A2058817]; International Collaborative R&D Program - Ministry of Trade, Industry and Energy (MOTIE), Korea [M0000053]	Yonsei University College of Medicine(General Electric); National Research Foundation of Korea (NRF) by the Ministry of Education; International Collaborative R&D Program - Ministry of Trade, Industry and Energy (MOTIE), Korea	This study was supported by a faculty research grant from Yonsei University College of Medicine for 2012 (No. 6-2012-0140). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2013R1A1A2058817) and by International Collaborative R&D Program (M0000053, Development of a Novel Multi-modal In vivo Imaging System for Animal-to-Human Use) funded by the Ministry of Trade, Industry and Energy (MOTIE), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2011, TRANSL ONCOL, V4, P29, DOI 10.1593/tlo.10187; Aguirre A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3233916; American College of Radiology, 2003, BREAST IM REP DAT SY; Bouchard R, 2014, IEEE T ULTRASON FERR, V61, P450, DOI 10.1109/TUFFC.2014.2930; Choi SH, 2010, THYROID, V20, P167, DOI 10.1089/thy.2008.0354; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Erpelding TN, 2010, RADIOLOGY, V256, P102, DOI 10.1148/radiol.10091772; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kang J, 2012, PHOTOACOUSTIC IMAGIN; Kang J, 2013, J BIOPHOTONICS; Kang J, 2011, APPL PHYS LETT, P99; Kim SH, 2010, KOREAN J RADIOL, V11, P149, DOI 10.3348/kjr.2010.11.2.149; Kitai T, 2012, BREAST CANC; Kwak JY, 2010, BRIT J SURG, V97, P517, DOI 10.1002/bjs.6943; Kwak JY, 2013, KOREAN J RADIOL, V14, P110, DOI 10.3348/kjr.2013.14.1.110; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Moon HJ, 2012, RADIOLOGY, V262, P1002, DOI 10.1148/radiol.11110839; Park S J, 2012, Ultraschall Med, V33, pE186, DOI 10.1055/s-0032-1325404; Park SH, 2009, AM J ROENTGENOL, V193, pW416, DOI 10.2214/AJR.09.2541; Rao B, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.3.036002; Siphanto RI, 2005, OPT EXPRESS, V13, P89, DOI 10.1364/OPEX.13.000089; Su Jimmy L, 2010, Expert Opin Med Diagn, V4, P497, DOI 10.1517/17530059.2010.529127; Wang B, 2012, ULTRASOUND MED BIOL, V38, P2098, DOI 10.1016/j.ultrasmedbio.2012.08.006; Wang XD, 2011, ULTRASOUND MED BIOL, V37, P484, DOI 10.1016/j.ultrasmedbio.2010.12.005; Xu G, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.010502; Xu M., 2006, REV SCI INSTRUM, P77, DOI [10.1063/1.2195024, DOI 10.1063/1.2195024]; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	29	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113358	10.1371/journal.pone.0113358	http://dx.doi.org/10.1371/journal.pone.0113358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415564	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600043
J	Volk, BM; Kunces, LJ; Freidenreich, DJ; Kupchak, BR; Saenz, C; Artistizabal, JC; Fernandez, ML; Bruno, RS; Maresh, CM; Kraemer, WJ; Phinney, SD; Volek, JS				Volk, Brittanie M.; Kunces, Laura J.; Freidenreich, Daniel J.; Kupchak, Brian R.; Saenz, Catherine; Artistizabal, Juan C.; Fernandez, Maria Luz; Bruno, Richard S.; Maresh, Carl M.; Kraemer, William J.; Phinney, Stephen D.; Volek, Jeff S.			Effects of Step-Wise Increases in Dietary Carbohydrate on Circulating Saturated Fatty Acids and Palmitoleic Acid in Adults with Metabolic Syndrome	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; MIDDLE-AGED ADULTS; CORONARY-HEART-DISEASE; SERUM-LIPIDS PREDICTS; ATHEROSCLEROSIS RISK; DESATURASE ACTIVITY; INSULIN-RESISTANCE; PLASMA; MARKERS; PHOSPHOLIPIDS	Recent meta-analyses have found no association between heart disease and dietary saturated fat; however, higher proportions of plasma saturated fatty acids (SFA) predict greater risk for developing type-2 diabetes and heart disease. These observations suggest a disconnect between dietary saturated fat and plasma SFA, but few controlled feeding studies have specifically examined how varying saturated fat intake across a broad range affects circulating SFA levels. Sixteen adults with metabolic syndrome (age 44.9 +/- 9.9 yr, BMI 37.9 +/- 6.3 kg/m(2)) were fed six 3-wk diets that progressively increased carbohydrate (from 47 to 346 g/day) with concomitant decreases in total and saturated fat. Despite a distinct increase in saturated fat intake from baseline to the low-carbohydrate diet (46 to 84 g/day), and then a gradual decrease in saturated fat to 32 g/day at the highest carbohydrate phase, there were no significant changes in the proportion of total SFA in any plasma lipid fractions. Whereas plasma saturated fat remained relatively stable, the proportion of palmitoleic acid in plasma triglyceride and cholesteryl ester was significantly and uniformly reduced as carbohydrate intake decreased, and then gradually increased as dietary carbohydrate was re-introduced. The results show that dietary and plasma saturated fat are not related, and that increasing dietary carbohydrate across a range of intakes promotes incremental increases in plasma palmitoleic acid, a biomarker consistently associated with adverse health outcomes.	[Volk, Brittanie M.; Kunces, Laura J.; Freidenreich, Daniel J.; Kupchak, Brian R.; Saenz, Catherine; Artistizabal, Juan C.; Maresh, Carl M.; Kraemer, William J.; Volek, Jeff S.] Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA; [Artistizabal, Juan C.; Fernandez, Maria Luz] Univ Connecticut, Nutr Sci Dept, Storrs, CT USA; [Bruno, Richard S.; Volek, Jeff S.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Phinney, Stephen D.] Univ Calif Davis, Sch Med, Davis, CA USA	University of Connecticut; University of Connecticut; University System of Ohio; Ohio State University; University of California System; University of California Davis	Volek, JS (corresponding author), Univ Connecticut, Dept Kinesiol, Storrs, CT 06269 USA.	volek.1@osu.edu	Kupchak, Brian/K-2527-2015	SAENZ, CATHERINE/0000-0002-7072-2039; Bruno, Richard/0000-0002-6772-2038; phinney, stephen/0000-0002-3322-3978	Dairy Research Institute; Beef Checkoff; Egg Nutrition Center; Robert C. And Veronica Atkins Foundation; Ohio State University	Dairy Research Institute; Beef Checkoff; Egg Nutrition Center; Robert C. And Veronica Atkins Foundation; Ohio State University(Ohio State University)	This work was funded by a grant from Dairy Research Institute, The Beef Checkoff, the Egg Nutrition Center, and the Robert C. And Veronica Atkins Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Partial funding for Open Access provided by The Ohio State University Open Access Fund.	Aarsland A, 1998, J LIPID RES, V39, P1280; BONADONNA RC, 1990, AM J PHYSIOL, V259, pE736, DOI 10.1152/ajpendo.1990.259.5.E736; Chavarro JE, 2013, AM J EPIDEMIOL, V178, P1246, DOI 10.1093/aje/kwt136; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Djousse L, 2012, CIRC-HEART FAIL, V5, P703, DOI 10.1161/CIRCHEARTFAILURE.112.967802; Djousse L, 2012, AM J CARDIOL, V110, P539, DOI 10.1016/j.amjcard.2012.04.027; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Forsythe CE, 2010, LIPIDS, V45, P947, DOI 10.1007/s11745-010-3467-3; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; King IB, 2006, AM J CLIN NUTR, V83, P227; Klein-Platat C, 2005, AM J CLIN NUTR, V82, P1178, DOI 10.1093/ajcn/82.6.1178; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kunesova M, 2002, LIPIDS, V37, P27, DOI 10.1007/s11745-002-0860-z; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIETTINEN TA, 1982, BRIT MED J, V285, P993, DOI 10.1136/bmj.285.6347.993; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; PHINNEY SD, 1983, METABOLISM, V32, P769, DOI 10.1016/0026-0495(83)90106-3; Raatz SK, 2001, J NUTR, V131, P231; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; SIMON JA, 1995, AM J EPIDEMIOL, V142, P469, DOI 10.1093/oxfordjournals.aje.a117662; U.S. Department of Agriculture anepartment of Agriculture and U.S. Department of Health and Human Services, 2010, DIET GUID AM 2010; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Volek JS, 2005, J NUTR, V135, P1339, DOI 10.1093/jn/135.6.1339; Wang L, 2003, NUTR METAB CARDIOVAS, V13, P256, DOI 10.1016/S0939-4753(03)80029-7; Wang L, 2003, AM J CLIN NUTR, V78, P91; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017; Zong G, 2013, AM J CLIN NUTR, V98, P319, DOI 10.3945/ajcn.113.061218; Zong G, 2012, AM J CLIN NUTR, V96, P970, DOI 10.3945/ajcn.112.040204	36	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113605	10.1371/journal.pone.0113605	http://dx.doi.org/10.1371/journal.pone.0113605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415333	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600064
J	Deisenroth, C; Black, MB; Pendse, S; Pluta, L; Witherspoon, SM; McMullen, PD; Thomas, RS				Deisenroth, Chad; Black, Michael B.; Pendse, Salil; Pluta, Linda; Witherspoon, Sam M.; McMullen, Patrick D.; Thomas, Russell S.			MYC Is an Early Response Regulator of Human Adipogenesis in Adipose Stem Cells	PLOS ONE			English	Article							C-MYC; GENE-EXPRESSION; DEREGULATED EXPRESSION; MESSENGER-RNA; DIFFERENTIATION; ONCOGENE; PROTEIN; FIBRONECTIN; INHIBITION; ACTIVATION	Adipose stem cell (ASC) differentiation is necessary for the proper maintenance and function of adipose tissue. The procurement and characterization of multipotent ASCs has enabled investigation into the molecular determinants driving human adipogenesis. Here, the transcription factor MYC was identified as a significant regulator of ASC differentiation. Expression of MYC transcript and protein was found to accumulate during the initial course of differentiation. Loss-of-function analysis using siRNA mediated knockdown of MYC demonstrated inhibition of hormonally stimulated adipogenesis. MYC exhibited an early and sustained expression pattern that preceded down regulation of key suppressor genes, as well as induction of transcriptional and functional effectors. Glucocorticoid stimulation was identified as a necessary component for MYC induction and was found to impact adipogenesis in a concentration-dependent manner. Global gene expression analysis of MYC knockdown in ASC enriched for functional pathways related to cell adhesion, cytoskeletal remodeling, and transcriptional components of adipogenesis. These results identify a functional role for MYC in promotion of multipotent ASC to the adipogenic lineage.	[Deisenroth, Chad; Black, Michael B.; Pendse, Salil; Pluta, Linda; McMullen, Patrick D.; Thomas, Russell S.] Inst Chem Safety Sci, Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; [Witherspoon, Sam M.] N Carolina Cent Univ, Biomfg Res Inst & Technol Enterprise, Durham, NC USA	The Hamner Institutes for Health Sciences; University of North Carolina; North Carolina Central University	Deisenroth, C (corresponding author), Inst Chem Safety Sci, Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.	CDeisenroth@thehamner.org	; McMullen, Patrick/E-5135-2015	Black, Michael/0000-0002-7314-5441; McMullen, Patrick/0000-0002-9635-932X; Thomas, Russell/0000-0002-2340-0301	American Chemistry Council's Long-Range Research Initiative	American Chemistry Council's Long-Range Research Initiative	This work was supported by the American Chemistry Council's Long-Range Research Initiative (http://lri.americanchemistry.com) for RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Ayala-Sumuano JT, SCI REP, V3, P2573; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; de Nigris F, 2007, ONCOGENE, V26, P382, DOI 10.1038/sj.onc.1209804; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Heath TJ, 2000, BIOCHEM BIOPH RES CO, V269, P438, DOI 10.1006/bbrc.2000.2316; Heath VJ, 2000, EXP CELL RES, V254, P91, DOI 10.1006/excr.1999.4736; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LAROCCA SA, 1994, ONCOGENE, V9, P3499; LARSSON LG, 1988, P NATL ACAD SCI USA, V85, P2638, DOI 10.1073/pnas.85.8.2638; Laudes M, J MOL ENDOCRINOL, V46, pR65; Lee HJ, PLOS ONE, V8; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; McMullen PD, 2014, CHEM-BIOL INTERACT, V209, P14, DOI 10.1016/j.cbi.2013.11.006; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nie Z, CELL, V151, P68; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Seguro LP, AUTOIMMUN REV, V12, P629; Shen L, EXP CELL RES, V317, P1796; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Siersbaek R, COLD SPRING HARB S Q, V76, P247; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	60	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114133	10.1371/journal.pone.0114133	http://dx.doi.org/10.1371/journal.pone.0114133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437437	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900123
J	Deja, S; Wieczorek, PP; Halama, M; Jasicka-Misiak, I; Kafarski, P; Poliwoda, A; Mlynarz, P				Deja, Stanislaw; Wieczorek, Piotr P.; Halama, Marek; Jasicka-Misiak, Izabela; Kafarski, Pawel; Poliwoda, Anna; Mlynarz, Piotr			Do Differences in Chemical Composition of Stem and Cap of Amanita muscaria Fruiting Bodies Correlate with Topsoil Type?	PLOS ONE			English	Article							SWEDISH BEECH FORESTS; ECTOMYCORRHIZA FORMATION; PHALLOIDES TISSUES; COLLECTION SITE; WILD MUSHROOMS; PINUS-RADIATA; SOIL; MACROFUNGI; METALS; ACCUMULATION	Fly agaric (Amanita muscaria) was investigated using a H-1 NMR-based metabolomics approach. The caps and stems were studied separately, revealing different metabolic compositions. Additionally, multivariate data analyses of the fungal basidiomata and the type of soil were performed. Compared to the stems, A. muscaria caps exhibited higher concentrations of isoleucine, leucine, valine, alanine, aspartate, asparagine, threonine, lipids (mainly free fatty acids), choline, glycerophosphocholine (GPC), acetate, adenosine, uridine, 4-aminobutyrate, 6-hydroxynicotinate, quinolinate, UDP-carbohydrate and glycerol. Conversely, they exhibited lower concentrations of formate, fumarate, trehalose, alpha- and beta-glucose. Six metabolites, malate, succinate, gluconate, N-acetylated compounds (NAC), tyrosine and phenylalanine, were detected in whole A. muscaria fruiting bodies but did not show significant differences in their levels between caps and stems (P value >0.05 and/or OPLS-DA loading correlation coefficient <0.4). This methodology allowed for the differentiation between the fruiting bodies of A. muscaria from mineral and mineral-organic topsoil. Moreover, the metabolomic approach and multivariate tools enabled to ascribe the basidiomata of fly agaric to the type of topsoil. Obtained results revealed that stems metabolome is more dependent on the topsoil type than caps. The correlation between metabolites and topsoil contents together with its properties exhibited mutual dependences.	[Deja, Stanislaw; Wieczorek, Piotr P.; Jasicka-Misiak, Izabela; Poliwoda, Anna] Opole Univ, Fac Chem, Opole, Poland; [Halama, Marek] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland; [Kafarski, Pawel; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland	University of Opole; University of Wroclaw; Wroclaw University of Science & Technology	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland.	piotr.mlynarz@pwr.wroc.pl	Deja, Stanislaw/AAI-7526-2020; Wieczorek, Piotr P./A-9649-2012; Kafarski, Paweł/AAA-9112-2019; Poliwoda, Anna/W-2957-2018	Deja, Stanislaw/0000-0002-7714-2547; Wieczorek, Piotr P./0000-0002-0016-0114; Jasicka-Misiak, Izabela/0000-0001-7788-5482; Poliwoda, Anna/0000-0002-0339-3861; Mlynarz, Piotr/0000-0002-8502-4022	Wroclaw Research Centre EIT + under project "Biotechnologies and advanced medical technologies" - BioMed - European Regional Development Fund [POIG.01.01.02-02-003/08]; European Social Fund	Wroclaw Research Centre EIT + under project "Biotechnologies and advanced medical technologies" - BioMed - European Regional Development Fund; European Social Fund(European Social Fund (ESF))	Funding: The research was supported by Wroclaw Research Centre EIT + under the project "Biotechnologies and advanced medical technologies" - BioMed (POIG.01.01.02-02-003/08) financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2). Stanislaw Deja was recipient of Ph.D. scholarship under a project funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RO, 1978, CHEMOSPHERE, V7, P371, DOI 10.1016/0045-6535(78)90138-8; AN Z, 2005, HDB IND MYCOLOGY; Bergemann SE, 2000, FOREST ECOL MANAG, V130, P99, DOI 10.1016/S0378-1127(99)00177-2; Bhatt RP, 2003, MYCOTAXON, V88, P249; Blanusa M, 2001, J AOAC INT, V84, P1964; Carlile M, 2001, FUNGI; Cayir A, 2010, BIOL TRACE ELEM RES, V134, P212, DOI 10.1007/s12011-009-8464-0; Crabtree CD, 2010, MYCOLOGIA, V102, P1229, DOI 10.3852/08-138; Daniele GM, 2005, B SOC ARGENT BOT, V40, P1; [邓旺秋 DENG WangQiu], 2006, [菌物学报, Mygosystema], V25, P109; Dighton J., 2005, FUNGAL COMMUNITY ITS, V3rd; Dighton J, 2016, FUNGI ECOSYSTEM PROC, DOI DOI 10.1201/9781315371528; Dijksterhuis J., 2007, FOOD MYCOLOGY MULTIF; Enjalbert F, 1996, MYCOLOGIA, V88, P909, DOI 10.2307/3761053; ENJALBERT F, 1989, MYCOLOGIA, V81, P266, DOI 10.2307/3759708; ENJALBERT F, 1993, TOXICON, V31, P803, DOI 10.1016/0041-0101(93)90386-W; Enjalbert F, 1999, CR ACAD SCI III-VIE, V322, P855, DOI 10.1016/S0764-4469(00)86651-2; Falandysz J, 1997, SCI TOTAL ENVIRON, V203, P221, DOI 10.1016/S0048-9697(97)00150-2; Garcia MA, 1998, ARCH ENVIRON CON TOX, V34, P330, DOI 10.1007/s002449900326; GAST CH, 1988, CHEMOSPHERE, V17, P789, DOI 10.1016/0045-6535(88)90258-5; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Geml J, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P173, DOI 10.1007/978-3-540-92160-8_9; Gn Guzman, 2000, ANN MUS ROV, V14, P189; Hall I.R., 2003, EDIBLE POISONOUS MUS; HANSEN PA, 1988, VEGETATIO, V78, P31, DOI 10.1007/BF00045637; HANSEN PA, 1989, VEGETATIO, V82, P69; Hawker LE, 1939, ANN BOT-LONDON, V3, P455, DOI 10.1093/oxfordjournals.aob.a085069; Hawkeswood TJ, 2006, CALODEMA, V7, P29; Horak E, 1971, NEW ZEAL J BOT, V9, P402; Hu JS, 2012, J SCI FOOD AGR, V92, P2664, DOI 10.1002/jsfa.5685; Krieglsteiner GJ, 2003, GROSSPILZE BADEN WUR, V4, P8; LEWIS DP, 1981, SOUTHWEST NAT, V26, P1, DOI 10.2307/3671322; MALAJCZUK N, 1984, NEW PHYTOL, V96, P43, DOI 10.1111/j.1469-8137.1984.tb03542.x; MALAJCZUK N, 1982, NEW PHYTOL, V91, P467, DOI 10.1111/j.1469-8137.1982.tb03325.x; McKenzie EHC, 2000, NEW ZEAL J BOT, V38, P635; McKnight TA, 2010, MYCOLOGIA, V102, P763, DOI 10.3852/09-131; Michelot D, 2003, MYCOL RES, V107, P131, DOI 10.1017/S0953756203007305; Mleczek M, 2013, J ENVIRON SCI HEAL B, V48, P69, DOI 10.1080/03601234.2012.716733; Moore D, 1994, GROWING FUNGUS, P423; Moore D., 2003, FUNGAL MORPHOGENESIS; Nehls U, 2001, PLANT CELL ENVIRON, V24, P741, DOI 10.1046/j.1365-3040.2001.00717.x; Neville P, 2004, AMANITEAE AMANITA LI, V9; Nyberg Harri, 1992, Karstenia, V32, P71; Oda T, 2004, MYCOL RES, V108, P885, DOI 10.1017/S0953756204000620; Peintner U, 1996, PHYTON-ANN REI BOT A, V36, P155; Phillips R., 2006, MUSHROOMS COMPREHENS; Rayner MC, 1926, NEW PHYTOL, V25, P338; Robinson Richard, 2010, Australasian Mycologist, V29, P4; RUHLING A, 1990, HOLARCTIC ECOL, V13, P11; SARASWATHIDEVI L, 1955, P INDIAN ACAD SCI  B, V41, P145; Sawyer NA, 2001, MYCOL RES, V105, P966, DOI 10.1016/S0953-7562(08)61953-X; SINGER R, 1953, MYCOLOGIA, V45, P865, DOI 10.1080/00275514.1953.12024322; Sobestiansky G, 2005, BRAZ ARCH BIOL TECHN, V48, P437, DOI 10.1590/S1516-89132005000300015; St'astny F, 2004, REDOX REP, V9, P229, DOI 10.1179/135100004225006001; TRAPPE JM, 1962, BOT REV, V28, P538, DOI 10.1007/BF02868758; Tulloss RE, 2005, MYCOTAXON, V93, P189; Tulloss RE, 2012, AMANITACEAE STUDIES; TYLER G, 1982, T BRIT MYCOL SOC, V79, P239, DOI 10.1016/S0007-1536(82)80109-5; TYLER G, 1985, FOREST ECOL MANAG, V10, P13, DOI 10.1016/0378-1127(85)90011-8; Van Laere A, 1994, GROWING FUNGUS, P211; WHELAN C, 1994, ASIAN FOLKLORE STUD, V53, P163, DOI 10.2307/1178564; Zhang Dan, 2008, Wuhan University Journal of Natural Sciences, V13, P267, DOI 10.1007/s11859-008-0302-2	63	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e104084	10.1371/journal.pone.0104084	http://dx.doi.org/10.1371/journal.pone.0104084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437454	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900002
J	He, ZX; Jiang, XQ; Ratnasekera, D; Grassi, F; Perera, U; Lu, BR				He, Zhuoxian; Jiang, Xiaoqi; Ratnasekera, Disna; Grassi, Fabrizio; Perera, Udugahapattuwage; Lu, Bao-Rong			Seed-Mediated Gene Flow Promotes Genetic Diversity of Weedy Rice within Populations: Implications for Weed Management	PLOS ONE			English	Article							ORYZA-SATIVA; RED RICE; DIFFERENTIATION; DISTANCE; INTROGRESSION; INFERENCE; SOFTWARE; LANDRACE; NUMBER; BARLEY	Increased infestation of weedy rice-a noxious agricultural pest has caused significant reduction of grain yield of cultivated rice (Oryza sativa) worldwide. Knowledge on genetic diversity and structure of weedy rice populations will facilitate the design of effective methods to control this weed by tracing its origins and dispersal patterns in a given region. To generate such knowledge, we studied genetic diversity and structure of 21 weedy rice populations from Sri Lanka based on 23 selected microsatellite (SSR) loci. Results indicated an exceptionally high level of within-population genetic diversity (H-e=0.62) and limited among-population differentiation (F-st=0.17) for this predominantly self-pollinating weed. UPGMA analysis showed a loose genetic affinity of the weedy rice populations in relation to their geographical locations, and no obvious genetic structure among populations across the country. This phenomenon was associated with the considerable amount of gene flow between populations. Limited admixture from STRUCTURE analyses suggested a very low level of hybridization (pollen-mediated gene flow) between populations. The abundant within-population genetic diversity coupled with limited population genetic structure and differentiation is likely caused by the considerable seed-mediated gene flow of weedy rice along with the long-distance exchange of farmer-saved rice seeds between weedy-rice contaminated regions in Sri Lanka. In addition to other effective weed management strategies, promoting the application of certified rice seeds with no weedy rice contamination should be the immediate action to significantly reduce the proliferation and infestation of this weed in rice ecosystems in countries with similar rice farming styles as in Sri Lanka.	[He, Zhuoxian; Jiang, Xiaoqi; Lu, Bao-Rong] Fudan Univ, Minist Educ Key Lab Biodivers & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China; [Ratnasekera, Disna; Perera, Udugahapattuwage] Univ Ruhuna, Dept Agr Biol, Fac Agr, Matara, Sri Lanka; [Grassi, Fabrizio] Univ Bari, Bot Garden, Dept Biol, Bari, Italy; [Grassi, Fabrizio] Univ Milan, Dept Biosci, Milan, Italy	Fudan University; University Ruhuna; Universita degli Studi di Bari Aldo Moro; University of Milan	Lu, BR (corresponding author), Fudan Univ, Minist Educ Key Lab Biodivers & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390; RATNASEKERA, DISNA/0000-0003-3176-6888; grassi, fabrizio/0000-0003-3606-6469	"973" program of the Ministry of Science and Technology [2011CB100401]; Natural Science Foundation of China [31271683, 31330014]	"973" program of the Ministry of Science and Technology(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was funded by the "973" program of the Ministry of Science and Technology (2011CB100401) and the Natural Science Foundation of China (31271683, 31330014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler DD, 2002, WEED SCI, V50, P273, DOI 10.1614/0043-1745(2002)050[0273:AIAAOF]2.0.CO;2; Burgos NR, 2006, FIELD CROP RES, V99, P96, DOI 10.1016/j.fcr.2006.03.009; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; Census and Statistics, 2007, STAT ABSTR; CHANDRASENA JPNR, 1988, TROP PEST MANAGE, V34, P278; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chin Duongvan, 2001, Weed Biology and Management, V1, P37, DOI 10.1046/j.1445-6664.2001.00009.x; Dai L, 2014, PEST MANAG SCI, V70, P113, DOI 10.1002/ps.3534; Dekker J, 1997, WEED SCI, V45, P357, DOI 10.1017/S0043174500092985; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Green JM, 2001, MOL ECOL, V10, P1035, DOI 10.1046/j.1365-294X.2001.01250.x; Gunatilaka GA, 1995, P RIC S 1990, P39; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jiang ZX, 2012, THEOR APPL GENET, V124, P309, DOI 10.1007/s00122-011-1706-5; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Marambe B, 2000, P WILD WEED RIC RIC, P79; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; NEI M, 1978, GENETICS, V89, P583; Parzies HK, 2004, GENET RESOUR CROP EV, V51, P471, DOI 10.1023/B:GRES.0000024157.67531.88; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perera U.I.P., 2010, P 15 INT FOR ENV S 2, P190; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Ratnasekera D, 2014, WEED BIOL MANAG, V14, P68, DOI 10.1111/wbm.12034; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rieseberg LH, 2004, NEW PHYTOL, V161, P59, DOI 10.1046/j.1469-8137.2003.00933.x; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Rong J, 2007, NEW PHYTOL, V173, P346, DOI 10.1111/j.1469-8137.2006.01906.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Shivrain VK, 2010, WEED RES, V50, P289, DOI 10.1111/j.1365-3180.2010.00780.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Weerasena SL, 2000, P ANN S DEP AGR ASDA; Xia HB, 2011, NEW PHYTOL, V191, P1119, DOI 10.1111/j.1469-8137.2011.03766.x; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]	43	21	21	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112778	10.1371/journal.pone.0112778	http://dx.doi.org/10.1371/journal.pone.0112778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436611	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900018
J	Jansen, K; Du, BG; Kayler, Z; Siegwolf, R; Ensminger, I; Rennenberg, H; Kammerer, B; Jaeger, C; Schaub, M; Kreuzwieser, J; Gessler, A				Jansen, Kirstin; Du, Baoguo; Kayler, Zachary; Siegwolf, Rolf; Ensminger, Ingo; Rennenberg, Heinz; Kammerer, Bernd; Jaeger, Carsten; Schaub, Marcus; Kreuzwieser, Jurgen; Gessler, Arthur			Douglas-Fir Seedlings Exhibit Metabolic Responses to Increased Temperature and Atmospheric Drought	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; RESPIRED CO2; ELEVATED CO2; CLIMATE-CHANGE; FOREST TREES; HEAT WAVES; PROLINE; STRESS; ARABIDOPSIS; DARK	In the future, periods of strongly increased temperature in concert with drought (heat waves) will have potentially detrimental effects on trees and forests in Central Europe. Norway spruce might be at risk in the future climate of Central Europe. However, Douglas-fir is often discussed as an alternative for the drought and heat sensitive Norway spruce, because some provenances are considered to be well adapted to drier and warmer conditions. In this study, we identified the physiological and growth responses of seedlings from two different Douglas-fir provenances to increased temperature and atmospheric drought during a period of 92 days. We analysed (i) plant biomass, (ii) carbon stable isotope composition as an indicator for time integrated intrinsic water use efficiency, (iii) apparent respiratory carbon isotope fractionation as well as (iv) the profile of polar low molecular metabolites. Plant biomass was only slightly affected by increased temperatures and atmospheric drought but the more negative apparent respiratory fractionation indicated a temperature-dependent decrease in the commitment of substrate to the tricarboxylic acid cycle. The metabolite profile revealed that the simulated heat wave induced a switch in stress protecting compounds from proline to polyols. We conclude that metabolic acclimation successfully contributes to maintain functioning and physiological activity in seedlings of both Douglas-fir provenances under conditions that are expected during heat waves (i.e. elevated temperatures and atmospheric drought). Douglas-fir might be a potentially important tree species for forestry in Central Europe under changing climatic conditions.	[Jansen, Kirstin; Kayler, Zachary; Gessler, Arthur] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Du, Baoguo; Rennenberg, Heinz; Kreuzwieser, Jurgen] Albert Ludwigs Univ Freiburg, Inst Forest Bot & Tree Physiol, Freiburg, Germany; [Du, Baoguo] Mianyang Normal Univ, Sichuan Prov Key Lab Ecol Secur & Protect, Mianyang, Peoples R China; [Siegwolf, Rolf] Paul Scherrer Inst, Lab Atmospher Chem Stable Isotopes & Ecosystem Fl, Villigen, Switzerland; [Ensminger, Ingo] Univ Toronto, Dept Biol, Mississauga, ON, Canada; [Kammerer, Bernd; Jaeger, Carsten] Albert Ludwigs Univ Freiburg, Ctr Biol Syst Anal ZBSA, Core Facil Metabol, Freiburg, Germany; [Schaub, Marcus; Gessler, Arthur] Swiss Fed Inst Forest, Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Gessler, Arthur] Berlin Brandenburg Inst, Adv Biodivers Res BBIB, Berlin, Germany	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Freiburg; Mianyang Teachers' College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Toronto; University Toronto Mississauga; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Gessler, A (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany.	arthur.gessler@wsl.ch	Ensminger, Ingo/D-8566-2012; Siegwolf, Rolf Theodor Walter/GLT-9297-2022; Schaub, Marcus/E-4874-2012; Siegwolf, Rolf TW/D-4121-2009; Gessler, Arthur/C-7121-2008	Ensminger, Ingo/0000-0001-9014-2499; Siegwolf, Rolf Theodor Walter/0000-0002-0249-0651; Schaub, Marcus/0000-0002-0158-8892; Siegwolf, Rolf TW/0000-0002-0249-0651; Gessler, Arthur/0000-0002-1910-9589; Rennenberg, Heinz/0000-0001-6224-2927; Jansen, Kirstin/0000-0003-0832-9225; Jaeger, Carsten/0000-0003-2192-1792; Kayler, Zachary/0000-0003-0090-7537	Deutsche Forschungsgemeinschaft (DFG) [GE1090/7-1, KR 2010/4-1, EN829/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) under contract numbers GE1090/7-1 to AG, KR 2010/4-1 to JK, and EN829/5-1 to IE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bansal S, 2015, GLOBAL CHANGE BIOL, V21, P947, DOI 10.1111/gcb.12719; Barbour MM, 2007, PLANT CELL ENVIRON, V30, P469, DOI 10.1111/j.1365-3040.2007.01634.x; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; BRANDL H, 1989, ALLG FORST JAGDZTG, V160, P91; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carter KK, 1996, CAN J FOREST RES, V26, P1089, DOI 10.1139/x26-120; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; DOEHLERT DC, 1981, FOREST SCI, V27, P641; Duquesnoy E, 2008, CARBOHYD RES, V343, P893, DOI 10.1016/j.carres.2008.01.001; Duranceau M, 1999, PLANT CELL ENVIRON, V22, P515, DOI 10.1046/j.1365-3040.1999.00420.x; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Edenhofer O., 2014, CONTRIBUTION WORKING; Erxleben A, 2012, PLANT CELL REP, V31, P427, DOI 10.1007/s00299-011-1177-9; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2009, NEW PHYTOL, V181, P374, DOI 10.1111/j.1469-8137.2008.02672.x; Ghashghaie J, 2001, PLANT CELL ENVIRON, V24, P505, DOI 10.1046/j.1365-3040.2001.00699.x; Griffin JJ, 2004, J AM SOC HORTIC SCI, V129, P497, DOI 10.21273/JASHS.129.4.0497; Hanewinkel M, 2010, AFZ DER WALD, V19, P30; Heidingsfelder A, 2004, SCHRIFTEN FORSTOKONO, V26; Hellmann H, 2000, PLANT PHYSIOL, V122, P357, DOI 10.1104/pp.122.2.357; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jansen K, 2013, TREES-STRUCT FUNCT, V27, P37, DOI 10.1007/s00468-012-0765-9; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kayler ZE, 2010, OECOLOGIA, V163, P227, DOI 10.1007/s00442-009-1531-6; KEELING CD, 1961, GEOCHIM COSMOCHIM AC, V24, P277, DOI 10.1016/0016-7037(61)90023-0; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Kodama N, 2011, PLANT BIOLOGY, V13, P115, DOI 10.1111/j.1438-8677.2010.00329.x; Kodama N, 2008, OECOLOGIA, V156, P737, DOI 10.1007/s00442-008-1030-1; Kohnle U, 2012, CAN J FOREST RES, V42, P382, DOI [10.1139/X11-191, 10.1139/x11-191]; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Kuokkanen K, 2001, TREES-STRUCT FUNCT, V15, P378, DOI 10.1007/s004680100108; Levesque M, 2014, AGR FOREST METEOROL, V197, P1, DOI 10.1016/j.agrformet.2014.06.001; Lewis JD, 2001, PLANT CELL ENVIRON, V24, P539, DOI 10.1046/j.1365-3040.2001.00700.x; Lewis JD, 2000, TREE PHYSIOL, V20, P447; Little E.L., 1971, MISC PUBL, V1146; Macheix J. J., 1990, Fruit phenolics.; Mani S, 2002, PLANT PHYSIOL, V128, P73, DOI 10.1104/pp.010572; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Miller JB, 2003, TELLUS B, V55, P207, DOI 10.1034/j.1600-0889.2003.00020.x; Nanjo T, 2003, PLANT CELL PHYSIOL, V44, P541, DOI 10.1093/pcp/pcg066; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Paajanen R, 2011, NEW PHYTOL, V190, P161, DOI 10.1111/j.1469-8137.2010.03583.x; PAUL MJ, 1989, J EXP BOT, V40, P1093, DOI 10.1093/jxb/40.10.1093; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; Randall WK, 2002, WASHINGTON TREE SEED; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Riikonen J, 2012, TREE PHYSIOL, V32, P1102, DOI 10.1093/treephys/tps072; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Ryan MG, 2010, TREE PHYSIOL, V30, P667, DOI 10.1093/treephys/tpq033; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; SMIRNOFF N, 1985, VEGETATIO, V62, P273, DOI 10.1007/BF00044753; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Solomon QD, 2007, PHYS SCI BASIS CONTR; SORENSEN FC, 1979, SILVAE GENET, V28, P96; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; St Clair JB, 2007, GLOBAL CHANGE BIOL, V13, P1441, DOI 10.1111/j.1365-2486.2007.01385.x; Stewart G. R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P609; Stoeckli R, 2003, EUROPEAN HEAT WAVE; Sudachkova N. E., 2002, Eurasian Journal of Forest Research, V4, P1; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Taylor CB, 1996, PLANT CELL, V8, P1221, DOI 10.1105/tpc.8.8.1221; Tcherkez G, 2004, FUNCT PLANT BIOL, V31, P857, DOI 10.1071/FP04053; Tcherkez G, 2003, PLANT PHYSIOL, V131, P237, DOI 10.1104/pp.013078; THOMAS H, 1980, ANNU REV PLANT PHYS, V31, P83, DOI 10.1146/annurev.pp.31.060180.000503; Tjoelker MG, 1999, GLOB CHANGE BIOL, V5, P679, DOI 10.1046/j.1365-2486.1999.00257.x; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner RA, 2011, NEW PHYTOL, V191, P10, DOI 10.1111/j.1469-8137.2011.03741.x; Yang YJ, 2013, FOOD CHEM, V138, P2057, DOI 10.1016/j.foodchem.2012.10.122	87	17	17	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114165	10.1371/journal.pone.0114165	http://dx.doi.org/10.1371/journal.pone.0114165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436455	Green Published, gold			2022-12-27	WOS:000347114900127
J	Lopez-Falcon, B; Meyer-Nava, S; Hernandez-Rodriguez, B; Campos, A; Montero, D; Rudino, E; Vazquez, M; Zurita, M; Valadez-Graham, V				Lopez-Falcon, Brenda; Meyer-Nava, Silvia; Hernandez-Rodriguez, Benjamin; Campos, Adam; Montero, Daniel; Rudino, Enrique; Vazquez, Martha; Zurita, Mario; Valadez-Graham, Viviana			Characterization of the Drosophila Group Ortholog to the Amino-Terminus of the Alpha-Thalassemia and Mental Retardation X-Linked (ATRX) Vertebrate Protein	PLOS ONE			English	Article							HISTONE CHAPERONE; CHROMATIN; DOMAIN; HETEROCHROMATIN; EXPRESSION; HOMOLOGY; MODEL; LOCALIZATION; RECOGNITION; MUTATIONS	The human ATRX gene encodes hATRX, a chromatin-remodeling protein harboring an helicase/ATPase and ADD domains. The ADD domain has two zinc fingers that bind to histone tails and mediate hATRX binding to chromatin. dAtrx, the putative ATRX homolog in Drosophila melanogaster, has a conserved helicase/ATPase domain but lacks the ADD domain. A bioinformatic search of the Drosophila genome using the human ADD sequence allowed us to identify the CG8290 annotated gene, which encodes three ADD harboring-isoforms generated by alternative splicing. This Drosophila ADD domain is highly similar in structure and in the amino acids which mediate the histone tail contacts to the ADD domain of hATRX as shown by 3D modeling. Very recently the CG8290 annotated gene has been named dadd1. We show through pull-down and CoIP assays that the products of the dadd1 gene interact physically with dAtrx(L) and HP1a and all of them mainly co-localize in the chromocenter, although euchromatic localization can also be observed through the chromosome arms. We confirm through ChIP analyses that these proteins are present in vivo in the same heterochromatic regions. The three isoforms are expressed throughout development. Flies carrying transheterozygous combinations of the dadd1 and atrx alleles are semi-viable and have different phenotypes including the appearance of melanotic masses. Interestingly, the dAdd1-b and c isoforms have extra domains, such as MADF, which suggest newly acquired functions of these proteins. These results strongly support that, in Drosophila, the atrx gene diverged and that the dadd1-encoded proteins participate with dAtrx in some cellular functions such as heterochromatin maintenance.	[Lopez-Falcon, Brenda; Meyer-Nava, Silvia; Hernandez-Rodriguez, Benjamin; Montero, Daniel; Vazquez, Martha; Zurita, Mario; Valadez-Graham, Viviana] Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Campos, Adam; Rudino, Enrique] Univ Nacl Autonoma Mexico, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	marioz@ibt.unam.mx; vvaladez@ibt.unam.mx	Hernández-Rodríguez, Benjamín/B-5697-2018	Hernández-Rodríguez, Benjamín/0000-0002-5118-8715; Vazquez, Martha/0000-0003-0329-8802; Rudino-Pinera, Enrique/0000-0001-8170-6379; Valadez, Viviana/0000-0002-2556-7375; Meyer, Silvia/0000-0003-0219-5959; Campos-Acevedo, Adam/0000-0002-3256-9088	Consejo Nacional de Ciencia y Tecnologia [127440, 177393]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IA200613]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by grant 127440 from Consejo Nacional de Ciencia y Tecnologia to MZ and grants 177393, Joven Investigador, from Consejo Nacional de Ciencia y Tecnologia and IA200613 from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico to VVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alekseyenko AA, 2014, GENE DEV, V28, P1445, DOI 10.1101/gad.241950.114; Antao JM, 2012, MOL CELL BIOL, V32, P2170, DOI 10.1128/MCB.00010-12; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Chauhan C, 2012, DEVELOPMENT, V139, P1997, DOI 10.1242/dev.076687; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; EISSENBERG JC, 1992, GENETICS, V131, P345; Emelyanov AV, 2010, J BIOL CHEM, V285, P15027, DOI 10.1074/jbc.M109.064790; ENGLAND BP, 1992, P NATL ACAD SCI USA, V89, P683, DOI 10.1073/pnas.89.2.683; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; Garrick D, 2004, GENE, V326, P23, DOI 10.1016/j.gene.2003.10.026; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Gibbons RJ, 2012, COLD SPRING HARB PER, V2; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gu TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003780; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herrera-Cruz M, 2012, J BIOL CHEM, V287, P33567, DOI 10.1074/jbc.M112.383505; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; Maheshwari S, 2008, MOL BIOL EVOL, V25, P2421, DOI 10.1093/molbev/msn190; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Minakhina S, 2011, DEV BIOL, V352, P308, DOI 10.1016/j.ydbio.2011.01.035; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Park DJ, 2004, GENE, V339, P39, DOI 10.1016/j.gene.2004.06.025; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Valadez-Graham V, 2012, NUCLEIC ACIDS RES, V40, P1460, DOI 10.1093/nar/gkr865; Wang W, 2004, NAT GENET, V36, P523, DOI 10.1038/ng1338	48	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113182	10.1371/journal.pone.0113182	http://dx.doi.org/10.1371/journal.pone.0113182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437195	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900031
J	Malinowski, JR; Denny, JC; Bielinski, SJ; Basford, MA; Bradford, Y; Peissig, PL; Carrell, D; Crosslin, DR; Pathak, J; Rasmussen, L; Pacheco, J; Kho, A; Newton, KM; Li, RL; Kullo, IJ; Chute, CG; Chisholm, RL; Jarvik, GP; Larson, EB; McCarty, CA; Masys, DR; Roden, DM; de Andrade, M; Ritchie, MD; Crawford, DC				Malinowski, Jennifer R.; Denny, Joshua C.; Bielinski, Suzette J.; Basford, Melissa A.; Bradford, Yuki; Peissig, Peggy L.; Carrell, David; Crosslin, David R.; Pathak, Jyotishman; Rasmussen, Luke; Pacheco, Jennifer; Kho, Abel; Newton, Katherine M.; Li, Rongling; Kullo, Iftikhar J.; Chute, Christopher G.; Chisholm, Rex L.; Jarvik, Gail P.; Larson, Eric B.; McCarty, Catherine A.; Masys, Daniel R.; Roden, Dan M.; de Andrade, Mariza; Ritchie, Marylyn D.; Crawford, Dana C.			Genetic Variants Associated with Serum Thyroid Stimulating Hormone (TSH) Levels in European Americans and African Americans from the eMERGE Network	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ELECTRONIC MEDICAL-RECORDS; REFERENCE LIMITS; NATIONAL-HEALTH; FREE T4; LOCI; CANCER; FOXE1; DIFFERENTIATION; HYPOTHYROIDISM	Thyroid stimulating hormone (TSH) hormone levels are normally tightly regulated within an individual; thus, relatively small variations may indicate thyroid disease. Genome-wide association studies (GWAS) have identified variants in PDE8B and FOXE1 that are associated with TSH levels. However, prior studies lacked racial/ethnic diversity, limiting the generalization of these findings to individuals of non-European ethnicities. The Electronic Medical Records and Genomics (eMERGE) Network is a collaboration across institutions with biobanks linked to electronic medical records (EMRs). The eMERGE Network uses EMR-derived phenotypes to perform GWAS in diverse populations for a variety of phenotypes. In this report, we identified serum TSH levels from 4,501 European American and 351 African American euthyroid individuals in the eMERGE Network with existing GWAS data. Tests of association were performed using linear regression and adjusted for age, sex, body mass index (BMI), and principal components, assuming an additive genetic model. Our results replicate the known association of PDE8B with serum TSH levels in European Americans (rs2046045 p=1.85x10(-17), beta=0.09). FOXE1 variants, associated with hypothyroidism, were not genome-wide significant (rs10759944: p=1.08x10(-6), beta=-0.05). No SNPs reached genome-wide significance in African Americans. However, multiple known associations with TSH levels in European ancestry were nominally significant in African Americans, including PDE8B (rs2046045 p=0.03, beta=-0.09), VEGFA (rs11755845 p=0.01, beta=-0.13), and NFIA (rs334699 p=1.50x10(-3), beta=-0.17). We found little evidence that SNPs previously associated with other thyroid-related disorders were associated with serum TSH levels in this study. These results support the previously reported association between PDE8B and serum TSH levels in European Americans and emphasize the need for additional genetic studies in more diverse populations.	[Denny, Joshua C.; Masys, Daniel R.; Ritchie, Marylyn D.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Malinowski, Jennifer R.; Bradford, Yuki; Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Basford, Melissa A.] Vanderbilt Univ, Res Off, Nashville, TN 37235 USA; [Pathak, Jyotishman; Chute, Christopher G.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Peissig, Peggy L.; Rasmussen, Luke] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Carrell, David; Newton, Katherine M.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Pacheco, Jennifer; Kho, Abel] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Li, Rongling] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Dept Hlth Sci Res, Rochester, MN USA; [Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Mayo Clinic; Vanderbilt University; Mayo Clinic; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Northwestern University; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Crawford, DC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	dana.crawford@case.edu	Chute, Christopher/AAT-8540-2021; Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021; Bielinski, Suzette/A-2238-2009; Crawford, Dana/O-5578-2019; Chisholm, Rex/B-3418-2009	Denny, Josh/0000-0002-3049-7332; Bielinski, Suzette/0000-0002-2905-5430; Crawford, Dana/0000-0002-6437-6248; McCarty, Catherine/0000-0003-1089-0142; Pacheco, Jennifer/0000-0001-8021-5818; Malinowski, Jennifer/0000-0001-7500-2199; Chisholm, Rex/0000-0002-5638-3990; Rasmussen, Luke/0000-0002-4497-8049	NHGRI; NIGMS [U01HG04599, U01HG006379, U01HG004610, U01HG006375, U01HG004608, U01HG006389, U01HG004609, U01HG006388, U01HG04603, U01HG006378, U01HG006385, U01HG006382, U01HG006380, U01HG006830, U01HG006828]; Group Health/UW ADPR/ACT [UO1 AG 0681]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006388, U01HG006382, U01HG006378, U01HG006385, U01HG004599, U01HG004610, U01HG006828, U01HG006380, U01HG006389, U01HG004609, U01HG004603, U01HG004608, U01HG006379, U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178, R01GM105688] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Group Health/UW ADPR/ACT; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The eMERGE Network is funded by NHGRI, with additional funding from NIGMS through the following grants: U01HG04599 and U01HG006379 to Mayo Clinic; U01HG004610 and U01HG006375 to Group Health Cooperative; U01HG004608 to Marshfield Clinic; U01HG006389 to Essentia Institute of Rural Health; U01HG004609 and U01HG006388 to Northwestern University; U01HG04603 and U01HG006378 to Vanderbilt University; U01HG006385 to the Coordinating Center; U01HG006382 to Geisinger Clinic; U01HG006380 to Icahn School of Medicine at Mount Sinai; U01HG006830 to The Children's Hospital of Philadelphia; and U01HG006828 to Cincinnati Children's Hospital and Boston Children's Hospital. Group Health/University of Washington received additional funding through Group Health/UW ADPR/ACT grant UO1 AG 0681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alul FY, 2013, HEREDITY, V110, P253, DOI 10.1038/hdy.2012.75; Alul FY, 2013, PEDIATR RES, V73, P484, DOI 10.1038/pr.2013.18; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAGCHI N, 1990, ARCH INTERN MED, V150, P785, DOI 10.1001/archinte.150.4.785; Boucai L, 2009, CLIN ENDOCRINOL, V70, P788, DOI 10.1111/j.1365-2265.2008.03390.x; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Finlayson A, 2014, BRIT J CANCER, V110, P1322, DOI 10.1038/bjc.2014.4; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horvath A, 2010, THYROID, V20, P363, DOI 10.1089/thy.2009.0260; Jorde R, 2006, EXP CLIN ENDOCR DIAB, V114, P343, DOI 10.1055/s-2006-924264; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Laurberg P, 2005, DRUG AGING, V22, P23, DOI 10.2165/00002512-200522010-00002; Marzullo P, 2010, J CLIN ENDOCR METAB, V95, P3965, DOI 10.1210/jc.2009-2798; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Means J H, 1940, Bull N Y Acad Med, V16, P14; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Panicker V, 2008, CLIN ENDOCRINOL, V68, P652, DOI 10.1111/j.1365-2265.2007.03079.x; Panicker V, 2008, J CLIN ENDOCR METAB, V93, P3519, DOI 10.1210/jc.2007-2650; Panicker Vijay, 2011, Clin Biochem Rev, V32, P165; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Rawal R, 2012, HUM MOL GENET, V21, P3275, DOI 10.1093/hmg/dds136; Ryckman KK, 2014, J PEDIATR ENDOCR MET, V27, P929, DOI 10.1515/jpem-2013-0366; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; StataCorp, 2011, STAT STAT SOFTW REL, P173; Taylor PN, 2011, EUR J ENDOCRINOL, V164, P773, DOI 10.1530/EJE-10-0938; Tomaz RA, 2012, CLIN ENDOCRINOL, V77, P926, DOI 10.1111/j.1365-2265.2012.04505.x; Turner S, GENETING GENETICS DO; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	50	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111301	10.1371/journal.pone.0111301	http://dx.doi.org/10.1371/journal.pone.0111301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436638	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900008
J	Ohmura-Kakutani, H; Akiyama, K; Maishi, N; Ohga, N; Hida, Y; Kawamoto, T; Iida, J; Shindoh, M; Tsuchiya, K; Shinohara, N; Hida, K				Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Hida, Yasuhiro; Kawamoto, Taisuke; Iida, Junichiro; Shindoh, Masanobu; Tsuchiya, Kunihiko; Shinohara, Nobuo; Hida, Kyoko			Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype	PLOS ONE			English	Article							PROMOTES ANGIOGENESIS; STEM-CELLS; CANCER; VEGF; POPULATION; MARKER; GENES	Tumor blood vessels play an important role in tumor progression and metastasis. It has been reported that tumor endothelial cells (TECs) exhibit highly angiogenic phenotypes compared with those of normal endothelial cells (NECs). TECs show higher proliferative and migratory abilities than those NECs, together with upregulation of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2). Furthermore, compared with NECs, stem cell markers such as Sca-1, CD90, and multidrug resistance 1 are upregulated in TECs, suggesting that stem-like cells exist in tumor blood vessels. In this study, to reveal the biological role of stem-like TECs, we analyzed expression of the stem cell marker aldehyde dehydrogenase (ALDH) in TECs and characterized ALDH(high) TECs. TECs and NECs were isolated from melanoma-xenografted nude mice and normal dermis, respectively. ALDH mRNA expression and activity were higher in TECs than those in NECs. Next, ALDH(high/low) TECs were isolated by fluorescence-activated cell sorting to compare their characteristics. Compared with ALDH(low) TECs, ALDH(high) TECs formed more tubes on Matrigel-coated plates and sustained the tubular networks longer. Furthermore, VEGFR2 expression was higher in ALDHhigh TECs than that in ALDH(low) TECs. In addition, ALDH was expressed in the tumor blood vessels of in vivo mouse models of melanoma and oral carcinoma, but not in normal blood vessels. These findings indicate that ALDH(high) TECs exhibit an angiogenic phenotype. Stem-like TECs may have an essential role in tumor angiogenesis.	[Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Kawamoto, Taisuke; Hida, Kyoko] Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan; [Akiyama, Kosuke; Maishi, Nako; Hida, Kyoko] Hokkaido Univ, Inst Med Genet, Div Vasc Biol, Sapporo, Hokkaido, Japan; [Hida, Yasuhiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Ohmura-Kakutani, Hitomi; Iida, Junichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Orthodont, Sapporo, Hokkaido, Japan; [Shindoh, Masanobu] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Sapporo, Hokkaido, Japan; [Tsuchiya, Kunihiko; Shinohara, Nobuo] Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Hida, K (corresponding author), Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan.	khida@igm.hokudai.ac.jp	Shindoh, Masanobu/A-4799-2012; Hida, Kyoko/AAE-3183-2020; Hida, Kyoko/A-8444-2012; Hida, Yasuhiro/A-7761-2012; Maishi, Nako/A-8403-2012	Shindoh, Masanobu/0000-0002-7782-5823; Hida, Kyoko/0000-0002-7968-6062; Hida, Yasuhiro/0000-0003-1759-4215; 				Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; KASTAN MB, 1990, BLOOD, V75, P1947; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Osawa T, 2012, CANCER SCI, V103, P1038, DOI 10.1111/j.1349-7006.2012.02261.x; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; St Croix B, 2000, SCIENCE, V289, P1197; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59	25	34	34	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113910	10.1371/journal.pone.0113910	http://dx.doi.org/10.1371/journal.pone.0113910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437864	Green Published, gold			2022-12-27	WOS:000347114900094
J	Peters, SE; Zhang, C; Livny, M; Re, C				Peters, Shanan E.; Zhang, Ce; Livny, Miron; Re, Christopher			A Machine Reading System for Assembling Synthetic Paleontological Databases	PLOS ONE			English	Article							BODY-SIZE; CLIMATE-CHANGE; COPES RULE; DIVERSITY; EVOLUTION; BIODIVERSITY; EXTINCTION; DYNAMICS; HISTORY; LIFE	Many aspects of macroevolutionary theory and our understanding of biotic responses to global environmental change derive from literature-based compilations of paleontological data. Existing manually assembled databases are, however, incomplete and difficult to assess and enhance with new data types. Here, we develop and validate the quality of a machine reading system, PaleoDeepDive, that automatically locates and extracts data from heterogeneous text, tables, and figures in publications. PaleoDeepDive performs comparably to humans in several complex data extraction and inference tasks and generates congruent synthetic results that describe the geological history of taxonomic diversity and genus-level rates of origination and extinction. Unlike traditional databases, PaleoDeepDive produces a probabilistic database that systematically improves as information is added. We show that the system can readily accommodate sophisticated data types, such as morphological data in biological illustrations and associated textual descriptions. Our machine reading approach to scientific data integration and synthesis brings within reach many questions that are currently underdetermined and does so in ways that may stimulate entirely new modes of inquiry.	[Peters, Shanan E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Zhang, Ce; Livny, Miron] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Re, Christopher] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Peters, SE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317; Zhang, Ce/0000-0002-8105-7505	NSF EarthCube award [ACI-1343760]; Defense Advanced Research Projects Agency (DARPA) XDATA Program [FA8750-12-2-0335]; DEFT Program [FA8750-13-2-0039]; DARPA's MEMEX program; National Science Foundation (NSF) CAREER Award [IIS-1353606]; Office of Naval Research (ONR) [N000141210041, N000141310129]; Sloan Research Fellowship; Moore Foundation; American Family Insurance; Google; Toshiba; ICER [1343760] Funding Source: National Science Foundation	NSF EarthCube award; Defense Advanced Research Projects Agency (DARPA) XDATA Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DEFT Program; DARPA's MEMEX program; National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Office of Naval Research (ONR)(Office of Naval Research); Sloan Research Fellowship(Alfred P. Sloan Foundation); Moore Foundation(Gordon and Betty Moore Foundation); American Family Insurance; Google(Google Incorporated); Toshiba; ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF EarthCube award ACI-1343760. CR also gratefully acknowledges the support of the Defense Advanced Research Projects Agency (DARPA) XDATA Program under No. FA8750-12-2-0335 and DEFT Program under No. FA8750-13-2-0039, DARPA's MEMEX program, the National Science Foundation (NSF) CAREER Award under No. IIS-1353606, the Office of Naval Research (ONR) under awards No. N000141210041 and No. N000141310129, the Sloan Research Fellowship, the Moore Foundation, American Family Insurance, Google, and Toshiba. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of DARPA, AFRL, NSF, ONR, or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; Ausich WI, 2005, PALEOBIOLOGY, V31, P538, DOI 10.1666/0094-8373(2005)031[0538:ARMHFO]2.0.CO;2; BAMBACH R K, 1977, Paleobiology, V3, P152; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Callison-Burch C, 2010, P NAACL HLT 2010 WOR, P1; Carlson A., 2010, 24 AAAI C ART INT; Dubois A, 2007, MOL PHYLOGENET EVOL, V42, P317, DOI 10.1016/j.ympev.2006.06.007; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Finnegan S, 2012, P NATL ACAD SCI USA, V109, P6829, DOI 10.1073/pnas.1117039109; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Getoor Lise, 2007, INTRO STAT RELATIONA; Govindaraju V., 2013, P 51 M ACL, P658; Hoffmann R, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P286; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Kopcke H, 2010, PROC VLDB ENDOW, V3, P484; Krishnamurthy R, 2008, SIGMOD RECORD, V37, P7, DOI 10.1145/1519103.1519105; Kumar A, 2013, COMMUN ACM, V56, P40, DOI 10.1145/2428556.2428570; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Laurin M, 2010, CONTRIB ZOOL, V79, P131, DOI 10.1163/18759866-07904001; Li Yunyao, 2011, 49 ANN M ASS COMP LI, P109; Liu J, 2014, PR MACH LEARN RES, V32, P289; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Mintz M., 2009, P JOINT C 47 ANN M A, V2, P1003, DOI DOI 10.3115/1690219.1690287; Murphy K, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P1917, DOI 10.1145/2505515.2514697; Niu F., 2012, VLDS CEUR WORKSHOP P, V884, P25; Niu F, 2011, PROC VLDB ENDOW, V4, P373, DOI 10.14778/1978665.1978669; PATTERSON C, 1989, ECOLOGY, V70, P802, DOI 10.2307/1941349; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; RAUP D M, 1976, Paleobiology, V2, P279; Recht B., 2011, ADV NEURAL INFORM PR, P693; Recht B., 2012, JMLR WORKSHOP C P, P11; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Slater GJ, 2013, METHODS ECOL EVOL, V4, P734, DOI 10.1111/2041-210X.12084; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Suchanek Fabian M, 2009, WWW; Suciu D., 2011, SYNTHESIS LECT DATA; Van Noorden R, 2014, NATURE, V506, P17, DOI 10.1038/506017a; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001; Zhang C., 2013, P 2013 ACM SIGMOD IN	50	59	63	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113523	10.1371/journal.pone.0113523	http://dx.doi.org/10.1371/journal.pone.0113523			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436610	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900048
J	Zhang, RL; Chopp, M; Roberts, C; Liu, XS; Wei, M; Nejad-Davarani, SP; Wang, XL; Zhang, ZG				Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Liu, Xianshuang; Wei, Min; Nejad-Davarani, Siamak P.; Wang, Xinli; Zhang, Zheng Gang			Stroke Increases Neural Stem Cells and Angiogenesis in the Neurogenic Niche of the Adult Mouse	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NEUROBLAST MIGRATION; STRING VESSELS; VASCULAR NICHE; PROLIFERATION; ISCHEMIA; ARCHITECTURE; ACTIVATION	The unique cellular and vascular architecture of the adult ventricular-subventricular zone (V/SVZ) neurogenic niche plays an important role in regulating neural stem cell function. However, the in vivo identification of neural stem cells and their relationship to blood vessels within this niche in response to stroke remain largely unknown. Using whole-mount preparation of the lateral ventricle wall, we examined the architecture of neural stem cells and blood vessels in the V/SVZ of adult mouse over the course of 3 months after onset of focal cerebral ischemia. Stroke substantially increased the number of glial fibrillary acidic protein (GFAP) positive neural stem cells that are in contact with the cerebrospinal fluid (CSF) via their apical processes at the center of pinwheel structures formed by ependymal cells residing in the lateral ventricle. Long basal processes of these cells extended to blood vessels beneath the ependymal layer. Moreover, stroke increased V/SVZ endothelial cell proliferation from 2% in non-ischemic mice to 12 and 15% at 7 and 14 days after stroke, respectively. Vascular volume in the V/SVZ was augmented from 3% of the total volume prior to stroke to 6% at 90 days after stroke. Stroke-increased angiogenesis was closely associated with neuroblasts that expanded to nearly encompass the entire lateral ventricular wall in the V/SVZ. These data indicate that stroke induces long-term alterations of the neural stem cell and vascular architecture of the adult V/SVZ neurogenic niche. These post-stroke structural changes may provide insight into neural stem cell mediation of stroke-induced neurogenesis through the interaction of neural stem cells with proteins in the CSF and their sub-ependymal neurovascular interaction.	[Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Liu, Xianshuang; Wei, Min; Nejad-Davarani, Siamak P.; Wang, Xinli; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	Nejad-Davarani, Siamak/AAH-8399-2021; zhang, zheng/HCH-9684-2022	Nejad-Davarani, Siamak/0000-0002-2415-6689	National Institutes of Health [RO1 AG037506, RO1 NS075156]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants: RO1 AG037506 (MC) and RO1 NS075156 (ZGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brown WR, 2010, J ALZHEIMERS DIS, V21, P725, DOI 10.3233/JAD-2010-100219; Challa VR, 2002, J NEUROL SCI, V203, P165, DOI 10.1016/S0022-510X(02)00284-8; Doetsch F, 1997, J NEUROSCI, V17, P5046; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Silva-Vargas V, 2013, CURR OPIN NEUROBIOL, V23, P935, DOI 10.1016/j.conb.2013.09.004; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Young CC, 2013, CEREB CORTEX, V23, P647, DOI 10.1093/cercor/bhs049; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134; Zhang ZG, 1999, BRAIN RES, V844, P55, DOI 10.1016/S0006-8993(99)01886-7; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	35	62	64	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113972	10.1371/journal.pone.0113972	http://dx.doi.org/10.1371/journal.pone.0113972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437857	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900104
J	Adamson, MM; Taylor, JL; Heraldez, D; Khorasani, A; Noda, A; Hernandez, B; Yesavage, JA				Adamson, Maheen M.; Taylor, Joy L.; Heraldez, Daniel; Khorasani, Allen; Noda, Art; Hernandez, Beatriz; Yesavage, Jerome A.			Higher Landing Accuracy in Expert Pilots is Associated with Lower Activity in the Caudate Nucleus	PLOS ONE			English	Article							DECISION-MAKING; PERFORMANCE; AGE; STRATEGY; RISK; TASK; FMRI; SIZE	The most common lethal accidents in General Aviation are caused by improperly executed landing approaches in which a pilot descends below the minimum safe altitude without proper visual references. To understand how expertise might reduce such erroneous decision-making, we examined relevant neural processes in pilots performing a simulated landing approach inside a functional MRI scanner. Pilots (aged 20-66) were asked to "fly'' a series of simulated "cockpit view'' instrument landing scenarios in an MRI scanner. The scenarios were either high risk (heavy fog-legally unsafe to land) or low risk (medium fog-legally safe to land). Pilots with one of two levels of expertise participated: Moderate Expertise (Instrument Flight Rules pilots, n=8) or High Expertise (Certified Instrument Flight Instructors or Air-Transport Pilots, n=12). High Expertise pilots were more accurate than Moderate Expertise pilots in making a "land'' versus "do not land'' decision (CFII: d'=3.62 +/- 2.52; IFR: d'=0.98 +/- 1.04; p<.01). Brain activity in bilateral caudate nucleus was examined for main effects of expertise during a "land'' versus "do not land'' decision with the no-decision control condition modeled as baseline. In making landing decisions, High Expertise pilots showed lower activation in the bilateral caudate nucleus (0.97 +/- 0.80) compared to Moderate Expertise pilots (1.91 +/- 1.16) (p<.05). These findings provide evidence for increased "neural efficiency'' in High Expertise pilots relative to Moderate Expertise pilots. During an instrument approach the pilot is engaged in detailed examination of flight instruments while monitoring certain visual references for making landing decisions. The caudate nucleus regulates saccade eye control of gaze, the brain area where the "expertise'' effect was observed. These data provide evidence that performing "real world'' aviation tasks in an fMRI provide objective data regarding the relative expertise of pilots and brain regions involved in it.	[Adamson, Maheen M.; Taylor, Joy L.; Yesavage, Jerome A.] WRIISC, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Adamson, Maheen M.; Taylor, Joy L.; Yesavage, Jerome A.] Sierra Pacific MIRECC, Palo Alto, CA 94304 USA; [Adamson, Maheen M.; Taylor, Joy L.; Heraldez, Daniel; Khorasani, Allen; Noda, Art; Hernandez, Beatriz; Yesavage, Jerome A.] Stanford Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Adamson, MM (corresponding author), WRIISC, Dept Vet Affairs, Palo Alto, CA 94304 USA.	madamson@stanford.edu		Adamson, Maheen/0000-0002-1534-4063	Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); War Related Illness and Injury Study Center (WRIISC); Medical Research Service of the Department of Veterans Affairs; NIH [P30 AG 17824, R37 AG 12713, P41 RR023953, 2P41RR009784]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953, P41RR009784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017824, R37AG012713] Funding Source: NIH RePORTER	Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); War Related Illness and Injury Study Center (WRIISC); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This research was supported by the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), the War Related Illness and Injury Study Center (WRIISC), and the Medical Research Service of the Department of Veterans Affairs. Additional support came from NIH P30 AG 17824 and NIH R37 AG 12713, P41 RR023953 (PI: Weiner), and 2P41RR009784 (P.I. Glover). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Adamson MM, 2012, AVIAT SPACE ENVIR MD, V83, P850, DOI 10.3357/ASEM.3215.2012; Adamson MM, 2010, J INT NEUROPSYCH SOC, V16, P412, DOI 10.1017/S1355617710000111; AOPA, 2007, NALL REP ACC TRENDS; Arce E, 2006, PSICOTHEMA, V18, P213; BEA, 2000, OBJ DEST TECHN REP B; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bellenkes AH, 1997, AVIAT SPACE ENVIR MD, V68, P569; Bernardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077764; Calhoun VD, 2002, MAGNET RESON MED, V48, P180, DOI 10.1002/mrm.10202; Causse M, 2013, NEUROIMAGE, V71, P19, DOI 10.1016/j.neuroimage.2012.12.060; Causse M, 2011, APPL PSYCHOPHYS BIOF, V36, P231, DOI 10.1007/s10484-011-9163-0; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Crespi S, 2012, J VISION, V12, DOI 10.1167/12.11.30; DICHIARA G, 1979, BRAIN RES, V176, P273, DOI 10.1016/0006-8993(79)90983-1; Durantin G, 2014, BEHAV BRAIN RES, V259, P16, DOI 10.1016/j.bbr.2013.10.042; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goudriaan AE, 2004, NEUROSCI BIOBEHAV R, V28, P123, DOI 10.1016/j.neubiorev.2004.03.001; Harrivel AR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00861; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Kasarskis P., 2001, P 11 INT S AV PSYCH, V6; Kennedy Q, 2010, AVIAT SPACE ENVIR MD, V81, P489, DOI 10.3357/ASEM.2684.2010; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Morrow DG, 2005, J GERONTOL B-PSYCHOL, V60, pP11, DOI 10.1093/geronb/60.1.P11; Orasanu J, 2001, FACTORS AVIATION ACC; Peres M, 2000, AVIAT SPACE ENVIR MD, V71, P1218; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack Russell A, 2011, Front Neuroinform, V5, P17, DOI 10.3389/fninf.2011.00017; Rao LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041048; Rhoda DA, 1999, ASSESSMENT THUNDERST; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Schriver AT, 2008, HUM FACTORS, V50, P864, DOI 10.1518/001872008X374974; Seo J, 2012, BEHAV BRAIN RES, V229, P185, DOI 10.1016/j.bbr.2012.01.019; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Stearns SC, 2000, J BIOSCIENCES, V25, P221, DOI 10.1007/BF02703928; Taylor JL, 2005, PSYCHOL AGING, V20, P117, DOI 10.1037/0882-7974.20.1.117; Taylor JL, 2007, NEUROLOGY, V68, P648, DOI 10.1212/01.wnl.0000255943.10045.c0; Tunik E, 2009, NEUROIMAGE, V47, P1757, DOI 10.1016/j.neuroimage.2009.04.077; Van Benthem K, 2011, 32 ANN C CO IN PRESS; Wan XH, 2012, J NEUROSCI, V32, P17492, DOI 10.1523/JNEUROSCI.2312-12.2012; Wan XH, 2011, SCIENCE, V331, P341, DOI 10.1126/science.1194732; Wright MJ, 2010, NEUROREPORT, V21, P94, DOI 10.1097/WNR.0b013e328333dff2; Yang JH, 2013, AVIAT SPACE ENVIR MD, V84, P116, DOI 10.3357/ASEM.3372.2013; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yesavage JA, 2011, J GERONTOL B-PSYCHOL, V66, P444, DOI 10.1093/geronb/gbr031	49	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112607	10.1371/journal.pone.0112607	http://dx.doi.org/10.1371/journal.pone.0112607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426935	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400020
J	Horchani, H; de Saint-Jean, M; Barelli, H; Antonny, B				Horchani, Habib; de Saint-Jean, Maud; Barelli, Helene; Antonny, Bruno			Interaction of the Spo20 Membrane-Sensor Motif with Phosphatidic Acid and Other Anionic Lipids, and Influence of the Membrane Environment	PLOS ONE			English	Article							AMPHIPATHIC HELICES; PLASMA-MEMBRANE; CURVATURE; PROTEIN; LOCALIZATION; METABOLISM; MECHANISMS; YEAST; SPECIFICITY; PACKING	The yeast protein Spo20 contains a regulatory amphipathic motif that has been suggested to recognize phosphatidic acid, a lipid involved in signal transduction, lipid metabolism and membrane fusion. We have investigated the interaction of the Spo20 amphipathic motif with lipid membranes using a bioprobe strategy that consists in appending this motif to the end of a long coiled-coil, which can be coupled to a GFP reporter for visualization in cells. The resulting construct is amenable to in vitro and in vivo experiments and allows unbiased comparison between amphipathic helices of different chemistry. In vitro, the Spo20 bioprobe responded to small variations in the amount of phosphatidic acid. However, this response was not specific. The membrane binding of the probe depended on the presence of phosphatidylethanolamine and also integrated the contribution of other anionic lipids, including phosphatidylserine and phosphatidyl-inositol-(4,5) bisphosphate. Inverting the sequence of the Spo20 motif neither affected the ability of the probe to interact with anionic liposomes nor did it modify its cellular localization, making a stereo-specific mode of phosphatidic acid recognition unlikely. Nevertheless, the lipid binding properties and the cellular localization of the Spo20 alpha-helix differed markedly from that of another amphipathic motif, Amphipathic Lipid Packing Sensor (ALPS), suggesting that even in the absence of stereo specific interactions, amphipathic helices can act as subcellular membrane targeting determinants in a cellular context.	[Barelli, Helene] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Valbonne, France; CNRS, F-06560 Valbonne, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Barelli, H (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Valbonne, France.	barelli@ipmc.cnrs.fr; antonny@ipmc.cnrs.fr	Horchani, Habib/AAE-4743-2020; Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; BARELLI, Helene/0000-0001-6376-863X	Agence Nationale de la Recherche [ANR-08-0060-01, LABEX SIGNALIFE ANR-11-LABX-0028-01]; European Research Council [ERC 268888]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Agence Nationale de la Recherche (ANR-08-0060-01 and "Investments for the Future" LABEX SIGNALIFE ANR-11-LABX-0028-01) and by an advanced grant from the European Research Council (ERC 268888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Cardenas J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-56; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Drin G, 2009, FEBS LETT; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Ferraz-Nogueira JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102526; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Klose C, 2013, CURR OPIN CELL BIOL, V25, P406, DOI 10.1016/j.ceb.2013.03.005; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	42	37	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113484	10.1371/journal.pone.0113484	http://dx.doi.org/10.1371/journal.pone.0113484			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426975	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400056
J	Sulkowski, G; Dabrowska-Bouta, B; Salinska, E; Struzynska, L				Sulkowski, Grzegorz; Dabrowska-Bouta, Beata; Salinska, Elzbieta; Struzynska, Lidia			Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain	PLOS ONE			English	Article							GROUP-I; ALTERED EXPRESSION; MULTIPLE-SCLEROSIS; MODEL; EXCITOTOXICITY; CALCIUM; MK-801; GLT-1; NMDA; ENCEPHALOMYELITIS	The etiology of multiple sclerosis (MS) is currently unknown. However, one potential mechanism involved in the disease may be excitotoxicity. The elevation of glutamate in cerebrospinal fluid, as well as changes in the expression of glutamate receptors (iGluRs and mGluRs) and excitatory amino acid transporters (EAATs), have been observed in the brains of MS patients and animals subjected to experimental autoimmune encephalomyelitis (EAE), which is the predominant animal model used to investigate the pathophysiology of MS. In the present paper, the effects of glutamatergic receptor antagonists, including amantadine, memantine, LY 367583, and MPEP, on glutamate transport, the expression of mRNA of glutamate transporters (EAATs), the kinetic parameters of ligand binding to N-methyl-D-aspartate (NMDA) receptors, and the morphology of nerve endings in EAE rat brains were investigated. The extracellular level of glutamate in the brain is primarily regulated by astrocytic glutamate transporter 1 (GLT-1) and glutamate-aspartate transporter (GLAST). Excess glutamate is taken up from the synaptic space and metabolized by astrocytes. Thus, the extracellular level of glutamate decreases, which protects neurons from excitotoxicity. Our investigations showed changes in the expression of EAAT mRNA, glutamate transport (uptake and release) by synaptosomal and glial plasmalemmal vesicle fractions, and ligand binding to NMDA receptors; these effects were partially reversed after the treatment of EAE rats with the NMDA antagonists amantadine and memantine. The antagonists of group I metabotropic glutamate receptors (mGluRs), including LY 367385 and MPEP, did not exert any effect on the examined parameters. These results suggest that disturbances in these mechanisms may play a role in the processes associated with glutamate excitotoxicity and the progressive brain damage in EAE.	[Sulkowski, Grzegorz; Dabrowska-Bouta, Beata; Struzynska, Lidia] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pathoneurochem, Warsaw, Poland; [Salinska, Elzbieta] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pharmaconeurochem, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Sulkowski, G (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Lab Pathoneurochem, Warsaw, Poland.	gsulkowski@imdik.pan.pl	Dąbrowska-Bouta, Beata/X-8384-2018; Sulkowski, Grzegorz/X-8927-2018	Dąbrowska-Bouta, Beata/0000-0002-8625-4559; Sulkowski, Grzegorz/0000-0002-4812-2205; Struzynska, Lidia/0000-0002-9007-792X; Salinska, Elzbieta/0000-0003-4212-221X	Polish Ministry of Science and Higher Education [NN 401620038]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by grant nr NN 401620038 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bolton C, 1997, J PHARMACOL EXP THER, V282, P397; Bolton C, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/mi/2006/93684; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; D'Antoni S, 2011, NEUROBIOL DIS, V42, P252, DOI 10.1016/j.nbd.2011.01.013; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Daniels KK, 1998, NEUROCHEM RES, V23, P103, DOI 10.1023/A:1022413823183; Danysz W, 1997, NEUROSCI BIOBEHAV R, V21, P455, DOI 10.1016/S0149-7634(96)00037-1; DIVAC I, 1977, NATURE, V266, P377, DOI 10.1038/266377a0; Domercq M, 1999, EUR J NEUROSCI, V11, P2226, DOI 10.1046/j.1460-9568.1999.00639.x; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kerschensteiner M, 2004, AM J PATHOL, V164, P1455, DOI 10.1016/S0002-9440(10)63232-4; Lassmann H, 2002, CLIN NEUROL NEUROSUR, V104, P168, DOI 10.1016/S0303-8467(02)00033-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marini AM, 1999, ANN NY ACAD SCI, V890, P421, DOI 10.1111/j.1749-6632.1999.tb08021.x; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Mitosek-Szewczyk K, 2008, NEUROSCIENCE, V155, P45, DOI 10.1016/j.neuroscience.2008.05.025; Ohgoh M, 2002, J NEUROIMMUNOL, V125, P170, DOI 10.1016/S0165-5728(02)00029-2; Otis TS, 2004, NEUROCHEM INT, V45, P537, DOI 10.1016/j.neuint.2003.11.007; Paul C, 2002, J PHARMACOL EXP THER, V302, P50, DOI 10.1124/jpet.302.1.50; PENG L, 1993, DEV NEUROSCI-BASEL, V15, P367, DOI 10.1159/000111357; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Rao VLR, 1998, J NEUROCHEM, V70, P2020; REYNOLDS IJ, 1987, P NATL ACAD SCI USA, V84, P7744, DOI 10.1073/pnas.84.21.7744; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Struzynska L, 2001, TOXICOLOGY, V165, P121, DOI 10.1016/S0300-483X(01)00415-2; Sulkowski G, 2002, EXP TOXICOL PATHOL, V54, P31, DOI 10.1078/0940-2993-00229; Sulkowski G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186068; Sulkowski G, 2013, J NEUROIMMUNOL, V261, P67, DOI 10.1016/j.jneuroim.2013.05.006; Sulkowski G, 2009, FOLIA NEUROPATHOL, V47, P329; Vallejo-Illarramendi A, 2006, NEUROBIOL DIS, V21, P154, DOI 10.1016/j.nbd.2005.06.017; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Wang XD, 1999, NEUROSCI LETT, V272, P21, DOI 10.1016/S0304-3940(99)00567-4; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; YUZAKI M, 1990, BRAIN RES, V517, P51, DOI 10.1016/0006-8993(90)91006-3; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X; Zieminska E, 2006, ACTA NEUROBIOL EXP, V66, P301	47	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113954	10.1371/journal.pone.0113954	http://dx.doi.org/10.1371/journal.pone.0113954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426719	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400105
J	Ventosa-Santaularia, D; Heres, DR; Martinez-Hernandez, LC				Ventosa-Santaularia, Daniel; Heres, David R.; Martinez-Hernandez, L. Catalina			Long-Memory and the Sea Level-Temperature Relationship: A Fractional Cointegration Approach	PLOS ONE			English	Article							LOCAL WHITTLE ESTIMATION; GLOBAL SURFACE-TEMPERATURE	Through thermal expansion of oceans and melting of land-based ice, global warming is very likely contributing to the sea level rise observed during the 20th century. The amount by which further increases in global average temperature could affect sea level is only known with large uncertainties due to the limited capacity of physics-based models to predict sea levels from global surface temperatures. Semi-empirical approaches have been implemented to estimate the statistical relationship between these two variables providing an alternative measure on which to base potentially disrupting impacts on coastal communities and ecosystems. However, only a few of these semi-empirical applications had addressed the spurious inference that is likely to be drawn when one nonstationary process is regressed on another. Furthermore, it has been shown that spurious effects are not eliminated by stationary processes when these possess strong long memory. Our results indicate that both global temperature and sea level indeed present the characteristics of long memory processes. Nevertheless, we find that these variables are fractionally cointegrated when sea-ice extent is incorporated as an instrumental variable for temperature which in our estimations has a statistically significant positive impact on global sea level.	[Ventosa-Santaularia, Daniel; Heres, David R.] CIDE, Div Econ, Mexico City, DF, Mexico; [Martinez-Hernandez, L. Catalina] Univ Konstanz, Dept Econ, Constance, Germany	Centro de Investigacion y Docencia Economicas A.C. (CIDE); University of Konstanz	Heres, DR (corresponding author), CIDE, Div Econ, Mexico City, DF, Mexico.	david.heres@cide.edu	Ventosa-Santaulària, Daniel/M-1533-2013	Heres, David/0000-0002-1193-8083				Bosello F, 2007, ENVIRON RESOUR ECON, V37, P549, DOI 10.1007/s10640-006-9048-5; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cameron C., 2005, MICROECONOMETRICS US, P1056; Cazenave A, 2014, NAT CLIM CHANGE, V4, P358, DOI [10.1038/nclimate2159, 10.1038/NCLIMATE2159]; CHEUNG YW, 1993, J BUS ECON STAT, V11, P103, DOI 10.2307/1391310; Church J., 2011, SURV GEOPHYS, V32, P1; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; DIEBOLD FX, 1991, ECON LETT, V35, P155, DOI 10.1016/0165-1765(91)90163-F; Dolado JJ, 2002, ECONOMETRICA, V70, P1963, DOI 10.1111/1468-0262.00359; Galeotti M, 2009, ENVIRON RESOUR ECON, V42, P551, DOI 10.1007/s10640-008-9224-x; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; GRANGER CWJ, 1986, OXFORD B ECON STAT, V48, P213, DOI 10.1111/j.1468-0084.1986.mp48003002.x; Grassi S, 2013, DYNAM ATMOS OCEANS, V64, P1, DOI 10.1016/j.dynatmoce.2013.07.001; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; HOSKING JRM, 1981, BIOMETRIKA, V68, P165, DOI 10.1093/biomet/68.1.165; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jevrejeva S, 2006, J GEOPHYS RES, V111; Jones PD, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000143; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Palma W., 2007, LONG MEMORY TIME SER; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Schmith T, 2012, J CLIMATE, V25, P7822, DOI 10.1175/JCLI-D-11-00598.1; Schmith T, 2007, SCIENCE, V317, DOI 10.1126/science.1143286; Shimotsu K, 2005, ANN STAT, V33, P1890, DOI 10.1214/009053605000000309; Shimotsu K, 2012, J ECONOMETRICS, V169, P266, DOI 10.1016/j.jeconom.2012.01.028; Shimotsu K, 2010, ECONOMET THEOR, V26, P501, DOI 10.1017/S0266466609100075; SOWELL F, 1992, J ECONOMETRICS, V53, P165, DOI 10.1016/0304-4076(92)90084-5; Stammer D, 2013, ANNU REV MAR SCI, V5, P21, DOI 10.1146/annurev-marine-121211-172406; Tsay WJ, 2000, J ECONOMETRICS, V96, P155, DOI 10.1016/S0304-4076(99)00056-1; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113439	10.1371/journal.pone.0113439	http://dx.doi.org/10.1371/journal.pone.0113439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426638	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400052
J	Jakobsen, AK; Jacobsson, LTH; Patschan, O; Askling, J; Kristensen, LE				Jakobsen, Ane Krag; Jacobsson, Lennart T. H.; Patschan, Oliver; Askling, Johan; Kristensen, Lars Erik			Is Nephrolithiasis an Unrecognized Extra-Articular Manifestation in Ankylosing Spondylitis? A Prospective Population-Based Swedish National Cohort Study with Matched General Population Comparator Subjects	PLOS ONE			English	Article							KIDNEY-STONES; DISEASE-ACTIVITY; PREVALENCE; MANAGEMENT; UROLITHIASIS; BONE; SPONDYLOARTHROPATHIES; SWEDEN; TRENDS; SERUM	Background: Ankylosing spondylitis (AS) is associated with several extra-articular manifestations. Nephrolithiasis (NL) has not been recognized as one of those, however, several factors known to increase the risk of NL are at play in AS patients. The objective was to estimate rates and predictors of NL in Swedish patients with AS compared to the general population. Methods and Findings: We performed a prospective population-based nationwide cohort study based on linkage of data from Swedish registries. 8,572 AS patients were followed for 49,258 person-years (py) and 39,639 matched general population comparators were followed for 223,985 py. Patients were followed prospectively together with comparator subjects from January 2001 through December 2009. The first occurrence of NL during follow-up was the primary outcome. Hazard Ratios (HR) were used to compare these rates adjusting for comorbidities and treatment, and to assess predictors for NL. Mean age at study entry was 46 years (inter quartile range 36-56 years), 65% were males. Based on 250 vs. 466 NL events, the adjusted HR of NL in AS patients was 2.1 (95% CI 1.8 to 2.4). Predictors of NL within the AS group included prior diagnosis of inflammatory bowel disease (IBD) (HR 2.3; 95% CI 1.7 to 3.3), prior diagnosis of NL (HR 16.4; 95% CI 11.5 to 23.4), and patients receiving anti-TNF treatment (HR 1.6; 95% CI 1.2 to 2.1). Male sex was a risk factor for NL both in AS patients and in the general population. Limitations: The risk for residual confounding and inability to study the chemical nature of NL were considered the main limitations of the study. Conclusions: Patients with AS are at increased risk of NL, which may be considered a novel extra-articular manifestation. Previous history of NL, IBD, AS disease severity and male sex were identified as predictors of NL in AS.	[Jakobsen, Ane Krag; Patschan, Oliver] Skane Univ, Dept Urol, Malmo, Sweden; [Jacobsson, Lennart T. H.; Kristensen, Lars Erik] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Askling, Johan] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Rheumatol Unit, Dept Med Solna, Stockholm, Sweden; [Kristensen, Lars Erik] Parker Inst, Frederiksberg, Denmark; [Kristensen, Lars Erik] Dept Rheumatol, Bispebjerg, Denmark; [Jacobsson, Lennart T. H.] Lund Univ, Dept Rheumatol, Malmo, Sweden	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Lund University	Kristensen, LE (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	larserik_kristensen@yahoo.com	Kristensen, Lars Erik/AAZ-2615-2020	Patschan, Oliver/0000-0001-5788-794X	Lund University; Oak foundation; Skane region; Osterlund Foundation; Kock Foundation; Reumatikerforbundet, The Swedish Foundation for Strategic Research	Lund University; Oak foundation; Skane region; Osterlund Foundation; Kock Foundation; Reumatikerforbundet, The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by unrestricted non-profitable organization grants from Lund University, the Oak foundation, The Skane region, Osterlund and Kock Foundations, and Reumatikerforbundet, The Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Bakland G, 2005, ARTHRIT RHEUM-ARTHR, V53, P850, DOI 10.1002/art.21577; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Cury DB, 2013, INT J NEPHROL RENOV, V6, P139, DOI 10.2147/IJNRD.S45466; Daudon M, 2004, DRUGS, V64, P245, DOI 10.2165/00003495-200464030-00003; Fallahi S, 2012, CASP J INTERN MED, V3, P508; Forsberg L, 2009, UTSKRIVNINGAR SLUTEN; Haglund E, 2011, ANN RHEUM DIS, V70, P943, DOI 10.1136/ard.2010.141598; Hess B, 1998, Curr Opin Urol, V8, P331, DOI 10.1097/00042307-199807000-00013; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; Hueppelshaeuser R, 2012, PEDIATR NEPHROL, V27, P1103, DOI 10.1007/s00467-012-2126-8; Incel NA, 2006, CLIN RHEUMATOL, V25, P667, DOI 10.1007/s10067-005-0114-0; Jordan KP, 2014, ANN RHEUM DIS, V73, P212, DOI 10.1136/annrheumdis-2012-202634; KaipianenSeppanen O, 1997, J RHEUMATOL, V24, P496; Klingberg E, 2012, SCAND J GASTROENTERO, V47, P435, DOI 10.3109/00365521.2011.648953; Korkmaz C, 2005, CLIN EXP RHEUMATOL, V23, P389; Lange U, 2005, OSTEOPOROSIS INT, V16, P1999, DOI 10.1007/s00198-005-1990-5; Lange U, 2001, OSTEOPOROSIS INT, V12, P1031, DOI 10.1007/s001980170013; Lee SH, 2013, RHEUMATOL INT, V33, P1689, DOI 10.1007/s00296-012-2624-9; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; MIELANTS H, 1995, J RHEUMATOL, V22, P2279; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Orlando A, 2009, WORLD J GASTROENTERO, V15, P2443, DOI 10.3748/wjg.15.2443; Rimbas M, 2011, WORLD J GASTROENTERO, V17, P1030, DOI 10.3748/wjg.v17.i8.1030; Romero Victoriano, 2010, Rev Urol, V12, pe86; Russinko PJ, 2003, UROLOGY, V62, DOI 10.1016/S0090-4295(03)00666-6; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Sakhaee K, 2011, KIDNEY INT, V79, P393, DOI 10.1038/ki.2010.473; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Strobel ES, 1998, CLIN RHEUMATOL, V17, P524, DOI 10.1007/BF01451293; Tiselius HG, 2011, EUR UROL SUPPL, V10, P408, DOI 10.1016/j.eursup.2011.07.002; Vilar MJP, 1997, SCAND J RHEUMATOL, V26, P19, DOI 10.3109/03009749709065659; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034	36	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113602	10.1371/journal.pone.0113602	http://dx.doi.org/10.1371/journal.pone.0113602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423471	gold, Green Submitted, Green Published			2022-12-27	WOS:000345899700042
J	Cunha, MG; Silva, ES; Sepulveda, N; Costa, SPT; Saboia, TC; Guerreiro, JF; Povoa, MM; Corran, PH; Riley, E; Drakeley, CJ				Cunha, Maristela G.; Silva, Eliane S.; Sepulveda, Nuno; Costa, Sheyla P. T.; Saboia, Tiago C.; Guerreiro, Joao F.; Povoa, Marinete M.; Corran, Patrick H.; Riley, Eleanor; Drakeley, Chris J.			Serologically Defined Variations in Malaria Endemicity in Para State, Brazil	PLOS ONE			English	Article							PLASMODIUM-VIVAX TRANSMISSION; MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGIONS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; FALCIPARUM; INFECTION; EXPOSURE; SEROEPIDEMIOLOGY; POPULATIONS	Background: Measurement of malaria endemicity is typically based on vector or parasite measures. A complementary approach is the detection of parasite specific IgG antibodies. We determined the antibody levels and seroconversion rates to both P. vivax and P. falciparum merozoite antigens in individuals living in areas of varying P. vivax endemicity in Para state, Brazilian Amazon region. Methodology/Principal Findings: The prevalence of antibodies to recombinant antigens from P. vivax and P. falciparum was determined in 1,330 individuals. Cross sectional surveys were conducted in the north of Brazil in Anaja's, Belem, Goianesia do Para, Jacareacanga, Itaituba, Trairao, all in the Para state, and Sucuriju, a free-malaria site in the neighboring state Amapa. Seroprevalence to any P. vivax antigens (MSP1 or AMA-1) was 52.5%, whereas 24.7% of the individuals were seropositive to any P. falciparum antigens (MSP1 or AMA-1). For P. vivax antigens, the seroconversion rates (SCR) ranged from 0.005 (Sucuriju) to 0.201 (Goianesia do Para '), and are strongly correlated to the corresponding Annual Parasite Index (API). We detected two sites with distinct characteristics: Goianesia do Para ' where seroprevalence curve does not change with age, and Sucuriju where seroprevalence curve is better described by a model with two SCRs compatible with a decrease in force of infection occurred 14 years ago (from 0.069 to 0.005). For P. falciparum antigens, current SCR estimates varied from 0.002 (Belem) to 0.018 (Goianesia do Para '). We also detected a putative decrease in disease transmission occurred similar to 29 years ago in Anajas, Goianesia do Para, Itaituba, Jacareacanga, and Trairao. Conclusions: We observed heterogeneity of serological indices across study sites with different endemicity levels and temporal changes in the force of infection insome of the sites. Our study provides further evidence that serology can be used to measure and monitor transmission of both major species of malaria parasite.	[Cunha, Maristela G.; Silva, Eliane S.; Costa, Sheyla P. T.; Saboia, Tiago C.; Guerreiro, Joao F.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Cunha, Maristela G.; Sepulveda, Nuno; Corran, Patrick H.; Riley, Eleanor; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Povoa, Marinete M.] Inst Evandro Chagas, Ananindeua, Para, Brazil	Universidade Federal do Para; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; Instituto Evandro Chagas	Cunha, MG (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	mgcunha@ufpa.br	Riley, Eleanor M/C-8960-2013; Sepulveda, Nuno/AAA-5544-2021; Riley, Eleanor/AAL-1382-2020; Povoa, Marinete Marins/C-7039-2017; Sepulveda, Nuno/S-9936-2019	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Povoa, Marinete Marins/0000-0003-3517-2227; Saboia, Tiago/0000-0002-3093-1872; Sepulveda, Nuno/0000-0002-8542-1706	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria [555654/2009-5]; FAPESPA; VALE S.A./ICAAF [070/2011]; FAPESPA/PPSUS/MS/ICAAF [182/2012]; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1240-10-2]; Fundacao para Ciencia e Tecnologia [Pest-OE-MAT-UI0006/2011]; Wellcome Trust [091924]	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); VALE S.A./ICAAF; FAPESPA/PPSUS/MS/ICAAF; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and FAPESPA-Fundacao Amazonia Paraense de Pesquisa, under the Rede Paraense de Malaria, Processo 555654/2009-5, FAPESPA and VALE S.A./ICAAF 070/2011 and FAPESPA/PPSUS/MS/ICAAF 182/2012. MGC acknowledges financial support from CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/studentship/Processo 1240-10-2. NS was supported by Fundacao para Ciencia e Tecnologia project Pest-OE-MAT-UI0006/2011. CJD and NS are supported by the Wellcome Trust (grant number 091924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Brasil P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-122; Bruce-Chwatt L. J., 1986, Memorias do Instituto Oswaldo Cruz, V81, P1, DOI 10.1590/S0074-02761986000600001; Carvalho LH, 1999, AM J TROP MED HYG, V60, P674, DOI 10.4269/ajtmh.1999.60.674; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; de Oliveira EC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-177; DECARVALHO ME, 1992, MEM I OSWALDO CRUZ, V87, P205, DOI 10.1590/S0074-02761992000200006; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Griffing SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058984; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; KAGAN IG, 1968, AM J TROP MED HYG, V17, P392, DOI 10.4269/ajtmh.1968.17.392; Kagan IG, 1969, WHOMAL69694, P1; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Ministerio da Saude, 2009, MAN DIAGN LAB MAL; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Morais CG, 2006, AM J TROP MED HYG, V75, P582, DOI 10.4269/ajtmh.2006.75.582; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ondigo BN, 2014, J INFECT DIS, V8; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y; Soares IS, 1999, ACTA TROP, V72, P13, DOI 10.1016/S0001-706X(98)00078-3; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Stevenson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077641; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Stresman GH, 2014, EPIDEMIOL INFECT, V142, P1978, DOI 10.1017/S0950268814000946; TAUIL P L, 1986, Memorias do Instituto Oswaldo Cruz, V81, P39, DOI 10.1590/S0074-02761986000600006; Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340; WHO Global Malaria Programme, 2011, WORLD MALARIA REPORT; Wickramarachchi T, 2006, INFECT IMMUN, V74, P798, DOI 10.1128/IAI.74.1.798-801.2006; Yee TW, 2010, J STAT SOFTW, V32, P1; [No title captured]	50	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113357	10.1371/journal.pone.0113357	http://dx.doi.org/10.1371/journal.pone.0113357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419900	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000346766900031
J	Kakehashi, A; Kato, A; Ishii, N; Wei, M; Morimura, K; Fukushima, S; Wanibuchi, H				Kakehashi, Anna; Kato, Ayumi; Ishii, Naomi; Wei, Min; Morimura, Keiichirou; Fukushima, Shoji; Wanibuchi, Hideki			Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling	PLOS ONE			English	Article							LIVER CELL-PROLIFERATION; VALERENIC ACID; FUNCTIONAL REGULATION; OXIDATIVE STRESS; HEPATIC FOCI; STEM; PHARMACOLOGY; EXPRESSION; APOPTOSIS; SUBTYPES	Valerian is widely used as a traditional medicine to improve the quality of sleep due to interaction of several active components with the c-aminobutyric acid (GABA) A receptor (GABA(A)R) system. Recently, activation of GABA signaling in stem cells has been reported to suppress cell cycle progression in vivo. Furthermore, possible inhibitory effects of GABA(A) R agonists on hepatocarcinogenesis have been reported. The present study was performed to investigate modulating effects of Valerian on hepatocarcinogenesis using a medium-term rat liver bioassay. Male F344 rats were treated with one of the most powerful Valerian species (Valeriana sitchensis) at doses of 0, 50, 500 and 5000 ppm in their drinking water after initiation of hepatocarcinogenesis with diethylnitrosamine (DEN). Formation of glutathione S-transferase placental form positive (GST-P+) foci was significantly inhibited by Valerian at all applied doses compared with DEN initiation control rats. Generation of 8-hydroxy-29-deoxyguanosine in the rat liver was significantly suppressed by all doses of Valerian, likely due to suppression of Nrf2, CYP7A1 and induction of catalase expression. Cell proliferation was significantly inhibited, while apoptosis was induced in areas of GST-P+ foci of Valerian groups associated with suppression of c-myc, Mafb, cyclin D1 and induction of p21(Waf1/Cip1), p53 and Bax mRNA expression. Interestingly, expression of the GABA(A) R alpha 1 subunit was observed in GST-P+ foci of DEN control rats, with significant elevation associated with Valerian treatment. These results indicate that Valerian exhibits inhibitory effects on rat hepatocarcinogenesis by inhibiting oxidative DNA damage, suppressing cell proliferation and inducing apoptosis in GST-P+ foci by activating GABA(A) R-mediated signaling.	[Kakehashi, Anna; Kato, Ayumi; Ishii, Naomi; Wei, Min; Morimura, Keiichirou; Fukushima, Shoji; Wanibuchi, Hideki] Osaka City Univ, Dept Mol Pathol, Grad Sch Med, Osaka 558, Japan	Osaka Metropolitan University	Kakehashi, A (corresponding author), Osaka City Univ, Dept Mol Pathol, Grad Sch Med, Osaka 558, Japan.	anna@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020; Wei, Min/GSI-8510-2022	Kakehashi, Anna/0000-0003-1149-1450; 	Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan. URL: http://www.mhlw.go.jp/english/. No number was supported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, CURR CANCER DRUG TAR, V12, P97; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Beaubrun G, 2000, PSYCHIATR SERV, V51, P1130, DOI 10.1176/appi.ps.51.9.1130; Behar TN, 1998, J NEUROSCI, V18, P6378; Biju Mangatt P, 2002, J Biochem Mol Biol Biophys, V6, P209, DOI 10.1080/10258140290018667; Biju MP, 2002, NEUROCHEM RES, V27, P905, DOI 10.1023/A:1020391514995; Biju MP, 2001, HEPATOL RES, V21, P136, DOI 10.1016/S1386-6346(01)00092-4; Bos R, 1998, PLANTA MED, V64, P143, DOI 10.1055/s-2006-957392; BOUNTHANH C, 1981, PLANTA MED, V41, P21, DOI 10.1055/s-2007-971668; Chen K, 2005, BRAIN RES BULL, V67, P310, DOI 10.1016/j.brainresbull.2005.07.004; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Eadie MJ, 2004, EPILEPSIA, V45, P1338, DOI 10.1111/j.0013-9580.2004.27904.x; FOERSTER W, 1984, PLANTA MED, V50, P7, DOI 10.1055/s-2007-969605; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GESSNER B, 1984, EEG-EMG-Z ELEK ELEKT, V15, P45; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; IMAIDA K, 1989, JPN J CANCER RES, V80, P326, DOI 10.1111/j.1349-7006.1989.tb02314.x; JONES HB, 1993, ARCH TOXICOL, V67, P622, DOI 10.1007/BF01974069; Kakehashi A, 2009, TOXICOL APPL PHARM, V238, P71, DOI 10.1016/j.taap.2009.04.018; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Kinoshita A, 2003, CARCINOGENESIS, V24, P1389, DOI 10.1093/carcin/bgg079; Kinoshita A, 2002, CARCINOGENESIS, V23, P341, DOI 10.1093/carcin/23.2.341; Kitano M, 1998, CARCINOGENESIS, V19, P1475, DOI 10.1093/carcin/19.8.1475; Leathwood P. D., 1985, PLANTA MED, V2, P144; LU FC, 1988, REGUL TOXICOL PHARM, V8, P45, DOI 10.1016/0273-2300(88)90006-2; Morazzoni P., 1995, Fitoterapia, V66, P99; Mowrey D, 1986, MEANING VALERIAN ROO, P12; Navarrete A, 2006, J AOAC INT, V89, P8; Obrietan K, 1998, J NEUROPHYSIOL, V79, P1360, DOI 10.1152/jn.1998.79.3.1360; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pradeep K, 2007, EUR J PHARMACOL, V560, P110, DOI 10.1016/j.ejphar.2006.12.023; Ramharter J, 2009, ORG LETT, V11, P1151, DOI 10.1021/ol9000137; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanders S, 1999, CARCINOGENESIS, V20, P41, DOI 10.1093/carcin/20.1.41; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schuller HM, 2012, CURR CANCER THER REV, V8, P116, DOI 10.2174/157339412800675351; SCHULTZ V, 1998, RATIONAL PHYTOTHERAP; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Tsuda H, 2003, TOXICOL PATHOL, V31, P80, DOI 10.1080/01926230390173879; Weng Y, 2009, ANESTH ANALG, V108, P1538, DOI 10.1213/ane.0b013e31819cd964; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	45	11	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113610	10.1371/journal.pone.0113610	http://dx.doi.org/10.1371/journal.pone.0113610			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419570	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900056
J	Mahdi, M; Matuz, K; Toth, F; Tozser, J				Mahdi, Mohamed; Matuz, Krisztina; Toth, Ferenc; Tozser, Jozsef			A Modular System to Evaluate the Efficacy of Protease Inhibitors against HIV-2	PLOS ONE			English	Article							VIRUS TYPE-2 HIV-2; GENE TRANSDUCTION; IMMUNODEFICIENCY; RESISTANCE; SUSCEPTIBILITY; PROTEINASES; INFECTION; SUBTYPE; IDENTIFICATION; PREVALENCE	The human immunodeficiency virus (HIV) protease is a homodimeric aspartyl protease that is crucial for the viral life-cycle, cleaving proviral polyproteins, hence creating mature protein components that are required for the formation of an infectious virus. With diagnostic measures and clinically used protease inhibitors focusing on HIV-1, due to its higher virulence and prevalence, studies of the efficacy of those inhibitors on HIV-2 protease remain widely lacking. Utilizing a wildtype HIV-2 vector backbone and cloning techniques we have developed a cassette system where the efficacy of clinically used protease inhibitors can be studied for various serotypes of HIV-2 protease both in enzymatic and cell culture assays. In our experiments, optimization of the expression protocol led to a relatively stable enzyme, for cell culture assays, the efficiency of transfection and transduction capability of the modified vector was tested and was not found to differ from that of the wild-type, moreover, a 2nd generation protease inhibitor was used to demonstrate the usefulness of the system. The combination of assays performed with our cassette system is expected to provide an accurate measure of the efficacy of currently used; as well as experimental protease inhibitors on HIV-2.	[Mahdi, Mohamed; Matuz, Krisztina; Toth, Ferenc; Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Lab Retroviral Biochem, H-4012 Debrecen, Hungary	University of Debrecen	Mahdi, M (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Lab Retroviral Biochem, H-4012 Debrecen, Hungary.	mohamed@med.unideb.hu; tozser@med.unideb.hu	Tozser, Jozsef/A-7840-2008; MAHDI, MOHD ADZIR/AAH-6171-2021; BIN MAHDI / ENG, MOHD ADZIR/AAD-8841-2020; Mahdi, Mohamed/AAH-6423-2021	Tozser, Jozsef/0000-0003-0274-0056; MAHDI, MOHD ADZIR/0000-0002-2843-181X; mahdi, mohamed/0000-0002-7959-5996; Toth, Ferenc/0000-0002-1170-6274	TAMOP "VED-ELEM" project [4.2.2.A-11/1/KONV-2012-0023]; Hungarian Science and Research Fund [K-101591]	TAMOP "VED-ELEM" project; Hungarian Science and Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported in part by the TAMOP 4.2.2.A-11/1/KONV-2012-0023 "VED-ELEM" project and by the Hungarian Science and Research Fund (K-101591 to J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHORN P, 1990, P NATL ACAD SCI USA, V87, P7472, DOI 10.1073/pnas.87.19.7472; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; Bock PJ, 2001, AIDS, V15, pS35, DOI 10.1097/00002030-200100005-00006; Brower ET, 2008, CHEM BIOL DRUG DES, V71, P298, DOI 10.1111/j.1747-0285.2008.00647.x; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Carvalho AC, 2012, HIV MED, V13, P219, DOI 10.1111/j.1468-1293.2011.00963.x; Charpentier C, 2013, CLIN INFECT DIS, V56, P1654, DOI 10.1093/cid/cit104; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Damond F, 2005, J CLIN MICROBIOL, V43, P484, DOI 10.1128/JCM.43.1.484-487.2005; Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; GUSTCHINA A, 1991, PROTEINS, V10, P325, DOI 10.1002/prot.340100406; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Miklossy G, 2008, PROTEIN ENG DES SEL, V21, P453, DOI 10.1093/protein/gzn022; Mukherjee S, 2007, J BIOTECHNOL, V127, P745, DOI 10.1016/j.jbiotec.2006.08.004; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P604, DOI 10.1128/AAC.00870-06; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pieniazek D, 2004, AIDS, V18, P495, DOI 10.1097/00002030-200402200-00016; Rodes B, 2006, J ANTIMICROB CHEMOTH, V57, P709, DOI 10.1093/jac/dkl034; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; TOZSER J, 1992, BIOCHEMISTRY-US, V31, P4793, DOI 10.1021/bi00135a008; TOZSER J, 1991, FEBS LETT, V279, P356, DOI 10.1016/0014-5793(91)80186-7; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Zhang X, 2010, J GENE MED, V12, P945, DOI 10.1002/jgm.1518	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113221	10.1371/journal.pone.0113221	http://dx.doi.org/10.1371/journal.pone.0113221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419967	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900025
J	Pan, SC; Chen, HH; Correia, C; Dai, HM; Witt, TA; Kleppe, LS; Burnett, JC; Simari, RD				Pan, Shuchong; Chen, Horng H.; Correia, Cristina; Dai, Haiming; Witt, Tyra A.; Kleppe, Laurel S.; Burnett, John C., Jr.; Simari, Robert D.			Cell Surface Protein Disulfide Isomerase Regulates Natriuretic Peptide Generation of Cyclic Guanosine Monophosphate	PLOS ONE			English	Article							RECEPTOR EXTRACELLULAR DOMAIN; THIOL/DISULFIDE EXCHANGE; ROTATION MECHANISM; MEMBRANE-FUSION; FAMILY; ACTIVATION; EXPRESSION; PATHWAYS; CYCLASE; PDI	Rationale: The family of natriuretic peptides (NPs), including atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), exert important and diverse actions for cardiovascular and renal homeostasis. The autocrine and paracrine functions of the NPs are primarily mediated through the cellular membrane bound guanylyl cyclase-linked receptors GC-A (NPR-A) and GC-B (NPR-B). As the ligands and receptors each contain disulfide bonds, a regulatory role for the cell surface protein disulfide isomerase (PDI) was investigated. Objective: We utilized complementary in vitro and in vivo models to determine the potential role of PDI in regulating the ability of the NPs to generate its second messenger, cyclic guanosine monophosphate. Methods and Results: Inhibition of PDI attenuated the ability of ANP, BNP and CNP to generate cGMP in human mesangial cells (HMCs), human umbilical vein endothelial cells (HUVECs), and human aortic smooth muscle cells (HASMCs), each of which were shown to express PDI. In LLC-PK1 cells, where PDI expression was undetectable by immunoblotting, PDI inhibition had a minimal effect on cGMP generation. Addition of PDI to cultured LLC-PK1 cells increased intracellular cGMP generation mediated by ANP. Inhibition of PDI in vivo attenuated NP-mediated generation of cGMP by ANP. Surface Plasmon Resonance demonstrated modest and differential binding of the natriuretic peptides with immobilized PDI in a cell free system. However, PDI was shown to co-localize on the surface of cells with GC-A and GC-B by co-immunoprecpitation and immunohistochemistry. Conclusion: These data demonstrate for the first time that cell surface PDI expression and function regulate the capacity of natriuretic peptides to generate cGMP through interaction with their receptors.	[Pan, Shuchong; Chen, Horng H.; Witt, Tyra A.; Kleppe, Laurel S.; Burnett, John C., Jr.; Simari, Robert D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55902 USA; [Correia, Cristina; Dai, Haiming] Mayo Clin, Div Oncol Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Simari, RD (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55902 USA.	rsimari@kumc.edu		Dai, Haiming/0000-0002-0484-7407; Correia, Cristina/0000-0002-9464-7555	Anexon, Inc.; Mayo Clinic Foundation; NIH [HL36634, HL76611, HL83231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076611, R01HL036634, R01HL083231] Funding Source: NIH RePORTER	Anexon, Inc.; Mayo Clinic Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research funding was obtained from Anexon, Inc., the Mayo Clinic Foundation, and NIH grants HL36634, HL76611, and HL83231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Dusterhoft S, 2013, J AM CHEM SOC, V135, P5776, DOI 10.1021/ja400340u; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Khambata RS, 2011, BRIT J PHARMACOL, V164, P584, DOI 10.1111/j.1476-5381.2011.01400.x; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Misono KS, 2005, PEPTIDES, V26, P957, DOI 10.1016/j.peptides.2004.12.021; Miyagi M, 2000, BBA-PROTEIN STRUCT M, V1478, P30, DOI 10.1016/S0167-4838(00)00002-9; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Pan SC, 2009, P NATL ACAD SCI USA, V106, P11282, DOI 10.1073/pnas.0811851106; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Puggina E, 2004, MOL CELL ENDOCRINOL, V219, P161, DOI 10.1016/j.mce.2003.12.015; Robinson JW, 2012, SCI SIGNAL, V4, P5; Rogelj S, 2000, BIOCHEM BIOPH RES CO, V273, P829, DOI 10.1006/bbrc.2000.3029; Toldo S, 2011, METHOD ENZYMOL, V489, P47, DOI 10.1016/B978-0-12-385116-1.00003-0; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Versteeg HH, 2011, CURR OPIN HEMATOL, V18, P343, DOI 10.1097/MOH.0b013e32834981de; Vogel Mark W, 2011, Curr Heart Fail Rep, V8, P22, DOI 10.1007/s11897-010-0038-0	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112986	10.1371/journal.pone.0112986	http://dx.doi.org/10.1371/journal.pone.0112986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419565	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900014
J	Besser, J; Malan, D; Wystub, K; Bachmann, A; Wietelmann, A; Sasse, P; Fleischmann, BK; Braun, T; Boettger, T				Besser, Johannes; Malan, Daniela; Wystub, Katharina; Bachmann, Angela; Wietelmann, Astrid; Sasse, Philipp; Fleischmann, Bernd K.; Braun, Thomas; Boettger, Thomas			MiRNA-1/133a Clusters Regulate Adrenergic Control of Cardiac Repolarization	PLOS ONE			English	Article							LONG-QT SYNDROME; NA+ CHANNEL BLOCKADE; K+ CURRENT; HEART-RATE; IN-VITRO; MICE; MODEL; HYPERTROPHY; DYSFUNCTION; ARRHYTHMIAS	The electrical properties of the heart are primarily determined by the activity of ion channels and the activity of these molecules is permanently modulated and adjusted to the physiological needs by adrenergic signaling. miRNAs are known to control the expression of many proteins and to fulfill distinct functions in the mammalian heart, though the in vivo effects of miRNAs on the electrical activity of the heart are poorly characterized. The miRNAs miR-1 and miR-133a are the most abundant miRNAs of the heart and are expressed from two miR-1/133a genomic clusters. Genetic modulation of miR-1/133a cluster expression without concomitant severe disturbance of general cardiomyocyte physiology revealed that these miRNA clusters govern cardiac muscle repolarization. Reduction of miR-1/133a dosage induced a longQT phenotype in mice especially at low heart rates. Longer action potentials in cardiomyocytes are caused by modulation of the impact of beta-adrenergic signaling on the activity of the depolarizing L-type calcium channel. Pharmacological intervention to attenuate beta-adrenergic signaling or L-type calcium channel activity in vivo abrogated the longQT phenotype that is caused by modulation of miR-1/133a activity. Thus, we identify the miR-1/133a miRNA clusters to be important to prevent a longQT-phenotype in the mammalian heart.	[Besser, Johannes; Wystub, Katharina; Bachmann, Angela; Wietelmann, Astrid; Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Malan, Daniela; Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Inst Physiol 1, Life & Brain Ctr, D-53115 Bonn, Germany	Max Planck Society; University of Bonn	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	thomas.boettger@mpi-bn.mpg.de; thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Boettger, Thomas/E-3406-2012; Sasse, Philipp/G-9866-2013	Boettger, Thomas/0000-0003-4280-8449; Sasse, Philipp/0000-0002-8502-9472; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society; Excellence Cluster Cardiopulmonary System	Max-Planck-Society(Max Planck Society); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG))	The work was supported by the Max-Planck-Society (www.mpg.de) and the Excellence Cluster Cardiopulmonary System (www.eccps.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2012, J MOL CELL CARDIOL, V52, P1027, DOI 10.1016/j.yjmcc.2012.01.020; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Drum BML, 2014, J MOL CELL CARDIOL, V66, P63, DOI 10.1016/j.yjmcc.2013.10.021; Fischer TH, 2013, J MOL CELL CARDIOL, V58, P182, DOI 10.1016/j.yjmcc.2012.11.003; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; JIA X, 2013, PLOS ONE, V8; Knollmann BC, 2004, J PHARMACOL EXP THER, V310, P311, DOI 10.1124/jpet.103.063743; Larson AC, 2004, MAGN RESON MED, V51, P93, DOI 10.1002/mrm.10664; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; MORRIS SA, 1989, J AM COLL CARDIOL, V14, P782, DOI 10.1016/0735-1097(89)90126-5; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Priori SG, 1996, CIRC RES, V78, P1009, DOI 10.1161/01.RES.78.6.1009; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Ridley JM, 2003, J PHYSIOL-LONDON, V549, P667, DOI 10.1113/jphysiol.2003.043976; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Takenaka K, 2003, CIRCULATION, V107, P838, DOI 10.1161/01.CIR.0000048142.85076.A2; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Tranquillo JV, 2005, EUROPACE, V7, pS56, DOI 10.1016/j.eupc.2005.03.015; Wang L, 1996, CIRC RES, V79, P79, DOI 10.1161/01.RES.79.1.79; Webster G, 2013, CIRCULATION, V127, P126, DOI 10.1161/CIRCULATIONAHA.111.060343; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113449	10.1371/journal.pone.0113449	http://dx.doi.org/10.1371/journal.pone.0113449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415383	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600048
J	Liu, H; Zhao, J; Xing, YB; Li, M; Du, MM; Suo, JJ; Liu, YX				Liu, Hui; Zhao, Jin; Xing, Yubin; Li, Meng; Du, Mingmei; Suo, Jijiang; Liu, Yunxi			Nosocomial Infection in Adult Admissions with Hematological Malignancies Originating from Different Lineages: A Prospective Observational Study	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; BLOOD-STREAM INFECTIONS; CANCER-PATIENTS; BONE-MARROW; MYELOID NEOPLASMS; LYMPHOID-TISSUES; ACUTE-LEUKEMIA; RISK-FACTORS; CLASSIFICATION; EPIDEMIOLOGY	Background: Nosocomial infection (NI) causes prolonged hospital stays, increased healthcare costs, and higher mortality among patients with hematological malignancies (HM). However, few studies have compared the incidence of NI according to the HM lineage. Objective: To compare the incidence of NI according to the type of HM lineage, and identify the risk factors for NI. Methods: This prospective observational study monitored adult patients with HM admitted for >48 hours to the General Hospital of the People's Liberation Army during 2010-2013. Attack rates and incidences of NI were compared, and multivariable logistic regression was used to control for confounding effects. Results: This study included 6,613 admissions from 1,922 patients. During these admissions, 1,023 acquired 1,136 NI episodes, with an attack rate of 15.47% and incidence of 9.6 parts per thousand (95% CI: 9.1-10.2). Higher rates and densities of NIs were observed among myeloid neoplasm (MN) admissions, compared to lymphoid neoplasm (LN) admissions (28.42% vs. 11.00%, P<0.001 and 11.4% vs. 8.4 parts per thousand, P<0.001). NI attack rates in acute myeloid leukemia (AML) and myelodysplastic/myeloproliferative neoplasm (MDS/MPN) were higher than those in MDS (30.69% vs. 20.19%, P<0.001; 38.89% vs. 20.19%, P=0.003). Attack rates in T/NK-cell neoplasm and B-cell neoplasm were higher than those in Hodgkin lymphoma (15.04% vs. 3.65%; 10.94% vs. 3.65%, P<0.001). Multivariable regression analysis indicated prolonged hospitalization, presence of central venous catheterization, neutropenia, current stem cell transplant, infection on admission, and old age were independently associated with higher NI incidence. After adjusting for these factors, MN admissions still had a higher risk of infection (odds ratio 1.34, 95% CI: 1.13-1.59, P<0.001). Conclusion: Different NI attack rates were observed for HM from different lineages, with MN lineages having a higher attack rate and incidence than LN lineages. Special attention should be paid to MN admissions, especially AML and MDS/MPN admissions, to control NI incidence.	[Liu, Hui; Xing, Yubin; Du, Mingmei] Dalian Med Univ, Affiliated Hosp 2, Dept Digest Med, Dalian, Peoples R China; [Liu, Hui; Suo, Jijiang; Liu, Yunxi] Chinese Peoples Liberat Army Gen Hosp, Dept Infect Management & Dis Control, Beijing, Peoples R China; [Zhao, Jin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Li, Meng] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China	Dalian Medical University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Liu, YX (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Infect Management & Dis Control, Beijing, Peoples R China.	yunxiliu6511@aliyun.com		Liu, Hui/0000-0003-4721-560X; Zhao, Jin/0000-0001-6902-9408	National Natural Science Foundation of China [30872155]; China Special Grant for the Prevention and Control of Infectious Diseases [2013ZX10004 805 - 003, 2013ZX10004 217-002, 2009ZX10004-204]; twelfth five year research foundation of Military Medical Sciences and Technology [AWS11L009, 11BJZ01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Special Grant for the Prevention and Control of Infectious Diseases; twelfth five year research foundation of Military Medical Sciences and Technology	This work was supported by 1 National Natural Science Foundation of China (No. 30872155); 2 China Special Grant for the Prevention and Control of Infectious Diseases (No. 2013ZX10004 805 - 003, 2013ZX10004 217-002, 2009ZX10004-204); 3 The twelfth five year research foundation of Military Medical Sciences and Technology [the key program (AWS11L009) and the Special Grant for health protection (11BJZ01)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; CARLISLE PS, 1993, INFECT CONT HOSP EP, V14, P320, DOI 10.1086/646750; Chen CY, 2010, EPIDEMIOL INFECT, V138, P1044, DOI 10.1017/S0950268809991208; Cugno C, 2012, PEDIATRIC REP, V4, P30, DOI 10.4081/pr.2012.e9; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046; Dettenkofer M, 2003, BONE MARROW TRANSPL, V31, P795, DOI 10.1038/sj.bmt.1703920; Engelhart S, 2002, INFECT CONT HOSP EP, V23, P244, DOI 10.1086/502043; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gonzalez-Barca E, 1999, EUR J CLIN MICROBIOL, V18, P539, DOI 10.1007/s100960050345; Harris NL, 2000, MODERN PATHOL, V13, P193, DOI 10.1038/modpathol.3880035; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Huoi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058121; Khayr W, 2012, DM-DIS MON, V58, P239, DOI 10.1016/j.disamonth.2012.01.001; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; PANNUTI CS, 1991, J CLIN ONCOL, V9, P77, DOI 10.1200/JCO.1991.9.1.77; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Roberts RR, 2010, MED CARE, V48, P1026, DOI 10.1097/MLR.0b013e3181ef60a2; Stenven H., 2008, WHO CLASSIFICATION T; Thirumala R, 2010, CRIT CARE CLIN, V26, P59, DOI 10.1016/j.ccc.2009.09.007; Tumbarello M, 2009, DIAGN MICR INFEC DIS, V64, P320, DOI 10.1016/j.diagmicrobio.2009.02.008; Urrea M, 2004, AM J INFECT CONTROL, V32, P205, DOI 10.1016/j.ajic.2003.10.013; Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Velasco E, 2004, EUR J CLIN MICROBIOL, V23, P596, DOI 10.1007/s10096-004-1181-x; Wisplinghoff H, 2003, INFECT CONT HOSP EP, V24, P905, DOI 10.1086/502158; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Xie DS, 2010, J HOSP INFECT, V76, P150, DOI 10.1016/j.jhin.2010.04.003; Yadegarynia D, 2003, CLIN INFECT DIS, V37, P1144, DOI 10.1086/378305; Zaoutis TE, 2010, CLIN INFECT DIS, V51, pE38, DOI 10.1086/655698	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113506	10.1371/journal.pone.0113506	http://dx.doi.org/10.1371/journal.pone.0113506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415334	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600052
J	Weisheit, C; Zhang, YY; Faron, A; Kopke, O; Weisheit, G; Steinstrasser, A; Frede, S; Meyer, R; Boehm, O; Hoeft, A; Kurts, C; Baumgarten, G				Weisheit, Christina; Zhang, Yunyang; Faron, Anton; Koepke, Odilia; Weisheit, Gunnar; Steinstraesser, Arne; Frede, Stilla; Meyer, Rainer; Boehm, Olaf; Hoeft, Andreas; Kurts, Christian; Baumgarten, Georg			Ly6C(low) and Not Ly6C(high) Macrophages Accumulate First in the Heart in a Model of Murine Pressure-Overload	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; MONOCYTES; ADHESION; INFLAMMATION; MIGRATION; FAILURE; ENDOTHELIUM	Cardiac tissue remodeling in the course of chronic left ventricular hypertrophy requires phagocytes which degrade cellular debris, initiate and maintain tissue inflammation and reorganization. The dynamics of phagocytes in left ventricular hypertrophy have not been systematically studied. Here, we characterized the temporal accumulation of leukocytes in the cardiac immune response by flow cytometry and fluorescence microscopy at day 3, 6 and 21 following transverse aortic constriction (TAC). Cardiac hypertrophy due to chronic pressure overload causes cardiac immune response and inflammation represented by an increase of immune cells at all three time points among which neutrophils reached their maximum at day 3 and macrophages at day 6. The cardiac macrophage population consisted of both Ly6C(low) and Ly6C(high) macrophages. Ly6C(low) macrophages were more abundant peaking at day 6 in response to pressure overload. During the development of cardiac hypertrophy the expression pattern of adhesion molecules was investigated by qRT-PCR and flow cytometry. CD11b, CX3CR1 and ICAM-1 determined by qRT-PCR in whole cardiac tissue were up-regulated in response to pressure overload at day 3 and 6. CD11b and CX3CR1 were significantly increased by TAC on the surface of Ly6C(low) but not on Ly6C(high) macrophages. Furthermore, ICAM-1 was up-regulated on cardiac endothelial cells. In fluorescence microscopy Ly6C(low) macrophages could be observed attached to the intra-and extra-vascular vessel-wall. Taken together, TAC induced the expression of adhesion molecules, which may explain the accumulation of Ly6C(low) macrophages in the cardiac tissue, where these cells might contribute to cardiac inflammation and remodeling in response to pressure overload.	[Weisheit, Christina; Zhang, Yunyang; Faron, Anton; Koepke, Odilia; Steinstraesser, Arne; Frede, Stilla; Boehm, Olaf; Hoeft, Andreas; Baumgarten, Georg] Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Weisheit, Gunnar] Acad High Sch Daun, Geschwister Sch Gymnasium, Daun, Germany; [Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany; [Kurts, Christian] Univ Hosp Bonn, Inst Expt Immunol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Weisheit, C (corresponding author), Univ Hosp Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany.	Christina.Weisheit@ukb.uni-bonn.de	Weisheit, Christina/V-2507-2018; Meyer, Rainer/H-5871-2013	Weisheit, Christina/0000-0002-7647-1613; Faron, Anton/0000-0002-5771-7235	Else Kroner-Forschungskolleg Bonn; flow-cytometry core facility; House for Experimental Therapy (HET) of the medical faculty of Bonn University	Else Kroner-Forschungskolleg Bonn; flow-cytometry core facility; House for Experimental Therapy (HET) of the medical faculty of Bonn University	Funding: The authors acknowledge support by the flow-cytometry core facility and by the House for Experimental Therapy (HET) of the medical faculty of Bonn University. CW was supported by the Else Kroner-Forschungskolleg Bonn, and CK is a member of the excellence cluster "ImmunoSensation" at Bonn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Ehrentraut S, 2011, SHOCK, V36, P613, DOI 10.1097/SHK.0b013e318235805f; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Herter J, 2013, J IMMUNOL, V190, P4451, DOI 10.4049/jimmunol.1203179; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kellermair J, 2013, BLOOD, V122, P3376, DOI 10.1182/blood-2013-04-499558; Koga K, 2013, AM J PHYSIOL-HEART C, V304, pH282, DOI 10.1152/ajpheart.00595.2012; Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massie BM, 2011, J MOL CELL CARDIOL, V51, P438, DOI 10.1016/j.yjmcc.2011.03.016; Mollmann H, 2010, CARDIOVASC RES, V87, P395, DOI 10.1093/cvr/cvq186; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Pratumvinit B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/359412; Roger VL, 2007, MED CLIN N AM, V91, P537, DOI 10.1016/j.mcna.2007.03.007; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Syrbe U, 2007, HYPERTENS RES, V30, P521, DOI 10.1291/hypres.30.521; Tirziu D, 2010, CIRCULATION, V122, P928, DOI 10.1161/CIRCULATIONAHA.108.847731; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	37	66	67	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112710	10.1371/journal.pone.0112710	http://dx.doi.org/10.1371/journal.pone.0112710			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415601	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600013
J	Brown, C; Murray-Rust, D; van Vliet, J; Alam, SJ; Verburg, PH; Rounsevell, MD				Brown, Calum; Murray-Rust, Dave; van Vliet, Jasper; Alam, Shah Jamal; Verburg, Peter H.; Rounsevell, Mark D.			Experiments in Globalisation, Food Security and Land Use Decision Making	PLOS ONE			English	Article							AGRICULTURAL LAND; ECONOMIC GLOBALIZATION; USE MODELS; TRADE; PRODUCTIVITY; LANDSCAPE; POLICY; SERVICES; IMPACT; WTO	The globalisation of trade affects land use, food production and environments around the world. In principle, globalisation can maximise productivity and efficiency if competition prompts specialisation on the basis of productive capacity. In reality, however, such specialisation is often constrained by practical or political barriers, including those intended to ensure national or regional food security. These are likely to produce globally sub-optimal distributions of land uses. Both outcomes are subject to the responses of individual land managers to economic and environmental stimuli, and these responses are known to be variable and often (economically) irrational. We investigate the consequences of stylised food security policies and globalisation of agricultural markets on land use patterns under a variety of modelled forms of land manager behaviour, including variation in production levels, tenacity, land use intensity and multi-functionality. We find that a system entirely dedicated to regional food security is inferior to an entirely globalised system in terms of overall production levels, but that several forms of behaviour limit the difference between the two, and that variations in land use intensity and functionality can substantially increase the provision of food and other ecosystem services in both cases. We also find emergent behaviour that results in the abandonment of productive land, the slowing of rates of land use change and the fragmentation or, conversely, concentration of land uses following changes in demand levels.	[Brown, Calum; Murray-Rust, Dave; Alam, Shah Jamal; Rounsevell, Mark D.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9XP, Midlothian, Scotland; [van Vliet, Jasper; Verburg, Peter H.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands	University of Edinburgh; Vrije Universiteit Amsterdam	Brown, C (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9XP, Midlothian, Scotland.	calum.brown@ed.ac.uk	Verburg, Peter h./A-8469-2010; Rounsevell, Mark D A/AAC-4498-2021; Brown, Calum/D-4341-2017; van Vliet, Jasper/G-3163-2013; Verburg, Peter H/Z-1582-2019; Brown, Calum/ABH-4673-2020	Verburg, Peter h./0000-0002-6977-7104; Rounsevell, Mark D A/0000-0001-7476-9398; Brown, Calum/0000-0001-9331-1008; van Vliet, Jasper/0000-0002-3996-5278; Brown, Calum/0000-0001-9331-1008; Alam, Shah Jamal/0000-0003-3671-0330	European Commission [Volante -FP7-ENV-2010-265104]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was carried out as part of the Visions of Land Use Transitions in Europe (VOLANTE) project (http://www.volante-project.eu/), funded by the European Commission under the Environment (including climate change) Theme of the 7th Framework Programme for Research and Technological Development: Volante -FP7-ENV-2010-265104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0656; Anderson K., 2009, DISTORTIONS AGR INCE; Anderson K, 2010, PHILOS T R SOC B, V365, P3007, DOI 10.1098/rstb.2010.0131; [Anonymous], 1958, IDEA SOCIAL SCI ITS; Arneth A, 2014, NAT CLIM CHANGE, V4, P550, DOI [10.1038/nclimate2250, 10.1038/NCLIMATE2250]; Baldwin RE, 2006, WORLD ECON, V29, P1451, DOI 10.1111/j.1467-9701.2006.00852.x; Batterbury S, 2001, ECUMENE, V8, P437, DOI 10.1177/096746080100800404; Bolliger J, 2007, LANDSCAPE ECOL, V22, P773, DOI 10.1007/s10980-007-9077-7; Boudjema G., 1999, ADV COMPLEX SYST, V2, P11, DOI DOI 10.1142/S0219525999000035; Bulte EH, 2007, J ENVIRON ECON MANAG, V54, P277, DOI 10.1016/j.jeem.2007.05.002; Burfisher ME, 2001, J ECON PERSPECT, V15, P125, DOI 10.1257/jep.15.1.125; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; DEJANVRY A, 1995, WORLD DEV, V23, P1349, DOI 10.1016/0305-750X(95)00056-I; Dibden J, 2009, ENVIRON PLANN A, V41, P163, DOI 10.1068/a40127; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Fortin E, 2005, SOC LEGAL STUD, V14, P147, DOI 10.1177/0964663905051217; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GOKLANY IM, 1995, CLIMATIC CHANGE, V30, P427, DOI 10.1007/BF01093855; Hay DA, 2001, ECON J, V111, P620, DOI 10.1111/1468-0297.00653; Helbing D, 2015, J STAT PHYS, V158, P735, DOI 10.1007/s10955-014-1024-9; Helbing D, 2010, QUANTITATIVE SOCIODYNAMICS: STOCHASTIC METHODS AND MOODELS OF SOCIAL INTERACTION PROCESSES, SECOND EDITION, P1, DOI 10.1007/978-3-642-11546-2; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Jager W, 2000, ECOL ECON, V35, P357, DOI 10.1016/S0921-8009(00)00220-2; Jongeneel RA, 2008, LAND USE POLICY, V25, P81, DOI 10.1016/j.landusepol.2007.03.001; Lambin EF, 2000, AGR ECOSYST ENVIRON, V82, P321, DOI 10.1016/S0167-8809(00)00235-8; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Magliocca NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073241; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; McKenzie LW, 1953, REV ECON STUD, V21, P165, DOI 10.2307/2295770; Menezes F., 2001, Development (London), V44, P29, DOI 10.1057/palgrave.development.1110288; Mughan A, 2003, ELECT STUD, V22, P617, DOI 10.1016/S0261-3794(02)00047-1; Murray-Rust D, 2014, ENVIRON MODELL SOFTW, V59, P187, DOI 10.1016/j.envsoft.2014.05.019; Murray-Rust D, 2011, J LAND USE SCI, V6, P83, DOI 10.1080/1747423X.2011.558600; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Otte A, 2007, LANDSCAPE ECOL, V22, P639, DOI 10.1007/s10980-007-9094-6; Parker DC, 2008, GEOFORUM, V39, P789, DOI 10.1016/j.geoforum.2007.05.005; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Plieninger T, 2006, LANDSCAPE ECOL, V21, P91, DOI 10.1007/s10980-005-8294-1; Potter C, 2005, PROG HUM GEOG, V29, P581, DOI 10.1191/0309132505ph569oa; Potter C, 2002, J RURAL STUD, V18, P35, DOI 10.1016/S0743-0167(01)00031-6; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.2307/3868443; Rounsevell MDA, 2012, LAND USE POLICY, V29, P899, DOI 10.1016/j.landusepol.2012.01.007; Schreinemachers P, 2006, J LAND USE SCI, V1, P29, DOI 10.1080/17474230600605202; Semwal RL, 2004, AGR ECOSYST ENVIRON, V102, P81, DOI 10.1016/S0167-8809(03)00228-7; Shackleton C. M., 2001, Development Southern Africa, V18, P581, DOI 10.1080/03768350120097441; Sheppard E, 2011, J ECON GEOGR, V11, P319, DOI 10.1093/jeg/lbq049; Siebert R, 2006, SOCIOL RURALIS, V46, P318, DOI 10.1111/j.1467-9523.2006.00420.x; Starr A., 2003, NEW POLIT SCI, V25, P19, DOI [10.1080/0739314032000071217, DOI 10.1080/0739314032000071217]; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Subramanian A, 2007, J INT ECON, V72, P151, DOI 10.1016/j.jinteco.2006.07.007; Swaffield S, 2006, LANDSCAPE ECOL, V21, P315, DOI 10.1007/s10980-004-4414-6; Thangavelu SM, 2005, WORLD ECON, V28, P1211, DOI 10.1111/j.1467-9701.2005.00731.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; van Meijl H, 2006, AGR ECOSYST ENVIRON, V114, P21, DOI 10.1016/j.agee.2005.11.006; van Vliet J, 2015, LANDSCAPE URBAN PLAN, V133, P24, DOI 10.1016/j.landurbplan.2014.09.001; Verburg PH, 2013, CURR OPIN ENV SUST, V5, P494, DOI 10.1016/j.cosust.2013.07.003; Walford N, 2003, J RURAL STUD, V19, P491, DOI 10.1016/S0743-0167(03)00030-5; Wurtenberger L, 2006, ECOL ECON, V57, P679, DOI 10.1016/j.ecolecon.2005.06.004; Yeates N., 2002, GLOBAL SOCIAL POLICY, V2, P69, DOI DOI 10.1177/1468018102002001095; Zasada I, 2011, LAND USE POLICY, V28, P639, DOI 10.1016/j.landusepol.2011.01.008	61	23	24	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114213	10.1371/journal.pone.0114213	http://dx.doi.org/10.1371/journal.pone.0114213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437010	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900131
J	Gong, YY; Liu, YY; Li, J; Su, L; Yu, S; Zhu, XN; Cao, XP; Xiao, HP				Gong, Ying-Ying; Liu, Yuan-Yuan; Li, Jin; Su, Lei; Yu, Shuang; Zhu, Xiao-Nan; Cao, Xiao-Pei; Xiao, Hai-Peng			Hypermethylation of Cox5a Promoter Is Associated with Mitochondrial Dysfunction in Skeletal Muscle of High Fat Diet-Induced Insulin Resistant Rats	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; DNA METHYLATION; OXIDATIVE-METABOLISM; GLUCOSE-TOLERANCE; INSIGHTS; YEAST; PGC-1-ALPHA; EPIGENETICS; HOMEOSTASIS	High-fat diet (HFD) is an environmental factor that contributes to the pathogenesis of obesity and type 2 diabetes. A number of genes influencing oxidative phosphorylation (OXPHOS) were found to be downregulated in skeletal muscle of humans and rats treated with HFD and have been implicated in mitochondrial dysfunction, insulin resistance, and consequent type 2 diabetes. In this study, we hypothesized that DNA methylation plays a crucial role in the regulation of OXPHOS genes in skeletal muscle of rats exposed to HFD. Using whole genome promoter methylation analysis of skeletal muscle followed by qPCR and bisulfite sequencing analysis, we identified hypermethylation of Cox5a in HFD rats. Furthermore, we found that Cox5a hypermethylation was associated with downregulation of Cox5a expression at the mRNA and protein level, and a reduction in mitochondrial complex IV activity and ATP content in HFD-induced insulin resistant rats compared to controls. Moreover, we found that while exposure to palmitate resulted in hypermethylation of the Cox5a promoter in rat myotubes, demethylation with 5-aza-2'-deoxycytidine was associated with preserved Cox5a expression, as well as restoration of complex IV activity and cellular ATP content. These novel observations indicate that Cox5a hypermethylation is associated with mitochondrial dysfunction in skeletal muscle of HFD-induced insulin resistant rats.	[Liu, Yuan-Yuan; Yu, Shuang; Cao, Xiao-Pei; Xiao, Hai-Peng] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Ying-Ying; Li, Jin; Su, Lei] Sun Yat Sen Univ, Dept Geriatr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xiao-Nan] Sun Yat Sen Univ, Dept Pharmacol, Zhong Shan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xiao, HP (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	xiaohp@mail.sysu.edu.cn	Su, Lei/U-6875-2019; liu, yuanyuan/GWZ-5838-2022					ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barres R, 2011, AM J CLIN NUTR, V93, p897S, DOI 10.3945/ajcn.110.001933; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boyle KE, 2011, J CLIN ENDOCR METAB, V96, P775, DOI 10.1210/jc.2010-2253; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gemma C, 2010, MOL GENET METAB, V100, P83, DOI 10.1016/j.ymgme.2010.02.004; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Jiang MH, 2008, DIABETOLOGIA, V51, P1525, DOI 10.1007/s00125-008-1034-8; Jiang MH, 2011, ENDOCRINOLOGY, V152, P1284, DOI 10.1210/en.2010-1162; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Kristensen JM, 2014, DIABETOLOGIA, V57, P1006, DOI 10.1007/s00125-014-3187-y; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MANDEL JL, 1974, NATURE, V251, P618, DOI 10.1038/251618a0; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1055, DOI 10.1152/ajpendo.00554.2001; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; TRUEBLOOD CE, 1987, MOL CELL BIOL, V7, P3520, DOI 10.1128/MCB.7.10.3520; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	42	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113784	10.1371/journal.pone.0113784	http://dx.doi.org/10.1371/journal.pone.0113784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436770	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900079
J	Guo, YY; Feng, YJ; Ge, Y; Tetreau, G; Chen, XW; Dong, XH; Shi, WP				Guo, Yanyan; Feng, Yanjie; Ge, Yang; Tetreau, Guillaume; Chen, Xiaowen; Dong, Xuehui; Shi, Wangpeng			The Cultivation of Bt Corn Producing Cry1Ac Toxins Does Not Adversely Affect Non-Target Arthropods	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; PRINCIPAL RESPONSE CURVES; COTESIA-MARGINIVENTRIS; FUNCTIONAL GUILDS; MULTIPLE CROPS; PESTICIDE USE; MAIZE; FIELD; IMPACT; COMMUNITY	Transgenic corn producing Cry1Ac toxins from Bacillus thuringiensis (Bt) provides effective control of Asian corn borer, Ostrinia furnacalis (Guenee), and thus reduces insecticide applications. However, whether Bt corn exerts undesirable effects on non-target arthropods (NTAs) is still controversial. We conducted a 2-yr study in Shangzhuang Agricultural Experiment Station to assess the potential impact of Bt corn on field population density, biodiversity, community composition and structure of NTAs. On each sampling date, the total abundance, Shannon's diversity index, Pielou's evenness index and Simpson's diversity index were not significantly affected by Bt corn as compared to non-Bt corn. The "sampling dates'' had a significant effect on these indices, but no clear tendencies related to "Bt corn'' or "sampling dates X corn variety'' interaction were recorded. Principal response curve analysis of variance indicated that Bt corn did not alter the distribution of NTAs communities. Bray-Curtis dissimilarity and distance analysis showed that Cry1Ac toxin exposure did not increase community dissimilarities between Bt and non-Bt corn plots and that the evolution of non-target arthropod community was similar on the two corn varieties. The cultivation of Bt corn failed to show any detrimental evidence on the density of non-target herbivores, predators and parasitoids. The composition of herbivores, predators and parasitoids was identical in Bt and non-Bt corn plots. Taken together, results from the present work support that Bt corn producing Cry1Ac toxins does not adversely affect NTAs.	[Guo, Yanyan; Feng, Yanjie; Ge, Yang; Shi, Wangpeng] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Guo, Yanyan; Tetreau, Guillaume] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Chen, Xiaowen; Dong, Xuehui] China Agr Univ, Dept Agr Sci, Beijing 100094, Peoples R China	China Agricultural University; Cornell University; China Agricultural University	Shi, WP (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	wpshi@cau.edu.cn	Tetreau, Guillaume/K-1283-2012; Shi, wp/AAF-9334-2020	Tetreau, Guillaume/0000-0003-3360-4786; 	Chinese Ministry of Agriculture [2014ZX08011-003]	Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This research was funded by the National Special Transgenic Project from the Chinese Ministry of Agriculture (grant No. 2014ZX08011-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Deeb MA, 2001, ENVIRON ENTOMOL, V30, P625, DOI 10.1603/0046-225X-30.3.625; Albajes R., 2013, IOBC/WPRS Bulletin, V97, P1; Albajes R, 2012, SPAN J AGRIC RES, V10, P977, DOI 10.5424/sjar/2012104-691-11; Alcantara EP, 2012, ENVIRON ENTOMOL, V41, P1268, DOI 10.1603/EN10297; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Bhatti MA, 2005, ENVIRON ENTOMOL, V34, P1336, DOI 10.1603/0046-225X(2005)034[1336:FEOTIO]2.0.CO;2; Blanchet F. G., 2013, VEGAN ECOLOGICAL DIV; BOYLE TP, 1990, RES J WATER POLLUT C, V62, P749; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Candolfi MP, 2004, BIOCONTROL SCI TECHN, V14, P129, DOI 10.1080/09583150310001655701; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clergue B, 2005, AGRON SUSTAIN DEV, V25, P1, DOI 10.1051/agro:2004049; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Comas J, 2013, J ECON ENTOMOL, V106, P1659, DOI 10.1603/EC12508; Cuppen JGM, 2000, AQUAT TOXICOL, V48, P233, DOI 10.1016/S0166-445X(99)00036-3; de la Poza M, 2005, CROP PROT, V24, P677, DOI 10.1016/j.cropro.2004.12.003; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Dutra CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044867; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; FELKL G, 1988, J APPL ENTOMOL, V105, P379, DOI 10.1111/j.1439-0418.1988.tb00200.x; Frampton G. K., 2000, ACS SYM SER, P54; Freier Bernd, 2004, IOBC-WPRS Bulletin, V27, P79; Gathmann Achim, 2006, Environmental Biosafety Research, V5, P27, DOI 10.1051/ebr:2006014; Gathmann A, 2006, MOL ECOL, V15, P2677, DOI 10.1111/j.1365-294X.2006.02962.x; Graef F, 2005, ENVIRON MONIT ASSESS, V111, P1, DOI 10.1007/s10661-005-8044-5; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; He KL, 2003, J ECON ENTOMOL, V96, P935, DOI 10.1603/0022-0493-96.3.935; HEONG KL, 1991, B ENTOMOL RES, V81, P407, DOI 10.1017/S0007485300031977; Higgins LS, 2009, ENVIRON ENTOMOL, V38, P281, DOI 10.1603/022.038.0135; Jasinski JR, 2003, ENVIRON ENTOMOL, V32, P407, DOI 10.1603/0046-225X-32.2.407; Jensen PD, 2010, ENVIRON ENTOMOL, V39, P707, DOI 10.1603/EN09037; Kim YH, 2012, J ASIA-PAC ENTOMOL, V15, P443, DOI 10.1016/j.aspen.2012.01.005; Kojima W, 2010, J INSECT PHYSIOL, V56, P1349, DOI 10.1016/j.jinsphys.2010.04.021; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Li XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061670; Lit Ireneo L. Jr., 2012, Philippine Entomologist, V26, P28; Litsinger JA, 1978, PHILIPPINE ENTOMOLOG, V4, P65; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Lundgren JG, 2009, RELATIONSHIPS NATURA; Magurran A.E., 2004, MEASURING BIOL DIVER; Meissle M, 2010, J APPL ENTOMOL, V134, P357, DOI 10.1111/j.1439-0418.2009.01491.x; Minarcikova L., 2013, IOBC/WPRS Bulletin, V97, P89; Moser T, 2007, ECOTOXICOLOGY, V16, P573, DOI 10.1007/s10646-007-0169-6; Mota T. A., 2013, African Journal of Biotechnology, V12, P6086; NAFUS DM, 1987, J ECON ENTOMOL, V80, P411, DOI 10.1093/jee/80.2.411; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Naranjo SE, 2009, NUTR NAT RES, V4, P1; Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057; Pascual S, 2010, J PEST SCI, V83, P121, DOI 10.1007/s10340-009-0278-5; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; PIMENTEL D, 1993, AGR ECOSYST ENVIRON, V46, P273, DOI 10.1016/0167-8809(93)90030-S; Pons X, 2005, EUR J ENTOMOL, V102, P73, DOI 10.14411/eje.2005.010; Prasifka JR, 2005, ENVIRON ENTOMOL, V34, P1181, DOI 10.1603/0046-225X(2005)034[1181:ATEOPM]2.0.CO;2; Priestley AL, 2009, TRANSGENIC RES, V18, P425, DOI 10.1007/s11248-008-9234-z; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramirez-Romero R, 2007, CROP PROT, V26, P953, DOI 10.1016/j.cropro.2006.09.001; Rauschen Stefan, 2010, Environmental Biosafety Research, V9, P87, DOI 10.1051/ebr/2010012; Rauschen S, 2009, TRANSGENIC RES, V18, P203, DOI 10.1007/s11248-008-9207-2; Rodriguez C. P., 1975, Philippine Entomologist, V3, P46; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis Joerg, 2008, V5, P87, DOI 10.1007/978-1-4020-8373-0_4; SALAMA HS, 1983, Z ANGEW ENTOMOL, V95, P425; Sanvido O, 2007, J VERBRAUCH LEBENSM, V2, P37, DOI 10.1007/s00003-007-0292-6; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; Schorling M., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P106, DOI 10.1007/s00003-006-0100-8; Shirai Yoichi, 2012, Bulletin of the National Institute of Agro-Environmental Sciences, V30, P1; Thompson GD, 2010, PHILIPP AGRIC SCI, V93, P375; Tian JC, 2014, ENVIRON ENTOMOL, V43, P242, DOI 10.1603/EN13184; Tian JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060125; Todd Jacqui H., 2008, Environmental Biosafety Research, V7, P35, DOI 10.1051/ebr:2008003; Van Den Brink Paul J., 1998, Aquatic Ecology, V32, P163, DOI 10.1023/A:1009944004756; Van den Brink Paul J., 2003, Australasian Journal of Ecotoxicology, V9, P141; van den Brink PJ, 2009, ENVIRON MONIT ASSESS, V152, P271, DOI 10.1007/s10661-008-0314-6; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Wang ZY, 2014, BIOL CONTROL, V68, P136, DOI 10.1016/j.biocontrol.2013.06.015; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu F, 2006, TRANSGENIC RES, V15, P277, DOI 10.1007/s11248-005-5237-1; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang B, 2014, APPL SOIL ECOL, V73, P156, DOI 10.1016/j.apsoil.2013.09.001; Zhang BY, 2011, TRANSGENIC RES, V20, P523, DOI 10.1007/s11248-010-9434-1; Zughart W, 2008, EUPHYTICA, V164, P845, DOI 10.1007/s10681-007-9475-6	88	19	20	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114228	10.1371/journal.pone.0114228	http://dx.doi.org/10.1371/journal.pone.0114228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437213	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900132
J	Hedman, E; Andersson, G; Lindefors, N; Gustavsson, P; Lekander, M; Ruck, C; Andersson, E; Ljotsson, B				Hedman, Erik; Andersson, Gerhard; Lindefors, Nils; Gustavsson, Petter; Lekander, Mats; Rueck, Christian; Andersson, Erik; Ljotsson, Brjann			Personality Change following Internet-Based Cognitive Behavior Therapy for Severe Health Anxiety	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; III-R HYPOCHONDRIASIS; SELF-REPORT MEASURES; PSYCHOMETRIC EVALUATION; COST-EFFECTIVENESS; SOCIAL ANXIETY; TRAIT CHANGE; DEPRESSION; DISORDERS; TEMPERAMENT	Personality traits have traditionally been viewed as stable, but recent studies suggest that they could be affected through psychological treatment. Internet-based cognitive behavior therapy (ICBT) for severe health anxiety (DSM-IV hypochondriasis) has been shown to be effective in reducing health anxiety, but its effect on measures of personality traits has not been investigated. The main aim of this study was to investigate the impact of ICBT on personality traits in the three broad dimensions -neuroticism, extraversion and aggression. We hypothesized that participants in ICBT would reduce their level of neuroticism compared to controls that did not receive the active treatment. No specific predictions were made regarding extraversion and aggression. Data from a randomized controlled trial were used in which participants were allocated to 12 weeks of ICBT (n=40) or to a basic attention control condition (n=41). Personality traits were assessed with the Swedish Universities Scales of Personality and the primary outcome of health anxiety was the Health Anxiety Inventory. There was a significant interaction effect of group and time on neuroticism-related scales, indicating larger pre-to post-treatment reductions in the Internet-based CBT group compared to the control condition. Analyses at 6-month follow-up showed that changes were stable. Traits relating to extraversion and aggression were largely unchanged. This study is the first to demonstrate that a brief ICBT intervention for severe health anxiety causes long-term changes in measures of personality traits related to neuroticism. The treatment thus has a broader impact than just reducing health anxiety.	[Hedman, Erik; Andersson, Gerhard; Lindefors, Nils; Rueck, Christian; Andersson, Erik; Ljotsson, Brjann] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Gustavsson, Petter; Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University; Linkoping University; Stockholm University	Hedman, E (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	kire.hedman@ki.se	Andersson, Gerhard/J-8529-2012	Andersson, Gerhard/0000-0003-4753-6745; Gustavsson, Petter/0000-0001-9571-9349; Andersson, Erik/0000-0003-0088-8719; Ruck, Christian/0000-0002-8742-0168; Hedman-Lagerlof, Erik/0000-0002-7939-9848	Stockholm County council; Karolinska Institutet	Stockholm County council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The funders of the study were Stockholm County council and Karolinska Institutet, which are both public institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera Z, 2012, EUR EAT DISORD REV, V20, P379, DOI 10.1002/erv.2163; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, Vxxxvii; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; BARSKY AJ, 1990, SOC PSYCH PSYCH EPID, V25, P89; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Burger JM, 1993, PERSONALITY; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Cervenka S, 2010, NEUROIMAGE, V50, P323, DOI 10.1016/j.neuroimage.2009.12.006; Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cuijpers P, 2010, ARCH GEN PSYCHIAT, V67, P1086, DOI 10.1001/archgenpsychiatry.2010.130; Eysenck HJ, 1959, BRIT J PSYCHIAT, V105, P61; Farde L, 1997, NATURE, V385, P590, DOI 10.1038/385590a0; Flaskerud Jacquelyn H, 2012, Issues Ment Health Nurs, V33, P631, DOI 10.3109/01612840.2011.647256; FURER P, 2007, TREATING HLTH ANXIET, V15; Furer P, 2005, J CONTEMP PSYCHOTHER, V35, P251, DOI 10.1007/s10879-005-4319-y; Gray J.A., 1991, EXPLORATIONS TEMPERA; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Gustavsson JP, 1997, PERS INDIV DIFFER, V22, P783, DOI 10.1016/S0191-8869(96)00268-1; Hedman E, 2013, PSYCHOL MED, V43, P363, DOI 10.1017/S0033291712001079; Hedman E, 2013, J MED INTERNET RES, V15, P131, DOI 10.2196/jmir.2818; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, BRIT J PSYCHIAT, V198, P230, DOI 10.1192/bjp.bp.110.086843; Hedman Erik, 2010, Cognitive Behaviour Therapy, V39, P239, DOI 10.1080/16506073.2010.496460; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.39; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lovas DA, 2010, J ANXIETY DISORD, V24, P931, DOI 10.1016/j.janxdis.2010.06.019; Ludtke O, 2011, J PERS SOC PSYCHOL, V101, P620, DOI 10.1037/a0023743; Lyoo IK, 2003, ACTA PSYCHIAT SCAND, V107, P298, DOI 10.1034/j.1600-0447.2003.00054.x; McManus F, 2012, J CONSULT CLIN PSYCH; Mortberg E, 2007, PSYCHIAT RES, V152, P81, DOI 10.1016/j.psychres.2006.10.003; NOYES R, 1994, GEN HOSP PSYCHIAT, V16, P78, DOI 10.1016/0163-8343(94)90049-3; NOYES R, 1993, ARCH GEN PSYCHIAT, V50, P961; NOYES R, 1991, COMPR PSYCHIAT, V32, P283, DOI 10.1016/0010-440X(91)90076-O; Pervin LA., 2008, HDB PERSONALITY THEO; Posternak MA, 2001, J AFFECT DISORDERS, V66, P139, DOI 10.1016/S0165-0327(00)00304-9; REICH J, 1986, AM J PSYCHIAT, V143, P760; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Ruck C, 2006, NORD J PSYCHIAT, V60, P486, DOI 10.1080/08039480601022116; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Seivewright H, 2008, BRIT J PSYCHIAT, V193, P332, DOI 10.1192/bjp.bp.108.052936; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, pS22; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; Spinhoven P, 2011, ACTA PSYCHIAT SCAND, V124, P462, DOI 10.1111/j.1600-0447.2011.01753.x; STAATS AW, 1993, BEHAV MODIF, V17, P8, DOI 10.1177/01454455930171003; Svanborg P, 1999, J PERS DISORD, V13, P241, DOI 10.1521/pedi.1999.13.3.241; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166; TAYLOR S, 2004, TREATING HLTH ANXIET, V15; Treanor M, 2011, CLIN PSYCHOL REV, V31, P617, DOI 10.1016/j.cpr.2011.02.003; Wilczek A, 2004, J AM PSYCHOANAL ASS, V52, P1163	58	28	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113871	10.1371/journal.pone.0113871	http://dx.doi.org/10.1371/journal.pone.0113871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437150	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900091
J	Lemire, P; Roy, D; Fittipaldi, N; Okura, M; Takamatsu, D; Bergman, E; Segura, M				Lemire, Paul; Roy, David; Fittipaldi, Nahuel; Okura, Masatoshi; Takamatsu, Daisuke; Bergman, Eugenia; Segura, Mariela			Implication of TLR- but Not of NOD2-Signaling Pathways in Dendritic Cell Activation by Group B Streptococcus Serotypes III and V	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; CAPSULAR POLYSACCHARIDES; INNATE IMMUNITY; NONPREGNANT ADULTS; NOD2; PATHOGEN; PHAGOCYTOSIS; DISEASE; COLONIZATION	Group B Streptococcus (GBS) is an important agent of life-threatening invasive infection. It has been previously shown that encapsulated type III GBS is easily internalized by dendritic cells (DCs), and that this internalization had an impact on cytokine production. The receptors underlying these processes are poorly characterized. Knowledge on the mechanisms used by type V GBS to activate DCs is minimal. In this work, we investigated the role of Toll-like receptor (TLR)/MyD88 signaling pathway, the particular involvement of TLR2, and that of the intracellular sensing receptor NOD2 in the activation of DCs by types III and V GBS. The role of capsular polysaccharide (CPS, one of the most important GBS virulence factors) in bacterial-DC interactions was evaluated using non-encapsulated mutants. Despite differences in the role of CPS between types III and V GBS in bacterial internalization and intracellular survival, no major differences were observed in their capacity to modulate release of cytokines by DC. For both serotypes, CPS had a minor role in this response. Production of cytokines by DCs was shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize GBS and become activated mostly through TLR signaling. Yet, GBS-infected TLR2(-/-) DCs only showed a partial reduction in the production of IL-6 and CXCL1 compared to control DCs. Surprisingly, CXCL10 release by type III or type V GBS-infected DCs was MyD88-independent. No differences in DC activation were observed between NOD2(-/-) and control DCs. These results demonstrate the involvement of various receptors and the complexity of the cytokine production pathways activated by GBS upon DC infection.	[Lemire, Paul; Roy, David; Bergman, Eugenia; Segura, Mariela] Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Okura, Masatoshi; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	Universite de Montreal; University of Toronto; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Segura, M (corresponding author), Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada.	mariela.segura@umontreal.ca	Segura, Mariela/AAG-5708-2020	Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [342150]; "Fonds de recherche du Quebec - Nature et technologies" PhD Awards	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds de recherche du Quebec - Nature et technologies" PhD Awards	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) through a grant to Mariela Segura (#342150). Paul Lemire and David Roy were the recipients of "Fonds de recherche du Quebec - Nature et technologies" PhD Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Amaya RA, 2004, J AM GERIATR SOC, V52, P46, DOI 10.1111/j.1532-5415.2004.52009.x; Andrade EB, 2013, J IMMUNOL, V191, P4759, DOI 10.4049/jimmunol.1301752; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Bebien M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002812; dos Santos MHB, 2013, ANTON LEEUW INT J G, V104, P1125, DOI 10.1007/s10482-013-0034-y; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bodazewska-Lubas M, 2013, POL J MICROBIOL, V62, P85, DOI 10.33073/pjm-2013-012; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Chaffin DO, 2005, J BACTERIOL, V187, P4615, DOI 10.1128/JB.187.13.4615-4626.2005; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng Q, 2001, INFECT IMMUN, V69, P2302, DOI 10.1128/IAI.69.4.2302-2308.2001; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Davies HD, 2001, J INFECT DIS, V184, P285, DOI 10.1086/322029; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Draper DW, 2006, IMMUNOL LETT, V102, P202, DOI 10.1016/j.imlet.2005.09.005; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Da Costa AFE, 2011, INT J MOL MED, V27, P739, DOI 10.3892/ijmm.2011.635; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Fujieda M, 2012, INFECT IMMUN, V80, P2053, DOI 10.1128/IAI.06232-11; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; Koedel U, 2009, CURR TOP MICROBIOL, V336, P15, DOI 10.1007/978-3-642-00549-7_2; Koenig JM, 2009, PEDIATR CLIN N AM, V56, P689, DOI 10.1016/j.pcl.2009.04.003; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; Lemire P, 2013, MICROB PATHOGENESIS, V65, P41, DOI 10.1016/j.micpath.2013.09.006; Lemire P, 2012, CELL MICROBIOL, V14, P1707, DOI 10.1111/j.1462-5822.2012.01830.x; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Nagl M, 2002, CLIN DIAGN LAB IMMUN, V9, P1165, DOI 10.1128/CDLI.9.6.1165-1168.2002; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Selvanantham T, 2013, J IMMUNOL, V191, P5646, DOI 10.4049/jimmunol.1301412; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talati AJ, 2008, MICROBES INFECT, V10, P1106, DOI 10.1016/j.micinf.2008.06.001; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tyrrell GJ, 2002, MICROBIOL-SGM, V148, P3921, DOI 10.1099/00221287-148-12-3921; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103	59	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113940	10.1371/journal.pone.0113940	http://dx.doi.org/10.1371/journal.pone.0113940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436906	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900100
J	Zhu, J; Bi, ZY; Yang, T; Wang, W; Li, Z; Huang, WT; Wang, LP; Zhang, SZ; Zhou, YF; Fan, NN; Bai, Y; Song, WT; Wang, CH; Wang, H; Bi, YY				Zhu, Jie; Bi, Zhuoyue; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Wang, Liping; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Song, Wentao; Wang, Chunhong; Wang, Hong; Bi, Yongyi			Regulation of PKM2 and Nrf2-ARE Pathway during Benzoquinone Induced Oxidative Stress in Yolk Sac Hematopoietic Stem Cells	PLOS ONE			English	Article							PYRUVATE-KINASE M2; IN-VITRO; BENZENE; METABOLITES; EXPOSURE; CANCER; TOXICITY; LEUKEMIA; BINDING; INDOOR	Benzene is an occupational toxicant and an environmental pollutant that is able to induce the production of reactive oxygen species (ROS), causing oxidative stress and damages of the macromolecules in target cells, such as the hematopoietic stem cells. We had previously found that embryonic yolk sac hematopoietic stem cells (YS-HSCs) are more sensitive to benzene toxicity than the adult bone marrow hematopoietic stem cells, and that nuclear factor-erythroid-2-related factor 2 (Nrf2) is the major regulator of cytoprotective responses to oxidative stress. In the present report, we investigated the effect of PKM2 and Nrf2-ARE pathway on the cellular antioxidant response to oxidative stress induced by benzene metabolite benzoquinone (BQ) in YS-HSC isolated from embryonic yolk sac and enriched by magnetic-activated cell sorting (MACS). Treatment of the YS-HSC with various concentrations of BQ for 6 hours induces ROS generation in a dose-dependent manner. Additional tests showed that BQ is also capable of inducing expression of NADPH oxidase1 (NOX1), and several other antioxidant enzymes or drug-metabolizing enzymes, including heme oxygenase 1 (HMOX1), superoxide dismutase (SOD), catalase and NAD(P) H dehydrogenase quinone 1 (NQO1). Concomitantly, only the expression of PKM2 protein was decreased by the treatment of BQ but not the PKM2 mRNA, which suggested that BQ may induce PKM2 degradation. Pretreatment of the cells with antioxidant N-acetylcysteine (NAC) decreased ROS generation and prevented BQ-induced PKM2 degradation, suggesting involvement of ROS in the PKM2 protein degradation in cellular response to BQ. These findings suggest that BQ is a potent inducer of ROS generation and the subsequent antioxidant responses of the YS-HSC. The accumulated ROS may attenuate the expression of PKM2, a key regulator of the pyruvate metabolism and glycolysis.	[Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China; [Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Hubei Key Lab Allergy & Immune Related Dis, Wuhan, Hubei, Peoples R China; [Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Wuhan Univ, Hubei Biomassresource Chem & Environm Biotechnol, Wuhan 430072, Hubei, Peoples R China; [Bi, Zhuoyue] Hubei Prov Acad Prevent Med, Hubei Prov Key Lab Appl Toxicol, Wuhan, Peoples R China; [Wang, Liping] Kunming Med Univ, Sch Publ Hlth, Chenggong Dist, Kunming, Peoples R China; [Song, Wentao] Nanchang Ctr Dis Control & Prevent, Nanchang, Peoples R China	Wuhan University; Wuhan University; Kunming Medical University	Wang, H (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China.	whwhgyg@163.com; yongyib@aliyun.com		Bi, Zhuoyue/0000-0001-8559-3543	Chinese National Natural Science Foundation [81372961, 81102104]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The project was supported by Chinese National Natural Science Foundation to YYB (no. 81372961) and Chinese National Natural Science Foundation to HW (grant no. 81102104, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Badham HJ, 2010, TOXICOL APPL PHARM, V244, P273, DOI 10.1016/j.taap.2010.01.002; Badham HJ, 2010, TOXICOL SCI, V113, P207, DOI 10.1093/toxsci/kfp242; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chatzis C, 2005, SCI TOTAL ENVIRON, V349, P72, DOI 10.1016/j.scitotenv.2005.01.034; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Harrison RM, 1999, OCCUP ENVIRON MED, V56, P774, DOI 10.1136/oem.56.11.774; KOLACHANA P, 1993, CANCER RES, V53, P1023; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lau A, 2009, MUTAT RES-GEN TOX EN, V676, P74, DOI 10.1016/j.mrgentox.2009.04.001; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ross D, 2000, J TOXICOL ENV HEAL A, V61, P357, DOI 10.1080/00984100050166361; Rubio V, 2011, TOXICOL IN VITRO, V25, P521, DOI 10.1016/j.tiv.2010.10.021; Shen Y, 1996, HUM EXP TOXICOL, V15, P422, DOI 10.1177/096032719601500510; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Steffen C, 2004, OCCUP ENVIRON MED, V61, P773, DOI 10.1136/oem.2003.010868; Swaen GMH, 2010, OCCUP ENVIRON MED, V67, P286, DOI 10.1136/oem.2009.047464; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Wang YH, 2013, BLOOD, V122; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang JF, 2003, BRIT MED BULL, V68, P209, DOI 10.1093/bmb/ldg029; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071153	28	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113733	10.1371/journal.pone.0113733	http://dx.doi.org/10.1371/journal.pone.0113733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437431	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900072
J	O'Toole, MD; Lea, MA; Guinet, C; Hindell, MA				O'Toole, Malcolm D.; Lea, Mary-Anne; Guinet, Christophe; Hindell, Mark A.			Estimating Trans-Seasonal Variability in Water Column Biomass for a Highly Migratory, Deep Diving Predator	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; BIOOPTICAL PROPERTIES; MIROUNGA-LEONINA; CASE-1 WATERS; CHLOROPHYLL; PHYTOPLANKTON; SCALE; TEMPERATURE; ABSORPTION; TILETAMINE	The deployment of animal-borne electronic tags is revolutionizing our understanding of how pelagic species respond to their environment by providing in situ oceanographic information such as temperature, salinity, and light measurements. These tags, deployed on pelagic animals, provide data that can be used to study the ecological context of their foraging behaviour and surrounding environment. Satellite-derived measures of ocean colour reveal temporal and spatial variability of surface chlorophyll-a (a useful proxy for phytoplankton distribution). However, this information can be patchy in space and time resulting in poor correspondence with marine animal behaviour. Alternatively, light data collected by animal-borne tag sensors can be used to estimate chlorophyll-a distribution. Here, we use light level and depth data to generate a phytoplankton index that matches daily seal movements. Time-depth-light recorders (TDLRs) were deployed on 89 southern elephant seals (Mirounga leonina) over a period of 6 years (1999-2005). TDLR data were used to calculate integrated light attenuation of the top 250 m of the water column (LA(250)), which provided an index of phytoplankton density at the daily scale that was concurrent with the movement and behaviour of seals throughout their entire foraging trip. These index values were consistent with typical seasonal chl-a patterns as measured from 8-daySea-viewing Wide Field-of-view Sensor (SeaWiFs) images. The availability of data recorded by the TDLRs was far greater than concurrent remotely sensed chl-a at higher latitudes and during winter months. Improving the spatial and temporal availability of phytoplankton information concurrent with animal behaviour has ecological implications for understanding the movement of deep diving predators in relation to lower trophic levels in the Southern Ocean. Light attenuation profiles recorded by animal-borne electronic tags can be used more broadly and routinely to estimate lower trophic distribution at sea in relation to deep diving predator foraging behaviour.	[O'Toole, Malcolm D.; Lea, Mary-Anne; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Guinet, Christophe] Ctr Eud Biol Chize, Marine Predator Dept, Villiers En Bois, France	University of Tasmania	O'Toole, MD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	otoolem@utas.edu.au	Guinet, Christophe/AAR-8457-2020; Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299; Hindell, Mark/0000-0002-7823-7185	Australian Research Council; Natural Sciences and Engineering Research Council of Canada; Sea World Research and Rescue Foundation Inc.; Australian Antarctic Science Programme; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sea World Research and Rescue Foundation Inc.; Australian Antarctic Science Programme; Australian Postgraduate Award(Australian Government)	This research was funded by the Australian Research Council, the Natural Sciences and Engineering Research Council of Canada, Sea World Research and Rescue Foundation Inc., and the Australian Antarctic Science Programme. MO was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2005, DEEP-SEA RES PT I, V52, P1989, DOI 10.1016/j.dsr.2005.06.015; Arrigo KR, 2008, J GEOPHYS RES C, V113, P1997; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Boyd IL, 1996, CAN J ZOOL, V74, P1696, DOI 10.1139/z96-187; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Burghart SE, 1999, POLAR BIOL, V22, P279, DOI 10.1007/s003000050421; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campagna C, 2001, MAR MAMMAL SCI, V17, P402, DOI 10.1111/j.1748-7692.2001.tb01283.x; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; d'Ovidio F, 2010, P NATL ACAD SCI USA, V107, P18366, DOI 10.1073/pnas.1004620107; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Sala JE, 2011, POLAR BIOL, V34, P1197, DOI 10.1007/s00300-011-0981-6; Fedak MA, 2013, DEEP-SEA RES PT II, V88-89, P7, DOI 10.1016/j.dsr2.2012.07.007; FENTON N, 1994, ANTARCT SCI, V6, P443, DOI 10.1017/S0954102094000684; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Garcia-Munoz C, 2013, POLAR BIOL, V36, P1107, DOI 10.1007/s00300-013-1333-5; Guinet C, 2013, EARTH SYST SCI DATA, V5, P15, DOI 10.5194/essd-5-15-2013; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; Hindell M, 2010, MARINE MAMMAL ECOLOG, P241; Hindell MA, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P72; Hirawake T, 2000, J OCEANOGR, V56, P245; Holm-Hansen O, 2005, MAR ECOL PROG SER, V297, P71, DOI 10.3354/meps297071; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Johnson R, 2013, J GEOPHYS RES-OCEANS, V118, P3694, DOI 10.1002/jgrc.20270; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Loisel H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015948; McCafferty DJ, 2004, MAR BIOL, V146, P191, DOI 10.1007/s00227-004-1428-1; McCafferty DJ, 1999, MAR BIOL, V134, P387, DOI 10.1007/s002270050555; McClain CR, 1998, SEA TECHNOL, V39, P10; Mcintyre T, 2012, ANTARCT SCI, V24, P561, DOI 10.1017/S0954102012000570; McMahon CR, 2008, J EXP MAR BIOL ECOL, V360, P71, DOI 10.1016/j.jembe.2008.03.012; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; Moore JK, 2002, J MARINE SYST, V37, P69, DOI 10.1016/S0924-7963(02)00196-3; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1998, J MARINE SYST, V17, P571, DOI 10.1016/S0924-7963(98)00065-7; ROBINS DB, 1995, DEEP-SEA RES PT II, V42, P1137, DOI 10.1016/0967-0645(95)00058-X; Sarkar D., 2019, NLME LINEAR NONLINEA; SMITH RC, 1978, LIMNOL OCEANOGR, V23, P247, DOI 10.4319/lo.1978.23.2.0247; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Stramski D, 2001, APPL OPTICS, V40, P2929, DOI 10.1364/AO.40.002929; Sumner M, 2010, METROPOLIS SAMPLER S; Sumner MD, 2003, REMOTE SENS ENVIRON, V84, P161, DOI 10.1016/S0034-4257(02)00103-7; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Teo SLH, 2009, AQUAT BIOL, V5, P195, DOI 10.3354/ab00152; Thomalla SJ, 2011, BIOGEOSCIENCES, V8, P2849, DOI 10.5194/bg-8-2849-2011; Thums M, 2008, MAR ECOL PROG SER, V370, P249, DOI 10.3354/meps07613; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Zhao L, 2013, CHIN J OCEANOL LIMN, V31, P247, DOI 10.1007/s00343-013-2085-3; Zuur Alain F., 2009, P1	67	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113171	10.1371/journal.pone.0113171	http://dx.doi.org/10.1371/journal.pone.0113171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427104	gold, Green Submitted, Green Published			2022-12-27	WOS:000349145400036
J	Ye, CY; Lin, ZX; Li, GM; Wang, YY; Qiu, J; Fu, F; Zhang, HQ; Chen, L; Ye, SS; Song, WJ; Jin, GL; Zhu, JW; Lu, YL; Guo, LB; Fan, LJ				Ye, Chu-Yu; Lin, Zhangxiang; Li, Gengmi; Wang, Ying-Ying; Qiu, Jie; Fu, Fei; Zhang, Haiqiang; Chen, Li; Ye, Sisi; Song, Weijie; Jin, Gulei; Zhu, Jinwen; Lu, Yongliang; Guo, Longbiao; Fan, Longjiang			Echinochloa Chloroplast Genomes: Insights into the Evolution and Taxonomic Identification of Two Weedy Species	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CRUS-GALLI; POPULATION; SEQUENCES; MARKERS; ANGIOSPERMS; ALIGNMENTS; MANAGEMENT; POACEAE; RICE	The genus Echinochloa (Poaceae) includes numerous problematic weeds that cause the reduction of crop yield worldwide. To date, DNA sequence information is still limited in the genus Echinochloa. In this study, we completed the entire chloroplast genomes of two Echinochloa species (Echinochloa oryzicola and Echinochloa crus-galli) based on high-throughput sequencing data from their fresh green leaves. The two Echinochloa chloroplast genomes are 139,891 and 139,800 base pairs in length, respectively, and contain 131 protein-coding genes, 79 indels and 466 substitutions helpful for discrimination of the two species. The divergence between the genus Echinochloa and Panicum occurred about 21.6 million years ago, whereas the divergence between E. oryzicola and E. crus-galli chloroplast genes occurred about 3.3 million years ago. The two reported Echinochloa chloroplast genome sequences contribute to better understanding of the diversification of this genus.	[Ye, Chu-Yu; Lin, Zhangxiang; Wang, Ying-Ying; Qiu, Jie; Fu, Fei; Zhang, Haiqiang; Chen, Li; Ye, Sisi; Fan, Longjiang] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Gengmi; Lu, Yongliang; Guo, Longbiao] Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Song, Weijie; Jin, Gulei] Guhe Info Corp, Hangzhou, Zhejiang, Peoples R China; [Zhu, Jinwen] Zhejiang Univ, Dept Plant Protect, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Guo, LB (corresponding author), Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China.	guolongbiao@caas.cn; fanlj@zju.edu.cn	Qiu, Jie/ABC-9247-2021	Qiu, Jie/0000-0003-1799-1907; Wang, Yingying/0000-0002-0603-6691; Fan, Longjiang/0000-0003-4846-0500	National Natural Science Foundation of China [31221004, 31171863]; National Transgenic Research Program [2014ZX001-003]; Fundamental Research Funds for the Central Universities [2014QNA6023]; Guhe info Corp.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Research Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guhe info Corp.	This work was supported by the National Natural Science Foundation of China (31221004, 31171863), the National Transgenic Research Program (2014ZX001-003), and the Fundamental Research Funds for the Central Universities (2014QNA6023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Guhe info Corp. provided support in the form of salaries for authors WS and GJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Aoki D, 2008, WEED BIOL MANAG, V8, P233, DOI 10.1111/j.1445-6664.2008.00303.x; Aoki D, 2009, WEED BIOL MANAG, V9, P225, DOI 10.1111/j.1445-6664.2009.00343.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clayton W. D., 2006, GRASSBASE ONLINE WOR; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; GRAF B, 1992, AGR SYST, V40, P345, DOI 10.1016/0308-521X(92)90046-Q; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HILU KW, 1994, PLANT SYST EVOL, V189, P247, DOI 10.1007/BF00939730; Holm L. G., 1977, The world's worst weeds.; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee RM, 2009, WEED SCI, V57, P463, DOI 10.1614/WS-09-021.1; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liebman M., 2001, WEEDS SOIL ENV; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Michael P, 2003, ECHINOCHLOA P BEAUV, V25, P390; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Moon ByeongChul, 2010, Journal of Crop Science and Biotechnology, V13, P121; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Rao AN, 2007, ADV AGRON, V93, P153, DOI 10.1016/S0065-2113(06)93004-1; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Small RL, 1999, MOL BIOL EVOL, V16, P491, DOI 10.1093/oxfordjournals.molbev.a026131; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Tabacchi M, 2006, WEED SCI, V54, P1086, DOI 10.1614/WS-06-018R1.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tateoka T., 1957, J JPN BOT, V32, P275; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsuchiya T, 1971, BARLEY GENET NWSL, V1, P71; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022993; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; YABUNO T, 1966, JPN J BOT, V19, P277; YABUNO T, 1981, CYTOLOGIA, V46, P393, DOI 10.1508/cytologia.46.393; Yamaguchi H, 2005, WEED BIOL MANAG, V5, P210, DOI 10.1111/j.1445-6664.2005.00185.x; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yasuda Kentaro, 2002, Weed Biology and Management, V2, P11, DOI 10.1046/j.1445-6664.2002.00041.x; Yin P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-22; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zou XH, 2013, NEW PHYTOL, V198, P1155, DOI 10.1111/nph.12230	54	33	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113657	10.1371/journal.pone.0113657	http://dx.doi.org/10.1371/journal.pone.0113657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427255	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400074
J	Christensen, B; Zachariae, ED; Scavenius, C; Thybo, M; Callesen, MM; Kloverpris, S; Oxvig, C; Enghild, JJ; Sorensen, ES				Christensen, Brian; Zachariae, Elias D.; Scavenius, Carsten; Thybo, Morten; Callesen, Morten M.; Kloverpris, Soren; Oxvig, Claus; Enghild, Jan J.; Sorensen, Esben S.			Identification of Transglutaminase Reactive Residues in Human Osteopontin and Their Role in Polymerization	PLOS ONE			English	Article							CRYPTIC EPITOPE SLAYGLR; TISSUE TRANSGLUTAMINASE; ADHESIVE PROPERTIES; BONE SIALOPROTEIN; CROSS-LINKING; SUBSTRATE; PHOSPHORYLATION; PROTEINS; COAGULATION; MEMBERS	Osteopontin (OPN) is a highly posttranslationally modified protein present in several tissues where it is implicated in numerous physiological processes. OPN primarily exerts its functions through interaction with integrins via the Arg-Gly-Asp and Ser-Val-Val-Tyr-Gly-Leu-Arg sequences located in the N-terminal part of the protein. OPN can be polymerized by the cross-linking enzyme transglutaminase 2 (TG2), and polymerization has been shown to enhance the biological activity of OPN. However, little is known about the reactivity and location of the glutamine and lysine residues involved in the TG2-mediated modification of OPN. Here we show that TG2 catalyses the incorporation of 5-(Biotinamido) pentylamine at glutamines in both the N- and C-terminal parts of OPN, whereas TG2 primarily incorporated the glutamine-donor peptide biotinyl-TVQQEL-OH into the C-terminal part of OPN. By mass spectrometric analyses we identified Gln34, Gln42, Gln193 and Gln248 as the major TG2 reactive glutamines in OPN. The distribution of reactive Gln and Lys residues in OPN proved to be important, as the full-length protein but not the physiologically highly active integrin-binding N-terminal part of OPN were able to polymerize in a TG2-mediated reaction. Collectively, these data provide important new molecular knowledge about the mechanism of OPN polymerization.	[Christensen, Brian; Zachariae, Elias D.; Scavenius, Carsten; Thybo, Morten; Callesen, Morten M.; Kloverpris, Soren; Oxvig, Claus; Enghild, Jan J.; Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Enghild, Jan J.; Sorensen, Esben S.] Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Sorensen, ES (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark.	ess@mb.au.dk	Scavenius, Carsten/Q-5941-2017	Scavenius, Carsten/0000-0002-4304-0681; Callesen, Morten/0000-0001-6258-2171; Enghild, Jan Johannes/0000-0001-9292-9172; Oxvig, Claus/0000-0002-4715-9719; Sorensen, Esben Skipper/0000-0002-7050-3354	The Danish Council for Independent Research - Natural Sciences [12-126168]	The Danish Council for Independent Research - Natural Sciences	This work was supported by The Danish Council for Independent Research - Natural Sciences (grant No. 12-126168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2012, J BIOL CHEM, V287, P3788, DOI 10.1074/jbc.M111.277996; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Forsprecher J, 2011, CELL ADHES MIGR, V5, P65, DOI 10.4161/cam.5.1.13369; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; GROOTJANS JJ, 1995, J BIOL CHEM, V270, P22855, DOI 10.1074/jbc.270.39.22855; Hamamoto S, 2011, J BONE MINER RES, V26, P2967, DOI 10.1002/jbmr.495; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Kariya Y, 2014, BIOCHEM J, V463, P93, DOI 10.1042/BJ20140060; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; Nishimichi N, 2011, J BIOL CHEM, V286, P11170, DOI 10.1074/jbc.M110.189258; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; SENGER DR, 1988, CANCER RES, V48, P5770; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113650	10.1371/journal.pone.0113650	http://dx.doi.org/10.1371/journal.pone.0113650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419572	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900063
J	Gruber, AV; Zizelski, G; Azem, A; Weiss, C				Gruber, Anna Vitlin; Zizelski, Gal; Azem, Abdussalam; Weiss, Celeste			The Cpn10(1) Co-Chaperonin of A. thaliana Functions Only as a Hetero-Oligomer with Cpn20	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; CHLOROPLAST CHAPERONINS; ANGSTROM RESOLUTION; GROEL; PLANT; COMPLEXES; PROTEOME; DOMAIN	The A. thaliana genome encodes five co-chaperonin homologs, three of which are destined to the chloroplast. Two of the proteins, Cpn10(2) and Cpn20, form functional homo-oligomers in vitro. In the current work, we present data on the structure and function of the third A. thaliana co-chaperonin, which exhibits unique properties. We found that purified recombinant Cpn10(1) forms inactive dimers in solution, in contrast to the active heptamers that are formed by canonical Cpn10s. Additionally, our data demonstrate that Cpn10(1) is capable of assembling into active hetero-oligomers together with Cpn20. This finding was reinforced by the formation of active co-chaperonin species upon mixing an inactive Cpn20 mutant with the inactive Cpn10(1). The present study constitutes the first report of a higher plant Cpn10 subunit that is able to function only upon formation of hetero-oligomers with other co-chaperonins.	[Gruber, Anna Vitlin; Zizelski, Gal; Azem, Abdussalam; Weiss, Celeste] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Azem, A (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	azema@tauex.tau.ac.il			BARD, the United States-Israel Binational Research and Development Fund [US-4443-11]	BARD, the United States-Israel Binational Research and Development Fund	This research was supported by Research Grant No. US-4443-11 from BARD, the United States-Israel Binational Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azem A, 1998, METHOD ENZYMOL, V290, P253, DOI 10.1016/S0076-6879(98)90024-6; Bartolucci C, 2005, J MOL BIOL, V354, P940, DOI 10.1016/j.jmb.2005.09.096; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Gruber AV, 2013, TRENDS PLANT SCI, V18, P688, DOI 10.1016/j.tplants.2013.08.001; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Nojima T, 2008, J BIOL CHEM, V283, P18385, DOI 10.1074/jbc.M709825200; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Sharkia R, 2003, BBA-PROTEINS PROTEOM, V1651, P76, DOI 10.1016/S1570-9639(03)00237-1; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Viitanen PV, 1998, METHOD ENZYMOL, V290, P218, DOI 10.1016/S0076-6879(98)90021-0; VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158; Vitlin A, 2011, PLANT MOL BIOL, V77, P105, DOI 10.1007/s11103-011-9797-6; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang XF, 2013, PLANT MOL BIOL, V83, P205, DOI 10.1007/s11103-013-0082-8; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	30	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113835	10.1371/journal.pone.0113835	http://dx.doi.org/10.1371/journal.pone.0113835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419702	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900072
J	Hadjigeorgiou, G; Dardiotis, E; Tsivgoulis, G; Doskas, T; Petrou, D; Makris, N; Vlaikidis, N; Thomaidis, T; Kyritsis, A; Fakas, N; Treska, X; Karageorgiou, C; Sotirli, S; Giannoulis, C; Papadimitriou, D; Mylonas, I; Kouremenos, E; Vlachos, G; Georgiopoulos, D; Mademtzoglou, D; Vikelis, M; Zintzaras, E				Hadjigeorgiou, Georgios; Dardiotis, Efthimios; Tsivgoulis, Georgios; Doskas, Triantafyllos; Petrou, Damianos; Makris, Nikolaos; Vlaikidis, Nikolaos; Thomaidis, Thomas; Kyritsis, Athanasios; Fakas, Nikolaos; Treska, Xoulietta; Karageorgiou, Clementine; Sotirli, Stefania; Giannoulis, Christos; Papadimitriou, Dimitra; Mylonas, Ioannis; Kouremenos, Evaggelos; Vlachos, Georgios; Georgiopoulos, Dimitrios; Mademtzoglou, Despoina; Vikelis, Michalis; Zintzaras, Elias			Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA)	PLOS ONE			English	Article							STOCKHOLM COUNTY; PEOPLE; ADHERENCE; SATISFACTION; DISABILITY; THERAPIES; CRISIS	Multiple sclerosis (MS) results in an extensive use of the health care system, even within the first years of diagnosis. The effectiveness and accessibility of the health care system may affect patients' quality of life. The aim of the present study was to evaluate the health care resource use of MS patients under interferon beta-1b (EXTAVIA) treatment in Greece, the demographic or clinical factors that may affect this use and also patient satisfaction with the health care system. Structured interviews were conducted for data collection. In total, 204 patients (74.02% females, mean age (SD) 43.58 (11.42) years) were enrolled in the study. Analysis of the reported data revealed that during the previous year patients made extensive use of health services in particular neurologists (71.08% visited neurologists in public hospitals, 66.67% in private offices and 48.53% in insurance institutes) and physiotherapists. However, the majority of the patients (52.45%) chose as their treating doctor private practice neurologists, which may reflect accessibility barriers or low quality health services in the public health system. Patients seemed to be generally satisfied with the received health care, support and information on MS (84.81% were satisfied from the information provided to them). Patients' health status (as denoted by disease duration, disability status and hospitalization needs) and insurance institute were found to influence their visits to neurologists. Good adherence (up to 70.1%) to the study medication was reported. Patients' feedback on currently provided health services could direct these services towards the patients' expectations.	[Hadjigeorgiou, Georgios; Dardiotis, Efthimios; Papadimitriou, Dimitra] Univ Hosp Larissa, Dept Neurol, Larisa, Greece; [Tsivgoulis, Georgios] Univ Athens, Sch Med, Dept Neurol 2, Attikon Univ Hosp, GR-11527 Athens, Greece; [Doskas, Triantafyllos] Athens Naval Hosp, Dept Neurol, Athens, Greece; [Petrou, Damianos] Vostanio Gen Hosp Mytilini, Outpatient Clin, Mitilini, Greece; [Makris, Nikolaos] Agios Andreas Gen Univ Patra, Dept Neurol, Patras, Greece; [Vlaikidis, Nikolaos] Papanikolaou Univ Hosp Thessaloniki, Univ Neurol Dept 3, Thessaloniki, Greece; [Thomaidis, Thomas] Greek Red Cross Hosp, Dept Neurol, Athens, Greece; [Kyritsis, Athanasios] Univ Hosp Ioannina, Univ Neurol Dept, Ioannina, Greece; [Fakas, Nikolaos] 401 Mil Hosp Athens, Dept Neurol, Athens, Greece; [Treska, Xoulietta] AHEPA Gen Univ Hosp Thessaloniki, Univ Neurol Dept 2, Thessaloniki, Greece; [Karageorgiou, Clementine] Gennimatas Gen Hosp, Dept Neurol, Athens, Greece; [Mylonas, Ioannis; Vikelis, Michalis] Interbalcan Med Ctr, Outpatient Clin, Thessaloniki, Greece; [Kouremenos, Evaggelos] 251 Air Force Hosp, Dept Neurol, Thessaloniki, Greece; [Vlachos, Georgios; Georgiopoulos, Dimitrios; Vikelis, Michalis] Novartis Hellas SACI, Dept Med, Athens, Greece; [Mademtzoglou, Despoina; Zintzaras, Elias] BECRO, Pharmaceut Serv, Athens, Greece; [Mademtzoglou, Despoina; Zintzaras, Elias] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece; [Zintzaras, Elias] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	General University Hospital of Larissa; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University Hospital Ioannina; University of Thessaly; Tufts University	Dardiotis, E (corresponding author), Univ Hosp Larissa, Dept Neurol, Larisa, Greece.	edar@med.uth.gr	Tsivgoulis, Georgios/AAD-7467-2019; Tsivgoulis, Georgios/AAD-5360-2020	Tsivgoulis, Georgios/0000-0002-0640-3797; MADEMTZOGLOU, Despoina/0000-0002-4494-7234; Dardiotis, Efthimios/0000-0003-2957-641X; Vlachos, George/0000-0002-0757-2808; Vikelis, Michail/0000-0002-2715-7898	Novartis Hellas S.A. (Greece); Novartis Hellas S.A.; BECRO, Pharmaceutical Services	Novartis Hellas S.A. (Greece); Novartis Hellas S.A.; BECRO, Pharmaceutical Services	The study was sponsored by Novartis Hellas S.A. (Greece). The funder Novartis Hellas S.A. provided support in the form of salaries for authors MV, GV and DG, and was responsible for protocol development, study coordination and site monitoring. The specific roles of these authors are articulated in the 'author contributions' section. Novartis also provided a standard pre-defined fee to investigators' research sites for each patient visit, according to GCP guidelines and internal Novartis processes. Novartis Hellas S.A. also funded BECRO, Pharmaceutical Services to perform statistical analysis of the data. Co-authors DM and EZ are employed by BECRO, Pharmaceutical Services. BECRO, Pharmaceutical Services provided support in the form of salaries for authors DM and EZ, but did not have any additional role in the study design, data collection and interpretation, decision to publish, or preparation of the manuscript.	Asche CV, 2010, J MANAGE CARE PHARM, V16, P703, DOI 10.18553/jmcp.2010.16.9.703; Beckerman H, 2008, MULT SCLER J, V14, P1269, DOI 10.1177/1352458508094884; Buchanan Robert J, 2006, J Health Hum Serv Adm, V29, P360; Carton H, 1998, J NEUROL NEUROSUR PS, V64, P444, DOI 10.1136/jnnp.64.4.444; Dardiotis E, 2014, NEUROEPIDEMIOLOGY, V43, P9, DOI 10.1159/000362723; Freedman MS, 2011, NEUROLOGY, V76, pS26, DOI 10.1212/WNL.0b013e318205051d; Freedman MS, 2009, CURR MED RES OPIN, V25, P2459, DOI 10.1185/03007990903158364; Gottberg K, 2008, MULT SCLER J, V14, P962, DOI 10.1177/1352458508089688; Gottberg K, 2002, ACTA NEUROL SCAND, V106, P241, DOI 10.1034/j.1600-0404.2002.01309.x; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; Kentikelenis A, 2014, LANCET, V383, P748, DOI 10.1016/S0140-6736(13)62291-6; Koudriavtseva T, 2012, NEUROL SCI, V33, P575, DOI 10.1007/s10072-011-0776-0; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Minden SL, 2008, NEUROLOGY, V70, P1141, DOI 10.1212/01.wnl.0000306411.46934.ef; Minden SL, 2007, MULT SCLER J, V13, P547, DOI 10.1177/1352458506071306; Moorer P, 2000, DISABIL REHABIL, V22, P695, DOI 10.1080/09638280050191963; Niakas D, 2013, INT J HEALTH SERV, V43, P597, DOI 10.2190/HS.43.4.a; Portaccio E, 2009, CNS DRUGS, V23, P453, DOI 10.2165/00023210-200923060-00001; Pozzilli C, 2011, J NEUROL SCI, V307, P120, DOI 10.1016/j.jns.2011.04.026; Rio J, 2005, J NEUROL, V252, P795, DOI 10.1007/s00415-005-0748-5; Rio J, 2009, NAT REV NEUROL, V5, P553, DOI 10.1038/nrneurol.2009.139; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Turner AP, 2013, ACCESS MULTIPLE SCLE; Wicks P, 2011, J MED INTERNET RES, V13, P117, DOI 10.2196/jmir.1687; Ytterberg C, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-36	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113933	10.1371/journal.pone.0113933	http://dx.doi.org/10.1371/journal.pone.0113933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419842	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900080
J	Nandakumar, S; Kannanganat, S; Posey, JE; Amara, RR; Sable, SB				Nandakumar, Subhadra; Kannanganat, Sunil; Posey, James E.; Amara, Rama Rao; Sable, Suraj B.			Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; IMMUNE-RESPONSE; CENTRAL MEMORY; ANTIGEN PERSISTENCE; EFFECTOR FUNCTIONS; EFFICACY; BOVIS; INFECTION	Mycobacterium bovis bacille Calmette-Guerin (BCG) is the most widely used live attenuated vaccine. However, the correlates of protection and waning of its immunity against tuberculosis is poorly understood. In this study, we correlated the longitudinal changes in the magnitude and functional quality of CD4(+) and CD8(+) T-cell response over a period of two years after mucosal or parenteral BCG vaccination with the strength of protection against Mycobacterium tuberculosis in mice. The BCG vaccination-induced CD4(+) and CD8(+) T cells exhibited comparable response kinetics but distinct functional attributes in-terms of IFN-gamma, IL-2 and TNF-alpha co-production and CD62L memory marker expression. Despite a near life-long BCG persistence and the induction of enduring CD4(+) T-cell responses characterized by IFN-gamma and/or TNF-alpha production with comparable protection, the protective efficacy waned regardless of the route of vaccination. The progressive decline in the multifactorial functional abilities of CD4(+) and CD8(+) T cells in-terms of type-1 cytokine production, proliferation and cytolytic potential corresponded with the waning of protection against M. tuberculosis infection. In addition, simultaneous increase in the dysfunctional and terminally-differentiated T cells expressing CTLA-4, KLRG-1 and IL-10 during the contraction phase of BCG-induced response coincided with the loss of protection. Our results question the empirical development of BCG-booster vaccines and emphasize the pursuit of strategies that maintain superior T-cell functional capacity. Furthermore, our results underscore the importance of understanding the comprehensive functional dynamics of antigen-specific T-cell responses in addition to cytokine polyfunctionality in BCG-vaccinated hosts while optimizing novel vaccination strategies against tuberculosis.	[Nandakumar, Subhadra; Posey, James E.; Sable, Suraj B.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30329 USA; [Kannanganat, Sunil; Amara, Rama Rao] Emory Univ, Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University	Sable, SB (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30329 USA.	SSable@cdc.gov	Amara, Rama/AAO-8136-2021; Sidharthan, Sunil Kannanganat/V-4917-2019; Sable, Suraj/AAI-2439-2020	Sidharthan, Sunil Kannanganat/0000-0003-4605-9799; Sable, Suraj/0000-0001-8440-1693	Centers for Disease Control and Prevention (CDC); Georgia Research Alliance	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Georgia Research Alliance	The study was supported by Centers for Disease Control and Prevention (CDC) intramural funds and the Georgia Research Alliance grant to SBS, RRA, JEP, and TM Shinnick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Baldwin SL, 2013, J IMMUNOL, V191, P2514, DOI 10.4049/jimmunol.1301161; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Brooks JV, 2001, INFECT IMMUN, V69, P2714, DOI 10.1128/IAI.69.4.2714-2717.2001; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1995, INFECT IMMUN, V63, P3259, DOI 10.1128/IAI.63.9.3259-3265.1995; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Henson SM, 2009, AGE, V31, P285, DOI 10.1007/s11357-009-9100-9; Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953; Hiraishi Y, 2011, VACCINE, V29, P2626, DOI 10.1016/j.vaccine.2011.01.042; Hofstadler G, 1998, AIDS PATIENT CARE ST, V12, P677, DOI 10.1089/apc.1998.12.677; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Ito M, 2006, J EXP MED, V203, P289, DOI 10.1084/jem.20051986; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jelley-Gibbs DM, 2005, J EXP MED, V201, P1101, DOI 10.1084/jem.20041852; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Kirman J, 1999, INFECT IMMUN, V67, P3786, DOI 10.1128/IAI.67.8.3786-3792.1999; Komine-Aizawa S, 2010, CLIN VACCINE IMMUNOL, V17, P1500, DOI 10.1128/CVI.00190-10; Lindenstrom T, 2014, EUR J IMMUNOL; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; McShane H, 2012, TUBERCULOSIS, V92, P283, DOI 10.1016/j.tube.2011.12.003; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Nandakumar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003705; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; ORME IM, 1986, TUBERCLE, V67, P133, DOI 10.1016/0041-3879(86)90007-3; Palendira U, 2002, INFECT IMMUN, V70, P1410, DOI 10.1128/IAI.70.3.1410-1416.2002; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reiley WW, 2010, P NATL ACAD SCI USA, V107, P19408, DOI 10.1073/pnas.1006298107; Ryan AA, 2009, J IMMUNOL, V182, P7172, DOI 10.4049/jimmunol.0801694; Sable SB, 2005, VACCINE, V23, P4175, DOI 10.1016/j.vaccine.2005.03.040; Sable SB, 2013, J INFECT DIS, V208, P541, DOI 10.1093/infdis/jit211; Sable SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022718; Sakai S, 2010, INT IMMUNOL, V22, P915, DOI 10.1093/intimm/dxq446; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; SMITH E, 1992, SCAND J INFECT DIS, V24, P109, DOI 10.3109/00365549209048409; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tree JA, 2004, CLIN EXP IMMUNOL, V138, P405, DOI 10.1111/j.1365-2249.2004.02648.x; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Vesosky B, 2006, INFECT IMMUN, V74, P3314, DOI 10.1128/IAI.01475-05; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Waddell RD, 2001, AIDS, V15, P55, DOI 10.1097/00002030-200101050-00009; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	88	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113951	10.1371/journal.pone.0113951	http://dx.doi.org/10.1371/journal.pone.0113951			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419982	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900081
J	da Luz, JMR; Paes, SA; Bazzolli, DMS; Totola, MR; Demuner, AJ; Kasuya, MCM				Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Soares Bazzolli, Denise Mara; Totola, Marcos Rogerio; Demuner, Antonio Jacinto; Megumi Kasuya, Maria Catarina			Abiotic and Biotic Degradation of Oxo-Biodegradable Plastic Bags by Pleurotus ostreatus	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; POLYETHYLENE; DIVERSITY; LACCASE; GROWTH; ENZYME; FUNGUS; LDPE	In this study, we evaluated the growth of Pleurotus ostreatus PLO6 using oxo-biodegradable plastics as a carbon and energy source. Oxo-biodegradable polymers contain pro-oxidants that accelerate their physical and biological degradation. These polymers were developed to decrease the accumulation of plastic waste in landfills. To study the degradation of the plastic polymers, oxo-biodegradable plastic bags were exposed to sunlight for up to 120 days, and fragments of these bags were used as substrates for P. ostreatus. We observed that physical treatment alone was not sufficient to initiate degradation. Instead, mechanical modifications and reduced titanium oxide (TiO2) concentrations caused by sunlight exposure triggered microbial degradation. The low specificity of lignocellulolytic enzymes and presence of endomycotic nitrogen-fixing microorganisms were also contributing factors in this process.	[Rodrigues da Luz, Jose Maria; Paes, Sirlaine Albino; Soares Bazzolli, Denise Mara; Totola, Marcos Rogerio; Demuner, Antonio Jacinto; Megumi Kasuya, Maria Catarina] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Kasuya, MCM (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mkasuya@ufv.br	da Luz, José Maria/B-2276-2018; Kasuya, Maria Catarina Megumi/E-1123-2013; Bazzolli, Denise Mara Soares/AAR-7924-2021	da Luz, José Maria/0000-0001-9826-7982; Kasuya, Maria Catarina Megumi/0000-0002-9539-9370; Bazzolli, Denise Mara Soares/0000-0002-0371-6966; Demuner, Antonio Jacinto/0000-0001-8918-2581	CAPES; CNPq; FAPEMIG	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by Brazilian Financial Agencies: CAPES, CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Braga GUL, 1999, J INVERTEBR PATHOL, V74, P112, DOI 10.1006/jipa.1999.4872; Contat-Rodrigo L, 2002, J APPL POLYM SCI, V83, P1683, DOI 10.1002/app.10087; Direito I. C. N., 2002, Revista Universidade Rural. Serie Ciencias da Vida, V22, P123; Esmaeili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071720; Fernandez G, 2009, PLANTA DANINHA, V27, P601, DOI 10.1590/S0100-83582009000300022; Flieger M, 2003, FOLIA MICROBIOL, V48, P27, DOI 10.1007/BF02931273; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; KASUYA MCM, 2012, FEEDSTOCKS PRODUCTIO, V1, P487; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Liang WY, 2013, POLYM DEGRAD STABIL, V98, P1754, DOI 10.1016/j.polymdegradstab.2013.05.027; Lin Q, 1999, SOIL BIOL BIOCHEM, V31, P1969, DOI 10.1016/S0038-0717(99)00120-0; Majcherczyk A, 1998, ENZYME MICROB TECH, V22, P335, DOI 10.1016/S0141-0229(97)00199-3; Miyazaki K, 2011, POLYM DEGRAD STABIL, V96, P1039, DOI 10.1016/j.polymdegradstab.2010.10.017; Miyazaki K, 2009, POLYM DEGRAD STABIL, V94, P2114, DOI 10.1016/j.polymdegradstab.2009.10.001; Mochi DA, 2005, NEOTROP ENTOMOL, V34, P961, DOI 10.1590/S1519-566X2005000600013; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Nunes M. D., 2012, Journal of Food Research, V1, P113; Nyanhongo GS, 2006, ENZYME MICROB TECH, V39, P1197, DOI 10.1016/j.enzmictec.2006.03.004; Ohtake Y, 1998, POLYM DEGRAD STABIL, V60, P79, DOI 10.1016/S0141-3910(97)00032-3; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; da Luz JMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069386; da Luz JMR, 2012, BRAZ J MICROBIOL, V43, P1508, DOI [10.1590/S1517-83822012000400035, 10.1590/S1517-838220120004000035]; da Luz JMR, 2013, LWT-FOOD SCI TECHNOL, V50, P575, DOI 10.1016/j.lwt.2012.08.006; Santo M, 2013, INT BIODETER BIODEGR, V84, P204, DOI 10.1016/j.ibiod.2012.03.001; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; Wen JW, 2011, INT BIODETER BIODEGR, V65, P600, DOI 10.1016/j.ibiod.2011.03.003; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0; Yamada-Onodera K, 2001, POLYM DEGRAD STABIL, V72, P323, DOI 10.1016/S0141-3910(01)00027-1; Yara R, 2006, J MICROBIOL, V44, P263	34	18	18	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e107438	10.1371/journal.pone.0107438	http://dx.doi.org/10.1371/journal.pone.0107438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419675	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900001
J	Seo, HY; Kwon, JS; Choi, YR; Kim, KM; Choi, EH; Kim, KN				Seo, Hye Yeon; Kwon, Jae-Sung; Choi, Yu-Ri; Kim, Kwang-Mahn; Choi, Eun Ha; Kim, Kyoung-Nam			Cellular Attachment and Differentiation on Titania Nanotubes Exposed to Air- or Nitrogen-Based Non-Thermal Atmospheric Pressure Plasma	PLOS ONE			English	Article							IMPLANT SURFACES; HYDROPHILICITY; STERILIZATION; OSTEOBLASTS; ADHESION; ENERGY; PLATES	The surface topography and chemistry of titanium implants are important factors for successful osseointegration. However, chemical modification of an implant surface using currently available methods often results in the disruption of topographical features and the loss of beneficial effects during the shelf life of the implant. Therefore, the aim of this study was to apply the recently highlighted portable non-thermal atmospheric pressure plasma jet (NTAPPJ), elicited from one of two different gas sources (nitrogen and air), to TiO2 nanotube surfaces to further improve their osteogenic properties while preserving the topographical morphology. The surface treatment was performed before implantation to avoid age-related decay. The surface chemistry and morphology of the TiO2 nanotube surfaces before and after the NTAPPJ treatment were determined using a field-emission scanning electron microscope, a surface profiler, a contact angle goniometer, and an X-ray photoelectron spectroscope. The MC3T3-E1 cell viability, attachment and morphology were confirmed using calcein AM and ethidium homodimer-1 staining, and analysis of gene expression using rat mesenchymal stem cells was performed using a real-time reverse-transcription polymerase chain reaction. The results indicated that both portable nitrogen-and air-based NTAPPJ could be used on TiO2 nanotube surfaces easily and without topographical disruption. NTAPPJ resulted in a significant increase in the hydrophilicity of the surfaces as well as changes in the surface chemistry, which consequently increased the cell viability, attachment and differentiation compared with the control samples. The nitrogen-based NTAPPJ treatment group exhibited a higher osteogenic gene expression level than the air-based NTAPPJ treatment group due to the lower atomic percentage of carbon on the surface that resulted from treatment. It was concluded that NTAPPJ treatment of TiO2 nanotube surfaces results in an increase in cellular activity. Furthermore, it was demonstrated that this treatment leads to improved osseointegration in vitro.	[Seo, Hye Yeon; Kwon, Jae-Sung; Choi, Yu-Ri; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea; [Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, BK Plus Project 21, Seoul 120749, South Korea; [Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kwangwoon University	Kim, KN (corresponding author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.	kimkn@yuhs.ac	Kwon, Jae-Sung/M-5430-2018; Choi, Eun Ha/AFN-9488-2022	Kwon, Jae-Sung/0000-0001-9803-7730; Choi, Eun Ha/0000-0001-5385-1878; KIM, KWANG-MAHN/0000-0002-5235-0294	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A1A2008659, NRF-2014H1A2A1020740, NRF-2010-0027953]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2012R1A1A2008659, NRF-2014H1A2A1020740 and NRF-2010-0027953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001; Bardos L, 2010, THIN SOLID FILMS, V518, P6705, DOI 10.1016/j.tsf.2010.07.044; Chien CC, 2008, DENT MATER, V24, P986, DOI 10.1016/j.dental.2007.11.020; Choi HS, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NF02; Choi YR, 2013, THIN SOLID FILMS, V547, P235, DOI 10.1016/j.tsf.2013.02.038; Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x; Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659; He J, 2008, J MATER SCI-MATER M, V19, P3465, DOI 10.1007/s10856-008-3505-3; Hyam RS, 2012, J NANOSCI NANOTECHNO, V12, P8908, DOI 10.1166/jnn.2012.6734; Ikeda D, 2002, SURF COAT TECH, V156, P301, DOI 10.1016/S0257-8972(02)00094-4; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kawai H, 2004, BIOMATERIALS, V25, P1805, DOI 10.1016/j.biomaterials.2003.08.032; Kim H, 2006, INT J ORAL MAX IMPL, V21, P354; Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x; Kwon OJ, 2006, J COLLOID INTERF SCI, V295, P409, DOI 10.1016/j.jcis.2005.11.007; Lavenus S, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/915327; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lee JH, 2012, IMPLANT DENT, V21, P415, DOI 10.1097/ID.0b013e31826a51f4; Lee JH, 2013, ACTA ODONTOL SCAND, V71, P168, DOI 10.3109/00016357.2011.654256; Malkoc S, 2012, AM J ORTHOD DENTOFAC, V141, P419, DOI 10.1016/j.ajodo.2011.12.009; Meredith DO, 2007, J MATER SCI-MATER M, V18, P405, DOI 10.1007/s10856-006-0706-5; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Pouvesle JM, 2008, PLASMA CHEMISTRY, P259; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x; Schwarz F, 2008, J CLIN PERIODONTOL, V35, P64, DOI 10.1111/j.1600-051X.2007.01159.x; Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027; Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771; Thierry B, 2000, J BIOMED MATER RES, V49, P88, DOI 10.1002/(SICI)1097-4636(200001)49:1<88::AID-JBM11>3.0.CO;2-I; Uhm SH, 2014, J BIOMED MATER RES B, V102, P592, DOI 10.1002/jbm.b.33038; Ungvari K, 2010, J BIOMED MATER RES B, V94B, P222, DOI 10.1002/jbm.b.31644; Vezeau PJ, 1996, J ORAL MAXIL SURG, V54, P738, DOI 10.1016/S0278-2391(96)90694-1; Walter MS, 2013, J MATER SCI-MATER M, V24, P2761, DOI 10.1007/s10856-013-5020-4; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085; Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	38	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113477	10.1371/journal.pone.0113477	http://dx.doi.org/10.1371/journal.pone.0113477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420027	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900040
J	Yaakoubi, H; Hamdani, S; Bekale, L; Carpentier, R				Yaakoubi, Hnia; Hamdani, Saber; Bekale, Laurent; Carpentier, Robert			Protective Action of Spermine and Spermidine against Photoinhibition of Photosystem I in Isolated Thylakoid Membranes	PLOS ONE			English	Article							PSAB GENE-PRODUCT; CUCUMIS-SATIVUS L; PHOTOSYNTHETIC APPARATUS; SUPEROXIDE-DISMUTASE; TRANSGLUTAMINASE ACTIVITY; SPINACH-CHLOROPLASTS; LEAF ORIENTATION; LOW-TEMPERATURE; ELECTRON FLOW; LIGHT	The photo-stability of photosystem I (PSI) is of high importance for the photosynthetic processes. For this reason, we studied the protective action of two biogenic polyamines (PAs) spermine (Spm) and spermidine (Spd) on PSI activity in isolated thylakoid membranes subjected to photoinhibition. Our results show that pre-loading thylakoid membranes with Spm and Spd reduced considerably the inhibition of O-2 uptake rates, P700 photooxidation and the accumulation of superoxide anions (O-2(-)) induced by light stress. Spm seems to be more effective than Spd in preserving PSI photo-stability. The correlation of the extent of PSI protection, photosystem II (PSII) inhibition and O-2(-) generation with increasing Spm doses revealed that PSI photo-protection is assumed by two mechanisms depending on the PAs concentration. Given their antioxidant character, PAs scavenge directly the O-2(-) generated in thylakoid membranes at physiological concentration (1 mM). However, for non-physiological concentration, the ability of PAs to protect PSI is due to their inhibitory effect on PSII electron transfer.	[Yaakoubi, Hnia; Hamdani, Saber; Bekale, Laurent; Carpentier, Robert] Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ GA9 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Carpentier, R (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Biol Vegetale, Trois Rivieres, PQ GA9 5H7, Canada.	Robert.Carpentier@uqtr.ca		Laurent Adonis, Bekale/0000-0001-5059-5442	Natural Sciences and Engineering Research Council of Canada [RGPIN1502]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada, www.nserc-crsng.gc.ca, RGPIN1502, RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aronova E E, 2005, Dokl Biol Sci, V403, P257, DOI 10.1007/s10630-005-0104-z; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barber J, 1981, PHOTOSYNTHESIS 1 PHO, P385; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beauchemkin R, 2007, BBA-BIOENERGETICS, V1767, P905, DOI 10.1016/j.bbabio.2007.04.001; BESFORD RT, 1993, PLANTA, V189, P201, DOI 10.1007/BF00195077; Bonenfant D, 1989, APPL BIOCHEM BIOTECH, P59; CARPENTIER R, 1984, ARCH BIOCHEM BIOPHYS, V228, P534, DOI 10.1016/0003-9861(84)90020-1; DANON A, 1994, SCIENCE, V266, P1717, DOI 10.1126/science.7992056; DELDUCA S, 1994, PLANTA, V193, P283, DOI 10.1007/BF00192542; Della Mea M, 2004, PLANTA, V219, P754, DOI 10.1007/s00425-004-1278-6; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dernetriou G, 2007, BBA-BIOENERGETICS, V1767, P272, DOI 10.1016/j.bbabio.2007.02.020; Govindachary S, 2004, PHYSIOL PLANTARUM, V121, P322, DOI 10.1111/j.0031-9317.2004.00305.x; Govindachary S, 2007, PHOTOSYNTH RES, V94, P333, DOI 10.1007/s11120-007-9199-4; Groppa MD, 2007, BIOMETALS, V20, P185, DOI 10.1007/s10534-006-9026-y; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamdani S, 2011, J PHOTOCH PHOTOBIO B, V104, P314, DOI 10.1016/j.jphotobiol.2011.02.007; Hamdani S, 2011, PLANT CELL PHYSIOL, V52, P866, DOI 10.1093/pcp/pcr040; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; He LX, 2002, PLANT CELL PHYSIOL, V43, P196, DOI 10.1093/pcp/pcf021; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; Hui Y, 2000, PHOTOCHEM PHOTOBIOL, V72, P508, DOI 10.1562/0031-8655(2000)072<0508:DOTPIC>2.0.CO;2; Hwang HJ, 2004, J PHOTOCH PHOTOBIO B, V73, P79, DOI 10.1016/j.jphotobiol.2003.09.008; Ioannidis NE, 2009, BBA-BIOENERGETICS, V1787, P1215, DOI 10.1016/j.bbabio.2009.05.014; James SA, 2000, TREE PHYSIOL, V20, P815; Jiang CD, 2006, ENVIRON EXP BOT, V55, P87, DOI 10.1016/j.envexpbot.2004.10.003; Jiao SX, 2004, PLANT SCI, V167, P733, DOI 10.1016/j.plantsci.2004.05.002; Joly D, 2005, PHOTOSYNTH RES, V84, P107, DOI 10.1007/s11120-004-7763-8; KAURSAWHNEY R, 1978, PLANT PHYSIOL, V62, P158, DOI 10.1104/pp.62.1.158; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KOTZABASIS K, 1993, PHOTOSYNTH RES, V38, P83, DOI 10.1007/BF00015064; Krieger-Liszkay A, 2000, FEBS LETT, V486, P191, DOI 10.1016/S0014-5793(00)02250-X; Kudoh H, 2002, PLANTA, V215, P541, DOI 10.1007/s00425-002-0790-9; Kuznetsov V.V., 2007, PLANT STRESS, V1, P50; La Porta N, 2005, TREE PHYSIOL, V25, P1033, DOI 10.1093/treephys/25.8.1033; Lutz C, 2005, BBA-BIOENERGETICS, V1710, P24, DOI 10.1016/j.bbabio.2005.09.001; Mapelli S., 2008, General and Applied Plant Physiology, V34, P55; MIYAKE C, 1992, PLANT CELL PHYSIOL, V33, P541; Miyake C, 2003, PLANT CELL PHYSIOL, V44, P457, DOI 10.1093/pcp/pcg053; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Navakoudis E, 2003, BBA-GEN SUBJECTS, V1621, P160, DOI 10.1016/S0304-4165(03)00056-4; Nayyar H, 2004, J AGRON CROP SCI, V190, P355, DOI 10.1111/j.1439-037X.2004.00106.x; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; OGAWA K, 1995, PLANT CELL PHYSIOL, V36, P565; Oh MH, 2009, PHOTOCH PHOTOBIO SCI, V8, P535, DOI 10.1039/b817808a; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quiles MJ, 2004, PLANT SCI, V166, P815, DOI 10.1016/j.plantsci.2003.11.025; Rajagopal S, 2003, PHOTOSYNTH RES, V78, P77, DOI 10.1023/A:1026085305499; Rajagopal S, 2002, J PHOTOCH PHOTOBIO B, V67, P194, DOI 10.1016/S1011-1344(02)00326-3; Sobieszczuk-Nowicka E, 2009, ACTA BIOCHIM POL, V56, P255; SONOIKE K, 1995, FEBS LETT, V362, P235, DOI 10.1016/0014-5793(95)00254-7; Sonoike K, 1996, PLANT SCI, V115, P157, DOI 10.1016/0168-9452(96)04341-5; Sonoike K, 1997, PHOTOSYNTH RES, V53, P55, DOI 10.1023/A:1005852330671; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; Stoynova EZ, 1999, PLANT GROWTH REGUL, V29, P175, DOI 10.1023/A:1006249514986; Takahashi Shunichi, 2002, BMC Plant Biol, V2, P2, DOI 10.1186/1471-2229-2-2; TERASHIMA I, 1994, PLANTA, V193, P300, DOI 10.1007/BF00192544; TIBURCIO AF, 1994, J EXP BOT, V45, P1789, DOI 10.1093/jxb/45.12.1789; Tjus SE, 1998, PLANT PHYSIOL, V116, P755, DOI 10.1104/pp.116.2.755; Tjus SE, 2001, PLANT PHYSIOL, V125, P2007, DOI 10.1104/pp.125.4.2007; Yang X, 2009, RUSS J PLANT PHYSL+, V56, P599, DOI 10.1134/S1021443709050033; Yordanov Ivan, 2000, Bulgarian Journal of Plant Physiology, V26, P70	65	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112893	10.1371/journal.pone.0112893	http://dx.doi.org/10.1371/journal.pone.0112893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420109	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900013
J	Totosy de Zepetnek, JO; Jermey, TL; MacDonald, MJ				Totosy de Zepetnek, Julia O.; Jermey, Tena L.; MacDonald, Maureen J.			Superficial Femoral Artery Endothelial Responses to a Short-Term Altered Shear Rate Intervention in Healthy Men	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; VELOCITY PROFILES; NITRIC-OXIDE; ACUTE EXERCISE; STRESS; ATHEROSCLEROSIS; DILATATION; LESIONS	In animal and in-vitro models, increased oscillatory shear stress characterized by increased retrograde shear-rate (SR) is associated with acutely decreased endothelial cell function. While previous research suggests a possible detrimental role of elevated retrograde SR on endothelial-function in the brachial artery in humans, little research has been conducted examining arteries in the leg. Examinations of altered shear pattern in the superficial femoral artery (SFA) are important, as this vessel is both prone to atherosclerosis and leg exercise is a common form of activity in humans. Seven healthy men participated; bilateral endothelial-function was assessed via flow-mediated-dilation (FMD) before and after 30-minute unilateral inflations of a thigh blood pressure cuff to either 75 mmHg or 100 mmHg on two separate visits. Inflation of the cuff induced increases in maximum anterograde (p<0.05), maximum retrograde (p<0.01), and oscillatory shear index (OSI) (p<0.001) in the cuffed leg at both inflation pressures. At 100 mmHg the increases in SR were larger in the retrograde than the anterograde direction evidenced by a decrease in mean SR (p<0.01). There was an acute decrease in relative FMD in the cuffed leg alone following inflation to both pressures. These results indicate that in the SFA, altered SR profiles incorporating increased retrograde and OSI influence the attenuation in FMD after a 30-minute unilateral thigh-cuff inflation intervention. Novel information highlighting the importance of OSI calculations and assessments of flow profiles add to current body of knowledge regarding the influence of changes in SR patterns on FMD. Findings from the current study may provide additional insight when designing strategies to combat impaired vascular function in the lower extremity where blood vessels are more prone to atherosclerosis in comparison to the upper extremity.	[Totosy de Zepetnek, Julia O.; Jermey, Tena L.; MacDonald, Maureen J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	MacDonald, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	macdonmj@mcmaster.ca	MacDonald, Maureen/L-2626-2019	MacDonald, Maureen/0000-0001-9851-3610; Totosy de Zepetnek, Julia/0000-0001-7011-5143	Natural Sciences and Engineering Research Council [RGPIN 238819-13]; Ontario Neurotrauma Foundation [2011-ONF-RHI-MT-888]; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Neurotrauma Foundation; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Natural Sciences and Engineering Research Council [RGPIN 238819-13] (MM), Ontario Neurotrauma Foundation [2011-ONF-RHI-MT-888] (JT), and Ontario Graduate Scholarship (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade CJ, 2012, EXP PHYSIOL, V97, P849, DOI 10.1113/expphysiol.2011.064212; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Donald AE, 2006, J AM COLL CARDIOL, V48, P1846, DOI 10.1016/j.jacc.2006.07.039; HALE JF, 1955, J PHYSIOL-LONDON, V128, P629, DOI 10.1113/jphysiol.1955.sp005330; Harris RA, 2008, OBESITY, V16, P578, DOI 10.1038/oby.2007.87; Harris RA, 2007, ULTRASOUND MED BIOL, V33, P1579, DOI 10.1016/j.ultrasmedbio.2007.04.014; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Johnson BD, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-34; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kooijman M, 2008, J PHYSIOL-LONDON, V586, P1137, DOI 10.1113/jphysiol.2007.145722; Kroger K, 1999, ANGIOLOGY, V50, P649, DOI 10.1177/000331979905000805; Llewellyn TL, 2012, ACTA PHYSIOL, V205, P394, DOI 10.1111/j.1748-1716.2012.02417.x; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; MALEK AM, 1994, J HYPERTENS, V12, P989; MCMILLAN DE, 1985, STROKE, V16, P582, DOI 10.1161/01.STR.16.4.582; Mohamied Y, 2014, ANN BIOMED ENG; Newcomer SC, 2008, AM J PHYSIOL-HEART C, V294, pH1833, DOI 10.1152/ajpheart.01108.2007; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; ROSS R, 1984, AM J PATHOL, V114, P79; SCHMIDSCHOENBEIN GW, 1975, MICROVASC RES, V10, P153, DOI 10.1016/0026-2862(75)90003-5; Schreuder THA, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.193; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thijssen DHJ, 2009, HYPERTENSION, V53, P986, DOI 10.1161/HYPERTENSIONAHA.109.131508; Thijssen DHJ, 2009, AM J PHYSIOL-HEART C, V296, pH57, DOI 10.1152/ajpheart.00980.2008; Tinken TM, 2009, HYPERTENSION, V54, P278, DOI 10.1161/HYPERTENSIONAHA.109.134361; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; Wang C, 2013, ARTERIOSCL THROM VAS, V33, P2130, DOI 10.1161/ATVBAHA.113.301826; Wood NB, 2006, J APPL PHYSIOL, V101, P1412, DOI 10.1152/japplphysiol.00051.2006; Wu SP, 2004, J MAGN RESON IMAGING, V19, P188, DOI 10.1002/jmri.10441; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	33	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113407	10.1371/journal.pone.0113407	http://dx.doi.org/10.1371/journal.pone.0113407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415320	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600046
J	Yang, BY; Liu, TY; Kulman, JD; Toby, GG; Kamphaus, GD; Patarroyo-White, S; Lu, Q; Reidy, TJ; Mei, BS; Jiang, HY; Pierce, GF; Sommer, JM; Peters, RT				Yang Buyue; Liu, Tongyao; Kulman, John D.; Toby, Garabet G.; Kamphaus, George D.; Patarroyo-White, Susannah; Lu, Qi; Reidy, Thomas J.; Mei, Baisong; Jiang, Haiyan; Pierce, Glenn F.; Sommer, Jurg M.; Peters, Robert T.			A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal In Vivo Efficacy but Exhibits Altered In Vitro Activity	PLOS ONE			English	Article							RECOMBINANT FACTOR-VIII; HEMOPHILIA-A MICE; PROLONGED ACTIVITY; FACTOR-IX; FUNCTIONAL-CHARACTERIZATION; RVIII-SINGLECHAIN; THROMBIN; DOMAIN; ACTIVATION; RECEPTOR	Recombinant factor VIII Fc (rFVIIIFc) is a fusion protein consisting of a single B-domain-deleted (BDD) FVIII linked recombinantly to the Fc domain of human IgG1 to extend half-life. To determine if rFVIIIFc could be further improved by maintaining the heavy and light chains within a contiguous single chain (SC), we evaluated the activity and function of SC rFVIIIFc, an isoform that is not processed at residue R1648. SC rFVIIIFc showed equivalent activity in a chromogenic assay compared to rFVIIIFc, but approximately 40% activity by the one-stage clotting assay in the presence of von Willebrand Factor (VWF), with full activity in the absence of VWF. Moreover, SC rFVIIIFc demonstrated markedly delayed thrombin-mediated release from VWF, but an activity similar to that of rFVIIIFc upon activation in FXa generation assays. Therefore, the apparent reduction in specific activity in the aPTT assay appears to be primarily due to delayed release of FVIII from VWF. To assess whether stability and activity of SC rFVIIIFc were affected in vivo, a tail vein transection model in Hemophilia A mice was utilized. The results demonstrated similar pharmacokinetic profiles and comparable efficacy for SC rFVIIIFc and rFVIIIFc. Thus, while the single chain configuration did not promote enhanced half-life, it reduced the rate of release of FVIII from VWF required for activation. This impaired release may underlie the observed reduction in the one-stage clotting assay, but does not appear to affect the physiological activity of SC rFVIIIFc.	[Yang Buyue; Liu, Tongyao; Kulman, John D.; Toby, Garabet G.; Kamphaus, George D.; Patarroyo-White, Susannah; Lu, Qi; Reidy, Thomas J.; Mei, Baisong; Jiang, Haiyan; Pierce, Glenn F.; Sommer, Jurg M.; Peters, Robert T.] Biogen Idec Inc, Hematol Res, Cambridge, MA 02142 USA	Biogen	Peters, RT (corresponding author), Biogen Idec Inc, Hematol Res, Cambridge, MA 02142 USA.	robert.peters@biogenidec.com			Biogen Idec	Biogen Idec(Biogen)	The funder (Biogen Idec) provided support in the form of salaries for all authors and funding of research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkman S, 2003, HAEMOPHILIA, V9, P101, DOI 10.1046/j.1365-2516.9.s1.4.x; Chang JY, 1997, J CLIN INVEST, V100, P886, DOI 10.1172/JCI119604; Dumont JA, 2012, BLOOD, V119, P3024, DOI 10.1182/blood-2011-08-367813; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kelley B, 2010, HAEMOPHILIA, V16, P717, DOI 10.1111/j.1365-2516.2009.02160.x; Ljung RCR, 1998, HAEMOPHILIA, V4, P409, DOI 10.1046/j.1365-2516.1998.440409.x; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Pan JL, 2009, BLOOD, V114, P2802, DOI 10.1182/blood-2009-03-212423; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peters RT, 2010, BLOOD, V115, P2057, DOI 10.1182/blood-2009-08-239665; PITTMAN DD, 1988, P NATL ACAD SCI USA, V85, P2429, DOI 10.1073/pnas.85.8.2429; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sandberg H, 2001, SEMIN HEMATOL, V38, P4, DOI 10.1053/shem.2001.25888; Sandberg H, 2012, THROMB RES, V130, P808, DOI 10.1016/j.thromres.2012.08.311; Siner JI, 2013, BLOOD, V121, P4396, DOI 10.1182/blood-2012-10-464164; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Thim L, 2011, J THROMB HAEMOST, V9, P712; White GC, 1997, THROMB HAEMOSTASIS, V77, P660; Zollner S, 2014, THROMB RES, V134, P125, DOI 10.1016/j.thromres.2014.03.028; Zollner SB, 2013, THROMB RES, V132, P280, DOI 10.1016/j.thromres.2013.06.017	27	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113600	10.1371/journal.pone.0113600	http://dx.doi.org/10.1371/journal.pone.0113600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415306	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600063
J	He, Y; Guo, YH; Zhou, Y; Zhang, Y; Fan, C; Ji, GX; Wang, Y; Ma, ZY; Lian, JQ; Hao, CQ; Yao, ZQ; Jia, ZS				He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng			CD100 Up-Regulation Induced by Interferon-alpha on B Cells Is Related to Hepatitis C Virus Infection	PLOS ONE			English	Article							IV SEMAPHORIN CD100; LYMPHOCYTE SEMAPHORIN; ANTIVIRAL TREATMENT; IMMUNE-RESPONSES; LEUKOCYTE SEMAPHORIN; HCV INFECTION; CD5 EXPANSION; T-CELLS; ACTIVATION; CD81	Objectives: CD100, also known as Sema4D, is a member of the semaphorin family and has important regulatory functions that promote immune cell activation and responses. The role of CD100 expression on B cells in immune regulation during chronic hepatitis C virus (HCV) infection remains unclear. Materials and Methods: We longitudinally investigated the altered expression of CD100, its receptor CD72, and other activation markers CD69 and CD86 on B cells in 20 chronic HCV-infected patients before and after treatment with pegylated interferon-alpha (Peg-IFN-alpha) and ribavirin (RBV) by flow cytometry. Results: The frequency of CD5(+) B cells as well as the expression levels of CD100, CD69 and CD86 was significantly increased in chronic HCV patients and returned to normal in patients with sustained virological response after discontinuation of IFN-alpha/RBV therapy. Upon IFN-alpha treatment, CD100 expression on B cells and the two subsets was further up-regulated in patients who achieved early virological response, and this was confirmed by in vitro experiments. Moreover, the increased CD100 expression via IFN-alpha was inversely correlated with the decline of the HCV-RNA titer during early-phase treatment. Conclusions: Peripheral B cells show an activated phenotype during chronic HCV infection. Moreover, IFN-alpha therapy facilitates the reversion of disrupted B cell homeostasis, and up-regulated expression of CD100 may be indirectly related to HCV clearance.	[He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng] Fourth Mil Med Univ, Dept Infect Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China; [He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng] Fourth Mil Med Univ, Ctr Liver Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China; [Yao, Zhi Q.] E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA	Air Force Military Medical University; Air Force Military Medical University; East Tennessee State University	Jia, ZS (corresponding author), Fourth Mil Med Univ, Dept Infect Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China.	jiazsh@fmmu.edu.cn	Ma, ZhiYuan/GWN-1061-2022	He, Yu/0000-0001-9616-5261	National Natural Science Foundation of China (NSFC) [81170389, 81300314]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by a National Natural Science Foundation of China (NSFC) grant to Zhansheng Jia (81170389) and Chao Fan (81300314). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BOUGERET C, 1992, J IMMUNOL, V148, P318; Chen ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018933; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Curry MP, 2003, J HEPATOL, V38, P642, DOI 10.1016/S0168-8278(03)00075-8; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Fujiwara K, 2013, HEPATOLOGY, V57, P483, DOI 10.1002/hep.25921; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Ito M, 2010, J INNATE IMMUN, V2, P607, DOI 10.1159/000317690; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Layden TJ, 2000, SEMIN LIVER DIS, V20, P173, DOI 10.1055/s-2000-9940; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073958; Meehan TF, 2014, MUCOSAL IMMUNOL, V7, P134, DOI 10.1038/mi.2013.32; Mizrahi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000818; Moorman J, 2009, IMMUNOLOGY, V128, P227, DOI 10.1111/j.1365-2567.2009.03106.x; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Sun HB, 2013, EXP BIOL MED, V238, P1275, DOI 10.1177/1535370213502626; Suzuki K, 2003, CYTOKINE GROWTH F R, V14, P17, DOI 10.1016/S1359-6101(02)00073-4; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Tucci Felicia, 2014, Virologica Sinica, V29, P3, DOI 10.1007/s12250-014-3414-1; Urbani S, 2008, J HEPATOL, V48, P548, DOI 10.1016/j.jhep.2007.12.014; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Zhang JY, 2013, EUR J IMMUNOL, V43, P1953, DOI 10.1002/eji.201243097; Zhang YS, 2013, CELL MOL IMMUNOL, V10, P97, DOI 10.1038/cmi.2012.65; Zuckerman E, 2003, J VIROL, V77, P10432, DOI 10.1128/JVI.77.19.10432-10436.2003; Zuckerman E, 2002, CLIN EXP IMMUNOL, V128, P353, DOI 10.1046/j.1365-2249.2002.01844.x	43	7	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113338	10.1371/journal.pone.0113338	http://dx.doi.org/10.1371/journal.pone.0113338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436996	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900040
J	Klosik, DF; Bornholdt, S				Klosik, David F.; Bornholdt, Stefan			The Citation Wake of Publications Detects Nobel Laureates' Papers	PLOS ONE			English	Article							STABILITY	For several decades, a leading paradigm of how to quantitatively assess scientific research has been the analysis of the aggregated citation information in a set of scientific publications. Although the representation of this information as a citation network has already been coined in the 1960s, it needed the systematic indexing of scientific literature to allow for impact metrics that actually made use of this network as a whole, improving on the then prevailing metrics that were almost exclusively based on the number of direct citations. However, besides focusing on the assignment of credit, the paper citation network can also be studied in terms of the proliferation of scientific ideas. Here we introduce a simple measure based on the shortest-paths in the paper's in-component or, simply speaking, on the shape and size of the wake of a paper within the citation network. Applied to a citation network containing Physical Review publications from more than a century, our approach is able to detect seminal articles which have introduced concepts of obvious importance to the further development of physics. We observe a large fraction of papers co-authored by Nobel Prize laureates in physics among the top-ranked publications.	[Klosik, David F.; Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	University of Bremen	Klosik, DF (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	klosik@itp.uni-bremen.de			Deutsche Forschungsgemeinschaft [BO 1242/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by Deutsche Forschungsgemeinschaft grant number BO 1242/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; FEYNMAN RP, 1949, PHYS REV, V76, P769, DOI 10.1103/PhysRev.76.769; GARFIELD E, 1992, THEOR MED, V13, P117, DOI 10.1007/BF02163625; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; HAMILTON DP, 1991, SCIENCE, V251, P25, DOI 10.1126/science.1986409; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazloumian A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018975; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Petersen AM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036114; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033833; Radicchi F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046116; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Slater JC, 1929, PHYS REV, V34, P1293, DOI 10.1103/PhysRev.34.1293; Walker D, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06010; West JD, 2010, COLL RES LIBR, V71, P236, DOI 10.5860/0710236; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	27	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113184	10.1371/journal.pone.0113184	http://dx.doi.org/10.1371/journal.pone.0113184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437855	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900033
J	Yan, Q; Li, XP; Tumer, NE				Yan, Qing; Li, Xiao-Ping; Tumer, Nilgun E.			Wild Type RTA and Less Toxic Variants Have Distinct Requirements for Png1 for Their Depurination Activity and Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							RICIN-A-CHAIN; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; N-GLYCANASE; RIBOSOME DEPURINATION; SHIGA TOXIN; ENZYMATIC INACTIVATION; CYTOPLASMIC PEPTIDE; GLUTAMIC ACID-177; GENETIC-ANALYSIS	Ricin A chain (RTA) undergoes retrograde trafficking and is postulated to use components of the endoplasmic reticulum (ER) associated degradation (ERAD) pathway to enter the cytosol to depurinate ribosomes. However, it is not known how RTA evades degradation by the proteasome after entry into the cytosol. We observed two distinct trafficking patterns among the precursor forms of wild type RTA and nontoxic variants tagged with enhanced green fluorescent protein (EGFP) at their C-termini in yeast. One group, which included wild type RTA, underwent ER-to-vacuole transport, while another group, which included the G83D variant, formed aggregates in the ER and was not transported to the vacuole. Peptide: N-glycanase (Png1), which catalyzes degradation of unfolded glycoproteins in the ERAD pathway affected depurination activity and toxicity of wild type RTA and G83D variant differently. PreG83D variant was deglycosylated by Png1 on the ER membrane, which reduced its depurination activity and toxicity by promoting its degradation. In contrast, wild type preRTA was deglycosylated by the free pool of Png1 in the cytosol, which increased its depurination activity, possibly by preventing its degradation. These results indicate that wild type RTA has a distinct requirement for Png1 compared to the G83D variant and is deglycosylated by Png1 in the cytosol as a possible strategy to avoid degradation by the ERAD pathway to reach the ribosome.	[Yan, Qing; Li, Xiao-Ping; Tumer, Nilgun E.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Tumer, NE (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA.	tumer@aesop.rutgers.edu			National Institutes of Health [AI072425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant AI072425 to Nilgun E. Turner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FRANKEL A, 1990, MOL CELL BIOL, V10, P6257, DOI 10.1128/MCB.10.12.6257; Frigerio L, 2001, PLANT PHYSIOL, V126, P167, DOI 10.1104/pp.126.1.167; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; KANE PM, 1992, J BIOL CHEM, V267, P447; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Li XP, 2013, J BIOL CHEM, V288, P30270, DOI 10.1074/jbc.M113.510966; MAY MJ, 1989, EMBO J, V8, P301, DOI 10.1002/j.1460-2075.1989.tb03377.x; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munishkin A, 1995, J BIOL CHEM, V270, P30581, DOI 10.1074/jbc.270.51.30581; Parikh BA, 2005, BIOCHEMISTRY-US, V44, P2478, DOI 10.1021/bi048188c; Pierce M, 2011, RNA, V17, P201, DOI 10.1261/rna.2375411; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; WINTHER JR, 1994, J BIOL CHEM, V269, P22007; Yan Q, 2012, TRAFFIC, V13, P1508, DOI 10.1111/j.1600-0854.2012.01404.x; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113719	10.1371/journal.pone.0113719	http://dx.doi.org/10.1371/journal.pone.0113719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436896	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900069
J	Jiang, W; Tang, JJ; Miao, HH; Qu, YX; Qin, J; Xu, J; Yang, JB; Li, BL; Song, BL				Jiang, Wei; Tang, Jing-Jie; Miao, Hong-Hua; Qu, Yu-Xiu; Qin, Jie; Xu, Jie; Yang, Jinbo; Li, Bo-Liang; Song, Bao-Liang			Forward Genetic Screening for Regulators Involved in Cholesterol Synthesis Using Validation-Based Insertional Mutagenesis	PLOS ONE			English	Article							HMG-COA REDUCTASE; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; FEEDBACK-REGULATION; STEROL RESISTANCE; DEGRADATION; INSIG-1; UBIQUITINATION; PROTEIN; BINDING	Somatic cell genetics is a powerful approach for unraveling the regulatory mechanism of cholesterol metabolism. However, it is difficult to identify the mutant gene(s) due to cells are usually mutagenized chemically or physically. To identify important genes controlling cholesterol biosynthesis, an unbiased forward genetics approach named validation-based insertional mutagenesis (VBIM) system was used to isolate and characterize the 25-hydroxycholesterol (25-HC)-resistant and SR-12813-resisitant mutants. Here we report that five mutant cell lines were isolated. Among which, four sterol-resistant mutants either contain a truncated NH2-terminal domain of sterol regulatory element-binding protein (SREBP)-2 terminating at amino acids (aa) 400, or harbor an overexpressed SREBP cleavage-activating protein (SCAP). Besides, one SR-12813 resistant mutant was identified to contain a truncated COOH-terminal catalytic domain of 3-hydroxy-3-methylglutarylcoenzyme A reductase (HMG-CoA reductase). This study demonstrates that the VBIM system can be a powerful tool to screen novel regulatory genes in cholesterol biosynthesis.	[Jiang, Wei; Tang, Jing-Jie; Miao, Hong-Hua; Qu, Yu-Xiu; Qin, Jie; Xu, Jie; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Song, Bao-Liang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wuhan University; Lanzhou University	Yang, JB (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	yangjb@lzu.edu.cn; blsong@whu.edu.cn	Yang, Jinbo/AAM-9580-2020	Song, Bao-Liang/0000-0002-6397-5935	Ministry of Science and Technology of China [2011CB910900, 2012CB524900]; National Natural Science Foundation of China [30925012, 31230020, 81260041, 81270155, 91213306]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the Ministry of Science and Technology of China (2011CB910900 and 2012CB524900), http://www.most.gov.cn/; and National Natural Science Foundation of China (30925012, 31230020, 81260041, 81270155, and 91213306), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Elsabrouty R, 2013, MOL BIOL CELL; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; LISCUM L, 1985, J BIOL CHEM, V260, P522; Lu T, 2009, COLD SPRING HARBOR P; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Miao HH, 2010, ACTA BIOCH BIOPH SIN, V42, P303, DOI 10.1093/abbs/gmq022; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	25	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112632	10.1371/journal.pone.0112632	http://dx.doi.org/10.1371/journal.pone.0112632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426949	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400021
J	Kim, EY; Jakobson, CM; Tullman-Ercek, D				Kim, Edward Y.; Jakobson, Christopher M.; Tullman-Ercek, Danielle			Engineering Transcriptional Regulation to Control Pdu Microcompartment Formation	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; SEROVAR TYPHIMURIUM LT2; COBALAMIN BIOSYNTHETIC COB; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; BACTERIAL MICROCOMPARTMENTS; ESCHERICHIA-COLI; ONE-STEP; PROTEIN; ORGANELLES	Bacterial microcompartments (MCPs) show great promise for the organization of engineered metabolic pathways within the bacterial cytoplasm. This subcellular organelle is composed of a protein shell of 100-200 nm diameter that natively encapsulates multi-enzyme pathways. The high energy cost of synthesizing the thousands of protein subunits required for each MCP demands precise regulation of MCP formation for both native and engineered systems. Here, we study the regulation of the propanediol utilization (Pdu) MCP, for which growth on 1,2-propanediol induces expression of the Pdu operon for the catabolism of 1,2-propanediol. We construct a fluorescence-based transcriptional reporter to investigate the activation of the Ppdu promoter, which drives the transcription of 21 pdu genes. Guided by this reporter, we find that MCPs can be expressed in strains grown in rich media, provided that glucose is not present. We also characterize the response of the Ppdu promoter to a transcriptional activator of the pdu operon, PocR, and find PocR to be a necessary component of Pdu MCP formation. Furthermore, we find that MCPs form normally upon the heterologous expression of PocR even in the absence of the natural inducer 1,2-propanediol and in the presence of glucose, and that Pdu MCPs formed in response to heterologous PocR expression can metabolize 1,2-propanediol in vivo. We anticipate that this technique of overexpressing a key transcription factor may be used to study and engineer the formation, size, and/or number of MCPs for the Pdu and related MCP systems.	[Kim, Edward Y.; Jakobson, Christopher M.; Tullman-Ercek, Danielle] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Tullman-Ercek, D (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	dtercek@berkeley.edu	Tullman-Ercek, Danielle/L-2792-2016		National Science Foundation [1150567]; University of California Berkeley Fellowship	National Science Foundation(National Science Foundation (NSF)); University of California Berkeley Fellowship	This work was supported by the National Science Foundation (1150567; www.nsf.gov) (EYK DTE) and a University of California Berkeley Fellowship (www.berkeley.edu) (CMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; CHEN P, 1995, J BACTERIOL, V177, P5401, DOI 10.1128/jb.177.19.5401-5410.1995; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Kim EY, 2013, CURR OPIN BIOTECH, V24, P627, DOI 10.1016/j.copbio.2012.11.012; Kim EY, 2013, BIOTECHNOL J; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTHETIC BIOL; Metcalf KJ, 2014, APPL ENVIRON MICROB, V80, P5927, DOI 10.1128/AEM.01330-14; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; Rondon MR, 1996, J BACTERIOL, V178, P2196, DOI 10.1128/jb.178.8.2196-2203.1996; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113814	10.1371/journal.pone.0113814	http://dx.doi.org/10.1371/journal.pone.0113814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427074	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400088
J	Koc, B; Bircan, HY; Adas, G; Kemik, O; Akcakaya, A; Yavuz, A; Karahan, S				Koc, Bora; Bircan, Huseyin Yuce; Adas, Gokhan; Kemik, Ozgur; Akcakaya, Adem; Yavuz, Alpaslan; Karahan, Servet			Complications Following Endoscopic Retrograde Cholangiopancreatography: Minimal Invasive Surgical Recommendations	PLOS ONE			English	Article							COMMON BILE-DUCT; DUODENAL PERFORATION; RETROPERITONEAL PERFORATION; PROSPECTIVE MULTICENTER; THERAPEUTIC ERCP; RISK-FACTORS; SPHINCTEROTOMY; MANAGEMENT; PANCREATICOBILIARY; EXPLORATION	Background: ERCP has a complication rate ranging between 4% and 16% such as post-ERCP pancreatitis, hemorrhage, cholangitis and perforation. Perforation rate was reported as 0.08% to 1% and mortality rate up to 1.5%. Besides, injury related death rate is 16% to 18%. In this study we aimed to present a retrospective review of our experience with post ERCP-related perforations, reveal the type of injuries and management recommendations with the minimally invasive approaches. Methods: Medical records of 28 patients treated for ERCP-related perforations in Okmeydani Training and Research Hospital between March 2007 and March 2013 were reviewed retrospectively. Patient age, gender, comorbidities, ERCP indication, ERCP findings and details were analyzed. All previous and current clinical history, laboratory and radiological findings were used to assess the evaluation of perforations. Results: Between March 2007 and March 2013, 2972 ERCPs were performed, 28 (0.94%) of which resulted in ERCP-related perforations. 10 of them were men (35.8%) and 18 women (64.2%). Mean age was 53.36 +/- 14.12 years with a range of 28 to 78 years. 14 (50%) patients were managed conservatively, while 14 (50%) were managed surgically. In 6 patients, laparoscopic exploration was performed due to the failure of non-surgical management. In 6 of the patients that ERC-Prelated perforation was suspected during or within 2 hours after ERCP, underwent to surgery primarily. There were two mortalities. The mean length of hospitalization stay was 10.46 +/- 2.83 days. The overall mortality rate was 7.1%. Conclusion: Successful management of ERCP-related perforation requires immediate diagnosis and early decision to decide whether to manage conservatively or surgically. Although traditionally conventional surgical approaches have been suggested for the treatment of perforations, laparoscopic techniques may be used in well-chosen cases especially in type II, III and IV perforations.	[Koc, Bora; Adas, Gokhan; Akcakaya, Adem; Karahan, Servet] Okmeydani Training & Res Hosp, Dept Surg, Istanbul, Turkey; [Bircan, Huseyin Yuce] Baskent Univ, Fac Med, Istanbul Res Hosp, Dept Surg, Istanbul, Turkey; [Kemik, Ozgur] Yuzuncu Yil Univ, Fac Med, Dept Surg, Van, Turkey; [Yavuz, Alpaslan] Yuzuncu Yil Univ, Fac Med, Dept Radiol, Van, Turkey	Istanbul Okmeydani Training & Research Hospital; Baskent University; Yuzuncu Yil University; Yuzuncu Yil University	Kemik, O (corresponding author), Yuzuncu Yil Univ, Fac Med, Dept Surg, Van, Turkey.	ozgurkemik@hotmail.com	Bircan, Huseyin Yuce/R-6394-2019; Yavuz, Alpaslan/H-3947-2014; Akcakaya, Adem/AAL-9655-2020	Yavuz, Alpaslan/0000-0002-8796-988X; 				Avgerinos DV, 2009, SURG ENDOSC, V23, P833, DOI 10.1007/s00464-008-0157-9; Baron TH, 2000, GASTROINTEST ENDOSC, V52, P566, DOI 10.1067/mge.2000.107212; Chaudhary A, 1996, ANN ROY COLL SURG, V78, P206; Christensen M, 2004, GASTROINTEST ENDOSC, V60, P721, DOI 10.1016/S0016-5107(04)02169-8; CHUNG RS, 1993, AM J SURG, V165, P700, DOI 10.1016/S0002-9610(05)80791-3; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Cotton PB, 2009, GASTROINTEST ENDOSC, V70, P80, DOI 10.1016/j.gie.2008.10.039; DUNHAM F, 1982, ENDOSCOPY, V14, P92, DOI 10.1055/s-2007-1021589; ELDER JB, 1988, POSTGRAD MED J, V64, P54; Enns R, 2002, ENDOSCOPY, V34, P293, DOI 10.1055/s-2002-23650; Fatima J, 2007, ARCH SURG-CHICAGO, V142, P448, DOI 10.1001/archsurg.142.5.448; Freeman ML, 2003, GASTROINTEST ENDOSC, V13, pxi; Genzlinger JL, 1999, AM J GASTROENTEROL, V94, P1267; Gurung R B, 2014, Kathmandu Univ Med J (KUMJ), V12, P55; Howard TJ, 1999, SURGERY, V126, P658, DOI 10.1067/msy.2099.99886; Katsinelos P, 2014, ANN GASTROENTEROL, V27, P65; Keeley SR, 2003, GASTROINTEST ENDOSC, V57, P756, DOI 10.1067/mge.2003.198; Knudson K, 2008, AM J SURG, V196, P975, DOI 10.1016/j.amjsurg.2008.07.045; Koc B, 2013, AM J SURG, V206, P457, DOI 10.1016/j.amjsurg.2013.02.004; Lai ECH, 2008, SURG-J R COLL SURG E, V6, P45; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Mao ZH, 2008, J LAPAROENDOSC ADV S, V18, P691, DOI 10.1089/lap.2008.0020; MARTIN DF, 1990, ENDOSCOPY, V22, P174, DOI 10.1055/s-2007-1012833; Masci E, 2001, AM J GASTROENTEROL, V96, P417; MCCUNE WS, 1968, ANN SURG, V167, P752, DOI 10.1097/00000658-196805000-00013; Morgan KA, 2009, AM SURGEON, V75, P477; PEEL ALG, 1974, ANN ROY COLL SURG, V55, P236; Preetha M, 2003, ANZ J SURG, V73, P1011, DOI 10.1046/j.1445-2197.2003.t01-15-.x; Sarli L, 2007, SURGERY, V142, P26, DOI 10.1016/j.surg.2007.02.002; SARR MG, 1986, SURGERY, V100, P461; SCARLETT PY, 1994, AUST NZ J SURG, V64, P843, DOI 10.1111/j.1445-2197.1994.tb04561.x; Sezgin O, 2000, J CLIN ULTRASOUND, V28, P303, DOI 10.1002/1097-0096(200007/08)28:6<303::AID-JCU7>3.0.CO;2-M; Silviera ML, 2009, J GASTROINTEST LIVER, V18, P73; Stapfer M, 2000, ANN SURG, V232, P191, DOI 10.1097/00000658-200008000-00007; Woods KE, 2010, WORLD J GASTRO ENDOS, V2, P165, DOI 10.4253/wjge.v2.i5.165; Wu Hao M, 2006, HPB (Oxford), V8, P393, DOI 10.1080/13651820600700617; Zissin R, 2000, ABDOM IMAGING, V25, P279, DOI 10.1007/s002610000033	37	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113073	10.1371/journal.pone.0113073	http://dx.doi.org/10.1371/journal.pone.0113073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426633	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400031
J	Zhu, KQ; Feng, HJ; Xu, YH; Mao, ZR; Zhang, W; Chen, J; Ma, LQ; Chen, MC; Shi, QN; Zhang, SJ				Zhu, Keqing; Feng, Haijia; Xu, Yinhan; Mao, Zhengrong; Zhang, Wei; Chen, Jian; Ma, Liqing; Chen, Minche; Shi, Qiunian; Zhang, Suojiang			An Analysis of 60 Years of Autopsy Data from Zhejiang University in Hangzhou, China	PLOS ONE			English	Article								Context: The autopsy rate gradually decreased during 1950-1999, and increased during the most recent decade (2000-2009). The diagnostic inaccuracy rate was continuously high during the 60 years. Objective: To investigate disagreement between the pathological and clinical diagnosis during 60 years (1950-2009). Data Sources: A 60-year retrospective study was carried out on the 4140 autopsy cases performed in Zhejiang University School of Medicine. Results: The highest number of cases was 1037 during 1960-1969, while the lowest was 102 during 1990-1999. During the 1999-2009 period, 978 cases were completed, which ranked second within the 60 years. The total clinical misdiagnosis rate was 46.38%, while the highest was 73.82% in 2000-2009. During the 60 years, the diseases associated with highest diagnostic inaccuracy rates were circulatory diseases (76.97%), cancer (60.99%), and brain diseases (54.48%). The invasive fungal infection rate was 1.84% of the 4140 cases, and the diagnostic inaccuracy rate for this condition reached as high as 86.10%. In the autopsied disease spectrum over the 60 years, the most common diseases were respiratory (1349, 32.58%), circulatory (495, 11.96%), and brain diseases (424, 10.24%). Conclusion: Although the number of autopsies decreased from 1950 to 1999, it increased from 2000 to 2009, while the discordance rate between clinical and autopsy diagnosis remained high throughout.	[Zhu, Keqing; Feng, Haijia; Xu, Yinhan; Mao, Zhengrong; Zhang, Wei; Chen, Jian; Ma, Liqing; Chen, Minche; Shi, Qiunian; Zhang, Suojiang] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Keqing] Zhejiang Univ, Sch Med, Dept Neurosci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Keqing] Zhejiang Univ, Sch Med, China Brain Bank, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, KQ (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	zhukeqing@zju.edu.cn			Zhejiang Provincial Natural Science Foundation [2010R50049]; Zhejiang Medical and Health Science and Technology Plan Project [WKJ2013-2-009]; Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China)	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Medical and Health Science and Technology Plan Project; Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China)	Funding: This work was supported by the Zhejiang Provincial Natural Science Foundation (2010R50049), by the Zhejiang Medical and Health Science and Technology Plan Project (WKJ2013-2-009) and by the Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALIC V, 1995, JAMA-J AM MED ASSOC, V273, P1907; Burton EC, 1998, JAMA-J AM MED ASSOC, V280, P1245, DOI 10.1001/jama.280.14.1245; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Li G D, 1989, Zhonghua Bing Li Xue Za Zhi, V18, P250; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Zhu Ke-qing, 2004, Zhonghua Nei Ke Za Zhi, V43, P128; Zhu MH, 2011, CHINESE MED J-PEKING, V124, P3403, DOI 10.3760/cma.j.issn.0366-6999.2011.20.035	7	5	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112500	10.1371/journal.pone.0112500	http://dx.doi.org/10.1371/journal.pone.0112500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426989	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400015
J	Fei, YT; Liu, DM; Luo, TH; Chen, G; Wu, H; Li, L; Yu, YG				Fei, Yong-tao; Liu, Dong-mei; Luo, Tong-hui; Chen, Gu; Wu, Hui; Li, Li; Yu, Yi-gang			Molecular Characterization of Lactobacillus plantarum DMDL 9010, a Strain with Efficient Nitrite Degradation Capacity	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; PCR	Nitrites commonly found in food, especially in fermented vegetables, are potential carcinogens. Therefore, limiting nitrites in food is critically important for food safety. A Lactobacillus strain (Lactobacillus sp. DMDL 9010) was previously isolated from fermented vegetables by our group, and is not yet fully characterized. A number of phenotypical and genotypical approaches were employed to characterize Lactobacillus sp. DMDL 9010. Its nitrite degradation capacity was compared with four other Lactobacillus strains, including Lactobacillus casei subsp. rhamnosus 719, Lactobacillus delbrueckii subsp. bulgaricu 1.83, Streptococcus thermophilus 1.204, and lactobacillus plantarum 8140, on MRS medium. Compared to these four Lactobacillus strains, Lactobacillus sp. DMDL 9010 had a significantly higher nitrite degradation capacity (P<0.001). Based on 16S rDNA sequencing and sequence comparison, Lactobacillus sp. DMDL 9010 was identified as either Lactobacillus plantarum or Lactobacillus pentosus. To further identify this strain, the flanking regions (922 bp and 806 bp upstream and downstream, respectively) of the L-lactate dehydrogenase 1 (L-ldh1) gene were amplified and sequenced. Lactobacillus sp. DMDL 9010 had 98.92 and 76.98% sequence identity in the upstream region with L. plantarum WCFS1 and L. pentosus IG1, respectively, suggesting that Lactobacillu sp. DMDL 9010 is an L. plantarum strain. It was therefore named L. plantarum DMDL 9010. Our study provides a platform for genetic engineering of L. plantarum DMDL 9010, in order to further improve its nitrite degradation capacity.	[Fei, Yong-tao; Liu, Dong-mei; Luo, Tong-hui; Chen, Gu; Wu, Hui; Li, Li; Yu, Yi-gang] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Liu, DM (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	dongmeiliu2013@163.com	Fei, Yongtao/GQA-8496-2022	CHEN, Gu/0000-0002-2221-8006	National Natural Science Foundation of China [31101254]; Natural Science Foundation of the Guangdong Province [S2011010005679]; Foundation of SCUT [D2116760]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Guangdong Province(National Natural Science Foundation of Guangdong Province); Foundation of SCUT	This study was financially supported by the National Natural Science Foundation of China (No. 31101254), the Natural Science Foundation of the Guangdong Province (No. S2011010005679), and the Foundation of SCUT (D2116760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chief A, 2003, J APPL MICROBIOL, V94, P1108; Cho JC, 2001, APPL ENVIRON MICROB, V67, P3677, DOI 10.1128/AEM.67.8.3677-3682.2001; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; Dong XJ, 2004, BERGEYS MANUAL SYSTE; ETCHELLS JL, 1964, APPL MICROBIOL, V12, P523, DOI 10.1128/AEM.12.6.523-535.1964; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; GRAHAM PH, 1991, INT J SYST BACTERIOL, V41, P582, DOI 10.1099/00207713-41-4-582; Hashimoto T, 2001, J JPN SOC FOOD SCI, V48, P409; Herbel SR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-27; Liu D-m, 2006, J S CHINA U TECHNOLO, V36, P140; Liu D-m, 2010, LIU DM, Patent No. 200611/23898; Olive DM, 1999, J CLIN MICROBIOL, V37, P1661, DOI 10.1128/JCM.37.6.1661-1669.1999; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Ross TL, 2005, J CLIN MICROBIOL, V43, P5642, DOI 10.1128/JCM.43.11.5642-5647.2005; Sen NP, 2001, J AGR FOOD CHEM, V49, P2096, DOI 10.1021/jf0011384; Socransky SS, 2004, ORAL MICROBIOL IMMUN, V19, P352, DOI 10.1111/j.1399-302x.2004.00168.x; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; ZANONI P, 1987, INT J SYST BACTERIOL, V37, P339, DOI 10.1099/00207713-37-4-339; [周劲松 Zhou Jinsong], 2013, [食品工业科技, Science & Technology of Food Industry], V34, P174; Zhou X-x, 2004, BIOTECHNOLOGY, V36, P35	20	31	37	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113792	10.1371/journal.pone.0113792	http://dx.doi.org/10.1371/journal.pone.0113792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423449	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700066
J	Levy, M; Nir, AR				Levy, Moshe; Nir, Adi Rizansky			The Pricing of Breakthrough Drugs: Theory and Policy Implications	PLOS ONE			English	Article							HEALTH; UTILITY	Pharmaceutical sales exceed $850 billion a year, of which 84% are accounted for by brand drugs. Drug prices are the focus of an ongoing heated debate. While some argue that pharmaceutical companies exploit monopolistic power granted by patent protection to set prices that are "too high'', others claim that these prices are necessary to motivate the high R&D investments required in the pharmaceutical industry. This paper employs a recently documented utility function of health and wealth to derive the theoretically optimal pricing of monopolistic breakthrough drugs. This model provides a framework for a quantitative discussion of drug price regulation. We show that mild price regulation can substantially increase consumer surplus and the number of patients who purchase the drug, while having only a marginal effect on the revenues of the pharmaceutical company.	[Levy, Moshe; Nir, Adi Rizansky] Hebrew Univ Jerusalem, Sch Business, Jerusalem, Israel	Hebrew University of Jerusalem	Levy, M (corresponding author), Hebrew Univ Jerusalem, Sch Business, Jerusalem, Israel.	mslm@huji.ac.il						Anell A, 2000, B WORLD HEALTH ORGAN, V78, P770; Angell M., 2004, TRUTH DRUG CO; Clementi F, 2005, NEW ECON WINDOWS, P3, DOI 10.1007/88-470-0389-X_1; Comanor WS, 2007, MANAG DECIS ECON, V28, P357, DOI 10.1002/mde.1346; Danzon PM, 2002, J LAW ECON, V45, P587, DOI 10.1086/368005; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Finkelstein A, 2008, WHAT GOOD IS WEALTH; Friedman M, 1953, ESSAYS POSITIVE EC, V3; Heffler S, 2002, HEALTH AFFAIR, V21, P207, DOI 10.1377/hlthaff.21.2.207; Levy M, 2005, EC EVOLVING COMPLEX, VIII; Levy M, 2012, J HEALTH ECON, V31, P379, DOI 10.1016/j.jhealeco.2012.02.003; Lu ZJ, 1998, REV ECON STAT, V80, P108, DOI 10.1162/003465398557212; Morgenstern O., 2007, THEORY GAMES EC BEHA; Nirei M, 2009, WORKING PAPER; Pareto V., 1897, COURS EC POLITIQUE, V2; PERSKY J, 1992, J ECON PERSPECT, V6, P181, DOI 10.1257/jep.6.2.181; Reekie DW, 1978, J IND ECON, V26, P223; Rockoff JD, 2011, WALL STREET J; Sloan FA, 1998, J HEALTH ECON, V17, P475, DOI 10.1016/S0167-6296(97)00025-8; US Department of Commerce International Trade Administration, 2004, PHARM PRIC CONTR OEC; VISCUSI WK, 1990, AM ECON REV, V80, P353; Weston JF, 1979, ISSUE PHARM EC; Weston JF, 1982, EFFECTIVENESS MED CO	23	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113894	10.1371/journal.pone.0113894	http://dx.doi.org/10.1371/journal.pone.0113894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25422889	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700075
J	Vyazunova, I; Maklakova, VI; Berman, S; De, I; Steffen, MD; Hong, W; Lincoln, H; Morrissy, AS; Taylor, MD; Akagi, K; Brennan, CW; Rodriguez, FJ; Collier, LS				Vyazunova, Irina; Maklakova, Vilena I.; Berman, Samuel; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Morrissy, A. Sorana; Taylor, Michael D.; Akagi, Keiko; Brennan, Cameron W.; Rodriguez, Fausto J.; Collier, Lara S.			Sleeping Beauty Mouse Models Identify Candidate Genes Involved in Gliomagenesis	PLOS ONE			English	Article							ASTROCYTE-SPECIFIC EXPRESSION; SOMATIC MUTAGENESIS; LEUKEMIA-VIRUS; CELL; MUTATIONS; TRANSPOSON; MACROPHAGE; TUMORS; LANDSCAPE; MUSKELIN	Genomic studies of human high-grade gliomas have discovered known and candidate tumor drivers. Studies in both cell culture and mouse models have complemented these approaches and have identified additional genes and processes important for gliomagenesis. Previously, we found that mobilization of Sleeping Beauty transposons in mice ubiquitously throughout the body from the Rosa26 locus led to gliomagenesis with low penetrance. Here we report the characterization of mice in which transposons are mobilized in the Glial Fibrillary Acidic Protein (GFAP) compartment. Glioma formation in these mice did not occur on an otherwise wild-type genetic background, but rare gliomas were observed when mobilization occurred in a p19Arf heterozygous background. Through cloning insertions from additional gliomas generated by transposon mobilization in the Rosa26 compartment, several candidate glioma genes were identified. Comparisons to genetic, epigenetic and mRNA expression data from human gliomas implicates several of these genes as tumor suppressor genes and oncogenes in human glioblastoma.	[Vyazunova, Irina; Maklakova, Vilena I.; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Vyazunova, Irina; Maklakova, Vilena I.; De, Ishani; Steffen, Megan D.; Hong, Won; Lincoln, Hayley; Collier, Lara S.] Univ Wisconsin, Univ Wisconsin Carbone Canc Ctr, Madison, WI 53706 USA; [Berman, Samuel; Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Morrissy, A. Sorana; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Akagi, Keiko] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Rodriguez, Fausto J.] Johns Hopkins Univ, Dept Pathol, Div Neuropathol, Baltimore, MD USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Collier, LS (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.	lcollier@wisc.edu	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; Morrissy, Sorana/0000-0001-8526-562X; Taylor, Michael/0000-0001-7009-3466	National Institute of Health (NIH) [R21-NS65352, R01-NS085364]; Goldhirsh foundation; Ohio Supercomputer Center [PAS0425]; Leon Levy Foundation; NIH [P01-CA95616]; NIH Cancer Center Support Grant (CCSG) [P30-CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057098, R01NS085364, R21NS065352] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldhirsh foundation; Ohio Supercomputer Center; Leon Levy Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R21-NS65352 and R01-NS085364 from the National Institute of Health (NIH) (LSC) and a grant from the Goldhirsh foundation (LSC); the Ohio Supercomputer Center PAS0425 (KA); the Leon Levy Foundation (CWB, Leon Levy Scholar) and NIH Grant P01-CA95616 (CWB). The UWCCC experimental pathology core is supported by NIH Cancer Center Support Grant (CCSG) P30-CA014520 and provided histopathology services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 1998, EMBO J, V17, P4964, DOI 10.1093/emboj/17.17.4964; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Ding H, 2001, CANCER RES, V61, P3826; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Ho HH, 2010, J INTERF CYTOK RES, V30, P893, DOI 10.1089/jir.2010.0046; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KLEMSZ MJ, 1993, J BIOL CHEM, V268, P5769; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Koso H, 2012, P NATL ACAD SCI US; Largaespada David A., 2008, V435, P95, DOI 10.1007/978-1-59745-232-8_7; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P694, DOI 10.1136/jcp.2006.039230; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Okosun J, 2013, NATURE GENETICS; Parry M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083244; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Suzuki E, 2013, IMMUNOLOGY, V139, P318, DOI 10.1111/imm.12070; Tagnaouti N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-28; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang HW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-132; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	63	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113489	10.1371/journal.pone.0113489	http://dx.doi.org/10.1371/journal.pone.0113489			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423036	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700037
J	Dettwiler, R; Schmitz, AL; Plattet, P; Zielinski, J; Mevissen, M				Dettwiler, Ramona; Schmitz, Andrea L.; Plattet, Philippe; Zielinski, Jana; Mevissen, Meike			Heterologous Expression of Equine CYP3A94 and Investigation of a Tunable System to Regulate Co-Expressed NADPH P450 Oxidoreductase Levels	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHINESE-HAMSTER CELLS; INITIAL-CHARACTERIZATION; CYTOCHROME-P450 3A4; STABLE EXPRESSION; LIVER-MICROSOMES; GENE-EXPRESSION; SMALL MOLECULES; REDUCTASE; ENZYMES	The activity of cytochrome P450 enzymes depends on the enzyme NADPH P450 oxidoreductase (POR). The aim of this study was to investigate the activity of the equine CYP3A94 using a system that allows to regulate the POR protein levels in mammalian cells. CYP3A94 and the equine POR were heterologously expressed in V79 cells. In the system used, the POR protein regulation is based on a destabilizing domain (DD) that transfers its instability to a fused protein. The resulting fusion protein is therefore degraded by the ubiquitin-proteasome system (UPS). Addition of "Shield-1" prevents the DD fusion protein from degradation. The change of POR levels at different Shield-1 concentrations was demonstrated by cytochrome c reduction, Western immunoblot analysis, and immunocytochemistry. The alteration of CYP3A94 activity was investigated using a substrate (BFC) known to detect CYP3A4 activity. Equine CYP3A94 was demonstrated to be metabolically active and its activity could be significantly elevated by co-expression of POR. Cytochrome c reduction was significantly increased in V79-CYP3A94/DD-POR cells compared to V79-CYP3A94 cells. Surprisingly, incubation with different Shield-1 concentrations resulted in a decrease in POR protein shown by Western immunoblot analysis. Cytochrome c reduction did not change significantly, but the CYP3A94 activity decreased more than 4-fold after incubation with 500 nM and 1 mu M Shield-1 for 24 hours. No differences were obtained when V79-CYP3A94 POR cells with and without Shield-1 were compared. The basal activity levels of V79-CYP3A94/DD-POR cells were unexpectedly high, indicating that DD/POR is not degraded without Shield-1. Shield-1 decreased POR protein levels and CYP3A94 activity suggesting that Shield-1 might impair POR activity by an unknown mechanism. Although regulation of POR with the pPTuner system could not be obtained, the cell line V79-CYP3A94/DD-POR system can be used for further experiments to characterize the equine CYP3A94 since the CYP activity was significantly enhanced with co-expressed POR.	[Dettwiler, Ramona; Schmitz, Andrea L.; Zielinski, Jana; Mevissen, Meike] Univ Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland; [Plattet, Philippe] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Div Neurol Sci, Bern, Switzerland	University of Bern; University of Bern	Mevissen, M (corresponding author), Univ Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland.	meike.mevissen@vetsuisse.unibe.ch		Mevissen, Meike/0000-0001-8766-9556	Swiss National Science Foundation (SNSF) [310030_149954, 310030_119911]; Berne University Research Foundation [10/2013, 46/2012]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Berne University Research Foundation	This work was supported by Swiss National Science Foundation (SNSF), http://www.snf.ch/en/Pages/default.aspx: #310030_149954, #310030_119911; and Berne University Research Foundation: #10/2013, #46/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200; Doehmer J, 1999, DRUG METAB REV, V31, P423, DOI 10.1081/DMR-100101928; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guengerich FP, 1997, CHEM-BIOL INTERACT, V106, P161, DOI 10.1016/S0009-2797(97)00068-9; Guo H, 1998, EXP CELL RES, V245, P57, DOI 10.1006/excr.1998.4235; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; KASPER CB, 1971, J BIOL CHEM, V246, P577; Knych HKD, 2008, BIOCHEM PHARMACOL, V76, P904, DOI 10.1016/j.bcp.2008.07.016; Knych HKD, 2009, ARCH BIOCHEM BIOPHYS, V485, P49, DOI 10.1016/j.abb.2009.02.009; Knych HKD, 2010, DRUG METAB DISPOS, V38, P1820, DOI 10.1124/dmd.110.032953; LU AYH, 1969, J BIOL CHEM, V244, P3714; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Olzmann JA, 2012, COLD SPRING HARB PER; Onderwater RCA, 1996, PROTEIN EXPRES PURIF, V8, P439, DOI 10.1006/prep.1996.0122; Pandey AV, 2006, BIOCHEM SOC T, V34, P1186, DOI 10.1042/BST0341186; Peters LM, 2013, TOXICOL APPL PHARM, V266, P101, DOI 10.1016/j.taap.2012.10.028; SAITO M, 1985, Journal of Free Radicals in Biology and Medicine, V1, P179, DOI 10.1016/0748-5514(85)90116-3; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Schmalix WA, 1996, DRUG METAB DISPOS, V24, P1314; Schmitz A, 2010, ANIM GENET, V41, P72, DOI 10.1111/j.1365-2052.2010.02111.x; Schmitz A., 2014, J VET PHARM THER; Schneider A, 1996, ARCH BIOCHEM BIOPHYS, V332, P295, DOI 10.1006/abbi.1996.0345; Schober W, 2010, CHEM-BIOL INTERACT, V183, P57, DOI 10.1016/j.cbi.2009.09.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; SEVRIOUKOVA IF, 1995, BIOCHIMIE, V77, P562, DOI 10.1016/0300-9084(96)88172-7; Siomi MC, 2009, ADV DRUG DELIVER REV, V61, P668, DOI 10.1016/j.addr.2009.04.008; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tyden E, 2004, TOXICOL APPL PHARM, V201, P112, DOI 10.1016/j.taap.2004.05.015; Tyden E., 2012, J VET PHARM THER; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wyss-Fluehmann G, 2010, ACTA NEUROPATHOL, V119, P617, DOI 10.1007/s00401-010-0644-7; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396	49	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113540	10.1371/journal.pone.0113540	http://dx.doi.org/10.1371/journal.pone.0113540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415624	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600055
J	Eichhorn, JM; Kothari, A; Chambers, TC				Eichhorn, Joshua M.; Kothari, Anisha; Chambers, Timothy C.			Cyclin B1 Overexpression Induces Cell Death Independent of Mitotic Arrest	PLOS ONE			English	Article							CANCER-CELLS; PHOSPHORYLATION; APOPTOSIS; VINBLASTINE; MITOSIS; KINASE; DRUGS; BCL-2; DEGRADATION; CHECKPOINT	Microtubule inhibitors are widely used in cancer chemotherapy. These drugs characteristically induce mitotic arrest and cell death but the mechanisms linking the two are not firmly established. One of the problems is that cancer cells vary widely in their sensitivity to these agents, and thus comparison of data from different systems is difficult. To alleviate this problem we sought to molecularly induce mitotic death and study its mechanisms, by expressing non-degradable cyclin B (R42A) in HeLa cells. However, this approach failed to induce significant mitotic arrest, Cdk1 activation, or phosphorylation of anti-apoptotic Bcl-2 proteins, all characteristics of cells treated with microtubule inhibitors. Furthermore, cyclin B1-R42A induced rapid cell death, and when expressed in synchronized cells, cell death occurred in G1 phase. Decreasing the plasmid concentration reduced transfection efficiency but restored mitotic arrest and eliminated non-specific death. These results show that inappropriate overexpression of cyclin B1 causes non-specific cell death and suggest caution in its use for the study of mitotic events.	[Eichhorn, Joshua M.; Kothari, Anisha; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu			National Institutes of Health from National Cancer Institute [CA-109821]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER	National Institutes of Health from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: Supported by National Institutes of Health Grant CA-109821 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bergstralh DT, 2006, CANCER TREAT REV, V32, P166, DOI 10.1016/j.ctrv.2006.01.004; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.360; Fan MY, 2000, CANCER RES, V60, P6403; Fan MY, 2001, CANCER RES, V61, P4450; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wolf F, 2007, CELL CYCLE, V6, P1408	20	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113283	10.1371/journal.pone.0113283	http://dx.doi.org/10.1371/journal.pone.0113283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415322	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600040
J	Goovaerts, O; Jennes, W; Massinga-Loembe, M; Ceulemans, A; Worodria, W; Mayanja-Kizza, H; Colebunders, R; Kestens, L				Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Worodria, William; Mayanja-Kizza, Harriet; Colebunders, Robert; Kestens, Luc		TB-IRIS Study Grp	Antigen-Specific Interferon-Gamma Responses and Innate Cytokine Balance in TB-IRIS	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESTORATION DISEASE; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; RISK-FACTORS; PROFILE; CELLS; EPIDEMIOLOGY	Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) remains a poorly understood complication in HIV-TB patients receiving antiretroviral therapy (ART). TB-IRIS could be associated with an exaggerated immune response to TB-antigens. We compared the recovery of IFN gamma responses to recall and TB-antigens and explored in vitro innate cytokine production in TB-IRIS patients. Methods: In a prospective cohort study of HIV-TB co-infected patients treated for TB before ART initiation, we compared 18 patients who developed TB-IRIS with 18 non-IRIS controls matched for age, sex and CD4 count. We analyzed IFN gamma ELISpot responses to CMV, influenza, TB and LPS before ART and during TB-IRIS. CMV and LPS stimulated ELISpot supernatants were subsequently evaluated for production of IL-12p70, IL-6, TNF alpha and IL-10 by Luminex. Results: Before ART, all responses were similar between TB-IRIS patients and non-IRIS controls. During TB-IRIS, IFN gamma responses to TB and influenza antigens were comparable between TB-IRIS patients and non-IRIS controls, but responses to CMV and LPS remained significantly lower in TB-IRIS patients. Production of innate cytokines was similar between TB-IRIS patients and non-IRIS controls. However, upon LPS stimulation, IL-6/IL-10 and TNF alpha/IL-10 ratios were increased in TB-IRIS patients compared to non-IRIS controls. Conclusion: TB-IRIS patients did not display excessive IFN gamma responses to TB-antigens. In contrast, the reconstitution of CMV and LPS responses was delayed in the TB-IRIS group. For LPS, this was linked with a pro-inflammatory shift in the innate cytokine balance. These data are in support of a prominent role of the innate immune system in TB-IRIS.	[Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Goovaerts, Odin; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Massinga-Loembe, Marguerite] Ctr Rech Med Lambarene CERMEL, Albert Schweitzer Hosp, Lambarene, Gabon; [Massinga-Loembe, Marguerite] Univ Tubingen, Inst Tropmed, Tubingen, Baden Wurttembe, Germany; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Worodria, William] Infect Dis Network Treatment & Res Africa INTERAC, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; Eberhard Karls University of Tubingen; Makerere University; Makerere University; Institute of Tropical Medicine (ITM); University of Antwerp	Goovaerts, O (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	ogoovaerts@itg.be	Mayanja-Kizza, Harriet/AAM-5372-2020; Locht, Camille/L-3516-2018; Jennes, Wim/M-2523-2013	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Colebunders, Robert/0000-0002-1919-1340; Locht, Camille/0000-0001-7295-7336; Massinga Loembe, Marguerite/0000-0002-7822-566X; Jennes, Wim/0000-0002-3125-6389	EC FP6 Specific Targeted Research Project (STREP) [LSHP-CT-2007-037659-TBIRIS]	EC FP6 Specific Targeted Research Project (STREP)	Funding: The TB-IRIS project was funded by an EC FP6 Specific Targeted Research Project (STREP) grant LSHP-CT-2007-037659-TBIRIS. This work was done in association with the Infectious Diseases Network for Treatment and Research in Africa (INTERACT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Beishuizen SJE, 2009, NETH J MED, V67, P327; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Byarugaba DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027803; Conesa-Botella A, 2012, CLIN INFECT DIS, V55, P1004, DOI 10.1093/cid/cis577; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; Dudhane A, 1996, AIDS RES HUM RETROV, V12, P885, DOI 10.1089/aid.1996.12.885; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; French Martyn A, 2007, Curr HIV/AIDS Rep, V4, P16, DOI 10.1007/s11904-007-0003-z; Fukuda T, 2013, MBIO, V4, DOI 10.1128/mBio.00472-12; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Goovaerts O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081856; Grant P, 2012, CULT DIALECTICS, P1; Tran HTT, 2014, IMMUNOBIOLOGY, V219, P37, DOI 10.1016/j.imbio.2013.07.004; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; LE JM, 1986, J IMMUNOL, V136, P4525; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Njeru D G, 2009, East Afr Med J, V86, pS58; Oliver BG, 2010, J INFECT DIS, V202, P1728, DOI 10.1086/657082; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Raices RM, 2008, CYTOKINE, V44, P234, DOI 10.1016/j.cyto.2008.08.004; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Tan D, 2008, HIV MED, V9, P307, DOI 10.1111/j.1468-1293.2008.00565.x; Tan DBA, 2011, AIDS, V25, P1455, DOI 10.1097/QAD.0b013e328348fb18; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; Van den Bergh R, 2006, LANCET INFECT DIS, V6, P2, DOI 10.1016/S1473-3099(05)70302-9; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; Van Tieu H, 2009, AIDS RES HUM RETROV, V25, P1083, DOI 10.1089/aid.2009.0055; Vignesh R, 2013, JAIDS-J ACQ IMM DEF, V64, P241, DOI 10.1097/QAI.0b013e31829f6df2; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; (WHO) WHO, 2012, IMPR DIAGN TREATM SM; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; World Health Organization, 2011, INFL UPD; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Worodria William, 2009, Expert Rev Respir Med, V3, P147, DOI 10.1586/ers.09.8	53	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113101	10.1371/journal.pone.0113101	http://dx.doi.org/10.1371/journal.pone.0113101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415590	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600030
J	Ogah, OS; Stewart, S; Onwujekwe, OE; Falase, AO; Adebayo, SO; Olunuga, T; Sliwa, K				Ogah, Okechukwu S.; Stewart, Simon; Onwujekwe, Obinna E.; Falase, Ayodele O.; Adebayo, Saheed O.; Olunuga, Taiwo; Sliwa, Karen			Economic Burden of Heart Failure: Investigating Outpatient and Inpatient Costs in Abeokuta, Southwest Nigeria	PLOS ONE			English	Article							VENTRICULAR DYSFUNCTION; RISK-FACTORS; COHORT; CARE; PREDOMINANCE; POPULATION; MORTALITY; REGISTRY; CLINICS; SWEDEN	Background: Heart failure (HF) is a deadly, disabling and often costly syndrome world-wide. Unfortunately, there is a paucity of data describing its economic impact in sub Saharan Africa; a region in which the number of relatively younger cases will inevitably rise. Methods: Heath economic data were extracted from a prospective HF registry in a tertiary hospital situated in Abeokuta, southwest Nigeria. Outpatient and inpatient costs were computed from a representative cohort of 239 HF cases including personnel, diagnostic and treatment resources used for their management over a 12-month period. Indirect costs were also calculated. The annual cost per person was then calculated. Results: Mean age of the cohort was 58.0+/-15.1 years and 53.1% were men. The total computed cost of care of HF in Abeokuta was 76, 288,845 Nigerian Naira (US$508, 595) translating to 319,200 Naira (US$2,128 US Dollars) per patient per year. The total cost of in-patient care (46% of total health care expenditure) was estimated as 34,996,477 Naira (about 301,230 US dollars). This comprised of 17,899,977 Naira-50.9% ($US114,600) and 17,806,500 naira -49.1%($US118,710) for direct and in-direct costs respectively. Outpatient cost was estimated as 41,292,368 Naira ($US 275,282). The relatively high cost of outpatient care was largely due to cost of transportation for monthly follow up visits. Payments were mostly made through out-of-pocket spending. Conclusion: The economic burden of HF in Nigeria is particularly high considering, the relatively young age of affected cases, a minimum wage of 18,000 Naira ($US120) per month and considerable component of out-of-pocket spending for those affected. Health reforms designed to mitigate the individual to societal burden imposed by the syndrome are required.	[Ogah, Okechukwu S.; Falase, Ayodele O.] Univ Coll Ibadan Hosp, Dept Med, Div Cardiol, Ibadan, Nigeria; [Ogah, Okechukwu S.; Stewart, Simon; Sliwa, Karen] Univ Witwatersrand, Fac Hlth Sci, Soweto Cardiovascular Res Unit, Johannesburg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovascular Res Africa, ZA-7925 Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Onwujekwe, Obinna E.] Univ Nigeria, Fac Hlth Sci & Technol, Dept Hlth Adm & Management, Nsukka, Enugu State, Nigeria; [Adebayo, Saheed O.] Fed Med Ctr, Dept Med, Abeokuta, Nigeria; [Stewart, Simon] Natl Hlth & Med Res Council, Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia	University of Witwatersrand; University of Cape Town; University of Cape Town; University of Nigeria	Ogah, OS (corresponding author), Univ Coll Ibadan Hosp, Dept Med, Div Cardiol, Ibadan, Nigeria.	osogah56156@yahoo.com	Stewart, Simon/M-3316-2016; Onwujekwe, Obinna/O-6232-2014	Stewart, Simon/0000-0001-9032-8998; Onwujekwe, Obinna/0000-0002-1214-4285	BMBF (Ministry of Research and Education, Germany); Sir Maurice Hatter Foundation	BMBF (Ministry of Research and Education, Germany)(Federal Ministry of Education & Research (BMBF)); Sir Maurice Hatter Foundation	Funding: The authors would like to acknowledge support from the BMBF (Ministry of Research and Education, Germany) and the Sir Maurice Hatter Foundation for funding the travel of OSO to Cape Town, South Africa, in May 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Denizar Vianna, 2005, Arq. Bras. Cardiol., V84, P422, DOI 10.1590/S0066-782X2005000500013; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Czech M, 2013, KARDIOL POL, V71, P224, DOI 10.5603/KP.2013.0032; Fagnani F, 2001, THERAPIE, V56, P5; Falase B, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.61.2162; Johnson A, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-8; Laabes EP, 2008, ACTA CARDIOL, V63, P437, DOI 10.2143/AC.63.4.2033041; Lawanson A O, 2012, Afr J Med Med Sci, V41, P357; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; McMurray J, 1996, PHARMACOECONOMICS, V9, P188, DOI 10.2165/00019053-199609030-00002; McMurray J, 1993, BR J MED EC, V6, P91; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Ogah OS, 2014, JACC-HEART FAIL, V2, P250, DOI 10.1016/j.jchf.2013.12.005; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Ojji DB, 2009, CARDIOVASC J AFR, V20, P349; Oyoo GO, 1999, E AFR MED J, V76, P23; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; RITS I A, 1964, World Med J, V11, P281; Ryden-Bergsten T, 1999, J INTERN MED, V246, P275, DOI 10.1046/j.1365-2796.1999.00520.x; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Soyibo A, AFRICAN J EC POLICY, V14; Stewart S, 2005, EUR J HEART FAIL, V7, P423, DOI 10.1016/j.ejheart.2005.01.001; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Whellan DJ, 2010, CIRC-CARDIOVASC QUAL, V3, P33, DOI 10.1161/CIRCOUTCOMES.109.854760; Wijeysundera HC, 2010, VALUE HEALTH, V13, P915, DOI 10.1111/j.1524-4733.2010.00797.x	29	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113032	10.1371/journal.pone.0113032	http://dx.doi.org/10.1371/journal.pone.0113032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415310	Green Published, gold			2022-12-27	WOS:000346906600027
J	Vega-Flores, G; Gruart, A; Delgado-Garcia, JM				Vega-Flores, German; Gruart, Agnes; Delgado-Garcia, Jose M.			Involvement of the GABAergic Septo-Hippocampal Pathway in Brain Stimulation Reward	PLOS ONE			English	Article							INTRACRANIAL SELF-STIMULATION; LONG-TERM POTENTIATION; THETA-RHYTHM; CONTAINING NEURONS; PREFRONTAL CORTEX; GAMMA-RHYTHM; AMINO-ACIDS; RAT; HIPPOCAMPUS; GABA	The hippocampus is a structure related to several cognitive processes, but not very much is known about its putative involvement in positive reinforcement. In its turn, the septum has been related to instrumental brain stimulation reward (BSR) by its electrical stimulation with trains of pulses. Although the anatomical relationships of the septo-hippocampal pathway are well established, the functional relationship between these structures during rewarding behaviors remains poorly understood. To explore hippocampal mechanisms involved in BSR, CA3-evoked field excitatory and inhibitory postsynaptic potentials (fEPSPs, fIPSPs) were recorded in the CA1 area during BSR in alert behaving mice. The synaptic efficiency was determined from changes in fEPSP and fIPSP amplitudes across the learning of a BSR task. The successive BSR sessions evoked a progressive increase of the performance in inverse relationship with a decrease in the amplitude of fEPSPs, but not of fIPSPs. Additionally, we evaluated CA1 local field potentials (LFPs) during a preference task, comparing 8-, 20-, and 100-Hz trains of septal BSR. We corroborate a clear preference for BSR at 100 Hz (in comparison with BSR at 20 Hz or 8 Hz), in parallel with an increase in the spectral power of the low theta band, and a decrease in the gamma. These results were replicated by intrahippocampal injections of a GABA(B) antagonist. Thus, the GABAergic septohippocampal pathway seems to carry information involved in the encoding of reward properties, where GABA(B) receptors seem to play a key role. With regard to the dorsal hippocampus, fEPSPs evoked at the CA3-CA1 synapse seem to reflect the BSR learning process, while hippocampal rhythmic activities are more related to reward properties.	[Vega-Flores, German; Gruart, Agnes; Delgado-Garcia, Jose M.] Pablo de Olavide Univ, Div Neurosci, Seville, Spain	Universidad Pablo de Olavide	Delgado-Garcia, JM (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville, Spain.	jmdelgar@upo.es	Vega-Flores, German/AAD-2013-2022; Delgado-Garcia, Jose M./V-1567-2019	Vega-Flores, German/0000-0001-5605-4567; 	Spanish MINECO [BFU2011-29089, BFU2011-29286]; Junta de Andalucia [BIO122, CVI 2487, P07-CVI-02686]	Spanish MINECO(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants from the Spanish MINECO (BFU2011-29089 and BFU2011-29286) and Junta de Andalucia (BIO122, CVI 2487, and P07-CVI-02686) to AG and JMD-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; BALL GG, 1971, PHYSIOL BEHAV, V6, P547, DOI 10.1016/0031-9384(71)90203-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUNO W, 1977, PHYSIOL BEHAV, V19, P615, DOI 10.1016/0031-9384(77)90035-X; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; CAZALA P, 1988, PHYSIOL BEHAV, V44, P53, DOI 10.1016/0031-9384(88)90345-9; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; COBO M, 1991, EUR J NEUROSCI, V3, P531, DOI 10.1111/j.1460-9568.1991.tb00840.x; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Fenton AA, 2010, J NEUROSCI, V30, P4613, DOI 10.1523/JNEUROSCI.5576-09.2010; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Grafen A., 2002, MODERN STAT LIFE SCI; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Habib D, 2009, HIPPOCAMPUS, V19, P299, DOI 10.1002/hipo.20507; HODOS W, 1962, J COMP PHYSIOL PSYCH, V55, P80, DOI 10.1037/h0047681; Huh CYL, 2010, J NEUROSCI, V30, P15951, DOI 10.1523/JNEUROSCI.3663-10.2010; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Johnston D, 2004, SYNAPTIC ORG BRAIN; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Leppa E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024159; Leung LS, 2007, HIPPOCAMPUS, V17, P281, DOI 10.1002/hipo.20267; LIEBMAN JM, 1983, NEUROSCI BIOBEHAV R, V7, P45, DOI 10.1016/0149-7634(83)90007-6; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Macey DJ, 2001, NEUROPHARMACOLOGY, V40, P676, DOI 10.1016/S0028-3908(00)00204-5; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; MILIARESSIS E, 1987, BEHAV NEUROSCI, V101, P827, DOI 10.1037/0735-7044.101.6.827; MORA F, 1990, PROG BRAIN RES, V85, P419; Muller R, 2012, NEUROSCIENCE, V205, P125, DOI 10.1016/j.neuroscience.2011.12.032; NUNEZ A, 1990, BRAIN RES, V533, P176, DOI 10.1016/0006-8993(90)91814-W; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; Risold P.Y., 2004, RAT NERVOUS SYSTEM, P605, DOI DOI 10.1016/B978-012547638-6/50021-3; Rubio SE, 2012, FASEB J, V26, P4458, DOI 10.1096/fj.12-208413; Sanchez-Campusano R, 2007, J NEUROSCI, V27, P6620, DOI 10.1523/JNEUROSCI.0488-07.2007; Schwartzkroin PA., 1986, HIPPOCAMPUS, P113; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sotty F, 2003, J PHYSIOL-LONDON, V551, P927, DOI 10.1113/jphysiol.2003.046847; Jurado-Parras MT, 2013, J NEUROSCI, V33, P2293, DOI 10.1523/JNEUROSCI.1013-12.2013; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vega-Flores G, 2014, CEREB CORTEX, V24, P2093, DOI 10.1093/cercor/bht060; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Welberg L, 2012, NAT REV NEUROSCI, V13, P603, DOI 10.1038/nrn3331; Welberg L, 2011, NAT REV NEUROSCI, V12, P490, DOI 10.1038/nrn3090; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wise RA, 2009, ENCY NEUROSCIENCE, P833; Wu M, 2000, J NEUROSCI, V20, P3900, DOI 10.1523/JNEUROSCI.20-10-03900.2000; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012; Wyble BP, 2000, J NEUROPHYSIOL, V83, P2138, DOI 10.1152/jn.2000.83.4.2138; Yanovsky Y, 1997, NEUROSCIENCE, V77, P87, DOI 10.1016/S0306-4522(96)00461-7; ZAREVICS P, 1979, BRAIN RES, V169, P499, DOI 10.1016/0006-8993(79)90399-8	72	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113787	10.1371/journal.pone.0113787	http://dx.doi.org/10.1371/journal.pone.0113787			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415445	Green Submitted, Green Published, gold			2022-12-27	WOS:000346906600078
J	Capozzi, F; Cavallo, A; Furlanetto, T; Becchio, C				Capozzi, Francesca; Cavallo, Andrea; Furlanetto, Tiziano; Becchio, Cristina			Altercentric Intrusions from Multiple Perspectives: Beyond Dyads	PLOS ONE			English	Article							AUTOMATICITY; EGOCENTRISM; PERCEPTION; CHILDRENS; SELECTION; DIRECTION; ADULTS; CUES; EYES	Recent findings suggest that in dyadic contexts observers rapidly and involuntarily process the visual perspective of others and cannot easily resist interference from their viewpoint. To investigate whether spontaneous perspective taking extends beyond dyads, we employed a novel visual perspective task that required participants to select between multiple competing perspectives. Participants were asked to judge their own perspective or the visual perspective of one or two avatars who either looked at the same objects or looked at different objects. Results indicate that when a single avatar was present in the room, participants processed the irrelevant perspective even when it interfered with participants' explicit judgments about the relevant perspective. A similar interference effect was observed when two avatars looked at the same discs, but not when they looked at different discs. Indeed, when the two avatars looked at different discs, the interference from the irrelevant perspective was significantly reduced. This is the first evidence that the number and orientation of agents modulate spontaneous perspective taking in non-dyadic contexts: observers may efficiently compute another's perspective, but in presence of more individuals holding discrepant perspectives, they may not spontaneously track multiple viewpoints. These findings are discussed in relation to the hypothesis that perspective calculation occurs in an effortless and automatic manner.	[Capozzi, Francesca; Cavallo, Andrea; Furlanetto, Tiziano; Becchio, Cristina] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Becchio, Cristina] Ist Italiano Tecnol, Genoa, Italy	University of Turin; Istituto Italiano di Tecnologia - IIT	Becchio, C (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	cristina.becchio@unito.it	Cavallo, Andrea/AAB-9615-2019	Cavallo, Andrea/0000-0002-3717-3760; Capozzi, Francesca/0000-0002-0062-437X	European Research Council under the European Union [312919]	European Research Council under the European Union(European Research Council (ERC))	This work received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n. 312919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Apperly I., 2010, MINDREADERS COGNITIV; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; BARGH J A, 1989, P3; BARGH JA, 1992, AM J PSYCHOL, V105, P181, DOI 10.2307/1423027; Bargh JA, 2012, TRENDS COGN SCI, V16, P593, DOI 10.1016/j.tics.2012.10.002; Bazzani L, 2013, EXPERT SYST, V30, P115, DOI 10.1111/j.1468-0394.2012.00622.x; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; Bockler A, 2011, COGNITION, V120, P292, DOI 10.1016/j.cognition.2011.05.002; Carrick OK, 2007, NEUROREPORT, V18, P763, DOI 10.1097/WNR.0b013e3280ebb44b; Epley N, 2004, J EXP SOC PSYCHOL, V40, P760, DOI 10.1016/j.jesp.2004.02.002; FLAVELL JH, 1981, DEV PSYCHOL, V17, P99, DOI 10.1037/0012-1649.17.1.99; Hudson M, 2009, COGNITION, V112, P423, DOI 10.1016/j.cognition.2009.06.011; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P497, DOI 10.1037/0096-1523.9.4.497; Kahneman D., 1984, VARIETIES ATTENTION, P29; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Qureshi AW, 2010, COGNITION, V117, P230, DOI 10.1016/j.cognition.2010.08.003; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; Schwarzkopf S, 2014, COGNITION, V131, P345, DOI 10.1016/j.cognition.2014.02.003; Surtees A, 2013, COGNITION, V129, P426, DOI 10.1016/j.cognition.2013.06.008; Surtees ADR, 2012, CHILD DEV, V83, P452, DOI 10.1111/j.1467-8624.2011.01730.x	25	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114210	10.1371/journal.pone.0114210	http://dx.doi.org/10.1371/journal.pone.0114210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25436911	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900130
J	Jung, HY; Cho, JH; Jang, HM; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Choi, JY; Park, SH; Kim, CD; Kim, YL				Jung, Hee-Yeon; Cho, Jang-Hee; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim		Clinical Res Ctr End Stage Renal	Free Thyroxine Level as an Independent Predictor of Infection-Related Mortality in Patients on Peritoneal Dialysis: A Prospective Multicenter Cohort Study	PLOS ONE			English	Article							THYROID-HORMONE METABOLISM; LOW TRIIODOTHYRONINE; SUBCLINICAL HYPOTHYROIDISM; STAGE; DISEASE; RISK; INFLAMMATION; ASSOCIATION; THYROTROPIN; PREVALENCE	Background: Previous studies have reported the relationship between thyroid hormone levels and mortality in dialysis patients. However, little is known about the association of free thyroxine (fT4) and mortality in patients on peritoneal dialysis (PD). This study investigated the association between basal and annual variation in fT4 level and mortality in PD patients. Methods: Patients on maintenance PD were enrolled from a prospective multicenter cohort study in Korea; their serum triiodothyronine, fT4, and thyroid-stimulating hormone levels were measured 12 months apart. Patients with overt thyroid disease and those receiving thyroid hormone replacement therapy were excluded from the analysis. Patients were divided into two groups based on the median levels of fT4. The differences of all-cause, infection-related, and cardiovascular mortalities were analyzed between the two groups. The association of basal levels and annual variation with mortality was investigated with Kaplan-Meier curves and Cox proportional hazard models. Results: Among 235 PD patients, 31 (13.2%) deaths occurred during the mean follow-up period of 24 months. Infection (38.7%) was the most common cause of death. Lower basal fT4 levels were an independent predictor of all-cause and infection-related death (hazard ratio [HR]=2.74, 95% confidence interval [CI] 1.27-5.90, P=0.01, and HR=6.33, 95% CI 1.16-34.64, P=0.03, respectively). Longitudinally, patients with persistently lower fT4 levels during the 12-month period had significantly higher all-cause mortality than those with persistently higher levels (HR=3.30, 95% CI 1.15-9.41, P=0.03). The area under the receiver operating characteristic curve of fT4 for predicting all-cause and infection-related mortality was 0.60 and 0.68, respectively. Conclusions: fT4 level is an independent predictor of mortality and is especially attributable to infection in PD patients. This predictor was consistent when considering both baseline measurements and annual variation patterns. Close attention to infection in PD patients with relatively lower fT4 levels should be considered.	[Jung, Hee-Yeon; Cho, Jang-Hee; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Taegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Taegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Jung, Hee-Yeon; Cho, Jang-Hee; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis, Taegu, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Plus KNU Biomed Convergence Program Bk21, Dept Biomed Sci, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Kyungpook National University	Kim, YL (corresponding author), Kyungpook Natl Univ, Dept Internal Med, Sch Med, Taegu, South Korea.	ylkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Jung, Hee-Yeon/AFB-8578-2022; Barretti, Pasqual/K-4156-2012	Cho, Jang-hee/0000-0002-7031-5214; Jung, Hee-Yeon/0000-0003-0232-7202; Barretti, Pasqual/0000-0003-4979-4836; Ryu, Dong-Ryeol/0000-0002-5309-7606	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020, A111345]; National Research Foundation - Korea Government (MEST) [20100019392]	Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea; National Research Foundation - Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	Funding: This study was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020 and A111345), and a National Research Foundation grant funded by the Korea Government (MEST) (No. 20100019392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagriacik EU, 2001, CELL IMMUNOL, V212, P92, DOI 10.1006/cimm.2001.1846; BESEDOVSKY H, 1975, P SOC EXP BIOL MED, V150, P466; BESEDOVSKY HO, 1985, INT J CANCER, V36, P209, DOI 10.1002/ijc.2910360213; Brough R, 2006, PEDIATR NEPHROL, V21, P400, DOI 10.1007/s00467-005-2115-2; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Carrero JJ, 2007, J INTERN MED, V262, P690, DOI 10.1111/j.1365-2796.2007.01865.x; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; CHOPRA IJ, 1983, ANN INTERN MED, V98, P946, DOI 10.7326/0003-4819-98-6-946; Cini G, 2009, BIOMED PHARMACOTHER, V63, P742, DOI 10.1016/j.biopha.2009.08.003; Drechsler C, 2013, AM J KIDNEY DIS; Enia G, 2007, NEPHROL DIAL TRANSPL, V22, P538, DOI 10.1093/ndt/gfl605; Fernandez-Reyes MJ, 2010, CLIN NEPHROL, V73, P238; FUJII T, 1989, ENDOCRINOLOGY, V124, P167, DOI 10.1210/endo-124-1-167; HERSHMAN JM, 1972, J CLIN ENDOCR METAB, V34, P574, DOI 10.1210/jcem-34-3-574; Iervasi G, 2007, ARCH INTERN MED, V167, P1526, DOI 10.1001/archinte.167.14.1526; Kang EW, 2008, AM J NEPHROL, V28, P908, DOI 10.1159/000141933; Kelly G S, 2000, Altern Med Rev, V5, P306; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Kruger TE, 1996, ADV NEUROIMMUNOL, V6, P387, DOI 10.1016/S0960-5428(97)00033-2; Lim VS, 2001, AM J KIDNEY DIS, V38, pS80, DOI 10.1053/ajkd.2001.27410; Lo JC, 2005, KIDNEY INT, V67, P1047, DOI 10.1111/j.1523-1755.2005.00169.x; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; McDonald S, 2012, ANZDATA REGISTRY REP; MCLARTY DG, 1975, LANCET, V2, P275; McQuade C, 2011, THYROID, V21, P837, DOI 10.1089/thy.2010.0298; Meuwese CL, 2012, CLIN J AM SOC NEPHRO, V7, P131, DOI 10.2215/CJN.05250511; Molinaro S, 2012, AM J MED SCI, V343, P65, DOI 10.1097/MAJ.0b013e31822846bd; OZAWA M, 1988, ENDOCRINOLOGY, V123, P1461, DOI 10.1210/endo-123-3-1461; PANG XP, 1989, ENDOCRINOLOGY, V125, P76, DOI 10.1210/endo-125-1-76; Rhee CM, 2013, CLIN J AM SOC NEPHRO, V8, P593, DOI 10.2215/CJN.06920712; ROBEY C, 1989, AM J KIDNEY DIS, V13, P99, DOI 10.1016/S0272-6386(89)80125-8; Perez SR, 2013, PERITON DIALYSIS INT, V33, P697, DOI 10.3747/pdi.2012.00098; SLAG MF, 1981, JAMA-J AM MED ASSOC, V245, P43, DOI 10.1001/jama.245.1.43; Sonawane S, 2006, SEMIN DIALYSIS, V19, P305, DOI 10.1111/j.1525-139X.2006.00177.x; Song SH, 2009, NEPHROL DIAL TRANSPL, V24, P1534, DOI 10.1093/ndt/gfn682; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tatar E, 2012, INT UROL NEPHROL, V44, P601, DOI 10.1007/s11255-011-0034-7; Tatar E, 2011, CLIN J AM SOC NEPHRO, V6, P2240, DOI 10.2215/CJN.02540311; US Renal Data System, 2013, USRDS 2013 ANN DAT R; Waring AC, 2012, J CLIN ENDOCR METAB, V97, P862, DOI 10.1210/jc.2011-2684; Wiederkehr MR, 2004, NEPHROL DIAL TRANSPL, V19, P1190, DOI 10.1093/ndt/gfh096; Yilmaz MI, 2011, AM J NEPHROL, V33, P25, DOI 10.1159/000322581; Zoccali C, 2006, KIDNEY INT, V70, P523, DOI 10.1038/sj.ki.5001566; Zoccali C, 2005, J AM SOC NEPHROL, V16, P2789, DOI 10.1681/ASN.2005040356; Zoccali C, 2006, J HYPERTENS, V24, P2039, DOI 10.1097/01.hjh.0000244954.62362.8f	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112760	10.1371/journal.pone.0112760	http://dx.doi.org/10.1371/journal.pone.0112760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436457	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900017
J	Li, L; Zhang, H; Meng, SQ; Qian, HZ				Li, Li; Zhang, Hong; Meng, Shu-qing; Qian, Hai-zhou			An Updated Meta-Analysis of the Efficacy and Safety of Acupuncture Treatment for Cerebral Infarction	PLOS ONE			English	Article							ISCHEMIC-STROKE; BRAIN; ELECTROACUPUNCTURE; PROLIFERATION; STIMULATION; DEFICITS; INJURY; MODEL	Background: Ischemic stroke is the second most common cause of death and the primary cause of disability throughout the world. Acupuncture is frequently advocated as an adjunct treatment during stroke rehabilitation. The aim of this study was to update the clinical efficacy and safety of acupuncture for cerebral infarction. Methods: Randomized controlled trials (RCT) on acupuncture treating cerebral infarction were searched from the following databases: PubMed, EMBASE, Cochrane Library, CNKI, CMB and VIP from inception to October 2013. The data of RCTs meeting the inclusive criteria were extracted according to Cochrane methods. The meta-analyses were conducted using Rev Man 5.0 software. Results: A total of 25 trials involving 2224 patients were included. The results of this meta-analysis showed that the groups receiving acupuncture (observation group) were superior to the comparison groups (control group), with significant differences in the Clinical Efficacy Rates [OR=4.04, 95% CI (2.93, 5.57), P<0.001], Fugl-Meyer Assessment [MD=11.22, 95% CI (7.62, 14.82), P<0.001], Barthel Index Score [MD=12.84, 95% CI (9.85, 15.82), P<0.001], and Neurological Deficit Score [MD=-22.71, 95% CI (23.84, 21.94), P<0.001]. Three trials reported minor adverse events. Conclusion: Current evidence provisionally demonstrates that acupuncture treatment is superior to either non-acupuncture or conventional therapy for cerebral infarction. Despite this conclusion, given the often low quality of the available trials, further large scale RCTs of better quality are still needed.	[Li, Li; Zhang, Hong; Meng, Shu-qing; Qian, Hai-zhou] Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430072, Peoples R China	Wuhan University	Zhang, H (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430072, Peoples R China.	zhangh9@yahoo.com			Scientific Research Foundation from Health Department of Hubei Province in China [JX5A04]	Scientific Research Foundation from Health Department of Hubei Province in China	This work was supported by the Key Projects of Scientific Research Foundation from Health Department of Hubei Province (JX5A04) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, ACUPUNCTURE REV ANAL, P4; Chen SQ, 1997, CHIN J REHABIL THEOR, V3, P161; Cheng HY, 2008, NEUROSCI LETT, V432, P111, DOI 10.1016/j.neulet.2007.12.009; Cheng X, 2011, WORLD J ACUPUNCT MOX, V21, P15; Feng Lingmei, 2007, J Tradit Chin Med, V27, P100; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Guo A, 2012, SHANGHAI J ACUPUNCT, V31, P80; Guo Zhili, 2007, J Tradit Chin Med, V27, P243; Hsing WT, 2012, J ALTERN COMPLEM MED, V18, P341, DOI 10.1089/acm.2011.0131; Huang F, 2008, SHANGHAI J ACUPUNCT, V27, P4; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Kong JC, 2010, CAN MED ASSOC J, V182, P1723, DOI 10.1503/cmaj.091113; Lee GJ, 2010, NEUROL RES, V32, pS79, DOI 10.1179/016164109X12537002794200; Lee JD, 2003, NEURORADIOLOGY, V45, P780, DOI 10.1007/s00234-003-1080-3; Li L, 2009, J ACUPUNCT TUINA SCI, V7, P137; LIN R, 2009, J PRACTICAL TRADITIO, V23, P90; Liu QJ, 2001, CHINESE J ORG CHEM, V21, P160; Pei J, 2001, J Tradit Chin Med, V21, P270; Rabinstein AA, 2003, NEUROLOGIST, V9, P137, DOI 10.1097/00127893-200305000-00002; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Rao Ping, 2006, Zhongguo Zhen Jiu, V26, P694; Ren L, 2008, NEUROL RES, V30, P985, DOI 10.1179/174313208X325182; Schuler MS, 2005, J AM GERIATR SOC, V53, P549, DOI 10.1111/j.1532-5415.2005.53178_6.x; Shen PF, 2012, AM J CHINESE MED, V40, P685, DOI 10.1142/S0192415X12500516; Shu XP, 2011, CHINA FOREIGN MED TR, V30, P10; Tao J, 2010, NEUROL RES, V32, P198, DOI 10.1179/174313209X414506; Tong Shuai, 2013, Zhongguo Zhen Jiu, V33, P399; Wang Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/480950; Weng ZM, 2013, INT J NURS, V32, P1074; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Wu X, 2001, WORLD J ACUPUNCT MOX, V11, P24; Wu YC, 2011, J ACUPUNCT TUINA SCI, V9, P315; Xie R, 2004, CHIN J GERIATR CARE, V2, P7; Yang D, 2008, J ACUPUNCT TUINA SCI, V6, P219; Zhang L, 2008, J ACUPUNCT TUINA SCI, V6, P222; Zhang Ning-xia, 2009, Zhen Ci Yan Jiu, V34, P406; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang Xin, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P483; Zhao JX, 2011, J TRADIT CHIN MED, V31, P349, DOI 10.1016/S0254-6272(12)60017-X; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011; Zhu S, 2005, WORLD J ACUPUNCT MOX, V15, P8	42	33	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114057	10.1371/journal.pone.0114057	http://dx.doi.org/10.1371/journal.pone.0114057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438041	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900115
J	Bob, F; Bota, S; Sporea, I; Sirli, R; Petrica, L; Schiller, A				Bob, Flaviu; Bota, Simona; Sporea, Ioan; Sirli, Roxana; Petrica, Ligia; Schiller, Adalbert			Kidney Shear Wave Speed Values in Subjects with and without Renal Pathology and Inter-Operator Reproducibility of Acoustic Radiation Force Impulse Elastography (ARFI) - Preliminary Results	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TISSUE ELASTICITY QUANTIFICATION; TRANSIENT ELASTOGRAPHY; LIVER FIBROSIS; ALLOGRAFT FIBROSIS; NONINVASIVE EVALUATION; DIAGNOSIS; DISEASE; TECHNOLOGY	Aim: to assess the inter-operator reproducibility of kidney shear wave speed, evaluated by means of Acoustic Radiation Force Impulse (ARFI) elastography, and the factors which influence it. Methods: Our prospective pilot study included 107 subjects with or without kidney pathology in which kidney shear wave speed was evaluated by means of ARFI elastography. Intraclass correlation coefficient (ICC) was used to assess ARFI elastography reproducibility. Results: A strong agreement was obtained between kidney shear wave speed measurements obtained by the two operators: ICC=0.71 (right kidney) and 0.69 (left kidney). Smaller ICCs were obtained in "healthy subjects", as compared to patients with kidney diseases (0.68 vs. 0.75), in women as compared with men (0.59 vs. 0.78), in subjects younger than 50 years as compared with those aged at least 50 years (0.63 vs. 0.71), in obese as compared with normal weight and overweight subjects (0.36 vs. 0.66 and 0.78) and in case of measurements depth <4 cm or >6 cm as compared with those performed at a depth of 4-6 cm from the skin (0.32 and 0.60 vs. 0.81). Conclusion: ARFI elastography is a reproducible method for kidney shear wave speed assessment.	[Bob, Flaviu; Petrica, Ligia; Schiller, Adalbert] Victor Babes Univ Med & Pharm, Dept Nephrol, Timisoara, Romania; [Bota, Simona; Sporea, Ioan; Sirli, Roxana] Victor Babes Univ Med & Pharm, Dept Gastroenterol & Hepatol, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Bota, S (corresponding author), Victor Babes Univ Med & Pharm, Dept Gastroenterol & Hepatol, Timisoara, Romania.	bota_simona1982@yahoo.com	Sirli, Roxana/L-4202-2013; Schiller, Adalbert A./AAT-8957-2021	Sirli, Roxana/0000-0002-0179-1014; Petrica, Ligia/0000-0003-3138-3051				Arndt R, 2010, TRANSPL INT, V23, P871, DOI 10.1111/j.1432-2277.2010.01057.x; Asano K, 2014, J ULTRAS MED, V33, P793, DOI 10.7863/ultra.33.5.793; Badea I, 2014, MED ULTRASON, V16, P89, DOI 10.11152/mu.201.3.2066.162.ib1asz2; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bob F, 2014, 26 C EUR FED SOC ULT; Bob F, 2013, EUR J ULTRASOUND, V34, pS16; Bota S, 2012, ULTRASOUND MED BIOL, V38, P1103, DOI 10.1016/j.ultrasmedbio.2012.02.032; Boursier J, 2010, EUR J GASTROEN HEPAT, V22, P1074, DOI 10.1097/MEG.0b013e328339e0a1; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Calvete AC, 2014, J ULTRAS MED, V33, P1031, DOI 10.7863/ultra.33.6.1031; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, P7; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Frey H, 2003, RADIOLOGE, V43, P850, DOI 10.1007/s00117-003-0943-2; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Gallotti A, 2010, RADIOL MED, V115, P889, DOI 10.1007/s11547-010-0504-5; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Grenier N, 2013, Diagn Interv Imaging, V94, P545, DOI 10.1016/j.diii.2013.02.003; Grenier N, 2012, EUR RADIOL, V22, P2138, DOI 10.1007/s00330-012-2471-9; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068925; Guzman-Aroca F, 2011, J ULTRAS MED, V30, P975, DOI 10.7863/jum.2011.30.7.975; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Landis J. R., 1977, BIOMETRICS; Neter J., 1988, APPL STAT; Ozkan F, 2013, ULTRASOUND MED BIOL, V39, P4, DOI 10.1016/j.ultrasmedbio.2012.09.013; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Palmeri ML, 2005, ULTRASONIC IMAGING, V27, P75, DOI 10.1177/016173460502700202; Piscaglia F, 2011, ULTRASCHALL MED, V32, P167, DOI 10.1055/s-0029-1245948; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sommerer C, 2013, TRANSPL INT, V26, P545, DOI 10.1111/tri.12073; Sporea I, 2011, Ultraschall Med, V32 Suppl 1, pS46, DOI 10.1055/s-0029-1245360; Sporea I, 2012, EUR J RADIOL, V81, P4112, DOI 10.1016/j.ejrad.2012.08.018; Stock KF, 2011, CLIN HEMORHEOL MICRO, V49, P527, DOI 10.3233/CH-2011-1503; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Syversveen T, 2012, EUR RADIOL, V22, P2130, DOI 10.1007/s00330-012-2476-4; Syversveen T, 2011, TRANSPL INT, V24, P100, DOI 10.1111/j.1432-2277.2010.01165.x; Topham PS, 2010, COMPREHENSIVE CLIN N, P75; Urban MW, 2013, IEEE INT ULTR S IUS; Wang L, 2014, EUR RADIOL, V24, P1694, DOI 10.1007/s00330-014-3162-5; Wojcinski S, 2013, INT J WOMENS HEALTH, V5, P619, DOI 10.2147/IJWH.S50953; Zheng XZ, 2012, RADIOL ONCOL, V46, P69, DOI 10.2478/v10019-011-0026-3	44	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113761	10.1371/journal.pone.0113761	http://dx.doi.org/10.1371/journal.pone.0113761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426849	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400084
J	Eberle, CA; Forcella, F; Gesch, R; Weyers, S; Peterson, D; Eklund, J				Eberle, Carrie A.; Forcella, Frank; Gesch, Russ; Weyers, Sharon; Peterson, Dean; Eklund, James			Flowering Dynamics and Pollinator Visitation of Oilseed Echium (Echium plantagineum)	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; HONEY-BEES; NECTAR; HABITAT; POLLEN	Echium (Echium plantagineum L.) is an alternative oilseed crop in summer-wet temperate regions that provides floral resources to pollinators. Its seed oil is rich in omega-3 fatty acids, such as stearidonic acid, which is desired highly by the cosmetic industry. Seeds were sown in field plots over three years in western Minnesota in spring (early-sown) or early summer (late-sown), and flower abundance, pollinator visitation, and seed yields were studied. Initial flowering commenced 41 to 55 d after sowing, and anthesis duration (first flowering to harvest) was 34 to 70 d. Late sowing dates delayed anthesis, but increased the intensity of visitation by pollinators. Cumulative flower densities ranged from 1 to 4.5 billion ha(-1). Flowers attracted numerous honey bees (Apis mellifera L.), as many as 35 per minute of observation, which represented about 50% of all insect visitors. Early-sown echium produced seed yields up to 750 kg ha(-1), which were 2-29 times higher than those of late-sown echium. Early sowing of echium in Minnesota provides abundant floral resources for pollinators for up to two months and simultaneously produces seed yields whose profits rival those of corn (Zea mays L.).	[Eberle, Carrie A.; Forcella, Frank; Gesch, Russ; Weyers, Sharon; Peterson, Dean; Eklund, James] ARS, USDA, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA	United States Department of Agriculture (USDA)	Eberle, CA (corresponding author), ARS, USDA, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA.	carrie.eberle@ars.usda.gov	Weyers, Sharon/ABA-6454-2020	Weyers, Sharon/0000-0003-3873-7748	USDA-National Institute of Food and Agriculture (NIFA) [2012-67009-20272]; ARS [ARS-0425705] Funding Source: Federal RePORTER	USDA-National Institute of Food and Agriculture (NIFA); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported through the USDA-National Institute of Food and Agriculture (NIFA) award 2012-67009-20272. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia New Zealand Food Authority, 2001, TECH REP SER ANZFA, V2; Berti M, 2004, ECHIUM E VULGARE E P; Berti M., 2007, ISSUES NEW CROPS NEW, P120; Boppre M, 2008, J AGR FOOD CHEM, V56, P5662, DOI 10.1021/jf800568u; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BURDON JJ, 1988, BIOL J LINN SOC, V34, P81, DOI 10.1111/j.1095-8312.1988.tb01949.x; Corbet SA, 2003, APIDOLOGIE, V34, P1, DOI 10.1051/apido:2002049; CORBET SA, 1984, AUST J ECOL, V9, P125, DOI 10.1111/j.1442-9993.1984.tb01351.x; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; Cullen JM, 1984, P 6 INT S BIOL CONTR, P249; CULVENOR CCJ, 1981, J AGR FOOD CHEM, V29, P958, DOI 10.1021/jf00107a018; DAVIS AR, 1992, J APICULT RES, V31, P83, DOI 10.1080/00218839.1992.11101267; Decourtye A., 2011, ECOSYSTEMS BIODIVERS, DOI [10.5772/24523, DOI 10.5772/24523]; ERICKSON EH, 1975, CROP SCI, V15, P84, DOI 10.2135/cropsci1975.0011183X001500010025x; Gray DA, 2010, EUR J LIPID SCI TECH, V112, P741, DOI 10.1002/ejlt.200900280; Groeneveld JH, 2014, GCB BIOENERGY, V6, P242, DOI 10.1111/gcbb.12122; Guil-Guerrero JL, 2007, EUR J LIPID SCI TECH, V109, P1226, DOI 10.1002/ejlt.200700207; HOOPER PT, 1977, AUST VET J, V53, P109, DOI 10.1111/j.1751-0813.1977.tb00129.x; Huang Z, 2010, AM BEE J, V150, P773; JIANG HF, 1993, AGRON J, V85, P221, DOI 10.2134/agronj1993.00021962008500020011x; Mathieson S., 1988, Australasian Beekeeper, V90, P208; McGregor SE, 1976, AGR HDB, V496, P275; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; NNFCC, 2009, ECH CROP FACT SHEET; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; PIGGIN CM, 1978, WEED RES, V18, P83, DOI 10.1111/j.1365-3180.1978.tb01140.x; Rader R, 2012, J APPL ECOL, V49, P126, DOI 10.1111/j.1365-2664.2011.02066.x; Rempel R.S., 2009, TRANSECT POINT DENSI; Rempel RS, 2012, CAN J FOREST RES, V42, P2052, DOI 10.1139/x2012-146; Rosa AD, 2011, SCI AGR, V68, P255, DOI 10.1590/S0103-90162011000200018; SEVERSON DW, 1984, ENVIRON ENTOMOL, V13, P1091, DOI 10.1093/ee/13.4.1091; Standifer L.N., 1977, ANN ENTOMOL SOC AM, V70, P691; Technology Crops International, 2010, TECHN CROPS GUID GRO; Vivarelli D, 2007, THESIS U BOLOGNA ITA, P106	34	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113556	10.1371/journal.pone.0113556	http://dx.doi.org/10.1371/journal.pone.0113556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427071	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400064
J	Hone, DWE; Farke, AA; Watabe, M; Shigeru, S; Tsogtbaatar, K				Hone, David W. E.; Farke, Andrew A.; Watabe, Mahito; Shigeru, Suzuki; Tsogtbaatar, Khishigjav			A New Mass Mortality of Juvenile Protoceratops and Size-Segregated Aggregation Behaviour in Juvenile Non-Avian Dinosaurs	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; LIFE-HISTORY; SEXUAL-MATURITY; RELATIVE GROWTH; EVOLUTION; GREGARIOUSNESS; NEOCERATOPSIA; PALEOECOLOGY; PATTERNS; MONGOLIA	Background: Monodominant bonebeds are a relatively common occurrence for non-avian dinosaurs, and have been used to infer associative, and potentially genuinely social, behavior. Previously known assemblages are characterized as either mixed size-classes (juvenile and adult-sized specimens together) or single size-classes of individuals (only juveniles or only adult-sized individuals within the assemblage). In the latter case, it is generally unknown if these kinds of size-segregated aggregations characterize only a particular size stage or represent aggregations that happened at all size stages. Ceratopsians ("horned dinosaurs'') are known from both types of assemblages. Methods/Principal Findings: Here we describe a new specimen of the ceratopsian dinosaur Protoceratops andrewsi, Granger and Gregory 1923 from Mongolia representing an aggregation of four mid-sized juvenile animals. In conjunction with existing specimens of groups of P. andrewsi that includes size-clustered aggregations of young juveniles and adult-sized specimens, this new material provides evidence for some degree of size-clustered aggregation behaviour in Protoceratops throughout ontogeny. This continuity of size-segregated (and presumably age-clustered) aggregation is previously undocumented in non-avian dinosaurs. Conclusions: The juvenile group fills a key gap in the available information on aggregations in younger ceratopsians. Although we support the general hypothesis that many non-avian dinosaurs were gregarious and even social animals, we caution that evidence for sociality has been overstated and advocate a more conservative interpretation of some data of 'sociality' in dinosaurs.	[Hone, David W. E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA; [Watabe, Mahito; Shigeru, Suzuki] Hayashibara Museum Nat Sci, Okayama, Japan; [Tsogtbaatar, Khishigjav] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar, Mongolia	University of Bristol; University of London; Queen Mary University London; Mongolian Academy of Sciences	Hone, DWE (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Farke, Andrew/0000-0002-6930-2002	National Environmental Research Council (NERC), United Kingdom [NE/I027630/1]; NERC [NE/I027630/1] Funding Source: UKRI; Natural Environment Research Council [NE/I027630/1] Funding Source: researchfish	National Environmental Research Council (NERC), United Kingdom; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by National Environmental Research Council (NERC), United Kingdom grant NE/I027630/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 1989, ANIMAL BEHAV EVOLUTI, P483; Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO, P406; BEKOFF M, 1984, ANNU REV ECOL SYST, V15, P191, DOI 10.1146/annurev.es.15.110184.001203; Bertram BCR, 1995, SERENGETI DYNAMICS E, P221; BRATTSTROM BH, 1974, AM ZOOL, V14, P35; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; BURGHARDT GM, 1977, SCIENCE, V195, P689, DOI 10.1126/science.195.4279.689; Burton R, 1985, BIRD BEHAV, P224; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Caro T., 1994, CHEETAHS SERENGETI P, P500; Carpenter K, 1999, EGGS NESTS BABY DINO, P338; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Costa JT, 1996, ANN ZOOL FENN, V42, P559; Currie PJ, 2011, ACTA PALAEONTOL POL, V56, P489, DOI 10.4202/app.2010.0055; Currie PJ, 2000, GAIA, V15, P217; DERUITER JR, 1986, BEHAVIOUR, V98, P240, DOI 10.1163/156853986X00982; DODSON P, 1976, J PALEONTOL, V50, P929; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Doody JS, 2013, ETHOLOGY, V119, P95, DOI 10.1111/eth.12047; Eberth DA, 2010, NEW PERSPECTIVES HOR, P447; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Estes R, 1991, BEHAV GUIDE AFRICAN, P80; Evans R.M., 1980, Behavior of Marine Animals, V4, P271; Farke AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004252; Fastovsky DE, 2011, J PALEONTOL, V85, P1035; Fastovsky DE, 1997, PALAIOS, V12, P59, DOI 10.2307/3515294; Faulkes Chris G., 2007, P427; FORSTER CA, 1990, J PALEONTOL, V64, P164, DOI 10.1017/S0022336000042402; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gates TA, 2005, PALAIOS, V20, P363, DOI 10.2110/palo.2003.p03-22; Gilmore, 1917, US GEOLOGICAL SURVEY, V103, P1; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Handa N, 2012, PALEONTOL RES, V16, P179, DOI 10.2517/1342-8144-16.3.179; Hone DWE, 2014, J ZOOL, V292, P260, DOI 10.1111/jzo.12114; Hone David W.E., 2014, P524; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; Horner JR, 2002, ENCY LIFE SCI, V5, P468; Hunt Rebecca K., 2010, P447; JERZYKIEWICZ T, 1993, CAN J EARTH SCI, V30, P2180, DOI 10.1139/e93-190; Kirkland James I., 2010, P509; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Krause J., 2002, LIVING GROUPS, P210; Lambert Olivier, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V71 Supplement, P5; Lang J.W., 2013, WORLD CROC C P 22 WO, P42; Lee A, 2006, J VERTEBR PALEONTOL, V26, p89A; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Loope DB, 1998, GEOLOGY, V26, P27, DOI 10.1130/0091-7613(1998)026<0027:LADIAL>2.3.CO;2; Makovicky P, 2007, J VERTEBR PALEONTOL, V27, p109A; Mathews JC, 2009, J VERTEBR PALEONTOL, V29, P286, DOI 10.1080/02724634.2009.10010382; MAZAK V, 1981, Mammalian Species, P1, DOI 10.2307/3504004; McFarland, 1993, ANIM BEHAV; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Nonacs P, 2001, ANN ZOOL FENN, V38, P239; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Raath MA, 1977, THESIS, P356; Roach Brian T., 2007, Bulletin of the Peabody Museum of Natural History, V48, P103, DOI 10.3374/0079-032X(2007)48[103:AROCPH]2.0.CO;2; Salgado L, 2012, J VERTEBR PALEONTOL, V32, P603, DOI 10.1080/02724634.2012.661004; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Saneyoshi M, 2011, PALAEOGEOGR PALAEOCL, V311, P38, DOI 10.1016/j.palaeo.2011.07.024; SCHALLER G B, 1972, P480; Sullivan C, 2009, VERT PAL AS, V37, P45; Sunquist M, 2002, WILD CATS WORLD, P462; Suzuki S, 2000, HAYASHIBARA MUS NAT, V1, P83; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; van Staaden Moira J., 1994, Mammalian Species, V483, P1; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173, DOI 10.1007/BF00299920; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; Von Richter W, 1994, MAMMAL SPEC, V50, P1; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; Wolfe D.G., 1998, NEW MEXICO MUSEUM NA, V14, P303; Xu Xing, 2013, Vertebrata Palasiatica, V51, P85; Yamashita C., 1991, CSG NEWSLETTER, V10, P13; You Hailu, 2004, P478; Zhao Q, ACTA PALAE IN PRESS	85	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113306	10.1371/journal.pone.0113306	http://dx.doi.org/10.1371/journal.pone.0113306			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426957	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400042
J	Kinner, S; Steinweg, V; Maderwald, S; Radtke, A; Sotiropoulos, G; Forsting, M; Schroeder, T				Kinner, Sonja; Steinweg, Verena; Maderwald, Stefan; Radtke, Arnold; Sotiropoulos, Georgios; Forsting, Michael; Schroeder, Tobias			Comparison of Different Magnetic Resonance Cholangiography Techniques in Living Liver Donors Including Gd-EOB-DTPA Enhanced T1-Weighted Sequences	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; BILIARY COMPLICATIONS; MR CHOLANGIOGRAPHY; BILE-DUCT; TRANSPLANTATION; ANATOMY; CT; EXPERIENCE; UTILITY; IMPACT	Objectives: Preoperative evaluation of potential living liver donors (PLLDs) includes the assessment of the biliary anatomy to avoid postoperative complications. Aim of this study was to compare T2-weighted (T2w) and Gd-EOB-DTPA enhanced T1-weighted (T1w) magnetic resonance cholangiography (MRC) techniques in the evaluation of PLLDs. Materials and Methods: 30 PLLDs underwent MRC on a 1.5 T Magnetom Avanto (Siemens, Erlangen, Germany) using (A) 2D T2w HASTE (Half Fourier Acquisition Single Shot Turbo Spin Echo) fat saturated (fs) in axial plane, (B) 2D T2w HASTE fs thick slices in coronal plane, (C) free breathing 3D T2w TSE (turbo spin echo) RESTORE (high-resolution navigator corrected) plus (D) maximum intensity projections (MIPs), (E) T2w SPACE (sampling perfection with application optimized contrasts using different flip angle evolutions) plus (F) MIPs and (G) T2w TSE BLADE as well as Gd-EOB-DTPA T1w images without (G) and with (H) inversion recovery. Contrast enhanced CT cholangiography served as reference imaging modality. Two independent reviewers evaluated the biliary tract anatomy on a 5-point scale subjectively and objectively. Data sets were compared using a Mann-Whitney-U-test. Kappa values were also calculated. Results: Source images and maximum intensity projections of 3D T2w TSE sequences (RESTORE and SPACE) proved to be best for subjective and objective evaluation directly followed by 2D HASTE sequences. Interobserver variabilities were good to excellent (k=0.622-0.804). Conclusions: 3D T2w sequences are essential for preoperative biliary tract evaluation in potential living liver donors. Furthermore, our results underline the value of different MRCP sequence types for the evaluation of the biliary anatomy in PLLDs including Gd-EOB-DTPA enhanced T1w MRC.	[Kinner, Sonja; Steinweg, Verena; Maderwald, Stefan; Forsting, Michael; Schroeder, Tobias] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Maderwald, Stefan] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Radtke, Arnold; Sotiropoulos, Georgios] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Kinner, S (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Sonja.Kinner@uni-due.de	Maderwald, Stefan/B-4241-2011					Akpinar E, 2009, J MAGN RESON IMAGING, V30, P578, DOI 10.1002/jmri.21887; An SK, 2006, AM J ROENTGENOL, V187, P1223, DOI 10.2214/AJR.05.0584; Basaran C, 2008, AM J ROENTGENOL, V190, P1527, DOI 10.2214/AJR.07.3006; Choi JY, 2008, EUR RADIOL, V18, P78, DOI 10.1007/s00330-007-0670-6; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V36, P632, DOI 10.1002/jmri.23683; Guda N, 2013, INDIAN J GASTROENTER, P1; Hashimoto M, 2008, RADIOGRAPHICS, V28, P119, DOI 10.1148/rg.281075058; Huber S, 2013, J COMPUT ASSIST TOMO, V37, P443, DOI 10.1097/RCT.0b013e318283bb5c; Hyodo T, 2012, BRIT J RADIOL, V85, P887, DOI 10.1259/bjr/21209407; Kawarada Y, 2000, J Hepatobiliary Pancreat Surg, V7, P580, DOI 10.1007/s005340070007; Kim SH, 2010, LIVER TRANSPLANT, V16, P1069, DOI 10.1002/lt.22116; Kochhar G, 2013, WORLD J GASTROENTERO, V19, P2841, DOI 10.3748/wjg.v19.i19.2841; Lee MS, 2011, J MAGN RESON IMAGING, V33, P149, DOI 10.1002/jmri.22429; Lim JS, 2006, AM J ROENTGENOL, V187, P1223; Mangold S, 2012, ABDOM IMAGING, V37, P244, DOI 10.1007/s00261-011-9736-7; Marcos A, 2000, LIVER TRANSPLANT, V6, pS59, DOI 10.1053/jlts.2000.19011; McSweeney SE, 2012, EUR J RADIOL, V81, P6, DOI 10.1016/j.ejrad.2010.10.013; Morita S, 2009, MAGN RESON MED SCI, V8, P101, DOI 10.2463/mrms.8.101; Nakamura T, 2002, TRANSPLANTATION, V73, P1896, DOI 10.1097/00007890-200206270-00008; Radtke A, 2012, AM J TRANSPLANT, V12, P718, DOI 10.1111/j.1600-6143.2011.03827.x; Radtke A, 2009, WORLD J SURG, V33, P1941, DOI 10.1007/s00268-009-0128-x; Ramacciato G, 2006, TRANSPL INT, V19, P122, DOI 10.1111/j.1432-2277.2005.00248.x; Ryoo I, 2010, INVEST RADIOL, V45, P217, DOI 10.1097/RLI.0b013e3181d2eeb1; Saidi RF, 2012, HPB, V14, P455, DOI 10.1111/j.1477-2574.2012.00475.x; Schroeder T, 2005, LIVER TRANSPLANT, V11, P776, DOI 10.1002/lt.20429; Smadja C, 1994, SURG LIVER BILIARY T, P11; Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4; Wang SF, 2011, LIVER TRANSPLANT, V17, P1127, DOI 10.1002/lt.22381; Yaprak O, 2011, HEPATOB PANCREAT DIS, V10, P474, DOI 10.1016/S1499-3872(11)60081-7; Yazumi S, 2005, J GASTROENTEROL, V40, P861, DOI 10.1007/s00535-005-1698-5; Yuan YF, 2010, SURG TODAY, V40, P411, DOI 10.1007/s00595-009-4143-1	31	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113882	10.1371/journal.pone.0113882	http://dx.doi.org/10.1371/journal.pone.0113882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426932	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400093
J	Zhao, ZH; Liao, GX; Li, YQ; Zhou, SL; Zou, HQ; Fernando, S				Zhao, Zhihong; Liao, Guixiang; Li, Yongqiang; Zhou, Shulu; Zou, Hequn; Fernando, Samitha			Prognostic Value of Carbonic Anhydrase IX Immunohistochemical Expression in Renal Cell Carcinoma: A Meta-Analysis of the Literature	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTORS; INDEPENDENT PREDICTOR; INTERLEUKIN-2 THERAPY; GENE-EXPRESSION; POOR-PROGNOSIS; CANCER; TUMOR; SURVIVAL; TISSUE	Background: Carbonic anhydrase IX (CAIX) protein has been correlated with progression and survival in patients with renal cell carcinoma (RCC). The prognostic value of CAIX in RCC however, remains inconclusive according to published works. This study aimed to analyze CAIX as a biological marker to predict RCC patient prognosis. Methods: A literature search of the PubMed and Web of Knowledge databases was performed to retrieve original studies from their inception to December of 2013. Fifteen studies, collectively including a total of 2611 patients with renal cell carcinoma, were carefully reviewed. Standard meta-analysis methods were applied to evaluate the prognostic impact of CAIX expression on patient prognosis. The hazard ratio (HR) and its 95% confidence interval (CI) were recorded for the relationship between CAIX expression and survival, and the data were analyzed using Review Manager 5.2 software and Stata software 11.0. Results: In patients with RCC, low CAIX expression was associated with poor disease-specific survival (HR=1.89, 95% CI: 1.20-2.98, P=0.006), unfavorable progression-free survival (HR=2.62, 95% CI: 1.14-6.05, P=0.02) and worse overall survival (HR=2.03, 95% CI: 1.28-3.21, P=0.002). Furthermore, low CAIX expression was significantly associated with the presence of lymph node metastases (odds ratio (OR) =0.31, 95% CI=0.15-0.62, P=0.0009) and distant metastases (OR=0.66, 95% CI=0.46-0.96, P=0.03) and predicted a higher tumor grade (OR=0.41, 95% CI=0.31-0.54, P<0.00001). Conclusions: Low CAIX expression most likely indicates poor prognosis in RCC patients. Moreover, low CAIX expression was significantly associated with unfavorable clinicopathological factors. To strengthen our findings, further well-designed prospective studies should be conducted to investigate the role of CAIX expression in RCC.	[Zhao, Zhihong; Li, Yongqiang; Zhou, Shulu; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Inst Urol & Nephrol, Guangzhou, Guangdong, Peoples R China; [Liao, Guixiang] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Fernando, Samitha] Univ London Imperial Coll Sci Technol & Med, London, England	Southern Medical University - China; Southern Medical University - China; Imperial College London	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Inst Urol & Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022		Natural Science Foundation of China [81270840]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Natural Science Foundation of China grant (81270840) [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins M, 2005, CLIN CANCER RES, V11, P3714, DOI 10.1158/1078-0432.CCR-04-2019; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biswas S, 2012, CARCINOGENESIS, V33, P1717, DOI 10.1093/carcin/bgs222; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Cho D, 2007, CLIN GENITOURIN CANC, V5, P379, DOI 10.3816/CGC.2007.n.020; Choschzick M, 2011, VIRCHOWS ARCH, V459, P193, DOI 10.1007/s00428-011-1105-y; Choueiri TK, 2013, UROL ONCOL-SEMIN ORI, V31, P1788, DOI 10.1016/j.urolonc.2012.07.004; da Costa WH, 2014, BJU INT, V113, pE157, DOI 10.1111/bju.12426; Dahinden C, 2010, CLIN CANCER RES, V16, P88, DOI 10.1158/1078-0432.CCR-09-0260; de la Taille A, 2000, UROLOGY, V56, P393, DOI 10.1016/S0090-4295(00)00647-6; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Di Napoli A, 2009, CANCER-AM CANCER SOC, V115, P2290, DOI 10.1002/cncr.24233; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; Dornbusch J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076386; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; Dudek AZ, 2010, ANTICANCER RES, V30, P987; Eckel-Passow JE, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-48; Edeline J, 2012, HUM PATHOL, V43, P1982, DOI 10.1016/j.humpath.2012.01.023; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Garcia-Donas J, 2013, ANN ONCOL, V24, P2409, DOI 10.1093/annonc/mdt219; Gigante M, 2012, ANTICANCER RES, V32, P5447; Gilbert SM, 2006, UROLOGY, V67, P942, DOI 10.1016/j.urology.2005.11.034; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; Gore ME, 2011, BRIT J CANCER, V104, P399, DOI 10.1038/sj.bjc.6606084; Ilie M, 2013, LUNG CANCER, V82, P16, DOI 10.1016/j.lungcan.2013.07.005; Jensen HK, 2008, BJU INT, V101, P41, DOI 10.1111/j.1464-410X.2008.07649.x; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Joseph RW, 2014, CANCER-AM CANCER SOC, V120, P1059, DOI 10.1002/cncr.28521; Kim HL, 2005, J UROLOGY, V173, P1496, DOI 10.1097/01.ju.0000154351.37249.f0; Kim HL, 2004, CLIN CANCER RES, V10, P5464, DOI 10.1158/1078-0432.CCR-04-0488; Kim HS, 2010, UROL ONCOL-SEMIN ORI, V28, P157, DOI 10.1016/j.urolonc.2008.08.002; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Klatte T, 2009, CLIN CANCER RES, V15, P1162, DOI 10.1158/1078-0432.CCR-08-1229; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Klatte T, 2009, CANCER EPIDEM BIOMAR, V18, P894, DOI 10.1158/1055-9965.EPI-08-0786; Koul H, 2011, AM J CANCER RES, V1, P240; Krieg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065338; Kroeger N, 2012, EUR UROL, V61, P888, DOI 10.1016/j.eururo.2012.01.012; Lam JS, 2005, CANCER-AM CANCER SOC, V103, P2517, DOI 10.1002/cncr.21127; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Li GR, 2008, J UROLOGY, V180, P510, DOI 10.1016/j.juro.2008.04.024; Li GR, 2007, CLIN EXP METASTAS, V24, P149, DOI 10.1007/s10585-007-9064-z; Maroto P, 2014, CLIN CANC RES; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Mocellin S, 2008, INT J CANCER, V123, P2370, DOI 10.1002/ijc.23794; Lopez CM, 2012, CLIN GENITOURIN CANC, V10, P262, DOI 10.1016/j.clgc.2012.06.005; Lopez CM, 2012, INVEST NEW DRUG, V30, P2443, DOI 10.1007/s10637-012-9836-4; Papworth K, 2010, ANTICANCER RES, V30, P2953; Parker AS, 2009, CANCER-AM CANCER SOC, V115, P2092, DOI 10.1002/cncr.24263; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Pena C, 2010, CLIN CANCER RES, V16, P4853, DOI 10.1158/1078-0432.CCR-09-3343; Phuoc NB, 2008, ONCOL REP, V20, P525, DOI 10.3892/or_00000037; Potter C, 2004, CELL CYCLE, V3, P164; Rasmussen S, 2013, IMMUNOPHARM IMMUNOT, V35, P487, DOI 10.3109/08923973.2013.802802; Sandlund J, 2007, BJU INT, V100, P556, DOI 10.1111/j.1464-410X.2007.07006.x; Shvarts O, 2005, J UROLOGY, V173, P725, DOI 10.1097/01.ju.0000152354.08057.2a; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Signoretti S, 2008, BJU INT, V101, P31, DOI 10.1111/j.1464-410X.2008.07646.x; Sim SH, 2012, BRIT J CANCER, V107, P1131, DOI 10.1038/bjc.2012.360; Soyupak B, 2005, UROL INT, V74, P68, DOI 10.1159/000082713; Takacova M, 2013, ONCOL LETT, V5, P191, DOI 10.3892/ol.2012.1001; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Tripodi SA, 2004, J ENZYM INHIB MED CH, V19, P287, DOI 10.1080/14756360410001689531; Xing XB, 2013, INT J CANCER, V132, P2589, DOI 10.1002/ijc.27947; Xu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009625; Yu WJ, 2013, ACTA HISTOCHEM, V115, P452, DOI 10.1016/j.acthis.2012.10.009; Zerati M, 2013, INT BRAZ J UROL, V39, P484, DOI 10.1590/S1677-5538.IBJU.2013.04.05; Zhang BY, 2013, BJU INT, V111, P1046, DOI 10.1111/bju.12075; Zhang YH, 2013, J SURG ONCOL, V108, P414, DOI 10.1002/jso.23402; Zhou GX, 2010, UROLOGY, V75, P257, DOI 10.1016/j.urology.2009.09.052	75	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114096	10.1371/journal.pone.0114096	http://dx.doi.org/10.1371/journal.pone.0114096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426861	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400113
J	Zupanc, J; Drasler, B; Boljte, S; Kralj-Iglic, V; Iglic, A; Erdogmus, D; Drobne, D				Zupanc, Jernej; Drasler, Barbara; Boljte, Sabina; Kralj-Iglic, Veronika; Iglic, Ales; Erdogmus, Deniz; Drobne, Damjana			Lipid Vesicle Shape Analysis from Populations Using Light Video Microscopy and Computer Vision	PLOS ONE			English	Article							GIANT PHOSPHOLIPID-VESICLES; STRUCTURAL-PROPERTIES; LIPOSOMES; DYNAMICS; MODEL; FIELD	We present a method for giant lipid vesicle shape analysis that combines manually guided large-scale video microscopy and computer vision algorithms to enable analyzing vesicle populations. The method retains the benefits of light microscopy and enables non-destructive analysis of vesicles from suspensions containing up to several thousands of lipid vesicles (1-50 mu m in diameter). For each sample, image analysis was employed to extract data on vesicle quantity and size distributions of their projected diameters and isoperimetric quotients (measure of contour roundness). This process enables a comparison of samples from the same population over time, or the comparison of a treated population to a control. Although vesicles in suspensions are heterogeneous in sizes and shapes and have distinctively non-homogeneous distribution throughout the suspension, this method allows for the capture and analysis of repeatable vesicle samples that are representative of the population inspected.	[Zupanc, Jernej] Seyens Ltd, Ljubljana, Slovenia; [Zupanc, Jernej; Drasler, Barbara; Boljte, Sabina; Drobne, Damjana] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Kralj-Iglic, Veronika] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia; [Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia; [Erdogmus, Deniz] Northeastern Univ, Boston, MA 02115 USA	University of Ljubljana; University of Ljubljana; University of Ljubljana; Northeastern University	Zupanc, J (corresponding author), Seyens Ltd, Ljubljana, Slovenia.	jernej.zupanc@seyens.com	Erdogmus, Deniz/A-8170-2009; Drasler, Barbara/P-7985-2018	Drasler, Barbara/0000-0001-5206-8136; Kralj-Iglic, Veronika/0000-0002-7496-2005	Slovenian Research Agency [J1-4109, BI-US/13-14/023]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by J1-4109 (Research project funded by the Slovenian Research Agency www.arrs.gov.si), and BI-US/13-14/023 (Bilateral project funded by the Slovenian Research Agency www.arrs.gov.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bibi S, 2011, INT J PHARMACEUT, V417, P138, DOI 10.1016/j.ijpharm.2010.12.021; Chen CX, 2013, ANAL METHODS-UK, V5, P2150, DOI 10.1039/c3ay40219c; Chow SK, 2006, J MICROSC-OXFORD, V222, P76, DOI 10.1111/j.1365-2818.2006.01577.x; Diguet A, 2012, J AM CHEM SOC, V134, P4898, DOI 10.1021/ja211664f; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Dimova R, 2014, ADV COLLOID INTERFAC, V208, P225, DOI 10.1016/j.cis.2014.03.003; Dua JS., 2012, INT J PHARM STUD RES, V3, P14; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Fa N, 2007, BBA-BIOMEMBRANES, V1768, P1830, DOI 10.1016/j.bbamem.2007.04.013; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; Hermann E, 2014, BIOINFORMATICS; Jalmar O, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.81; Kralj-Iglic V, 2002, PHYS LETT A, V296, P151, DOI 10.1016/S0375-9601(02)00265-7; Kralj-Iglic V, 2001, COLLOID SURFACE A, V181, P315, DOI 10.1016/S0927-7757(00)00802-5; Ma B, 2007, MICRON, V38, P492, DOI 10.1016/j.micron.2006.07.027; MACEACHREN AM, 1985, GEOGR ANN B, V67, P53, DOI 10.2307/490799; Mavcic B, 2004, BIOELECTROCHEMISTRY, V63, P183, DOI 10.1016/j.bioelechem.2003.09.022; Menger FM, 1998, CURR OPIN CHEM BIOL, V2, P726, DOI 10.1016/S1367-5931(98)80110-5; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Morita M, 2010, BIOPHYS CHEM, V147, P81, DOI 10.1016/j.bpc.2009.12.004; Mura S, 2008, COLLOID SURFACE A, V323, P175, DOI 10.1016/j.colsurfa.2007.09.036; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Pecreaux J, 2004, EUR PHYS J E, V13, P277, DOI 10.1140/epje/i2004-10001-9; Peetla C, 2009, MOL PHARMACEUT, V6, P1264, DOI 10.1021/mp9000662; Pencer J, 2001, BIOPHYS J, V81, P2716, DOI 10.1016/S0006-3495(01)75914-0; Piccinini F, 2013, J MICROSC-OXFORD, V252, P226, DOI 10.1111/jmi.12084; Sato K, 2006, J BIOSCI BIOENG, V102, P171, DOI 10.1263/jbb.102.171; Takahashi T, 2013, TOXINS, V5, P637, DOI 10.3390/toxins5040637; Tomita T, 2011, LANGMUIR, V27, P10106, DOI 10.1021/la2018456; Umalkar DG, 2011, PHARM SCI MONITOR, V2; Usenik P, 2011, MED BIOL ENG COMPUT, V49, P957, DOI 10.1007/s11517-011-0789-0; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Westerhausen C, 2012, BIOPHYS J, V102, P1032, DOI 10.1016/j.bpj.2011.12.004; Zupanc J, 2012, CARBON, V50, P1170, DOI 10.1016/j.carbon.2011.10.030; Zupanc J, 2011, J LIPOSOME RES, V21, P315, DOI 10.3109/08982104.2011.573794; Zupanc J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533319	38	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113405	10.1371/journal.pone.0113405	http://dx.doi.org/10.1371/journal.pone.0113405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426933	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400048
J	Guo, HC; Yan, D; Wei, YQ; Han, SC; Qian, HS; Yang, YS; Zhang, YP; Liu, XT; Sun, SQ				Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Qian, Haisheng; Yang, Yunshang; Zhang, Yingpeng; Liu, Xiangtao; Sun, Shiqi			Inhibition of Murine Bladder Cancer Cell Growth In Vitro by Photocontrollable siRNA Based on Upconversion Fluorescent Nanoparticles	PLOS ONE			English	Article							RNA INTERFERENCE; PHOTODYNAMIC THERAPY; CAGED SIRNAS	This study provides a unique approach to activate caged small interfering RNAs (siRNAs) using indirect UV light emitted by the near-infrared (NIR)-to-UV upconversion process to achieve high spatial and temporal gene interference patterns. siRNA molecules against the anti-apoptotic gene survivin was caged by light-sensitive molecules (4,5-dimethoxy-2-nitroacetophenone, DMNPE), which rendered them temporarily non-functional. NIR-to-UV NaYF4:Yb, Tm upconversion nanoparticles (UCPs) served as delivery vehicles and activators of the caged siRNA molecules in murine bladder cancer cells (MB49 cell line). Upconverted UV light at 355 nm was emitted from the NIR-irradiated UCPs, which well coincided with the wavelength needed to uncage DMNPE. Consequently, UV light acted as a switch to uncage the delivered siRNA molecule, thereby rendering fully functional for exerting its therapeutic effect in the bladder cancer cells. To achieve the highest RNA interference efficiency, conditions such as time after cellular uptake, excitation time, UCPs concentration and laser power were optimized. Results showed that 200 mu g/mL nanoparticle concentration combined with 12 h incubation with MB49 cells and excitation with NIR laser at 100 mW power for 15 min provided the ideal interference efficiency and strongest induction of MB49 cell death. Our findings demonstrate the potential biological application of UCPs in treating bladder cancer by a novel therapeutic approach.	[Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Liu, Xiangtao; Sun, Shiqi] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Minist Agr, Lanzhou 730046, Gansu, Peoples R China; [Guo, Huichen; Yan, Dan; Wei, Yanquan; Han, Shichong; Liu, Xiangtao; Sun, Shiqi] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Anim Virol, Minist Agr, Lanzhou 730046, Gansu, Peoples R China; [Qian, Haisheng] Hefei Univ Technol, Sch Med Engn, Hefei 230009, Peoples R China; [Yang, Yunshang; Zhang, Yingpeng] Lanzhou Univ Technol, Sch Petrochem Engn, Lanzhou 730050, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hefei University of Technology; Lanzhou University of Technology	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Minist Agr, Xujiaping 1, Lanzhou 730046, Gansu, Peoples R China.	sunshiqi@caas.cn	Qian, Haisheng/E-3328-2013; Yang, Yun-Shang/AAA-8406-2020	Qian, Haisheng/0000-0003-4903-3447; 	National Natural Science Foundation of China [31100688, 21471043]; International Science & Technology Cooperation Program of China [2014DFA31890]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2013KFKT010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences	This research was supported in part by grants from the National Natural Science Foundation of China (No. 31100688, No. 21471043), International Science & Technology Cooperation Program of China (No. 2014DFA31890), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (SKLVEB2013KFKT010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebi M, 2012, MED PRIN PRACT, V21, P295, DOI 10.1159/000334811; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; Blidner RA, 2008, MOL BIOSYST, V4, P431, DOI 10.1039/b801532e; Casey JP, 2009, MOL PHARMACEUT, V6, P669, DOI 10.1021/mp900082q; Chang H, 2007, CANCER GENE THER, V14, P677, DOI 10.1038/sj.cgt.7701063; Chatterjee DK, 2008, NANOMEDICINE-UK, V3, P73, DOI 10.2217/17435889.3.1.73; Guo HC, 2011, LANGMUIR, V27, P2854, DOI 10.1021/la102872v; Guo HC, 2010, NANOMED-NANOTECHNOL, V6, P486, DOI 10.1016/j.nano.2009.11.004; Hou JQ, 2006, CHINESE MED J-PEKING, V119, P1118, DOI 10.1097/00029330-200607010-00012; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Liu G, 2007, HISTOL HISTOPATHOL, V22, P211, DOI 10.14670/HH-22.211; Mikat V, 2007, RNA, V13, P2341, DOI 10.1261/rna.753407; Ning S, 2004, INT J ONCOL, V25, P1065; Qian HS, 2009, SMALL, V5, P2285, DOI 10.1002/smll.200900692; Shah S, 2009, NUCLEIC ACIDS RES, V37, P4508, DOI 10.1093/nar/gkp415; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Soukka T, 2008, ANN NY ACAD SCI, V1130, P188, DOI 10.1196/annals.1430.027; Wang Xiao-Lin, 2008, Ai Zheng, V27, P253	19	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112713	10.1371/journal.pone.0112713	http://dx.doi.org/10.1371/journal.pone.0112713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423032	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700013
J	Singh, VK; Wise, SY; Fatanmi, OO; Scott, J; Romaine, PLP; Newman, VL; Verma, A; Elliott, TB; Seed, TM				Singh, Vijay K.; Wise, Stephen Y.; Fatanmi, Oluseyi O.; Scott, Jessica; Romaine, Patricia L. P.; Newman, Victoria L.; Verma, Amit; Elliott, Thomas B.; Seed, Thomas M.			Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure	PLOS ONE			English	Article							INDUCED GASTROINTESTINAL INJURY; ALPHA-TOCOPHEROL SUCCINATE; COLONY-STIMULATING FACTOR; TOTAL-BODY IRRADIATION; VITAMIN-E; BACTERIAL TRANSLOCATION; ABDOMINAL RADIATION; HEMATOPOIETIC STEM; DELTA-TOCOTRIENOL; RADIOPROTECTIVE EFFICACY	The purpose of this study was to elucidate the role of gamma-tocotrienol (GT3)-mobilized progenitors in mitigating damage to mice exposed to a supralethal dose of cobalt-60 gamma-radiation. CD2F1 mice were transfused 24 h post-irradiation with whole blood or isolated peripheral blood mononuclear cells (PBMC) from donors that had received GT3 72 h prior to blood collection and recipient mice were monitored for 30 days. To understand the role of GT3-induced granulocyte colony-stimulating factor (G-CSF) in mobilizing progenitors, donor mice were administered a neutralizing antibody specific to G-CSF or its isotype before blood collection. Bacterial translocation from gut to heart, spleen and liver of irradiated recipient mice was evaluated by bacterial culture on enriched and selective agar media. Endotoxin in serum samples also was measured. We also analyzed the colony-forming units in the spleens of irradiated mice. Our results demonstrate that whole blood or PBMC from GT3-administered mice mitigated radiation injury when administered 24 h post-irradiation. Furthermore, administration of a G-CSF antibody to GT3-injected mice abrogated the efficacy of blood or PBMC obtained from such donors. Additionally, GT3-mobilized PBMC inhibited the translocation of intestinal bacteria to the heart, spleen, and liver, and increased colony forming unit-spleen (CFU-S) numbers in irradiated mice. Our data suggests that GT3 induces G-CSF, which mobilizes progenitors and these progenitors mitigate radiation injury in recipient mice. This approach using mobilized progenitor cells from GT3-injected donors could be a potential treatment for humans exposed to high doses of radiation.	[Singh, Vijay K.; Wise, Stephen Y.; Fatanmi, Oluseyi O.; Scott, Jessica; Romaine, Patricia L. P.; Newman, Victoria L.; Verma, Amit; Elliott, Thomas B.] Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA; [Singh, Vijay K.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiat Biol, Bethesda, MD 20814 USA; [Seed, Thomas M.] Tech Micro Serv, Bethesda, MD USA	United States Department of Defense; Uniformed Services University of the Health Sciences - USA	Singh, VK (corresponding author), Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA.	vijay.singh@usuhs.edu	Singh, Vijay/GWZ-8972-2022	Singh, Vijay/0000-0002-6631-3849; FATANMI, OLUSEYI/0000-0002-7942-2497	Armed Forces Radiobiology Research Institute [RBB2GQ, RAB2HD]	Armed Forces Radiobiology Research Institute	This work was supported by intramural research funding from the Armed Forces Radiobiology Research Institute grant # RBB2GQ and RAB2HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	BARANOV AE, 1995, STEM CELLS, V13, P69; Berbee M, 2012, CURR OPIN SUPPORT PA, V6, P54, DOI 10.1097/SPC.0b013e32834e3bd7; Berbee M, 2011, INT J RADIAT ONCOL, V79, P884, DOI 10.1016/j.ijrobp.2010.08.032; Berbee M, 2009, RADIAT RES, V171, P596, DOI 10.1667/RR1632.1; Brook I, 2004, MIL MED, V169, P194, DOI 10.7205/MILMED.169.3.194; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Carter AB, 2007, WASH QUART, V30, P19, DOI 10.1162/wash.2007.30.4.19; Chun H, 1997, J GASTROENTEROL, V32, P189, DOI 10.1007/BF02936366; Fushiki S, 2013, BRAIN DEV-JPN, V35, P220, DOI 10.1016/j.braindev.2012.09.004; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; GUZMANSTEIN G, 1989, J SURG RES, V46, P104, DOI 10.1016/0022-4804(89)90211-4; Hall EJ, 2006, RADIOBIOLOGY RADIBIO; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; International Standardization Organization and ASTM International, 2013, STAND PRACT US AL EP, P7; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kulkarni S, 2013, CYTOKINE, V62, P278, DOI 10.1016/j.cyto.2013.03.009; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; Li XH, 2013, RADIAT RES, V180, P649, DOI 10.1667/RR13398.1; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Nagy V, 2000, APPL RADIAT ISOTOPES, V52, P1039, DOI 10.1016/S0969-8043(00)00052-X; National Research Council of the National Academy of Sciences, 2011, GUIDE CARE USE LAB A; Nesaretnam K, 2008, CANCER LETT, V269, P388, DOI 10.1016/j.canlet.2008.03.063; Ohnishi T, 2012, RADIAT RES, V177, P1, DOI 10.1667/RR2830.1; Packer L, 1991, AM J CLIN NUTR, V53; Palozza P, 2008, FREE RADICAL BIO MED, V44, P1452, DOI 10.1016/j.freeradbiomed.2008.01.001; Palozza P, 2006, MOL CELL BIOCHEM, V287, P21, DOI 10.1007/s11010-005-9020-7; Papas A., 1999, VITAMIN FACTOR; PEARCE BC, 1994, J MED CHEM, V37, P526, DOI 10.1021/jm00030a012; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Pulliam AC, 2008, EXP HEMATOL, V36, P1084, DOI 10.1016/j.exphem.2008.03.016; Ray S, 2013, INT IMMUNOPHARMACOL, V15, P557, DOI 10.1016/j.intimp.2012.12.034; Schimpl G, 1997, EUR SURG RES, V29, P187, DOI 10.1159/000129523; Seed TM, 2005, HEALTH PHYS, V89, P531, DOI 10.1097/01.HP.0000175153.19745.25; Seed TM, 2003, PHYS GUIDE TERRORIST, P339; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Singh PK, 2012, RADIAT RES, V177, P133, DOI 10.1667/RR2627.1; Singh V., 2012, MICCAI WSHP SPARS TE, P1; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Singh VK, 2014, LIFE SCI, V98, P113, DOI 10.1016/j.lfs.2014.01.065; Singh VK, 2013, J RADIAT RES, V54, P973, DOI 10.1093/jrr/rrt048; Singh VK, 2013, INT J RADIAT BIOL, V89, P334, DOI 10.3109/09553002.2013.762137; Singh VK, 2012, EXP HEMATOL, V40, P407, DOI 10.1016/j.exphem.2012.01.005; Singh VK, 2012, INT J RADIAT BIOL, V88, P296, DOI 10.3109/09553002.2012.652726; Singh VK, 2011, INT J RADIAT ONCOL, V79, P571, DOI 10.1016/j.ijrobp.2010.08.019; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Singh VK, 2010, EXP HEMATOL, V38, P61, DOI 10.1016/j.exphem.2009.10.008; Singh VK, 2014, RAD PROT DO IN PRESS; Singh VK, 2015, CYTOKINE, V71, P22; SOUBA WW, 1990, J SURG RES, V48, P1, DOI 10.1016/0022-4804(90)90136-P; Uy GL, 2008, EXPERT OPIN BIOL TH, V8, P1797, DOI 10.1517/14712598.8.11.1797 ; Weaver CH, 2001, BONE MARROW TRANSPL, V27, pS23, DOI 10.1038/sj.bmt.1702865; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144	55	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114078	10.1371/journal.pone.0114078	http://dx.doi.org/10.1371/journal.pone.0114078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423021	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700085
J	Cassone, BJ; Carter, FMC; Michel, AP; Stewart, LR; Redinbaugh, MG				Cassone, Bryan J.; Carter, Fiorella M. Cisneros; Michel, Andrew P.; Stewart, Lucy R.; Redinbaugh, Margaret G.			Genetic Insights into Graminella nigrifrons Competence for Maize fine streak virus Infection and Transmission	PLOS ONE			English	Article							MOSAIC-VIRUS; INSECT VECTOR; INTRACELLULAR-TRANSPORT; POPULATION-GENETICS; MOVEMENT PROTEIN; DWARF-VIRUS; PLANT; LEAFHOPPER; RHABDOVIRUS; PLANTHOPPER	Background: Most plant-infecting rhabdoviruses are transmitted by one or a few closely related insect species. Additionally, intraspecific differences in transmission efficacy often exist among races/biotypes within vector species and among strains within a virus species. The black-faced leafhopper, Graminella nigrifrons, is the only known vector of the persistent propagative rhabdovirus Maize fine streak virus (MFSV). Only a small percentage of leafhoppers are capable of transmitting the virus, although the mechanisms underlying vector competence are not well understood. Methodology: RNA-Seq was carried out to explore transcript expression changes and sequence variation in G. nigrifrons and MFSV that may be associated with the ability of the vector to acquire and transmit the virus. RT-qPCR assays were used to validate differential transcript accumulation. Results/Significance: Feeding on MFSV-infected maize elicited a considerable transcriptional response in G. nigrifrons, with increased expression of cytoskeleton organization and immunity transcripts in infected leafhoppers. Differences between leafhoppers capable of transmitting MFSV, relative to non-transmitting but infected leafhoppers were more limited, which may reflect difficulties discerning between the two groups and/or the likelihood that the transmitter phenotype results from one or few genetic differences. The ability of infected leafhoppers to transmit MFSV did not appear associated with virus transcript accumulation in the infected leafhoppers or sequence polymorphisms in the viral genome. However, the non-structural MFSV 3 gene was expressed at unexpectedly high levels in infected leafhoppers, suggesting it plays an active role in the infection of the insect host. The results of this study begin to define the functional roles of specific G. nigrifrons and MFSV genes in the viral transmission process.	[Cassone, Bryan J.; Stewart, Lucy R.; Redinbaugh, Margaret G.] ARS, USDA, Corn Soybean & Wheat Qual Res Unit, OARDC, Wooster, OH 44691 USA; [Carter, Fiorella M. Cisneros; Stewart, Lucy R.; Redinbaugh, Margaret G.] Ohio State Univ, Dept Plant Pathol, OARDC, Wooster, OH 44691 USA; [Michel, Andrew P.] Ohio State Univ, Dept Entomol, OARDC, Wooster, OH 44691 USA	United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Redinbaugh, MG (corresponding author), ARS, USDA, Corn Soybean & Wheat Qual Res Unit, OARDC, Wooster, OH 44691 USA.	peg.redinbaugh@ars.usda.gov	Redinbaugh, Margaret/A-3611-2013		USDA-ARS; Ohio State University, Ohio Agriculture Research and Development Center; ARS [ARS-0423065] Funding Source: Federal RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Ohio State University, Ohio Agriculture Research and Development Center(Ohio State University); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by the USDA-ARS and the Ohio State University, Ohio Agriculture Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; Ammar ED, 2002, ADV BOT RES, V36, P141, DOI 10.1016/S0065-2296(02)36062-2; Ammar El Desouky, 1994, Advances in Disease Vector Research, V10, P289; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Ammar ED, 2008, VIRUS RES, V131, P77, DOI 10.1016/j.virusres.2007.08.010; Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13; BANERJEE AK, 1987, MICROBIOL REV, V51, P66, DOI 10.1128/MMBR.51.1.66-87.1987; Bangham J, 2007, P ROY SOC B-BIOL SCI, V274, P2027, DOI 10.1098/rspb.2007.0611; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Baton LA, 2008, INSECT SCI, V15, P15, DOI 10.1111/j.1744-7917.2008.00184.x; Boutte Y, 2007, CELL BIOL INT, V31, P649, DOI 10.1016/j.cellbi.2007.01.006; Cassone BJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-133; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040613; CIAMPOR F, 1988, ACTA VIROL, V32, P168; CONTI M, 1980, ANN APPL BIOL, V95, P83, DOI 10.1111/j.1744-7348.1980.tb03973.x; Creamer R, 1997, PLANT DIS, V81, P63, DOI 10.1094/PDIS.1997.81.1.63; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; FALK BW, 1985, PHYTOPATHOLOGY, V75, P852, DOI 10.1094/Phyto-75-852; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingery RE, 2004, J ECON ENTOMOL, V97, P768, DOI 10.1603/0022-0493(2004)097[0768:EOECAL]2.0.CO;2; Goodin MM, 2007, J GEN VIROL, V88, P1810, DOI 10.1099/vir.0.82698-0; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Gray SM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2501; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YW, 2005, J VIROL, V79, P2108, DOI 10.1128/JVI.79.4.2108-2114.2005; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Komarova AV, 2007, NUCLEIC ACIDS RES, V35, P1522, DOI 10.1093/nar/gkl1127; KRAMER JP, 1967, ANN ENTOMOL SOC AM, V60, P604, DOI 10.1093/aesa/60.3.604; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Magwire MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002337; Massah A., 2005, Iranian Journal of Plant Pathology, V41, P151; Melcher U, 2000, J GEN VIROL, V81, P257, DOI 10.1099/0022-1317-81-1-257; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moshe A, 2012, VIRUSES-BASEL, V4, P2218, DOI 10.3390/v4102218; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; NAULT LR, 1989, ANNU REV ENTOMOL, V34, P503, DOI 10.1146/annurev.en.34.010189.002443; Oksayan Sibil, 2012, Infectious Disorders - Drug Targets, V12, P38; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Power AG, 1995, APHID TRANSMISSION B; Redinbaugh MG, 2002, PHYTOPATHOLOGY, V92, P1167, DOI 10.1094/PHYTO.2002.92.11.1167; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roossinck MJ, 2006, MUTANT CLOUDS OCCUPA; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; SCHOLTHOF KBG, 1994, VIROLOGY, V204, P279, DOI 10.1006/viro.1994.1532; STONER WN, 1967, ANN ENTOMOL SOC AM, V60, P496, DOI 10.1093/aesa/60.3.496; Sylvester E.S., 1992, Advances in Disease Vector Research, V9, P313; Tilsner J, 2012, PLANT PHYSIOL, V158, P1359, DOI 10.1104/pp.111.189605; Todd JC, 2010, PHYTOPATHOLOGY, V100, P1138, DOI 10.1094/PHYTO-05-10-0144; Tsai CW, 2005, J VIROL, V79, P5304, DOI 10.1128/JVI.79.9.5304-5314.2005; Varki A, 2009, ESSENTIALS GLYCOBIOL, P57; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Walker PJ, 2011, VIRUS RES, V162, P110, DOI 10.1016/j.virusres.2011.09.004; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wayne ML, 1996, MOL BIOL EVOL, V13, P191, DOI 10.1093/oxfordjournals.molbev.a025555; Wei TY, 2006, J VIROL, V80, P8593, DOI 10.1128/JVI.00537-06; Wei TY, 2009, J VIROL, V83, P10830, DOI 10.1128/JVI.01067-09; Whitfield AE, 2011, INSECT MOL BIOL, V20, P225, DOI 10.1111/j.1365-2583.2010.01060.x; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238	71	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113529	10.1371/journal.pone.0113529	http://dx.doi.org/10.1371/journal.pone.0113529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420026	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900047
J	Glatthorn, J; Beckschafer, P				Glatthorn, Jonas; Beckschaefer, Philip			Standardizing the Protocol for Hemispherical Photographs: Accuracy Assessment of Binarization Algorithms	PLOS ONE			English	Article							LEAF-AREA INDEX; CANOPY-PHOTOGRAPHS; METHODOLOGY; CONVERSION; EXPOSURE; STANDS; FILM	Hemispherical photography is a well-established method to optically assess ecological parameters related to plant canopies; e.g. ground-level light regimes and the distribution of foliage within the crown space. Interpreting hemispherical photographs involves classifying pixels as either sky or vegetation. A wide range of automatic thresholding or binarization algorithms exists to classify the photographs. The variety in methodology hampers ability to compare results across studies. To identify an optimal threshold selection method, this study assessed the accuracy of seven binarization methods implemented in software currently available for the processing of hemispherical photographs. Therefore, binarizations obtained by the algorithms were compared to reference data generated through a manual binarization of a stratified random selection of pixels. This approach was adopted from the accuracy assessment of map classifications known from remote sensing studies. Percentage correct ((P) over cap (c)) and kappa-statistics ((K) over cap) were calculated. The accuracy of the algorithms was assessed for photographs taken with automatic exposure settings (auto-exposure) and photographs taken with settings which avoid overexposure (histogram-exposure). In addition, gap fraction values derived from hemispherical photographs were compared with estimates derived from the manually classified reference pixels. All tested algorithms were shown to be sensitive to overexposure. Three of the algorithms showed an accuracy which was high enough to be recommended for the processing of histogram-exposed hemispherical photographs: "Minimum'' ((P) over cap (c) 98.8%; (K) over cap 0.952), "Edge Detection'' ((P) over cap (c) 98.1%; (K) over cap 0.950), and "Minimum Histogram'' ((P) over cap (c) 98.1%; (K) over cap 0.947). The Minimum algorithm overestimated gap fraction least of all (11%). The overestimation by the algorithms Edge Detection (63%) and Minimum Histogram (67%) were considerably larger. For the remaining four evaluated algorithms (IsoData, Maximum Entropy, MinError, and Otsu) an incompatibility with photographs containing overexposed pixels was detected. When applied to histogram-exposed photographs, these algorithms overestimated the gap fraction by at least 180%.	[Glatthorn, Jonas] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Ecol, D-37073 Gottingen, Germany; [Beckschaefer, Philip] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Glatthorn, J (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Ecol, D-37073 Gottingen, Germany.	jglatth@gwdg.de	Glatthorn, Jonas/R-9802-2016	Glatthorn, Jonas/0000-0002-7019-1899; Beckschafer, Philip/0000-0003-1728-724X	Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ); German Ministry for Economic Cooperation (BMZ) [08.7860.3-001.00]	Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ); German Ministry for Economic Cooperation (BMZ)	The authors' thanks are due to the Advisory Group on International Agricultural Research (BEAF) at the German Agency for International Cooperation (GIZ) and the German Ministry for Economic Cooperation (BMZ) for funding the research project MMC ("Making the Mekong Connected", Project No. 08.7860.3-001.00) within which this study had been carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors	[Anonymous], 1999, IMAGING SOFTWARE EXT; Barney Smith EH, 2010, ANAL BINARIZATION GR, P27; Beaudet M, 2002, AGR FOREST METEOROL, V110, P217, DOI 10.1016/S0168-1923(01)00289-1; Beckschafer P, 2013, IFOREST, V6, P228, DOI [10.3832/ifor0957-006, 10.3832/ifor0968-006]; Cescatti A, 2007, AGR FOREST METEOROL, V143, P1, DOI 10.1016/j.agrformet.2006.04.009; CHEN JM, 1991, AGR FOREST METEOROL, V56, P129, DOI 10.1016/0168-1923(91)90108-3; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Comber A, 2005, INT J APPL EARTH OBS, V7, P189, DOI 10.1016/j.jag.2005.02.001; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; Englund SR, 2000, CAN J FOREST RES, V30, P1999, DOI 10.1139/cjfr-30-12-1999; Frazer G.W., 1997, METHOD ESTIMATING CA; Gonzalez Tagle M. A., 2011, Forstarchiv, V82, P20; Hale SE, 2002, AGR FOREST METEOROL, V112, P51, DOI 10.1016/S0168-1923(02)00042-4; Inoue A, 2004, AGR FOREST METEOROL, V126, P89, DOI 10.1016/j.agrformet.2004.06.002; Inoue A., 2011, Journal of Forest Science (Prague), V57, P78, DOI 10.17221/68/2010-JFS; Ishida M, 2004, CAN J FOREST RES, V34, P2208, DOI 10.1139/X04-103; Jarcuska B., 2010, Journal of Forest Science (Prague), V56, P147, DOI 10.17221/76/2009-JFS; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jonckheere I, 2005, AGR FOREST METEOROL, V132, P96, DOI 10.1016/j.agrformet.2005.06.003; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kato S, 2000, J FOREST RES, V5, P109, DOI [10.1007/BF02762529, DOI 10.1007/BF02762529]; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Macfarlane C, 2011, AGR FOREST METEOROL, V151, P833, DOI 10.1016/j.agrformet.2011.01.019; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Nobis M., 2005, SIDELOOK 1 1 IMAGING; Ntirogiannis K, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P217, DOI 10.1109/DAS.2008.41; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; OLSSON L, 1982, CAN J FOREST RES, V12, P822, DOI 10.1139/x82-123; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park E, 2009, KOREAN J LAB MED, V29, P1, DOI 10.3343/kjlm.2009.29.1.1; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2014, IMAGEJ; RICH PM, 1989, MANUAL ANAL HEMISPHE; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Ryu Y, 2010, AGR FOREST METEOROL, V150, P463, DOI 10.1016/j.agrformet.2010.01.009; Schroder J, 2007, EUR J FOREST RES, V126, P459, DOI 10.1007/s10342-006-0167-x; Schwalbe E, 2009, PHOTOGRAMM ENG REM S, V75, P375, DOI 10.14358/PERS.75.4.375; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; van Gardingen PR, 1999, AGR FOREST METEOROL, V94, P243, DOI 10.1016/S0168-1923(99)00018-0; Wagner S., 2004, Forstarchiv, V75, P110; Wagner S, 1998, AGR FOREST METEOROL, V90, P103, DOI 10.1016/S0168-1923(97)00073-7; Wagner S, 1994, THESIS U GOTTINGEN G; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Yamamoto K, 2004, LIA WIN32 LIA32 DIGI; Zhang YQ, 2005, AGR FOREST METEOROL, V133, P166, DOI 10.1016/j.agrformet.2005.09.009	47	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e111924	10.1371/journal.pone.0111924	http://dx.doi.org/10.1371/journal.pone.0111924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420014	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900004
J	Brand, J; Kopke, S; Kasper, J; Rahn, A; Backhus, I; Poettgen, J; Stellmann, JP; Siemonsen, S; Heesen, C				Brand, Judith; Koepke, Sascha; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Siemonsen, Susanne; Heesen, Christoph			Magnetic Resonance Imaging in Multiple Sclerosis - Patients' Experiences, Information Interests and Responses to an Education Programme	PLOS ONE			English	Article							PREFERENCES; CHALLENGE; ACCURACY	Background: Magnetic resonance imaging (MRI) is a key diagnostic and monitoring tool in multiple sclerosis (MS) management. However, many scientific uncertainties, especially concerning correlates to impairment and prognosis remain. Little is known about MS patients' experiences, knowledge, attitudes, and unmet information needs concerning MRI. Methods: We performed qualitative interviews (n=5) and a survey (n=104) with MS patients regarding MRI patient information, and basic MRI knowledge. Based on these findings an interactive training program of 2 hours was developed and piloted in n=26 patients. Results: Interview analyses showed that patients often feel lost in the MRI scanner and left alone with MRI results and images while 90% of patients in the survey expressed a high interest in MRI education. Knowledge on MRI issues was fair with some important knowledge gaps. Major information interests were relevance of lesions as well as the prognostic and diagnostic value of MRI results. The education program was highly appreciated and resulted in a substantial knowledge increase. Patients reported that, based on the program, they felt more competent to engage in encounters with their physicians. Conclusion: This work strongly supports the further development of an evidence-based MRI education program for MS patients to enhance participation in health-care.	[Brand, Judith; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Heesen, Christoph] UMC Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res INIMS, Hamburg, Germany; [Brand, Judith; Kasper, Juergen; Rahn, Anne; Backhus, Imke; Poettgen, Jana; Stellmann, Jan-Patrick; Heesen, Christoph] UMC Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Koepke, Sascha] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Kasper, Juergen] UMC Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Rahn, Anne; Backhus, Imke] Univ Hamburg, MIN Fac, Unit Hlth Sci & Educ, Hamburg, Germany; [Siemonsen, Susanne] UMC Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, MS Imaging Sect, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heesen, C (corresponding author), UMC Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res INIMS, Hamburg, Germany.		Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS"	German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS"	Funding: The funder of this work is the German ministery of education and research within the German MS comptence network project "Decision coaching on immunotherapy in MS". www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; Arnold Dl, 2011, Int MS J, V17, P58; Barratt A, 2008, PATIENT EDUC COUNS, V73, P407, DOI 10.1016/j.pec.2008.07.054; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; Dobson R, 2014, NEUROLOGY, V82, P248, DOI 10.1212/WNL.0000000000000036; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2013, J NEUROL SCI, V331, P2, DOI 10.1016/j.jns.2013.02.018; Heesen C, 2013, J NEUROL SCI, V13, P352; Heesen C, 2011, 16 RMS C 13 14 5 201; Kappos L, 2013, LANCET, V335, P964; Kaulen B, 2012, MULT SCLER J, V18, P59; Kopke S, 2009, MULT SCLER J, V15, P96, DOI 10.1177/1352458508095921; Kopke S, 2013, J NEUROL NEUROSURG P; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rio J, 2009, NAT REV NEUROL, V5, P553, DOI 10.1038/nrneurol.2009.139; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sailer M, 2008, ROFO-FORTSCHR RONTG, V180, P994, DOI 10.1055/s-2008-1027817; Schaffler N, 2013, ACTA NEUROL SCAND, V128, P114, DOI 10.1111/ane.12083; Schaffler N, 2011, ACTA NEUROL SCAND, V124, P151, DOI 10.1111/j.1600-0404.2010.01454.x; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113252	10.1371/journal.pone.0113252	http://dx.doi.org/10.1371/journal.pone.0113252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415501	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600036
J	Sharir, R; Semo, J; Shimoni, S; Ben-Mordechai, T; Landa-Rouben, N; Maysel-Auslender, S; Shaish, A; Entin-Meer, M; Keren, G; George, J				Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Ben-Mordechai, Tamar; Landa-Rouben, Natalie; Maysel-Auslender, Sofia; Shaish, Aviv; Entin-Meer, Michal; Keren, Gad; George, Jacob			Experimental Myocardial Infarction Induces Altered Regulatory T Cell Hemostasis, and Adoptive Transfer Attenuates Subsequent Remodeling	PLOS ONE			English	Article							ANTI-CD25 MONOCLONAL-ANTIBODY; SELF-TOLERANCE; HEART-FAILURE; CORONARY; MECHANISMS; DEPLETION; ISCHEMIA; RECOVERY; TREGS	Background: Ischemic cardiac damage is associated with upregulation of cardiac pro-inflammatory cytokines, as well as invasion of lymphocytes into the heart. Regulatory T cells (Tregs) are known to exert a suppressive effect on several immune cell types. We sought to determine whether the Treg pool is influenced by myocardial damage and whether Tregs transfer and deletion affect cardiac remodeling. Methods and Results: The number and functional suppressive activity of Tregs were assayed in mice subjected to experimental myocardial infarction. The numbers of splenocyte-derived Tregs in the ischemic mice were significantly higher after the injury than in the controls, and their suppressive properties were significantly compromised. Compared with PBS, adoptive Treg transfer to mice with experimental infarction reduced infarct size and improved LV remodeling and functional performance by echocardiography. Treg deletion with blocking anti-CD25 antibodies did not influence infarct size or echocardiographic features of cardiac remodeling. Conclusion: Treg numbers are increased whereas their function is compromised in mice with that underwent experimental infarction. Transfer of exogeneous Tregs results in attenuation of myocardial remodeling whereas their ablation has no effect. Thus, Tregs may serve as interesting potential interventional targets for attenuating left ventricular remodeling.	[Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; George, Jacob] Kaplan Med Ctr, Ctr Heart, Rehovot, Israel; [Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; George, Jacob] Hebrew Univ Jerusalem, Jerusalem, Israel; [Sharir, Rinat; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, IL-69978 Tel Aviv, Israel; [Sharir, Rinat; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; Keren, Gad] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Mordechai, Tamar; Landa-Rouben, Natalie] Tel Aviv Univ, Neufeld Cardiac Res Inst, Sheba Ctr Regenerat Med Stem Cells & Tissue Engn, Ramat Gan, Israel; [Ben-Mordechai, Tamar; Landa-Rouben, Natalie] Tamman Cardiovasc Res Inst, Ramat Gan, Israel; [Shaish, Aviv] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center	George, J (corresponding author), Kaplan Med Ctr, Ctr Heart, Rehovot, Israel.	jgeorge@bezeqint.net						Abbate A, 2008, HEART, V94, P737, DOI 10.1136/hrt.2007.115329; Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; Betts RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027849; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Cleland JGF, 2001, EUR HEART J, V22, P623, DOI 10.1053/euhj.2000.2493; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; GERSHON RK, 1972, J IMMUNOL, V108, P586; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maisel A, 1998, CIRC RES, V82, P458, DOI 10.1161/01.RES.82.4.458; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Matsumoto K, 2011, INT HEART J, V52, P382, DOI 10.1536/ihj.52.382; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; MOREAU JL, 1987, EUR J IMMUNOL, V17, P929, DOI 10.1002/eji.1830170706; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; Petzold C, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/940710; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sharir R, 2014, CARDIOVASC RES, V103, P585, DOI 10.1093/cvr/cvu159; Sharpe N, 1998, Lancet, V352 Suppl 1, pSI3, DOI 10.1016/S0140-6736(98)90012-5; Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Ulrich Hofmann NB, 2012, CIRCULATION; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	44	48	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113653	10.1371/journal.pone.0113653	http://dx.doi.org/10.1371/journal.pone.0113653			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436994	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900060
J	Lung, TWC; Hayes, AJ; Herman, WH; Si, L; Palmer, AJ; Clarke, PM				Lung, Tom W. C.; Hayes, Alison J.; Herman, William H.; Si, Lei; Palmer, Andrew J.; Clarke, Philip M.			A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SHORT-TERM MORTALITY; FOLLOW-UP; NONDIABETIC POPULATION; REGISTRY POPULATION; MELLITUS PREVALENCE; NATIONWIDE COHORTS; ALLEGHENY COUNTY; YOUNG-ADULTS; TIME TRENDS	Aims: Type 1 diabetes has been associated with an elevated relative risk (RR) of mortality compared to the general population. To review published studies on the RR of mortality of Type 1 diabetes patients compared to the general population, we conducted a meta-analysis and examined the temporal changes in the RR of mortality over time. Methods: Systematic review of studies reporting RR of mortality for Type 1 diabetes compared to the general population. We conducted meta-analyses using a DerSimonian and Laird random effects model to obtain the average effect and the distribution of RR estimates. Sub-group meta-analyses and multivariate meta-regression analysis was performed to examine heterogeneity. Summary RR with 95% CIs was calculated using a random-effects model. Results: 26 studies with a total of 88 subpopulations were included in the meta-analysis and overall RR of mortality was 3.82 (95% CI 3.41, 3.4.29) compared to the general population. Observations using data prior to 1971 had a much larger estimated RR (5.80 (95% CI 4.20, 8.01)) when compared to: data between; 1971 and 1980 (5.06 (95% CI 3.44, 7.45)); 1981-90 (3.59 (95% CI 3.15, 4.09)); and those after 1990 (3.11 (95% CI 2.47, 3.91)); suggesting mortality of Type 1 diabetes patients when compared to the general population have been improving over time. Similarly, females (4.54 (95% CI 3.79-5.45)) had a larger RR estimate when compared to males (3.25 (95% CI 2.82-3.73) and the meta-regression found evidence for temporal trends and sex (p<0.01) accounting for heterogeneity between studies. Conclusions: Type 1 diabetes patients' mortality has declined at a faster rate than the general population. However, the largest relative improvements have occurred prior to 1990. Emphasis on intensive blood glucose control alongside blood pressure control and statin therapy may translate into further reductions in mortality in coming years.	[Lung, Tom W. C.; Clarke, Philip M.] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Sch Populat Hlth, Melbourne, Vic 3053, Australia; [Hayes, Alison J.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Herman, William H.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [Si, Lei; Palmer, Andrew J.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia	University of Melbourne; University of Sydney; University of Michigan System; University of Michigan; University of Tasmania	Lung, TWC (corresponding author), Univ Melbourne, Ctr Hlth Policy Programs & Econ, Sch Populat Hlth, Melbourne, Vic 3053, Australia.	tom.lung@unimelb.edu.au	Si, Lei/AAM-3218-2020; Lung, Thomas/J-9686-2017; Palmer, Andrew/J-7289-2014	Si, Lei/0000-0002-3044-170X; Lung, Thomas/0000-0001-9978-6311; Palmer, Andrew/0000-0002-9703-7891; Clarke, Philip/0000-0002-7555-5348	Australian NHMRC [571122, 1028335]; NHMRC [1028335, 571372]; National Institute of Diabetes and Digestive and Kidney Diseases [P60DK020572, P30DK092926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572, P60DK020572] Funding Source: NIH RePORTER	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PMC was funded from an Australian NHMRC Career Development Award (571122) and partially funded from the NHMRC project grant (1028335). TWCL was partially funded from the NHMRC Capacity Building Grant (571372) and the NHMRC project grant (1028335). AJH was supported by NHMRC Capacity Building Grant (571372). AJP and WHH were partially supported by an Australian NHMRC project grant (1028335). WHH was supported by grant numbers P60DK020572 (MDRTC) and P30DK092926 (MCDTR) both from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman S, 2009, SWISS MED WKLY, V139, P576; [Anonymous], 1995, AM J EPIDEMIOLOGY, V142, P612; [Anonymous], DIAB CONTR COMPL IR; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Barcelo A, 2007, DIABETES RES CLIN PR, V75, P214, DOI 10.1016/j.diabres.2006.06.021; BOTHA JL, 1992, INT J EPIDEMIOL, V21, P1132, DOI 10.1093/ije/21.6.1132; Brown LJ, 2001, DIABETES CARE, V24, P56, DOI 10.2337/diacare.24.1.56; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; ColladoMesa F, 1997, DIABETES CARE, V20, P1237, DOI 10.2337/diacare.20.8.1237; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Feltbower RG, 2008, DIABETES CARE, V31, P922, DOI 10.2337/dc07-2029; Florkowski CM, 2003, DIABETIC MED, V20, P191, DOI 10.1046/j.1464-5491.2003.00895.x; Gnavi R, 2004, INT J EPIDEMIOL, V33, P864, DOI 10.1093/ije/dyh089; Grauslund J, 2010, J DIABETES COMPLICAT, V24, P223, DOI 10.1016/j.jdiacomp.2009.05.003; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Ioacara S, 2009, DIABETES RES CLIN PR, V86, P146, DOI 10.1016/j.diabres.2009.08.012; Jess T, 2007, AM J GASTROENTEROL, V102, P609, DOI 10.1111/j.1572-0241.2006.01000.x; JONER G, 1991, DIABETOLOGIA, V34, P29, DOI 10.1007/BF00404021; Jorgensen ME, 2013, DIABETOLOGIA, V56, P2401, DOI 10.1007/s00125-013-3025-7; Joslin EP, 1917, TREATMENT DIABETES M; Kesteloot H, 2006, EUR HEART J, V27, P107, DOI 10.1093/eurheartj/ehi511; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Lipton R, 1999, PEDIATRICS, V103, P952, DOI 10.1542/peds.103.5.952; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; MCNALLY PC, 1995, DIABETIC MED, V12, P961, DOI 10.1111/j.1464-5491.1995.tb00406.x; Miller RG, 2012, DIABETES; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; MUGGEO M, 1995, DIABETOLOGIA, V38, P318, DOI 10.1007/s001250050288; Murray P, 2010, CURR ATHEROSCLER REP, V12, P432, DOI 10.1007/s11883-010-0128-1; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; NYSTROM L, 1992, DIABETIC MED, V9, P422, DOI 10.1111/j.1464-5491.1992.tb01811.x; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; Podar T, 2000, DIABETES CARE, V23, P290, DOI 10.2337/diacare.23.3.290; Ranjit Unnikrishnan I, 2011, J Assoc Physicians India, V59 Suppl, P8; Raymond NT, 1995, J EPIDEMIOL COMMUN H, V49, P570, DOI 10.1136/jech.49.6.570; RILEY MD, 1995, DIABETES RES CLIN PR, V29, P27, DOI 10.1016/0168-8227(95)01106-N; Roberts SE, 2004, BRIT MED J, V328, P741, DOI 10.1136/bmj.328.7442.741; SARTOR G, 1995, DIABETIC MED, V12, P607, DOI 10.1111/j.1464-5491.1995.tb00550.x; SARTOR G, 1991, DIABETIC MED, V8, P18, DOI 10.1111/j.1464-5491.1991.tb01510.x; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4; Soltesz GPC, 2003, DIABETES YOUNG GLOBA; Swerdlow AJ, 1996, INT J EPIDEMIOL, V25, P1250, DOI 10.1093/ije/25.6.1250; Waernbaum I, 2006, DIABETOLOGIA, V49, P653, DOI 10.1007/s00125-005-0135-x; Wibell L, 2001, J INTERN MED, V249, P263, DOI 10.1046/j.1365-2796.2001.00802.x; Yurkovich M, 2014, ARTHRIT CARE RES, V66, P608, DOI 10.1002/acr.22173	48	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113635	10.1371/journal.pone.0113635	http://dx.doi.org/10.1371/journal.pone.0113635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426948	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400069
J	Malagun, M; Nano, G; Chevallier, C; Opina, R; Sawiya, G; Kivavia, J; Kalinoe, A; Nathaniel, K; Kaminiel, O; Millan, J; Carmone, A; Dini, M; Palou, T; Topma, K; Lavu, E; Markby, J				Malagun, Malin; Nano, Gideon; Chevallier, Caroline; Opina, Ragagalo; Sawiya, Gola; Kivavia, Joseph; Kalinoe, Albina; Nathaniel, Kathalina; Kaminiel, Oscillah; Millan, John; Carmone, Andrea; Dini, Mary; Palou, Theresa; Topma, Kum; Lavu, Evelyn; Markby, Jessica			Multisite Evaluation of Point of Care CD4 Testing in Papua New Guinea	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; CELL ENUMERATION; PERFORMANCE EVALUATION; SOUTH-AFRICA; PIMA CD4; BLOOD; COUNTRIES; INITIATION; ANALYZER; CLINICS	Laboratory-based CD4 monitoring of HIV patients presents challenges in resource limited settings (RLS) including frequent machine breakdown, poor engineering support and limited cold chain and specimen transport logistics. This study assessed the performance of two CD4 tests designed for use in RLS; the Dynal assay and the Alere PIMA test (PIMA). Accuracy of Dynal and PIMA using venous blood was assessed in a centralised laboratory by comparison to BD FACSCount (BD FACS). Dynal had a mean bias of -50.35 cells/mu l (r(2) = 0.973, p<0.0001, n=101) and PIMA -22.43 cells/ml (r(2) =0.964, p<0.0001, n=139) compared to BD FACS. Similar results were observed for PIMA operated by clinicians in one urban (n=117) and two rural clinics (n=98). Using internal control beads, PIMA precision was 10.34% CV (low bead mean 214.24 cells/mu l) and 8.29% (high bead mean 920.73 cells/mu l) and similar % CV results were observed external quality assurance (EQA) and replicate patient samples. Dynal did not perform using EQA and no internal controls are supplied by the manufacturer, however duplicate testing of samples resulted in r(2) =0.961, p<0.0001, mean bias=-1.44 cells/ml. Using the cut-off of 350 cells/ml compared to BD FACS, PIMA had a sensitivity of 88.85% and specificity of 98.71% and Dynal 88.61% and 100%. A total of 0.44% (2/452) of patient samples were misclassified as "no treat'' and 7.30% (33/452) "treat'' using PIMA whereas with Dynal 8.91% (9/101) as "treat'' and 0% as "no treat''. In our setting PIMA was found to be accurate, precise and user-friendly in both laboratory and clinic settings. Dynal performed well in initial centralized laboratory evaluation, however lacks requisite quality control measures, and was technically more difficult to use, making it less suitable for use at lower tiered laboratories.	[Malagun, Malin; Chevallier, Caroline] Clinton Hlth Access Initiat, Port Moresby, Papua N Guinea; [Nano, Gideon] Natl Dept Hlth, HIV Div, Port Moresby, Papua N Guinea; [Opina, Ragagalo; Sawiya, Gola] Port Moresby Gen Hosp, Heduru Clin, Madang, Papua N Guinea; [Kivavia, Joseph] Cent Publ Hlth Lab, HIV Sect, Port Moresby, Papua N Guinea; [Kalinoe, Albina; Nathaniel, Kathalina] Port Moresby Gen Hosp, Dept Pathol, Port Moresby, Papua N Guinea; [Kaminiel, Oscillah] Cent Publ Hlth Lab, Qual Assurance Sect, Port Moresby, Papua N Guinea; [Millan, John] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Carmone, Andrea; Markby, Jessica] Clinton Hlth Access Initiat, Goroka, Papua N Guinea; [Dini, Mary; Palou, Theresa] Goroka Gen Hosp, Dept Pathol, Madang, Papua N Guinea; [Topma, Kum] Asaro Dist Hlth Ctr, Madang, Eastern Highlan, Papua N Guinea; [Lavu, Evelyn] Cent Publ Hlth Lab, Madang, Papua N Guinea		Carmone, A (corresponding author), Clinton Hlth Access Initiat, Goroka, Papua N Guinea.	acarmone@clintonhealthaccess.org		Carmone, Andy Elizabeth/0000-0002-6455-6206	Papua New Guinea National AIDS Council; Papua New Guinean Research Advisory Committee; Medical Research Advisory Committee (RAC) [RES08 0015]; Medical Research Advisory Committee (MRAC) [10.28]	Papua New Guinea National AIDS Council; Papua New Guinean Research Advisory Committee; Medical Research Advisory Committee (RAC); Medical Research Advisory Committee (MRAC)	Funding: Support for this study was provided by the Papua New Guinea National AIDS Council. This study was approved by the Papua New Guinean Research Advisory Committee and the Medical Research Advisory Committee Grant number (RAC Approval Number RES08 0015 and MRAC Approval Number 10.28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum LL, 2007, CURR OPIN HIV AIDS, V2, P234, DOI 10.1097/COH.0b013e3280ef6909; Bergeron M, 2010, CYTOM PART B-CLIN CY, V78B, P41, DOI 10.1002/cyto.b.20487; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chevallier C, 2012, COMMUNICATION; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Glencross D, 2010, 17 INT AIDS C VIENN; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Marinucci F, 2011, CYTOM PART A, V79A, P368, DOI 10.1002/cyto.a.21064; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Peter T, 2008, CYTOM PART B-CLIN CY, V74B, pS123, DOI 10.1002/cyto.b.20416; Plate MM, 2009, VIRAL IMMUNOL, V22, P329, DOI 10.1089/vim.2009.0027; PNG National Department of Health, 2007, 2007 STI HIV AIDS AN; PNG National Department of Health, 2010, 2010 STI HIV AIDS AN; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9; Truett AA, 2006, JAIDS-J ACQ IMM DEF, V41, P168, DOI 10.1097/01.qai.0000191282.77954.fc; Westerman L, 2009, INT AIDS S CAP TOWN; World Health Organization Prequalification of Diagnostics Programme, 2011, 009903200 PQDX WHO; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112173	10.1371/journal.pone.0112173	http://dx.doi.org/10.1371/journal.pone.0112173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426710	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400011
J	Miller, PS; Boone, JD; Briggs, JR; Lawler, DF; Levy, JK; Nutter, FB; Slater, M; Zawistowski, S				Miller, Philip S.; Boone, John D.; Briggs, Joyce R.; Lawler, Dennis F.; Levy, Julie K.; Nutter, Felicia B.; Slater, Margaret; Zawistowski, Stephen			Simulating Free-Roaming Cat Population Management Options in Open Demographic Environments	PLOS ONE			English	Article							TRAP-NEUTER-RETURN; FERAL CATS; EUTHANASIA; CONTRACEPTION; PROGRAMS; MODELS; IMPACT	Large populations of free-roaming cats (FRCs) generate ongoing concerns for welfare of both individual animals and populations, for human public health, for viability of native wildlife populations, and for local ecological damage. Managing FRC populations is a complex task, without universal agreement on best practices. Previous analyses that use simulation modeling tools to evaluate alternative management methods have focused on relative efficacy of removal (or trap-return, TR), typically involving euthanasia, and sterilization (or trap-neuter-return, TNR) in demographically isolated populations. We used a stochastic demographic simulation approach to evaluate removal, permanent sterilization, and two postulated methods of temporary contraception for FRC population management. Our models include demographic connectivity to neighboring untreated cat populations through natural dispersal in a metapopulation context across urban and rural landscapes, and also feature abandonment of owned animals. Within population type, a given implementation rate of the TR strategy results in the most rapid rate of population decline and (when populations are isolated) the highest probability of population elimination, followed in order of decreasing efficacy by equivalent rates of implementation of TNR and temporary contraception. Even low levels of demographic connectivity significantly reduce the effectiveness of any management intervention, and continued abandonment is similarly problematic. This is the first demographic simulation analysis to consider the use of temporary contraception and account for the realities of FRC dispersal and owned cat abandonment.	[Miller, Philip S.] Int Union Conservat Nat, Conservat Breeding Specialist Grp, Species Survival Commiss, Apple Valley, MN 55124 USA; [Boone, John D.] Great Basin Bird Observ, Reno, NV USA; [Briggs, Joyce R.] Alliance Contracept Cats & Dogs, Portland, OR USA; [Lawler, Dennis F.] Illinois State Museum, Springfield, IL USA; [Levy, Julie K.] Univ Florida, Maddies Shelter Med Program, Dept Small Anim Clin Sci, Gainesville, FL USA; [Nutter, Felicia B.] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA USA; [Slater, Margaret] Amer Soc Prevent Cruelty Anim, Shelter Res & Dev, Florence, MA USA; [Zawistowski, Stephen] Amer Soc Prevent Cruelty Anim, New York, NY USA	State University System of Florida; University of Florida; Tufts University	Miller, PS (corresponding author), Int Union Conservat Nat, Conservat Breeding Specialist Grp, Species Survival Commiss, Apple Valley, MN 55124 USA.	pmiller@cbsg.org			American Society for the Prevention of Cruelty to Animals; National Science Foundation [EF-0832858]; Division Of Environmental Biology [1146198] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	American Society for the Prevention of Cruelty to Animals; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a grant from the American Society for the Prevention of Cruelty to Animals (www.aspca.org) (no grant number available) to JRB. Additional funding from the National Science Foundation (www.nsf.gov), grant #EF-0832858, to MRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, RAMAS METAPOP VIABIL; Alliance for Contraception in Cats & Dogs, 2013, CONTR FERT CONTR DOG; Andersen MC, 2004, JAVMA-J AM VET MED A, V225, P1871, DOI 10.2460/javma.2004.225.1871; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Budke CM, 2009, J APPL ANIM WELF SCI, V12, P277, DOI 10.1080/10888700903163419; Castillo D, 2003, NAT AREA J, V23, P247; Centers for Disease Control and Prevention, 2011, COMP AN RAB PREV CON; Centers for Disease Control and Prevention, 2004, TOX IMP MESS CAT OWN; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Courchamp F, 2000, J APPL ECOL, V37, P903, DOI 10.1046/j.1365-2664.2000.00545.x; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Crowell-Davis SL, 2004, J FELINE MED SURG, V6, P19, DOI 10.1016/j.jfms.2003.09.013; Foley P, 2005, JAVMA-J AM VET MED A, V227, P1775, DOI 10.2460/javma.2005.227.1775; Gunther I, 2011, JAVMA-J AM VET MED A, V238, P1134, DOI 10.2460/javma.238.9.1134; Hone J, 2010, J APPL ECOL, V47, P507, DOI 10.1111/j.1365-2664.2010.01812.x; Lacy R.C., 2009, VORTEX STOCHASTIC SI; Lessa ICM, 2012, BRAZ J BIOL, V72, P445, DOI 10.1590/S1519-69842012000300005; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1354, DOI 10.2460/javma.2004.225.1354; Levy JK, 2008, J AM VET MED ASSOC, V222, P42; Levy JK, 2011, THERIOGENOLOGY, V76, P1517, DOI 10.1016/j.theriogenology.2011.06.022; Lohr CA, 2013, CONSERV BIOL, V27, P64, DOI 10.1111/j.1523-1739.2012.01935.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Loyd KAT, 2010, ECOL SOC, V15; McCarthy RJ, 2013, JAVMA-J AM VET MED A, V243, P502, DOI 10.2460/javma.243.4.502; Nutter FB, 2005, THESIS N CAROLINA ST; Patronek GJ, 2010, AM J VET RES, V71, P161, DOI 10.2460/ajvr.71.2.161; Rubion S, 2009, REPROD DOMEST ANIM, V44, P79, DOI 10.1111/j.1439-0531.2009.01415.x; Say L, 1999, P ROY SOC B-BIOL SCI, V266, P2071, DOI 10.1098/rspb.1999.0889; Schmidt PM, 2009, WILDLIFE RES, V36, P117, DOI 10.1071/WR08018; Short J, 2005, WILDLIFE RES, V32, P489, DOI 10.1071/WR04102; Turner D.C., 2000, DOMESTIC CAT BIOL IT; van Aarde R.J., 1984, Acta Zoologica Fennica, P107; Zawistowski S, 1998, J Appl Anim Welf Sci, V1, P193, DOI 10.1207/s15327604jaws0103_1	34	50	50	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113553	10.1371/journal.pone.0113553	http://dx.doi.org/10.1371/journal.pone.0113553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426960	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400063
J	Wehbe, L; Murphy, B; Talukdar, P; Fyshe, A; Ramdas, A; Mitchell, T				Wehbe, Leila; Murphy, Brian; Talukdar, Partha; Fyshe, Alona; Ramdas, Aaditya; Mitchell, Tom			Simultaneously Uncovering the Patterns of Brain Regions Involved in Different Story Reading Subprocesses	PLOS ONE			English	Article							SENTENCE COMPREHENSION; REPRESENTATIONS; INFORMATION; LANGUAGE; FORM	Story understanding involves many perceptual and cognitive subprocesses, from perceiving individual words, to parsing sentences, to understanding the relationships among the story characters. We present an integrated computational model of reading that incorporates these and additional subprocesses, simultaneously discovering their fMRI signatures. Our model predicts the fMRI activity associated with reading arbitrary text passages, well enough to distinguish which of two story segments is being read with 74% accuracy. This approach is the first to simultaneously track diverse reading subprocesses during complex story processing and predict the detailed neural representation of diverse story features, ranging from visual word properties to the mention of different story characters and different actions they perform. We construct brain representation maps that replicate many results from a wide range of classical studies that focus each on one aspect of language processing and offer new insights on which type of information is processed by different areas involved in language processing. Additionally, this approach is promising for studying individual differences: it can be used to create single subject maps that may potentially be used to measure reading comprehension and diagnose reading disorders.	[Wehbe, Leila; Fyshe, Alona; Ramdas, Aaditya; Mitchell, Tom] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Wehbe, Leila; Fyshe, Alona; Mitchell, Tom] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Murphy, Brian] Queens Univ Belfast, Sch Elect Elect Engn & Comp Sci, Belfast, Antrim, North Ireland; [Talukdar, Partha] Indian Inst Sci, Supercomp Educ & Res Ctr, Bangalore 560012, Karnataka, India	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Queens University Belfast; Indian Institute of Science (IISC) - Bangalore	Wehbe, L (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.	lwehbe@cs.cmu.edu		Fyshe, Alona/0000-0003-4367-0306	National Science Foundation [0835797]; National Institute of Child Health and human Development [5R01HD075328]; Rothberg Brain Imaging Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075328] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Rothberg Brain Imaging Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: This work was supported by the National Science Foundation (nsf.gov, 0835797, TM); the National Institute of Child Health and human Development (nichd.nih.gov, 5R01HD075328, TM); and the Rothberg Brain Imaging Award (http://www.cmu.edu/news/archive/2011/July/july7_rothbergawards.shtml, LW AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; Currie G, 1990, NATURE FICTION; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Fedorenko E, 2012, NEUROPSYCHOLOGIA, V50, P499, DOI 10.1016/j.neuropsychologia.2011.09.014; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hasson U, 2012, NEUROIMAGE, V62, P1272, DOI 10.1016/j.neuroimage.2012.02.004; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Manning C. D, 1999, FDN STAT NATURAL LAN, V999; Mason R. A., 2006, HDB PSYCHOLINGUISTIC, P799; Meyler A, 2007, CEREB CORTEX, V17, P2780, DOI 10.1093/cercor/bhm006; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy B., 2012, INT C COMP LING COLI; Murphy B, 2011, BRAIN LANG, V117, P12, DOI 10.1016/j.bandl.2010.09.013; Nestor A, 2013, HUM BRAIN MAPP, V34, P3101, DOI 10.1002/hbm.22128; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Ravizza SM, 2005, NEUROPSYCHOLOGIA, V43, P2057, DOI 10.1016/j.neuropsychologia.2005.03.014; Rowling J. K., 2012, HARRY POTTER SORCERE; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001	29	106	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112575	10.1371/journal.pone.0112575	http://dx.doi.org/10.1371/journal.pone.0112575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426840	Green Accepted, Green Published, gold			2022-12-27	WOS:000349145400019
J	Akrawi, DS; Li, XJ; Sundquist, J; Sundquist, K; Zoller, B				Akrawi, Delshad Saleh; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina; Zoller, Bengt			Familial Risks of Kidney Failure in Sweden: A Nationwide Family Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; INCIDENT DIALYSIS PATIENTS; 1ST-DEGREE RELATIVES; AFRICAN-AMERICANS; POPULATION; HISTORY; PREVALENCE	Background: The value of family history as a risk factor for kidney failure has not been determined in a nationwide setting. Aim: This nationwide family study aimed to determine familial risks for kidney failure in Sweden. Methods: The Swedish multi-generation register on 0-78-year-old subjects were linked to the Swedish patient register and the Cause of death register for 1987-2010. Individuals diagnosed with acute kidney failure (n=10063), chronic kidney failure (n=18668), or unspecified kidney failure (n=3731) were included. Kidney failure patients with cystic kidney disease, congenital kidney and urinary tract malformations, urolithiasis, and rare inherited kidney syndromes, and hyperoxaluria were excluded. Standardized incidence ratios (SIRs) were calculated for individuals whose parents/siblings were diagnosed with kidney failure compared to those whose parents or siblings were not. Results: The concordant (same disease) familial risks (sibling/parent history) were increased for chronic kidney failure SIR=2.02 (95% confidence interval, CI 1.90-2.14) but not for acute kidney failure SIR=1.08 (95% CI 0.94-1.22) and for unspecified kidney failure SIR=1.25 (95% CI 0.94-1.63). However, the discordant (different disease) familial risk for acute kidney failure SIR=1.19 (95% CI 1.06-1.32) and unspecified kidney failure SIR=1.63 (95% CI 1.40-1.90) was significantly increased in individuals with a family history of chronic kidney failure. The familial risk for chronic kidney failure was similar for males SIR=2.04 (95% CI 1.90-2.20) and females SIR=1.97 (95% CI 1.78-2.17). Familial risks for chronic kidney failure were highest at age of 10-19 years SIR=6.33 (95% CI 4.16-9.22). Conclusions: The present study shows that family history is an important risk factor for chronic kidney failure but to a lower degree for acute kidney failure and unspecified kidney failure.	[Akrawi, Delshad Saleh; Li, Xinjun; Sundquist, Jan; Sundquist, Kristina; Zoller, Bengt] Lund Univ Reg Skane, Ctr Primary Care Res, Malmo, Sweden; [Sundquist, Jan] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Lund University; Stanford University	Akrawi, DS (corresponding author), Lund Univ Reg Skane, Ctr Primary Care Res, Malmo, Sweden.	delshad.akrawi@med.lu.se	Zöller, Bengt/H-8856-2012; Zöller, Bengt/M-3217-2019	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Li, Xinjun/0000-0002-5559-4657	Swedish Heart-Lung Foundation; Swedish Research Council [K2009-70X-15428-05-3, K2012-70X-15428-08-3]; Swedish Council for Working Life and Social Research [2007-1754]; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants awarded to Dr. Bengt Zoller by the Swedish Heart-Lung Foundation, ALF funding from RegionSkane awarded to Dr. Bengt Zoller and Prof. Kristina Sundquist, grants awarded to Prof. Kristina Sundquist by the Swedish Research Council (K2009-70X-15428-05-3 and K2012-70X-1542808-3), and grants awarded to Prof. Jan Sundquist by the Swedish Council for Working Life and Social Research (2007-1754) and King Gustaf V and Queen Victoria's Foundation of Freemasons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman S, 1996, AM J KIDNEY DIS, V27, P341, DOI 10.1016/S0272-6386(96)90356-X; Breslow N E, 1987, IARC Sci Publ, P1; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Drawz PE, 2011, NAT REV NEPHROL, V7, P458, DOI 10.1038/nrneph.2011.85; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; FREEDMAN BI, 1993, AM J KIDNEY DIS, V21, P387, DOI 10.1016/S0272-6386(12)80266-6; Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942; Freedman BI, 2005, AM J NEPHROL, V25, P529, DOI 10.1159/000088491; Hemminki K, 2001, BRIT J CANCER, V84, P388, DOI 10.1054/bjoc.2000.1585; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Jenssen GR, 2014, ACTA PAEDIATR, V103, P1192, DOI 10.1111/apa.12742; Jurkovitz C, 2005, AM J KIDNEY DIS, V46, P11, DOI 10.1053/j.ajkd.2005.04.012; Jurkovitz C, 2002, AM J KIDNEY DIS, V40, P1173, DOI 10.1053/ajkd.2002.36866; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lawlor DA, 2009, DEIGNING ANAL UNDERS; Lei HH, 1998, J AM SOC NEPHROL, V9, P1270; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li PKT, 2013, TRANSPLANTATION, V95, P653, DOI 10.1097/TP.0b013e31828848bc; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; O'Dea DF, 1998, AM J KIDNEY DIS, V32, P794, DOI 10.1016/S0272-6386(98)70135-0; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Rosen M, 2005, HANDBOOK OF EPIDEMIOLOGY, P231; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Satko SG, 2004, CURR OPIN NEPHROL HY, V13, P337, DOI 10.1097/00041552-200405000-00012; [The National Board of Health and Welfare Swedish], 2000, STOCKH EP CENTR; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Witasp A, 2012, J NEPHROL, V25, P851, DOI 10.5301/jn.5000216; Zoller B, 2011, CIRCULATION, V124, P1012, DOI 10.1161/CIRCULATIONAHA.110.965020	31	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113353	10.1371/journal.pone.0113353	http://dx.doi.org/10.1371/journal.pone.0113353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423475	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700032
J	Hsin, CH; Chen, MK; Tang, CH; Lin, HP; Chou, MY; Lin, CW; Yang, SF				Hsin, Chung-Han; Chen, Mu-Kuan; Tang, Chih-Hsin; Lin, Huang-Pin; Chou, Ming-Yung; Lin, Chiao-Wen; Yang, Shun-Fa			High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; SERUM-LEVELS; CANCER; STROMELYSIN-3; EXPRESSION; TUMOR; HEAD; PROGRESSION; INVASION; BREAST	Background: Matrix metalloproteinase-11 (MMP-11) is reported to be overexpressed in several cancers and may contribute to tumorigenesis. The current study investigated the association between the clinicopathological characteristics and plasma level of MMP-11 in oral squamous cell carcinoma (OSCC) patients. Methodology and Principal Findings: The plasma MMP-11 concentration was determined by ELISA on 330 male OSCC patients. In addition, the metastatic effects of the MMP-11 knockdown on the oral cancer cells were investigated by cell migration assay. Our results showed that the plasma MMP-11 levels were significantly higher in patients with advanced T status (p = 0.001), lymph node metastasis (p = 0.006) and higher TNM stages (p < 0.001). Moreover, treatment with the MMP-11 shRNA exerted an inhibitory effect on migration in SCC9 oral cancer cells. Conclusion: Our study showed that plasma level of MMP-11 may be useful for assessment of the disease progression, especially lymph node metastasis, in patients with OSCC.	[Hsin, Chung-Han; Lin, Huang-Pin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han; Lin, Huang-Pin] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chen, Mu-Kuan; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Dept Biotechnol, Coll Hlth Sci, Taichung, Taiwan; [Chou, Ming-Yung; Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Chou, Ming-Yung; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.	cwlin@csmu.edu.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Tang, Chih Hsin/O-5212-2015	Yang, Shun-Fa/0000-0002-0365-7927; Tang, Chih Hsin/0000-0002-7113-8352	National Science Council, Taiwan [NSC 101-2314-B-040-019]; Health and welfare surcharge of tobacco products, Ministry of Health and Welfare [MOHW103-TD-B-111-08]; Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-001]; Chung Shan Medical University and Changhua Christian Hospital [CSMU-CCH-102-004]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Health and welfare surcharge of tobacco products, Ministry of Health and Welfare; Chung Shan Medical University Hospital, Taiwan; Chung Shan Medical University and Changhua Christian Hospital	This study was supported by a research grant from National Science Council, Taiwan (NSC 101-2314-B-040-019), Health and welfare surcharge of tobacco products, Ministry of Health and Welfare (MOHW103-TD-B-111-08), Chung Shan Medical University Hospital, Taiwan (CSH-2014-C-001) and Chung Shan Medical University and Changhua Christian Hospital (CSMU-CCH-102-004). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi A, 1996, OTOLARYNG HEAD NECK, V114, P65, DOI 10.1016/S0194-5998(96)70285-1; ANDERSON IC, 1995, CANCER RES, V55, P4120; Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Birkedal-Hansen B, 2000, Oral Dis, V6, P376; Cox G, 2001, ANTICANCER RES, V21, P4207; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Deng H, 2005, BIOCHEM BIOPH RES CO, V326, P274, DOI 10.1016/j.bbrc.2004.11.027; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiorentino M, 2009, INT J MOL MED, V23, P389, DOI 10.3892/ijmm_00000143; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiratsuka H, 1997, CANCER, V80, P351; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Kok SH, 2007, ORAL ONCOL, V43, P639, DOI 10.1016/j.oraloncology.2006.07.007; Kuropkat C, 2002, ANTICANCER RES, V22, P2221; LEFEBVRE O, 1995, DEVELOPMENT, V121, P947; Lin CW, 2014, EXPERT OPIN THER TAR, V18, P1109, DOI 10.1517/14728222.2014.947962; LIOTTA LA, 1986, CANCER RES, V46, P1; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; O-charoenrat P, 2001, ARCH OTOLARYNGOL, V127, P813; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; Riedel F, 2000, ANTICANCER RES, V20, P3045; Roscilli G, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-54; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; Rosenthal EL, 2004, ARCH OTOLARYNGOL, V130, P943, DOI 10.1001/archotol.130.8.943; ROUYER N, 1994, INVAS METAST, V14, P269; Shekhar MPV, 2001, CANCER RES, V61, P1320; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soni S, 2003, INT J CANCER, V107, P309, DOI 10.1002/ijc.11366; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tu HF, 2011, HEAD NECK-J SCI SPEC, V33, P396, DOI 10.1002/hed.21467; Yan D, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-151; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113129	10.1371/journal.pone.0113129	http://dx.doi.org/10.1371/journal.pone.0113129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423087	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700022
J	Mahapatra, B; Saggurti, N				Mahapatra, Bidhubhusan; Saggurti, Niranjan			Exposure to Pornographic Videos and Its Effect on HIV-Related Sexual Risk Behaviours among Male Migrant Workers in Southern India	PLOS ONE			English	Article							YOUNG-ADULTS; INTERNET; ADOLESCENTS; TRANSMISSION; MIGRATION; ATTITUDES; HIV/AIDS; ORIGIN; ACCESS; PLACE	Objective: Research on pornography and its association with HIV-related sexual behaviours is limited in India. This study aims to examine the prevalence and correlates of viewing pornographic videos and examine its associations with HIV-related sexual risk behaviours among male migrant workers in India. Methods: Data were drawn from a cross-sectional survey conducted in 2007-08 across 21 districts in four states of India. Respondents included 11,219 male migrants aged 18 years or older, who had migrated to at least two places in the past two years for work. Bivariate and multivariate methods were used to examine the association between viewing pornography and HIV-related sexual risk behaviours. Results: Two-fifths (40%) of the migrants had viewed pornographic videos in one month prior to the survey. Migrants aged 25-29 years, literate, unmarried and away from native village for more than five years were more likely to view pornography than their counterparts. Migrants who viewed pornographic videos were more likely to engage in paid (Adjusted odds ratio [AOR]: 4.2, 95% confidence interval [CI]: 3.7-4.8) and unpaid sex (AOR: 4.2, 95% CI: 3.7-4.7), report inconsistent condom use in paid sex (AOR: 2.3, 95% CI: 1.7-3.0) and experience STI-like symptoms (AOR: 1.7, 95% CI: 1.5-1.8) than their counterparts. Conclusions: The findings regarding migrants' exposure to pornography and its linkage with high HIV risk behaviour suggest that the HIV prevention programmes for migrants need to be more innovative to communicate on the negative-effects of viewing pornography. More importantly, programmes need to find alternative ways to engage migrants in infotainment activities during their leisure time in an effort to reduce their exposure to pornographic videos as well as risky sexual behaviours.	[Mahapatra, Bidhubhusan] Internat Ctr Integrated Mt Dev, Kathmandu, Nepal; [Saggurti, Niranjan] Populat Council, New Delhi, India		Mahapatra, B (corresponding author), Internat Ctr Integrated Mt Dev, Kathmandu, Nepal.	bbmahapatra@gmail.com	Mahapatra, Bidhubhusan/M-1411-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425				Bailey A., 2008, CULTURE RISK HIV AID; Braun-Courville DK, 2009, J ADOLESCENT HEALTH, V45, P156, DOI 10.1016/j.jadohealth.2008.12.004; Brown JD, 2009, COMMUN RES, V36, P129, DOI 10.1177/0093650208326465; Deering KN, 2008, AIDS, V22, pS165, DOI 10.1097/01.aids.0000343774.59776.95; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Ganju D, 2013, CULT HEALTH SEX, V15, P341, DOI 10.1080/13691058.2012.756932; Greenfield PM, 2004, J APPL DEV PSYCHOL, V25, P741, DOI 10.1016/j.appdev.2004.09.009; Haggstrom-Nordin E, 2005, INT J STD AIDS, V16, P102, DOI 10.1258/0956462053057512; Halli SS, 2007, CULT HEALTH SEX, V9, P85, DOI 10.1080/13691050600963898; International Institute for Population Sciences (IIPS) and Population Council, 2010, YOUTH IND SIT NEEDS; Kraus SW, 2008, CYBERPSYCHOL BEHAV, V11, P162, DOI 10.1089/cpb.2007.0054; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kulasekaran RA, 2013, SEX TRANSM INFECT, V89, pA305, DOI 10.1136/sextrans-2013-051184.0952; Lo VH, 2005, J BROADCAST ELECTRON, V49, P221, DOI 10.1207/s15506878jobem4902_5; Luder MT, 2011, ARCH SEX BEHAV, V40, P1027, DOI 10.1007/s10508-010-9714-0; Lurie M, 1997, S AFR MED J, V87, P908; Mahapatra B, 2013, SEX HEALTH, V10, P305, DOI 10.1071/SH12215; Mahapatra B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062167; Malamuth N M, 2000, Annu Rev Sex Res, V11, P26; McFarlane M, 2004, J WOMENS HEALTH, V13, P689, DOI 10.1089/jwh.2004.13.689; McFarlane M, 2002, J ADOLESCENT HEALTH, V31, P11, DOI 10.1016/S1054-139X(02)00373-7; National AIDS Control Organization (NACO), 2007, TARG INT COR GROUPS, V1; Oddone-Paolucci E., 2000, CHANGING FAMILY CHIL, P48, DOI DOI 10.4324/9781315201702; Population Council Karnataka Health Promotion Trust (KHPT) Annamalai University, 2012, MIGR HIV RISK MAL MI; Puri M, 2006, J ADOLESCENT HEALTH, V38, P237, DOI 10.1016/j.jadohealth.2004.10.001; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Rogala C, 2003, WOMEN HEALTH ISS, V13, P39, DOI 10.1016/S1049-3867(02)00174-3; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043222; Saggurti N, 2012, AIDS BEHAV, V16, P1649, DOI 10.1007/s10461-011-0022-z; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Singh SK, 2003, PATTERN SINGLE MALE; Tian LH, 2008, SEX TRANSM DIS, V35, P905, DOI 10.1097/OLQ.0b013e318181294b; VOELLER B, 1991, ARCH SEX BEHAV, V20, P233, DOI 10.1007/BF01541846; Wingood GM, 2001, PEDIATRICS, V107, P1116, DOI 10.1542/peds.107.5.1116; Wright PJ, 2013, J SEX RES, V50, P60, DOI 10.1080/00224499.2011.628132; Zillmann D, 2000, J ADOLESCENT HEALTH, V27, P41, DOI 10.1016/S1054-139X(00)00137-3	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113599	10.1371/journal.pone.0113599	http://dx.doi.org/10.1371/journal.pone.0113599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423311	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700041
J	Talei, D; Valdiani, A; Rafii, MY; Maziah, M				Talei, Daryush; Valdiani, Alireza; Rafii, Mohd Yusop; Maziah, Mahmood			Proteomic Analysis of the Salt-Responsive Leaf and Root Proteins in the Anticancer Plant Andrographis paniculata Nees	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; WATER RELATIONS; ASCORBATE PEROXIDASE; ANTIOXIDANT SYSTEMS; NACL STRESS; RICE; DROUGHT; EXPRESSION; TOLERANCE; GENE	Separation of proteins based on the physicochemical properties with different molecular weight and isoelectric points would be more accurate. In the current research, the 45-day-old seedlings were treated with 0 (control) and 12 dS m(-1) of sodium chloride in the hydroponic system. After 15 days of salt exposure, the total protein of the fresh leaves and roots was extracted and analyzed using two-dimensional electrophoresis system (2-DE). The analysis led to the detection of 32 induced proteins (19 proteins in leaf and 13 proteins in the root) as well as 12 upregulated proteins (four proteins in leaf and eight proteins in the root) in the salt-treated plants. Of the 44 detected proteins, 12 were sequenced, and three of them matched with superoxide dismutase, ascorbate peroxidase and ribulose-1, 5-bisphosphate oxygenase whereas the rest remained unknown. The three known proteins associate with plants response to environmental stresses and could represent the general stress proteins in the present study too. In addition, the proteomic feedback of different accessions of A. paniculata to salt stress can potentially be used to breed salt-tolerant varieties of the herb.	[Talei, Daryush] Shahed Univ, Med Plants Res Ctr, Tehran, Iran; [Talei, Daryush] Univ Putra Malaysia, Dept Cell & Mol Biol, Fac Biotechnol & Biomol Sci, Upm Serdang, Selangor De, Malaysia; [Valdiani, Alireza; Maziah, Mahmood] Univ Putra Malaysia, Dept Biochem, Fac Biotechnol & Biomol Sci, Upm Serdang, Selangor De, Malaysia; [Rafii, Mohd Yusop; Maziah, Mahmood] Univ Putra Malaysia, Inst Trop Agr, Upm Serdang, Selangor De, Malaysia; [Maziah, Mahmood] Univ Putra Malaysia, Inst Biosci, Upm Serdang, Selangor De, Malaysia	Shahed University; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Talei, D (corresponding author), Shahed Univ, Med Plants Res Ctr, Tehran, Iran.	d.talei@shahed.ac.ir; maziahm@upm.edu.my	Rafii, M.Y./G-9925-2015; Talei, Daryush/V-9062-2019	Rafii, M.Y./0000-0003-4763-6367; Talei, Daryush/0000-0001-8699-850X; Valdiani, Alireza/0000-0003-4290-8730	Universiti Putra Malaysia, Andrographis grant	Universiti Putra Malaysia, Andrographis grant	Funding provided by Universiti Putra Malaysia, Andrographis grant (MYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, BIOL PLANTARUM, V48, P555, DOI 10.1023/B:BIOP.0000047152.07878.e7; Alamgir ANM, 1999, BANGLADESH J BOTANY, V28, P145; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Ashraf M, 2004, FLORA, V199, P361, DOI 10.1078/0367-2530-00165; Ashraf MY, 2002, TASKS VEG SCI, V37, P237; Benavides MP, 2000, AUST J PLANT PHYSIOL, V27, P273; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Chai L, 2011, AFR J BIOTECHNOL, V10, P18085, DOI 10.5897/AJB11.2419; Comba ME, 1998, AUST J PLANT PHYSIOL, V25, P665, DOI 10.1071/PP97156; Daryush Talei, 2012, Australian Journal of Crop Science, V6, P1059; Daryush Talei, 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P639; Dooki AD, 2006, PROTEOMICS, V6, P6498, DOI 10.1002/pmic.200600367; Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002; Guan QingJie, 2009, Genomics and Applied Biology, V28, P631; Guo BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065867; Hernandez J, 1999, NEW PHYTOL, V141, P241, DOI 10.1046/j.1469-8137.1999.00341.x; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hernandez-Nistal J, 2002, PLANT SCI, V163, P507, DOI 10.1016/S0168-9452(02)00153-X; Kettman JR, 2002, PROTEOMICS, V2, P624, DOI 10.1002/1615-9861(200206)2:6<624::AID-PROT624>3.0.CO;2-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechno S, 1997, J PLANT PHYSIOL, V150, P206, DOI 10.1016/S0176-1617(97)80204-0; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mittova V, 2002, PHYSIOL PLANTARUM, V115, P393, DOI 10.1034/j.1399-3054.2002.1150309.x; Mohammed A., 2005, RES J AGR BIOL SCI, V1, P38; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parida Asish, 2002, Journal of Plant Biology, V45, P28; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Prochazkova D, 2007, BIOL PLANTARUM, V51, P401, DOI 10.1007/s10535-007-0088-7; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rossignol M, 2006, PROTEOMICS, V6, P5529, DOI 10.1002/pmic.200600260; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Saqib M, 2006, J PLANT NUTR SOIL SC, V169, P542, DOI 10.1002/jpln.200520557; Sharma P., 2012, J BOT; Shen W, 2001, PLANT PHYSIOL, V125, P1429, DOI 10.1104/pp.125.3.1429; Sivakumar P, 2000, BIOCHEM BIOPH RES CO, V279, P512, DOI 10.1006/bbrc.2000.4005; Srivastava S, 2006, PLANT BIOTECHNOL J, V4, P529, DOI 10.1111/j.1467-7652.2006.00201.x; Talei D, 2013, BIOTECHNOL APPL BIOC, V2013, DOI [10.1155/2013/319047, DOI 10.1155/2013/319047]; Talei D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/319047; Talei D, 2012, MAYDICA, V57, P98; Talei D, 2013, EUPHYTICA, V189, P147, DOI 10.1007/s10681-012-0782-1; Valdiani A, 2014, GENE, V542, P156, DOI 10.1016/j.gene.2014.03.039; Valdiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087034; Valdiani A, 2012, SCI WORLD J, DOI 10.1100/2012/297545; Valdiani A, 2012, GENE, V505, P23, DOI 10.1016/j.gene.2012.05.056; Valdiani A, 2012, MOL BIOL REP, V39, P5409, DOI 10.1007/s11033-011-1341-x; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	56	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112907	10.1371/journal.pone.0112907	http://dx.doi.org/10.1371/journal.pone.0112907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423252	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700016
J	Van Huffel, L; Tomson, CRV; Ruige, J; Nistor, I; Van Biesen, W; Bolignano, D				Van Huffel, Liesbeth; Tomson, Charles R. V.; Ruige, Johannes; Nistor, Ionut; Van Biesen, Wim; Bolignano, Davide			Dietary Restriction and Exercise for Diabetic Patients with Chronic Kidney Disease: A Systematic Review	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY PARADOX; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; SEVERE HYPOGLYCEMIA; GLYCEMIC CONTROL; HOSPITAL STAY; MUSCLE MASS; ALL-CAUSE	Background: Obesity and sedentary lifestyle are major health problems and key features to develop cardiovascular disease. Data on the effects of lifestyle interventions in diabetics with chronic kidney disease (CKD) have been conflicting. Study Design: Systematic review. Population: Diabetes patients with CKD stage 3 to 5. Search Strategy and Sources: Medline, Embase and Central were searched to identify papers. Intervention: Effect of a negative energy balance on hard outcomes in diabetics with CKD. Outcomes: Death, cardiovascular events, glycaemic control, kidney function, metabolic parameters and body composition. Results: We retained 11 studies. There are insufficient data to evaluate the effect on mortality to promote negative energy balance. None of the studies reported a difference in incidence of Major Adverse Cardiovascular Events. Reduction of energy intake does not alter creatinine clearance but significantly reduces proteinuria (mean difference from -0.66 to -1.77 g/24 h). Interventions with combined exercise and diet resulted in a slower decline of eGFR (-9.2 vs. -20.7 mL/min over two year observation; p<0.001). Aerobic and resistance exercise reduced HbA1c (-0.51 (-0.87 to -0.14); p=0.007 and -0.38 (-0.72 to -0.22); p=0.038, respectively). Exercise interventions improve the overall functional status and quality of life in this subgroup. Aerobic exercise reduces BMI (-0.74% (-1.29 to -0.18); p=0.009) and body weight (-2.2 kg (-3.9 to -0.6); p=0.008). Resistance exercise reduces trunk fat mass (-0,7+/-0,1 vs. +0,8 kg +/-0,1 kg; p=0,001-0,005). In none of the studies did the intervention cause an increase in adverse events. Limitations: All studies used a different intervention type and mixed patient groups. Conclusions: There is insufficient evidence to evaluate the effect of negative energy balance interventions on mortality in diabetic patients with advanced CKD. Overall, these interventions have beneficial effects on glycaemic control, BMI and body composition, functional status and quality of life, and no harmful effects were observed.	[Van Huffel, Liesbeth; Ruige, Johannes] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Van Huffel, Liesbeth; Nistor, Ionut; Van Biesen, Wim; Bolignano, Davide] Ghent Univ Hosp, ERBP, Ghent, Belgium; [Tomson, Charles R. V.] Southmead Hosp, Richard Bright Kidney Unit, Bristol, Avon, England; [Nistor, Ionut] Univ Med & Pharm Gr T Popa, Dr CI Parhon Univ Hosp, Iasi, Romania; [Van Biesen, Wim] Ghent Univ Hosp, Div Renal, Ghent, Belgium; [Bolignano, Davide] CNR Inst Clin Physiol, Reggio Di Calabria, Italy	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Southmead Hospital; Grigore T Popa University of Medicine & Pharmacy; Ghent University; Ghent University Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Van Biesen, W (corresponding author), Ghent Univ Hosp, ERBP, Ghent, Belgium.	guidelines@era-edta.org	Biguzzi, Felipe A/E-4724-2015; Bolignano, Davide/AAB-3232-2019	Bolignano, Davide/0000-0003-3032-245X; Tomson, Charles/0000-0002-0224-8726				Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Abdulla J, 2008, EUR HEART J, V29, P594, DOI 10.1093/eurheartj/ehn010; Afshinnia F, 2010, NEPHROL DIAL TRANSPL, V25, P1173, DOI 10.1093/ndt/gfp640; Balducci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049297; Bolignano D, 2013, NEPHROL DIAL TRANSPL, V28, P82, DOI 10.1093/ndt/gft302; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Cappy C S, 1999, J Ren Nutr, V9, P63; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Centers for Disease Control and Prevention (CDC), 2014, NAT CHRON KIDN DIS F; Chen PY, 2010, J NURS RES, V18, P98, DOI 10.1097/JNR.0b013e3181dda726; Fleischmann E, 1999, KIDNEY INT, V55, P1560, DOI 10.1046/j.1523-1755.1999.00389.x; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Heiwe S, 2011, COCHRANE DB SYST REV, V5; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Huang CX, 2010, KIDNEY INT, V77, P624, DOI 10.1038/ki.2009.524; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Kalantar-Zadeh K, 2010, MAYO CLIN PROC, V85, P991, DOI 10.4065/mcp.2010.0336; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Leehey DJ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-62; MacLaughlin HL, 2010, AM J KIDNEY DIS, V55, P69, DOI 10.1053/j.ajkd.2009.09.011; MARCKMANN P, 1989, J INTERN MED, V226, P429, DOI 10.1111/j.1365-2796.1989.tb01419.x; Matsuoka Kempei, 1991, Journal of Diabetic Complications, V5, P98, DOI 10.1016/0891-6632(91)90032-K; McAuley PA, 2012, MAYO CLIN PROC, V87, P443, DOI 10.1016/j.mayocp.2012.01.013; McCoy RG, 2013, ENDOCR PRACT, V19, P792, DOI 10.4158/EP12382.OR; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; Noori N, 2010, AM J CLIN NUTR, V92, P1060, DOI 10.3945/ajcn.2010.29188; Norris SL, 2005, COCHRANE DB SYST REV, V3; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Ramkumar N, 2005, PERITON DIALYSIS INT, V25, P461; Saiki A, 2005, INT J OBESITY, V29, P1115, DOI 10.1038/sj.ijo.0803009; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; SOLERTE SB, 1989, INT J OBESITY, V13, P203; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Tawney KW, 2000, AM J KIDNEY DIS, V36, P581, DOI 10.1053/ajkd.2000.16197; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Wang JL, 2012, NEPHRON CLIN PRACT, V121, pC102, DOI 10.1159/000345159; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Zhao YN, 2012, DIABETES CARE, V35, P1126, DOI 10.2337/dc11-2048; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	46	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113667	10.1371/journal.pone.0113667	http://dx.doi.org/10.1371/journal.pone.0113667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423489	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700050
J	Droogendyk, L; Wright, SC				Droogendyk, Lisa; Wright, Stephen C.			Perceptions of Interpersonal Versus Intergroup Violence: The Case of Sexual Assault	PLOS ONE			English	Article								The social identity approach makes a distinction between behavior motivated by intergroup versus interpersonal identities, which may be relevant to victim blaming in the case of rape. Using a mock jury paradigm, we examined the impact of defining rape as an act of interpersonal violence (personal assault) versus intergroup violence (a "hate crime''), crossed with a manipulation describing the attacker as either an acquaintance or stranger. Defining rape in intergroup terms led to less victim blame than when it was defined in interpersonal terms, and participants blamed the victim more when she was assaulted by an acquaintance than a stranger.	[Droogendyk, Lisa; Wright, Stephen C.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Droogendyk, L (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	ldroogen@sfu.ca						BAGBY RM, 1992, EUR J SOC PSYCHOL, V22, P397, DOI 10.1002/ejsp.2420220408; BELL ST, 1994, J APPL SOC PSYCHOL, V24, P1719, DOI 10.1111/j.1559-1816.1994.tb01571.x; Bieneck S, 2011, J INTERPERS VIOLENCE, V26, P1785, DOI 10.1177/0886260510372945; BRIDGES JS, 1989, SEX ROLES, V21, P273, DOI 10.1007/BF00289907; Brownmiller S., 1976, OUR WILL MEN WOMEN R; Carney KM, 2001, STJOHNS LAW REV, V75, P315; Cruwys T, 2015, SOC PSYCHOL PERS SCI, V6, P65, DOI 10.1177/1948550614543309; DONAT PLN, 1992, J SOC ISSUES, V48, P9, DOI 10.1111/j.1540-4560.1992.tb01154.x; Drury J, 2009, BRIT J SOC PSYCHOL, V48, P487, DOI 10.1348/014466608X357893; Frese B, 2004, J INTERPERS VIOLENCE, V19, P143, DOI 10.1177/0886260503260245; Greer G., 1971, FEMALE EUNUCH; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Haslam SA, 2005, INT REV IND ORG PSYC, V20; Johnson KP, 1995, FAMILY CONSUMER SCI, DOI DOI 10.1177/1077727X95233004; JONES C, 1973, J PERS SOC PSYCHOL, V26, P415, DOI 10.1037/h0034463; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Lerner M.J., 1980, BELIEF JUST WORLD PE, DOI DOI 10.1007/978-1-4899-0448-5_2; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; Masser B, 2010, SEX ROLES, V62, P494, DOI 10.1007/s11199-009-9648-y; Mazelan Patti, 1980, VICTIMOLOGY, V5, P121; McKimmie BM, 2013, PSYCHOL PUBLIC POL L, V19, P343, DOI 10.1037/a0030505; Pilkington E., 2011, GUARDIAN; POLLARD P, 1992, BRIT J SOC PSYCHOL, V31, P307, DOI 10.1111/j.2044-8309.1992.tb00975.x; Rothschild E, 1993, MARYLAND J CONT LEGA, V4, P231; Schoen M, 2013, IEEE INT SYMP POWER; Stormo KJ, 1997, J APPL SOC PSYCHOL, V27, P279, DOI 10.1111/j.1559-1816.1997.tb00633.x; Stott C, 2001, BRIT J SOC PSYCHOL, V40, P359, DOI 10.1348/014466601164876; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Turner J.C., 1987, REDISCOVERING SOCIAL; Viki GT, 2004, LAW HUMAN BEHAV, V28, P295, DOI 10.1023/B:LAHU.0000029140.72880.69; Workman JE, 1999, SEX ROLES, V41, P261, DOI 10.1023/A:1018858313267	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112365	10.1371/journal.pone.0112365	http://dx.doi.org/10.1371/journal.pone.0112365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IM	25419567	Green Published, gold			2022-12-27	WOS:000346766900007
J	Miller, F; Burghard, A; Salcher, R; Scheper, V; Leibold, W; Lenarz, T; Paasche, G				Miller, Felicitas; Burghard, Alice; Salcher, Rolf; Scheper, Verena; Leibold, Wolfgang; Lenarz, Thomas; Paasche, Gerrit			Treatment of Middle Ear Ventilation Disorders: Sheep as Animal Model for Stenting the Human Eustachian Tube - A Cadaver Study	PLOS ONE			English	Article							DYSFUNCTION; ANATOMY; TOLERABILITY; PROSTHESIS; TUBOPLASTY; SAFETY; PIG	Eustachian tube disorders can lead to chronic otitis media with consecutive conductive hearing loss. To improve treatment and to develop new types of implants such as stents, an adequate experimental animal model is required. As the middle ear of sheep is known to be comparable to the human middle ear, the dimensions of the Eustachian tube in two strains of sheep were investigated. The Eustachian tube and middle ear of half heads of heathland and blackface sheep were filled with silicone rubber, blended with barium sulfate to induce X-ray visibility. Images were taken by digital volume tomography. The tubes were segmented, and a three-dimensional model of every Eustachian tube was generated. The lengths, diameters and shapes were determined. Additionally, the feasibility of endoscopic stent implantation and fixation was tested in cadaver experiments. The length of the tube between ostium pharyngeum and the isthmus and the diameters were comparable to published values for the human tube. The tube was easily accessible through the nose, and then stents could be implanted and fixed at the isthmus. The sheep appears to be a promising model for testing new stent treatments for middle ear ventilation disorders.	[Miller, Felicitas; Burghard, Alice; Salcher, Rolf; Scheper, Verena; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Leibold, Wolfgang] Univ Vet Med Hannover, Dept Immunol, Hannover, Germany; [Scheper, Verena; Lenarz, Thomas; Paasche, Gerrit] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Paasche, G (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Paasche.Gerrit@mh-hannover.de	Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793; Burghard, Alice/0000-0002-6482-1815	German Federal Ministry of Education and Research (BMBF) [FKZ 03IS2081E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF) as part of REMEDIS: Higher quality of life through novel micro-implants (FKZ 03IS2081E). URL: www.bmbf.de; http://remedis.med.uni-rostock.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezold F., 1882, CORROSIONS ANATOMIE; BROWNING GG, 1992, CLIN OTOLARYNGOL, V17, P317, DOI 10.1111/j.1365-2273.1992.tb01004.x; Granstrom G, 2009, PERIODONTOL 2000, V49, P179, DOI 10.1111/j.1600-0757.2008.00281.x; Gurr A, 2010, LARYNGO RHINO OTOL, V89, P17, DOI 10.1055/s-0029-1224158; Lang J, 1992, KLIN ANATOMIE OHRES, P92; LESINSKI SG, 1980, LARYNGOSCOPE, V90, P1413; Lieberum B, 1996, HNO, V44, P140; Litner JA, 2009, J INT ADV OTOL, V5, P290; McCoul ED, 2012, LARYNGOSCOPE, V122, P718, DOI 10.1002/lary.23181; Ockermann T, 2010, LARYNGOSCOPE, V120, P1411, DOI 10.1002/lary.20950; Pahnke J., 2000, LARYNGORHINOOTOLOGIE, V79, pS1; Pahnke J, 1991, THESIS WURZBURG; Pau HW, 2011, HNO, V59, P953, DOI 10.1007/s00106-011-2368-y; Poe DS, 2011, AM J OTOLARYNG, V32, P115, DOI 10.1016/j.amjoto.2009.11.008; Poe DS, 2001, OTOL NEUROTOL, V22, P590, DOI 10.1097/00129492-200109000-00005; Pracy JP, 1998, J ANAT, V192, P359, DOI 10.1046/j.1469-7580.1998.19230359.x; Presti P, 2011, J INT ADV OTOL, V7, P1; PROCTOR B, 1967, ARCHIV OTOLARYNGOL, V86, P503; PROCTOR B, 1973, ARCH OTOLARYNGOL, V97, P2; Schnabl J, 2012, OTOL NEUROTOL, V33, P481, DOI 10.1097/MAO.0b013e318248ee3a; Schroder S, 2013, HNO, V61, P142, DOI 10.1007/s00106-012-2573-3; Schrom T, 2007, HNO, V55, P871, DOI 10.1007/s00106-007-1539-3; Steinbach E, 1991, ARCH OTORHINOLARYN S, V2, P271; SUCHESTON ME, 1971, ARCHIV OTOLARYNGOL, V93, P58; Sudhoff H, 2009, HNO, V57, P428, DOI 10.1007/s00106-009-1908-1; WRIGHT JW, 1977, LARYNGOSCOPE, V87, P207; ZOLLNER F, 1955, J Laryngol Otol, V69, P637, DOI 10.1017/S0022215100051240	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113906	10.1371/journal.pone.0113906	http://dx.doi.org/10.1371/journal.pone.0113906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419714	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900079
J	Chattaway, MA; Jenkins, C; Rajendram, D; Cravioto, A; Talukder, KA; Dallman, T; Underwood, A; Platt, S; Okeke, IN; Wain, J				Chattaway, Marie Anne; Jenkins, Claire; Rajendram, Dunstan; Cravioto, Alejandro; Talukder, Kaisar Ali; Dallman, Tim; Underwood, Anthony; Platt, Steve; Okeke, Iruka N.; Wain, John			Enteroaggregative Escherichia coli Have Evolved Independently as Distinct Complexes within the E-coli Population with Varying Ability to Cause Disease	PLOS ONE			English	Article							DIARRHEAL DISEASE; DNA PROBE; ADHERENCE; GENETICS; STRAINS; CASE/CONTROL; EXPRESSION; VIRULENCE; OUTBREAK; ENGLAND	Enteroaggregative E. coli (EAEC) is an established diarrhoeagenic pathotype. The association with virulence gene content and ability to cause disease has been studied but little is known about the population structure of EAEC and how this pathotype evolved. Analysis by Multi Locus Sequence Typing of 564 EAEC isolates from cases and controls in Bangladesh, Nigeria and the UK spanning the past 29 years, revealed multiple successful lineages of EAEC. The population structure of EAEC indicates some clusters are statistically associated with disease or carriage, further highlighting the heterogeneous nature of this group of organisms. Different clusters have evolved independently as a result of both mutational and recombination events; the EAEC phenotype is distributed throughout the population of E. coli.	[Chattaway, Marie Anne; Jenkins, Claire; Dallman, Tim] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Rajendram, Dunstan] Publ Hlth England, Genom Serv Unit, London, England; [Cravioto, Alejandro; Talukder, Kaisar Ali] Int Vaccine Inst, Seoul, South Korea; [Cravioto, Alejandro] Int Ctr Diarrhoeal Dis Res, Ctr Food & Water Borne Dis, Dhaka 1000, Bangladesh; [Underwood, Anthony; Platt, Steve] PHE, Bioinformat, London, England; [Okeke, Iruka N.] Haverford Coll, Haverford, PA 19041 USA; [Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	Public Health England; Public Health England; International Vaccine Institute; International Centre for Diarrhoeal Disease Research (ICDDR); Haverford College; University of East Anglia	Chattaway, MA (corresponding author), Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England.	marie.chattaway@phe.gov.uk	Okeke, Iruka N/N-1595-2019; Dallman, Timothy J/ABD-6662-2021; Wain, John Richard/B-3446-2013	Okeke, Iruka N/0000-0002-1694-7587; Chattaway, Marie Anne/0000-0002-5288-9089; Wain, John Richard/0000-0002-1257-1148; Underwood, Anthony/0000-0002-8547-4277	Gastrointestinal Bacteria Reference Unit, Public Health England; International Centre for Diarrhoeal Disease Research, Bangladesh; Society for Applied Microbiology; US National Science Foundation [1329248, 0948460]; Society for General Microbiology	Gastrointestinal Bacteria Reference Unit, Public Health England; International Centre for Diarrhoeal Disease Research, Bangladesh; Society for Applied Microbiology; US National Science Foundation(National Science Foundation (NSF)); Society for General Microbiology	Funding: This study was supported by Gastrointestinal Bacteria Reference Unit, Public Health England, International Centre for Diarrhoeal Disease Research, Bangladesh, Society for Applied Microbiology (Supervisor fund), the US National Science Foundation (Awards #1329248 and #0948460) and Society for General Microbiology (Presidents fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Beutin L, 2005, J CLIN MICROBIOL, V43, P703, DOI 10.1128/JCM.43.2.703-710.2005; Castellani A, 2005, BERGYS MANUAL SYSTEM, P607; Chattaway M, 2013, EUROSURVEILLANCE, P18; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Dallman T, 2012, J CLIN MICROBIOL, V50, P4116, DOI 10.1128/JCM.02047-12; Dallman TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098103; Didelot X, CLONALFRAME USER GUI; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Galtier N, 2007, SYSTEMATIC BIOL, V56, P633, DOI 10.1080/10635150701546231; Gross R. J., 1985, The virulence of Escherichia coli, P345; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Spencer J, 1999, EPIDEMIOL INFECT, V123, P413, DOI 10.1017/S0950268899002976; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112967	10.1371/journal.pone.0112967	http://dx.doi.org/10.1371/journal.pone.0112967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415318	Green Published, gold, Green Accepted			2022-12-27	WOS:000346906600022
J	Radbruch, A; Eidel, O; Wiestler, B; Paech, D; Burth, S; Kickingereder, P; Nowosielski, M; Baumer, P; Wick, W; Schlemmer, HP; Bendszus, M; Ladd, M; Nagel, AM; Heiland, S				Radbruch, Alexander; Eidel, Oliver; Wiestler, Benedikt; Paech, Daniel; Burth, Sina; Kickingereder, Philipp; Nowosielski, Martha; Bauemer, Philipp; Wick, Wolfgang; Schlemmer, Heinz-Peter; Bendszus, Martin; Ladd, Mark; Nagel, Armin Michael; Heiland, Sabine			Quantification of Tumor Vessels in Glioblastoma Patients Using Time-of-Flight Angiography at 7 Tesla: A Feasibility Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; VASCULAR-PERMEABILITY; MR-ANGIOGRAPHY; BLOOD-VESSELS; ANGIOGENESIS; ENHANCEMENT; GLIOMAS; BRAIN; BEVACIZUMAB; ARTERIES	Purpose: To analyze if tumor vessels can be visualized, segmented and quantified in glioblastoma patients with time of flight (ToF) angiography at 7 Tesla and multiscale vessel enhancement filtering. Materials and Methods: Twelve patients with newly diagnosed glioblastoma were examined with ToF angiography (TR=15 ms, TE=4.8 ms, flip angle=15 degrees, FOV=160x210 mm(2), voxel size: 0.31x0.31x0.40 mm(3)) on a whole-body 7 T MR system. A volume of interest (VOI) was placed within the border of the contrast enhancing part on T1-weighted images of the glioblastoma and a reference VOI was placed in the non-affected contralateral white matter. Automated segmentation and quantification of vessels within the two VOIs was achieved using multiscale vessel enhancement filtering in ImageJ. Results: Tumor vessels were clearly visible in all patients. When comparing tumor and the reference VOI, total vessel surface (45.3+/-13.9 mm2 vs. 29.0+/- 21.0 mm(2) (p<0.035)) and number of branches (3.5+/- 1.8 vs. 1.0+/- 0.6 (p, 0.001) per cubic centimeter were significantly higher, while mean vessel branch length was significantly lower (3.8+/- 1.5 mm vs 7.2+/- 2.8 mm (p, 0.001)) in the tumor. Discussion: ToF angiography at 7-Tesla MRI enables characterization and quantification of the internal vascular morphology of glioblastoma and may be used for the evaluation of therapy response within future studies.	[Radbruch, Alexander; Eidel, Oliver; Paech, Daniel; Burth, Sina; Kickingereder, Philipp; Nowosielski, Martha; Bauemer, Philipp; Bendszus, Martin; Heiland, Sabine] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Baden Wurttembe, Germany; [Radbruch, Alexander; Schlemmer, Heinz-Peter] German Canc Res Ctr, Heidelberg, Baden Wurttembe, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Baden Wurttembe, Germany; [Nowosielski, Martha] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Ladd, Mark; Nagel, Armin Michael] German Canc Res Ctr, Dept Med Phys, Heidelberg, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Baden Wurttembe, Germany.	a.radbruch@dkfz.de	Nowosielski, Martha/AAD-5442-2022; Wick, Wolfgang/AAA-2545-2020; Nagel, Armin M/C-4671-2016; Vollmuth, Philipp/AAK-3267-2021; Radbruch, Alexander/ABA-6277-2021	Wick, Wolfgang/0000-0002-6171-634X; Nagel, Armin M/0000-0003-0948-1421; Radbruch, Alexander/0000-0001-6238-6525; Wiestler, Benedikt/0000-0002-2963-7772; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Paech, Daniel/0000-0001-5755-6833; Ladd, Mark/0000-0002-4128-9440	Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)	Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)	Funding: This research was supported by a grant of the "Intramurales Forderprogramm of the German Cancer Research Cneter (DKFZ)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Arjaans M, 2013, CANCER RES, V73, P3347, DOI 10.1158/0008-5472.CAN-12-3518; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Budai A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/154860; Cain RJ, 2011, METHODS MOL BIOL, V769, P167, DOI 10.1007/978-1-61779-207-6_12; Chapman BE, 2005, MED IMAGE ANAL, V9, P191, DOI 10.1016/j.media.2004.08.001; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Gagner JP, 2005, BRAIN PATHOL, V15, P342; Gerstner ER, 2008, CURR OPIN NEUROL, V21, P728, DOI 10.1097/WCO.0b013e328318402a; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kang CK, 2009, MAGN RESON MED, V61, P136, DOI 10.1002/mrm.21786; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kraff O, 2014, J MAGN RESON IMAGING; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Liem MK, 2010, STROKE, V41, P2812, DOI 10.1161/STROKEAHA.110.586883; Marks Peter C, 2013, Open Med Imaging J, V7, P19; Martin-Vaquero P, 2011, AM J VET RES, V72, P350, DOI 10.2460/ajvr.72.3.350; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitter S, 2013, MAGN RESON MED; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; VANTYEN R, 1994, MAGNET RESON MED, V31, P184, DOI 10.1002/mrm.1910310212; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Westin CF, 2001, J MAGN RESON IMAGING, V14, P63, DOI 10.1002/jmri.1152; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YUAN F, 1994, CANCER RES, V54, P4564; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	36	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110727	10.1371/journal.pone.0110727	http://dx.doi.org/10.1371/journal.pone.0110727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415327	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600004
J	Xu, XJ; Liu, JX; Zeng, X; Lu, FF; Chen, AM; Huo, X				Xu, Xijin; Liu, Junxiao; Zeng, Xiang; Lu, Fangfang; Chen, Aimin; Huo, Xia			Elevated Serum Polybrominated Diphenyl Ethers and Alteration of Thyroid Hormones in Children from Guiyu, China	PLOS ONE			English	Article							WASTE RECYCLING TOWN; POLYCHLORINATED-BIPHENYLS PCBS; UMBILICAL-CORD BLOOD; ELECTRONIC-WASTE; BREAST-MILK; ORGANOCHLORINE PESTICIDES; PRENATAL EXPOSURE; FLAME RETARDANTS; CADMIUM EXPOSURE; RELEVANT FACTORS	Informal electronic waste (e-waste) recycling results in serious environmental pollution of polybrominated diphenyl ethers (PBDEs) and heavy metals. This study explored whether there is an association between PBDEs, heavy metal and key growth-and development-related hormones in children from Guiyu, an e-waste area in southern China. We quantified eight PBDE congeners using gas chromatographic mass spectrometry, lead and cadmium utilizing graphite furnace atomic absorption spectrometry, three thyroids with radioimmunoassay and two types of growth hormones by an enzyme-linked immune-sorbent assay (ELISA) in 162 children, 4 to 6 years old, from Guiyu. In blood, median total PBDE was 189.99 ng/g lipid. Lead and cadmium concentrations in blood averaged 14.53 +/- 4.85 mu g dL(-1) and 0.77 +/- 0.35 mu g L-1, respectively. Spearman partial correlation analysis illustrated that lead was positively correlated with BDE153 and BDE183. Thyroid-stimulating hormone (TSH) was positively correlated with almost all PBDE congeners and negatively correlated with insulin-like growth factor binding protein-3 (IGFBP-3), whereas free triiodothyronine (FT3) and free thyroxine (FT4) were negatively correlated with BDE154. However, no correlation between the hormones and blood lead or cadmium levels was found in this study. Adjusted multiple linear regression analysis showed that total PBDEs was negatively associated with FT3 and positively associated with TSH. Notably, FT4 was positively correlated with FT3, house functions as a workshop, and father's work involved in e-waste recycling and negatively correlated with vitamin consumptions. TSH was negatively related with FT4, paternal residence time in Guiyu, working hours of mother, and child bean products intake. IGFBP-3 was positively correlated with IGF-1 and house close to an e-waste dump. These results suggest that elevated PBDEs and heavy metals related to e-waste in Guiyu may be important risk factors for hormone alterations in children.	[Xu, Xijin; Liu, Junxiao; Zeng, Xiang; Lu, Fangfang; Huo, Xia] Shantou Univ, Coll Med, Lab Environm Med & Dev Toxicol, Shantou, Peoples R China; [Xu, Xijin; Liu, Junxiao; Zeng, Xiang; Lu, Fangfang; Huo, Xia] Shantou Univ, Coll Med, Prov Key Lab Infect Dis & Mol Immunopathol, Shantou, Peoples R China; [Xu, Xijin] Shantou Univ, Coll Med, Dept Cell Biol & Genet, Shantou, Peoples R China; [Zeng, Xiang] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Chen, Aimin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH 45267 USA	Shantou University; Shantou University; Shantou University; University of Groningen; University System of Ohio; University of Cincinnati	Huo, X (corresponding author), Shantou Univ, Coll Med, Lab Environm Med & Dev Toxicol, Shantou, Peoples R China.	xhuo@stu.edu.cn		Huo, Xia/0000-0002-2102-4840; Xu, Xijin/0000-0003-2094-3164; Chen, Aimin/0000-0001-9713-6438	National Natural Science Foundation of China [21377077]; Project of International Cooperation and Innovation Platform in Guangdong Universities [2013gjhz0007]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC4ES019755, P30ES006096] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of International Cooperation and Innovation Platform in Guangdong Universities; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Natural Science Foundation of China (21377077) and Project of International Cooperation and Innovation Platform in Guangdong Universities (2013gjhz0007) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahab N, 2008, ENVIRON RES, V107, P380, DOI 10.1016/j.envres.2008.01.006; Alabi OA, 2012, SCI TOTAL ENVIRON, V423, P62, DOI 10.1016/j.scitotenv.2012.01.056; Betts KS, 2012, ENVIRON HEALTH PERSP, V120, pA268, DOI 10.1289/ehp.120-a268; Boada LD, 2007, GROWTH HORM IGF RES, V17, P506, DOI 10.1016/j.ghir.2007.05.004; Cao Y, 2009, ENVIRON HEALTH PERSP, V117, P1580, DOI 10.1289/ehp.0900765; Caride A, 2010, J PHYSIOL BIOCHEM, V66, P213, DOI 10.1007/s13105-010-0027-5; Carrizo D, 2007, ENVIRON SCI TECHNOL, V41, P4907, DOI 10.1021/es070217u; Chen AM, 2011, ENVIRON HEALTH PERSP, V119, P431, DOI 10.1289/ehp.1002452; Chen C, 2010, ENVIRON INT, V36, P163, DOI 10.1016/j.envint.2009.10.009; Chen LG, 2006, ENVIRON SCI TECHNOL, V40, P1190, DOI 10.1021/es052123v; Chevrier J, 2010, ENVIRON HEALTH PERSP, V118, P1444, DOI 10.1289/ehp.1001905; Christensen KLY, 2013, INT J HYG ENVIR HEAL, V216, P624, DOI 10.1016/j.ijheh.2012.08.005; Covaci A, 2005, J CHROMATOGR B, V827, P216, DOI 10.1016/j.jchromb.2005.09.020; Dundar B, 2006, ENVIRON RES, V101, P140, DOI 10.1016/j.envres.2005.10.002; Eljarrat E, 2004, ENVIRON SCI TECHNOL, V38, P2603, DOI 10.1021/es0301424; Eskenazi B, 2011, ENVIRON HEALTH PERSP, V119, P1442, DOI 10.1289/ehp.1002874; Fangstrom B, 2005, ENVIRON SCI TECHNOL, V39, P9457, DOI 10.1021/es0513032; Fischer D, 2006, ENVIRON HEALTH PERSP, V114, P1581, DOI 10.1289/ehp.8554; FRANKLIN RC, 1985, ARCH DIS CHILD, V60, P141, DOI 10.1136/adc.60.2.141; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Hallgren S, 2002, TOXICOLOGY, V177, P227, DOI 10.1016/S0300-483X(02)00222-6; Hallgren S, 2001, ARCH TOXICOL, V75, P200, DOI 10.1007/s002040000208; Han GG, 2011, BIOMED ENVIRON SCI, V24, P112, DOI 10.3967/0895-3988.2011.02.004; Harley KG, 2011, AM J EPIDEMIOL, V174, P885, DOI 10.1093/aje/kwr212; Herbstman JB, 2008, ENVIRON HEALTH PERSP, V116, P1376, DOI 10.1289/ehp.11379; Hooper K, 2000, ENVIRON HEALTH PERSP, V108, P387, DOI 10.2307/3454377; Huo X, 2007, ENVIRON HEALTH PERSP, V115, P1113, DOI 10.1289/ehp.9697; Inoue K, 2006, ENVIRON HEALTH PERSP, V114, P1179, DOI 10.1289/ehp.9032; Jin J, 2009, ENVIRON INT, V35, P1048, DOI 10.1016/j.envint.2009.05.006; Johnsen SP, 2004, EUR J EPIDEMIOL, V19, P41, DOI 10.1023/B:EJEP.0000013396.40006.8f; Kim UJ, 2012, ENVIRON SCI TECHNOL, V46, P6261, DOI 10.1021/es2038678; Kortenkamp A, 2011, METAL IONS LIFE SCI, V8, P305, DOI 10.1039/978184973211600305; Labunsk I, 2013, ENVIRON SCI-PROC IMP, V15, P503, DOI 10.1039/c2em30785e; Lagiou P, 2014, EUR J EPIDEMIOL, V29, P343, DOI 10.1007/s10654-014-9914-3; Li LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062526; Li Y, 2011, ENVIRON MONIT ASSESS, V177, P343, DOI 10.1007/s10661-010-1638-6; Lindberg P, 2004, ENVIRON SCI TECHNOL, V38, P93, DOI 10.1021/es034614q; Link B, 2005, CHEMOSPHERE, V58, P1185, DOI 10.1016/j.chemosphere.2004.09.061; Liu JX, 2011, NEUROTOXICOLOGY, V32, P458, DOI 10.1016/j.neuro.2011.03.012; Lunder S, 2010, ENVIRON SCI TECHNOL, V44, P5256, DOI 10.1021/es1009357; Luo Q, 2007, TALANTA, V72, P1644, DOI 10.1016/j.talanta.2007.03.012; Luo Y, 2009, SCI TOTAL ENVIRON, V407, P1105, DOI 10.1016/j.scitotenv.2008.10.044; Mazdai A, 2003, ENVIRON HEALTH PERSP, V111, P1249, DOI 10.1289/ehp.6146; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; Morck A, 2003, DRUG METAB DISPOS, V31, P900, DOI 10.1124/dmd.31.7.900; Ogunseitan OA, 2009, SCIENCE, V326, P670, DOI 10.1126/science.1176929; PENNY R, 1983, J CLIN ENDOCR METAB, V56, P177, DOI 10.1210/jcem-56-1-177; Perez-Maldonado IN, 2009, CHEMOSPHERE, V75, P1215, DOI 10.1016/j.chemosphere.2009.01.083; Qu WY, 2007, ENVIRON INT, V33, P1029, DOI 10.1016/j.envint.2007.05.009; Ramos JJ, 2007, J CHROMATOGR A, V1152, P124, DOI 10.1016/j.chroma.2006.12.050; Rice DC, 2007, NEUROTOXICOL TERATOL, V29, P511, DOI 10.1016/j.ntt.2007.03.061; Shen HT, 2010, CHEMOSPHERE, V80, P170, DOI 10.1016/j.chemosphere.2010.03.012; Shy CG, 2012, INT J HYG ENVIR HEAL, V215, P345, DOI 10.1016/j.ijheh.2011.10.004; Sly J. Leith, 2012, Reviews on Environmental Health, V27, P151, DOI 10.1515/reveh-2012-0024; Ste-Marie N, 2012, AM J EPIDEMIOL, V176, P80; Suciu N, 2013, HDB ENV CHEM, V23, P349; Talsness CE, 2008, ENVIRON RES, V108, P158, DOI 10.1016/j.envres.2008.08.008; Thuresson K, 2006, ENVIRON HEALTH PERSP, V114, P176, DOI 10.1289/ehp.8350; Toms LML, 2008, ENVIRON SCI TECHNOL, V42, P7510, DOI 10.1021/es800719v; Turyk ME, 2008, ENVIRON HEALTH PERSP, V116, P1635, DOI 10.1289/ehp.11707; Wang HM, 2010, INT J HYG ENVIR HEAL, V213, P369, DOI 10.1016/j.ijheh.2010.06.004; Wu KS, 2010, ENVIRON SCI TECHNOL, V44, P813, DOI 10.1021/es9024518; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Xu PW, 2014, SCI TOTAL ENVIRON, V499, P55, DOI 10.1016/j.scitotenv.2014.08.057; Xu XJ, 2013, ENVIRON POLLUT, V182, P63, DOI 10.1016/j.envpol.2013.07.005; Yang H, 2013, ENVIRON SCI POLLUT R, V20, P4441, DOI 10.1007/s11356-012-1366-2; Zhai WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092465; Zhang JQ, 2010, ENVIRON SCI TECHNOL, V44, P3956, DOI 10.1021/es902883a; Zhang QY, 2011, SCI TOTAL ENVIRON, V410, P53, DOI 10.1016/j.scitotenv.2011.09.032; Zhang SH, 2014, CHEMOSPHERE, V102, P55, DOI 10.1016/j.chemosphere.2013.12.020; Zhao YX, 2013, ENVIRON SCI TECHNOL, V47, P5939, DOI 10.1021/es305349x; Zheng GN, 2013, J EXPO SCI ENV EPID, V23, P67, DOI 10.1038/jes.2012.84; Zheng LK, 2008, ENVIRON RES, V108, P15, DOI 10.1016/j.envres.2008.04.002; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zota AR, 2011, ENVIRON SCI TECHNOL, V45, P7896, DOI 10.1021/es200422b	75	27	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113699	10.1371/journal.pone.0113699	http://dx.doi.org/10.1371/journal.pone.0113699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415336	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600071
J	Back, M; Avignon, A; Stanke-Labesque, F; Boegner, C; Attalin, V; Leprieur, E; Sultan, A				Back, Magnus; Avignon, Antoine; Stanke-Labesque, Francoise; Boegner, Catherine; Attalin, Vincent; Leprieur, Elodie; Sultan, Ariane			Leukotriene Production Is Increased in Abdominal Obesity	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; AIRWAY INFLAMMATION; ASTHMA; DISEASE; ATHEROSCLEROSIS; RECEPTOR; PROTEIN	Obesity is a major risk factor for insulin resistance and type-2 diabetes. A chronic low grade inflammatory state has been described during obesity and associated with insulin resistance pathogenesis. Results from animal studies are in favor of a role of the leukotriene (LT) pathway in obesity induced-insulin resistance. However, there is a paucity of data regarding this association in human obesity. Therefore, the aim of this study was to investigate whether LT production was associated with insulin resistance and other metabolic parameters in a cohort of obese subjects. Forty-six (70% females) obese subjects (BMI >= 30 kg/m(2)) without known diabetes and without inflammatory disease (CRP<10 mg/l) were included. Median age was 44 years (16-80) with a median BMI of 36.8 kg/m(2) (30-51). Insulin resistance was evaluated by HOMA-IR index and glucose tolerance test. Urinary LTE4 (U-LTE4) concentration was measured by enzyme immune assay. Screening for obstructive sleep apnea was performed. There was a positive association of U-LTE4 with waist to hip ratio, systolic blood pressure and HOMA-IR in univariate analysis. Further, waist to hip ratio remained the only parameter significantly correlated with U-LTE4, in adjusted multivariate analysis. Taken together, these results confirm the previously established notion of chronic low grade inflammation in obesity and further suggests a role for the LT pathway in obesity-associated development of insulin resistance in humans.	[Back, Magnus] Karolinska Inst, Dept Med, Stockholm, Sweden; [Avignon, Antoine; Boegner, Catherine; Attalin, Vincent; Leprieur, Elodie; Sultan, Ariane] CHRU Montpellier, Endocrinol Diabetol Nutr Dept, Montpellier, France; [Avignon, Antoine; Sultan, Ariane] Univ Montpellier I, INSERM, U1046, Montpellier, France; [Stanke-Labesque, Francoise] Univ Grenoble, INSERM, U1042, Grenoble, France	Karolinska Institutet; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Back, M (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	Magnus.Back@ki.se; a-sultan@chu-montpellier.fr	Avignon, Antoine/AAD-5441-2020; Stanke, Francoise/M-7142-2014	Stanke, Francoise/0000-0002-4643-6323	Res Med Foundation (La Jolla, CA, USA); French-Swedish Foundation (Stockholm, Sweden); Swedish Research Council [2011-2988]; Swedish Heart and Lung Foundation [20120474, 20120827]	Res Med Foundation (La Jolla, CA, USA); French-Swedish Foundation (Stockholm, Sweden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	Funding: This study was supported by grants from Res Med Foundation (La Jolla, CA, USA) and the French-Swedish Foundation (Stockholm, Sweden). MB is supported by the Swedish Research Council (grant number 2011-2988), and the Swedish Heart and Lung Foundation (grant numbers 20120474 and 20120827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Back M, 2007, CIRC RES, V100, P946, DOI 10.1161/01.RES.0000264498.60702.0d; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Boizel R, 2010, DIABETOLOGIA, V53, P2068, DOI 10.1007/s00125-010-1822-9; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Elks CM, 2010, CURR HYPERTENS REP, V12, P99, DOI 10.1007/s11906-010-0096-4; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Giouleka P, 2011, EUR J CLIN INVEST, V41, P30, DOI 10.1111/j.1365-2362.2010.02371.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hardy G, 2005, PROSTAG OTH LIPID M, V78, P291, DOI 10.1016/j.prostaglandins.2005.10.001; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; Kaaman M, 2006, INT J OBESITY, V30, P447, DOI 10.1038/sj.ijo.0803147; Lessard A, 2008, CHEST, V134, P317, DOI 10.1378/chest.07-2959; Martinez-Clemente M, 2011, CURR OPIN CLIN NUTR, V14, P347, DOI 10.1097/MCO.0b013e32834777fa; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mothe-Satney I, 2012, DIABETES, V61, P2311, DOI 10.2337/db11-1455; Neels JG, 2013, ADIPOCYTE, V2, P262, DOI 10.4161/adip.24835; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Rafnsson A, 2013, DIS MARKERS, V2013, P475, DOI 10.1155/2013/370461; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Shen YL, 2011, SLEEP, V34, P1135, DOI 10.5665/SLEEP.1178; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Stanke-Labesque F, 2012, J LIPID RES, V53, P1944, DOI 10.1194/jlr.P022814; Stanke-Labesque F, 2009, J ALLERGY CLIN IMMUN, V124, P364, DOI 10.1016/j.jaci.2009.05.033; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; van Veen IH, 2008, ALLERGY, V63, P570, DOI 10.1111/j.1398-9995.2007.01597.x; Won KB, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-41	37	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e104593	10.1371/journal.pone.0104593	http://dx.doi.org/10.1371/journal.pone.0104593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437865	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900003
J	Gillon, TER; Pels, A; von Dadelszen, P; MacDonell, K; Magee, LA				Gillon, Tessa E. R.; Pels, Anouk; von Dadelszen, Peter; MacDonell, Karen; Magee, Laura A.			Hypertensive Disorders of Pregnancy: A Systematic Review of International Clinical Practice Guidelines	PLOS ONE			English	Article							QUALITY; PREECLAMPSIA; MANAGEMENT; DIAGNOSIS; VALIDITY; ONSET; CARE	Background: Clinical practice guidelines (CPGs) are developed to assist health care providers in decision-making. We systematically reviewed existing CPGs on the HDPs (hypertensive disorders of pregnancy) to inform clinical practice. Methodology & Principal Findings: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register, Health Technology Assessments, and Database of Abstracts of Reviews of Effects (Ovid interface), Grey Matters, Google Scholar, and personal records were searched for CPGs on the HDPs (Jan/03 to Nov/13) in English, French, Dutch, or German. Of 13 CPGs identified, three were multinational and three developed for community/midwifery use. Length varied from 3-1188 pages and three guidelines did not formulate recommendations. Eight different grading systems were identified for assessing evidence quality and recommendation strength. No guideline scored >= 80% on every domain of the AGREE II, a tool for assessing guideline methodological quality; two CPGs did so for 5/6 domains. Consistency was seen for (i) definitions of hypertension, proteinuria, chronic and gestational hypertension; (ii) pre-eclampsia prevention for women at increased risk: calcium when intake is low and low-dose aspirin, but not vitamins C and E or diuretics; (iii) antihypertensive treatment of severe hypertension; (iv) MgSO4 for eclampsia and severe pre-eclampsia; (v) antenatal corticosteroids at <34 wks when delivery is probable within 7 days; (vi) delivery for women with severe pre-eclampsia pre-viability or pre-eclampsia at term; and (vii) active management of the third stage of labour with oxytocin. Notable inconsistencies were in: (i) definitions of pre-eclampsia and severe pre-eclampsia; (ii) target BP for non-severe hypertension; (iii) timing of delivery for women with pre-eclampsia and severe pre-eclampsia; (iv) MgSO4 for non-severe pre-eclampsia, and (v) postpartum maternal monitoring. Conclusions: Existing international HDP CPGs have areas of consistency with which clinicians and researchers can work to develop auditable standards, and areas of inconsistency that should be addressed by future research.	[Gillon, Tessa E. R.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Pels, Anouk] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [von Dadelszen, Peter; Magee, Laura A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [von Dadelszen, Peter; Magee, Laura A.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [MacDonell, Karen] Coll Phys & Surg British Columbia, Vancouver, BC, Canada; [Magee, Laura A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Magee, Laura A.] BC Womens Hosp & Hlth Ctr, Dept Med, Vancouver, BC, Canada	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia	Magee, LA (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	LMagee@cw.bc.ca	von Dadelszen, Peter/AAP-7480-2021	von Dadelszen, Peter/0000-0003-4136-3070				Al-Ansary LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053744; American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V119, P396, DOI 10.1097/AOG.0b013e318249ff06; American College of Obstetricians and Gynecologists-Medical Specialty Society, 2001, 009420 NGC; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Der Deutschen Gesellschaft fur Gynakologie und Geburtshilfe, 2007, DIAGN THER HYP SCHW; Fervers B, 2005, INT J QUAL HEALTH C, V17, P123, DOI 10.1093/intqhc/mzi011; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Lagunes-Espinosa Alma Luisa, 2011, Rev Med Inst Mex Seguro Soc, V49, P213; Leis Marquez MT, 2010, GINECOLOGIA OBSTET M, V78, P461; Lindheimer MD, 2009, J CLIN HYPERTENS, V11, P214, DOI 10.1111/j.1751-7176.2009.00085.x; Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x; Luijtjes SHE, 2013, HYPERTENS PREGNANCY, P1; Magee LA, 2007, BJOG, V114, P770, DOI [10.1111/j.1471-0528.2007.01315.x, DOI 10.1111/J.1471-0528.2007.01315.X]; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Magee LA, 2009, SEMIN PERINATOL, V33, P138, DOI 10.1053/j.semperi.2009.02.001; Maternity Children and Young People s Health and Young People's Health, 2011, MAT MAN HYP DIS PREG; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Milne F, 2009, BMJ, V339; Mounier-Vehier C, 2005, MED THERAPEUTIQUE CA, V1, P65; Myatt L, 2014, HYPERTENSION, V63, P1293, DOI 10.1161/HYPERTENSIONAHA.113.02664; Nagy E, 2008, CLIN CHEM, V54, P1872, DOI 10.1373/clinchem.2008.109082; National Guideline Clearinghouse, 2013, NAT GUID CLEAR INCL; National Institute for Health and Care Excellence (NICE), 2013, HYPERTENSION PREGNAN; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; NVOG, 2018, HYP AAND ZWANG; Pentheroudakis G, 2008, ANN ONCOL, V19, P2067, DOI 10.1093/annonc/mdn418; Pradervand P, 2009, REV MED SUISSE, V5, P1758; Rath W, 2009, DTSCH ARZTEBLATT, V106; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Schutte JM, 2008, BJOG-INT J OBSTET GY, V115, P732, DOI 10.1111/j.1471-0528.2008.01702.x; Seeland U, 2012, DEUT MED WOCHENSCHR, V137, P1568, DOI 10.1055/s-0032-1305187; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Societe francaise d'anesthesie et de reanimation College national des gynecologues et obstetriciens francais Societe francaise de medecine perinatale Societe francaise de neonatalogie, 2009, ANN FR ANESTH, V28, P275, DOI DOI 10.1016/J.ANNFAR.2009.02.015; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Visintin C, 2011, OBSTET ANESTHESIA, V31, P143; Watine J, 2006, CLIN CHEM, V52, P65, DOI 10.1373/clinchem.2005.056952; Watine JC, 2008, CLIN BIOCHEM, V41, P459, DOI 10.1016/j.clinbiochem.2007.12.020; World Health Organization, 2011, WHO REC PREV TREATM; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036; Zuleta-Tobon JJ, 2013, INT J GYNECOL OBSTET, V121, P78, DOI 10.1016/j.ijgo.2012.10.031	45	136	146	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113715	10.1371/journal.pone.0113715	http://dx.doi.org/10.1371/journal.pone.0113715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436639	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000347114900068
J	Huc-Brandt, S; Hieu, N; Imberdis, T; Cubedo, N; Silhol, M; Leighton, PLA; Domaschke, T; Allison, WT; Perrier, V; Rossel, M				Huc-Brandt, Sylvaine; Hieu, Nelson; Imberdis, Thibaut; Cubedo, Nicolas; Silhol, Michelle; Leighton, Patricia L. A.; Domaschke, Thomas; Allison, W. Ted; Perrier, Veronique; Rossel, Mireille			Zebrafish Prion Protein PrP2 Controls Collective Migration Process during Lateral Line Sensory System Development	PLOS ONE			English	Article							MORPHOGENESIS; EXPRESSION; CELLS	Prion protein is involved in severe neurodegenerative disorders but its physiological role is still in debate due to an absence of major developmental defects in knockout mice. Previous reports in zebrafish indicate that the two prion genes, PrP1 and PrP2, are both involved in several steps of embryonic development thus providing a unique route to discover prion protein function. Here we investigate the role of PrP2 during development of a mechano-sensory system, the posterior lateral line, using morpholino knockdown and PrP2 targeted inactivation. We confirm the efficiency of the translation blocking morpholino at the protein level. Development of the posterior lateral line is altered in PrP2 morphants, including nerve axonal outgrowth and primordium migration defects. Reduced neuromast deposition was observed in PrP2 morphants as well as in PrP2(-/-) mutants. Rosette formation defects were observed in PrP2 morphants, strongly suggesting an abnormal primordium organization and reflecting loss of cell cohesion during migration of the primordium. In addition, the adherens junction proteins, E-cadherin and beta-catenin, were mis-localized after reduction of PrP2 expression and thus contribute to the primordium disorganization. Consequently, hair cell differentiation and number were affected and this resulted in reduced functional neuromasts. At later developmental stages, myelination of the posterior lateral line nerve was altered. Altogether, our study reports an essential role of PrP2 in collective migration process of the primordium and in neuromast formation, further implicating a role for prion protein in cell adhesion.	[Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] Univ Montpellier 2, F-34095 Montpellier, France; [Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] INSERM, U710, F-34095 Montpellier, France; [Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] EPHE, F-75007 Paris, France; [Imberdis, Thibaut] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Leighton, Patricia L. A.; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2E9, Canada; [Leighton, Patricia L. A.; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Boston University; University of Alberta; University of Alberta	Rossel, M (corresponding author), Univ Montpellier 2, F-34095 Montpellier, France.	mireille.rossel@univ-montp2.fr	Perrier, Veronique/AAK-3594-2020; Allison, W. Ted/A-2612-2014; Brandt, Sylvaine/AAJ-1277-2021	Allison, W. Ted/0000-0002-8461-4864; Brandt, Sylvaine/0000-0002-5582-4643; Imberdis, thibaut/0000-0002-0818-2617; Rossel, Mireille/0000-0003-2275-0817; perrier, veronique/0000-0002-6570-7504	"Ecole Pratique des Hautes Etudes"; "Chercheur d'Avenir" program; Alzheimer Society of Canada; Alberta Innovates; Erasmus program; Inserm; Region Languedoc-Roussillon [2010-Q-025]; Alberta Prion Research Institute; Alzheimer Society of Alberta; Northwest Territories	"Ecole Pratique des Hautes Etudes"; "Chercheur d'Avenir" program(Region Occitanie); Alzheimer Society of Canada; Alberta Innovates; Erasmus program; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Alberta Prion Research Institute; Alzheimer Society of Alberta; Northwest Territories	Funding: The post-doctoral funding for SH-B and the Ph.D. fellowship of TI were provided by the "Ecole Pratique des Hautes Etudes". NH was supported by studentship from the "Chercheur d'Avenir 2009" program and PLAL by studentships from the Alzheimer Society of Canada and Alberta Innovates. TD was supported by an Erasmus program. The research was supported by Inserm dotation, as well as the Region Languedoc-Roussillon, grant 2010-Q-025 "Chercheur d'Avenir 2009". WTA was supported by the Alberta Prion Research Institute and Alzheimer Society of Alberta and Northwest Territories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2011, CELL ADHES MIGR, V5, P499, DOI 10.4161/cam.5.6.19113; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Chitnis AB, 2012, DEV NEUROBIOL, V72, P234, DOI 10.1002/dneu.20962; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; DeCarvalho AC, 2004, DEV DYNAM, V229, P869, DOI 10.1002/dvdy.10475; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Fishman MC, 1997, METHOD CELL BIOL, V52, P67, DOI 10.1016/S0091-679X(08)60374-X; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Kaiser DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051305; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khalife M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023253; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Schuster K, 2010, P NATL ACAD SCI USA, V107, P19531, DOI 10.1073/pnas.1002171107; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Solis GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070327; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Urso E, 2012, CELL MOL NEUROBIOL, V32, P989, DOI 10.1007/s10571-012-9815-5; van Bebber F, 2013, J NEUROCHEM, V127, P471, DOI 10.1111/jnc.12198	43	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113331	10.1371/journal.pone.0113331	http://dx.doi.org/10.1371/journal.pone.0113331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436888	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900039
J	Presslauer, C; Nagasawa, K; Dahle, D; Babiak, J; Fernandes, JMO; Babiak, I				Presslauer, Christopher; Nagasawa, Kazue; Dahle, Dalia; Babiak, Joanna; Fernandes, Jorge M. O.; Babiak, Igor			Induced Autoimmunity against Gonadal Proteins Affects Gonadal Development in Juvenile Zebrafish	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; GERM-CELLS; SPATIOTEMPORAL EXPRESSION; MAMMALIAN WILDLIFE; ATLANTIC SALMON; GENE-EXPRESSION; IMMUNE-SYSTEM; DANIO-RERIO; MATURATION; SERTOLI	A method to mitigate or possibly eliminate reproduction in farmed fish is highly demanded. The existing approaches have certain applicative limitations. So far, no immunization strategies affecting gonadal development in juvenile animals have been developed. We hypothesized that autoimmune mechanisms, occurring spontaneously in a number of diseases, could be induced by targeted immunization. We have asked whether the immunization against specific targets in a juvenile zebrafish gonad will produce an autoimmune response, and, consequently, disturbance in gonadal development. Gonadal soma-derived factor (Gsdf), growth differentiation factor (Gdf9), and lymphocyte antigen 75 (Cd205/Ly75), all essential for early gonad development, were targeted with 5 immunization tests. Zebrafish (n5329) were injected at 6 weeks post fertilization, a booster injection was applied 15 days later, and fish were sampled at 30 days. We localized transcripts encoding targeted proteins by in situ hybridization, quantified expression of immune-, apoptosis-, and gonad-related genes with quantitative real-time PCR, and performed gonadal histology and whole-mount immunohistochemistry for Bcl2-interacting-killer (Bik) pro-apoptotic protein. The treatments resulted in an autoimmune reaction, gonad developmental retardation, intensive apoptosis, cell atresia, and disturbed transcript production. Testes were remarkably underdeveloped after anti-Gsdf treatments. Anti-Gdf9 treatments promoted apoptosis in testes and abnormal development of ovaries. Anti-Cd205 treatment stimulated a strong immune response in both sexes, resulting in oocyte atresia and strong apoptosis in supporting somatic cells. The effect of immunization was FSH-independent. Furthermore, immunization against germ cell proteins disturbed somatic supporting cell development. This is the first report to demonstrate that targeted autoimmunity can disturb gonadal development in a juvenile fish. It shows a straightforward potential to develop auto-immunization-based technologies to mitigate fish reproduction before they reach maturation. However, the highly variable results between treatments and individuals suggest significant optimization should be performed to achieve the full potential of this technology.	[Presslauer, Christopher; Nagasawa, Kazue; Dahle, Dalia; Babiak, Joanna; Fernandes, Jorge M. O.; Babiak, Igor] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway	Nord University	Babiak, I (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway.	Igor.Babiak@uin.no	Fernandes, Jorge MO/A-3526-2013; Fernandes, Jorge/AAC-4632-2022; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge MO/0000-0002-2550-1640; Fernandes, Jorge/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302; Babiak, Igor/0000-0002-1462-2690	Marine Biotechnology in Northern Norway (MABIT) program [AF0059]; University of Nordland	Marine Biotechnology in Northern Norway (MABIT) program; University of Nordland	The study was funded by Marine Biotechnology in Northern Norway (MABIT) program (www.mabit.no), grant # AF0059; and by University of Nordland (www.uin.no) - all granted to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Benfey Tillmann J., 1999, Reviews in Fisheries Science, V7, P39, DOI 10.1080/10641269991319162; BOYD JM, 1995, ONCOGENE, V11, P1921; Buonocore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047957; Chen J, 2013, CHINESE SCI BULL, V58, P7, DOI 10.1007/s11434-012-5577-1; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Clelland ES, 2011, GEN COMP ENDOCR, V171, P211, DOI 10.1016/j.ygcen.2011.01.009; Cooper DW, 2006, REPRODUCTION, V132, P821, DOI 10.1530/REP-06-0037; Cooper DW, 2001, REPROD FERT DEVELOP, V13, P451, DOI 10.1071/RD01072; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Draper Bruce W, 2012, Methods Mol Biol, V916, P157, DOI 10.1007/978-1-61779-980-8_12; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Gautier A, 2011, GENE, V472, P7, DOI 10.1016/j.gene.2010.10.014; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Gupta SK, 2011, AM J REPROD IMMUNOL, V66, P51, DOI 10.1111/j.1600-0897.2011.01004.x; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; He Z, 2012, GEN COMP ENDOCR, V178, P355, DOI 10.1016/j.ygcen.2012.06.016; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hu YL, 2010, MOL IMMUNOL, V47, P738, DOI 10.1016/j.molimm.2009.10.010; Huttenhuis HBT, 2005, DEV COMP IMMUNOL, V29, P1033, DOI 10.1016/j.dci.2005.03.005; Janz DM, 1997, GEN COMP ENDOCR, V105, P186, DOI 10.1006/gcen.1996.6820; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Jorstad KE, 2008, REV FISH SCI, V16, P285, DOI 10.1080/10641260701678017; Juengel JL, 2002, BIOL REPROD, V67, P1777, DOI 10.1095/biolreprod.102.007146; Karlsen O, 2006, AQUACULTURE, V255, P242, DOI 10.1016/j.aquaculture.2005.12.029; KARLSEN O, 1995, AQUACULTURE, V133, P159, DOI 10.1016/0044-8486(94)00399-9; Kato M, 1998, IMMUNOGENETICS, V47, P442, DOI 10.1007/s002510050381; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; LAIRD LM, 1980, REPROD NUTR DEV, V20, P1781, DOI 10.1051/rnd:19801004; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; Liu ZW, 2012, MOL BIOL REP, V39, P3863, DOI 10.1007/s11033-011-1165-8; Maack G, 2003, FISH PHYSIOL BIOCHEM, V28, P125, DOI 10.1023/B:FISH.0000030497.59378.88; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Matthews M, 2002, LAB ANIMAL, V31, P34; McClure CA, 2007, AQUACULTURE, V272, P370, DOI 10.1016/j.aquaculture.2007.08.039; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; Nagasawa K, 2012, FISHERIES SCI, V78, P791, DOI 10.1007/s12562-012-0501-9; Nagasawa K, 2010, BIOL REPROD, V83, P597, DOI 10.1095/biolreprod.109.082081; Naz RK, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.00999.x; Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x; Poon SK, 2009, REPRODUCTION, V138, P709, DOI 10.1530/REP-09-0198; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Sambroni E, 2013, J MOL ENDOCRINOL, V50, P1, DOI 10.1530/JME-12-0197; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White YAR, 2011, DEV DYNAM, V240, P1929, DOI 10.1002/dvdy.22695; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhao L, 2011, ACTA HISTOCHEM, V113, P771, DOI 10.1016/j.acthis.2010.11.005	67	10	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114209	10.1371/journal.pone.0114209	http://dx.doi.org/10.1371/journal.pone.0114209			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436775	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000347114900129
J	Rojas, C; Pan-Castillo, B; Valls, C; Pujadas, G; Garcia-Vallve, S; Arola, L; Mulero, M				Rojas, Cristina; Pan-Castillo, Belen; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis; Mulero, Miquel			Resveratrol Enhances Palmitate-Induced ER Stress and Apoptosis in Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; STEAROYL-COA DESATURASE; UNSATURATED FATTY-ACIDS; ACTIVATING AMPK; HEPG2 CELLS; BETA-CELLS; U937 CELLS; KINASE; DEATH	Background: Palmitate, a saturated fatty acid (FA), is known to induce toxicity and cell death in various types of cells. Resveratrol (RSV) is able to prevent pathogenesis and/or decelerate the progression of a variety of diseases. Several in vitro and in vivo studies have also shown a protective effect of RSV on fat accumulation induced by FAs. Additionally, endoplasmic reticulum (ER) stress has recently been linked to cellular adipogenic responses. To address the hypothesis that the RSV effect on excessive fat accumulation promoted by elevated saturated FAs could be partially mediated by a reduction of ER stress, we studied the RSV action on experimentally induced ER stress using palmitate in several cancer cell lines. Principal Findings: We show that, unexpectedly, RSV promotes an amplification of palmitate toxicity and cell death and that this mechanism is likely due to a perturbation of palmitate accumulation in the triglyceride form and to a less important membrane fluidity variation. Additionally, RSV decreases radical oxygen species (ROS) generation in palmitate-treated cells but leads to enhanced X-box binding protein-1 (XBP1) splicing and C/EBP homologous protein (CHOP) expression. These molecular effects are induced simultaneously to caspase-3 cleavage, suggesting that RSV promotes palmitate lipoapoptosis primarily through an ER stress-dependent mechanism. Moreover, the lipotoxicity reversion induced by eicosapentaenoic acid (EPA) or by a liver X receptor (LXR) agonist reinforces the hypothesis that RSV-mediated inhibition of palmitate channeling into triglyceride pools could be a key factor in the aggravation of palmitate-induced cytotoxicity. Conclusions: Our results suggest that RSV exerts its cytotoxic role in cancer cells exposed to a saturated FA context primarily by triglyceride accumulation inhibition, probably leading to an intracellular palmitate accumulation that triggers a lipid-mediated cell death. Additionally, this cell death is promoted by ER stress through a CHOP-mediated apoptotic process and may represent a potential anticancer strategy.	[Rojas, Cristina; Pan-Castillo, Belen; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis; Mulero, Miquel] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, E-43007 Tarragona, Spain; [Pan-Castillo, Belen] Swansea Univ, Inst Life, Ctr Nanohlth, Reprod Biol & Gynecol Oncol Grp, Swansea SA2 8PP, W Glam, Wales; [Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis] CEICS, TECNIO, CTNS, Reus 43204, Spain	Universitat Rovira i Virgili; Swansea University	Mulero, M (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, E-43007 Tarragona, Spain.	miquel.mulero@urv.cat	Pujadas, Gerard/B-1457-2010; Garcia-Vallve, Santi/A-4226-2008; Mulero, Miquel/L-4672-2014; Arola, Lluís/C-6074-2011; Valls-Bautista, Cristina/K-8769-2014; PUJADAS, GERARD/W-9348-2019	Pujadas, Gerard/0000-0003-2598-8089; Garcia-Vallve, Santi/0000-0002-0348-7497; Mulero, Miquel/0000-0003-2545-2065; Arola, Lluís/0000-0003-2767-1974; Valls-Bautista, Cristina/0000-0001-5583-5695; PUJADAS, GERARD/0000-0003-2598-8089	Ministerio de Educacion y Ciencia of the Spanish Goverment [AGL2008-00387/ALI, AGL2011-25831/ALI]	Ministerio de Educacion y Ciencia of the Spanish Goverment(German Research Foundation (DFG))	This reserach was supported by grants from the Ministerio de Educacion y Ciencia of the Spanish Goverment (AGL2008-00387/ALI and AGL2011-25831/ALI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brittes J, 2010, CHEM PHYS LIPIDS, V163, P747, DOI 10.1016/j.chemphyslip.2010.07.004; CHAJES V, 1995, INT J CANCER, V63, P169, DOI 10.1002/ijc.2910630204; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Chen SF, 2012, J NUTR BIOCHEM, V23, P1100, DOI 10.1016/j.jnutbio.2011.06.003; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu BQ, 2010, BIOCHEM BIOPH RES CO, V391, P778, DOI 10.1016/j.bbrc.2009.11.137; Luo J, 2009, CELL, V138, P807, DOI 10.1016/j.cell.2009.08.006; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Morgan NG, 2008, BIOCHEM SOC T, V36, P905, DOI 10.1042/BST0360905; Park JW, 2001, CARCINOGENESIS, V22, P1633, DOI 10.1093/carcin/22.10.1633; Park JW, 2001, CANCER LETT, V163, P43, DOI 10.1016/S0304-3835(00)00658-3; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; RIBONI L, 1984, NEUROCHEM PATHOL, V2, P171, DOI 10.1007/BF02834351; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Thorn K, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-108; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Yoon DH, 2011, BIOCHEM BIOPH RES CO, V414, P49, DOI 10.1016/j.bbrc.2011.09.019; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zhang LX, 2010, EXP CELL RES, V316, P716, DOI 10.1016/j.yexcr.2009.12.008	54	43	43	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113929	10.1371/journal.pone.0113929	http://dx.doi.org/10.1371/journal.pone.0113929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436452	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900097
J	Kessler, N; Walter, F; Persicke, M; Albaum, SP; Kalinowski, J; Goesmann, A; Niehaus, K; Nattkemper, TW				Kessler, Nikolas; Walter, Frederik; Persicke, Marcus; Albaum, Stefan P.; Kalinowski, Joern; Goesmann, Alexander; Niehaus, Karsten; Nattkemper, Tim W.			ALLocator: An Interactive Web Platform for the Analysis of Metabolomic LC-ESI-MS Datasets, Enabling Semi-Automated, User-Revised Compound Annotation and Mass Isotopomer Ratio Analysis	PLOS ONE			English	Article							CORYNEBACTERIUM-GLUTAMICUM; SPECTROMETRY DATA; KYOTO ENCYCLOPEDIA; EXTRACTION; QUANTIFICATION; PEPTIDES; MZMINE; GENES; KEGG; TOOL	Adduct formation, fragmentation events and matrix effects impose special challenges to the identification and quantitation of metabolites in LC-ESI-MS datasets. An important step in compound identification is the deconvolution of mass signals. During this processing step, peaks representing adducts, fragments, and isotopologues of the same analyte are allocated to a distinct group, in order to separate peaks from coeluting compounds. From these peak groups, neutral masses and pseudo spectra are derived and used for metabolite identification via mass decomposition and database matching. Quantitation of metabolites is hampered by matrix effects and nonlinear responses in LC-ESI-MS measurements. A common approach to correct for these effects is the addition of a U-C-13-labeled internal standard and the calculation of mass isotopomer ratios for each metabolite. Here we present a new web-platform for the analysis of LC-ESI-MS experiments. ALLocator covers the workflow from raw data processing to metabolite identification and mass isotopomer ratio analysis. The integrated processing pipeline for spectra deconvolution "ALLocatorSD" generates pseudo spectra and automatically identifies peaks emerging from the U-C-13-labeled internal standard. Information from the latter improves mass decomposition and annotation of neutral losses. ALLocator provides an interactive and dynamic interface to explore and enhance the results in depth. Pseudo spectra of identified metabolites can be stored in user- and method-specific reference lists that can be applied on succeeding datasets. The potential of the software is exemplified in an experiment, in which abundance fold-changes of metabolites of the L-arginine biosynthesis in C. glutamicum type strain ATCC 13032 and L-arginine producing strain ATCC 21831 are compared. Furthermore, the capability for detection and annotation of uncommon large neutral losses is shown by the identification of (gamma-) glutamyl dipeptides in the same strains. ALLocator is available online at: https://allocator.cebitec.uni-bielefeld.de. A login is required, but freely available.	[Kessler, Nikolas; Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany; [Walter, Frederik; Niehaus, Karsten] Univ Bielefeld, Dept Proteome & Metabolome Res, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Walter, Frederik; Persicke, Marcus; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Kessler, Nikolas; Albaum, Stefan P.] Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, D-33615 Bielefeld, Germany; [Goesmann, Alexander] Univ Giessen, D-35392 Giessen, Germany; [Kessler, Nikolas; Walter, Frederik] Univ Bielefeld, Ctr Biotechnol, CLIB Grad Cluster Ind Biotechnol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Bielefeld; Justus Liebig University Giessen; University of Bielefeld	Albaum, SP (corresponding author), Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, Univ Str 25, D-33615 Bielefeld, Germany.	allocator@cebitec.uni-bielefeld.de	Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Goesmann, Alexander/0000-0002-7086-2568	Deutsche Forschungsgemeinschaft; Bielefeld University; CLIB Graduate Cluster Industrial Biotechnology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University; CLIB Graduate Cluster Industrial Biotechnology	The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. NK and FW were supported by a fellowship from the CLIB Graduate Cluster Industrial Biotechnology (http://www.graduatecluster.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran R, 2013, MAR DRUGS, V11, P3617, DOI 10.3390/md11103617; Baran R, 2010, ANAL CHEM, V82, P9034, DOI 10.1021/ac1020112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bueschl C, 2013, ANAL BIOANAL CHEM, V405, P27, DOI 10.1007/s00216-012-6375-y; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; de Jong FA, 2012, BIOANALYSIS, V4, P2303, DOI [10.4155/BIO.12.202, 10.4155/bio.12.202]; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Harrison AG, 2003, J MASS SPECTROM, V38, P174, DOI 10.1002/jms.427; HASEGAWA M, 1978, AGR BIOL CHEM TOKYO, V42, P371, DOI 10.1080/00021369.1978.10862984; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huang XJ, 2014, ANAL CHEM, V86, P1632, DOI 10.1021/ac403384n; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kessler N, 2013, BIOINFORMATICS, V29, P2452, DOI 10.1093/bioinformatics/btt414; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kuhl C, 2010, ANAL CHEM, V84, P1; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Mashego MR, 2004, BIOTECHNOL BIOENG, V85, P620, DOI 10.1002/bit.10907; Milgram E, 2009, METABOLOMICS SURVEY; Nakayama K, 1974, US Pat, Patent No. [3,902,967, 3902967]; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Petri K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-713; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Prospect P, 2010, J CHEM EDUC, V87, P10; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Salek RM, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat029; Satman MH, 2010, RUNIVERSAL RUNIVERSA; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; VITALI RA, 1965, J BIOL CHEM, V240, P2508; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhang WC, 2014, ANAL CHEM, V86, P6245, DOI 10.1021/ac501162k	39	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113909	10.1371/journal.pone.0113909	http://dx.doi.org/10.1371/journal.pone.0113909			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426929	Green Published, gold			2022-12-27	WOS:000349145400100
J	McNamara, A; Moakes, K; Aston, P; Gavin, C; Sterr, A				McNamara, Adam; Moakes, Kaylee; Aston, Philip; Gavin, Christine; Sterr, Annette			The Importance of the Derivative in Sex-Hormone Cycles: A Reason Why Behavioural Measures in Sex-Hormone Studies Are So Mercurial	PLOS ONE			English	Article							FUNCTIONAL CEREBRAL ASYMMETRIES; MENSTRUAL-CYCLE; MENTAL ROTATION; GENDER SIMILARITIES; SPATIAL ABILITIES; STEREOTYPE THREAT; WOMEN; PERFORMANCE; TASK; PROGESTERONE	To study the dynamic changes in cognition across the human menstrual cycle, twenty, healthy, naturally-cycling women undertook a lateralized spatial figural comparison task on twelve occasions at approximately 3-4 day intervals. Each session was conducted in laboratory conditions with response times, accuracy rates, eye movements, salivary estrogen and progesterone concentrations and Profile of Mood states questionnaire data collected on each occasion. The first two sessions of twelve for the response variables were discarded to avoid early effects of learning thereby providing 10 sessions spread across each participant's complete menstrual cycle. Salivary progesterone data for each participant was utilized to normalize each participant's data to a standard 28 day cycle. Data was analysed categorically by comparing peak progesterone (luteal phase) to low progesterone (follicular phase) to emulate two-session repeated measures typical studies. Neither a significant difference in reaction times or accuracy rates was found. Moreover no significant effect of lateral presentation was observed upon reaction times or accuracy rates although inter and intra individual variance was sizeable. We demonstrate that hormone concentrations alone cannot be used to predict the response times or accuracy rates. In contrast, we constructed a standard linear model using salivary estrogen, salivary progesterone and their respective derivative values and found these inputs to be very accurate for predicting variance observed in the reaction times for all stimuli and accuracy rates for right visual field stimuli but not left visual field stimuli. The identification of sex-hormone derivatives as predictors of cognitive behaviours is of importance. The finding suggests that there is a fundamental difference between the up-surge and decline of hormonal concentrations where previous studies typically assume all points near the peak of a hormonal surge are the same. How contradictory findings in sex-hormone research may have come about are discussed.	[McNamara, Adam; Moakes, Kaylee; Sterr, Annette] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Aston, Philip; Gavin, Christine] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	McNamara, A (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England.	adamjonmcnamara@gmail.com			Engineering and Physical Sciences Research Council [EP/I000992/1]; ESRC/MRC [G0901322-1/1]; EPSRC [EP/I000992/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/I000992/1] and the ESRC/MRC interdisciplinary studentship grant supporting KM [training grant number G0901322-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SEX DIFFERENCES BRAI; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Bayer U, 2008, NEUROPSYCHOLOGIA, V46, P2415, DOI 10.1016/j.neuropsychologia.2008.02.028; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bennis WM, 2010, BEHAV BRAIN SCI, V33, P85, DOI 10.1017/S0140525X1000004X; BIBAWI D, 1995, NEUROPSYCHOLOGIA, V33, P131, DOI 10.1016/0028-3932(94)00103-V; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Courvoisier DS, 2013, HORM BEHAV, V63, P345, DOI 10.1016/j.yhbeh.2012.12.007; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; Eckel LA, 2007, SEX DIFFERENCES BRAI, P35; Ertman N, 2011, LEARN MEMORY, V18, P759, DOI 10.1101/lm.023267.111; Fernandez G, 2003, J NEUROSCI, V23, P3790; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Halari R, 2005, BEHAV NEUROSCI, V119, P104, DOI 10.1037/0735-7044.119.1.104; Hausmann M, 1999, BRAIN COGNITION, V41, P263, DOI 10.1006/brcg.1999.1126; Hausmann M, 2005, NEUROPSYCHOLOGIA, V43, P1559, DOI 10.1016/j.neuropsychologia.2005.01.017; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; Hausmann M, 2000, NEUROPSYCHOLOGIA, V38, P1362, DOI 10.1016/S0028-3932(00)00045-2; Hollander A, 2005, J INT NEUROPSYCH SOC, V11, P263, DOI 10.1017/S1355617705050319; Hyde JS, 2007, CURR DIR PSYCHOL SCI, V16, P259, DOI 10.1111/j.1467-8721.2007.00516.x; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Langlois J, 2013, ANAT SCI EDUC, V6, P368, DOI 10.1002/ase.1360; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Maeda Y, 2013, EDUC PSYCHOL REV, V25, P69, DOI 10.1007/s10648-012-9215-x; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Mareckova K, 2014, SOC COGN AFFECT NEUR, V9, P191, DOI 10.1093/scan/nss128; McCormick CM, 2001, HORM BEHAV, V39, P29, DOI 10.1006/hbeh.2000.1636; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; O'Connor PJ, 2004, J PSYCHOSOM RES, V57, P435, DOI 10.1016/j.jpsychores.2003.12.006; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Peters M, 2006, CORTEX, V42, P1005, DOI 10.1016/S0010-9452(08)70206-5; Phillips K, 1997, HORM BEHAV, V32, P167, DOI 10.1006/hbeh.1997.1418; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Pletzer B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053824; RODE C, 1995, NEUROPSYCHOLOGIA, V33, P855, DOI 10.1016/0028-3932(95)00015-U; Sanders G, 1998, NEUROPSYCHOLOGIA, V36, P869, DOI 10.1016/S0028-3932(98)00022-0; Sherwin BB, 2012, BEHAV NEUROSCI, V126, P123, DOI 10.1037/a0025539; Hyde JS, 2006, SCIENCE, V314, P599, DOI 10.1126/science.1132154; Small CM, 2007, ANN EPIDEMIOL, V17, P163, DOI 10.1016/j.annepidem.2006.05.005; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stubbs ML, 2008, ANN NY ACAD SCI, V1135, P58, DOI 10.1196/annals.1429.008; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2011, PSYCHON B REV, V18, P267, DOI 10.3758/s13423-010-0042-0; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Wister JA, 2013, SEX ROLES, V68, P19, DOI 10.1007/s11199-012-0156-0	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111891	10.1371/journal.pone.0111891	http://dx.doi.org/10.1371/journal.pone.0111891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426968	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400007
J	Li, C; Xie, Y; Li, ZK; Yang, MY; Sun, XF; Fan, JP; Zhu, HLYXD; Wang, CF; Li, M				Li, Chao; Xie, Yang; Li, Zhikun; Yang, Mingyuan; Sun, Xiaofei; Fan, Jianping; Zhu, Honglei Yi Xiaodong; Wang, Chuanfeng; Li, Ming			Intraoperative Blood Loss in Female Patients with Adolescent Idiopathic Scoliosis during Different Phases of the Menstrual Cycle	PLOS ONE			English	Article							POSTERIOR SPINAL-FUSION; VON-WILLEBRAND-FACTOR; PLATELET-FUNCTION; YOUNG-WOMEN; FACTOR-VIII; COAGULATION; SURGERY; ESTROGEN; INSTRUMENTATION; FIBRINOLYSIS	Background: The vast majority of AIS patients who require surgical intervention are women. Blood loss is a major concern during the operation. Methods: The medical records of all female AIS patients who underwent posterior correction and fusion operations using the all-pedicle screw system from January 2012 to January 2014 were reviewed. Patients with irregular menstruation; underwent osteotomy; use coagulants were excluded from the study. The remaining patients were divided into 4 groups according to the operation date in the menstrual cycle (A: premenstrual group, 24-30 d; B: follicle group, 6-11 d; C: ovulatory group, 12-17 d; D: luteal group, 18-23 d). The information of patients from the 4 groups was reviewed. The data was analyzed using analysis of variance, the Student-Newman-Keels test and Kruskal-Wallis Test. Results: A total of 161 patients were included in this study. There were 40 patients included in group A, 38 patients in group B, 41 patients in group C and 42 patients in group D. The 4 groups were matched in age (P=0.238), body height (P=0.291), body weight (P=0.756), Risser sign (P=0.576), mean curve Cobb angle (P=0.520), and bending flexibility index (P=0.547), the number of levels fused (P=0.397). The activated partial thromboplastin time (P=0.235) and prothrombin time (P=0.074) tended to be higher in group A, but the difference was not statistically significant. The fibrinogen level was lower in group B than the other 3 groups (P=0.039). Blood loss and normalized intraoperative blood loss (NBL) was significantly higher in group A than the other 3 groups (P < 0.01). Conclusions: The hemostatic function tended to be lower in the premenstrual phase. The fibrinogen level was lowest in the mid-follicle phase. Female AIS patients tended to endure more intraoperative blood loss when the operation was performed in the premenstrual phase during the menstrual cycle.	[Li, Chao; Li, Zhikun; Yang, Mingyuan; Sun, Xiaofei; Fan, Jianping; Li, Ming] Second Mil Med Univ, Changhai Hosp, Dept Spine Surg, Shanghai, Peoples R China; [Xie, Yang; Wang, Chuanfeng] Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, CF (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China.	cfeng_wong@163.com; limingch@21cn.com						Aubourg R, 2011, J VISC SURG, V148, pE405, DOI 10.1016/j.jviscsurg.2011.10.001; Bjerkreim I, 2007, SPINE, V32, P2103, DOI 10.1097/BRS.0b013e318145a54a; BLOMBACK M, 1992, THROMB HAEMOSTASIS, V67, P70; Blomback M, 1997, THROMB HAEMOSTASIS, V77, P105; Bolis P F, 1982, Clin Exp Obstet Gynecol, V9, P22; Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995; CEDERBLAD G, 1977, HAEMOSTASIS, V6, P294; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; DALY L, 1990, AM J OBSTET GYNECOL, V163, P430, DOI 10.1016/0002-9378(90)90596-Y; Dapper D V B, 2002, East Afr Med J, V79, P181; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Feuring A, 2002, BLOOD COAGUL FIBRIN, V13, P443, DOI 10.1097/00001721-200207000-00009; Fruzzetti F, 2010, CONTRACEPTION, V81, P8, DOI 10.1016/j.contraception.2009.08.010; Giardina EGV, 2004, J CLIN ENDOCR METAB, V89, P6179, DOI 10.1210/jc.2004-0598; Gill JB, 2008, J BONE JOINT SURG AM, V90A, P2399, DOI 10.2106/JBJS.G.01179; GUAY J, 1994, CAN J ANAESTH, V41, P775, DOI 10.1007/BF03011583; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Hresko MT, 2013, NEW ENGL J MED, V368, P834, DOI 10.1056/NEJMcp1209063; Ialenti MN, 2013, J PEDIATR ORTHOPED, V33, P372, DOI 10.1097/BPO.0b013e3182870325; Ibrahimi E, 2014, INT J REPROD CONTRAC, V3, P31; Jain A, 2012, SPINE, V37, P1683, DOI 10.1097/BRS.0b013e318254168f; Kadir RA, 1999, THROMB HAEMOSTASIS, V82, P1456; Klein HG, 2013, MOLLISONS BLOOD TRAN; Knol HM, 2008, THROMB HAEMOSTASIS, V99, P1019; Koh SCL, 2005, CLIN APPL THROMB-HEM, V11, P295, DOI 10.1177/107602960501100308; Kujovich JL, 2004, BRIT J HAEMATOL, V126, P443, DOI 10.1111/j.1365-2141.2004.05041.x; Larsen LF, 1996, SCAND J CLIN LAB INV, V56, P241, DOI 10.3109/00365519609088613; LEBECH AM, 1989, HORM METAB RES, V21, P445, DOI 10.1055/s-2007-1009258; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; Luyer MDP, 2001, J CLIN ENDOCR METAB, V86, P3629, DOI 10.1210/jc.86.8.3629; MANDALAKI T, 1980, NEW ENGL J MED, V302, P1093; Miller CH, 2002, THROMB HAEMOSTASIS, V87, P1082; Norris LA, 1997, BAILLIERE CLIN OB GY, V11, P545, DOI 10.1016/S0950-3552(97)80027-2; Nuttall GA, 2000, SPINE, V25, P596, DOI 10.1097/00007632-200003010-00010; Onundarson PT, 2001, THROMB HAEMOSTASIS, V85, P183; Paraskevaidis E, 2002, OBSTET GYNECOL, V99, P997, DOI 10.1016/S0029-7844(02)02003-3; Prisco D., 2005, HEMATOL REP, V1, P1; Raggio CL, 2006, ORTHOP CLIN N AM, V37, P555, DOI 10.1016/j.ocl.2006.09.010; Repina Margarita A, 2002, Med Sci Monit, V8, pPI78; Ricci G, 2004, HUM REPROD, V19, P838, DOI 10.1093/humrep/deh185; Roell A, 2007, PLATELETS, V18, P165, DOI 10.1080/09537100600936224; Sitruk-Ware R, 2013, BEST PRACT RES CL EN, V27, P13, DOI 10.1016/j.beem.2012.09.004; SOLERTE SB, 1988, BRIT J OBSTET GYNAEC, V95, P1305, DOI 10.1111/j.1471-0528.1988.tb06822.x; Tzortzopoulou A, 2008, COCHRANE DATABASE SY, V3; von Rooijen M, 2007, THROMB HAEMOSTASIS, V97, P15, DOI 10.1160/TH06-09-0540; Wang YP, 2008, SPINE, V33, P2166, DOI 10.1097/BRS.0b013e318185798d; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112499	10.1371/journal.pone.0112499	http://dx.doi.org/10.1371/journal.pone.0112499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422893	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700011
J	Weber, JP; Toft-Bertelsen, TL; Mohrmann, R; Delgado-Martinez, I; Sorensen, JB				Weber, Jens P.; Toft-Bertelsen, Trine L.; Mohrmann, Ralf; Delgado-Martinez, Ignacio; Sorensen, Jakob B.			Synaptotagmin-7 Is an Asynchronous Calcium Sensor for Synaptic Transmission in Neurons Expressing SNAP-23	PLOS ONE			English	Article							READILY RELEASABLE POOL; TRANSMITTER RELEASE; CA2+ SENSOR; NEUROTRANSMITTER RELEASE; INSULIN-SECRETION; GENETIC-ANALYSIS; EXOCYTOSIS; SNARE; VII; VESICLES	Synchronization of neurotransmitter release with the presynaptic action potential is essential for maintaining fidelity of information transfer in the central nervous system. However, synchronous release is frequently accompanied by an asynchronous release component that builds up during repetitive stimulation, and can even play a dominant role in some synapses. Here, we show that substitution of SNAP-23 for SNAP-25 in mouse autaptic glutamatergic hippocampal neurons results in asynchronous release and a higher frequency of spontaneous release events (mEPSCs). Use of neurons from double-knock-out (SNAP-25, synaptotagmin-7) mice in combination with viral transduction showed that SNAP-23-driven release is triggered by endogenous synaptotagmin-7. In the absence of synaptotagmin-7 release became even more asynchronous, and the spontaneous release rate increased even more, indicating that synaptotagmin-7 acts to synchronize release and suppress spontaneous release. However, compared to synaptotagmin-1, synaptotagmin-7 is a both leaky and asynchronous calcium sensor. In the presence of SNAP-25, consequences of the elimination of synaptotagmin-7 were small or absent, indicating that the protein pairs SNAP-25/synaptotagmin-1 and SNAP-23/synaptotagmin-7 might act as mutually exclusive calcium sensors. Expression of fusion proteins between pHluorin (pH-sensitive GFP) and synaptotagmin-1 or -7 showed that vesicles that fuse using the SNAP-23/synaptotagmin-7 combination contained synaptotagmin-1, while synaptotagmin-7 barely displayed activity-dependent trafficking between vesicle and plasma membrane, implying that it acts as a plasma membrane calcium sensor. Overall, these findings support the idea of alternative syt:SNARE combinations driving release with different kinetics and fidelity.	[Weber, Jens P.; Toft-Bertelsen, Trine L.; Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Weber, Jens P.] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Mohrmann, Ralf] Univ Saarland, Dept Physiol, Homburg, Germany; [Delgado-Martinez, Ignacio] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [Sorensen, Jakob B.] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark	University of Copenhagen; Vrije Universiteit Amsterdam; Saarland University; National University of Singapore; Lundbeckfonden; University of Copenhagen	Sorensen, JB (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	jakobbs@sund.ku.dk	Toft-Bertelsen, Trine Lisberg/AAC-7594-2019; Delgado Martinez, Ignacio/GVS-1508-2022; Martinez, Ignacio Delgado/AAT-2768-2020; Toft-Bertelsen, Trine/G-8067-2017	Toft-Bertelsen, Trine Lisberg/0000-0001-9009-0094; Martinez, Ignacio Delgado/0000-0003-1616-8943; Toft-Bertelsen, Trine/0000-0001-9009-0094; Sorensen, Jakob/0000-0001-5465-3769	Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; European Union [HEALTH-F2-2009-242167]; Deutsche Forschungsgemeinschaft [SFB 1027]; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Medical Research Council (J.B.S.), the European Union Seventh Framework Program under grant agreement no. HEALTH-F2-2009-242167 ('SynSys' project; J.B.S.), and Deutsche Forschungsgemeinschaft (SFB 1027; R.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Chieregatti E, 2004, MOL BIOL CELL, V15, P1918, DOI 10.1091/mbc.E03-09-0684; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Deak F, 2009, J NEUROSCI, V29, P8639, DOI 10.1523/JNEUROSCI.0898-09.2009; Dean C, 2012, MOL BIOL CELL, V23, P1715, DOI 10.1091/mbc.E11-08-0707; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Fukuda M, 2002, BIOCHEM J, V365, P173, DOI 10.1042/BJ20011877; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Gauthier BR, 2008, FASEB J, V22, P194, DOI 10.1096/fj.07-8333com; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gonelle-Gispert C, 1999, BIOCHEM J, V339, P159, DOI 10.1042/0264-6021:3390159; Grant NJ, 1999, J NEUROCHEM, V72, P363, DOI 10.1046/j.1471-4159.1999.0720363.x; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Matsuoka H, 2011, CELL TISSUE RES, V344, P41, DOI 10.1007/s00441-011-1131-8; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mohrmann R, 2013, J NEUROSCI, V33, P14417, DOI 10.1523/JNEUROSCI.1236-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Nagy G, 2008, MOL BIOL CELL, V19, P3769, DOI 10.1091/mbc.E07-12-1218; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Raingo J, 2012, NAT NEUROSCI, V15, P738, DOI 10.1038/nn.3067; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Walter AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003362; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Weber JP, 2010, EMBO J, V29, P2477, DOI 10.1038/emboj.2010.130; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Wierda KDB, 2014, J NEUROSCI, V34, P2100, DOI 10.1523/JNEUROSCI.3934-13.2014; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xue M, 2010, PLOS ONE, V5; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	78	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114033	10.1371/journal.pone.0114033	http://dx.doi.org/10.1371/journal.pone.0114033			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422940	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700084
J	Hong, SY; O'Sullivan, D; Sadahiro, Y				Hong, Seong-Yun; O'Sullivan, David; Sadahiro, Yukio			Implementing Spatial Segregation Measures in R	PLOS ONE			English	Article							LOCAL INDICATORS; INDEXES; ASSOCIATION; SCALE; SPACE	Reliable and accurate estimation of residential segregation between population groups is important for understanding the extent of social cohesion and integration in our society. Although there have been considerable methodological advances in the measurement of segregation over the last several decades, the recently developed measures have not been widely used in the literature, in part due to their complex calculation. To address this problem, we have implemented several newly proposed segregation indices in R, an open source software environment for statistical computing and graphics, as a package called seg. Although there are already a few standalone applications and add-on packages that provide access to similar methods, our implementation has a number of advantages over the existing tools. First, our implementation is flexible in the sense that it provides detailed control over the calculation process with a wide range of input parameters. Most of the parameters have carefully chosen defaults, which perform acceptably in many situations, so less experienced users can also use the implemented functions without too much difficulty. Second, there is no need to export results to other software programs for further analysis. We provide coercion methods that enable the transformation of our output classes into general R classes, so the user can use thousands of standard and modern statistical techniques, which are already available in R, for the post-processing of the results. Third, our implementation does not require commercial software to operate, so it is accessible to a wider group of people.	[Hong, Seong-Yun; Sadahiro, Yukio] Univ Tokyo, Ctr Spatial Informat Sci, Tokyo, Japan; [O'Sullivan, David] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA	University of Tokyo; University of California System; University of California Berkeley	Hong, SY (corresponding author), Univ Tokyo, Ctr Spatial Informat Sci, Tokyo, Japan.	yun.hong@csis.u-tokyo.ac.jp	Hong, Seong-Yun/J-9014-2013	Hong, Seong-Yun/0000-0001-5049-8810; O'Sullivan, David/0000-0001-8078-3241	Japan Society for the Promotion of Science (JSPS) [24-02309]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Grant-in-Aid for Scientific Research, KAKENHI 24-02309 (SYH) from the Japan Society for the Promotion of Science (JSPS, URL: http://www.jsps.go.jp/j-grantsinaid/20_tokushourei/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Apparicio P, 2014, SOC SCI COMPUT REV, V32, P117, DOI 10.1177/0894439313504539; Duncan OD, 1955, AM SOCIOL REV, V20, P210, DOI 10.2307/2088328; Farber S, 2012, ENVIRON PLANN A, V44, P315, DOI 10.1068/a44203; Frank AI, 2003, SOCIOLECONOMIC APPL; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Hong SY, 2014, J GEOGR SYST, V16, P211, DOI 10.1007/s10109-013-0190-7; Johnston R, 2011, GEOJOURNAL, V76, P447, DOI 10.1007/s10708-010-9366-6; Johnston R, 2010, J ETHN MIGR STUD, V36, P697, DOI 10.1080/13691830903505045; Kramer M, 2010, INT J HEALTH GEOGR, V9, P1; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Morril R. K., 1991, GEOGRAPHY RES FORUM, V11, P25; Peach C, 2010, J ETHN MIGR STUD, V36, P1519, DOI 10.1080/1369183X.2010.511508; Peach C, 2009, J ETHN MIGR STUD, V35, P1381, DOI 10.1080/13691830903125885; Poulsen M, 2002, INT J URBAN REGIONAL, V26, P229, DOI 10.1111/1468-2427.00377; Poulsen M, 2010, ENVIRON PLANN A, V42, P874, DOI 10.1068/a42181; Reardon SF, 2009, SOC SCI RES, V38, P57, DOI 10.1016/j.ssresearch.2008.10.002; Reardon SF, 2004, SOCIOL METHODOL, V34, P121, DOI 10.1111/j.0081-1750.2004.00150.x; Sadahiro Y, 2013, J GEOGRAPHICAL SYSTE, V119, P1; TOBLER WR, 1979, J AM STAT ASSOC, V74, P519, DOI 10.2307/2286968; WHITE MJ, 1983, AM J SOCIOL, V88, P1008, DOI 10.1086/227768; Wong D. W. S., 2003, Computers, Environment and Urban Systems, V27, P53, DOI 10.1016/S0198-9715(01)00018-7; Wong DW, 2007, URBAN GEOGR, V28, P305, DOI 10.2747/0272-3638.28.4.305; Wong DWS, 2011, J GEOGR SYST, V13, P127, DOI 10.1007/s10109-010-0112-x; WONG DWS, 1993, URBAN STUD, V30, P559, DOI 10.1080/00420989320080551	25	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113767	10.1371/journal.pone.0113767	http://dx.doi.org/10.1371/journal.pone.0113767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415326	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600076
J	Shi, CH; Tian, JH; Ren, D; Wei, HL; Zhang, LH; Wang, Q; Yang, KH				Shi, Chunhu; Tian, Jinhui; Ren, Dan; Wei, Hongli; Zhang, Lihuan; Wang, Quan; Yang, Kehu			Methodological Reporting of Randomized Trials in Five Leading Chinese Nursing Journals	PLOS ONE			English	Article							CONSORT; INTERVENTIONS; EXTENSION; QUALITY	Background: Randomized controlled trials (RCTs) are not always well reported, especially in terms of their methodological descriptions. This study aimed to investigate the adherence of methodological reporting complying with CONSORT and explore associated trial level variables in the Chinese nursing care field. Methods: In June 2012, we identified RCTs published in five leading Chinese nursing journals and included trials with details of randomized methods. The quality of methodological reporting was measured through the methods section of the CONSORT checklist and the overall CONSORT methodological items score was calculated and expressed as a percentage. Meanwhile, we hypothesized that some general and methodological characteristics were associated with reporting quality and conducted a regression with these data to explore the correlation. The descriptive and regression statistics were calculated via SPSS 13.0. Results: In total, 680 RCTs were included. The overall CONSORT methodological items score was 6.34+/-0.97 (Mean +/- SD). No RCT reported descriptions and changes in "trial design,'' changes in "outcomes'' and "implementation,'' or descriptions of the similarity of interventions for "blinding.'' Poor reporting was found in detailing the "settings of participants'' (13.1%), "type of randomization sequence generation'' (1.8%), calculation methods of "sample size'' (0.4%), explanation of any interim analyses and stopping guidelines for "sample size'' (0.3%), "allocation concealment mechanism'' (0.3%), additional analyses in "statistical methods'' (2.1%), and targeted subjects and methods of "blinding'' (5.9%). More than 50% of trials described randomization sequence generation, the eligibility criteria of "participants,'' "interventions,'' and definitions of the "outcomes'' and "statistical methods.'' The regression analysis found that publication year and ITT analysis were weakly associated with CONSORT score. Conclusions: The completeness of methodological reporting of RCTs in the Chinese nursing care field is poor, especially with regard to the reporting of trial design, changes in outcomes, sample size calculation, allocation concealment, blinding, and statistical methods.	[Shi, Chunhu; Tian, Jinhui; Wang, Quan; Yang, Kehu] Lanzhou Univ, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China; [Shi, Chunhu; Tian, Jinhui; Wang, Quan; Yang, Kehu] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou 730000, Peoples R China; [Shi, Chunhu; Tian, Jinhui; Yang, Kehu] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Ren, Dan; Wang, Quan] Lanzhou Univ, Sch Clin Med 1, Lanzhou 730000, Peoples R China; [Wei, Hongli; Zhang, Lihuan] Lanzhou Univ, Sch Clin Med 2, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Yang, KH (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China.	kehuyangebm2006@126.com		Shi, Chunhu/0000-0003-0151-0451				Adie S, 2013, ANN SURG, V258, P872, DOI 10.1097/SLA.0b013e31829664b9; Altman DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4796; Altman DG, 2012, STAT MED, V31, P2985, DOI 10.1002/sim.5402; Borglin G, 2010, INT J NURS STUD, V47, P123, DOI 10.1016/j.ijnurstu.2009.06.016; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Ciliska D., 1998, EVIDENCE BASED NURSI, V1, P38, DOI DOI 10.1136/EBN.1.2.38; CONSORT Group, CONSORT END J; Cullum N, 2000, EVIDENCE BASED NURSI, V3, P100, DOI DOI 10.1136/EBN.3.4.100; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Institute of Scientific and Technical Information of China, 2012, CHIN S T J CIT REP; Li XL, 2002, J NURSES TRAINING, V17, P16; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mayo-Wilson E, 2013, TRIALS, V14, DOI [10.1192/bjp.bp.112.123745, 10.1186/1745-6215-14-242, 10.1007/s11292-013-9180-5]; [梅丽娟 Mei Lijuan], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P735; Mohler R, 2012, INT J NURS STUD, V49, P40, DOI 10.1016/j.ijnurstu.2011.08.003; Parent Nicole, 2009, Can J Cardiovasc Nurs, V19, P25; Polit DF, 2011, NURS RES, V60, P9, DOI 10.1097/NNR.0b013e3181ff7309; Samaan Z, 2013, J MULTIDISCIP HEALTH, V6, P169, DOI 10.2147/JMDH.S43952; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Smith BA, 2008, NURS OUTLOOK, V56, P31, DOI 10.1016/j.outlook.2007.09.002; Stephenson J, 1998, BMJ-BRIT MED J, V316, P611, DOI 10.1136/bmj.316.7131.611; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; University of Oxford, 2010, STUD DES; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Zhang XX, 2009, CHINESE J PRACTICAL, V25, P72; Zhu D, 2003, J PRACT NURS, V19, P60; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113002	10.1371/journal.pone.0113002	http://dx.doi.org/10.1371/journal.pone.0113002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415382	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600024
J	Cao, J; Li, MM; Wang, Y; Yu, GJ; Yan, CH				Cao, Jia; Li, Minming; Wang, Yu; Yu, Guangjun; Yan, Chonghuai			Environmental Lead Exposure among Preschool Children in Shanghai, China: Blood Lead Levels and Risk Factors	PLOS ONE			English	Article							OUTCOMES	Objective: To determine blood lead levels and to identify related risk factors among children in Shanghai; to explore the lead change trend of children after industrial transformation and to provide data for policy development to control environmental lead pollution in Shanghai. Methods: A stratified-clustered-random sampling method was used. A tungsten atomizer absorption spectrophotometer was employed to determine blood lead levels. Results: The arithmetic mean, geometric mean and median of blood lead levels of 0- to 6-year-old children from Shanghai were 22.49 mg/L, 19.65 mg/L and 19.5 mg/L, including 0.26% (6/2291) with concentrations >100 mg/L and 2.7% (61/2291) with concentrations >50 mg/L. Boys' levels (23.57 mg/L) were greater than those of girls (21.2 mg/L). The blood lead levels increased with age. This survey showed that the Chongming district was the highest and Yangpu district was the lowest, this result is completely opposite with the earlier survey in Shanghai. Risk factors for lead contamination included housing environment, parents' education levels, social status, hobbies, and children's nutritional status. Conclusions: The blood lead levels of children in Shanghai were lower than the earlier data of Shanghai and those of published studies in China, but higher than the blood lead levels of developed countries. The blood lead levels of urban districts are higher than the central districts with the industrial transformation. Society and the government should take an active interest in childhood lead poisoning of urban areas.	[Cao, Jia; Li, Minming; Yan, Chonghuai] Shanghai Jiao Tong Univ, Sch Med, Minist Educ Shanghai Key Lab Childrens Environm H, Xinhua Hosp, Shanghai 200030, Peoples R China; [Wang, Yu; Yu, Guangjun] Shanghai Childrens Hosp, Shanghai 200040, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, GJ (corresponding author), Shanghai Childrens Hosp, Shanghai 200040, Peoples R China.	yugj1688@shchildren.com.cn; yanch@shkeylab-ceh.org			National Basic Research Program of China ("973" Program) [2012CB525001]; Public Welfare Project of the Chinese Ministry of Environmental Pollution [201309048]; Natural Science Foundation of China [30901205]; Shanghai Science and Technology Committee [124119a1400]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); Public Welfare Project of the Chinese Ministry of Environmental Pollution; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	Funding: The National Basic Research Program of China ("973" Program) (Grant No. 2012CB525001) and the Public Welfare Project of the Chinese Ministry of Environmental Pollution (Grant No. 201309048) had a role in the study design. The "985" project of Shanghai Jiao Tong University School of Medicine and the Natural Science Foundation of China (Grant No. 30901205) had a role in the data collection and analysis. The Shanghai Science and Technology Committee (Grant No. 124119a1400) had a role in the preparation of the manuscript.	Fadrowski JJ, 2010, ARCH INTERN MED, V170, P75, DOI 10.1001/archinternmed.2009.417; Gao WZ, 2001, ENVIRON RES, V87, P11, DOI 10.1006/enrs.2001.4281; Jakubowski M, 2011, INT J OCCUP MED ENV, V24, P1, DOI 10.2478/s13382-011-0009-z; Krieg EF, 2011, REPROD TOXICOL, V32, P277, DOI 10.1016/j.reprotox.2011.05.012; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Luo QY ZW, 2011, XIAN DAI YU FANG YI, V38, P614; Oulhote Y, 2013, INT J HYG ENVIR HEAL, V216, P743, DOI 10.1016/j.ijheh.2013.02.007; Piomelli S, 2002, PEDIATR CLIN N AM, V49, P1285, DOI 10.1016/S0031-3955(02)00097-4; Rothenberg SJ, 2000, ENVIRON RES, V82, P81, DOI 10.1006/enrs.1999.4007; Sallmen M, 2000, EPIDEMIOLOGY, V11, P148, DOI 10.1097/00001648-200003000-00011; Wang SQ, 2006, ENVIRON RES, V101, P412, DOI 10.1016/j.envres.2005.11.007; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Wu MQ, 2009, ZHONGGUO ER TONG BAO, V8, P401; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Xiong GR YZ, 2011, JIAN YAN YI XUE YU L, V8, P443; Yan Chonghuai, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P172	16	30	35	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113297	10.1371/journal.pone.0113297	http://dx.doi.org/10.1371/journal.pone.0113297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436459	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900037
J	Kalliokoski, O; Teilmann, AC; Jacobsen, KR; Abelson, KSP; Hau, J				Kalliokoski, Otto; Teilmann, A. Charlotte; Jacobsen, Kirsten R.; Abelson, Klas S. P.; Hau, Jann			The Lonely Mouse - Single Housing Affects Serotonergic Signaling Integrity Measured by 8-OH-DPAT-Induced Hypothermia in Male Mice	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; MALE LABORATORY MICE; 5-HT1A RECEPTOR; BODY-TEMPERATURE; SOCIAL-ISOLATION; HOUSED MICE; FEMALE MICE; HEART-RATE; RESPONSES; MODEL	Male BALB/c mice single-housed for a period of three weeks were found to respond with a more marked hypothermia to a challenge with a selective serotonergic agonist (8-OH-DPAT) than their group-housed counterparts. This effect of single housing was verified by screening a genetically heterogeneous population of male mice on a C57BL/6 background from a breeding colony. Enhanced activity of the implicated receptor (5-HT1A) leading to an amplified hypothermic effect is strongly associated with depressive states. We therefore suggest that the 8-OH-DPAT challenge can be used to demonstrate a negative emotional state brought on by e.g. long-term single housing in male laboratory mice. The study emphasizes the importance of social housing, and demonstrates that male mice deprived of social contact respond with altered serotonergic signaling activity. Male mice not only choose social contact when given the option, as has previously been shown, but will also, when it is deprived, be negatively affected by its absence. We propose that the 8-OH-DPAT challenge constitutes a simple, but powerful, tool capable of manifesting the effect of social deprivation in laboratory mice. It potentially allows not only for an unbiased, biochemical evaluation of psychological stressors, but may also allow for determining whether the effect of these can be counteracted.	[Kalliokoski, Otto; Teilmann, A. Charlotte; Jacobsen, Kirsten R.; Abelson, Klas S. P.; Hau, Jann] Univ Copenhagen, Dept Expt Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen	Kalliokoski, O (corresponding author), Univ Copenhagen, Dept Expt Med, Fac Hlth & Med Sci, Copenhagen, Denmark.	otto.kalliokoski@gmail.com	Kalliokoski, Otto/I-3828-2019; Hau, Jann/C-8692-2012	Kalliokoski, Otto/0000-0001-6531-3487; Hau, Jann/0000-0001-8586-5705; Abelson, Klas/0000-0002-4986-7882; Rosenmay Jacobsen, Kirsten/0000-0002-3211-7890	Faculty of Health and Medical Sciences at the University of Copenhagen	Faculty of Health and Medical Sciences at the University of Copenhagen	Funding: ACT was funded on a scholarship granted by The Faculty of Health and Medical Sciences at the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GUIDE CARE USE LAB A; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bartolomucci A, 2009, SCAND J LAB ANIM SCI, V36, P87; BAUMEL I, 1970, PSYCHOPHARMACOLOGIA, V18, P320, DOI 10.1007/BF00412678; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Bert B, 2006, BEHAV BRAIN RES, V167, P328, DOI 10.1016/j.bbr.2005.09.020; BILL DJ, 1991, BRIT J PHARMACOL, V103, P1857, DOI 10.1111/j.1476-5381.1991.tb12342.x; Bouwknecht JA, 2000, EUR J PHARMACOL, V400, P59, DOI 10.1016/S0014-2999(00)00387-3; BRAIN P, 1975, LIFE SCI, V16, P187, DOI 10.1016/0024-3205(75)90017-X; Brain PF, 1997, AGGRESSION LAB RODEN; Branchi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062226; Bundgaard CJ, 2012, IN VIVO, V26, P883; Caramaschi D, 2007, PHYSIOL BEHAV, V90, P590, DOI 10.1016/j.physbeh.2006.11.010; CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Festing M. F. W., 2011, HDB LAB ANIMAL SCI E, V1, P209; Fournier S, 2012, J APPL PHYSIOL, V112, P1474, DOI 10.1152/japplphysiol.01477.2011; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; GOODWIN GM, 1985, NEUROPHARMACOLOGY, V24, P1187, DOI 10.1016/0028-3908(85)90153-4; Gordon CJ, 2004, COMPARATIVE MED, V54, P63; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gunther L, 2008, EUR J PHARMACOL, V593, P49, DOI 10.1016/j.ejphar.2008.07.011; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Hubrecht R, 1993, LAB ANIM, V27, P301; Hunt C, 2006, PHYSIOL BEHAV, V87, P519, DOI 10.1016/j.physbeh.2005.11.013; Hurko Orest, 2005, NeuroRx, V2, P671, DOI 10.1602/neurorx.2.4.671; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Kalliokoski O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058460; Krohn TC, 2006, ANIM WELF, V15; Lerer B, 1999, NEUROPSYCHOPHARMACOL, V20, P628, DOI 10.1016/S0893-133X(98)00106-7; Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1; McEnany Geoffry W, 2005, Issues Ment Health Nurs, V26, P781, DOI 10.1080/01612840591008410; MISSLIN R, 1982, PSYCHONEUROENDOCRINO, V7, P217, DOI 10.1016/0306-4530(82)90015-4; OCONNELL MT, 1992, BRIT J PHARMACOL, V106, P603, DOI 10.1111/j.1476-5381.1992.tb14382.x; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Rainer Q, 2012, MOL PHARMACOL, V81, P106, DOI 10.1124/mol.111.075796; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; RAO GN, 1990, GUIDELINES FOR THE WELL-BEING OF RODENTS IN RESEARCH, P47; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rilke O, 1998, PHARMACOL BIOCHEM BE, V59, P891, DOI 10.1016/S0091-3057(97)00509-1; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schiller L, 2006, BRAIN RES, V1103, P76, DOI 10.1016/j.brainres.2006.05.051; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Szuba MP, 1997, BIOL PSYCHIAT, V42, P1130, DOI 10.1016/S0006-3223(97)00046-2; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	53	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111065	10.1371/journal.pone.0111065	http://dx.doi.org/10.1371/journal.pone.0111065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436462	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900007
J	Liu, YC; Pujara, T; Mehta, JS				Liu, Yu-Chi; Pujara, Tarak; Mehta, Jodhbir S.			New Instruments for Lenticule Extraction in Small Incision Lenticule Extraction (SMILE)	PLOS ONE			English	Article							CONTRAST SENSITIVITY; REFRACTIVE SURGERY; COMPLICATIONS; ABERRATIONS; ASTIGMATISM; SAFETY	Small incision lenticule extraction (SMILE) is an alternative to Laser-Assisted in situ Keratomileusis (LASIK) for correction of myopia. In cases where surgeons inadvertently dissect the posterior surface first, identification of the anterior surface and subsequent removal become difficult since the anterior surface of the lenticule is compacted against the anterior stromal surface. This may result in incomplete lenticule removal, and a remnant of intrastromal lenticule in SMILE may lead to visual sequelae. In order to aid surgeons in lenticule removal, we have designed and developed 5 novel SMILE lenticule strippers to locate and extract the lenticules more easily. The aim of this study was to investigate and compare the efficacy and quality of these lenticule strippers in assisting SMILE. Thirty porcine eyes were used. The ease of extraction and removal of the lenticule with different strippers was graded by an experienced SMILE surgeon, the extracted lenticule circularity was evaluated by calculating the lenticule circularity, and the intactness of the extracted lenticule edge was assessed using scanning electron microscopy. We found these novel strippers can be of great help to improve the safety and quality of SMILE surgery, particularly in those cases of difficult lenticule extraction.	[Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Pujara, Tarak] Carl Zeiss Meditec AG, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Carl Zeiss AG; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020	Liu, Yu Chi/0000-0001-5408-0382	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme	This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013) and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2014, J CATARACT REFR SURG, V40, P1415, DOI 10.1016/j.jcrs.2013.12.026; Dong ZX, 2013, J CATARACT REFR SURG, V39, P952, DOI 10.1016/j.jcrs.2013.04.016; Ivarsen A, 2014, OPHTHALMOLOGY, V121, P822, DOI 10.1016/j.ophtha.2013.11.006; Mehta JS, 2008, CORNEA, V27, P706, DOI 10.1097/QAI.0b013e31815ee267; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Riau AK, 2014, INVEST OPHTH VIS SCI, V55, P3186, DOI 10.1167/iovs.14-14434; Riau AK, 2013, J REFRACT SURG, V29, P236, DOI 10.3928/1081597X-20130318-02; Sekundo W, 2014, GRAEF ARCH CLIN EXP, V252, P837, DOI 10.1007/s00417-014-2608-4; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Vestergaard AH, 2014, J CATARACT REFR SURG, V40, P403, DOI 10.1016/j.jcrs.2013.07.053	12	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113774	10.1371/journal.pone.0113774	http://dx.doi.org/10.1371/journal.pone.0113774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436451	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900077
J	Lu, PX; Huang, H; Yuan, J; Zhao, F; Chen, ZY; Zhang, QW; Ahuja, AT; Zhou, BP; Wang, YXJ				Lu, Pu-Xuan; Huang, Hua; Yuan, Jing; Zhao, Feng; Chen, Zhi-Yi; Zhang, Qinwei; Ahuja, Anil T.; Zhou, Bo-Ping; Wang, Yi-Xiang J.			Decreases in Molecular Diffusion, Perfusion Fraction and Perfusion-Related Diffusion in Fibrotic Livers: A Prospective Clinical Intravoxel Incoherent Motion MR Imaging Study	PLOS ONE			English	Article							FIBROSIS; DISEASE; CIRRHOSIS; DIAGNOSIS; IVIM	Purpose: This study was aimed to determine whether pure molecular-based diffusion coefficient (D) and perfusion-related diffusion parameters (perfusion fraction f, perfusion-related diffusion coefficient D*) differ in healthy livers and fibrotic livers through intra-voxel incoherent motion (IVIM) MR imaging. Material and Methods: 17 healthy volunteers and 34 patients with histopathologically confirmed liver fibrosis patients (stage 1=14, stage 2=8, stage 3& 4=12, METAVIR grading) were included. Liver MR imaging was performed at 1.5-T. IVIM diffusion weighted imaging sequence was based on standard single-shot DW spin echo-planar imaging, with ten b values of 10, 20, 40, 60, 80, 100, 150, 200, 400, 800 sec/mm(2) respectively. Pixel-wise realization and regions-of-interest based quantification of IVIM parameters were performed. Results: D, f, and D* in healthy volunteer livers and patient livers were 1.096+/-0.155 vs 0.917+/-0.152 (1023 mm(2)/s, p=0.0015), 0.164+/-0.021 vs 0.123+/-0.029 (p< 0.0001), and 13.085+/-2.943 vs 9.423+/-1.737 (1023 mm(2)/s, p< 0.0001) respectively, all significantly lower in fibrotic livers. As the fibrosis severity progressed, D, f, and D* values decreased, with a trend significant for f and D*. Conclusion: Fibrotic liver is associated with lower pure molecular diffusion, lower perfusion volume fraction, and lower perfusion-related diffusion. The decrease of f and D* in the liver is significantly associated liver fibrosis severity.	[Lu, Pu-Xuan; Huang, Hua] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Dept Radiol, Shenzhen, Peoples R China; [Yuan, Jing; Zhao, Feng; Zhang, Qinwei; Ahuja, Anil T.; Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Chen, Zhi-Yi] Guangzhou Med Univ, Affiliated Hosp 3, Lab Ultrasound Mol Imaging, Guangzhou, Guangdong, Peoples R China; [Zhou, Bo-Ping] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Dept Hepatol, Shenzhen, Peoples R China	Guangdong Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Guangzhou Medical University; Guangdong Medical University	Wang, YXJ (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	yixiang_wang@cuhk.edu.hk	Ahuja, Anil T/H-4031-2017; Wang, Yi Xiang/I-5952-2016; Yuan, Jing/E-4236-2013	Ahuja, Anil T/0000-0002-0726-5402; Wang, Yi Xiang/0000-0001-5697-0717; Yuan, Jing/0000-0001-8112-3608	Shenzhen municipal government [JCYJ20130401164750006]	Shenzhen municipal government	This study was funded by the Shenzhen municipal government project No. JCYJ20130401164750006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Allkemper T, 2014, RADIOLOGY, V271, P408, DOI 10.1148/radiol.13130342; Anania C, 2011, HEPAT MON, V11, P479; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bokacheva L, 2014, J MAGN RESON IMAGING, V40, P813, DOI 10.1002/jmri.24462; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Deng M, 2012, BRIT J RADIOL, V85, pE590, DOI 10.1259/bjr/98745548; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Gaeta M, 2014, ACAD RADIOL, V21, P1286, DOI 10.1016/j.acra.2014.05.021; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; Guiu B, 2012, RADIOLOGY, V265, P96, DOI 10.1148/radiol.12112478; Guiu B, 2011, EUR RADIOL, V21, P463, DOI 10.1007/s00330-010-2017-y; Hashimoto K, 2006, ONCOL REP, V16, P677; Hollingsworth KG, 2006, NMR BIOMED, V19, P231, DOI 10.1002/nbm.1028; Ito K, 2004, INTERVIROLOGY, V47, P134, DOI 10.1159/000078465; JANES CH, 1993, ANN INTERN MED, V118, P96, DOI 10.7326/0003-4819-118-2-199301150-00003; Joo I, 2014, RADIOLOGY, V270, P131, DOI 10.1148/radiol.13122506; LAUTT WW, 1977, GASTROENTEROLOGY, V73, P1163; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee JT, 2012, MAGN RESON IMAGING, V30, P572, DOI 10.1016/j.mri.2011.12.013; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mannelli L, 2012, J MAGN RESON IMAGING, V36, P1490, DOI 10.1002/jmri.23743; MORENO AH, 1967, J CLIN INVEST, V46, P436, DOI 10.1172/JCI105545; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Patel K, 2014, CURR OPIN GASTROEN, V30, P253, DOI 10.1097/MOG.0000000000000059; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Poyraz AK, 2012, J MAGN RESON IMAGING, V35, P1108, DOI 10.1002/jmri.23519; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Sy S, 2010, PHYS MED BIOL, V55, P7587, DOI 10.1088/0031-9155/55/24/013; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667, DOI 10.2214/ajr.176.3.1760667; Waker-Samuel S, 2011, MAGN RESON MED, V65, P438, DOI 10.1002/mrm.22572; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang YXJ, 2014, QUANT IMAGING MED SU, V4, P152, DOI 10.3978/j.issn.2223-4292.2014.04.04; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Wang YXJ, 2011, RADIOLOGY, V259, P712, DOI 10.1148/radiol.11101638; Wang YXJ, 2005, CLIN RADIOL, V60, P1051, DOI 10.1016/j.crad.2005.04.016; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Zhang JL, 2012, MAGN RESON MED, V67, P89, DOI 10.1002/mrm.22982; Zhang QY, 2013, IEEE INT CONGR BIG, P141, DOI 10.1109/BigData.Congress.2013.27; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1017, DOI 10.1016/j.mri.2013.03.007; Zhao F, 2013, QUANT IMAG MED SURG, V3, P308, DOI 10.3978/j.issn.2223-4292.2013.12.10; Zhao F, 2012, KOREAN J RADIOL, V13, P736, DOI 10.3348/kjr.2012.13.6.736; Zhao F, 2012, EUR RADIOL, V22, P1709, DOI 10.1007/s00330-012-2419-0	52	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113846	10.1371/journal.pone.0113846	http://dx.doi.org/10.1371/journal.pone.0113846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436458	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900087
J	Angkurawaranon, C; Jiraporncharoen, W; Chenthanakij, B; Doyle, P; Nitsch, D				Angkurawaranon, Chaisiri; Jiraporncharoen, Wichuda; Chenthanakij, Boriboon; Doyle, Pat; Nitsch, Dorothea			Urban Environments and Obesity in Southeast Asia: A Systematic Review, Meta-Analysis and Meta-Regression	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; NONCOMMUNICABLE DISEASES; NUTRITIONAL-STATUS; SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; HEALTH; OVERWEIGHT; PREVALENCE; CHILDREN	Many environmental factors contribute to the rise in prevalence of obesity in populations but one key driver is urbanization. Countries in Southeast (SE) Asia have undergone rapid changes in urbanization in recent decades. The aim of this study is to provide a systematic review of studies exploring the relationship between living in an urban or rural environment (urbanicity) and obesity in Southeast Asia. In particular, the review will investigate whether the associations are uniform across countries and ages, and by sex. The literature search was conducted up to June 2014 using five databases: EMBASE, PubMed, GlobalHealth, DigitalJournal and Open Grey. Forty-five articles representing eight of the eleven countries in SE Asia were included in the review. The review found a consistent positive association between urbanicity and obesity in countries of Southeast Asia, in all age groups and both genders. Regional differences between the associations are partly explained by gross national income (GNI). In countries with lower GNI per capita, the association between urbanicity and obesity was greater. Such findings have implications for policy makers. They imply that population level interventions need to be country or region specific, tailored to suit the current stage of economic development. In addition, less developed countries might be more vulnerable to the negative health impact of urbanization than more developed countries.	[Angkurawaranon, Chaisiri; Doyle, Pat; Nitsch, Dorothea] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England; [Angkurawaranon, Chaisiri; Jiraporncharoen, Wichuda] Chiang Mai Univ, Dept Family Med, Fac Med, Chiang Mai 50000, Thailand; [Chenthanakij, Boriboon] Chiang Mai Univ, Dept Emergency Med, Fac Med, Chiang Mai 50000, Thailand	University of London; London School of Hygiene & Tropical Medicine; Chiang Mai University; Chiang Mai University	Angkurawaranon, C (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England.	chaisiri.angkurawaranon@lshtm.ac.uk	Angkurawaranon, Chaisiri/I-6140-2015	Angkurawaranon, Chaisiri/0000-0003-4206-9164; Nitsch, Dorothea/0000-0001-5767-248X; Jiraporncharoen, Wichuda/0000-0002-8131-6474	Faculty of Medicine, Chiang Mai University, Thailand	Faculty of Medicine, Chiang Mai University, Thailand	The authors received no specific funding for this work. CA is a PhD student funded by the Faculty of Medicine Development Scholarship (Faculty of Medicine, Chiang Mai University, Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2007, OBESITY, V15, P3113, DOI 10.1038/oby.2007.371; Aekplakorn W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-854; Aekplakorn W, 2011, ASIA-PAC J PUBLIC HE, V23, P792, DOI 10.1177/1010539511424482; Ahmad Ali Zainuddin, 2013, Malaysian Journal of Nutrition, V19, P149; Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; Azmi M Y Jr, 2009, Malays J Nutr, V15, P97; Banwell C, 2009, J EPIDEMIOL COMMUN H, V63, P366, DOI 10.1136/jech.2008.080820; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Canoy D, 2007, OBES REV, V8, P1, DOI [10.1111/j.1467-789X.2007.00310.x, 10.1111/j.1467-789X.2007.00308.x]; Chinh VD, 2010, ASIA PAC J CLIN NUTR, V19, P209; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Davey TM, 2013, PUBLIC HEALTH, V127, P1057, DOI 10.1016/j.puhe.2013.09.008; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; Firestone R, 2011, SOC SCI MED, V72, P1420, DOI 10.1016/j.socscimed.2011.03.003; Fuke Y, 2007, DIABETES RES CLIN PR, V77, pS224, DOI 10.1016/j.diabres.2007.01.062; Gu DF, 2003, EUR J CARDIOV PREV R, V10, P249, DOI 10.1097/01.hjr.0000085254.65733.21; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; Hanh TTM, 2001, J AM COLL NUTR, V20, P616, DOI 10.1080/07315724.2001.10719066; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Institute for Health Metrics and Evaluatoin, GBD ARR DIAGR; Jinam TA, 2008, ETHNIC HEALTH, V13, P277, DOI 10.1080/13557850801930478; Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu20100060, 10.3390/nu2010060]; Julia M., 2004, Food and Nutrition Bulletin, V25, P354; Jurgensen Nanna, 2009, BMC Oral Health, V9, P29, DOI 10.1186/1472-6831-9-29; Kinra S, 2004, INT J EPIDEMIOL, V33, P777, DOI 10.1093/ije/dyh161; KOYAMA H, 1988, HUM BIOL, V60, P263; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Le Nguyen BK, 2013, BRIT J NUTR, V110; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leowski J, 2009, HEALTH POLICY, V92, P43, DOI 10.1016/j.healthpol.2009.02.003; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ly KA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-35; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mai TTT, 2003, J NUTR SCI VITAMINOL, V49, P13, DOI 10.3177/jnsv.49.13; Ghazali SM, 2006, TROP BIOMED, V23, P148; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Myo Thet Htoon, 1992, Asia Pac J Public Health, V6, P188; Naidu BM, 2013, ASIA PAC J CLIN NUTR, V22, P408, DOI 10.6133/apjcn.2013.22.3.18; Nambooze J, 2014, ENVIRON HEALTH PREV, V19, P143, DOI 10.1007/s12199-013-0367-1; Narain JP, 2011, NATL MED J INDIA, V24, P280; Ng N, 2006, B WORLD HEALTH ORGAN, V84, P305, DOI 10.2471/BLT.05.023721; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Ramke J, 2012, PUBLIC HEALTH NUTR, V15, P2118, DOI 10.1017/S1368980011003491; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Rasiah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-886; Rojroongwasinkul N, 2013, BRIT J NUTR, V110; Sakamoto N, 2001, INT J OBESITY, V25, P389, DOI 10.1038/sj.ijo.0801477; Sandjaja S, 2013, BRIT J NUTR, V110, pS11, DOI 10.1017/S0007114513002109; Sartika Ratu Ayu Dewi, 2011, Malays J Nutr, V17, P337; Shariff ZM, 2014, ASIA PAC J CLIN NUTR, V23, P138, DOI 10.6133/apjcn.2014.23.1.05; Suzana S, 2012, ASIA-PAC J PUBLIC HE, V24, P318, DOI 10.1177/1010539510380736; Tang HK, 2007, ASIA PAC J CLIN NUTR, V16, P74; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Toh CM, 2002, BRIT MED J, V324, P427; Tran TMH, 2001, J NUTR SCI VITAMINOL, V47, P147, DOI 10.3177/jnsv.47.147; Tuan NT, 2008, EUR J CLIN NUTR, V62, P78, DOI 10.1038/sj.ejcn.1602675; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; van Lierop A, 2008, ASIA PAC J CLIN NUTR, V17, P603; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Hien VTT, 2013, PUBLIC HEALTH NUTR, V16, P922, DOI 10.1017/S1368980012003552; Mohamud WNW, 2012, DIABETES RES CLIN PR, V96, P90, DOI [10.1016/j.diabres.2011.12.023, 10.1016/j.diabres.2011.11.020]; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2013, OB OV; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Zaini M Z Anuar, 2005, Asia Pac J Public Health, V17, P71, DOI 10.1177/101053950501700203; Zalilah M S, 2006, Med J Malaysia, V61, P48	75	34	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113547	10.1371/journal.pone.0113547	http://dx.doi.org/10.1371/journal.pone.0113547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426942	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000349145400062
J	Sahler, J; Woeller, CF; Phipps, RP				Sahler, Julie; Woeller, Collynn F.; Phipps, Richard P.			Microparticles Engineered to Highly Express Peroxisome Proliferator-Activated Receptor-gamma Decreased Inflammatory Mediator Production and Increased Adhesion of Recipient Monocytes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; PPAR-GAMMA; OXIDIZED LDL; FIBRONECTIN; PLATELETS; INTEGRIN; DIFFERENTIATION; OVEREXPRESSION; INDUCTION; DISEASES	Circulating blood microparticles are submicron vesicles released primarily by megakaryocytes and platelets that act as transcellular communicators. Inflammatory conditions exhibit elevated blood microparticle numbers compared to healthy conditions. Direct functional consequences of microparticle composition, especially internal composition, on recipient cells are poorly understood. Our objective was to evaluate if microparticle composition could impact the function of recipient cells, particularly during inflammatory provocation. We therefore engineered the composition of megakaryocyte culture-derived microparticles to generate distinct microparticle populations that were given to human monocytes to assay for influences recipient cell function. Herein, we tested the responses of monocytes exposed to either control microparticles or microparticles that contain the anti-inflammatory transcription factor, peroxisome proliferator-activated receptor-gamma (PPAR gamma). In order to normalize relative microparticle abundance from two microparticle populations, we implemented a novel approach that utilizes a Nanodrop Spectrophotometer to assay for microparticle density rather than concentration. We found that when given to peripheral blood mononuclear cells, microparticles were preferentially internalized by CD11b+ cells, and furthermore, microparticle composition had a profound functional impact on recipient monocytes. Specifically, microparticles containing PPAR gamma reduced activated monocyte production of the proinflammatory cytokines interleukin-8 and monocyte chemotactic protein-1 compared to activated monocytes exposed to control microparticles. Additionally, treatment with PPAR gamma microparticles greatly increased monocyte cell adherence. This change in morphology occurred simultaneously with increased production of the key extracellular matrix protein, fibronectin and increased expression of the fibronectin-binding integrin, ITGA5. PPAR gamma microparticles also changed monocyte mRNA levels of several genes including those under PPAR gamma control. Overall, the delivery of PPAR gamma from microparticles to human monocytes influenced gene expression, decreased inflammatory mediator production and increased monocyte adherence. These results support the concept that the composition of blood microparticles has a profound impact on the function of cells with which they interact, and likely plays a role in vascular inflammation.	[Sahler, Julie; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Sahler, Julie; Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	Richard_Phipps@urmc.rochester.edu	Woeller, Collynn/U-3877-2019	Woeller, Collynn/0000-0001-7197-5057	National Institute of Health [T90-DE021985, T32-HL066988, HL095467, UL-1RR024160, ES001247]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095467, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by the National Institute of Health grants: T90-DE021985, T32-HL066988, HL095467, UL-1RR024160 and ES001247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Garcia-Bates TM, 2008, CLIN CANCER RES, V14, P6414, DOI 10.1158/1078-0432.CCR-08-0457; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ray DM, 2008, THROMB HAEMOSTASIS, V99, P86, DOI 10.1160/TH07-05-0328; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sahler J, 2012, J THROMB HAEMOST, V10, P2563, DOI 10.1111/jth.12017; TAKIZAWA T, 1995, CLIN EXP IMMUNOL, V101, P376; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; TSUCHIYA S, 1982, CANCER RES, V42, P1530; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; White ES, 2001, J IMMUNOL, V167, P5362, DOI 10.4049/jimmunol.167.9.5362; Xu Y, 2011, TRANSFUSION, V51, P363, DOI 10.1111/j.1537-2995.2010.02819.x	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113189	10.1371/journal.pone.0113189	http://dx.doi.org/10.1371/journal.pone.0113189			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426628	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400038
J	Spackman, E; Richmond, S; Sculpher, M; Bland, M; Brealey, S; Gabe, R; Hopton, A; Keding, A; Lansdown, H; Perren, S; Torgerson, D; Watt, I; MacPherson, H				Spackman, Eldon; Richmond, Stewart; Sculpher, Mark; Bland, Martin; Brealey, Stephen; Gabe, Rhian; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Perren, Sara; Torgerson, David; Watt, Ian; MacPherson, Hugh			Cost-Effectiveness Analysis of Acupuncture, Counselling and Usual Care in Treating Patients with Depression: The Results of the ACUDep Trial	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL	Background: New evidence on the clinical effectiveness of acupuncture plus usual care (acupuncture) and counselling plus usual care (counselling) for patients with depression suggests the need to investigate the health-related quality of life and costs of these treatments to understand whether they should be considered a good use of limited health resources. Methods and Findings: The cost-effectiveness analyses are based on the Acupuncture, Counselling or Usual care for Depression (ACUDep) trial results. Statistical analyses demonstrate a difference in mean quality adjusted life years (QALYs) and suggest differences in mean costs which are mainly due to the price of the interventions. Probabilistic sensitivity analysis is used to express decision uncertainty. Acupuncture and counselling are found to have higher mean QALYs and costs than usual care. In the base case analysis acupuncture has an incremental cost-effectiveness ratio (ICER) of 4,560 pound per additional QALY and is cost-effective with a probability of 0.62 at a cost-effectiveness threshold of 20,000 pound per QALY. Counselling compared with acupuncture is more effective and more costly with an ICER of 71,757 pound and a probability of being cost-effective of 0.36. A scenario analysis of counselling versus usual care, excluding acupuncture as a comparator, results in an ICER of 7,935 pound and a probability of 0.91. Conclusions: Acupuncture is cost-effective compared with counselling or usual care alone, although the ranking of counselling and acupuncture depends on the relative cost of delivering these interventions. For patients in whom acupuncture is unavailable or perhaps inappropriate, counselling has an ICER less than most cost-effectiveness thresholds. However, further research is needed to determine the most cost-effective treatment pathways for depressed patients when the full range of available interventions is considered.	[Spackman, Eldon; Sculpher, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richmond, Stewart; Bland, Martin; Brealey, Stephen; Gabe, Rhian; Hopton, Ann; Keding, Ada; Lansdown, Harriet; Perren, Sara; Torgerson, David; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Watt, Ian] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of Hull; University of York - UK	Spackman, E (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	eldon.spackman@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Spackman, David Eldon/0000-0001-8558-5973; Gabe, Rhian/0000-0002-0273-3094; Keding, Ada/0000-0002-1182-887X; brealey, stephen/0000-0001-9749-7014; Sculpher, Mark/0000-0003-3746-9913	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0707-10186]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (RP-PG-0707-10186). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders, and the University of York in its role as sponsor for the study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; Churchill R, 2001, HTA, V5, P183; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2013, METHODS ESTIMATION N; Curtis L., 2012, UNIT COSTS HLTH SOCI; DOLAN P, 1995, HEALTH ECON, V4, P289, DOI 10.1002/hec.4730040405; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Gilbody S, 2002, IMPROVING RECOGNITIO; Hopton AK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000456; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; MacPherson H, 2012, BMC GASTROENTEROLOGY, V12; MacPherson H, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001518; MacPherson H, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-209; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mellor-Clark J, 2001, OCCAS PAP R COLL GEN, Vvi-7; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NHS Choices, 2014, AC; NICE, 2010, DEPR TREATM MAN DEPR, P707; Seggar L, 2002, BEHAV THER, V33, P17; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Whiting M, 2008, COMPLEMENT THER MED, V16, P87, DOI 10.1016/j.ctim.2007.07.005; Willan AR, 2005, STAT MED, V24, P131, DOI 10.1002/sim.1794	27	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113726	10.1371/journal.pone.0113726	http://dx.doi.org/10.1371/journal.pone.0113726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426637	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400082
J	Wang, S; Lu, AX; Chen, XM; Wei, L; Ding, JQ				Wang, Shuang; Lu, Aixia; Chen, Xiangming; Wei, Lin; Ding, Jiqiang			RABEX-5 Is Upregulated and Plays an Oncogenic Role in Gastric Cancer Development by Activating the VEGF Signaling Pathway	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; HUMAN PROSTATE-CANCER; INDUCED APOPTOSIS; BREAST-CANCER; EXPRESSION; GROWTH; RAB5A; METASTASIS; MIGRATION; INVASION	RABEX-5, a guanine-nucleotide exchange factor (GEF) for RAB-5, is implicated in tumorigenesis and in the development of certain human cancers. Here, we report that RABEX-5 promotes tumor growth and the metastatic ability of gastric cancer cells both in vitro and in vivo. Expression of RABEX-5 is significantly higher in gastric cancer tissues and is associated with tumor size and lymph node metastasis. In addition, targeted silencing of RABEX-5 reduced gastric cancer cell proliferation and colony formation in vitro via the induction of a G0/G1 phase arrest, and stimulated gastric cancer cell apoptosis. Knockdown of RABEX-5 also inhibited wound healing, migration and the invasive abilities of gastric cancer cells. The results of in vivo animal experiments were also consistent with these in vitro findings. Silencing of RABEX-5 led to decreased expression of VEGF. These results indicate that RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.	[Wang, Shuang; Chen, Xiangming; Wei, Lin] Cent Hosp Taian, Dept Clin Oncol, Tai An, Shandong, Peoples R China; [Lu, Aixia] Cent Hosp Taian, Dept Nursing, Tai An, Shandong, Peoples R China; [Ding, Jiqiang] Canc Prevent & Control Hosp Taian, Dept Radiat Oncol, Tai An, Shandong, Peoples R China		Ding, JQ (corresponding author), Canc Prevent & Control Hosp Taian, Dept Radiat Oncol, Tai An, Shandong, Peoples R China.	taishandjq@126.com						Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Beierle EA, 2005, J SURG RES, V127, P21, DOI 10.1016/j.jss.2005.03.009; Chan CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056819, 10.1371/journal.pone.0068504]; Coffey JC, 2005, J BIOL CHEM, V280, P20968, DOI 10.1074/jbc.M414696200; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gibson EM, 2002, CANCER RES, V62, P488; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hu L, 2014, ONCOTARGET, V5, P1885, DOI 10.18632/oncotarget.1871; Kim J, 2014, WORLD J GASTROENTERO, V20, P9600, DOI 10.3748/wjg.v20.i28.9600; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Maroof H, 2014, EXP MOL PATHOL; Mendoza P, 2014, SMALL GTPASES, V5; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Olchowik Marta, 2009, Postepy Biochem, V55, P171; Poza-Guedes P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/372567; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Wang Ying-jian, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P185; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang PS, 2011, CANCER SCI, V102, P2172, DOI 10.1111/j.1349-7006.2011.02089.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang HT, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-31; Zhang X, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-52; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x; Zhong H, 2000, CANCER RES, V60, P1541	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113891	10.1371/journal.pone.0113891	http://dx.doi.org/10.1371/journal.pone.0113891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427001	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400095
J	Bai, BL; Zhang, Q; Liu, XZ; Miao, CY; Shangguan, SF; Bao, YH; Guo, J; Wang, L; Zhang, T; Li, HL				Bai, Baoling; Zhang, Qin; Liu, Xiaozhen; Miao, Chunyue; Shangguan, Shaofang; Bao, Yihua; Guo, Jin; Wang, Li; Zhang, Ting; Li, Huili			Different Epigenetic Alterations Are Associated with Abnormal IGF2/Igf2 Upregulation in Neural Tube Defects	PLOS ONE			English	Article							IGF2 EXPRESSION; GENE-EXPRESSION; SHANXI PROVINCE; HIGH PREVALENCE; METHYLATION; H19; METABOLISM; CANCER	The methylation status of DNA methylation regions (DMRs) of the imprinted gene IGF2/Igf2 is associated with neural tube defects (NTDs), which are caused by a failure of the neural tube to fold and close and are the second-most common birth defect; however, the characterization of the expression level of IGF2/Igf2 in neural tissue from human fetuses affected with NTDs remains elusive. More importantly, whether abnormal chromatin structure also influences IGF2/Igf2 expression in NTDs is unclear. Here, we investigated the transcriptional activity of IGF2/Igf2 in normal and NTD spinal cord tissues, the methylation status of different DMRs, and the chromatin structure of the promoter. Our data indicated that in NTD samples from both human fetuses and retinoic acid (RA)-treated mouse fetuses, the expression level of IGF2/Igf2 was upregulated 6.41-fold and 1.84-fold, respectively, compared to controls. H19 DMR1, but not IGF2 DMR0, was hypermethylated in human NTD samples. In NTD mice, h19 DMR1 was stable, whereas the chromatin structure around the promoter of Igf2 might be loosened, which was displayed by higher H3K4 acetylation and lower H3K27 trimethylation. Therefore, the data revealed that IGF2/Igf2 expression can be ectopically up-regulated by dual epigenetic factors in NTDs. In detail, the upregulation of IGF2/Igf2 is likely controlled by hypermethylation of H19 DMR1 in human NTDs, however, in acute external RA-induced NTD mice it is potentially determined by more open chromatin structure.	[Bai, Baoling; Zhang, Qin; Liu, Xiaozhen; Miao, Chunyue; Shangguan, Shaofang; Bao, Yihua; Guo, Jin; Wang, Li; Zhang, Ting; Li, Huili] Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing 100020, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, HL (corresponding author), Capital Inst Pediat, Beijing Municipal Key Lab Child Dev & Nutri, Beijing 100020, Peoples R China.	lihuili2011@gmail.com	Li, Huili/AAP-9120-2020	Li, Huili/0000-0002-9248-0720; Zhang, Qin/0000-0002-4597-7697	National Natural Science Foundation of China, Beijing, China [81471163, 81300489]; National "973'' project [2013CB945404]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); National "973'' project(National Basic Research Program of China)	This study is supported by National Natural Science Foundation of China, Beijing, China (No. 81471163; No. 81300489) and National "973'' project (2013CB945404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi Habib W, 2014, HUM MOL GENET; Brouwer-Visser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100165; Byrne J, 1996, AM J MED GENET, V66, P303, DOI 10.1002/(SICI)1096-8628(19961218)66:3<303::AID-AJMG13>3.3.CO;2-2; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054492; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Liu Z, 2012, EUR J HUM GENET, V20, P516, DOI 10.1038/ejhg.2011.242; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Stolk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078462; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wang F, 2013, GENES NUTR, V8, P581, DOI 10.1007/s12263-013-0355-5; Wang J, 2011, REPROD TOXICOL, V32, P313, DOI 10.1016/j.reprotox.2011.06.117; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wei XW, 2013, NEUROCHEM RES, V38, P1605, DOI 10.1007/s11064-013-1062-8; Wu LH, 2013, MOL CELL BIOCHEM, V380, P33, DOI 10.1007/s11010-013-1655-1; Zhang HY, 2008, EXP NEUROL, V212, P515, DOI 10.1016/j.expneurol.2008.04.044; Zhang Q, 2013, NEUROBIOL DIS, V54, P404, DOI 10.1016/j.nbd.2013.01.014; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	33	13	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113308	10.1371/journal.pone.0113308	http://dx.doi.org/10.1371/journal.pone.0113308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423083	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700030
J	Jang, S; Javadov, S				Jang, Sehwan; Javadov, Sabzali			Inhibition of JNK Aggravates the Recovery of Rat Hearts after Global Ischemia: The Role of Mitochondrial JNK	PLOS ONE			English	Article							N-TERMINAL KINASE; REACTIVE OXYGEN; MYOCARDIAL REPERFUSION; OXIDATIVE STRESS; PROTEIN-KINASES; INFARCT SIZE; ACTIVATION; APOPTOSIS; INJURY; DEATH	c-Jun N-terminal kinase (JNK), a stress-activated MAPK, is activated during cardiac ischemia-reperfusion (IR). The role of JNK inhibitors in cardioprotection against IR still remains controversial, in part, due to spill-over effects of non-specific inhibitors. In the present study, we sought to examine whether inhibition of JNK by SU3327, a specific JNK inhibitor that inhibits upstream JNK signaling rather than the kinase activity of JNK, improves cardiac function and reduces heart damage during IR. Hearts of male Sprague-Dawley rats perfused by Langendorff were subjected to 25 min of global ischemia followed by 30 min reperfusion in the presence or absence of SU3327. Cardiac function was monitored throughout the perfusion period. Myocardial damage was extrapolated from LDH activity in the coronary effluent. At the end of reperfusion, mitochondria were isolated and used to measure respiration rates and mitochondrial permeability transition pore opening. Protein analysis of mitochondria predictably revealed that SU3327 inhibited JNK phosphorylation. Although SU3327 significantly reduced cell damage during the first minutes of reperfusion, it did not improve cardiac function and, furthermore, reduced the mitochondrial respiratory control index. Interestingly, SU3327 activated the other stress-related MAPK, p38, and greatly increased its translocation to mitochondria. Mitochondrial P-JNK and P-p38 were co-immunoprecipitated with complex III of the electron transfer chain. Thus, JNK plays an essential role in cardiac signaling under both physiological and pathological conditions. Its inhibition by SU3327 during IR aggravates cardiac function. The detrimental effects of JNK inhibition are associated with reciprocal p38 activation and mitochondrial dysfunction.	[Jang, Sehwan; Javadov, Sabzali] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Javadov, S (corresponding author), Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA.	sabzali.javadov@upr.edu	Javadov, Sabzali/J-9594-2017	Javadov, Sabzali/0000-0002-7024-5383	National Heart, Lung, And Blood Institute of the National Institutes of Health [SC1HL118669]; RCMI National Center for Research Resources National Institutes of Health [G12RR-003051]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL118669] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); RCMI National Center for Research Resources National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number SC1HL118669 (to S.J.), and in part, by the RCMI National Center for Research Resources National Institutes of Health Grant G12RR-003051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Cicconi S, 2003, J CELL PHYSIOL, V195, P27, DOI 10.1002/jcp.10219; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Fryer RM, 2001, AM J PHYSIOL-HEART C, V281, pH1184, DOI 10.1152/ajpheart.2001.281.3.H1184; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Javadov S, 2008, CARDIOVASC RES, V77, P416, DOI 10.1093/cvr/cvm039; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Khaliulin I, 2004, FREE RADICAL BIO MED, V37, P1, DOI 10.1016/j.freeradbiomed.2004.04.017; Khaliulin I, 2007, J PHYSIOL-LONDON, V581, P1147, DOI 10.1113/jphysiol.2007.130369; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Kumar Y, 2003, PROTEOMICS, V3, P513, DOI 10.1002/pmic.200390065; Lochner A, 2003, CARDIOVASC DRUG THER, V17, P217, DOI 10.1023/A:1026116022552; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Skyschally A, 2009, CIRC RES, V104, P15, DOI 10.1161/CIRCRESAHA.108.186429; Talmor D, 2000, CIRC RES, V86, P1004, DOI 10.1161/01.RES.86.9.1004; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; ZAMZAMI N, 2003, METH MOL B, V282, P103	46	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113526	10.1371/journal.pone.0113526	http://dx.doi.org/10.1371/journal.pone.0113526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423094	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700038
J	Liu, X; Xu, ZW; Zhu, L; Liao, S; Guo, WZ				Liu, Xiao; Xu, Zhiwen; Zhu, Ling; Liao, Shan; Guo, Wanzhu			Transcriptome Analysis of Porcine Thymus following Porcine Cytomegalovirus Infection	PLOS ONE			English	Article							KAPPA-B; APOPTOSIS; BETA; EXPRESSION; HERPESVIRUS; ACTIVATION; CYTOKINES; RESPONSES; ALPHA; CELLS	Porcine cytomegalovirus (PCMV) is a major immunosuppressive virus that mainly affects the immune function of T lymphocytes and macrophages. Despite being widely distributed around the world, no significantly different PCMV serotypes have been found. Moreover, the molecular immunosuppressive mechanisms of PCMV, along with the host antiviral mechanisms, are still not well characterized. To understand the potential impact of PCMV on the function of immune organs, we examined the transcriptome of PCMV-infected thymuses by microarray analysis. We identified 5,582 genes that were differentially expressed as a result of PCMV infection. Of these, 2,161 were upregulated and 3,421 were downregulated compared with the uninfected group. We confirmed the expression of 13 differentially expressed immune-related genes using quantitative real-time RTPCR, and further confirmed the expression of six of those cytokines by western blot. Gene ontology, gene interaction networks, and KEGG pathway analysis of our results indicated that PCMV regulates multiple functional pathways, including the immune system, cellular and metabolic processes, networks of cytokine-cytokine receptor interactions, the TGF-beta signaling pathway, the lymphocyte receptor signaling pathway, and the TNF-alpha signaling pathway. Our study is the first comprehensive attempt to explore the host transcriptional response to PCMV infection in the porcine immune system. It provides new insights into the immunosuppressive molecular mechanisms and pathogenesis of PCMV. This previously unrecognized endogenous antiviral mechanism has implications for the development of host-directed strategies for the prevention and treatment of immunosuppressive viral diseases.	[Liu, Xiao; Xu, Zhiwen; Zhu, Ling; Liao, Shan; Guo, Wanzhu] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com			Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-11-1059]; program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team [2013TD0015]; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team; Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University	This study was supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (Project No: NCET-11-1059), program for Changjiang Scholars and Innovative Research Team in University (Project No: IRT13083), Sichuan Youth Waterfowl Disease Control and Prevention Science and Technology Innovative Research Team (Project No: 2013TD0015), and by the Excellent Doctoral Dissertation Fostering Foundation of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2006, J NEUROVIROL, V12, P501, DOI 10.1080/13550280601064921; Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Chang WLW, 2009, VIROLOGY, V390, P330, DOI 10.1016/j.virol.2009.05.013; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Contini P, 2005, J IMMUNOL, V175, P7244, DOI 10.4049/jimmunol.175.11.7244; Desloges N, 2008, MED MICROBIOL IMMUN, V197, P277, DOI 10.1007/s00430-007-0060-3; Dorstyn L, 1999, J BIOL CHEM, V274, P30778, DOI 10.1074/jbc.274.43.30778; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; EDINGTON N, 1988, VET MICROBIOL, V17, P117, DOI 10.1016/0378-1135(88)90003-X; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fryer JFL, 2001, J CLIN MICROBIOL, V39, P1155, DOI 10.1128/JCM.39.3.1155-1156.2001; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; Gu WW, 2014, VIROLOGY, V460, P165, DOI 10.1016/j.virol.2014.05.014; Heise MT, 1998, VIROLOGY, V241, P331, DOI 10.1006/viro.1997.8969; Ho JWY, 1999, J CLIN PATHOL-MOL PA, V52, P269, DOI 10.1136/mp.52.5.269; Kim MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096302; Lee GC, 2006, VIRUS RES, V117, P209, DOI 10.1016/j.virusres.2005.08.018; Levine AJ, 2013, J NEUROIMMUNOL, V265, P96, DOI 10.1016/j.jneuroim.2013.09.016; Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121; Lisnic VJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003611; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064648; Liu X, 2012, J VIROL METHODS, V186, P30, DOI 10.1016/j.jviromet.2012.08.024; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; Montaner S, 2001, CANCER RES, V61, P2641; Mueller NJ, 2004, J INFECT DIS, V189, P1628, DOI 10.1086/383351; O'Malley JT, 2009, AUDIOL NEURO-OTOL, V14, P78, DOI 10.1159/000158536; Orange JS, 1996, J IMMUNOL, V156, P4746; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Scobie L, 2010, XENOTRANSPLANTATION, V17, P118, DOI 10.1111/j.1399-3089.2010.00573_19.x; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; van Beurden SJ, 2012, J VIROL, V86, P10150, DOI 10.1128/JVI.01271-12; van Gent M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003960; Veloso A, 2011, DEV COMP IMMUNOL, V35, P241, DOI 10.1016/j.dci.2010.10.001; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wang YL, 2006, CYTOKINE, V35, P193, DOI 10.1016/j.cyto.2006.08.001; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Yoon KJ, 1996, VET MED-US, V91, P779; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006	43	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113921	10.1371/journal.pone.0113921	http://dx.doi.org/10.1371/journal.pone.0113921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423176	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700078
J	Steinbach, S; Krolop, N; Strommer, S; Herrera-Perez, Z; Geraci, S; Friedemann, J; Gretz, N; Neiger, R				Steinbach, Sarah; Krolop, Nora; Strommer, Sellyn; Herrera-Perez, Zeneida; Geraci, Stefania; Friedemann, Jochen; Gretz, Norbert; Neiger, Reto			A Pilot Study to Assess the Feasibility of Transcutaneous Glomerular Filtration Rate Measurement Using Fluorescence-Labelled Sinistrin in Dogs and Cats	PLOS ONE			English	Article							INJECTION INULIN-CLEARANCE; FITC-SINISTRIN; MARKER	In dogs and cats an assessment of renal function is often needed, however, existing methods including urine and plasma clearances are invasive, cumbersome and time consuming. This pilot study evaluated the feasibility of a transcutaneous glomerular filtration rate (GFR) measurement in dogs and cats. Additionally the optimal dose and location for the transcutaneous measurement device were investigated. Renal elimination of fluorescein-isothiocyanate-labelled sinistrin (FITC-S) was measured transcutaneously for 4 hours. The procedures were performed in awake, freely moving animals using escalating doses of FITC-S (10 mg/kg, 30 mg/kg, 50 mg/kg) with a wash-out period of at least 24 h in between. Multiple devices were placed on each animal. The resulting FITC-S disappearance curves were visually assessed to determine the most suitable location and the appropriate dose to reach an adequate transcutaneous peak signal for kinetic analysis. In both species 30 mg/kg were adequate for kinetic calculation. The most suitable place for the device was the lateral thoracic wall in dogs and the ventral abdominal wall in cats, respectively. Transcutaneous FITC-S clearance was then repeated using the optimal dose and location and in parallel with an additional plasma sinistrin clearance. Plasma elimination half-lives [min] were 26, 31 and 35, and corresponding transcutaneous elimination half-lives [min] were 26, 34 and 55, respectively in the dogs. Plasma elimination half-lives [min] were 51, 60 and 61, and corresponding transcutaneous elimination half-lives [min] were 75, 96 and 83, respectively in the cats. In conclusion, transcutaneous FITC-S clearance is a feasible method for the assessment of GFR in awake dogs and cats. It is noninvasive, well tolerated and easy to perform even in a clinical setting with results being readily available. A dose of 30 mg/kg of FITC-S seems adequate for kinetic assessment. Further studies are now needed to establish reference values and evaluate transcutaneous renal clearance in various conditions.	[Steinbach, Sarah; Krolop, Nora; Strommer, Sellyn; Neiger, Reto] Univ Giessen, Small Anim Clin, D-35390 Giessen, Germany; [Herrera-Perez, Zeneida; Geraci, Stefania; Friedemann, Jochen; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Mannheim, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg	Steinbach, S (corresponding author), Univ Giessen, Small Anim Clin, D-35390 Giessen, Germany.	sarah.steinbach@vetmed.uni-giessen.de		Steinbach, Sarah/0000-0002-9226-6804	EU	EU(European Commission)	One of the authors (NG) is owner of a patent covering FITC-sinistrin and the technology for its measurement. Part of the work was supported by EU-Framework Programme 7: PLACE-it and ITN Marie-Curie EU-Framework Programme 7: NephroTools. NG was involved in study design, analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinen LK, 2008, J MED CHEM, V51, P957, DOI 10.1021/jm070842+; Finch NC, 2013, J VET INTERN MED, V27, P782, DOI 10.1111/jvim.12089; GLEADHILL A, 1995, RES VET SCI, V59, P118, DOI 10.1016/0034-5288(95)90044-6; Haller M, 2003, J FELINE MED SURG, V5, P175, DOI 10.1016/S1098-612X(03)00005-6; Haller M, 1998, RES VET SCI, V64, P151, DOI 10.1016/S0034-5288(98)90011-X; Heiene RD, 1998, J VET INTERN MED, V12, P401, DOI 10.1111/j.1939-1676.1998.tb02143.x; Katayama M, 2013, J VET INTERN MED, V27, P17, DOI 10.1111/jvim.12017; MOE L, 1995, RES VET SCI, V58, P138, DOI 10.1016/0034-5288(95)90067-5; MONTEIRORIVIERE NA, 1990, J INVEST DERMATOL, V95, P582, DOI 10.1111/1523-1747.ep12505567; PETERS AM, 1992, NEPHROL DIAL TRANSPL, V7, P205, DOI 10.1093/oxfordjournals.ndt.a092106; Peters AM, 2004, EUR J NUCL MED MOL I, V31, P137, DOI 10.1007/s00259-003-1341-8; Pill J, 2005, EUR J MED CHEM, V40, P1056, DOI 10.1016/j.ejmech.2005.03.020; Pill J, 2006, N-S ARCH PHARMACOL, V373, P204, DOI 10.1007/s00210-006-0067-0; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Schock-Kusch D, 2011, KIDNEY INT, V79, P1254, DOI 10.1038/ki.2011.31; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Von Hendy-Willson VE, 2011, VET J, V188, P156, DOI 10.1016/j.tvjl.2010.05.006; Watson ADJ, 2002, J VET INTERN MED, V16, P22, DOI 10.1892/0891-6640(2002)016&lt;0022:PECCTI&gt;2.3.CO;2; WHITE AJ, 1991, EUR J NUCL MED, V18, P385, DOI 10.1007/BF02258428; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	21	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111734	10.1371/journal.pone.0111734	http://dx.doi.org/10.1371/journal.pone.0111734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423195	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700007
J	Vavilala, DT; Ponnaluri, VKC; Kanjilal, D; Mukherji, M				Vavilala, Divya Teja; Ponnaluri, V. K. Chaithanya; Kanjilal, Debolina; Mukherji, Mridul			Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; HISTONE LYSINE DEMETHYLASES; OXYGEN-INDUCED RETINOPATHY; PATHOLOGICAL RETINAL NEOVASCULARIZATION; MOUSE MODEL; TRANSCRIPTIONAL ACTIVITY; FACTOR EXPRESSION; PROLYL HYDROXYLATION; DIABETIC-RETINOPATHY	Pathological activation of the hypoxia-inducible-factor (HIF) pathway leading to expression of pro-angiogenic genes, such as vascular endothelial growth factor (VEGF), is the fundamental cause of neovascularization in ocular ischemic diseases and cancers. We have shown that pure honokiol inhibits the HIF pathway and hypoxia-mediated expression of pro-angiogenic genes in a number of cancer and retinal pigment epithelial (RPE) cell lines. The crude extracts, containing honokiol, from Magnolia plants have been used for thousands of years in the traditional oriental medicine for a number of health benefits. We have recently demonstrated that daily intraperitoneal injection of honokiol starting at postnatal day (P) 12 in an oxygen induced retinopathy mouse model significantly reduced retinal neovascularization at P17. Here, we evaluate the mechanism of HIF inhibition by honokiol in RPE cells. Using chromatin immunoprecipitation experiments, we demonstrate that honokiol inhibits binding of HIF to hypoxia-response elements present on VEGF promoter. We further show using a number of in vitro angiogenesis assays that, in addition to anti-HIF effect, honokiol manifests potent anti-angiogenic effect on human retinal micro vascular endothelial cells. Our results suggest that honokiol possesses potent anti-HIF and anti-angiogenic properties. These properties of honokiol make it an ideal therapeutic agent for the treatment of ocular neovascular diseases and solid tumors.	[Vavilala, Divya Teja; Ponnaluri, V. K. Chaithanya; Kanjilal, Debolina; Mukherji, Mridul] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Mukherji, M (corresponding author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA.	mukherjim@umkc.edu	Kanjilal, Dinakar/D-4731-2013	Kanjilal, Dinakar/0000-0001-9728-3147				Afzal A, 2007, MICROVASC RES, V74, P131, DOI 10.1016/j.mvr.2007.04.011; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Arden GB, 2011, CURR DIABETES REV, V7, P291, DOI 10.2174/157339911797415620; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Chintala S, 2010, CANCER CHEMOTH PHARM, V66, P899, DOI 10.1007/s00280-009-1238-8; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Creighton-Gutteridge M, 2007, CLIN CANCER RES, V13, P1010, DOI 10.1158/1078-0432.CCR-06-2301; DeNiro M, 2010, MOL PHARMACOL, V77, P348, DOI 10.1124/mol.109.061366; Dorey CK, 1996, ARCH OPHTHALMOL-CHIC, V114, P1210, DOI 10.1001/archopht.1996.01100140410008; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Harada H, 2009, BRIT J CANCER, V100, P747, DOI 10.1038/sj.bjc.6604939; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Iwase T, 2012, ARVO ANN M; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kaluz S, 2006, MOL CELL BIOL, V26, P5895, DOI 10.1128/MCB.00552-06; Kim YH, 2011, CANCER CHEMOTH PHARM, V68, P405, DOI 10.1007/s00280-010-1500-0; Kumar VP, 2012, BIOORG MED CHEM LETT, V22, P1439, DOI 10.1016/j.bmcl.2011.12.015; Kummar S, 2011, CLIN CANCER RES, V17, P5123, DOI 10.1158/1078-0432.CCR-11-0682; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu M, 1999, INVEST OPHTH VIS SCI, V40, P3281; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V438, P71, DOI 10.1016/j.bbrc.2013.07.028; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V415, P373, DOI 10.1016/j.bbrc.2011.10.075; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2012, TRENDS PHARM SCI; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shui YB, 2006, INVEST OPHTH VIS SCI, V47, P1571, DOI 10.1167/iovs.05-1475; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; Tripathi S, 2012, BIOORG MED CHEM LETT, V22, P216, DOI 10.1016/j.bmcl.2011.11.030; Vavilala D.T., 2012, BIOCH BIOPHYS RES CO; Vavilala DT, 2013, BIOCHEM BIOPH RES CO, V438, P697, DOI 10.1016/j.bbrc.2013.07.118; Vavilala DT, 2013, DRUG DEVELOP RES, V74, P15, DOI 10.1002/ddr.21051; Vavilala DT, 2012, BIOCHEM BIOPH RES CO, V422, P369, DOI 10.1016/j.bbrc.2012.04.143; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wong V K, 1997, Hawaii Med J, V56, P289; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002	62	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113717	10.1371/journal.pone.0113717	http://dx.doi.org/10.1371/journal.pone.0113717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422886	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700059
J	Bizic-Ionescu, M; Amann, R; Grossart, HP				Bizic-Ionescu, Mina; Amann, Rudolf; Grossart, Hans-Peter			Massive Regime Shifts and High Activity of Heterotrophic Bacteria in an Ice-Covered Lake	PLOS ONE			English	Article							SP-NOV.; COMMUNITY COMPOSITION; CARBON-DIOXIDE; UNDER-ICE; FRESH; PHYTOPLANKTON; WINTER; POPULATIONS; METHANE	In winter 2009/10, a sudden under-ice bloom of heterotrophic bacteria occurred in the seasonally ice-covered, temperate, deep, oligotrophic Lake Stechlin (Germany). Extraordinarily high bacterial abundance and biomass were fueled by the breakdown of a massive bloom of Aphanizomenon flos-aquae after ice formation. A reduction in light resulting from snow coverage exerted a pronounced physiological stress on the cyanobacteria. Consequently, these were rapidly colonized, leading to a sudden proliferation of attached and subsequently of free-living heterotrophic bacteria. Total bacterial protein production reached 201 mg C L-1 d(-1), ca. five times higher than spring-peak values that year. Fluorescence in situ hybridization and denaturing gradient gel electrophoresis at high temporal resolution showed pronounced changes in bacterial community structure coinciding with changes in the physiology of the cyanobacteria. Pyrosequencing of 16S rRNA genes revealed that during breakdown of the cyanobacterial population, the diversity of attached and free-living bacterial communities were reduced to a few dominant families. Some of these were not detectable during the early stages of the cyanobacterial bloom indicating that only specific, well adapted bacterial communities can colonize senescent cyanobacteria. Our study suggests that in winter, unlike commonly postulated, carbon rather than temperature is the limiting factor for bacterial growth. Frequent phytoplankton blooms in ice-covered systems highlight the need for year-round studies of aquatic ecosystems including the winter season to correctly understand element and energy cycling through aquatic food webs, particularly the microbial loop. On a global scale, such knowledge is required to determine climate change induced alterations in carbon budgets in polar and temperate aquatic systems.	[Bizic-Ionescu, Mina; Amann, Rudolf] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bizic-Ionescu, Mina; Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Grossart, Hans-Peter] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Max Planck Society; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Grossart, HP (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	hgrossart@igb-berlin.de	Bizic, Mina/AAC-4802-2022; Bizic, Mina/AEB-9802-2022; Amann, Rudolf I/C-6534-2014	Bizic, Mina/0000-0002-6870-4018; Bizic, Mina/0000-0002-6870-4018; Amann, Rudolf I/0000-0002-0846-7372	Leibniz Institute	Leibniz Institute	Funding provided by the Leibniz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON B, 2007, GLOBAL LAKE RIVER IC; Bertilsson S, 2013, LIMNOL OCEANOGR, V58, P1998, DOI 10.4319/lo.2013.58.6.1998; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Chapman WL, 1991, ARCTIC SO OCEAN SEA, DOI 10.7265/N5057CVT; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Dokulil MT, 2009, AQUAT ECOL, V43, P715, DOI 10.1007/s10452-009-9282-3; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Glatz RE, 2006, GEOBIOLOGY, V4, P53, DOI 10.1111/j.1472-4669.2006.00057.x; GREENBANK J, 1945, ECOL MONOGR, V15, P343, DOI 10.2307/1948427; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Humphry DR, 2001, INT J SYST EVOL MICR, V51, P1235, DOI 10.1099/00207713-51-4-1235; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Kankaala P, 2013, LIMNOL OCEANOGR, V58, P1915, DOI 10.4319/lo.2013.58.6.1915; Karlsson J, 2013, GEOPHYS RES LETT, V40, P1123, DOI 10.1002/grl.50152; Keto Juha, 2000, Boreal Environment Research, V5, P15; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; KLING GW, 1992, HYDROBIOLOGIA, V240, P23, DOI 10.1007/BF00013449; Koschel R, 2003, ADV LIMNOL, V58, P1; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Levasseur M, 2013, NAT GEOSCI, V6, P691, DOI 10.1038/NGEO1910; Llorens-Mares T, 2012, ENV MICROBIOL REP, V4, P50, DOI 10.1111/j.1758-2229.2011.00278.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Parry M. L., 2007, CLIMATE CHANGE 2007; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pizzetti I, 2011, APPL ENVIRON MICROB, V77, P5009, DOI 10.1128/AEM.02931-10; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosel S, 2012, MICROB ECOL, V64, P571, DOI 10.1007/s00248-012-0049-3; Rosel S, 2012, AQUAT MICROB ECOL, V66, P169, DOI 10.3354/ame01568; RUTTNER F, 1968, FUNDAMENTALS LIMNOLO; Straskrabova V, 2005, GLOBAL PLANET CHANGE, V46, P57, DOI 10.1016/j.gloplacha.2004.11.006; Tada Y, 2014, ISME J, V8, P441, DOI 10.1038/ismej.2013.148; Tamaki H, 2003, INT J SYST EVOL MICR, V53, P519, DOI 10.1099/ijs.0.02369-0; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; TULONEN T, 1994, J PLANKTON RES, V16, P1411, DOI 10.1093/plankt/16.10.1411; Twiss MR, 2012, J GREAT LAKES RES, V38, P18, DOI 10.1016/j.jglr.2011.12.008; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P769, DOI 10.1099/ijs.0.03056-0; Zeder M, 2011, CYTOM PART A, V79A, P306, DOI 10.1002/cyto.a.21034; Zhu F, 2003, INT J SYST EVOL MICR, V53, P853, DOI 10.1099/ijs.0.02310-0	42	33	34	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113611	10.1371/journal.pone.0113611	http://dx.doi.org/10.1371/journal.pone.0113611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419654	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900057
J	But, A; Wang, HN; Mannisto, S; Pukkala, E; Haukka, J				But, Anna; Wang, Haining; Mannisto, Satu; Pukkala, Eero; Haukka, Jari			Assessing the Effect of Treatment Duration on the Association between Anti-Diabetic Medication and Cancer Risk	PLOS ONE			English	Article							DETECTION BIAS; TYPE-2; PREVALENCE; STATEMENT; ALGORITHM; MORTALITY; SMOKING; FINLAND; BURDEN; COHORT	Most studies that have evaluated the association between anti-diabetic medication and cancer risk have suffered from methodological drawbacks. To avoid time-related biases, we evaluated the effect of treatment duration on the cancer risk among naive users of anti-diabetic medication as compared to non-users. In addition, we addressed the influence of common risk factors such as smoking and BMI. The study population comprised 23,394 participants of FINRISK surveys. Data on cancer and anti-diabetic medication were linked with the study cohorts. We applied Lexis tabulation to the data and analyzed split records by using Poisson regression. Changes in cancer incidence in relation to treatment duration were examined by modeling the rate ratio (RR). After a median follow-up of 9 years, 53 cancer cases among users of anti-diabetic medication and 1,028 among non-users were diagnosed. No significant difference in cancer risk between users and non-users was observed after adjustment. The RR for all medication regardless of its duration was 1.01 [95% CI 0.75-1.33], and 1.37 [0.94-1.94] for period of 1-4 years. The results were similar for metformin, sulfonylurea, and insulin. This study demonstrates that evaluation of the variation in cancer risk in relation to treatment duration is of particular importance for enhancing the accuracy of conclusions on the link between exposure to anti-diabetic medication and cancer risk.	[But, Anna; Haukka, Jari] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Wang, Haining] Peking Univ, Hosp 3, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Pukkala, Eero] Finnish Canc Registry, FIN-00170 Helsinki, Finland	University of Helsinki; Peking University; Finland National Institute for Health & Welfare; Finnish Cancer Registry	But, A (corresponding author), Univ Helsinki, Hjelt Inst, Helsinki, Finland.	anna.but@helsinki.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Mannisto, Satu/0000-0002-8668-3046	European Community [282526]	European Community(European Commission)	The research leading to the results of this study has received funding from the European Community's Seventh Framework Programme (FP-7) under grant agreement number 282526, the CARING project. The funding source had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433; Badrick E, 2014, EUR J CANCER, V50, P2119, DOI 10.1016/j.ejca.2014.04.032; Bailey T, 2013, AM J MED, V126, pS10, DOI 10.1016/j.amjmed.2013.06.009; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; CARBONE D, 1992, AM J MED, V93, pS13, DOI 10.1016/0002-9343(92)90621-H; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Carstensen B., 2012, DCRC TABULATION OUTL; Carstensen B, 2008, R PACKAGE VERSION, V1; Colmers IN, 2013, DIABETES CARE, V36, P3070, DOI 10.2337/dc13-0045; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; GANDINI S, 2014, CANCER PREV RES; Garber AJ, 2013, ENDOCR PRACT, V19, P327, DOI 10.4158/EP12437.GL; GROUP TDS, 2003, DIA CARE, V26, P61, DOI DOI 10.2337/DIACARE.26.1.61; Habel LA, 2013, DIABETES CARE, V36, P3953, DOI 10.2337/dc13-0140; Handelsman Y, 2013, ENDOCR PRACT, V19, P675, DOI 10.4158/EP13248.CS; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; KLAUKKA T, 2001, NORSK EPIDEMIOLOGI, V11; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mayor S, 2005, BRIT MED J, V331, P656, DOI 10.1136/bmj.331.7518.656-a; Morrison M, 2013, ADV EXP MED BIOL, V771, P229; Niemi M., 2006, DIABETES FINLAND PRE; Olsen JH, 1997, APMIS, V105, P141; Onitilo AA, 2014, EUR J CANCER PREV, V23, P134, DOI 10.1097/CEJ.0b013e3283656394; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Walker JJ, 2013, LANCET DIABETES ENDO, V1, P132, DOI 10.1016/S2213-8587(13)70028-7; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, OB PREV MAN GLOB EP; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113162	10.1371/journal.pone.0113162	http://dx.doi.org/10.1371/journal.pone.0113162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419576	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900021
J	Fu, L; Yu, Z; Chen, YH; Xia, MZ; Wang, H; Zhang, C; Tao, FB; Xu, DX				Fu, Lin; Yu, Zhen; Chen, Yuan-Hua; Xia, Mi-Zhen; Wang, Hua; Zhang, Cheng; Tao, Fang-Biao; Xu, De-Xiang			Orally Administered Melatonin Prevents Lipopolysaccharide-Induced Neural Tube Defects in Mice	PLOS ONE			English	Article							INTRAUTERINE FETAL-DEATH; SKELETAL DEVELOPMENT RETARDATION; NECROSIS-FACTOR-ALPHA; GROWTH RESTRICTION; REACTIVE OXYGEN; METABOLITE N-1-ACETYL-5-METHOXYKYNURAMINE; CHEMOKINE EXPRESSION; N-ACETYLCYSTEINE; PRETERM LABOR; TNF-ALPHA	Lipopolysaccharide (LPS) has been associated with adverse pregnant outcomes, including fetal demise, intra-uterine growth restriction (IUGR), neural tube defects (NTDs) and preterm delivery in rodent animals. Previous studies demonstrated that melatonin protected against LPS-induced fetal demise, IUGR and preterm delivery. The aim of the present study was to investigate the effects of melatonin on LPS-induced NTDs. All pregnant mice except controls were intraperitoneally injected with LPS (25 mg/kg) daily from gestational day (GD)8 to GD12. Some pregnant mice were orally administered with melatonin (MT, 50 mg/kg) before each LPS injection. A five-day LPS injection resulted in 27.5% of fetuses with anencephaly, exencephaly or encephalomeningocele. Additional experiment showed that maternal LPS exposure significantly down-regulated placental proton-coupled folate transporter (pcft) and disturbed folate transport from maternal circulation through the placentas into the fetus. Interestingly, melatonin significantly attenuated LPS-induced down-regulation of placental pcft. Moreover, melatonin markedly improved the transport of folate from maternal circulation through the placentas into the fetus. Correspondingly, orally administered melatonin reduced the incidence of LPS-induced anencephaly, exencephaly or encephalomeningocele. Taken together, these results suggest that orally administered melatonin prevents LPS-induced NTDs through alleviating LPS-induced disturbance of folate transport from maternal circulation through the placenta into the fetus.	[Fu, Lin; Yu, Zhen; Chen, Yuan-Hua; Wang, Hua; Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China; [Fu, Lin; Chen, Yuan-Hua; Wang, Hua; Tao, Fang-Biao; Xu, De-Xiang] Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China; [Xia, Mi-Zhen] Anhui Med Univ, Sch Life Sci, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China.	fbtao@126.com; xudex@126.com			National Natural Science Foundation of China [81172711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81172711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JR, 2013, PEDIATR RES, V73, P388, DOI 10.1038/pr.2013.14; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Chang CF, 2012, J PINEAL RES, V52, P312, DOI 10.1111/j.1600-079X.2011.00945.x; Chen YH, 2006, J PINEAL RES, V40, P40, DOI 10.1111/j.1600-079X.2005.00274.x; Cherukad J, 2012, PLACENTA, V33, P440, DOI 10.1016/j.placenta.2012.02.005; Rubio APD, 2014, J PINEAL RES, V56, P154, DOI 10.1111/jpi.12108; Farkas SA, 2013, EPIGENETICS-US, V8, P303, DOI 10.4161/epi.23988; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Ge DX, 2013, J PINEAL RES, V55, P377, DOI 10.1111/jpi.12084; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Leazer TM, 2002, REPROD TOXICOL, V16, P173, DOI 10.1016/S0890-6238(02)00011-4; Lee YD, 2009, J PINEAL RES, V46, P53, DOI 10.1111/j.1600-079X.2008.00621.x; Liu XZ, 2013, J PINEAL RES, V55, P14, DOI 10.1111/jpi.12045; Miller SL, 2014, J PINEAL RES, V56, P283, DOI 10.1111/jpi.12121; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; POEGGELER B, 1994, ANN NY ACAD SCI, V738, P419, DOI 10.1111/j.1749-6632.1994.tb21831.x; Ressmeyer AR, 2003, REDOX REP, V8, P205, DOI 10.1179/135100003225002709; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rivera DL, 1998, FASEB J, V12, P189, DOI 10.1096/fasebj.12.2.189; Schaefer M, 2009, J PINEAL RES, V46, P49, DOI 10.1111/j.1600-079X.2008.00614.x; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu DX, 2007, J PINEAL RES, V43, P74, DOI 10.1111/j.1600-079X.2007.00445.x; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Xu DX, 2006, AM J OBSTET GYNECOL, V195, P1707, DOI 10.1016/j.ajog.2006.03.047; Xu DX, 2006, TOXICOL LETT, V163, P20, DOI 10.1016/j.toxlet.2005.09.009; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2014, TOXICOL LETT, V224, P201, DOI 10.1016/j.toxlet.2013.10.021; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	40	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113763	10.1371/journal.pone.0113763	http://dx.doi.org/10.1371/journal.pone.0113763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420102	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900069
J	Mosing, MA; Pedersen, NL; Madison, G; Ullen, F				Mosing, Miriam A.; Pedersen, Nancy L.; Madison, Guy; Ullen, Fredrik			Genetic Pleiotropy Explains Associations between Musical Auditory Discrimination and Intelligence	PLOS ONE			English	Article							SWEDISH TWIN REGISTRY; GENERAL INTELLIGENCE; PSYCHOMETRIC INTELLIGENCE; INSPECTION TIME; SENSORY DISCRIMINATION; INDIVIDUAL-DIFFERENCES; COGNITIVE-ABILITIES; WORKING-MEMORY; BRAIN VOLUME; HERITABILITY	Musical aptitude is commonly measured using tasks that involve discrimination of different types of musical auditory stimuli. Performance on such different discrimination tasks correlates positively with each other and with intelligence. However, no study to date has explored these associations using a genetically informative sample to estimate underlying genetic and environmental influences. In the present study, a large sample of Swedish twins (N=10,500) was used to investigate the genetic architecture of the associations between intelligence and performance on three musical auditory discrimination tasks (rhythm, melody and pitch). Phenotypic correlations between the tasks ranged between 0.23 and 0.42 (Pearson r values). Genetic modelling showed that the covariation between the variables could be explained by shared genetic influences. Neither shared, nor non-shared environment had a significant effect on the associations. Good fit was obtained with a two-factor model where one underlying shared genetic factor explained all the covariation between the musical discrimination tasks and IQ, and a second genetic factor explained variance exclusively shared among the discrimination tasks. The results suggest that positive correlations among musical aptitudes result from both genes with broad effects on cognition, and genes with potentially more specific influences on auditory functions.	[Mosing, Miriam A.; Ullen, Fredrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Madison, Guy] Umea Univ, Dept Psychol, S-90187 Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University	Mosing, MA (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	Miriam.Mosing@ki.se	Madison, Guy/I-6152-2019; Mosing, Miriam/ABD-9751-2020	Madison, Guy/0000-0001-5366-1169; Mosing, Miriam Anna/0000-0003-2049-125X	Bank of Sweden Tercentenary Foundation [M11-0451:1]; Swedish Scientific Council [521-2010-3195]; Sven and Dagmar Salen Foundation	Bank of Sweden Tercentenary Foundation; Swedish Scientific Council; Sven and Dagmar Salen Foundation	This work was supported by the Bank of Sweden Tercentenary Foundation (grant nr M11-0451:1, www.rj.se), the Swedish Scientific Council (grant nr 521-2010-3195, www.vr.se), and Sven and Dagmar Salen Foundation (www.salenstiftelsen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton GS, 2001, INTELLIGENCE, V29, P263, DOI 10.1016/S0160-2896(01)00066-6; [Anonymous], 1993, EDUC PSYCHOL-UK, DOI [DOI 10.1080/0144341930130103, 10.1080/0144341930130103]; BARWICK J, 1989, BRIT J EDUC PSYCHOL, V59, P253, DOI 10.1111/j.2044-8279.1989.tb03097.x; Bentley A., 1966, MEASURES MUSICAL ABI; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Edmonds CJ, 2008, INTELLIGENCE, V36, P210, DOI 10.1016/j.intell.2007.05.004; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Galton Francis, 1883, INQUIRES HUMAN FACUL; Gordon E. E., 1988, MUSICAL APTITUDE PRO; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Helmbold N, 2007, J PERS, V75, P985, DOI 10.1111/j.1467-6494.2007.00463.x; Law LNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052508; Lee T, 2012, BEHAV GENET, V42, P528, DOI 10.1007/s10519-012-9526-1; Li SC, 1998, INTELLIGENCE, V26, P99, DOI 10.1016/S0160-2896(99)80057-9; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Luciano M, 2005, BIOL PSYCHOL, V70, P1, DOI 10.1016/j.biopsycho.2004.11.011; Luciano M, 2004, BEHAV GENET, V34, P41, DOI 10.1023/B:BEGE.0000009475.35287.9d; Luciano M, 2001, INTELLIGENCE, V29, P443, DOI 10.1016/S0160-2896(01)00071-X; LYNN R, 1989, PERS INDIV DIFFER, V10, P25, DOI 10.1016/0191-8869(89)90173-6; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Milovanov R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00321; Mosing MA, 2014, PSYCHOL SCI, V25, P1795, DOI 10.1177/0956797614541990; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Neale M. C., 2006, MX STAT MODELING, V7th; Noack H, 2012, PSYCHOL AGING, V27, P627, DOI 10.1037/a0027251; Oikkonen J, 2014, MOL PSYCHIAT; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Piswanger J., 1979, WIENER MATRIZEN TEST; Plomin R, 2004, J PERS SOC PSYCHOL, V86, P112, DOI 10.1037/0022-3514.86.1.112; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; Rushton JP, 2009, INT J NEUROSCI, V119, P691, DOI 10.1080/00207450802325843; Schellenberg EG, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P499, DOI 10.1016/B978-0-12-381460-9.00012-2; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schweizer K, 2005, INTELLIGENCE, V33, P589, DOI 10.1016/j.intell.2005.07.001; Schweizer K, 2004, INTELLIGENCE, V32, P329, DOI 10.1016/j.intell.2004.06.006; Seashore C. E., 1919, PSYCHOL MUSICAL TALE; Seashore CE, 1960, 2 REV MANUAL INSTRUC; Sergeant D., 1974, PSYCHOL MUSIC, V2, P32, DOI [10.1177/030573567422005, DOI 10.1177/030573567422005]; Shuter-Dyson Rosamund., 1999, PSYCHOL MUSIC, V2nd ed., P627; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stankov L, 2001, INTELLIGENCE, V29, P1, DOI 10.1016/S0160-2896(00)00038-6; Troche SJ, 2014, INTELLIGENCE, V44, P40, DOI 10.1016/j.intell.2014.02.009; Troche SJ, 2009, PERS INDIV DIFFER, V47, P52, DOI 10.1016/j.paid.2009.02.001; Ukkola-Vuoti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056356; Ullen F, 2014, PERS INDIV DIFFER, V63, P87, DOI 10.1016/j.paid.2014.01.057; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; WING HD, 1962, J RES MUSIC EDUC, V10, P39, DOI 10.2307/3343909	55	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113874	10.1371/journal.pone.0113874	http://dx.doi.org/10.1371/journal.pone.0113874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419664	Green Published, gold			2022-12-27	WOS:000346766900078
J	Wang, Z; Zhang, XX; Lu, X; Liu, B; Li, Y; Long, C; Li, AM				Wang, Zhu; Zhang, Xu-Xiang; Lu, Xin; Liu, Bo; Li, Yan; Long, Chao; Li, Aimin			Abundance and Diversity of Bacterial Nitrifiers and Denitrifiers and Their Functional Genes in Tannery Wastewater Treatment Plants Revealed by High-Throughput Sequencing	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL COMMUNITY; ACTIVATED-SLUDGE; GRANULAR SLUDGE; QUANTIFICATION; REMOVAL; ARCHAEA; REACTOR; OXYGEN; NITRIFICATION	Biological nitrification/ denitrification is frequently used to remove nitrogen from tannery wastewater containing high concentrations of ammonia. However, information is limited about the bacterial nitrifiers and denitrifiers and their functional genes in tannery wastewater treatment plants (WWTPs) due to the low-throughput of the previously used methods. In this study, 454 pyrosequencing and Illumina high-throughput sequencing, combined with molecular methods, were used to comprehensively characterize structures and functions of nitrification and denitrification bacterial communities in aerobic and anaerobic sludge of two full-scale tannery WWTPs. Pyrosequencing of 16S rRNA genes showed that Proteobacteria and Synergistetes dominated in the aerobic and anaerobic sludge, respectively. Ammonia-oxidizing bacteria (AOB) amoA gene cloning revealed that Nitrosomonas europaea dominated the ammonia-oxidizing community in the WWTPs. Metagenomic analysis showed that the denitrifiers mainly included the genera of Thauera, Paracoccus, Hyphomicrobium, Comamonas and Azoarcus, which may greatly contribute to the nitrogen removal in the two WWTPs. It is interesting that AOB and ammonia-oxidizing archaea had low abundance although both WWTPs demonstrated high ammonium removal efficiency. Good correlation between the qPCR and metagenomic analysis is observed for the quantification of functional genes amoA, nirK, nirS and nosZ, indicating that the metagenomic approach may be a promising method used to comprehensively investigate the abundance of functional genes of nitrifiers and denitrifiers in the environment.	[Wang, Zhu; Zhang, Xu-Xiang; Lu, Xin; Liu, Bo; Li, Yan; Long, Chao; Li, Aimin] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Bo] Nanjing Univ Lianyungang, Res Inst, Lianyungang, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; liaimin@nju.edu.cn	Zhu, Wang/AAT-1740-2021; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; 王, 铸/I-3824-2016; zhang, xu/GYE-3558-2022	王, 铸/0000-0002-6763-8194; 	National Natural Science Foundation of China [51378252]; National Science and Technology Major Project of China [2011ZX07210-001-1]; Technology Support Project of Jiangsu Province [BE2011722, BE2013704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Technology Support Project of Jiangsu Province	This study was financially supported by National Natural Science Foundation of China (Grant No. 51378252, PI: BL, URL: http://www.nsfc.gov.cn), National Science and Technology Major Project of China (No. 2011ZX07210-001-1, PI: AL, URL: http://www.nmp.gov.cn/) and Technology Support Project of Jiangsu Province (Grant No. BE2011722, PI: BL; Grant No. BE2013704, PI: XXZ; URL: www.jskjjh.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann B, 1996, J BACTERIOL, V178, P4367, DOI 10.1128/jb.178.15.4367-4374.1996; Beaumont HJE, 2005, J BACTERIOL, V187, P6849, DOI 10.1128/JB.187.19.6849-6851.2005; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; BONIN P, 1989, CAN J MICROBIOL, V35, P1061, DOI 10.1139/m89-177; Chen J, 2012, GEOMICROBIOL J, V29, P226, DOI 10.1080/01490451.2011.558562; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cortes-Lorenzo C, 2014, ECOL ENG, V71, P126, DOI 10.1016/j.ecoleng.2014.07.025; Figuerola ELM, 2010, J HAZARD MATER, V181, P281, DOI 10.1016/j.jhazmat.2010.05.009; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Gieseke A, 2003, ENVIRON MICROBIOL, V5, P355, DOI 10.1046/j.1462-2920.2003.00423.x; Guo GX, 2013, ENVIRON SCI TECHNOL, V47, P3105, DOI 10.1021/es304714a; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Jia WL, 2013, BIORESOURCE TECHNOL, V136, P444, DOI 10.1016/j.biortech.2013.02.117; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Leta S, 2004, APPL MICROBIOL BIOT, V66, P333, DOI 10.1007/s00253-004-1715-2; Limpiyakorn T, 2007, FEMS MICROBIOL ECOL, V60, P501, DOI 10.1111/j.1574-6941.2007.00307.x; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Liu BB, 2006, FEMS MICROBIOL ECOL, V55, P274, DOI 10.1111/j.1574-6941.2005.00033.x; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Ma B, 2013, BIORESOURCE TECHNOL, V129, P606, DOI 10.1016/j.biortech.2012.11.025; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Murugananthan M, 2004, SEP PURIF TECHNOL, V40, P69, DOI 10.1016/j.seppur.2004.01.005; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Novak D, 2013, WATER RES, V47, P3644, DOI 10.1016/j.watres.2013.04.027; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reyes M, 2015, ENVIRON TECHNOL, V36, P45, DOI 10.1080/09593330.2014.934745; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scholten E, 1999, INT J SYST BACTERIOL, V49, P1045, DOI 10.1099/00207713-49-3-1045; Shapleigh JP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P769, DOI 10.1007/0-387-30742-7_23; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Tallec G, 2006, WATER RES, V40, P2972, DOI 10.1016/j.watres.2006.05.037; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093422; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Yoon DN, 2010, J MICROBIOL, V48, P275, DOI 10.1007/s12275-010-9366-8; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang B, 2010, BIORESOURCE TECHNOL, V101, P3054, DOI 10.1016/j.biortech.2009.12.048; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2011, APPL MICROBIOL BIOT, V91, P1215, DOI 10.1007/s00253-011-3408-y; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhao YG, 2013, BIORESOURCE TECHNOL, V143, P439, DOI 10.1016/j.biortech.2013.06.020	53	106	114	8	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113603	10.1371/journal.pone.0113603	http://dx.doi.org/10.1371/journal.pone.0113603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420093	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900055
J	Kigozi, G; Musoke, R; Kighoma, N; Watya, S; Serwadda, D; Nalugoda, F; Kiwanuka, N; Wabwire-Mangen, F; Tobian, A; Makumbi, F; Galiwango, RM; Sewankambo, N; Nkale, J; Nalwoga, GK; Anyokorit, M; Lutalo, T; Gray, RH; Wawer, MJ				Kigozi, Godfrey; Musoke, Richard; Kighoma, Nehemiah; Watya, Stephen; Serwadda, David; Nalugoda, Fred; Kiwanuka, Noah; Wabwire-Mangen, Fred; Tobian, Aaron; Makumbi, Fredrick; Galiwango, Ronald Moses; Sewankambo, Nelson; Nkale, James; Nalwoga, Grace Kigozi; Anyokorit, Margaret; Lutalo, Tom; Gray, Ronald Henry; Wawer, Maria Joan			Effects of Medical Male Circumcision (MC) on Plasma HIV Viral Load in HIV plus HAART Naive Men; Rakai, Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COITAL ACT; TRANSMISSION; PREVENTION; INFECTION; KISUMU; KENYA	Background: Medical male circumcision (MC) of HIV-infected men may increase plasma HIV viral load and place female partners at risk of infection. We assessed the effect of MC on plasma HIV viral load in HIV-infected men in Rakai, Uganda. Methods: 195 consenting HIV-positive, HAART naive men aged 12 and above provided blood for plasma HIV viral load testing before surgery and weekly for six weeks and at 2 and 3 months post surgery. Data were also collected on baseline social demographic characteristics and CD4 counts. Change in log(10) plasma viral load between baseline and follow-up visits was estimated using paired t tests and multivariate generalized estimating equation (GEE). Results: Of the 195 men, 129 had a CD4 count >= 350 and 66 had CD4 <350 cells/mm(3). Men with CD4 counts <350 had higher baseline mean log(10) plasma viral load than those with CD4 counts >= 350 cells/mm(3) (4.715 vs 4.217 cps/mL, respectively, p=0.0005). Compared to baseline, there was no statistically significant increase in post-MC HIV plasma viral loads irrespective of CD4. Multivariate analysis showed that higher baseline log(10) plasma viral load was significantly associated with reduction in mean log(10) plasma viral load following MC (coef. =-0.134, p<0.001). Conclusion: We observed no increase in plasma HIV viral load following MC in HIV-infected, HAART naive men.	[Kigozi, Godfrey; Musoke, Richard; Kighoma, Nehemiah; Watya, Stephen; Serwadda, David; Nalugoda, Fred; Makumbi, Fredrick; Galiwango, Ronald Moses; Nkale, James; Nalwoga, Grace Kigozi; Anyokorit, Margaret; Lutalo, Tom; Gray, Ronald Henry; Wawer, Maria Joan] Rakai Hlth Sci Program, Entebbe, Uganda; [Watya, Stephen] Urocare clin, Kampala, Uganda; [Serwadda, David; Kiwanuka, Noah; Wabwire-Mangen, Fred; Makumbi, Fredrick] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Tobian, Aaron; Gray, Ronald Henry; Wawer, Maria Joan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Rakai Health Sciences Program; Makerere University; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kigozi, G (corresponding author), Rakai Hlth Sci Program, Entebbe, Uganda.	gkigozi@rhsp.org		Sewankambo, Nelson/0000-0001-9362-053X; Musoke, Richard/0000-0002-2566-4191	Bill and Melinda Gates Foundation; African Doctoral dissertation fellowship (ADDRF)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); African Doctoral dissertation fellowship (ADDRF)	Funding: The study was funded by Bill and Melinda Gates Foundation and supported by African Doctoral dissertation fellowship (ADDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V64, P511, DOI 10.1097/QAI.0b013e3182a7ef05; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organization, 2007, NEW DAT MAL CIRC HIV	8	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e110382	10.1371/journal.pone.0110382	http://dx.doi.org/10.1371/journal.pone.0110382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415874	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600001
J	Rintahaka, J; Yu, X; Kant, R; Palva, A; von Ossowski, I				Rintahaka, Johanna; Yu, Xia; Kant, Ravi; Palva, Airi; von Ossowski, Ingemar			Phenotypical Analysis of the Lactobacillus rhamnosus GG Fimbrial spaFED Operon: Surface Expression and Functional Characterization of Recombinant SpaFED Pili in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GENOME SEQUENCE; PROTEIN-PRODUCTION; ACID BACTERIA; ADHESION; CASEI; RESPONSES; CLUSTER; SPACBA; NISIN	A noticeable genomic feature of many piliated Gram-positive bacterial species is the presence of more than one pilus-encoding operon. Paradigmatically, the gut-adapted Lactobacillus rhamnosus GG strain contains two different fimbrial operons in its genome. However, whereas one of these operons (called spaCBA) is encoding for the functionally mucus-/collagen-binding SpaCBA pilus, for the other operon (called spaFED) any native expression of the SpaFED-called pili is still the subject of some uncertainty. Irrespective of such considerations, we decided it would be of relevance or interest to decipher the gross structure of this pilus type, and as well assess its functional capabilities for cellular adhesion and immunostimulation. For this, and by following the approach we had used previously to explicate the immuno-properties of SpaCBA pili, we constructed nisin-inducible expression clones producing either wild-type or SpaF pilin-deleted surface-assembled L. rhamnosus GG SpaFED pili on Lactococcus lactis cells. Using these piliated lactococcal constructs, we found that the pilin-polymerized architecture of a recombinant-produced SpaFED pilus coincides with sequence-based functional predictions of the related pilins, and in fact is prototypical of those other sortase-dependent pilus-like structures thus far characterized for piliated Gram-positive bacteria. Moreover, we confirmed that among the different pilin subunits encompassing spaFED operon-encoded pili, the SpaF pilin is a main adhesion determinant, and when present in the assembled structure can mediate pilus binding to mucus, certain extracellular matrix proteins, and different gut epithelial cell lines. However, somewhat unexpectedly, when recombinant SpaFED pili are surface-attached, we found that they could not potentiate the existing lactococcal cell-induced immune responses so elicited from intestinal- and immune-related cells, but rather instead, they could dampen them. Accordingly, we have now provided the first phenotypical description of a spaFED pilus operon, and with that furthered the functional understanding of surface piliation for a particular gut-commensalic genre of piliated Gram-positive bacteria.	[Rintahaka, Johanna; Yu, Xia; Kant, Ravi; Palva, Airi; von Ossowski, Ingemar] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	Palva, A (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	airi.palva@helsinki.fi; ingemar.von.ossowski@helsinki.fi	Kant, Ravi/AAF-8495-2021	Kant, Ravi/0000-0003-3878-9775; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Academy of Finland-Center of Excellence in Microbial Food Safety (CoE-MiFoSa) [118602, 141140]; Academy of Finland [118165, 277362]; China Scholarship Council; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland-Center of Excellence in Microbial Food Safety (CoE-MiFoSa); Academy of Finland(Academy of Finland); China Scholarship Council(China Scholarship Council); University of Helsinki Applied Bioscience (ABS) Graduate School	Financing of the operating expenses and costs for this project (including some salaries) was obtained from the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant Nos. 118602 and 141140), and as well from Academy of Finland general research grants (Nos. 118165 and 277362)(http://www.aka.fi). Personal salary funding to Xia Yu was through the China Scholarship Council. Ravi Kant received some salary funding from The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardita CS, 2014, APPL ENVIRON MICROB, V80, P5068, DOI 10.1128/AEM.01039-14; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Chen ZL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00073-12; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Danne C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003860; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Garcia-Fruitos E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-157; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102762; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Pittet V, 2012, J BACTERIOL, V194, P726, DOI 10.1128/JB.06430-11; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Toh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075073; Tompkins TA, 2012, J BACTERIOL, V194, P902, DOI 10.1128/JB.06584-11; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	37	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113922	10.1371/journal.pone.0113922	http://dx.doi.org/10.1371/journal.pone.0113922			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415357	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600083
J	Sommer, R; Exner, TE; Titz, A				Sommer, Roman; Exner, Thomas E.; Titz, Alexander			A Biophysical Study with Carbohydrate Derivatives Explains the Molecular Basis of Monosaccharide Selectivity of the Pseudomonas aeruginosa Lectin LecB	PLOS ONE			English	Article							PARTICLE MESH EWALD; STRUCTURAL BASIS; PA-IIL; FREE-ENERGY; CYSTIC-FIBROSIS; BINDING; FUCOSE; THERMODYNAMICS; RECOGNITION; INFECTIONS	The rise of resistances against antibiotics in bacteria is a major threat for public health and demands the development of novel antibacterial therapies. Infections with Pseudomonas aeruginosa are a severe problem for hospitalized patients and for patients suffering from cystic fibrosis. These bacteria can form biofilms and thereby increase their resistance towards antibiotics. The bacterial lectin LecB was shown to be necessary for biofilm formation and the inhibition with its carbohydrate ligands resulted in reduced amounts of biofilm. The natural ligands for LecB are glycosides of D-mannose and L-fucose, the latter displaying an unusual strong affinity. Interestingly, although mannosides are much weaker ligands for LecB, they do form an additional hydrogen bond with the protein in the crystal structure. To analyze the individual contributions of the methyl group in fucosides and the hydroxymethyl group in mannosides to the binding, we designed and synthesized derivatives of these saccharides. We report glycomimetic inhibitors that dissect the individual interactions of their saccharide precursors with LecB and give insight into the biophysics of binding by LecB. Furthermore, theoretical calculations supported by experimental thermodynamic data suggest a perturbed hydrogen bonding network for mannose derivatives as molecular basis for the selectivity of LecB for fucosides. Knowledge gained on the mode of interaction of LecB with its ligands at ambient conditions will be useful for future drug design.	[Sommer, Roman; Titz, Alexander] Helmholtz Inst Pharmaceut Res Saarland HIPS, D-66123 Saarbrucken, Germany; [Sommer, Roman; Exner, Thomas E.; Titz, Alexander] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Sommer, Roman; Exner, Thomas E.; Titz, Alexander] Univ Konstanz, Grad Sch Chem Biol, D-78457 Constance, Germany; [Exner, Thomas E.] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	Helmholtz Association; University of Konstanz; University of Konstanz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Titz, A (corresponding author), Helmholtz Inst Pharmaceut Res Saarland HIPS, Campus C 2-3, D-66123 Saarbrucken, Germany.	alexander.titz@helmholtz-hzi.de	Titz, Alexander/E-6701-2010	Titz, Alexander/0000-0001-7408-5084; Sommer, Roman/0000-0003-0592-0810	Helmholtz Association [VH-NG-934]; Konstanz Research School Chemical Biology; Zukunftskolleg; Deutsche Forschungsgemeinschaft [Ti756/2-1]	Helmholtz Association(Helmholtz Association); Konstanz Research School Chemical Biology; Zukunftskolleg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: The authors thank the Helmholtz Association (to AT; grant no. VH-NG-934, http://www.helmholtz.de), the Konstanz Research School Chemical Biology (to RS, TEE, AT; http://www.chembiol.uni-konstanz.de/), the Zukunftskolleg (to AT; http://www.zukunftskolleg.uni-konstanz.de), and the Deutsche Forschungsgemeinschaft (to AT; grant no. Ti756/2-1, http://www.dfg.de) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-36; Bernardi A, 2013, CHEM SOC REV, V42, P4709, DOI 10.1039/c2cs35408j; BIHOVSKY R, 1988, J ORG CHEM, V53, P4026, DOI 10.1021/jo00252a027; Bordoni A, 2008, CARBOHYD RES, V343, P1863, DOI 10.1016/j.carres.2008.02.019; Carchon G, 2001, TETRAHEDRON LETT, V42, P8821, DOI 10.1016/S0040-4039(01)01906-2; Carpintero M, 2001, EUR J ORG CHEM, V2001, P4127, DOI 10.1002/1099-0690(200111)2001:21<4127::AID-EJOC4127>3.0.CO;2-6; Case DA, 2012, AMBER 12 COMPUTER PR; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CROSS A, 1983, REV INFECT DIS, V5, pS837; Daniellou R, 2005, ADV SYNTH CATAL, V347, P1863, DOI 10.1002/adsc.200505170; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Frisch M.J., 2016, GAUSSIAN16 REV B01; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Guo ZW, 1996, SYNTHETIC COMMUN, V26, P2067, DOI 10.1080/00397919608003565; Hauck D, 2013, ACS CHEM BIOL, V8, P1775, DOI 10.1021/cb400371r; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KONDO H, 1994, J ORG CHEM, V59, P864, DOI 10.1021/jo00083a032; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; LANGER AW, 1974, ADV CHEM SER, P1; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Loris R, 2003, J MOL BIOL, V331, P861, DOI 10.1016/S0022-2836(03)00754-X; Mishra NK, 2010, CARBOHYD RES, V345, P1432, DOI 10.1016/j.carres.2010.04.021; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Mitchell EP, 2005, PROTEINS, V58, P735, DOI 10.1002/prot.20330; Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951; Nishi Y, 2009, BIOSCI BIOTECH BIOCH, V73, P562, DOI 10.1271/bbb.80609; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perret S, 2005, BIOCHEM J, V389, P325, DOI 10.1042/BJ20050079; Phiasivongsa P, 2003, TETRAHEDRON LETT, V44, P5495, DOI 10.1016/S0040-4039(03)01328-5; Polakova M, 2005, CHEM PAP, V59, P289; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabin C, 2006, FEBS LETT, V580, P982, DOI 10.1016/j.febslet.2006.01.030; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; SIMONSON T, 1993, MOL PHYS, V80, P441, DOI 10.1080/00268979300102371; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Sommer R, 2013, CHIMIA, V67, P286, DOI 10.2533/chimia.2013.286; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Sudakevitz D, 2004, MOL MICROBIOL, V52, P691, DOI 10.1111/j.1365-2958.2004.04020.x; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Titz A., 2014, TOPICS MED CHEM SPRI, DOI [10.1007/7355_2014_44, DOI 10.1007/7355_2014_44.]; Tummler B, 1999, MOL MED TODAY, V5, P351, DOI 10.1016/S1357-4310(99)01506-3; Turnbull WB, 2004, J AM CHEM SOC, V126, P1047, DOI 10.1021/ja0378207; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wilkins MR, 1999, METH MOL B, V112, P531; Wu AM, 2010, FEBS LETT, V584, P2371, DOI 10.1016/j.febslet.2010.04.026	56	29	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112822	10.1371/journal.pone.0112822	http://dx.doi.org/10.1371/journal.pone.0112822			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415418	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600018
J	Lohr, C; Van Dongen, R; Huntley, B; Gibson, L; Morris, K				Lohr, Cheryl; Van Dongen, Ricky; Huntley, Bart; Gibson, Lesley; Morris, Keith			Remotely Monitoring Change in Vegetation Cover on the Montebello Islands, Western Australia, in Response to Introduced Rodent Eradication	PLOS ONE			English	Article							LAGORCHESTES-HIRSUTUS; NORTHERN-TERRITORY; SEED PREDATION; TANAMI DESERT; BLACK RATS; IMAGERY; HAWAII	The Montebello archipelago consists of 218 islands; 80 km from the north-west coast of Western Australia. Before 1912 the islands had a diverse terrestrial fauna. By 1952 several species were locally extinct. Between 1996 and 2011 rodents and cats were eradicated, and 5 mammal and 2 bird species were translocated to the islands. Monitoring of the broader terrestrial ecosystem over time has been limited. We used 20 dry-season Landsat images from 1988 to 2013 and estimation of green fraction cover in nadir photographs taken at 27 sites within the Montebello islands and six sites on Thevenard Island to assess change in vegetation density over time. Analysis of data averaged across the 26-year period suggests that 719 ha out of 2169 ha have increased in vegetation cover by up to 32%, 955 ha have remained stable and 0.6 ha have declined in vegetation cover. Over 492 ha (22%) had no vegetation cover at any time during the period analysed. Chronological clustering analysis identified two breakpoints in the average vegetation cover data occurring in 1997 and 2003, near the beginning and end of the rodent eradication activities. On many islands vegetation cover was declining prior to 1996 but increased after rodents were eradicated from the islands. Data for North West and Trimouille islands were analysed independently because of the potential confounding effect of native fauna being introduced to these islands. Mala (Lagorchestes hirsutus) and Shark Bay mice (Pseudomys fieldi) both appear to suppress native plant recruitment but not to the same degree as introduced rodents. Future research should assess whether the increase in vegetation cover on the Montebello islands is due to an increase in native or introduced plants.	[Lohr, Cheryl; Morris, Keith] Dept Pk & Wildlife, Sci & Conservat Div, Woodvale, WA, Australia; [Van Dongen, Ricky; Huntley, Bart] Dept Pk & Wildlife, GIS Sect, Kensington, WA, Australia; [Gibson, Lesley] Keiran McNamara Conservat Sci Ctr, Dept Pk & Wildlife, Sci & Conservat Div, Kensington, WA 6151, Australia		Lohr, C (corresponding author), Dept Pk & Wildlife, Sci & Conservat Div, Woodvale, WA, Australia.	cheryl.lohr@dpaw.wa.gov.au	Lohr, Cheryl/T-6744-2019	Lohr, Cheryl/0000-0002-8925-0983; Huntley, Barton/0000-0002-9519-4105	Gorgon Barrow Island Net Conservation Benefits fund; Western Australia Department of Parks and Wildlife	Gorgon Barrow Island Net Conservation Benefits fund; Western Australia Department of Parks and Wildlife	This project was funded by the Gorgon Barrow Island Net Conservation Benefits fund and the Western Australia Department of Parks and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1999, P WALIS FOR 1999 PER, P74; BOLTON BL, 1978, AUST WILDLIFE RES, V5, P285; BORCHERT MI, 1978, OECOLOGIA, V33, P101, DOI 10.1007/BF00376999; Burbidge AA, 1971, 9 DEP FISH FAUN; Burbidge Andrew A., 2004, Conservation Science Western Australia, V5, P194; Burbidge Andrew A., 2000, CALMScience, V3, P95; Bureau of Meteorology, 2014, DAT SERV; Campbell DJ, 1999, J ROY SOC NEW ZEAL, V29, P265, DOI 10.1080/03014223.1999.9517597; Chevis H, 1990, REPORT VISIT MONTE B; CLARK DA, 1981, BIOTROPICA, V13, P182, DOI 10.2307/2388123; Clout M., 2002, TURNING TIDE ERADICA; Cole JR, 2000, WILDLIFE RES, V27, P437, DOI 10.1071/WR97053; Coops NC, 2003, TREE PHYSIOL, V23, P23, DOI 10.1093/treephys/23.1.23; Graham MF, 2002, TURNING TIDE ERADICA; Hill FL, 1952, LINNEAN, V165, P113; Langford D, 2000, RECOVERY PLAN MALA L; Langford Don, 2001, Australian Mammalogy, V23, P37; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; Li G., 2006, EXPLORING DATA TABLE, P281; Macfarlane C, 2012, METHODS ECOL EVOL, V3, P405, DOI 10.1111/j.2041-210X.2011.00151.x; Marshall VM, 2012, J ARID ENVIRON, V78, P1, DOI 10.1016/j.jaridenv.2011.11.005; McClelland PJ, 2002, TURNING TIDE ERADICA; Montague PD, 1914, P ZOOL SOC LOND, V1914, P625; Morris K, 2000, 17 W AUSTR DEP CONS; Murray BR, 1999, WILDLIFE RES, V26, P421, DOI 10.1071/WR97046; Pender RJ, 2013, BIOL INVASIONS, V15, P213, DOI 10.1007/s10530-012-0280-3; Robinson T, 2012, 285 DEP AGR FOOD; Roder A, 2008, REMOTE SENS ENVIRON, V112, P2863, DOI 10.1016/j.rse.2008.01.018; SCOWCROFT PG, 1984, PAC SCI, V38, P80; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; TOWNS DR, 2002, TURNING TIDE ERADICA; USGS, 2014, LANDS MISS; Wallace Jeremy, 2006, Ecological Management & Restoration, V7, pS31, DOI 10.1111/j.1442-8903.2006.00289.x; WEST CJ, 2002, TURNING TIDE ERADICA; Yabe Tatsuo, 1998, Mammal Study, V23, P123, DOI 10.3106/mammalstudy.23.123; Young LC, 2013, BIOL INVASIONS, V15, P2627, DOI 10.1007/s10530-013-0479-y	36	5	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114095	10.1371/journal.pone.0114095	http://dx.doi.org/10.1371/journal.pone.0114095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436454	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900117
J	Li, YB; Wang, JX; Gao, X; Han, WH; Zheng, YX; Xu, H; Zhang, CL; He, QC; Zhang, LH; Li, ZX; Zhou, DM				Li, Yingbo; Wang, Jinxi; Gao, Xing; Han, Weihua; Zheng, Yongxiang; Xu, Huan; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Li, Zhongxin; Zhou, Demin			c-Met Targeting Enhances the Effect of Irradiation and Chemical Agents against Malignant Colon Cells Harboring a KRAS Mutation	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; HEPATOCYTE GROWTH-FACTOR; K-RAS MUTATIONS; 1ST-LINE TREATMENT; RNA INTERFERENCE; GENE; PROGRESSION; ACTIVATION; INHIBITOR; CARCINOMA	Although EGFR-targeted therapy has been beneficial to colorectal cancer patients, several studies have showed this clinical benefit was restricted to patients with wild-type KRAS exon 2 colorectal cancer. Therefore, it is crucial to explore efficient treatment strategies in patients with KRAS mutations. c-Met is an emerging target for the development of therapeutics against colorectal cancer. In this study, we first used the SW620 cell line, which has an activating KRAS mutation, to generate a stable cell line with conditional regulation of c-Met, which is an essential gene for growth and an oncogene. Using this approach, we evaluated the benefits of combined c-Met-targeted therapy with irradiation or chemical agents. In this cell line, we observed that the proliferation and migration of SW620 cells were reduced by the induction of c-Met shRNA. Furthermore, c-Met knockdown enhanced the anti-proliferative effects of 5-FU and Taxol but not cisplatin, irinotecan or sorafenib. These enhancements were also observed in another colon cancer cells line HCT-116, which also has a KRAS mutation. The response of SW620 cells to irradiation was also enhanced by c-Met knockdown. This method and obtained data might have important implications for exploring the combinatory effects of targeted therapies with conventional medications. Moreover, the data suggested that the combination of c-Met-targeted therapy with chemotherapy or irradiation might be an effective strategy against colorectal cancer harboring a KRAS mutation.	[Li, Yingbo; Wang, Jinxi; Gao, Xing; Zheng, Yongxiang; Xu, Huan; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Li, Zhongxin; Zhou, Demin] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Wang, Jinxi; Gao, Xing; Han, Weihua; Li, Zhongxin] Hebei Med Univ, Hosp 4, Dept Surg 2, Shijiazhuang, Hebei, Peoples R China; [Li, Yingbo; Zheng, Yongxiang; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Zhou, Demin] Peking Univ, Sch Pharmaceut Sci, Beijing 100871, Peoples R China	Peking University; Hebei Medical University; Peking University	Li, ZX (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	lizhongxin99@163.com; deminzhou@bjmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB12300]; National Natural Science Foundation of China [20932001, 91029711, 81172332, 81301881]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No. 2010CB12300) and the National Natural Science Foundation of China (Grants Nos. 20932001, 91029711, 81172332 and 81301881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2012, INT J BIOCHEM CELL B, V44, P759, DOI 10.1016/j.biocel.2012.01.015; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Conte P, 2012, CLIN BREAST CANCER, V12, P157, DOI 10.1016/j.clbc.2012.03.005; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Fukuura T, 1998, BRIT J CANCER, V78, P454, DOI 10.1038/bjc.1998.514; Gridelli C, 2011, LUNG CANCER, V71, P249, DOI 10.1016/j.lungcan.2010.12.008; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Jin X, 2012, NUCLEIC ACIDS RES, V40, P1797, DOI 10.1093/nar/gkr927; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kataoka H, 2000, CANCER RES, V60, P6148; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Li YB, 2011, PLANTA MED, V77, P354, DOI 10.1055/s-0030-1250385; Li YB, 2013, CANCER LETT, V340, P88, DOI 10.1016/j.canlet.2013.07.005; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; McNeil C, 2008, J NATL CANCER I, V100, P1667, DOI 10.1093/jnci/djn429; Osada S, 2010, HEPATO-GASTROENTEROL, V57, P76; Skobeleva N, 2007, MOL CANCER THER, V6, P898, DOI 10.1158/1535-7163.MCT-06-0602; Stintzing S, 2012, ANN ONCOL, V23, P1693, DOI 10.1093/annonc/mdr571; Wen JH, 2007, BIOCHEM BIOPH RES CO, V358, P117, DOI 10.1016/j.bbrc.2007.04.098; Yu HL, 2012, BIOCHEM BIOPH RES CO, V427, P659, DOI 10.1016/j.bbrc.2012.09.117; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707; Zhou DM, 2006, CURR TOP MED CHEM, V6, P901, DOI 10.2174/156802606777303630	27	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113186	10.1371/journal.pone.0113186	http://dx.doi.org/10.1371/journal.pone.0113186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427200	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400037
J	Thiel, CS; Tauber, S; Schutte, A; Schmitz, B; Nuesse, H; Moelier, R; Ullrich, O				Thiel, Cora S.; Tauber, Svantje; Schuette, Andreas; Schmitz, Burkhard; Nuesse, Harald; Moelier, Ralf; Ullrich, Oliver			Functional Activity of Plasmid DNA after Entry into the Atmosphere of Earth Investigated by a New Biomarker Stability Assay for Ballistic Spaceflight Experiments	PLOS ONE			English	Article							MARTIAN CONDITIONS DATA; EXPOSE-E; ARTIFICIAL METEORITES; EXPERIMENT PROTECT; NUCLEIC-ACIDS; OUTER-SPACE; MARS; SURVIVAL; SPORES; LIFE	Sounding rockets represent an excellent platform for testing the influence of space conditions during the passage of Earth's atmosphere and re-entry on biological, physical and chemical experiments for astrobiological purposes. We designed a robust functionality biomarker assay to analyze the biological effects of suborbital spaceflights prevailing during ballistic rocket flights. During the TEXUS-49 rocket mission in March 2011, artificial plasmid DNA carrying a fluorescent marker (enhanced green fluorescent protein: EGFP) and an antibiotic resistance cassette (kanamycin/neomycin) was attached on different positions of rocket exterior; (i) circular every 90 degree on the outer surface concentrical of the payload, (ii) in the grooves of screw heads located in between the surface application sites, and (iii) on the surface of the bottom side of the payload. Temperature measurements showed two major peaks at 118 and 130 degrees C during the 780 seconds lasting flight on the inside of the recovery module, while outer gas temperatures of more than 1000 degrees C were estimated on the sample application locations. Directly after retrieval and return transport of the payload, the plasmid DNA samples were recovered. Subsequent analyses showed that DNA could be recovered from all application sites with a maximum of 53% in the grooves of the screw heads. We could further show that up to 35% of DNA retained its full biological function, i. e., mediating antibiotic resistance in bacteria and fluorescent marker expression in eukariotic cells. These experiments show that our plasmid DNA biomarker assay is suitable to characterize the environmental conditions affecting DNA during an atmospheric transit and the re-entry and constitute the first report of the stability of DNA during hypervelocity atmospheric transit indicating that sounding rocket flights can be used to model the high-speed atmospheric entry of organics-laden artificial meteorites.	[Thiel, Cora S.; Tauber, Svantje; Ullrich, Oliver] Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland; [Tauber, Svantje; Ullrich, Oliver] Univ Magdeburg, Inst Engn Mech, Dept Machine Design Engn Design & Product Dev, D-39106 Magdeburg, Germany; [Schuette, Andreas] Airbus DS, Bremen, Germany; [Nuesse, Harald] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Moelier, Ralf] German Aerosp Ctr DLR EV, Inst Aerosp Med, Radiat Biol Dept, Res Grp Astrobiol, Cologne, Koln, Germany; [Ullrich, Oliver] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Geneva; University of Zurich; University of Munster; Helmholtz Association; German Aerospace Centre (DLR); University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Thiel, CS (corresponding author), Univ Zurich, Fac Med, Inst Anat, Zurich, Switzerland.	cora.thiel@uzh.ch; oliver.ullrich@uzh.ch			German Aerospace Center (DLR) [50WB0912]	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	Funding: Support was provided by the German Aerospace Center (DLR) through grant no. 50WB0912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni P., 2007, COMPLETE COURSE ASTR, P273; Brack A, 2002, PLANET SPACE SCI, V50, P763, DOI 10.1016/S0032-0633(02)00018-1; Brandstatter F, 2008, PLANET SPACE SCI, V56, P976, DOI 10.1016/j.pss.2007.12.014; BUCKER H, 1969, BIOPHYSIK, V6, P69, DOI 10.1007/BF01403870; CADET J, 1985, BIOCHIMIE, V67, P277, DOI 10.1016/S0300-9084(85)80070-5; CADET J, 1993, ANAL CHEM, V65, pA675, DOI 10.1021/ac00063a001; Cady SL, 2003, ASTROBIOLOGY, V3, P351, DOI 10.1089/153110703769016442; Chiter A, 2000, FEBS LETT, V481, P164, DOI 10.1016/S0014-5793(00)01986-4; Demets R, 2005, ADV SPACE RES, V36, P311, DOI 10.1016/j.asr.2005.07.005; Demets R, 2000, P FOTON BION INT C S, P183; Demets R, 2001, P FOT BION INT C SAM, P175; Demets R, 2001, P FOT BION INT C SAM, P166; DOTY P, 1960, P NATL ACAD SCI USA, V46, P461, DOI 10.1073/pnas.46.4.461; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; Dubins DN, 2001, J AM CHEM SOC, V123, P9254, DOI 10.1021/ja004309u; Fajardo-Cavazos P, 2005, ASTROBIOLOGY, V5, P726, DOI 10.1089/ast.2005.5.726; Foucher F, 2010, ICARUS, V207, P616, DOI 10.1016/j.icarus.2009.12.014; Gladman B, 1997, ICARUS, V130, P228, DOI 10.1006/icar.1997.5828; Gladman BJ, 1996, SCIENCE, V271, P1387, DOI 10.1126/science.271.5254.1387; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; HAWLEY SA, 1974, BIOPOLYMERS, V13, P1417, DOI 10.1002/bip.1974.360130712; Horneck G, 1984, ADV SPACE RES, P419; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hoyle F., 2000, ASTRONOMICAL ORIGINS, DOI [10.1007/978-94-011-4297-7, DOI 10.1007/978-94-011-4297-7]; Hoyle F, 1981, EVOLUTION FROM SPACE; Jung W, 2011, HDB RAUMFAHRTTECHNIK, P206; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; MARGUET E, 1994, NUCLEIC ACIDS RES, V22, P1681, DOI 10.1093/nar/22.9.1681; McKay CP, 2013, ASTROBIOLOGY, V13, P334, DOI 10.1089/ast.2012.0878; Moeller R, 2012, ASTROBIOLOGY, V12, P457, DOI 10.1089/ast.2011.0739; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P389, DOI 10.1016/j.tim.2009.07.001; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P243, DOI 10.1016/j.tim.2009.03.004; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL, 2005, MUTAT RES-FUND MOL M, V571, P249, DOI 10.1016/j.mrfmmm.2004.10.012; Onofri S, 2012, ASTROBIOLOGY, V12, P508, DOI 10.1089/ast.2011.0736; Parnell J, 2008, ICARUS, V197, P282, DOI 10.1016/j.icarus.2008.04.014; Pavlov A. K., 2007, Biophysics, V52, P640, DOI 10.1134/S0006350907060176; Preu P, 2014, TEXUS SOUNDING ROCKE, P1; Rettberg P, 2004, ADV SPACE RES-SERIES, V33, P1294, DOI 10.1016/j.asr.2003.09.050; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; RUSSELL AP, 1974, NUCLEIC ACIDS RES, V1, P959, DOI 10.1093/nar/1.8.959; Sancho LG, 2007, ASTROBIOLOGY, V7, P443, DOI 10.1089/ast.2006.0046; Seibert G, 2006, HIST SOUNDING ROCKET, P1; Smeller L, 2002, BBA-PROTEIN STRUCT M, V1595, P11, DOI 10.1016/S0167-4838(01)00332-6; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Tepfer D, 2012, ASTROBIOLOGY, V12, P517, DOI 10.1089/ast.2011.0744; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; Wassmann M, 2012, ASTROBIOLOGY, V12, P498, DOI 10.1089/ast.2011.0772; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; Westall F, 2008, METEORITES STONES WI, P8; Wynn-Williams DD, 2000, PLANET SPACE SCI, V48, P1065, DOI 10.1016/S0032-0633(00)00080-5	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112979	10.1371/journal.pone.0112979	http://dx.doi.org/10.1371/journal.pone.0112979			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426925	Green Published, Green Accepted, gold			2022-12-27	WOS:000349145400027
J	Yu, RJ; Cui, ZK; Li, M; Yang, YX; Zhong, JP				Yu, Rongjie; Cui, Zekai; Li, Mei; Yang, Yanxu; Zhong, Jiaping			Dimer-Dependent Intrinsic/Basal Activity of the Class B G Protein-Coupled Receptor PAC1 Promotes Cellular Anti-Apoptotic Activity through Wnt/beta-Catenin Pathways that Are Associated with Dimer Endocytosis	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; EXPRESSION; DIMERIZATION; CAVEOLAE; INCREASES; NUCLEUS; TUMORS; CELLS; VIP	The high expression of PACAP (pituitary adenylate cyclase-activating polypeptide)preferring receptor PAC1 is associated with nerve injury and tumors. Our previous report (Yu R, et al. PLoS One 2012; 7: e51811) confirmed the dimerization of PAC1 and found that the M-PAC1 mutation in the N-terminal first Cys/Ala lost the ability to form dimers. In this study, Chinese hamster ovary (CHO-K1) cells overexpressing wild-type PAC1 (PAC1-CHO) had significantly higher anti-apoptotic activities against serum withdrawal-induced apoptosis associated with a lower caspase 3 activity and a higher Bcl-2 level in a ligand-independent manner than those of CHO cells overexpressing the mutant M-PAC1 (M-PAC1-CHO). PAC1-CHO had significantly higher beta-catenin, cyclin D1 and c-myc levels corresponding to the Wnt/beta-catenin signal than did M-PAC1-CHO. In addition, the Wnt/beta-catenin pathway inhibitor XAV939 significantly inhibited the anti-apoptotic activities of PAC1-CHO. Top-flash assays demonstrated that PAC1-CHO had a significantly stronger Wnt/beta-catenin signal than did M-PAC1-CHO. Acetylcysteine (NAC) as an inhibitor of the dimerization of PAC1 inhibited the anti-apoptotic activities that were endowed by PAC1 and decreased the Wnt/beta-catenin signal in Top-flash assays. In the PAC1 Tet (tetracycline)-on inducible gene expression system by doxycycline (Dox), higher expression levels of PAC1 resulted in higher anti-apoptotic activities that were associated with a stronger Wnt/beta-catenin signal. A similar correlation was also found with the down-regulation of PAC1 in the Neuro2a neuroblastoma cell. BiFC combined with fluorescence confocal imaging indicated that during serum-withdrawal-induced apoptosis, PAC1 dimers displayed significant endocytosis. These findings indicate that PAC1 has ligand-independent and dimer-dependent intrinsic/basal activity, conferring cells with anti-apoptotic activities against serum withdrawal, which is involved in the Wnt/beta-catenin signal and is associated with the endocytosis of PAC1 dimers. The discovery and study of the dimer-dependent basal activity of PAC1 not only help us understand the physiological and pathological role of PAC1 but also promote the development of drugs targeting PAC1.	[Yu, Rongjie; Cui, Zekai; Li, Mei; Yang, Yanxu; Zhong, Jiaping] Jinan Univ, Dept Cell Biol, Inst Biomed, Guangzhou, Guangdong, Peoples R China	Jinan University	Yu, RJ (corresponding author), Jinan Univ, Dept Cell Biol, Inst Biomed, Guangzhou, Guangdong, Peoples R China.	rongjie_yu1123@163.com		Yu, Rongjie/0000-0001-9285-5783; Cui, Zekai/0000-0003-3670-6219	National Natural Science Foundation of China [31100545, 31200679]; Science and Technology Bureau of Guangdong Province [2011B090400024]; Natural Science Foundation of Guangdong Province [S2011010002931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (31100545 and 31200679), the Science and Technology Bureau of Guangdong Province (2011B090400024) and the Natural Science Foundation of Guangdong Province (S2011010002931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINO H, 1995, GENE, V164, P301, DOI 10.1016/0378-1119(95)00391-I; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Cao YJ, 2000, FEBS LETT, V469, P142, DOI 10.1016/S0014-5793(00)01269-2; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cohen JR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-676; D'Amico AG, 2013, J MOL NEUROSCI, V51, P503, DOI 10.1007/s12031-013-0076-7; Graul RC, 2001, AAPS PHARMSCI, V3; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lang B, 2006, J CLIN INVEST, V116, P1924, DOI 10.1172/JCI27597; Lee JC, 2010, BRAIN RES, V1351, P32, DOI 10.1016/j.brainres.2010.06.048; Lieu SN, 2006, ANN NY ACAD SCI, V1070, P399, DOI 10.1196/annals.1317.052; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; OKAZAKI K, 1992, FEBS LETT, V298, P49, DOI 10.1016/0014-5793(92)80020-H; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pellon-Cardenas O, 2011, CURR DRUG TARGETS, V12, P1216, DOI 10.2174/138945011795906552; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Reubi JC, 2000, CANCER RES, V60, P3105; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Seaborn T, 2011, CURR PHARM DESIGN, V17, P204, DOI 10.2174/138161211795049679; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Tokuda N, 2006, ANN NY ACAD SCI, V1070, P581, DOI 10.1196/annals.1317.085; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Yu RJ, 2013, NEUROSCI LETT, V549, P92, DOI 10.1016/j.neulet.2013.06.015; Yu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051811; Zhang HH, 2012, PEPTIDES, V38, P337, DOI 10.1016/j.peptides.2012.09.009; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x; Zhang WS, 2009, CELL SIGNAL, V21, P237, DOI 10.1016/j.cellsig.2008.10.008	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113913	10.1371/journal.pone.0113913	http://dx.doi.org/10.1371/journal.pone.0113913			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426938	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400101
J	de Carvalho, JV; de Castro, RO; da Silva, EZM; Silveira, PP; da Silva-Januario, ME; Arruda, E; Jamur, MC; Oliver, C; Aguiar, RS; Dasilva, LLP				de Carvalho, Julianne V.; de Castro, Rodrigo O.; da Silva, Elaine Z. M.; Silveira, Paola P.; da Silva-Januario, Mara E.; Arruda, Eurico; Jamur, Maria C.; Oliver, Constance; Aguiar, Renato S.; daSilva, Luis L. P.			Nef Neutralizes the Ability of Exosomes from CD4(+) T Cells to Act as Decoys during HIV-1 Infection	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; COMPLEX CLASS-I; LONG-TERM SURVIVOR; DOWN-REGULATION; SOLUBLE CD4; MHC-I; INTRACELLULAR TRAFFICKING; MULTIVESICULAR BODIES; REDUCED SENSITIVITY; CYTOPLASMIC DOMAIN	Nef is an HIV-1 accessory protein that promotes viral replication and pathogenesis. A key function of Nef is to ensure sustained depletion of CD4 and MHC-I molecules in infected cells by inducing targeting of these proteins to multivesicular bodies (MVBs), and ultimately to lysosomes for degradation. Nef also affects cellular secretory routes promoting its own secretion via exosomes. To better understand the effects of Nef on the exocytic pathway, we investigated whether this viral factor modifies the composition of exosomes released by T lymphocytes. We showed that both CD4 and MHC-I molecules are secreted in exosomes from T cells and that the expression of Nef reduces the amount of these proteins in exosomes. To investigate the functional role for this novel activity of Nef, we performed in vitro HIV-1 infection assays in the presence of distinct populations of exosomes. We demonstrated that exosomes released by CD4(+) T cells, but not CD4(-) T cells, efficiently inhibit HIV-1 infection in vitro. Because CD4 is the main receptor for HIV-1 infection, these results suggest that CD4 molecules displayed on the surface of exosomes can bind to envelope proteins of HIV-1 hindering virus interaction with target cells and infection. Importantly, CD4-depleted exosomes released by CD4(+) T cells expressing Nef have a reduced capacity to inhibit HIV-1 infection in vitro. These results provide evidence that Nef promotes HIV-1 infection by reducing the expression of CD4 in exosomes from infected cells, besides the original role of Nef in reducing the CD4 levels at the cell surface.	[de Carvalho, Julianne V.; de Castro, Rodrigo O.; da Silva, Elaine Z. M.; da Silva-Januario, Mara E.; Arruda, Eurico; Jamur, Maria C.; Oliver, Constance; daSilva, Luis L. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil; [Silveira, Paola P.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Dasilva, LLP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil.	lldasilva@fmrp.usp.br	Da Silva, Elaine Z/O-5535-2015; daSilva, Luis LP/AAD-5657-2019; Silveira, Patrícia P/A-7139-2011; Arruda, Eurico/E-4101-2012; LP daSilva, Luis/A-9949-2010; Aguiar, Renato S/G-3542-2015; Silva, Mara/HGC-4994-2022	Da Silva, Elaine Z/0000-0002-2749-6275; daSilva, Luis LP/0000-0003-3558-0087; LP daSilva, Luis/0000-0003-3558-0087; Aguiar, Renato S/0000-0001-5180-3717; Silva, Mara/0000-0001-6375-4502	Sao Paulo Research Foundation (FAPESP) [2009/50650-6]; Brazilian National Council for Scientific and Technological Development (CNPq) [470707/2009-7]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP; FAPESP	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work in this article was supported by the Sao Paulo Research Foundation (FAPESP), through a Young Investigators grant (nr. 2009/50650-6) (http://www.fapesp.br/en/), by the Brazilian National Council for Scientific and Technological Development (CNPq) project nr. 470707/2009-7 (http://www.cnpq.br) and by the Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP to LLPdS, JVC and EZMS thank FAPESP for a doctoral fellowship. ROC was supported by a postdoctoral training grant from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Amorim NA, 2014, J BIOL CHEM, V289, P27744, DOI 10.1074/jbc.M114.560193; ANDERSON SJ, 1994, J VIROL, V68, P3092, DOI 10.1128/JVI.68.5.3092-3101.1994; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bruno CJ, 2010, J ANTIMICROB CHEMOTH, V65, P1839, DOI 10.1093/jac/dkq261; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; daSilva LLP, 2009, J VIROL, V83, P6578, DOI 10.1128/JVI.00548-09; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Dustin ML, 2014, MOL BIOL CELL, V25, P1699, DOI 10.1091/mbc.E13-11-0636; Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; MOORE JP, 1991, J VIROL, V65, P1133, DOI 10.1128/JVI.65.3.1133-1140.1991; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Naslund TI, 2014, AIDS, V28, P171, DOI 10.1097/QAD.0000000000000159; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873; SANFRIDSON A, 1994, J BIOL CHEM, V269, P3917; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	74	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113691	10.1371/journal.pone.0113691	http://dx.doi.org/10.1371/journal.pone.0113691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423108	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700054
J	Xu, YG; Guo, MZ; Zou, Q; Liu, XY; Wang, CY; Liu, Y				Xu, Yungang; Guo, Maozu; Zou, Quan; Liu, Xiaoyan; Wang, Chunyu; Liu, Yang			System-Level Insights into the Cellular Interactome of a Non-Model Organism: Inferring, Modelling and Analysing Functional Gene Network of Soybean (Glycine max)	PLOS ONE			English	Article							SEMANTIC SIMILARITY; SCALE-FREE; ONTOLOGY; PREDICTION; ASSOCIATION; INTEGRATION; SEQUENCE; YEAST	Cellular interactome, in which genes and/or their products interact on several levels, forming transcriptional regulatory-, protein interaction-, metabolic-, signal transduction networks, etc., has attracted decades of research focuses. However, such a specific type of network alone can hardly explain the various interactive activities among genes. These networks characterize different interaction relationships, implying their unique intrinsic properties and defects, and covering different slices of biological information. Functional gene network (FGN), a consolidated interaction network that models fuzzy and more generalized notion of gene-gene relations, have been proposed to combine heterogeneous networks with the goal of identifying functional modules supported by multiple interaction types. There are yet no successful precedents of FGNs on sparsely studied non-model organisms, such as soybean (Glycine max), due to the absence of sufficient heterogeneous interaction data. We present an alternative solution for inferring the FGNs of soybean (SoyFGNs), in a pioneering study on the soybean interactome, which is also applicable to other organisms. SoyFGNs exhibit the typical characteristics of biological networks: scale-free, small-world architecture and modularization. Verified by co-expression and KEGG pathways, SoyFGNs are more extensive and accurate than an orthology network derived from Arabidopsis. As a case study, network-guided disease-resistance gene discovery indicates that SoyFGNs can provide system-level studies on gene functions and interactions. This work suggests that inferring and modelling the interactome of a non-model plant are feasible. It will speed up the discovery and definition of the functions and interactions of other genes that control important functions, such as nitrogen fixation and protein or lipid synthesis. The efforts of the study are the basis of our further comprehensive studies on the soybean functional interactome at the genome and microRNome levels. Additionally, a web tool for information retrieval and analysis of SoyFGNs can be accessed at SoyFN: http://nclab.hit.edu.cn/SoyFN.	[Xu, Yungang; Guo, Maozu; Liu, Xiaoyan; Wang, Chunyu; Liu, Yang] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China; [Xu, Yungang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Xiamen University	Xu, YG (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China.	xuyungang@hit.edu.cn; maozuguo@hit.edu.cn	Wang, Chunyu/AAN-5766-2020; Zou, Quan/A-7801-2015; Xu, Yungang/GWV-2305-2022; Xu, Yungang/N-2822-2014	Wang, Chunyu/0000-0002-2965-9920; Xu, Yungang/0000-0002-9834-3006	Natural Science Foundation of China [91335112, 61370010, 61271346, 61172098]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20112302110040]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work is supported by the Natural Science Foundation of China (91335112, 61370010, 61271346, and 61172098); and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20112302110040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2005, J BIOCHEM, V138, P1, DOI 10.1093/jb/mvi094; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, METH MOL B, V316, P67; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hwang S, 2011, NAT PROTOC, V6, P1429, DOI 10.1038/nprot.2011.372; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Knepper Caleb, 2010, Arabidopsis Book, V8, pe012, DOI 10.1199/tab.0124; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee I, 2011, PROG BIOPHYS MOL BIO, V106, P435, DOI 10.1016/j.pbiomolbio.2011.01.003; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lord P W, 2003, Pac Symp Biocomput, P601; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stumpf MP, 2007, EPL-EUROPHYS LETT, V71, P152; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu YG, 2014, BIOINFORMATICS, V30, P94, DOI 10.1093/bioinformatics/btt605; Xu YG, 2013, GENOMICS, V101, P368, DOI 10.1016/j.ygeno.2013.04.010	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113907	10.1371/journal.pone.0113907	http://dx.doi.org/10.1371/journal.pone.0113907			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423109	Green Submitted, gold, Green Published			2022-12-27	WOS:000345899700077
J	Di, GH; Liu, Y; Lu, Y; Liu, J; Wu, CT; Duan, HF				Di, Guo-hu; Liu, Yang; Lu, Ying; Liu, Jin; Wu, Chutse; Duan, Hai-Feng			IL-6 Secreted from Senescent Mesenchymal Stem Cells Promotes Proliferation and Migration of Breast Cancer Cells	PLOS ONE			English	Article							STROMAL CELLS; CELLULAR SENESCENCE; IN-VITRO; MARROW; GROWTH; DIFFERENTIATION; TRANSFORMATION; ADIPOGENESIS; METASTASIS; MODEL	Human mesenchymal stem cells (hMSCs) are currently investigated for a variety of therapeutic applications. However, MSCs isolated from primary tissue cannot meet clinical grade needs and should be expanded in vitro for several passages. Although hMSCs show low possibility for undergoing oncogenic transformation, they do, similar to other somatic cells, undergo cellular senescence and their therapeutic potential is diminished when cultured in vitro. However, the role of senescent MSCs in tumor progression remains largely elusive. In the current study, by establishing senescent human umbilical cord mesenchymal stem cells (s-UCMSCs) through the replicative senescence model and genotoxic stress induced premature senescence model, we show that s-UCMSCs significantly stimulate proliferation and migration of breast cancer cells in vitro and tumor progression in a co-transplant xenograft mouse model compared with 'young' counterparts (defined as MSCs at passage 5, in contrast to senescent MSCs at passage 45). In addition, we identified IL-6, a known pleiotropic cytokine, as a principal mediator for the tumor-promoting activity of s-UCMSCs by induction of STAT3 phosphorylation. Depletion of IL-6 from s-UCMSCs conditioned medium partially abrogated the stimulatory effect of s-UCMSCs on the proliferation and migration of breast tumor cells.	[Di, Guo-hu; Liu, Yang; Liu, Jin; Wu, Chutse; Duan, Hai-Feng] BIRM, Beijing 100850, Peoples R China; [Lu, Ying] 307 Hosp, Beijing 100071, Peoples R China; [Di, Guo-hu] Shandong Acad Med Sci, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Shandong Eye Inst, Qingdao 266071, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Duan, HF (corresponding author), BIRM, 27 Taiping Rd, Beijing 100850, Peoples R China.	duanhf0720@163.com		Di, Guohu/0000-0001-9940-730X	National Basic Research and Development of China (973 program) [2010CB529903, 2010CB833600, 2012CB518105]; National Science Foundation of China [81201760, 30973670, 3090592]; Chinese National Science and Technology Major Project [2012ZX09102301-001, 2011ZX09102-001-30]	National Basic Research and Development of China (973 program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science and Technology Major Project	This work was supported by the National Basic Research and Development of China (973 program) (Nos. 2010CB529903, 2010CB833600 and 2012CB518105); the National Science Foundation of China (Nos. 81201760, 30973670 and 3090592); and the Chinese National Science and Technology Major Project (Nos. 2012ZX09102301-001 and 2011ZX09102-001-30). The funders had no role in study design, data collectin and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL; Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Di GH, 2012, CYTOTHERAPY, V14, P412, DOI 10.3109/14653249.2011.646044; Di GH, 2012, J CELL PHYSIOL, V227, P879, DOI 10.1002/jcp.23066; Duggal S, 2011, J CELL PHYSIOL, V226, P2908, DOI 10.1002/jcp.22637; Efimenko A, 2014, STEM CELL TRANSL MED, V3, P32, DOI 10.5966/sctm.2013-0014; Fecteau JF, 2013, BLOOD, V121, P971, DOI 10.1182/blood-2012-08-447813; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012; Han I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt443; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Ko E, 2012, STEM CELLS DEV, V21, P1877, DOI 10.1089/scd.2011.0284; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Lisanti MP, 2011, CELL CYCLE, V10, P2059, DOI 10.4161/cc.10.13.16233; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sensebe L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt217; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tian K, 2010, CELL PHYSIOL BIOCHEM, V26, P799, DOI 10.1159/000323973; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tsai K.S., 2011, GASTROENTEROLOGY; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366	35	66	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113572	10.1371/journal.pone.0113572	http://dx.doi.org/10.1371/journal.pone.0113572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419563	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900049
J	Hoser, MJ; Mansukoski, HK; Morrical, SW; Eboigbodin, KE				Hoser, Mark J.; Mansukoski, Hannu K.; Morrical, Scott W.; Eboigbodin, Kevin E.			Strand Invasion Based Amplification (SIBA (R)): A Novel Isothermal DNA Amplification Technology Demonstrating High Specificity and Sensitivity for a Single Molecule of Target Analyte	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; PROTEIN; BACTERIOPHAGE-T4; DIAGNOSTICS; INVITRO; SYSTEM; PCR	Isothermal nucleic acid amplification technologies offer significant advantages over polymerase chain reaction (PCR) in that they do not require thermal cycling or sophisticated laboratory equipment. However, non-target-dependent amplification has limited the sensitivity of isothermal technologies and complex probes are usually required to distinguish between non-specific and target-dependent amplification. Here, we report a novel isothermal nucleic acid amplification technology, Strand Invasion Based Amplification (SIBA). SIBA technology is resistant to non-specific amplification, is able to detect a single molecule of target analyte, and does not require target-specific probes. The technology relies on the recombinase-dependent insertion of an invasion oligonucleotide (IO) into the double-stranded target nucleic acid. The duplex regions peripheral to the IO insertion site dissociate, thereby enabling target-specific primers to bind. A polymerase then extends the primers onto the target nucleic acid leading to exponential amplification of the target. The primers are not substrates for the recombinase and are, therefore unable to extend the target template in the absence of the IO. The inclusion of 29-O-methyl RNA to the IO ensures that it is not extendible and that it does not take part in the extension of the target template. These characteristics ensure that the technology is resistant to non-specific amplification since primer dimers or mis-priming are unable to exponentially amplify. Consequently, SIBA is highly specific and able to distinguish closely-related species with single molecule sensitivity in the absence of complex probes or sophisticated laboratory equipment. Here, we describe this technology in detail and demonstrate its use for the detection of Salmonella.	[Hoser, Mark J.] GeneForm Technol, Mol Biol, Broadstairs, Kent, England; [Mansukoski, Hannu K.] Pfizer, Med Commun, Sandwhich, Kent, England; [Morrical, Scott W.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Eboigbodin, Kevin E.] Orion Diagnost, Res & Dev, Espoo, Finland	Pfizer; University of Vermont	Hoser, MJ (corresponding author), GeneForm Technol, Mol Biol, Broadstairs, Kent, England.	markhoser@gmail.com	Eboigbodin, Kevin Efosa/I-9152-2018	Eboigbodin, Kevin Efosa/0000-0002-8262-8226	Geneform Technologies, UK; Orion Diagnostica, Finland	Geneform Technologies, UK; Orion Diagnostica, Finland	The study was funded by Geneform Technologies, UK and Orion Diagnostica, Finland. The work was performed at Geneform Technologies and repeated at Orion Diagnostica Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Demidov Vadim V, 2002, Expert Rev Mol Diagn, V2, P542, DOI 10.1586/14737159.2.6.542; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; KOENIG VL, 1974, INT J BIOCHEM, V5, P601, DOI 10.1016/0020-711X(74)90022-6; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; Lee D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-7; Maher RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066654; MORRICAL SW, 1990, J BIOL CHEM, V265, P15096; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Stump MD, 1999, NUCLEIC ACIDS RES, V27, P4642, DOI 10.1093/nar/27.23.4642; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Taylor A, 2013, BIOPHYS CHEM, V171, P1, DOI 10.1016/j.bpc.2012.11.001; Tong YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-50; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100; Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200; VOET JG, 1970, J BIOL CHEM, V245, P1020; WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691; WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392	26	27	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112656	10.1371/journal.pone.0112656	http://dx.doi.org/10.1371/journal.pone.0112656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419812	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900010
J	Kim, JH; Choi, SH; Ryoo, I; Yun, TJ; Kim, TM; Lee, SH; Park, CK; Kim, JH; Sohn, CH; Park, SH; Kim, IH				Kim, Jae Hyun; Choi, Seung Hong; Ryoo, Inseon; Yun, Tae Jin; Kim, Tae Min; Lee, Se-Hoon; Park, Chul-Kee; Kim, Ji-Hoon; Sohn, Chul-Ho; Park, Sung-Hye; Kim, Il Han			Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; HIGH-GRADE GLIOMAS; HISTOGRAM ANALYSIS; TRUE PROGRESSION; RADIATION-THERAPY; TUMOR PROGRESSION; MALIGNANT GLIOMA; PHASE-III; SURVIVAL; PSEUDOPROGRESSION	Purpose: To assess the prognosis predictability of a measurable enhancing lesion using histogram parameters produced by the normalized cerebral blood volume (nCBV) and normalized apparent diffusion coefficient (nADC) after completion of standard concomitant chemoradiotherapy (CCRT) and adjuvant temozolomide (TMZ) medication in glioblastoma multiforme (GBM) patients. Materials and Methods: This study was approved by the institutional review board (IRB), and the requirement for informed consent was waived. A total of 59 patients with newly diagnosed GBM who received standard CCRT with TMZ and adjuvant TMZ for six cycles underwent perfusion-weighted and diffusion-weighted imaging. Twenty-seven patients had a measurable enhancing lesion and 32 patients lacked a measurable enhancing lesion based on the Response Assessment in Neuro-Oncology (RANO) criteria in the follow - up MRI, which was performed within 3 months after adjuvant TMZ therapy was completed. We measured the nCBV and nADC histogram parameters based on the measurable enhancing lesion. The progression free survival (PFS) was analyzed by the Kaplan-Meier method with the use of the log-rank test. Results: The median PFS of patients lacking measurable enhancing lesion was longer than for those with measurable enhancing lesions (17.6 vs 3.3 months, P<.0001). There was a significant, positive correlation between the 99th percentile nCBV value of a measurable enhancing lesion and the PFS (P=.044, R-2=.152). In addition, the median PFS was longer in patients with a 99th percentile nCBV value >= 4.5 than it was in those with a value <4.5 (4.4 vs 3.1 months, P=.036). Conclusion: We found that the nCBV value can be used for the prognosis prediction of a measurable enhancing lesion after the completion of standard treatment for GBM, wherein a high 99th percentile nCBV value (>= 4.5) suggests a better PFS for GBM patients.	[Kim, Jae Hyun; Choi, Seung Hong; Ryoo, Inseon; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Ctr Nanoparticle Res, Inst Basic Sci, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Kim, Tae Min; Lee, Se-Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Canc Res Inst, Seoul 151, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Il Han] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021	Park, Chul-Kee/0000-0002-2350-9876; Choi, Seung Hong/0000-0002-0412-2270; Yun, Tae Jin/0000-0001-8441-4574	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028, HI13C0015]; Research Center Program of IBS (Institute for Basic Science) in Korea	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs; Research Center Program of IBS (Institute for Basic Science) in Korea	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300), the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028 and HI13C0015), and the Research Center Program of IBS (Institute for Basic Science) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Asao C, 2005, AM J NEURORADIOL, V26, P1455; Barajas RF, 2009, RADIOLOGY, V253, P486, DOI 10.1148/radiol.2532090007; Bjornerud A, 2003, P HUM BRAIN MAPPING, V19, P1018; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Brat DJ, 2003, ANN INTERN MED, V138, P659, DOI 10.7326/0003-4819-138-8-200304150-00014; Cha Soonmee, 2003, Magn Reson Imaging Clin N Am, V11, P403, DOI 10.1016/S1064-9689(03)00066-7; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472; Hein PA, 2004, AM J NEURORADIOL, V25, P201; Hilario A, 2012, AM J NEURORADIOL, V33, P701, DOI 10.3174/ajnr.A2846; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Hwang EJ, 2013, J NEURO-ONCOL, V112, P427, DOI 10.1007/s11060-013-1072-z; Jeon HJ, 2009, CLIN NEUROL NEUROSUR, V111, P679, DOI 10.1016/j.clineuro.2009.06.013; Johnson DR, 2013, CANCER-AM CANCER SOC, V119, P3489, DOI 10.1002/cncr.28259; Jung SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069323; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kim HS, 2010, RADIOLOGY, V256, P906, DOI 10.1148/radiol.10091461; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063462; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lee WJ, 2012, ACAD RADIOL, V19, P1353, DOI 10.1016/j.acra.2012.06.011; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Quinn JA, 2009, J NEURO-ONCOL, V95, P393, DOI 10.1007/s11060-009-9937-x; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Song YS, 2013, KOREAN J RADIOL, V14, P662, DOI 10.3348/kjr.2013.14.4.662; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014	43	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113587	10.1371/journal.pone.0113587	http://dx.doi.org/10.1371/journal.pone.0113587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419975	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900053
J	Lopes, RL; Borges, TJ; Araujo, JF; Pinho, NG; Bergamin, LS; Battastini, AMO; Muraro, SP; Souza, APD; Zanin, RF; Bonorino, C				Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Pinho, Nathana G.; Bergamin, Leticia S.; Battastini, Ana Maria O.; Muraro, Stefanie P.; Souza, Ana Paula D.; Zanin, Rafael F.; Bonorino, Cristina			Extracellular Mycobacterial DnaK Polarizes Macrophages to the M2-Like Phenotype	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; ALTERNATIVE ACTIVATION; INTERLEUKIN-10 PRODUCTION; NITRIC-OXIDE; TUBERCULOSIS; HEAT-SHOCK-PROTEIN-70; CELLS; EXPRESSION; ANTIGEN	Macrophages are myeloid cells that play an essential role in inflammation and host defense, regulating immune responses and maintaining tissue homeostasis. Depending on the microenvironment, macrophages can polarize to two distinct phenotypes. The M1 phenotype is activated by IFN-gamma and bacterial products, and displays an inflammatory profile, while M2 macrophages are activated by IL-4 and tend to be anti-inflammatory or immunosupressive. It was observed that DnaK from Mycobacterium tuberculosis has immunosuppressive properties, inducing a tolerogenic phenotype in dendritic cells and MDSCs, contributing to graft acceptance and tumor growth. However, its role in macrophage polarization remains to be elucidated. We asked whether DnaK was able to modulate macrophage phenotype. Murine macrophages, derived from bone marrow, or from the peritoneum, were incubated with DnaK and their phenotype compared to M1 or M2 polarized macrophages. Treatment with DnaK leads macrophages to present higher arginase I activity, IL-10 production and FIZZ1 and Ym1 expression. Furthermore, DnaK increased surface levels of CD206. Importantly, DnaK-treated macrophages were able to promote tumor growth in an allogeneic melanoma model. Our results suggest that DnaK polarizes macrophages to the M2-like phenotype and could constitute a virulence factor and is an important immunomodulator of macrophage responses.	[Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Pinho, Nathana G.; Zanin, Rafael F.; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Biomed Res Inst, Lab Cellular & Mol Immunol, Porto Alegre, RS, Brazil; [Lopes, Rafael L.; Borges, Thiago J.; Araujo, Jessica F.; Zanin, Rafael F.; Bonorino, Cristina] Pontificia Univ Catolica Rio Grande do Sul, Sch Biosci, Dept Cellular & Mol Biol, Porto Alegre, RS, Brazil; [Muraro, Stefanie P.; Souza, Ana Paula D.] Pontificia Univ Catolica Rio Grande do Sul, Sch Pharm, Porto Alegre, RS, Brazil; [Muraro, Stefanie P.; Souza, Ana Paula D.] Pontificia Univ Catolica Rio Grande do Sul, Lab Clin & Expt Immunol, Biomed Res Inst, Porto Alegre, RS, Brazil; [Bergamin, Leticia S.; Battastini, Ana Maria O.] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul	Bonorino, C (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Biomed Res Inst, Lab Cellular & Mol Immunol, Porto Alegre, RS, Brazil.	cbonorino@pucrs.br	Bonorino, Cristina/U-2780-2019; Battastini, Ana M/E-2809-2012; Duarte, Ana/S-1904-2016; Lopes, Rafael/GZN-1671-2022; Duarte, Ana/GRT-0033-2022; Souza, Ana/J-9534-2015; Muraro, Stefanie P/M-6705-2013; Borges, Thiago/Q-3711-2019; Muraro, Stefanie P/AAM-2017-2021	Battastini, Ana M/0000-0001-6068-3278; Duarte, Ana/0000-0002-6021-5068; Muraro, Stefanie P/0000-0002-5105-6659; Borges, Thiago/0000-0002-6554-0169; Muraro, Stefanie P/0000-0002-5105-6659; Zanin, Rafael/0000-0003-3146-0221	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [11/0903-1]; PUCRS; FINEP [01.08.0600-00]; CAPES; FAPERGS/CAPES	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); PUCRS; FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS/CAPES	RLL, TJB, JFA, NGP, SPM, ADS, RFZ, and CB were funded by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (www.fapergs.rs.gov.br) grant number 11/0903-1, PUCRS and FINEP (www.finep.gov.br) grant 01.08.0600-00. RLL is a recipient of CAPES (www.capes.gov.br) fellowship, and TJB is a recipient of a FAPERGS/CAPES fellowship. LSB and AOB received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borges TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014264; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; De La Barrera S, 2004, CLIN EXP IMMUNOL, V138, P128, DOI 10.1111/j.1365-2249.2004.02577.x; de Souza AP, 2009, EXPERT REV ANTICANC, V9, P1317, DOI [10.1586/era.09.88, 10.1586/ERA.09.88]; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Doeppner TR, 2013, J CEREBR BLOOD F MET, V33, P1778, DOI 10.1038/jcbfm.2013.126; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Leek RD, 1996, CANCER RES, V56, P4625; Lugo-Villarino G, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00043; Luo XJ, 2011, INFLAMMATION, V34, P432, DOI 10.1007/s10753-010-9250-z; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MEHLERT A, 1989, MOL MICROBIOL, V3, P125, DOI 10.1111/j.1365-2958.1989.tb01801.x; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Raju B, 2008, TUBERCULOSIS, V88, P39, DOI 10.1016/j.tube.2007.07.003; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spiering R, 2012, CELL STRESS CHAPERON; Stocki P, 2012, J BIOL CHEM; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tomioka H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/635451; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110	46	22	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113441	10.1371/journal.pone.0113441	http://dx.doi.org/10.1371/journal.pone.0113441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419575	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900035
J	Maksimow, A; Silfverhuth, M; Langsjo, J; Kaskinoro, K; Georgiadis, S; Jaaskelainen, S; Scheinin, H				Maksimow, Anu; Silfverhuth, Minna; Langsjo, Jaakko; Kaskinoro, Kimmo; Georgiadis, Stefanos; Jaaskelainen, Satu; Scheinin, Harry			Directional Connectivity between Frontal and Posterior Brain Regions Is Altered with Increasing Concentrations of Propofol	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; CORTICAL EFFECTIVE CONNECTIVITY; FUNCTIONAL CONNECTIVITY; SEVOFLURANE ANESTHESIA; EEG ACTIVITY; CONSCIOUSNESS; BREAKDOWN; UNCONSCIOUSNESS; PROPAGATION; INTEGRATION	Recent studies using electroencephalography (EEG) suggest that alteration of coherent activity between the anterior and posterior brain regions might be used as a neurophysiologic correlate of anesthetic-induced unconsciousness. One way to assess causal relationships between brain regions is given by renormalized partial directed coherence (rPDC). Importantly, directional connectivity is evaluated in the frequency domain by taking into account the whole multichannel EEG, as opposed to time domain or two channel approaches. rPDC was applied here in order to investigate propofol induced changes in causal connectivity between four states of consciousness: awake (AWA), deep sedation (SED), loss (LOC) and return of consciousness (ROC) by gathering full 10/20 system human EEG data in ten healthy male subjects. The target-controlled drug infusion was started at low rate with subsequent gradual stepwise increases at 10 min intervals in order to carefully approach LOC (defined as loss of motor responsiveness to a verbal stimulus). The direction of the causal EEG-network connections clearly changed from AWA to SED and LOC. Propofol induced a decrease (p=0.002-0.004) in occipital-to-frontal rPDC of 8-16 Hz EEG activity and an increase (p=0.001-0.040) in frontal-to-occipital rPDC of 10-20 Hz activity on both sides of the brain during SED and LOC. In addition, frontal-to-parietal rPDC within 1-12 Hz increased in the left hemisphere at LOC compared to AWA (p=0.003). However, no significant changes were detected between the SED and the LOC states. The observed decrease in back-to-front EEG connectivity appears compatible with impaired information flow from the posterior sensory and association cortices to the executive prefrontalareas, possibly related to decreased ability to perceive the surrounding world during sedation. The observed increase in the opposite (front-to-back) connectivity suggests a propofol concentration dependent association and is not directly related to the level of consciousness per se.	[Maksimow, Anu; Kaskinoro, Kimmo] Turku Univ Hosp, Dept Perioperat Serv Intens Care & Pain Med, FIN-20520 Turku, Finland; [Maksimow, Anu; Langsjo, Jaakko; Kaskinoro, Kimmo; Scheinin, Harry] Univ Turku, Turku PET Ctr, Turku, Finland; [Silfverhuth, Minna] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland; [Langsjo, Jaakko] Tampere Univ Hosp, Intens Care Unit, Tampere, Finland; [Georgiadis, Stefanos] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Jaaskelainen, Satu] Turku Univ Hosp, Dept Clin Neurophysiol, FIN-20520 Turku, Finland; [Scheinin, Harry] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland	University of Turku; University of Turku; University of Oulu; Tampere University; Tampere University Hospital; University of Eastern Finland; University of Turku; University of Turku	Maksimow, A (corresponding author), Turku Univ Hosp, Dept Perioperat Serv Intens Care & Pain Med, FIN-20520 Turku, Finland.	anu.maksimow@utu.fi	Jääskeläinen, Satu/X-8755-2019	Scheinin, Harry/0000-0002-1171-3511	Academy of Finland [8111818]; Turku University Hospital (EVO) [13323]; Seinajoki Central Hospital (EVO) [1133]; The Finnish Medical Foundation; The Paulo Foundation; The Instrumentarium Science Foundation; SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation) [1104/10]	Academy of Finland(Academy of Finland); Turku University Hospital (EVO); Seinajoki Central Hospital (EVO); The Finnish Medical Foundation; The Paulo Foundation; The Instrumentarium Science Foundation; SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation)	This study was funded by the Academy of Finland (project no. 8111818), Turku University Hospital (EVO grant no. 13323), Seinajoki Central Hospital (EVO grant no. 1133), The Finnish Medical Foundation, The Paulo Foundation, The Instrumentarium Science Foundation, and by the SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation grant 1104/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; BAARS BJ, 1995, CONSCIOUS COGN, V4, P159, DOI 10.1006/ccog.1995.1021; Babiloni C, 2009, NEUROBIOL AGING, V30, P93, DOI 10.1016/j.neurobiolaging.2007.05.007; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Deshpande G, 2010, BRAIN RES, V1318, P110, DOI 10.1016/j.brainres.2009.12.075; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hagemann D, 2001, PSYCHOPHYSIOLOGY, V38, P847, DOI 10.1111/1469-8986.3850847; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaminski M, 1997, ELECTROEN CLIN NEURO, V102, P216, DOI 10.1016/S0013-4694(96)95721-5; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lehnertz K, 2011, PHYSIOL MEAS, V32, P1715, DOI 10.1088/0967-3334/32/11/R01; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Papana A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036207; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Rummel C, 2007, J NEUROSCI METH, V166, P138, DOI 10.1016/j.jneumeth.2007.06.023; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schelter B, 2006, J NEUROSCI METH, V152, P210, DOI 10.1016/j.jneumeth.2005.09.001; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Taxidis J, 2010, BIOL CYBERN, V102, P327, DOI 10.1007/s00422-010-0370-1; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; Winterhalder M, 2005, SIGNAL PROCESS, V85, P2137, DOI 10.1016/j.sigpro.2005.07.011; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	44	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113616	10.1371/journal.pone.0113616	http://dx.doi.org/10.1371/journal.pone.0113616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419791	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900059
J	Tschulakow, A; Christner, S; Julien, S; Ludinsky, M; van der Giet, M; Schraermeyer, U				Tschulakow, Alexander; Christner, Sarah; Julien, Sylvie; Ludinsky, Maximilian; van der Giet, Markus; Schraermeyer, Ulrich			Effects of a Single Intravitreal Injection of Aflibercept and Ranibizumab on Glomeruli of Monkeys	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THROMBOTIC MICROANGIOPATHY; VEGF TRAP; NEPHROTIC SYNDROME; BEVACIZUMAB; ANTIBODY; PHARMACOKINETICS; PROTEINURIA; INHIBITION; RELAPSE	Purpose: It is known that endothelial cells in the kidney are also strongly VEGF-dependent. Whether intravitreal drugs can be detected within the glomeruli or affect VEGF in glomerular podocytes is not known. Therefore, the aim of this pilot study was to investigate the effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys. Methods: The kidneys of eight cynomolgus monkeys, which were intravitreally injected either with 2 mg of aflibercept or with 0.5 mg of ranibizumab, were investigated one and seven days after injection. Two animals served as controls. The distribution of aflibercept, ranibizumab and VEGF was evaluated using anti-Fc- or anti-F(ab)-fragment and anti-VEGF antibodies respectively. The ratio of stained area/nuclei was calculated using a semi-quantitative computer assisted method. Glomerular endothelial cell fenestration was quantified in electron microscopy using a systematic uniform random sampling protocol and estimating the ratio of fenestrae per mu m. Results: Compared to the controls, the anti-VEGF stained area/nuclei ratio of the ranibizumab-treated animals showed no significant changes whereas the stained areas of the aflibercept-treated monkeys showed a significant decrease post-treatment. Immune reactivity (IR) against aflibercept or ranibizumab was detected in aflibercept- or ranibizumab treated animals respectively. The number of fenestrations of the glomerular endothelial cells has shown no significant differences except one day after aflibercept injection in which the number was increased. Conclusion: Surprisingly, both drugs could be detected within the capillaries of the glomeruli. After a single intravitreal injection of aflibercept, VEGF IR in the podocytes was significantly reduced compared to controls. Ranibizumab injection had no significant effect on the glomeruli's VEGF level. Whether this is caused by aflibercept's higher affinity to VEGF or because it is used in a higher stoichiometric concentration compared to ranibizumab remains to be investigated.	[Tschulakow, Alexander; Christner, Sarah; Julien, Sylvie; Ludinsky, Maximilian; Schraermeyer, Ulrich] Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Tubingen, Germany; [Julien, Sylvie; Schraermeyer, Ulrich] STZ OcuTox Preclin Drug Assessment, Hechingen, Germany; [van der Giet, Markus] Charite, Div Nephrol, Charite Campus Benjamin Franklin, D-13353 Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schraermeyer, U (corresponding author), Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Tubingen, Germany.	Ulrich.Schraermeyer@med.uni-tuebingen.de		van der Giet, Markus/0000-0003-3590-5451; Julien-Schraermeyer, Sylvie/0000-0002-2322-511X	Novartis Pharma AG	Novartis Pharma AG	The study was financially supported by Novartis Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. STZ OcuTox Preclinical Drug Assessment provided support in the form of an honorarium for author US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anto HR, 2012, CAN J OPHTHALMOL, V47, P84, DOI 10.1016/j.jcjo.2011.12.024; Barbazetto IA, 2010, AM J OPHTHALMOL, V149, P939, DOI 10.1016/j.ajo.2010.01.007; Bollee G, 2009, NEPHROL DIAL TRANSPL, V24, P682, DOI 10.1093/ndt/gfn657; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; Chakravarthy U, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.04.015; Csaky K, 2009, AM J OPHTHALMOL, V148, P647, DOI 10.1016/j.ajo.2009.06.014; Davidovic SP, 2012, EUR J OPHTHALMOL, V22, P792, DOI 10.5301/ejo.5000118; Dinc E, 2013, CUTAN OCUL TOXICOL; Drury JA, 2011, HISTOPATHOLOGY, V59, P1156, DOI 10.1111/j.1365-2559.2011.04046.x; Elger M, 1998, Adv Anat Embryol Cell Biol, V139, P1; Eremina V, 2004, CURR OPIN NEPHROL HY, V13, P9, DOI 10.1097/00041552-200401000-00002; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Frangie C, 2007, LANCET ONCOL, V8, P177, DOI 10.1016/S1470-2045(07)70037-2; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Georgalas I, 2014, CURR DRUG SAF; Heiduschka P, 2007, INVEST OPHTH VIS SCI, V48, P2814, DOI 10.1167/iovs.06-1171; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ichimura K, 2008, J AM SOC NEPHROL, V19, P1463, DOI 10.1681/ASN.2007101138; Izzedine H, 2007, NEPHROL DIAL TRANSPL, V22, P1481, DOI 10.1093/ndt/gfl565; Jamrozy-Witkowska Agnieszka, 2011, Klin Oczna, V113, P127; Julien S, 2014, BR J OPHTHALMOL; Kachouie NN, 2009, BIOTECHNIQUES, V47, pIX, DOI 10.2144/000113202; Klettner A., 2014, J BIOCH PHARM RES, V2, P8; KONDO H, 1985, ARCH HISTOL JAPON, V48, P117, DOI 10.1679/aohc.48.117; Lafayette RA, 2014, AM J NEPHROL, V40, P75, DOI 10.1159/000365156; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; Liu A, 1999, KIDNEY INT, V56, P1334, DOI 10.1046/j.1523-1755.1999.00661.x; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Matsuyama K, 2010, BRIT J OPHTHALMOL, V94, P1215, DOI 10.1136/bjo.2008.156810; Najafian B, 2011, AM J NEPHROL, V33, P34, DOI 10.1159/000327075; Nguyen DC, 2011, IMMUNOGENETICS, V63, P351, DOI 10.1007/s00251-011-0514-z; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Pelle G, 2011, AM J KIDNEY DIS, V57, P756, DOI 10.1053/j.ajkd.2010.11.030; Perez-Valdivia MA, 2014, NEFROLOGIA, V34, P421, DOI 10.3265/Nefrologia.pre2014.Mar.12388; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Proetzel G, 2014, METHODS, V65, P148, DOI 10.1016/j.ymeth.2013.07.005; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Roncone D, 2007, NAT CLIN PRACT NEPHR, V3, P287, DOI 10.1038/ncpneph0476; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Sato T, 2013, PEDIATR INT, V55, pe46, DOI 10.1111/ped.12017; Schraermeyer U, 2013, EXPERT OPIN BIOL TH, V13, P157, DOI 10.1517/14712598.2012.748741; Schraermeyer U, 2012, GRAEF ARCH CLIN EXP, V250, P1303, DOI 10.1007/s00417-012-2055-z; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Stewart MW, 2012, CLIN OPHTHALMOL, V6, P1175, DOI 10.2147/OPTH.S33372; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Stokes MB, 2008, KIDNEY INT, V74, P1487, DOI 10.1038/ki.2008.256; Tufro A, 2012, SEMIN NEPHROL, V32, P385, DOI 10.1016/j.semnephrol.2012.06.010; Webb NJA, 1998, CLIN SCI, V94, P395, DOI 10.1042/cs0940395; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	52	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113701	10.1371/journal.pone.0113701	http://dx.doi.org/10.1371/journal.pone.0113701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415380	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600072
J	Yang, YL; Chan, KA; Hsieh, FJ; Chang, LY; Wang, MY				Yang, Ya-Ling; Chan, K. Arnold; Hsieh, Fon-Jou; Chang, Li-Yun; Wang, Ming-Yang			Pregnancy-Associated Breast Cancer in Taiwanese Women: Potential Treatment Delay and Impact on Survival	PLOS ONE			English	Article							FEATURES; MANAGEMENT; POPULATION; CARCINOMA; LACTATION; OUTCOMES	This study investigated the clinicopathologic characteristics and survival of women diagnosed with pregnancy-associated breast cancer (PABC) in Taiwan. PABC is defined as breast cancer diagnosed during pregnancy or within 1 year after obstetric delivery. Our sample of PABC patients (N=26) included all patients diagnosed at a major medical center in northern Taiwan from 1984 through 2009. Among these patients, 15 were diagnosed during pregnancy and 11 were diagnosed within 1 year after delivery. The comparison group included 104 patients within the same age range as the PABC patients and diagnosed with breast cancer not associated with pregnancy from 2004 through 2009 at the same hospital. Patients' initiating treatment delayed, 5-year and 10-year overall survival were delineated by stratified Kaplan-Meier estimates. Patients' characteristics were associated with initiating treatment delayed was evaluated with multivariate proportional hazards modeling. Antepartum PABC patients were younger and had longer time between diagnosis and treatment initiation than postpartum PABC patients. The predictor of treatment delayed was including birth parity, cancer stage, and pregnancy. The PABC group had larger tumors, more advanced cancer stage, and tumors with less progesterone receptor than the comparison group. The antepartum PABC patients had higher mortality than postpartum PABC and comparison groups within 5 years after diagnosis. Based on these results, we confirmed that pregnant women with breast cancer were more likely to delay treatment. Therefore, we recommend that breast cancer screening should be integrated into the prenatal and postnatal routine visits for early detection of the women's breast problems.	[Yang, Ya-Ling] Natl Taiwan Univ Hosp, Dept Nursing, Coll Med, Taipei 10051, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10051, Taiwan; [Hsieh, Fon-Jou] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10051, Taiwan; [Chang, Li-Yun] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 10051, Taiwan; [Wang, Ming-Yang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 10051, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, MY (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, 7 Chung Shan South Rd, Taipei 10051, Taiwan.	suryang1971@hotmail.com		Chan, Kinwei/0000-0001-8161-1986; YANG, YA-LING/0000-0002-7540-3301	National Science Council of Taiwan [NSC98-2314-B-002-093-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding: The National Science Council of Taiwan (NSC98-2314-B-002-093-MY2) provided financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJCC, 2002, CANC STAG HDB; [Anonymous], TAIW CANC REG ANN RE; Axelrod D, 2008, J AM COLL SURGEONS, V206, P1193, DOI 10.1016/j.jamcollsurg.2007.12.026; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Beadle BM, 2009, CANCER-AM CANCER SOC, V115, P1174, DOI 10.1002/cncr.24165; Chang KJ, 2008, J ONCOLOGY SOC, V24, P85; Chang LY, 2012, J MED ULTRASOUND, V20, P1, DOI 10.1016/j.jmu.2012.01.001; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Cox D. R., 1984, ANAL SURVIVAL DATA; Daling JR, 2002, CANCER EPIDEM BIOMAR, V11, P235; Eedrarapalli P, 2006, J OBSTET GYNAECOL, V26, P1; Garcia-Manero M, 2009, EJSO-EUR J SURG ONC, V35, P215, DOI 10.1016/j.ejso.2008.04.010; Gentilini O, 2005, EJSO-EUR J SURG ONC, V31, P232, DOI 10.1016/j.ejso.2004.11.012; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Halaska MJ, 2009, BREAST J, V15, P461, DOI 10.1111/j.1524-4741.2009.00760.x; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Ibrahim EM, 2000, MED ONCOL, V17, P293, DOI 10.1007/BF02782194; ISHIDA T, 1992, JPN J CANCER RES, V83, P1143, DOI 10.1111/j.1349-7006.1992.tb02737.x; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Keleher AJ, 2002, J AM COLL SURGEONS, V194, P54, DOI 10.1016/S1072-7515(01)01105-X; Keyser Erin A, 2012, Rev Obstet Gynecol, V5, P94; Logue K, 2009, CLIN J ONCOL NURS, V13, P25, DOI 10.1188/09.CJON.25-27; Loibl S, 2006, CANCER-AM CANCER SOC, V106, P237, DOI 10.1002/cncr.21610; Loibl S, 2012, LANCET ONCOL, V13, P887, DOI 10.1016/S1470-2045(12)70261-9; Middleton LP, 2003, CANCER, V98, P1055, DOI 10.1002/cncr.11614; Murphy CG, 2012, CANCER-AM CANCER SOC, V118, P3254, DOI 10.1002/cncr.26654; Pavlidis N, 2005, CANCER TREAT REV, V31, P439, DOI 10.1016/j.ctrv.2005.04.010; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Reed W, 2003, VIRCHOWS ARCH, V443, P44, DOI 10.1007/s00428-003-0817-z; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Rodriguez AO, 2008, OBSTET GYNECOL, V112, P71, DOI 10.1097/AOG.0b013e31817c4ebc; Royal College of Obstetricians and Gynecologists (RCOG), 2004, PREGN BREAST CANC GR, V12; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smith LH, 2003, AM J OBSTET GYNECOL, V189, P1128, DOI 10.1067/S0002-9378(03)00537-4; Zhang J, 2003, J EXP CLIN CANC RES, V22, P23	35	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e111934	10.1371/journal.pone.0111934	http://dx.doi.org/10.1371/journal.pone.0111934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415309	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600009
J	Doppler, SA; Werner, A; Barz, M; Lahm, H; Deutsch, MA; Dressen, M; Schiemann, M; Voss, B; Gregoire, S; Kuppusamy, R; Wu, SM; Lange, R; Krane, M				Doppler, Stefanie A.; Werner, Astrid; Barz, Melanie; Lahm, Harald; Deutsch, Marcus-Andre; Dressen, Martina; Schiemann, Matthias; Voss, Bernhard; Gregoire, Serge; Kuppusamy, Rajarajan; Wu, Sean M.; Lange, Ruediger; Krane, Markus			Myeloid Zinc Finger 1 (Mzf1) Differentially Modulates Murine Cardiogenesis by Interacting with an Nkx2.5 Cardiac Enhancer	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; SMOOTH-MUSCLE; GENE-EXPRESSION; PROTEIN MZF1; IN-VITRO; HEART; MOUSE; MESODERM; TRANSCRIPTION	Vertebrate heart development is strictly regulated by temporal and spatial expression of growth and transcription factors (TFs). We analyzed nine TFs, selected by in silico analysis of an Nkx2.5 enhancer, for their ability to transactivate the respective enhancer element that drives, specifically, expression of genes in cardiac progenitor cells (CPCs). Mzf1 showed significant activity in reporter assays and bound directly to the Nkx2.5 cardiac enhancer (Nkx2.5 CE) during murine ES cell differentiation. While Mzf1 is established as a hematopoietic TF, its ability to regulate cardiogenesis is completely unknown. Mzf1 expression was significantly enriched in CPCs from in vitro differentiated ES cells and in mouse embryonic hearts. To examine the effect of Mzf1 overexpression on CPC formation, we generated a double transgenic, inducible, tetOMzf1-Nkx2.5 CE eGFP ES line. During in vitro differentiation an early and continuous Mzf1 overexpression inhibited CPC formation and cardiac gene expression. A late Mzf1 overexpression, coincident with a second physiological peak of Mzf1 expression, resulted in enhanced cardiogenesis. These findings implicate a novel, temporal-specific role of Mzf1 in embryonic heart development. Thereby we add another piece of puzzle in understanding the complex mechanisms of vertebrate cardiac development and progenitor cell differentiation. Consequently, this knowledge will be of critical importance to guide efficient cardiac regenerative strategies and to gain further insights into the molecular basis of congenital heart malformations.	[Doppler, Stefanie A.; Werner, Astrid; Barz, Melanie; Lahm, Harald; Deutsch, Marcus-Andre; Dressen, Martina; Voss, Bernhard; Lange, Ruediger; Krane, Markus] Tech Univ Munich, Dept Expt Surg, Dept Cardiovasc Surg, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Schiemann, Matthias] TUM, Clin Cooperat Grp Antigen Specif Immunotherapy &, Helmholtz Ctr Munich Neuherberg, Munich, Germany; [Gregoire, Serge] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Div Cardiol,Dept Med, Boston, MA USA; [Kuppusamy, Rajarajan; Wu, Sean M.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, Stanford, CA 94305 USA; [Kuppusamy, Rajarajan; Wu, Sean M.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lange, Ruediger; Krane, Markus] DZHK German Ctr Cardiovasc Res Partner Site Munic, Munich, Germany	German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Stanford University; German Centre for Cardiovascular Research	Doppler, SA (corresponding author), Tech Univ Munich, Dept Expt Surg, Dept Cardiovasc Surg, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany.	doppler@dhm.mhn.de	Krane, Markus/AAD-2006-2021; Deutsch, Marcus-Andre/AAL-8367-2020; Deutsch, Marcus-André/AFV-4686-2022	Krane, Markus/0000-0002-5466-9290; Wu, Sean/0000-0002-0000-3821	Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie; DSHF; DGTHG; Bayerische Forschungsstiftung [AZ-1012-12]; Deutsche Stiftung fur Herzforschung [F/37/11]; Deutsches Zentrum fur Herz Kreislauf Forschung [DZHK B 13-050A, DZHK B 14-013SE]; Deutsche Forschungsgemeinschaft - Sachmittelantrag [KR3770/7-1, KR3770/9-1]	Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie; DSHF; DGTHG; Bayerische Forschungsstiftung; Deutsche Stiftung fur Herzforschung; Deutsches Zentrum fur Herz Kreislauf Forschung; Deutsche Forschungsgemeinschaft - Sachmittelantrag	This work was supported by the Dr. Rusche Forschungspreis 2011 of the Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie (http://www.dshf.de/dr_rusche_forschungsprojekt_projekte.php). Grant Support (Doppler et al.): The study was supported by Dr. Rusche Forschungsprojekt (2011) of the DSHF and DGTHG. Marcus-Andre Deutsch (MAD) is supported by Dr. Rusche Forschungsprojekt (2014) of the DSHF and DGTHG. Rudiger Lange (RL) is supported by Bayerische Forschungsstiftung (AZ-1012-12). Markus Krane (MK) is supported by Deutsche Stiftung fur Herzforschung (F/37/11), Deutsches Zentrum fur Herz Kreislauf Forschung (DZHK B 13-050A), Deutsche Forschungsgemeinschaft - Sachmittelantrag (KR3770/7-1), Deutsches Zentrum fur Herz Kreislauf Forschung (DZHK B 14-013SE), and Deutsche Forschungsgemeinschaft - Sachmittelantrag (KR3770/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GJ, 2000, J MOL CELL CARDIOL, V32, P1447, DOI 10.1006/jmcc.2000.1185; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen YH, 2007, DEV BIOL, V308, P421, DOI 10.1016/j.ydbio.2007.05.037; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gregoire S, 2013, CIRC RES, V112, P900, DOI 10.1161/CIRCRESAHA.113.259259; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Huang Xiaojing, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f10s14; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Lien CL, 1999, DEVELOPMENT, V126, P75; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; MORRIS JF, 1995, BLOOD, V86, P3640; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113775	10.1371/journal.pone.0113775	http://dx.doi.org/10.1371/journal.pone.0113775			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436607	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900078
J	Dubois, M; Le Joncour, V; Tonon, MC; Anouar, Y; Proust, F; Morin, F; Gandolfo, P; Joly, F; Hilber, P; Castel, H				Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Joly, Florence; Hilber, Pascal; Castel, Helene			Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice	PLOS ONE			English	Article							POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; HIPPOCAMPAL CELL-PROLIFERATION; MAMMALIAN TARGET; RAPAMYCIN PATHWAY; COGNITIVE IMPAIRMENTS; SYNAPTIC PLASTICITY; MTOR PATHWAY; FEAR MEMORY; MOUSE MODEL; RAD001	Cancer and treatments may induce cognitive impairments in cancer patients, and the causal link between chemotherapy and cognitive dysfunctions was recently validated in animal models. New cancer targeted therapies have become widely used, and their impact on brain functions and quality of life needs to be explored. We evaluated the impact of everolimus, an anticancer agent targeting the mTOR pathway, on cognitive functions, cerebral metabolism, and hippocampal cell proliferation/vascular density in mice. Adult mice received everolimus daily for 2 weeks, and behavioral tests were performed from 1 week after the last treatment. Everolimus-treated mice displayed a marked reduction in weight gain from the last day of the treatment period. Ex vivo analysis showed altered cytochrome oxidase activity in selective cerebral regions involved in energy balance, food intake, reward, learning and memory modulation, sleep/wake cycle regulation, and arousal. Like chemotherapy, everolimus did not alter emotional reactivity, learning and memory performances, but in contrast to chemotherapy, did not affect behavioral flexibility or reactivity to novelty. In vivo hippocampal neural cell proliferation and vascular density were also unchanged after everolimus treatments. In conclusion, two weeks daily everolimus treatment at the clinical dose did not evoke alteration of cognitive performances evaluated in hippocampal- and prefrontal cortex-dependent tasks that would persist at one to four weeks after the end of the treatment completion. However, acute everolimus treatment caused selective CO modifications without altering the mTOR effector P70S6 kinase in cerebral regions involved in feeding behavior and/or the sleep/wake cycle, at least in part under control of the solitary nucleus and the parasubthalamic region of the hypothalamus. Thus, this area may represent a key target for everolimus-mediating peripheral modifications, which has been previously associated with symptoms such as weight loss and fatigue.	[Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Castel, Helene] Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France; [Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Castel, Helene] Univ Rouen, Inst Res & Biomed Innovat IRIB, PRES Normandie Univ, Mont St Aignan, France; [Dubois, Martine; Gandolfo, Pierrick; Joly, Florence; Hilber, Pascal; Castel, Helene] North West Canceropole CNO, Lille, France; [Joly, Florence; Hilber, Pascal] Univ Rouen, Lab Psychol & Neurosci Cognit & Affect PSY NCA, EA4700, Mont St Aignan, France; [Joly, Florence] Ctr Francois Baclesse, F-14021 Caen, France; [Joly, Florence] CHU Caen, F-14000 Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Universite de Rouen Normandie; UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE; Universite de Caen Normandie	Castel, H (corresponding author), Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France.	helene.castel@univ-rouen.fr	Anouar, Youssef/F-9683-2017; JOLY, Florence/L-7752-2015; Le Joncour, Vadim/X-6274-2019; joly, florence/AAF-9191-2020; castel, helene/B-8675-2009	Le Joncour, Vadim/0000-0001-8153-8563; castel, helene/0000-0002-8972-5555; joly, florence/0000-0001-6168-4942; DUBOIS, Martine/0000-0002-7200-9624; Morin, Fabrice/0000-0001-6785-1967	university of Roue; Inserm; Novartis [071160-001141-05]	university of Roue; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Novartis(Novartis)	This work was supported by university of Roue, Inserm and the Baclesse center receiving a grant by Novartis (Novartis) 071160-001141-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges L, 2011, J CLIN ONCOL S7, V29; Anandappa G, 2010, Cancer Manag Res, V2, P61; Arabo A, 2005, NEUROSCIENCE, V135, P691, DOI 10.1016/j.neuroscience.2005.06.069; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Balenci L, 2007, J NEUROSCI, V27, P4716, DOI 10.1523/JNEUROSCI.0830-07.2007; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bianco R, 2008, BRIT J CANCER, V98, P923, DOI 10.1038/sj.bjc.6604269; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Ciriello J, 2008, AM J PHYSIOL-REG I, V294, pR1276, DOI 10.1152/ajpregu.00437.2007; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Di Lorenzo G, 2011, EUR UROL, V59, P526, DOI 10.1016/j.eururo.2011.01.002; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dubois M, 2014, NEUROPHARMACOLOGY, V79, P234, DOI 10.1016/j.neuropharm.2013.11.012; Farb A, 2002, CIRCULATION, V106, P2379, DOI 10.1161/01.CIR.0000033973.06059.04; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Glusker P, 2006, NEW ENGL J MED, V354, P980; Goto M, 2004, J COMP NEUROL, V469, P581, DOI 10.1002/cne.11036; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hallmann R, 2000, ENDOTHELIUM-J ENDOTH, V7, P135, DOI 10.3109/10623320009072208; Hebert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093691; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Horvath TL, 1999, J COMP NEUROL, V415, P145; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huynh H, 2009, J CELL MOL MED, V13, P1371, DOI 10.1111/j.1582-4934.2008.00364.x; Joly F, 2011, PSYCHO-ONCOLOGY, V20, P1251, DOI 10.1002/pon.1903; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Krab LC, 2008, TRENDS GENET, V24, P498, DOI 10.1016/j.tig.2008.07.005; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Larkin JMG, 2010, ONCOLOGIST, V15, P1135, DOI 10.1634/theoncologist.2010-0078; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Martin G, 2007, J CLIN ONCOL, V25, P3559, DOI 10.1200/JCO.2007.12.8710; Martins L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046923; Mascaro MB, 2005, NEUROSCI LETT, V386, P34, DOI 10.1016/j.neulet.2005.05.062; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mori H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1013, DOI 10.1152/ajpendo.00262.2009; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Okada K, 2011, NEUROSCI LETT, V495, P201, DOI 10.1016/j.neulet.2011.03.065; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pawaskar DK, 2013, CANCER CHEMOTH PHARM, V71, P1219, DOI 10.1007/s00280-013-2116-y; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Raman L, 2011, PEDIATR RES, V70, P159, DOI 10.1203/PDR.0b013e3182218622; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Strazielle C, 1998, EXP BRAIN RES, V121, P35, DOI 10.1007/s002210050434; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tanaka Chiaki, 2008, J Clin Oncol, V26, P1596, DOI 10.1200/JCO.2007.14.1127; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Xu GY, 2010, PEPTIDES, V31, P2185, DOI 10.1016/j.peptides.2010.08.018; Yang X, 2008, J Anim Sci, V86, pE36; Yasoshima Y, 2006, NEUROSCIENCE, V141, P35, DOI 10.1016/j.neuroscience.2006.03.019; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhu XX, 2012, AM J PHYSIOL-ENDOC M, V303, pE1446, DOI 10.1152/ajpendo.00427.2012	77	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113533	10.1371/journal.pone.0113533	http://dx.doi.org/10.1371/journal.pone.0113533			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436776	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900049
J	Qureshi, JA; Kostyk, BC; Stansly, PA				Qureshi, Jawwad A.; Kostyk, Barry C.; Stansly, Philip A.			Insecticidal Suppression of Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae) Vector of Huanglongbing Pathogens	PLOS ONE			English	Article							ANTHRANILIC DIAMIDE INSECTICIDE; FIELD POPULATIONS; TAMARIXIA-RADIATA; ABUNDANCE; HOMOPTERA; DISEASE; FLORIDA	Diaphorina citri vectors pathogens that cause 'huanglongbing' or citrus greening disease which poses a serious threat to citrus production worldwide. Vector suppression is critical to reduce disease spread. Efficacy is a main concern when choosing an insecticide. Insecticidal treatments of 49 products or 44 active ingredients (a.i) labeled or experimental were field tested between 2005-2013 as foliar sprays (250 treatments, 39 a.i) or soil applications (47 treatments, 9 a.i) to control D. citri in citrus. A combined effect of nymphal and adult suppression in response to sprays of 23 insecticides representing 9 modes of action (MoA) groups and 3 unknown MoA provided more than 90% reduction of adult D. citri over 24-68 days. Observable effects on nymphs were generally of shorter duration due to rapid maturation of flush. However, reduction of 76-100% nymphs or adults over 99-296 days was seen on young trees receiving drenches of the neonicotinoids imidacloprid, thiamethoxam or clothianidin (MoA 4A) and a novel anthranilic diamide, cyantraniliprole (MoA 28). Effective products identified for foliar sprays to control D. citri provide sufficient MoA groups for rotation to delay evolution of insecticide resistance by D. citri and other pests. However, cyantraniliprole is now the only available alternative for rotation with neonicotinoids in soil application to young trees. Sprays of up to eight of the most effective insecticides could be rotated over a year without repetition of any MoA and little or no recourse to neonicotinoids or cyantraniliprole, so important for protection of young trees. Other considerations effecting decisions of what and when to spray include prevalence of huanglongbing, pest pressure, pre-harvest intervals, overall budget, equipment availability, and conservation of beneficial arthropods. Examples of spray programs utilizing broad-spectrum and relatively selective insecticides are provided to improve vector management and may vary depending on individual or regional assessment of all factors.	[Qureshi, Jawwad A.; Kostyk, Barry C.; Stansly, Philip A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA	State University System of Florida; University of Florida	Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA.	jawwadq@ufl.edu			Citrus Research and Development Foundation Inc., Florida	Citrus Research and Development Foundation Inc., Florida	Funding: This research was supported by the Citrus Research and Development Foundation Inc., Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belasque J, 2010, J PLANT PATHOL, V92, P285; Bove JM, 2006, J PLANT PATHOL, V88, P7; Croxton S, 2012, ARTHROP MANAG TESTS, P37, DOI [10.4182/amt.2012.D1, DOI 10.4182/AMT.2012.D1]; (FDQO-CG-ACP), 2009, FED DOM QUAR ORD CIT; Foster SP, 2012, PEST MANAG SCI, V68, P629, DOI 10.1002/ps.2306; French J. V., 2001, Subtropical Plant Science, V53, P14; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert S.E., 2005, PEST ALERT CITRUS GR; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HALBERT SE, 1998, TRIOLOGY, V37, P6; Hall DG, 2007, HORTSCIENCE, V42, P364, DOI 10.21273/HORTSCI.42.2.364; Hall DG, 2010, BIOCONTROL, V55, P601, DOI 10.1007/s10526-010-9283-0; Hodges A, 2012, EC IMPACTS CITRUS GR; Hoy M.A., 2001, CITRUS IND, V81, P48; Jackson L.K., 1999, CITRUS GROWING FLORI; Knapp JL, 1995, CITRUS LEAFMINER PHY; McCoy C. W., 1985, Biological control in agricultural IPM systems, P481; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Michaud JP, 2002, ENTOMOL NEWS, V113, P216; Qureshi J. A., 2013, CITRUS IND, V94, P6; Qureshi J. A., 2012, CITRUS IND, V93, P14; Qureshi JA, 2010, TAMARIXIA RADIATA WA; Qureshi JA, 2008, PEST MANAG SCI, V64, P1159, DOI 10.1002/ps.1612; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2011, PROC FL STATE HORTIC, V124, P85; Qureshi JA, 2009, PROC FL STATE HORTIC, V122, P189; Qureshi JA, 2011, ENVIRON ENTOMOL, V40, P1503, DOI 10.1603/EN11171; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Rogers M. E., 2008, CITRUS IND, V89, P12; Rogers M.E., 2007, 2007 FLORIDA CITRUS, DOI [10.32473/edis-in686-2006, DOI 10.32473/EDIS-IN686-2006]; Roistacher C. N., 1996, INT ORG CITRUS VIROL, V13, P279, DOI [10.5070/C53KG8M6JR, DOI 10.5070/C53KG8M6JR]; *SAS I, 2004, SAS WIND VERS 9 1; Stansly P.A., 2011, ARTHROP MGT TESTS, V36, DOI [10.4182/ amt.2011.D4, DOI 10.4182/AMT.2011.D4]; Stansly P.A., 2011, ARTHR MANAG TESTS, V36, pD16, DOI [10.4182/amt.2011.D16, DOI 10.4182/AMT.2011.D16, 10.4182/amt.2011.D16.]; Stansly P.A., 2013, ARTHROPOD MANAGEMENT, V38, P1, DOI [10.4182/amt.2013.D12, DOI 10.4182/AMT.2013.D12]; Stansly P.A., 2007, ARTHR M TESTS, V32, pD11; Stansly P.A., ARTHROP MGT TESTS, V34, DOI [10.4182/amt.2009.D8, DOI 10.4182/AMT.2009.D8]; Stansly P.A., 2007, ARTHROPOD MGT TESTS, V32, pD10; Stansly P A, 2008, ARTHROP MANAG TESTS, V33, pD10; Stansly P. A., 2014, ARTHROP MANAG TESTS, V39, DOI [10.4182/amt.2014, DOI 10.4182/AMT.2014]; Stansly P.A., 2012, ARTHROP MGT TESTS, V37, DOI [10.4182/amt.2012.D15, DOI 10.4182/AMT.2012.D15]; Stansly P. A., 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D15, DOI 10.4182/AMT.2013.D15]; Stansly P.A., 2009, CITRUS IND, V90, P14; Stansly PA, 2012, ARTHROPOD MANAGEMENT, V37, DOI [10.4182/amt.2012.D10, DOI 10.4182/AMT.2012.D10]; Stansly PA, 2011, ARTHROP MANAG TESTS, V36, DOI [10.4182/amt.2011.D15., DOI 10.4182/AMT.2011.D15]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D8, DOI 10.4182/AMT.2012.D8]; Stansly PA, 2006, ARTHROP MANAG TESTS, V31, pD19; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D9, DOI 10.4182/AMT.2013.D9]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D10, DOI 10.4182/AMT.2013.D10]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D7., DOI 10.4182/AMT.2012.D7]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D9, DOI 10.4182/AMT.2012.D9]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D7, DOI 10.4182/AMT.2010.D7]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D9, DOI 10.4182/AMT.2010.D9]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D16, DOI 10.4182/AMT.2012.D16]; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD13, DOI DOI 10.1093/AMT/33.1.D13; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD11; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D10, DOI 10.4182/AMT.2009.D10]; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD12; Stansly PA, 2011, ARTHROP MANAG TESTS, V36, DOI [10.4182/amt.2011.D14, DOI 10.4182/AMT.2011.D14]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D14, DOI 10.4182/AMT.2012.D14]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D11, DOI 10.4182/AMT.2009.D11]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D12., DOI 10.4182/AMT.2009.D12]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D2, DOI 10.4182/AMT.2009.D2]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D14, DOI 10.4182/AMT.2013.D14]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D8, DOI 10.4182/AMT.2010.D8]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D13, DOI 10.4182/AMT.2009.D13]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D11, DOI 10.4182/AMT.2013.D11]; Stansly PA, 2009, ARTHROPOD MANAGEMENT, V34, DOI [10.4182/amt.2009.D9, DOI 10.4182/AMT.2009.D9]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D10., DOI 10.4182/AMT.2010.D10]; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Tiwari S, 2013, PEST MANAG SCI, V69, P1066, DOI 10.1002/ps.3468; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tsai JH, 2002, FLA ENTOMOL, V85, P446, DOI 10.1653/0015-4040(2002)085[0446:SAOTAC]2.0.CO;2; Vanden Berg MA, 1992, ENTOMOPHAGA, V37, P599	77	118	126	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112331	10.1371/journal.pone.0112331	http://dx.doi.org/10.1371/journal.pone.0112331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437858	Green Published, gold			2022-12-27	WOS:000347114900013
J	Ai, N; Welsh, WJ; Santhanam, U; Hu, H; Lyga, J				Ai, Ni; Welsh, William J.; Santhanam, Uma; Hu, Hong; Lyga, John			Novel Virtual Screening Approach for the Discovery of Human Tyrosinase Inhibitors	PLOS ONE			English	Article							SHAPE SIGNATURES; DRUG DISCOVERY; DESIGN	Tyrosinase is the key enzyme involved in the human pigmentation process, as well as the undesired browning of fruits and vegetables. Compounds inhibiting tyrosinase catalytic activity are an important class of cosmetic and dermatological agents which show high potential as depigmentation agents used for skin lightening. The multi-step protocol employed for the identification of novel tyrosinase inhibitors incorporated the Shape Signatures computational algorithm for rapid screening of chemical libraries. This algorithm converts the size and shape of a molecule, as well its surface charge distribution and other bio-relevant properties, into compact histograms (signatures) that lend themselves to rapid comparison between molecules. Shape Signatures excels at scaffold hopping across different chemical families, which enables identification of new actives whose molecular structure is distinct from other known actives. Using this approach, we identified a novel class of depigmentation agents that demonstrated promise for skin lightening product development.	[Ai, Ni] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Welsh, William J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Santhanam, Uma; Hu, Hong; Lyga, John] AVON Prod Inc, Global R&D, Suffern, NY USA	Zhejiang University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Avon Products	Ai, N (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	ai_ni@zju.edu.cn			AVON Products, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	AVON Products, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: The funder (AVON Products, Inc.) provided support in the form of salaries for authors [NA and WJW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chekmarev DS, 2008, CHEM RES TOXICOL, V21, P1304, DOI 10.1021/tx800063r; Dessalew N, 2006, CHEM BIOL DRUG DES, V68, P154, DOI 10.1111/j.1747-0285.2006.00430.x; Hartman I, 2009, PHARM RES-DORDR, V26, P2247, DOI 10.1007/s11095-009-9941-z; HEARING VJ, 1989, PIGM CELL RES, V2, P75, DOI 10.1111/j.1600-0749.1989.tb00166.x; Heikamp K, 2012, FUTURE MED CHEM, V4, P1945, DOI [10.4155/FMC.12.126, 10.4155/fmc.12.126]; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Khan MTH, 2012, CURR MED CHEM, V19, P2262; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kubo I, 2000, BIOORGAN MED CHEM, V8, P1749, DOI 10.1016/S0968-0896(00)00102-4; KUBO I, 1994, J NAT PROD, V57, P545, DOI 10.1021/np50106a021; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Loizzo MR, 2012, COMPR REV FOOD SCI F, V11, P378, DOI 10.1111/j.1541-4337.2012.00191.x; Lyga JW, 2012, United States patent, Patent No. [US 8,329,149, 8329149]; Masamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P631, DOI 10.1271/bbb.67.631; Meek PJ, 2006, DRUG DISCOV TODAY, V11, P895, DOI 10.1016/j.drudis.2006.08.014; Perez-Gilabert M, 2001, BIOCHEM BIOPH RES CO, V285, P257, DOI 10.1006/bbrc.2001.5189; Pirhadi S, 2013, CURR TOP MED CHEM, V13, P1036, DOI 10.2174/1568026611313090006; Sakuma K, 1999, ARCH PHARM RES, V22, P335, DOI 10.1007/BF02979054; Shimizu K, 2000, PLANTA MED, V66, P11, DOI 10.1055/s-2000-11113; Singh N, 2006, J COMPUT AIDED MOL D; Wang CY, 2006, CHEM RES TOXICOL, V19, P1595, DOI 10.1021/tx060218k; Wang JG, 2006, BIOORG MED CHEM; Yang F, 1999, PIGM CELL RES, V12, P237, DOI 10.1111/j.1600-0749.1999.tb00756.x; Zauhar RJ, 2003, J MED CHEM, V46, P5674, DOI 10.1021/jm030242k	25	18	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112788	10.1371/journal.pone.0112788	http://dx.doi.org/10.1371/journal.pone.0112788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426625	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400024
J	Dutta, AK; Santra, S; Sharma, H; Voshavar, C; Xu, LP; Mabrouk, O; Antonio, T; Reith, MEA				Dutta, Aloke K.; Santra, Soumava; Sharma, Horrick; Voshavar, Chandrashekhar; Xu, Liping; Mabrouk, Omar; Antonio, Tamara; Reith, Maarten E. A.			Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; IN-VIVO; STRUCTURAL EXPLORATION; ATYPICAL DEPRESSION; PYRAN BIOMIMETICS; NUCLEUS-ACCUMBENS; NEXT-GENERATION; HIGH-AFFINITY	Major depressive disorder (MDD) is a debilitating disease affecting a wide cross section of people around the world. The current therapy for depression is less than adequate and there is a considerable unmet need for more efficacious treatment. Dopamine has been shown to play a significant role in depression including production of anhedonia which has been one of the untreated symptoms in MDD. It has been hypothesized that drugs acting at all three monoamine transporters including dopamine transporter should provide more efficacious antidepressants activity. This has led to the development of triple reuptake inhibitor D-473 which is a novel pyran based molecule and interacts with all three monoamine transporters. The monoamine uptake inhibition activity in the cloned human transporters expressed in HEK-293 cells (70.4, 9.18 and 39.7 for DAT, SERT and NET, respectively) indicates a serotonin preferring triple reuptake inhibition profile for this drug. The drug D-473 exhibited good brain penetration and produced efficacious activity in rat forced swim test under oral administration. The optimal efficacy dose did not produce any locomotor activation. Microdialysis experiment demonstrated that systemic administration of D-473 elevated extracellular level of the three monoamines DA, 5-HT, and NE efficaciously in the dorsal lateral striatum (DLS) and the medial prefrontal cortex (mPFC) area, indicating in vivo blockade of all three monoamine transporters by D-473. Thus, the current biological data from D-473 indicate potent antidepressant activity of the molecule.	[Dutta, Aloke K.; Santra, Soumava; Sharma, Horrick; Voshavar, Chandrashekhar; Xu, Liping] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA; [Mabrouk, Omar] Univ Michigan, Dept Pharmacol & Chem, Ann Arbor, MI 48109 USA; [Antonio, Tamara; Reith, Maarten E. A.] NYU, Dept Psychiat, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Dept Biochem & Mol Pharmacol, New York, NY USA	Wayne State University; University of Michigan System; University of Michigan; New York University; New York University	Dutta, AK (corresponding author), Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA.	adutta@wayne.edu	Voshavar, Chandra/AAG-1587-2020; Santra, Soumava/L-2561-2019; Reith, Maarten E./AAD-2303-2019	Voshavar, Chandra/0000-0003-3350-3977; Reith, Maarten E./0000-0002-1900-842X; Santra, Soumava/0000-0003-4304-4030; dutta, aloke/0000-0003-3347-0538	National Institute of Mental Health/The National Institute of Health [MH084888]; National Center for Advancing Translational Sciences of the National Institutes of Health [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084888] Funding Source: NIH RePORTER	National Institute of Mental Health/The National Institute of Health; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by National Institute of Mental Health/The National Institute of Health MH084888 (AKD). The microdialysis studies were partly supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 2UL1TR000433 (OSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio L, 2008, EUR J PHARMACOL, V587, P141, DOI 10.1016/j.ejphar.2008.04.008; ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; CHEN NH, 1994, J NEUROCHEM, V63, P1701; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; DEWIT H, 1993, PSYCHOPHARMACOLOGY, V112, P324, DOI 10.1007/BF02244928; DILSAVER SC, 1994, AM J PSYCHIAT, V151, P1312; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dutta AK, 2008, EUR J PHARMACOL, V589, P73, DOI 10.1016/j.ejphar.2008.05.008; Dutta AK, 2011, EUR J PHARMACOL, V671, P39, DOI 10.1016/j.ejphar.2011.09.162; Dwoskin LP, 2006, CNS DRUG REV, V12, P178, DOI 10.1111/j.1527-3458.2006.00178.x; Gold PW, 1999, P ASSOC AM PHYSICIAN, V111, P22, DOI 10.1046/j.1525-1381.1999.09423.x; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Golembiowska K, 2012, SYNAPSE, V66, P435, DOI 10.1002/syn.21531; Gopishetty B, 2011, J MED CHEM, V54, P2924, DOI 10.1021/jm200020a; Guiard BP, 2009, CURR DRUG TARGETS, V10, P1069, DOI 10.2174/138945009789735156; Howell LL, 2014, ADV PHARMACOL, V69, P129, DOI 10.1016/B978-0-12-420118-7.00004-4; HURD YL, 1989, EUR J PHARMACOL, V166, P251, DOI 10.1016/0014-2999(89)90066-6; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; Li MY, 1996, J NEUROCHEM, V66, P559; Liang YQ, 2008, J PHARMACOL EXP THER, V327, P573, DOI 10.1124/jpet.108.143610; Marks DM, 2008, CURR NEUROPHARMACOL, V6, P338, DOI 10.2174/157015908787386078; MAURICE T, 1992, NEUROSCI LETT, V138, P63, DOI 10.1016/0304-3940(92)90473-K; Millan MJ, 2009, NEUROTHERAPEUTICS, V6, P53, DOI 10.1016/j.nurt.2008.10.039; Mischoulon D, 2000, CAN J PSYCHIAT, V45, P476, DOI 10.1177/070674370004500509; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; NOMIKOS GG, 1989, NEUROPSYCHOPHARMACOL, V2, P273, DOI 10.1016/0893-133X(89)90031-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; Rakofsky JJ, 2009, CURR OPIN CHEM BIOL, V13, P291, DOI 10.1016/j.cbpa.2009.04.617; Reith MEA, 2012, J PHARMACOL EXP THER, V343, P413, DOI 10.1124/jpet.112.193771; Risinger R, 2014, PSYCHOPHARMACOLOGY, V231, P2299, DOI 10.1007/s00213-013-3391-3; Santra S, 2012, CHEMMEDCHEM, V7, P2093, DOI 10.1002/cmdc.201200352; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; Sorensen G, 2014, BASIC CLIN PHARMACOL, V114, P451, DOI 10.1111/bcpt.12182; Strakowski SM, 1996, AM J PSYCHIAT, V153, P674; Tran P, 2012, J PSYCHIATR RES, V46, P64, DOI 10.1016/j.jpsychires.2011.09.003; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Zhang SJ, 2006, J MED CHEM, V49, P4239, DOI 10.1021/jm0601699; Zhang SJ, 2005, J MED CHEM, V48, P4962, DOI 10.1021/jm049021k; Zhang SJ, 2004, BIOORGAN MED CHEM, V12, P6301, DOI 10.1016/j.bmc.2004.07.069; Zhang SJ, 2003, BIOORG MED CHEM LETT, V13, P1591, DOI 10.1016/S0960-894X(03)00169-0	50	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113420	10.1371/journal.pone.0113420	http://dx.doi.org/10.1371/journal.pone.0113420			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427177	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400051
J	Trotteyn, MJ; Ezcurra, MD				Jimena Trotteyn, M.; Ezcurra, Martin D.			Osteology of Pseudochampsa ischigualastensis gen. et comb. nov (Archosauriformes: Proterochampsidae) from the Early Late Triassic Ischigualasto Formation of Northwestern Argentina	PLOS ONE			English	Article							DIAPSIDA ARCHOSAURIFORMES; EARLY EVOLUTION; EARLY HISTORY; REPTILIA; ORIGIN	Proterochampsids are crocodile-like, probably semi-aquatic, quadrupedal archosauriforms characterized by an elongated and dorsoventrally low skull. The group is endemic from the Middle-Late Triassic of South America. The most recently erected proterochampsid species is "Chanaresuchus ischigualastensis'', based on a single, fairly complete skeleton from the early Late Triassic Ischigualasto Formation of northwestern Argentina. We describe here in detail the non-braincase cranial and postcranial anatomy of this species and revisit its taxonomy and phylogenetic relationships. The phylogenetic analysis recovered 'Chanaresuchus ischigualastensis' as part of a trichotomy together with Gualosuchus reigi and Chanaresuchus bonapartei. Accordingly, "Chanaresuchus ischigualastensis'' can be potentially more closely related to Gualosuchus reigi, or even Rhadinosuchus gracilis, than to Chanaresuchus bonapartei. In addition, after discussing previously claimed synapomorphies of Chanaresuchus, we could not find unambiguous support for the monophyly of the genus. As a result, we propose here the erection of the new genus Pseudochampsa for 'Chanaresuchus ischigualastensis', which results in the new combination Pseudochampsa ischigualastensis. The information provided here about the anatomy and taxonomy of Pseudochampsa ischiguaslastensis will be useful for future quantitative analyses focused on the biogeography and macroevolutionary history of proterochampsids.	[Jimena Trotteyn, M.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Jimena Trotteyn, M.] Univ Nacl San Juan, Fac Ciencias Exactas Fis & Nat, Inst Geol, INGEO, San Juan, PR, Argentina; [Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Juan; University of Birmingham	Trotteyn, MJ (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	jtrotteyn@unsj.edu.ar	Trotteyn, María Jimena/I-8926-2019	Trotteyn, María Jimena/0000-0002-8624-4297	DFG Emmy Noether Programme [BU 2587/3-1]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2012-0741]; Universidad de San Juan [UNSJ 22/13-CS]	DFG Emmy Noether Programme(German Research Foundation (DFG)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Universidad de San Juan	Funding: MDE is supported by a grant of the DFG Emmy Noether Programme to Richard Butler (BU 2587/3-1). MJT is supported by a grant of the Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2012-0741) and Universidad de San Juan (UNSJ 22/13-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcucci A.B., 1989, Historical Biology, V3, P85; Benton M. J, 1990, DINOSAURIA; BONAPARTE JF, 1971, AN ACAD BRAS CIENC, V43, P417; CODDINGTON J, 1994, CLADISTICS, V10, P415; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Dilkes D, 2012, PALAEONTOLOGY, V55, P853, DOI 10.1111/j.1475-4983.2012.01170.x; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, P ROY SOC B-BIOL SCI, V277, P2547, DOI 10.1098/rspb.2010.0508; Ezcurra MD, 2013, AMEGHINIANA, V50, pR45; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Trotteyn MJ, 2011, AMEGHINIANA, V48, P424, DOI 10.5710/AMGH.v48i4(351); Trotteyn MJ, 2013, GEOL SOC SPEC PUBL, V379, P59, DOI 10.1144/SP379.23; Kischlat EE., 2000, PALEONTOLOGIA RIO GR, P398; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Romer A.S., 1972, Breviora, VNo. 385, P1; Romer A. S., 1956, VERTEBRATE PALEONTOL; ROMER ALFRED SHERWOOD, 1966, BREV MUS COMP ZOOL HARVARD, V252, P1; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; SILL WILLIAM D., 1967, BULL MUS COMP ZOOL HARVARD UNIV, V135, P415; Sookias RB, 2013, GEOL SOC SPEC PUBL, V379, P35, DOI 10.1144/SP379.6; Sues HD, 2013, GEOL SOC SPEC PUBL, V379, P49, DOI 10.1144/SP379.13; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P867, DOI 10.1080/02724634.2012.670178; Trotteyn MJ, 2012, J VERTEBR PALEONTOL, V32, P485, DOI 10.1080/02724634.2012.645975; Trotteyn MJ, 2011, THESIS U NACL CUYO; Trotteyn MJ, 2012, AMGHINIANA, V49, pR58; von Huene FRF, 1946, BIOL ZBL, V65, P268; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062	36	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111388	10.1371/journal.pone.0111388	http://dx.doi.org/10.1371/journal.pone.0111388			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426846	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400005
J	Moore-Colyer, MJS; Lumbis, K; Longland, A; Harris, P				Moore-Colyer, Meriel Jean Scott; Lumbis, Kimberly; Longland, Annette; Harris, Patricia			The Effect of Five Different Wetting Treatments on the Nutrient Content and Microbial Concentration in Hay for Horses	PLOS ONE			English	Article							SOAKING; DUST	Five different hays were used to determine the effect of 5 different soaking and steaming treatments on the water soluble carbohydrate and microbial (bacteria and mould) contents of UK hay. Hays were subjected to the following 5 treatments: 1. Dry; 2. Steamed for 50 minutes in the Haygain-600 steamer; 3. Soaked in water at 16 degrees C for 9 hours; 4. Steamed then soaked and 5. Soaked then steamed. Post treatment hays were tested for water soluble carbohydrates, bacteria and mould contents. Differences between means were determined using ANOVA and least significant difference with hay (5), bale (3) and treatment (5) as fixed factors, thus n=75. Protein and ash proportions were unaltered in any of the treatments. Soaked, steamed then soaked and soaked then steamed treatments were all equally effective at reducing water soluble carbohydrates, with significantly (P<0.05) lower mean contents (79-83 g/kg DM) compared with 126 and 122 g/kg dry matter (DM) for dry and steamed respectively. Steamed and soaked then steamed had significantly (P<0.05) less bacteria (1.04 x 10(3) and 4.9 x 10(2) CFU/g DM) compared with soaked which increased CFU/g DM from 6.0 x 10(4) in dry hay up to 3.5 x 10(5). Mould contents CFU/g DM were significantly (P<0.05) reduced by steaming (2) and soaking then steaming (1.9) but no difference was seen between dry (1148), soaked (692) or steamed then soaked (501). Soaking for 9 hours followed by steaming for 50 minutes in the Haygain steamer was the most effective method for reducing water soluble carbohydrates and microbial contamination in hay. Soaking or steaming+soaking lowered water soluble carbohydrates but significantly reduced the hygienic quality of the hay which could potentially compromise the health of the horse.	[Moore-Colyer, Meriel Jean Scott; Lumbis, Kimberly] Royal Agr Univ, Cirencester, Glos, England; [Longland, Annette] Pantafallen Fach, Equine Serv, Tregaron, Ceredigion, Wales; [Longland, Annette] Pantafallen Fach, Livestock Nutr Serv, Tregaron, Ceredigion, Wales; [Harris, Patricia] Mars Horsecare UK LTD, Equine Studies Grp, Waltham Ctr Pet Nutr, Melton Mowbray, Leics, England	Mars; WALTHAM Petcare Science Institute	Moore-Colyer, MJS (corresponding author), Royal Agr Univ, Cirencester, Glos, England.	meriel.moore-colyer@rau.ac.uk			Waltham Centre for Pet Nutrition	Waltham Centre for Pet Nutrition	The consumables for the research were funded by Waltham Centre for Pet Nutrition. The funders (with the exception of Patrica A. Harris, co-author and collaborator) had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript. The experiment is in no way linked to any core activity, employment, consultancy, patents, products in development or marketed products associated with Waltham Centre for Pet Nutrition.	Adams RS, 1993, DEP DAIRY ANIMAL SCI; AOAC, 2000, OFF METH AN AOAC; Blackman M, 1998, ANIM SCI, V66, P745, DOI 10.1017/S1357729800009334; Brown E, 2013, P BSAS INNOVATION AN, V4, P104; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Earing JE, 2013, J ANIM SCI, V91, P5813, DOI 10.2527/jas.2013-6333; Elliott J, 2007, 1 WALTH ROYAL VET CO; Frank N, 2009, J EQUINE VET SCI, V29, P259, DOI 10.1016/j.jevs.2009.04.183; Genstat, 2013, STAT SOFTW LAWS AGR; Geor RJ., 2013, EQUINE APPL CLIN NUT, P469; Geor RJ, 2007, 1 WALTH ROYAL VET CO; Harris P. A., 2010, The impact of nutrition on the health and welfare of horses. 5th European Workshop on Equine Nutrition, Cirencester, UK, 19-22 September, 2010, P215; Jackson CA, 2000, EQUINE VET J, V32, P432, DOI 10.2746/042516400777591165; James R., 2010, EUR WORKSH EQ NUTR C, P128; KAMPHEUS J, 1991, J EQUINE VET SCI, V11, P36, DOI 10.1016/S0737-0806(06)81245-1; Kamphues J., 2004, VORLESUNGEN UBUNGE S, V10th; King L, 2012, THESIS ROYAL AGR COL; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Longland A.C., 2009, J EQUINE VET SCI, V29, P383, DOI [10.1016/j.jevs.2009.04.085, DOI 10.1016/J.JEVS.2009.04.085]; Longland AC, 2007, 1 WALTH ROYAL VET CO; Martinson K, 2012, J EQUINE VET SCI, V32, P332, DOI 10.1016/j.jevs.2011.11.009; Mc Call J, 2014, YOUR ON LINE SOURCE; Mc Pherson E, 1983, EQUINE VET J, V13, P167; Moore-Colyer M.J.S., 2012, FORAGES GRAZING HORS, P101, DOI DOI 10.3920/978-90-8686-755-4_9; Moore-Colyer MJS, 2012, P BSAS NOTT UK APR; MooreColyer MJS, 1996, ANIM SCI, V63, P337, DOI 10.1017/S1357729800014892; NRC, 2007, NUTR REQ HORS; Pagan JD, 2013, 1 EQ SCI SOC S; Petrie A, 1999, STAT VET ANIMAL SCI; Robinson NE, 2001, EQUINE VET EDUC, V13, P247, DOI 10.1111/j.2042-3292.2001.tb00104.x; Seguin V, 2011, J SCI FOOD AGR, DOI [10.1002/lsfa.4680, DOI 10.1002/ISFA.4680]; Seguin V, 2010, AGR ECOSYST ENVIRON, V135, P206, DOI 10.1016/j.agee.2009.09.012; Stockdale C, 2010, EAAP PUBLICATION, V128, P136; Taylor J, 2013, EFFECT 5 DIFFERENT W; Treiber KH, 2006, J NUTR, V136, p2094S, DOI 10.1093/jn/136.7.2094S; Valluru R, 2008, J EXP BOT, V59, P2905, DOI 10.1093/jxb/ern164; Virkajarvi P, 2012, GRASS PHYSL ITS RELA; Warr EM, 1992, EQUINE VET EDUC, V5, P169; Woods P. S., 1993, EQUINE VET J, V25, P172	39	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114079	10.1371/journal.pone.0114079	http://dx.doi.org/10.1371/journal.pone.0114079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426729	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000349145400112
J	Petit, M; Vezina, F				Petit, Magali; Vezina, Francois			Reaction Norms in Natural Conditions: How Does Metabolic Performance Respond to Weather Variations in a Small Endotherm Facing Cold Environments?	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; SEASONAL ACCLIMATIZATION; PHENOTYPIC PLASTICITY; MOUNTAIN CHICKADEES; OXYGEN-CONSUMPTION; SUMMIT METABOLISM; BASAL; WINTER; FLEXIBILITY; ENERGETICS	Reaction norms reflect an organisms' capacity to adjust its phenotype to the environment and allows for identifying trait values associated with physiological limits. However, reaction norms of physiological parameters are mostly unknown for endotherms living in natural conditions. Black-capped chickadees (Poecile atricapillus) increase their metabolic performance during winter acclimatization and are thus good model to measure reaction norms in the wild. We repeatedly measured basal (BMR) and summit (Msum) metabolism in chickadees to characterize, for the first time in a free-living endotherm, reaction norms of these parameters across the natural range of weather variation. BMR varied between individuals and was weakly and negatively related to minimal temperature. Msum varied with minimal temperature following a Z-shape curve, increasing linearly between 24 degrees C and -10 degrees C, and changed with absolute humidity following a U-shape relationship. These results suggest that thermal exchanges with the environment have minimal effects on maintenance costs, which may be individual-dependent, while thermogenic capacity is responding to body heat loss. Our results suggest also that BMR and Msum respond to different and likely independent constraints.	[Petit, Magali; Vezina, Francois] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Petit, Magali; Vezina, Francois] Grp Rech Environm Nord BOREAS, Rimouski, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Etud Nord, Quebec City, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Sci Biodiversite Quebec, Montreal, PQ, Canada	University of Quebec	Petit, M (corresponding author), Univ Quebec, Dept Biol Chim & Geog, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada.	magali.petit@uqar.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [9045333]; Fonds de Recherche du Quebec sur la nature et les technologies [132032]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec sur la nature et les technologies	This work was funded by a Discovery grant (9045333) from the Natural Sciences and Engineering Research Council (NSERC) of Canada http://www.nserc-crsng.gc.ca/index_eng.asp as well as a Nouveaux chercheurs grant (132032) from the Fonds de Recherche du Quebec sur la nature et les technologies http://www.frqnt.gouv.qc.ca/ to FV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2014, R LANG ENV STAT COMP; BAKKEN GS, 1991, PHYSIOL ZOOL, V64, P1023, DOI 10.1086/physzool.64.4.30157955; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Bozinovic F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P452, DOI 10.1086/518376; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; CHAPLIN SB, 1976, J COMP PHYSIOL, V112, P335, DOI 10.1007/BF00692303; CHAPPELL MA, 1980, J MAMMAL, V61, P278, DOI 10.2307/1380049; Chappell MA, 1999, J EXP BIOL, V202, P2269; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cooper SJ, 2000, CONDOR, V102, P635, DOI 10.1650/0010-5422(2000)102[0635:SEOMCA]2.0.CO;2; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; Cooper SJ, 2005, CONDOR, V107, P151, DOI 10.1650/7597; Cortes PA, J EXPT ZOOLO A UNPUB; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; DESROCHERS A, 1990, J FIELD ORNITHOL, V61, P79; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; GESSAMAN JA, 1988, PHYSIOL ZOOL, V61, P507, DOI 10.1086/physzool.61.6.30156159; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAYES SR, 1980, J THERM BIOL, V5, P119, DOI 10.1016/0306-4565(80)90010-8; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Jackson DM, 2001, J ANIM ECOL, V70, P633, DOI 10.1046/j.1365-2656.2001.00518.x; Jacobs PJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P762, DOI 10.1086/676933; Lewden A, 2014, IBIS, V156, P321, DOI 10.1111/ibi.12142; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 1996, J AVIAN BIOL, V27, P279, DOI 10.2307/3677259; Maggini I, 2013, J AVIAN BIOL, V44, P479, DOI 10.1111/j.1600-048X.2013.05869.x; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Olson Jennifer R., 2007, P263; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Petit M, 2014, PHYSIOL BIOCHEM ZOOL, V87, P539, DOI 10.1086/676669; Petit M, 2014, J EXP BIOL, V217, P824, DOI 10.1242/jeb.095703; Petit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068292; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; ROBINSON DE, 1976, J COMP PHYSIOL, V105, P153, DOI 10.1007/BF00691117; SAARELA S, 1995, J COMP PHYSIOL B, V165, P366, DOI 10.1007/BF00387307; SCHEINER SM, 1991, J EVOLUTION BIOL, V4, P23, DOI 10.1046/j.1420-9101.1991.4010023.x; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Sharbaugh SM, 2001, PHYSIOL BIOCHEM ZOOL, V74, P568, DOI 10.1086/322170; Smit B, 2010, FUNCT ECOL, V24, P330, DOI 10.1111/j.1365-2435.2009.01646.x; Smith S.M., 1991, BLACK CAPPED CHICKAD; Swanson DL, 2013, PHYSIOL BIOCHEM ZOOL, V86, P421, DOI 10.1086/671447; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P566, DOI 10.1086/316696; Swanson DL, 2001, J COMP PHYSIOL B, V171, P475, DOI 10.1007/s003600100197; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; WALSBERG GE, 1995, J EXP BIOL, V198, P1499; WEBSTER MD, 1987, J COMP PHYSIOL B, V157, P253, DOI 10.1007/BF00692370; Williams JB, 2000, J EXP BIOL, V203, P3153; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Wolf BO, 1996, ECOLOGY, V77, P2228, DOI 10.2307/2265716; Zhao ZJ, 2010, J THERM BIOL, V35, P401, DOI 10.1016/j.jtherbio.2010.08.005; Zheng WH, 2008, COMP BIOCHEM PHYS A, V151, P519, DOI 10.1016/j.cbpa.2008.07.009; Zuur Alain F., 2009, P1	61	28	28	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113617	10.1371/journal.pone.0113617	http://dx.doi.org/10.1371/journal.pone.0113617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426860	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400068
J	Venkataraman, K; Khoo, C; Wee, HL; Tan, CS; Ma, S; Heng, D; Lee, J; Tai, ES; Thumboo, J				Venkataraman, Kavita; Khoo, ChinMeng; Wee, Hwee Lin; Tan, Chuen Seng; Ma, Stefan; Heng, Derrick; Lee, Jeannette; Tai, E. Shyong; Thumboo, Julian			Associations between Disease Awareness and Health-Related Quality of Life in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; DIABETIC-RETINOPATHY; CARDIOVASCULAR RISK; FOOT ULCERATION; SINGAPORE; HYPERTENSION; PREVALENCE; INDIVIDUALS	Background: Health related quality of life (HRQoL) is an important dimension of individuals' well-being, and especially in chronic diseases like diabetes and hypertension. The objective of this study was to evaluate the contributions of disease process, comorbidities, medication or awareness of the disease to HRQoL in diabetes mellitus, hypertension and dyslipidemia. Methods: This was a cross-sectional study of 3514 respondents from the general community in Singapore, assessed for HRQoL, disease and comorbid conditions through self-report, clinical and laboratory investigations. HRQoL was assessed using SF-36 health survey version 2. For each condition, participants were categorized as having 1) no disease, 2) undiagnosed, 3) diagnosed, not taking medication, and 4) diagnosed, taking medication. Analysis used one-way ANOVA and multiple linear regression. Results: Diagnosed disease was associated with lower physical health component summary (PCS) scores across all three conditions. After adjustment for comorbidities, this association remained significant only for those not on medication in diabetes (-2.7 +/- 1.2 points, p=0.03) and dyslipidemia (-1.3 +/- 0.4 points, p=0.003). Diagnosed hypertension (no medication -2.6 +/- 0.9 points, p=0.002; medication -1.4 +/- 0.5 points, p=0.004) and dyslipidemia (no medication -0.9 +/- 0.4 points, p=0.03; medication -1.9 +/- 0.5 points, p<0.001) were associated with lower mental health component summary (MCS) scores. Undiagnosed disease was associated with higher MCS in diabetes (2.4 +/- 1.0 points, p=0.01) and dyslipidemia (0.8 +/- 0.4 points, p=0.045), and PCS in hypertension (1.2 +/- 0.4 points, p=0.004). Conclusions: Disease awareness was associated with lower HRQoL across the diseases studied, with PCS associations partially mediated by comorbidities. Equally importantly, undiagnosed disease was not associated with HRQoL deficits, which may partly explain why these individuals do not seek medical care.	[Venkataraman, Kavita; Tan, Chuen Seng; Lee, Jeannette] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Venkataraman, Kavita; Khoo, ChinMeng; Tan, Chuen Seng; Lee, Jeannette; Tai, E. Shyong; Thumboo, Julian] Natl Univ Hlth Syst, Singapore, Singapore; [Khoo, ChinMeng; Tai, E. Shyong; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore; [Wee, Hwee Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wee, Hwee Lin; Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Ma, Stefan; Heng, Derrick] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Ministry of Health-Singapore	Thumboo, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore.	julian.thumboo@sgh.com.sg	Tan, Chuen Seng/K-1078-2013; Wee, Hwee Lin/D-4126-2012; Khoo, Chin Meng/AAD-8790-2022; Venkataraman, Kavita/Q-8956-2019; Tan, Chuen Seng/I-6854-2019	Tan, Chuen Seng/0000-0002-6513-2309; Wee, Hwee Lin/0000-0002-7150-1801; Venkataraman, Kavita/0000-0002-3139-6998; Tan, Chuen Seng/0000-0002-6513-2309; Tai, E Shyong/0000-0003-2929-8966	National Medical Research Council, Singapore [0838/2004, IRG07nov013, NMRC/0863/2004]; Biomedical Research Council [03/1/27/18/216, 08/1/35/19/550]; Diabetes Research Fund, National University of Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Diabetes Research Fund, National University of Singapore(National University of Singapore)	This work was supported by grants from the National Medical Research Council, Singapore (Grant numbers: 0838/2004, IRG07nov013, and NMRC/0863/2004); the Biomedical Research Council (Grant numbers: 03/1/27/18/216 and 08/1/35/19/550) and the Diabetes Research Fund, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2005, NATL HLTH SURVEY 200; [Anonymous], 2011, NATL HLTH SURVEY 201; Carlsson CM, 2002, DRUG AGING, V19, P793, DOI 10.2165/00002512-200219100-00008; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P7586, DOI 10.1167/iovs.11-7698; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; DOWNS JR, 1993, JAMA-J AM MED ASSOC, V269, P3107, DOI 10.1001/jama.269.24.3107; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022; Einvik G, 2010, J PSYCHOSOM RES, V68, P567, DOI 10.1016/j.jpsychores.2009.11.004; Evans MA, 2009, PHARMACOTHERAPY, V29, P800, DOI 10.1592/phco.29.7.800; Heyworth ITM, 2009, BRIT J GEN PRACT, V59, P833, DOI 10.3399/bjgp09X453990; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P29, DOI 10.1136/jech.44.1.29; Korhonen PE, 2011, J HYPERTENS, V29, P2070, DOI 10.1097/HJH.0b013e32834bbca7; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Mo Health, 2011, SCREENING CARDIOVASC; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Poljicanin T, BMC PUBLIC HLTH, V10, P12; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Stein J D, 2002, J Clin Hypertens (Greenwich), V4, P181, DOI 10.1111/j.1524-6175.2002.00970.x; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; TESTA MA, 1993, NEW ENGL J MED, V328, P907, DOI 10.1056/NEJM199304013281302; Thumboo J, 1999, LUPUS, V8, P514, DOI 10.1191/096120399678840747; Thumboo J, 2013, QUAL LIFE RES, V22, P2501, DOI 10.1007/s11136-013-0381-1; Trevisol DJ, 2012, J HUM HYPERTENS, V26, P374, DOI 10.1038/jhh.2011.48; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; Vathesatogkit P, PLOS ONE, V7; Venkataraman K, 2013, CLIN ENDOCRINOL, V78, P865, DOI 10.1111/j.1365-2265.2012.04480.x; Ware J, 2007, USERS MANUAL SF36V2; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557	41	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113802	10.1371/journal.pone.0113802	http://dx.doi.org/10.1371/journal.pone.0113802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426951	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400087
J	Blanchet, L; Grefte, S; Smeitink, JAM; Willems, PHGM; Koopman, WJH				Blanchet, Lionel; Grefte, Sander; Smeitink, Jan A. M.; Willems, Peter H. G. M.; Koopman, Werner J. H.			Photo-Induction and Automated Quantification of Reversible Mitochondrial Permeability Transition Pore Opening in Primary Mouse Myotubes	PLOS ONE			English	Article							CA-2&-INDUCED MEMBRANE TRANSITION; ATP-SYNTHASE; CELL-DEATH; INTACT-CELLS; C-SUBUNIT; FLUORESCENCE; APOPTOSIS; RELEASE; CALCEIN; IMAGES	Opening of the mitochondrial permeability transition pore (mPTP) is involved in various cellular processes including apoptosis induction. Two distinct states of mPTP opening have been identified allowing the transfer of molecules with a molecular weight <1500 Da or <300 Da. The latter state is considered to be reversible and suggested to play a role in normal cell physiology. Here we present a strategy combining live-cell imaging and computer-assisted image processing allowing spatial visualization and quantitative analysis of reversible mPTP openings ("Delta Psi flickering") in primary mouse myotubes. The latter were stained with the photosensitive cation TMRM, which partitions between the cytosol and mitochondrial matrix as a function of mitochondrial membrane potential (Delta Psi). Controlled illumination of TMRM-stained primary mouse myotubes induced DY flickering in particular parts of the cell ("flickering domains"). A novel quantitative automated analysis was developed and validated to detect and quantify the frequency, size, and location of individual DY flickering events in myotubes.	[Blanchet, Lionel; Grefte, Sander; Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Dept Biochem, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Blanchet, Lionel] Radboud Univ Nijmegen, Inst Mol & Mat Analyt Chem Chemometr, NL-6525 ED Nijmegen, Netherlands; [Blanchet, Lionel; Grefte, Sander; Willems, Peter H. G. M.; Koopman, Werner J. H.] Radboud Univ Nijmegen, Ctr Syst Biol & Bioenerget, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Smeitink, Jan A. M.] Radboud Univ Nijmegen, Dept Paediat, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Koopman, WJH (corresponding author), Radboud Univ Nijmegen, Dept Biochem, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	w.koopman@ncmls.ru.nl	Smeitink, Jan/C-1351-2013; Blanchet, Lionel/H-3150-2019; Koopman, Werner J.H./AAC-9668-2020; Willems, P.H.G.M./L-4759-2015; Blanchet, Lionel/C-8829-2011; Koopman, Werner J.H./D-3592-2009	Blanchet, Lionel/0000-0003-2284-8101; Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Blanchet, Lionel/0000-0003-2284-8101; Koopman, Werner J.H./0000-0002-5340-6747	Netherlands Organization for Scientific Research (NWO) [911-02-008]; NWO Centres for Systems Biology Research initiative [CSBR09/013V]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Centres for Systems Biology Research initiative	This research was supported by an equipment grant from the Netherlands Organization for Scientific Research (NWO, No: 911-02-008) and the NWO Centres for Systems Biology Research initiative (CSBR09/013V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Blattner JR, 2001, ANAL BIOCHEM, V295, P220, DOI 10.1006/abio.2001.5219; Blinova K, 2004, J MICROSC-OXFORD, V213, P70, DOI 10.1111/j.1365-2818.2004.01278.x; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jacobson J, 2002, J CELL SCI, V115, P1175; Jones RA, 2002, EUR J BIOCHEM, V269, P3990, DOI 10.1046/j.1432-1033.2002.03087.x; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Nogueira V, 2005, J BIOENERG BIOMEMBR, V37, P25, DOI 10.1007/s10863-005-4120-3; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Petrat F, 2003, ARCH BIOCHEM BIOPHYS, V412, P207, DOI 10.1016/S0003-9861(03)00063-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Ward MW, 2000, J NEUROSCI, V20, P7208	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e114090	10.1371/journal.pone.0114090	http://dx.doi.org/10.1371/journal.pone.0114090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423172	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700087
J	Dai, YE; Tang, LJ; Healy, J; Sinnett, D				Dai, Yue-e; Tang, Linjun; Healy, Jasmine; Sinnett, Daniel			Contribution of Polymorphisms in IKZF1 Gene to Childhood Acute Leukemia: A Meta-Analysis of 33 Case-Control Studies	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SUSCEPTIBILITY LOCI; ASSOCIATION; ARID5B; VARIANTS; RISK; 10Q21.2; 7P12.2; IKAROS; POPULATION	Objective: Two common polymorphisms in the IKZF1 gene (rs4132601 and rs11978267 variants) have been reported to be associated with childhood acute leukemia (AL) risk, however the results were inconsistent. Here, we conducted a meta-analysis to generate large-scale evidence on whether IKZF1 variants are risk factors for childhood AL. Methods: The PubMed, Embase, EBSCO, and Web of Science were searched up to June 2, 2014 for studies on the association of IKZF1 polymorphisms with childhood AL risk. Data were extracted and the odd ratios (ORs) and95% confidence intervals (95% CIs) were calculated by a fixed-effects orrandom-effects model. Subgroup analysis by ethnicity and leukemia subtype, sensitivity and cumulative meta-analyses were performed. Moreover, publication bias was assessed by Begg's and Egger's tests. Results: In total, 33 case control studies were finally included in this meta-analysis. For rs4132601 polymorphism, significantly increased AL risk was observed in all genetic models (the association was still significant when the p value was Bonferroni adjusted to 0.025). In the subgroup analysis by tumor type, statistical association was observed in B-cell precursor ALL (BCP-ALL). Additionally, when stratified by ethnicity, significantly increased AL risk was only observed in European subgroup, but not among African or mixed population subgroups. Finally, similar results were found forrs11978267 polymorphism. Conclusion: In summary, this meta-analysis provides evidence that rs4132601 and rs11978267 polymorphisms in the IKZF1 gene mightcontribute to the occurrence of BCP-ALL, especially in European populations. Moreover, further studies with large sample size are required to clarify possibleroles of IKZF1 variants in other ethnic groups (e. g., Asians and Africans).	[Dai, Yue-e] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Tang, Linjun] Tongling Peoples Hosp, Dept Neurosurg, Tongling, Anhui, Peoples R China; [Healy, Jasmine; Sinnett, Daniel] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Sinnett, Daniel] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Nanjing Medical University; Universite de Montreal; Universite de Montreal	Dai, YE (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.	yueedai@163.com	sinnett, daniel/S-4589-2017	sinnett, daniel/0000-0003-3625-6676				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Emerenciano M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-127; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves M, 1999, EUR J CANCER, V35, P173, DOI 10.1016/S0959-8049(98)00433-X; GREAVES MF, 1988, LEUKEMIA, V2, P120; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Healy J, 2010, HAEMATOL-HEMATOL J, V95, P1608, DOI 10.3324/haematol.2010.022459; Huy NT, 2010, CRIT CARE, V14, DOI 10.1186/cc9268; Jackson D, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-103; Kersey JH, 1997, BLOOD, V90, P4243, DOI 10.1182/blood.V90.11.4243.4243_4243_4251; Lautner-Csorba O, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-42; Lin CY, 2014, BLOOD CELL MOL DIS, V52, P140, DOI 10.1016/j.bcmd.2013.10.003; Linabery AM, 2013, LEUKEMIA RES, V37, P936, DOI 10.1016/j.leukres.2013.04.022; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; McNeil DE, 2002, MED PEDIATR ONCOL, V39, P554, DOI 10.1002/mpo.10161; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2000, CURR OPIN ONCOL, V12, P3, DOI 10.1097/00001622-200001000-00002; Ross JA, 2013, PEDIATR BLOOD CANCER, V60, P31, DOI 10.1002/pbc.24131; Rudant J, 2013, LEUKEMIA, V27, P746, DOI 10.1038/leu.2012.244; Stiller CA, 1996, BRIT MED BULL, V52, P682; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vijayakrishnan J, 2010, LEUKEMIA LYMPHOMA, V51, P1870, DOI 10.3109/10428194.2010.511356; Wang YP, 2013, GENE, V524, P203, DOI 10.1016/j.gene.2013.04.028; Wu JJ, 2012, CLIN CANCER RES, V18, P3972, DOI 10.1158/1078-0432.CCR-11-1531; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Yang YL, 2011, CANCER SCI, V102, P1874, DOI 10.1111/j.1349-7006.2011.02031.x; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113748	10.1371/journal.pone.0113748	http://dx.doi.org/10.1371/journal.pone.0113748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423013	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700061
J	Espel, EV; Glynn, LM; Sandman, CA; Davis, EP				Espel, Emma V.; Glynn, Laura M.; Sandman, Curt A.; Davis, Elysia Poggi			Longer Gestation among Children Born Full Term Influences Cognitive and Motor Development	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; LAST MENSTRUAL PERIOD; LATE-PRETERM; MATERNAL CORTISOL; BRAIN; PREGNANCY; AGE; EXPOSURE; RISK; ABNORMALITIES	Children born preterm show persisting impairments in cognitive functioning, school achievement, and brain development. Most research has focused on implications of birth prior to 37 gestational weeks; however, the fetal central nervous system continues to make fundamental changes throughout gestation. Longer gestation is associated with reduced morbidity and mortality even among infants born during the period clinically defined as full term (37-41 gestational weeks). The implications of shortened gestation among term infants for neurodevelopment are poorly understood. The present study prospectively evaluates 232 mothers and their full term infants (50.4% male infants) at three time points across the first postnatal year. We evaluate the association between gestational length and cognitive and motor development. Infants included in the study were full term (born between 37 and 41 weeks gestation). The present study uses the combination of Last Menstrual Period (LMP) and early ultrasound for accurate gestational dating. Hierarchical Linear Regression analyses revealed that longer gestational length is associated with higher scores on the Bayley scales of mental and motor development at 3, 6 and 12 months of age after considering socio-demographic, pregnancy, and infant-level covariates. Findings were identical using revised categories of early, term, and late term proposed by the Working Group for Defining Term Pregnancy. Our findings indicate that longer gestation, even among term infants, benefits both cognitive and motor development.	[Espel, Emma V.; Davis, Elysia Poggi] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Glynn, Laura M.] Chapman Univ, Crean Coll Hlth & Behav Sci, Dept Psychol, Orange, CA USA; [Sandman, Curt A.; Davis, Elysia Poggi] Univ Calif Irvine, Coll Med, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of Denver; Chapman University System; Chapman University; University of California System; University of California Irvine	Davis, EP (corresponding author), Univ Denver, Dept Psychol, Denver, CO 80208 USA.	Elysia.Davis@du.edu	Espel, Emma/AAH-5968-2020	Davis, Elysia/0000-0001-6345-9271	National Institute of Child Health and Human Development [HD-50662, HD-65823, HD-51852, HD-40967]; National Institute of Neurological Disorders and Stroke [NS-41298]; National Institute of Mental Health Silvio O. Conte Center [MH096889]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065823] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051852, R01HD040967, R01HD050662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041298] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health Silvio O. Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Child Health and Human Development awards HD-50662 and HD-65823 to Elysia Poggi Davis, HD-51852 to Curt A. Sandman and HD-40967 to Laura M. Glynn, National Institute of Neurological Disorders and Stroke award NS-41298 to Curt A Sandman, and a National Institute of Mental Health Silvio O. Conte Center award MH096889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman I, 2006, CLIN PERINATOL, V33, P947, DOI 10.1016/j.clp.2006.09.004; Bayley N, 1993, BAYLEY SCALES INFANT; Bourgeois JP, 1997, ACTA PAEDIATR, V86, P27; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Class Quetzal A, 2008, Dev Neurosci, V30, P419, DOI 10.1159/000191213; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00001; Davis EP, 2005, DEV NEUROSCI-BASEL, V27, P299, DOI 10.1159/000086709; Engle WA, 2011, CLIN PERINATOL, V38, P493, DOI 10.1016/j.clp.2011.06.009; Glynn LM, 2012, DEVELOPMENTAL SCI, V15, P601, DOI 10.1111/j.1467-7687.2012.01159.x; Glynn LM, 2011, CURR DIR PSYCHOL SCI, V20, P384, DOI 10.1177/0963721411422056; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Huppi PS, 1998, PEDIATR RES, V44, P584; Kaufman AS, 2014, ENVIRON RES, V132, P413, DOI 10.1016/j.envres.2014.04.015; Kim DJ, 2014, NEUROIMAGE, V100, P619, DOI 10.1016/j.neuroimage.2014.06.048; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; MacDorman MF, 2012, NATL VITAL STAT REP, P60; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; Melbourne A, 2014, NEUROIMAGE, V89, P23, DOI 10.1016/j.neuroimage.2013.11.048; Murthy K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.023; Noble KG, 2012, PEDIATRICS, V130, pE257, DOI 10.1542/peds.2011-2157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Phua DYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036502; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Rose O, 2013, PEDIATRICS, V131, pE1475, DOI 10.1542/peds.2012-3215; Ruth CA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-62; Sandman CA, 2012, NEUROENDOCRINOLOGY, V95, P7, DOI DOI 10.1159/000327017; Sandman CA, 2006, PEPTIDES, V27, P1457, DOI 10.1016/j.peptides.2005.10.002; Sandman CA, 2012, EXPERT REV ENDOCRINO, V7, P445, DOI 10.1586/EEM.12.33; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235; Taipale P, 2001, OBSTET GYNECOL, V97, P189, DOI 10.1016/S0029-7844(00)01131-5; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; Yang SM, 2010, INT J EPIDEMIOL, V39, P1240, DOI 10.1093/ije/dyq070; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	40	37	37	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113758	10.1371/journal.pone.0113758	http://dx.doi.org/10.1371/journal.pone.0113758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423150	Green Published, gold			2022-12-27	WOS:000345899700063
J	Yamada, H; Kikuchi, S; Inui, T; Takahashi, H; Kimura, K				Yamada, Hidetoshi; Kikuchi, Sayaka; Inui, Tomoki; Takahashi, Hideyuki; Kimura, Ken-ichi			Gentiolactone, a Secoiridoid Dilactone from Gentiana triflora, Inhibits TNF-alpha, iNOS and Cox-2 mRNA Expression and Blocks NF-kappa B Promoter Activity in Murine Macrophages	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATION; ATHEROSCLEROSIS; INNATE; RATS	Background: Gentian roots have been used as a herbal medicine because of their anti-inflammatory activities. However, the molecular mechanisms of these anti-inflammatory effects remain to be completely explained. Methods and Findings: Here, we investigated anti-inflammatory effects of gentian roots and showed that root extracts from Gentiana triflora inhibited lipopolysaccharide (LPS)-induced expression of TNF-alpha in RAW264.7 cells. The extracts also contained swertiamarin and gentiopicroside, which are the major active compounds of gentian roots; however, neither compound had any effect on LPS-induced TNF-alpha production in our test system. We isolated gentiolactone as an inhibitor of TNF-alpha production from the extracts. Gentiolactone also inhibited LPS-induced inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (Cox-2) expression at the mRNA level. Moreover, gentiolactone suppressed NF-kappa B transcriptional activity without inhibition of IkB degradation or NF-kappa B nuclear transport. Conclusions: Our results indicate that inhibition of TNF-alpha, iNOS and Cox-2 expression by gentiolactone is one of the mechanisms of the anti-inflammatory properties of gentian roots.	[Yamada, Hidetoshi; Kikuchi, Sayaka; Takahashi, Hideyuki] Iwate Biotechnol Res Ctr, Dept Bioresource Sci, Kitakami, Iwate, Japan; [Inui, Tomoki; Kimura, Ken-ichi] Iwate Univ, Grad Sch Agr, Morioka, Iwate 020, Japan	Iwate Biotechnology Research Center; Iwate University	Yamada, H (corresponding author), Iwate Biotechnol Res Ctr, Dept Bioresource Sci, Kitakami, Iwate, Japan.	hyamada@ibrc.or.jp	Takahashi, Hideyuki/V-6943-2018	Takahashi, Hideyuki/0000-0002-2265-5353	Basic Biotechnology Project of Iwate Prefecture, Japan; Adaptable and Seamless Technology Transfer Program through Target (A-STEP) [241FT0403]	Basic Biotechnology Project of Iwate Prefecture, Japan; Adaptable and Seamless Technology Transfer Program through Target (A-STEP)	This work was supported by a fund from the Basic Biotechnology Project of Iwate Prefecture, Japan, and the Adaptable and Seamless Technology Transfer Program through Target (A-STEP, 241FT0403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberham A, 2007, J PHARMACEUT BIOMED, V45, P437, DOI 10.1016/j.jpba.2007.07.001; AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Feldmann M, 1997, ADV IMMUNOL, V64, P283, DOI 10.1016/S0065-2776(08)60891-3; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; HALL IH, 1980, J PHARM SCI, V69, P537, DOI 10.1002/jps.2600690516; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kataoka T, 2009, J ANTIBIOT, V62, P655, DOI 10.1038/ja.2009.98; Kim TH, 2012, MOL MED, V18, P455, DOI 10.2119/molmed.2011.00308; Kwak WJ, 2005, BIOL PHARM BULL, V28, P750, DOI 10.1248/bpb.28.750; LEE KH, 1977, SCIENCE, V196, P533, DOI 10.1126/science.191909; Lian LH, 2010, CHEM-BIOL INTERACT, V188, P127, DOI 10.1016/j.cbi.2010.06.004; Liang XY, 2011, J ETHNOPHARMACOL, V134, P971, DOI 10.1016/j.jep.2011.02.008; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mehta JL, 1998, J AM COLL CARDIOL, V31, P1217, DOI 10.1016/S0735-1097(98)00093-X; Park KS, 2013, CYTOKINE, V62, P407, DOI 10.1016/j.cyto.2013.04.005; Park KS, 2010, EVID-BASED COMPL ALT, V7, P41, DOI 10.1093/ecam/nem129; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SUHR IH, 1978, PHYTOCHEMISTRY, V17, P135, DOI 10.1016/S0031-9422(00)89695-8; Vaidya HB, 2012, EXP CLIN CARDIOL, V17, P12; Vaidya H, 2009, J NAT MED-TOKYO, V63, P437, DOI 10.1007/s11418-009-0350-8; VANDERNAT J, 1982, PLANTA MED, V45, P161, DOI 10.1055/s-2007-971351; VANDERSLUIS WG, 1981, PLANTA MED, V42, P139, DOI 10.1055/s-2007-971611; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang SF, 2013, PLANTA MED, V79, P680, DOI 10.1055/s-0032-1328460; Yu FR, 2004, J ETHNOPHARMACOL, V95, P77, DOI 10.1016/j.jep.2004.06.025; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	29	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113834	10.1371/journal.pone.0113834	http://dx.doi.org/10.1371/journal.pone.0113834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423092	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700070
J	Carpanese, E; Moretto, P; Filpa, V; Marchet, S; Moro, E; Crema, F; Frigo, G; Giaroni, C				Carpanese, Elisa; Moretto, Paola; Filpa, Viviana; Marchet, Silvia; Moro, Elisabetta; Crema, Francesca; Frigo, Gianmario; Giaroni, Cristina			Antagonism of Ionotropic Glutamate Receptors Attenuates Chemical Ischemia-Induced Injury in Rat Primary Cultured Myenteric Ganglia	PLOS ONE			English	Article							GUINEA-PIG ILEUM; INTESTINAL ISCHEMIA; ROS GENERATION; NMDA RECEPTORS; CA2+ OVERLOAD; NEURONS; OXYGEN; HYPOXIA; ISCHEMIA/REPERFUSION; MODULATION	Alterations of the enteric glutamatergic transmission may underlay changes in the function of myenteric neurons following intestinal ischemia and reperfusion (I/R) contributing to impairment of gastrointestinal motility occurring in these pathological conditions. The aim of the present study was to evaluate whether glutamate receptors of the NMDA and AMPA/kainate type are involved in myenteric neuron cell damage induced by I/R. Primary cultured rat myenteric ganglia were exposed to sodium azide and glucose deprivation (in vitro chemical ischemia). After 6 days of culture, immunoreactivity for NMDA, AMPA and kainate receptors subunits, GluN1 and GluA(1-4), GluK(1-3) respectively, was found in myenteric neurons. In myenteric cultured ganglia, in normal metabolic conditions, -AP5, an NMDA antagonist, decreased myenteric neuron number and viability, determined by calcein AM/ethidium homodimer-1 assay, and increased reactive oxygen species (ROS) levels, measured with hydroxyphenyl fluorescein. CNQX, an AMPA/kainate antagonist exerted an opposite action on the same parameters. The total number and viability of myenteric neurons significantly decreased after I/R. In these conditions, the number of neurons staining for GluN(1) and GluA(1-4) subunits remained unchanged, while, the number of GluK(1-3)-immunopositive neurons increased. After I/R, -AP5 and CNQX, concentration-dependently increased myenteric neuron number and significantly increased the number of living neurons. Both -AP5 and CNQX (100-500 mM) decreased I/R-induced increase of ROS levels in myenteric ganglia. On the whole, the present data provide evidence that, under normal metabolic conditions, the enteric glutamatergic system exerts a dualistic effect on cultured myenteric ganglia, either by improving or reducing neuron survival via NMDA or AMPA/kainate receptor activation, respectively. However, blockade of both receptor pathways may exert a protective role on myenteric neurons following and I/R damage. The neuroprotective effect may depend, at least in part, on the ability of both receptors to increase intraneuronal ROS production.	[Carpanese, Elisa; Filpa, Viviana; Marchet, Silvia; Giaroni, Cristina] Univ Insubria, Dept Clin & Expt Med, Varese, Italy; [Moretto, Paola] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Moro, Elisabetta; Crema, Francesca; Frigo, Gianmario] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy	University of Insubria; University of Insubria; University of Pavia	Giaroni, C (corresponding author), Univ Insubria, Dept Clin & Expt Med, Varese, Italy.	cristina.giaroni@uninsubria.it	MARCHET, SILVIA/AAF-5898-2021; giaroni, cristina/A-8181-2011	MARCHET, SILVIA/0000-0002-7858-3256; GIARONI, CRISTINA/0000-0002-3760-3441	Italian Ministry of Research and University (PRIN); University of Insubria; University of Pavia	Italian Ministry of Research and University (PRIN)(Ministry of Education, Universities and Research (MIUR)); University of Insubria; University of Pavia	The study was supported with grants from the Italian Ministry of Research and University (PRIN 2008) and from grants from the University of Insubria and of Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the change.	Ballabeni V, 2002, LIFE SCI, V71, P2025, DOI 10.1016/S0024-3205(02)01966-5; Bielefeldt K, 1997, DIGEST DIS SCI, V42, P878, DOI 10.1023/A:1018899927786; BURGOYNE RD, 1993, J NEUROCYTOL, V22, P689, DOI 10.1007/BF01181314; Calcina F, 2005, NEUROSCIENCE, V134, P39, DOI 10.1016/j.neuroscience.2005.03.052; Carriedo SG, 2000, J NEUROSCI, V20, P240, DOI 10.1523/JNEUROSCI.20-01-00240.2000; Carriedo SG, 1998, J NEUROSCI, V18, P7727; Giaroni C, 2013, NEUROGASTROENT MOTIL, V25, pE114, DOI 10.1111/nmo.12061; Giaroni C, 2011, NEUROGASTROENT MOTIL, V23, pe91, DOI 10.1111/j.1365-2982.2010.01644.x; Giaroni C, 2003, EUR J PHARMACOL, V476, P63, DOI 10.1016/S0014-2999(03)02147-2; Giuliani D, 2006, NEUROCHEM INT, V48, P191, DOI 10.1016/j.neuint.2005.10.005; Grammatopoulos TN, 2004, NEUROSCI RES, V50, P299, DOI 10.1016/j.neures.2004.07.010; Haglund U, 1999, LANGENBECK ARCH SURG, V384, P233, DOI 10.1007/s004230050197; HANANI M, 1994, NEUROGASTROENT MOTIL, V6, P103; He Z, 2009, EUR J PHARMACOL, V603, P50, DOI 10.1016/j.ejphar.2008.12.010; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; IWASAKI Y, 1995, J NEUROL SCI, V134, P21, DOI 10.1016/0022-510X(95)00217-6; Jorgensen NK, 1999, J NEUROSCI RES, V56, P358; Kirchgessner AL, 1997, J NEUROSCI, V17, P8804; Kirchgessner Annette L., 2001, Current Opinion in Pharmacology, V1, P591, DOI 10.1016/S1471-4892(01)00101-1; Lau A, 2001, PFLUGERS ARCH, V460, P525; Lindestrom LM, 2004, DIGEST DIS SCI, V49, P1212, DOI 10.1023/B:DDAS.0000037815.63547.08; Liu MT, 1997, J NEUROSCI, V17, P4764; Marino S, 2007, NEUROTOXICOLOGY, V28, P622, DOI 10.1016/j.neuro.2007.01.005; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; Nowicki Philip T, 2005, Semin Pediatr Surg, V14, P152, DOI 10.1053/j.sempedsurg.2005.05.003; Pachernegg S, 2012, TRENDS NEUROSCI, V35, P240, DOI 10.1016/j.tins.2011.11.010; Radenovic L, 2004, BRAIN RES BULL, V64, P85, DOI 10.1016/j.brainresbull.2004.06.001; Rivera LR, 2009, ACTA NEUROPATHOL, V118, P261, DOI 10.1007/s00401-009-0549-5; Rivera LR, 2011, CELL TISSUE RES, V344, P111, DOI 10.1007/s00441-010-1126-x; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Selvatici R, 2009, NEUROCHEM RES, V34, P909, DOI 10.1007/s11064-008-9852-0; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Thompson JW, 2012, CURR NEUROPHARMACOL, V10, P354, DOI 10.2174/157015912804143577; Thomson ABR, 2001, DIGEST DIS SCI, V46, P2555, DOI 10.1023/A:1012782321827; Thornton M, 2002, INT J COLORECTAL DIS, V17, P287, DOI 10.1007/s00384-002-0408-5; Thrasivoulou C, 2006, AGING CELL, V5, P247, DOI 10.1111/j.1474-9726.2006.00214.x; Varming T, 1996, J NEUROSCI RES, V44, P40, DOI 10.1002/(SICI)1097-4547(19960401)44:1<40::AID-JNR5>3.0.CO;2-I; WEISS JH, 1994, NEUROSCIENCE, V60, P659, DOI 10.1016/0306-4522(94)90494-4	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113613	10.1371/journal.pone.0113613	http://dx.doi.org/10.1371/journal.pone.0113613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419700	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900058
J	Glass, N; Perrin, NA; Kohli, A; Remy, MM				Glass, Nancy; Perrin, Nancy A.; Kohli, Anjalee; Remy, Mitima Mpanano			Livestock/Animal Assets Buffer the Impact of Conflict-Related Traumatic Events on Mental Health Symptoms for Rural Women	PLOS ONE			English	Article							SEXUAL VIOLENCE; SOUTH KIVU; EASTERN; SURVIVORS; FAMILIES; CONGO	Background: In the context of multiple adversities, women are demonstrating resilience in rebuilding their futures, through participation in microfinance programs. In addition to the economic benefits of microfinance, there is evidence to suggest that it is an effective vehicle for improving health. Methods: The parent study is a community-based trial to evaluate the effectiveness of a livestock microfinance intervention, Pigs for Peace (PFP), on health and economic outcomes with households in 10 villages in eastern Democratic Republic of Congo. The analysis for this manuscript includes only baseline data from female participants enrolled in the ongoing parent study. Multiple regression analysis was used to examine if livestock/animal asset value moderates the relationship between conflict-related traumatic events and current mental health symptoms. Findings: The majority of women are 25 years or older, married, have on average 4 children in the home and have never attended school. Nearly 50% of women report having at least one livestock/animal asset at baseline. Over the past 10 years, women report on average more than 4 (M=4.31, SD 3.64) traumatic events (range 0-18). Women reported symptoms consistent with PTSD with a mean score of .2.30 (SD=0.66range 0-4) and depression with a mean score of 1.86 (SD = 0.49, range 0-3.47). The livestock/animal asset value by conflict-related traumatic events interaction was significant for both the PTSD (p=0.021) and depression (p=0.002) symptom models. Interpretation: The study provides evidence of the moderating affect of livestock/animal assets on mental health symptoms for women who have experienced conflict. The findings supports evidence about the importance of livestock/animal assets to economics in rural households but expands on previous research by demonstrating the psychosocial effects of these assets on women's health.	[Glass, Nancy; Kohli, Anjalee] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA; [Perrin, Nancy A.] Ctr Hlth Res, Portland, OR USA; [Remy, Mitima Mpanano] Programme Appui Initiat Econ PAIDEK, Bukavu, DEM REP CONGO	Johns Hopkins University	Glass, N (corresponding author), Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA.	nglass1@son.jhmi.edu		Glass, Nancy/0000-0002-6691-3684	National Institutes of Health/National Institute of Minority Health and Health Disparities (NIMHD) [R01MD006075]; National Institute on Minority Health and Health Disparities [R01MD006075] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Minority Health and Health Disparities (NIMHD); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study is funded by the National Institutes of Health/National Institute of Minority Health and Health Disparities (NIMHD, R01MD006075). The sponsors had no role in study design, data collection, analysis, interpretation, or writing this report.	Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Consortium for Improved Agriculture-based Livelihoods in Central Africa, 2008, FIN REP PHAS I CIALC; Cox TP, 2012, DISASTERS, V36, P233, DOI 10.1111/j.1467-7717.2011.01257.x; Cox TP, 2008, LAND CASUALTY SOIL C; Cyrulnik B, 2008, UNBROKEN SOUL TRAGED, P22; Garcia-Moreno C, 2005, WHO MULTI COUNTRY ST; Gertler P, 2009, HEALTH ECON, V18, P257, DOI 10.1002/hec.1372; Glass N, 2012, GLOB PUBLIC HEALTH, V7, P184, DOI 10.1080/17441692.2011.594449; Greeson JKP, 2013, J INTERPERSONAL VIOL; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580; Kohli A, 2012, FAMILY COMMUNITY REJ; Kohrt BA, 2012, BRIT J PSYCHIAT, V201, P268, DOI 10.1192/bjp.bp.111.096222; Leatherman S, 2011, HLTH POLICY PLANNING, P1; Maass BL, 2010, DIAGNOSTIC SURVEY LI; Maass BL, 2012, TROP ANIM HEALTH PRO, V44, P1221, DOI 10.1007/s11250-011-0061-5; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mupawaenda AC, 2009, TROP ANIM HLTH PROD, V41; Nanama S, 2012, SOC SCI MED, V74, P444, DOI 10.1016/j.socscimed.2011.11.009; Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34; Omba Kalonda J C, 2008, Med Trop (Mars), V68, P576; Onyut Lamaro P, 2009, Confl Health, V3, P6, DOI 10.1186/1752-1505-3-6; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roberts B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-7; Rossi L, 2006, PUBLIC HEALTH NUTR, V9, P551, DOI 10.1079/PHN2005928; Sabin M, 2003, JAMA-J AM MED ASSOC, V290, P635, DOI 10.1001/jama.290.5.635; Silove, 2004, MEASURING TRAUMA MEA; Verhoef HS, 2002, HDB APPL DEV SCI PRO; Wakabi W, 2008, LANCET, V372, P2011, DOI 10.1016/S0140-6736(08)61854-1; World Health Organization, 2011, MENT HLTH ATL 2011 D; Zozo R, 2010, REPORT PARTICIPATORY	35	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e111708	10.1371/journal.pone.0111708	http://dx.doi.org/10.1371/journal.pone.0111708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419743	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900002
J	Han, Z; Jin, L; Chen, FY; Loturco, JJ; Cohen, LB; Bondar, A; Lazar, J; Pieribone, VA				Han, Zhou; Jin, Lei; Chen, Fuyi; Loturco, Joseph J.; Cohen, Lawrence B.; Bondar, Alexey; Lazar, Josef; Pieribone, Vincent A.			Mechanistic Studies of the Genetically Encoded Fluorescent Protein Voltage Probe ArcLight	PLOS ONE			English	Article							OPTICAL ELECTROPHYSIOLOGY; ELECTRICAL-ACTIVITY; ACTION-POTENTIALS; SENSOR; NEURONS; PHOSPHATASE; SPIKING; CELLS; FRET	ArcLight, a genetically encoded fluorescent protein voltage probe with a large Delta F/Delta V, is a fusion between the voltage sensing domain of the Ciona instestinalis voltage sensitive phosphatase and super ecliptic pHluorin carrying a single mutation (A227D in the fluorescent protein). Without this mutation the probe produces only a very small change in fluorescence in response to voltage deflections (similar to 1%). The large signal afforded by this mutation allows optical detection of action potentials and sub-threshold electrical events in single-trials in vitro and in vivo. However, it is unclear how this single mutation produces a probe with such a large modulation of its fluorescence output with changes in membrane potential. In this study, we identified which residues in super ecliptic pHluorin (vs eGFP) are critical for the ArcLight response, as a similarly constructed probe based on eGFP also exhibits large response amplitude if it carries these critical residues. We found that D147 is responsible for determining the pH sensitivity of the fluorescent protein used in these probes but by itself does not result in a voltage probe with a large signal. We also provide evidence that the voltage dependent signal of ArcLight is not simply sensing environmental pH changes. A two-photon polarization microscopy study showed that ArcLight's response to changes in membrane potential includes a reorientation of the super ecliptic pHluorin. We also explored different changes including modification of linker length, deletion of nonessential amino acids in the super ecliptic pHluorin, adding a farnesylation site, using tandem fluorescent proteins and other pH sensitive fluorescent proteins.	[Han, Zhou; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT 06519 USA; [Han, Zhou; Jin, Lei; Cohen, Lawrence B.; Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Chen, Fuyi; Loturco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Cohen, Lawrence B.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Bondar, Alexey; Lazar, Josef] Acad Sci Czech Republic, Inst Nanobiol & Struct Biol GCRC, Nove Hrady, Czech Republic; [Bondar, Alexey; Lazar, Josef] Univ South Bohemia, Dept Mol Biol, Ceske Budejovice, Czech Republic; [Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; University of Connecticut; Korea Institute of Science & Technology (KIST); Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Yale University	Pieribone, VA (corresponding author), John B Pierce Lab Inc, New Haven, CT 06519 USA.	vpieribo@jbpierce.org	Bondar, Alexey/G-9459-2014; Lazar, Josef/AAI-7246-2020; Lazar, Josef/H-7487-2014; Lazar, Josef/D-8523-2012	Bondar, Alexey/0000-0002-1980-2930; Lazar, Josef/0000-0002-6285-3995; Pieribone, Vincent/0000-0002-5836-5454; Lazar, Josef/0000-0002-8579-8589	National Institutes of Health [U24NS057631, DC005259-43, ARRA U24NS057631-03S1, ARRA-R01NS065110, R01NS083875]; World Class Institute program of the National Research Foundation of Korea [WCI 2009-003]; Czech Republic Science Foundation [P205/13-10799S]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631, R01NS065110, U01NS090565, R01NS083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005259, R01DC005259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); Czech Republic Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (U24NS057631, DC005259-43, ARRA U24NS057631-03S1, ARRA-R01NS065110 and R01NS083875), the World Class Institute program of the National Research Foundation of Korea, Grant Number: WCI 2009-003, and the Czech Republic Science Foundation grant P205/13-10799S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Han Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081295; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jin L, 2011, J NEUROSCI METH, V199, P1, DOI 10.1016/j.jneumeth.2011.03.028; Johansson MK, 2002, J AM CHEM SOC, V124, P6950, DOI 10.1021/ja025678o; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	23	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113873	10.1371/journal.pone.0113873	http://dx.doi.org/10.1371/journal.pone.0113873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419571	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900077
J	Porto-Neto, LR; Reverter, A; Prayaga, KC; Chan, EKF; Johnston, DJ; Hawken, RJ; Fordyce, G; Garcia, JF; Sonstegard, TS; Bolormaa, S; Goddard, ME; Burrow, HM; Henshall, JM; Lehnert, SA; Barendse, W				Porto-Neto, Laercio R.; Reverter, Antonio; Prayaga, Kishore C.; Chan, Eva K. F.; Johnston, David J.; Hawken, Rachel J.; Fordyce, Geoffry; Garcia, Jose Fernando; Sonstegard, Tad S.; Bolormaa, Sunduimijid; Goddard, Michael E.; Burrow, Heather M.; Henshall, John M.; Lehnert, Sigrid A.; Barendse, William			The Genetic Architecture of Climatic Adaptation of Tropical Cattle	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; BOVINE SKELETAL-MUSCLE; BEEF-CATTLE; BOOPHILUS-MICROPLUS; BOS-TAURUS; NORTHERN AUSTRALIA; WIDE ASSOCIATION; ADAPTIVE TRAITS; BREEDS; GENOTYPES	Adaptation of global food systems to climate change is essential to feed the world. Tropical cattle production, a mainstay of profitability for farmers in the developing world, is dominated by heat, lack of water, poor quality feedstuffs, parasites, and tropical diseases. In these systems European cattle suffer significant stock loss, and the cross breeding of taurine x indicine cattle is unpredictable due to the dilution of adaptation to heat and tropical diseases. We explored the genetic architecture of ten traits of tropical cattle production using genome wide association studies of 4,662 animals varying from 0% to 100% indicine. We show that nine of the ten have genetic architectures that include genes of major effect, and in one case, a single location that accounted for more than 71% of the genetic variation. One genetic region in particular had effects on parasite resistance, yearling weight, body condition score, coat colour and penile sheath score. This region, extending 20 Mb on BTA5, appeared to be under genetic selection possibly through maintenance of haplotypes by breeders. We found that the amount of genetic variation and the genetic correlations between traits did not depend upon the degree of indicine content in the animals. Climate change is expected to expand some conditions of the tropics to more temperate environments, which may impact negatively on global livestock health and production. Our results point to several important genes that have large effects on adaptation that could be introduced into more temperate cattle without detrimental effects on productivity.	[Porto-Neto, Laercio R.; Reverter, Antonio; Henshall, John M.; Lehnert, Sigrid A.] Queensland Biosci Precinct, CSIRO Food Futures Flagship, St Lucia, Qld, Australia; [Porto-Neto, Laercio R.; Reverter, Antonio; Burrow, Heather M.; Henshall, John M.; Lehnert, Sigrid A.; Barendse, William] Queensland Biosci Precinct, CSIRO Anim Food & Hlth Sci, St Lucia, Qld, Australia; [Prayaga, Kishore C.] Zoetis Inc, Parkville, Vic, Australia; [Chan, Eva K. F.] Garvan Inst Med Res, Sydney, NSW, Australia; [Johnston, David J.] Univ New England, Anim Genet & Breeding Unit, Armidale, NSW, Australia; [Hawken, Rachel J.] Cobb Vantress Inc, Siloam Springs, AZ USA; [Fordyce, Geoffry] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Sao Paulo, Brazil; [Sonstegard, Tad S.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Bolormaa, Sunduimijid; Goddard, Michael E.] Dept Primary Ind Victoria, Bundoora, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zoetis; Garvan Institute of Medical Research; University of New England; University of Queensland; Universidade Estadual Paulista; United States Department of Agriculture (USDA); Victorian Department of Environment & Primary Industries	Barendse, W (corresponding author), Queensland Biosci Precinct, CSIRO Anim Food & Hlth Sci, St Lucia, Qld, Australia.	bill.barendse@csiro.au	Lehnert, Sigrid A/A-3676-2013; Reverter, Antonio/C-9699-2013; Porto-Neto, Laercio R/D-2594-2012; Barendse, William J/D-8608-2011	Lehnert, Sigrid A/0000-0003-4891-9094; Reverter, Antonio/0000-0002-4681-9404; Porto-Neto, Laercio R/0000-0002-3536-8265; Barendse, William J/0000-0002-5464-0658; Goddard, Michael/0000-0001-9917-7946; Burrow, Heather/0000-0002-7989-0426; Chan, Eva/0000-0002-6104-3763	Cooperative Research Centre for Beef Genetic Technologies; Cooperative Research Centre for Cattle and Beef Quality; CSIRO through its Food Futures Flagship	Cooperative Research Centre for Beef Genetic Technologies(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centre for Cattle and Beef Quality(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); CSIRO through its Food Futures Flagship	The data collection was funded by the Cooperative Research Centre for Beef Genetic Technologies, the Cooperative Research Centre for Cattle and Beef Quality and their core partners. The Cooperative Research Centres have closed and funding for the analysis and write-up has come from non-specific funding from CSIRO through its Food Futures Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman J, 1982, AM BRAHMAN HIST AM B; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barwick SA, 2009, ANIM PROD SCI, V49, P367, DOI 10.1071/EA08273; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285; Bock RE, 1999, AUST VET J, V77, P461, DOI 10.1111/j.1751-0813.1999.tb12093.x; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burrow HM, 1998, LIVEST PROD SCI, V55, P227, DOI 10.1016/S0301-6226(98)00139-0; DAVIS GP, 1993, AUST J AGR RES, V44, P179, DOI 10.1071/AR9930179; Dobzhansky T, 1952, HETEROSIS; Falconer D. S., 1996, INTRO QUANTITATIVE G; FELIUS M, 1985, GENUS BOS CATTLE BRE; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; FRISCH JE, 1984, J AGR SCI, V103, P137, DOI 10.1017/S0021859600043409; FRISCH JE, 1977, ANIM PROD, V25, P343, DOI 10.1017/S0003356100016755; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Hawken RJ, 2012, J ANIM SCI, V90, P1398, DOI 10.2527/jas.2011-4410; Heffernan C, 2013, ANIMAL HLTH RES REV; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Mariasegaram M, 2007, ANIM GENET, V38, P54, DOI 10.1111/j.1365-2052.2007.01560.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MCLEAN RW, 1983, J AGR SCI, V101, P17, DOI 10.1017/S0021859600036315; Menjo D, 2009, TROP ANIM HEALTH PRO, V41, P171, DOI 10.1007/s11250-008-9172-z; Olson T, 1999, GENETICS OF CATTLE, P33; PEACOCK FM, 1981, J ANIM SCI, V52, P1007, DOI 10.2527/jas1981.5251007x; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Prayaga KC, 2009, ANIM PROD SCI, V49, P413, DOI 10.1071/EA08247; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; SANDERS JO, 1980, J ANIM SCI, V50, P1188, DOI 10.2527/jas1980.5061188x; SEIFERT GW, 1971, AUST J AGR RES, V22, P159, DOI 10.1071/AR9710159; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sutherst RW, 2006, AUST J AGR RES, V57, P743, DOI 10.1071/AR05265; Turner LB, 2010, ANIM PROD SCI, V50, P235, DOI 10.1071/AN09135; WHARTON RH, 1970, AUST J AGR RES, V21, P163, DOI 10.1071/AR9700163; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	49	77	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113284	10.1371/journal.pone.0113284	http://dx.doi.org/10.1371/journal.pone.0113284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419663	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900029
J	Wrede, D; Taha, M; Miranda, AF; Kadali, K; Stevenson, T; Ball, AS; Mouradov, A				Wrede, Digby; Taha, Mohamed; Miranda, Ana F.; Kadali, Krishna; Stevenson, Trevor; Ball, Andrew S.; Mouradov, Aidyn			Co-Cultivation of Fungal and Microalgal Cells as an Efficient System for Harvesting Microalgal Cells, Lipid Production and Wastewater Treatment	PLOS ONE			English	Article							FILAMENTOUS FUNGI; MARINE MICROALGAE; BIOFUEL PRODUCTION; OLEAGINOUS FUNGI; BIODIESEL; BIOMASS; ALGAE; FLOCCULATION; PELLETIZATION; CHLORELLA	The challenges which the large scale microalgal industry is facing are associated with the high cost of key operations such as harvesting, nutrient supply and oil extraction. The high-energy input for harvesting makes current commercial microalgal biodiesel production economically unfeasible and can account for up to 50% of the total cost of biofuel production. Co-cultivation of fungal and microalgal cells is getting increasing attention because of high efficiency of bio-flocculation of microalgal cells with no requirement for added chemicals and low energy inputs. Moreover, some fungal and microalgal strains are well known for their exceptional ability to purify wastewater, generating biomass that represents a renewable and sustainable feedstock for biofuel production. We have screened the flocculation efficiency of the filamentous fungus A. fumigatus against 11 microalgae representing freshwater, marine, small (5 mm), large (over 300 mm), heterotrophic, photoautotrophic, motile and non-motile strains. Some of the strains are commercially used for biofuel production. Lipid production and composition were analysed in fungal-algal pellets grown on media containing alternative carbon, nitrogen and phosphorus sources contained in wheat straw and swine wastewater, respectively. Co-cultivation of algae and A. fumigatus cells showed additive and synergistic effects on biomass production, lipid yield and wastewater bioremediation efficiency. Analysis of fungal-algal pellet's fatty acids composition suggested that it can be tailored and optimised through co-cultivating different algae and fungi without the need for genetic modification.	[Wrede, Digby; Taha, Mohamed; Miranda, Ana F.; Kadali, Krishna; Stevenson, Trevor; Ball, Andrew S.; Mouradov, Aidyn] RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia	Royal Melbourne Institute of Technology (RMIT)	Mouradov, A (corresponding author), RMIT Univ, Sch Appl Sci, Bundoora, Vic 3083, Australia.	aidyn.mouradov@rmit.edu.au	Ball, Andrew S/I-3389-2013; Miranda, Ana F/AAI-6109-2020	Miranda, Ana F/0000-0003-3941-975X; Ball, Andrew/0000-0003-2387-968X; Mouradov, Aidyn/0000-0003-2945-3751	School of Applied Sciences RMIT	School of Applied Sciences RMIT	The authors received funding for this project from the School of Applied Sciences RMIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AM, 2013, CRIT REV BIOTECHNOL, V33, P293, DOI 10.3109/07388551.2012.695333; Beckett RP, 2013, FUNGAL BIOL-UK, V117, P431, DOI 10.1016/j.funbio.2013.04.007; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Borowitzka MA, 2013, MITIG ADAPT STRAT GL, V18, P13, DOI 10.1007/s11027-010-9271-9; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Coward T, 2013, ALGAL RES, V2, P135, DOI 10.1016/j.algal.2012.12.001; de Boer K, 2012, J APPL PHYCOL, V24, P1681, DOI 10.1007/s10811-012-9835-z; DOE US, 2010, NAT ALG BIOF TECHN R; Duong VT, 2012, ENERGIES, V5, P1835, DOI 10.3390/en5061835; Garg S, 2014, BIORESOURCE TECHNOL, V159, P437, DOI 10.1016/j.biortech.2014.03.030; Gonzalez-Fernandez C, 2013, J APPL PHYCOL, V25, P991, DOI 10.1007/s10811-012-9957-3; Grima EM, 2003, BIOTECHNOL ADV, V20, P491; Gultom SO, 2013, ENERGIES, V6, P5921, DOI 10.3390/en6115921; Guo SL, 2013, BIORESOURCE TECHNOL, V145, P285, DOI 10.1016/j.biortech.2013.01.120; Hamawand I, 2014, FUEL, V117, P422, DOI 10.1016/j.fuel.2013.09.040; Heredia-Arroyo T, 2010, APPL BIOCHEM BIOTECH, V162, P1978, DOI 10.1007/s12010-010-8974-4; Karimi K, 2013, BIOTECHNOL ADV, V31, P466, DOI 10.1016/j.biotechadv.2013.01.009; Keymer P, 2013, BIORESOURCE TECHNOL, V131, P128, DOI 10.1016/j.biortech.2012.12.125; Khot M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-71; Krogh KBRM, 2009, ENZYME MICROB TECH, V44, P359, DOI 10.1016/j.enzmictec.2009.02.007; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Lee AK, 2013, APPL ENERG, V108, P45, DOI 10.1016/j.apenergy.2013.03.003; Lee J, 2013, BIORESOURCE TECHNOL, V131, P195, DOI 10.1016/j.biortech.2012.11.130; Leite GB, BIORESOURCE TECHNOLO; Leite GB, 2013, BIORESOURCE TECHNOL, V145, P134, DOI 10.1016/j.biortech.2013.02.007; Li SL, 2011, AFR J MICROBIOL RES, V5, P2075; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu DY, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-149; Liu Y, 2008, BIOTECHNOL BIOENG, V99, P117, DOI 10.1002/bit.21531; Liu Z, 2008, RAPID COMMUN MASS SP, V22, P3434, DOI 10.1002/rcm.3755; Luo SS, 2013, RES J BIOTECHNOL, V8, P56; Manheim D, 2013, ENVIRON PROG SUSTAIN, V32, P946, DOI 10.1002/ep.11861; Milledge J, 2013, REV ENVIRON SCI BIO, V12, P165, DOI 10.1007/s11157-012-9301-z; Miranda A.F., 2014, J SUSTAIN BIOENERGY, V04, P97, DOI [10.4236/jsbs.2014.41010, DOI 10.4236/JSBS.2014.41010]; Muradov N., 2014, LIBERATING ENERGY CA; Muradov N, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-30; Muradov N, 2012, BIOMASS BIOENERG, V42, P123, DOI 10.1016/j.biombioe.2012.03.003; Muradov NZ, 2008, INT J HYDROGEN ENERG, V33, P6804, DOI 10.1016/j.ijhydene.2008.08.054; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Olguin EJ, 2012, BIOTECHNOL ADV, V30, P1031, DOI 10.1016/j.biotechadv.2012.05.001; Pinzi S, 2014, BIOFUEL BIOPROD BIOR, V8, P126, DOI 10.1002/bbb.1435; Pires J, 2013, ENVIRON SCI POLLUT R, V20, P5096, DOI 10.1007/s11356-013-1791-x; Powell RJ, 2013, APPL ENVIRON MICROB, V79, P6093, DOI 10.1128/AEM.01496-13; Pragya N, 2013, RENEW SUST ENERG REV, V24, P159, DOI 10.1016/j.rser.2013.03.034; Price MS, 2001, BIORESOURCE TECHNOL, V77, P41, DOI 10.1016/S0960-8524(00)00135-8; Rajkumar R, 2014, BIORESOURCES, V9, P1606; Ranzi E, 2008, ENERG FUEL, V22, P4292, DOI 10.1021/ef800551t; Reed T.B., 1981, COMBUSTION PYROLYSIS, P496; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Sergeeva YE, 2008, APPL BIOCHEM MICRO+, V44, P523, DOI 10.1134/S0003683808050128; Sharif Hossain A. B. M., 2008, American Journal of Biochemistry and Biotechnology, V4, P250; Sharma KK, 2013, BIOFUELS-UK, V4, P397, DOI [10.4155/BFS.13.25, 10.4155/bfs.13.25]; Sharma P, 2011, ENVIRON MONIT ASSESS, V183, P151, DOI 10.1007/s10661-011-1914-0; Singh AP, 2014, BIOMASS BIOENERG, V62, P198, DOI 10.1016/j.biombioe.2013.12.013; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Swami D, 2006, INT J ENVIRON POLLUT, V27, P324, DOI 10.1504/IJEP.2006.010576; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; Uduman N, 2010, CHEM ENG J, V162, P935, DOI 10.1016/j.cej.2010.06.046; Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005; Vijay M, 2014, INT SCHOLARLY RES NO, V2014; Wan C, 2013, BIORESOURCE TECHNOL, V135, P207, DOI 10.1016/j.biortech.2012.10.004; WEBBER MM, 1970, CAN J BOTANY, V48, P1521, DOI 10.1139/b70-229; Wei P, 2014, RENEW SUST ENERG REV, V30, P388, DOI 10.1016/j.rser.2013.10.017; WITTENBERG KM, 1991, CAN J ANIM SCI, V71, P429, DOI 10.4141/cjas91-053; Wu YH, 2014, RENEW SUST ENERG REV, V33, P675, DOI 10.1016/j.rser.2014.02.026; Xia CJ, 2014, APPL BIOCHEM BIOTECH, V172, P3502, DOI 10.1007/s12010-014-0759-8; Xia CJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-15; Xie SX, 2013, ALGAL RES, V2, P28, DOI 10.1016/j.algal.2012.11.004; Yin LJ, 2010, J FOOD SCI, V75, pH317, DOI 10.1111/j.1750-3841.2010.01867.x; Zhang JG, 2012, BIORESOURCE TECHNOL, V114, P529, DOI 10.1016/j.biortech.2012.03.054; Zhou WG, 2013, SEP PURIF TECHNOL, V107, P158, DOI 10.1016/j.seppur.2013.01.030; Zhou WG, 2012, APPL BIOCHEM BIOTECH, V167, P214, DOI 10.1007/s12010-012-9667-y; Zoller S, 2003, MOL PHYLOGENET EVOL, V29, P629, DOI 10.1016/S1055-7903(03)00215-X	76	113	118	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113497	10.1371/journal.pone.0113497	http://dx.doi.org/10.1371/journal.pone.0113497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419574	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900042
J	Kowalczykiewicz, D; Swiercz, A; Handschuh, L; Lesniak, K; Figlerowicz, M; Wrzesinski, J				Kowalczykiewicz, Dorota; Swiercz, Aleksandra; Handschuh, Luiza; Lesniak, Katarzyna; Figlerowicz, Marek; Wrzesinski, Jan			Characterization of Sus scrofa Small Non-Coding RNAs Present in Both Female and Male Gonads	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; PIRNA AMPLIFICATION; MICRORNA BIOGENESIS; FRAGMENTS TRFS; PIWI PROTEINS; IDENTIFICATION; SPERMATOGENESIS; ARGONAUTE; GENOMICS; PROFILE	Small non-coding RNAs (sncRNAs) are indispensable for proper germ cell development, emphasizing the need for greater elucidation of the mechanisms of germline development and regulation of this process by sncRNAs. We used deep sequencing to characterize three families of small non-coding RNAs (piRNAs, miRNAs, and tRFs) present in Sus scrofa gonads and focused on the small RNA fraction present in both male and female gonads. Although similar numbers of reads were obtained from both types of gonads, the number of unique RNA sequences in the ovaries was several times lower. Of the sequences detected in the testes, 2.6% of piRNAs, 9% of miRNAs, and 10% of tRFs were also present in the ovaries. Notably, the majority of the shared piRNAs mapped to ribosomal RNAs and were derived from clustered loci. In addition, the most abundant miRNAs present in the ovaries and testes are conserved and are involved in many biological processes such as the regulation of homeobox genes, the control of cell proliferation, and carcinogenesis. Unexpectedly, we detected a novel sncRNA type, the tRFs, which are 30-36-nt RNA fragments derived from tRNA molecules, in gonads. Analysis of S. scrofa piRNAs show that testes specific piRNAs are biased for 59 uracil but both testes and ovaries specific piRNAs are not biased for adenine at the 10th nucleotide position. These observations indicate that adult porcine piRNAs are predominantly produced by a primary processing pathway or other mechanisms and secondary piRNAs generated by ping-pong mechanism are absent.	[Kowalczykiewicz, Dorota; Swiercz, Aleksandra; Handschuh, Luiza; Lesniak, Katarzyna; Figlerowicz, Marek; Wrzesinski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Swiercz, Aleksandra; Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Handschuh, Luiza] Poznan Univ Med Sci, Dept Hematol, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Technology; Poznan University of Medical Sciences	Wrzesinski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	wrzesinj@ibch.poznan.pl	Swiercz, Aleksandra/K-6507-2014; Handschuh, Luiza/AAF-3136-2020; Figlerowicz, Marek/B-9550-2015	Swiercz, Aleksandra/0000-0002-5574-8222; Wrzesinski, Jan/0000-0002-3777-4320; Figlerowicz, Marek/0000-0002-6392-0192; Handschuh, Luiza/0000-0001-9803-6877	Polish Ministry of Science and Higher Education [NN-303414237, DPN/N103/COST/2009]; National Science Centre, Poland [DEC-2011/01/B/ST6/07021]; KNOW Poznan RNA Centre [01/KNOW2/2014]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland); KNOW Poznan RNA Centre	Funding: This work was supported by the Polish Ministry of Science and Higher Education (grants NN-303414237, DPN/N103/COST/2009), the National Science Centre, Poland (grant DEC-2011/01/B/ST6/07021) and KNOW Poznan RNA Centre, 01/KNOW2/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Banisch TU, 2012, CURR TOP DEV BIOL, V99, P79, DOI 10.1016/B978-0-12-387038-4.00004-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cai P, 2013, PLOS ONE, V18; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cook MS, 2013, CURR TOP DEV BIOL, V102, P159, DOI 10.1016/B978-0-12-416024-8.00006-4; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Di Giacomo M, 2013, MOL CELL, V50, P601, DOI 10.1016/j.molcel.2013.04.026; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Franca LR, 2005, THERIOGENOLOGY, V63, P300, DOI 10.1016/j.theriogenology.2004.09.014; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Fu Q, 2014, SPERMATOGENESIS, V4, pe27889, DOI [DOI 10.4161/SPMG.27889, 10.4161/spmg.27889]; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; Griwna ST, 2006, P NATL ACAD SCI USA, V103, P13837; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackenberg M, 2013, DNA RES, V20, P109, DOI 10.1093/dnares/dss037; Hale BJ, 2014, MOL REPROD DEV, V81, P148, DOI 10.1002/mrd.22272; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Hunter MG, 2000, REV REPROD, V5, P122, DOI 10.1530/revreprod/5.2.122; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jackowiak P, 2011, NUCLEIC ACIDS RES, V39, P7361, DOI 10.1093/nar/gkr450; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kowalczykiewicz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043816; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu G, 2011, PLOS ONE, V7; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Nowacka M, 2013, PLANT MOL BIOL, V83, P191, DOI 10.1007/s11103-013-0079-3; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Prather RS, 2013, NAT BIOTECHNOL, V31, P122, DOI 10.1038/nbt.2490; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Simon B, 2011, STRUCTURE, V19, P172, DOI 10.1016/j.str.2010.11.015; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Steitz H, 2011, SILENCE, V2011, P2; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669	78	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113249	10.1371/journal.pone.0113249	http://dx.doi.org/10.1371/journal.pone.0113249			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415416	Green Submitted, gold, Green Published			2022-12-27	WOS:000346906600035
J	Bates, JL; Karriker, LA; Stock, ML; Pertzborn, KM; Baldwin, LG; Wulf, LW; Lee, CJ; Wang, C; Coetzee, JF				Bates, Jessica L.; Karriker, Locke A.; Stock, Matthew L.; Pertzborn, Kelly M.; Baldwin, Luke G.; Wulf, Larry W.; Lee, C. J.; Wang, Chong; Coetzee, Johann F.			Impact of Transmammary-Delivered Meloxicam on Biomarkers of Pain and Distress in Piglets after Castration and Tail Docking	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; BODY-TEMPERATURE; SUBSTANCE-P; HUMAN-MILK; RESPONSES; STRESS; PERFORMANCE; ANESTHESIA; ANALGESIA; CELECOXIB	To investigate a novel route for providing analgesia to processed piglets via transmammary drug delivery, meloxicam was administered orally to sows after farrowing. The objectives of the study were to demonstrate meloxicam transfer from sows to piglets via milk and to describe the analgesic effects in piglets after processing through assessment of pain biomarkers and infrared thermography (IRT). Ten sows received either meloxicam (30 mg/kg) (n=5) or whey protein (placebo) (n=5) in their daily feedings, starting four days after farrowing and continuing for three consecutive days. During this period, blood and milk samples were collected at 12-hour intervals. On Day 5 after farrowing, three boars and three gilts from each litter were castrated or sham castrated, tail docked, and administered an iron injection. Piglet blood samples were collected immediately before processing and at predetermined times over an 84-hour period. IRT images were captured at each piglet blood collection point. Plasma was tested to confirm meloxicam concentrations using a validated high-performance liquid chromatography-mass spectrometry method. Meloxicam was detected in all piglets nursing on medicated sows at each time point, and the mean (+/- standard error of the mean) meloxicam concentration at castration was 568.9 +/- 105.8 ng/mL. Furthermore, ex-vivo prostaglandin E-2 (PGE(2)) synthesis inhibition was greater in piglets from treated sows compared to controls (p=0.0059). There was a time-by-treatment interaction for plasma cortisol (p=0.0009), with meloxicam-treated piglets demonstrating lower cortisol concentrations than control piglets for 10 hours after castration. No differences in mean plasma substance P concentrations between treatment groups were observed (p=0.67). Lower cranial skin temperatures on IRT were observed in placebo compared to meloxicam- treated piglets (p=0.015). This study demonstrates the successful transfer of meloxicam from sows to piglets through milk and corresponding analgesia after processing, as evidenced by a decrease in cortisol and PGE(2) levels and maintenance of cranial skin temperature.	[Bates, Jessica L.; Karriker, Locke A.; Baldwin, Luke G.] Iowa State Univ, Swine Med Educ Ctr, Coll Vet Med, Ames, IA USA; [Stock, Matthew L.; Pertzborn, Kelly M.; Wulf, Larry W.; Lee, C. J.; Coetzee, Johann F.] Iowa State Univ, Pharmacol Analyt Support Team, Coll Vet Med, Ames, IA 50011 USA; [Wang, Chong] Iowa State Univ, Coll Vet Med, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Coetzee, JF (corresponding author), Iowa State Univ, Pharmacol Analyt Support Team, Coll Vet Med, Ames, IA 50011 USA.	hcoetzee@iastate.edu	Coetzee, Hans/GOK-3477-2022; Wang, Chong/AAI-3796-2020	Coetzee, Hans/0000-0003-1802-3991; Wang, Chong/0000-0003-4489-4344	Iowa Livestock Health Advisory Council [109-05-56]; Swine Medicine Education Center; Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2013-67015-21332]	Iowa Livestock Health Advisory Council; Swine Medicine Education Center; Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture	This study was funded by the Iowa Livestock Health Advisory Council under account #109-05-56 and the Swine Medicine Education Center. Dr. Coetzee is supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-21332 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association, 2013, AVMA GUID EUTH AN 20, P58; Boehringer Ingelheim, 2013, BOEHR ING MET LAB; Brideau C, 2001, AM J VET RES, V62, P1755, DOI 10.2460/ajvr.2001.62.1755; Brown J, 2013, 12063 NAT PORK BOARD; Carroll JA, 2006, J ANIM SCI, V84, P1271, DOI 10.2527/2006.8451271x; Coetzee JF, 2008, AM J VET RES, V69, P751, DOI 10.2460/ajvr.69.6.751; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Dzikamunhenga RS, 2014, ANIM HEALTH RES REV, V15, P14, DOI 10.1017/S1466252314000061; Federation of Animal Science Societies Writing Committee, 2010, GUID CAR US AGR AN R, P142; Gardiner SJ, 2005, EUR J CLIN PHARMACOL, V61, P405, DOI 10.1007/s00228-005-0937-2; Giorgi M, 2011, VET J, V190, P143, DOI 10.1016/j.tvjl.2010.09.013; Hale TW, 2004, J HUM LACT, V20, P397, DOI 10.1177/0890334404269875; Hansson M, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-34; Jacqz-Aigrain E, 2007, THER DRUG MONIT, V29, P815, DOI 10.1097/FTD.0b013e31815d0f01; Keita A, 2010, VET ANAESTH ANALG, V37, P367, DOI 10.1111/j.1467-2995.2010.00546.x; Kendall PE, 2009, LIVEST SCI, V125, P155, DOI 10.1016/j.livsci.2009.04.004; Kilching T, 2010, 21 INT PIG VET SOC C, P851; Knoppert DC, 2003, PHARMACOTHERAPY, V23, P97, DOI 10.1592/phco.23.1.97.31925; Liu Z, 2008, CELL MOL NEUROBIOL, V28, P939, DOI 10.1007/s10571-008-9268-z; Malreddy PR, 2013, J VET PHARMACOL THER, V36, P14, DOI 10.1111/j.1365-2885.2012.01384.x; Marchant-Forde JN, 2009, J ANIM SCI, V87, P1479, DOI 10.2527/jas.2008-1080; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; National Research Council, 2012, NUTR REQ SWIN, P208; O'Connor A, 2014, ANIM HEALTH RES REV, V15, P39, DOI 10.1017/S1466252314000073; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Pairis-Garcia MD, 2015, J VET PHARMACOL THER, V38, P265, DOI 10.1111/jvp.12170; Prunier A, 2005, J ANIM SCI, V83, P216; Reiner G, 2012, BERL MUNCH TIERARZTL, V125, P305, DOI 10.2376/0005-9366-125-305; Reyes L, 2002, PHARMACOL BIOCHEM BE, V73, P521, DOI 10.1016/S0091-3057(02)00820-1; Rohlinger P., 1979, MONATSHEFTE VETERINA, P287; Schmidt M, 2013, J SWINE HEALTH PROD, V21, P203; Stewart M, 2005, ANIM WELFARE, V14, P319; Sutherland MA, 2012, J ANIM SCI, V90, P2211, DOI 10.2527/jas.2011-4260; Tenbergen R, 2014, J SWINE HEALTH PROD, V22, P64; Traulsen I, 2010, ZUCHTUNGSKUNDE, V82, P437; Zoels S, 2006, 22 INT PIG VET SOC C, pWP	39	31	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113678	10.1371/journal.pone.0113678	http://dx.doi.org/10.1371/journal.pone.0113678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437866	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900064
J	Guo, MH; Gelman, H; Gruebele, M				Guo, Minghao; Gelman, Hannah; Gruebele, Martin			Coupled Protein Diffusion and Folding in the Cell	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; IN-VIVO; ANOMALOUS DIFFUSION; ESCHERICHIA-COLI; MONOMERIC RED; LIVING CELLS; KINETICS; COMPARTMENTS; AGGREGATION; STABILITY	When a protein unfolds in the cell, its diffusion coefficient is affected by its increased hydrodynamic radius and by interactions of exposed hydrophobic residues with the cytoplasmic matrix, including chaperones. We characterize protein diffusion by photobleaching whole cells at a single point, and imaging the concentration change of fluorescent-labeled protein throughout the cell as a function of time. As a folded reference protein we use green fluorescent protein. The resulting region-dependent anomalous diffusion is well characterized by 2-D or 3-D diffusion equations coupled to a clustering algorithm that accounts for position-dependent diffusion. Then we study diffusion of a destabilized mutant of the enzyme phosphoglycerate kinase (PGK) and of its stable control inside the cell. Unlike the green fluorescent protein control's diffusion coefficient, PGK's diffusion coefficient is a non-monotonic function of temperature, signaling 'sticking' of the protein in the cytosol as it begins to unfold. The temperature-dependent increase and subsequent decrease of the PGK diffusion coefficient in the cytosol is greater than a simple size-scaling model suggests. Chaperone binding of the unfolding protein inside the cell is one plausible candidate for even slower diffusion of PGK, and we test the plausibility of this hypothesis experimentally, although we do not rule out other candidates.	[Guo, Minghao; Gelman, Hannah; Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gruebele, M (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	gruebele@scs.uiuc.edu			National Science Foundation [MCB 1413256]; James R. Eiszner Chair in Chemistry; Div Of Molecular and Cellular Bioscience [1413256] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); James R. Eiszner Chair in Chemistry; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by a grant from the National Science Foundation (MCB 1413256). Development of FLIP in the authors lab was also supported by the James R. Eiszner Chair in Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dhar A, 2011, BIOPHYS J, V101, P421, DOI 10.1016/j.bpj.2011.05.071; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Ecroyd H, 2008, IUBMB LIFE, V60, P769, DOI 10.1002/iub.117; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fee CJ, 2004, BIOCONJUGATE CHEM, V15, P1304, DOI 10.1021/bc049843w; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hancock R, 2013, INT REV CEL MOL BIO, V307, pxiii; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Liu F, 2009, J COMPUT APPL MATH, V231, P160, DOI 10.1016/j.cam.2009.02.013; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Monkos K, 2013, GEN PHYSIOL BIOPHYS, V32, P67, DOI 10.4149/gpb_2013011; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Mustapha K, 2012, NUMER ALGORITHMS, V61, P525, DOI 10.1007/s11075-012-9547-0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang SH, 2008, BIOTECHNOL BIOENG, V99, P146, DOI 10.1002/bit.21512; Wirth AJ, 2013, J AM CHEM SOC, V135, P19215, DOI 10.1021/ja4087165; Wustner D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-296	38	30	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113040	10.1371/journal.pone.0113040	http://dx.doi.org/10.1371/journal.pone.0113040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436502	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900027
J	Zhang, SJ; Yuan, Y; Hao, DP				Zhang, Shaojun; Yuan, Yuan; Hao, Dapeng			A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; PATHWAY CHOICE; SURVIVAL; SENSITIVITY; INACTIVATION; CARCINOMA; TUMORS; BRCANESS	Detecting mutation in BRCA1/2 is a generally accepted strategy for screening ovarian cancers that have impaired homologous recombination (HR) ability and improved sensitivity to PARP inhibitor. However, a substantial subset of BRCA-mutant ovarian cancer patients shows less impaired or unimpaired HR ability, resulting in nonequivalent outcome after ovarian cancer development. We hypothesize that genomic instability provides a lifetime record of DNA repair deficiency and predicts ovarian cancer outcome. Based on the multi-dimensional TCGA ovarian cancer data, we developed a biological rationale-driven genomic instability score integrating somatic mutation and copy number change in a tumor genome. The score successfully divided BRCA-mutant ovarian tumors into cases of significantly improved outcome and cases of unimproved outcome. The score was also capable of discriminating HR-deficiency indicated by BRCA1 epigenetically silencing, EMSY amplification and homozygous deletion of core HR genes. We further found that the score was positively correlated with the complete response rate of chemotherapy and the rate of platinum-sensitivity, and predicted improved outcome of ovarian cancer, regardless of BRCA-mutation status. The score may have important value in outcome prediction and clinical trial design.	[Zhang, Shaojun; Yuan, Yuan; Hao, Dapeng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Yuan, Yuan] Harbin Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 4, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University	Hao, DP (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	haodapeng@ems.hrbmu.edu.cn						Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; [Anonymous], 2011, NATURE, V474, P609; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baumbusch LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054356; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Chiang JW, 2006, GYNECOL ONCOL, V101, P403, DOI 10.1016/j.ygyno.2005.10.034; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Herzog TJ, 2003, GYNECOL ONCOL, V90, pS3, DOI 10.1016/S0090-8258(03)00467-0; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kunos CA, 2011, GYNECOL ONCOL, V120, P224, DOI 10.1016/j.ygyno.2010.10.018; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Majdak EJ, 2005, CANCER, V104, P1004, DOI 10.1002/cncr.21276; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Driscoll M, 2008, CURR GENOMICS, V9, P137, DOI 10.2174/138920208784340795; Park S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.29; Pharoah PDP, 1999, CANCER RES, V59, P868; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stefansson OA, 2012, EPIGENETICS-US, V7, P1225, DOI 10.4161/epi.22561; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	42	18	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113169	10.1371/journal.pone.0113169	http://dx.doi.org/10.1371/journal.pone.0113169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437005	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900030
J	Clement, AM; Ahlberg, PE				Clement, Alice M.; Ahlberg, Per E.			The First Virtual Cranial Endocast of a Lungfish (Sarcopterygii: Dipnoi)	PLOS ONE			English	Article							INNER-EAR; TETRAPOD; INTERRELATIONSHIPS; EVOLUTION; BRAIN; COELACANTH	Lungfish, or dipnoans, have a history spanning over 400 million years and are the closest living sister taxon to the tetrapods. Most Devonian lungfish had heavily ossified endoskeletons, whereas most Mesozoic and Cenozoic lungfish had largely cartilaginous endoskeletons and are usually known only from isolated tooth plates or disarticulated bone fragments. There is thus a substantial temporal and evolutionary gap in our understanding of lungfish endoskeletal morphology, between the diverse and highly variable Devonian forms on the one hand and the three extant genera on the other. Here we present a virtual cranial endocast of Rhinodipterus kimberleyensis, from the Late Devonian Gogo Formation of Australia, one of the most derived fossil dipnoans with a well-ossified braincase. This endocast, generated from a Computed Microtomography (mCT) scan of the skull, is the first virtual endocast of any lungfish published, and only the third fossil dipnoan endocast to be illustrated in its entirety. Key features include long olfactory canals, a telencephalic cavity with a moderate degree of ventral expansion, large suparaotic cavities, and moderately enlarged utricular recesses. It has numerous similarities to the endocasts of Chirodipterus wildungensis and Griphognathus whitei, and to a lesser degree to 'Chirodipterus' australis and Dipnorhynchus sussmilchi. Among extant lungfish, it consistently resembles Neoceratodus more closely than Lepidosiren and Protopterus. Several trends in the evolution of the brains and labyrinth regions in dipnoans, such as the expansions of the utricular recess and telencephalic regions over time, are identified and discussed.	[Clement, Alice M.; Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden		Clement, AM (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden.	alice.clement@ebc.uu.se	Clement, Alice/ABH-2642-2020	Clement, Alice/0000-0003-0380-7347; Ahlberg, Per/0000-0001-9054-2900	Wallenberg Scholarship from the Knut and Alice Wallenberg foundation	Wallenberg Scholarship from the Knut and Alice Wallenberg foundation	This work was funded by a Wallenberg Scholarship from the Knut and Alice Wallenberg foundation, awarded to PEA. https://www.wallenberg.com/kaw/en/foundation/knut-and-alice-wallenberg-foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Anthony J., 1958, ANATOMIE LATIMERIA C; BEMIS WE, 1984, PALEOBIOLOGY, V10, P293, DOI 10.1017/S0094837300008277; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Burrow CJ, 2005, MICRON, V36, P551, DOI 10.1016/j.micron.2005.05.005; CAMPBELL K S, 1982, Journal of Vertebrate Paleontology, V2, P286; Campbell K. S. W., 2000, Records of the Australian Museum, V52, P103; Chang M.M., 1984, Proceedings of the Linnean Society of New South Wales, V107, P171; Chang M-M, 1982, BRAINCASE YOUNGOLEPI; Christensen-Dalsgaard J, 2011, BIOL LETTERS, V7, P139, DOI 10.1098/rsbl.2010.0636; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; Clack JA, 2011, BIOL LUNGFISHES; Clement AM, 2012, PALAEONTOLOGY, V55, P51, DOI 10.1111/j.1475-4983.2011.01118.x; Clement AM, 2010, BIOL LETTERS, V6, P509, DOI 10.1098/rsbl.2009.1033; Clement Gael, 2010, P363; Cloutier R, 1996, INTERRELATIONSHIPS F, P445, DOI DOI 10.1016/B978-012670950-6/50018-7; Cloutier Richard, 1996, P198; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; Dupret V, 2014, NATURE; Edinger T., 1921, SENCKENBERGIANA, V3, P121, DOI DOI 10.1002/AJMG.A.30539; Friedman M, 2007, EARTH ENV SCI T R SO, V98, P179, DOI 10.1017/S175569100700607X; Friedman M, 2007, ZOOL J LINN SOC-LOND, V151, P115, DOI 10.1111/j.1096-3642.2007.00320.x; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; FRITZSCH B, 1987, NATURE, V327, P153, DOI 10.1038/327153a0; Fulliquet G., 1886, RECHERCHES CERVEAU P; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P81, DOI 10.1080/00288330.1986.9516132; Heinicke Matthew P., 2009, P348; Holmgren N., 1925, Acta Zoologica Stockholm, V6, P59; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1942, ZOOL BIDR UPPS, V21, P235; Jarvik E., 1980, BASIC STRUCTURE EVOL; Jorgensen JM, 2010, BIOL LUNGFISHES, V1, P489; Joss JMP, 2006, GEN COMP ENDOCR, V148, P285, DOI 10.1016/j.ygcen.2005.10.010; Kardong K., 2006, VERTEBRATES COMP ANA; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Long JA, 2010, ANN REV EARTH PLANET, V38, P665; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; MARSHALL C, 1992, J MOL EVOL, V35, P93; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; NORTHCUTT RG, 1986, J MORPHOL, P277; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; Platt C, 2004, J COMP NEUROL, V471, P277, DOI 10.1002/cne.20038; PLAYFORD PE, 1980, AAPG BULL, V64, P814; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; Popper Arthur N., 1993, P99; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; PRIDMORE PA, 1994, PHILOS T ROY SOC B, V344, P105, DOI 10.1098/rstb.1994.0058; Retzius G, 1881, GEHORORGAN WIRBELTIE; Rudebeck Birger, 1945, ACTA ZOOL [STOCKHOLM], V26, P9; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Sanchez S, 2013, PLOS ONE, V8; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Sandberg C.A., 1988, COUR FORSCH I SENCKE, V102, P263; Save-Soderbergh G., 1952, KUNGLINGA SVENSKA VE, V4, P1; Snitting D, 2008, J VERTEBR PALEONTOL, V28, P637, DOI 10.1671/0272-4634(2008)28[637:AROTAO]2.0.CO;2; Sollas W. J., 1903, Philosophical Transactions, V(B), P259; Stensio E., 1963, SKRIFTER UTGITT NORS, V13, P1; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Wilder B. G., 1887, American Naturalist, Vxxi, P544; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Young JZ, 1981, LIFE VERTEBRATES; Zhu Min, 1995, Geobios Memoire Special (Villeurbanne), V19, P293	69	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113898	10.1371/journal.pone.0113898	http://dx.doi.org/10.1371/journal.pone.0113898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427173	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400096
J	Finn, RN; Chauvigne, F; Hlidberg, JB; Cutler, CP; Cerda, J				Finn, Roderick Nigel; Chauvigne, Francois; Hlidberg, Jon Baldur; Cutler, Christopher P.; Cerda, Joan			The Lineage-Specific Evolution of Aquaporin Gene Clusters Facilitated Tetrapod Terrestrial Adaptation	PLOS ONE			English	Article							GENOME PROVIDES INSIGHTS; VASOPRESSIN V2 RECEPTOR; WATER CHANNELS; SALT-GLANDS; DIFFERENTIAL EXPRESSION; URINE CONCENTRATION; ANURAN AMPHIBIANS; HARDERIAN-GLAND; MIP FAMILY; TREE FROG	A major physiological barrier for aquatic organisms adapting to terrestrial life is dessication in the aerial environment. This barrier was nevertheless overcome by the Devonian ancestors of extant Tetrapoda, but the origin of specific molecular mechanisms that solved this water problem remains largely unknown. Here we show that an ancient aquaporin gene cluster evolved specifically in the sarcopterygian lineage, and subsequently diverged into paralogous forms of AQP2, -5, or -6 to mediate water conservation in extant Tetrapoda. To determine the origin of these apomorphic genomic traits, we combined aquaporin sequencing from jawless and jawed vertebrates with broad taxon assembly of >2,000 transcripts amongst 131 deuterostome genomes and developed a model based upon Bayesian inference that traces their convergent roots to stem subfamilies in basal Metazoa and Prokaryota. This approach uncovered an unexpected diversity of aquaporins in every lineage investigated, and revealed that the vertebrate superfamily consists of 17 classes of aquaporins (Aqp0 - Aqp16). The oldest orthologs associated with water conservation in modern Tetrapoda are traced to a cluster of three aqp2-like genes in Actinistia that likely arose >500 Ma through duplication of an aqp0-like gene present in a jawless ancestor. In sea lamprey, we show that aqp0 first arose in a protocluster comprised of a novel aqp14 paralog and a fused aqp01 gene. To corroborate these findings, we conducted phylogenetic analyses of five syntenic nuclear receptor subfamilies, which, together with observations of extensive genome rearrangements, support the coincident loss of ancestral aqp2-like orthologs in Actinopterygii. We thus conclude that the divergence of sarcopterygian-specific aquaporin gene clusters was permissive for the evolution of water conservation mechanisms that facilitated tetrapod terrestrial adaptation.	[Finn, Roderick Nigel; Chauvigne, Francois] Univ Bergen, Dept Biol, Bergen, Norway; [Finn, Roderick Nigel] Inst Marine Res, N-5024 Bergen, Norway; [Chauvigne, Francois; Cerda, Joan] CSIC, Inst Ciencies Mar, IRTA, E-08028 Barcelona, Spain; [Hlidberg, Jon Baldur] Www Fauna Is, Reykjavik, Iceland; [Cutler, Christopher P.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Cutler, Christopher P.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	University of Bergen; Institute of Marine Research - Norway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; University System of Georgia; Georgia Southern University; Mount Desert Island Biological Laboratory	Finn, RN (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	nigel.finn@bio.uib.no; joan.cerda@irta.cat	Cerdà, Joan/M-1099-2016; Finn, Roderick Nigel/Y-2916-2019; Chauvigne, Francois/D-6854-2017	Cerdà, Joan/0000-0003-2568-6398; Finn, Roderick Nigel/0000-0002-8776-3945; Chauvigne, Francois/0000-0001-5571-7517	Research Council of Norway (RCN) [178837/40, 224816/E40]; Spanish Ministry of Science and Innovation (MICINN) [AGL2010-15597]; National Science Foundation, USA (NSF) [IOS 0844818, 1041885, 1241312]; MICINN; RCN [224816/E40]	Research Council of Norway (RCN)(Research Council of Norway); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation, USA (NSF)(National Science Foundation (NSF)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); RCN	This work was supported by the Research Council of Norway (RCN) project #178837/40 and 224816/E40 to (RNF), the Spanish Ministry of Science and Innovation (MICINN) AGL2010-15597 to (JC) and by the National Science Foundation, USA (NSF) IOS 0844818, 1041885 and 1241312 to (CPC). FC was supported by a postdoctoral (Juan de la Cierva Programme) fellowship from MICINN and the RCN (224816/E40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; BEAMISH FWH, 1980, CAN J FISH AQUAT SCI, V37, P1739, DOI 10.1139/f80-219; Beitz E, 2006, BIOL CELL, V98, P101, DOI 10.1042/BC20050025; Bernard C, 1859, LECONS PROPRIETES PH; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blair JE, 2009, TIMETREE LIFE, P220; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Cardoso KC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-605; Carroll RL, 2001, J PALEONTOL, V75, P1202, DOI 10.1666/0022-3360(2001)075<1202:TOAERO>2.0.CO;2; Cass AN, 2013, EVOL DEV, V15, P119, DOI 10.1111/ede.12022; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Colombo L, 2006, J ENDOCRINOL INVEST, V29, P373, DOI 10.1007/BF03344112; Cramp RL, 2008, J EXP BIOL, V211, P1482, DOI 10.1242/jeb.015636; Cutler CP, 2008, COMP BIOCHEM PHYS B, V149, P63, DOI 10.1016/j.cbpb.2007.08.007; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delporte C, 2014, BBA-GEN SUBJECTS, V1840, P1524, DOI 10.1016/j.bbagen.2013.08.007; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Engelund MB, 2013, J EXP BIOL, V216, P3873, DOI 10.1242/jeb.087890; Evans David H., 1993, P315; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Garcia Hector Escriva, 2003, Journal of Structural and Functional Genomics, V3, P177, DOI 10.1023/A:1022638706822; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Grigg G, 1993, FAUNA AUSTR A, P326; Grohme MA, 2013, BIOINFORM BIOL INSIG, V7, P153, DOI 10.4137/BBI.S11497; Grosberg RK, 2012, CURR BIOL, V22, pR900, DOI 10.1016/j.cub.2012.09.050; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Gwee PC, 2008, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-47; Hamdi M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-104; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hasegawa T, 2005, CELL TISSUE RES, V322, P407, DOI 10.1007/s00441-005-0037-8; Hasegawa T, 2003, ENDOCRINOLOGY, V144, P4087, DOI 10.1210/en.2003-0418; Hedges S. Blair, 2009, P309; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones CD, 2005, P NATL ACAD SCI USA, V102, P11373, DOI 10.1073/pnas.0503528102; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Konno N, 2010, ENDOCRINOLOGY, V151, P1089, DOI 10.1210/en.2009-1070; Kubota M, 2006, J EXP BIOL, V209, P3199, DOI 10.1242/jeb.02351; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lake JA, 2013, GENOME BIOL EVOL, V5, P2440, DOI 10.1093/gbe/evt194; Lau KK, 2009, GEN COMP ENDOCR, V160, P288, DOI 10.1016/j.ygcen.2008.12.007; Ma TH, 1997, GENOMICS, V43, P387, DOI 10.1006/geno.1997.4836; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Magallon S., 2009, TIMETREE LIFE, P133; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mathas M, 2012, MOL ENDOCRINOL, V26, P14, DOI 10.1210/me.2011-1235; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Morris C, 1892, AM NAT, V26, P975; Muller C, 2006, J EXP BIOL, V209, P4067, DOI 10.1242/jeb.02491; Muffato M, 2008, BIOESSAYS, V30, P122, DOI 10.1002/bies.20707; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nishimura H, 2002, EXPTL BIOL REV, P129; Nishimura H, 2008, PFLUG ARCH EUR J PHY, V456, P755, DOI 10.1007/s00424-008-0469-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogushi Y, 2010, J EXP BIOL, V213, P288, DOI 10.1242/jeb.036871; Ogushi Y, 2007, ENDOCRINOLOGY, V148, P5891, DOI 10.1210/en.2007-0613; Ogushi Y, 2010, AM J PHYSIOL-REG I, V299, pR1150, DOI 10.1152/ajpregu.00320.2010; Oksche A, 1996, HUM GENET, V98, P587, DOI 10.1007/s004390050264; Pandey RN, 2010, COMP BIOCHEM PHYS A, V157, P86, DOI 10.1016/j.cbpa.2010.04.007; PANG PKT, 1977, AM ZOOL, V17, P365; PAO GM, 1991, MOL MICROBIOL, V5, P33, DOI 10.1111/j.1365-2958.1991.tb01823.x; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PAYNE AP, 1994, J ANAT, V185, P1; Di Giorgio JP, 2014, J MEMBRANE BIOL, V247, P107, DOI 10.1007/s00232-013-9618-8; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rehorek SJ, 2006, ANN ANAT, V188, P319, DOI 10.1016/j.aanat.2006.01.018; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Saitoh Y, 2014, ENDOCRINOLOGY, V155, P2166, DOI 10.1210/en.2013-1928; Sawyer SA, 1999, COMPUTER PACKAGE STA; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; Schneider I, 2012, DEV CELL, V23, P1121, DOI 10.1016/j.devcel.2012.11.011; Shibata Y, 2011, ZOOL SCI, V28, P664, DOI 10.2108/zsj.28.664; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Shuttleworth TJ, 1999, J EXP ZOOL, V283, P689, DOI 10.1002/(SICI)1097-010X(19990601)283:7<689::AID-JEZ7>3.0.CO;2-T; Smith HW, 1953, FISH PHILOS STORY OU; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Soto G, 2012, GENE, V503, P165, DOI 10.1016/j.gene.2012.04.021; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki M, 2007, COMP BIOCHEM PHYS A, V148, P72, DOI 10.1016/j.cbpa.2006.12.021; Suzuki M, 2009, COMP BIOCHEM PHYS A, V153, P231, DOI 10.1016/j.cbpa.2009.02.035; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; SWEET G, 1990, J BACTERIOL, V172, P424, DOI 10.1128/JB.172.1.424-430.1990; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; TAPLIN LE, 1981, SCIENCE, V212, P1045, DOI 10.1126/science.212.4498.1045; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; VargasPoussou R, 1997, J AM SOC NEPHROL, V8, P1855; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808; Zapater C, 2013, GEN COMP ENDOCR, V182, P24, DOI 10.1016/j.ygcen.2012.11.015; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	121	87	93	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113686	10.1371/journal.pone.0113686	http://dx.doi.org/10.1371/journal.pone.0113686			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426855	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400077
J	Lazic, SE; Fuss, J; Gass, P				Lazic, Stanley E.; Fuss, Johannes; Gass, Peter			Quantifying the Behavioural Relevance of Hippocampal Neurogenesis	PLOS ONE			English	Article							EXPERIMENTAL STROKE; SAMPLE-SIZE; MEDIATION; DESIGN; QUALITY; MODELS; BIAS	Few studies that examine the neurogenesis-behaviour relationship formally establish covariation between neurogenesis and behaviour or rule out competing explanations. The behavioural relevance of neurogenesis might therefore be overestimated if other mechanisms account for some, or even all, of the experimental effects. A systematic review of the literature was conducted and the data reanalysed using causal mediation analysis, which can estimate the behavioural contribution of new hippocampal neurons separately from other mechanisms that might be operating. Results from eleven eligible individual studies were then combined in a meta-analysis to increase precision (representing data from 215 animals) and showed that neurogenesis made a negligible contribution to behaviour (standarised effect = 0.15; 95% CI = -0.04 to 0.34; p = 0.128); other mechanisms accounted for the majority of experimental effects (standardised effect = 1.06; 95% CI = 0.74 to 1.38; p = 1.7 x 10(-11)).	[Lazic, Stanley E.] Novartis Inst Biomed Res, In Silico Lead Discovery, Basel, Switzerland; [Fuss, Johannes; Gass, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany	Novartis; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Lazic, SE (corresponding author), Novartis Inst Biomed Res, In Silico Lead Discovery, Basel, Switzerland.	stan.lazic@cantab.net	Fuss, Johannes/AAI-6580-2021		German Ministry for Education and Research (BMBF) National Bernstein Network for Computational Neuroscience [01GQ1003B]; Deutsche Forschungsgemeinschaft [SFB636-TP3]	German Ministry for Education and Research (BMBF) National Bernstein Network for Computational Neuroscience(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by grants from the German Ministry for Education and Research (BMBF, 01GQ1003B) National Bernstein Network for Computational Neuroscience and from the Deutsche Forschungsgemeinschaft (SFB636-TP3) to P.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Bewick V, 2003, CRIT CARE, V7, P451, DOI 10.1186/cc2401; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Borenstein M., 2009, INTRO METAANALYSIS; Bozzola M, 2009, MOL GENET METAB, V98, P310, DOI 10.1016/j.ymgme.2009.05.009; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Castro JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008618; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Fiedler K, 2011, J EXP SOC PSYCHOL, V47, P1231, DOI 10.1016/j.jesp.2011.05.007; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Hassler U, 2003, J ROY STAT SOC D-STA, V52, P367, DOI 10.1111/1467-9884.00365; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; KOLLER D., 2009, PROBABILISTIC GRAPHI; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lazic SE, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-37; Lazic SE, 2012, J R SOC INTERFACE, V9, P907, DOI 10.1098/rsif.2011.0510; Lazic SE, 2010, NEUROBIOL AGING, V31, P2169, DOI 10.1016/j.neurobiolaging.2010.04.037; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; LIPP HP, 1988, J NEUROSCI, V8, P1905; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Moja L, 2014, EUR J CLIN INVEST, V44, P597, DOI 10.1111/eci.12264; Pearl J., 2009, CAUSALITY MODELS REA; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Philip M, 2009, STROKE, V40, P577, DOI 10.1161/STROKEAHA.108.524330; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rooke EDM, 2011, PARKINSONISM RELAT D, V17, P313, DOI 10.1016/j.parkreldis.2011.02.010; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Thoemmes F, 2010, STRUCT EQU MODELING, V17, P510, DOI 10.1080/10705511.2010.489379; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Vadodaria KC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00055; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Yuan Y, 2009, PSYCHOL METHODS, V14, P301, DOI 10.1037/a0016972; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113855	10.1371/journal.pone.0113855	http://dx.doi.org/10.1371/journal.pone.0113855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426717	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400091
J	Manson, JH; Gervais, MM; Fessler, DMT; Kline, MA				Manson, Joseph H.; Gervais, Matthew M.; Fessler, Daniel M. T.; Kline, Michelle A.			Subclinical Primary Psychopathy, but Not Physical Formidability or Attractiveness, Predicts Conversational Dominance in a Zero-Acquaintance Situation	PLOS ONE			English	Article							EVOLUTIONARY PSYCHOLOGY; NONVERBAL BEHAVIOR; SOCIAL-DOMINANCE; RESOURCE CONTROL; SELF-REPORT; DARK TRIAD; PERSONALITY; MODEL; POWER; TIME	The determinants of conversational dominance are not well understood. We used videotaped triadic interactions among unacquainted same-sex American college students to test predictions drawn from the theoretical distinction between dominance and prestige as modes of human status competition. Specifically, we investigated the effects of physical formidability, facial attractiveness, social status, and self-reported subclinical psychopathy on quantitative (proportion of words produced), participatory (interruptions produced and sustained), and sequential (topic control) dominance. No measure of physical formidability or attractiveness was associated with any form of conversational dominance, suggesting that the characteristics of our study population or experimental frame may have moderated their role in dominance dynamics. Primary psychopathy was positively associated with quantitative dominance and (marginally) overall triad talkativeness, and negatively associated (in men) with affect word use, whereas secondary psychopathy was unrelated to conversational dominance. The two psychopathy factors had significant opposing effects on quantitative dominance in a multivariate model. These latter findings suggest that glibness in primary psychopathy may function to elicit exploitable information from others in a relationally mobile society.	[Manson, Joseph H.; Fessler, Daniel M. T.] Univ Calif Los Angeles, Dept Anthropol, Ctr Behav Evolut & Culture, Los Angeles, CA 90024 USA; [Manson, Joseph H.; Fessler, Daniel M. T.] Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA 90024 USA; [Gervais, Matthew M.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Gervais, Matthew M.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Kline, Michelle A.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Arizona State University; Arizona State University-Tempe	Manson, JH (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Ctr Behav Evolut & Culture, Los Angeles, CA 90024 USA.	jmanson@anthro.ucla.edu			International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	International Society for Human Ethology; UCLA Academic Senate Faculty Grants Program	Funding provided by International Society for Human Ethology (http://www.ishe.org) and UCLA Academic Senate Faculty Grants Program (http://www.senate.ucla.edu/committees/cor/fgp/frg-guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barkow J. H., 1989, DARWIN SEX STATUS BI, DOI 10.1002/AJPA.1330840213; Billings ME, 2011, SLEEP, V34, P1653, DOI 10.5665/sleep.1428; Blaker N.M., 2014, PSYCHOL SOCIAL STATU, P119; Bonito JA, 2003, COMMUN MONOGR, V70, P83, DOI 10.1080/0363775032000133755; BOTTGER PC, 1984, J APPL PSYCHOL, V69, P214, DOI 10.1037/0021-9010.69.2.214; Brandt DR, 1980, COMMUNICATION Q, V28, P31, DOI [10.1080/01463378009369356, DOI 10.1080/01463378009369356]; Brown P., 1978, POLITENESS SOME UNIV; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Cheng JT, 2010, EVOL HUM BEHAV, V31, P334, DOI 10.1016/j.evolhumbehav.2010.02.004; Cleckley H., 1941, MASK SANITY; Cooke DJ, 2001, PSYCHOL ASSESSMENT, V13, P171, DOI 10.1037//1040-3590.13.2.171; Cosmides L, 2013, ANNU REV PSYCHOL, V64, P201, DOI 10.1146/annurev.psych.121208.131628; DeLisi M, 2010, J PSYCHOPATHOL BEHAV, V32, P169, DOI 10.1007/s10862-009-9147-z; Edens JF, 2006, J ABNORM PSYCHOL, V115, P131, DOI 10.1037/0021-843X.115.1.131; Farley SD, 2008, J NONVERBAL BEHAV, V32, P241, DOI 10.1007/s10919-008-0054-x; Fast LA, 2008, J PERS SOC PSYCHOL, V94, P334, DOI 10.1037/0022-3514.94.2.334; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Frederick David A, 2005, Body Image, V2, P81, DOI 10.1016/j.bodyim.2004.12.002; Gervais MM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2773; Glenn AL, 2011, AGGRESS VIOLENT BEH, V16, P371, DOI 10.1016/j.avb.2011.03.009; Grammer K, 2000, EVOL HUM BEHAV, V21, P371, DOI 10.1016/S1090-5138(00)00053-2; Gurven M, 2013, J PERS SOC PSYCHOL, V104, P354, DOI 10.1037/a0030841; Haas A, 2005, SOCIOL FORUM, V20, P449, DOI 10.1007/s11206-005-6597-2; Hall JA, 2005, PSYCHOL BULL, V131, P898, DOI 10.1037/0033-2909.131.6.898; Hare RD, 1996, CRIM JUSTICE BEHAV, V23, P25, DOI 10.1177/0093854896023001004; Hare Robert D, 2005, Curr Psychiatry Rep, V7, P57, DOI 10.1007/s11920-005-0026-3; Hawley PH, 1999, DEV REV, V19, P97, DOI 10.1006/drev.1998.0470; Hawley PH, 2002, INT J BEHAV DEV, V26, P167, DOI 10.1080/01650250042000726; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hinde RA, 1978, J SOC BIOL STRUCT, V1, P27, DOI [10.1016/0140-1750(78)90016-7, DOI 10.1016/0140-1750(78)90016-7]; Itakura H, 2004, LANG SOC, V33, P223, DOI 10.1017/S0047404504332033; Itakura H, 2001, J PRAGMATICS, V33, P1859, DOI 10.1016/S0378-2166(00)00082-5; Johnson RT, 2007, EVOL HUM BEHAV, V28, P345, DOI 10.1016/j.evolhumbehav.2007.04.003; Kraus MW, 2009, PSYCHOL SCI, V20, P99, DOI 10.1111/j.1467-9280.2008.02251.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lee K, 2013, EUR J PERSONALITY, V27, P169, DOI 10.1002/per.1860; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Lynam D.R., 2006, HDB PSYCHOPATHY, P133; Lynam DR, 1999, J PERS ASSESS, V73, P110, DOI 10.1207/S15327752JPA730108; MALAMUTH NM, 1994, AGGRESSIVE BEHAV, V20, P185, DOI 10.1002/1098-2337(1994)20:3<185::AID-AB2480200305>3.0.CO;2-3; Mast MS, 2002, HUM COMMUN RES, V28, P420, DOI 10.1111/j.1468-2958.2002.tb00814.x; MEALEY L, 1995, BEHAV BRAIN SCI, V18, P523, DOI 10.1017/S0140525X00039595; Mehu M, 2007, EVOL HUM BEHAV, V28, P415, DOI 10.1016/j.evolhumbehav.2007.05.010; Morrison D, 2001, J FORENSIC PSYCHIATR, V12, P330, DOI 10.1080/09585180110056867; MULLEN B, 1989, J EXP SOC PSYCHOL, V25, P545, DOI 10.1016/0022-1031(89)90005-X; Neumann CS, 2012, BEHAV SCI LAW, V30, P557, DOI 10.1002/bsl.2038; O'Halloran KA, 2005, J PRAGMATICS, V37, P1945, DOI 10.1016/j.pragma.2004.10.018; PALMER MT, 1989, COMMUN MONOGR, V56, P1, DOI 10.1080/03637758909390246; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Price ME, 2011, PERS INDIV DIFFER, V50, P636, DOI 10.1016/j.paid.2010.12.009; Roberts F, 2004, HUM COMMUN RES, V30, P376, DOI 10.1093/hcr/30.3.376; ROSA E, 1979, SOC FORCES, V58, P18, DOI 10.2307/2577782; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sade D.S., 1967, P99; Salekin RT, 2004, J CLIN CHILD ADOLESC, V33, P731, DOI 10.1207/s15374424jccp3304_8; Schegloff E. A., 2007, SEQUENCE ORG INTERAC, V1; Sell A, 2012, HUM NATURE-INT BIOS, V23, P30, DOI 10.1007/s12110-012-9131-2; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snyder JK, 2008, PERS RELATIONSHIP, V15, P425, DOI 10.1111/j.1475-6811.2008.00208.x; Ten Have P., 1999, DOING CONVERSATION A; Vitacco MJ, 2008, CRIM JUSTICE BEHAV, V35, P48, DOI 10.1177/0093854807309806; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Williams KM, 2007, J PERS ASSESS, V88, P205, DOI 10.1080/00223890701268074; Zeigler-Hill V, 2014, PERS INDIV DIFFER, V66, P118, DOI 10.1016/j.paid.2014.03.037	71	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113135	10.1371/journal.pone.0113135	http://dx.doi.org/10.1371/journal.pone.0113135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426962	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400035
J	Qi, SS; Dai, ZC; Zhai, DL; Chen, SC; Si, CC; Huang, P; Wang, RP; Zhong, QX; Du, DL				Qi, Shan-Shan; Dai, Zhi-Cong; Zhai, De-Li; Chen, Si-Chong; Si, Chun-Can; Huang, Ping; Wang, Rui-Ping; Zhong, Qiong-Xin; Du, Dao-Lin			Curvilinear Effects of Invasive Plants on Plant Diversity: Plant Community Invaded by Sphagneticola trilobata	PLOS ONE			English	Article							WEDELIA-TRILOBATA; SPECIES-DIVERSITY; CONSEQUENCES; BIODIVERSITY; URBANIZATION; IMPACTS; TIME	The effects of invasive plants on the species diversity of plant communities are controversial, showing either a positive or negative linear relationship. Based on community data collected from forty 5 m x 5 m plots invaded by Sphagneticola trilobata in eight cities across Hainan Island, China, we found S. trilobata decreased plant community diversity once its cover was beyond 10%. We demonstrated that the effects of invasive/native plants on the plant diversity of communities invaded by S. trilobata were curvilinear. These effects, which showed peaks under different degrees of vegetation cover, appeared not only for S. trilobata and all invasive plants, but also for all native plants. Invasive plants primarily had negative effects on plant diversity when they became abundant at a much lower cover level (less than 35%), compared with the native plants (over 60%). Thus, it is necessary to distinguish a range for assessing the effects of plants, especially invasive plants. Our results also confirmed that the invasion intensity of invasive alien plants increased with the intensity of local economic development. We highlight and further discuss the critical importance of curvilinear effects of biological invasion to provide ideas regarding the conservation of local biodiversity and the management of invasive plants.	[Qi, Shan-Shan; Dai, Zhi-Cong; Si, Chun-Can; Huang, Ping; Du, Dao-Lin] Jiangsu Univ, Inst Environm & Ecol, Sch Environm & Safety Engn, Zhenjiang, Peoples R China; [Zhai, De-Li] World Agroforestry Ctr ICRAF, Cent & East Asia Off, Kunming, Peoples R China; [Zhai, De-Li] Chinese Acad Sci, Kunming Inst Bot, CMES, Kunming, Peoples R China; [Chen, Si-Chong] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Si, Chun-Can] Jingdezhen Univ, Dept Biol & Chem Engn, Jingdezhen, Peoples R China; [Huang, Ping; Du, Dao-Lin] Jiangsu Univ, Minist Educ & Jiangsu Prov, Key Lab Modern Agr Equipment & Technol, Zhenjiang, Peoples R China; [Wang, Rui-Ping; Zhong, Qiong-Xin] Hainan Normal Univ, Coll Life Sci, Haikou, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of New South Wales Sydney; Jiangsu University; Hainan Normal University	Du, DL (corresponding author), Jiangsu Univ, Inst Environm & Ecol, Sch Environm & Safety Engn, Zhenjiang, Peoples R China.	ddl@ujs.edu.cn	Du, Daolin/HHC-9359-2022	Du, Daolin/0000-0003-1764-2205; Dai, Zhi-Cong/0000-0002-0748-8059	National Natural Science Foundation of China [NSFC-30970556, 31170386]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Technology and Material of Water Treatment [ESK201001]; Jiangsu University Research Foundation [09JDG020, 14JDG010]; Research and Innovation Project for College Graduates of Jiangsu Province of China [CXZZ12_0697]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Technology and Material of Water Treatment; Jiangsu University Research Foundation; Research and Innovation Project for College Graduates of Jiangsu Province of China	This study was partially supported by the National Natural Science Foundation of China (NSFC-30970556, 31170386), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Collaborative Innovation Center of Technology and Material of Water Treatment (ESK201001), the Jiangsu University Research Foundation (09JDG020, 14JDG010), the Research and Innovation Project for College Graduates of Jiangsu Province of China (CXZZ12_0697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2013, ENVIRON SCI TECHNOL, V47, P7624, DOI 10.1021/es400382c; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cushman JH, 2010, BIOL INVASIONS, V12, P2765, DOI 10.1007/s10530-009-9682-2; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Ehrenfeld JG, 2001, ECOL APPL, V11, P1259, DOI 10.1890/1051-0761(2001)011[1259:ISATSE]2.0.CO;2; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Gonzalez-Sanson G, 2010, ECOL INDIC, V10, P766, DOI 10.1016/j.ecolind.2009.11.009; Goodall J, 2012, BIOL INVASIONS, V14, P1947, DOI 10.1007/s10530-012-0205-1; IUCN, 2010, 100 WORLDS WORST INV; Karalius T, 2010, BIOL INVASIONS, V12, P1125, DOI 10.1007/s10530-009-9530-4; Knapp S, 2012, ECOLOGY, V93, pS83, DOI 10.1890/11-0392.1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Li PX, 2011, COMMUNITY ECOL, V12, P1, DOI 10.1556/ComEc.12.2011.1.1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mcart SH, 2012, OECOLOGIA, V168, P1013, DOI 10.1007/s00442-011-2150-6; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Peru N, 2010, ECOL INDIC, V10, P1025, DOI 10.1016/j.ecolind.2010.02.011; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Pretto F, 2010, PLANT ECOL, V210, P225, DOI 10.1007/s11258-010-9751-8; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Qi SS, 2014, ANN BOT-LONDON, V114, P425, DOI 10.1093/aob/mcu075; Qian H, 2006, ECOL LETT, V9, P1293, DOI 10.1111/j.1461-0248.2006.00982.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Reid AM, 2009, BIOL CONSERV, V142, P2342, DOI 10.1016/j.biocon.2009.05.011; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; SAS Institute Inc, 2004, SAS STAT US GUID VER; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schob C, 2012, NEW PHYTOL, V196, P824, DOI 10.1111/j.1469-8137.2012.04306.x; Si CC, 2014, BIOL INVASIONS, V16, P2323, DOI 10.1007/s10530-014-0667-4; Simpson M, 2013, ENVIRON CONSERV, V40, P167, DOI 10.1017/S037689291200032X; Sinkins PA, 2012, PLANT ECOL, V213, P1251, DOI 10.1007/s11258-012-0083-8; Song LY, 2010, BIOL INVASIONS, V12, P1221, DOI 10.1007/s10530-009-9541-1; Statistical Bureau of Hainan Province and Survey Office of National Bureau of Statistics in Hainan, 2007, HAIN STAT YB 2006 GR; Steudel B, 2012, ECOL LETT, V15, P1397, DOI 10.1111/j.1461-0248.2012.01863.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; White LF, 2011, J EXP MAR BIOL ECOL, V405, P111, DOI 10.1016/j.jembe.2011.05.024; Xie LJ, 2010, ALLELOPATHY J, V25, P31; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426; Yu H, 2011, BIOL INVASIONS, V13, P747, DOI 10.1007/s10530-010-9865-x; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zhai D-L, 2013, REG ENVIRON CHANGE, V9, P1; Zhai DL, 2012, J ENVIRON MANAGE, V96, P64, DOI 10.1016/j.jenvman.2011.10.011	48	20	23	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113964	10.1371/journal.pone.0113964	http://dx.doi.org/10.1371/journal.pone.0113964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426856	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400106
J	Singleton, J; Osborn, JL; Lillis, L; Hawkins, K; Guelig, D; Price, W; Johns, R; Ebels, K; Boyle, D; Weigl, B; LaBarre, P				Singleton, Jered; Osborn, Jennifer L.; Lillis, Lorraine; Hawkins, Kenneth; Guelig, Dylan; Price, Will; Johns, Rachel; Ebels, Kelly; Boyle, David; Weigl, Bernhard; LaBarre, Paul			Electricity-Free Amplification and Detection for Molecular Point-of-Care Diagnosis of HIV-1	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; REVERSE-TRANSCRIPTION; PLASMODIUM-FALCIPARUM; DNA AMPLIFICATION; RAPID DETECTION; ANTIRETROVIRAL THERAPY; VIRUS; LAMP; TRANSMISSION; IDENTIFICATION	In resource-limited settings, the lack of decentralized molecular diagnostic testing and sparse access to centralized medical facilities can present a critical barrier to timely diagnosis, treatment, and subsequent control and elimination of infectious diseases. Isothermal nucleic acid amplification methods, including reverse transcription loop-mediated isothermal amplification (RT-LAMP), are well-suited for decentralized point-of-care molecular testing in minimal infrastructure laboratories since they significantly reduce the complexity of equipment and power requirements. Despite reduced complexity, however, there is still a need for a constant heat source to enable isothermal nucleic acid amplification. This requirement poses significant challenges for laboratories in developing countries where electricity is often unreliable or unavailable. To address this need, we previously developed a low-cost, electricity-free heater using an exothermic reaction thermally coupled with a phase change material. This heater achieved acceptable performance, but exhibited considerable variability. Furthermore, as an enabling technology, the heater was an incomplete diagnostic solution. Here we describe a more precise, affordable, and robust heater design with thermal standard deviation <0.5 degrees C at operating temperature, a cost of approximately US$.06 per test for heater reaction materials, and an ambient temperature operating range from 16 degrees C to 30 degrees C. We also pair the heater with nucleic acid lateral flow (NALF)-detection for a visual readout. To further illustrate the utility of the electricity-free heater and NALF-detection platform, we demonstrate sensitive and repeatable detection of HIV-1 with a beta-actin positive internal amplification control from processed sample to result in less than 80 minutes. Together, these elements are building blocks for an electricity-free platform capable of isothermal amplification and detection of a variety of pathogens.	[Singleton, Jered; Osborn, Jennifer L.; Lillis, Lorraine; Hawkins, Kenneth; Guelig, Dylan; Johns, Rachel; Ebels, Kelly; Boyle, David; Weigl, Bernhard; LaBarre, Paul] PATH, Seattle, WA 98121 USA; [Price, Will] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA	Oregon Health & Science University	LaBarre, P (corresponding author), PATH, Seattle, WA 98121 USA.	plabarre@path.org			NIH [R01 EB012641, NIAID R01AI097038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by NIH (R01 EB012641) (NIAID R01AI097038); http://nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004; Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; Aonuma H, 2010, EXP PARASITOL, V125, P179, DOI 10.1016/j.exppara.2009.12.023; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Brown J, 2011, AM J TROP MED HYG, V85, P327, DOI 10.4269/ajtmh.2011.10-0399; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Di Carlo D, 2003, LAB CHIP, V3, P287, DOI 10.1039/b305162e; Domingo G, 2013, Disposable Sample Processing Unit. United States, Patent No. [12/172,086, 20090036665]; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hosaka N, 2009, J VIROL METHODS, V157, P195, DOI 10.1016/j.jviromet.2009.01.004; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Inacio J, 2008, J CLIN MICROBIOL, V46, P713, DOI 10.1128/JCM.00514-07; Khamadi S, 2008, J TROP PEDIATRICS, V54, P370, DOI 10.1093/tropej/fmn036; Kuboki N, 2003, J CLIN MICROBIOL, V41, P5517, DOI 10.1128/JCM.41.12.5517-5524.2003; Kurosaki Y, 2007, J VIROL METHODS, V141, P78, DOI 10.1016/j.jviromet.2006.11.031; LaBarre P, 2011, P SPIE; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Liang C, 2012, ANAL CHEM, V84, P3758, DOI 10.1021/ac3003825; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Mens PF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-279; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Morisset D, 2008, EUR FOOD RES TECHNOL, V227, P1287, DOI 10.1007/s00217-008-0850-x; Nature Publishing Group, 2006, EST GLOB HLTH IMP IM; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nyandiko WM, 2010, JAIDS-J ACQ IMM DEF, V54, P42, DOI 10.1097/QAI.0b013e3181d8ad51; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Poon LLM, 2006, CLIN CHEM, V52, P303; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Roskos K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069355; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Singleton J, 2013, SPIE P, V8615; Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902; Teng PH, 2007, J VIROL METHODS, V146, P317, DOI 10.1016/j.jviromet.2007.07.027; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wang J, 2006, LAB CHIP, V6, P46, DOI 10.1039/b511494b; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yamamura M, 2009, JPN J INFECT DIS, V62, P20; Yeh HY, 2005, J MICROBIOL METH, V63, P36, DOI 10.1016/j.mimet.2005.02.015; Yun SS, 2010, LAB CHIP, V10, P1442, DOI 10.1039/b925244d	55	53	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113693	10.1371/journal.pone.0113693	http://dx.doi.org/10.1371/journal.pone.0113693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426953	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400079
J	Vafidis, JO; Vaughan, IP; Jones, TH; Facey, RJ; Parry, R; Thomas, RJ				Vafidis, James O.; Vaughan, Ian P.; Jones, T. Hefin; Facey, Richard J.; Parry, Rob; Thomas, Robert J.			Habitat Use and Body Mass Regulation among Warblers in the Sahel Region during the Non-Breeding Season	PLOS ONE			English	Article							ACROCEPHALUS-SCHOENOBAENUS; SEDGE WARBLERS; POPULATION LIMITATION; RESOURCE AVAILABILITY; PHRAGMITES-AUSTRALIS; FOOD AVAILABILITY; HIRUNDO-RUSTICA; SURVIVAL RATES; SAND MARTINS; MIGRANT BIRD	Migratory birds face significant challenges across their annual cycle, including occupying an appropriate non-breeding home range with sufficient foraging resources. This can affect demographic processes such as over-winter survival, migration mortality and subsequent breeding success. In the Sahel region of Africa, where millions of migratory songbirds attempt to survive the winter, some species of insectivorous warblers occupy both wetland and dry-scrubland habitats, whereas other species are wetland or dry-scrubland specialists. In this study we examine evidence for strategic regulation of body reserves and competition-driven habitat selection, by comparing invertebrate prey activity-density, warbler body size and extent of fat and pectoral muscle deposits, in each habitat type during the non-breeding season. Invertebrate activity-density was substantially higher in wetland habitats than in dry-scrubland. Eurasian reed warblers Acrocephalus scirpaceus occupying wetland habitats maintained lower body reserves than conspecifics occupying dry-scrub habitats, consistent with buffering of reserves against starvation in food-poor habitat. A similar, but smaller, difference in body reserves between wet and dry habitat was found among subalpine warblers Sylvia cantillans but not in chiffchaffs Phylloscopus collybita inhabiting dry-scrub and scrub fringing wetlands. Body reserves were relatively low among habitat specialist species; resident African reed warbler A. baeticatus and migratory sedge warbler A. schoenobaenus exclusively occupying wetland habitats, and Western olivaceous warblers Iduna opaca exclusively occupying dry habitats. These results suggest that specialists in preferred habitats and generalists occupying prey-rich habitats can reduce body reserves, whereas generalists occupying prey-poor habitats carry an increased level of body reserves as a strategic buffer against starvation.	[Vafidis, James O.; Vaughan, Ian P.; Jones, T. Hefin; Facey, Richard J.; Thomas, Robert J.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Parry, Rob] Wildlife Trust South & West Wales, Tondu CF32 0EW, Bridgend, Wales	Cardiff University	Vafidis, JO (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	vafidisjo@cardiff.ac.uk	Vaughan, Ian/A-4782-2010; Thomas, Robert J/A-6612-2010	Vaughan, Ian/0000-0002-7263-3822; Thomas, Robert J/0000-0001-5256-3313; Jones, T Hefin/0000-0002-7874-3627	European Social Fund Knowledge Economy Skills Scholarship project [JV 502719]; Eco-Explore Community Interest Company; Cardiff University, School of Biosciences; Wildlife Trust for South and West Wales	European Social Fund Knowledge Economy Skills Scholarship project; Eco-Explore Community Interest Company; Cardiff University, School of Biosciences; Wildlife Trust for South and West Wales	The research is funded by the European Social Fund Knowledge Economy Skills Scholarship project (JV 502719), Eco-Explore Community Interest Company (RT http://www.eco-explore.co.uk/) and Cardiff University, School of Biosciences, with support from The Wildlife Trust for South and West Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDLEY DJ, 1987, BIRD STUDY, V34, P226, DOI 10.1080/00063658709476965; AIDLEY DJ, 1987, BIRD STUDY, V34, P219, DOI 10.1080/00063658709476964; [Anonymous], 2014, R LANG ENV STAT COMP; BAILLIE SR, 1992, IBIS, V134, P120; Bairlein F., 1995, MANUAL FIELD METHODS; Baumann Sabine, 2001, Vogelwelt, V122, P67; Bayly NJ, 2007, ANIM BEHAV, V74, P471, DOI 10.1016/j.anbehav.2006.11.030; Bedford AP, 2005, HYDROBIOLOGIA, V549, P267, DOI 10.1007/s10750-005-5439-9; BEDNEKOFF PA, 1995, FUNCT ECOL, V9, P457, DOI 10.2307/2390009; Bergstrom BJ, 2008, J AVIAN BIOL, V39, P507, DOI 10.1111/j.0908-8857.2008.03999.x; BIBBY CJ, 1981, ORNIS SCAND, V12, P1, DOI 10.2307/3675898; BLACK WC, 1985, J MED ENTOMOL, V22, P550, DOI 10.1093/jmedent/22.5.550; Blem C.R., 1990, Current Ornithology, V7, P59; BLEM CR, 1975, WILSON BULL, V87, P543; Boano Giovanni, 2004, Avocetta, V28, P77; Borrow N, 2001, BIRDS W AFRICA; Brown DR, 2006, OECOLOGIA, V149, P22, DOI 10.1007/s00442-006-0418-z; Brown Margaret E., 1996, Current Ornithology, V13, P67; BRYANT DM, 1995, BIRD STUDY, V42, P57, DOI 10.1080/00063659509477149; CATCHPOLE CK, 1973, J ANIM ECOL, V42, P623, DOI 10.2307/3128; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; COX GW, 1968, EVOLUTION, V22, P180, DOI 10.1111/j.1558-5646.1968.tb03461.x; DENHELD JJ, 1981, ARDEA, V69, P185; Dhondt AA., 2011, INTERSPECIFIC COMPET; Ekman JB, 1990, BEHAV ECOL, V1, P62, DOI 10.1093/beheco/1.1.62; Fernandez G, 2006, CONDOR, V108, P547, DOI 10.1650/0010-5422(2006)108[547:SAABSD]2.0.CO;2; Flade M, 2011, J ORNITHOL, V152, P129, DOI 10.1007/s10336-011-0666-5; Foppen R, 1999, ARDEA, V87, P113; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Gosler AG, 1996, J ANIM ECOL, V65, P1, DOI 10.2307/5695; Goulson D, 2005, J APPL ECOL, V42, P795, DOI 10.1111/j.1365-2664.2005.01078.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Green RE, 1972, WICKEN FEN GROUP REP, V4, P8; GREENBERG R, 1995, J AVIAN BIOL, V26, P260, DOI 10.2307/3677328; Greenberg R., 1986, Current Ornithology, V3, P281; Grimmett, 1987, REV PROBLEMS AFFECTI; HAWKE CJ, 1996, REEDBED MANAGEMENT C; Herremans M, 1997, ATLAS SO AFRICAN BIR, V2, P96; Hinde R. A., 1956, Ibis, V98, P340; HOGSETTE JA, 1993, J ECON ENTOMOL, V86, P450, DOI 10.1093/jee/86.2.450; HOSMER DW, 2000, WILEY PS TX, P1; Hutto R.L., 1985, P455; Hutto R.L., 1980, P181; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; Jedlicka JA, 2006, J TROP ECOL, V22, P385, DOI 10.1017/S0266467406003191; JENNI L, 1987, ARDEA, V75, P271; Jenni-Eiermann S, 2011, J ORNITHOL, V152, P113, DOI 10.1007/s10336-010-0572-2; JOHNSON DH, 1985, J WILDLIFE MANAGE, V49, P569, DOI 10.2307/3801673; Johnson MD, 2006, CONSERV BIOL, V20, P1433, DOI 10.1111/j.1523-1739.2006.00490.x; Johnson MD, 2005, J ANIM ECOL, V74, P333, DOI 10.1111/j.1365-2656.2005.00928.x; Jones P, 1996, BIRD STUDY, V43, P73, DOI 10.1080/00063659609460997; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; KARR JR, 1976, AM NAT, V110, P973, DOI 10.1086/283121; Kuhn M., 2013, CONTRAST COLLECTION; LEISLER B, 1992, IBIS, V134, P77; Leisler B., 2011, REED WARBLERS DIVERS, DOI [10.1163/9789004278028, DOI 10.1163/9789004278028]; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOSKE K-H, 1990, Ringing and Migration, V11, P23; MacArthur RH, 1972, CHALLENGING BIOL PRO, P253; Neto JM, 2010, J ORNITHOL, V151, P201, DOI 10.1007/s10336-009-0444-9; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MOLLER AP, 1989, J ANIM ECOL, V58, P1051, DOI 10.2307/5141; Moreau R., 1972, PALAEARCTIC AFRICAN; Newton I., 1998, POPULATION LIMITATIO; Norman D, 2013, IBIS, V155, P284, DOI 10.1111/ibi.12036; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Perez-Tris J, 2002, J ANIM ECOL, V71, P211, DOI 10.1046/j.1365-2656.2002.00590.x; RABOL J, 1987, ORNIS SCAND, V18, P101, DOI 10.2307/3676845; Ratikainen II, 2013, ANIM BEHAV, V85, P427, DOI 10.1016/j.anbehav.2012.12.002; Redfern C, 2002, MIGRATION ATLAS MOVE, P548; Rogers Christopher M., 2005, P106; Salewski V, 2006, J ORNITHOL, V147, P192, DOI 10.1007/s10336-006-0057-5; Salewski V, 2003, BEHAV ECOL, V14, P493, DOI 10.1093/beheco/arg021; Salewski V, 2002, IBIS, V144, P85, DOI 10.1046/j.0019-1019.2001.00007.x; Salewski V, 2002, AVIAN SCI, V2, P1; Salewski V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059110; Sauvage Alain, 1998, Malimbus, V20, P33; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt MH, 2005, BIOL CONSERV, V121, P157, DOI 10.1016/j.biocon.2004.03.032; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Svensson L., 1992, IDENTIFICATION GUIDE; SVENSSON SE, 1978, OIKOS, V30, P467, DOI 10.2307/3543342; Szep T, 1995, J APPL STAT, V22, P891, DOI 10.1080/02664769524694; Thaxter Chris B., 2006, Ringing & Migration, V23, P65; Thomas RJ, 2000, ANIM BEHAV, V59, P787, DOI 10.1006/anbe.1999.1360; Tscharntke T, 1999, AQUAT BOT, V64, P399, DOI 10.1016/S0304-3770(99)00066-2; van den Brink B, 2000, OSTRICH, V71, P198, DOI 10.1080/00306525.2000.9639911; Venables WN., 2002, MODERN APPL STAT S 4; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; WITTER MS, 1995, BEHAV ECOL, V6, P343, DOI 10.1093/beheco/6.3.343; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Witter MS, 1997, FUNCT ECOL, V11, P11, DOI 10.1046/j.1365-2435.1997.00041.x; WITTER MS, 1995, FUNCT ECOL, V9, P568, DOI 10.2307/2390146; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zwarts BL, 2009, LIVING EDGE WETLANDS	106	6	8	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113665	10.1371/journal.pone.0113665	http://dx.doi.org/10.1371/journal.pone.0113665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426716	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000349145400076
J	Wright, RC; Khakhar, A; Eshleman, JR; Ostermeier, M				Wright, R. Clay; Khakhar, Arjun; Eshleman, James R.; Ostermeier, Marc			Advancements in the Development of HIF-1 alpha-Activated Protein Switches for Use in Enzyme Prodrug Therapy	PLOS ONE			English	Article							SUICIDE GENE-THERAPY; CREB-BINDING PROTEIN; PHASE-I; ESCHERICHIA-COLI; STRUCTURAL BASIS; BREAST-CANCER; TAZ1 DOMAIN; ACTIVATION; HYPOXIA; DNA	While gene-directed enzyme prodrug therapy has shown potential as a cancer therapeutic in animal and clinical trials, concerns over the efficacy, selectivity, and safety of gene delivery vehicles have restricted its advance. In an attempt to relieve some of the demands on targeted gene delivery vehicles and achieve the full potential of enzyme prodrug therapy, cancer-targeted activity can be engineered into the enzyme itself. We previously engineered a switchable prodrug-activating enzyme that selectively kills human cancer cells accumulating the cancer marker hypoxia-inducible factor-1 alpha (HIF-1 alpha). This HIF-1 alpha-activated protein switch (Haps59) is designed to increase its ability to convert the prodrug 5-fluorocytosine into the chemotherapeutic 5-fluorouracil in a HIF-1 alpha-dependent manner. However, in cancer cell lines expressing Haps59 the 5FC sensitivity difference between the presence and absence of HIF-1 alpha was not as large as desired. In this work, we aimed to improve the cancer specificity of this switch via a directed evolution approach utilizing random mutagenesis, linker mutagenesis, and random insertion and circular permutation. We identified improved HIF-1 alpha-activated protein switches that confer E. coli with modest increases in HIF-1 alpha-dependent 5FC toxicity. Additionally, the current bottleneck in the development of improved HIF-1 alpha-activated protein switches is screening switch candidates in mammalian cells. To accommodate higher throughput and reduce experimental variability, we explored the use of Flp recombinase-mediated isogenic integration in 293 cells. These experiments raised the possibility that Haps59 can be activated by other interactors of the CH1 domain, and experiments in E. coli indicated that CITED2 can also activate Haps59. Although many CH1 binding partners are also oncogenes, CH1's promiscuous binding and subsequent off-target activation of Haps59 needs to be examined under normal physiological conditions to identify off-target activators. With aberrant activating molecules identified, further directed evolution can be performed to improve the cancer specificity of HIF-1 alpha-activated protein switches.	[Wright, R. Clay; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Khakhar, Arjun] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Eshleman, James R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Ctr, Baltimore, MD 21205 USA; [Eshleman, James R.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ostermeier, M (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	oster@jhu.edu	Wright, Clay/AAG-3790-2020; Ostermeier, Marc/A-2697-2010	Wright, Clay/0000-0001-7125-3943; Ostermeier, Marc/0000-0003-0900-3665	National Institutes of Health [R01GM066972]; National Science Foundation [GRFP201008916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant R01GM066972 to MO (www.nih.gov) and National Science Foundation fellowship GRFP201008916 to RCW (www.nsf.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAWE KD, 1987, BRIT J CANCER, V56, P531, DOI 10.1038/bjc.1987.237; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Brix G, 1999, MAGN RESON IMAGING, V17, P151, DOI 10.1016/S0730-725X(98)00115-5; Carpentier G, 2008, IMAGEJ DOT BLOT ANAL; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Crystal RG, 1997, HUM GENE THER, V8, P985, DOI 10.1089/hum.1997.8.8-985; Cunningham C, 2001, Hum Gene Ther, V12, P1594; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; DELHASE M, 1993, J MOL ENDOCRINOL, V11, P129, DOI 10.1677/jme.0.0110129; Duval DL, 2007, MOL ENDOCRINOL, V21, P172, DOI 10.1210/me.2006-0245; Fera D, 2012, BIOCHEMISTRY-US, V51, P9524, DOI 10.1021/bi3011863; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Fox ME, 1996, GENE THER, V3, P173; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Freytag SO, 2002, CANCER RES, V62, P4968; Freytag SO, 2003, CANCER RES, V63, P7497; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gamero AM, 2010, CANCER PREV RES, V3, P495, DOI 10.1158/1940-6207.CAPR-09-0105; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gilkes DM, 2013, P NATL ACAD SCI USA, V104, P7009; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARRIS JD, 1994, GENE THER, V1, P170; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hottiger MO, 2000, TRENDS MICROBIOL, V8, P560, DOI 10.1016/S0966-842X(00)01874-6; HUBER BE, 1994, ANN NY ACAD SCI, V716, P104, DOI 10.1111/j.1749-6632.1994.tb21706.x; Itaka K, 2011, CURR GENE THER, V11, P457, DOI 10.2174/156652311798192879; Johnson AJ, 2011, CANCER GENE THER, V18, P533, DOI 10.1038/cgt.2011.6; Kanwar M, 2013, METHOD ENZYMOL, V523, P369, DOI 10.1016/B978-0-12-394292-0.00017-5; Kucerova L, 2013, CANC LETT, V59, P5830; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lau WM, 2010, INT J CANCER, V126, P876, DOI 10.1002/ijc.24780; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Matt T, 2004, BIOCHEM J, V381, P685, DOI 10.1042/BJ20040564; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Pandha HS, 1999, J CLIN ONCOL, V17, P2180, DOI 10.1200/JCO.1999.17.7.2180; Perez OD, 2012, MOL THER, V20, P1689, DOI 10.1038/mt.2012.83; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rasband WS, 2014, IMAGEJ; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Song C, 2011, HUM GENE THER, V22, P439, DOI 10.1089/hum.2010.116; Stolworthy TS, 2008, J MOL BIOL, V377, P854, DOI 10.1016/j.jmb.2008.01.002; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; TSCHIERSCH B, 1977, CANCER TREAT REP, V61, P1489; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wennbo H, 2000, ONCOGENE, V19, P1072, DOI 10.1038/sj.onc.1203349; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108; Wu ZZ, 2011, J CELL PHYSIOL, V226, P2415, DOI 10.1002/jcp.22589; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; Zaoui K, 2012, CANCER GENE THER, V19, P181, DOI 10.1038/cgt.2011.75; Zhang GY, 2009, CLIN CANCER RES, V15, P201, DOI 10.1158/1078-0432.CCR-08-1094; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhong H, 1999, CANCER RES, V59, P5830	64	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114032	10.1371/journal.pone.0114032	http://dx.doi.org/10.1371/journal.pone.0114032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426963	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400108
J	Krizkova, K; Veverka, V; Maletinska, L; Hexnerova, R; Brzozowski, AM; Jiracek, J; Zakova, L				Krizkova, Kvetoslava; Veverka, Vaclav; Maletinska, Lenka; Hexnerova, Rozalie; Brzozowski, Andrzej M.; Jiracek, Jiri; Zakova, Lenka			Structural and Functional Study of the GlnB22-Insulin Mutant Responsible for Maturity-Onset Diabetes of the Young	PLOS ONE			English	Article							INSULIN GENE-MUTATIONS; BIOLOGICAL-ACTIVITY; PIG INSULIN; B-CHAIN; RECEPTOR; ANALOGS; PROTEIN; SITE; B22; CONFORMATION	The insulin gene mutation c.137G>A (R46Q), which changes an arginine at the B22 position of the mature hormone to glutamine, causes the monogenic diabetes variant maturity-onset diabetes of the young (MODY). In MODY patients, this mutation is heterozygous, and both mutant and wild-type (WT) human insulin are produced simultaneously. However, the patients often depend on administration of exogenous insulin. In this study, we chemically synthesized the MODY mutant [GlnB22]-insulin and characterized its biological and structural properties. The chemical synthesis of this insulin analogue revealed that its folding ability is severely impaired. In vitro and in vivo tests showed that its binding affinity and biological activity are reduced (both approximately 20% that of human insulin). Comparison of the solution structure of [GlnB22]-insulin with the solution structure of native human insulin revealed that the most significant structural effect of the mutation is distortion of the B20-B23 beta-turn, leading to liberation of the B chain C-terminus from the protein core. The distortion of the B20-B23 beta-turn is caused by the extended conformational freedom of the GlnB22 side chain, which is no longer anchored in a hydrogen bonding network like the native ArgB22. The partially disordered [GlnB22]-insulin structure appears to be one reason for the reduced binding potency of this mutant and may also be responsible for its low folding efficiency in vivo. The altered orientation and flexibility of the B20-B23 beta-turn may interfere with the formation of disulfide bonds in proinsulin bearing the R46Q (GlnB22) mutation. This may also have a negative effect on the WT proinsulin simultaneously biosynthesized in beta-cells and therefore play a major role in the development of MODY in patients producing [GlnB22]-insulin.	[Krizkova, Kvetoslava; Veverka, Vaclav; Maletinska, Lenka; Hexnerova, Rozalie; Jiracek, Jiri; Zakova, Lenka] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic; [Brzozowski, Andrzej M.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5DD, N Yorkshire, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Zakova, L (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	zakova@uochb.cas.cz	Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019; Zakova, Lenka/A-7119-2008; Mlčochová, Květoslava/L-6979-2017; Hexnerová, Rozálie/O-6968-2017; Zakova, Lenka/Y-6234-2019; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Maletinska, Lenka/G-5283-2014	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Mlčochová, Květoslava/0000-0002-6226-8067; Hexnerová, Rozálie/0000-0002-3537-8439; Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; 	Charles University Grant Agency [638613]; Medical Research Council [MR/K000179/1]; Ministry of Education of the Czech Republic (programme "NAVRAT'') [LK11205]; Research Project of the Academy of Sciences of the Czech Republic [RVO: 61388963]; MRC [MR/K000179/1] Funding Source: UKRI	Charles University Grant Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education of the Czech Republic (programme "NAVRAT''); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the following: the Charles University Grant Agency (grant No. 638613) http://www.cuni.cz/UKEN-65.html (to KK); the Medical Research Council (grant MR/K000179/1) http://www.mrc.ac.uk/(to AMB, JJ); the Ministry of Education of the Czech Republic (programme "NAVRAT'' LK11205) http://www.msmt.cz/?lang=2 (to VV); and the Research Project of the Academy of Sciences of the Czech Republic RVO: 61388963 www.uochb.cz (to KK, VV, LM, RH, JJ, LZ).	Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Boesgaard TW, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-42; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Chang SG, 1998, BIOCHEM J, V329, P631, DOI 10.1042/bj3290631; De Meyts P, 1976, METHODS RECEPTOR RES, V1, P301; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Du HJ, 2006, ACTA BIOCH BIOPH SIN, V38, P537, DOI 10.1111/j.1745-7270.2006.00198.x; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Kalra Sanjay, 2011, Indian J Endocrinol Metab, V15, pS12, DOI 10.4103/2230-8210.83056; KATSOYANNIS PG, 1975, J CHEM SOC PERK T 1, P464, DOI 10.1039/p19750000464; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurapkat G, 1997, PROTEIN SCI, V6, P580; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKI F, 1979, H-S Z PHYSIOL CHEM, V360, P1619, DOI 10.1515/bchm2.1979.360.2.1619; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P17613; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Nishi M, 2011, J DIABETES INVEST, V2, P92, DOI 10.1111/j.2040-1124.2011.00100.x; RIBEL U, 1990, DIABETES, V39, P1033, DOI 10.2337/diabetes.39.9.1033; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Stoy J, 2010, REV ENDOCR METAB DIS, V11, P205, DOI 10.1007/s11154-010-9151-3; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; WANG SH, 1991, J PROTEIN CHEM, V10, P313, DOI 10.1007/BF01025630; WEITZEL G, 1977, H-S Z PHYSIOL CHEM, V358, P1573, DOI 10.1515/bchm2.1977.358.2.1573; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; ZHU SQ, 1981, SCI SINICA, V24, P264; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4021; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	52	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112883	10.1371/journal.pone.0112883	http://dx.doi.org/10.1371/journal.pone.0112883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423173	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700015
J	Mazzei, M; Carrozza, ML; Luisi, E; Forzan, M; Giusti, M; Sagona, S; Tolari, F; Felicioli, A				Mazzei, Maurizio; Carrozza, Maria Luisa; Luisi, Elena; Forzan, Mario; Giusti, Matteo; Sagona, Simona; Tolari, Francesco; Felicioli, Antonio			Infectivity of DWV Associated to Flower Pollen: Experimental Evidence of a Horizontal Transmission Route	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; HONEYBEES APIS-MELLIFERA; MITES VARROA-DESTRUCTOR; KASHMIR BEE VIRUS; PARASITIC MITE; REPLICATION; PREVALENCE; PATHOGENS; COLONIES; HOST	Deformed wing virus (DWV) is a honeybee pathogen whose presence is generally associated with infestation of the colony by the mite Varroa destructor, leading to the onset of infections responsible for the collapse of the bee colony. DWV contaminates bee products such as royal jelly, bee-bread and honey stored within the infected hive. Outside the hive, DWV has been found in pollen loads collected directly from infected as well as uninfected forager bees. It has been shown that the introduction of virus-contaminated pollen into a DWV-free hive results in the production of virus-contaminated food, whose role in the development of infected bees from virus-free eggs has been experimentally demonstrated. The aim of this study was twofold: (i) to ascertain the presence of DWV on pollen collected directly from flowers visited by honeybees and then quantify the viral load and (ii) determine whether the virus associated with pollen is infective. The results of our investigation provide evidence that DWV is present on pollen sampled directly from visited flowers and that, following injection in individuals belonging to the pollinator species Apis mellifera, it is able to establish an active infection, as indicated by the presence of replicating virus in the head of the injected bees. We also provide the first indication that the pollinator species Osmia cornuta is susceptible to DWV infection.	[Mazzei, Maurizio; Luisi, Elena; Forzan, Mario; Giusti, Matteo; Sagona, Simona; Tolari, Francesco; Felicioli, Antonio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Carrozza, Maria Luisa] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; Scuola Normale Superiore di Pisa	Felicioli, A (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	Antonio.felicioli@unipi.it	Sagona, Simona/AAT-8969-2021; Mazzei, Maurizio/H-5788-2016; Felicioli, Antonio/AAT-2167-2021; sagona, simona/GXH-0254-2022	Mazzei, Maurizio/0000-0003-3797-8320; Forzan, Mario/0000-0003-2474-8219	European Union FP/Project STEP [244090-STEP-FP]; Fondi di Ateneo	European Union FP/Project STEP; Fondi di Ateneo	This study was financially supported in part by European Union FP/Project STEP (Grant no 244090-STEP-FP) and by Fondi di Ateneo 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Barriga GP, 2012, VIRUS GENES, V45, P606, DOI 10.1007/s11262-012-0791-0; Berenyi O, 2007, APPL ENVIRON MICROB, V73, P3605, DOI 10.1128/AEM.00696-07; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; de Miranda JR, 2010, J INVERTEBR PATHO S1, V1, P48; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nordstrom S, 2003, EXP APPL ACAROL, V29, P293, DOI 10.1023/A:1025853731214; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	28	64	67	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113448	10.1371/journal.pone.0113448	http://dx.doi.org/10.1371/journal.pone.0113448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419704	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900037
J	Russo, R; Cassiano, MGV; Ciociaro, A; Adornetto, A; Varano, GP; Chiappini, C; Berliocchi, L; Tassorelli, C; Bagetta, G; Corasaniti, MT				Russo, Rossella; Cassiano, Maria Gilda Valentina; Ciociaro, Antonella; Adornetto, Annagrazia; Varano, Giuseppe Pasquale; Chiappini, Carlotta; Berliocchi, Laura; Tassorelli, Cristina; Bagetta, Giacinto; Corasaniti, Maria Tiziana			Role of D-Limonene in Autophagy Induced by Bergamot Essential Oil in SH-SY5Y Neuroblastoma Cells	PLOS ONE			English	Article							COLON-CANCER CELLS; IN-VITRO ACTIVITY; RAT; GROWTH; COMPLEX; DEATH; PREVENTION; INHIBITION; MECHANISM; SIGNALS	Bergamot (Citrus bergamia, Risso et Poiteau) essential oil (BEO) is a well characterized, widely used plant extract. BEO exerts anxiolytic, analgesic and neuroprotective activities in rodents through mechanisms that are only partly known and need to be further investigated. To gain more insight into the biological effects of this essential oil, we tested the ability of BEO (0.005-0.03%) to modulate autophagic pathways in human SH-SY5Y neuroblastoma cells. BEO-treated cells show increased LC3II levels and appearance of dot-like formations of endogenous LC3 protein that colocalize with the lysosome marker LAMP-1. Autophagic flux assay using bafilomycin A1 and degradation of the specific autophagy substrate p62 confirmed that the observed increase of LC3II levels in BEO-exposed cells is due to autophagy induction rather than to a decreased autophagosomal turnover. Induction of autophagy is an early and not cell-line specific response to BEO. Beside basal autophagy, BEO also enhanced autophagy triggered by serum starvation and rapamycin indicating that the underlying mechanism is mTOR independent. Accordingly, BEO did not affect the phosphorylation of ULK1 (Ser757) and p70(S6K) (Thr389), two downstream targets of mTOR. Furthermore, induction of autophagy by BEO is beclin-1 independent, occurs in a concentration-dependent manner and is unrelated to the ability of BEO to induce cell death. In order to identify the active constituents responsible for these effects, the two most abundant monoterpenes found in the essential oil, d-limonene (125-750 mu M) and linalyl acetate (62.5-375 mu M), were individually tested at concentrations comparable to those found in 0.005-0.03% BEO. The same features of stimulated autophagy elicited by BEO were reproduced by d-limonene, which rapidly increases LC3II and reduces p62 levels in a concentration-dependent manner. Linalyl acetate was ineffective in replicating BEO effects; however, it greatly enhanced LC3 lipidation triggered by d-limonene.	[Russo, Rossella; Adornetto, Annagrazia; Varano, Giuseppe Pasquale; Bagetta, Giacinto] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Sect Preclin & Translat Pharmacol, I-87036 Cosenza, Italy; [Cassiano, Maria Gilda Valentina; Ciociaro, Antonella; Chiappini, Carlotta; Berliocchi, Laura; Corasaniti, Maria Tiziana] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Tassorelli, Cristina] Univ Pavia, Headache Sci Ctr, Natl Neurol Inst C Mondino, I-27100 Pavia, Italy; [Tassorelli, Cristina] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Calabria; Magna Graecia University of Catanzaro; IRCCS Istituto Neurologico Besta; University of Pavia; University of Pavia	Russo, R (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Sect Preclin & Translat Pharmacol, I-87036 Cosenza, Italy.	rossella.russo@unical.it; mtcorasa@unicz.it	Tassorelli, Cristina/AAC-1483-2019; Bagetta, Giacinto/E-8402-2012; Bagetta, Giacinto/N-9716-2018; Corasaniti, Maria Tiziana/N-1332-2015; Adornetto, Annagrazia/AAG-5467-2020	Tassorelli, Cristina/0000-0003-1513-2113; Bagetta, Giacinto/0000-0001-8540-6218; Bagetta, Giacinto/0000-0001-8540-6218; Corasaniti, Maria Tiziana/0000-0001-6472-0697; Adornetto, Annagrazia/0000-0003-1869-2642; Russo, Rossella/0000-0001-8758-6523; Berliocchi, Laura/0000-0002-3014-1838				Amantea D, 2009, INT REV NEUROBIOL, V85, P389, DOI 10.1016/S0074-7742(09)85027-7; Bagetta G, 2010, FITOTERAPIA, V81, P453, DOI 10.1016/j.fitote.2010.01.013; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Berliocchi L, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-83; Berliocchi L, 2011, FOOD CHEM TOXICOL, V49, P2780, DOI 10.1016/j.fct.2011.08.017; Bicas JL, 2011, FOOD CHEM TOXICOL, V49, P1610, DOI 10.1016/j.fct.2011.04.012; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chaudhary SC, 2012, HUM EXP TOXICOL, V31, P798, DOI 10.1177/0960327111434948; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; Cosentino M, 2014, PHYTOTHER RES; CROWELL PL, 1991, J BIOL CHEM, V266, P17679; Dugo P, 2000, J PHARMACEUT BIOMED, V24, P147, DOI 10.1016/S0731-7085(00)00400-3; ELSON CE, 1988, CARCINOGENESIS, V9, P331, DOI 10.1093/carcin/9.2.331; Manuele MG, 2010, CANCER INVEST, V28, P135, DOI 10.3109/07357900903179583; Manuele MG, 2009, PHYTOTHER RES, V23, P1011, DOI 10.1002/ptr.2743; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Itani WS, 2008, CANCER BIOL THER, V7, P1765, DOI 10.4161/cbt.7.11.6740; Jia SS, 2013, ONCOL REP, V29, P349, DOI 10.3892/or.2012.2093; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karlson J, 1996, ANTI-CANCER DRUG, V7, P422, DOI 10.1097/00001813-199606000-00008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Laird K, 2012, J HOSP INFECT, V80, P61, DOI 10.1016/j.jhin.2011.04.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MALTZMAN TH, 1989, CARCINOGENESIS, V10, P781, DOI 10.1093/carcin/10.4.781; Miller JA, 2013, CANCER PREV RES, V6, P577, DOI 10.1158/1940-6207.CAPR-12-0452; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mondello L, 1993, FLAVOUR FRAG J, V8, P17, DOI 10.1002/ffj.2730080105; Mondello Luigi, 1995, Flavour and Fragrance Journal, V10, P33, DOI 10.1002/ffj.2730100106; Morrone LA, 2007, PHARMACOL RES, V55, P255, DOI 10.1016/j.phrs.2006.11.010; Murthy KNC, 2012, LIFE SCI, V91, P429, DOI 10.1016/j.lfs.2012.08.016; Ndao DH, 2012, PSYCHO-ONCOLOGY, V21, P247, DOI 10.1002/pon.1898; Rabi Thangaiyan, 2009, J Carcinog, V8, P9, DOI 10.4103/1477-3163.51368; Romano L, 2005, J ANTIMICROB CHEMOTH, V55, P110, DOI 10.1093/jac/dkh503; Rombola L, 2009, FUNCT NEUROL, V24, P107; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; Russo R, 2013, FITOTERAPIA, V89, P48, DOI 10.1016/j.fitote.2013.05.014; Saiyudthong S, 2011, PHYTOTHER RES, V25, P858, DOI 10.1002/ptr.3325; Sakurada T, 2009, INT REV NEUROBIOL, V85, P237, DOI 10.1016/S0074-7742(09)85018-6; Sanguinetti M, 2007, J ANTIMICROB CHEMOTH, V59, P305, DOI 10.1093/jac/dkl473; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Verzera A, 2003, J AGR FOOD CHEM, V51, P206, DOI 10.1021/jf0206872; Verzera A., 1996, Perfumer & Flavorist, V21, P19; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	49	32	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113682	10.1371/journal.pone.0113682	http://dx.doi.org/10.1371/journal.pone.0113682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419658	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900064
J	Merikanto, I; Laakso, JT; Kaitala, V				Merikanto, Ilona; Laakso, Jouni T.; Kaitala, Veijo			Invasion Ability and Disease Dynamics of Environmentally Growing Opportunistic Pathogens under Outside-Host Competition	PLOS ONE			English	Article							FLAVOBACTERIUM-COLUMNARE; EVOLUTIONARY DYNAMICS; CHANNEL CATFISH; VIRULENCE; POPULATION; TRANSMISSION; STABILITY; MORTALITY; PREDATION; COMMUNITY	Most theories of the evolution of virulence concentrate on obligatory host-pathogen relationship. Yet, many pathogens replicate in the environment outside-host where they compete with non-pathogenic forms. Thus, replication and competition in the outside-host environment may have profound influence on the evolution of virulence and disease dynamics. These environmentally growing opportunistic pathogens are also a logical step towards obligatory pathogenicity. Efficient treatment methods against these diseases, such as columnaris disease in fishes, are lacking because of their opportunist nature. We present a novel epidemiological model in which replication and competition in the outside-host environment influences the invasion ability of a novel pathogen. We also analyze the long-term host-pathogen dynamics. Model parameterization is based on the columnaris disease, a bacterial fresh water fish disease that causes major losses in fish farms worldwide. Our model demonstrates that strong competition in the outside-host environment can prevent the invasion of a new environmentally growing opportunist pathogen and long-term disease outbreaks.	[Merikanto, Ilona; Laakso, Jouni T.; Kaitala, Veijo] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Merikanto, Ilona] Natl Inst Hlth & Welf, Helsinki, Finland; [Laakso, Jouni T.] Univ Jyvaskyla, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Jyvaskyla	Merikanto, I (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ilona.merikanto@helsinki.fi	merikanto, ilona/AAF-2395-2021; Laakso, Jouni/I-7794-2013	Merikanto, Ilona/0000-0002-1222-6678; Laakso, Jouni/0000-0001-8245-9912	Finnish Academy [1267541, 1130724, 1255572]; Research Foundation of the University of Helsinki; Ella and Georg Ehrnrooth foundation	Finnish Academy(Academy of Finland); Research Foundation of the University of Helsinki; Ella and Georg Ehrnrooth foundation	This study was funded by the Finnish Academy projects #1267541 for VK, #1130724 and #1255572 for JL, and by a personal grant for IM from the Research Foundation of the University of Helsinki and Ella and Georg Ehrnrooth foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2006, BROCK BIOL MICROORGA; Boldin B, 2012, EVOLUTION, V66, P2514, DOI 10.1111/j.1558-5646.2012.01613.x; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Caraco T, 2008, J THEOR BIOL, V250, P569, DOI 10.1016/j.jtbi.2007.10.029; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Ehrlich GD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-225; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hiltunen T, 2012, ACTA OECOL, V38, P77, DOI 10.1016/j.actao.2011.09.010; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Menon P, 2003, WATER RES, V37, P4151, DOI 10.1016/S0043-1354(03)00349-X; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Roche B, 2011, ECOL LETT, V14, P569, DOI 10.1111/j.1461-0248.2011.01619.x; SERVAIS P, 1985, APPL ENVIRON MICROB, V49, P1448, DOI 10.1128/AEM.49.6.1448-1454.1985; Soto E, 2008, J APPL MICROBIOL, V104, P1302, DOI 10.1111/j.1365-2672.2007.03632.x; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2006, J FISH DIS, V29, P757, DOI 10.1111/j.1365-2761.2006.00771.x; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Trivedi SR, 2011, J FELINE MED SURG, V13, P163, DOI 10.1016/j.jfms.2011.01.009; Veneault-Fourrey C, 2011, CURR OPIN PLANT BIOL, V14, P444, DOI 10.1016/j.pbi.2011.03.022; von Graevenitz A, 1977, Annu Rev Microbiol, V31, P447; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wedekind C, 2010, ECOLOGY, V91, P1251, DOI 10.1890/09-1067.1	46	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113436	10.1371/journal.pone.0113436	http://dx.doi.org/10.1371/journal.pone.0113436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415341	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600047
J	Garrisi, VM; Strippoli, S; De Summa, S; Pinto, R; Perrone, A; Guida, G; Azzariti, A; Guida, M; Stefania, T				Garrisi, Vito Michele; Strippoli, Sabino; De Summa, Simona; Pinto, Rosamaria; Perrone, Antonella; Guida, Gabriella; Azzariti, Amalia; Guida, Michele; Stefania, Tommasi			Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; CELLS; VEMURAFENIB; SURVIVAL; PROTEIN	Introduction: Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of care for metastatic melanoma patients with BRAF V600, while chemotherapy continued to be widely used in BRAF wild type patients. Materials and Methods: In order to discover novel candidate biomarkers predictive to treatment, serum of 39 metastatic melanoma vemurafenib (n=19) or chemotherapy (n=20) treated patients at baseline, at disease control and at progression, were analyzed using SELDI-TOF technology. In silico analysis was used to identify more significant peaks. Results: In patients with different BRAF status, we found 5 peptides significantly deregulated, with the down-regulation of the m/z 9176 peak strongly associated with BRAF mutation. At baseline as predictive biomarkers we identified 2 peptides m/z 6411, 4075 - as significantly up-regulated in responders to chemotherapy and 4 peaks - m/z 5900, 12544, 49124 and 11724 - significantly up-regulated in longer vs shorter responders to vemurafenib. After response, 3 peptides (m/z 4658, 18639, and 9307) resulted significantly down regulated while 3 peptides m/z 9292, 7765 and 9176 appeared up-regulated respectively in chemotherapy and vemurafenib responder patients. In vemurafenib treated patients, 16 peaks appeared deregulated at progression compared to baseline time. In silico analysis identified proteins involved in invasiveness (SLAIN1) and resistance (ABCC12) as well as in the pathway of detoxification (NQO1) and apoptosis (RBM10, TOX3, MTEFD1, TSPO2). Proteins associated with the modulation of neuronal plasticity (RIN1) and regulatory activity factors of gene transcription (KLF17, ZBTB44) were also highlighted. Conclusion: Our exploratory study highlighted some factors that deserve to be further investigated in order to provide a framework for improving melanoma treatment management through the development of biomarkers which could act as the strongest surrogates of the key biological events in stage IV melanoma.	[Garrisi, Vito Michele; Strippoli, Sabino; De Summa, Simona; Pinto, Rosamaria; Perrone, Antonella; Azzariti, Amalia; Guida, Michele; Stefania, Tommasi] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Bari, Italy; [Guida, Gabriella] Univ Bari, Dept Basic Med Sci, Fac Med & Surg, Sch Med, Bari, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro	Stefania, T (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Bari, Italy.	s.tommasi@oncologico.bari.it	Guida, Michele/AAG-7017-2020; De Summa, Simona/K-2582-2018; Azzariti, Amalia/K-4498-2016; strippoli, sabino/AAF-6774-2021; Tommasi, Stefania/J-6732-2012	De Summa, Simona/0000-0001-9607-3754; Azzariti, Amalia/0000-0002-6149-5049; strippoli, sabino/0000-0001-7982-7788; Tommasi, Stefania/0000-0002-2157-2978; Guida, Gabriella/0000-0003-2345-2838; Guida, michele/0000-0001-8411-0319	IRCCS Istituto Tumori "Giovanni Paolo II"; MIUR Italian Ministry of University [PON01_01297]	IRCCS Istituto Tumori "Giovanni Paolo II"; MIUR Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	Funding: The study has been supported by internal research grants of IRCCS Istituto Tumori "Giovanni Paolo II" and by MIUR Italian Ministry of University and research) http://www.istruzione.it/, GRANT Number: PON01_01297, Author who received the funding: ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara A, 2014, HEPATOLOGY, V60, P1302, DOI 10.1002/hep.27275; Alcazar O, 2012, INT J CANCER, V131, P18, DOI 10.1002/ijc.26320; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baquero P, 2013, CANCER LETT, V335, P232, DOI 10.1016/j.canlet.2013.02.033; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen BL, 2008, ONCOL REP, V20, P1093, DOI 10.3892/or_00000114; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cooper CDO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023916; Croft A, 2014, J INVEST DERMATOL, V134, P488, DOI 10.1038/jid.2013.325; Daniele S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04749; Davidov T, 2014, J SURG RES, V190, P565, DOI 10.1016/j.jss.2014.03.042; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fang P, 2012, TUMOR BIOL, V33, P1511, DOI 10.1007/s13277-012-0402-7; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Findeisen P, 2008, JCO, V27, P2199; Forsea AM, 2012, BRIT J DERMATOL, V167, P1124, DOI 10.1111/j.1365-2133.2012.11125.x; Garrisi VM, 2013, CLIN BIOCHEM, V46, P259, DOI 10.1016/j.clinbiochem.2012.11.003; Garrisi VM, 2011, CLIN BIOCHEM, V44, P936, DOI 10.1016/j.clinbiochem.2011.04.013; Garrisi VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049631; Garrisi VM, 2008, EXPERT REV PROTEOMIC, V5, P779, DOI 10.1586/14789450.5.6.779; Guida M, 2012, EXPERT OPIN THER TAR, V16, pS61, DOI 10.1517/14728222.2011.645807; Guida M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-115; Hersh E, 2012, PIGM CELL MELANOMA R, V25, P863; Hersh EM, 2010, CANCER-AM CANCER SOC, V116, P155, DOI 10.1002/cncr.24720; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iwanicki MP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-244; Jang S, 2014, CLIN PHARMACOL THER, V95, P24, DOI 10.1038/clpt.2013.197; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Mactier S, 2011, J PROTEOME RES, V10, P1030, DOI 10.1021/pr100803b; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Mocellin S, 2012, CURR MED CHEM, V19, P3893, DOI 10.2174/092986712802002509; Mocellin S, 2008, INT J CANCER, V123, P2370, DOI 10.1002/ijc.23794; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Orlandi R, 2014, ANN ONCOL, V25, P352, DOI 10.1093/annonc/mdt490; Pey AL, 2014, BBA-MOL BASIS DIS, V1842, P2163, DOI 10.1016/j.bbadis.2014.08.011; Pooley KA, 2013, HUM MOL GENET, V22, P5056, DOI 10.1093/hmg/ddt355; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Santagata S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007932; Shin N, 2011, INT J CANCER, V128, P2872, DOI 10.1002/ijc.25641; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Takeuchi H, 2010, MOL CELL BIOL, V30, P1689, DOI 10.1128/MCB.01105-09; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Verdoliva V, 2013, PONE; Vereecken P, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/260643; Xue Q, 2013, J CANCER RES CLIN, V139, P1539, DOI 10.1007/s00432-013-1474-5; Yang H, 2010, ONCOL REP, V24, P1257, DOI 10.3892/or_00000980	50	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112025	10.1371/journal.pone.0112025	http://dx.doi.org/10.1371/journal.pone.0112025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437182	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900011
J	Graf, DRH; Jones, CM; Hallin, S				Graf, Daniel R. H.; Jones, Christopher M.; Hallin, Sara			Intergenomic Comparisons Highlight Modularity of the Denitrification Pathway and Underpin the Importance of Community Structure for N2O Emissions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NITROUS-OXIDE PRODUCTION; NOS GENE-CLUSTER; WOLINELLA-SUCCINOGENES; SPATIAL-PATTERNS; MOLECULAR-BASIS; NITRIC-OXIDE; BACTERIAL; SOIL; DIVERSITY	Nitrous oxide (N2O) is a potent greenhouse gas and the predominant ozone depleting substance. The only enzyme known to reduce N2O is the nitrous oxide reductase, encoded by the nosZ gene, which is present among bacteria and archaea capable of either complete denitrification or only N2O reduction to di-nitrogen gas. To determine whether the occurrence of nosZ, being a proxy for the trait N2O reduction, differed among taxonomic groups, preferred habitats or organisms having either NirK or NirS nitrite reductases encoded by the nirK and nirS genes, respectively, 652 microbial genomes across 18 phyla were compared. Furthermore, the association of different co-occurrence patterns with enzymes reducing nitric oxide to N2O encoded by nor genes was examined. We observed that co-occurrence patterns of denitrification genes were not randomly distributed across taxa, as specific patterns were found to be more dominant or absent than expected within different taxonomic groups. The nosZ gene had a significantly higher frequency of co-occurrence with nirS than with nirK and the presence or absence of a nor gene largely explained this pattern, as nirS almost always co-occurred with nor. This suggests that nirS type denitrifiers are more likely to be capable of complete denitrification and thus contribute less to N2O emissions than nirK type denitrifiers under favorable environmental conditions. Comparative phylogenetic analysis indicated a greater degree of shared evolutionary history between nosZ and nirS. However 30% of the organisms with nosZ did not possess either nir gene, with several of these also lacking nor, suggesting a potentially important role in N2O reduction. Co-occurrence patterns were also non-randomly distributed amongst preferred habitat categories, with several habitats showing significant differences in the frequencies of nirS and nirK type denitrifiers. These results demonstrate that the denitrification pathway is highly modular, thus underpinning the importance of community structure for N2O emissions.	[Graf, Daniel R. H.; Jones, Christopher M.; Hallin, Sara] Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Hallin, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala, Sweden.	Sara.Hallin@slu.se	Hallin, Sara/H-4648-2012; Jones, Christopher/H-4369-2015; Jones, Chris/G-7687-2011	Hallin, Sara/0000-0002-9069-9024; Jones, Christopher/0000-0002-2723-6019; Jones, Chris/0000-0002-2723-6019	Oscar and Lili Lamm foundation [2010-11-13]; Faculty of Natural Resources and Agricultural Sciences at the Swedish University of Agricultural Sciences; Swedish Research Council [2011-4421]	Oscar and Lili Lamm foundation; Faculty of Natural Resources and Agricultural Sciences at the Swedish University of Agricultural Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Oscar and Lili Lamm foundation (www.stiftelsenlamm.a.se/) through a grant (contract 2010-11-13) to SH, strategic funding from the Faculty of Natural Resources and Agricultural Sciences at the Swedish University of Agricultural Sciences to SH, and a research grant (contract 2011-4421) from the Swedish Research Council (www.vr.se) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baek SH, 2004, J BACTERIOL, V186, P6025, DOI 10.1128/JB.186.18.6025-6031.2004; Baneras L, 2012, INT MICROBIOL, V15, P89, DOI 10.2436/20.1501.01.162; Barth KR, 2009, MICROBIOL-SGM, V155, P4093, DOI 10.1099/mic.0.032961-0; Bartossek R, 2010, ENVIRON MICROBIOL, V12, P1075, DOI 10.1111/j.1462-2920.2010.02153.x; Campbell MA, 2011, FEMS MICROBIOL LETT, V322, P82, DOI 10.1111/j.1574-6968.2011.02340.x; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Clark IM, 2012, PHILOS T R SOC B, V367, P1235, DOI 10.1098/rstb.2011.0314; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Dalber A, 2005, J INORG BIOCHEM, V99, P185, DOI 10.1016/j.jinorgbio.2004.09.018; Desnues C, 2007, WATER RES, V41, P3407, DOI 10.1016/j.watres.2007.04.018; Edenhofer O., 2014, CONTRIBUTION WORKING; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Etchebehere C, 2005, APPL ENVIRON MICROB, V71, P5642, DOI 10.1128/AEM.71.9.5642-5645.2005; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2014, NAT CLIM CHANGE, V4, P801, DOI [10.1038/NCLIMATE2301, 10.1038/nclimate2301]; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jones CM, 2011, FEMS MICROBIOL ECOL, V76, P541, DOI 10.1111/j.1574-6941.2011.01071.x; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kern M, 2009, BBA-BIOENERGETICS, V1787, P646, DOI 10.1016/j.bbabio.2008.12.010; KIZAWA H, 1991, J BIOL CHEM, V266, P10632; Kool DM, 2011, SOIL BIOL BIOCHEM, V43, P174, DOI 10.1016/j.soilbio.2010.09.030; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Kraft B, 2014, ENVIRON MICROBIOL, V16, P3275, DOI 10.1111/1462-2920.12552; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu BB, 2013, ENVIRON MICROBIOL, V15, P2816, DOI 10.1111/1462-2920.12142; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu XQ, 2008, FEMS MICROBIOL LETT, V289, P46, DOI 10.1111/j.1574-6968.2008.01362.x; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; PAYNE WJ, 1982, J BACTERIOL, V152, P915; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Philippot L, 2005, TRENDS MICROBIOL, V13, P191, DOI 10.1016/j.tim.2005.03.001; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Philippot L, 2009, ENVIRON MICROBIOL, V11, P3096, DOI 10.1111/j.1462-2920.2009.02014.x; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Rockstrom J, 2009, ECOL SOC, V14; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Santoro AE, 2006, APPL ENVIRON MICROB, V72, P2102, DOI 10.1128/AEM.72.3.2102-2109.2006; Shapleigh JP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P769, DOI 10.1007/0-387-30742-7_23; Simon J, 2004, FEBS LETT, V569, P7, DOI 10.1016/j.febslet.2004.05.060; Simon J, 2013, BBA-BIOENERGETICS, V1827, P114, DOI 10.1016/j.bbabio.2012.07.005; Smith JM, 2008, APPL ENVIRON MICROB, V74, P5615, DOI 10.1128/AEM.00349-08; Spiro S, 2012, PHILOS T R SOC B, V367, P1213, DOI 10.1098/rstb.2011.0309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein LY, 2011, BIOCHEM SOC T, V39, P1826, DOI 10.1042/BST20110712; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Sutton M.A., 2011, EUROPEAN NITROGEN AS; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Vial L, 2006, J BACTERIOL, V188, P5364, DOI 10.1128/JB.00521-06; Wu DM, 2013, SOIL BIOL BIOCHEM, V60, P165, DOI 10.1016/j.soilbio.2013.01.028; Yuan Q, 2012, ENV MICROBIOL REP, V4, P113, DOI 10.1111/j.1758-2229.2011.00311.x; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	74	277	290	22	226	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114118	10.1371/journal.pone.0114118	http://dx.doi.org/10.1371/journal.pone.0114118			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436772	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900119
J	Heiden, S; Grund, C; Roder, A; Granzow, H; Kuhnel, D; Mettenleiter, TC; Romer-Oberdorfer, A				Heiden, Sandra; Grund, Christian; Roeder, Anja; Granzow, Harald; Kuehnel, Denis; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela			Different Regions of the Newcastle Disease Virus Fusion Protein Modulate Pathogenicity	PLOS ONE			English	Article							PARAMYXOVIRUS TYPE-1; NUCLEOTIDE-SEQUENCE; CYTOPLASMIC DOMAIN; TISSUE-CULTURE; CLEAVAGE SITE; GLYCOPROTEIN; VIRULENCE; REQUIREMENTS; REPLICATION; CLEAVABILITY	Newcastle disease virus (NDV), also designated as Avian paramyxovirus type 1 (APMV-1), is the causative agent of a notifiable disease of poultry but it exhibits different pathogenicity dependent on the virus strain. The molecular basis for this variability is not fully understood. The efficiency of activation of the fusion protein (F) is determined by presence or absence of a polybasic amino acid sequence at an internal proteolytic cleavage site which is a major determinant of NDV virulence. However, other determinants of pathogenicity must exist since APMV-1 of high (velogenic), intermediate (mesogenic) and low (lentogenic) virulence specify a polybasic F cleavage site. We aimed at elucidation of additional virulence determinants by constructing a recombinant virus that consists of a lentogenic NDV Clone 30 backbone and the F protein gene from a mesogenic pigeon paramyxovirus-1 (PPMV-1) isolate with an intracerebral pathogenicity index (ICPI) of 1.1 specifying the polybasic sequence R-R-K-K-R* F motif at the cleavage site. The resulting virus was characterized by an ICPI of 0.6, indicating a lentogenic pathotype. In contrast, alteration of the cleavage site G-R-Q-G-R* L of the lentogenic Clone 30 to R-R-K-K-R* F resulted in a recombinant virus with an ICPI of 1.36 which was higher than that of parental PPMV-1. Substitution of different regions of the F protein of Clone 30 by those of PPMV-1, while maintaining the polybasic amino acid sequence at the F cleavage site, resulted in recombinant viruses with ICPIs ranging from 0.59 to 1.36 suggesting that virulence is modulated by regions of the F protein other than the polybasic cleavage site.	[Heiden, Sandra; Roeder, Anja; Kuehnel, Denis; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Grund, Christian] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Granzow, Harald] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectiol, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Romer-Oberdorfer, A (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany.	angela.roemer-oberdoerfer@fli.bund.de	Mettenleiter, h. c. Thomas C./U-1016-2019		MSD Animal Health; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture	MSD Animal Health(Merck & CompanyIntervet International B.V.); Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture	The study was funded in part by MSD Animal Health (http://www.msd-animal-health.nl/) and supported by the budget of the Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture. No other individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; ALEXANDER DJ, 1985, VET REC, V117, P429, DOI 10.1136/vr.117.17.429; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Alexander DJ, 1997, DIS POULTRY, P541; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; BIANCIFIORI F, 1983, COMP IMMUNOL MICROB, V6, P247, DOI 10.1016/0147-9571(83)90017-6; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CEC, 1992, OFFICIAL J EUROPEAN, V260, P1; Collins MS, 1996, ARCH VIROL, V141, P635, DOI 10.1007/BF01718322; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Deng R, 1997, ARCH VIROL, P115; Dolganiuc V, 2003, J VIROL, V77, P12968, DOI 10.1128/JVI.77.24.12968-12979.2003; Dortmans JCFM, 2011, J GEN VIROL, V92, P336, DOI 10.1099/vir.0.026344-0; Dortmans JCFM, 2009, J GEN VIROL, V90, P2746, DOI 10.1099/vir.0.014118-0; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Gravel KA, 2003, J VIROL, V77, P11040, DOI 10.1128/JVI.77.20.11040-11049.2003; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; KAWAHARA N, 1992, J GEN VIROL, V73, P583, DOI 10.1099/0022-1317-73-3-583; King A M Q, 2012, VIRUS TAXONOMY PARAM, P672; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; MILLAR NS, 1988, J GEN VIROL, V69, P613, DOI 10.1099/0022-1317-69-3-613; Morrison TG, 2001, TRENDS MICROBIOL, V9, P103, DOI 10.1016/S0966-842X(01)01959-X; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1977, VIROLOGY, V77, P125, DOI 10.1016/0042-6822(77)90412-3; Paldurai A, 2014, J VIROL, V88, P8579, DOI 10.1128/JVI.00666-14; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Ramp K, 2011, AVIAN DIS, V55, P413, DOI 10.1637/9652-011111-Reg.1; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Romer-Oberdorfer A, 1999, J GEN VIROL, V80, P2987, DOI 10.1099/0022-1317-80-11-2987; SAKAGUCHI T, 1991, VIROLOGY, V184, P504, DOI 10.1016/0042-6822(91)90420-G; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Werner O, 1999, AVIAN PATHOL, V28, P79, DOI 10.1080/03079459995082	45	21	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113344	10.1371/journal.pone.0113344	http://dx.doi.org/10.1371/journal.pone.0113344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437176	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900041
J	Jeong, BH; Shin, B; Eom, JS; Yoo, H; Song, W; Han, S; Lee, KJ; Jeon, K; Um, SW; Koh, WJ; Suh, GY; Chung, MP; Kim, H; Kwon, OJ; Woo, S; Park, HY				Jeong, Byeong-Ho; Shin, Beomsu; Eom, Jung Seop; Yoo, Hongseok; Song, Wonjun; Han, Sangbin; Lee, Kyung Jong; Jeon, Kyeongman; Um, Sang-Won; Koh, Won-Jung; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Woo, Sookyoung; Park, Hye Yun			Development of a Prediction Rule for Estimating Postoperative Pulmonary Complications	PLOS ONE			English	Article							MAJOR NONCARDIAC SURGERY; COLLEGE-OF-PHYSICIANS; LAPAROSCOPIC CHOLECYSTECTOMY; NONCARDIOTHORACIC SURGERY; INCENTIVE SPIROMETRY; ABDOMINAL-SURGERY; OUTCOMES; RISK; INDEX; ASSOCIATION	Patient-and procedure-related factors associated with postoperative pulmonary complications (PPCs) have changed over the last decade. Therefore, we sought to identify independent risk factors of PPCs and to develop a clinically applicable scoring system. We retrospectively analyzed clinical data from 2,059 patients who received preoperative evaluations from respiratory physicians between June 2011 and October 2012. A new scoring system for estimating PPCs was developed using beta coefficients of the final multiple regression models. Of the 2,059 patients studied, 140 (6.8%) had PPCs. A multiple logistic regression model revealed seven independent risk factors (with scores in parentheses): age >= 70 years (2 points), current smoker (1 point), the presence of airflow limitation (1 point), American Society of Anesthesiologists class >= 2 (1 point), serum albumin <4 g/dL (1 point), emergency surgery (2 points), and non-laparoscopic abdominal/cardiac/aortic aneurysm repair surgery (4 points). The area under the curve was 0.79 (95% CI, 0.75-0.83) with the newly developed model. The new risk stratification including laparoscopic surgery has a good discriminative ability for estimating PPCs in our study cohort. Further research is needed to validate this new prediction rule.	[Jeong, Byeong-Ho; Shin, Beomsu; Yoo, Hongseok; Song, Wonjun; Lee, Kyung Jong; Jeon, Kyeongman; Um, Sang-Won; Koh, Won-Jung; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung; Park, Hye Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Eom, Jung Seop] Pusan Natl Univ, Coll Med, Dept Internal Med, Pusan 609735, South Korea; [Han, Sangbin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Woo, Sookyoung] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Pusan National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	hyeyunpark@skku.edu	Yoo, Hongseok/AAZ-8139-2020; Suh, Gee Young/O-3676-2019; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011; Shin, Beomsu/AAP-3328-2020; Jeon, Kyeongman/F-5963-2019; Koh, Won-Jung/D-9586-2018	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Koh, Won-Jung/0000-0002-4756-3527; Jeong, Byeong-Ho/0000-0002-3124-1718; Yoo, Hongseok/0000-0002-2227-6441	Samsung Medical Center Foundation [SMO1140211]	Samsung Medical Center Foundation(Samsung)	This study was supported by Samsung Medical Center Foundation (SMO1140211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Cashman JN, 2004, BRIT J ANAESTH, V93, P212, DOI 10.1093/bja/aeh180; DALES RE, 1993, CHEST, V104, P155, DOI 10.1378/chest.104.1.155; Fisher BW, 2002, AM J MED, V112, P219, DOI 10.1016/S0002-9343(01)01082-8; Fleischmann KE, 2003, AM J MED, V115, P515, DOI 10.1016/S0002-9343(03)00474-1; FORD GT, 1983, AM REV RESPIR DIS, V127, P431, DOI 10.1164/arrd.1983.127.4.431; FRAZEE RC, 1991, ANN SURG, V213, P651, DOI 10.1097/00000658-199106000-00016; KINGSTON HGG, 1984, ANESTH ANALG, V63, P844; Kundra P, 2010, SURG LAPARO ENDO PER, V20, P170, DOI 10.1097/SLE.0b013e3181db81ce; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leung JM, 2001, J AM GERIATR SOC, V49, P1080, DOI 10.1046/j.1532-5415.2001.49212.x; Liu LL, 2000, J AM GERIATR SOC, V48, P405, DOI 10.1111/j.1532-5415.2000.tb04698.x; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Nafiu OO, 2011, ANESTH ANALG, V112, P23, DOI 10.1213/ANE.0b013e3181fcc51a; Nimmo AF, 1996, BRIT J ANAESTH, V77, P317, DOI 10.1093/bja/77.3.317; PASULKA PS, 1986, ANN INTERN MED, V104, P540, DOI 10.7326/0003-4819-104-4-540; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Restrepo RD, 2011, RESP CARE, V56, P1600, DOI 10.4187/respcare.01471; Smetana Gerald W, 2009, Cleve Clin J Med, V76 Suppl 4, pS60, DOI 10.3949/ccjm.76.s4.10; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Smetana GW, 1999, NEW ENGL J MED, V340, P937, DOI 10.1056/NEJM199903253401207; Webb S, 2012, SURG ENDOSC, V26, P732, DOI 10.1007/s00464-011-1944-2; Weller WE, 2008, ANN SURG, V248, P10, DOI 10.1097/SLA.0b013e31816d953a	24	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113656	10.1371/journal.pone.0113656	http://dx.doi.org/10.1371/journal.pone.0113656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437175	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900061
J	Lauver, DA; Carey, EG; Bergin, IL; Lucchesi, BR; Gurm, HS				Lauver, D. Adam; Carey, E. Grant; Bergin, Ingrid L.; Lucchesi, Benedict R.; Gurm, Hitinder S.			Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RENAL ISCHEMIA/REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; MEDULLARY BLOOD-FLOW; ERECTILE DYSFUNCTION; PRIMARY ANGIOPLASTY; ISO-OSMOLAR; BOLD MRI; MEDIA; PHARMACOKINETICS	Contrast-induced acute kidney injury (CIAKI) is one of the commonest complications associated with contrast media (CM). Although the exact etiology of CIAKI remains unclear, one hypothesis involves vasoconstriction of afferent arterioles resulting in renal ischemia. Increased renal blood flow, therefore, might represent an attractive target for the treatment of CIAKI. In this study we evaluated the protective effects of the phosphodiesterase type 5 (PDE5) inhibitor, sildenafil citrate, in a rabbit model of CIAKI. New Zealand white rabbits were used due to their susceptibility to CIAKI. To evaluate the effects of sildenafil, the drug was administered before CM infusion and repeatedly throughout the remainder of the experiment (6 mg/kg, p.o.). Animals were sacrificed after 48 hours and kidneys were prepared for histological evaluation. Intravenous administration of CM produced marked kidney injury. Serum creatinine concentrations were elevated within two hours of the infusion and remained elevated for the duration of the experiment. Histological evaluation of the kidneys revealed significant tubular necrosis. The effects of the CM were dose dependent. Treatment with sildenafil was associated with lesser degree of histological injury, attenuation in markers of acute kidney injury (48 hour creatinine 1.54+/-0.21 versus 4.42+/-1.31 mg/dl, p<0.05) and reduction in electrolyte derangement (percent change in serum K+ at 48 hours 2.55+/-3.80% versus 15.53+/-4.47%, p<0.05; serum Na+ at 48 hours -0.14+/-0.26% versus -1.97+/-1.29%, p=0.20). The results suggest a possible role for PDE5 inhibitors in the treatment of CIAKI and warrant further evaluation to determine the exact mechanism of protection.	[Lauver, D. Adam; Carey, E. Grant; Lucchesi, Benedict R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bergin, Ingrid L.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Gurm, Hitinder S.] Univ Michigan, Dept Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lauver, DA (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	dlauver@umich.edu		Lauver, Dale/0000-0003-2752-1124; Gurm, Hitinder/0000-0002-1646-0218	Frankel Cardiovascular Center at the University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center) [P30DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Frankel Cardiovascular Center at the University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the Frankel Cardiovascular Center at the University of Michigan [DAL] and by grant number P30DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases (Michigan Diabetes Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN KJ, 1994, INVEST RADIOL, V29, P955, DOI 10.1097/00004424-199411000-00002; Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; BAKRIS GL, 1985, KIDNEY INT, V27, P465, DOI 10.1038/ki.1985.32; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Bolognese L, 2012, AM J CARDIOL, V109, P67, DOI 10.1016/j.amjcard.2011.08.006; Briguori C, 2006, KIDNEY INT, V69, pS30, DOI 10.1038/sj.ki.5000372; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; de Medeiros PJ, 2010, ACTA CIR BRAS, V25, P490, DOI 10.1590/S0102-86502010000600006; El-Sakka AI, 2004, EUR UROL, V46, P503, DOI 10.1016/j.eururo.2004.06.005; Erley CM, 1998, KIDNEY INT, V54, pS192, DOI 10.1046/j.1523-1755.1998.06744.x; Finn William F, 2006, Nephrol Dial Transplant, V21, pi2, DOI 10.1093/ndt/gfl213; Franchini KG, 1997, AM J PHYSIOL-REG I, V272, pR1472, DOI 10.1152/ajpregu.1997.272.5.R1472; Grossman EB, 2004, KIDNEY INT, V66, P367, DOI 10.1111/j.1523-1755.2004.00739.x; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Heinrich MC, 2005, RADIOLOGY, V235, P843, DOI 10.1148/radiol.2353040726; HEYMAN SN, 1991, KIDNEY INT, V40, P632, DOI 10.1038/ki.1991.255; Kucuk A, 2012, MOL BIOL REP, V39, P9775, DOI 10.1007/s11033-012-1843-1; Lameire N, 2006, AM J CARDIOL, V98, p21K, DOI 10.1016/j.amjcard.2006.01.021; LARSON TS, 1983, J LAB CLIN MED, V101, P385; Leoni LAB, 2013, AGING MALE, V16, P85, DOI 10.3109/13685538.2013.801952; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Linkermann A, 2013, J AM SOC NEPHROL, V24, P1545, DOI 10.1681/ASN.2012121169; Liss P, 1996, KIDNEY INT, V49, P1268, DOI 10.1038/ki.1996.181; Lledo-Garcia E, 2011, J UROLOGY, V186, P331, DOI 10.1016/j.juro.2011.03.036; Madsen Troy E, 2009, Crit Pathw Cardiol, V8, P167, DOI 10.1097/HPC.0b013e3181bda03b; Maioli M, 2011, CIRC-CARDIOVASC INTE, V4, P456, DOI 10.1161/CIRCINTERVENTIONS.111.961391; Malavaud B, 2001, TRANSPLANTATION, V72, P1331, DOI 10.1097/00007890-200110150-00027; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019; Nichols DJ, 2002, BRIT J CLIN PHARMACO, V53, p5S, DOI 10.1046/j.0306-5251.2001.00027.x; Nygren A, 1992, Acta Radiol Suppl, V378 ( Pt 3), P123; Persson PB, 2005, NEPHROL DIAL TRANSPL, V20, pI2, DOI 10.1093/ndt/gfh1066; Pettersson G, 2002, ACAD RADIOL, V9, pS62, DOI 10.1016/S1076-6332(03)80398-7; Porst H, 2003, UROLOGY, V62, P121, DOI 10.1016/S0090-4295(03)00359-5; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Tumkur SM, 2006, KIDNEY INT, V70, P139, DOI 10.1038/sj.ki.5000347; Tumlin J, 2006, AM J CARDIOL, V98, p14K, DOI 10.1016/j.amjcard.2006.01.020; VADSTRUP S, 1983, ACTA PHYSIOL SCAND, V117, P177, DOI 10.1111/j.1748-1716.1983.tb07195.x; Wada Y, 2009, NEPHROLOGY, V14, P357, DOI 10.1111/j.1440-1797.2009.01132.x; Whitaker RM, 2013, J PHARMACOL EXP THER, V347, P626, DOI 10.1124/jpet.113.208017; Wright PJ, 2006, INT J CLIN PRACT, V60, P967, DOI 10.1111/j.1742-1241.2006.01049.x; Zhang YD, 2014, RADIOLOGY, V270, P409, DOI 10.1148/radiol.13122495; Zhang YD, 2012, CONTRAST MEDIA MOL I, V7, P418, DOI 10.1002/cmmi.1468	48	37	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113598	10.1371/journal.pone.0113598	http://dx.doi.org/10.1371/journal.pone.0113598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426714	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400067
J	Gadoud, A; Kane, E; Macleod, U; Ansell, P; Oliver, S; Johnson, M				Gadoud, Amy; Kane, Eleanor; Macleod, Una; Ansell, Pat; Oliver, Steven; Johnson, Miriam			Palliative Care among Heart Failure Patients in Primary Care: A Comparison to Cancer Patients Using English Family Practice Data	PLOS ONE			English	Article							LIFE; END; HOSPITALIZATION; SOCIETY	Introduction: Patients with heart failure have a significant symptom burden and other palliative care needs often over a longer period than patients with cancer. It is acknowledged that this need may be unmet but by how much has not been quantified in primary care data at the population level. Methods: This was the first use of Clinical Practice Research Datalink, the world's largest primary care database to explore recognition of the need for palliative care. Heart failure and cancer patients who had died in 2009 aged 18 or over and had at least one year of primary care records were identified. A palliative approach to care among patients with heart failure was compared to that among patients with cancer using entry onto a palliative care register as a marker for a palliative approach to care. Results: Among patients with heart failure, 7% (234/3 122) were entered on the palliative care register compared to 48% (3 669/7 608) of cancer patients. Of heart failure patients on the palliative care register, 29% (69/234) were entered onto the register within a week of their death. Conclusions: This confirms that the stark inequity in recognition of palliative care needs for people with heart failure in a large primary care dataset. We recommend a move away from prognosis based criteria for palliative care towards a patient centred approach, with assessment of and attention to palliative needs including advance care planning throughout the disease trajectory.	[Gadoud, Amy; Macleod, Una; Johnson, Miriam] Univ Hull, Hull York Med Sch, Kingston Upon Hull, East Yorkshire, England; [Kane, Eleanor; Ansell, Pat; Oliver, Steven] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Oliver, Steven] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK; University of Hull; University of York - UK	Gadoud, A (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull, East Yorkshire, England.	amy.gadoud@hyms.ac.uk	Gadoud, Amy/E-8420-2014	Gadoud, Amy/0000-0001-6351-1535; Johnson, Miriam/0000-0001-6204-9158; Kane, Eleanor/0000-0002-7438-9982	Hull York Medical School; Academy of Medical Sciences (AMS) [AMS-SGCL11-Gadoud] Funding Source: researchfish; National Institute for Health Research [CL-2013-03-002] Funding Source: researchfish	Hull York Medical School; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	CPRD data were obtained free of charge under a Medical Research Council (MRC) initiative. AG salary funded by Hull York Medical School. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Barclay S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X549018; Bhattarai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029776; BMA & NHS Employers, 2009, QUALITY OUTCOMES FRA; Boyd KJ, 2009, PALLIATIVE MED, V23, P767, DOI 10.1177/0269216309346541; Campbell S, 2010, QUALITY OUTCOMES FRA; Department of Health, 2008, END LIF CAR STRAT PR; Haga K, 2012, HEART, V98, P579, DOI 10.1136/heartjnl-2011-301021; Harrison N, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X641465; Health and Social Care Information Centre, 2010, QUAL OUTC FRAM 2009; Hogg KJ, 2012, HEART, V98, P523, DOI 10.1136/heartjnl-2012-301753; Howlett J, 2010, CAN J CARDIOL, V26, P135, DOI 10.1016/S0828-282X(10)70351-2; Husted MG, 2014, BMJ SUPPORT PALLIAT, V4, P146, DOI 10.1136/bmjspcare-2013-000601; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khan NF, 2010, ANN FAM MED, V8, P418, DOI 10.1370/afm.1162; Ko DT, 2008, AM HEART J, V155, P324, DOI 10.1016/j.ahj.2007.08.036; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; National Institute for Health and Care Excellence (NICE), 2013, QUAL OUTC FRAM QOF; National Survey of Patient Activity Data for Specialist Palliative Care Services, 2013, MIN DAT SET FULL REP; Office for National Statistics, 2010, POP EST UK ENGL WAL; Omega, 2009, END LIF CAR PRIM CAR; Primary Care Commissioning, 2009, DEC 2009 QOF BUS RUL; Shamini G, 2006, USERS GUIDE DATA COL; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Stewart S, 2002, BRIT MED J, V325, P915, DOI 10.1136/bmj.325.7370.915; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Warmenhoven F, 2012, ANN FAM MED, V10, P330, DOI 10.1370/afm.1373; Whellan DJ, 2014, J CARD FAIL, V20, P121, DOI 10.1016/j.cardfail.2013.12.003; You JJ, 2013, CANADIAN MED ASS J	33	64	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113188	10.1371/journal.pone.0113188	http://dx.doi.org/10.1371/journal.pone.0113188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423169	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000345899700023
J	Harrison, N; Lone, MA; Kaul, TK; Rodrigues, PR; Ogungbe, IV; Gill, MS				Harrison, Neale; Lone, Museer A.; Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo Victor; Gill, Matthew S.			Characterization of N-Acyl Phosphatidylethanolamine-Specific Phospholipase-D Isoforms in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; HYDROLASE FAMILY; C. ELEGANS; ANANDAMIDE; BIOSYNTHESIS; ACID; ACYLETHANOLAMINES; ETHANOLAMINE	N-acylethanolamines are an important class of lipid signaling molecules found in many species, including the nematode Caenorhabditis elegans (C. elegans) where they are involved in development and adult lifespan. In mammals, the relative activity of the biosynthetic enzyme N-acyl phosphatidylethanolamine-specific phospholipase-D and the hydrolytic enzyme fatty acid amide hydrolase determine N-acylethanolamine levels. C. elegans has two N-acyl phosphatidylethanolamine-specific phospholipase-D orthologs, nape-1 and nape-2, that are likely to have arisen from a gene duplication event. Here, we find that recombinant C. elegans NAPE-1 and NAPE-2 are capable of generating N-acylethanolamines in vitro, confirming their functional conservation. In vivo, they exhibit overlapping expression in the pharynx and the nervous system, but are also expressed discretely in these and other tissues, suggesting divergent roles. Indeed, nape-1 over-expression results in delayed growth and shortened lifespan only at 25 degrees C, while nape-2 over-expression results in significant larval arrest and increased adult lifespan at 15 degrees C. Interestingly, deletion of the N-acylethanolamine degradation enzyme faah-1 exacerbates nape-1 over-expression phenotypes, but suppresses the larval arrest phenotype of nape-2 over-expression, suggesting that faah-1 is coupled to nape-2, but not nape-1, in a negative feedback loop. We also find that over-expression of either nape-1 or nape-2 significantly enhances recovery from the dauer larval stage in the insulin signaling mutant daf-2(e1368), but only nape-1 over-expression reduces daf-2 adult lifespan, consistent with increased levels of the N-acylethanolamine eicosapentaenoyl ethanolamine. These results provide evidence that N-acylethanolamine biosynthetic enzymes in C. elegans have conserved function and suggest a temperature-dependent, functional divergence between the two isoforms.	[Harrison, Neale; Lone, Museer A.; Kaul, Tiffany K.; Rodrigues, Pedro Reis; Ogungbe, Ifedayo Victor; Gill, Matthew S.] Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Gill, MS (corresponding author), Scripps Florida, Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA.	mgill@scripps.edu		Lone, Museer/0000-0001-9710-775X; Gill, Matthew/0000-0003-0818-8792	National Institutes of Health [AG036992]; NATIONAL INSTITUTE ON AGING [R01AG036992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health to MSG (AG036992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita G, 2009, INT REV NEUROBIOL, V85, P35, DOI 10.1016/S0074-7742(09)85004-6; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cadas H, 1996, J NEUROSCI, V16, P3934; Coulon D, 2012, PLANT SCI, V184, P129, DOI 10.1016/j.plantsci.2011.12.015; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Hansen HS, 1999, LIPIDS, V34, pS327, DOI 10.1007/BF02562333; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kaul TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086979; Kilaru A, 2012, PLANTA, V236, P809, DOI 10.1007/s00425-012-1669-z; Kilaru A, 2010, LIPIDS, V45, P863, DOI 10.1007/s11745-010-3457-5; Kim J, 2002, J NEUROSCI, V22, P10182; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; Morishita J, 2005, J NEUROCHEM, V94, P753, DOI 10.1111/j.1471-4159.2005.03234.x; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Rahman IA, 2014, PHARM RES; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Sun YX, 2004, BIOCHEM J, V380, P749, DOI 10.1042/BJ20040031; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wang J, 2006, J BIOL CHEM, V281, P12325, DOI 10.1074/jbc.M512359200; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; Woollard A, 2005, WORMBOOK, DOI [10.1895/wormbook.1.2.1, DOI 10.1895/W0RMB00K.1.2.1]; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	38	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113007	10.1371/journal.pone.0113007	http://dx.doi.org/10.1371/journal.pone.0113007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423491	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700018
J	Ngesa, O; Mwambi, H				Ngesa, Oscar; Mwambi, Henry			Prevalence and Risk Factors of Anaemia among Children Aged between 6 Months and 14 Years in Kenya	PLOS ONE			English	Article							IRON-DEFICIENCY; YOUNG-CHILDREN; MALARIA; EPIDEMIOLOGY; AFRICA; GROWTH	Background: Anaemia is one of the significant public health problems among children in the world. Understanding risk factors of anaemia provides more insight to the nature and types of policies that can be put up to fight anaemia. We estimated the prevalence and risk factors of anaemia in a population-based, cross-sectional survey. Methodology: Blood samples from 11,711 children aged between 6 months and 14 years were collected using a single-use, spring-loaded, sterile lancet to make a finger prick. Anaemia was measured based on haemoglobin concentration level. The generalized linear model framework was used to analyse the data, in which the response variable was either a child was anemic or not anemic. Results: The overall prevalence of anaemia among the children in Kenya was estimated to be 28.8%. The risk of anaemia was found to decrease with age progressively with increase in each year of age; children below 1 year were at highest risk of anaemia. The risk of anaemia was significantly higher in male than female children. Mothers with secondary and above education had a protective effect on the risk of anaemia on their children. Malaria diagnosis status of a child was positively associated with risk anaemia. Conclusion: Controlling co-morbidity of malaria and improving maternal knowledge are potential options for reducing the burden of anaemia.	[Ngesa, Oscar; Mwambi, Henry] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, KwaZulu Natal, South Africa	University of Kwazulu Natal	Ngesa, O (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, KwaZulu Natal, South Africa.	oscanges@gmail.com			University of KwaZulu-Natal	University of KwaZulu-Natal	We thank, with profound appreciation, The Kenya National Bureau of Statistics (KNBS) for providing the data used in this study. The authors also thank the University of KwaZulu-Natal for supporting ON's post-doctoral studies under which the current study was undertaken.	Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; [Anonymous], 2008, WORLDWIDE PREVALENCE; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hall A, 2002, PUBLIC HEALTH NUTR, V5, P413, DOI 10.1079/PHN2001327; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Kraemer K, 2007, NUTR ANEMIA; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Leenstra T, 2009, EUR J CLIN NUTR, V63, P173, DOI 10.1038/sj.ejcn.1602919; Leite MS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-69; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; McCullagh P, 1989, GEN LINEAR MODELS; Ministry of Health Kenya, 2011, KEN NAT MAL IND SURV; Muller M., 2012, HDB COMPUTATIONAL ST, P681; Muthayya S, 2012, J NUTR, V142, P1997, DOI 10.3945/jn.111.155135; Mwanri L, 2000, J NUTR, V130, P2691, DOI 10.1093/jn/130.11.2691; Obonyo C, 1998, AM J TROP MED HYG, V55, P525; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Owusu-Agyei S, 2002, AM J TROP MED HYG, V67, P371, DOI 10.4269/ajtmh.2002.67.371; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158	30	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113756	10.1371/journal.pone.0113756	http://dx.doi.org/10.1371/journal.pone.0113756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423084	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700062
J	Tehrani, N; Del Rosario, J; Dominguez, M; Kalb, R; Mano, I				Tehrani, Nazila; Del Rosario, John; Dominguez, Moises; Kalb, Robert; Mano, Itzhak			The Insulin/IGF Signaling Regulators Cytohesin/GRP-1 and PIP5K/PPK-1 Modulate Susceptibility to Excitotoxicity in C. elegans	PLOS ONE			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE AKT; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; NEURONAL DEATH; HIPPOCAMPAL-NEURONS; CELL-DEATH; GLUTAMATE TRANSPORTERS; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTOR	During ischemic stroke, malfunction of excitatory amino acid transporters and reduced synaptic clearance causes accumulation of Glutamate (Glu) and excessive stimulation of postsynaptic neurons, which can lead to their degeneration by excitotoxicity. The balance between cell death-promoting (neurotoxic) and survival-promoting (neuroprotective) signaling cascades determines the fate of neurons exposed to the excitotoxic insult. The evolutionary conserved Insulin/IGF Signaling (IIS) cascade can participate in this balance, as it controls cell stress resistance in nematodes and mammals. Blocking the IIS cascade allows the transcription factor FoxO3/DAF-16 to accumulate in the nucleus and activate a transcriptional program that protects cells from a range of insults. We study the effect of IIS cascade on neurodegeneration in a C. elegans model of excitotoxicity, where a mutation in a central Glu transporter (glt-3) in a sensitizing background causes Glu-Receptor -dependent neuronal necrosis. We expand our studies on the role of the IIS cascade in determining susceptibility to excitotoxic necrosis by either blocking IIS at the level of PI3K/AGE-1 or stimulating it by removing the inhibitory effect of ZFP-1 on the expression of PDK-1. We further show that the components of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex, known to regulate PIP2 production and the IIS cascade, modulate nematode excitotoxicity: mutations that are expected to reduce the complex's ability to produce PIP2 and inhibit the IIS cascade protect from excitotoxicity, while overstimulation of PIP2 production enhances neurodegeneration. Our observations therefore affirm the importance of the IIS cascade in determining the susceptibility to necrotic neurodegeneration in nematode excitotoxicity, and demonstrate the ability of Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex to modulate neuroprotection.	[Tehrani, Nazila; Del Rosario, John; Dominguez, Moises; Mano, Itzhak] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Tehrani, Nazila; Mano, Itzhak] CUNY, Grad Ctr, Grad Program Neurobiol, New York, NY USA; [Del Rosario, John] CUNY City Coll, MA Program Biol, New York, NY 10031 USA; [Dominguez, Moises] CUNY City Coll, Undergrad Program Biol, New York, NY 10031 USA; [Kalb, Robert] Univ Penn, Childrens Hosp Philadelphia, Neurosci Grad Grp, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mano, I (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	imano@ccny.cuny.edu		Del Rosario, John Smith/0000-0003-4947-5835	Sinsheimer Foundation [P60134007]; American Heart Association, National Center [0635367N]; Research Centers in Minority Institutions (RCMI) [5G12RR003060-26, 8G12MD7603-28]; National Science Foundation [IOS 1022281]; City College Academy of Professional Preparation Program (CCAPP); NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056833] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	Sinsheimer Foundation; American Heart Association, National Center(American Heart Association); Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); City College Academy of Professional Preparation Program (CCAPP); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the Sinsheimer Foundation (P60134007) and the American Heart Association, National Center (0635367N). The Mano lab is also supported by the Research Centers in Minority Institutions (RCMI) grants 5G12RR003060-26 & 8G12MD7603-28 and by the National Science Foundation (IOS 1022281). M.D. was supported by City College Academy of Professional Preparation Program (CCAPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar MA, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-9; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; Back T, 2004, J NEUROL, V251, P388, DOI 10.1007/s00415-004-0399-y; Barger AJ, 1998, J NEUROSCI, V18, P2871; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Brockie PJ, 2006, IONOTROPIC GLUTAMATE; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Cecere G, 2013, MOL CELL, V50, P894, DOI 10.1016/j.molcel.2013.06.002; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; Davis SJ, 2014, J NEUROSCI, V34, P9562, DOI 10.1523/JNEUROSCI.0838-14.2014; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Dillin A, 2011, PHILOS T R SOC B, V366, P94, DOI 10.1098/rstb.2010.0271; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Grishok A, 2008, P NATL ACAD SCI USA, V105, P20386, DOI 10.1073/pnas.0810589105; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hoyert DL, 2012, DEATHS PRELIMINARY D; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kennedy LM, 2014, GENETICS, V197, P207, DOI 10.1534/genetics.114.162917; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimata T, 2012, GENETICS, V191, P509, DOI 10.1534/genetics.111.137844; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Lai TW, 2014, PROGR NEUROBIOLOGY, V115; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mano I, 2007, J BIOL CHEM, V282, P34412, DOI 10.1074/jbc.M704134200; Mano I, 2009, J NEUROCHEM, V108, P1373, DOI 10.1111/j.1471-4159.2008.05804.x; Mansisidor AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002299; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Morley JF, 2002, P NATL ACAD SCI USA, V16, P16; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murphy C. T., 2013, INSULIN INSULIN LIKE; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sasaki J, 2010, NATURE, V465, P497, DOI 10.1038/nature09023; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Teuliere J, 2014, GENETICS; Tymianski M, 2014, NAT REV NEUROL, V10, P66, DOI 10.1038/nrneurol.2013.271; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Weinkove D, 2008, DEV BIOL, V313, P384, DOI 10.1016/j.ydbio.2007.10.029; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9	89	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113060	10.1371/journal.pone.0113060	http://dx.doi.org/10.1371/journal.pone.0113060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422944	Green Published, gold			2022-12-27	WOS:000345899700020
J	Wada, M; Horinaka, M; Yamazaki, T; Katoh, N; Sakai, T				Wada, Makoto; Horinaka, Mano; Yamazaki, Toshikazu; Katoh, Norito; Sakai, Toshiyuki			The Dual RAF/MEK Inhibitor CH5126766/RO5126766 May Be a Potential Therapy for RAS-Mutated Tumor Cells	PLOS ONE			English	Article							B-RAF; FEEDBACK PHOSPHORYLATION; MEK INHIBITION; MELANOMA-CELLS; WILD-TYPE; C-RAF; METASTATIC MELANOMA; TARGETED THERAPY; BRAF INHIBITION; K-RAS	Although melanoma is the most aggressive skin cancer, recent advances in BRAF and/or MEK inhibitors against BRAF-mutated melanoma have improved survival rates. Despite these advances, a treatment strategy targeting NRAS-mutated melanoma has not yet been elucidated. We discovered CH5126766/RO5126766 as a potent and selective dual RAF/MEK inhibitor currently under early clinical trials. We examined the activity of CH5126766/RO5126766 in a panel of malignant tumor cell lines including melanoma with a BRAF or NRAS mutation. Eight cell lines including melanoma were assessed for their sensitivity to the BRAF, MEK, or RAF/MEK inhibitor using in vitro growth assays. CH5126766/RO5126766 induced G1 cell cycle arrest in two melanoma cell lines with the BRAF V600E or NRAS mutation. In these cells, the G1 cell cycle arrest was accompanied by up-regulation of the cyclin-dependent kinase inhibitor p27 and down-regulation of cyclinD1. CH5126766/RO5126766 was more effective at reducing colony formation than a MEK inhibitor in NRAS- or KRAS-mutated cells. In the RAS-mutated cells, CH5126766/RO5126766 suppressed the MEK reactivation caused by a MEK inhibitor. In addition, CH5126766/RO5126766 suppressed the tumor growth in SK-MEL-2 xenograft model. The present study indicates that CH5126766/RO5126766 is an attractive RAF/MEK inhibitor in RAS-mutated malignant tumor cells including melanoma.	[Wada, Makoto; Horinaka, Mano; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Grad Sch Med Sci, Kyoto, Japan; [Wada, Makoto; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kyoto, Japan; [Yamazaki, Toshikazu] Chugai Pharmaceut Co Ltd, Div Res, Kamakura Res Lab, Kamakura, Kanagawa, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Grad Sch Med Sci, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp		Wada, Makoto/0000-0003-4222-9762	Chugai Pharmaceutical Co., Ltd [J102001145]	Chugai Pharmaceutical Co., Ltd	This study was funded by Chugai Pharmaceutical Co., Ltd (J102001145). The funder provided support in the form of salaries for author T.Y., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bottos A, 2012, P NATL ACAD SCI USA, V109, pE353, DOI 10.1073/pnas.1105026109; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ishii N, 2013, CANCER RES, V73, P4050, DOI 10.1158/0008-5472.CAN-12-3937; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Knight DA, 2013, J CLIN INVEST, V123, P1371, DOI 10.1172/JCI66236; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; PADUA RA, 1985, MOL CELL BIOL, V5, P582, DOI 10.1128/MCB.5.3.582; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Riely GJ, 2011, J THORAC ONCOL, V6, P1435, DOI 10.1097/JTO.0b013e318223c099; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Smalley KSM, 2009, ONCOGENE, V28, P85, DOI 10.1038/onc.2008.362; Smalley KS, 2007, BRIT J CANCER, V96, P45; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Tsimberidou AM, 2010, CANCER CHEMOTH PHARM, V65, P235, DOI 10.1007/s00280-009-1027-4; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015	43	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113217	10.1371/journal.pone.0113217	http://dx.doi.org/10.1371/journal.pone.0113217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422890	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700027
J	He, Y; Fisher, R; Chowdhury, S; Sultana, I; Pereira, CP; Bray, M; Reed, JL				He, Yong; Fisher, Robert; Chowdhury, Soma; Sultana, Ishrat; Pereira, Claudia P.; Bray, Mike; Reed, Jennifer L.			Vaccinia Virus Induces Rapid Necrosis in Keratinocytes by a STAT3-Dependent Mechanism	PLOS ONE			English	Article							CELL-DEATH; STAT3 ACTIVATION; PHOSPHORYLATION; MITOCHONDRIA; NECROPTOSIS; APOPTOSIS; KINASE	Rationale: Humans with a dominant negative mutation in STAT3 are susceptible to severe skin infections, suggesting an essential role for STAT3 signaling in defense against cutaneous pathogens. Methods: To focus on innate antiviral defenses in keratinocytes, we used a standard model of cutaneous infection of severe combined immunodeficient mice with the current smallpox vaccine, ACAM-2000. In parallel, early events post-infection with the smallpox vaccine ACAM-2000 were investigated in cultured keratinocytes of human and mouse origin. Results: Mice treated topically with a STAT3 inhibitor (Stattic) developed larger vaccinia lesions with higher virus titers and died more rapidly than untreated controls. Cultured human and murine keratinocytes infected with ACAM-2000 underwent rapid necrosis, but when treated with Stattic or with inhibitors of RIP1 kinase or caspase-1, they survived longer, produced higher titers of virus, and showed reduced activation of type I interferon responses and inflammatory cytokines release. Treatment with inhibitors of RIP1 kinase and STAT3, but not caspase-1, also reduced the inflammatory response of keratinocytes to TLR ligands. Vaccinia growth properties in Vero cells, which are known to be defective in some antiviral responses, were unaffected by inhibition of RIP1K, caspase-1, or STAT3. Conclusions: Our findings indicate that keratinocytes suppress the replication and spread of vaccinia virus by undergoing rapid programmed cell death, in a process requiring STAT3. These data offer a new framework for understanding susceptibility to skin infection in patients with STAT3 mutations. Interventions which promote prompt necroptosis/pyroptosis of infected keratinocytes may reduce risks associated with vaccination with live vaccinia virus.	[He, Yong; Fisher, Robert; Chowdhury, Soma; Sultana, Ishrat; Pereira, Claudia P.; Reed, Jennifer L.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Reed, JL (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	jennifer.reed@fda.hhs.gov			Medical Countermeasures Initiative and Modernization of Science - Food and Drug Administration, Center for Biologics Evaluation and Research	Medical Countermeasures Initiative and Modernization of Science - Food and Drug Administration, Center for Biologics Evaluation and Research	This work was supported by Medical Countermeasures Initiative and Modernization of Science funding awarded by the Food and Drug Administration, Center for Biologics Evaluation and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Earl PL, 1991, CURRENT PROTOCOLS MO; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fisher RW, 2011, CLIN VACCINE IMMUNOL, V18, P67, DOI 10.1128/CVI.00280-10; HANSON CV, 1978, J GEN VIROL, V40, P345, DOI 10.1099/0022-1317-40-2-345; Hatch GJ, 2013, J VIROL, V87, P7805, DOI 10.1128/JVI.03481-12; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kojima H, 2005, P NATL ACAD SCI USA, V102, P4524, DOI 10.1073/pnas.0500679102; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Olaiwan A, 2011, J AM ACAD DERMATOL, V65, P1167, DOI 10.1016/j.jaad.2010.09.714; Popov S, 2009, DNA CELL BIOL, V28, P103, DOI 10.1089/dna.2008.0792; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Wharton Melinda, 2003, MMWR Recomm Rep, V52, P1; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	27	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113690	10.1371/journal.pone.0113690	http://dx.doi.org/10.1371/journal.pone.0113690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419841	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900066
J	Matsuoka, S; Gupta, S; Suzuki, E; Hiromi, Y; Asaoka, M				Matsuoka, Shinya; Gupta, Swati; Suzuki, Emiko; Hiromi, Yasushi; Asaoka, Miho			gone early, a Novel Germline Factor, Ensures the Proper Size of the Stem Cell Precursor Pool in the Drosophila Ovary	PLOS ONE			English	Article							MORPHOGEN GRADIENT FORMATION; KINESIN-LIKE PROTEIN; GENE-EXPRESSION; EGF RECEPTOR; CONTRACTILE RING; FAMILY; DPP; TRANSCRIPTION; ACTIVATION; WINGLESS	In order to sustain lifelong production of gametes, many animals have evolved a stem cell-based gametogenic program. In the Drosophila ovary, germline stem cells (GSCs) arise from a pool of primordial germ cells (PGCs) that remain undifferentiated even after gametogenesis has initiated. The decision of PGCs to differentiate or remain undifferentiated is regulated by somatic stromal cells: specifically, epidermal growth factor receptor (EGFR) signaling activated in the stromal cells determines the fraction of germ cells that remain undifferentiated by shaping a Decapentaplegic (Dpp) gradient that represses PGC differentiation. However, little is known about the contribution of germ cells to this process. Here we show that a novel germline factor, Gone early (Goe), limits the fraction of PGCs that initiate gametogenesis. goe encodes a non-peptidase homologue of the Neprilysin family metalloendopeptidases. At the onset of gametogenesis, Goe was localized on the germ cell membrane in the ovary, suggesting that it functions in a peptidase-independent manner in cell-cell communication at the cell surface. Overexpression of Goe in the germline decreased the number of PGCs that enter the gametogenic pathway, thereby increasing the proportion of undifferentiated PGCs. Inversely, depletion of Goe increased the number of PGCs initiating differentiation. Excess PGC differentiation in the goe mutant was augmented by halving the dose of argos, a somatically expressed inhibitor of EGFR signaling. This increase in PGC differentiation resulted in a massive decrease in the number of undifferentiated PGCs, and ultimately led to insufficient formation of GSCs. Thus, acting cooperatively with a somatic regulator of EGFR signaling, the germline factor goe plays a critical role in securing the proper size of the GSC precursor pool. Because goe can suppress EGFR signaling activity and is expressed in EGF-producing cells in various tissues, goe may function by attenuating EGFR signaling, and thereby affecting the stromal environment.	[Matsuoka, Shinya; Gupta, Swati; Hiromi, Yasushi; Asaoka, Miho] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 411, Japan; [Matsuoka, Shinya; Suzuki, Emiko; Hiromi, Yasushi; Asaoka, Miho] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Asaoka, M (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	masaoka@nibb.ac.jp		Asaoka, Miho/0000-0001-5591-8626; Suzuki, Emiko/0000-0002-4005-0542	MEXT [14436948, 13350457]; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (grant # 14436948) to M.A. from MEXT (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for Scientific Research (C) (grant # 13350457) to M.A. from MEXT, and a Research Fellowship for Young Scientists to S.M. (no grant#) from JSPS (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Alexandre C, 1999, DEVELOPMENT, V126, P5689; Asaoka M, 2004, DEVELOPMENT, V131, P5079, DOI 10.1242/dev.01391; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brooks DR, 2003, J BIOL CHEM, V278, P52340, DOI 10.1074/jbc.M308858200; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Ghiglione C, 2003, DEVELOPMENT, V130, P4483, DOI 10.1242/dev.00617; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Golembo M, 1996, DEVELOPMENT, V122, P3363; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; Guichard A, 1999, DEVELOPMENT, V126, P2663; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; King R. C., 1970, OVARIAN DEV DROSOPHI; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Matsuoka S, 2013, MECH DEVELOP, V130, P241, DOI 10.1016/j.mod.2013.01.002; Minestrini G, 2002, J CELL SCI, V115, P725; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rebay I, 2002, DEV BIOL, V251, P1, DOI 10.1006/dbio.2002.0806; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sheng XR, 2011, DEVELOPMENT, V138, P3367, DOI 10.1242/dev.065797; Sheng XR, 2009, DEV BIOL, V334, P335, DOI 10.1016/j.ydbio.2009.07.031; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Tucker M, 2008, DEV BIOL, V318, P215, DOI 10.1016/j.ydbio.2008.02.062; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Van Doren M, 1998, CURR BIOL, V8, P243; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	50	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113423	10.1371/journal.pone.0113423	http://dx.doi.org/10.1371/journal.pone.0113423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420147	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900034
J	Boyd, A; Meynard, JL; Morand-Joubert, L; Michon, A; Boccara, F; Bastard, JP; Samri, A; Haddour, N; Mallat, Z; Capeau, J; Desvarieux, M; Girard, PM				Boyd, Anders; Meynard, Jean-Luc; Morand-Joubert, Laurence; Michon, Adrien; Boccara, Franck; Bastard, Jean-Philippe; Samri, Assia; Haddour, Nabila; Mallat, Ziad; Capeau, Jacqueline; Desvarieux, Moise; Girard, Pierre-Marie		Collaboration HIV Inflammation & C	Association of Residual Plasma Viremia and Intima-Media Thickness in Antiretroviral-Treated Patients with Controlled Human Immunodeficiency Virus Infection	PLOS ONE			English	Article							HIV VIREMIA; THERAPY; RALTEGRAVIR; RISK; ATHEROSCLEROSIS; ACTIVATION; DECREASES; DISEASE; MARKERS	Background: While residual plasma viremia is commonly observed in HIV-infected patients undergoing antiretroviral treatment (ART), little is known about its subclinical consequences. Methods: This cross-sectional study included 47 male, never-smoking, non-diabetic patients with >= 4 years of ART and controlled HIV-replication (HIV-viral load, VL <20 copies/mL for >= 1 year). Residual HIV-VL was measured using an ultrasensitive assay (quantification limit: 1 copy/ml). Patients were categorized as having detectable (D; 1-20 copies/mL, n=14) or undetectable (UD; <1 copies/mL, n=33) HIV-VL. Linear regression was used to model the difference in total carotid intima-media thickness [c-IMT, measures averaged across common carotid artery (cca), bifurcation, and internal carotid artery] and cca-IMT alone across detection groups. Multivariable models were constructed for each endpoint in a forward-stepwise approach. Results: No significant differences were observed between viremia groups with respect to median ART-duration (9.6 years, IQR=6.8-10.9), nadir CD4+T-cell (208/mm(3), IQR=143-378), and CD4+T-cell count (555/mm(3), IQR=458-707). Median adjusted inflammatory markers tended to be higher in patients with D-than UD-viremia, with differences in IL-10 being significant (p=0.03). After adjustment on age, systolic blood pressure, and insulin resistance, mean cca-IMT was significantly lower in patients with undetectable (0.668 mm +/- 0.010) versus detectable viremia (0.727 mm +/- 0.015, p=0.002). Cca-IMT was also independently associated with age and insulin resistance. Mean adjusted total c-IMT was no different between viremia groups (p=0.2), however there was large variability in bifurcation c-IMT measurements. Conclusions: Higher cca-IMT was observed in patients with detectable, compared to undetectable, HIV-VL in never-smoking ART-controlled patients, suggesting that residual HIV viremia may be linked to atherosclerosis.	[Boyd, Anders; Girard, Pierre-Marie] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Meynard, Jean-Luc; Boccara, Franck; Bastard, Jean-Philippe; Samri, Assia; Haddour, Nabila; Capeau, Jacqueline; Girard, Pierre-Marie] Univ Paris 06, Sorbonne Univ, Paris, France; [Meynard, Jean-Luc; Girard, Pierre-Marie] Hop St Antoine, AP HP, Dept Infect & Trop Dis, F-75571 Paris, France; [Morand-Joubert, Laurence] Univ Paris 06, Sorbonne Univ, INSERM,UMR S 1136,Lab Virol St Antoine, Inst Pierre Louis Epidemiol & Sante Publ,AP HP, Paris, France; [Michon, Adrien] Hop Europeen Georges Pompidou, Serv Med Interne, Paris, France; [Boccara, Franck; Haddour, Nabila] Hop St Antoine, AP HP, Dept Cardiol, F-75571 Paris, France; [Boccara, Franck] INSERM, UMR S 938, Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline] Hop Tenon, AP HP, Inserm UMR S938, Serv Biochim & Hormonol, F-75970 Paris, France; [Bastard, Jean-Philippe; Capeau, Jacqueline] Inst Cardiometab & Nutr, Paris, France; [Samri, Assia] INSERM, UMR S945, IFR113, Dept Immunol, Paris, France; [Mallat, Ziad] INSERM, Cardiovasc Res Ctr, U970, Paris, France; [Mallat, Ziad] Univ Paris Descartes Univ, Paris, France; [Mallat, Ziad] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Desvarieux, Moise] INSERM, U738, Paris, France; [Desvarieux, Moise] Ecole Hautes Etudes Sante Publ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boyd, A (corresponding author), INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France.	boyd@u707.jussieu.fr	Boyd, Anders/GLQ-8906-2022; Mallat, Ziad/D-4041-2012; Desvarieux, Moise/C-4991-2019	Boyd, Anders/0000-0001-9512-8928; Mallat, Ziad/0000-0003-0443-7878; 	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS) [2007/303]; Sidaction [AI 20]; Agence nationale de recherche sur le sida et les hepatites virales; Ecole des Hautes Etudes en Sante Publique, France	Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Sidaction; Agence nationale de recherche sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Ecole des Hautes Etudes en Sante Publique, France	This study was funded by the Agence Nationale de Recherche sur le Sida et les Hepatites (ANRS grant 2007/303 to MD) and Sidaction (grant AI 20). AB was awarded a postdoctoral fellowship from the Agence nationale de recherche sur le sida et les hepatites virales. MD is also the recipient of a Chair in Chronic Disease from the Ecole des Hautes Etudes en Sante Publique, France. This collaboration was rendered possible by a Contrat d'Interface (to MD) between INSERM and Hopital Saint-Antoine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando F, 2000, J Epidemiol, V10, pS10; Baker JV, 2011, CLIN INFECT DIS, V53, P826, DOI 10.1093/cid/cir497; Bastard JP, 2012, ANTIVIR THER, V17, P915, DOI 10.3851/IMP2093; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2013, AIDS, V27, P2603, DOI 10.1097/QAD.0b013e3283634819; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gupta SK, 2013, JAIDS-J ACQ IMM DEF, V64, P279, DOI 10.1097/QAI.0b013e3182a97c39; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; KOENKER R, 1982, ECONOMETRICA, V50, P43, DOI 10.2307/1912528; Lake JE, 2014, HIV MED, V15, P431, DOI 10.1111/hiv.12128; Lam YMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031990; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Mercie P, 2005, HIV MED, V6, P380, DOI 10.1111/j.1468-1293.2005.00324.x; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Silva EF, 2013, J INFECT DIS, V208, P892, DOI 10.1093/infdis/jit280; Vallejo A, 2012, AIDS, V26, P1885, DOI 10.1097/QAD.0b013e3283584521	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113876	10.1371/journal.pone.0113876	http://dx.doi.org/10.1371/journal.pone.0113876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415323	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600082
J	Mena, A; Moldes, L; Meijide, H; Canizares, A; Castro-Iglesias, A; Delgado, M; Pertega, S; Pedreira, J; Bou, G; Poveda, E				Mena, Alvaro; Moldes, Luz; Meijide, Hector; Canizares, Angelina; Castro-Iglesias, Angeles; Delgado, Manuel; Pertega, Sonia; Pedreira, Jose; Bou, German; Poveda, Eva			Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing	PLOS ONE			English	Article							C VIRUS-INFECTION; VIRAL-HEPATITIS; NATURAL-HISTORY; DRUG-USERS; EPIDEMIOLOGY; CARE; PREVALENCE; MORTALITY; COHORT	Background: The US Centers for Disease Control and Prevention (CDC) recently add the advice of one-time testing of HCV infection in persons born during 1945-1965. Moreover, the US Preventive Services Task Force (USPSTF) newly recommended one-time HIV testing for persons aged 15-65. Herein, we evaluate the potential impact of these recommendations in a reference medical area of Spain. Methods: All assays results entries for HCV and HIV serological markers ordered at a reference lab from primary care and specialized physicians between 2008 and 2012 were recorded in a medical area which covers 501,526 citizens in Northern Spain. The year of birth were also documented. Results: A total of 108,159 anti-HCV-Ab results were generated during the study period. The global rate of anti-HCV-Ab+ was 7.7% (95% CI: 7.6%-7.9%), being more prevalent in men than women (8.6% vs. 4.5%). By year of birth, the highest prevalence was found in persons born between 1955 and 1970. HCV genotype 1 was the most prevalent (59.7%) followed by genotype 3 (22.7%). Regard HIV infection, among 65,279 anti-HIV results generated the prevalence of anti-HIV+ was 1.1% (95% CI: 1.0%-1.2%), being more frequent in men (2% vs 0.5%). The years of birth with highest rates of HIV infection exactly match with those for HCV infection. Conclusions: The highest rates of HCV and HIV infections are found between 1960 and 1965. Different historical and social circumstances such as the huge intravenous drug use epidemic in the eighties in Spain, might explain it. Therefore, each country needs to determine its own HCV and HIV seroprevalences by year of birth to establish the proper recommendations for the screening of both infections.	[Mena, Alvaro; Meijide, Hector; Castro-Iglesias, Angeles; Delgado, Manuel; Pedreira, Jose; Poveda, Eva] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Grp Virol Clin, La Coruna, Spain; [Moldes, Luz; Canizares, Angelina; Bou, German] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Serv Microbiol, La Coruna, Spain; [Meijide, Hector] Hosp Quiron, Serv Internal Med, La Coruna, Spain; [Delgado, Manuel] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Serv Aparato Digest, La Coruna, Spain; [Pertega, Sonia] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Unidad Epidemiol Clin & Bioestadist, La Coruna, Spain	Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Mena, A (corresponding author), Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Grp Virol Clin, La Coruna, Spain.	alvaro.mena.de.cea@sergas.es	Pértega-Díaz, Sonia/E-4353-2013; Bou, German/H-6683-2015	Pértega-Díaz, Sonia/0000-0003-3891-3203; POVEDA, EVA/0000-0003-4835-9875; Bou, German/0000-0001-8837-0062	Fondo de Investigacion Sanitaria [CP08/00214, PI10/02166, PI13/02266, CM13/00328]; Fundacion Profesor Novoa Santos, A Coruna	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Profesor Novoa Santos, A Coruna	Funding: This work was supported in part by grants from Fondo de Investigacion Sanitaria (CP08/00214, PI10/02166, PI13/02266, CM13/00328), and Fundacion Profesor Novoa Santos, A Coruna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centro Nacional de Epidemiologia, 2013, VIG EP VIH SIDA ESP; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Echevarria JM, 2006, ENFERM INFEC MICR CL, V24, P20; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; European Center for Disease Prevention and Control (ECDC), 2007, HIV INF EUR 25 YEARS; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mahajan R, 2014, CLIN INFECT DIS, V58, P1055, DOI 10.1093/cid/ciu077; Mathei C, 2002, J VIRAL HEPATITIS, V9, P157, DOI 10.1046/j.1365-2893.2002.00339.x; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Oliva J, 2014, GAC SANIT, V28, P116, DOI 10.1016/j.gaceta.2013.06.009; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roy K, 2002, EPIDEMIOL INFECT, V129, P577, DOI 10.1017/S0950268802007902; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Watson J C, 1998, MMWR Recomm Rep, V47, P1; World Health Organization, 2010, 63 WORLD HLTH ASS VI	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113062	10.1371/journal.pone.0113062	http://dx.doi.org/10.1371/journal.pone.0113062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436642	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900028
J	Morgan-Bathke, M; Harris, ZI; Arnett, DG; Klein, RR; Burd, R; Ann, DK; Limesand, KH				Morgan-Bathke, Maria; Harris, Zoey I.; Arnett, Deborah G.; Klein, Rob R.; Burd, Randy; Ann, David K.; Limesand, Kirsten H.			The Rapalogue, CCI-779, Improves Salivary Gland Function following Radiation	PLOS ONE			English	Article							NECK-CANCER; MAMMALIAN TARGET; HEAD; AUTOPHAGY; THERAPY; RADIOTHERAPY; INJURY; PROLIFERATION; CHLOROQUINE; APOPTOSIS	The standard of care for head and neck cancer typically includes surgical resection of the tumor followed by targeted head and neck radiation. However depending on tumor location and stage, some cases may not require surgical resection while others may be treated with chemoradiation. Unfortunately, these radiation treatments cause chronic negative side effects for patients. These side effects are associated with damage to surrounding normal salivary gland tissue and include xerostomia, changes in taste and malnutrition. The underlying mechanisms of chronic radiation-induced salivary gland dysfunction are unknown, however, in rodent models persistently elevated proliferation is correlated with reduced stimulated salivary flow. The rapalogue, CCI-779, has been used in other cell systems to induce autophagy and reduce proliferation, therefore the aim of this study was to determine if CCI-779 could be utilized to ameliorate chronic radiation-induced salivary gland dysfunction. Four to six week old Atg5(f/f); Aqp5-Cre, Atg5(+/+); Aqp5-Cre and FVB mice were treated with targeted head and neck radiation. FVB mice were treated with CCI-779, chloroquine, or DMSO post-radiation. Stimulated salivary flow rates were determined and parotid and submandibular salivary gland tissues were collected for analyses. Mice with a defect in autophagy, via a conditional knockout of Atg5 in the salivary glands, display increased compensatory proliferation in the acinar cell compartment and hypertrophy at 24-72 hours following radiation. FVB mice treated with post-therapy CCI-779 have significant improvements in salivary gland physiology as determined by stimulated salivary flow rates, proliferation indices and amylase production and secretion. Consequently, post-radiation use of CCI-779 allows for improvement of salivary gland function and reestablishment of glandular homeostasis. As CCI-779 is already FDA approved for other uses, it could have a secondary use to alleviate the chronic side effects in head and neck cancer patients who have completed antitumor therapy.	[Morgan-Bathke, Maria; Harris, Zoey I.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; [Klein, Rob R.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Ann, David K.] City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA	University of Arizona; University of Arizona; City of Hope; Beckman Research Institute of City of Hope	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA.	dann@coh.org; limesank@u.arizona.edu			National Institutes of Health [R01DE018888, RC1DE20335]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: KHL received funding from National Institutes of Health (R01DE018888); KHL and DKA received funding from National Institutes of Health RC1DE20335. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JL, 2004, INT J RADIAT ONCOL, V59, P960, DOI 10.1016/j.ijrobp.2003.12.024; Bhide SA, 2010, INT J RADIAT ONCOL, V76, P1360, DOI 10.1016/j.ijrobp.2009.04.005; Blanchard P, 2011, RADIOTHER ONCOL, V100, P33, DOI 10.1016/j.radonc.2011.05.036; Boraks George, 2008, Braz. Dent. J., V19, P73, DOI 10.1590/S0103-64402008000100013; Bozorgi SS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.108; Bralic M, 2005, ACTA MED OKAYAMA, V59, P153; Burlage FR, 2009, RADIOTHER ONCOL, V90, P253, DOI 10.1016/j.radonc.2008.11.011; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cady Jormain, 2007, Clin J Oncol Nurs, V11, P875, DOI 10.1188/07.CJON.875-880; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Denaro N, 2013, ONCOLOGY-BASEL, V84, P174, DOI 10.1159/000346132; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Donovan M, 2012, INT J PALLIAT NURS, V18, P448, DOI 10.12968/ijpn.2012.18.9.448; Egger M, 2013, J SURG RES, V4804, P428; Eisbruch A, 2001, INT J RADIAT ONCOL, V45, P577; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Fernandez-Yunquera Ainhoa, 2014, World J Transplant, V4, P133, DOI 10.5500/wjt.v4.i2.133; Ferriera T, 2012, IMAGEJ; Gera J, 2011, LEUKEMIA LYMPHOMA, V52, P1857, DOI 10.3109/10428194.2011.580478; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Hancock Pamela J, 2003, J Can Dent Assoc, V69, P585; Henson BS, 1999, ORAL ONCOL, V35, P234, DOI 10.1016/S1368-8375(98)00104-3; Hoebers FJP, 2008, EUR J NUCL MED MOL I, V35, P509, DOI 10.1007/s00259-007-0624-x; Huang M, 2013, PHARMGENOMICS PERS M, V6, P9; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Morgan-Bathke M, 2013, J DENT RES, V92, P911, DOI 10.1177/0022034513499350; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Muhvic-Urek M, 2006, PHYSIOL RES, V55, P89, DOI 10.33549/physiolres.930739; Petrelli F, 2014, ORAL ONCOL EPUB; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P267, DOI 10.1016/S1079-2104(03)00369-X; Ren GX, 2014, ONCOL REP, V31, P2804, DOI 10.3892/or.2014.3134; Robar JL, 2007, INT J RADIAT ONCOL, V68, P1121, DOI 10.1016/j.ijrobp.2007.01.030; Ryter S, 2013, MOL CELLS; Saba N, 2014, CANCER IN PRESS; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P513, DOI 10.1007/s00405-003-0631-x; Spiegelberg L, 2014, ORAL DIS, V20, pe111, DOI 10.1111/odi.12162; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wang XK, 2011, J PHARMACOL EXP THER, V339, P421, DOI 10.1124/jpet.111.185249; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152	46	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113183	10.1371/journal.pone.0113183	http://dx.doi.org/10.1371/journal.pone.0113183			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437438	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900032
J	Reichert, CF; Maire, M; Gabel, V; Hofstetter, M; Viola, AU; Kolodyazhniy, V; Strobel, W; Goetz, T; Bachmann, V; Landolt, HP; Cajochen, C; Schmidt, C				Reichert, Carolin F.; Maire, Micheline; Gabel, Virginie; Hofstetter, Marcel; Viola, Antoine U.; Kolodyazhniy, Vitaliy; Strobel, Werner; Goetz, Thomas; Bachmann, Valerie; Landolt, Hans-Peter; Cajochen, Christian; Schmidt, Christina			The Circadian Regulation of Sleep: Impact of a Functional ADA-Polymorphism and Its Association to Working Memory Improvements	PLOS ONE			English	Article							INTERNAL BIOLOGICAL TIME; MULTIPLE COMPARISONS; HOMEOSTATIC CONTROL; SPINDLE FREQUENCY; ADENOSINE; MELATONIN; BRAIN; WAKEFULNESS; PRESSURE; PHASE	Sleep is regulated in a time-of-day dependent manner and profits working memory. However, the impact of the circadian timing system as well as contributions of specific sleep properties to this beneficial effect remains largely unexplored. Moreover, it is unclear to which extent inter-individual differences in sleep-wake regulation depend on circadian phase and modulate the association between sleep and working memory. Here, sleep electroencephalography (EEG) was recorded during a 40-h multiple nap protocol, and working memory performance was assessed by the n-back task 10 times before and after each scheduled nap sleep episode. Twenty-four participants were genotyped regarding a functional polymorphism in adenosine deaminase (rs73598374, 12 G/A-, 12 G/G-allele carriers), previously associated with differences in sleep-wake regulation. Our results indicate that genotype-driven differences in sleep depend on circadian phase: heterozygous participants were awake longer and slept less at the end of the biological day, while they exhibited longer non rapid eye movement (NREM) sleep and slow wave sleep concomitant with reduced power between 8-16 Hz at the end of the biological night. Slow wave sleep and NREM sleep delta EEG activity covaried positively with overall working memory performance, independent of circadian phase and genotype. Moreover, REM sleep duration benefitted working memory particularly when occurring in the early morning hours and specifically in heterozygous individuals. Even though based on a small sample size and thus requiring replication, our results suggest genotype-dependent differences in circadian sleep regulation. They further indicate that REM sleep, being under strong circadian control, boosts working memory performance according to genotype in a time-of-day dependent manner. Finally, our data provide first evidence that slow wave sleep and NREM sleep delta activity, majorly regulated by sleep homeostatic mechanisms, is linked to working memory independent of the timing of the sleep episode within the 24-h cycle.	[Reichert, Carolin F.; Maire, Micheline; Gabel, Virginie; Hofstetter, Marcel; Viola, Antoine U.; Cajochen, Christian; Schmidt, Christina] Univ Basel, Hosp Psychiat, Ctr Chronobiol, CH-4012 Basel, Switzerland; [Kolodyazhniy, Vitaliy] Salzburg Univ, Inst Psychol, Div Clin Psychol Psychotherapy & Hlth Psychol, A-5020 Salzburg, Austria; [Strobel, Werner] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Goetz, Thomas] Off Publ Hlth, Dept Psychiat, D-60313 Frankfurt, Germany; [Bachmann, Valerie; Landolt, Hans-Peter] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Basel; Salzburg University; University of Basel; University of Zurich	Cajochen, C (corresponding author), Univ Basel, Hosp Psychiat, Ctr Chronobiol, CH-4012 Basel, Switzerland.	christian.cajochen@upkbs.ch	Landolt, Hans-Peter/H-6951-2016	Landolt, Hans-Peter/0000-0003-0887-9403; Reichert, Carolin/0000-0003-1535-2386	Swiss National Foundation [310030_130689]; L. & Th. La Roche-Stiftung [DMS2189]; Niklaus und Bertha Burckhardt-Burgin-Stiftung [DPE2110]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); L. & Th. La Roche-Stiftung; Niklaus und Bertha Burckhardt-Burgin-Stiftung	This work was supported by the Swiss National Foundation (grant number #310030_130689; http://www.snf.ch/en/Pages/default.aspx); the L. & Th. La Roche-Stiftung (grant number DMS2189; https://nachwuchs.unibas.ch/004_2_4.html); and the Niklaus und Bertha Burckhardt-Burgin-Stiftung (grant number DPE2110; https://nachwuchs.unibas.ch/004_2_6.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2011, RAPID EYE MOVEMENT S, P80; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BONNET MH, 1992, SLEEP, V15, P526; Buschkuehl M, 2012, DEV COGN NEUROS-NETH, V2, pS167, DOI 10.1016/j.dcn.2011.10.001; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Dijk DJ, 1997, J PHYSIOL-LONDON, V505, P851, DOI 10.1111/j.1469-7793.1997.851ba.x; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dijk DJ, 1999, LUNG BIOL HEALTH DIS, V133, P111; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Ehrhart J, 2000, CLIN NEUROPHYSIOL, V111, P940, DOI 10.1016/S1388-2457(00)00247-9; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Gorfine T, 2009, HUM BRAIN MAPP, V30, P541, DOI 10.1002/hbm.20525; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; James JE, 2007, HUM PSYCHOPHARM CLIN, V22, P549, DOI 10.1002/hup.881; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Knoblauch V, 2005, SLEEP, V28, P1093, DOI 10.1093/sleep/28.9.1093; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Kuriyama K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00127; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Landolt HP, 2011, PROG BRAIN RES, V193, P51, DOI 10.1016/B978-0-444-53839-0.00004-1; Lavie P, 1997, J BIOL RHYTHM, V12, P657, DOI 10.1177/074873049701200622; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Legault G, 2006, BEHAV BRAIN RES, V170, P148, DOI 10.1016/j.bbr.2006.02.010; Leonhart R, 2004, LEHRBUCH STAT; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Mackiewicz M, 2003, J NEUROCHEM, V85, P348, DOI 10.1046/j.1471-4159.2003.01687.x; Maire M, 2013, J COGNITIVE BEHAV PS; Mazzotti DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044154; Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Munch M, 2005, NEUROBIOL AGING, V26, P1307, DOI 10.1016/j.neurobiolaging.2005.03.004; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch B, 2009, NEUROPSYCHOPHARMACOL, V34, P1843, DOI 10.1038/npp.2009.6; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reichert CF, 2014, J BIOL RHYTHM, V29, P119, DOI 10.1177/0748730414524898; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Riksen NP, 2008, PHARMACOGENET GENOM, V18, P843, DOI 10.1097/FPC.0b013e328305e630; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Scullin MK, 2012, BRAIN, V135, P2789, DOI 10.1093/brain/aws192; Shochat T, 1997, AM J PHYSIOL-REG I, V273, pR364, DOI 10.1152/ajpregu.1997.273.1.R364; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	70	5	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113734	10.1371/journal.pone.0113734	http://dx.doi.org/10.1371/journal.pone.0113734			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437848	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000347114900073
J	Camerlink, I; Turner, SP; Ursinus, WW; Reimert, I; Bolhuis, JE				Camerlink, Irene; Turner, Simon P.; Ursinus, Winanda W.; Reimert, Inonge; Bolhuis, J. Elizabeth			Aggression and Affiliation during Social Conflict in Pigs	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; INDIVIDUAL AGGRESSIVENESS; DOMINANCE RELATIONSHIPS; AGONISTIC BEHAVIOR; DOMESTICATED PIGS; TRANSPORT STRESS; SERUM; HAPTOGLOBIN; BIOMARKERS	Social conflict is mostly studied in relation to aggression. A more integral approach, including aggressive and affiliative behaviour as well as physiology, may however give a better understanding of the animals' experience during social conflict. The experience of social conflict may also be reflected in the spatial distribution between conspecifics. The objective was to assess the relationship between behaviour, physiology, and spatial integration in pigs (Sus scrofa) during social conflict. Hereto, 64 groups of pigs (9 wk of age) were studied in a 24 h regrouping test whereby pairs of familiar pigs were grouped with 2 unfamiliar pairs, in either barren or straw-enriched housing. Data on aggressive and affiliative behaviour, skin lesions, body weight, and haptoglobin could be summarized into three principal component analysis factors. These three factors were analysed in relation to spatial integration, i.e. inter-individual distances and lying in body contact. Pigs stayed up to 24 h after encounter in closer proximity to the familiar pig than to unfamiliar pigs. Pigs with a high factor 1 score were more inactive, gave little social nosing, had many skin lesions and a high body weight. They tended to space further away from the familiar pig (b=1.9 cm; P=0.08) and unfamiliar ones (b=0.7 cm; P=0.05). Pigs that were involved in much aggression (factor 2), and that had a strong increase in haptoglobin (factor 3), tended to be relatively most far away from unfamiliar pigs (b=0.03 times further; P=0.08). Results on lying in body contact were coherent with results on distances. Pigs in enriched housing spaced further apart than pigs in barren housing (P<0.001). The combined analysis of measures revealed animals that may either promote or slow down group cohesion, which may not have become clear from single parameters. This emphasizes the importance of an integral approach to social conflict.	[Camerlink, Irene; Ursinus, Winanda W.; Reimert, Inonge; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Camerlink, Irene] Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Turner, Simon P.] SRUC, Edinburgh, Midlothian, Scotland; [Ursinus, Winanda W.] Wageningen UR Livestock Res, Anim Behav & Welf, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Camerlink, I (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	Irene.Camerlink@sruc.ac.uk	Camerlink, Irene/AAO-9931-2020; Bolhuis, J. Elizabeth/P-7978-2015	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Ursinus, Winanda/0000-0002-3186-6793; Turner, Simon/0000-0001-9198-9448; Camerlink, Irene/0000-0002-3427-2210	Netherlands Organization for Scientific Research (NWO); Dutch Ministry of Economic Affairs	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This study is part of the project, "Seeking sociable swine? Incorporating social genetic effects into pig breeding programs to achieve balanced improvement in productivity and welfare," which is financially supported by the program "The Value of Animal Welfare" of the Netherlands Organization for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; Andersen IL, 2004, ANIM BEHAV, V68, P965, DOI 10.1016/j.anbehav.2003.12.016; Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; Arnold K, 2007, PRIMATES PERSPECTIVE, P592; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Blumstein DT, 2009, P ROY SOC B-BIOL SCI, V276, P3007, DOI 10.1098/rspb.2009.0703; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Camerlink I, 2014, J ANIM SCI, V92, P2612, DOI 10.2527/jas.2013-7220; Camerlink I, 2013, APPL ANIM BEHAV SCI, V145, P84, DOI 10.1016/j.applanim.2013.02.008; Camerlink I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065136; Chen HH, 2003, CAN J VET RES, V67, P283; Cray C, 2009, COMPARATIVE MED, V59, P517; D'Eath RB, 2002, APPL ANIM BEHAV SCI, V77, P267, DOI 10.1016/S0168-1591(02)00077-1; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; De Jong IC, 1999, THESIS U GRONINGEN N; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; deJonge FH, 1996, PHYSIOL BEHAV, V60, P389, DOI 10.1016/0031-9384(96)00013-3; Duboscq J, 2014, ANIM BEHAV, V87, P107, DOI 10.1016/j.anbehav.2013.10.018; Durrell JL, 2004, APPL ANIM BEHAV SCI, V89, P41, DOI 10.1016/j.applanim.2004.05.003; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; El-Deeb W. M., 2014, Comparative Clinical Pathology, V23, P577, DOI 10.1007/s00580-012-1654-8; Elwood RW, 1998, NATURE, V393, P66, DOI 10.1038/29980; Erhard HW, 1997, APPL ANIM BEHAV SCI, V54, P137, DOI 10.1016/S0168-1591(97)00068-3; EWBANK R, 1971, ANIM PROD, V13, P685, DOI 10.1017/S0003356100000179; Febrer K, 2006, ANIM BEHAV, V72, P1291, DOI 10.1016/j.anbehav.2006.03.019; FERNANDEZ X, 1994, PHYSIOL BEHAV, V56, P841, DOI 10.1016/0031-9384(94)90313-1; Francois N, 1999, BEHAV PROCESS, V47, P73, DOI 10.1016/S0376-6357(99)00050-9; FRASER D, 1985, APPL ANIM BEHAV SCI, V14, P117, DOI 10.1016/0168-1591(85)90023-1; FRASER D, 1991, APPL ANIM BEHAV SCI, V30, P307, DOI 10.1016/0168-1591(91)90135-K; Gomez-Laguna J, 2010, VET J, V185, P83, DOI 10.1016/j.tvjl.2010.04.018; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6; Jensen P, 1998, APPL ANIM BEHAV SCI, V58, P49, DOI 10.1016/S0168-1591(97)00097-X; Kaburu SSK, 2013, ANIM BEHAV, V86, P519, DOI 10.1016/j.anbehav.2013.06.003; Kutsukake N, 2008, ANIM BEHAV, V75, P1441, DOI 10.1016/j.anbehav.2007.09.018; Kutsukake N, 2009, ECOL RES, V24, P521, DOI 10.1007/s11284-008-0563-4; LAMPREAVE F, 1994, ELECTROPHORESIS, V15, P672, DOI 10.1002/elps.1150150195; Li YZ, 2009, J ANIM SCI, V87, P1472, DOI 10.2527/jas.2008-1202; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lomborg SR, 2008, VET RES COMMUN, V32, P575, DOI 10.1007/s11259-008-9057-7; Marchant-Forde J. N., 2005, Pig News and Information, V26, p63N; Marco-Ramell A., 2011, VET J, V190, pe66, DOI DOI 10.1016/J.TVJL.2011.01.003; McBride G, 1995, BEHAV ENV, P53; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; MCCORT WD, 1982, BEHAV PROCESS, V7, P169, DOI 10.1016/0376-6357(82)90025-0; MENDL M, 1992, ANIM BEHAV, V44, P1107, DOI 10.1016/S0003-3472(05)80323-9; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Munsterhjelm C, 2009, APPL ANIM BEHAV SCI, V118, P42, DOI 10.1016/j.applanim.2009.01.007; Murata H, 2007, VET J, V173, P473, DOI 10.1016/j.tvjl.2006.05.008; Ott S, 2014, RES VET SCI, V97, P124, DOI 10.1016/j.rvsc.2014.06.002; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Piccione G, 2012, SMALL RUMINANT RES, V107, P167, DOI 10.1016/j.smallrumres.2012.05.008; Pineiro C, 2007, ANIMAL, V1, P133, DOI 10.1017/S1751731107283909; Pineiro C, 2004, J ANIM SCI, V82, P277; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Reimert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108700; Reimert I, 2014, PHYSIOL BEHAV, V129, P221, DOI 10.1016/j.physbeh.2014.02.059; Reimert I, 2014, APPL ANIM BEHAV SCI, V151, P24, DOI 10.1016/j.applanim.2013.11.015; Ruis MAW, 2001, APPL ANIM BEHAV SCI, V70, P201, DOI 10.1016/S0168-1591(00)00150-7; RUSHEN J, 1987, CAN J ANIM SCI, V67, P951, DOI 10.4141/cjas87-100; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Soler L, 2013, RES VET SCI, V95, P298, DOI 10.1016/j.rvsc.2013.03.007; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Stukenborg A, 2011, APPL ANIM BEHAV SCI, V129, P28, DOI 10.1016/j.applanim.2010.10.004; Turner SP, 2010, ANIM WELFARE, V19, P123; Turner SP, 2013, APPL ANIM BEHAV SCI, V146, P26, DOI 10.1016/j.applanim.2013.03.012; Turner SP, 2011, APPL ANIM BEHAV SCI, V134, P1, DOI 10.1016/j.applanim.2011.06.001; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; WARBURTON K, 1991, J THEOR BIOL, V150, P473, DOI 10.1016/S0022-5193(05)80441-2	75	21	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113502	10.1371/journal.pone.0113502	http://dx.doi.org/10.1371/journal.pone.0113502			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427249	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400058
J	Qin, XY; Cheng, Y; Murthy, SRK; Selvaraj, P; Loh, YP				Qin, Xiao-Yan; Cheng, Yong; Murthy, Saravana R. K.; Selvaraj, Prabhuanand; Loh, Y. Peng			Carboxypeptidase E-Delta N, a Neuroprotein Transiently Expressed during Development Protects Embryonic Neurons against Glutamate Neurotoxicity	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; COLORECTAL-CANCER; CEREBRAL-CORTEX; BRAIN; RAT; SURVIVAL; STRESS; GENES; BDNF; EXPOSURE	Neuroprotective proteins expressed in the fetus play a critical role during early embryonic neurodevelopment, especially during maternal exposure to alcohol and drugs that cause stress, glutamate neuroexcitotoxicity, and damage to the fetal brain, if prolonged. We have identified a novel protein, carboxypeptidase E-Delta N (CPE-Delta N), which is a splice variant of CPE that has neuroprotective effects on embryonic neurons. CPE-Delta N is transiently expressed in mouse embryos from embryonic day 5.5 to postnatal day 1. It is expressed in embryonic neurons, but not in 3 week or older mouse brains, suggesting a function primarily in utero. CPE-Delta N expression was up-regulated in embryonic hippocampal neurons in response to dexamethasone treatment. CPE-Delta N transduced into rat embryonic cortical and hippocampal neurons protected them from glutamate and H2O2-induced cell death. When transduced into embryonic cortical neurons, CPE-Delta N was found in the nucleus and enhanced the transcription of FGF2 mRNA. Embryonic cortical neurons challenged with glutamate resulted in attenuated FGF2 levels and cell death, but CPE-Delta N transduced neurons treated in the same manner showed increased FGF2 expression and normal viability. This neuroprotective effect of CPE-Delta N was mediated by secreted FGF2. Through receptor signaling, FGF2 activated the AKT and ERK signaling pathways, which in turn increased BCL-2 expression. This led to inhibition of caspase-3 activity and cell survival. [GRAPHICS] .	[Qin, Xiao-Yan; Cheng, Yong; Murthy, Saravana R. K.; Selvaraj, Prabhuanand; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Qin, Xiao-Yan] Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China	Minzu University of China	Loh, YP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov		Cheng, Yong/0000-0002-7529-4408; Qin, Xiao-Yan/0000-0001-8847-4267	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Cantile M, 2013, INT J MOL SCI, V14, P21727, DOI 10.3390/ijms141121727; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Cheng Y, 2015, MOL PSYCHIATR, V20, P744, DOI 10.1038/mp.2014.136; Cheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071578; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Fujita K, 2011, PLACENTA, V32, P737, DOI 10.1016/j.placenta.2011.07.001; Glazner GW, 1999, J NEUROCHEM, V73, P2341, DOI 10.1046/j.1471-4159.1999.0732341.x; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gozes I, 2005, CNS DRUG REV, V11, P353; Gressens P, 1997, J CLIN INVEST, V100, P390, DOI 10.1172/JCI119545; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Henderson JL, 1998, DEV BRAIN RES, V105, P287, DOI 10.1016/S0165-3806(97)00192-2; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Johnson-Farley NN, 2007, BRAIN RES, V1154, P40, DOI 10.1016/j.brainres.2007.04.026; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2013, ONCOGENE; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; McEwen BS, 1997, ANN NY ACAD SCI, V821, P271, DOI 10.1111/j.1749-6632.1997.tb48286.x; Merrill RA, 2004, DEV DYNAM, V231, P564, DOI 10.1002/dvdy.20159; MEYER JS, 1983, EXP NEUROL, V82, P432, DOI 10.1016/0014-4886(83)90415-6; PENNING DH, 1995, ANESTHESIOLOGY, V82, P521, DOI 10.1097/00000542-199502000-00022; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rangon CM, 2007, J NEUROSCI, V27, P7532, DOI 10.1523/JNEUROSCI.5330-06.2007; Reynolds JD, 1995, ALCOHOL CLIN EXP RES, V19, P1447, DOI 10.1111/j.1530-0277.1995.tb01006.x; Sari Y, 2013, J MOL NEUROSCI, V49, P150, DOI 10.1007/s12031-012-9921-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; STEINBEHRENS BA, 1994, J NEUROCHEM, V63, P596; Stockl S, 2013, J CELL SCI, V126, P2890, DOI 10.1242/jcs.124305; Swinehart IT, 2013, DEVELOPMENT, V140, P4574, DOI 10.1242/dev.096693; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; ZHENG M, 1994, J NEUROSCI, V14, P4656; Zhou FC, 2004, J MOL NEUROSCI, V24, P189, DOI 10.1385/JMN:24:2:189; Zhou K, 2013, TUMOR BIOL, V34, P3691, DOI 10.1007/s13277-013-0952-3	44	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112996	10.1371/journal.pone.0112996	http://dx.doi.org/10.1371/journal.pone.0112996			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426952	gold, Green Submitted, Green Published			2022-12-27	WOS:000349145400028
J	Szczech, LA; Stewart, RC; Su, HL; DeLoskey, RJ; Astor, BC; Fox, CH; McCullough, PA; Vassalotti, JA				Szczech, Lynda A.; Stewart, Rebecca C.; Su, Hsu-Lin; DeLoskey, Richard J.; Astor, Brad C.; Fox, Chester H.; McCullough, Peter A.; Vassalotti, Joseph A.			Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease)	PLOS ONE			English	Article							NEPHROPATHY; PREVALENCE; IRBESARTAN; TRENDS	This US, multicenter, observational study assessed the CKD prevalence in adult patients with type-2 diabetes mellitus (T2DM) and characterized the proportion of detected and undiagnosed CKD in the primary care setting using the following: a clinician survey; a patient physical exam and medical history; a single blood draw for estimated glomerular filtration rate (eGFR) and glycosolated hemoglobin (HbA1c); urine dipstick for protein; urine albumin-creatinine ratio (ACR); two patient quality of life questionnaires; and a 15-month medical record review. The study consisted of 9339 adults with T2DM and 466 investigator sites. Of the 9339 enrolled, 9307 had complete data collection for analysis. The 15-month retrospective review showed urine protein, urine ACR, and eGFR testing were not performed in 51.4%, 52.9% and 15.2% of individuals, respectively. Of the 9307 patients, 5036 (54.1%) had Stage 1-5 CKD based on eGFR and albuminuria; however, only 607 (12.1%) of those patients were identified as having CKD by their clinicians. Clinicians were more successful in diagnosing patients with Stage 3-5 CKD than Stages 1 and 2. There were no differences in clinicians' likelihood of identification of CKD based on practice setting, number of years in practice, or self-reported patients seen per week. Awareness or patient self-reported CKD was 81.1% with practitioner detection versus 2.6% in the absence of diagnosis. Primary care of T2DM demonstrates recommended urine CKD testing is underutilized, and CKD is significantly under-diagnosed. This is the first study to show CKD detection is associated with awareness.	[Szczech, Lynda A.] Durham Nephrol Associates, Durham, NC 27704 USA; [Stewart, Rebecca C.; Vassalotti, Joseph A.] Natl Kidney Fdn Inc, Sci Act Dept, New York, NY USA; [Su, Hsu-Lin; DeLoskey, Richard J.] Covance Inc, Princeton, NJ USA; [Astor, Brad C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Astor, Brad C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Fox, Chester H.] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA; [McCullough, Peter A.] Baylor Heart & Vasc Inst, Baylor Hlth Care Syst, Dallas, TX USA; [Vassalotti, Joseph A.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Covance; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Baylor Health Care System; Icahn School of Medicine at Mount Sinai	Szczech, LA (corresponding author), Durham Nephrol Associates, Durham, NC 27704 USA.	Kidneyfan@gmail.com			Boehringer Ingelheim Pharmaceuticals Inc.; Eli Lilly Co.; Durham Nephrology Associates	Boehringer Ingelheim Pharmaceuticals Inc.(Boehringer Ingelheim); Eli Lilly Co.(Eli Lilly); Durham Nephrology Associates	Funding: The ADD-CKD Study was financially sponsored by Boehringer Ingelheim Pharmaceuticals Inc. (www.boehringer-ingelheim.com) and Eli Lilly & Co. (www.lilly.com) The funders, Boehringer Ingelheim Pharmaceuticals Inc. (www.boehringer-ingelheim.com) and Eli Lilly & Co. (www.lilly.com), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Kidney Foundation was responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Richard J. Deloskey and Hsu-Lin Su are employed by Covance Inc. Covance Inc. provided support in the form of salaries for authors Richard J. Deloskey and Hsu-Lin Su, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Lynda A. Szczech is a nephrologist employed by Durham Nephrology Associates. Durham Nephrology Associates provided support in the form of salary for author Lynda A. Szczech, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Allen AS, 2011, J GEN INTERN MED, V26, P386, DOI 10.1007/s11606-010-1523-6; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Burrows N. R., 2010, Morbidity and Mortality Weekly Report, V59, P1361; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 2011, KIDNEY INT, V79, P99, DOI 10.1038/ki.2010.291; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; System USRD, 2011, USRDS 2011 ANN DAT R; Tuot DS, 2011, CLIN J AM SOC NEPHRO, V6, P1838, DOI 10.2215/CJN.00730111; US Preventive Service Task Force, 2012, ANN INTERN MED; US Renal Data System, 2010, USRDS 2010 ANN DAT R	20	76	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e110535	10.1371/journal.pone.0110535	http://dx.doi.org/10.1371/journal.pone.0110535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427285	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400002
J	Zhang, Y; Zhu, CG; Guo, YL; Xu, RX; Li, S; Dong, Q; Li, JJ				Zhang, Yan; Zhu, Cheng-Gang; Guo, Yuan-Lin; Xu, Rui-Xia; Li, Sha; Dong, Qian; Li, Jian-Jun			Higher Fibrinogen Level is Independently Linked with the Presence and Severity of New-Onset Coronary Atherosclerosis among Han Chinese Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDIVIDUAL PARTICIPANT METAANALYSIS; CARDIOVASCULAR-DISEASE; PLASMA-FIBRINOGEN; ARTERY-DISEASE; CAROTID ATHEROSCLEROSIS; ELEVATED FIBRINOGEN; RISK-FACTORS; INFLAMMATION; PREDICTOR	Background: Fibrinogen is a coagulation/inflammatory biomarker strongly associated with atherogenesis. However, no data is currently available regarding the association of fibrinogen level with the presence and severity of new-onset coronary atherosclerosis assessed by Gensini score (GS), particularly in Han Chinese with a large sample size. Methods and Results: We studied 2288 consecutive, new-onset subjects undergoing coronary angiography with angina-like chest pain. Clinical and laboratory data were collected. Coronary stenotic lesions were considered to be the incidence of coronary atherosclerosis. The severity of coronary stenosis was determined by the GS system. Data indicated that patients with high GS had significantly elevated fibrinogen level (p<0.001). The prevalence and severity of coronary atherosclerosis were dramatically increased according to fibrinogen tertiles. Spearman correlation analysis revealed a positive association between fibrinogen level and GS (r=0.138, p<0.001). Multivariate logistic regression analysis demonstrated that plasma fibrinogen level was independently associated with high GS (OR=1.275, 95% CI 1.082-1.502, p=0.004) after adjusting for potential confounders. Moreover, fibrinogen level was also independently related to the presence of coronary atherosclerosis (fibrinogen tertile 2: OR=1.192, 95% CI 0.889-1.598, p=0.241; tertile 3: OR=2.003, 95% CI 1.383-2.903, p<0.001) and high GS (fibrinogen tertile 2: OR=1.079, 95% CI 0.833-1.397, p=0.565; tertile 3: OR=1.524, 95% CI 1.155-2.011, p=0.003) in a dose-dependent manner. Receiver-operating characteristic curve analysis showed that the best fibrinogen cut-off value for predicting the severity of coronary stenosis was 3.21 g/L. Conclusions: Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis in Han Chinese population.	[Zhang, Yan; Zhu, Cheng-Gang; Guo, Yuan-Lin; Xu, Rui-Xia; Li, Sha; Dong, Qian; Li, Jian-Jun] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Div Dyslipidemia,FuWai Hosp,Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Li, JJ (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Div Dyslipidemia,FuWai Hosp,Peking Union Med Coll, BeiLiShi Rd 167, Beijing 100037, Peoples R China.	13901010368@163.com	Guo, Yuan-Lin/K-4887-2019; Stefanadis, Christodoulos/ABH-2232-2020; xu, rui/GRX-5734-2022	Guo, Yuan-Lin/0000-0002-7159-0189; Stefanadis, Christodoulos/0000-0001-5974-6454; 	National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; De Luca G, 2011, J THROMB THROMBOLYS, V31, P458, DOI 10.1007/s11239-010-0531-z; Eapen DJ, 2013, J AM COLL CARDIOL, V62, P329, DOI 10.1016/j.jacc.2013.03.072; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Forsyth CB, 2001, J EXP MED, V193, P1123, DOI 10.1084/jem.193.10.1123; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Gensini GG, 1975, CORONARY ARTERIOGRAP, P271; Green D, 2010, J THROMB HAEMOST, V8, P489, DOI 10.1111/j.1538-7836.2009.03727.x; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hong LF, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/485687; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Katritsis D, 2001, CLIN CHEM, V47, P882; Kim PY, 2007, J THROMB HAEMOST, V5, P1250, DOI 10.1111/j.1538-7836.2007.02426.x; Kostis JB, 2004, EUR J CARDIOV PREV R, V11, P9, DOI 10.1097/01.hjr.0000114968.39211.01; Ndrepepa G, 2013, AM J CARDIOL, V111, P804, DOI 10.1016/j.amjcard.2012.11.060; Palmieri V, 2003, AM HEART J, V145, P467, DOI 10.1067/mhj.2003.144; Paramo JA, 2004, HAEMATOLOGICA, V89, P1226; Sabeti S, 2005, STROKE, V36, P1400, DOI 10.1161/01.STR.0000169931.96670.fc; Shojaie M, 2009, VASC HEALTH RISK MAN, V5, P673; Sinning C, 2013, CLIN RES CARDIOL, V102, P495, DOI 10.1007/s00392-013-0555-4; Sinning JM, 2006, EUR HEART J, V27, P2962, DOI 10.1093/eurheartj/ehl362; Stefanadi E, 2010, CURR MED CHEM, V17, P1690, DOI 10.2174/092986710791111288; Tousoulis D, 2011, BLOOD REV, V25, P239, DOI 10.1016/j.blre.2011.05.001; Wattanakit K, 2005, AM HEART J, V149, P606, DOI 10.1016/j.ahj.2004.07.019; Witte KKA, 2008, INT J CARDIOL, V129, P363, DOI 10.1016/j.ijcard.2007.07.119	28	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113460	10.1371/journal.pone.0113460	http://dx.doi.org/10.1371/journal.pone.0113460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426943	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400055
J	Cha, HJ; Jeong, JH; Rojviriya, C; Kim, YG				Cha, Hyung Jin; Jeong, Jae-Hee; Rojviriya, Catleya; Kim, Yeon-Gil			Structure of Putrescine Aminotransferase from Escherichia coli Provides Insights into the Substrate Specificity among Class III Aminotransferases	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; UTILIZATION PATHWAY; CRYSTAL-STRUCTURES; POLYAMINE LEVELS; SEQUENCE; PROTEIN; YGJG	YgjG is a putrescine aminotransferase enzyme that transfers amino groups from compounds with terminal primary amines to compounds with an aldehyde group using pyridoxal-5'-phosphate (PLP) as a cofactor. Previous biochemical data show that the enzyme prefers primary diamines, such as putrescine, over ornithine as a substrate. To better understand the enzyme's substrate specificity, crystal structures of YgjG from Escherichia coli were determined at 2.3 and 2.1 angstrom resolutions for the free and putrescine-bound enzymes, respectively. Sequence and structural analyses revealed that YgjG forms a dimer that adopts a class III PLP-dependent aminotransferase fold. A structural comparison between YgjG and other class III aminotransferases revealed that their structures are similar. However, YgjG has an additional N-terminal helical structure that partially contributes to a dimeric interaction with the other subunit via a helix-helix interaction. Interestingly, the YgjG substrate-binding site entrance size and charge distribution are smaller and more hydrophobic than other class III aminotransferases, which suggest that YgjG has a unique substrate binding site that could accommodate primary aliphatic diamine substrates, including putrescine. The YgjG crystal structures provide structural clues to putrescine aminotransferase substrate specificity and binding.	[Cha, Hyung Jin; Jeong, Jae-Hee; Rojviriya, Catleya; Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, YG (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea.	ygkim76@postech.ac.kr		Cha, Hyung Jin/0000-0003-1476-3888	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0007201]; Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (grant 2011-0007201) and by the Marine Extreme Genome Research Center Program of the Ministry of Land, Transport and Maritime Affairs.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; BOYLE SM, 1977, BIOCHIM BIOPHYS ACTA, V477, P221, DOI 10.1016/0005-2787(77)90047-8; Cha HJ, 2013, MOL CELLS, V36, P39, DOI 10.1007/s10059-013-0013-1; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HE Y, 1993, EUR J BIOCHEM, V217, P89, DOI 10.1111/j.1432-1033.1993.tb18222.x; Hirotsu K, 2005, CHEM REC, V5, P160, DOI 10.1002/tcr.20042; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jeong JH, 2014, PROTEINS, V82, P1072, DOI 10.1002/prot.24444; Jortzik E, 2010, J MOL BIOL, V402, P445, DOI 10.1016/j.jmb.2010.07.039; KIM KH, 1964, J BIOL CHEM, V239, P783; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linsalata M, 2002, ANTICANCER RES, V22, P2465; Liu WS, 2004, BIOCHEMISTRY-US, V43, P10896, DOI 10.1021/bi049218e; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANAGIOTIDIS CA, 1987, P NATL ACAD SCI USA, V84, P4423, DOI 10.1073/pnas.84.13.4423; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; POULIN R, 1995, BIOCHEM J, V311, P723, DOI 10.1042/bj3110723; Rausch C, 2013, PROTEINS, V81, P774, DOI 10.1002/prot.24233; Samsonova NN, 2005, FEBS LETT, V579, P4107, DOI 10.1016/j.febslet.2005.06.038; Samsonova NN, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-2; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeo SJ, 2012, ACTA CRYSTALLOGR F, V68, P1070, DOI 10.1107/S1744309112030886	35	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113212	10.1371/journal.pone.0113212	http://dx.doi.org/10.1371/journal.pone.0113212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423189	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700024
J	Kvillemo, P; Branstrom, R				Kvillemo, Pia; Branstrom, Richard			Coping with Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							CONTROLLED-TRIAL; HEALTH OUTCOMES; MINDFULNESS; STRESS; WOMEN; ADJUSTMENT; INTERVENTION; STRATEGIES; SYMPTOMS; THERAPY	Objective: The primary aim of this study was to examine the associations between different types of coping and psychological well-being and physical health among women with breast cancer. A second aim was to explore the potential moderating influences of situational and measurement factors on the associations between coping and psychological well-being and physical health. Methods: On 14 February 2011, a literature search was made for articles published in the PubMed and PsycINFO databases before January 2010. On 5 September 2013, a repeated literature search was made for articles published before May 2013. In the final analyses, 78 studies with 11 948 participants were included. Results: Efforts to facilitate adaptation to stress, such as Acceptance and Positive Reappraisal, were related to higher well-being and health. Disengagement and avoidance types of coping were associated with lower well-being and health. The analyses indicated that, in several circumstances, coping effectiveness was dependent on cancer stage, treatment, disease duration, and type of coping measure. Conclusions: Use of coping targeting adjustment and avoiding use of disengagement forms of coping were related to better psychological well-being and physical health. Adaptive strategies and avoiding disengagement forms of coping seemed particularly beneficial for women undergoing treatment.	[Kvillemo, Pia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Branstrom, Richard] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Kvillemo, P (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	pia.kvillemo@ki.se	Bränström, Richard/E-1647-2017	Bränström, Richard/0000-0002-5889-2481	Swedish Council for Working Life and Social Research [2006-0069]; Center for Health Care Science at the Karolinska Institute, Sweden [2008-4737]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Center for Health Care Science at the Karolinska Institute, Sweden(Karolinska Institutet)	This work was supported by the Swedish Council for Working Life and Social Research under Grant nr: 2006-0069; Center for Health Care Science at the Karolinska Institute, Sweden under Grant nr: 2008-4737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein M., 2009, INTRO METAANALYSIS; Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248; Branstrom R, 2010, ANN BEHAV MED, V39, P151, DOI 10.1007/s12160-010-9168-6; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Compas BE, 2006, PSYCHO-ONCOLOGY, V15, P1038, DOI 10.1002/pon.999; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Danhauer SC, 2009, J BEHAV MED, V32, P371, DOI 10.1007/s10865-009-9211-x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Foley E, 2010, J CONSULT CLIN PSYCH, V78, P72, DOI 10.1037/a0017566; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Hulbert-Williams NJ, 2012, PSYCHO-ONCOLOGY, V21, P792, DOI 10.1002/pon.1994; International Agency for Research on Cancer (IARC), 2013, GLOBOCAN 2012; Lazarus R, 1984, STRESS APPRASISAL CO; Lengacher CA, 2009, PSYCHO-ONCOLOGY, V18, P1261, DOI 10.1002/pon.1529; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Monti DA, 2006, PSYCHO-ONCOL, V15, P363, DOI 10.1002/pon.988; Moskowitz JT, 2009, PSYCHOL BULL, V135, P121, DOI 10.1037/a0014210; National Academies of Sciences Engineering and Medicine, 2018, LONG TERM SURV CAR C, DOI 10.17226/11993; Panagiotou OA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f707; Papageorgiou C, 2003, COGNITIVE THER RES, V27, P243, DOI 10.1023/A:1023918331490; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Schreiber JA, 2012, J CANCER SURVIV, V6, P82, DOI 10.1007/s11764-011-0193-7; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Stanton AL, 2000, J CONSULT CLIN PSYCH, V68, P875, DOI 10.1037/0022-006X.68.5.875; The National Board of Health and Welfare, 2013, CAUS DEATH 2012; WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026; WHO, 1948, 2 WHO	33	86	89	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e112733	10.1371/journal.pone.0112733	http://dx.doi.org/10.1371/journal.pone.0112733			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423095	Green Submitted, Green Published, gold			2022-12-27	WOS:000345899700014
J	Peredo, J; Villace, P; Ortin, J; de Lucas, S				Peredo, Joan; Villace, Patricia; Ortin, Juan; de Lucas, Susana			Human Staufen1 Associates to MiRNAs Involved in Neuronal Cell Differentiation and is Required for Correct Dendritic Formation	PLOS ONE			English	Article							ROUGH ENDOPLASMIC-RETICULUM; RNA-BINDING-PROTEIN; MESSENGER-RNAS; DEPENDENT LOCALIZATION; ENRICHMENT ANALYSIS; TARGET PREDICTION; GRANULES; TRANSLATION; MICRORNAS; GENE	Double-stranded RNA-binding proteins are key elements in the intracellular localization of mRNA and its local translation. Staufen is a double-stranded RNA binding protein involved in the localised translation of specific mRNAs during Drosophila early development and neuronal cell fate. The human homologue Staufen1 forms RNA-containing complexes that include proteins involved in translation and motor proteins to allow their movement within the cell, but the mechanism underlying translation repression in these complexes is poorly understood. Here we show that human Staufen1-containing complexes contain essential elements of the gene silencing apparatus, like Ago1-3 proteins, and we describe a set of miRNAs specifically associated to complexes containing human Staufen1. Among these, miR-124 stands out as particularly relevant because it appears enriched in human Staufen1 complexes and is over-expressed upon differentiation of human neuroblastoma cells in vitro. In agreement with these findings, we show that expression of human Staufen1 is essential for proper dendritic arborisation during neuroblastoma cell differentiation, yet it is not necessary for maintenance of the differentiated state, and suggest potential human Staufen1 mRNA targets involved in this process.	[Peredo, Joan; Villace, Patricia; Ortin, Juan; de Lucas, Susana] Ctr Nacl Biotecnol CSIC, Dept Biol Mol & Celular, Madrid, Spain; [Peredo, Joan; Ortin, Juan; de Lucas, Susana] Ciber Enfermedades Resp ISCIII, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Biol Mol & Celular, Madrid, Spain.	jortin@cnb.csic.es; s.delucas@ed.ac.uk	Ortin, Juan/L-3622-2013	Ortin, Juan/0000-0002-6200-4678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC]; Fundacion Marcelino Botin	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marcelino Botin	This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) (www.mineco.gob.es/portal/site/mineco/idi) grant BFU2010-17540/BMC and by Fundacion Marcelino Botin (www.fundacionbotin.org). SdL was a postdoctoral fellow from FISS, Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion). JP was a graduate fellow from Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bassell GJ, 2004, CURR OPIN NEUROBIOL, V14, P574, DOI 10.1016/j.conb.2004.08.010; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Campbell SA, 2005, J VIROL, V79, P6281, DOI 10.1128/JVI.79.10.6281-6290.2005; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Choi J, 2012, HUM MOL GENET, V21, P1566, DOI 10.1093/hmg/ddr594; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Gimenez-Cassina A, 2006, J NEUROSCI RES, V84, P755, DOI 10.1002/jnr.20976; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim M, 2012, CURR PROTEIN PEPT SC, V13, P358, DOI 10.2174/138920312801619420; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebeau G, 2008, MOL CELL BIOL, V28, P2896, DOI 10.1128/MCB.01844-07; Lebeau G, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-22; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JY, 2013, CELL MOL IMMUNOL, V10, P107, DOI 10.1038/cmi.2012.62; Loya CM, 2010, GENE DEV, V24, P625, DOI 10.1101/gad.1907710; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nam J, 2011, SEMIN CELL DEV BIOL, V22, P492, DOI 10.1016/j.semcdb.2011.06.005; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wickham L, 1999, MOL CELL BIOL, V19, P2220; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	65	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113704	10.1371/journal.pone.0113704	http://dx.doi.org/10.1371/journal.pone.0113704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423178	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700055
J	Tsao, WC; Lyu, RK; Ro, LS; Lao, MF; Chen, CM; Wu, YR; Huang, CC; Chang, HS; Kuo, HC; Chu, CC; Chang, KH				Tsao, Wei-Chia; Lyu, Rong-Kuo; Ro, Long-Sun; Lao, Ming-Fen; Chen, Chiung-Mei; Wu, Yih-Ru; Huang, Chin-Chang; Chang, Hong-Shiu; Kuo, Hung-Chao; Chu, Chun-Che; Chang, Kuo-Hsuan			Clinical Correlations of Motor and Somatosensory Evoked Potentials in Neuromyelitis Optica	PLOS ONE			English	Article							ACUTE DISSEMINATED ENCEPHALOMYELITIS; CERVICAL SPONDYLOTIC MYELOPATHY; DEFINITE MULTIPLE-SCLEROSIS; REVISED DIAGNOSTIC-CRITERIA; SPINAL-CORD; ANTI-AQUAPORIN-4 ANTIBODY; TRANSVERSE MYELITIS; EARLY ABNORMALITIES; FUTURE DISABILITY; RESPONSES	Background: Motor and somatosensory evoked potentials (MEPs and SSEPs) are sensitive tools for detecting subclinical lesions, assessing disease severity, and determining the prognosis for outcomes of patients with inflammatory neurological diseases such as multiple sclerosis. However, their roles in neuromyelitis optica (NMO), a severe inflammatory neurological disease that predominantly involves optic nerves and spinal cord, have not yet been clarified. Methods and Findings: Clinical symptoms and examination findings at relapses of 30 NMO patients were retrospectively reviewed. Abnormal MEPs were observed in 69.2% of patients. Patients with abnormal motor central conduction time (CCT) of the lower limbs had higher Kurtzke Expanded Disability Status Scale (EDSS) scores than those with normal responses (P=0.027). Abnormal SSEPs were found in 69.0% of patients. Patients with abnormal lower limb sensory CCT had higher EDSS scores than those with normal responses (P=0.019). In 28 patients followed up more than 6 months, only one of 11 patients (9.1%) with normal SSEPs of the lower limbs had new relapses within 6 months, whereas 8 of 17 patients (47.1%, P=0.049) with abnormal SSEPs of the lower limbs had new relapses. Conclusions: These results indicate MEPs and SSEPs of the lower limbs are good indicators for the disability status at relapses of NMO. Lower limb SSEPs may be a good tool for reflecting the frequency of relapses of NMO.	[Tsao, Wei-Chia; Lyu, Rong-Kuo; Ro, Long-Sun; Lao, Ming-Fen; Chen, Chiung-Mei; Wu, Yih-Ru; Huang, Chin-Chang; Chang, Hong-Shiu; Kuo, Hung-Chao; Chu, Chun-Che; Chang, Kuo-Hsuan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol,Linkou Med Ctr, Taoyuan, Taiwan; [Tsao, Wei-Chia] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lyu, RK (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol,Linkou Med Ctr, Taoyuan, Taiwan.	lyu5172@cgmh.org.tw; gophy5128@cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	tsao, wei-chia/0000-0003-0992-1589				AlDeeb SM, 1997, BRAIN, V120, P1115, DOI 10.1093/brain/120.7.1115; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Bedi GS, 2011, MULT SCLER J, V17, P1225, DOI 10.1177/1352458511404586; BEER S, 1995, J NEUROL NEUROSUR PS, V59, P152, DOI 10.1136/jnnp.59.2.152; Bot JCJ, 2004, NEUROLOGY, V62, P226, DOI 10.1212/WNL.62.2.226; Brass SD, 2003, PEDIATR NEUROL, V29, P227, DOI 10.1016/S0887-8994(03)00235-2; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Casanova B, 2006, MULT SCLER, V12, P521, DOI 10.1191/135248506ms1351xx; Chang KH, 2013, MULT SCLER J, V19, P299, DOI 10.1177/1352458512451659; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; Comi G, 1999, MULT SCLER J, V5, P263, DOI 10.1191/135245899678846195; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; CUSICK JF, 1979, ARCH NEUROL-CHICAGO, V36, P140, DOI 10.1001/archneur.1979.00500390058005; Fernandez O, 2013, MULT SCLER J, V19, P1822, DOI 10.1177/1352458513506955; Hollinger P, 2002, J NEUROL, V249, P320, DOI 10.1007/s004150200012; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; JONES SM, 1991, ARCH NEUROL-CHICAGO, V48, P944, DOI 10.1001/archneur.1991.00530210070026; Kallmann BA, 2006, MULT SCLER J, V12, P58, DOI 10.1191/135248506ms1244oa; Kanzaki M, 2008, EUR NEUROL, V60, P37, DOI 10.1159/000127978; Kieseier BC, 2013, JAMA NEUROL, V70, P390, DOI 10.1001/jamaneurol.2013.668; Kim SH, 2013, JAMA NEUROL, V70, P1110, DOI 10.1001/jamaneurol.2013.3071; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Leocani L, 2006, J NEUROL NEUROSUR PS, V77, P1030, DOI 10.1136/jnnp.2005.086280; LEVY WJ, 1984, NEUROSURGERY, V15, P214, DOI 10.1227/00006123-198408000-00011; Lycklama G, 2003, LANCET NEUROL, V2, P555, DOI 10.1016/S1474-4422(03)00504-0; Lyu RK, 2004, J NEUROL NEUROSUR PS, V75, P256; MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211; Masuhr F, 2002, EUR J NEUROL, V9, P430, DOI 10.1046/j.1468-1331.2002.t01-1-00417.x; MAYR N, 1991, NEUROLOGY, V41, P566, DOI 10.1212/WNL.41.4.566; O'Connor P, 1998, ANN NEUROL, V44, P404, DOI 10.1002/ana.410440320; PELOSI L, 1991, J NEUROL NEUROSUR PS, V54, P1099, DOI 10.1136/jnnp.54.12.1099; Puri V, 2005, Electromyogr Clin Neurophysiol, V45, P273; Qian WS, 2011, J MAGN RESON IMAGING, V33, P1312, DOI 10.1002/jmri.22575; RESTUCCIA D, 1994, ELECTROEN CLIN NEURO, V92, P502, DOI 10.1016/0168-5597(94)90134-1; Rivero RLM, 2014, MAGN RESON IMAGING, V32, P457, DOI 10.1016/j.mri.2014.01.023; Saiz A, 2007, J NEUROL, V254, P1233, DOI 10.1007/s00415-007-0509-8; Schlaeger R, 2014, CLIN NEUROPHYSIOL, V125, P1889, DOI 10.1016/j.clinph.2013.12.117; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; SLIMP JC, 1990, AM J PHYS MED REHAB, V69, P293, DOI 10.1097/00002060-199012000-00003; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113631	10.1371/journal.pone.0113631	http://dx.doi.org/10.1371/journal.pone.0113631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422930	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700044
J	Prochaska, JJ; Grana, RA				Prochaska, Judith J.; Grana, Rachel A.			E-Cigarette Use among Smokers with Serious Mental Illness	PLOS ONE			English	Article							DEVICE E-CIGARETTE; SMOKING-CESSATION; ELECTRONIC CIGARETTE; TOBACCO CESSATION; HEALTH; INDIVIDUALS; RELIABILITY; VARENICLINE; DEPENDENCE; DISORDERS	Background: We examined electronic cigarette (EC) use, correlates of use, and associated changes in smoking behavior among smokers with serious mental illness in a clinical trial. Methods: Adult smokers were recruited during acute psychiatric hospitalization (N=956, 73% enrollment among approached smokers) in the San Francisco Bay Area between 2009-2013. At baseline, participants averaged 17 (SD=10) cigarettes per day for 19 (SD=14) years; 24% intended to quit smoking in the next month. Analyses examined frequency and correlates of EC use reported over the 18-month trial and changes in smoking behavior by EC use status. Findings: EC use was 11% overall, and by year of enrollment, increased from 0% in 2009 to 25% in 2013. In multiple logistic regression, the likelihood of EC use was significantly greater with each additional year of recruitment, for those aged 18-26, and for those in the preparation versus precontemplation stage of change, and unlikely among Hispanic participants. EC use was unrelated to gender, psychiatric diagnosis, and measures of tobacco dependence at baseline. Further, over the 18-month trial, EC use was not associated with changes in smoking status or, among continued smokers, with reductions in cigarettes per day. Interpretation: Within a clinical trial with smokers with serious mental illness, EC use increased over time, particularly among younger adults and those intending to quit tobacco. EC use was unrelated to changes in smoking. The findings are of clinical interest and warrant further study.	[Prochaska, Judith J.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Grana, Rachel A.] Univ Calif San Francisco, Cardiovasc Res Inst, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Prochaska, JJ (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	JPro@Stanford.edu	Prochaska, Judith J/I-4510-2013	Prochaska, Judith J/0000-0001-7925-326X	National Institute of Mental Health [R01MH083684]; State of California Tobacco-Related Disease Research Program [21BT-0018, 21-FT-0040]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083684] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); State of California Tobacco-Related Disease Research Program(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (#R01MH083684) and State of California Tobacco-Related Disease Research Program (#21BT-0018, #21-FT-0040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Caponnetto P, 2013, INT J ENV RES PUB HE, V10, P446, DOI 10.3390/ijerph10020446; Chapman S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3840; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Dawood N, 2008, ARCH INTERN MED, V168, P1961, DOI 10.1001/archinte.168.18.1961; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Dutton J, 2014, GUARDIAN; Eisen SV, 2004, MED CARE, V42, P1230, DOI 10.1097/00005650-200412000-00010; Epstein J, 2004, SERIOUS MENTAL ILLNE; Etter JF, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3845; Evins AE, 2010, EVID-BASED MENT HEAL, V13, P120, DOI 10.1136/ebmh.13.4.120; Fiore MC, 2008, TREATING TOBACCO USE; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Goniewicz ML, 2013, DRUG ALCOHOL REV, V32, P133, DOI 10.1111/j.1465-3362.2012.00512.x; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grana RA, 2014, JAMA INTERN MED, V174, P812, DOI 10.1001/jamainternmed.2014.187; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hall SM, 2006, AM J PUBLIC HEALTH, V96, P1808, DOI 10.2105/AJPH.2005.080382; Hall SM, 2009, ANNU REV CLIN PSYCHO, V5, P409, DOI 10.1146/annurev.clinpsy.032408.153614; Herzog B, 2013, TOBACCO TALK Q2 US T; Hickman NJ, 2011, J EMPIR RES HUM RES, V6, P65, DOI 10.1525/jer.2011.6.3.65; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; LONGO DR, 1995, JAMA-J AM MED ASSOC, V274, P488, DOI 10.1001/jama.274.6.488; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; Prochaska JJ, 2004, J CONSULT CLIN PSYCH, V72, P1144, DOI 10.1037/0022-006X.72.6.1144; Prochaska JJ, 2008, AM J PUBLIC HEALTH, V98, P446, DOI 10.2105/AJPH.2006.101147; Prochaska JJ, 2014, AM J PUBLIC HEALTH, V104, P1557, DOI 10.2105/AJPH.2013.301403; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steinberg ML, 2004, TOB CONTROL, V13, P206; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tsoi DT, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007253.pub3; Vickerman KA, 2013, NICOTINE TOB RES, V15, P1787, DOI 10.1093/ntr/ntt061; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams JM, 2013, AM J PUBLIC HEALTH, V103, P1549, DOI 10.2105/AJPH.2013.301232; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; Zevin S, 1999, CLIN PHARMACOKINET, V36, P425, DOI 10.2165/00003088-199936060-00004	49	60	60	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113013	10.1371/journal.pone.0113013	http://dx.doi.org/10.1371/journal.pone.0113013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX2IM	25419703	Green Published, gold			2022-12-27	WOS:000346766900016
J	Sun, JW; Wu, JB; Guan, DX; Yao, FQ; Yuan, FH; Wang, AZ; Jin, CJ				Sun, Jinwei; Wu, Jiabing; Guan, Dexin; Yao, Fuqi; Yuan, Fenghui; Wang, Anzhi; Jin, Changjie			Estimating Daytime Ecosystem Respiration to Improve Estimates of Gross Primary Production of a Temperate Forest	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; ELEVATED ATMOSPHERIC CO2; LEAF RESPIRATION; GAS-EXCHANGE; (CO2)-C-12 EMISSION; XANTHIUM-STRUMARIUM; SOIL RESPIRATION; DARK RESPIRATION; LIGHT-INHIBITION; PHOTOSYNTHESIS	Leaf respiration is an important component of carbon exchange in terrestrial ecosystems, and estimates of leaf respiration directly affect the accuracy of ecosystem carbon budgets. Leaf respiration is inhibited by light; therefore, gross primary production (GPP) will be overestimated if the reduction in leaf respiration by light is ignored. However, few studies have quantified GPP overestimation with respect to the degree of light inhibition in forest ecosystems. To determine the effect of light inhibition of leaf respiration on GPP estimation, we assessed the variation in leaf respiration of seedlings of the dominant tree species in an old mixed temperate forest with different photosynthetically active radiation levels using the Laisk method. Canopy respiration was estimated by combining the effect of light inhibition on leaf respiration of these species with within-canopy radiation. Leaf respiration decreased exponentially with an increase in light intensity. Canopy respiration and GPP were overestimated by approximately 20.4% and 4.6%, respectively, when leaf respiration reduction in light was ignored compared with the values obtained when light inhibition of leaf respiration was considered. This study indicates that accurate estimates of daytime ecosystem respiration are needed for the accurate evaluation of carbon budgets in temperate forests. In addition, this study provides a valuable approach to accurately estimate GPP by considering leaf respiration reduction in light in other ecosystems.	[Sun, Jinwei; Wu, Jiabing; Guan, Dexin; Yuan, Fenghui; Wang, Anzhi; Jin, Changjie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Sun, Jinwei; Yao, Fuqi] Changjiang River Sci Res Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Yangtze River Water Resources Protection Bureau	Sun, JW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	sunjinwei615@126.com; dxguan@iae.ac.cn	Yuan, Fenghui/M-7424-2013; SUN, JIN/GPX-9641-2022; Yuan, Fenghui/W-3609-2019; Guan, Dexin/I-4184-2018	Yuan, Fenghui/0000-0003-1004-873X; Yuan, Fenghui/0000-0003-1004-873X; Guan, Dexin/0000-0002-2183-3779	National Science Foundation of China [41375119]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-11]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology	This study was financially supported by the National Science Foundation of China (no. 41375119), and the State Key Laboratory of Forest and Soil Ecology (Grant No. LFSE2013-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor JS., 2001, TERRESTRIAL GLOBAL P, P33, DOI DOI 10.1016/B978-012505290-0/50004-1; Atkin OK, 2007, NEW PHYTOL, V174, P367, DOI 10.1111/j.1469-8137.2007.02011.x; AVELANGE MH, 1991, PLANTA, V183, P150, DOI 10.1007/BF00197782; Barford CC, 2001, SCIENCE, V294, P1688, DOI 10.1126/science.1062962; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Bruhn D, 2011, BIOSYSTEMS, V103, P309, DOI 10.1016/j.biosystems.2010.10.007; Crous KY, 2012, PLANT CELL ENVIRON, V35, P966, DOI 10.1111/j.1365-3040.2011.02465.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; GEMEL J, 1992, PLANT PHYSIOL, V100, P908, DOI 10.1104/pp.100.2.908; Goudriaan J., 1977, CROP MICROMETEOROLOG; Goudriaan J, 1994, MODELLING CROP GROWT, P341; Goudriaan J, 1994, MODELLING POTENTIAL, P2; Graham D, 1980, BIOCH PLANTS, V2, P525; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; Guidolotti G, 2013, TREE PHYSIOL, V33, P960, DOI 10.1093/treephys/tpt065; Heskel MA, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00120.1; Heskel MA, 2012, AM J BOT, V99, P1702, DOI 10.3732/ajb.1200251; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Igamberdiev AU, 2003, BBA-BIOENERGETICS, V1606, P117, DOI 10.1016/S0005-2728(03)00106-3; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Kasimova MR, 2006, PLANT CELL, V18, P688, DOI 10.1105/tpc.105.039354; KIRSCHBAUM MUF, 1987, PLANT PHYSIOL, V83, P1032, DOI 10.1104/pp.83.4.1032; Kolb TE, 1997, ENVIRON POLLUT, V98, P195, DOI 10.1016/S0269-7491(97)00132-2; Law BE, 1999, GLOBAL CHANGE BIOL, V5, P169, DOI 10.1046/j.1365-2486.1999.00214.x; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lohila A, 2003, PLANT SOIL, V251, P303, DOI 10.1023/A:1023004205844; Loreto F, 2001, AUST J PLANT PHYSIOL, V28, P1103; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Nunes-Nesi A, 2007, PHYSIOL PLANTARUM, V129, P45, DOI 10.1111/j.1399-3054.2006.00778.x; PARNIK T, 1995, J EXP BOT, V46, P1439, DOI 10.1093/jxb/46.special_issue.1439; Pinelli P, 2003, J EXP BOT, V54, P1761, DOI 10.1093/jxb/erg187; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Ross IU, 1981, RAD REGIME ARCHITECT, P3; RYAN MG, 1994, OECOLOGIA, V100, P213, DOI 10.1007/BF00316947; Shapiro JB, 2004, NEW PHYTOL, V162, P377, DOI 10.1111/j.1469-8137.2004.01046.x; Shi TT, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012832; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P231, DOI 10.1016/0168-1923(86)90061-4; Tcherkez G, 2005, PLANT PHYSIOL, V138, P1596, DOI 10.1104/pp.105.062141; Thomas SC, 2002, TREE PHYSIOL, V22, P117, DOI 10.1093/treephys/22.2-3.117; Tingey DT, 2007, PLANT CELL ENVIRON, V30, P1400, DOI 10.1111/j.1365-3040.2007.01713.x; Turpin DH, 1990, PLANT PHYSL BIOCH MO, P422; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; VILLAR R, 1994, PLANT PHYSIOL, V105, P167, DOI 10.1104/pp.105.1.167; VILLAR R, 1995, PLANT PHYSIOL, V107, P421, DOI 10.1104/pp.107.2.421; Wang M, 2010, TREE PHYSIOL, V30, P149, DOI 10.1093/treephys/tpp098; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wohlfahrt G, 2005, AGR FOREST METEOROL, V130, P13, DOI 10.1016/j.agrformet.2005.02.001; Wu JB, 2006, FOREST ECOL MANAG, V223, P35, DOI 10.1016/j.foreco.2005.10.055; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; YODER BJ, 1994, FOREST SCI, V40, P513; Yuste JC, 2005, TREE PHYSIOL, V25, P609, DOI 10.1093/treephys/25.5.609; Zaragoza-Castells J, 2007, PLANT CELL ENVIRON, V30, P820, DOI 10.1111/j.1365-3040.2007.01672.x	58	3	4	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113512	10.1371/journal.pone.0113512	http://dx.doi.org/10.1371/journal.pone.0113512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419844	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900045
J	Xiong, W; Zhao, J; Yu, HL; Li, XY; Sun, SQ; Li, Y; Xia, Q; Zhang, CL; He, QC; Gao, XS; Zhang, LH; Zhou, DM				Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Gao, Xianshu; Zhang, Lihe; Zhou, Demin			Elevated Expression of AKR1C3 Increases Resistance of Cancer Cells to Ionizing Radiation via Modulation of Oxidative Stress	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; KETO REDUCTASE 1C3; GENE-EXPRESSION; BREAST-CANCER; PROGNOSTIC MARKER; PROSTATE-CANCER; REVEALS ROLES; RADIORESISTANCE; TUMOR; BIOLOGY	With the aim to elucidate the etiology of radioresistance, we explored the genetic alterations in non-radioresistant vs. resistant esophageal cancer cells acquired by long-term fractionated radiation. We found AKR1C3, an aldo-keto reductase expressed seldom in most human tissues, expressed higher in radioresistance-acquired cells. Suppression of AKR1C3 via RNAi or its chemical inhibitors restored the sensitivity of the acquired tumor cells and xenograft BALB/c nude mice to ionizing radiation (IR). Cellular monitoring of the oxidative stress in the AKR1C3-elevated cells indicated that IR-induced ROS accumulation and the concomitant DNA damage was significantly alleviated, and such protective consequence disappeared upon AKR1C3 knockdown. These findings uncover the potential involvement of AKR1C3 in removal of cellular ROS and explain, at least partially, the acquired radioresistance by AKR1C3 overexpression. A retrospective analysis of esophageal carcinomas also indicated a significant expression of AKR1C3 in radio-resistant but not radio-sensitive surgical samples. Our study may provide a potential biomarker for predicting prognosis of radiotherapy and even direct a targeted therapy for esophageal cancer and other tumors.	[Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Gao, Xianshu; Zhang, Lihe; Zhou, Demin] State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Gao, Xianshu] Peking Univ, Affiliated Hosp 1, Beijing 100871, Peoples R China; [Xiong, Wei; Zhao, Jing; Yu, Hongliang; Li, Xiaoying; Sun, Shaoqian; Li, Yi; Xia, Qing; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Zhou, Demin] Peking Univ, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Xiong, Wei] Tangshan Peoples Hosp, Tangshan, Hebei, Peoples R China; [Zhao, Jing] Beijing Union Med Coll Hosp, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Gao, XS (corresponding author), State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.	gao7777@139.com; deminzhou@bjmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB12300]; National Natural Science Foundation of China [91029711, 20932001, 20852001]; Education Ministry [20110001110054]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Ministry	This work was supported by the National Basic Research Program of China (973 Program 2010CB12300 for DM Zhou), the National Natural Science Foundation of China (91029711, 20932001 and 20852001) and Funding from the Education Ministry (20110001110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Azzarello JT, 2010, INT J CLIN EXP PATHO, V3, P147; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Davies NJ, 2009, CANCER RES, V69, P4769, DOI 10.1158/0008-5472.CAN-08-4533; De Bacco F, 2011, J NATL CANCER I, V103, P645, DOI 10.1093/jnci/djr093; Desmond JC, 2003, CANCER RES, V63, P505; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dozmorov MG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-672; Fukuda K, 2004, BRIT J CANCER, V91, P1543, DOI 10.1038/sj.bjc.6602187; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Guryanova OA, 2011, JNCI-J NATL CANCER I, V103, P617, DOI 10.1093/jnci/djr103; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ishikawa KI, 2006, INT J RADIAT ONCOL, V65, P234, DOI 10.1016/j.ijrobp.2005.12.048; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Lee HC, 2004, INT J MOL MED, V13, P883; Li Hong-Zhen, 2010, Chin J Cancer, V29, P882; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Majima HJ, 2006, OXIDATIVE STRESS, DISEASE AND CANCER, P61, DOI 10.1142/9781860948046_0002; Matsuura K, 1998, J BIOCHEM-TOKYO, V124, P940, DOI 10.1093/oxfordjournals.jbchem.a022211; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Novotna R, 2008, TOXICOL LETT, V181, P1, DOI 10.1016/j.toxlet.2008.06.858; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; VONESSEN CF, 1991, CLIN EXP METASTAS, V9, P77, DOI 10.1007/BF01756381; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	40	22	26	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e111911	10.1371/journal.pone.0111911	http://dx.doi.org/10.1371/journal.pone.0111911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419901	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900003
J	Cucuzza, LS; Divari, S; Mulasso, C; Biolatti, B; Cannizzo, FT				Cucuzza, Laura Starvaggi; Divari, Sara; Mulasso, Chiara; Biolatti, Bartolomeo; Cannizzo, Francesca T.			Regucalcin Expression in Bovine Tissues and Its Regulation by Sex Steroid Hormones in Accessory Sex Glands	PLOS ONE			English	Article							SENESCENCE MARKER PROTEIN-30; HEPATOMA H4-II-E CELLS; MESSENGER-RNA EXPRESSION; EPITHELIAL NRK52E CELLS; INTRACELLULAR SIGNALING FACTORS; INCREASES CA2+-ATPASE ACTIVITY; RAT-LIVER MICROSOMES; REAL-TIME PCR; GENE-EXPRESSION; TRANSGENIC RATS	Regucalcin (RGN) is a mammalian Ca2+-binding protein that plays an important role in intracellular Ca2+ homeostasis. Recently, RGN has been identified as a target gene for sex steroid hormones in the prostate glands and testis of rats and humans, but no studies have focused on RGN expression in bovine tissues. Thus, in the present study, we examined RGN mRNA and protein expression in the different tissues and organs of veal calves and beef cattle. Moreover, we investigated whether RGN expression is controlled through sex steroid hormones in bovine target tissues, namely the bulbo-urethral and prostate glands and the testis. Sex steroid hormones are still illegally used in bovine husbandry to increase muscle mass. The screening of the regulation and function of anabolic sex steroids via modified gene expression levels in various tissues represents a new approach for the detection of illicit drug treatments. Herein, we used quantitative PCR, western blot and immunohistochemistry analyses to demonstrate RGN mRNA and protein expression in bovine tissues. In addition, estrogen administration down-regulated RGN gene expression in the accessory sex glands of veal calves and beef cattle, while androgen treatment reduced RGN gene expression only in the testis. The confirmation of the regulation of RGN gene expression through sex steroid hormones might facilitate the potential detection of hormone abuse in bovine husbandry. Particularly, the specific response in the testis suggests that this tissue is ideal for the detection of illicit androgen administration in veal calves and beef cattle.	[Cucuzza, Laura Starvaggi; Divari, Sara; Mulasso, Chiara; Biolatti, Bartolomeo; Cannizzo, Francesca T.] Univ Turin, Dept Vet Sci, Turin, Italy	University of Turin	Cannizzo, FT (corresponding author), Univ Turin, Dept Vet Sci, Turin, Italy.	tiziana.cannizzo@unito.it		Divari, Sara/0000-0002-6085-0336; Cannizzo, Francesca Tiziana/0000-0001-9553-5996; BIOLATTI, Bartolomeo/0000-0003-3657-3954; Starvaggi Cucuzza, Laura/0000-0002-9798-352X	COOP ITALIA; Ministero delle Politiche Agricole e Forestali	COOP ITALIA; Ministero delle Politiche Agricole e Forestali	This work was partially funded by COOP ITALIA, Regione Piemonte 2004 project, "Applicazione della genomica nel controllo dell'uso di anabolizzanti in zootecnia: identificazione di markers genetici innovative'' and by the Ministero delle Politiche Agricole e Forestali, "SAFORISK project, "Prevenzione dell'uso di anabolizzanti in zootecnia. Creazione di un Marchio a difesa degli allevamenti italiani'' (D.M. 2089/09, 29th of January 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter T, 2006, INT J MOL MED, V18, P171; Arun P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016545; Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Bakalska Mariana, 2004, Endocr Regul, V38, P103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannizzo FT, 2008, VET REC, V163, P448, DOI 10.1136/vr.163.15.448; Carraro L, 2009, PHYSIOL GENOMICS, V38, P138, DOI 10.1152/physiolgenomics.00014.2009; Chiusolo A, 2008, TOXICOL LETT, V182, P84, DOI 10.1016/j.toxlet.2008.08.014; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; De Maria R, 2010, VET REC, V167, P291, DOI 10.1136/vr.b4879; Delibato E, 2009, J SEP SCI, V32, P3817, DOI 10.1002/jssc.200900166; Divari S, 2013, FOOD CHEM, V141, P4358, DOI 10.1016/j.foodchem.2013.07.029; Divari S, 2011, FOOD ADDIT CONTAM A, V28, P1677, DOI 10.1080/19440049.2011.609492; Erkkila K, 1997, J CLIN ENDOCR METAB, V82, P2314, DOI 10.1210/jc.82.7.2314; FRANCHI E, 1985, TISSUE CELL, V17, P13, DOI 10.1016/0040-8166(85)90012-6; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fukaya Y, 2004, INT J MOL MED, V14, P427; Giampietri C, 2005, CONTRACEPTION, V72, P298, DOI 10.1016/j.contraception.2005.04.011; Gorczynska-Fjalling Eleonora, 2004, Reprod Biol, V4, P219; Grima J, 1998, J BIOL CHEM, V273, P21040, DOI 10.1074/jbc.273.33.21040; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishii K, 2005, HISTOL HISTOPATHOL, V20, P761, DOI 10.14670/HH-20.761; Izumi T, 2004, J CELL BIOCHEM, V93, P598, DOI 10.1002/jcb.20214; Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042; Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z; Kim SK, 2007, FERTIL STERIL, V87, P547, DOI 10.1016/j.fertnstert.2006.07.1524; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kurota H, 1996, MOL CELL BIOCHEM, V155, P105; Laurentino SS, 2011, REPRODUCTION, V142, P447, DOI 10.1530/REP-11-0085; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopparelli RM, 2012, RES VET SCI, V93, P226, DOI 10.1016/j.rvsc.2011.07.004; Lv S, 2007, J PROTEOME RES, V6, P2746, DOI 10.1021/pr0701759; Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17; Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158; Maia CJB, 2008, MOL CELL BIOCHEM, V311, P81, DOI 10.1007/s11010-007-9697-x; Manna PR, 1999, ENDOCRINOLOGY, V140, P1739, DOI 10.1210/en.140.4.1739; Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; Meyer HHD, 2001, APMIS, V109, P1, DOI 10.1111/j.1600-0463.2001.tb00010.x; Misawa H, 2002, J CELL BIOCHEM, V84, P795, DOI 10.1002/jcb.10082; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Misawa H, 2001, INT J MOL MED, V8, P513; Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x; Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157; Nakagawa T, 2005, J CELL BIOCHEM, V96, P1274, DOI 10.1002/jcb.20617; Nakagawa T, 2005, INT J MOL MED, V16, P637; Nakagawa T, 2008, INT J MOL MED, V21, P605; Nakashima C, 2007, INT J MOL MED, V20, P709; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Pandey AK, 2010, J ENDOCRINOL, V204, P67, DOI 10.1677/JOE-09-0206; Pegolo S, 2014, RES VET SCI, V96, P472, DOI 10.1016/j.rvsc.2014.03.020; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1; SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A; SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V143, P67, DOI 10.1007/BF00925928; SPRUILL WA, 1983, P NATL ACAD SCI-BIOL, V80, P760, DOI 10.1073/pnas.80.3.760; Stella R, 2011, J PROTEOME RES, V10, P2744, DOI 10.1021/pr101255c; TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209; Takahashi H, 1999, J CELL BIOCHEM, V74, P663, DOI 10.1002/(SICI)1097-4644(19990915)74:4<663::AID-JCB15>3.0.CO;2-2; Tobisawa M, 2003, J NEUROL SCI, V209, P47, DOI 10.1016/S0022-510X(02)00460-4; Tsurusaki Y, 2004, INT J MOL MED, V14, P277; Tsurusaki Y, 2003, J CELL BIOCHEM, V90, P619, DOI 10.1002/jcb.10652; Uslenghi F, 2013, FOOD ADDIT CONTAM A, V30, P253, DOI 10.1080/19440049.2012.740777; VANDERWAL P, 1975, J ANIM SCI, V41, P978, DOI 10.2527/jas1975.413978x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490; Yamaguchi M, 2002, INT J MOL MED, V10, P377; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2004, INT J MOL MED, V13, P437; Yamaguchi M, 2002, J CELL BIOCHEM, V86, P184, DOI 10.1002/jcb.10209; Yamaguchi M, 2002, J CELL BIOCHEM, V86, P520, DOI 10.1002/jcb.10249; YAMAGUCHI M, 1989, CHEM PHARM BULL, V37, P1031; Yamaguchi M, 1999, J CELL BIOCHEM, V74, P81, DOI 10.1002/(SICI)1097-4644(19990701)74:1<81::AID-JCB9>3.0.CO;2-3; YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V143, P137, DOI 10.1007/BF01816947; YAMAGUCHI M, 1988, CHEM PHARM BULL, V36, P3532; Yamaguchi M, 2008, J CELL BIOCHEM, V104, P795, DOI 10.1002/jcb.21664; Yamaguchi M, 2008, INT J MOL MED, V21, P771; Yamaguchi M, 2012, INTEGR BIOL-UK, V4, P1215, DOI 10.1039/c2ib20118f; Yamaguchi M, 2012, INTEGR BIOL-UK, V4, P825, DOI 10.1039/c2ib20042b; Yamaguchi M, 2009, MOL CELL BIOCHEM, V327, P53, DOI 10.1007/s11010-009-0042-4; Zhou SF, 2011, CLIN BIOCHEM, V44, P331, DOI 10.1016/j.clinbiochem.2010.10.008	86	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113950	10.1371/journal.pone.0113950	http://dx.doi.org/10.1371/journal.pone.0113950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415588	Green Published, gold			2022-12-27	WOS:000346906600085
J	Herrera, CA; Rada, G; Kuhn-Barrientos, L; Barrios, X				Herrera, Cristian A.; Rada, Gabriel; Kuhn-Barrientos, Lucy; Barrios, Ximena			Does Ownership Matter? An Overview of Systematic Reviews of the Performance of Private For-Profit, Private Not-For-Profit and Public Healthcare Providers	PLOS ONE			English	Article							QUALITY-OF-CARE; HOSPITAL OWNERSHIP; SECTOR; PROVISION; EXPENDITURE; MORTALITY; SERVICES; EXPLAINS	Introduction: Ownership of healthcare providers has been considered as one factor that might influence their health and healthcare related performance. The aim of this article was to provide an overview of what is known about the effects on economic, administrative and health related outcomes of different types of ownership of healthcare providers -namely public, private non-for-profit (PNFP) and private for-profit (PFP)-based on the findings of systematic reviews (SR). Methods and Findings: An overview of systematic reviews was performed. Different databases were searched in order to select SRs according to an explicit comprehensive criterion. Included SRs were assessed to determine their methodological quality. Of the 5918 references reviewed, fifteen SR were included, but six of them were rated as having major limitations, so they weren't incorporated in the analyses. According to the nine analyzed SR, ownership does seem to have an effect on health and healthcare related outcomes. In the comparison of PFP and PNFP providers, significant differences in terms of mortality of patients and payments to facilities have been found, both being higher in PFP facilities. In terms of quality and economic indicators such as efficiency, there are no concluding results. When comparing PNFP and public providers, as well as for PFP and public providers, no clear differences were found. Conclusion: PFP providers seem to have worst results than their PNFP counterparts, but there are still important evidence gaps in the literature that needs to be covered, including the comparison between public and both PFP and PNFP providers. More research is needed in low and middle income countries to understand the impact on and development of healthcare delivery systems.	[Herrera, Cristian A.; Barrios, Ximena] Pontificia Univ Catolica Chile, Dept Publ Hlth, Fac Med, Santiago, Chile; [Herrera, Cristian A.; Rada, Gabriel; Kuhn-Barrientos, Lucy; Barrios, Ximena] Pontificia Univ Catolica Chile, Evidence Based Hlth Care Program, Fac Med, Santiago, Chile; [Rada, Gabriel] Pontificia Univ Catolica Chile, Dept Internal Med, Fac Med, Santiago, Chile; [Kuhn-Barrientos, Lucy] Minist Hlth Chile, Natl Hlth Technol Assessment Commiss, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Herrera, CA (corresponding author), Pontificia Univ Catolica Chile, Dept Publ Hlth, Fac Med, Alameda 340, Santiago, Chile.	crherrer@uc.cl		Rada, Gabriel/0000-0003-2435-0710; Herrera, Cristian/0000-0002-6219-7975				[Anonymous], 2008, COCHRANE HDB SYSTEMA; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Becker GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006170.pub2; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Clinicas de Chile AG, 2007, DIMENSIONAMIENTO SEC; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; Donovan J, 1997, Fund Raising Manage, V28, P32; Eggleston K, 2008, HEALTH ECON, V17, P1345, DOI 10.1002/hec.1333; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Gray BH, 1986, PROFIT ENTERPRISE HL; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Hasan MM, 1996, NEW ENGL J MED, V334, P1055, DOI 10.1056/NEJM199604183341610; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Japsen B, 1998, Mod Healthc, V28, P40; LAVIS JN, 2005, J HLTH SERV RES P S1, V10, pS35; Lawrence D, 1997, HEALTH AFFAIR, V16, P121; Levin A, 2011, HEALTH POLICY PLANN, V26, pi4, DOI 10.1093/heapol/czr037; Lewis S, 2001, BRIT MED J, V323, P926, DOI 10.1136/bmj.323.7318.926; MAREK T, 2005, AFRICA REGION HUMAN; Mogyorosy Zsolt, 2004, Orvosi Hetilap, V145, P1413; Montagu D., 2011, PRIVATE VERSUS PUBLI; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Rosenau PV, 2003, PSYCHIAT SERV, V54, P183, DOI 10.1176/appi.ps.54.2.183; Rosenau PV, 2003, SOC SCI QUART, V84, P219, DOI 10.1111/1540-6237.8402001; Rosenthal G, 1996, INT J HEALTH PLAN M, V11, P203; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Shen YC, 2007, INQUIRY-J HEALTH CAR, V44, P41, DOI 10.5034/inquiryjrnl_44.1.41; Sibbel R, 2012, GESUNDHEITSWESEN, V74, P379, DOI 10.1055/s-0031-1280844; Sloan FA, 2000, HANDB ECON, V17, P1141; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Sulzbach S, 2011, HEALTH POLICY PLANN, V26, pi72, DOI 10.1093/heapol/czr031; Tiemann O, 2012, HEALTH POLICY, V104, P163, DOI 10.1016/j.healthpol.2011.11.010; Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017; World Bank, 2004, WORLD DEV REP MAK SE	38	51	51	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e93456	10.1371/journal.pone.0093456	http://dx.doi.org/10.1371/journal.pone.0093456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437212	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900001
J	Hines, EA; Szakaly, RJ; Leng, N; Webster, AT; Verheyden, JM; Lashua, AJ; Kendziorski, C; Rosenthal, LA; Gern, JE; Sorkness, RL; Sun, X; Lemanske, RF				Hines, Elizabeth A.; Szakaly, Renee J.; Leng, Ning; Webster, Anais T.; Verheyden, Jamie M.; Lashua, Amber J.; Kendziorski, Christina; Rosenthal, Louis A.; Gern, James E.; Sorkness, Ronald L.; Sun, Xin; Lemanske, Robert F., Jr.			Comparison of Temporal Transcriptomic Profiles from Immature Lungs of Two Rat Strains Reveals a Viral Response Signature Associated with Chronic Lung Dysfunction	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GROWTH-FACTOR-BETA; BROWN-NORWAY RATS; POSTBRONCHIOLITIS AIRWAY DYSFUNCTION; WHEEZING RHINOVIRUS ILLNESSES; GENE-EXPRESSION PROFILES; INNATE IMMUNE-RESPONSE; BRONCHIOLAR MAST-CELLS; EARLY-LIFE; EPITHELIAL-CELLS	Early life respiratory viral infections and atopic characteristics are significant risk factors for the development of childhood asthma. It is hypothesized that repeated respiratory viral infections might induce structural remodeling by interfering with the normal process of lung maturation; however, the specific molecular processes that underlie these pathological changes are not understood. To investigate the molecular basis for these changes, we used an established Sendai virus infection model in weanling rats to compare the post-infection transcriptomes of an atopic asthma susceptible strain, Brown Norway, and a non-atopic asthma resistant strain, Fischer 344. Specific to this weanling infection model and not described in adult infection models, Sendai virus in the susceptible, but not the resistant strain, results in morphological abnormalities in distal airways that persist into adulthood. Gene expression data from infected and control lungs across five time points indicated that specific features of the immune response following viral infection were heightened and prolonged in lungs from Brown Norway rats compared with Fischer 344 rats. These features included an increase in macrophage cell number and related gene expression, which then transitioned to an increase in mast cell number and related gene expression. In contrast, infected Fischer F344 lungs exhibited more efficient restoration of the airway epithelial morphology, with transient appearance of basal cell pods near distal airways. Together, these findings indicate that the pronounced macrophage and mast cell responses and abnormal re-epithelialization precede the structural defects that developed and persisted in Brown Norway, but not Fischer 344 lungs.	[Hines, Elizabeth A.; Verheyden, Jamie M.; Lashua, Amber J.; Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Szakaly, Renee J.; Webster, Anais T.; Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Szakaly, Renee J.; Rosenthal, Louis A.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Med, Madison, WI USA; [Leng, Ning; Kendziorski, Christina] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sun, X (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	xsun@wisc.edu; rfl@medicine.wisc.edu			National Science Foundation [2011101268]; National Institutes of Health [T32 GM109899-40]; National Heart, Lung and Blood Institute [HL113870, HL097134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113870, R01HL097134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109899] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: E.A.H. was supported by National Science Foundation graduate research fellowship #2011101268, and National Institutes of Health predoctoral training grant to University of Wisconsin Laboratory of Genetics T32 GM109899-40. This work was supported by National Heart, Lung and Blood Institute HL113870 (to X.S.) and HL097134 (to X.S. and R.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Anyanwu AC, 2014, AM J PHYSIOL-LUNG C, V306, pL749, DOI 10.1152/ajplung.00236.2013; Becnel D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-122; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; CASTLEMAN WL, 1990, AM J PATHOL, V137, P821; CASTLEMAN WL, 1987, AM J PATHOL, V129, P277; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cormier SA, 2010, EXPERT REV ANTI-INFE, V8, P1371, DOI [10.1586/eri.10.125, 10.1586/ERI.10.125]; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Duvernelle C, 2003, PULM PHARMACOL THER, V16, P181, DOI 10.1016/S1094-5539(03)00051-8; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fang KC, 1999, J IMMUNOL, V162, P5528; Gelfand EW, 2012, CURR OPIN IMMUNOL, V24, P713, DOI 10.1016/j.coi.2012.08.011; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; Gomes I, 2005, J ALLERGY CLIN IMMUN, V116, P796, DOI 10.1016/j.jaci.2005.06.031; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P532, DOI 10.1016/j.jaci.2011.06.037; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hizawa N, 2006, CLIN EXP ALLERGY, V36, P872, DOI 10.1111/j.1365-2222.2006.02413.x; Holtzman MJ, 2012, J CLIN INVEST, V122, P2741, DOI 10.1172/JCI60325; Ikegami M, 1999, AM J PHYSIOL-LUNG C, V277, pL983, DOI 10.1152/ajplung.1999.277.5.L983; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Kazi AS, 2010, AM J PHYSIOL-LUNG C, V299, pL794, DOI 10.1152/ajplung.00372.2009; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kohan M, 2007, CLIN EXP ALLERGY, V37, P1444, DOI 10.1111/j.1365-2222.2007.02801.x; Komissarov AA, 2012, AM J PHYSIOL-LUNG C, V303, pL1037, DOI 10.1152/ajplung.00117.2012; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kumar A, 1997, AM J RESP CRIT CARE, V155, P130, DOI 10.1164/ajrccm.155.1.9001301; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Liu W, 2012, EXP LUNG RES, V38, P375, DOI 10.3109/01902148.2012.714840; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsumoto H, 2005, THORAX, V60, P277, DOI 10.1136/thx.2004.028936; MICKLEM K, 1989, BRIT J HAEMATOL, V73, P6, DOI 10.1111/j.1365-2141.1989.tb00210.x; Mikus LD, 2001, AM J RESP CELL MOL, V24, P74, DOI 10.1165/ajrcmb.24.1.4125; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Mukhopadhyay S, 2010, J ALLERGY CLIN IMMUN, V126, P70, DOI 10.1016/j.jaci.2010.03.027; Nauta AJ, 2002, EUR J IMMUNOL, V32, P783, DOI 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; O'Brian AL, 2012, J ALLERGY CLIN IMMUN, V129, P1162, DOI 10.1016/j.jaci.2011.11.046; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Olsson N, 2000, J LEUKOCYTE BIOL, V67, P350, DOI 10.1002/jlb.67.3.350; Papin JF, 2013, AM J PHYSIOL-LUNG C, V304, pL530, DOI 10.1152/ajplung.00173.2012; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Potaczek DP, 2007, ALLERGY, V62, P1095, DOI 10.1111/j.1398-9995.2007.01446.x; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Ramirez Ixsy A, 2014, Ann Am Thorac Soc, V11, P554, DOI 10.1513/AnnalsATS.201310-346OC; REDDY SPM, 1995, J BIOL CHEM, V270, P26451, DOI 10.1074/jbc.270.44.26451; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rosenthal LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032061; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Skevaki Chrysanthi L, 2012, Clin Transl Allergy, V2, P14, DOI 10.1186/2045-7022-2-14; SORDEN SD, 1995, LAB INVEST, V73, P197; SORDEN SD, 1995, EXP LUNG RES, V21, P197, DOI 10.3109/01902149509068827; SORKNESS R, 1994, AM J RESP CRIT CARE, V150, P28, DOI 10.1164/ajrccm.150.1.8025764; Sorkness RL, 1999, AM J RESP CRIT CARE, V160, P705, DOI 10.1164/ajrccm.160.2.9810002; Sorkness RL, 2004, J APPL PHYSIOL, V96, P904, DOI 10.1152/japplphysiol.00674.2003; Sorkness RL, 2002, PEDIATR RES, V52, P382, DOI 10.1203/01.PDR.0000025345.35944.85; Sorkness RL, 2002, J ALLERGY CLIN IMMUN, V110, P607, DOI 10.1067/mai.2002.128241; Sorkness RL, 2013, AM J RESP CELL MOL B; Sorkness RL, 2013, AM J RESP CELL MOL, V49, P808, DOI 10.1165/rcmb.2013-0096OC; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stone AES, 2003, CYTOKINE, V24, P103, DOI 10.1016/j.cyto.2003.07.005; Trivedi NN, 2010, AM J RESP CELL MOL, V42, P257, DOI 10.1165/rcmb.2009-0324RT; Uhl EW, 1996, AM J RESP CRIT CARE, V154, P1834, DOI 10.1164/ajrccm.154.6.8970378; van der Zalm MM, 2011, AM J RESP CRIT CARE, V183, P262, DOI 10.1164/rccm.200905-0716OC; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Xu YD, 2003, AM J PHYSIOL-LUNG C, V285, pL527, DOI 10.1152/ajplung.00298.2002; Yang F, 1996, AM J RESP CELL MOL, V14, P161, DOI 10.1165/ajrcmb.14.2.8630266; Yuan M, 2006, J AM STAT ASSOC, V101, P1323, DOI 10.1198/016214505000000394	99	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112997	10.1371/journal.pone.0112997	http://dx.doi.org/10.1371/journal.pone.0112997			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437859	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900024
J	Skrastina, D; Petrovskis, I; Lieknina, I; Bogans, J; Renhofa, R; Ose, V; Dishlers, A; Dekhtyar, Y; Pumpens, P				Skrastina, Dace; Petrovskis, Ivars; Lieknina, Ilva; Bogans, Janis; Renhofa, Regina; Ose, Velta; Dishlers, Andris; Dekhtyar, Yuri; Pumpens, Paul			Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles	PLOS ONE			English	Article							ALUMINUM-HYDROXIDE; INTERSTITIAL FLUID; IMMUNE-RESPONSE; ANTIGEN; VACCINE; ANTIBODY; CELLS; PROTEIN; ADSORPTION; TOXICITY	Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commercially available Silica nanoparticles (initial particles size of 10-20 nm) with that of aluminium hydroxide, or Alum, as well as that of complete and incomplete Freund's adjuvants for the immunisation of BALB/c mice with virus-like particles (VLPs) formed by recombinant full-length Hepatitis B virus core (HBc) protein. The induction of B-cell and T-cell responses was studied after immunisation. Silica nanoparticles were able to adsorb maximally 40% of the added HBc, whereas the adsorption capacity of Alum exceeded 90% at the same VLPs/adjuvant ratio. Both Silica and Alum formed large complexes with HBc VLPs that sedimented rapidly after formulation, as detected by dynamic light scattering, spectrophotometry, and electron microscopy. Both Silica and Alum augmented the humoral response against HBc VLPs to the high anti-HBc level in the case of intraperitoneal immunisation, whereas in subcutaneous immunisation, the Silica-adjuvanted anti-HBc level even exceeded the level adjuvanted by Alum. The adjuvanting of HBc VLPs by Silica resulted in the same typical IgG2a/IgG1 ratios as in the case of the adjuvanting by Alum. The combination of Silica with monophosphoryl lipid A (MPL) led to the same enhancement of the HBc-specific T-cell induction as in the case of the Alum and MPL combination. These findings demonstrate that Silica is not a weaker putative adjuvant than Alum for induction of B-cell and T-cell responses against recombinant HBc VLPs. This finding may have an essential impact on the development of the set of Silica-adjuvanted vaccines based on a long list of HBc-derived virus-like particles as the biological component.	[Skrastina, Dace; Petrovskis, Ivars; Lieknina, Ilva; Bogans, Janis; Renhofa, Regina; Ose, Velta; Dishlers, Andris; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Dekhtyar, Yuri] Riga Tech Univ, Inst Biomed Engn & Nanotechnol, Riga, Latvia	Latvian Biomedical Research & Study Centre; Riga Technical University	Skrastina, D (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	daceskr@biomed.lu.lv	Pumpens, Paul/A-2163-2008	Dishlers, Andris/0000-0002-0112-3948; Petrovskis, Ivars/0000-0002-1382-3466	ERDF [2013/0053/2DP/2.1.1.1.0/13/APIA/VIAA/006]	ERDF(European Commission)	This work was supported by ERDF 2013/0053/2DP/2.1.1.1.0/13/APIA/VIAA/006 (http://biomed.lu.lv/en/research/projects/all-projects/technology-to-obtain-high-quality-virus-like-nanostructures-based-on-hbv-core-antigen/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; Blumen SR, 2007, AM J RESP CELL MOL, V36, P333, DOI 10.1165/rcmb.2006-0319OC; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087; Chang MF, 2001, VACCINE, V19, P2884, DOI 10.1016/S0264-410X(00)00559-4; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Cielens I, 2014, MOL BIOTECHNOL, V56, P459, DOI 10.1007/s12033-014-9743-3; COLLIER LH, 1979, LANCET, V1, P1364; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; De Gregorio E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00214; Dekhtyar Yu, 2012, INORGANIC NANOPARTIC; Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876; Faquim-Mauro EL, 2000, INT IMMUNOL, V12, P1733, DOI 10.1093/intimm/12.12.1733; FROST L, 1985, ALLERGY, V40, P368, DOI 10.1111/j.1398-9995.1985.tb00249.x; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Glenny AT, 1921, J HYG-CAMBRIDGE, V20, P176, DOI 10.1017/S0022172400033945; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; HOFFNAGLE JH, 1973, LANCET, V2, P869; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Klingstrom J, 2004, VACCINE, V22, P4029, DOI 10.1016/j.vaccine.2004.03.045; Lincopan N, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-5; Liu TL, 2013, J COLLOID INTERF SCI, V400, P168, DOI 10.1016/j.jcis.2013.03.005; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mendez IZR, 2007, VACCINE, V25, P825, DOI 10.1016/j.vaccine.2006.09.039; Mercuri LP, 2006, SMALL, V2, P254, DOI 10.1002/smll.200500274; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MILICH DR, 1995, J VIROL, V69, P2776, DOI 10.1128/JVI.69.5.2776-2785.1995; MONDELLI M, 1982, J IMMUNOL, V129, P2773; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morefield GL, 2004, VACCINE, V22, P1973, DOI 10.1016/j.vaccine.2003.10.040; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Pumpens Paul, 2009, P205; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Roseman AM, 2012, J MOL BIOL, V423, P63, DOI 10.1016/j.jmb.2012.06.032; Sayers S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/831486; Schwarz TF, 2008, EXPERT REV VACCINES, V7, P1465, DOI 10.1586/14760584.7.10.1465; Sominskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075938; Stephens P, 2014, VACCINE, V32, P2139, DOI 10.1016/j.vaccine.2014.02.047; Vallhov H, 2007, NANO LETT, V7, P3576, DOI [10.1021/nl0714785, 10.1021/nI0714785]; Vallhov H, 2012, SMALL, V8, P2116, DOI 10.1002/smll.201102620; Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060; Wang XP, 2013, ACTA BIOMATER, V9, P7480, DOI 10.1016/j.actbio.2013.03.031; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wibowo N, 2014, VACCINE, V32, P3664, DOI 10.1016/j.vaccine.2014.04.043; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wolff L, 2009, VACCINE, V27, P1834, DOI 10.1016/j.vaccine.2009.01.037; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	56	30	32	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114006	10.1371/journal.pone.0114006	http://dx.doi.org/10.1371/journal.pone.0114006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436773	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900109
J	James, KA; Verkhivker, GM				James, Kevin A.; Verkhivker, Gennady M.			Structure-Based Network Analysis of Activation Mechanisms in the ErbB Family of Receptor Tyrosine Kinases: The Regulatory Spine Residues Are Global Mediators of Structural Stability and Allosteric Interactions	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOLECULAR-DYNAMICS SIMULATION; FREE-ENERGY LANDSCAPE; EGF RECEPTOR; ONCOGENIC MUTATIONS; PROTEIN-KINASES; LUNG-CANCER; CATALYTIC SUBUNIT; SOMATIC MUTATIONS; DOMAIN	The ErbB protein tyrosine kinases are among the most important cell signaling families and mutation-induced modulation of their activity is associated with diverse functions in biological networks and human disease. We have combined molecular dynamics simulations of the ErbB kinases with the protein structure network modeling to characterize the reorganization of the residue interaction networks during conformational equilibrium changes in the normal and oncogenic forms. Structural stability and network analyses have identified local communities integrated around high centrality sites that correspond to the regulatory spine residues. This analysis has provided a quantitative insight to the mechanism of mutation-induced "superacceptor'' activity in oncogenic EGFR dimers. We have found that kinase activation may be determined by allosteric interactions between modules of structurally stable residues that synchronize the dynamics in the nucleotide binding site and the alpha C-helix with the collective motions of the integrating alpha F-helix and the substrate binding site. The results of this study have pointed to a central role of the conserved His-Arg-Asp (HRD) motif in the catalytic loop and the Asp-Phe-Gly (DFG) motif as key mediators of structural stability and allosteric communications in the ErbB kinases. We have determined that residues that are indispensable for kinase regulation and catalysis often corresponded to the high centrality nodes within the protein structure network and could be distinguished by their unique network signatures. The optimal communication pathways are also controlled by these nodes and may ensure efficient allosteric signaling in the functional kinase state. Structure-based network analysis has quantified subtle effects of ATP binding on conformational dynamics and stability of the EGFR structures. Consistent with the NMR studies, we have found that nucleotide-induced modulation of the residue interaction networks is not limited to the ATP site, and may enhance allosteric cooperativity with the substrate binding region by increasing communication capabilities of mediating residues.	[James, Kevin A.; Verkhivker, Gennady M.] Chapman Univ, Sch Computat Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [James, Kevin A.; Verkhivker, Gennady M.] Chapman Univ, Crean Sch Hlth & Life Sci, Schmid Coll Sci & Technol, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Verkhivker, GM (corresponding author), Chapman Univ, Sch Computat Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external was funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cembran A, 2014, PHYS CHEM CHEM PHYS, V16, P6508, DOI 10.1039/c4cp00110a; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Ghosh A, 2011, J BIOL CHEM, V286, P37721, DOI 10.1074/jbc.M111.246702; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hao DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028322; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Lavery R, 2007, J BIOSCIENCES, V32, P891, DOI 10.1007/s12038-007-0089-x; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Littlefield P, 2013, P NATL ACAD SCI USA, V110, P15169, DOI 10.1073/pnas.1314719110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Marsh JA, 2013, J MOL BIOL, V425, P3250, DOI 10.1016/j.jmb.2013.06.019; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Massarelli E, 2013, LUNG CANCER, V80, P235, DOI 10.1016/j.lungcan.2013.01.018; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2012, ADV PROTEIN CHEM STR, V87, P363, DOI 10.1016/B978-0-12-398312-1.00012-3; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mustafa M, 2011, PROTEINS, V79, P99, DOI 10.1002/prot.22862; Navizet I, 2004, BIOPHYS J, V87, P1426, DOI 10.1529/biophysj.104.042085; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oruganty K, 2013, BBA-PROTEINS PROTEOM, V1834, P1322, DOI 10.1016/j.bbapap.2013.02.040; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sacquin-Mora S, 2006, BIOPHYS J, V90, P2706, DOI 10.1529/biophysj.105.074997; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shih Andrew J, 2011, Cancers (Basel), V3, P1195, DOI 10.3390/cancers3011195; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Shin AJ, 2011, BIOCHEM J, V436, P241, DOI 10.1042/BJ20101791; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Telesco SE, 2013, BIOTECHNOL J, V8, P1452, DOI 10.1002/biot.201300022; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tsai CJ, 2014, PHYS CHEM CHEM PHYS, V16, P6332, DOI 10.1039/c3cp54253j; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wan SZ, 2012, MOL CANCER THER, V11, P2394, DOI 10.1158/1535-7163.MCT-12-0644-T; Wan SZ, 2011, J COMPUT CHEM, V32, P2843, DOI 10.1002/jcc.21866; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; Whitford PC, 2013, P NATL ACAD SCI USA, V110, P7114, DOI 10.1073/pnas.1305236110; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	140	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113488	10.1371/journal.pone.0113488	http://dx.doi.org/10.1371/journal.pone.0113488			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427151	Green Published, gold			2022-12-27	WOS:000349145400057
J	Fletcher, SJ; Iqbal, M; Jabbari, S; Stekel, D; Rappoport, JZ				Fletcher, Sarah J.; Iqbal, Mudassar; Jabbari, Sara; Stekel, Dov; Rappoport, Joshua Z.			Analysis of Occludin Trafficking, Demonstrating Continuous Endocytosis, Degradation, Recycling and Biosynthetic Secretory Trafficking	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-TESTIS BARRIER; EPITHELIAL-CELLS; TIGHT; PROTEIN; EXOCYTOSIS; LYSOSOMES; POLARITY; PERMEABILITY; TEMPERATURE	Tight junctions (TJs) link adjacent cells and are critical for maintenance of apical-basolateral polarity in epithelial monolayers. The TJ protein occludin functions in disparate processes, including wound healing and Hepatitis C Virus infection. Little is known about steady-state occludin trafficking into and out of the plasma membrane. Therefore, we determined the mechanisms responsible for occludin turnover in confluent Madin-Darby canine kidney (MDCK) epithelial monolayers. Using various biotin-based trafficking assays we observed continuous and rapid endocytosis of plasma membrane localised occludin (the majority internalised within 30 minutes). By 120 minutes a significant reduction in internalised occludin was observed. Inhibition of lysosomal function attenuated the reduction in occludin signal post-endocytosis and promoted co-localisation with the late endocytic system. Using a similar method we demonstrated that similar to 20% of internalised occludin was transported back to the cell surface. Consistent with these findings, significant co-localisation between internalised occludin and recycling endosomal compartments was observed. We then quantified the extent to which occludin synthesis and transport to the plasma membrane contributes to plasma membrane occludin homeostasis, identifying inhibition of protein synthesis led to decreased plasma membrane localised occludin. Significant co-localisation between occludin and the biosynthetic secretory pathway was demonstrated. Thus, under steady-state conditions occludin undergoes turnover via a continuous cycle of endocytosis, recycling and degradation, with degradation compensated for by biosynthetic exocytic trafficking. We developed a mathematical model to describe the endocytosis, recycling and degradation of occludin, utilising experimental data to provide quantitative estimates for the rates of these processes.	[Fletcher, Sarah J.] Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Iqbal, Mudassar; Stekel, Dov] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, Leics, England; [Jabbari, Sara] Univ Birmingham, Sch Math, Birmingham, W Midlands, England; [Jabbari, Sara] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Rappoport, Joshua Z.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Birmingham; University of Nottingham; University of Birmingham; University of Birmingham; Northwestern University; Feinberg School of Medicine	Fletcher, SJ (corresponding author), Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	s.j.fletcher@bham.ac.uk	Jabbari, Sara/ABA-5537-2020; Jabbari, Sara/M-2925-2016; Iqbal, Mudassar/AAQ-4306-2021; Stekel, Dov/F-3053-2014	Jabbari, Sara/0000-0001-5235-0406; Jabbari, Sara/0000-0001-5235-0406; Iqbal, Mudassar/0000-0002-5006-4331; Stekel, Dov/0000-0002-2492-8079	Nottingham-Birmingham Strategic Funding Scheme; BBSRC (Biotechnology and Biological Sciences Research Council); Advantage West Midlands	Nottingham-Birmingham Strategic Funding Scheme; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Advantage West Midlands(General Electric)	This study was supported by: Nottingham-Birmingham Strategic Funding Scheme: Experimental analysis and modelling of occluding trafficking during epithelial polarisation and wound healing; Primary Investigators: Dr. Josh Rappoport and Dr Dov Stekel provided funding for Sarah Fletcher and Mudassar Iqbal and reagent funding (http://www.horizon.ac.uk/Funding-Calls/universityo-f-nottingham-nottingham-birmingham-strategic-funding- scheme) (JZR SJF DS MI). Post-doctoral researcher funded by BBSRC (Biotechnology and Biological Sciences Research Council): Regulation of occludin trafficking during epithelial polarisation; Primary Investigator: Dr. Josh Rappoport (http://www.bbsrc.ac.uk/home/home.aspx); Provided funding for reagents and Sarah Fletcher (JZR SJF). MRC Biomedical Informatics Fellowship; Primary Investigator: Dr Sara Jabarri; Provided funding for Sara Jabarri (SJ). Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform with support from Advantage West Midlands; Primary Investigator: Dr Josh Rappoport; Provided funding for the Nikon A1R microscope used in this research (JZR SJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Herman D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-119; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Liu SF, 2010, VIROLOGY, V407, P160, DOI 10.1016/j.virol.2010.08.009; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Rappoport JZ, 2001, AM J PHYSIOL-CELL PH, V281, pC1926, DOI 10.1152/ajpcell.2001.281.6.C1926; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wilson PD, 1997, AM J PHYSIOL-RENAL, V272, pF434, DOI 10.1152/ajprenal.1997.272.4.F434; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111176	10.1371/journal.pone.0111176	http://dx.doi.org/10.1371/journal.pone.0111176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422932	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700004
J	Mori, V; Amici, A; Mazzola, F; Di Stefano, M; Conforti, L; Magni, G; Ruggieri, S; Raffaelli, N; Orsomando, G				Mori, Valerio; Amici, Adolfo; Mazzola, Francesca; Di Stefano, Michele; Conforti, Laura; Magni, Giulio; Ruggieri, Silverio; Raffaelli, Nadia; Orsomando, Giuseppe			Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; NMN/NAMN ADENYLYLTRANSFERASE; SUBCELLULAR COMPARTMENTATION; WALLERIAN DEGENERATION; HUMAN ERYTHROCYTES; REDOX STATE; RAT-LIVER; IN-VIVO; EXPRESSION	NAD plays essential redox and non-redox roles in cell biology. In mammals, its de novo and recycling biosynthetic pathways encompass two independent branches, the "amidated'' and "deamidated'' routes. Here we focused on the indispensable enzymes gating these two routes, i.e. nicotinamide mononucleotide adenylyltransferase (NMNAT), which in mammals comprises three distinct isozymes, and NAD synthetase (NADS). First, we measured the in vitro activity of the enzymes, and the levels of all their substrates and products in a number of tissues from the C57BL/6 mouse. Second, from these data, we derived in vivo estimates of enzymes'rates and quantitative contributions to NAD homeostasis. The NMNAT activity, mainly represented by nuclear NMNAT1, appears to be high and nonrate-limiting in all examined tissues, except in blood. The NADS activity, however, appears rate-limiting in lung and skeletal muscle, where its undetectable levels parallel a relative accumulation of the enzyme's substrate NaAD (nicotinic acid adenine dinucleotide). In all tissues, the amidated NAD route was predominant, displaying highest rates in liver and kidney, and lowest in blood. In contrast, the minor deamidated route showed higher relative proportions in blood and small intestine, and higher absolute values in liver and small intestine. Such results provide the first comprehensive picture of the balance of the two alternative NAD biosynthetic routes in different mammalian tissues under physiological conditions. This fills a gap in the current knowledge of NAD biosynthesis, and provides a crucial information for the study of NAD metabolism and its role in disease.	[Mori, Valerio; Amici, Adolfo; Mazzola, Francesca; Orsomando, Giuseppe] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy; [Di Stefano, Michele; Conforti, Laura] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Life Sci, Nottingham, England; [Magni, Giulio] Univ Camerino, Sch Biosci & Biotechnol, I-62032 Camerino, Italy; [Ruggieri, Silverio; Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy	Marche Polytechnic University; University of Nottingham; University of Camerino; Marche Polytechnic University	Orsomando, G (corresponding author), Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy.	g.orsomando@univpm.it	Amici, Adolfo/C-5342-2012; Mazzola, Francesca/ADC-1197-2022; di stefano, michele/AAC-2205-2019; Orsomando, Giuseppe/L-2120-2015	Amici, Adolfo/0000-0002-1081-7749; di stefano, michele/0000-0002-6971-6854; Orsomando, Giuseppe/0000-0001-6640-097X; Mazzola, Francesca/0000-0001-9140-012X	grant "Ricerca Scientifica Ateneo - RSA"; grant Marie Curie Intra European Fellowship within the 7th European Community Framework Program	grant "Ricerca Scientifica Ateneo - RSA"; grant Marie Curie Intra European Fellowship within the 7th European Community Framework Program	This work was funded by grants "Ricerca Scientifica Ateneo - RSA 2010/2012" (to GO and GM) and by a Marie Curie Intra European Fellowship within the 7th European Community Framework Program (to MDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cappellacci L, 2011, EUR J MED CHEM, V46, P1499, DOI 10.1016/j.ejmech.2011.01.055; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; COLLINS PB, 1972, J BIOL CHEM, V247, P778; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; FLODGAARD H, 1974, J BIOL CHEM, V249, P3465; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; FREY PA, 1995, BIOCHEMISTRY-US, V34, P11307, DOI 10.1021/bi00036a001; GHOLSON RK, 1966, NATURE, V212, P933, DOI 10.1038/212933a0; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; KORNBERG A, 1950, J BIOL CHEM, V182, P779; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; MICHELI V, 1990, ARCH BIOCHEM BIOPHYS, V283, P40, DOI 10.1016/0003-9861(90)90609-3; Micheli V, 1999, LIFE SCI, V64, P2479, DOI 10.1016/S0024-3205(99)00205-2; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Orsomando G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053271; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Petrelli R, 2011, CURR MED CHEM, V18, P1973, DOI 10.2174/092986711795590048; PREISS J, 1958, J BIOL CHEM, V233, P493; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; RECHSTEINER M, 1976, NATURE, V259, P695, DOI 10.1038/259695a0; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; SEGEL IH, 1975, ENZYME KINETICS, P564; SESTINI S, 1993, ARCH BIOCHEM BIOPHYS, V302, P206, DOI 10.1006/abbi.1993.1200; Shibata K, 2013, BIOSCI BIOTECHNOL BI, V77; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Stavrum AK, 2013, J BIOL CHEM, V288, P34555, DOI 10.1074/jbc.M113.474908; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Williamson DH, 1974, METHOD ENZYMAT AN, P2267; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; YOZA N, 1991, ANAL BIOCHEM, V199, P279, DOI 10.1016/0003-2697(91)90102-Y; ZEREZ CR, 1990, BLOOD, V75, P1576; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	64	85	86	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113939	10.1371/journal.pone.0113939	http://dx.doi.org/10.1371/journal.pone.0113939			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423279	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700079
J	Yamaji, K; Kubo, S; Inoue, K; Kadota, K; Kuramitsu, S; Shirai, S; Ando, K; Nobuyoshi, M; Mitsudo, K; Kimura, T				Yamaji, Kyohei; Kubo, Shunsuke; Inoue, Katsumi; Kadota, Kazushige; Kuramitsu, Shoichi; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo; Mitsudo, Kazuaki; Kimura, Takeshi			Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND FINDINGS; ROUTINE CLINICAL-PRACTICE; LATE ADVERSE EVENTS; BARE-METAL; FOLLOW-UP; IMPLANTATION; REGISTRY; APPOSITION; REVASCULARIZATION; MECHANISMS	Background: Localized hypersensitivity reaction, delayed arterial healing, and neoatherosclerosis inside the stent have been suggested as the underlying pathologic mechanisms of very late stent thrombosis (VLST) of drug-eluting stent (DES). The present study sought to explore the prevalence of inflammatory cell infiltrates and evidence for fragments of atherosclerotic plaques in the aspirated thrombi in patients with DES VLST. Methods and Results: From April 2004 to September 2012, 48 patients with stent thrombosis (ST) of DES underwent thrombus aspiration with retrieved material sufficient for the histopathologic analysis; early ST (EST, within 30 days): N=17, late ST (LST, between 31 and 365 days): N=7, and very late ST (VLST,>1 year): N=24. Eosinophil fraction in the aspirated thrombi was significantly higher in patients with VLST (8.2 +/- 5.7%) as compared with those with EST (4.3+/-3.0%) and LST (5.5+/-3.8%) (P=0.03). Eosinophil fraction in the aspirated thrombi was significantly higher in 12 VLST patients with angiographic peri-stent contrast staining (PSS) and/or incomplete stent apposition (ISA) by intravascular ultrasound than in 12 VLST patients without PSS or ISA (10.6+/-6.1% versus 5.8+/-4.1%, P=0.03). Evidences for fragments of atherosclerotic plaques in the aspirated thrombi were observed only in 3 (13%) out of 24 patients with DES VLST. Conclusions: Eosinophil fraction in the aspirated thrombi was significantly higher in patients with DES VLST as compared with those with EST and LST. Evidences for fragments of atherosclerotic plaques were relatively uncommon in patients with DES VLST.	[Yamaji, Kyohei; Kuramitsu, Shoichi; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan; [Kubo, Shunsuke; Kadota, Kazushige; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan; [Inoue, Katsumi] Kokura Mem Hosp, Div Lab Med, Kitakyushu, Fukuoka, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kokura Memorial Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kyoto University	Yamaji, K (corresponding author), Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan.	kyohei@yamaji.info						Ako J, 2005, J AM COLL CARDIOL, V46, P1002, DOI 10.1016/j.jacc.2005.05.068; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Imai M, 2014, CARDIOVASC INTERV TH, V29, P226, DOI 10.1007/s12928-014-0248-6; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Inoue K, 2008, J CARDIOL, V51, P60, DOI 10.1016/j.jjcc.2007.08.001; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kimura T, 2010, CIRCULATION, V122, P52, DOI 10.1161/CIRCULATIONAHA.109.903955; Kon H, 2011, CIRC-CARDIOVASC INTE, V4, pE1, DOI 10.1161/CIRCINTERVENTIONS.110.958090; Kosonen P, 2013, INT J CARDIOL, V168, P1010, DOI 10.1016/j.ijcard.2012.10.033; Kozuma K, 2013, EUROINTERVENTION, V9, P831, DOI 10.4244/EIJV9I7A137; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pesarini G, 2013, CATHETER CARDIO INTE, V82, P1056, DOI 10.1002/ccd.24938; Sonoda Shinjo, 2012, J Cardiol Cases, V6, pe126, DOI 10.1016/j.jccase.2012.04.007; Tada T, 2012, CIRC-CARDIOVASC INTE, V5, P649, DOI 10.1161/CIRCINTERVENTIONS.112.968487; Umeda H, 2009, INT J CARDIOL, V133, P321, DOI 10.1016/j.ijcard.2007.12.067; van Werkum JW, 2009, CIRCULATION, V119, P828, DOI 10.1161/CIRCULATIONAHA.108.799403; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Yamaji K, 2012, CIRC-CARDIOVASC INTE, V5, P47, DOI 10.1161/CIRCINTERVENTIONS.111.964965	32	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113870	10.1371/journal.pone.0113870	http://dx.doi.org/10.1371/journal.pone.0113870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423451	gold, Green Published, Green Submitted			2022-12-27	WOS:000345899700074
J	Yin, YT; He, YC; Liu, W; Gan, L; Fu, CH; Jia, HB; Li, MT				Yin, Yongtai; He, Yuchi; Liu, Wei; Gan, Lu; Fu, Chunhua; Jia, Haibo; Li, Maoteng			The Durative Use of Suspension Cells and Callus for Volatile Oil by Comparative with Seeds and Fruits in Capparis spinosa L.	PLOS ONE			English	Article							TOCOPHEROL COMPOSITION; GROWING WILD; PLANT; CULTURES; EXTRACT; SYSTEM; TAXOL; BUDS	Capparis spinosa is one of the most important eremophytes among the medicinal plants, and continued destruction of these plants poses a major threat to species survival. The development of methods to extract compounds, especially those of medicinal value, without harvesting the whole plant is an issue of considerable socioeconomic importance. On the basis of an established system for culture of suspension cells and callus in vitro, Gas Chromatograph- Mass Spectrometer (GCMS) was used for the volatile oil composition analyzing in seed, fruit, suspension cells and callus. Fatty acids were the major component, and the highest content of alkanes was detected in seed, with,1.0% in suspension cells and callus. Esters, olefins and heterocyclic compounds were significantly higher in fruit than in the other materials. The content of acid esters in the suspension cells and callus was significantly higher than in seed and fruit. This indicated that the suspension cells and callus could be helpful for increasing the value of volatile oil and replacing seeds and fruit partially as a source of some compounds of the volatile oil and may also produce some new medical compounds. The above results give valuable information for sustainable use of C. spinosa and provide a foundation for use of the C. spinosa suspension cells and callus as an ongoing medical resource.	[Yin, Yongtai; Liu, Wei; Gan, Lu; Fu, Chunhua; Jia, Haibo; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Yin, Yongtai; Fu, Chunhua; Jia, Haibo; Li, Maoteng] Huazhong Univ Sci & Technol, Phys Minist Educ, Key Lab Mol Biol, Wuhan 430074, Peoples R China; [He, Yuchi] Hubei Univ, Fac Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei University	Jia, HB (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	haibo.jia@mail.hust.edu.cn; limaoteng426@mail.hust.edu.cn		, Yongtai Yin/0000-0002-6494-4268	New Century Talents Support Program by the Chinese Natural Science Foundation, Ministry of Education of China [31270373, NCET110172]	New Century Talents Support Program by the Chinese Natural Science Foundation, Ministry of Education of China	The research was supported by New Century Talents Support Program by the Chinese Natural Science Foundation (31270373), Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2004, PHARM BIOL, V42, P286, DOI 10.1080/13880200490511792; Arena A, 2008, PHYTOTHER RES, V22, P313, DOI 10.1002/ptr.2313; Bertoli A, 2013, FOOD CHEM, V141, P776, DOI 10.1016/j.foodchem.2013.02.081; Calis I, 2002, PHYTOCHEMISTRY, V59, P451, DOI 10.1016/S0031-9422(01)00399-5; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Cisneros FH, 2014, J AGR FOOD CHEM, V62, P5191, DOI 10.1021/jf500936j; Deng CH, 2004, ANN CHIM-ROME, V94, P921, DOI 10.1002/adic.200490114; DICOSMO F, 1989, CHEM BRIT, V25, P1001; Dong J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-239; EKOKOSKI E, 1994, MOL CELL ENDOCRINOL, V103, P125, DOI 10.1016/0303-7207(94)90079-5; Fici S, 2001, PLANT SYST EVOL, V228, P123, DOI 10.1007/s006060170024; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Khanfar MA, 2003, NAT PROD RES, V17, P9, DOI 10.1080/10575630290034302; Lam SK, 2009, BIOSCIENCE REP, V29, P293, DOI 10.1042/BSR20080110; Leena Tripathi, 2003, Tropical Journal of Pharmaceutical Research, V2, P243; Levizou E, 2004, PHOTOSYNTHETICA, V42, P229, DOI 10.1023/B:PHOT.0000040594.85407.f4; [栗茂腾 LI Maoteng], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P25; Liu W, 2008, CHINA MED HERALD, V5, P19; Liu W, 2011, J MED PLANTS RES, V5, P5899; Lucchesini M, 2009, SCI HORTIC-AMSTERDAM, V122, P484, DOI 10.1016/j.scienta.2009.06.011; Matthaus B, 2005, J AGR FOOD CHEM, V53, P7136, DOI 10.1021/jf051019u; Matthaus B, 2002, J AGR FOOD CHEM, V50, P7323, DOI 10.1021/jf020530+; Mishra SN, 2007, INDIAN J TRADIT KNOW, V6, P230; Morihara N, 2011, PLANT FOOD HUM NUTR, V66, P17, DOI 10.1007/s11130-011-0216-6; Mulabagal V., 2004, INT J APPL SCI ENG, V2, P29, DOI DOI 10.1016/S0168-1656(98)00195-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEELANDS PJ, 1983, BIOCHEM J, V212, P573, DOI 10.1042/bj2120573; Ozcan M, 2005, J MED FOOD, V8, P405, DOI 10.1089/jmf.2005.8.405; Peters JM, 2000, CARCINOGENESIS, V21, P823, DOI 10.1093/carcin/21.4.823; SaurabhChattopadhyay, 2002, Biotechnology and Bioprocess Engineering, V7, P138; Sher H, 2010, J MED PLANTS RES, V4, P1751; Sher H, 2010, J MED PLANTS RES, V4, P1209; SLICHENMYER WJ, 1991, ANTI-CANCER DRUG, V2, P519, DOI 10.1097/00001813-199112000-00002; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Tikunov YM, 2010, PLANT PHYSIOL, V152, P55, DOI 10.1104/pp.109.146670; Tlili N, 2011, J AM OIL CHEM SOC, V88, P1787, DOI 10.1007/s11746-011-1855-3; Tlili N, 2009, J AGR FOOD CHEM, V57, P5381, DOI 10.1021/jf900457p; Tsay HS, 1994, J AGR ASSOC CHINA, P32; Wang LM, 2009, FOOD CHEM, V114, P233, DOI 10.1016/j.foodchem.2008.09.044; Wu CT, 2003, BIOL PHARM BULL, V26, P845, DOI 10.1248/bpb.26.845; Wu JY, 2001, J BIOTECHNOL, V85, P67, DOI 10.1016/S0168-1656(00)00383-7; Youssef O, 2011, FOOD CHEM, V124, P1770, DOI 10.1016/j.foodchem.2010.08.023; Zhou HF, 2011, J AGR FOOD CHEM, V59, P3060, DOI 10.1021/jf105017j	44	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113668	10.1371/journal.pone.0113668	http://dx.doi.org/10.1371/journal.pone.0113668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25422894	gold, Green Submitted, Green Published			2022-12-27	WOS:000345899700051
J	Bonifaz-Pena, V; Contreras, AV; Struchiner, CJ; Roela, RA; Furuya-Mazzotti, TK; Chammas, R; Rangel-Escareno, C; Uribe-Figueroa, L; Gomez-Vazquez, MJ; McLeod, HL; Hidalgo-Miranda, A; Parra, EJ; Fernandez-Lopez, JC; Suarez-Kurtz, G				Bonifaz-Pena, Vania; Contreras, Alejandra V.; Struchiner, Claudio Jose; Roela, Rosimeire A.; Furuya-Mazzotti, Tatiane K.; Chammas, Roger; Rangel-Escareno, Claudia; Uribe-Figueroa, Laura; Jose Gomez-Vazquez, Maria; McLeod, Howard L.; Hidalgo-Miranda, Alfredo; Parra, Esteban J.; Carlos Fernandez-Lopez, Juan; Suarez-Kurtz, Guilherme			Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations	PLOS ONE			English	Article							GENOME-WIDE PATTERNS; WARFARIN PHARMACOGENETICS; HAPLOTYPE RECONSTRUCTION; GENOTYPE DATA; DIVERSITY; POLYMORPHISM; INFERENCE; ASSOCIATION; IRINOTECAN; ADMIXTURE	Studies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used the Affymetrix Drug Metabolizing Enzymes and Transporters (DMET) Plus array to characterize the distribution of polymorphisms of pharmacogenetics and pharmacogenomics (PGx) relevance in two samples from the most populous Latin American countries, Brazil and Mexico. The sample from Brazil included 268 individuals from the southeastern state of Rio de Janeiro, and was stratified into census categories. The sample from Mexico comprised 45 Native American Zapotecas and 224 self-identified Mestizo individuals from 5 states located in geographically distant regions in Mexico. We evaluated the admixture proportions in the Brazilian and Mexican samples using a panel of Ancestry Informative Markers extracted from the DMET array, which was validated with genome-wide data. A substantial variation in ancestral proportions across census categories in Brazil, and geographic regions in Mexico was identified. We evaluated the extent of genetic differentiation (measured as FST values) of the genetic markers of the DMET Plus array between the relevant parental populations. Although the average levels of genetic differentiation are low, there is a long tail of markers showing large frequency differences, including markers located in genes belonging to the Cytochrome P450, Solute Carrier (SLC) and UDP-glucuronyltransferase (UGT) families as well as other genes of PGx relevance such as ABCC8, ADH1A, CHST3, PON1, PPARD, PPARG, and VKORC1. We show how differences in admixture history may have an important impact in the distribution of allele and genotype frequencies at the population level.	[Bonifaz-Pena, Vania; Rangel-Escareno, Claudia; Jose Gomez-Vazquez, Maria; Carlos Fernandez-Lopez, Juan] Natl Inst Genom Med, Computat Genom Consortium, Mexico City, DF, Mexico; [Contreras, Alejandra V.] Natl Inst Genom Med, Nutrigenet & Nutrigen Lab, Mexico City, DF, Mexico; [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Roela, Rosimeire A.; Furuya-Mazzotti, Tatiane K.; Chammas, Roger] Univ Sao Paulo, Dept Radiol & Oncol, Sao Paulo, Brazil; [Uribe-Figueroa, Laura] Natl Inst Genom Med, Genotyping & Express Anal Unit, Mexico City, DF, Mexico; [McLeod, Howard L.] Univ S Florida, Moffitt Canc Ctr, DeBartolo Family Personalized Med Inst, Tampa, FL USA; [Hidalgo-Miranda, Alfredo] Natl Inst Genom Med, Canc Genom Lab, Mexico City, DF, Mexico; [Parra, Esteban J.] Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; [Suarez-Kurtz, Guilherme] Inst Nacl Canc, Div Farmacol, Rio De Janeiro, Brazil; [Rangel-Escareno, Claudia] Claremont Grad Univ, Inst Math Sci, Claremont, CA USA; [McLeod, Howard L.] Pharmacogenet Every Nation Initiat, Pharmacogen Dept, Tampa, FL USA	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Instituto Nacional de Medicina Genomica; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Instituto Nacional de Medicina Genomica; University of Toronto; University Toronto Mississauga; National Cancer Institute (Inca); Claremont Colleges; Claremont Graduate School	Fernandez-Lopez, JC (corresponding author), Natl Inst Genom Med, Computat Genom Consortium, Mexico City, DF, Mexico.	jfernandez@inmegen.gob.mx; Kurtz@inca.gov.br	Chammas, Roger/A-8004-2011; McLeod, Howard/ABD-8364-2021; Suarez-Kurtz, Guilherme/J-6648-2012; Struchiner, Claudio Jose/HGB-9492-2022; Hidalgo-Miranda, Alfredo/B-2123-2010; Suarez-Kurtz, Guilherme/P-4620-2019; Furuya, Tatiane Katsue/B-5842-2015; Struchiner, Claudio J/M-9360-2013; Furuya, Tatiane K/E-5543-2013; Rangel-Escareno, Claudia/F-4587-2012; Roela, Rosimeire A/AAC-9377-2021; Fernandez, Juan Carlos/C-4976-2013; Contreras, Alejandra Virginia/E-7815-2013	Chammas, Roger/0000-0003-0342-8726; McLeod, Howard/0000-0002-9004-9232; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Struchiner, Claudio J/0000-0003-2114-847X; Rangel-Escareno, Claudia/0000-0003-1303-0834; Fernandez, Juan Carlos/0000-0003-3680-4193; Contreras, Alejandra Virginia/0000-0003-3653-5958; parra, esteban J/0000-0002-2057-8577	Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq [304063/2011-8,]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ [E-26/102796/2012, E-26/110683/2012]; Financiadora de Estudos e Projetos (FINEP) FINEP [01.08.0123.00]	Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP) FINEP	FUNDERS: (1) Funding supported by Conselho Nacional do Desenvolvimento Cientifico (CNPq) CNPq no. 304063/2011-8, http://www.cnpq.br (GS-K). (2) Funding supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) FAPERJ no. E-26/102796/2012, URL: http://www.faperj.br; FAPERJ no. E-26/110683/2012, URL: http://www.faperj.br (GS-K). (3) Funding supported by Financiadora de Estudos e Projetos (FINEP) FINEP no. 01.08.0123.00, URL: http://www.finep.gov.br (GS-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SPONSORSHIPS: (1) The Affymetrix DMETplus chips were provided by the Pharmacogenetics for every nation initiative (PGENI), a USA-based global health non-profit organization. PGENI is supported by individual donors and does not solicit funding from health care-oriented companies. (2) The Affymetrix DMET Plus array data for the European, African and East Asian HapMap samples were provided by Affymetrix Inc.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Bastos João Luiz, 2008, Rev. Saúde Pública, V42, P324, DOI 10.1590/S0034-89102008005000005; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Burmester JK, 2010, METHODS MOL BIOL, V632, P99, DOI 10.1007/978-1-60761-663-4_7; Cha PC, 2009, J HUM GENET, V54, P572, DOI 10.1038/jhg.2009.80; Contreras AV, 2011, PHARMACOGENOMICS, V12, P745, DOI 10.2217/PGS.11.8; Cote JF, 2007, CLIN CANCER RES, V13, P3269, DOI 10.1158/1078-0432.CCR-06-2290; Deshpande O, 2009, P ROY SOC B-BIOL SCI, V276, P291, DOI 10.1098/rspb.2008.0750; Elhaik E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049837; Falush D, 2003, GENETICS, V164, P1567; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Harrell FE, 2001, REGRESSION MODELING; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hicks JK, 2014, CURR DRUG METAB, V15, P218, DOI 10.2174/1389200215666140202215316; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kim SY, 2013, BRIT J CANCER, V109, P1420, DOI 10.1038/bjc.2013.479; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Moreno EA, 2014, SCIENCE, V344, P1280; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Perera MA, 2014, CLIN PHARMACOL THER, V95, P242, DOI 10.1038/clpt.2013.209; Perini JA, 2008, CLIN PHARMACOL THER, V84, P722, DOI 10.1038/clpt.2008.166; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Saito Y, 2009, DRUG METAB DISPOS, V37, P272, DOI 10.1124/dmd.108.024208; Salzano FM, 2002, EVOLUTION GENETICS L; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191; Suarez-Kurtz G, 2012, PHARMACOGENOMICS, V13, P771, DOI [10.2217/pgs.12.39, 10.2217/PGS.12.39]; Suarez-Kurtz G, 2011, BRIT J CLIN PHARMACO, V72, P451, DOI 10.1111/j.1365-2125.2011.04018.x; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	44	51	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e112640	10.1371/journal.pone.0112640	http://dx.doi.org/10.1371/journal.pone.0112640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419701	Green Submitted, Green Published, gold			2022-12-27	WOS:000346766900009
J	Brannmark, C; Paul, A; Ribeiro, D; Magnusson, B; Brolen, G; Enejder, A; Forslow, A				Brannmark, Cecilia; Paul, Alexandra; Ribeiro, Diana; Magnusson, Bjorn; Brolen, Gabriella; Enejder, Annika; Forslow, Anna			Increased Adipogenesis of Human Adipose-Derived Stem Cells on Polycaprolactone Fiber Matrices	PLOS ONE			English	Article							STOKES-RAMAN SCATTERING; HUMAN BONE-MARROW; IN-VITRO; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; GENE-EXPRESSION; STROMAL CELLS; EXTRACELLULAR-MATRIX; SPHEROID FORMATION; TISSUE	With accelerating rates of obesity and type 2 diabetes world-wide, interest in studying the adipocyte and adipose tissue is increasing. Human adipose derived stem cells differentiated to adipocytes in vitro - are frequently used as a model system for white adipocytes, as most of their pathways and functions resemble mature adipocytes in vivo. However, these cells are not completely like in vivo mature adipocytes. Hosting the cells in amore physiologically relevant environment compared to conventional two-dimensional cell culturing on plastic surfaces, can produce spatial cues that drive the cells towards a more mature state. We investigated the adipogenesis of adipose derived stem cells on electro spun polycaprolactone matrices and compared functionality to conventional two-dimensional cultures as well as to human primary mature adipocytes. To assess the degree of adipogenesis we measured cellular glucose-uptake and lipolysis and used a range of different methods to evaluate lipid accumulation. We compared the averaged results from a whole population with the single cell characteristics - studied by coherent anti-Stokes Raman scattering microscopy - to gain a comprehensive picture of the cell phenotypes. In adipose derived stem cells differentiated on a polycaprolactone-fiber matrix; an increased sensitivity in insulin-stimulated glucose uptake was detected when cells were grown on either aligned or random matrices. Furthermore, comparing differentiation of adipose derived stem cells on aligned polycaprolactone-fiber matrixes, to those differentiated in two-dimensional cultures showed, an increase in the cellular lipid accumulation, and hormone sensitive lipase content. In conclusion, we propose an adipocyte cell model created by differentiation of adipose derived stem cells on aligned polycaprolactone-fiber matrices which demonstrates increased maturity, compared to 2D cultured cells.	[Brannmark, Cecilia; Ribeiro, Diana; Magnusson, Bjorn; Brolen, Gabriella; Forslow, Anna] Astra Zeneca, Reagent & Assay Dev Discovery Sci R&D, Molndal, Sweden; [Paul, Alexandra; Ribeiro, Diana; Enejder, Annika] Chalmers Univ Technol, Mol Microscopy Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	AstraZeneca; Chalmers University of Technology	Brannmark, C (corresponding author), Astra Zeneca, Reagent & Assay Dev Discovery Sci R&D, Molndal, Sweden.	cecilia.brannmark@neuro.gu.se	Paul, Alexandra/L-8289-2017	Paul, Alexandra/0000-0002-8368-9880	European Union [607842]; Swedish Research Council; VINNOVA VINNMER	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA VINNMER(Vinnova)	AE, AP and DR are funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7(2007-2013) under REA grant agreement no [607842]. AE is also funded by the Swedish Research Council and a VINNOVA VINNMER grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2000, J CONTROL RELEASE, V63, P275, DOI 10.1016/S0168-3659(99)00200-X; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Chandler EM, 2011, BIOTECHNOL BIOENG, V108, P1683, DOI 10.1002/bit.23079; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Chun TH, 2012, ADIPOCYTE, V1, P89, DOI 10.4161/adip.19752; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; DARNEY PD, 1989, AM J OBSTET GYNECOL, V160, P1292, DOI 10.1016/S0002-9378(89)80015-8; Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Enejder A, 2010, IEEE J SEL TOP QUANT, V16, P506, DOI 10.1109/JSTQE.2009.2032512; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Galateanu B, 2012, INT J MOL SCI, V13, P15881, DOI 10.3390/ijms131215881; Galateanu B, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-35; Gerlach JC, 2012, TISSUE ENG PART C-ME, V18, P54, DOI [10.1089/ten.tec.2011.0216, 10.1089/ten.TEC.2011.0216]; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gugerell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090676; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Im GI, 2012, CELL TRANSPLANT, V21, P2397, DOI 10.3727/096368912X638865; Kang XH, 2007, BIOMATERIALS, V28, P450, DOI 10.1016/j.biomaterials.2006.08.052; Kimura Y, 2002, TISSUE ENG, V8, P603, DOI 10.1089/107632702760240526; Kolambkar YM, 2014, TISSUE ENG PT A, V20, P398, DOI [10.1089/ten.TEA.2012.0426, 10.1089/ten.tea.2012.0426]; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Le TT, 2010, J LIPID RES, V51, P3091, DOI 10.1194/jlr.R008730; Lee JS, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024103; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Liao H, 2013, J TISSUE ENG REGEN M; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI [10.1089/ten.tea.2009.0810, 10.1089/ten.TEA.2009.0810]; Myneni VD, 2014, BLOOD; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Niemela* SM, 2008, ADIPOSE TISSUE ADIPO; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Ogawa Rei, 2004, Journal of Nippon Medical School, V71, P240, DOI 10.1272/jnms.71.240; Pereira IHL, 2014, J MATER SCI-MATER M, V25, P1137, DOI 10.1007/s10856-013-5133-9; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068; Shi XE, 2014, INT J MOL SCI, V15, P8526, DOI 10.3390/ijms15058526; Tanzi MC, 2009, EXPERT REV MED DEVIC, V6, P533, DOI 10.1586/ERD.09.37; Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028; Van Heimburg D, 2003, INT J ARTIF ORGANS, V26, P1064, DOI 10.1177/039139880302601204; Vashi AV, 2006, TISSUE ENG, V12, P3035, DOI 10.1089/ten.2006.12.3035; Wang LN, 2013, ACTA BIOMATER, V9, P8921, DOI 10.1016/j.actbio.2013.06.035; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Yun YP, 2014, J BIOMED NANOTECHNOL, V10, P1080, DOI 10.1166/jbn.2014.1819; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	62	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113620	10.1371/journal.pone.0113620	http://dx.doi.org/10.1371/journal.pone.0113620			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419971	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900060
J	Ghezzo, A; Salvioli, S; Solimando, MC; Palmieri, A; Chiostergi, C; Scurti, M; Lomartire, L; Bedetti, F; Cocchi, G; Follo, D; Pipitone, E; Rovatti, P; Zamberletti, J; Gomiero, T; Castellani, G; Franceschi, C				Ghezzo, Alessandro; Salvioli, Stefano; Solimando, Maria Caterina; Palmieri, Alice; Chiostergi, Chiara; Scurti, Maria; Lomartire, Laura; Bedetti, Federica; Cocchi, Guido; Follo, Daniela; Pipitone, Emanuela; Rovatti, Paolo; Zamberletti, Jessica; Gomiero, Tiziano; Castellani, Gastone; Franceschi, Claudio			Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; SHORT-TERM-MEMORY; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; INTELLECTUAL DISABILITIES; SPATIAL PERCEPTION; DEMENTIA; ADULTS; POPULATION; PREVALENCE	Down Syndrome (DS) is characterised by premature aging and an accelerated decline of cognitive functions in the vast majority of cases. As the life expectancy of DS persons is rapidly increasing, this decline is becoming a dramatic health problem. The aim of this study was to thoroughly evaluate a group of 67 non-demented persons with DS of different ages (11 to 66 years), from a neuropsychological, neuropsychiatric and psychomotor point of view in order to evaluate in a cross-sectional study the age-related adaptive and neuropsychological features, and to possibly identify early signs predictive of cognitive decline. The main finding of this study is that both neuropsychological functions and adaptive skills are lower in adult DS persons over 40 years old, compared to younger ones. In particular, language and short memory skills, frontal lobe functions, visuo-spatial abilities and adaptive behaviour appear to be the more affected domains. A growing deficit in verbal comprehension, along with social isolation, loss of interest and greater fatigue in daily tasks, are the main features found in older, non demented DS persons evaluated in our study. It is proposed that these signs can be alarm bells for incipient dementia, and that neuro-cognitive rehabilitation and psycho-pharmacological interventions must start as soon as the fourth decade (or even earlier) in DS persons, i.e. at an age where interventions can have the greatest efficacy.	[Ghezzo, Alessandro; Salvioli, Stefano; Scurti, Maria; Lomartire, Laura; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Ghezzo, Alessandro] Assoc Nazl Famiglie Persone Con Disabilita Affett, Macerata, Italy; [Salvioli, Stefano; Scurti, Maria; Lomartire, Laura; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy; [Solimando, Maria Caterina; Palmieri, Alice] Univ Bologna, Serv Disabled Students, Bologna, Italy; [Chiostergi, Chiara] Fdn Don Carlo Gnocchi Onlus, Falconara, AN, Italy; [Bedetti, Federica; Cocchi, Guido] Univ Bologna, Dept Med & Surg Sci, Operat Unit Neonatol, Bologna, Italy; [Follo, Daniela] CEPS Ctr Emiliano Studi Sociali Trisomia 21, Bologna, Italy; [Pipitone, Emanuela] Azienda USL Bologna, Bologna, Italy; [Rovatti, Paolo; Zamberletti, Jessica] Comune Bologna Settore Salute Sport & Citta Sana, Bologna, Italy; [Gomiero, Tiziano] Assoc Nazl Famiglie Persone Con Disabilita Affett, Project DAD Alzheimer Dementia, Trient, Italy; [Castellani, Gastone] Univ Bologna, Dept Phys, I-40126 Bologna, Italy; [Franceschi, Claudio] IRCCS Inst Neurol Sci, Bologna, Italy; [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Organ Synth & Photoreact ISOF, I-40126 Bologna, Italy; [Franceschi, Claudio] CNR, Natl Res Council Italy, Inst Mol Genet, Unit Bologna, I-40126 Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Bologna; AUSL di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Salvioli, S (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	stefano.salvioli@unibo.it	Castellani, Gastone c/L-3333-2017; Franceschi, Claudio/L-4484-2017; Gomiero, Tiziano/H-7011-2019; Salvioli, Stefano/K-6663-2016	Castellani, Gastone c/0000-0003-4892-925X; Franceschi, Claudio/0000-0001-9841-6386; Gomiero, Tiziano/0000-0002-2931-9571; Salvioli, Stefano/0000-0002-6191-1225	Carisbo Foundation (Bologna, Italy) [2007.0228]; European Union [259679]; Italian Ministry of Health	Carisbo Foundation (Bologna, Italy)(Fondazione Carisbo); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	The research leading to these results received funding from the Carisbo Foundation (Bologna, Italy Project: INVECCHIAMENTO PRECOCE E DECLINO NEURO-COGNITIVO NELLA SINDROME DI DOWN nr. 2007.0228), European Union's Seventh Framework Programme (FP7/2007-2011 under grant agreement n. 259679) (IDEAL), and the Italian Ministry of Health, Progetto Ricerca Finalizzata 2008, convenzione 35: "An integrated approach to identify functional, biochemical and genetic markers for diagnostic and prognostic purposes in the elderly, in the centenarians and in people with dementia, Alzheimer's disease, mild cognitive impairment" to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adattamento italiano a cura di Giulia Balboni e Luigi Pedrabissi, 2003, VINELAND ADAPTIVE BE; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], WAIS R SCALA INTELLI; Appollonio I, 2005, NEUROL SCI, V26, P108, DOI 10.1007/s10072-005-0443-4; Appollonio I., 2004, DEMENZE, V7, P28; BADDELY A, 1986, WORKING MEMORY; Ball SL, 2010, J INTELL DISABIL RES, V54, P320, DOI 10.1111/j.1365-2788.2010.01261.x; Ball SL, 2006, INT J GERIATR PSYCH, V21, P661, DOI 10.1002/gps.1545; Bargagna S., 2004, PSICOL CLIN SVILUPP, V3, P459; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binetti G, 1998, NEUROPSYCHOLOGY, V12, P29, DOI 10.1037/0894-4105.12.1.29; Binetti G, 1996, ANN NY ACAD SCI, V777, P221, DOI 10.1111/j.1749-6632.1996.tb34422.x; Bisiacchi P.S., 2005, BVN 5 11 BATTERIA VA; Bittles AH, 2004, DEV MED CHILD NEUROL, V46, P282, DOI 10.1017/S0012162204000441; Carlier M, 2006, BEHAV GENET, V36, P365, DOI 10.1007/s10519-006-9048-9; COOPER SA, 1994, BRIT J PSYCHIAT, V165, P399, DOI 10.1192/bjp.165.3.399; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crosson B, 1999, CEREB CORTEX, V9, P307, DOI 10.1093/cercor/9.4.307; Dalton AJ, 1986, PSYCHIAT CLIN N AM, V9, P959; Dane S, 2007, INT J DEV NEUROSCI, V25, P223, DOI 10.1016/j.ijdevneu.2007.03.005; de Graaf G, 2007, J INTELLECT DISABIL, V55, P462; Deb S, 2007, J INTELL DISABIL RES, V51, P726, DOI 10.1111/j.1365-2788.2007.00956.x; Deb S, 2007, BRIT J PSYCHIAT, V190, P440, DOI 10.1192/bjp.bp.106.024984; DelBo R, 1997, J NEUROL SCI, V145, P87, DOI 10.1016/S0022-510X(96)00249-3; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; Formica U, 2000, FORMICA U I CONTROLL, P17; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Head E, 2007, J ALZHEIMERS DIS, V11, P61; HIXSON JE, 1990, J LIPID RES, V31, P545; HOF PR, 1995, ARCH NEUROL-CHICAGO, V52, P379, DOI 10.1001/archneur.1995.00540280065020; HOLLAND AJ, 1995, J NEUROL NEUROSUR PS, V59, P111, DOI 10.1136/jnnp.59.2.111; Holland AJ, 2000, J INTELL DISABIL RES, V44, P138, DOI 10.1046/j.1365-2788.2000.00263.x; Iacono T, 2010, RES DEV DISABIL, V31, P568, DOI 10.1016/j.ridd.2009.12.009; Jarrold C, 2001, Downs Syndr Res Pract, V7, P17, DOI 10.3104/reviews.110; Kittler P, 2006, J INTELL DISABIL RES, V50, P1, DOI 10.1111/j.1365-2788.2005.00715.x; Koran MEI, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-8; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Parmenter TR, 2008, EVID-BASED MENT HEAL, V11, P11, DOI 10.1136/ebmh.11.1.11; PENROSE LS, 1949, J MENT SCI, V95, P685, DOI 10.1192/bjp.95.400.685; Prasher VP, 2008, INT J GERIATR PSYCH, V23, P1134, DOI 10.1002/gps.2039; PRASHER VP, 1995, INT J GERIATR PSYCH, V10, P25, DOI 10.1002/gps.930100106; Rubin SS, 1998, MENT RETARD, V36, P175, DOI 10.1352/0047-6765(1998)036<0175:OPIPWD>2.0.CO;2; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SILVERSTEIN AB, 1985, AM J MENT DEF, V89, P555; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Vicari S, 1995, J INTELL DISABIL RES, V39, P532, DOI 10.1111/j.1365-2788.1995.tb00574.x; Vicari S, 2004, J INTELL DISABIL RES, V48, P80, DOI 10.1111/j.1365-2788.2004.00478.x; Viggiano MP, 2001, LATERALITY, V6, P283, DOI 10.1080/13576500143000041; Warrington Elizabeth K, 1991, VISUAL OBJECT SPACE; Wechsler D., 1991, WISC 3 WECHSLER INTE; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	60	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113111	10.1371/journal.pone.0113111	http://dx.doi.org/10.1371/journal.pone.0113111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419980	Green Published, gold			2022-12-27	WOS:000346766900018
J	Yuan, LH; Ma, WW; Liu, JM; Meng, LP; Liu, JX; Li, S; Han, J; Liu, QR; Feng, LL; Wang, C; Xiao, R				Yuan, Linhong; Ma, Weiwei; Liu, Jinmeng; Meng, Liping; Liu, Jixia; Li, Shuang; Han, Jing; Liu, Quanri; Feng, Lingli; Wang, Chao; Xiao, Rong			Effects of GSTM1/GSTT1 Gene Polymorphism and Fruit & Vegetable Consumption on Antioxidant Biomarkers and Cognitive Function in the Elderly: A Community Based Cross-Sectional Study	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEALTHY-SUBJECTS; DIETARY-INTAKE; DNA-DAMAGE; ASSOCIATION; IMPAIRMENT; CANCER; M1	Background: It was reported that Glutathione S-transferase (GST) gene polymorphism and fruit and vegetable (FV) intake were associated with body antioxidant capacity. The oxidative/anti-oxidative imbalance played an important role in the pathogenesis of AD. However, the association of GST genotype, dietary FV consumption with body antioxidant biomarkers and cognitive function in the elderly is not clear. Objective: The aim of the present study was to determine the association of GST genotype, and dietary FV intake, with antioxidant biomarkers and cognitive function in the elderly. Methods: Food frequency questionnaire was used to collect data of dietary FV intakes in 504 community dwelling elderly aged from 55 to 75 years old. GSTM1 and GSTT1 genotypes were determined by using multiple-PCR method. Plasma and erythrocyte antioxidant biomarkers were measured. Cognitive function was measured by using Montreal Cognitive Assessment. Statistical analysis was applied for exploring the association of GST genotype and FV intake with antioxidant biomarkers level and cognitive function in the elderly. Results: Individual GSTM1 or GSTT1 gene deletion affects body antioxidant biomarkers levels, including erythrocyte GST activity, plasma total antioxidant capacity, and glutathione levels. GSTM1 and/or GSTT1 gene deletion have no effects on cognitive function in the surveyed participants. The effect of GST genotype on antioxidant biomarkers are FV intake dependent. There is interaction of FV intake and GST genotype on cognitive function in the elderly. Conclusion: GST genotype or daily FV consumption impact body antioxidant biomarkers, but not cognitive function in the elderly. There were combined effects of GST genotype and FV consumption on cognitive function in the elderly population. Large scale perspective population study is required to explore the association of GST genetic polymorphism, FV consumption and antioxidant biomarkers and cognitive function in the elderly.	[Yuan, Linhong; Ma, Weiwei; Liu, Jinmeng; Han, Jing; Liu, Quanri; Feng, Lingli; Wang, Chao; Xiao, Rong] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Yuan, Linhong; Xiao, Rong] Capital Med Univ, Beijing Key Lab Environm Toxicol, Beijing, Peoples R China; [Meng, Liping] Chinese Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China; [Liu, Jixia; Li, Shuang] Nanyuan Community Hlth Serv Ctr Fengtai Dist, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention	Xiao, R (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	ylhmedu@126.com	meng, li/GVT-2063-2022		National Natural Science Foundation of China [81273071]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304188]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201310025011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	The study was supported by the grants from: National Natural Science Foundation of China (No. 81273071) (http:// www. nsfc. gov. cn/), the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (No. CIT&TCD201304188) (http://www.bjedu.gov. cn/ publish/portal27/), and the Scientific Research Common Program of Beijing Municipal Commission of Education (No. KM201310025011) (http://www.bjedu.gov.cn/publish/portal27/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan B, 2005, PHYSIOL RES, V54, P287, DOI 10.33549/physiolres.930530; Aggarwal NT, 2005, J NEUROL NEUROSUR PS, V76, P1479, DOI 10.1136/jnnp.2004.053561; Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003; Butterfield DA, 2007, BRAIN RES, V1148, P243, DOI 10.1016/j.brainres.2007.02.084; Chedraui P, 2013, CLIMACTERIC, V16, P85, DOI 10.3109/13697137.2013.802884; Chen B, 2010, DIGEST DIS SCI, V55, P1831, DOI 10.1007/s10620-009-1000-4; Dauchet L, 2008, BRIT J NUTR, V100, P633, DOI 10.1017/S000711450892170X; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Drewnowski A, 1997, AM J CLIN NUTR, V65, P1796, DOI 10.1093/ajcn/65.6.1796; Dusinska M, 2001, MUTAT RES-FUND MOL M, V482, P47, DOI 10.1016/S0027-5107(01)00209-3; Dusinska M, 2012, MUTAT RES-FUND MOL M, V736, P130, DOI 10.1016/j.mrfmmm.2012.03.003; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Eum KD, 2013, NEUROTOXICOLOGY, V39, P65, DOI 10.1016/j.neuro.2013.08.002; Fuciarelli M, 2009, ARCH TOXICOL, V83, P115, DOI 10.1007/s00204-008-0334-6; Girisha K M, 2004, Indian J Med Sci, V58, P520; Habig W H, 1981, Methods Enzymol, V77, P398; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Kang JH, 2005, ANN NEUROL, V57, P713, DOI 10.1002/ana.20476; Lakhdar R, 2011, EXP LUNG RES, V37, P195, DOI 10.3109/01902148.2010.535093; Lam TK, 2009, CANCER EPIDEM BIOMAR, V18, P184, DOI 10.1158/1055-9965.EPI-08-0710; Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RH, 2013, J FOOD SCI, V78, pA18, DOI 10.1111/1750-3841.12101; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Mangialasche F, 2009, AGEING RES REV, V8, P285, DOI 10.1016/j.arr.2009.04.002; Martin NJ, 2009, MUTAT RES-GEN TOX EN, V674, P93, DOI 10.1016/j.mrgentox.2008.09.009; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Min J, 2006, REPROD TOXICOL, V22, P418, DOI 10.1016/j.reprotox.2006.01.003; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Mustafa MD, 2010, CLIN BIOCHEM, V43, P1124, DOI 10.1016/j.clinbiochem.2010.06.018; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Polidori MC, 2009, J ALZHEIMERS DIS, V17, P921, DOI 10.3233/JAD-2009-1114; Rafee L, 2014, J RES MED SCI, V19, P200; Shenderov Boris A, 2014, Microb Ecol Health Dis, V25, DOI 10.3402/mehd.v25.24145; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Tang JJ, 2010, MOL BIOL REP, V37, P405, DOI 10.1007/s11033-009-9877-8; Tang KF, 2012, J ANDROL, V33, P257, DOI 10.2164/jandrol.110.012468; Traykov L, 2007, ENCEPHALE, V33, P310; Vojtkova J, 2013, CENT EUR J PUBL HEAL, V21, P88, DOI 10.21101/cejph.a3807; Wark PA, 2004, CARCINOGENESIS, V25, P2135, DOI 10.1093/carcin/bgh238; Wilkinson J, 1997, P SOC EXP BIOL MED, V216, P192; Ye XW, 2013, BRIT J NUTR, V109, P503, DOI 10.1017/S0007114512001183; Yuan LH, 2012, BRIT J NUTR, V107, P928, DOI 10.1017/S0007114511003746; Yuan LH, 2013, NUTRITION, V29, P965, DOI 10.1016/j.nut.2012.12.025; Zhao HC, 2008, FOOD NUTR CHINA, V5, P34; ZHONG S, 1993, CARCINOGENESIS, V14, P1821, DOI 10.1093/carcin/14.9.1821; Zhong SL, 2006, CLIN CHIM ACTA, V364, P205, DOI 10.1016/j.cccn.2005.06.021	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113588	10.1371/journal.pone.0113588	http://dx.doi.org/10.1371/journal.pone.0113588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420021	gold, Green Published, Green Submitted			2022-12-27	WOS:000346766900054
J	Zhou, Y; Qin, TC; Xiao, YZ; Qin, FJ; Lei, CF; Sun, XL				Zhou, Yin; Qin, Tongcheng; Xiao, Yuzhou; Qin, Fujun; Lei, Chengfeng; Sun, Xiulian			Genomic and Biological Characterization of a New Cypovirus Isolated from Dendrolimus punctatus	PLOS ONE			English	Article							CYTOPLASMIC-POLYHEDROSIS-VIRUS; CRYO-EM STRUCTURE; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; CAPSID PROTEINS; ATOMIC MODEL; CLONING; GENE; EXPRESSION; SEGMENT-1	A novel cypovirus (designated DpCPV-MC) was isolated from the pine moth Dendrolimus punctatus using serial in vivo cloning procedures. DpCPV-MC occurs in typical polyhedral occlusion bodies, containing a number of spherical virions. Laboratory bioassays indicated that the infectivity of DpCPV-MC against second-instar Spodoptera exigua larvae does not differ significantly from that of Dendrolimus punctatus cypovirus 1. Full-length amplification of the DpCPV-MC cDNAs identified 16 dsRNA genome segments. Each segment encodes one open reading frame with unique conserved terminal sequences at the 59 and 39 ends, which differ from those of all previously reported cypoviruses. On a phylogenetic tree based on the amino acid sequences of the polyhedrin of 19 cypovirus species, DpCPV-MC was closest to the type-4 cypoviruses. Homology searches showed that ten segments of DpCPV-MC (S1, S2, S3, S4, S5, S7, S8, S9, S12, and S13) encode putative CPV structural and nonstructural proteins, three segments (S6, S10 and S14) encode putative insect proteins or other viral proteins, and the other three segments (S11, S15, and S16) encode proteins that have no obvious sequence similarity to any known protein. Based on RNA secondary structures analysis, two segments of them (S11 and S16) were predicted to possibly transcript less efficiently than the other segments. We speculate that DpCPV-MC is composed of several genotypes. The ten CPV-related segments constantly exist in all genotypes, and one or two of the six CPV-unrelated segments co-exist with the ten CPV-related segments in one DpCPV-MC genotype, thus each virion contains no more than 12 segments. Based on our results and the literature, DpCPV-MC is a new cypovirus (Cypovirus 22, strain DpCPV-22).	[Zhou, Yin; Qin, Tongcheng; Xiao, Yuzhou; Qin, Fujun; Lei, Chengfeng; Sun, Xiulian] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Sun, XL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Hubei, Peoples R China.	sunxl@wh.iov.cn	Sun, Xiulian/AAC-8151-2022; Zhou, yixin/HGE-2329-2022	Sun, Xiulian/0000-0003-2080-4113; 	MOST, China [2011AA10A204]; Chinese Academy of Sciences [KSCX2-EW-G-6]	MOST, China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by a key project from the 863 projects (2011AA10A204) of MOST, China, and the Knowledge Innovation Programs (KSCX2-EW-G-6) of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLA M, 1988, J VIROL, V62, P211, DOI 10.1128/JVI.62.1.211-217.1988; Baldo AM, 1999, J VIROL, V73, P7710, DOI 10.1128/JVI.73.9.7710-7721.1999; Chakrabarti M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-181; Chavali VRM, 2008, VIROLOGY, V377, P7, DOI 10.1016/j.virol.2008.03.038; Chavali VRM, 2007, VIRUS GENES, V35, P433, DOI 10.1007/s11262-006-0070-z; Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Ghorai S, 2010, VIROLOGY, V404, P21, DOI 10.1016/j.virol.2010.04.019; Graham RI, 2007, VIRUS GENES, V35, P463, DOI 10.1007/s11262-007-0113-0; Green TB, 2007, J INVERTEBR PATHOL, V95, P26, DOI 10.1016/j.jip.2006.10.006; Hagiwara K, 1998, J VIROL, V72, P5762, DOI 10.1128/JVI.72.7.5762-5768.1998; Hagiwara K, 1998, BIOCHEM BIOPH RES CO, V247, P549, DOI 10.1016/S0006-291X(98)80004-1; Hagiwara K, 2000, J GEN VIROL, V81, P1143, DOI 10.1099/0022-1317-81-4-1143; Hagiwara K, 2002, J GEN VIROL, V83, P1477, DOI 10.1099/0022-1317-83-6-1477; Hagiwara K, 2001, ARCH VIROL, V146, P181, DOI 10.1007/s007050170202; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hughes AL, 2003, MOL BIOL EVOL, V20, P979, DOI 10.1093/molbev/msg107; Hukuhara T, 1991, REOVIRIDAE ATLAS INV, P394; Ikeda K, 1998, ARCH VIROL, V143, P241, DOI 10.1007/s007050050283; Jangam S. R., 2007, International Journal of Virology, V3, P60; Jehle JA, 1998, J MOL EVOL, V46, P215, DOI 10.1007/PL00006296; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Li YQ, 2007, J GEN VIROL, V88, P991, DOI 10.1099/vir.0.82673-0; Lin YH, 2012, VIROLOGY, V426, P42, DOI 10.1016/j.virol.2012.01.013; Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Qanungo KR, 2002, J GEN VIROL, V83, P1483, DOI 10.1099/0022-1317-83-6-1483; Robertson J. L., 1992, PESTICIDE BIOASSAYS, P127; Shapiro A, 2005, J VIROL, V79, P9430, DOI 10.1128/JVI.79.15.9430-9438.2005; SHOREY HH, 1965, J ECON ENTOMOL, V58, P522, DOI 10.1093/jee/58.3.522; Sinha-Datta U, 2005, BIOCHEM BIOPH RES CO, V332, P710, DOI 10.1016/j.bbrc.2005.05.011; SMITH IRL, 1988, VIROLOGY, V166, P240, DOI 10.1016/0042-6822(88)90165-1; SPSS S, 2003, BAS 12 0 WIND US GUI; Sun Xiulian, 1998, Virologica Sinica, V13, P83; Tan L, 2008, VIRUS GENES, V36, P587, DOI 10.1007/s11262-008-0222-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Xiao Yuzhou, 2010, Chinese Journal of Applied and Environmental Biology, V16, P84, DOI 10.3724/SP.J.1145.2010.00084; Yang CW, 2012, P NATL ACAD SCI USA, V109, P6118, DOI 10.1073/pnas.1200206109; Yang J, 2014, NUCLEIC ACIDS RES, V42, P2538, DOI 10.1093/nar/gkt1256; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zhao SL, 2003, VIRUS RES, V94, P17, DOI 10.1016/S0168-1702(03)00118-7; Zhao SL, 2003, ARCH VIROL, V148, P1357, DOI 10.1007/s00705-003-0103-z	45	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113201	10.1371/journal.pone.0113201	http://dx.doi.org/10.1371/journal.pone.0113201			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419713	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900023
J	Huang, X; Chen, J; Bao, YN; Liu, LJ; Jiang, H; An, X; Dai, LJ; Wang, B; Peng, DX				Huang, Xing; Chen, Jie; Bao, Yaning; Liu, Lijun; Jiang, Hui; An, Xia; Dai, Lunjin; Wang, Bo; Peng, Dingxiang			Transcript Profiling Reveals Auxin and Cytokinin Signaling Pathways and Transcription Regulation during In Vitro Organogenesis of Ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; DIFFERENTIAL GENE-EXPRESSION; DE-NOVO CHARACTERIZATION; RNA-SEQ DATA; TRANSGENIC PLANTS; ARABIDOPSIS; REGENERATION; IDENTIFICATION; GENOTYPES; PROTEIN	In vitro organogenesis, one of the most common pathways leading to in vitro plant regeneration, is widely used in biotechnology and the fundamental study of plant biology. Although previous studies have constructed a complex regulatory network model for Arabidopsis in vitro organogenesis, no related study has been reported in ramie. To generate more complete observations of transcriptome content and dynamics during ramie in vitro organogenesis, we constructed a reference transcriptome library and ten digital gene expression (DGE) libraries for illumina sequencing. Approximately 111.34 million clean reads were obtained for transcriptome and the DGE libraries generated between 13.5 and 18.8 million clean reads. De novo assembly produced 43,222 unigenes and a total of 5,760 differentially expressed genes (DEGs) were filtered. Searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database, 26 auxin related and 11 cytokinin related DEGs were selected for qRT-PCR validation of two ramie cultivars, which had high (Huazhu No. 5) or extremely low (Dazhuhuangbaima) shoot regeneration abilities. The results revealed differing regulation patterns of auxin and cytokinin in different genotypes. Here we report the first genome-wide gene expression profiling of in vitro organogenesis in ramie and provide an overview of transcription and phytohormone regulation during the process. Furthermore, the auxin and cytokinin related genes have distinct expression patterns in two ramie cultivars with high or extremely low shoot regeneration ability, which has given us a better understanding of the in vitro organogenesis mechanism. This result will provide a foundation for future phytohormone research and lead to improvements of the ramie regeneration system.	[Huang, Xing; Chen, Jie; Bao, Yaning; Liu, Lijun; Jiang, Hui; An, Xia; Dai, Lunjin; Wang, Bo; Peng, Dingxiang] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei Province, Peoples R China	Huazhong Agricultural University	Wang, B (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei Province, Peoples R China.	wangbo@mail.hzau.edu.cn; pdxiang@mail.hzau.edu.cn	Huang, Xing/AAE-1191-2019; huang, xing/T-3308-2017	huang, xing/0000-0003-3950-0080	National Natural Science Funds [31171594]; Supporting Program for Sci & Tech Research of China [2010BAD02B01]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Supporting Program for Sci & Tech Research of China	National Natural Science Funds (31171594)(http://www.nsfc.gov.cn/); Supporting Program for Sci & Tech Research of China (2010BAD02B01)(http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An X, 2014, MOL BIOL REP, V41, P3257, DOI 10.1007/s11033-014-3188-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argueso CT, 2010, CURR OPIN PLANT BIOL, V13, P533, DOI 10.1016/j.pbi.2010.08.006; Bai L, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29582; Bai L, 2014, PLANT CELL, V26, P1497, DOI 10.1105/tpc.114.124586; Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Bao YH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-132; Basu S, 2009, LETT APPL MICROBIOL, V48, P593, DOI 10.1111/j.1472-765X.2009.02584.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Brenner WG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-112; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Cohen O, 2012, J EXP BOT, V63, P4947, DOI 10.1093/jxb/ers172; De Smet I, 2011, PLANT PHYSIOL, V155, P209, DOI 10.1104/pp.110.168161; Deng G, 2014, PLANTA, V239, P1175, DOI 10.1007/s00425-014-2040-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duclercq J, 2011, TRENDS PLANT SCI, V16, P597, DOI 10.1016/j.tplants.2011.08.004; DUSI DMA, 1993, PLANT CELL REP, V12, P625, DOI 10.1007/BF00232812; Finet C, 2012, DEV BIOL, V369, P19, DOI 10.1016/j.ydbio.2012.05.039; Finet C, 2010, PLANT J, V63, P952, DOI 10.1111/j.1365-313X.2010.04292.x; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hankoua BB, 2005, PLANT CELL TISS ORG, V82, P221, DOI 10.1007/s11240-005-0514-5; Hu W, 2011, PLANT MOL BIOL, V76, P57, DOI 10.1007/s11103-011-9768-y; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kristiansson E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-345; Landi L, 2006, PLANT CELL REP, V25, P281, DOI 10.1007/s00299-005-0066-5; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Liu TM, 2014, MOL GENET GENOMICS, V289, P675, DOI 10.1007/s00438-014-0842-4; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XF, 2010, PLANT CELL TISS ORG, V100, P165, DOI 10.1007/s11240-009-9633-8; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meng L, 2010, CRIT REV PLANT SCI, V29, P108, DOI 10.1080/07352681003617327; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motte H, 2014, BIOTECHNOL ADV, V32, P107, DOI 10.1016/j.biotechadv.2013.12.002; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Mukhopadhyay A, 2013, BIORESOURCE TECHNOL, V137, P202, DOI 10.1016/j.biortech.2013.03.139; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Pourhosseini L, 2013, PLANT CELL TISS ORG, V112, P101, DOI 10.1007/s11240-012-0210-1; Santos AM, 2009, J EXP BOT, V60, P4159, DOI 10.1093/jxb/erp250; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Sul IW, 2005, PLANT CELL TISS ORG, V80, P353, DOI 10.1007/s11240-004-1365-1; Swarup R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00225; Takacs EM, 2012, PLANT CELL, V24, P3219, DOI 10.1105/tpc.112.099614; Takada S, 2001, DEVELOPMENT, V128, P1127; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang B, 2008, IN VITRO CELL DEV-PL, V44, P105, DOI 10.1007/s11627-008-9121-6; Wang B, 2007, BOT STUD, V48, P173; Wang J, 2014, MOL BIOL REP, V41, P901, DOI 10.1007/s11033-013-2934-3; Wang LJ, 2005, MOL PLANT MICROBE IN, V18, P375, DOI 10.1094/MPMI-18-0375; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XX, 2012, PLANT MOL BIOL REP, V30, P547, DOI 10.1007/s11105-011-0361-y; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D, 2009, CELL, V136, P1172, DOI 10.1016/j.cell.2009.03.009; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yang B, 2010, ENVIRON POLLUT, V158, P551, DOI 10.1016/j.envpol.2009.08.043; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	93	24	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113768	10.1371/journal.pone.0113768	http://dx.doi.org/10.1371/journal.pone.0113768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415356	gold, Green Submitted, Green Published			2022-12-27	WOS:000346906600077
J	Villalonga-Olives, E; Kawachi, I; Almansa, J; Witte, C; Lange, B; Kiese-Himmel, C; von Steinbuchel, N				Villalonga-Olives, Ester; Kawachi, Ichiro; Almansa, Josue; Witte, Claudia; Lange, Benjamin; Kiese-Himmel, Christiane; von Steinbuechel, Nicole			Pediatric Health-Related Quality of Life: A Structural Equation Modeling Approach	PLOS ONE			English	Article							CONCEPTUAL-MODEL; EUROPEAN COUNTRIES; IQOLA PROJECT; CHILD HEALTH; ADOLESCENTS; OUTCOMES; GERMAN; REPRESENTATIVENESS; RELIABILITY; CHALLENGES	Objectives: One of the most referenced theoretical frameworks to measure Health Related Quality of Life (HRQoL) is the Wilson and Cleary framework. With some adaptions this framework has been validated in the adult population, but has not been tested in pediatric populations. Our goal was to empirically investigate it in children. Methods: The contributory factors to Health Related Quality of Life that we included were symptom status (presence of chronic disease or hospitalizations), functional status (developmental status), developmental aspects of the individual (social-emotional) behavior, and characteristics of the social environment (socioeconomic status and area of education). Structural equation modeling was used to assess the measurement structure of the model in 214 German children (3-5 years old) participating in a follow-up study that investigates pediatric health outcomes. Results: Model fit was chi(2) = 5.5; df = 6; p = 0.48; SRMR = 0.01. The variance explained of Health Related Quality of Life was 15%. Health Related Quality of Life was affected by the area education (i.e. where kindergartens were located) and development status. Developmental status was affected by the area of education, socioeconomic status and individual behavior. Symptoms did not affect the model. Conclusions: The goodness of fit and the overall variance explained were good. However, the results between children' and adults' tests differed and denote a conceptual gap between adult and children measures. Indeed, there is a lot of variety in pediatric Health Related Quality of Life measures, which represents a lack of a common definition of pediatric Health Related Quality of Life. We recommend that researchers invest time in the development of pediatric Health Related Quality of Life theory and theory based evaluations.	[Villalonga-Olives, Ester; Witte, Claudia; Lange, Benjamin; Kiese-Himmel, Christiane; von Steinbuechel, Nicole] Univ Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany; [Villalonga-Olives, Ester; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Almansa, Josue] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands	University of Gottingen; Harvard University; Harvard T.H. Chan School of Public Health; University of Groningen	Villalonga-Olives, E (corresponding author), Univ Gottingen, Inst Med Psychol & Med Sociol, D-37073 Gottingen, Germany.	ester.villalonga@gmail.com	Almansa, Josue/J-4503-2019	Almansa, Josue/0000-0001-9724-9328	Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung [FP17-09]; Albert and Barbara von Metzler Stiftung; Gemeinnutzige Hertie-Stiftung; Adolf Messer-Stiftung	Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung; Albert and Barbara von Metzler Stiftung; Gemeinnutzige Hertie-Stiftung; Adolf Messer-Stiftung	This study is funded by the Niedersachsisches Institut fur fruhkindliche Bildung und Entwicklung (nifbe FP17-09); the Albert and Barbara von Metzler Stiftung, Gemeinnutzige Hertie-Stiftung, Adolf Messer-Stiftung (all in Frankfurt/Main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis F, 2009, PEDIATRICS, V123, P569, DOI 10.1542/peds.2008-0323; Ashing-Giwa KT, 2005, QUAL LIFE RES, V14, P297, DOI 10.1007/s11136-004-0729-7; Bakas T, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-134; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; Davis E, 2006, DEV MED CHILD NEUROL, V48, P311, DOI 10.1017/S0012162206000673; DIMDI, 2005, INT CLASS FUNCT DIS; Dopfner M, 1993, VERHALTENSBEURTEI LU; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Elwood JM, 2013, INT J EPIDEMIOL, V42, P1014, DOI 10.1093/ije/dyt101; Ferrans CE, 2005, J NURS SCHOLARSHIP, V37, P336, DOI 10.1111/j.1547-5069.2005.00058.x; Hays RD, 2005, EVAL HEALTH PROF, V28, P295, DOI 10.1177/0163278705278277; Heo S, 2005, J CARD FAIL, V11, P372, DOI 10.1016/j.cardfail.2004.12.001; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kastner-Koller U, 2002, WIENER ENTWICKLUNGST; Kawachi I., 2003, NEIGHBORHOODS HLTH; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Matterne U, 2011, QUAL LIFE RES, V20, P1295, DOI 10.1007/s11136-011-9868-9; Maurice-Stam H, 2008, PEDIATR BLOOD CANCER, V50, P1047, DOI 10.1002/pbc.21374; Musil CM, 1998, RES NURS HEALTH, V21, P271; Ravens-Sieberer U, 2007, BUNDESGESUNDHEITSBLA, V50, P810, DOI 10.1007/s00103-007-0244-4; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Riley AW, 2004, MED CARE, V42, P221, DOI 10.1097/01.mlr.0000114910.46921.73; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Seid M, 2000, AM J MED QUAL, V15, P182, DOI 10.1177/106286060001500409; Simon AE, 2008, PEDIATRICS, V121, pE118, DOI 10.1542/peds.2007-0480; Sousa KH, 2006, QUAL LIFE RES, V15, P725, DOI 10.1007/s11136-005-3975-4; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; Taillefer MC, 2003, SOC INDIC RES, V64, P293, DOI 10.1023/A:1024740307643; Valderas JM, 2008, QUAL LIFE RES, V17, P1125, DOI 10.1007/s11136-008-9396-4; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	35	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113166	10.1371/journal.pone.0113166	http://dx.doi.org/10.1371/journal.pone.0113166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MM	25415751	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600031
J	Cao, Y; Portela, M; Janikiewicz, J; Doig, J; Abbott, CM				Cao, Yuan; Portela, Miriam; Janikiewicz, Justyna; Doig, Jennifer; Abbott, Catherine M.			Characterisation of Translation Elongation Factor eEF1B Subunit Expression in Mammalian Cells and Tissues and Co-Localisation with eEF1A2	PLOS ONE			English	Article							PROXIMITY LIGATION ASSAY; TRANSFER-RNA-SYNTHETASE; PROTEIN-KINASE CKII; SACCHAROMYCES-CEREVISIAE; SEQUENCING REVEALS; IN-SITU; COMPLEX; PHOSPHORYLATION; EF-1-BETA; CLONING	Translation elongation is the stage of protein synthesis in which the translation factor eEF1A plays a pivotal role that is dependent on GTP exchange. In vertebrates, eEF1A can exist as two separately encoded tissue-specific isoforms, eEF1A1, which is almost ubiquitously expressed, and eEF1A2, which is confined to neurons and muscle. The GTP exchange factor for eEF1A1 is a complex called eEF1B made up of subunits eEF1Ba, eEF1Bd and eEF1Bc. Previous studies have cast doubt on the ability of eEF1B to interact with eEF1A2, suggesting that this isoform might use a different GTP exchange factor. We show that eEF1B subunits are all widely expressed to varying degrees in different cell lines and tissues, and at different stages of development. We show that ablation of any of the subunits in human cell lines has a small but significant impact on cell viability and cycling. Finally, we show that both eEF1A1 and eEF1A2 colocalise with all eEF1B subunits, in such close proximity that they are highly likely to be in a complex.	[Cao, Yuan; Portela, Miriam; Janikiewicz, Justyna; Doig, Jennifer; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	Abbott, CM (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland.	C.Abbott@ed.ac.uk		Abbott, Catherine/0000-0001-8794-7173; Janikiewicz, Justyna/0000-0002-6484-9164	Wellcome Trust [094180/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by Wellcome Trust 094180/Z/10/Z, http://www.wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21138; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Chambers DM, 2001, GENOMICS, V77, P145, DOI 10.1006/geno.2001.6626; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Guerrucci MA, 1999, GENE, V233, P83, DOI 10.1016/S0378-1119(99)00153-5; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; JANSSEN GMC, 1994, J BIOL CHEM, V269, P31410; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kaitsuka T, 2011, EMBO REP, V12, P673, DOI 10.1038/embor.2011.82; Kim J, 2009, LAB INVEST, V89, P867, DOI 10.1038/labinvest.2009.53; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Minella O, 1998, BIOSCIENCE REP, V18, P119, DOI 10.1023/A:1020140527930; MORALES J, 1992, NUCLEIC ACIDS RES, V20, P4091, DOI 10.1093/nar/20.15.4091; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Perez JMJ, 1998, PROTEIN EXPRES PURIF, V13, P259, DOI 10.1006/prep.1998.0895; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; PIZZUTI A, 1993, BIOCHEM BIOPH RES CO, V197, P154, DOI 10.1006/bbrc.1993.2454; Sheu GT, 1999, MOL CELL BIOCHEM, V191, P181, DOI 10.1023/A:1006802125856; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Timchenko AA, 2013, BIOCHEMISTRY-US, V52, P5345, DOI 10.1021/bi400400r; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; VANDAMME H, 1991, EUR J BIOCHEM, V197, P505, DOI 10.1111/j.1432-1033.1991.tb15938.x; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201	35	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114117	10.1371/journal.pone.0114117	http://dx.doi.org/10.1371/journal.pone.0114117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436608	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900118
J	Chen, CY; Yu, C; Chang, CC; Lin, CW				Chen, Chen-Yu; Yu, Chun; Chang, Chia-Chen; Lin, Chii-Wann			Comparison of a Novel Computerized Analysis Program and Visual Interpretation of Cardiotocography	PLOS ONE			English	Article							FETAL HEART-RATE; RATE TRACINGS; NATIONAL-INSTITUTE; CHILD-HEALTH; RATE PATTERN; INTEROBSERVER; MULTICENTER; OBSERVERS; CONSENSUS; SYSTEM	Objective: To compare a novel computerized analysis program with visual cardiotocography (CTG) interpretation results. Methods: Sixty-two intrapartum CTG tracings with 20- to 30-minute sections were independently interpreted using a novel computerized analysis program, as well as the visual interpretations of eight obstetricians, to evaluate the baseline fetal heart rate (FHR), baseline FHR variability, number of accelerations, number/type of decelerations, uterine contraction (UC) frequency, and the National Institute of Child Health and Human Development (NICHD) 3-Tier FHR classification system. Results: There was no significant difference in interobserver variation after adding the components of computerized analysis to results from the obstetricians' visual interpretations, with excellent agreement for the baseline FHR (ICC 0.91), the number of accelerations (ICC 0.85), UC frequency (ICC 0.97), and NICHD category I (kappa statistic 0.91); good agreement for baseline variability (kappa statistic 0.68), the numbers of early decelerations (ICC 0.78) and late decelerations (ICC 0.67), category II (kappa statistic 0.78), and overall categories (kappa statistic 0.80); and moderate agreement for the number of variable decelerations (ICC 0.60), and category III (kappa statistic 0.50). Conclusions: This computerized analysis program is not inferior to visual interpretation, may improve interobserver variations, and could play a vital role in prenatal telemedicine.	[Chen, Chen-Yu; Yu, Chun; Chang, Chia-Chen; Lin, Chii-Wann] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Chen, Chen-Yu; Yu, Chun; Chang, Chia-Chen; Lin, Chii-Wann] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Chen-Yu] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Chen-Yu] Mackay Med Coll, Taipei, Taiwan; [Chen, Chen-Yu] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan	National Taiwan University; National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management	Lin, CW (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	cwlinx@ntu.edu.tw	Chang, Chia-Chen/D-1600-2011; Lin, Chii-Wann/B-5527-2009	Chang, Chia-Chen/0000-0001-5466-4724; Lin, Chii-Wann/0000-0002-8721-3441				Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Amer-Wahlin I, 2011, ACTA OBSTET GYN SCAN, V90, P990, DOI 10.1111/j.1600-0412.2011.01203.x; Ayres-de Campos D, 2000, J Matern Fetal Med, V9, P311; Ayres-De-Campos D, 2004, EUR J OBSTET GYN R B, V117, P174, DOI 10.1016/j.ejogrb.2004.03.013; Ayres-De-Campos D, 2008, J PERINAT MED, V36, P260, DOI 10.1515/JPM.2008.030; Begg LM, 2007, COCHRANE DB SYST REV, V2; Blackwell SC, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.086; Buscicchio G, 2006, J MATERN-FETAL NEO M, V19, P39, DOI 10.1080/14767050500361505; Caldeyro-Barcia R, 1969, DIAGNOSIS TREATMENT, P205; Chen CY, 2009, IEEE ENG MED BIO, P2567, DOI 10.1109/IEMBS.2009.5335287; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Chudacek V, 2011, PHYSIOL MEAS, V32, P1347, DOI 10.1088/0967-3334/32/8/022; CHUNG TKH, 1995, BRIT J OBSTET GYNAEC, V102, P454, DOI 10.1111/j.1471-0528.1995.tb11317.x; Costa MA, 2010, J PERINAT MED, V38, P191, DOI [10.1515/JPM.2010.030, 10.1515/jpm.2010.030]; Devoe L, 2000, AM J OBSTET GYNECOL, V183, P361, DOI 10.1067/mob.2000.107665; Di Lieto A, 2003, GYNECOL OBSTET INVES, V55, P37, DOI 10.1159/000068955; DONKER DK, 1993, EUR J OBSTET GYN R B, V52, P21, DOI 10.1016/0028-2243(93)90220-7; Figueras F, 2005, J PERINAT MED, V33, P241, DOI 10.1515/JPM.2005.044; Freeman RK, 2002, OBSTET GYNECOL, V100, P813, DOI 10.1016/S0029-7844(02)02211-1; Graatsma EM, 2009, BJOG-INT J OBSTET GY, V116, P334, DOI 10.1111/j.1471-0528.2008.01951.x; Huhn EA, 2011, PRENATAL DIAG, V31, P509, DOI 10.1002/pd.2728; JOHNSON N, 1991, BRIT J OBSTET GYNAEC, V98, P36, DOI 10.1111/j.1471-0528.1991.tb10308.x; KEITH RDF, 1995, BRIT J OBSTET GYNAEC, V102, P688, DOI 10.1111/j.1471-0528.1995.tb11425.x; Kruger K, 1999, AM J OBSTET GYNECOL, V181, P1072, DOI 10.1016/S0002-9378(99)70083-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lu W, 2006, MED PHYS, V33, P3634, DOI 10.1118/1.2348764; Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395; Maeda K, 2003, FETAL DIAGN THER, V18, P370, DOI 10.1159/000071982; MODANLOU HD, 1982, AM J OBSTET GYNECOL, V142, P1033, DOI 10.1016/0002-9378(82)90789-X; Neilson JP, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000116.pub2; Parer JT, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.037; Schiermeier S, 2011, GYNECOL OBSTET INVES, V72, P169, DOI 10.1159/000327133; Serra V, 2009, ULTRASOUND OBST GYN, V34, P74, DOI 10.1002/uog.6365; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Signorini MG, 2003, IEEE T BIO-MED ENG, V50, P365, DOI 10.1109/TBME.2003.808824; Taylor GM, 2000, BRIT J OBSTET GYNAEC, V107, P1130, DOI 10.1111/j.1471-0528.2000.tb11112.x; Todros T, 1996, EUR J OBSTET GYN R B, V68, P83, DOI 10.1016/0301-2115(96)02487-6	37	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112296	10.1371/journal.pone.0112296	http://dx.doi.org/10.1371/journal.pone.0112296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437442	Green Published, Green Submitted, gold			2022-12-27	WOS:000347114900012
J	Dias, RRF; de Carvalho, ECQ; Leite, CCD; Tedesco, RC; Calabrese, KD; Silva, AC; DaMatta, RA; Sarro-Silva, MD				Furtado Dias, Raul Ramos; Queiroz de Carvalho, Eulogio Carlos; da Silva Leite, Carla Cristina; Tedesco, Roberto Carlos; Calabrese, Katia da Silva; Silva, Antonio Carlos; DaMatta, Renato Augusto; Sarro-Silva, Maria de Fatima			Toxoplasma gondii Oral Infection Induces Intestinal Inflammation and Retinochoroiditis in Mice Genetically Selected for Immune Oral Tolerance Resistance	PLOS ONE			English	Article							OCULAR TOXOPLASMOSIS; IFN-GAMMA; DISEASE; SUSCEPTIBILITY; PATHOGENESIS; NECROSIS	Toxoplasmosis is a worldwide disease with most of the infections originating through the oral route and generates various pathological manifestations, ranging from meningoencephalitis to retinochoroiditis and inflammatory bowel disease. Animal models for these pathologies are scarce and have limitations. We evaluated the outcome of Toxoplasma gondii oral infection with 50 or 100 cysts of the ME-49 strain in two lines of mice with extreme phenotypes of susceptibility (TS) or resistance (TR) to immune oral tolerance. Therefore, the aim of this study was to evaluate the behaviour of TS and TR mice, orally infected by T. gondii, and determine its value as a model for inflammatory diseases study. Mortality during the acute stage of the infection for TR was 50% for both dosages, while 10 and 40% of the TS died after infection with these respective dosages. In the chronic stage, the remaining TS succumbed while TR survived for 90 days. The TS displayed higher parasite load with lower intestinal inflammation and cellular proliferation, notwithstanding myocarditis, pneumonitis and meningoencephalitis. TR presented massive necrosis of villi and crypt, comparable to inflammatory bowel disease, with infiltration of lymphoid cells in the lamina propria of the intestines. Also, TR mice infected with 100 cysts presented intense cellular infiltrate within the photoreceptor layer of the eyes, changes in disposition and morphology of the retina cell layers and retinochoroiditis. During the infection, high levels of IL-6 were detected in the serum of TS mice and TR mice presented high amounts of IFN-gamma and TNF-alpha. Both mice lineages developed different disease outcomes, but it is emphasized that TR and TS mice presented acute and chronic stages of the infection, demonstrating that the two lineages offer an attractive model for studying toxoplasmosis.	[Furtado Dias, Raul Ramos; da Silva Leite, Carla Cristina; DaMatta, Renato Augusto; Sarro-Silva, Maria de Fatima] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, BR-28013602 Campos Dos Goytacazes, RJ, Brazil; [Furtado Dias, Raul Ramos; Calabrese, Katia da Silva] Fiocruz MS, Lab Imunomodulacao & Protozool, Inst Oswaldo Cruz IOC, BR-21045900 Rio De Janeiro, Brazil; [Queiroz de Carvalho, Eulogio Carlos] Univ Estadual N Fluminen, Lab Sanidade Anim, BR-28013602 Campos dos Goytacazes, RJ, Brazil; [Tedesco, Roberto Carlos] Univ Fed Sao Paulo, Disciplina Anat Topog & Descrit, BR-04023900 Sao Paulo, Brazil; [Silva, Antonio Carlos; Sarro-Silva, Maria de Fatima] Univ Estado Rio de Janeiro UERJ, Lab Imunobiol, BR-20550900 Rio De Janeiro, RJ, Brazil	Universidade Estadual do Norte Fluminense; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado do Rio de Janeiro	DaMatta, RA (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.	renato@uenf.br	DaMatta, Renato/G-8367-2015; Calabrese, Katia S/V-2631-2018	DaMatta, Renato/0000-0002-0108-9268; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Estadual do Norte Fluminense (FENORTE); Oswaldo Cruz Institute	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Estadual do Norte Fluminense (FENORTE); Oswaldo Cruz Institute	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Estadual do Norte Fluminense (FENORTE) and Oswaldo Cruz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Brandtzaeg P, 1996, ANN NY ACAD SCI, V778, P1, DOI 10.1111/j.1749-6632.1996.tb21110.x; Calabrese KS, 2008, MICRON, V39, P1335, DOI 10.1016/j.micron.2008.02.003; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Csongei V, 2010, WORLD J GASTROENTERO, V16, P176, DOI 10.3748/wjg.v16.i2.176; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; Da Silva MDS, 2004, ANN NY ACAD SCI, V1029, P398, DOI 10.1196/annals.1309.024; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Gormley PD, 1999, EXP EYE RES, V68, P657, DOI 10.1006/exer.1998.0655; HAY J, 1984, ANN TROP MED PARASIT, V78, P109, DOI 10.1080/00034983.1984.11811784; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Johnson J, 2002, INT J PARASITOL, V32, P179, DOI 10.1016/S0020-7519(01)00321-6; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; King MD, 2003, J PARASITOL, V89, P856, DOI 10.1645/GE-79R; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lahmar I, 2010, EXP PARASITOL, V124, P190, DOI 10.1016/j.exppara.2009.09.010; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Lu FL, 2005, INFECT IMMUN, V73, P5160, DOI 10.1128/IAI.73.8.5160-5165.2005; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Okamoto R, 2005, DIG DIS SCI S1, P34; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Pavesio CE, 1996, BRIT J OPHTHALMOL, V80, P1099, DOI 10.1136/bjo.80.12.1099; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Silva AC, 2001, MICROBES INFECT, V3, P1; Silva MF, 2010, IMMUNOLOGY, V130, P447, DOI 10.1111/j.1365-2567.2010.03248.x; Silva MFS, 2006, CLIN EXP ALLERGY, V36, P1; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; SUZUKI Y, 1993, RES IMMUNOL, V144, P66, DOI 10.1016/S0923-2494(05)80102-6; Tavares D, 2006, MICROBES INFECT, V8, P957, DOI 10.1016/j.micinf.2005.09.018; Tedesco RC, 2007, MICRON, V38, P729, DOI 10.1016/j.micron.2007.05.005; Tedesco RC, 2005, PARASITOLOGY, V131, P303, DOI 10.1017/S003118200500781X; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; VAZ NM, 1977, J ALLERGY CLIN IMMUN, V60, P110, DOI 10.1016/0091-6749(77)90035-5; Wallace GR, 2008, CLIN EXP IMMUNOL, V153, P309, DOI 10.1111/j.1365-2249.2008.03692.x; WILLIAMS DM, 1978, INFECT IMMUN, V19, P416, DOI 10.1128/IAI.19.2.416-420.1978; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113374	10.1371/journal.pone.0113374	http://dx.doi.org/10.1371/journal.pone.0113374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437299	Green Published, gold, Green Submitted			2022-12-27	WOS:000347114900042
J	Ito, T; Sendai, Y; Yamazaki, S; Seki-Soma, M; Hirose, K; Watanabe, M; Fukawa, K; Nakauchi, H				Ito, Tetsuya; Sendai, Yutaka; Yamazaki, Satoshi; Seki-Soma, Marie; Hirose, Kensuke; Watanabe, Motoo; Fukawa, Kazuo; Nakauchi, Hiromitsu			Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency	PLOS ONE			English	Article							RAG MUTATIONS; IN-VIVO; BLASTOCYST COMPLEMENTATION; NUCLEAR TRANSFER; DNA METHYLATION; HUMANIZED MICE; MOUSE MODEL; CLONED PIGS; GENES; IMMUNODEFICIENCY	Although severe combined immune deficiency (SCID) is a very important research model for mice and SCID mice are widely used, there are only few reports describing the SCID pig models. Therefore, additional research in this area is needed. In this study, we describe the generation of Recombination activating gene-1 (Rag-1)-deficient neonatal piglets in Duroc breed using somatic cell nuclear transfer (SCNT) with gene targeting and analysis using fluorescence-activated cell sorting (FACS) and histology. We constructed porcine Rag-1 gene targeting vectors for the Exon 2 region and obtained heterozygous/homozygous Rag-1 knockout cell colonies using SCNT. We generated two Rag-1-deficient neonatal piglets and compared them with wild-type neonatal piglets. FACS analysis showed that Rag-1 disruption causes a lack of Immunoglobulin M-positive B cells and CD3-positive T cells in peripheral blood mononuclear cells. Consistent with FACS analysis, histological analysis revealed structural defects and an absence of mature lymphocytes in the spleen, mesenteric lymph node (MLNs), and thymus in Rag-1-deficient piglets. These results confirm that Rag-1 is necessary for the generation of lymphocytes in pigs, and Rag-1-deficient piglets exhibit a T and B cell deficient SCID (T-B-SCID) phenotype similar to that of rodents and humans. The T-B-SCID pigs with Rag-1 deficiency generated in this study could be a suitably versatile model for laboratory, translational, and biomedical research, including the development of a humanized model and assessment of pluripotent stem cells.	[Ito, Tetsuya; Hirose, Kensuke; Fukawa, Kazuo] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan; [Sendai, Yutaka] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Biol Sci Sect, Ibaraki, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Seki-Soma, Marie] ZEN NOH Natl Federat Agr Cooperat Assoc, Zen Noh Inst Anim Hlth, Chiba, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ito, T (corresponding author), ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan.	itou-tetsuya@zennoh.or.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Archer GS, 2003, BIOL REPROD, V69, P430, DOI 10.1095/biolreprod.103.016147; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Butler JE, 2006, VET RES, V37, P417, DOI 10.1051/vetres:2006009; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deshmukh RS, 2011, EPIGENETICS-US, V6, P177, DOI 10.4161/epi.6.2.13519; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Huang J, 2014, J IMMUNOL, V193, P1496, DOI 10.4049/jimmunol.1400915; Hwang KC, 2009, DEV DYNAM, V238, P1701, DOI 10.1002/dvdy.21986; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, EFFICIENT XENOENGRAF; KARALUS U, 1990, ANIM REPROD SCI, V22, P235, DOI 10.1016/0378-4320(90)90064-M; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937560.0426; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mendicino M, 2011, TRANSGENIC RES, V20, P625, DOI 10.1007/s11248-010-9444-z; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nischang M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13618; Nishana M, 2012, IMMUNOLOGY, V137, P271, DOI 10.1111/imm.12009; Noguchi M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-157; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sechin A, 1999, THERIOGENOLOGY, V51, P1175, DOI 10.1016/S0093-691X(99)80020-X; Sendai Y, 2006, TRANSPLANTATION, V81, P760, DOI 10.1097/01.tp.0000190422.66657.f1; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Sun XZ, 2012, IMMUNOLOGY, V137, P149, DOI 10.1111/j.1365-2567.2012.03615.x; Suzuki S, 2014, EXP ANIM TOKYO, V63, P215, DOI 10.1538/expanim.63.215; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zschemisch NH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-60	63	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113833	10.1371/journal.pone.0113833	http://dx.doi.org/10.1371/journal.pone.0113833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437445	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900083
J	Kalimeri, M; Girard, E; Madern, D; Sterpone, F				Kalimeri, Maria; Girard, Eric; Madern, Dominique; Sterpone, Fabio			Interface Matters: The Stiffness Route to Stability of a Thermophilic Tetrameric Malate Dehydrogenase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CONFORMATIONAL FLEXIBILITY; LACTATE-DEHYDROGENASES; PROTEIN STABILITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ADAPTATION; THERMOSTABILITY; TEMPERATURE; COMPRESSIBILITY	In this work we investigate by computational means the behavior of two orthologous bacterial proteins, a mesophilic and a thermophilic tetrameric malate dehydrogenase (MalDH), at different temperatures. Namely, we quantify how protein mechanical rigidity at different length-and time-scales correlates to protein thermophilicity as commonly believed. In particular by using a clustering analysis strategy to explore the conformational space of the folded proteins, we show that at ambient conditions and at the molecular length-scale the thermophilic variant is indeed more rigid that the mesophilic one. This rigidification is the result of more efficient inter-domain interactions, the strength of which is further quantified via ad hoc free energy calculations. When considered isolated, the thermophilic domain is indeed more flexible than the respective mesophilic one. Upon oligomerization, the induced stiffening of the thermophilic protein propagates from the interface to the active site where the loop, controlling the access to the catalytic pocket, anchors down via an extended network of ion-pairs. On the contrary in the mesophilic tetramer the loop is highly mobile. Simulations at high temperature, could not reactivate the mobility of the loop in the thermophile. This finding opens questions on the similarities of the binding processes for these two homologues at their optimal working temperature and suggests for the thermophilic variant a possible cooperative role of cofactor/substrate.	[Kalimeri, Maria; Sterpone, Fabio] Univ Paris Diderot, Sorbonne Paris Cite, Lab Biochim Theor, Inst Biol Physicochim,CNRS,UPR9080, Paris, France; [Girard, Eric; Madern, Dominique] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Girard, Eric; Madern, Dominique] CNRS, Inst Biol Struct, Grenoble, France; [Girard, Eric; Madern, Dominique] Commissariat Energie Atom & Energies Alternat, Inst Biol Struct, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Madern, D (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.	dominique.madern@ibs.fr; fabio.sterpone@ibpc.fr		Girard, Eric/0000-0002-5758-6095; Kalimeri, Maria/0000-0002-6569-7553	European Research Council under the European Community [258748];  [ANR-11-LABX-0011-01]	European Research Council under the European Community(European Research Council (ERC)); 	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) Grant Agreement no. 258748. FS and MK also acknowledge the financial support for infrastructures from ANR-11-LABX-0011-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2012, J CHEM THEORY COMPUT, V8, P4610, DOI 10.1021/ct3003207; [Anonymous], 2014, R LANG ENV STAT COMP; Basu S, 2013, J CHEM INF MODEL, V53, P423, DOI 10.1021/ci300474h; Bjork A, 2004, J MOL BIOL, V341, P1215, DOI 10.1016/j.jmb.2004.06.079; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chang YY, 2013, ACTA CRYSTALLOGR F, V69, P1249, DOI 10.1107/S174430911302472X; Chapman ADM, 1999, J MOL BIOL, V285, P703, DOI 10.1006/jmbi.1998.2357; Colombo G, 1999, J AM CHEM SOC, V121, P6895, DOI 10.1021/ja990420s; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; Dadarlat VM, 2003, P NATL ACAD SCI USA, V100, P14778, DOI 10.1073/pnas.2434157100; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fitter J, 2000, BIOPHYS J, V79, P1629, DOI 10.1016/S0006-3495(00)76413-7; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Hartigan J., 1975, CLUSTERING ALGORITHM; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hummer G, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/034; Hung CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083091; Irimia A, 2004, J MOL BIOL, V335, P343, DOI 10.1016/j.jmb.2003.10.054; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kalimeri M, 2013, J PHYS CHEM B, V117, P13775, DOI 10.1021/jp407078z; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Madern D, 2000, BIOCHEMISTRY-US, V39, P1001, DOI 10.1021/bi9910023; Madern D, 2002, J MOL EVOL, V54, P825, DOI 10.1007/s00239-001-0088-8; Marchi M, 2003, J PHYS CHEM B, V107, P6598, DOI 10.1021/jp0342935; Marcos E, 2012, J CHEM THEORY COMPUT, V8, P1129, DOI 10.1021/ct200877z; McCully ME, 2013, PROTEIN ENG DES SEL, V26, P35, DOI 10.1093/protein/gzs063; Meinhold L, 2008, BIOPHYS J, V94, P4812, DOI 10.1529/biophysj.107.121418; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rathi PC, 2014, J CHEM INF MODEL, V54, P355, DOI 10.1021/ci400568c; Rycroft CH, 2009, CHAOS, V19, DOI 10.1063/1.3215722; Sanderova H, 2004, PROTEIN SCI, V13, P89, DOI 10.1110/ps.03272504; Schulten K., 2000, LECT THEORETICAL BIO; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; Sterpone F, 2012, CHEM SOC REV, V41, P1665, DOI 10.1039/c1cs15199a; Sterpone F, 2009, J PHYS CHEM B, V113, P131, DOI 10.1021/jp805199c; Talon R, 2014, FMICB, V5; Tehei M, 2005, J BIOL CHEM, V280, P40974, DOI 10.1074/jbc.M508417200; Teilum K, 2011, BBA-PROTEINS PROTEOM, V1814, P969, DOI 10.1016/j.bbapap.2010.11.005; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang T, 2007, J CHEM THEORY COMPUT, V3, P1476, DOI 10.1021/ct700063c; Wells SA, 2014, PROTEINS, V82, P2657, DOI 10.1002/prot.24630; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	58	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113895	10.1371/journal.pone.0113895	http://dx.doi.org/10.1371/journal.pone.0113895			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437494	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900093
J	Boyle, M; Chun, C; Strojny, C; Narayanan, R; Bartholomew, A; Sundivakkam, P; Alapati, S				Boyle, Michael; Chun, Crystal; Strojny, Chelsee; Narayanan, Raghuvaran; Bartholomew, Amelia; Sundivakkam, Premanand; Alapati, Satish			Chronic Inflammation and Angiogenic Signaling Axis Impairs Differentiation of Dental-Pulp Stem Cells	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SIDE POPULATION; IN-VIVO; TNF; ACTIVATION; EXPRESSION; INDUCTION; LIPOPOLYSACCHARIDES	Dental-pulp tissue is often exposed to inflammatory injury. Sequested growth factors or angiogenic signaling proteins that are released following inflammatory injury play a pivotal role in the formation of reparative dentin. While limited or moderate angiogenesis may be helpful for dental pulp maintenance, the induction of significant level of angiogenesis is probably highly detrimental. Hitherto, several studies have addressed the effects of proinflammatory stimuli on the survival and differentiation of dental-pulp stem cells (DPSC), in vitro. However, the mechanisms communal to the inflammatory and angiogenic signaling involved in DPSC survival and differentiation remain unknown. Our studies observed that short-term exposure to TNF-alpha (6 and 12 hours [hrs]) induced apoptosis with an upregulation of VEGF expression and NF-kappa B signaling. However, long-term (chronic) exposure (14 days) to TNF-alpha resulted in an increased proliferation with a concomitant shortening of the telomere length. Interestingly, DPSC pretreated with Nemo binding domain (NBD) peptide (a cell permeable NF-kappa B inhibitor) significantly ameliorated TNF-alpha-and/or VEGF-induced proliferation and the shortening of telomere length. NBD peptide pretreatment significantly improved TNF-alpha-induced downregulation of proteins essential for differentiation, such as bone morphogenic proteins (BMP)-1 & 2, BMP receptor isoforms-1&2, trasnforming growth factor (TGF), osteoactivin and osteocalcin. Additionally, inhibition of NF-kappa B signaling markedly increased the mineralization potential, a process abrogated by chronic exposure to TNF-alpha. Thus, our studies demonstrated that chronic inflammation mediates telomere shortening via NF-kappa B signaling in human DPSC. Resultant chromosomal instability leads to an emergence of increased proliferation of DPSC, while negatively regulating the differentiation of DPSC, in vitro.	[Boyle, Michael; Chun, Crystal; Strojny, Chelsee; Narayanan, Raghuvaran; Sundivakkam, Premanand; Alapati, Satish] Univ Illinois, Coll Dent, Dept Endodont, Chicago, IL 60607 USA; [Bartholomew, Amelia; Sundivakkam, Premanand] Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sundivakkam, P (corresponding author), Univ Illinois, Coll Dent, Dept Endodont, Chicago, IL 60607 USA.	cprem@uic.edu; salapati@uic.edu		Alapati, Satish/0000-0002-4237-5674	NIH/NIDCR [DE019514-SBA]; American Association of Endodontics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019514, R56DE023806] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Association of Endodontics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by Grant NIH/NIDCR grant (DE019514-SBA) to SA and American Association of Endodontics (year: 2014) to PS and SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfuso F, 2006, ENDOTHELIUM-J ENDOTH, V13, P359, DOI 10.1080/10623320600972101; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bletsa A, 2004, NEUROIMMUNOMODULAT, V11, P376, DOI 10.1159/000080148; BORREGAARD N, 1994, J LEUKOCYTE BIOL, V56, P80, DOI 10.1002/jlb.56.1.80; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Coil J, 2004, J ENDODONT, V30, P88, DOI 10.1097/00004770-200402000-00006; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Felaco M, 2000, LIFE SCI, V68, P297, DOI 10.1016/S0024-3205(00)00935-8; Feng XM, 2013, CELL BIOL INT, V37, P1267, DOI 10.1002/cbin.10141; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Hahn CL, 2007, J ENDODONT, V33, P213, DOI 10.1016/j.joen.2006.11.008; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]; Jontell M, 1998, CRIT REV ORAL BIOL M, V9, P179, DOI 10.1177/10454411980090020301; Karaoz E, 2011, HISTOCHEM CELL BIOL, V136, P455, DOI 10.1007/s00418-011-0858-3; Kim MK, 2014, ARCH ORAL BIOL, V59, P102, DOI 10.1016/j.archoralbio.2013.10.009; Kohno S, 2003, J DENT RES, V82, P177, DOI 10.1177/154405910308200306; Le Roy C, 2009, CYTOM PART A, V75A, P882, DOI 10.1002/cyto.a.20774; Lisignoli G, 2004, EXP GERONTOL, V39, P659, DOI 10.1016/j.exger.2003.09.030; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Matsushita K, 2000, J DENT RES, V79, P1596, DOI 10.1177/00220345000790081201; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; NAKANE A, 1995, J ENDODONT, V21, P128, DOI 10.1016/S0099-2399(06)80437-1; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Tran-Hung L, 2008, ARCH ORAL BIOL, V53, P9, DOI 10.1016/j.archoralbio.2007.07.001; Tran-Hung L, 2006, J DENT RES, V85, P819, DOI 10.1177/154405910608500908; Ueda M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt420; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang JM, 2010, BIOCHEM BIOPH RES CO, V400, P334, DOI 10.1016/j.bbrc.2010.08.058; Wang JM, 2010, J ENDODONT, V36, P453, DOI 10.1016/j.joen.2009.11.018; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446	40	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113419	10.1371/journal.pone.0113419	http://dx.doi.org/10.1371/journal.pone.0113419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427002	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400050
J	Cao, XB; Fan, GQ; Zhao, ZL; Deng, MJ; Dong, YP				Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng			Morphological Changes of Paulownia Seedlings Infected Phytoplasmas Reveal the Genes Associated with Witches' Broom through AFLP and MSAP	PLOS ONE			English	Article							DNA METHYLATION; FLAVONOID PATHWAY; EXPRESSION; CLASSIFICATION; IDENTIFICATION; AMPLIFICATION; RESISTANCE; LEAVES; RICE	Paulownia witches' broom (PaWB) caused by phytoplasma might result in devastating damage to the growth and wood production of Paulownia. To study the effect of phytoplasma on DNA sequence and to discover the genes related to PaWB occurrence, DNA polymorphisms and DNA methylation levels and patterns in PaWB seedlings, the ones treated with various concentration of methyl methane sulfonate (MMS) and healthy seedlings were investigated with amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MSAP). Our results indicated that PaWB seedlings recovered a normal morphology, similar to healthy seedlings, after treatment with more than 20 mg.L-1 MMS; Phytoplasma infection did not change the Paulownia genomic DNA sequence at AFLP level, but changed the global DNA methylation levels and patterns; Genes related to PaWB were discovered through MSAP and validated using quantitative real-time PCR (qRT-PCR). These results implied that changes of DNA methylation levels and patterns were closely related to the morphological changes of seedlings infected with phytoplasmas.	[Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			Zhongyuan Scholarship Foundation of Henan Province [122101110700]	Zhongyuan Scholarship Foundation of Henan Province	This work was funded by Zhongyuan Scholarship Foundation of Henan Province (122101110700), http://www.ha.hrss.gov.cn/viewpage?path=/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertaccini A, 2009, PHYTOPATHOL MEDITERR, V48, P355; Cao XB, 2014, INT J MOL SCI, V15, P14669, DOI 10.3390/ijms150814669; [曹喜兵 Cao Xibing], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P535; [曹喜兵 Cao Xibing], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P214; [曹喜兵 Cao Xibing], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P145; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Fan GuoQiang, 2007, Scientia Silvae Sinicae, V43, P138; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gimenez C, 2006, PLANT MOL BIOL REP, V24, P33, DOI 10.1007/BF02914044; Himeno M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04111; Hiruki C, 1997, ACTA HORTIC, V496, P63, DOI DOI 10.17660/ACTAH0RTIC.1999.496.6; Jin K, 1981, PR FORESTRY TECHNOL, V12, P008; Jorgensen I, 2003, PRIVATE FORESTRY BAS; Kathiria P, 2010, PLANT PHYSIOL, V153, P1859, DOI 10.1104/pp.110.157263; KING GJ, 1995, J HORTIC SCI BIOTECH, V70, P333, DOI 10.1080/14620316.1995.11515304; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Kovi M, 2011, THEOR APPL GENET, V123, P705, DOI 10.1007/s00122-011-1620-x; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Leljak-Levanic D, 2010, J APPL MICROBIOL, V109, P2069, DOI 10.1111/j.1365-2672.2010.04837.x; Li Ming, 2008, Scientia Silvae Sinicae, V44, P152; Liu RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez F, 2012, BIOMASS BIOENERG, V45, P77, DOI 10.1016/j.biombioe.2012.05.010; Margaria P, 2014, PLANT CELL ENVIRON, V37, P2183, DOI 10.1111/pce.12332; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pracros P, 2007, B INSECTOL, V60, P221; Richards EJ, 1997, TRENDS GENET, V13, P319, DOI 10.1016/S0168-9525(97)01199-2; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Stankovic D, 2009, ARCH BIOL SCI, V61, P827, DOI 10.2298/ABS0904827S; Sung PH, 2011, J AGR FOOD CHEM, V59, P4637, DOI 10.1021/jf200259n; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Wu Y, 2012, PLANT GROWTH REGUL, V66, P137, DOI 10.1007/s10725-011-9637-3; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; Yu YH, 2013, NEW PHYTOL, V200, P834, DOI 10.1111/nph.12418; Zhai XiaoQiao, 2010, Scientia Silvae Sinicae, V46, P176; [张延召 ZHANG Yan-zhao], 2009, [河南农业大学学报, Journal of Henan Agricultural University], V43, P610; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	46	13	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112533	10.1371/journal.pone.0112533	http://dx.doi.org/10.1371/journal.pone.0112533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427154	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400016
J	Illert, AL; Seitz, AK; Rummelt, C; Kreutmair, S; Engh, RA; Goodstal, S; Peschel, C; Duyster, J; von Bubnoff, N				Illert, Anna L.; Seitz, Anna K.; Rummelt, Christoph; Kreutmair, Stefanie; Engh, Richard A.; Goodstal, Samantha; Peschel, Christian; Duyster, Justus; von Bubnoff, Nikolas			Inhibition of Aurora Kinase B Is Important for Biologic Activity of the Dual Inhibitors of BCR-ABL and Aurora Kinases R763/AS703569 and PHA-739358 in BCR-ABL Transformed Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; SMALL-MOLECULE INHIBITOR; PATIENTS RECEIVING IMATINIB; SUPPRESSES TUMOR-GROWTH; I DOSE-ESCALATION; 6-YEAR FOLLOW-UP; TYROSINE KINASE; CYTOGENETIC RESPONSES; PHASE-I	ABL tyrosine kinase inhibitors (TKI) like Imatinib, Dasatinib and Nilotinib are the gold standard in conventional treatment of CML. However, the emergence of resistance remains a major problem. Alternative therapeutic strategies of ABLTKI-resistant CML are urgently needed. We asked whether dual inhibition of BCR-ABL and Aurora kinases A-C could overcome resistance mediated by ABL kinase mutations. We therefore tested the dual ABL and Aurora kinase inhibitors PHA-739358 and R763/AS703569 in Ba/F3-cells ectopically expressing wild type (wt) or TKI-resistant BCR-ABL mutants. We show that both compounds exhibited strong anti-proliferative and pro-apoptotic activity in ABL TKI resistant cell lines including cells expressing the strongly resistant T315I mutation. Cell cycle analysis indicated polyploidisation, a consequence of continued cell cycle progression in the absence of cell division by Aurora kinase inhibition. Experiments using drug resistant variants of Aurora B indicated that PHA-739358 acts on both, BCR-ABL and Aurora Kinase B, whereas Aurora kinase B inhibition might be sufficient for the anti-proliferative activity observed with R763/AS703569. Taken together, our data demonstrate that dual ABL and Aurora kinase inhibition might be used to overcome ABL TKI resistant CML.	[Illert, Anna L.; Rummelt, Christoph; Kreutmair, Stefanie; Duyster, Justus; von Bubnoff, Nikolas] Univ Freiburg, Med Ctr, Clin Internal Med Hematol Oncol & Stem Cell Trans, D-79106 Freiburg, Germany; [Seitz, Anna K.; Peschel, Christian] Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany; [Engh, Richard A.] Univ Tromso, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway; [Engh, Richard A.] Univ Tromso, Norwegian Struct Biol Ctr, Dept Pharm, Tromso, Norway; [Goodstal, Samantha] EMD Serono Res & Dev Inst Inc, Billerica, MA USA	University of Freiburg; Technical University of Munich; University of Munich; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Merck KGaA; EMD Serono Inc.	Illert, AL (corresponding author), Univ Freiburg, Med Ctr, Clin Internal Med Hematol Oncol & Stem Cell Trans, D-79106 Freiburg, Germany.	Lena.Illert@uniklinik-freiburg.de	von Bubnoff, Nikolas/AAG-1845-2021; Kreutmair, Stefanie/AAE-6952-2022; Illert, Anna L/G-8127-2019; Kreutmair, Stefanie/GOK-2757-2022; von Bubnoff, Nikolas/F-2351-2017	Kreutmair, Stefanie/0000-0001-8466-6675; von Bubnoff, Nikolas/0000-0001-9593-8947; Rummelt, Christoph/0000-0002-6471-7030; Engh, Richard/0000-0002-6207-0560	Bundesministerium fur Bildung und Forschung (NGFNplus); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft [SFB 684/A11]; Gertrud-und-Erwin-Ruppert-Stiftung Munchen	Bundesministerium fur Bildung und Forschung (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm-Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gertrud-und-Erwin-Ruppert-Stiftung Munchen	Funding: This work was supported by a grant to JD and NVB from the Bundesministerium fur Bildung und Forschung (NGFNplus), and from the Wilhelm-Sander Stiftung, by a grant to JD from the Deutsche Forschungsgemeinschaft (SFB 684/A11), and by a grant to NVB by the Gertrud-und-Erwin-Ruppert-Stiftung Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2010, CURR ONCOL REP, V12, P302, DOI 10.1007/s11912-010-0116-1; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Benten D, 2009, NEOPLASIA, V11, P934, DOI 10.1593/neo.09664; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Brummendorf T, 2009, AM SOC HEM ANN M; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Burris H, 2006, EUR J CANCER, VS4, P107; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Carpinelli P, 2008, EXPERT OPIN THER TAR, V12, P69, DOI 10.1517/14728222.12.1.69; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Cohen RB, 2009, CLIN CANCER RES, V15, P6694, DOI 10.1158/1078-0432.CCR-09-1445; Cortes J, 2010, J CLIN ONCOL AM S S, V28; Cortes JKH, 2010, J CLIN ONCOL AM SO S, V28; Cortes-Franco J, 2009, BLOOD            NOV, V114; Cozza G, 2009, BIOCHEM J, V421, P387, DOI 10.1042/BJ20090069; Dar AA, 2008, CANCER RES, V68, P8998, DOI 10.1158/0008-5472.CAN-08-2658; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; De Jonge M, 2006, EJC SUPPL, V4, P12, DOI 10.1016/S1359-6349(06)70032-5; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; den Hollander J, 2010, BLOOD; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Donato NJ, 2010, BIOCHEM PHARMACOL, V79, P688, DOI 10.1016/j.bcp.2009.10.009; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FApperley J, 2007, LANCET ONCOL, V8, P1116, DOI 10.1016/S1470-2045(07)70379-0; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Giles FJ, 2013, LEUKEMIA, V27, P113, DOI 10.1038/leu.2012.186; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goldberg Stuart L, 2014, Leuk Res Rep, V3, P58, DOI 10.1016/j.lrr.2014.06.003; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gontarewicz A, 2010, RECENT RESULTS CANC, V184, P199, DOI 10.1007/978-3-642-01222-8_14; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Graux C, 2013, LEUKEMIA RES, V37, P1100, DOI 10.1016/j.leukres.2013.04.025; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hartsink-Segers SA, 2013, LEUKEMIA, V27, P560, DOI 10.1038/leu.2012.256; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hochhaus A, 2008, BLOOD, V111, P1039, DOI 10.1182/blood-2007-07-103523; Hochhaus A, 2007, SEMIN HEMATOL, V44, pS15, DOI 10.1053/j.seminhematol.2006.12.002; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Jayanthan A, 2013, LEUKEMIA LYMPHOMA, V54, P1505, DOI 10.3109/10428194.2012.752079; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2005, CANCER-AM CANCER SOC, V103, P2099, DOI 10.1002/cncr.21032; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2009, CANCER-AM CANCER SOC, V115, P4136, DOI 10.1002/cncr.24504; Kantarjian H, 2009, BLOOD, V113, P6322, DOI 10.1182/blood-2008-11-186817; Kantarjian HM, 2013, CANCER-AM CANCER SOC, V119, P2611, DOI 10.1002/cncr.28113; Kawasaki A, 2001, J CELL BIOL, V152, P275, DOI 10.1083/jcb.152.2.275; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kelly KR, 2012, INT J CANCER, V131, P2693, DOI 10.1002/ijc.27579; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lowenberg B, 2011, BLOOD, V118, P6030, DOI 10.1182/blood-2011-07-366930; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Mazzorana M, 2008, MOL CELL BIOCHEM, V316, P57, DOI 10.1007/s11010-008-9822-5; McLaughlin J, 2009, J CANC RES CLIN ONCO; McLaughlin J, 2010, J CANCER RES CLIN, V136, P99, DOI 10.1007/s00432-009-0641-1; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Mita M, 2014, TARGET ONCOL, V9, P215, DOI 10.1007/s11523-013-0288-3; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Oke A, 2009, CANCER RES, V69, P4150, DOI 10.1158/0008-5472.CAN-08-3203; Palandri F, 2009, HAEMATOL-HEMATOL J, V94, P205, DOI 10.3324/haematol.13529; Palandri F, 2008, HAEMATOL-HEMATOL J, V93, P1792, DOI 10.3324/haematol.13068; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Qi WQ, 2012, INT J CANCER, V130, P2997, DOI 10.1002/ijc.26324; Raymond E, 2014, INVEST NEW DRUG, V32, P94, DOI 10.1007/s10637-013-9950-y; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Renshaw JS, 2007, J CLIN ONCOL, V25; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah M, 2012, BLOOD CELL MOL DIS, V48, P199, DOI 10.1016/j.bcmd.2012.01.005; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Sonet A, 2008, BLOOD, P112; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tanaka R, 2011, CANCER LETT, V312, P228, DOI 10.1016/j.canlet.2011.08.009; Tanaka T, 1999, CANCER RES, V59, P2041; Tatsuka M, 1998, CANCER RES, V58, P4811; Thiollier C, 2012, J EXP MED, V209, P2017, DOI 10.1084/jem.20121343; Tsuboi K, 2011, LEUKEMIA RES, V35, P1384, DOI 10.1016/j.leukres.2011.04.008; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; von Bubnoff N, 2010, DTSCH ARZTEBL INT, V107, P114, DOI 10.3238/arztebl.2010.0114; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Yamauchi T, 2013, CANCER SCI, V104, P926, DOI 10.1111/cas.12164; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Yang J, 2014, INT J CANCER, V134, P1183, DOI 10.1002/ijc.28434; Yuan HF, 2012, CARCINOGENESIS, V33, P285, DOI 10.1093/carcin/bgr278; Zhang WW, 2009, J CLIN ONCOL, V27, P3642, DOI 10.1200/JCO.2008.19.4076; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	122	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112318	10.1371/journal.pone.0112318	http://dx.doi.org/10.1371/journal.pone.0112318			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426931	Green Submitted, Green Published, gold			2022-12-27	WOS:000349145400013
J	Li, YD; Baran, U; Wang, RKK				Li, Yuandong; Baran, Utku; Wang, Ruikang K.			Application of Thinned-Skull Cranial Window to Mouse Cerebral Blood Flow Imaging Using Optical Microangiography	PLOS ONE			English	Article							MICRO-ANGIOGRAPHY; PERFUSION; TISSUE; SKIN	In vivo imaging of mouse brain vasculature typically requires applying skull window opening techniques: open-skull cranial window or thinned-skull cranial window. We report non-invasive 3D in vivo cerebral blood flow imaging of C57/BL mouse by the use of ultra-high sensitive optical microangiography (UHS-OMAG) and Doppler optical microangiography (DOMAG) techniques to evaluate two cranial window types based on their procedures and ability to visualize surface pial vessel dynamics. Application of the thinned-skull technique is found to be effective in achieving high quality images for pial vessels for short-term imaging, and has advantages over the open-skull technique in available imaging area, surgical efficiency, and cerebral environment preservation. In summary, thinned-skull cranial window serves as a promising tool in studying hemodynamics in pial microvasculature using OMAG or other OCT blood flow imaging modalities.	[Li, Yuandong; Baran, Utku; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Baran, Utku] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019	Wang, Ruikang/0000-0001-5169-8822; Baran, Utku/0000-0002-7740-4252	National Institutes of Health [R01EB009682, R01HL093140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding came from the National Institutes of Health (R01EB009682 and R01HL093140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; Baran U, 2015, J BIOPHOTONICS, V8, P46, DOI 10.1002/jbio.201300154; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; Cipolla, 2009, CEREBRAL CIRCULATION; Clark S, 1999, MICROVASC RES, V57, P284, DOI 10.1006/mvre.1998.2124; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Hendargo HC, 2011, BIOMED OPT EXPRESS, V2, P2175, DOI 10.1364/BOE.2.002175; Holtmaat Anthony, 2012, Cold Spring Harb Protoc, V2012, P694, DOI 10.1101/pdb.prot069617; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Isshiki M, 2014, MICROSCOPY-JPN, V63, P53, DOI 10.1093/jmicro/dft043; Jia YL, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3625238; JONES EG, 1970, J ANAT, V106, P507; Kazmi SMS, 2013, J CEREBR BLOOD F MET, V33, P798, DOI 10.1038/jcbfm.2013.57; Kelly EA, 2010, J VIS EXP; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Potter SM, 1996, GENE, V173, P25, DOI 10.1016/0378-1119(95)00681-8; Reif R, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/509783; Shi L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.106015; Stetter Christian, 2013, Exp Transl Stroke Med, V5, P9, DOI 10.1186/2040-7378-5-9; Szu JI, 2012, JOVE-J VIS EXP, DOI 10.3791/50053; Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002; Wang HQ, 2015, J BIOPHOTONICS, V8, P265, DOI 10.1002/jbio.201400012; Wang RKK, 2002, PHYS MED BIOL, V47, P2281, DOI 10.1088/0031-9155/47/13/307; Wang RKK, 2007, OPT EXPRESS, V15, P11402, DOI 10.1364/OE.15.011402; Wang RK, 2007, OPT EXPRESS, V15, P4083, DOI 10.1364/OE.15.004083; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Yousefi S, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2152839; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	36	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113658	10.1371/journal.pone.0113658	http://dx.doi.org/10.1371/journal.pone.0113658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426632	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400075
J	Lapoint, RT; Magnacca, KN; O'Grady, PM				Lapoint, Richard T.; Magnacca, Karl N.; O'Grady, Patrick M.			Phylogenetics of the Antopocerus-Modified Tarsus Clade of Hawaiian Drosophila: Diversification across the Hawaiian Islands	PLOS ONE			English	Article							ADAPTIVE RADIATION; SEXUAL SELECTION; SPECIES GROUP; COURTSHIP SONGS; LEK BEHAVIOR; EVOLUTION; DIPTERA; BIOGEOGRAPHY; SPECIATION; SEQUENCE	The Hawaiian Drosophilidae radiation is an ecologically and morphologically diverse clade of almost 700 described species. A phylogenetic approach is key to understanding the evolutionary forces that have given rise to this diverse lineage. Here we infer the phylogeny for the antopocerus, modified tarsus and ciliated tarsus (AMC) clade, a lineage comprising 16% (91 of 687 species) of the described Hawaiian Drosophilidae. To improve on previous analyses we constructed the largest dataset to date for the AMC, including a matrix of 15 genes for 68 species. Results strongly support most of the morphologically defined species groups as monophyletic. We explore the correlation of increased diversity in biogeography, sexual selection and ecology on the present day diversity seen in this lineage using a combination of dating methods, rearing records, and distributional data. Molecular dating analyses indicate that AMC lineage started diversifying about 4.4 million years ago, culminating in the present day AMC diversity. We do not find evidence that ecological speciation or sexual selection played a part in generating this diversity, but given the limited number of described larval substrates and secondary sexual characters analyzed we can not rule these factors out entirely. An increased rate of diversification in the AMC is found to overlap with the emergence of multiple islands in the current chain of high islands, specifically Oahu and Kauai.	[Lapoint, Richard T.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Magnacca, Karl N.] Oahu Army Nat Resource Program, Honolulu, HI USA; [O'Grady, Patrick M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Arizona; University of California System; University of California Berkeley	Lapoint, RT (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	rlapoint@email.arizona.edu	O'Grady, Patrick/J-3421-2019	O'Grady, Patrick/0000-0002-6075-8951	NIH PERT from the University of Arizona [K12 GM000708]; University of California, Berkeley; NSF [DEB0842348]; Direct For Biological Sciences [1241253] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH PERT from the University of Arizona; University of California, Berkeley(University of California System); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH PERT funds (K12 GM000708) from the University of Arizona to RTL, Walker funds from the University of California, Berkeley, to RTL, and NSF DEB0842348 awarded to PMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves H, 2010, BEHAV GENET, V40, P694, DOI 10.1007/s10519-010-9364-y; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; BELL WJ, 1994, J KANSAS ENTOMOL SOC, V67, P267; Bennett GM, 2013, J BIOGEOGR, V40, P1512, DOI 10.1111/jbi.12099; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bess EC, 2014, J BIOGEOGR, V41, P158, DOI 10.1111/jbi.12191; Boake CRB, 2005, BEHAV GENET, V35, P297, DOI 10.1007/s10519-005-3221-4; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; Bonacum J., 2001, THESIS YALE U NEW HA; CARSON HL, 1989, EVOLUTION, V43, P190, DOI 10.1111/j.1558-5646.1989.tb04217.x; Carson HL, 1997, J HERED, V88, P343, DOI 10.1093/oxfordjournals.jhered.a023115; CARSON HL, 1983, GENETICS, V103, P465; Castaneda MD, 2011, MOL PHYLOGENET EVOL, V61, P784, DOI 10.1016/j.ympev.2011.07.004; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Da Lage JL, 2007, J ZOOL SYST EVOL RES, V45, P47, DOI 10.1111/j.1439-0469.2006.00389.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Evenhuis NL, 2003, BISHOP MUSEUM OCCASI, V76; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Fleischer RC, 2008, CURR BIOL, V18, P1927, DOI 10.1016/j.cub.2008.10.051; Funk VA, 1995, BIOGEOGRAPHIC PATTER; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Goodman KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073019; Grimaldi DA, 1987, AM MUS NOVIT, V2880, P1; Haines WP, 2014, NATURE COMMUNICATION, V5, P1, DOI DOI 10.1038/NC0MMS4502; HARDY DE, 1977, P ENTOMOL SOC WASH, V79, P82; HARDY DE, 1979, P HAWAII ENTOMOL SOC, V23, P71; Hardy DE, 1965, INSECTS HAWAII, V12, P1; Heed WB, 1968, U TEXAS PUBLICATIONS, V6818, P387; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HOIKKALA A, 1994, ANIM BEHAV, V47, P1363, DOI 10.1006/anbe.1994.1184; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Jordan S, 2003, SYST BIOL, V52, P89, DOI 10.1080/10635150390132803; Jordan S, 2005, MOL ECOL, V14, P3457, DOI 10.1111/j.1365-294X.2005.02669.x; Kambysellis Michael P., 1997, P475; KAMBYSELLIS MP, 1995, CURR BIOL, V5, P1129, DOI 10.1016/S0960-9822(95)00229-6; KANESHIRO KY, 1976, P HAWAII ENTOMOL SOC, V22, P255; KANESHIRO KY, 1983, ANNU REV ENTOMOL, V28, P161, DOI 10.1146/annurev.en.28.010183.001113; Knope ML, 2012, J BIOGEOGR, V39, P1206, DOI 10.1111/j.1365-2699.2012.02687.x; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kopp A, 2011, EVOL DEV, V13, P504, DOI 10.1111/j.1525-142X.2011.00507.x; Lapoint RT, 2013, MOL PHYLOGENET EVOL, V69, P95, DOI 10.1016/j.ympev.2013.04.032; Lapoint RT, 2011, MOL PHYLOGENET EVOL, V58, P492, DOI 10.1016/j.ympev.2010.12.015; Lapoint RT, 2009, ZOOTAXA, P53, DOI 10.11646/zootaxa.2003.1.3; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MADDISON D, 2002, MACCLADE ANAL PHYLOG; Magnacca KN, 2008, ZOOTAXA, P1; Magnacca KN, 2006, CLADISTICS, V22, P393, DOI 10.1111/j.1096-0031.2006.00119.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Miller M.A., 2010, P GAT COMP ENV WORKS; MONTGOMERY SL, 1975, P HAWAII ENTOMOL SOC, V22, P65; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; O'Grady Patrick M., 2004, Bishop Museum Bulletins in Entomology, V12, P117; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; O'Grady PM, 2010, RECORDS HAWAII BIOL, V108, P3; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SHELLY TE, 1989, BEHAVIOUR, V111, P34, DOI 10.1163/156853989X00565; SHELLY TE, 1988, ECOL ENTOMOL, V13, P51, DOI 10.1111/j.1365-2311.1988.tb00332.x; SHELLY TE, 1987, ANIM BEHAV, V35, P1394, DOI 10.1016/S0003-3472(87)80012-X; Sherrod David R., 2007, GEOLOGIC MAP STATE H; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SPIETH HERMAN T., 1966, UNIV TEX PUBL, V6615, P245; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark JB, 2010, J MORPHOL, V271, P86, DOI 10.1002/jmor.10783; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Throckmorton L. H., 1966, P335; TOMPKINS L, 1993, EVOLUTION, V47, P1407, DOI [10.2307/2410156, 10.1111/j.1558-5646.1993.tb02163.x]; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Yassin A, 2013, SYST ENTOMOL, V38, P349, DOI 10.1111/j.1365-3113.2012.00665.x; Zilversmit M, 2002, Pac Symp Biocomput, P512	91	14	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113227	10.1371/journal.pone.0113227	http://dx.doi.org/10.1371/journal.pone.0113227			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25420017	Green Published, gold, Green Submitted			2022-12-27	WOS:000346766900026
J	Liu, QC; Wen, CL; Zhao, H; Zhang, LY; Wang, J; Wang, YQ				Liu, Qianchun; Wen, Changlong; Zhao, Hong; Zhang, Liying; Wang, Jian; Wang, Yongqin			RNA-Seq Reveals Leaf Cuticular Wax-Related Genes in Welsh Onion	PLOS ONE			English	Article							ALLIUM-FISTULOSUM L.; FATTY-ACID ELONGASE; SSR-MARKERS; ARABIDOPSIS-THALIANA; FUSARIUM-OXYSPORUM; ABC TRANSPORTER; BIOSYNTHESIS; ENCODES; CUTICLE; TRANSCRIPTOME	The waxy cuticle plays a very important role in plant resistance to various biotic and abiotic stresses and is an important characteristic of Welsh onions. Two different types of biangan Welsh onions (BG) were selected for this study: BG, a wild-type covered by wax, which forms a continuous lipid membrane on its epidermal cells, and GLBG, a glossy mutant of BG whose epidermal cells are not covered by wax. To elucidate the waxy cuticle-related gene expression changes, we used RNA-Seq to compare these two Welsh onion varieties with distinct differences in cuticular wax. The de novo assembly yielded 42,881 putative unigenes, 25.41% of which are longer than 1,000 bp. Among the high-quality unique sequences, 22,289 (52.0%) had at least one significant match to an existing gene model. A total of 798 genes, representing 1.86% of the total putative unigenes, were differentially expressed between these two Welsh onion varieties. The expression patterns of four important unigenes that are related to waxy cuticle biosynthesis were confirmed by RT-qPCR and COG class annotation, which demonstrated that these genes play an important role in defense mechanisms and lipid transport and metabolism. To our knowledge, this study is the first exploration of the Welsh onion waxy cuticle. These results may help to reveal the molecular mechanisms underlying the waxy cuticle and will be useful for waxy gene cloning, genetics and breeding as well as phylogenetic and evolutionary studies of the Welsh onion.	[Liu, Qianchun; Wen, Changlong; Zhao, Hong; Zhang, Liying; Wang, Jian; Wang, Yongqin] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing 100097, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Wang, YQ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Key Lab Biol & Genet Improvement Hort Crops North, Minist Agr, Beijing 100097, Peoples R China.	wangyongqin@nercv.org			National Natural Science Foundation of China [31372066]; Natural Science Foundation of Beijing [6132016]; Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences [KJCX20140111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences	The National Natural Science Foundation of China (No. 31372066), The Natural Science Foundation of Beijing (No. 6132016), and the Science and Technology Innovation Capability Construction of the Beijing Academy of Agriculture and Forestry Sciences (No. KJCX20140111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amid A, 2012, J EXP BOT, V63, P5289, DOI 10.1093/jxb/ers191; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072910; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dong YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-154; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; JENKS MA, 1994, PLANT PHYSIOL, V105, P1239, DOI 10.1104/pp.105.4.1239; Jiangsu New Medical College, 1986, DICT TRAD CHIN MED, P2316; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; KOLATTUKUDY PE, 1981, ANNU REV PLANT PHYS, V32, P539, DOI 10.1146/annurev.pp.32.060181.002543; KOLATTUKUDY PE, 1996, PLANT CUTICLES INTEG, P83, DOI DOI 10.1016/J.MICRON.2007.11.010; Krauss P, 1997, PLANT CELL ENVIRON, V20, P1079, DOI 10.1111/j.1365-3040.1997.tb00684.x; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Kurata T, 2003, PLANT J, V36, P55, DOI 10.1046/j.1365-313X.2003.01854.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Qin P, 2013, PLANT CELL PHYSIOL, V54, P138, DOI 10.1093/pcp/pcs162; RIEDERER M, 1990, PLANTA, V180, P154, DOI 10.1007/BF00193990; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451; Tanino KK, 2013, PHYSIOL PLANTARUM, V147, P101, DOI 10.1111/j.1399-3054.2012.01716.x; Tawaraya K, 2012, BIOL FERT SOILS, V48, P839, DOI 10.1007/s00374-012-0669-2; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsukazaki H, 2012, MOL BREEDING, V30, P1689, DOI 10.1007/s11032-012-9752-5; Ueda H, 2013, BIOSCI BIOTECH BIOCH, V77, P1809, DOI 10.1271/bbb.130084; Vu HQ, 2012, GENOME, V55, P797, DOI 10.1139/g2012-065; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xu N, 2013, ALLELOPATHY J, V32, P243; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	48	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113290	10.1371/journal.pone.0113290	http://dx.doi.org/10.1371/journal.pone.0113290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415343	gold, Green Published, Green Submitted			2022-12-27	WOS:000346906600041
J	Zimmermann, C; Rudloff, S; Lochnit, G; Arampatzi, S; Maison, W; Zimmer, KP				Zimmermann, Christian; Rudloff, Silvia; Lochnit, Guenter; Arampatzi, Sevgi; Maison, Wolfgang; Zimmer, Klaus-Peter			Epithelial Transport of Immunogenic and Toxic Gliadin Peptides In Vitro	PLOS ONE			English	Article							INTESTINAL BARRIER FUNCTION; T-CELL RESPONSE; CELIAC-DISEASE; IMMUNE-RESPONSES; ALPHA-GLIADIN; CACO-2 CELLS; PERMEABILITY; GLUTEN; ENTEROCYTES; ABSORPTION	Scope: Celiac disease is an autoimmune disorder caused by failure of oral tolerance against gluten in genetically predisposed individuals. The epithelial translocation of gluten-derived gliadin peptides is an important pathogenetic step; the underlying mechanisms, however, are poorly understood. Thus, we investigated the degradation and epithelial translocation of two different gliadin peptides, the toxic P31-43 and the immunogenic P56-68. As the size, and hence, the molecular weight of peptides might have an effect on the transport efficiency we chose two peptides of the same, rather short chain length. Methods and Results: Fluorescence labeled P31-43 and P56-68 were synthesized and studied in a transwell system with human enterocytes. Fluorometric measurements were done to reveal antigen translocation and flow cytometry as well as confocal microscopy were used to investigate cellular uptake of peptides. Structural changes of these peptides were analysed by MALDI-TOF-MS. According to fluorescence intensities, significantly more P31-43 compared to P56-68 was transported through the enterocyte layer after 24 h incubation. In contrast to previous reports, however, mass spectrometric data do not only show a time-dependent cleavage of the immunogenic P56-68, but we observed for the first time the degradation of the toxic peptide P31-43 at the apical side of epithelial cells. Conclusion: Considering the degradation of gliadin peptides by enterocytes, measurement of fluorescence signals do not completely represent translocated intact gliadin peptides. From our experiments it is obvious that even short peptides can be digested prior to the translocation across the epithelial barrier. Thus, the chain length and the sensibility to degradations of gliadin peptides as well as the integrity of the epithelial barrier seem to be critical for the uptake of gliadin peptides and the subsequent inflammatory immune response.	[Zimmermann, Christian; Rudloff, Silvia; Zimmer, Klaus-Peter] Univ Giessen, Dept Pediat, D-35392 Giessen, Germany; [Rudloff, Silvia] Univ Giessen, Inst Nutr Sci, D-35392 Giessen, Germany; [Lochnit, Guenter] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Arampatzi, Sevgi] Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; [Maison, Wolfgang] Univ Hamburg, D-20146 Hamburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; University of Hamburg	Zimmermann, C (corresponding author), Univ Giessen, Dept Pediat, Feulgenstr 12, D-35392 Giessen, Germany.	christian.zimmermann@paediat.med.uni-giessen.de	Zimmer, Klaus-Peter/AAY-9261-2020; Maison, Wolfgang/AFP-2593-2022; Zimmer, Klaus-Peter/AAY-9351-2020	Maison, Wolfgang/0000-0003-2793-5722; Zimmermann, Christian/0000-0002-7915-2730				Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; BAI JPF, 1994, PHARMACEUT RES, V11, P897, DOI 10.1023/A:1018946228432; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Ciccocioppo R, 2005, CLIN EXP IMMUNOL, V140, P408, DOI 10.1111/j.1365-2249.2005.02783.x; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Iacomino G, 2013, J AGR FOOD CHEM, V61, P1088, DOI 10.1021/jf3045523; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Londei M, 2004, J PEDIATR GASTR NUTR, V39, pS729, DOI 10.1097/00005176-200406003-00006; Lubbing N, 2011, PEDIATR RES, V70, P357, DOI 10.1203/PDR.0b013e31822a31e7; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mamone G, 2007, J CHROMATOGR B, V855, P236, DOI 10.1016/j.jchromb.2007.05.009; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; PAPPENHEIMER JR, 1994, P NATL ACAD SCI USA, V91, P1942, DOI 10.1073/pnas.91.5.1942; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Snoeck V, 2005, MICROBES INFECT, V7, P997, DOI 10.1016/j.micinf.2005.04.003; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Tjon JML, 2010, IMMUNOGENETICS, V62, P641, DOI 10.1007/s00251-010-0465-9; TOWNLEY RRW, 1973, LANCET, V1, P1363; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Weangsripanaval T, 2006, J NUTR, V136, P2874, DOI 10.1093/jn/136.11.2874; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; WILSON G, 1990, J CONTROL RELEASE, V11, P25, DOI 10.1016/0168-3659(90)90118-D; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656	41	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113932	10.1371/journal.pone.0113932	http://dx.doi.org/10.1371/journal.pone.0113932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415429	gold, Green Published			2022-12-27	WOS:000346906600084
J	Bade, B; Zdebik, A; Wagenpfeil, S; Graber, S; Geisel, J; Vogt, T; Reichrath, J				Bade, Benjamin; Zdebik, Alexander; Wagenpfeil, Stefan; Graeber, Stefan; Geisel, Juergen; Vogt, Thomas; Reichrath, Joerg			Low Serum 25-Hydroxyvitamin D Concentrations Are Associated with Increased Risk for Melanoma and Unfavourable Prognosis	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; TERM-FOLLOW-UP; PROSTATE-CANCER; SUBSEQUENT RISK; SUN EXPOSURE; COLON-CANCER; CALCIUM; D-3; MORTALITY; CELLS	Background: Low vitamin D status (serum 25(OH) D concentration) is associated with increased incidence and unfavourable outcome of various types of cancer. However, there are limited data on influence of serum 25(OH) D on risk and prognosis of malignant melanoma. Methods: Basal serum 25(OH) D concentrations were retrospectively analyzed in a cohort of melanoma patients (n=324) and healthy controls (n=141). We tested the hypothesis that serum 25(OH) D concentrations are predictive of melanoma risk, thickness of primary melanomas, and overall survival (OS). Results: Median serum 25(OH) D concentrations were significantly lower (p=0.004) in melanoma patients (median=13.6 ng/ml) as compared to controls (median=15.6 ng/ml). Primary tumors of patients with low serum 25(OH) D concentrations (, 10 ng/ml) had significantly (p=0.006) greater Breslow thickness (median: 1.9 mm) as compared to patients with higher levels (>20 ng/ml; median: 1.00 mm). Patients with 25(OH) D serum concentrations in the lowest quartile had inferior overall survival (median: 80 months) comparing with the highest quartile (median: 195 months; p=0.049). Conclusions: Our data support the concept that serum 25(OH) D concentrations are associated with risk and prognosis of melanoma. Whether normalizing serum 25(OH) D concentrations in these patients improves outcomes will require testing in future clinical trials.	[Bade, Benjamin; Zdebik, Alexander; Vogt, Thomas; Reichrath, Joerg] Saarland Univ Hosp, Ctr Clin & Expt Photodermatol, Dept Dermatol, Homburg, Germany; [Wagenpfeil, Stefan; Graeber, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Geisel, Juergen] Saarland Univ Hosp, Dept Clin Chem & Lab Med, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Reichrath, J (corresponding author), Saarland Univ Hosp, Ctr Clin & Expt Photodermatol, Dept Dermatol, Homburg, Germany.	joerg.reichrath@uks.eu			program of the medical faculty of the Saarland University [HOMFOR2013]	program of the medical faculty of the Saarland University	Funding: This study has been conducted using infrastructure and personel of the Department of Dermatology of the Saarland University. This study has been supported in part by a research grant of the HOMFOR2013 program of the medical faculty of the Saarland University to JR (http://www.uniklinikum-saarland.de/de/forschung/). There were no other sources of funding that have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Berwick M, 2008, ADV EXP MED BIOL, V624, P117, DOI 10.1007/978-0-387-77574-6_10; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; CORNWELL ML, 1992, PHOTODERMATOL PHOTO, V9, P109; Diaz GD, 2000, CANCER RES, V60, P2304; Evans SRT, 2000, INT J ONCOL, V16, P1249; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P2784, DOI 10.1158/1055-9965.EPI-07-0672; Fernandez-Garcia NI, 2005, ONCOGENE, V24, P6533, DOI 10.1038/sj.onc.1208801; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Goodwin PJ, 2008, J CLIN ONCOL, V26; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Hintzpeter B, 2008, EUR J CLIN NUTR, V62, P1079, DOI 10.1038/sj.ejcn.1602825; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holmberg L, 2009, CANCER CAUSE CONTROL, V20, P663, DOI 10.1007/s10552-008-9279-6; International Agency for Research on Cancer, 2008, IARC WORK GROUP REP, V5; Iseki K, 1999, INT J CANCER, V81, P730, DOI 10.1002/(SICI)1097-0215(19990531)81:5&lt;730::AID-IJC11&gt;3.0.CO;2-Q; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; MEGGOUH F, 1991, CANCER RES, V51, P1227; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Mimouni FB, 2009, CURR OPIN CLIN NUTR, V12, P287, DOI 10.1097/MCO.0b013e32832a1329; NELEMANS PJ, 1993, ENVIRON HEALTH PERSP, V101, P252, DOI 10.2307/3431552; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Nurnberg B, 2009, ANTICANCER RES, V29, P3669; Reichrath R, 2004, CANCER CAUSE CONTROL, V15, P97; Rosso S, 2008, EUR J CANCER, V44, P1275, DOI 10.1016/j.ejca.2008.03.009; Scaglione-Sewell BA, 2000, ENDOCRINOLOGY, V141, P3931, DOI 10.1210/en.141.11.3931; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Tangrea J, 1997, CANCER CAUSE CONTROL, V8, P615, DOI 10.1023/A:1018450531136; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Tuohimaa P., 2009, PSYCHONEUROENDOCRINO, V34, P278; VANDEWALLE B, 1994, CANCER LETT, V86, P67, DOI 10.1016/0304-3835(94)90181-3; VANDEWALLE B, 1995, CANCER LETT, V97, P99, DOI 10.1016/0304-3835(95)03958-Y; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358	44	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112863	10.1371/journal.pone.0112863	http://dx.doi.org/10.1371/journal.pone.0112863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437008	gold, Green Published, Green Submitted			2022-12-27	WOS:000347114900021
J	Biran, S; Gat, Y; Fass, D				Biran, Shai; Gat, Yair; Fass, Deborah			The Eps1p Protein Disulfide Isomerase Conserves Classic Thioredoxin Superfamily Amino Acid Motifs but Not Their Functional Geometries	PLOS ONE			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY; SACCHAROMYCES-CEREVISIAE; PDI FAMILY; DOMAIN; SERVER; FOLD	The widespread thioredoxin superfamily enzymes typically share the following features: a characteristic alpha-beta fold, the presence of a Cys-X-X-Cys (or Cys-X-X-Ser) redox-active motif, and a proline in the cis configuration abutting the redox-active site in the tertiary structure. The Cys-X-X-Cys motif is at the solvent-exposed amino terminus of an a-helix, allowing the first cysteine to engage in nucleophilic attack on substrates, or substrates to attack the Cys-X-X-Cys disulfide, depending on whether the enzyme functions to reduce, isomerize, or oxidize its targets. We report here the X-ray crystal structure of an enzyme that breaks many of our assumptions regarding the sequence-structure relationship of thioredoxin superfamily proteins. The yeast Protein Disulfide Isomerase family member Eps1p has Cys-X-X-Cys motifs and proline residues at the appropriate primary structural positions in its first two predicted thioredoxin-fold domains. However, crystal structures show that the Cys-X-X-Cys of the second domain is buried and that the adjacent proline is in the trans, rather than the cis isomer. In these configurations, neither the "active-site" disulfide nor the backbone carbonyl preceding the proline is available to interact with substrate. The Eps1p structures thus expand the documented diversity of the PDI oxidoreductase family and demonstrate that conserved sequence motifs in common folds do not guarantee structural or functional conservation.	[Biran, Shai; Gat, Yair; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il			European Research Council under the European Union's Seventh Framework Programme [310649]	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC))	This research was supported by the European Research Council under the European Union's Seventh Framework Programme, Grant number: 310649 (http://erc.europa.eu). Further support was provided by the Kimmelman Center for Macromolecular Assemblies (http://www.weizmann.ac.il/acadaff/Scientific_Activities/current/kimmelman_center.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Gat Y, 2014, PROTEIN SCI, V23, P1102, DOI 10.1002/pro.2496; Gulerez IE, 2012, ACTA CRYSTALLOGR F, V68, P378, DOI 10.1107/S1744309112005866; He JW, 2005, FEBS LETT, V579, P2277, DOI 10.1016/j.febslet.2005.03.019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113431	10.1371/journal.pone.0113431	http://dx.doi.org/10.1371/journal.pone.0113431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437863	Green Submitted, gold, Green Published			2022-12-27	WOS:000347114900044
J	Anderova, M; Benesova, J; Mikesova, M; Dzamba, D; Honsa, P; Kriska, J; Butenko, O; Novosadova, V; Valihrach, L; Kubista, M; Dmytrenko, L; Cicanic, M; Vargova, L				Anderova, Miroslava; Benesova, Jana; Mikesova, Michaela; Dzamba, David; Honsa, Pavel; Kriska, Jan; Butenko, Olena; Novosadova, Vendula; Valihrach, Lukas; Kubista, Mikael; Dmytrenko, Lesia; Cicanic, Michal; Vargova, Lydia			Altered Astrocytic Swelling in the Cortex of alpha-Syntrophin-Negative GFAP/EGFP Mice	PLOS ONE			English	Article							3-DIMENSIONAL CONFOCAL MORPHOMETRY; BLOOD-BRAIN-BARRIER; DIFFUSION PARAMETERS; VOLUME REGULATION; GLIAL-CELLS; AQUAPORIN-4; EXPRESSION; K+; MORPHOLOGY; ISCHEMIA	Brain edema accompanying ischemic or traumatic brain injuries, originates from a disruption of ionic/neurotransmitter homeostasis that leads to accumulation of K+ and glutamate in the extracellular space. Their increased uptake, predominantly provided by astrocytes, is associated with water influx via aquaporin-4 (AQP4). As the removal of perivascular AQP4 via the deletion of alpha-syntrophin was shown to delay edema formation and K+ clearance, we aimed to elucidate the impact of alpha-syntrophin knockout on volume changes in individual astrocytes in situ evoked by pathological stimuli using three dimensional confocal morphometry and changes in the extracellular space volume fraction (alpha) in situ and in vivo in the mouse cortex employing the real-time iontophoretic method. RT-qPCR profiling was used to reveal possible differences in the expression of ion channels/transporters that participate in maintaining ionic/neurotransmitter homeostasis. To visualize individual astrocytes in mice lacking alpha-syntrophin we crossbred GFAP/EGFP mice, in which the astrocytes are labeled by the enhanced green fluorescent protein under the human glial fibrillary acidic protein promoter, with alpha-syntrophin knockout mice. Three-dimensional confocal morphometry revealed that alpha-syntrophin deletion results in significantly smaller astrocyte swelling when induced by severe hypoosmotic stress, oxygen glucose deprivation (OGD) or 50 mM K+. As for the mild stimuli, such as mild hypoosmotic or hyperosmotic stress or 10 mM K+, alpha-syntrophin deletion had no effect on astrocyte swelling. Similarly, evaluation of relative alpha changes showed a significantly smaller decrease in alpha-syntrophin knockout mice only during severe pathological conditions, but not during mild stimuli. In summary, the deletion of alpha-syntrophin markedly alters astrocyte swelling during severe hypoosmotic stress, OGD or high K+.	[Anderova, Miroslava; Benesova, Jana; Mikesova, Michaela; Dzamba, David; Honsa, Pavel; Kriska, Jan; Butenko, Olena] Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Novosadova, Vendula; Valihrach, Lukas; Kubista, Mikael] Acad Sci Czech Republ, Gene Express Lab, Inst Biotechnol, Prague, Czech Republic; [Anderova, Miroslava; Dmytrenko, Lesia; Cicanic, Michal; Vargova, Lydia] Charles Univ Prague, Fac Med 2, Dept Neurosci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague	Anderova, M (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Kubista, Mikael/A-5689-2008; Valihrach, Lukas/H-4368-2014; Novosadova, Vendula/AAJ-1449-2021; Anderova, Miroslava/H-2249-2014; Butenko, Olena/AAL-3766-2021; Kriska, Jan/D-4889-2019	Kubista, Mikael/0000-0002-2940-352X; Valihrach, Lukas/0000-0002-6704-4337; Anderova, Miroslava/0000-0002-9030-4571; Butenko, Olena/0000-0003-2959-559X; Kriska, Jan/0000-0001-5684-5828	Grant Agency of the Czech Republic [GA CR 13-02154S, P304/12/G069]; European Regional Development Fund [BIOCEV CZ.1.05/1.1.00/02.0109]; Operational Programme Education for Competitiveness from the European Social Fund [CZ.1.07/2.3.00/30.0045]; state budget of the Czech Republic	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); Operational Programme Education for Competitiveness from the European Social Fund; state budget of the Czech Republic	This study was supported by the grants GA CR 13-02154S, and P304/12/G069 from the Grant Agency of the Czech Republic, by the project BIOCEV CZ.1.05/1.1.00/02.0109 from the European Regional Development Fund and by the Operational Programme Education for Competitiveness CZ.1.07/2.3.00/30.0045 from the European Social Fund and the state budget of the Czech Republic. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Benesova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029725; Benesova J, 2009, J NEUROSCI RES, V87, P96, DOI 10.1002/jnr.21828; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Dmytrenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068044; Florence CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051124; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Lindinger MI, 2011, J PHYSIOL-LONDON, V589, P2887, DOI 10.1113/jphysiol.2011.206730; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Matthias K, 2003, J NEUROSCI, V23, P1750; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Nolte C, 2001, GLIA, V33, P72; PasantesMorales H, 1996, METAB BRAIN DIS, V11, P187, DOI 10.1007/BF02237957; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Rusnakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069734; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Song D, 2014, J NEUROSCI RES; SYKOVA E, 1992, MONITORING NEURONAL, P261; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargova L, 2001, J NEUROSCI RES, V65, P129, DOI 10.1002/jnr.1136.abs; Vorisek I, 1997, J CEREBR BLOOD F MET, V17, P191; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zoremba N, 2008, J CEREBR BLOOD F MET, V28, P1665, DOI 10.1038/jcbfm.2008.58	48	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113444	10.1371/journal.pone.0113444	http://dx.doi.org/10.1371/journal.pone.0113444			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426721	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400053
J	Cheng, HY; Kang, PJ; Chuang, YH; Wang, YH; Jan, MC; Wu, CF; Lin, CL; Liu, CJ; Liaw, YF; Lin, SM; Chen, PJ; Lee, SD; Yu, MW				Cheng, Hsiang-Yun; Kang, Pei-Jen; Chuang, Ya-Hui; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen; Liaw, Yun-Fan; Lin, Shi-Ming; Chen, Pei-Jer; Lee, Shou-Dong; Yu, Ming-Whei			Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma	PLOS ONE			English	Article							CD8 T-CELLS; SOLUBLE RECEPTORS; PD-1 EXPRESSION; VIRUS; EXHAUSTION; IMMUNITY	Objective: Recent evidence indicates a crucial role of the immunoinhibitory receptor programmed death-1 (PD-1) in enforcing T-cell dysfunction during chronic viral infection and cancer. We assessed the impact of circulating soluble PD-1 (sPD-1) levels on long-term dynamics of hepatitis B virus (HBV) load and hepatocellular carcinoma (HCC) risk. Methods: In a case-cohort study on longitudinal analysis of viral load within a cohort of 2903 men chronically infected with HBV, followed up from baseline (1989-1992) through 2010, we determined sPD-1 levels in baseline plasma with enzyme-linked immunosorbent assay from 126 men who subsequently developed HCC and 1155 men who did not develop HCC. To evaluate whether patients' characteristics involved the use of sPD-1 as a biomarker, sPD-1 was also tested in 614 newly-diagnosed patients with HBV-related HCC recruited from a multicenter study for comparison with the 1155 noncases in the case-cohort study. Results: Plasma quartile levels of sPD-1 were positively associated with HCC risk for men in the case-cohort analysis (vs. quartile 1: adjusted odds ratios [95% confidence intervals] for quartile 2-quartile 4 were 1.51 [0.75-3.03], 2.15 [1.12-4.13], and 2.29 [1.20-4.38], respectively), and in the case-control study regardless of age-of-onset and clinical stage. Furthermore, we found longitudinal effect of elevated sPD-1 levels to maintain higher viral load for 4 or more years, with greater and more prolonged effect among HBV genotype C-vs. non-C-infected participants. High levels of viral load and sPD-1 (vs. absence of both) was associated with a 6.29-fold increase in risk of HCC, and combining both conditions with HBV genotype C yielded an odds ratio of 30.47 with significant additive interaction (relative excess risk due to interaction: 27.08 [95% confidence interval=8.76-45.41]). Conclusions: Our data suggest plasma sPD-1 as an important immune-related marker for assessment of HBV activity and HCC risk.	[Cheng, Hsiang-Yun; Kang, Pei-Jen; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Yu, Ming-Whei] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lin, Chih-Lin] Taipei City Hosp, Dept Gastroenterol, Ren Ai Branch, Taipei, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei 100, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liaw, Yun-Fan; Lin, Shi-Ming] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Liver Res Unit, Taipei, Taiwan; [Lee, Shou-Dong] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Veterans General Hospital; Cheng Hsin General Hospital	Yu, MW (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	yumw@ntu.edu.tw			National Science Council, Taiwan [NSC 101-2314-B-002-077-MY3, NSC 101-2325-B-002-021, NSC 102-2325-B-002-021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by grants NSC 101-2314-B-002-077-MY3, NSC 101-2325-B-002-021, and NSC 102-2325-B-002-021 (to MWY) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Desmond CP, 2008, ANTIVIR THER, V13, P161; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070169; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen LH, 2011, HEPATOLOGY, V53, P1839, DOI 10.1002/hep.24308; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shih WL, 2012, INT J CANCER, V131, P2612, DOI 10.1002/ijc.27508; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sung FY, 2009, GASTROENTEROLOGY, V137, P1687, DOI 10.1053/j.gastro.2009.07.063; Thompson A, 2007, GASTROENTEROLOGY, V133, P1031, DOI 10.1053/j.gastro.2007.07.038; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wu CF, 2008, CARCINOGENESIS, V29, P106, DOI 10.1093/carcin/bgm252; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5	33	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e95870	10.1371/journal.pone.0095870	http://dx.doi.org/10.1371/journal.pone.0095870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427199	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400001
J	Habermann, M; Gouveia, N				Habermann, Mateus; Gouveia, Nelson			Socioeconomic Position and Low Birth Weight among Mothers Exposed to Traffic-Related Air Pollution	PLOS ONE			English	Article							USE REGRESSION-MODELS; RESIDENTIAL PROXIMITY; ANGELES-COUNTY; OUTCOMES; TOXICS; HEALTH	Background: Atmospheric pollution is a major public health concern. It can affect placental function and restricts fetal growth. However, scientific knowledge remains too limited to make inferences regarding causal associations between maternal exposure to air pollution and adverse effects on pregnancy. This study evaluated the association between low birth weight (LBW) and maternal exposure during pregnancy to traffic related air pollutants (TRAP) in Sao Paulo, Brazil. Methods and findings: Analysis included 5,772 cases of term-LBW (<2,500 g) and 5,814 controls matched by sex and month of birth selected from the birth registration system. Mothers' addresses were geocoded to estimate exposure according to 3 indicators: distance from home to heavy traffic roads, distance-weighted traffic density (DWTD) and levels of particulate matter <= 10 mg/m(3) estimated through land use regression (LUR-PM10). Final models were evaluated using multiple logistic regression adjusting for birth, maternal and pregnancy characteristics. We found decreased odds in the risk of LBW associated with DWTD and LUR-PM10 in the highest quartiles of exposure with a significant linear trend of decrease in risk. The analysis with distance from heavy traffic roads was less consistent. It was also observed that mothers with higher education and neighborhood-level income were potentially more exposed to TRAP. Conclusions: This study found an unexpected decreased risk of LBW associated with traffic related air pollution. Mothers with advantaged socioeconomic position (SEP) although residing in areas of higher vehicular traffic might not in fact be more expose to air pollution. It can also be that the protection against LBW arising from a better SEP is stronger than the effect of exposure to air pollution, and this exposure may not be sufficient to increase the risk of LBW for these mothers.	[Habermann, Mateus; Gouveia, Nelson] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil	Universidade de Sao Paulo	Habermann, M (corresponding author), Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil.	mathab@usp.br	Gouveia, Nelson C/C-4580-2013	Gouveia, Nelson C/0000-0003-0625-0265				Aguilera I, 2009, ENVIRON HEALTH PERSP, V117, P1322, DOI 10.1289/ehp.0800256; Almeida Marcia Furquim de, 2006, Rev. bras. epidemiol., V9, P56; Barbon AL, 2003, AN 14 ENC NAT EST PO; CETESB (Environmental Sanitation Technology Company), 2010, REP AIR QUAL STATE P; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; Dolinoy DC, 2004, ENVIRON HEALTH PERSP, V112, P1717, DOI 10.1289/ehp.7066; FRAIGNEAU YC, 1995, SCI TOTAL ENVIRON, V169, P83, DOI 10.1016/0048-9697(95)04636-F; Gehring U, 2011, ENVIRON RES, V111, P125, DOI 10.1016/j.envres.2010.10.004; Genereux M, 2008, J EPIDEMIOL COMMUN H, V62, P695, DOI 10.1136/jech.2007.066167; Gouveia N, 2004, J EPIDEMIOL COMMUN H, V58, P11, DOI 10.1136/jech.58.1.11; Grineski S, 2007, SOC SCI QUART, V88, P535, DOI 10.1111/j.1540-6237.2007.00470.x; Habermann M, 2013, ENG SANIT AMBIENT, V17, P155; Johnson M, 2010, ATMOS ENVIRON, V44, P3660, DOI 10.1016/j.atmosenv.2010.06.041; Kashima S, 2011, ENVIRON RES, V111, P377, DOI 10.1016/j.envres.2011.02.005; Kumar N, 2012, ATMOS ENVIRON, V49, P171, DOI 10.1016/j.atmosenv.2011.12.001; Lacasana M, 2005, EUR J EPIDEMIOL, V20, P183, DOI 10.1007/s10654-004-3005-9; Laurent O, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-18; Malmqvist E, 2011, ENVIRON HEALTH PERSP, V119, P553, DOI 10.1289/ehp.1002564; Montagne D, 2013, ENVIRON SCI TECHNOL, V47, P8523, DOI 10.1021/es400920a; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998; de Medeiros APP, 2009, ENVIRON HEALTH PERSP, V117, P127, DOI 10.1289/ehp.11679; Sahsuvaroglu T, 2006, J AIR WASTE MANAGE, V56, P1059, DOI 10.1080/10473289.2006.10464542; Shah PS, 2011, ENVIRON INT, V37, P498, DOI 10.1016/j.envint.2010.10.009; Sram RJ, 2005, ENVIRON HEALTH PERSP, V113, P375, DOI 10.1289/ehp.6362; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; van den Hooven EH, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-59; Veras MM, 2008, BIOL REPROD, V79, P578, DOI 10.1095/biolreprod.108.069591; Veras MM, 2009, ENVIRON RES, V109, P536, DOI 10.1016/j.envres.2009.03.006; WHO World Health Organization, 2006, WHO AIR QULA GUID GL; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wilhelm M, 2003, ENVIRON HEALTH PERSP, V111, P207, DOI 10.1289/ehp.5688; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; Woodruff TJ, 2009, ENVIRON RES, V109, P311, DOI 10.1016/j.envres.2008.12.012; Wünsch Filho Victor, 2010, Rev. bras. epidemiol., V13, P175, DOI 10.1590/S1415-790X2010000200001; Yorifuji T, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-34; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60; Zou B, 2009, J ENVIRON MONITOR, V11, P475, DOI 10.1039/b813889c	39	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113900	10.1371/journal.pone.0113900	http://dx.doi.org/10.1371/journal.pone.0113900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426640	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400097
J	Pierce, BK; Voegel, T; Kirkpatrick, BC				Pierce, Brittany K.; Voegel, Tanja; Kirkpatrick, Bruce C.			The Xylella fastidiosa PD1063 Protein Is Secreted in Association with Outer Membrane Vesicles	PLOS ONE			English	Article							PIERCES-DISEASE; GENOME SEQUENCE; AXENIC CULTURE; AX21 PROTEIN; SP-NOV; BACTERIAL; VIRULENCE; PATHOGEN; ORYZAE; TRANSMISSION	Xylella fastidiosa is a gram-negative, xylem-limited plant pathogenic bacterium that causes disease in a variety of economically important agricultural crops including Pierce's disease of grapevines. Xylella fastidiosa biofilms formed in the xylem vessels of plants play a key role in early colonization and pathogenicity by providing a protected niche and enhanced cell survival. Here we investigate the role of Xylella fastidiosa PD1063, the predicted ortholog of Xanthomonas oryzae pv. oryzae PXO_03968, which encodes an outer membrane protein. To assess the function of the Xylella fastidiosa ortholog, we created Xylella fastidiosa mutants deleted for PD1063 and then assessed biofilm formation, cell-cell aggregation and cell growth in vitro. We also assessed disease severity and pathogen titers in grapevines mechanically inoculated with the Xylella fastidiosa PD1063 mutant. We found a significant decrease in cell-cell aggregation among PD1063 mutants but no differences in cell growth, biofilm formation, disease severity or titers in planta. Based on the demonstration that Xanthomonas oryzae pv. oryzae PXO_03968 encodes an outer membrane protein, secreted in association with outer membrane vesicles, we predicted that PD1063 would also be secreted in a similar manner. Using anti-PD1063 antibodies, we found PD1063 in the supernatant and secreted in association with outer membrane vesicles. PD1063 purified from the supernatant, outer membrane fractions and outer membrane vesicles was 19.2 kD, corresponding to the predicted size of the processed protein. Our findings suggest Xylella fastidiosa PD1063 is not essential for development of Pierce's disease in Vitis vinifera grapevines although further research is required to determine the function of the PD1063 outer membrane protein in Xylella fastidiosa.	[Pierce, Brittany K.; Kirkpatrick, Bruce C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Voegel, Tanja] Univ British Columbia, Dept Biol, Kelowna, BC, Canada	University of California System; University of California Davis; University of British Columbia	Kirkpatrick, BC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bckirkpatrick@ucdavis.edu		Voegel, Tanja/0000-0002-3348-3374	United States Department of Agriculture [2010-34442-21101]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The work reported in this manuscript was supported by a grant from the United States Department of Agriculture, grant #2010-34442-21101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahar O, 2014, PEERJ, V2, DOI 10.7717/peerj.242; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Burdman S, 2000, FEMS MICROBIOL LETT, V189, P259, DOI 10.1111/j.1574-6968.2000.tb09240.x; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guilhabert MR, 2003, MOL PLANT PATHOL, V4, P279, DOI [10.1046/j.1364-3703.2003.00175.x, 10.1046/J.1364-3703.2003.00175.X]; Guilhabert MR, 2001, MOL PLANT MICROBE IN, V14, P701, DOI 10.1094/MPMI.2001.14.6.701; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARTUNG JS, 1994, PHYTOPATHOLOGY, V84, P591, DOI 10.1094/Phyto-84-591; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; HEWITT WB, 1946, PHYTOPATHOLOGY, V36, P117; Hill BL, 1997, PHYTOPATHOLOGY, V87, P1197, DOI 10.1094/PHYTO.1997.87.12.1197; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; HOPKINS DL, 1985, PHYTOPATHOLOGY, V75, P713, DOI 10.1094/Phyto-75-713; Ionescu M, 2014, P NATL ACAD SCI USA, V111, pE3910, DOI 10.1073/pnas.1414944111; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Leite B, 2004, FEMS MICROBIOL LETT, V230, P283, DOI 10.1016/S0378-1097(03)00917-0; Matsumoto A, 2009, APPL ENVIRON MICROB, V75, P1679, DOI 10.1128/AEM.00024-09; McCarthy Y, 2011, J BACTERIOL, V193, P6375, DOI 10.1128/JB.05949-11; Morris CE, 2003, ANNU REV PHYTOPATHOL, V41, P429, DOI 10.1146/annurev.phyto.41.022103.134521; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; NIKAIDO H, 1983, METHOD ENZYMOL, V97, P85; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Purcell AH, 1999, PHYTOPATHOLOGY, V89, P53, DOI 10.1094/PHYTO.1999.89.1.53; Qian GL, 2013, J PROTEOME RES, V12, P3327, DOI 10.1021/pr4001543; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; SWINGS J, 1990, INT J SYST BACTERIOL, V40, P309, DOI 10.1099/00207713-40-3-309; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828	42	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113504	10.1371/journal.pone.0113504	http://dx.doi.org/10.1371/journal.pone.0113504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426629	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400059
J	Rein, R; Nonaka, T; Bril, B				Rein, Robert; Nonaka, Tetsushi; Bril, Blandine			Movement Pattern Variability in Stone Knapping: Implications for the Development of Percussive Traditions	PLOS ONE			English	Article							TOOL PRODUCTION; CUMULATIVE CULTURE; DYNAMICAL-SYSTEMS; PHASE-TRANSITIONS; CRAFT PRODUCTION; HAMMERING TASK; EARLY HOMINIDS; TIME SCALES; SKILL; EVOLUTION	The earliest direct evidence for tool-use by our ancestors are 2.6 million year old stone tools from Africa. These earliest artifacts show that, already, early hominins had developed the required advanced movement skills and cognitive capacities to manufacture stone tools. Currently, it is not well understood, however, which specific movement skills are required for successful stone knapping and accordingly it is unknown how these skills emerged during early hominin evolution. In particular, it is not clear which striking movements are indicative of skilled performance, how striking movement patterns vary with task and environmental constraints, and how movement patterns are passed on within social groups. The present study addresses these questions by investigating striking movement patterns and striking variability in 18 modern stone knappers (nine experienced and nine novices). The results suggest that no single movement pattern characterizes successful stone knapping. Participants showed large inter-individual movement variability of the elementary knapping action irrespective of knapping experience and knapping performance. Changes in task- and environmental constraints led knappers to adapt their elementary striking actions using a combination of individual and common strategies. Investigation of striking pattern similarities within social groups showed only partial overlap of striking patterns across related individuals. The results therefore suggest that striking movement patterns in modern stone knappers are largely specific to the individual and movement variability is not indicative of knapping performance. The implications of these results for the development of percussive traditions are discussed.	[Rein, Robert] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany; [Nonaka, Tetsushi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Bril, Blandine] Ecole Hautes Etud Sci Sociales, Grp Rech Apprentissage & Contexte, Paris, France	German Sport University Cologne; Kobe University	Rein, R (corresponding author), German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany.	mail@robertrein.de	Nonaka, Tetsushi/Q-8745-2019	Nonaka, Tetsushi/0000-0003-2011-8818	European Union [29065]; Fyssen Foundation (Paris, France); Grants-in-Aid for Scientific Research [25330178] Funding Source: KAKEN	European Union(European Commission); Fyssen Foundation (Paris, France); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work has been funded through a grant by the European Union, project "Handtomouth: a framework for understanding the archaeological and fossil records of human cognitive evolution" (Project reference: 29065) to BB, and a personal grant by the Fyssen Foundation (Paris, France, www.fondationfyssen.fr) to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasbakk B, 2001, BIOL CYBERN, V84, P75, DOI 10.1007/s004229900075; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Biro D, 2013, PHILOS T R SOC LON B, V368, P1; Biryukova EV, 2008, MOTOR CONTROL, V12, P181, DOI 10.1123/mcj.12.3.181; Biryukova EV, 2000, J BIOMECH, V33, P985, DOI 10.1016/S0021-9290(00)00040-3; Bleed P, 2008, J ARCHAEOL METHOD TH, V15, P154, DOI 10.1007/s10816-007-9046-0; Braun DR, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-9059-2; Bril B., 2005, STONE KNAPPING NECES, P53; Bril B, 2012, PHILOS T R SOC B, V367, P59, DOI 10.1098/rstb.2011.0147; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Castro L, 2014, J THEOR BIOL, V347, P74, DOI 10.1016/j.jtbi.2014.01.006; CAVALLISFORZA LL, 1986, LANGUAGE, V62, P38, DOI 10.2307/415600; Chen HH, 2005, J MOTOR BEHAV, V37, P247, DOI 10.3200/JMBR.37.3.247-256; Chow JY, 2008, MOTOR CONTROL, V12, P219, DOI 10.1123/mcj.12.3.219; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Davidson I, 2005, J ROY ANTHROPOL INST, V11, P793, DOI 10.1111/j.1467-9655.2005.00262.x; de la Torre I, 2009, VERTEBR PALEOBIOL PA, P15; Dean LG, 2014, BIOL REV, V89, P284, DOI 10.1111/brv.12053; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2011, AM ANTIQUITY, V76, P229, DOI 10.7183/0002-7316.76.2.229; Ferguson JR, 2008, J ARCHAEOL METHOD TH, V15, P51, DOI 10.1007/s10816-007-9047-z; Finlay N, 2008, J ARCHAEOL METHOD TH, V15, P68, DOI 10.1007/s10816-007-9048-y; Fragaszy DM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0410; Gowlett J.A.J., 2005, P50; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1983, SYNERGETICS INTRO, DOI 10.1007/978-3-642-88338-5; Hogberg A, 2008, J ARCHAEOL METHOD TH, V15, P112, DOI 10.1007/s10816-007-9050-4; Hong SL, 2006, EXP BRAIN RES, V169, P350, DOI 10.1007/s00221-005-0145-4; Hopkinson T., 2005, HOMINID INDIVIDUAL C, P13; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Huber L, 2009, PHILOS T R SOC B, V364, P2299, DOI 10.1098/rstb.2009.0060; Huys R, 2004, HUM MOVEMENT SCI, V23, P315, DOI 10.1016/j.humov.2004.08.009; INGOLD T, 2001, LIFE MIND, P255; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Jaric S, 1999, HUM MOVEMENT SCI, V18, P819, DOI 10.1016/S0167-9457(99)00042-1; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kelso S., 1995, DYNAMIC PATTERNS SEL; KIMURA M, 1964, GENETICS, V49, P561; Kimura Y, 1999, J HUM EVOL, V37, P807, DOI 10.1006/jhev.1999.0316; Kreighbaum E., 1996, BIOMECHANICS QUALITA; Kudo K, 2000, J MOTOR BEHAV, V32, P337, DOI 10.1080/00222890009601384; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Leakey M.D., 1971, OLDUVAI GORGE; Leventhal EL, 2010, J HAND SURG-AM, V35A, P1097, DOI 10.1016/j.jhsa.2010.04.021; Lewis HM, 2012, PHILOS T R SOC B, V367, P2171, DOI 10.1098/rstb.2012.0119; Liu YT, 2003, J MOTOR BEHAV, V35, P197, DOI 10.1080/00222890309602133; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Machin A, 2009, J SOC ARCHAEOL, V9, P35, DOI 10.1177/1469605308099370; Magermans DJ, 2005, CLIN BIOMECH, V20, P591, DOI 10.1016/j.clinbiomech.2005.02.006; Mauss M, 1992, INCORPORATIONS, P455; McGuigan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050863; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Minar CJ, 2001, J ANTHROPOL RES, V57, P369, DOI 10.1086/jar.57.4.3631351; Morgan TJH, 2014, INT C PERC TECHN HUM; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Newell K. M., 1993, VARIABILITY MOTOR CO, P510; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; NEWELL KM, 1993, VARIABILITY MOTOR CO, pR6; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Olausson D., 1998, LITHIC TECHNOLOGY, V23, P90; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Parry R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00306; Pelegrin J., 2009, COGNITIVE ARCHAEOLOG, P95; Petraglia M. D., 2005, HOMINID INDIVIDUAL C, P197; Pinheiro J., 2006, NLME PACKAGE LINEAR, V314; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; R Core Team, 2018, R LANG ENV STAT COMP; Raiss P, 2007, Z ORTHOP UNFALLCHIR, V145, P493, DOI 10.1055/s-2007-965468; Reed E, 1996, RES ECOL PS, P431; Rein R, 2007, THESIS U OTAGO DUNED; Rein R, 2013, AM J PHYS ANTHROPOL, V150, P539, DOI 10.1002/ajpa.22224; Rein Robert, 2010, Motor Control, V14, P211; Rein R, 2010, EXP BRAIN RES, V201, P307, DOI 10.1007/s00221-009-2040-x; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roux V, 2003, J ARCHAEOL METHOD TH, V10, P1, DOI 10.1023/A:1022869912427; Roux V, 2003, AM ANTIQUITY, V68, P768, DOI 10.2307/3557072; Roux V., 2005, STONE KNAPPING NECES, P1; RYU J, 1991, J HAND SURG-AM, V16A, P409, DOI 10.1016/0363-5023(91)90006-W; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; SCHOLZ JP, 1995, PHYS THER, V75, P133, DOI 10.1093/ptj/75.2.133; Schrauf C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041044; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Shea N, 2009, PHILOS T R SOC B, V364, P2429, DOI 10.1098/rstb.2009.0061; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Steele J, 1999, NATURE, V399, P24, DOI 10.1038/19869; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Stout D, 2010, J HUM EVOL, V58, P474, DOI 10.1016/j.jhevol.2010.02.005; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Toth N., 2006, OLDOWAN CASE STUDIES, P155; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; Vernooij CA, 2012, Z PSYCHOL, V220, P29, DOI 10.1027/2151-2604/a000088; Voelkl B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000611; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2009, J HUM EVOL, V57, P420, DOI 10.1016/j.jhevol.2008.12.010; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Williams EM, 2014, J HUM EVOL, V72, P52, DOI 10.1016/j.jhevol.2014.03.004; Williams EM, 2010, AM J PHYS ANTHROPOL, V143, P134, DOI 10.1002/ajpa.21302; Williams EM, 2008, ANN M PAL SOC VANC B; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005; Williams JP, 2011, J ARCHAEOL SCI, V38, P865, DOI 10.1016/j.jas.2010.11.008; Withagen R, 2010, THEOR PSYCHOL, V20, P489, DOI 10.1177/0959354310361405; Wood B, 1997, NATURE, V385, P292, DOI 10.1038/385292a0; Yamamoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055768; Zatsiorsky VM, 2002, KINETICS HUMAN MOTIO, Vxvii	117	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113567	10.1371/journal.pone.0113567	http://dx.doi.org/10.1371/journal.pone.0113567			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA8CZ	25426630	Green Published, Green Submitted, gold			2022-12-27	WOS:000349145400066
J	Fernandes, M; Stein, A; Newton, CR; Cheikh-Ismail, L; Kihara, M; Wulff, K; Quintana, ED; Aranzeta, L; Soria-Frisch, A; Acedo, J; Ibanez, D; Abubakar, A; Giuliani, F; Lewis, T; Kennedy, S; Villar, J				Fernandes, Michelle; Stein, Alan; Newton, Charles R.; Cheikh-Ismail, Leila; Kihara, Michael; Wulff, Katharina; Quintana, Enrique de Leon; Aranzeta, Luis; Soria-Frisch, Aureli; Acedo, Javier; Ibanez, David; Abubakar, Amina; Giuliani, Francesca; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose		Int Fetal Newborn Growth	The INTERGROWTH-21st Project Neurodevelopment Package: A Novel Method for the Multi-Dimensional Assessment of Neurodevelopment in Pre-School Age Children	PLOS ONE			English	Article							VISUAL-ACUITY; CONTRAST SENSITIVITY; YOUNG-CHILDREN; INFANTS; VALIDATION; CHILDHOOD; EPIDEMIOLOGY; IMPAIRMENT; GUIDELINES; DISORDERS	Background: The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Project is a population-based, longitudinal study describing early growth and development in an optimally healthy cohort of 4607 mothers and newborns. At 24 months, children are assessed for neurodevelopmental outcomes with the INTERGROWTH-21st Neurodevelopment Package. This paper describes neurodevelopment tools for preschoolers and the systematic approach leading to the development of the Package. Methods: An advisory panel shortlisted project-specific criteria (such as multi-dimensional assessments and suitability for international populations) to be fulfilled by a neurodevelopment instrument. A literature review of well-established tools for preschoolers revealed 47 candidates, none of which fulfilled all the project's criteria. A multi-dimensional assessment was, therefore, compiled using a package-based approach by: (i) categorizing desired outcomes into domains, (ii) devising domain-specific criteria for tool selection, and (iii) selecting the most appropriate measure for each domain. Results: The Package measures vision (Cardiff tests); cortical auditory processing (auditory evoked potentials to a novelty oddball paradigm); and cognition, language skills, behavior, motor skills and attention (the INTERGROWTH-21st Neurodevelopment Assessment) in 35-45 minutes. Sleep-wake patterns (actigraphy) are also assessed. Tablet-based applications with integrated quality checks and automated, wireless electroencephalography make the Package easy to administer in the field by non-specialist staff. The Package is in use in Brazil, India, Italy, Kenya and the United Kingdom. Conclusions: The INTERGROWTH-21st Neurodevelopment Package is a multidimensional instrument measuring early child development (ECD). Its developmental approach may be useful to those involved in large-scale ECD research and surveillance efforts.	[Fernandes, Michelle; Cheikh-Ismail, Leila; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Fernandes, Michelle; Cheikh-Ismail, Leila; Lewis, Tamsin; Kennedy, Stephen; Villar, Jose] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Stein, Alan; Newton, Charles R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Kihara, Michael] US Int Univ, Dept Psychol, Nairobi, Kenya; [Wulff, Katharina] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Quintana, Enrique de Leon; Aranzeta, Luis] Ctr Tecnol & Innovac, Mexico City, DF, Mexico; [Soria-Frisch, Aureli; Acedo, Javier; Ibanez, David] Starlab Barcelona SL, Neurosci Business Unit, Barcelona, Spain; [Abubakar, Amina] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Newton, Charles R.; Kihara, Michael; Abubakar, Amina] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Giuliani, Francesca] Univ Turin, Dipartimento Sci Pediat & Adolescenza, SCDU Neonatol, Turin, Italy	University of Oxford; University of Oxford; University of Oxford; United States International University Africa; University of Oxford; Lancaster University; University of Turin	Fernandes, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	michelle.fernandes@obs-gyn.ox.ac.uk	Sanchez Luna, Manuel/H-2165-2014; Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Abubakar, Amina/F-1479-2017; Matijasevich, Alicia/C-5576-2009	Sanchez Luna, Manuel/0000-0001-9543-7392; Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Papageorghiou, Aris T./0000-0001-8143-2232; Soria-Frisch, Aureli/0000-0002-4704-927X; Abubakar, Amina/0000-0002-3686-7904; Cheikh Ismail, Leila/0000-0003-3048-7481; Matijasevich, Alicia/0000-0003-0060-1589	Bill & Melinda Gates Foundation [49038]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The INTERGROWTH-21st Project was supported by the INTERGROWTH-21st Grant ID# 49038 from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) to the University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RJ, 1992, OPTOMETRY VISION SCI, V69, P440, DOI 10.1097/00006324-199206000-00005; Adams RJ, 2002, VISION RES, V42, P1205, DOI 10.1016/S0042-6989(02)00038-X; ADOH TO, 1994, VISION RES, V34, P555, DOI 10.1016/0042-6989(94)90168-6; ADOH TO, 1992, OPTOMETRY VISION SCI, V69, P427, DOI 10.1097/00006324-199206000-00003; BAYLEY N, 1964, MONOGR SOC RES CHILD, V29, P1, DOI 10.2307/1165805; Bayley N, 1993, BAYLEY SCALES INFANT; Behrman RE, 2007, NEURODEVELOPMENTAL H, P346; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Caspi A, 2003, J PERS, V71, P495, DOI 10.1111/1467-6494.7104001; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Doyle LW, 2010, PEDIATRICS, V126, P342, DOI 10.1542/peds.2010-0710; Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fernald LC, 2009, EXAMINING EARLY CHIL; FIRST LR, 1994, NEW ENGL J MED, V330, P478, DOI 10.1056/NEJM199402173300708; Fogarty Associates, CARD CONTR TEST; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Gladstone M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000273; Griffiths R, 1996, MANUAL GRIFFITHS MEN; Griffiths R, 1954, ABILITIES BABIES STU; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Henry B, 1996, DEV PSYCHOL, V32, P614; Jon C, 2009, PEDIATRIC OTOLARYNGOLOGY FOR THE CLINICIAN, P35, DOI 10.1007/978-1-60327-127-1_5; Khan NZ, 2010, PEDIATRICS, V125, pE755, DOI 10.1542/peds.2008-3471; Kihara M, 2010, CLIN NEUROPHYSIOL, V121, P564, DOI 10.1016/j.clinph.2009.11.086; Koot HM, 1997, J ABNORM CHILD PSYCH, V25, P183, DOI 10.1023/A:1025791814893; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711; MARCUS RE, 1951, AMA ARCH OTOLARYNGOL, V53, P134; Marlow N, 2008, REPORT BAPM RCPCH WO; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neu B, 1997, Strabismus, V5, P185, DOI 10.3109/09273979709044534; Northern JL, 2002, HEARING CHILDREN; Ohuma EO, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/1471-0528.12080; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Ostrander R, 1998, J CONSULT CLIN PSYCH, V66, P660, DOI 10.1037/0022-006X.66.4.660; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; SADEH A, 1991, PEDIATRICS, V87, P494; So K, 2007, J SLEEP RES, V16, P181, DOI 10.1111/j.1365-2869.2007.00582.x; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Sutton PS, 2013, J TROPICAL PEDIAT; SUZUKI T, 1961, ARCHIV OTOLARYNGOL, V74, P192; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; TELLER DY, 1979, INFANT BEHAV DEV, V2, P135, DOI 10.1016/S0163-6383(79)80016-8; The International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Study Group, 2014, LANCET UNPUB; Verweyen Petra, 2004, Community Eye Health, V17, P27; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; WHITNEY MP, 1993, J DEV BEHAV PEDIATR, V14, P71	53	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113360	10.1371/journal.pone.0113360	http://dx.doi.org/10.1371/journal.pone.0113360			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU9GL	25423589	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000345899700033
J	Goncalves, LD; Campanhon, IB; Domingues, RR; Leme, AFP; da Silva, MRS				Goncalves, Lorena Da Ros; Campanhon, Isabele Batista; Domingues, Romenia R.; Paes Leme, Adriana F.; Soares da Silva, Marcia Regina			Comparative Salivary Proteome of Hepatitis B- and C-Infected Patients	PLOS ONE			English	Article							CHRONIC ACTIVE HEPATITIS; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; QUANTITATIVE-ANALYSIS; VIRAL-HEPATITIS; SERUM; IRON; ASSOCIATION; COMPLEMENT; MECHANISMS	Hepatitis B and C virus (HBV and HCV) infections are an important cause of cirrhosis and hepatocellular carcinoma. The natural history has a prominent latent phase, and infected patients may remain undiagnosed; this situation may lead to the continuing spread of these infections in the community. Compelling reasons exist for using saliva as a diagnostic fluid because it meets the demands of being an inexpensive, noninvasive and easy-to-use diagnostic method. Indeed, comparative analysis of the salivary proteome using mass spectrometry is a promising new strategy for identifying biomarkers. Our goal is to apply an Orbitrap-based quantitative approach to explore the salivary proteome profile in HBV-and HCV-infected patients. In the present study, whole saliva was obtained from 20 healthy, (control) 20 HBV-infected and 20 HCV-infected subjects. Two distinct pools containing saliva from 10 subjects of each group were obtained. The samples were ultracentrifuged and fractionated, and all fractions were hydrolyzed (trypsin) and injected into an LTQ-VELOS ORBITRAP. The identification and analyses of peptides were performed using Proteome Discoverer1.3 and ScaffoldQ + v. 3.3.1. From a total of 362 distinct proteins identified, 344 proteins were identified in the HBV, 326 in the HCV and 303 in the control groups. Some blood proteins, such as flavin reductase (which converts biliverdin to bilirubin), were detected only in the HCV group. The data showed a reduced presence of complement C3, ceruloplasmin, alpha(1)-acid glycoprotein and alpha(2)-acid glycoprotein in the hepatitis-infected patients. Peptides of serotransferrin and haptoglobin were less detected in the HCV group. This study provides an integrated perspective of the salivary proteome, which should be further explored in future studies targeting specific disease markers for HBV and HCV infection.	[Goncalves, Lorena Da Ros; Campanhon, Isabele Batista; Soares da Silva, Marcia Regina] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941 Rio De Janeiro, RJ, Brazil; [Domingues, Romenia R.; Paes Leme, Adriana F.] LNBio, Brazilian Biosci Natl Lab, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro	Goncalves, LD (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941 Rio De Janeiro, RJ, Brazil.	lorena.da@terra.com.br	Leme, Adriana F Paes/C-9679-2012	Leme, Adriana F Paes/0000-0001-7959-147X; Soares, Marcia/0000-0001-9272-9488	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [APQ1 E-26/111.770/2012]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (APQ1 E-26/111.770/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024; Atta M, 2012, INFLAMM RES, V61, P1101, DOI 10.1007/s00011-012-0502-2; Bachtiar Indra, 2010, BMC Res Notes, V3, P319, DOI 10.1186/1756-0500-3-319; Bencharit S, 2013, SALIVARY PROTEINS AS; Castagnola M, 2011, ACTA OTORHINOLARYNGO, V31, P347; Cha YJ, 2013, PERFORMANCE EVALUATI; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g; Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x; Fye HKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068381; Ganapathy-Kanniappan S, 2012, ONCOTARGET, V3, P940, DOI 10.18632/oncotarget.623; Gangadharan B, 2011, J PROTEOME RES, V10, P2643, DOI 10.1021/pr101077c; Georgopoulou U, 2014, VIRULENCE, V5, P465, DOI 10.4161/viru.28508; Goncalves LD, 2010, J PROTEOMICS, V73, P1334, DOI 10.1016/j.jprot.2010.02.018; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Jehmlich N, 2013, J PERIODONTAL RES, V48, P392, DOI 10.1111/jre.12025; Kobayashi S, 2012, HEPATOL RES, V42, P1187, DOI 10.1111/j.1872-034X.2012.01044.x; Koffler J, 2013, EUR ARCH OTO-RHINO-L, V270, P1493, DOI 10.1007/s00405-012-2201-6; Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; Miller CS, 2014, J DENT RES, V93, P72, DOI 10.1177/0022034514537522; Moorthy M, 2008, INDIAN J MED MICROBI, V26, P327; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; PERMAN JA, 1979, J PEDIATR-US, V94, P564, DOI 10.1016/S0022-3476(79)80011-6; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Price L, 2009, CAN J GASTROENTEROL, V23, P822, DOI 10.1155/2009/290383; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Rath T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058955; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sarvari J, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8351; Schulz BL, 2013, CRIT REV BIOTECHNOL, V33, P246, DOI 10.3109/07388551.2012.687361; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; Trepo C., 2014, LANCET; Vagu C, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13136; Villar LM, 2014, J MED VIROL, V86, P1515, DOI 10.1002/jmv.23993; WALSHE JM, 1962, LANCET, V2, P263; Wong David T W, 2012, J Am Dent Assoc, V143, p19S; Yang Xu, 2005, Zhonghua Nei Ke Za Zhi, V44, P13; Zeng DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077942; Zhang AH, 2013, CLIN CHIM ACTA, V415, P261, DOI 10.1016/j.cca.2012.11.001; Zhang S, 2013, ACTA BIOCH BIOPH SIN, V45, P1021, DOI 10.1093/abbs/gmt110; Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-0586	47	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113683	10.1371/journal.pone.0113683	http://dx.doi.org/10.1371/journal.pone.0113683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423034	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700053
J	van Hoek, AJ; Campbell, H; Andrews, N; Vasconcelos, M; Amirthalingam, G; Miller, E				van Hoek, Albert Jan; Campbell, Helen; Andrews, Nick; Vasconcelos, Mariza; Amirthalingam, Gayatri; Miller, Elizabeth			The Burden of Disease and Health Care Use among Pertussis Cases in School Aged Children and Adults in England and Wales; A Patient Survey	PLOS ONE			English	Article								Background: In 2011-2012 a large pertussis outbreak occurred in England. This provided an opportunity to estimate the disease burden in those aged 5 years and over. As pertussis is likely to be under reported both laboratory-confirmed and non-confirmed cases were included. Methods: Laboratory-confirmed cases of pertussis, as well as their coughing but non-confirmed household members, were sent a questionnaire that collected information on clinical features and quality of life for the most severe day of disease and the day the patient filled in the questionnaire. The EuroQol-5 dimension questionnaire (EQ-5D) was used to evaluate quality of life. The duration of symptoms was obtained by contacting the patient every two weeks until symptoms stopped. Results: Data for 535 (out of 1262) laboratory confirmed pertussis patients and 44 (out of 140) coughing household contacts was available for analysis. On the most severe day, 56% of laboratory-confirmed cases reported they had 20+ more paroxysms, 58% reported they had a severe cough and 46% reported disruption of sleep for more than 4 hours. For non-confirmed coughing household contacts there were a similar number of coughing spells per day at the height, though the cough was reported to be less severe and to cause less sleep disruption. The main clinical symptoms on the worst day for both were shortness of breath, tiredness, sore ribs and vomiting. The duration of symptoms for both patient groups was around 160 days (162 and 168 days). Under base case assumptions the overall loss of quality of life was 0.097 QALY (0.089-0.106) for confirmed pertussis cases and 0.0365 QALY (0.023-0.054) for coughing household contacts. Conclusion: Pertussis is a serious disease in those aged 5 years and over, causing disruption of sleep and daily activities over long period of time. The burden of illness due to undiagnosed pertussis is also considerable.	[van Hoek, Albert Jan; Campbell, Helen; Vasconcelos, Mariza; Amirthalingam, Gayatri; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England; [Andrews, Nick] Publ Hlth England, Stat & Modelling Unit, London, England	Public Health England; Public Health England	van Hoek, AJ (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England.	albertjan.vanhoek@phe.gov.uk	Datta, Samik/S-3822-2016		Public Health England	Public Health England	The study was funded by Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2013, EUROSURVEILLANCE, V18, P1; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Curtis L., 2011, UNITS COSTS HLTH SOC; de Greeff SC, 2012, CLIN VACCINE IMMUNOL, V19, P1452, DOI 10.1128/CVI.00229-12; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Miller E, 2000, Commun Dis Public Health, V3, P132; Public Health England, 2013, ENH PERT SURV; Szende A, 2007, EQ 5D VALUE SETS; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030	10	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e111807	10.1371/journal.pone.0111807	http://dx.doi.org/10.1371/journal.pone.0111807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423321	Green Published, Green Submitted, gold			2022-12-27	WOS:000345899700008
J	Vergallo, C; Ahmadi, M; Mobasheri, H; Dini, L				Vergallo, Cristian; Ahmadi, Meysam; Mobasheri, Hamid; Dini, Luciana			Impact of Inhomogeneous Static Magnetic Field (31.7-232.0 mT) Exposure on Human Neuroblastoma SH-SY5Y Cells during Cisplatin Administration	PLOS ONE			English	Article							STABILITY; MEMBRANE; PROTEINS; DRUGS; WATER	Beneficial or adverse effects of Static Magnetic Fields (SMFs) are a large concern for the scientific community. In particular, the effect of SMF exposure during anticancer therapies still needs to be fully elucidated. Here, we evaluate the effects of SMF at induction levels that cisPt-treated cancer patients experience during the imaging process conducted in Low field (200-500 mT), Open field (300-700 mT) and/or inhomogeneous High field (1.5-3 T) Magnetic Resonance Imaging (MRI) machines. Human adrenergic neuroblastoma SH-SY5Y cells treated with 0.1 mu M cisPt (i.e. the lowest concentration capable of inducing apoptosis) were exposed to SMF and their response was studied in vitro. Exposure of 0.1 mu M cisPt-treated cells to SMF for 2 h decreased cell viability (30%) and caused overexpression of the apoptosis-related cleaved caspase-3 protein (46%). Furthermore, increase in ROS (Reactive Oxygen Species) production (23%) and reduction in the number of mitochondria vs controls were seen. The sole exposure of SMF for up to 24 h had no effect on cell viability but increased ROS production and modified cellular shape. On the other hand, the toxicity of cisPt was significantly prevented during 24 h exposure to SMF as shown by the levels of cell viability, cleaved caspase-3 and ROS production. In conclusion, due to the cytoprotective effect of 31.7-232.0 mT SMF on low-cisPt-concentration-treated SH-SY5Y cells, our data suggest that exposure to various sources of SMF in cancer patients under a cisPt regimen should be strictly controlled.	[Vergallo, Cristian; Dini, Luciana] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy; [Ahmadi, Meysam; Mobasheri, Hamid] Univ Tehran, Lab Membrane Biophys & Macromol, Inst Biochem & Biophys, Tehran 131451384, Iran; [Ahmadi, Meysam] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman 76175113, Iran; [Mobasheri, Hamid] Univ Tehran, BRC, Tehran 131451384, Iran	University of Salento; University of Tehran; Kerman University of Medical Sciences; University of Tehran	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy.	luciana.dini@unisalento.it	Mobasheri, Hamid/GYD-7401-2022; Vergallo, Cristian/J-4303-2019; Mobasheri, Hamid/AAX-7520-2020	Vergallo, Cristian/0000-0002-0264-4753; Ahmadi Zeid-abadi, Meysam/0000-0002-4196-2893				Keller GA, 2010, CURR DRUG SAF, V5, P105, DOI 10.2174/157488610789869256; Arcon I, 2004, COLLOID SURFACE B, V33, P199, DOI 10.1016/j.colsurfb.2003.09.007; BAEHNER RL, 1976, BLOOD, V48, P309; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Calabro E, 2013, BIOELECTROMAGNETICS, V34, P618, DOI 10.1002/bem.21815; Chang KT, 2008, COMP MATER SCI, V43, P1048, DOI 10.1016/j.commatsci.2008.02.020; Chen D, 2009, CURR PHARM DESIGN, V15, P777, DOI 10.2174/138161209787582183; Chen WF, 2010, CANCER BIOTHER RADIO, V25, P401, DOI 10.1089/cbr.2009.0743; Chibowski E, 2005, LANGMUIR, V21, P8114, DOI 10.1021/la050575f; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Coffey AM, 2013, J MAGN RESON, V237, P169, DOI 10.1016/j.jmr.2013.10.013; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Dini L, 2010, EXP BIOL MED, V235, P1432, DOI 10.1258/ebm.2010.010122; Dini Luciana, 2009, P409, DOI 10.1007/978-1-4020-9292-3_15; DUDA D, 1991, J TRACE ELEM ELECT H, V5, P181; El-Bialy NS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/189352; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Ghodbane S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/602987; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Gray JR, 2000, BIOELECTROMAGNETICS, V21, P575, DOI 10.1002/1521-186X(200012)21:8<575::AID-BEM3>3.0.CO;2-F; GREENE RF, 1979, AM J HOSP PHARM, V36, P38, DOI 10.1093/ajhp/36.1.38; Health Protection Agency, 2008, RAD EXP MED DIAGN IM, P1; Heinrich A, 2011, J MAGN RESON IMAGING, V34, P758, DOI 10.1002/jmri.22720; Ivanov AI, 1998, J BIOL CHEM, V273, P14721, DOI 10.1074/jbc.273.24.14721; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Knoll C, 2006, LARYNGOSCOPE, V116, P72, DOI 10.1097/01.mlg.0000185596.20207.d2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu Y, 2011, TUMORI, V97, P386, DOI 10.1700/912.10039; Marcuzzi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.112; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Marlin JW, 2010, J CELL DEATH, V3, P23; McEvoy GK, 1992, AM HOSP FORMULARY SE; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Momekov G, 2006, ARCH TOXICOL, V80, P555, DOI 10.1007/s00204-006-0078-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Drug Information Service, 1985, NDIS PROF CISPL; OZEKI S, 1991, J PHYS CHEM-US, V95, P10557, DOI 10.1021/j100179a012; Pagliara P, 2005, EUR J HISTOCHEM, V49, P75; Pashley RM, 2003, J PHYS CHEM B, V107, P1714, DOI 10.1021/jp026744b; Peleg-Shulman T, 2001, BBA-BIOMEMBRANES, V1510, P278, DOI 10.1016/S0005-2736(00)00359-X; Qi H, 2011, BIOELECTROMAGNETICS, V32, P191, DOI 10.1002/bem.20625; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sabo J, 2002, BIOELECTROCHEMISTRY, V56, P227, DOI 10.1016/S1567-5394(02)00027-0; Schaefer DJ, 2000, J MAGN RESON IMAGING, V12, P20, DOI 10.1002/1522-2586(200007)12:1<20::AID-JMRI3>3.3.CO;2-P; Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k; Shalaby TE, 2006, ROMANIAN J BIOPHYS, V16, P229; SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O; Sun RG, 2012, GEN PHYSIOL BIOPHYS, V31, P1, DOI 10.4149/gpb_2012_002; Szczes A, 2011, CHEM ENG PROCESS, V50, P124, DOI 10.1016/j.cep.2010.12.005; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Tofani S, 2003, PHARMACOL RES, V48, P83, DOI 10.1016/S1043-6618(03)00062-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Yoshioka H, 2009, TITLE VOLUME IMAGING, P34	58	37	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2014	9	11							e113530	10.1371/journal.pone.0113530	http://dx.doi.org/10.1371/journal.pone.0113530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU9GL	25423171	Green Published, gold, Green Submitted			2022-12-27	WOS:000345899700039
J	He, W; Hu, CX; Hou, JK; Fan, L; Xu, YW; Liu, MH; Yan, SY; Chen, GQ; Huang, Y				He, Wei; Hu, Chuan-Xi; Hou, Jia-Kai; Fan, Li; Xu, Yi-Wei; Liu, Man-Hua; Yan, Shu-Yang; Chen, Guo-Qiang; Huang, Ying			Microtubule-Associated Protein 1 Light Chain 3 Interacts with and Contributes to Growth Inhibiting Effect of PML	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR-BODIES; SELECTIVE AUTOPHAGY; RAR-ALPHA; CELL-DEATH; ISOFORM IV; ATG8; LC3; LIR; PATHOGENESIS	Previously we reported that the expression of promyelocytic leukemia (PML)-retinoic acid receptor alpha (RAR alpha) fusion gene, which is caused by specific translocation (15; 17) in acute promyelocytic leukemia, can enhance constitutive autophagic activity in leukemic and nonleukemic cells, and PML overexpression can sequestrate part of microtubule-associated protein light chain 3 (LC3) protein in PML nuclear bodies, suggesting that LC3 protein also distributes into nuclei although it is currently thought to function primarily in the cytoplasm, the site of autophagosomal formation. However, its potential significance of nucleoplasmic localizations remains greatly elusive. Here we demonstrate that PML interacts with LC3 in a cell type-independent manner as assessed by Co-IP assay and co-localization observation. Overexpressed PML significantly coprecipitates with endogenous and nuclear LC3 protein. Furthermore, a fraction of endogenous PML protein is found to be co-localized with LC3 protein under steady state condition, which is further enhanced by IFN alpha induction, indicating that PML up-regulation potentiates this interaction. Additionally, DsRed-PML associates with EGFP-LC3 during telophase and G1 phase but not in metaphase and anaphase. Two potential LC3-interacting region (LIR) motifs in PML are required for interaction of PML with LC3 while this association is independent of autophagic activity. Finally, we show that interaction between PML and LC3 contributes to cell growth inhibition function of PML. Considering that PML is an important tumor suppressor, we propose that nuclear portion of LC3 protein may associate with PML to control cell growth for prevention and inhibition of cancer occurrence and development.	[He, Wei; Hu, Chuan-Xi; Fan, Li; Xu, Yi-Wei; Liu, Man-Hua; Chen, Guo-Qiang; Huang, Ying] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China; [Hou, Jia-Kai; Yan, Shu-Yang; Chen, Guo-Qiang] Univ Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Hou, Jia-Kai; Yan, Shu-Yang; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Huang, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Shanghai 200030, Peoples R China.	huangying@shsmu.edu.cn	Hou, Jiakai/ABE-6514-2020; Hou, Jiakai/H-6984-2019	Hou, Jiakai/0000-0003-2875-8756; Hou, Jiakai/0000-0002-5603-810X; chen, guo qiang/0000-0003-4936-2363	National Basic Research Program of China [81372191, 81270620]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (81372191; 81270620 from HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Batty EC, 2012, ADV EXP MED BIOL, V770, P39; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; Brown NJM, 2009, FRONT BIOSCI-LANDMRK, V14, P1684, DOI 10.2741/3333; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Huang Y, 2011, AUTOPHAGY, V7, P1132, DOI 10.4161/auto.7.10.16636; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Jul-Larsen A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-89; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuo HY, 2013, CARCINOGENESIS, V34, P1708, DOI 10.1093/carcin/bgt109; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Maroui MA, 2011, J VIROL, V85, P13164, DOI 10.1128/JVI.05808-11; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakahara F, 2014, INT J HEMATOL; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Palibrk V, 2014, CELL CYCLE, V13, P1749, DOI 10.4161/cc.28653; Pankiv S, 2010, AUTOPHAGY, V6, P550, DOI 10.4161/auto.6.4.11670; Pearson M, 2001, ONCOGENE, V20, P7250, DOI 10.1038/sj.onc.1204856; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Ruthardt M, 1998, ONCOGENE, V16, P1945, DOI 10.1038/sj.onc.1201722; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Seillier M, 2012, CELL DEATH DIFFER, V19, P1525, DOI 10.1038/cdd.2012.30; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Stadler M, 1995, ONCOGENE, V11, P2565; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Yan ZW, 2013, BIOCHEM BIOPH RES CO, V430, P926, DOI 10.1016/j.bbrc.2012.12.052; Yu Y, 2007, J PROTEOME RES, V6, P3808, DOI 10.1021/pr0700100; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113089	10.1371/journal.pone.0113089	http://dx.doi.org/10.1371/journal.pone.0113089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419843	Green Submitted, gold, Green Published			2022-12-27	WOS:000346766900017
J	Lu, L; Shi, WL; Deshmukh, RR; Long, J; Cheng, XL; Ji, WD; Zeng, GH; Chen, XL; Zhang, YJ; Dou, QP				Lu, Li; Shi, Wenli; Deshmukh, Rahul R.; Long, Jie; Cheng, Xiaoli; Ji, Weidong; Zeng, Guohua; Chen, Xianliang; Zhang, Yajie; Dou, Q. Ping			Tumor Necrosis Factor-alpha Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; COMPOUND WITHAFERIN-A; TNF-INDUCED APOPTOSIS; PROSTATE-CANCER; HL-60 CELLS; NUDE-MICE; GOD VINE; IN-VIVO; CELASTROL; DEATH	The inflammatory microenvironment plays an important role in the process of tumor development. Tumor necrosis factor-alpha (TNF-alpha), a key pro-inflammatory cytokine, has a significant role in this process. Natural medicinal products such as Withaferin A (WA) and Celastrol (Cel) have shown anti-cancer and anti-inflammatory properties that can be attributed to multiple mechanisms including, but not limited to, apoptosis induction due to the inhibition of proteasomal activities. This study aimed to investigate the effects of TNF-alpha in combination with WA or Cel in vitro in MDA-MB-231 breast cancer cells. TNF-alpha, when combined with WA or Cel, activated caspase-3 and -9 and downregulated XIAP in a dose-dependent manner, leading to induction of apoptosis in MDA-MB-231 breast cancer cells. The combination also caused accumulation of the proteasomal target protein I kappa B alpha, resulting in inhibition of the nuclear translocation of nuclear factor-kappa B (NF-kappa B). Taken together, these results suggest that TNF-alpha could sensitize breast cancer cells MDA-MB-231 to WA and Cel, at least in part, through inhibiting the activation of NF-kappa B signaling, leading to XIAP inhibition with subsequent upregulation of caspase-3 and -9 activities. Thus, the anti-cancer activities of TNF-alpha are enhanced when combined with the natural proteasome inhibitors, WA or Cel.	[Lu, Li; Shi, Wenli; Cheng, Xiaoli] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Lu, Li; Deshmukh, Rahul R.; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Lu, Li; Deshmukh, Rahul R.; Dou, Q. Ping] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA; [Long, Jie; Chen, Xianliang; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ji, Weidong; Zeng, Guohua] Guangzhou Med Univ, Minimally Invas Surg Ctr, Affiliated Hosp 1, Guangdong Prov Key Lab Urol,Dept Urol, Guangzhou, Guangdong, Peoples R China; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Guangzhou Medical University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Guangzhou Medical University; Guangzhou Medical University; Wayne State University; Wayne State University	Zhang, YJ (corresponding author), Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	yajie.zhang@163.com; doup@karmanos.org	Deshmukh, Rahul R./AAU-1316-2020	Deshmukh, Rahul R./0000-0002-4067-8524; Dou, Qingping/0000-0002-6465-1473	National Cancer Institute [1R01CA20009]; National Natural Science Foundation of China [81101747]; NATIONAL CANCER INSTITUTE [R21CA184788] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Cancer Institute grants (1R01CA20009 to QPD) and the National Natural Science Foundation of China (81101747 to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2007, J CELL BIOCHEM, V102, P580, DOI 10.1002/jcb.21500; Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gupta SV, 2013, CLIN CANCER RES, V19, P2406, DOI 10.1158/1078-0432.CCR-12-2754; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li H, 2005, EUR J PHARMACOL, V512, P231, DOI 10.1016/j.ejphar.2005.02.030; Lu L, 2011, EUR J PHARMACOL, V658, P242, DOI 10.1016/j.ejphar.2011.02.043; Lu L, 2011, ANTICANCER RES, V31, P1; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Nagase M, 2003, BIOSCI BIOTECH BIOCH, V67, P1883, DOI 10.1271/bbb.67.1883; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; SHOHAT B., 1967, CANCER CHEMOTHER REP, V51, P271; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Tao XL, 2001, J RHEUMATOL, V28, P2160; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529	44	21	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113783	10.1371/journal.pone.0113783	http://dx.doi.org/10.1371/journal.pone.0113783			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419573	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900070
J	Peng, XL; Qu, W; Wang, LZ; Huang, BQ; Ying, CJ; Sun, XF; Hao, LP				Peng, Xiao Lin; Qu, Wei; Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping			Resveratrol Ameliorates High Glucose and High-Fat/Sucrose Diet-Induced Vascular Hyperpermeability Involving Cav-1/eNOS Regulation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED WINE POLYPHENOLS; CELL-PROLIFERATION; PERMEABILITY; EXPRESSION; ACTIVATION; CAVEOLAE; PHOSPHORYLATION; TRANSPORT; PROTECTS	Vascular endothelial hyperpermeability is one of the manifestations of endothelial dysfunction. Resveratrol (Res) is considered to be beneficial in protecting endothelial function. However, currently, the exact protective effect and involved mechanisms of Res on endothelial dysfunction-hyperpermeability have not been completely clarified. The aim of present study is to investigate the effects of Res on amelioration of endothelial hyperpermeability and the role of caveolin-1 (Cav-1)/endothelial nitric oxide synthase (eNOS) pathway. Adult male Wistar rats were treated with a normal or high-fat/sucrose diet (HFS) with or without Res for 13 weeks. HFS and in vitro treatment with high glucose increased hyperpermeability in rat aorta, heart, liver and kidney and cultured bovine aortic endothelial cells (BAECs), respectively, which was attenuated by Res treatment. Application of Res reversed the changes in eNOS and Cav-1 expressions in aorta and heart of rats fed HFS and in BAECs incubated with high glucose. Res stimulated the formation of NO inhibited by high glucose in BAECs. Beta-Cyclodextrin (beta-CD), caveolae inhibitor, showed the better beneficial effect than Res alone to up-regulate eNOS phosphorylative levels, while NG-Nitro-77 L-arginine methyl ester (L-NAME), eNOS inhibitor, had no effect on Cav-1 expression. Our studies suggested that HFS and in vitro treatment with high glucose caused endothelial hyperpermeability, which were ameliorated by Res at least involving Cav-1/eNOS regulation.	[Peng, Xiao Lin; Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Peng, Xiao Lin] Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Qu, Wei] Binzhou Med Univ, Dept Hyg, Coll Basic Sci, Yantai, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, Hubei Key Lab Food Nutr & Safety, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Minist Educ, Key Lab Environm & Hlth, Wuhan, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Minist Environm Protect, Wuhan, Peoples R China; [Wang, Lin Zhi; Huang, Bin Qing; Ying, Chen Jiang; Sun, Xiu Fa; Hao, Li Ping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubating, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Binzhou Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hao, LP (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Sch Publ Hlth, Wuhan 430074, Peoples R China.	haolp@mails.tjmu.edu.cn	Ying, Chen/GRX-5695-2022; Ying, Chen Jiang/H-7708-2019	Ying, Chen Jiang/0000-0003-4813-5951	National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China [2008BAI58B06]; National Natural Science Foundation of China [81172657]	National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology R&D Program of the 11th Five year Plan of the People's Republic of China (No. 2008BAI58B06) and the National Natural Science Foundation of China (Grant No. 81172657). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal N, 2012, FOOD CHEM TOXICOL, V50, P415, DOI 10.1016/j.fct.2011.10.037; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cho IJ, 2008, BIOCHEM BIOPH RES CO, V367, P190, DOI 10.1016/j.bbrc.2007.12.140; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Elcioglu KH, 2010, EUR J PHARMACOL, V642, P113, DOI 10.1016/j.ejphar.2010.05.049; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Guo R, 2014, MED SCI MONIT BASIC, V20, P82, DOI 10.12659/MSMBR.890858; Hu P, 2014, EUR J NUTR; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim YH, 2012, ACTA OPHTHALMOL, V90, pE31, DOI 10.1111/j.1755-3768.2011.02243.x; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Napoli R, 2005, METABOLISM, V54, P306, DOI 10.1016/j.metabol.2004.09.010; Nobe K, 2006, J PHARMACOL EXP THER, V318, P530, DOI 10.1124/jpet.106.105015; Nosal R, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/706269; Omar HA, 2012, FUTURE ONCOL, V8, P1503, DOI [10.2217/fon.12.142, 10.2217/FON.12.142]; Onat D, 2011, CURR DIABETES REP, V11, P193, DOI 10.1007/s11892-011-0182-2; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Rathel TR, 2007, J HYPERTENS, V25, P541, DOI 10.1097/HJH.0b013e328013e805; de Quiros ARB, 2007, J SEP SCI, V30, P1262, DOI 10.1002/jssc.200600489; Sanchez JBJ, 2005, J CHROMATOGR A, V1074, P133, DOI 10.1016/j.chroma.2005.03.093; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Schmitt CA, 2009, NITRIC OXIDE-BIOL CH, V21, P77, DOI 10.1016/j.niox.2009.05.006; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Sun SW, 2010, ACTA PHARMACOL SIN, V31, P1336, DOI 10.1038/aps.2010.87; Tian C, 2013, GENES NUTR, V8, P231, DOI 10.1007/s12263-012-0319-1; Wang NS, 2011, AM J PHYSIOL-ENDOC M, V300, pE195, DOI 10.1152/ajpendo.00414.2010; WILLIAMSON JR, 1987, DIABETES, V36, P813, DOI 10.2337/diabetes.36.7.813; Xu Q, 2009, BIOCHEM BIOPH RES CO, V388, P389, DOI 10.1016/j.bbrc.2009.08.021; Yang HL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-22; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zhang Peng, 2014, Genes Cancer, V5, P154; Zhao LN, 2011, J MOL NEUROSCI, V44, P122, DOI 10.1007/s12031-010-9487-x	45	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2014	9	11							e113716	10.1371/journal.pone.0113716	http://dx.doi.org/10.1371/journal.pone.0113716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX2IM	25419974	Green Published, Green Submitted, gold			2022-12-27	WOS:000346766900067
J	Ghosh, P; Naha, A; Pazhani, GP; Ramamurthy, T; Mukhopadhyay, AK				Ghosh, Priyanka; Naha, Arindam; Pazhani, G. P.; Ramamurthy, T.; Mukhopadhyay, Asish K.			Genetic Traits of Vibrio cholerae O1 Haitian Isolates That Are Absent in Contemporary Strains from Kolkata, India	PLOS ONE			English	Article							EL-TOR STRAINS; VARIANT; OUTBREAK; BANGLADESH; BIOTYPE; CTXB; SUSCEPTIBILITY; RESISTANCE; AFRICA; OGAWA	The world's worst cholera epidemic in Haiti (2010) coerced to trace the origin and dissemination of the causative agent Vibrio cholerae O1 for proper management of cholera. Sequence analysis of the Haitian strain showed several variations in the genes encoding cholera toxin B subunit (ctxB); toxin-co-regulated pilus (tcpA), repeat in toxins (rtxA), quinolone resistance-determining region (QRDR) of gyrase A (gyrA), rstB of RS element along with the change in the number of repeat sequences at the promoter region of ctxAB. Our earlier studies showed that variant tcpA (tcpA CIRS) and ctxB (ctxB7) first appeared in Kolkata during 2003 and 2006, respectively. The present study revealed that a variant rtxA was first isolated in Kolkata during 2004 and probably formed the genetic background for the emergence of the ctxB7 allele as we were unable to detect a single strain with the combination of El Tor rtxA and ctxB7. The variant gyrA was first time detected in Kolkata during 1994. The Kolkata strains contained four heptad repeats (TTTTGAT) in their CT promoter regions whereas Haitian strains carried 5 heptad repeats. Haitian strains had 3 nucleotide deletions at the rstB gene, which is a unique feature of the classical biotype strains. But the Kolkata strains did not have such deletion mutations in the rstB. Our study demonstrated the existence of some Haitian genetic traits in Kolkata isolates along with the dissimilarities in genomic content with respect to rstB and ctxAB promoter region. Finally, we conclude that Haitian variant strain may be evolved due to sequential event in the Indian subcontinent strain with some cryptic modification in the genome.	[Ghosh, Priyanka; Naha, Arindam; Pazhani, G. P.; Ramamurthy, T.; Mukhopadhyay, Asish K.] Natl Inst Cholera Enter Dis, Div Bacteriol, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Mukhopadhyay, AK (corresponding author), Natl Inst Cholera Enter Dis, Div Bacteriol, Kolkata, India.	asish_mukhopadhyay@yahoo.com	Mukhopadhyay, Asish/ABE-7697-2020; Ghosh, Priyanka/AAU-2775-2021	NAHA, ARINDAM/0000-0001-6255-7152; Ghosh, Priyanka/0000-0002-4666-7420; Pazhani, Gururaja Perumal/0000-0001-9500-006X	Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Infectious Diseases Japan; Indian Council of Medical Research, government of India; Department of Science & Technology (DST), India [IF110706]	Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Infectious Diseases Japan; Indian Council of Medical Research, government of India(Indian Council of Medical Research (ICMR)); Department of Science & Technology (DST), India(Department of Science & Technology (India))	Funding: This study was supported in part by the Japan Initiative for Global Re-search Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, National Institute of Infectious Diseases Japan, and by the Indian Council of Medical Research, government of India. P.G. acknowledges the Inspire fellowship (IF110706) received from the Department of Science & Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranwal S, 2002, ANTIMICROB AGENTS CH, V46, P2676, DOI 10.1128/AAC.46.8.2676-2678.2002; Centers for Disease Control and Prevention, 2010, LAB TEST RES CHOL OU; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Choi SY, 2010, J MED MICROBIOL, V59, P302, DOI 10.1099/jmm.0.017053-0; Diaz-Quinonez A, 2014, MMWR-MORBID MORTAL W, V63, P552; Dolores J, 2013, MBIO, V4, DOI 10.1128/mBio.00624-12; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; Ghosh P, 2014, J CLIN MICROBIOL, V52, P1020, DOI 10.1128/JCM.03042-13; Goel AK, 2008, J INFECTION, V57, P280, DOI 10.1016/j.jinf.2008.06.015; HASAN NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI DOI 10.1073/pnas.1207359109; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hooper DC, 1998, BBA-GENE STRUCT EXPR, V1400, P45, DOI 10.1016/S0167-4781(98)00127-4; Islam MS, 2009, JAMA-J AM MED ASSOC, V302, P2321, DOI 10.1001/jama.2009.1750; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Krishna BVS, 2006, T ROY SOC TROP MED H, V100, P224, DOI 10.1016/j.trstmh.2005.07.007; Kumar P, 2014, INFECT GENET EVOL, V25, P93, DOI 10.1016/j.meegid.2014.03.020; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Marin MA, 2012, EPIDEMIOL INFECT, V140, P1386, DOI 10.1017/S0950268811001944; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Naha A, 2013, J CLIN MICROBIOL, V51, P1040, DOI 10.1128/JCM.03162-12; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Okada K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030863; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Quilici ML, 2010, EMERG INFECT DIS, V16, P1804, DOI 10.3201/eid1611.100568; Raychoudhuri A, 2009, EMERG INFECT DIS, V15, P131, DOI 10.3201/eid1501.080543; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; UN (United Nations), 2011, FIN REP IND PAN EXP; World Health Organization, 2010, WKLY EPIDEMIOL REC, V86, P325	39	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e112973	10.1371/journal.pone.0112973	http://dx.doi.org/10.1371/journal.pone.0112973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415339	Green Published, gold, Green Submitted			2022-12-27	WOS:000346906600023
J	Jeong, SJ; Lee, HS; Lee, JK; Jeong, JW; Lee, SC; Kim, JH; Hong, SK; Byun, SS; Lee, SE				Jeong, Seong Jin; Lee, Han Sol; Lee, Jeong Keun; Jeong, Jin Woo; Lee, Sang Cheol; Kim, Jeong Hyun; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun			The Long-Term Influence of Body Mass Index on the Success Rate of Mid-Urethral Sling Surgery among Women with Stress Urinary Incontinence or Stress-Predominant Mixed Incontinence: Comparisons between Retropubic and Transobturator Approaches	PLOS ONE			English	Article							FREE VAGINAL TAPE; OBESE; INTERVENTION; OVERWEIGHT; OUTCOMES	Objectives: Mid-urethral sling (MUS) surgery for the treatment of urinary incontinence has been widespread since the introduction of tension-free vaginal tape in the mid-1990s. The majority of studies with short-term follow-up <2 years found no differences in the surgical outcomes according to body mass index (BMI). However, considering the chronic influence of obesity on pelvic floor musculature, it is cautiously speculated that higher BMI could increase stress on pelvic floor and sub-urethral tape, possibly decreasing the long-term success rate in the obese population. We aimed to compare the long-term effects of BMI on the outcomes of MUS between women with retropubic and transobturator approaches. Methods: We performed a retrospective analysis on 243 consecutive women who received MUS and were followed up for >= 36 months. The influence of BMI on the success rates was separately estimated and the factors for treatment failure were examined using logistic regression in either approach. Results: The mean follow-up was 58.4 months, and 30.5% were normal weight, 51.0% overweight, and 18.5% obese. Patients received either the retropubic (30.5%) or transobturator (69.5%) approach. The success rates (%) under the transobturator approach differed according to the BMI groups (94.3, 88.6, and 78.6, respectively; P=0.037) while those under the retropubic approach were not different according to the BMI groups. However, in multivariate models, only the presence of preoperative mixed urinary incontinence (MUI) was proven to be the risk factor for treatment failure in the transobturator approach (OR 6.39, P=0.003). The percent of subjects with MUI was higher in obese women than in non-obese women with the transobturator approach. Conclusions: BMI was not independently associated with failures in either approach. Higher success rates in women with lower BMI in the transobturator approach were attributed to the lower percent of preoperative MUI in those with lower BMI.	[Jeong, Seong Jin; Lee, Han Sol; Lee, Jeong Keun; Jeong, Jin Woo; Lee, Sang Cheol; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Kim, Jeong Hyun] Kangwon Natl Univ Hosp, Dept Urol, Chunchon, South Korea	Seoul National University (SNU); Kangwon National University; Kangwon National University Hospital	Lee, SE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	urojsj@empal.com			Seoul National University Bundang Hospital [06-2013-062]	Seoul National University Bundang Hospital	This study was supported by a grant from Seoul National University Bundang Hospital Research Fund (No. 06-2013-062). SJJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-fattah M, 2010, INT J GYNECOL OBSTET, V110, P18, DOI 10.1016/j.ijgo.2010.02.016; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Al-Ali BM, 2013, WORLD J UROL, V31, P875, DOI 10.1007/s00345-011-0805-x; [Anonymous], 2001, OFF DIS PREV HLTH PR; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Coyne KS, 2006, UROLOGY, V68, P9, DOI 10.1016/j.urology.2006.05.042; Davis TL, 2004, AM J OBSTET GYNECOL, V191, P176, DOI 10.1016/j.ajog.2004.03.085; Delorme E, 2004, EUR UROL, V45, P203, DOI 10.1016/j.eururo.2003.12.001; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Esin S, 2011, J OBSTET GYNAECOL, V31, P645, DOI 10.3109/01443615.2011.597461; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hellberg D, 2007, INT UROGYNECOL J, V18, P423, DOI 10.1007/s00192-006-0162-2; Hunskaar S, 2008, NEUROUROL URODYNAM, V27, P749, DOI 10.1002/nau.20635; Hwang IS, 2012, KOREAN J UROL, V53, P171, DOI 10.4111/kju.2012.53.3.171; Killingsworth LB, 2009, INT UROGYNECOL J, V20, P1103, DOI 10.1007/s00192-009-0909-7; Ku JH, 2006, INT J UROL, V13, P379, DOI 10.1111/j.1442-2042.2006.01302.x; Laurikainen E, 2014, EUR UROL, V65, P1109, DOI 10.1016/j.eururo.2014.01.031; Liu PE, 2011, INT UROGYNECOL J, V22, P259, DOI 10.1007/s00192-010-1311-1; McAchran Sarah E, 2010, Curr Urol Rep, V11, P315, DOI 10.1007/s11934-010-0131-7; Noblett K L, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P323, DOI 10.1007/BF02765589; Paick JS, 2007, J UROLOGY, V178, P985, DOI 10.1016/j.juro.2007.05.026; Petros PE, 1993, SCAND J UROL NE S153, P1; Rechberger T, 2010, INT UROGYNECOL J, V21, P801, DOI 10.1007/s00192-010-1116-2; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Schierlitz L, 2012, OBSTET GYNECOL, V119, P321, DOI 10.1097/AOG.0b013e31823dfc73; STAMEY TA, 1980, ANN SURG, V192, P465, DOI 10.1097/00000658-198010000-00005; Ting BL, 2002, J KOREAN CONTINENCE, V6, P10; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23	29	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2014	9	11							e113517	10.1371/journal.pone.0113517	http://dx.doi.org/10.1371/journal.pone.0113517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MM	25415490	Green Published, Green Submitted, gold			2022-12-27	WOS:000346906600054
J	Dai, LL; Mao, YY; Luo, XM; Shen, YP				Dai, Lin-Lin; Mao, Yuan-Yuan; Luo, Xiao-Ming; Shen, Yue-Ping			Prenatal Care in Combination with Maternal Educational Level Has a Synergetic Effect on the Risk of Neonatal Low Birth Weight: New Findings in a Retrospective Cohort Study in Kunshan City, China	PLOS ONE			English	Article							PRETERM BIRTH; ASSOCIATION; OUTCOMES; INEQUALITIES; ADEQUACY; INDEXES; VISITS	Objectives: To investigate the dose-response relationship and synergetic effect of the maternal educational level and two measures of prenatal care on neonatal low birth weight (LBW) risk. Methods: Data were derived from the Perinatal Health Care Surveillance System (PHCSS) from January 2001 to September 2009 in Kunshan City, Jiangsu province, eastern China, which included data on 31412 women with a normal birth weight delivery and 640 women with a LBW delivery. Logistic modelling was performed to estimate the association including the joint effects with odds ratio (OR) and 95% confidence interval (CI) between the prenatal care measures and LBW risk after adjusting for the potential confounders. The dose-response relationship between the number of prenatal care visits and the risk of LBW was investigated by modeling the quantitative exposure with restricted cubic splines (RCS). Results: There was a significant synergetic effect on the LBW risk between maternal educational attainment and the number of prenatal care visits (chi(2)=4.98, P=0.0257), whereas no significant maternal educational attainment interaction was found with the week of initiation of prenatal care after adjusting for relevant confounding factors (chi(2)=2.04, P=0.1530), and the LBW risk displayed a 'U-shape' curve tendency among the different number of prenatal care visits (P for nonlinearity=0.0002) using RCS. In particular, the ORs were approaching the curve's bottom when the women had 9 or 10 prenatal care visits. Comparing with 5 prenatal care visits, the ORs and 95% CI of LBW risk for 7, 9, 11 and >= 13 visits were 0.92 (0.82-1.03), 0.50 (0.38-0.66), 0.62 (0.47-0.82), and 0.99 (0.61-1.60), respectively. Conclusions: Our findings suggest that appropriate prenatal care, in combination with a higher maternal educational level, can produce a protective interaction effect on LBW risk. Reasonable health resource assignment for different social statuses should be taken into account by policy-makers in developing countries.	[Dai, Lin-Lin; Shen, Yue-Ping] Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China; [Mao, Yuan-Yuan] Kunshan First Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Luo, Xiao-Ming] Kunshan Fourth Peoples Hosp, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Shen, YP (corresponding author), Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China.	shenyueping@suda.edu.cn	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to gratefully acknowledge the work and support of the leaders and health care professionals at all levels responsible for the operation of the Perinatal Health Care Surveillance System in Kunshan City, Jiangsu Province, China. This study was supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Alibekova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084237; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barros H, 1996, J PUBLIC HEALTH MED, V18, P321, DOI 10.1093/oxfordjournals.pubmed.a024513; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE, 1980, IARC SCI PUBL, P5; Cano-Serral Gemma, 2006, Gac Sanit, V20, P25, DOI 10.1157/13084124; Collins JW, 1997, J NATL MED ASSOC, V89, P198; Goldani MZ, 2004, AM J PUBLIC HEALTH, V94, P1366, DOI 10.2105/AJPH.94.8.1366; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hien NT, 2005, TROP DOCT, V35, P103, DOI 10.1258/0049475054036823; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lauderdale Diane S, 2010, Med Care Res Rev, V67, P609, DOI 10.1177/1077558709351530; Li CY, 2008, PUBLIC HEALTH, V122, P243, DOI 10.1016/j.puhe.2007.05.011; Liu Ying-hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1029; Liu YH, 2008, AM J PUBLIC HEALTH, V98, P687, DOI 10.2105/AJPH.2006.088716; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Nwaru BI, 2012, EUR J PUBLIC HEALTH, V22, P776, DOI 10.1093/eurpub/ckr182; Orsini N, 2011, STATA J, V11, P1; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; RUTTER DR, 1990, SOC SCI MED, V30, P553, DOI 10.1016/0277-9536(90)90154-K; VanderWeele TJ, 2009, J CLIN EPIDEMIOL, V62, P438, DOI 10.1016/j.jclinepi.2008.08.001; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005	29	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113377	10.1371/journal.pone.0113377	http://dx.doi.org/10.1371/journal.pone.0113377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	24594907	gold, Green Published, Green Submitted			2022-12-27	WOS:000349145400046
J	Chang, D; Gao, F; Slavney, A; Ma, L; Waldman, YY; Sams, AJ; Billing-Ross, P; Madar, A; Spritz, R; Keinan, A				Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Spritz, Richard; Keinan, Alon			Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI INFECTION; ONLINE MENDELIAN INHERITANCE; INFLAMMATORY-BOWEL-DISEASE; SEX-DIFFERENCES; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; GENDER-DIFFERENCES; QUALITY-CONTROL; CROHNS-DISEASE	Many complex human diseases are highly sexually dimorphic, suggesting a potential contribution of the X chromosome to disease risk. However, the X chromosome has been neglected or incorrectly analyzed in most genome-wide association studies (GWAS). We present tailored analytical methods and software that facilitate X-wide association studies (XWAS), which we further applied to reanalyze data from 16 GWAS of different autoimmune and related diseases (AID). We associated several X-linked genes with disease risk, among which (1) ARHGEF6 is associated with Crohn's disease and replicated in a study of ulcerative colitis, another inflammatory bowel disease (IBD). Indeed, ARHGEF6 interacts with a gastric bacterium that has been implicated in IBD. (2) CENPI is associated with three different AID, which is compelling in light of known associations with AID of autosomal genes encoding centromere proteins, as well as established autosomal evidence of pleiotropy between autoimmune diseases. (3) We replicated a previous association of FOXP3, a transcription factor that regulates T-cell development and function, with vitiligo; and (4) we discovered that C1GALT1C1 exhibits sex-specific effect on disease risk in both IBDs. These and other X-linked genes that we associated with AID tend to be highly expressed in tissues related to immune response, participate in major immune pathways, and display differential gene expression between males and females. Combined, the results demonstrate the importance of the X chromosome in autoimmunity, reveal the potential of extensive XWAS, even based on existing data, and provide the tools and incentive to properly include the X chromosome in future studies.	[Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Chang, Diana; Keinan, Alon] Cornell Univ, Program Computat Biol & Med, Ithaca, NY USA; [Slavney, Andrea; Billing-Ross, Paul; Keinan, Alon] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY USA; [Ma, Li] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Spritz, Richard] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA	Cornell University; Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Anschutz Medical Campus	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	ak735@cornell.edu	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Edward Mallinckrodt, Jr. Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Edward Mallinckrodt, Jr. Foundation	This work was supported in part by National Institutes of Health Grant R01HG006849. AK was also supported by The Ellison Medical Foundation and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arbiza L, 2014, AM J HUM GENET, V94, P827, DOI 10.1016/j.ajhg.2014.04.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek HY, 2007, ANN NY ACAD SCI, V1096, P18, DOI 10.1196/annals.1397.065; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2002, ALCOHOL RES HEALTH, V26, P208; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chang D, 2014, BIORXIV; Chang D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003820; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; Conde L, 2013, BRIT J HAEMATOL, V162, P858, DOI 10.1111/bjh.12438; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamdouch K, 2011, CLIN CHIM ACTA, V412, P2267, DOI 10.1016/j.cca.2011.08.024; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hindorff L., 2013, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jacob S, 2002, J PINEAL RES, V33, P186, DOI 10.1034/j.1600-079X.2002.02943.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang B, 2011, J THEOR BIOL, V277, P67, DOI 10.1016/j.jtbi.2011.01.029; Jin X, 2013, INT J MED SCI, V10, P1479, DOI 10.7150/ijms.6934; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawakami Atsushi, 2002, Medical Electron Microscopy, V35, P1, DOI 10.1007/s007950200000; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai F, 1999, NEUROLOGY, V53, P331, DOI 10.1212/WNL.53.2.331; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li N, 2014, EUR REV MED PHARMACO, V18, P78; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mason KD, 2013, P NATL ACAD SCI USA, V110, P2599, DOI 10.1073/pnas.1215097110; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Moretti S, 2009, HISTOL HISTOPATHOL, V24, P849, DOI 10.14670/HH-24.849; Morrow EH, 2013, EVOL APPL, V6, P1208, DOI 10.1111/eva.12097; Muscat JE, 1996, CANCER RES, V56, P5192; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pohanka M, 2013, CENT EUR J MED, V8, P369, DOI 10.2478/s11536-013-0177-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Selmi C, 2012, AUTOIMMUN REV, V11, pA531, DOI 10.1016/j.autrev.2011.11.024; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stouffer S.A., 1949, ADJUSTMENT ARMY LIFE; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Terry PD, 2009, INFLAMM BOWEL DIS, V15, P134, DOI 10.1002/ibd.20527; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thornton T, 2012, GENET EPIDEMIOL, V36, P438, DOI 10.1002/gepi.21638; THURNHER M, 1992, EUR J IMMUNOL, V22, P1835, DOI 10.1002/eji.1830220724; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weatherhead SC, 2011, J INVEST DERMATOL, V131, P1916, DOI 10.1038/jid.2011.134; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	165	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113684	10.1371/journal.pone.0113684	http://dx.doi.org/10.1371/journal.pone.0113684			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479423	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200028
J	Chang, YM; Chen, LC; Wang, HY; Chiang, CL; Chang, CT; Chung, YC				Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chiang, Chui-Liang; Chang, Chen-Tien; Chung, Yun-Chin			Characterization of an Acidic Chitinase from Seeds of Black Soybean (Glycine max (L) Merr Tainan No. 3)	PLOS ONE			English	Article							ZEA-MAYS; PURIFICATION	Using 4-methylumbelliferyl-beta-D-N, N', N ''-triacetylchitotrioside (4-MU-GlcNAc(3)) as a substrate, an acidic chitinase was purified from seeds of black soybean (Glycine max Tainan no. 3) by ammonium sulfate fractionation and three successive steps of column chromatography. The purified chitinase was a monomeric enzyme with molecular mass of 20.1 kDa and isoelectric point of 4.34. The enzyme catalyzed the hydrolysis of synthetic substrates p-nitrophenyl N-acetyl chitooligosaccharides with chain length from 3 to 5 (GlcNAc(n), n = 3-5), and pNp-GlcNAc(4) was the most degradable substrate. Using pNp-GlcNAc(4) as a substrate, the optimal pH for the enzyme reaction was 4.0; kinetic parameters K-m and k(cat) were 245 mM and 10.31 min(-1), respectively. This enzyme also showed activity toward CM-chitinRBV, a polymer form of chitin, and N-acetyl chitooligosaccharides, an oligomer form of chitin. The smallest oligomer substrate was an N-acetylglucosamine tetramer. These results suggested that this enzyme was an endo-splitting chitinase with short substrate cleavage activity and useful for biotechnological applications, in particular for the production of N-acetyl chitooligosaccharides.	[Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chang, Chen-Tien; Chung, Yun-Chin] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chiang, Chui-Liang] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung, Taiwan	Providence University - Taiwan; Central Taiwan University Science & Technology	Chang, CT (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	ctchang@pu.edu.tw; ycchun@pu.edu.tw	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Science Council of the Republic of China (Taiwan) [NSC-94-2321-B-126-001]	National Science Council of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (Taiwan) (NSC-94-2321-B-126-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, APPL MICROBIOL BIOT; [Anonymous], 1999, CHITIN AND CHITINASE; [Anonymous], 2000, ENZYME MICROB TECHNO; BERKELEY RC, 1972, ANAL BIOCHEM, V46, P687, DOI 10.1016/0003-2697(72)90343-0; Chiang Chui-Liang, 2006, Taiwanese Journal of Agricultural Chemistry and Food Science, V44, P207; Chiang CL, 2005, J AGR FOOD CHEM, V53, P7579, DOI 10.1021/jf040472n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dawson RCM, 1969, DATA BIOCH RES, P483; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hollis T, 1997, ARCH BIOCHEM BIOPHYS, V344, P335, DOI 10.1006/abbi.1997.0225; ISHIGE F, 1991, PLANT CELL PHYSIOL, V32, P681, DOI 10.1093/oxfordjournals.pcp.a078131; Jrudel J, 1989, ANAL BIOCHEM, V178, P62; Koga D, 1999, EXS, V87, P111; Kuo CJ, 2009, BOT STUD, V50, P281; KUROSAKI F, 1989, PHYTOCHEMISTRY, V28, P2989, DOI 10.1016/0031-9422(89)80265-1; Lai LS, 2006, J AGR FOOD CHEM, V54, P8611, DOI 10.1021/jf060888w; LIN ZF, 1992, PROCESS BIOCHEM, V27, P83, DOI 10.1016/0032-9592(92)80014-T; LIU WH, 1968, BIOCHEMISTRY-US, V7, P2886, DOI 10.1021/bi00848a027; MCBRIDE JD, 1993, ELECTROPHORESIS, V14, P165, DOI 10.1002/elps.1150140126; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Park SM, 2002, ENZYME MICROB TECH, V30, P697, DOI 10.1016/S0141-0229(02)00042-X; POWNING RF, 1965, COMP BIOCHEM PHYSIOL, V14, P127, DOI 10.1016/0010-406X(65)90013-7; PUNJA ZK, 1993, J NEMATOL, V25, P526; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; WADSWORTH SA, 1984, J AGR FOOD CHEM, V32, P1284, DOI 10.1021/jf00126a018; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; Yeboah NA, 1998, PLANT MOL BIOL, V36, P407, DOI 10.1023/A:1005921104288	31	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113596	10.1371/journal.pone.0113596	http://dx.doi.org/10.1371/journal.pone.0113596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25479423	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900053
J	Wang, J; Qin, TQ; Chen, JR; Li, YL; Wang, L; Huang, H; Li, J				Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Yulin; Wang, Ling; Huang, He; Li, Jing			Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Article							SERUM URIC-ACID; MUSCLE-CELL-PROLIFERATION; BLOOD-PRESSURE; PREDICTORS; CHINESE; PATHOGENESIS; ASSOCIATION; COHORT; LEVEL; BIAS	Background: Observational studies of the relationship between hyperuricemia and the incidence of hypertension are controversial. We conducted a systematic review and meta-analysis to assess the association and consistency between uric acid levels and the risk of hypertension development. Methods: We searched MEDLINE, EMBASE, CBM (Chinese Biomedicine Database) through September 2013 and reference lists of retrieved studies to identify cohort studies and nested case-control studies with uric acid levels as exposure and incident hypertension as outcome variables. Two reviewers independently extracted data and assessed study quality using Newcastle-Ottawa Scale. Extracted information included study design, population, definition of hyperuricemia and hypertension, number of incident hypertension, effect sizes, and adjusted confounders. Pooled relative risks (RRs) and corresponding 95% confidence intervals (CIs) for the association between hyperuricemia and risk of hypertension were calculated using a random-effects model. Results: We included 25 studies with 97,824 participants assessing the association between uric acid and incident hypertension in our meta-analysis. The quality of included studies is moderate to high. Random-effects meta-analysis showed that hyperuricemia was associated with a higher risk of incident hypertension, regardless of whether the effect size was adjusted or not, whether the data were categorical or continuous as 1 SD/1 mg/dl increase in uric acid level (unadjusted: RR=1.73, 95% CI 1.46 similar to 2.06 for categorical data, RR=1.22, 95% CI 1.03 similar to 1.45 for a 1 SD increase; adjusted: RR=1.48, 95% CI 1.33 similar to 1.65 for categorical data, RR=1.15, 95% CI 1.06 similar to 1.26 for a 1 mg/dl increase), and the risk is consistent in subgroup analyses and have a dose-response relationship. Conclusions: Hyperuricemia may modestly increase the risk of hypertension incidence, consistent with a dose-response relationship.	[Wang, Ji; Qin, Tianqiang; Chen, Jianrong; Li, Jing] Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China; [Li, Yulin] Chengdu Univ, TCM, Affiliated Hosp 2, Chengdu, Peoples R China; [Wang, Ling] Mianyang Peoples Hosp, Dept Cardiol, Mianyang City, Peoples R China; [Huang, He] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University; Chengdu University; Sichuan University	Li, J (corresponding author), Sichuan Univ, West China Hosp, Dept Evidence Based Med & Clin Epidemiol, Chengdu 610064, Peoples R China.	lijing68@hotmail.com		Li, Jing/0000-0003-1191-9971; Norback, Dan/0000-0002-5174-6668				Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2004, KIDNEY INT, V66, P281, DOI 10.1111/j.1523-1755.2004.00729.x; FESSEL WJ, 1980, AM J MED, V68, P401, DOI 10.1016/0002-9343(80)90111-4; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Gaffo AL, 2013, ANN RHEUM DIS, V72, P1321, DOI 10.1136/annrheumdis-2012-201916; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HUNT SC, 1991, HYPERTENSION, V17, P969, DOI 10.1161/01.HYP.17.6.969; Imazu M, 2001, HYPERTENS RES, V24, P531, DOI 10.1291/hypres.24.531; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; KAHN HA, 1972, AM HEART J, V84, P171, DOI 10.1016/0002-8703(72)90331-6; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Mahomed F.-A., 1879, LANCET, V113, P399; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nakanishi N, 1998, J HYPERTENS, V16, P753, DOI 10.1097/00004872-199816060-00006; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; RAO GN, 1991, J BIOL CHEM, V266, P8604; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; SELBY JV, 1990, AM J EPIDEMIOL, V131, P1017, DOI 10.1093/oxfordjournals.aje.a115593; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Wells G.A., NEWCASTLE OTTAWA SCA; [吴云涛 Wu Yuntao], 2010, [中华高血压杂志, Chinese Journal of Hypertension], V18, P545; Yang T, 2012, METABOLISM, V61, P1747, DOI 10.1016/j.metabol.2012.05.006; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang H, 2001, CHIN J HYPERTENS, V9, P160; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891	46	168	190	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114259	10.1371/journal.pone.0114259	http://dx.doi.org/10.1371/journal.pone.0114259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25136984	Green Submitted, Green Published, gold			2022-12-27	WOS:000347114900134
J	Pei, XY; Dai, Y; Felthousen, J; Chen, S; Takabatake, Y; Zhou, L; Youssefian, LE; Sanderson, MW; Bodie, WW; Kramer, LB; Orlowski, RZ; Grant, S				Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Orlowski, Robert Z.; Grant, Steven			Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells	PLOS ONE			English	Article							DOWN-REGULATION; BONE-MARROW; INDUCE APOPTOSIS; UP-REGULATION; FACTOR-I; MCL-1; PHOSPHORYLATION; SURVIVAL; PROTEIN; BIM	The anti-apoptotic protein Mcl-1 plays a major role in multiple myeloma (MM) cell survival as well as bortezomib- and microenvironmental forms of drug resistance in this disease. Consequently, there is a critical need for strategies capable of targeting Mcl-1-dependent drug resistance in MM. The present results indicate that a regimen combining Chk1 with MEK1/2 inhibitors effectively kills cells displaying multiple forms of drug resistance stemming from Mcl-1 up-regulation in association with direct transcriptional Mcl-1 down-regulation and indirect disabling of Mcl-1 anti-apoptotic function through Bim up-regulation and increased Bim/Mcl-1 binding. These actions release Bak from Mcl-1, accompanied by Bak/Bax activation. Analogous events were observed in both drug-naive and acquired bortezomib-resistant MM cells displaying increased Mcl-1 but diminished Bim expression, or cells ectopically expressing Mcl-1. Moreover, concomitant Chk1 and MEK1/2 inhibition blocked Mcl-1 up-regulation induced by IL-6/IGF-1 or co-culture with stromal cells, effectively overcoming microenvironment-related drug resistance. Finally, this regimen down-regulated Mcl-1 and robustly killed primary CD138(+) MM cells, but not normal hematopoietic cells. Together, these findings provide novel evidence that this targeted combination strategy could be effective in the setting of multiple forms of Mcl-1-related drug resistance in MM.	[Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Richmond, VA 23298 USA; [Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA; [Grant, Steven] Inst Mol Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Grant, S (corresponding author), Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	National Institutes of Health [CA100866, CA93738, P50 CA142509-01]; MMRF; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by awards CA100866, CA93738, and P50 CA142509-01 from the National Institutes of Health and the MMRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2010, LEUKEMIA, V24, P851, DOI 10.1038/leu.2010.3; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Dai Y, 2011, BLOOD, V117, P1947, DOI 10.1182/blood-2010-06-291146; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.411; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fulda S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00121; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hu JS, 2012, BLOOD, V119, P826, DOI 10.1182/blood-2011-07-366492; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kale AJ, 2012, J MED CHEM, V55, P10317, DOI 10.1021/jm300434z; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Khoury JD, 2003, J PATHOL, V199, P90, DOI 10.1002/path.1254; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Laubach JP, 2011, J NATL COMPR CANC NE, V9, P1209, DOI 10.6004/jnccn.2011.0098; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; MOALLI PA, 1993, CANCER RES, V53, P3877; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Pagnucco G, 2004, ANN NY ACAD SCI, V1028, P390, DOI 10.1196/annals.1322.047; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Pei XY, 2011, BLOOD, V118, P5189, DOI 10.1182/blood-2011-02-339432; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Schmidmaier R., 2006, Experimental Oncology, V28, P12; Schmidmaier R, 2004, BLOOD, V104, P1825, DOI 10.1182/blood-2003-12-4218; Senderowicz AM, 2000, ONCOGENE, V19, P6600, DOI 10.1038/sj.onc.1204085; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Zhang B, 2003, ONCOGENE, V22, P1848, DOI 10.1038/sj.onc.1206358; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhang J, 2003, ONCOGENE, V22, P6289, DOI 10.1038/sj.onc.1206718	64	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89064	10.1371/journal.pone.0089064	http://dx.doi.org/10.1371/journal.pone.0089064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594907	Green Submitted, Green Published, gold			2022-12-27	WOS:000332475500008
